data_1tba_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tba _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.585 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.61 93.08 9.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 111.233 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.585 ' CD2' ' CD2' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -99.79 23.14 10.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.587 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 3.4 m -52.22 -31.47 32.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.919 -1.113 . . . . 0.0 109.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.493 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -91.9 -26.4 19.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.616 HG12 ' CG1' ' A' ' 28' ' ' ILE . 1.8 mm -50.74 -48.8 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.332 . . . . 0.0 108.944 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.509 ' CD1' ' HG2' ' A' ' 67' ' ' MET . 0.7 OUTLIER -78.69 -10.68 59.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 0.0 110.193 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.46 ' HB2' ' HA2' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -87.99 -15.22 37.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 110.859 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 148.78 81.78 0.04 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.116 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.574 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 33.04 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.067 0.937 . . . . 0.0 112.719 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.616 ' CG1' HG12 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -139.78 165.02 22.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.767 -1.208 . . . . 0.0 109.765 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' GLU . 69.8 m-20 -88.71 126.63 35.41 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.523 ' HB2' HD23 ' A' ' 18' ' ' LEU . 60.0 p -37.74 -28.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.113 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' ASP . 31.0 mt-10 -57.59 -12.7 2.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 110.447 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 13.88 17.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -96.33 115.5 27.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -1.149 . . . . 0.0 109.515 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -89.05 138.72 31.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 109.431 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.897 -1.127 . . . . 0.0 111.506 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.132 0.491 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 26.8 pt-20 -100.85 -21.12 15.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.828 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.438 ' C ' HD13 ' A' ' 56' ' ' ILE . 5.1 mt -102.1 -45.04 5.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 110.694 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.29 -54.36 21.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.381 -0.824 . . . . 0.0 110.056 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -68.52 -19.86 64.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 44.6 m-20 -86.62 -37.88 17.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.53 ' CG2' HG21 ' A' ' 21' ' ' THR . 11.3 mt -52.56 -48.32 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.423 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.11 -22.02 4.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -124.53 8.97 8.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.515 HD23 ' CE1' ' B' ' 190' ' ' PHE . 12.3 mt -75.17 -2.23 26.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.047 . . . . 0.0 110.272 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.72 42.42 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -143.89 13.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.431 HD23 ' CD1' ' B' ' 194' ' ' ILE . 3.7 pp -133.32 -31.9 1.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 110.655 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.37 -40.11 0.05 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.479 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.7 mm? -49.84 -20.53 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -1.226 . . . . 0.0 110.531 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -46.89 -39.9 13.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 109.916 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.9 -51.0 60.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.509 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -72.37 -1.98 17.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 21' ' ' THR . 1.5 tm? -76.46 -60.56 2.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.967 0.889 . . . . 0.0 108.944 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -78.87 0.53 26.87 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.251 0.548 . . . . 0.0 109.993 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.415 ' C ' HG21 ' A' ' 71' ' ' VAL . 5.2 tt0 -88.16 8.55 26.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 111.364 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.54 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.1 t -138.19 1.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.941 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.541 HG12 ' CD2' ' A' ' 18' ' ' LEU . 4.1 tp -149.08 73.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 6.8 p-10 -75.96 55.77 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.173 -0.954 . . . . 0.0 108.843 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.537 ' CD1' ' HB1' ' B' ' 101' ' ' ALA . 6.0 mt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.583 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 35.6 mm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.191 0.52 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 5.3 t 62.11 129.28 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.58 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.47 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 49.8 Cg_endo -77.57 135.46 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 124.026 1.54 . . . . 0.0 110.253 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -97.59 137.77 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.68 135.22 45.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 110.114 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -114.64 -29.96 6.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 1.8 m120 -170.0 171.78 6.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 110.119 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.497 ' N ' ' O ' ' B' ' 126' ' ' ALA . 0.5 OUTLIER -144.6 160.6 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.081 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 20.5 t -134.96 132.37 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.851 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.29 156.21 48.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.33 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' THR . . . . . 0.456 HG21 ' N ' ' B' ' 74' ' ' VAL . 13.5 m -108.7 144.25 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.456 ' N ' HG21 ' B' ' 73' ' ' THR . 8.1 t -132.18 156.89 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 109.961 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -130.15 130.56 44.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' B' ' 80' ' ' LEU . 53.3 mt -82.31 -19.65 38.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . 0.418 ' C ' ' SG ' ' B' ' 78' ' ' CYS . . . 79.75 4.53 89.44 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . 0.418 ' SG ' ' C ' ' B' ' 77' ' ' GLY . 23.1 m -143.66 146.72 33.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -1.181 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.95 153.02 30.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.476 ' CD1' HD11 ' B' ' 76' ' ' LEU . 14.4 mt -132.42 167.62 19.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 2.8 t70 -99.88 94.77 6.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.43 HD21 HG22 ' B' ' 102' ' ' VAL . 26.2 mt -40.94 -46.15 2.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -0.837 . . . . 0.0 110.827 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -54.51 -48.84 71.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.498 HG22 ' CE1' ' B' ' 88' ' ' HIS . 20.1 m -77.57 -38.54 48.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 110.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.435 ' O ' ' HB1' ' B' ' 89' ' ' ALA . 55.3 t -54.73 -47.9 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.062 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.37 -29.56 63.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.023 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 28.5 tp -78.21 -30.16 48.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 109.987 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.498 ' CE1' HG22 ' B' ' 84' ' ' THR . 0.7 OUTLIER -91.5 -25.76 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.945 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' B' ' 85' ' ' VAL . . . -71.01 131.82 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 110.071 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 -69.53 -29.74 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -133.5 79.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -143.31 152.79 42.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -130.3 136.97 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.149 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -125.89 101.54 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 110.386 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.21 110.33 63.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.861 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.82 -15.38 26.67 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.057 1.556 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.45 -15.29 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.651 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -102.65 -43.09 5.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.081 -1.012 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.594 ' CE2' ' HB1' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -165.19 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 111.314 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.29 54.0 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.143 -0.973 . . . . 0.0 111.128 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.594 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -149.42 166.14 29.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.43 HG22 HD21 ' B' ' 82' ' ' LEU . 66.8 t -99.43 166.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.93 . . . . 0.0 109.985 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' B' ' 114' ' ' LEU . 23.1 mm -129.84 107.45 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.38 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.535 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.0 OUTLIER -89.67 164.72 14.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.009 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.71 135.24 6.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 19.0 pt -133.58 159.48 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.795 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' B' ' 108' ' ' GLU . 1.4 ptt180 -102.62 17.65 23.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.523 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' B' ' 107' ' ' ARG . 0.5 OUTLIER -161.05 88.94 1.63 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 110.446 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.3 Cg_endo -75.88 162.37 92.4 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.35 -0.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.36 83.54 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.055 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 124' ' ' THR . 14.6 p -134.05 178.4 6.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 110.272 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.466 HG21 ' CG2' ' B' ' 124' ' ' THR . 5.2 t -131.82 159.24 39.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.428 ' HB1' ' CZ ' ' B' ' 139' ' ' TYR . . . -152.8 155.44 37.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.966 -1.084 . . . . 0.0 110.868 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.533 ' CD1' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -131.66 115.1 15.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.739 . . . . 0.0 109.611 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.37 146.08 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.946 . . . . 0.0 110.753 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 3.5 m-30 -104.51 157.81 16.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.374 -0.829 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.91 -15.43 30.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.353 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 60.2 p -84.8 4.5 32.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.09 -28.59 7.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 3.6 ttmt -67.88 127.91 34.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -1.169 . . . . 0.0 110.116 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' B' ' 74' ' ' VAL . 0.2 OUTLIER -136.03 157.72 46.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.49 HG12 ' CG1' ' A' ' 71' ' ' VAL . 11.4 t -123.06 129.86 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.366 -0.834 . . . . 0.0 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.85 139.55 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.476 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 27' ' ' ASN . 10.2 t -142.6 156.83 45.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.523 ' CA ' ' HB3' ' A' ' 27' ' ' ASN . . . 123.83 -13.89 8.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -76.87 158.71 30.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.117 . . . . 0.0 110.029 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.414 ' C ' ' OG ' ' B' ' 128' ' ' SER . 25.2 mtmt -109.47 -1.15 18.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.278 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -163.89 -170.12 2.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . 0.455 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.0 OUTLIER -68.44 -60.58 2.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -55.86 -31.95 63.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -65.04 -42.1 94.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' B' ' 136' ' ' SER . 0.4 OUTLIER -79.72 -38.69 32.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . 0.423 ' CG ' ' CE2' ' B' ' 155' ' ' PHE . 10.8 mttm -53.1 -39.5 63.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.118 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.4 -47.04 29.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.421 ' HB3' ' HG2' ' B' ' 109' ' ' PRO . . . -53.97 -43.59 70.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.438 ' HB3' HG23 ' B' ' 74' ' ' VAL . 0.9 OUTLIER -62.01 -55.71 26.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -46.21 -44.8 16.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 110.082 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -57.79 -51.35 69.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.535 ' CE1' ' HB3' ' B' ' 104' ' ' MET . 22.7 m-85 -58.2 -57.63 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.463 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -50.28 -31.68 14.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.11 62.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.312 -0.868 . . . . 0.0 109.855 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.425 HD11 ' SD ' ' B' ' 104' ' ' MET . 50.5 mt -45.03 -38.86 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.478 ' CG2' ' CB ' ' B' ' 150' ' ' ALA . 41.0 mm -69.37 -52.73 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.676 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.463 ' NE2' ' O ' ' B' ' 140' ' ' ALA . 16.1 mt-30 -64.97 -28.48 69.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -75.1 -21.2 59.06 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.435 HG22 HD11 ' B' ' 146' ' ' ILE . 3.8 mt -84.29 -21.24 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.74 -22.26 5.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -64.41 179.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.312 . . . . 0.0 111.199 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -113.76 36.35 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.592 -0.692 . . . . 0.0 110.304 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.478 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . . . -60.46 148.33 37.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.97 . . . . 0.0 110.201 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -113.47 -157.97 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.227 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' B' ' 152' ' ' PHE . 1.0 OUTLIER -147.09 77.93 1.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 110.077 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -144.75 178.95 7.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' B' ' 153' ' ' THR . 15.1 t0 66.97 22.3 10.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 110.298 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.423 ' CE2' ' CG ' ' B' ' 133' ' ' LYS . 8.4 t80 -77.38 132.74 38.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -164.97 133.48 3.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.149 -0.969 . . . . 0.0 110.731 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.455 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 33.9 mt -81.2 108.37 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.721 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.09 -2.04 32.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.746 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 8.9 t-20 -152.24 120.36 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.936 -1.103 . . . . 0.0 110.983 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.495 HD13 ' N ' ' B' ' 219' ' ' GLN . 70.8 mt -114.38 137.76 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 109.428 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -106.99 135.28 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 110.798 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.78 177.08 20.77 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.1 OUTLIER -169.65 153.33 4.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.246 . . . . 0.0 110.722 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.47 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 24.6 p -169.11 165.46 11.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 109.824 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 22.4 p-10 -115.94 134.05 55.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.328 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.571 ' HB ' ' CE2' ' B' ' 168' ' ' PHE . 33.6 m -80.06 4.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 110.089 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.59 -4.51 2.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.49 -0.756 . . . . 0.0 111.138 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.571 ' CE2' ' HB ' ' B' ' 166' ' ' VAL . 22.4 p90 -145.91 153.11 49.47 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.9 -1.125 . . . . 0.0 110.532 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 44.0 Cg_endo -71.51 159.72 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.072 1.564 . . . . 0.0 110.329 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.455 HG21 ' N ' ' B' ' 171' ' ' ARG . 2.1 mp -128.38 152.93 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.514 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.455 ' N ' HG21 ' B' ' 170' ' ' ILE . 7.1 mmt180 -82.11 101.45 10.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.81 . . . . 0.0 109.998 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 18.8 mt -55.0 -42.03 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 110.512 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.92 -21.61 59.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.14 -45.52 31.27 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.518 ' HB3' ' CD1' ' B' ' 193' ' ' LEU . 0.1 OUTLIER -67.84 -36.67 80.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.88 61.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.303 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -91.12 -16.37 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' SER . . . . . 0.563 ' OG ' ' CZ ' ' B' ' 237' ' ' PHE . 0.3 OUTLIER -99.59 -33.37 10.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -120.89 37.06 4.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.42 -21.2 6.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' THR . . . . . 0.461 ' O ' ' CG ' ' B' ' 182' ' ' PHE . 16.2 p -87.53 23.47 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' B' ' 181' ' ' THR . 0.9 OUTLIER -169.82 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.282 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 13.5 p -89.98 151.07 21.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.276 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.9 m -128.69 148.73 50.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -158.1 112.6 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.55 104.02 53.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.94 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.35 -3.17 12.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.467 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.8 -7.32 30.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.464 HD21 ' HB2' ' B' ' 190' ' ' PHE . 2.5 tt -148.66 -44.02 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 110.551 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.515 ' CE1' HD23 ' A' ' 59' ' ' LEU . 12.6 t80 -117.12 110.17 41.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . 0.511 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 45.6 Cg_endo -74.79 -12.81 22.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.924 1.486 . . . . 0.0 110.21 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -92.9 179.52 39.77 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' B' ' 175' ' ' LEU . 3.7 tt -115.18 148.34 39.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 110.102 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.431 ' CD1' HD23 ' A' ' 62' ' ' LEU . 4.3 mt -123.3 103.37 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.279 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.496 ' CD1' HD11 ' B' ' 230' ' ' ILE . 27.0 t80 -95.03 120.47 35.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 197' ' ' MET . 1.8 ttp180 -90.03 82.62 6.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.427 ' C ' ' O ' ' B' ' 196' ' ' ARG . 31.2 tpp -42.63 130.16 4.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 14.9 t -70.51 -52.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -143.68 117.11 5.92 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.98 171.89 59.82 Favored 'Cis proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.025 -2.073 . . . . 0.0 110.601 -0.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -82.31 108.69 15.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.138 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' B' ' 222' ' ' GLU . 9.2 mt -150.8 155.95 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.39 131.21 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 109.671 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.491 ' N ' HD11 ' B' ' 204' ' ' LEU . 5.3 mp -119.19 123.04 43.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' B' ' 205' ' ' LEU . 4.4 mm? -94.12 124.04 37.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.448 HG12 HD13 ' B' ' 212' ' ' ILE . 2.5 mp -124.55 122.44 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 95.6 m-85 -110.36 149.84 29.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.47 HG22 HD13 ' B' ' 172' ' ' LEU . 40.8 t -45.73 -24.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.096 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -29.23 70.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.363 -0.836 . . . . 0.0 110.331 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 109.85 2.91 30.31 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 123.61 27.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -1.156 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.494 HD13 HG22 ' B' ' 212' ' ' ILE . 19.4 mm -116.56 125.43 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 4.0 t -110.62 154.82 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.052 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 5.2 mp -141.87 103.35 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -0.884 . . . . 0.0 110.481 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.401 ' O ' HG22 ' B' ' 202' ' ' ILE . 13.3 t -126.66 152.57 46.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.984 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.45 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 106.64 -4.41 36.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' B' ' 223' ' ' ILE . . . -68.87 162.67 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -1.193 . . . . 0.0 110.013 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -114.68 -6.9 12.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.15 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.495 ' N ' HD13 ' B' ' 160' ' ' ILE . 1.9 tt0 -159.66 147.44 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' B' ' 219' ' ' GLN . 20.7 ttm180 -43.85 -37.25 2.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -61.43 -34.07 74.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 110.156 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.461 ' HB3' HD13 ' B' ' 202' ' ' ILE . 6.2 mt-10 -63.73 -53.31 53.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 110.254 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.512 HG12 ' CB ' ' B' ' 217' ' ' ALA . 18.7 mm -57.71 -42.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.408 ' CD1' ' HG2' ' B' ' 65' ' ' PRO . 2.7 m-85 -66.56 -28.84 68.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.107 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 2.6 tt0 -82.4 -50.06 9.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.153 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' B' ' 225' ' ' GLN . . . -45.51 -43.59 11.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.728 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 26.2 t80 -69.69 -41.46 75.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -15.38 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.174 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -92.53 -42.0 9.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 110.027 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.496 HD11 ' CD1' ' B' ' 195' ' ' TYR . 1.5 tp -90.55 -14.74 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.57 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.5 t80 -49.28 -49.72 68.72 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.3 Cg_endo -70.39 -45.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.47 1.247 . . . . 0.0 110.272 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' B' ' 175' ' ' LEU . 22.4 t -49.96 -39.24 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.705 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.33 -50.75 20.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.744 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 14.0 t -55.93 -33.16 64.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.17 -32.38 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.77 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.563 ' CZ ' ' OG ' ' B' ' 178' ' ' SER . 22.5 m-85 -117.36 37.72 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 110.092 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -61.31 171.95 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.127 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.407 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 5.7 tptm -102.49 -47.14 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 110.111 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.662 ' N ' ' CZ ' ' B' ' 99' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.235 0.541 . . . . 0.0 109.825 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -66.91 82.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.174 -0.954 . . . . 0.0 110.762 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.598 ' CD1' ' HB ' ' A' ' 71' ' ' VAL . 0.4 OUTLIER -98.59 -0.16 43.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.08 -1.013 . . . . 0.0 110.706 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.591 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 8.2 m -45.98 -29.34 1.41 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.57 -32.26 5.78 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.63 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -55.81 -43.07 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 108.738 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.471 ' CD1' ' SD ' ' A' ' 67' ' ' MET . 3.4 pp -82.4 -28.71 31.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.545 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -93.36 13.12 22.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.397 -0.814 . . . . 0.0 108.871 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 142.85 94.46 0.2 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.588 ' ND2' ' CD1' ' A' ' 35' ' ' LEU . 7.0 p30 -20.27 132.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.031 0.919 . . . . 0.0 112.39 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.724 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -147.11 163.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 31' ' ' GLU . 80.3 m-20 -87.3 124.2 33.1 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.565 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 5.3 p -37.96 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.793 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.4 mm-40 -55.1 -15.99 2.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 110.164 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.86 27.49 5.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.492 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -123.33 121.22 35.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.098 -1.236 . . . . 0.0 110.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.724 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -94.24 157.8 15.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.759 -1.213 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.588 ' CD1' ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.997 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.274 0.559 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -100.87 -17.73 16.71 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' ILE . 4.0 mt -99.26 -44.24 6.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.436 -0.79 . . . . 0.0 110.384 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.555 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.21 -54.25 42.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 110.085 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -67.41 -22.47 65.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.475 -0.765 . . . . 0.0 110.211 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.58 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 7.0 m-80 -87.4 -28.65 22.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.31 -0.869 . . . . 0.0 109.186 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 12.6 mt -56.93 -48.3 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.462 -0.773 . . . . 0.0 108.981 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.49 -22.09 5.11 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.07 25.76 5.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.847 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.532 ' CB ' HG22 ' A' ' 21' ' ' THR . 6.2 mt -92.79 22.63 4.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.01 . . . . 0.0 109.88 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.38 52.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HG3' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -169.82 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD13 HD21 ' A' ' 59' ' ' LEU . 3.4 mt -112.79 -50.03 2.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 109.805 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.85 -31.11 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER -75.2 0.92 14.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.787 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' LEU . 10.5 t70 -43.71 -41.34 4.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.777 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -46.23 78.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.414 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.471 ' SD ' ' CD1' ' A' ' 24' ' ' LEU . 15.9 ttm -65.99 -9.61 31.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 109.417 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.0 tm? -71.41 -61.73 1.67 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.987 0.899 . . . . 0.0 108.687 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.61 -1.74 26.0 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 11.9 tt0 -85.9 11.59 11.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.272 -0.893 . . . . 0.0 111.347 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.598 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.2 t -144.88 3.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.963 -1.085 . . . . 0.0 110.565 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.595 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 4.1 tp -147.33 74.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.7 54.38 1.8 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.144 -0.972 . . . . 0.0 108.553 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.645 ' CD1' ' CD1' ' B' ' 116' ' ' PHE . 7.5 mt . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 121.564 0.697 . . . . 0.0 110.397 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.481 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.3 mp . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 120.927 0.394 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 5.9 t 63.76 139.4 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 109.987 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.489 ' CB ' HD12 ' B' ' 214' ' ' LEU . 45.1 Cg_endo -72.32 135.67 25.06 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.115 1.587 . . . . 0.0 110.856 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 51.6 m -100.18 136.84 39.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.489 HD21 ' CG2' ' B' ' 160' ' ' ILE . 84.6 mt -70.4 133.79 47.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -130.82 -3.29 4.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 110.348 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.443 ' CB ' ' HB ' ' B' ' 161' ' ' VAL . 0.4 OUTLIER -162.51 126.41 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.332 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.489 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 14.1 mm -115.21 157.17 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 7.7 t -141.82 121.53 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 109.692 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.5 162.88 26.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 110.549 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.1 p -121.85 135.4 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.527 HG12 ' CE1' ' B' ' 152' ' ' PHE . 13.0 t -125.23 148.45 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 17.5 m -118.08 142.19 47.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' B' ' 150' ' ' ALA . 40.6 mt -101.29 -50.86 3.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.075 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.56 -12.5 23.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.46 172.46 9.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' B' ' 117' ' ' ALA . 0.5 OUTLIER -101.71 150.53 23.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.184 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.518 HD21 ' CD1' ' B' ' 148' ' ' PHE . 17.4 mt -126.23 175.78 7.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -0.908 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.59 96.85 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.049 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.571 HD11 ' CE1' ' B' ' 94' ' ' TYR . 17.7 mt -43.87 -41.13 4.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.875 . . . . 0.0 110.329 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.416 ' HE3' ' CD2' ' B' ' 94' ' ' TYR . 12.8 mmtp -55.55 -47.45 76.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 110.343 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -79.91 -41.24 26.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 54.4 t -54.8 -54.59 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.933 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.71 69.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.927 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 34.9 tp -81.84 -25.1 35.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -98.34 -42.27 7.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.127 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -47.6 133.2 13.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.066 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . 0.515 ' HG3' ' N ' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -70.63 -25.28 62.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.515 ' N ' ' HG3' ' B' ' 90' ' ' ARG . 1.2 m-20 -138.7 79.18 1.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.345 -0.847 . . . . 0.0 109.794 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.13 171.9 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.531 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.52 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -157.23 172.01 19.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 110.051 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.571 ' CE1' HD11 ' B' ' 82' ' ' LEU . 18.6 t80 -135.7 129.21 32.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' B' ' 95' ' ' ASN . 6.7 p30 -123.17 102.34 37.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.095 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.32 -26.06 17.83 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.015 1.534 . . . . 0.0 110.479 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -75.43 -20.94 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -100.07 -71.64 0.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -149.3 163.5 37.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 110.402 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.51 47.96 1.24 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 109.305 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.641 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -126.35 144.5 50.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.904 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.518 ' CG2' HD21 ' B' ' 82' ' ' LEU . 6.8 t -90.02 124.95 42.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.52 ' HB ' ' CG ' ' B' ' 93' ' ' GLU . 8.8 mm -88.27 110.35 20.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.857 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.429 ' HB2' HD11 ' B' ' 115' ' ' ILE . 3.1 ttm -106.49 161.08 14.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 110.387 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 0.5 OUTLIER -162.29 126.6 3.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.893 . . . . 0.0 110.293 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.41 HG12 ' OH ' ' B' ' 139' ' ' TYR . 37.4 pt -107.85 176.37 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.981 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -120.04 42.05 3.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' B' ' 107' ' ' ARG . 0.3 OUTLIER 170.7 85.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 48.8 Cg_endo -78.3 160.23 91.81 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.723 -2.199 . . . . 0.0 110.467 -0.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -67.56 105.25 1.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.95 . . . . 0.0 109.777 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' B' ' 124' ' ' THR . 11.2 p -152.85 176.67 11.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.615 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.537 HG21 ' CG2' ' B' ' 124' ' ' THR . 5.3 t -131.37 171.42 13.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -156.74 141.61 17.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.991 -1.068 . . . . 0.0 110.642 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.493 HD13 ' CG1' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -98.53 103.78 15.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.449 -0.782 . . . . 0.0 109.048 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.464 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 4.4 mt -89.76 135.74 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.119 -0.988 . . . . 0.0 110.61 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 74' ' ' LEU . 3.0 m-30 -110.35 150.72 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.102 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.514 ' O ' ' CG ' ' B' ' 79' ' ' ARG . . . -70.05 -10.9 60.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.274 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -7.37 53.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.77 -18.61 40.23 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -88.32 160.07 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -1.183 . . . . 0.0 110.246 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 3.3 ptm -156.69 164.44 38.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.252 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.513 HG13 ' CG1' ' A' ' 71' ' ' VAL . 35.7 t -128.57 161.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 110.485 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.443 ' N ' HG11 ' B' ' 122' ' ' VAL . 53.3 t -138.76 151.23 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.015 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.537 ' CG2' HG21 ' B' ' 112' ' ' THR . 1.2 t -157.23 164.26 37.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 110.344 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.43 ' HA3' HG21 ' B' ' 111' ' ' THR . . . 110.79 -39.2 2.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.489 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -42.48 158.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -1.106 . . . . 0.0 110.317 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -124.05 -6.02 7.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.6 175.44 9.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.146 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.59 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.22 -16.71 5.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.264 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -49.66 32.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -25.06 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 110.422 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -78.91 -26.09 43.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.521 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 7.4 mt -79.12 -49.82 12.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -65.79 -30.83 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 51.0 p -67.97 -60.57 2.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.198 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' B' ' 134' ' ' LEU . 1.4 ptm180 -54.68 -33.19 60.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.006 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.416 ' O ' HG13 ' B' ' 142' ' ' ILE . 0.1 OUTLIER -65.91 -40.78 91.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 0.0 110.074 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 11.7 m-85 -65.98 -49.25 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.489 ' CB ' ' HB2' ' B' ' 152' ' ' PHE . . . -55.62 -30.58 61.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -71.94 -31.68 66.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.48 HG23 HD11 ' B' ' 142' ' ' ILE . 34.5 mt -61.79 -42.7 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.528 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 1.8 mp -67.51 -44.5 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -72.94 -30.05 63.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.655 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -20.11 61.52 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.436 HD12 HG22 ' B' ' 146' ' ' ILE . 3.6 mt -86.14 -24.07 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.72 -26.27 3.65 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.535 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.518 ' CD1' HD21 ' B' ' 80' ' ' LEU . 12.3 m-85 -52.27 158.16 1.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.943 -1.328 . . . . 0.0 110.988 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.65 34.72 2.16 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -68.57 169.6 10.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.352 -0.842 . . . . 0.0 110.421 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.91 112.74 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 110.264 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.527 ' CE1' HG12 ' B' ' 74' ' ' VAL . 83.5 t80 -58.97 108.34 0.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.441 HG21 ' O ' ' B' ' 152' ' ' PHE . 1.4 p -156.18 169.37 24.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' B' ' 153' ' ' THR . 4.2 t70 62.41 28.84 17.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.217 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -70.91 134.02 46.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.953 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.91 131.41 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.496 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.427 ' C ' ' HG2' ' B' ' 158' ' ' GLN . 14.7 mt -82.91 131.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.427 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 3.6 mt-30 -128.76 0.32 5.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.781 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.472 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 2.1 t-20 -147.79 110.11 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.921 -1.112 . . . . 0.0 110.709 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.489 ' CG2' HD21 ' B' ' 67' ' ' LEU . 66.4 mt -113.26 141.35 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.589 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' B' ' 69' ' ' ASN . 72.8 t -115.93 130.05 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.13 -0.981 . . . . 0.0 110.645 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.97 168.3 19.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' B' ' 213' ' ' VAL . 1.0 OUTLIER -166.57 149.44 6.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.262 . . . . 0.0 110.545 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.8 OUTLIER -170.07 170.18 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.021 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 164.08 12.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.032 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.583 ' O ' ' CD2' ' B' ' 168' ' ' PHE . 32.6 m -113.2 11.97 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.279 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.53 -2.25 2.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 26.1 p90 -161.37 150.09 13.09 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.987 -1.071 . . . . 0.0 110.568 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.508 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 47.8 Cg_endo -73.88 170.24 20.53 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.133 1.596 . . . . 0.0 110.732 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.47 HG21 ' N ' ' B' ' 171' ' ' ARG . 4.4 mp -140.36 151.28 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 110.378 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.47 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.3 OUTLIER -80.76 80.27 7.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 109.946 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.468 HD13 ' N ' ' B' ' 208' ' ' VAL . 18.9 mt -47.07 -37.97 10.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 110.42 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.17 -55.27 22.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.24 92.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.469 HD12 ' CG1' ' B' ' 233' ' ' VAL . 18.3 tp -70.12 -39.67 75.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -1.169 . . . . 0.0 110.373 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.64 -26.69 67.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.955 . . . . 0.0 110.18 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -77.01 -30.05 55.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 1.3 p -87.42 -44.64 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -105.72 26.51 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 110.259 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.55 54.85 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.7 m -53.8 -39.03 65.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -1.188 . . . . 0.0 110.433 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.497 ' CE1' HG21 ' B' ' 198' ' ' VAL . 19.9 m-85 -108.26 -26.97 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.401 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.9 p -96.05 158.05 15.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.624 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.2 m -132.43 119.75 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.677 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -125.42 112.13 15.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 110.565 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -118.94 102.55 49.11 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 109.666 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.61 -1.18 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.93 1.489 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -98.95 -3.64 34.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.036 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.415 HD21 ' HB2' ' B' ' 190' ' ' PHE . 0.3 OUTLIER -150.93 -37.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.586 ' CZ ' HD13 ' B' ' 205' ' ' LEU . 7.8 t80 -127.95 110.98 20.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.86 -17.64 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.888 1.467 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.87 -179.94 44.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' B' ' 172' ' ' LEU . 7.6 tt -118.38 130.07 55.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -1.143 . . . . 0.0 110.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.44 HG13 HD12 ' B' ' 205' ' ' LEU . 5.7 mt -102.96 100.94 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 109.914 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -91.79 120.26 32.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.471 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.428 ' HG2' HG21 ' B' ' 203' ' ' VAL . 1.1 mtp180 -92.54 83.45 4.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.457 ' HB2' ' CD1' ' B' ' 204' ' ' LEU . 33.7 tpp -42.11 126.81 3.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.935 . . . . 0.0 110.189 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.497 HG21 ' CE1' ' B' ' 182' ' ' PHE . 61.9 t -63.17 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -137.4 118.13 10.65 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.16 169.54 73.53 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.986 -2.089 . . . . 0.0 110.369 -0.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -76.85 95.35 4.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.044 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.448 HD13 ' HB1' ' B' ' 217' ' ' ALA . 31.8 mm -130.96 149.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.428 HG21 ' HG2' ' B' ' 196' ' ' ARG . 71.4 t -101.83 105.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.032 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' B' ' 197' ' ' MET . 4.5 mp -95.82 118.5 32.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.45 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.586 HD13 ' CZ ' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -89.65 117.41 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 109.935 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.468 HG23 ' CD2' ' B' ' 172' ' ' LEU . 3.2 mt -113.0 136.0 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.351 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.496 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 44.7 m-85 -119.62 145.2 46.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 64.3 t -49.19 -24.36 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -62.67 -38.65 91.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 110.133 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 123.36 8.77 6.29 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -90.06 145.22 25.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.241 . . . . 0.0 110.232 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' B' ' 163' ' ' SER . 30.3 mm -130.05 121.69 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.335 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 57.4 t -113.86 155.74 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.051 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.489 HD12 ' CB ' ' B' ' 65' ' ' PRO . 2.6 mp -140.12 121.94 15.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 110.629 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 6.2 t -137.02 146.48 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.886 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 111.18 3.9 27.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.448 ' HB1' HD13 ' B' ' 202' ' ' ILE . . . -82.99 138.45 33.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -29.27 32.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.45 ' O ' HD13 ' B' ' 160' ' ' ILE . 3.2 tt0 -136.17 -152.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 110.029 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -100.11 -36.89 9.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.432 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.69 -27.38 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.119 -0.988 . . . . 0.0 110.518 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.61 -47.43 54.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.242 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.496 HG22 HD11 ' B' ' 223' ' ' ILE . 40.8 mm -62.63 -37.61 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.29 -29.19 67.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.923 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -37.63 41.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.321 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.365 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.505 ' HA ' ' CG2' ' B' ' 230' ' ' ILE . 27.9 t80 -64.81 -46.54 81.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.394 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.42 -32.68 71.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -85.14 -25.94 27.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.426 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.505 ' CG2' ' HA ' ' B' ' 227' ' ' PHE . 8.7 tp -97.2 -17.94 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.595 ' N ' ' CD ' ' B' ' 232' ' ' PRO . 14.3 t80 -59.63 -41.34 85.76 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.943 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -77.93 -47.22 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.36 1.189 . . . . 0.0 110.384 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.469 ' CG1' HD12 ' B' ' 175' ' ' LEU . 18.4 t -53.49 -50.8 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.724 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.497 ' CD1' HG13 ' B' ' 230' ' ' ILE . 95.7 mt -59.14 -38.13 78.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.833 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 3.4 t -65.53 -39.39 91.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.392 -0.818 . . . . 0.0 109.816 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . 0.508 ' HG2' ' CE1' ' B' ' 237' ' ' PHE . 0.8 OUTLIER -60.14 -33.85 72.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.677 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.508 ' CE1' ' HG2' ' B' ' 236' ' ' GLU . 65.2 m-85 -115.39 37.41 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.827 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -62.52 168.64 3.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 0.0 110.257 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.413 ' HB2' ' C ' ' B' ' 169' ' ' PRO . 0.0 OUTLIER -111.84 -33.32 6.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 110.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.196 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.602 HD21 ' CD2' ' B' ' 99' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 19' ' ' ASP . 1.9 p30 -86.19 109.12 18.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.614 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 3.4 mt -101.17 18.45 19.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.519 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 1.3 m -45.19 -29.86 1.05 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.057 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.441 ' C ' HG23 ' A' ' 28' ' ' ILE . . . -98.44 -27.8 8.4 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.495 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.608 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 1.1 mm -52.36 -45.87 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.912 -1.346 . . . . 0.0 109.359 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 68' ' ' LEU . 2.0 pp -85.86 -26.51 25.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.608 -1.308 . . . . 0.0 109.665 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CD1' HG23 ' B' ' 215' ' ' THR . 0.5 OUTLIER -83.88 7.41 18.22 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 142.61 106.04 0.57 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 6.4 p-10 -24.49 135.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.784 0.802 . . . . 0.0 111.396 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.664 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -150.42 161.77 3.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.553 ' N ' HG12 ' A' ' 28' ' ' ILE . 5.3 m-20 -87.48 119.2 27.52 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.553 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 1.3 p -39.53 -26.69 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.898 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.1 tt0 -57.55 -13.37 3.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.117 -0.989 . . . . 0.0 110.43 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.23 27.71 4.67 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.416 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.5 mmt-85 -120.77 122.19 39.83 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.085 -1.244 . . . . 0.0 109.861 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.664 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 3.1 tt -87.67 162.07 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.933 -1.105 . . . . 0.0 111.738 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.498 HD21 ' N ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 O-C-N 121.472 -0.767 . . . . 0.0 111.355 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.14 0.495 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.503 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -100.28 -22.13 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.349 -0.844 . . . . 0.0 109.469 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.441 HD11 ' CE2' ' A' ' 25' ' ' PHE . 3.7 mt -95.39 -45.21 7.22 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.546 -0.721 . . . . 0.0 110.157 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.544 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -49.5 -52.47 29.21 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.152 -0.968 . . . . 0.0 109.6 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.79 -23.21 66.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 12.5 m-20 -85.83 -33.99 21.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 15.6 mt -54.22 -42.14 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 109.372 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.35 -14.89 35.96 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.444 ' HB3' ' CD1' ' B' ' 189' ' ' LEU . 49.7 m -122.07 0.05 9.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.12 -1.223 . . . . 0.0 110.297 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 1.2 mt -81.38 8.32 9.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -91.18 43.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.494 ' CG ' HD22 ' A' ' 62' ' ' LEU . 5.9 pttt -172.88 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' B' ' 194' ' ' ILE . 3.7 mt -105.15 -43.82 4.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.03 -28.3 0.09 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.525 ' CD1' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -84.53 0.19 50.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -1.212 . . . . 0.0 110.108 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.491 ' HA ' ' HG ' ' A' ' 68' ' ' LEU . 4.7 t70 -50.36 -39.69 47.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 109.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.47 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -58.7 -32.2 68.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.895 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.485 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.45 -26.79 63.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.885 . . . . 0.0 109.74 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.533 ' CD2' HD22 ' A' ' 24' ' ' LEU . 7.4 mt -64.43 -61.7 2.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.725 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.3 pp -58.04 -12.63 3.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.676 -0.64 . . . . 0.0 110.341 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' C ' HG21 ' A' ' 71' ' ' VAL . 2.9 tt0 -87.05 2.75 48.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 110.592 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.58 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.8 t -127.74 -0.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.393 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.614 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.8 tp -150.51 68.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -73.43 56.95 0.52 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.849 -1.157 . . . . 0.0 108.975 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.619 ' CD1' ' CD2' ' B' ' 99' ' ' PHE . 5.6 mt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.693 0.759 . . . . 0.0 110.472 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.487 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 4.2 mt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.156 0.503 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 91.8 t 59.34 142.22 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.436 -0.79 . . . . 0.0 110.301 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.3 Cg_endo -72.97 123.96 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.844 1.444 . . . . 0.0 110.745 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.433 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 9.3 m -92.06 135.0 34.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.476 ' HG ' ' NH2' ' B' ' 220' ' ' ARG . 19.0 mt -69.95 125.41 26.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 110.323 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.423 ' NE2' HG23 ' B' ' 66' ' ' THR . 78.1 mm-40 -101.4 -27.29 13.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -156.14 162.73 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.425 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.517 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 17.0 mm -136.48 150.64 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.794 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 24.1 t -136.76 140.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -143.99 149.4 36.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.909 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.38 128.32 45.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -0.954 . . . . 0.0 110.539 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.417 HG11 ' N ' ' B' ' 75' ' ' THR . 59.0 t -119.67 151.2 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 109.955 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 23.5 m -129.49 142.91 50.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.535 ' CD1' ' CD1' ' B' ' 80' ' ' LEU . 49.4 mt -100.05 -46.2 5.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.18 55.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.5 158.65 43.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -1.178 . . . . 0.0 110.212 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.451 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -80.13 142.96 34.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.535 ' CD1' ' CD1' ' B' ' 76' ' ' LEU . 25.7 mt -116.65 153.68 31.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.423 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' B' ' 82' ' ' LEU . 8.2 t0 -96.93 86.9 4.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.45 HD23 HG22 ' B' ' 102' ' ' VAL . 8.6 mt -40.66 -43.62 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.845 . . . . 0.0 110.362 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -54.13 -45.45 71.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.94 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 14.7 m -81.02 -44.5 17.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.96 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' B' ' 148' ' ' PHE . 40.8 t -54.94 -43.08 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 110.159 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.86 -25.59 48.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.69 -33.49 20.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.213 -0.929 . . . . 0.0 110.124 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.0 m80 -83.22 -44.83 14.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' B' ' 85' ' ' VAL . . . -53.31 141.84 22.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.089 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . 0.41 ' O ' ' OD1' ' B' ' 91' ' ' ASN . 21.7 mtt85 -81.05 -15.44 56.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.483 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' B' ' 104' ' ' MET . 16.0 m-20 -139.54 79.94 1.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' B' ' 93' ' ' GLU . . . -152.95 161.91 41.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' B' ' 92' ' ' ALA . 37.7 mt-10 -142.46 161.61 37.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 110.132 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -152.04 130.56 12.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.928 . . . . 0.0 110.324 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.41 122.99 6.28 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.11 -16.71 28.56 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.908 1.478 . . . . 0.0 110.343 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -77.78 -9.73 59.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -109.3 -59.94 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.261 -0.899 . . . . 0.0 110.137 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.619 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -163.07 -159.23 0.53 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.496 -0.753 . . . . 0.0 110.704 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.489 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -121.38 49.8 1.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 111.602 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.608 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -143.57 163.77 32.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.45 HG22 HD23 ' B' ' 82' ' ' LEU . 90.0 t -101.41 136.93 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.509 HD13 ' CZ ' ' B' ' 99' ' ' PHE . 3.1 mp -106.03 111.34 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.369 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.481 ' HE2' ' CD1' ' B' ' 115' ' ' ILE . 14.6 ttm -94.53 170.52 9.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.323 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -157.56 113.15 2.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.502 HG21 ' CE1' ' B' ' 139' ' ' TYR . 48.3 pt -101.29 170.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' B' ' 108' ' ' GLU . 5.3 mmt85 -124.93 46.32 2.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 0.0 110.291 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' B' ' 107' ' ' ARG . 0.0 OUTLIER 175.27 79.21 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 0.0 110.338 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -81.63 161.56 79.77 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.756 -2.185 . . . . 0.0 110.473 -0.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.15 106.38 1.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -147.27 177.5 9.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.645 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.7 m -124.57 159.14 31.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.474 ' HB3' ' CE2' ' B' ' 139' ' ' TYR . . . -147.48 138.35 23.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 110.41 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' B' ' 121' ' ' MET . 8.0 mt -98.46 120.51 39.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 109.723 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.481 ' CD1' ' HE2' ' B' ' 104' ' ' MET . 3.6 mt -111.97 115.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.985 . . . . 0.0 110.375 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 3.6 m-30 -94.93 168.32 10.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.451 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -78.41 -13.52 59.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.4 t -81.05 -7.81 59.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.79 -26.27 20.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -56.2 149.74 15.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -1.135 . . . . 0.0 110.096 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 1.7 tmm? -148.66 128.82 13.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.533 ' CG1' HG13 ' A' ' 71' ' ' VAL . 73.4 t -114.91 128.1 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.501 HG11 ' N ' ' B' ' 124' ' ' THR . 97.2 t -112.86 151.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.349 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.501 ' N ' HG11 ' B' ' 123' ' ' VAL . 1.8 t -155.09 164.42 38.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 109.983 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.569 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 110.83 -34.84 5.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.528 ' HB3' ' CA ' ' B' ' 132' ' ' SER . . . -42.24 149.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -1.148 . . . . 0.0 110.442 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -3.19 30.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.475 ' N ' HG13 ' B' ' 70' ' ' ILE . 3.0 m -167.17 -163.23 0.51 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . 0.401 ' HA ' HD13 ' B' ' 157' ' ' ILE . 3.1 mt-10 -78.24 -44.65 24.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.316 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.11 -26.1 66.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 110.387 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.93 -58.29 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.885 . . . . 0.0 110.286 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.528 ' CA ' ' HB3' ' B' ' 126' ' ' ALA . 2.2 m -47.57 -40.01 18.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 12.2 mttt -60.24 -51.06 71.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.467 ' O ' ' HG3' ' B' ' 137' ' ' ARG . 39.6 mt -62.88 -32.81 74.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -74.3 -41.1 61.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.271 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 3.6 p -65.7 -52.09 54.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.499 ' HB2' ' CZ ' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -55.15 -34.1 63.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.449 ' HD3' ' HD2' ' B' ' 137' ' ' ARG . 7.0 mptt -65.42 -36.67 84.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 110.032 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.502 ' CE1' HG21 ' B' ' 106' ' ' ILE . 31.4 m-85 -71.41 -52.3 19.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.875 . . . . 0.0 110.04 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.74 64.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.087 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -40.71 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.447 HD11 ' SD ' ' B' ' 104' ' ' MET . 24.6 mt -59.37 -54.93 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.517 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 10.0 mt -55.73 -46.61 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 35.0 mt-30 -66.26 -35.24 79.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' B' ' 145' ' ' LYS . 10.1 tttm -71.55 -21.05 61.94 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mt -83.31 -18.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.88 -21.37 12.43 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' B' ' 85' ' ' VAL . 12.3 m-85 -57.55 172.6 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.278 . . . . 0.0 111.016 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.54 54.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.75 . . . . 0.0 110.328 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.517 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -90.74 130.57 36.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 110.423 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -121.85 119.28 31.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 17.0 t80 -60.79 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -140.6 171.35 14.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 110.227 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' B' ' 153' ' ' THR . 56.5 m-20 58.37 19.32 6.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.367 -0.833 . . . . 0.0 110.559 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.49 ' HB2' ' CE1' ' B' ' 152' ' ' PHE . 15.1 t80 -68.69 136.79 53.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.92 136.5 1.93 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 70.7 mt -79.29 124.51 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -118.5 -8.81 10.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.114 -0.991 . . . . 0.0 110.992 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 30.4 t30 -148.98 134.42 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.783 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.402 HG12 ' CD1' ' B' ' 70' ' ' ILE . 60.0 mt -129.4 142.85 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.747 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.1 135.75 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.985 . . . . 0.0 110.55 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -136.94 173.11 22.32 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.3 t -164.82 151.18 10.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -1.184 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.453 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.0 p -170.21 146.57 2.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.03 169.53 9.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.962 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.31 -83.33 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -176.01 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' B' ' 238' ' ' ARG . 14.8 p90 -131.8 159.45 71.92 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.363 -0.836 . . . . 0.0 109.576 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.474 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -71.34 152.19 60.74 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.873 1.46 . . . . 0.0 110.146 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.26 148.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.561 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -86.88 106.45 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.934 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.505 HD21 ' CB ' ' B' ' 193' ' ' LEU . 21.9 mt -63.23 -59.91 4.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.342 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 23.5 pt-20 -50.19 -33.85 20.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . 0.456 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -72.96 -41.57 48.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' B' ' 179' ' ' HIS . 9.7 tp -80.23 -32.28 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -1.119 . . . . 0.0 110.23 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -73.95 -24.3 59.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 110.178 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -79.14 -42.61 25.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 t -78.74 -52.19 8.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.14 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.443 ' HB2' HD13 ' B' ' 175' ' ' LEU . 29.7 m170 -93.41 13.48 21.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.072 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -46.42 -32.97 5.63 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.8 t -54.08 -24.15 16.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -1.221 . . . . 0.0 110.378 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.567 ' CE1' ' CG2' ' B' ' 198' ' ' VAL . 26.4 m-85 -133.05 13.63 4.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 58.8 m -129.65 150.38 51.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.281 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.92 133.94 53.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.495 ' O ' ' CD2' ' B' ' 185' ' ' TYR . 26.4 t80 -150.45 102.61 3.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.101 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' B' ' 190' ' ' PHE . 1.3 mt-10 -113.31 115.26 47.56 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 110.091 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.82 -1.49 10.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.403 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -100.27 6.82 44.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 58' ' ' SER . 0.4 OUTLIER -166.36 -38.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 110.386 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.516 ' CZ ' HD22 ' A' ' 59' ' ' LEU . 1.8 t80 -118.65 114.05 36.08 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.4 -31.12 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.863 1.454 . . . . 0.0 110.568 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.449 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.96 -179.72 44.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.505 ' CB ' HD21 ' B' ' 172' ' ' LEU . 8.5 tt -113.42 133.78 55.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -1.125 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 62' ' ' LEU . 53.0 mt -100.68 109.11 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.491 ' CD2' HD12 ' B' ' 230' ' ' ILE . 15.4 t80 -99.69 114.15 27.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -90.63 98.47 11.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.104 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' B' ' 226' ' ' ALA . 0.5 OUTLIER -56.73 131.09 48.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.419 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.567 ' CG2' ' CE1' ' B' ' 182' ' ' PHE . 13.2 t -70.82 -48.75 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.061 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 6.9 tttm -144.29 117.03 5.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.7 Cg_endo -72.79 163.18 89.58 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.931 -2.112 . . . . 0.0 110.63 0.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.492 ' O ' ' CD1' ' B' ' 202' ' ' ILE . 0.0 OUTLIER -70.94 99.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' B' ' 201' ' ' LYS . 37.6 mm -143.65 145.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.06 141.47 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.704 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 133.99 50.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.042 -1.036 . . . . 0.0 110.716 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.466 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 2.6 mm? -103.32 116.6 32.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.449 HG13 HD11 ' B' ' 212' ' ' ILE . 3.5 mp -114.3 120.73 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.09 -1.006 . . . . 0.0 110.406 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' B' ' 209' ' ' SER . 66.9 m-85 -110.88 143.76 40.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 110.208 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.474 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 17.2 t -44.11 -25.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 207' ' ' PHE . 25.2 m -59.94 -38.33 82.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.31 -0.869 . . . . 0.0 110.36 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 115.83 13.91 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.61 133.39 44.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.023 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.449 HD11 HG13 ' B' ' 206' ' ' ILE . 29.0 mm -118.52 136.68 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.941 . . . . 0.0 110.429 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 4.6 t -119.93 155.51 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 109.921 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.435 HD11 ' N ' ' B' ' 214' ' ' LEU . 4.9 mp -134.34 123.2 23.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.975 . . . . 0.0 110.376 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.584 HG23 ' CD1' ' A' ' 25' ' ' PHE . 8.3 t -141.27 147.57 38.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.07 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.92 5.82 43.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.453 ' HB1' HD12 ' B' ' 223' ' ' ILE . . . -89.08 134.6 33.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -1.124 . . . . 0.0 110.119 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -27.34 48.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.363 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.22 163.0 33.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.267 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . 0.505 ' CG ' ' CE1' ' B' ' 224' ' ' TYR . 4.9 ttm180 -65.54 -20.58 66.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 110.119 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -54.67 -44.32 73.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 226' ' ' ALA . 30.1 mt-10 -72.71 -39.98 66.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.911 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.453 HD12 ' HB1' ' B' ' 217' ' ' ALA . 34.0 mm -57.91 -41.51 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.891 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' B' ' 220' ' ' ARG . 10.1 m-85 -79.04 -47.22 16.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.103 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -65.54 -42.72 91.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' B' ' 222' ' ' GLU . . . -57.47 -44.54 84.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.606 ' CZ ' ' CE2' ' B' ' 231' ' ' TYR . 32.6 t80 -67.6 -28.66 67.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.145 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.27 -19.18 61.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.108 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.77 -31.86 15.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.491 HD12 ' CD2' ' B' ' 195' ' ' TYR . 9.2 tp -85.51 -22.61 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.606 ' CE2' ' CZ ' ' B' ' 227' ' ' PHE . 0.3 OUTLIER -40.89 -50.95 7.45 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.963 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.1 Cg_endo -69.22 -42.2 4.19 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.428 1.225 . . . . 0.0 110.633 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.43 ' CG1' HD13 ' B' ' 230' ' ' ILE . 24.4 t -53.66 -40.36 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.551 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 74.0 mt -61.25 -45.02 96.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 22.9 t -64.64 -46.71 81.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -35.91 49.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -108.58 38.56 2.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.467 ' HB3' ' CE1' ' B' ' 168' ' ' PHE . 1.0 OUTLIER -89.05 149.31 23.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -94.21 -60.16 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.5 mmm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.225 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HB2' ' CD2' ' B' ' 99' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.41 105.42 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 111.194 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.553 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 6.8 mt -117.97 3.64 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.958 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.529 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 6.2 m -38.44 -30.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.679 0.752 . . . . 0.0 109.549 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.515 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -100.55 -31.49 5.78 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.559 ' CA ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -56.32 -43.36 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.074 -1.251 . . . . 0.0 108.762 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.518 ' CD1' ' HG2' ' A' ' 67' ' ' MET . 1.8 pp -80.78 6.34 13.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 108.977 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -110.65 -18.08 13.24 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.544 -0.723 . . . . 0.0 111.034 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 158.3 67.02 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 C-N-CA 118.448 -1.834 . . . . 0.0 111.59 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' B' ' 125' ' ' GLY . 4.0 m120 41.28 111.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.943 . . . . 0.0 113.271 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.769 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -156.02 151.44 9.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLU . 12.6 m-20 -89.06 137.09 32.63 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.584 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . 83.3 p -39.81 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.241 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -48.6 -21.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.6 29.5 5.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.33 131.5 54.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.122 -1.222 . . . . 0.0 110.085 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.769 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -101.86 139.16 37.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.546 ' CG ' ' HB3' ' A' ' 27' ' ' ASN . 2.8 pp . . . . . 0 N--CA 1.491 1.593 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.419 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.184 0.516 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 18.3 tp10 -97.49 -25.46 15.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.014 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.45 ' C ' HD13 ' A' ' 56' ' ' ILE . 5.9 mt -110.01 -44.94 3.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.626 -0.672 . . . . 0.0 110.055 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.02 -45.77 3.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.578 0.704 . . . . 0.0 109.984 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.27 -50.62 63.09 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 58' ' ' SER . 64.0 m-20 -58.72 -38.77 79.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 109.174 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.541 ' N ' HD11 ' A' ' 59' ' ' LEU . 8.0 mt -50.91 -40.14 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.096 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -12.97 48.71 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -125.09 -0.24 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -1.12 . . . . 0.0 110.344 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.541 HD11 ' N ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -80.52 51.86 1.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 24.3 t -134.06 50.24 2.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.887 . . . . 0.0 110.273 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 60' ' ' SER . 5.3 pttp 179.34 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.087 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.52 HD11 ' N ' ' A' ' 63' ' ' GLY . 1.1 pp -140.26 -29.54 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.054 -1.029 . . . . 0.0 111.146 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.52 ' N ' HD11 ' A' ' 62' ' ' LEU . . . 178.5 -48.99 0.09 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 HD12 ' A' ' 62' ' ' LEU . 1.1 pp -82.95 -5.27 58.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.264 . . . . 0.0 110.812 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.7 t70 -44.47 -35.35 2.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.66 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -63.8 -47.04 82.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 0.0 109.619 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.518 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 7.1 ttp -65.02 -10.92 33.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.692 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 21' ' ' THR . 4.9 tt -73.35 -61.27 1.88 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 65' ' ' ASP . 1.1 pp -73.78 0.86 11.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 109.939 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -91.78 15.28 13.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 0.0 110.796 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 1.6 t -130.43 0.35 2.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.917 0.865 . . . . 0.0 109.016 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.58 HG12 ' HB3' ' A' ' 18' ' ' LEU . 1.3 tp -151.0 76.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 5.4 t0 -75.09 57.09 0.81 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.383 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.608 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 8.5 mt . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.469 -0.769 . . . . 0.0 110.572 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 29.6 mt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.262 0.553 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.528 HG13 ' CE1' ' B' ' 224' ' ' TYR . 3.0 t 65.8 142.64 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 110.383 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.47 ' HG3' ' O ' ' B' ' 223' ' ' ILE . 46.8 Cg_endo -75.96 137.88 20.17 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.098 1.578 . . . . 0.0 110.317 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.427 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 49.1 m -97.66 132.61 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 44.4 mt -69.72 120.61 15.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.961 . . . . 0.0 109.826 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' B' ' 66' ' ' THR . 25.2 mm-40 -110.4 -14.04 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.443 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 1.7 t30 -162.56 144.52 10.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.987 . . . . 0.0 110.812 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.55 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 6.0 mm -126.35 150.75 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 109.333 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.74 126.29 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.011 -1.056 . . . . 0.0 110.549 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.83 170.75 15.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 110.05 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -141.2 145.26 35.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 t -127.97 155.74 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 25.9 m -106.0 129.64 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.458 ' CD2' ' HB2' ' B' ' 150' ' ' ALA . 72.8 mt -84.29 -69.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.89 28.39 2.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . 0.45 ' SG ' ' HB1' ' B' ' 149' ' ' ALA . 39.8 t -164.02 152.1 12.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.455 ' O ' HD22 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -73.23 139.81 46.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.455 HD22 ' O ' ' B' ' 79' ' ' ARG . 28.9 mt -118.28 140.21 50.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 110.385 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 94.92 9.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.881 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.486 HD21 ' CG2' ' B' ' 102' ' ' VAL . 14.4 mt -44.05 -52.67 6.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.365 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -49.86 -43.46 49.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.028 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 28.0 m -76.27 -48.84 18.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 0.0 110.129 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.84 -47.81 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' B' ' 102' ' ' VAL . . . -67.36 -23.56 65.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 tp -75.61 -42.22 52.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -88.26 -31.79 18.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' B' ' 92' ' ' ALA . . . -57.05 109.84 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.87 -22.35 66.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.052 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.48 ' ND2' ' HG3' ' B' ' 105' ' ' ARG . 2.4 t-20 -134.08 79.63 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' B' ' 89' ' ' ALA . . . -149.0 163.07 38.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -144.91 127.05 15.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.187 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -114.6 125.58 53.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.218 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.75 106.0 20.73 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.231 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.94 -21.78 20.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.033 1.544 . . . . 0.0 110.241 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -82.4 8.38 11.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.085 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.522 ' HB3' ' CD2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER -131.27 -70.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 18' ' ' LEU . 24.4 p90 -134.74 -173.62 3.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.046 . . . . 0.0 110.436 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 64.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.608 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -159.29 177.0 11.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.298 -0.876 . . . . 0.0 110.566 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.486 ' CG2' HD21 ' B' ' 82' ' ' LEU . 92.2 t -119.13 124.93 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.563 HD13 ' CZ ' ' B' ' 99' ' ' PHE . 5.5 mt -89.66 107.36 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.504 ' HB3' ' CD1' ' B' ' 115' ' ' ILE . 37.8 ttm -108.31 151.14 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.48 ' HG3' ' ND2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -139.23 145.36 39.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.552 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 15.0 pt -111.66 175.35 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.136 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.6 mtt180 -116.73 26.73 9.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 110.408 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 1.5 tm-20 -175.88 87.13 0.29 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.752 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.45 153.38 91.59 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.759 -2.184 . . . . 0.0 110.242 -0.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.6 OUTLIER -67.11 104.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 0.0 109.915 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' B' ' 124' ' ' THR . 68.0 p -146.75 176.87 9.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.925 . . . . 0.0 110.566 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.448 HG23 HD12 ' A' ' 23' ' ' ILE . 1.2 m -115.76 144.18 44.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.558 ' HB3' ' CE2' ' B' ' 139' ' ' TYR . . . -135.21 129.58 33.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.959 -1.088 . . . . 0.0 110.885 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.575 ' N ' ' CD2' ' B' ' 114' ' ' LEU . 3.5 mm? -89.59 120.49 30.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.044 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.504 ' CD1' ' HB3' ' B' ' 104' ' ' MET . 1.6 mp -108.92 122.92 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' B' ' 120' ' ' LYS . 3.6 m-30 -96.49 149.04 22.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.71 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.51 -6.0 27.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.961 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.4 p -86.91 -16.77 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.424 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 119.31 -26.88 7.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 4.0 mttt -78.44 145.45 35.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -1.194 . . . . 0.0 110.157 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 7.3 ptt? -152.26 151.51 31.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 110.204 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.487 HG23 ' CG1' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -110.47 162.38 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.902 . . . . 0.0 109.771 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.453 HG21 ' O ' ' B' ' 122' ' ' VAL . 12.7 t -145.2 119.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.52 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 10.2 t -113.56 151.33 31.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.91 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.563 ' N ' ' OD1' ' A' ' 27' ' ' ASN . . . 118.45 -31.48 5.58 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.407 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.55 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -39.92 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.0 110.305 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -104.4 -16.13 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.185 -0.947 . . . . 0.0 109.741 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 7.2 t -169.22 175.24 5.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.92 . . . . 0.0 110.043 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.07 -40.63 73.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.3 -47.12 65.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' B' ' 127' ' ' LYS . 15.8 t0 -58.17 -55.01 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 110.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' B' ' 126' ' ' ALA . 8.7 t -49.46 -47.43 48.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' B' ' 133' ' ' LYS . 1.3 tppt? -49.83 -40.48 42.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.41 -46.26 41.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.38 53.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -53.35 44.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.812 . . . . 0.0 110.067 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.09 -38.7 5.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.116 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -62.93 -56.39 17.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' B' ' 113' ' ' ALA . 51.6 m-85 -56.03 -47.54 77.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.855 . . . . 0.0 109.976 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.94 -24.72 54.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.012 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 19.0 ttt180 -77.32 -51.84 10.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.436 ' O ' HG13 ' B' ' 146' ' ' ILE . 7.1 mt -45.75 -36.79 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' B' ' 150' ' ' ALA . 34.8 mm -76.48 -52.79 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.82 -32.0 73.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.62 -26.15 60.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.436 HG13 ' O ' ' B' ' 142' ' ' ILE . 11.3 mt -77.71 -24.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.86 -21.16 6.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -57.82 178.6 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.277 . . . . 0.0 110.944 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . 0.45 ' HB1' ' SG ' ' B' ' 78' ' ' CYS . . . -113.89 45.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.528 -0.733 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' B' ' 76' ' ' LEU . . . -81.59 109.84 16.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 110.475 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.453 ' O ' HD21 ' B' ' 76' ' ' LEU . 6.2 tttp -85.34 -170.28 3.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.136 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -136.75 103.53 5.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.0 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -166.41 169.5 13.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.875 . . . . 0.0 110.308 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' B' ' 153' ' ' THR . 8.2 t0 69.58 10.99 7.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.818 . . . . 0.0 110.63 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.406 ' CE2' ' HD3' ' B' ' 133' ' ' LYS . 39.8 t80 -48.25 151.64 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 142.85 3.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.539 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.444 HG22 HD11 ' B' ' 157' ' ' ILE . 42.7 mm -79.75 149.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 109.951 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -118.87 -60.18 1.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -143.07 169.28 17.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 110.643 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.518 HD13 ' CA ' ' B' ' 219' ' ' GLN . 45.4 mt -140.87 138.01 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 109.775 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 26.1 t -110.47 129.42 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.06 174.82 18.22 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.38 146.21 3.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -1.209 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.5 OUTLIER -170.65 150.46 3.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.94 165.46 12.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -110.11 -83.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 179.65 -29.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.232 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 3.5 p90 -134.43 158.22 75.66 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.464 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.3 Cg_endo -71.88 159.91 49.2 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.998 1.525 . . . . 0.0 110.588 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.0 151.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.459 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 2.1 ptm180 -87.61 103.66 15.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.505 ' HB3' ' CE1' ' B' ' 185' ' ' TYR . 12.7 mt -53.54 -33.16 53.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.28 -43.35 95.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.66 -29.32 73.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' B' ' 179' ' ' HIS . 0.1 OUTLIER -79.32 -32.03 43.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -1.096 . . . . 0.0 110.068 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.499 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -87.0 -25.53 24.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.91 -39.6 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 29.9 t -84.73 -38.84 19.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' B' ' 175' ' ' LEU . 69.4 m80 -107.27 15.4 25.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -44.61 -35.89 4.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.55 4.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -138.95 9.7 2.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 110.264 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.437 ' OG ' HD23 ' B' ' 193' ' ' LEU . 1.8 t -122.19 122.31 38.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.12 127.84 45.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.942 . . . . 0.0 110.234 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' B' ' 172' ' ' LEU . 23.0 t80 -126.13 120.5 30.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -137.68 102.33 8.64 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 110.054 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.32 0.1 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.13 1.594 . . . . 0.0 110.365 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -99.88 -4.78 29.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -148.44 -38.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 110.472 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.469 ' HB2' HD21 ' B' ' 189' ' ' LEU . 6.7 t80 -124.39 113.78 27.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.382 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.04 -19.27 26.71 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.956 1.503 . . . . 0.0 110.079 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -97.72 179.92 33.14 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.437 HD23 ' OG ' ' B' ' 183' ' ' SER . 0.9 OUTLIER -113.19 145.99 40.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -1.185 . . . . 0.0 110.533 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.445 HD12 HD23 ' A' ' 62' ' ' LEU . 5.8 mt -109.09 110.36 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -107.54 120.53 42.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.33 93.08 6.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.934 . . . . 0.0 110.046 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 52.9 tpp -49.64 136.04 17.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.437 ' O ' ' HE2' ' B' ' 201' ' ' LYS . 73.0 t -73.12 -50.71 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -142.3 115.91 6.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.152 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.415 ' CB ' ' HG2' ' B' ' 222' ' ' GLU . 48.8 Cg_endo -73.73 165.21 85.44 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.994 -2.086 . . . . 0.0 110.541 -0.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' B' ' 198' ' ' VAL . 0.0 OUTLIER -74.75 98.86 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.992 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 31.7 mm -139.76 144.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.498 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 90.4 t -93.45 118.61 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' B' ' 204' ' ' LEU . 6.1 mp -115.58 123.77 49.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.568 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' B' ' 193' ' ' LEU . 5.7 mt -94.83 129.37 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.914 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.467 HG22 ' CD2' ' B' ' 234' ' ' LEU . 3.7 mp -118.8 129.47 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.549 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.475 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 96.6 m-85 -114.26 149.72 35.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 110.062 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 65.1 t -55.19 -24.8 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.0 p -64.36 -26.48 68.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.328 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 108.06 19.9 8.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -1.162 . . . . 0.0 110.274 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.72 132.99 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.384 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 21.2 t -125.79 130.97 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' B' ' 214' ' ' LEU . 4.7 mp -118.42 126.28 51.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.403 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.444 ' OG1' HG21 ' B' ' 161' ' ' VAL . 1.1 t -147.3 136.03 22.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.968 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.452 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 120.45 7.55 8.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.523 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -86.87 134.36 33.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -1.213 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -78.36 -21.19 49.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.518 ' CA ' HD13 ' B' ' 160' ' ' ILE . 0.0 OUTLIER -139.1 -170.38 2.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -89.94 -36.54 14.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.133 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -52.79 -31.31 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.174 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.415 ' HG2' ' CB ' ' B' ' 200' ' ' PRO . 24.1 mt-10 -70.45 -56.99 5.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 110.109 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.511 HG12 ' CB ' ' B' ' 217' ' ' ALA . 31.0 mm -50.93 -38.73 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.528 ' CE1' HG13 ' B' ' 64' ' ' VAL . 1.1 m-30 -67.79 -50.97 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -27.47 67.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.044 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.447 ' HB2' HD21 ' B' ' 214' ' ' LEU . . . -58.43 -52.48 65.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.655 ' CZ ' ' CD1' ' B' ' 231' ' ' TYR . 41.9 t80 -61.93 -42.33 98.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.946 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -18.17 52.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 110.306 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -96.7 -28.57 14.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.455 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 4.2 tp -98.29 -10.66 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.655 ' CD1' ' CZ ' ' B' ' 227' ' ' PHE . 14.9 t80 -59.18 -42.52 93.71 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 111.013 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 47.3 Cg_endo -76.23 -44.0 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.381 1.2 . . . . 0.0 110.353 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 7.7 t -55.27 -38.51 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.873 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.467 ' CD2' HG22 ' B' ' 206' ' ' ILE . 40.4 mt -67.27 -50.65 59.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -0.831 . . . . 0.0 110.201 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 1.6 m -58.4 -29.48 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.85 -35.42 76.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.99 39.44 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.8 176.71 1.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.115 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 -59.53 1.7 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.213 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.578 ' CD2' ' CD1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.49 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -93.7 97.4 10.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.063 -1.023 . . . . 0.0 111.004 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.599 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -108.06 6.36 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.976 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.513 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 5.6 m -43.19 -26.77 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.483 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' CA ' HG22 ' A' ' 56' ' ' ILE . . . -98.55 -19.26 23.28 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.624 HG12 ' CG1' ' A' ' 28' ' ' ILE . 1.3 mm -57.07 -46.79 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.67 -1.488 . . . . 0.0 109.0 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 25' ' ' PHE . 1.1 pp -83.53 -24.43 31.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.922 -1.111 . . . . 0.0 109.976 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.463 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -83.82 9.25 12.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 137.34 103.71 0.66 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.561 ' C ' ' O ' ' A' ' 26' ' ' GLY . 20.0 p-10 -18.56 129.77 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.717 0.77 . . . . 0.0 111.827 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.624 ' CG1' HG12 ' A' ' 23' ' ' ILE . 1.5 pp -138.93 170.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.726 -0.609 . . . . 0.0 109.533 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 31' ' ' GLU . 77.5 m-20 -88.17 120.34 29.43 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.557 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 4.6 p -35.33 -31.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.594 0.711 . . . . 0.0 109.662 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.9 tt0 -47.14 -23.35 0.49 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.23 21.78 5.1 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.38 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.528 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.98 134.27 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.315 . . . . 0.0 109.351 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.553 ' HA ' HG21 ' A' ' 28' ' ' ILE . 5.4 tt -87.82 162.06 17.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.895 -1.128 . . . . 0.0 111.157 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.529 ' CD1' ' ND2' ' A' ' 27' ' ' ASN . 3.1 pp . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.846 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.086 0.469 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.4 tp10 -100.24 -26.51 13.89 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.089 -1.007 . . . . 0.0 108.693 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.462 ' HB3' HD13 ' A' ' 56' ' ' ILE . 2.8 mt -98.32 -39.01 9.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.402 0.62 . . . . 0.0 109.689 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -44.38 -46.71 9.56 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.29 -32.6 74.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 109.553 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 59' ' ' LEU . 92.4 m-20 -76.76 -39.07 52.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.409 -0.807 . . . . 0.0 109.676 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.526 HG22 ' CA ' ' A' ' 22' ' ' GLY . 1.0 OUTLIER -53.46 -34.38 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.384 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.31 -27.12 72.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.48 ' O ' ' CD1' ' B' ' 189' ' ' LEU . 11.5 t -117.82 8.94 12.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 62' ' ' LEU . 6.0 mt -96.16 13.8 26.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.44 41.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.23 -0.919 . . . . 0.0 110.306 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HG3' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.57 19.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD1' HD21 ' A' ' 59' ' ' LEU . 6.0 mt -118.06 -58.64 1.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.361 -0.837 . . . . 0.0 109.232 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.4 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.5 mm? -52.13 -26.0 10.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -1.19 . . . . 0.0 110.57 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -45.95 -36.77 5.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.46 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.4 m -70.04 -59.5 2.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 110.048 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.477 ' SD ' ' HA2' ' B' ' 216' ' ' GLY . 0.2 OUTLIER -64.77 -11.96 42.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.03 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 20' ' ' LEU . 6.1 tt -69.39 -62.17 1.49 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.391 -0.818 . . . . 0.0 109.292 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.8 pp -66.78 -6.3 15.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.427 ' O ' HG21 ' A' ' 71' ' ' VAL . 2.1 tt0 -84.58 16.37 3.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.619 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.504 ' O ' HD13 ' B' ' 114' ' ' LEU . 2.9 t -141.37 4.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.932 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.599 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 1.4 tp -147.3 77.2 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.579 -0.701 . . . . 0.0 109.359 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.8 t70 -82.83 50.64 1.74 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 108.908 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.536 ' CD1' ' HB2' ' B' ' 99' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.74 -0.6 . . . . 0.0 111.657 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.445 HG11 ' HD2' ' B' ' 65' ' ' PRO . 45.3 t -71.77 134.75 83.61 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.445 ' HD2' HG11 ' B' ' 64' ' ' VAL . 44.4 Cg_endo -71.55 135.66 26.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.937 1.493 . . . . 0.0 110.318 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.6 m -96.44 130.58 43.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.361 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 33.2 mt -74.76 123.35 24.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.867 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -113.95 -3.66 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -0.887 . . . . 0.0 110.705 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.525 ' CB ' ' HB ' ' B' ' 161' ' ' VAL . 0.2 OUTLIER -156.36 142.83 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.914 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.53 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 19.9 mm -132.13 150.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.829 . . . . 0.0 109.809 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.523 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 22.0 t -141.44 134.65 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' B' ' 157' ' ' ILE . . . -141.64 165.27 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 68.1 p -110.15 145.65 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.72 131.21 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 41.4 m -111.84 128.59 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.457 ' HB3' ' HA ' ' B' ' 150' ' ' ALA . 49.0 mt -88.07 -17.33 31.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -2.31 84.26 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 3.6 t -137.33 151.14 48.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.339 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.447 ' O ' ' CD2' ' B' ' 80' ' ' LEU . 0.9 OUTLIER -78.46 164.15 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.447 ' CD2' ' O ' ' B' ' 79' ' ' ARG . 23.8 mt -140.48 153.38 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 82' ' ' LEU . 34.8 t0 -92.77 100.59 13.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.463 HD23 HG22 ' B' ' 102' ' ' VAL . 18.0 mt -44.23 -34.95 2.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 1.9 tmtm? -66.14 -36.12 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 20.8 m -89.25 -40.13 13.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.561 HG21 ' CE2' ' B' ' 148' ' ' PHE . 91.1 t -58.29 -50.48 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 110.272 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.78 63.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.139 -0.976 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 27.6 tp -57.74 -28.48 63.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.453 ' HB2' HD12 ' B' ' 146' ' ' ILE . 3.7 m-70 -98.94 -40.37 8.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.319 -0.863 . . . . 0.0 110.081 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' CE ' ' B' ' 104' ' ' MET . . . -47.38 124.3 6.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 20.9 mtt180 -67.28 -21.35 65.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.42 79.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -158.13 165.18 35.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.19 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -145.24 152.93 40.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.154 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -139.52 122.53 16.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.265 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.73 134.72 10.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.87 . . . . 0.0 110.228 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.85 -41.04 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.948 1.499 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -50.37 -23.2 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -98.32 -65.44 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.585 ' CE1' ' O ' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.79 167.15 7.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.469 -0.77 . . . . 0.0 111.295 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.92 56.07 3.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.684 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.585 ' O ' ' CE1' ' B' ' 99' ' ' PHE . . . -148.88 159.62 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.977 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.463 HG22 HD23 ' B' ' 82' ' ' LEU . 30.8 t -101.02 132.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.848 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.468 HG12 ' OG ' ' A' ' 30' ' ' SER . 6.5 mt -95.74 112.46 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.481 ' CE ' ' HB3' ' B' ' 89' ' ' ALA . 2.8 ttm -102.29 157.76 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 110.014 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -161.66 131.58 4.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.137 -0.977 . . . . 0.0 110.439 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 26.7 pt -115.64 172.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.463 ' HA ' ' HG2' ' B' ' 110' ' ' LYS . 7.7 mtp180 -115.45 29.53 7.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -174.63 86.16 0.33 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.503 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' B' ' 111' ' ' THR . 51.0 Cg_endo -78.23 148.77 85.4 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.777 -2.176 . . . . 0.0 110.319 -0.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' B' ' 107' ' ' ARG . 12.0 mtmm -58.25 86.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.879 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.47 HG21 ' HA3' ' B' ' 125' ' ' GLY . 11.3 p -130.45 168.64 16.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.519 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.525 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 4.0 t -130.38 164.22 25.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.61 166.26 30.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.01 -1.057 . . . . 0.0 110.903 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.516 ' CD1' HD12 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -113.17 107.88 16.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.525 ' CD1' ' HG3' ' B' ' 121' ' ' MET . 13.8 mm -91.75 125.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 111.186 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 4.6 m-30 -103.57 166.06 10.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.479 -0.763 . . . . 0.0 109.64 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.05 -14.85 58.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.263 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' B' ' 79' ' ' ARG . 1.1 p -73.53 -30.27 62.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.305 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.75 -23.43 5.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -65.94 163.6 16.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.178 . . . . 0.0 110.049 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.525 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.8 OUTLIER -159.05 124.88 4.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 110.766 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.477 HG12 ' CG1' ' A' ' 71' ' ' VAL . 2.9 t -101.8 136.22 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 0.0 109.655 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.418 HG13 ' N ' ' B' ' 124' ' ' THR . 76.9 t -115.71 165.42 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.156 -0.965 . . . . 0.0 110.662 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 27' ' ' ASN . 5.9 t -169.52 155.89 6.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.439 -0.788 . . . . 0.0 110.014 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.522 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 113.8 -4.06 24.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -84.21 168.99 15.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.192 -1.181 . . . . 0.0 110.502 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.439 ' C ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -121.89 -19.21 6.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 110.292 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' B' ' 129' ' ' GLU . 1.0 OUTLIER -139.86 -178.92 5.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -68.74 -43.59 75.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -33.5 72.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -50.64 37.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.251 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' B' ' 136' ' ' SER . 5.2 t -61.21 -22.21 64.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.942 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.5 -49.53 18.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.843 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -45.47 74.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -50.68 -49.01 58.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.832 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 132' ' ' SER . 0.6 OUTLIER -66.85 -49.5 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.682 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -54.05 -29.68 44.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' B' ' 141' ' ' ARG . 27.4 mmtt -70.86 -55.84 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.702 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 47.0 m-85 -49.47 -48.49 47.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -57.01 -36.54 70.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.395 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 65.6 ttt180 -57.51 -38.36 74.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.425 -0.797 . . . . 0.0 109.949 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.464 HG23 HD13 ' B' ' 146' ' ' ILE . 12.2 mt -66.76 -59.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.477 HG22 HD11 ' B' ' 143' ' ' ILE . 89.3 mt -56.6 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' B' ' 140' ' ' ALA . 20.5 mt-30 -67.55 -40.57 84.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 109.715 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -70.32 -21.29 62.94 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.464 HD13 HG23 ' B' ' 142' ' ' ILE . 6.5 mt -75.72 -29.46 20.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 125.07 -29.84 4.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.561 ' CE2' HG21 ' B' ' 85' ' ' VAL . 9.8 m-85 -43.89 156.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.014 -1.286 . . . . 0.0 110.637 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.62 48.58 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.129 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' B' ' 76' ' ' LEU . . . -84.42 171.49 12.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.403 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' B' ' 153' ' ' THR . 16.2 tttt -160.78 108.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.193 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.414 ' O ' ' CD2' ' B' ' 152' ' ' PHE . 47.7 t80 -49.7 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.265 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.9 OUTLIER -145.65 168.43 20.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.332 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.523 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t70 63.37 24.02 14.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -67.72 132.98 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 110.023 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -166.24 134.69 2.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.481 HG22 HD11 ' B' ' 157' ' ' ILE . 18.0 mt -79.38 122.85 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.59 6.38 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.523 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 1.1 m120 -154.51 123.08 6.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.374 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 215' ' ' THR . 30.8 mt -122.64 149.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.525 ' HB ' ' CB ' ' B' ' 69' ' ' ASN . 58.6 t -130.35 138.38 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.572 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.37 171.57 25.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.34 152.85 5.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.938 -1.33 . . . . 0.0 110.697 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.475 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 31.0 p -166.79 166.4 15.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.53 171.31 8.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.75 -83.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt 178.1 -23.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.036 -1.04 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -125.48 153.67 72.5 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.979 -1.076 . . . . 0.0 109.703 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 44.3 Cg_endo -72.34 147.29 46.87 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.943 1.496 . . . . 0.0 110.248 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.449 HG22 ' CD2' ' B' ' 234' ' ' LEU . 2.0 mp -108.23 156.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 110.599 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 14.2 mtt180 -91.29 101.97 14.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.775 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 25.2 mt -63.9 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.27 -34.29 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -64.97 -51.11 54.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.463 HD12 ' CG1' ' B' ' 233' ' ' VAL . 16.6 tp -65.71 -41.83 91.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -1.074 . . . . 0.0 109.907 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 180' ' ' GLY . . . -58.46 -43.53 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.8 t80 -59.76 -30.11 68.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -59.56 2.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.42 ' O ' ' N ' ' B' ' 183' ' ' SER . 41.5 m170 -97.98 32.53 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.338 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 176' ' ' ALA . . . -47.93 -62.74 3.97 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' THR . . . . . 0.559 HG22 ' CE1' ' B' ' 182' ' ' PHE . 10.3 t -45.85 -24.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -1.195 . . . . 0.0 110.272 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.559 ' CE1' HG22 ' B' ' 181' ' ' THR . 20.7 m-85 -102.43 -14.19 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.469 ' O ' ' O ' ' B' ' 180' ' ' GLY . 0.3 OUTLIER -140.86 149.04 41.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.931 . . . . 0.0 110.089 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -121.01 137.58 54.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.588 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -134.71 109.43 8.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 0.0 109.79 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.03 121.63 33.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.19 -11.98 25.32 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.891 1.469 . . . . 0.0 110.279 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.73 -23.85 22.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.113 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.48 ' CD1' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -89.84 -63.21 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.591 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 0.1 OUTLIER -169.68 161.07 7.18 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.43 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.9 Cg_endo -69.82 0.37 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.136 1.598 . . . . 0.0 111.842 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.591 ' HA3' ' CE2' ' B' ' 190' ' ' PHE . . . -89.25 149.41 20.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' B' ' 205' ' ' LEU . 10.3 tt -110.33 130.83 55.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -1.171 . . . . 0.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . . . . . . . . . 3.3 mt -95.63 111.21 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.225 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -100.89 113.7 26.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.297 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -91.1 88.58 7.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 110.145 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.42 ' HE3' ' HB2' ' B' ' 197' ' ' MET . 46.1 tpp -57.55 125.2 21.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.867 . . . . 0.0 110.377 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 34.7 t -57.52 -49.62 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.57 124.73 5.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.997 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.8 148.68 92.39 Favored 'Cis proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.011 -2.079 . . . . 0.0 110.424 -0.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -56.22 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.335 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' B' ' 222' ' ' GLU . 36.6 mm -136.84 153.5 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.17 112.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.925 . . . . 0.0 110.297 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' B' ' 226' ' ' ALA . 1.7 mp -107.42 149.13 28.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 0.2 OUTLIER -114.85 115.8 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.445 HD13 ' N ' ' B' ' 206' ' ' ILE . 4.6 mp -104.85 139.58 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -122.69 155.6 36.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.43 HG21 HD13 ' B' ' 172' ' ' LEU . 63.9 t -59.13 -31.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.348 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.3 t -57.04 -39.13 74.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.099 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.22 10.88 5.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.426 ' O ' HD12 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -89.66 135.45 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.426 HD12 ' O ' ' B' ' 211' ' ' LYS . 25.5 mm -113.74 134.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.3 t -114.32 163.45 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 1.4 mp -145.92 129.8 17.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.915 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 15.1 t -158.83 149.05 19.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 110.333 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.477 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 101.95 5.17 50.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.94 33.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -1.191 . . . . 0.0 110.161 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -93.18 -6.12 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.123 -0.985 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -154.68 -179.99 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.143 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -79.05 -25.34 43.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 110.22 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.79 -23.89 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.424 ' HB3' HD13 ' B' ' 202' ' ' ILE . 0.5 OUTLIER -78.13 -50.37 12.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 110.19 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 20.3 mm -58.8 -38.13 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.432 ' OH ' HG12 ' B' ' 64' ' ' VAL . 3.0 m-85 -70.6 -38.53 74.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.311 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -30.3 59.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.551 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.457 ' O ' HG12 ' B' ' 230' ' ' ILE . . . -64.72 -49.85 69.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -0.962 . . . . 0.0 110.417 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.475 ' CE1' ' SG ' ' B' ' 164' ' ' CYS . 16.1 t80 -69.07 -41.22 77.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.479 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -51.57 -38.19 53.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.82 -10.1 35.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.294 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.457 HG12 ' O ' ' B' ' 226' ' ' ALA . 10.5 mm -96.22 -17.73 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.58 ' N ' ' CD ' ' B' ' 232' ' ' PRO . 4.9 t80 -61.73 -42.1 81.41 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 48.5 Cg_endo -76.71 -49.26 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.346 1.182 . . . . 0.0 110.21 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.463 ' CG1' HD12 ' B' ' 175' ' ' LEU . 21.3 t -44.87 -40.48 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.764 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.449 ' CD2' HG22 ' B' ' 170' ' ' ILE . 74.0 mt -70.75 -63.36 1.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.779 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -46.9 -33.2 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.33 -34.19 77.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.403 -0.811 . . . . 0.0 110.014 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 57.3 m-85 -120.89 39.63 3.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.269 -0.894 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.49 ' NH2' ' O ' ' B' ' 239' ' ' LYS . 0.0 OUTLIER -71.57 -173.72 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.927 . . . . 0.0 110.175 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.49 ' O ' ' NH2' ' B' ' 238' ' ' ARG . 2.4 ttpt -125.68 -39.55 2.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.21 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' B' ' 99' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.93 76.85 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.045 -1.034 . . . . 0.0 110.615 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -93.99 -0.32 55.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 111.253 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 9.0 m -45.91 -24.25 0.38 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.889 -1.132 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.454 ' C ' HG22 ' A' ' 28' ' ' ILE . . . -97.04 -31.93 6.7 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.607 ' CG1' HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -47.94 -47.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.403 . . . . 0.0 109.132 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.513 ' HB2' ' ND2' ' B' ' 159' ' ' ASN . 1.8 pp -83.51 -26.74 29.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.969 -1.082 . . . . 0.0 110.549 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -80.96 6.92 11.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.096 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 138.33 106.58 0.74 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 26' ' ' GLY . 5.9 p30 -16.94 133.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.915 0.864 . . . . 0.0 112.186 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.565 ' CG1' HG12 ' A' ' 23' ' ' ILE . 2.0 pp -146.44 167.29 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.487 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.8 m-20 -87.88 121.14 29.93 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.542 ' OG ' ' CD1' ' B' ' 103' ' ' ILE . 9.3 p -36.93 -28.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.145 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.6 tt0 -58.51 -11.95 3.47 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.181 -0.949 . . . . 0.0 110.446 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.64 23.94 6.34 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.531 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.4 tpp180 -107.34 120.45 42.19 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.045 -1.268 . . . . 0.0 109.644 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.557 ' HA ' HG21 ' A' ' 28' ' ' ILE . 2.5 tm? -88.59 134.07 33.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.405 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 27' ' ' ASN . 1.1 pp . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.03 . . . . 0.0 109.993 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.23 0.538 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -100.46 -17.67 17.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.901 . . . . 0.0 109.591 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.468 HD11 ' CE1' ' A' ' 25' ' ' PHE . 4.0 mt -95.32 -47.06 6.47 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.513 -0.742 . . . . 0.0 109.977 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.575 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.58 -50.89 52.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -63.75 -25.82 68.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.795 . . . . 0.0 110.06 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 3.5 m-80 -83.29 -33.88 25.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 4.3 mt -51.93 -46.03 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.292 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.28 -19.93 26.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.73 9.9 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -1.191 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 3.0 mt -84.76 15.85 3.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.141 -0.974 . . . . 0.0 110.419 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.0 p -105.94 39.78 1.71 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 110.221 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 29.31 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 63' ' ' GLY . 2.1 pp -147.5 -35.44 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.103 -0.998 . . . . 0.0 111.152 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' N ' HD11 ' A' ' 62' ' ' LEU . . . -170.14 -51.29 0.04 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.294 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.4 mm? -42.83 -24.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -1.232 . . . . 0.0 110.572 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 63' ' ' GLY . 1.8 t70 -42.79 -38.97 2.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.854 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 58.5 m -66.84 -56.88 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.406 -0.809 . . . . 0.0 109.809 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.451 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -65.22 -10.54 32.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.486 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.554 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -67.92 -63.93 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.745 0.783 . . . . 0.0 109.298 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -68.57 -5.12 18.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.808 -0.557 . . . . 0.0 110.226 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' C ' HG21 ' A' ' 71' ' ' VAL . 31.6 tt0 -83.17 5.68 21.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 111.201 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.575 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.3 t -140.22 4.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.173 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.562 HD12 ' CD2' ' A' ' 18' ' ' LEU . 5.2 tp -145.48 73.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.779 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t70 -81.8 51.77 1.79 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.528 HD12 ' CG1' ' A' ' 72' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.528 -0.732 . . . . 0.0 111.46 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.243 0.544 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 70.2 t -89.82 142.2 28.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 110.505 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.2 Cg_endo -75.35 134.54 17.36 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.052 1.554 . . . . 0.0 110.417 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -90.71 127.17 36.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 mt -73.03 132.65 43.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.125 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -98.05 -41.08 8.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.101 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -170.03 179.07 3.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' B' ' 126' ' ' ALA . 9.5 mt -150.53 167.8 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.125 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.466 ' N ' ' CG2' ' B' ' 70' ' ' ILE . 52.8 t -137.4 140.64 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.131 -0.981 . . . . 0.0 110.426 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.55 50.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.426 -0.797 . . . . 0.0 110.068 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' THR . . . . . 0.409 HG21 ' O ' ' B' ' 73' ' ' THR . 1.8 t -115.24 133.85 55.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.422 HG22 ' OG ' ' B' ' 136' ' ' SER . 66.2 t -126.71 146.76 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 57.5 m -110.13 141.26 43.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.559 ' O ' ' CB ' ' B' ' 151' ' ' LYS . 7.4 mt -105.2 -72.93 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.485 -0.759 . . . . 0.0 109.898 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.33 -10.18 10.83 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' B' ' 148' ' ' PHE . 68.5 m -109.31 119.92 40.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.034 -1.274 . . . . 0.0 109.354 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.48 ' O ' HD22 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -44.02 147.94 0.45 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 110.032 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' B' ' 148' ' ' PHE . 27.0 mt -116.73 144.59 44.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 111.173 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' LYS . 0.2 OUTLIER -101.28 83.04 2.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.486 -0.758 . . . . 0.0 109.152 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' B' ' 81' ' ' ASP . 10.3 mt -37.09 -30.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.636 -0.665 . . . . 0.0 110.933 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' B' ' 81' ' ' ASP . 0.0 OUTLIER -70.28 -46.04 65.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 109.937 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 97.9 m -82.21 -31.41 30.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.382 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.5 -43.04 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.77 51.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 tp -85.24 -43.23 13.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.261 -0.9 . . . . 0.0 110.452 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.516 ' HB3' ' CG1' ' B' ' 146' ' ' ILE . 0.3 OUTLIER -74.43 -44.84 50.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 110.591 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.88 128.48 33.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.438 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -66.55 -24.93 66.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 9.0 p30 -135.22 79.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.077 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -160.07 137.04 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -117.39 171.18 8.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.448 ' HB2' HG21 ' B' ' 102' ' ' VAL . 13.3 t80 -164.2 102.2 0.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 110.301 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.437 ' HB3' ' HD3' ' B' ' 98' ' ' ARG . 0.7 OUTLIER -119.1 136.95 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.272 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -21.01 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.996 1.524 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -76.65 -17.3 59.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' B' ' 98' ' ' ARG . 3.2 mpt_? -96.45 -63.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.649 ' CE2' ' CB ' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.86 166.69 11.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.494 -0.754 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.97 53.43 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 111.909 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.649 ' CB ' ' CE2' ' B' ' 99' ' ' PHE . . . -153.19 154.25 34.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.143 . . . . 0.0 110.463 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' B' ' 114' ' ' LEU . 39.7 t -89.81 139.08 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.542 ' CD1' ' OG ' ' A' ' 30' ' ' SER . 8.4 mt -100.35 114.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 109.845 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.447 ' SD ' HD13 ' B' ' 115' ' ' ILE . 1.7 ttm -99.8 170.86 8.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 0.1 OUTLIER -169.99 132.42 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 0.0 110.046 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.467 HG12 ' OH ' ' B' ' 139' ' ' TYR . 22.8 pt -128.45 163.56 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.352 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -110.64 26.23 10.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.258 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER -172.76 86.28 0.41 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.267 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.465 ' O ' HG13 ' B' ' 106' ' ' ILE . 47.3 Cg_endo -74.85 161.52 94.6 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.564 -0.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -72.28 82.9 1.03 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' B' ' 124' ' ' THR . 37.0 p -132.46 176.3 8.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 110.518 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.571 ' CG2' ' CG2' ' B' ' 124' ' ' THR . 5.8 t -135.68 174.07 11.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.6 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' B' ' 122' ' ' VAL . . . -170.25 176.45 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.967 -1.083 . . . . 0.0 111.091 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.465 HD13 ' HB ' ' B' ' 122' ' ' VAL . 0.4 OUTLIER -143.17 122.89 13.35 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.491 HG21 ' N ' ' B' ' 116' ' ' PHE . 20.4 mt -100.35 160.34 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.006 . . . . 0.0 111.479 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 72' ' ' ILE . 34.8 m-85 -119.42 156.17 30.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 110.246 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -64.8 -16.45 63.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 4.4 p -71.29 -36.73 71.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.482 ' O ' HD13 ' B' ' 76' ' ' LEU . . . 129.41 4.24 4.96 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . 0.419 ' C ' ' HG3' ' B' ' 121' ' ' MET . 0.5 OUTLIER -100.4 138.89 36.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -1.175 . . . . 0.0 110.003 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.515 ' SD ' ' CG ' ' B' ' 76' ' ' LEU . 0.0 OUTLIER -128.03 129.45 46.72 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.04 . . . . 0.0 110.163 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.534 HG12 ' CG1' ' A' ' 71' ' ' VAL . 18.3 t -97.44 132.36 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 0.0 109.713 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.451 ' HA ' ' HB3' ' B' ' 113' ' ' ALA . 29.7 t -114.95 149.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 110.574 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.571 ' CG2' ' CG2' ' B' ' 112' ' ' THR . 6.2 t -149.54 156.48 42.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.521 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 110.04 -32.81 6.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.498 ' HB3' ' CA ' ' B' ' 132' ' ' SER . . . -45.35 125.13 5.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -1.115 . . . . 0.0 110.089 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -92.29 -17.92 24.09 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.23 -0.919 . . . . 0.0 109.802 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 42.0 t -142.44 151.87 42.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.387 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.16 -49.88 11.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -40.87 98.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.056 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -38.67 77.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.498 ' CA ' ' HB3' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -69.06 -44.43 72.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.161 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -25.56 65.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.23 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 0.6 OUTLIER -85.25 -36.26 21.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.338 -0.851 . . . . 0.0 110.287 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' B' ' 109' ' ' PRO . . . -70.49 -36.11 73.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.047 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.422 ' OG ' HG22 ' B' ' 74' ' ' VAL . 28.8 t -71.64 -59.8 2.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.507 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.0 ptm180 -46.19 -37.36 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.507 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 8.8 mttt -64.72 -45.98 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.467 ' OH ' HG12 ' B' ' 106' ' ' ILE . 9.5 m-85 -57.47 -56.95 15.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.516 ' HB2' ' NE2' ' B' ' 144' ' ' GLN . . . -49.04 -40.77 32.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.475 ' HA ' ' OE1' ' B' ' 144' ' ' GLN . 2.4 ttt-85 -53.4 -47.29 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.085 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.81 -25.44 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 110.349 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.62 ' CG2' ' CB ' ' B' ' 149' ' ' ALA . 0.5 OUTLIER -83.83 -51.2 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 109.397 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.682 ' HG3' ' HA ' ' B' ' 150' ' ' ALA . 19.9 mt-30 -46.96 -36.5 7.79 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -72.16 -31.65 66.14 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' B' ' 143' ' ' ILE . 0.1 OUTLIER -74.71 -45.02 45.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.41 -26.16 1.37 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.15 -1.5 . . . . 0.0 112.033 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.565 ' O ' HG23 ' B' ' 143' ' ' ILE . 0.1 OUTLIER -142.31 -154.61 0.53 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.291 -1.711 . . . . 0.0 112.598 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . 0.62 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . . . 41.22 29.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.54 1.162 . . . . 0.0 107.889 -178.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.682 ' HA ' ' HG3' ' B' ' 144' ' ' GLN . . . -89.74 -19.06 25.21 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.814 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' B' ' 76' ' ' LEU . 1.9 mptt -71.03 133.21 46.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.568 -1.333 . . . . 0.0 110.33 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -115.19 75.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.858 . . . . 0.0 110.269 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -137.79 -174.05 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.229 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 1.9 t0 56.39 16.77 2.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -68.57 125.85 27.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.215 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -160.24 131.93 6.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 110.259 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.431 ' C ' ' HG2' ' B' ' 158' ' ' GLN . 21.4 mt -79.43 132.01 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.857 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.431 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 38.3 mm-40 -130.7 1.16 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 110.652 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -148.33 108.53 4.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.977 -1.077 . . . . 0.0 111.236 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' B' ' 219' ' ' GLN . 69.8 mt -117.67 137.26 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.837 . . . . 0.0 109.209 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 88.9 t -114.37 139.13 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 111.031 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -147.02 171.18 27.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.4 p -155.84 163.42 39.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.257 . . . . 0.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 17.6 p -165.65 169.84 14.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.843 . . . . 0.0 110.223 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 15.5 p-10 -120.55 144.01 48.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 109.988 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.592 ' HB ' ' CZ ' ' B' ' 168' ' ' PHE . 25.3 m -94.02 2.7 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.988 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 28.2 tttp 71.86 10.16 6.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 110.917 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 9.3 p90 -166.23 154.58 9.79 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 110.416 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.65 158.02 51.35 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.996 1.524 . . . . 0.0 110.784 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.47 HD13 ' HA2' ' B' ' 210' ' ' GLY . 2.4 mp -131.07 147.86 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.229 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.422 ' N ' HG21 ' B' ' 170' ' ' ILE . 7.5 ttm180 -76.93 92.05 3.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.924 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.469 HD12 ' N ' ' B' ' 208' ' ' VAL . 13.6 mt -50.57 -37.25 38.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.39 -43.49 60.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.245 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.39 80.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -51.77 22.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -1.123 . . . . 0.0 110.12 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.498 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -57.84 -29.71 65.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.114 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -72.38 -36.54 68.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.13 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.59 -27.4 17.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.959 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -129.15 34.9 4.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 110.004 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.22 -18.29 64.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' THR . . . . . 0.51 HG21 ' N ' ' B' ' 182' ' ' PHE . 8.9 t -69.31 -21.43 63.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -1.137 . . . . 0.0 110.31 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.51 ' N ' HG21 ' B' ' 181' ' ' THR . 41.3 m-85 -129.57 3.14 5.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' B' ' 195' ' ' TYR . 0.9 OUTLIER -139.47 135.42 33.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 154.98 29.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.071 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -147.08 105.72 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.342 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 190' ' ' PHE . 7.4 mt-10 -108.75 105.27 56.71 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.74 -2.07 10.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.981 1.516 . . . . 0.0 110.599 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -19.88 16.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.074 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' B' ' 190' ' ' PHE . 4.7 tt -132.91 -29.73 1.44 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 110.551 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.488 ' HB2' HD21 ' B' ' 189' ' ' LEU . 1.9 t80 -131.8 111.29 14.7 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.32 -7.92 21.79 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.867 1.456 . . . . 0.0 110.231 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.97 179.98 21.89 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.454 HD11 ' O ' ' B' ' 172' ' ' LEU . 3.5 tt -113.74 125.95 54.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.398 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.463 HG12 HD21 ' B' ' 205' ' ' LEU . 44.2 mt -91.77 112.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.96 . . . . 0.0 109.953 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 2.2 t80 -108.49 124.61 50.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.381 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.454 ' HB2' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -105.82 79.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.057 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 32.1 ttm -49.11 134.72 17.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 40.5 t -73.01 -43.1 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.3 OUTLIER -143.2 116.43 6.05 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.113 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.1 Cg_endo -73.54 156.02 99.67 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.99 -2.087 . . . . 0.0 110.529 -0.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.511 ' O ' ' CD1' ' B' ' 202' ' ' ILE . 2.9 tptt -67.37 94.87 0.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.511 ' CD1' ' O ' ' B' ' 201' ' ' LYS . 11.2 mm -141.09 158.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.215 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 62.2 t -105.54 116.22 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.943 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.472 ' CD2' HG23 ' B' ' 230' ' ' ILE . 5.2 mp -108.12 108.67 19.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.497 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.463 HD21 HG12 ' B' ' 194' ' ' ILE . 0.9 OUTLIER -95.08 118.88 32.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.447 ' O ' HD23 ' B' ' 172' ' ' LEU . 3.2 mp -116.76 120.9 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.162 -0.962 . . . . 0.0 110.486 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' B' ' 207' ' ' PHE . 30.1 m-85 -93.33 172.22 8.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.469 ' N ' HD12 ' B' ' 172' ' ' LEU . 27.2 t -60.32 -39.83 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.327 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 50.6 m -53.16 -42.28 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.455 -0.778 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' B' ' 170' ' ' ILE . . . 125.81 4.34 6.75 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.31 136.45 44.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 110.089 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.456 ' HB ' ' SG ' ' B' ' 164' ' ' CYS . 14.6 mm -119.41 136.49 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.328 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 84.0 t -121.88 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.939 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.03 117.16 21.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 13.6 t -135.57 160.53 38.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.105 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.57 -5.88 64.91 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' B' ' 222' ' ' GLU . . . -73.54 136.18 44.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.16 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.425 ' N ' ' OE2' ' B' ' 222' ' ' GLU . 0.0 OUTLIER -84.57 -8.69 58.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.092 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.467 ' HA ' ' CD1' ' B' ' 160' ' ' ILE . 1.0 OUTLIER -156.89 -174.02 4.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -82.15 -32.63 29.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 1.0 OUTLIER -52.44 -29.61 25.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.052 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.425 ' OE2' ' N ' ' B' ' 218' ' ' LYS . 21.1 mt-10 -76.85 -48.0 19.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.3 -39.03 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -69.88 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -83.59 -46.77 12.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.265 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.71 -40.65 20.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.441 ' O ' HG21 ' B' ' 230' ' ' ILE . 14.6 t80 -74.37 -48.33 28.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.0 -17.38 62.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.007 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -86.4 -32.92 20.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 109.922 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.472 HG23 ' CD2' ' B' ' 204' ' ' LEU . 1.0 OUTLIER -99.12 -17.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.846 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.589 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 51.9 t80 -47.71 -46.96 62.22 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.2 Cg_endo -71.43 -49.36 0.36 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.387 1.204 . . . . 0.0 110.18 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 9.3 t -47.71 -43.28 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.642 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.453 HD21 HG23 ' B' ' 170' ' ' ILE . 91.0 mt -63.12 -51.22 67.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 232' ' ' PRO . 59.6 p -54.11 -27.76 35.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.65 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.82 -38.47 79.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.919 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -110.15 37.77 2.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -63.21 163.21 10.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.202 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.61 -28.83 6.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.877 . . . . 0.0 110.218 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.61 HD23 ' CE2' ' B' ' 99' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.433 ' O ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -93.8 128.38 40.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.122 -0.987 . . . . 0.0 111.497 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.57 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 9.6 mt -124.64 24.98 7.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 110.47 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.544 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 8.4 m -49.01 -36.6 18.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.464 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -85.67 -24.66 41.54 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.497 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.611 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 9.5 mm -50.37 -54.22 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.883 -1.363 . . . . 0.0 109.011 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.519 HD12 ' CD1' ' A' ' 64' ' ' LEU . 1.6 pp -79.33 8.89 5.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 110.023 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.413 ' HB2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -111.75 -15.41 13.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.006 -1.059 . . . . 0.0 111.026 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 156.99 44.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.531 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.556 ' HA ' ' CG2' ' B' ' 124' ' ' THR . 0.7 OUTLIER 61.72 132.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.929 -1.336 . . . . 0.0 110.185 178.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.611 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -162.2 158.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.818 0.818 . . . . 0.0 109.524 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLU . 77.1 m-20 -88.49 118.36 28.08 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.549 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -39.68 -26.82 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.992 -179.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 18.0 pt-20 -55.16 -16.33 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.043 -1.035 . . . . 0.0 109.991 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.98 14.29 10.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.52 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.69 115.88 28.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.074 -1.25 . . . . 0.0 109.939 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.587 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 1.2 tt -87.67 158.85 18.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.918 -1.114 . . . . 0.0 110.872 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 27' ' ' ASN . 4.0 pp . . . . . 0 N--CA 1.492 1.631 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.711 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.211 0.529 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 1.6 tp10 -88.67 -52.04 5.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.519 ' CD1' HD12 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -93.5 -11.6 31.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.546 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -56.7 -54.05 50.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -0.996 . . . . 0.0 108.784 178.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.63 -23.34 64.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' SER . 45.8 m-80 -80.06 -33.31 39.1 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.546 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 24.6 mt -50.01 -41.98 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.51 -14.61 28.74 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -116.99 -7.1 11.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.89 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.574 HD12 ' CE1' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -76.88 53.99 0.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.95 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m -126.81 32.59 5.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.786 . . . . 0.0 110.365 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HG3' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.19 17.87 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.322 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.486 ' CD2' ' HG3' ' A' ' 61' ' ' LYS . 6.9 mt -112.89 -63.09 1.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.561 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.5 -39.96 0.03 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.519 ' CD1' HD12 ' A' ' 24' ' ' LEU . 3.5 mm? -53.3 -19.4 3.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -1.117 . . . . 0.0 110.644 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' HD22 ' A' ' 69' ' ' LEU . 4.8 p-10 -46.07 -40.75 11.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 110.068 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -59.49 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.51 ' SD ' ' CD1' ' A' ' 24' ' ' LEU . 12.6 ttm -70.75 -3.49 19.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.766 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.5 tm? -69.43 -58.29 4.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 65' ' ' ASP . 1.6 pp -77.92 1.42 20.66 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.478 0.656 . . . . 0.0 109.613 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.441 ' CB ' ' HA ' ' A' ' 67' ' ' MET . 3.9 tt0 -87.94 15.5 7.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 3.8 t -138.93 -0.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.729 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.584 ' CD1' HD21 ' A' ' 18' ' ' LEU . 2.9 tp -151.17 84.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.515 -0.741 . . . . 0.0 109.32 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 2.1 p-10 -87.4 49.19 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.964 -1.085 . . . . 0.0 108.486 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.547 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 9.9 mt . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.675 0.75 . . . . 0.0 110.872 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' B' ' 64' ' ' VAL . 6.3 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.07 0.462 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' B' ' 63' ' ' ILE . 56.6 t 58.46 126.34 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.595 -0.691 . . . . 0.0 110.223 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 45.9 Cg_endo -73.49 151.53 47.68 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.858 1.451 . . . . 0.0 110.568 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.405 ' O ' ' CA ' ' B' ' 162' ' ' GLY . 98.1 m -101.47 164.79 11.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -89.48 128.67 36.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.28 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.33 -32.62 10.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.507 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 7.6 m-20 -170.05 171.62 6.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.525 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 16.5 mm -131.77 155.52 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 110.149 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 37.6 t -138.29 113.7 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.864 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.505 ' CB ' ' HA ' ' B' ' 157' ' ' ILE . . . -128.42 156.46 43.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 110.587 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 26.1 p -105.69 114.16 28.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.93 120.64 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' B' ' 153' ' ' THR . 52.5 m -97.08 160.68 14.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.52 ' CD1' ' CD1' ' B' ' 80' ' ' LEU . 22.0 mt -107.32 -59.89 1.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.237 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.86 -0.1 6.65 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 21.6 p -142.37 170.18 16.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -1.152 . . . . 0.0 110.187 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.453 ' HG2' ' N ' ' B' ' 80' ' ' LEU . 0.1 OUTLIER -83.34 154.32 24.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.52 ' CD1' ' CD1' ' B' ' 76' ' ' LEU . 70.8 mt -128.32 144.49 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.093 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 5.7 m-20 -89.86 94.6 9.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.501 ' HB3' ' CE1' ' B' ' 94' ' ' TYR . 12.3 mt -46.63 -45.17 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -54.78 -45.06 74.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 110.106 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 7.0 m -82.5 -38.68 23.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.44 -48.06 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' B' ' 82' ' ' LEU . . . -73.43 -24.24 60.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.277 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 19.7 tp -85.98 -23.8 26.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.498 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.4 OUTLIER -96.75 -42.91 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.181 -0.95 . . . . 0.0 110.378 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.471 ' HB2' ' HB1' ' B' ' 92' ' ' ALA . . . -45.92 123.49 4.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.129 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -24.05 64.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.25 -0.906 . . . . 0.0 110.293 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -137.14 79.59 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' B' ' 89' ' ' ALA . . . -164.96 161.24 19.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 0.0 109.856 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' B' ' 92' ' ' ALA . 58.6 mm-40 -152.78 138.38 17.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 110.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' B' ' 82' ' ' LEU . 19.8 t80 -93.17 148.24 22.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.725 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.444 ' HB3' ' HB2' ' B' ' 98' ' ' ARG . 0.1 OUTLIER -138.44 103.9 7.82 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 110.628 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.37 -17.71 16.44 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.045 1.55 . . . . 0.0 110.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.07 -4.23 58.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 0.0 110.269 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -116.55 -65.39 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.61 ' CE2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -153.67 -168.07 2.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.356 -0.84 . . . . 0.0 111.294 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.18 53.7 0.68 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.61 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -145.33 164.21 32.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 0.0 110.93 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.415 HG12 ' HB3' ' B' ' 86' ' ' ALA . 86.2 t -102.27 127.0 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.818 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -94.61 108.78 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 3.4 ttm -93.63 170.75 9.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.01 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.6 119.66 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.5 HG22 ' CE1' ' B' ' 139' ' ' TYR . 8.7 pt -122.58 149.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.32 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 2.3 ptt180 -99.12 33.13 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.1 tt0 -171.93 84.2 0.46 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 47.7 Cg_endo -76.51 162.1 92.49 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.657 -2.226 . . . . 0.0 110.463 -0.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -70.36 79.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.008 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.427 HG23 ' C ' ' B' ' 125' ' ' GLY . 67.7 p -131.12 -179.7 5.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.532 HG21 ' CG2' ' B' ' 124' ' ' THR . 13.4 t -138.58 158.48 44.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.427 ' HB1' ' CE2' ' B' ' 139' ' ' TYR . . . -149.77 154.96 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.934 -1.104 . . . . 0.0 111.162 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.477 HD12 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -124.16 111.61 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.13 136.96 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 111.483 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 5.2 m-30 -96.84 169.33 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.77 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.06 -0.96 42.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 110.097 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.7 -7.31 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.08 -2.49 40.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . 0.521 ' HB3' ' CD2' ' B' ' 116' ' ' PHE . 0.1 OUTLIER -85.42 146.11 27.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.111 -1.229 . . . . 0.0 110.024 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 29.2 ttp -149.51 125.55 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 71' ' ' VAL . 48.7 t -97.38 148.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.95 107.72 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 111.355 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.556 ' CG2' ' HA ' ' A' ' 27' ' ' ASN . 9.7 t -108.53 144.44 36.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.094 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.52 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 126.5 -27.2 5.03 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -52.92 149.01 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.03 -1.277 . . . . 0.0 109.719 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.0 OUTLIER -94.66 -19.97 19.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.027 -1.046 . . . . 0.0 109.862 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.416 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -161.99 -159.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -75.34 -36.83 60.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.07 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.48 -38.94 92.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.086 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.61 -52.8 22.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.299 -0.876 . . . . 0.0 110.231 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 30.3 t -45.91 -36.4 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.203 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -73.83 -31.93 63.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 50.5 mt -80.95 -46.63 14.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.47 -29.57 61.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.143 -0.973 . . . . 0.0 109.88 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.438 ' O ' ' C ' ' B' ' 137' ' ' ARG . 23.4 t -76.3 -64.43 1.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 110.243 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.581 ' HA ' ' CE1' ' B' ' 152' ' ' PHE . 14.6 ptm180 -41.79 -31.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.526 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 4.9 mmtm -67.83 -50.99 53.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.471 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.5 ' CE1' HG22 ' B' ' 106' ' ' ILE . 18.1 m-85 -60.03 -52.13 66.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.342 -0.849 . . . . 0.0 109.673 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.33 62.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.639 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -52.26 -40.44 61.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.646 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.448 ' O ' HG13 ' B' ' 146' ' ' ILE . 84.2 mt -63.34 -43.0 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.835 . . . . 0.0 110.195 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.532 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 52.0 mt -75.5 -49.06 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.71 -37.43 84.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' B' ' 141' ' ' ARG . 32.5 tttp -71.82 -27.03 62.64 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 142' ' ' ILE . 6.2 mt -74.01 -10.64 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.67 -19.3 28.66 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.532 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 6.4 m-85 -55.18 157.98 3.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -1.222 . . . . 0.0 111.057 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.41 49.72 0.99 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.62 -0.675 . . . . 0.0 109.742 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' B' ' 76' ' ' LEU . . . -96.26 144.78 26.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 110.835 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.427 ' O ' HD21 ' B' ' 76' ' ' LEU . 9.2 ptpt -142.28 -157.6 0.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.45 -0.781 . . . . 0.0 109.551 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.581 ' CE1' ' HA ' ' B' ' 137' ' ' ARG . 33.8 m-85 -106.09 117.39 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.016 . . . . 0.0 110.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' B' ' 75' ' ' THR . 0.8 OUTLIER -151.27 163.28 39.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' B' ' 75' ' ' THR . 13.8 t0 42.65 26.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 110.438 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 1.4 t80 -76.63 124.05 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 110.023 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . 0.443 ' N ' ' CD1' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -163.75 131.57 3.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.366 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.505 ' HA ' ' CB ' ' B' ' 72' ' ' ALA . 31.5 mt -78.78 107.87 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -110.45 12.01 23.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.657 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.526 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 6.2 m120 -153.46 115.44 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.548 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.495 HD11 HG22 ' B' ' 160' ' ' ILE . 31.2 mt -117.73 162.7 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.667 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.34 128.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.033 . . . . 0.0 110.624 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' B' ' 66' ' ' THR . . . -133.53 175.18 20.36 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 3.3 m -167.49 154.11 8.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -1.223 . . . . 0.0 110.456 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.432 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -169.95 161.9 9.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.122 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' B' ' 211' ' ' LYS . 4.2 m-20 -106.65 157.54 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.569 HG13 ' CZ ' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -110.46 3.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 3.8 tmtm? 74.34 -4.06 2.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.504 -0.748 . . . . 0.0 111.166 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.569 ' CZ ' HG13 ' B' ' 166' ' ' VAL . 38.5 p90 -149.57 144.91 18.31 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.009 -1.057 . . . . 0.0 110.278 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.468 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.7 Cg_endo -71.92 157.64 54.41 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.174 1.618 . . . . 0.0 110.714 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.18 154.35 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 110.284 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.34 90.4 8.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 109.994 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.486 ' CD1' ' HA2' ' B' ' 192' ' ' GLY . 24.3 mt -52.17 -34.25 44.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.518 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -62.86 -58.91 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -56.34 -42.24 88.66 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' B' ' 179' ' ' HIS . 14.5 tp -71.88 -38.37 70.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.185 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' B' ' 193' ' ' LEU . . . -71.13 -17.31 62.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -83.09 -40.86 19.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.123 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 15.3 t -81.61 -45.63 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.533 ' CD2' HD13 ' B' ' 175' ' ' LEU . 52.2 m-70 -95.4 14.93 20.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.33 -29.97 5.52 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 92.2 m -71.95 -25.44 61.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.3 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -106.1 -21.32 13.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' B' ' 194' ' ' ILE . 1.1 m -124.86 171.61 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.5 t -137.95 135.39 35.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.894 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.494 ' CD2' ' HD3' ' B' ' 187' ' ' PRO . 64.4 t80 -128.55 135.59 49.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.578 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' B' ' 190' ' ' PHE . 12.3 mm-40 -131.94 93.79 26.28 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . 0.494 ' HD3' ' CD2' ' B' ' 185' ' ' TYR . 42.0 Cg_endo -68.99 -7.08 19.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.034 1.544 . . . . 0.0 110.365 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -100.41 -1.68 35.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -153.48 -48.33 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.134 -0.979 . . . . 0.0 110.565 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.574 ' CE1' HD12 ' A' ' 59' ' ' LEU . 3.0 t80 -108.76 117.56 53.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 110.514 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.53 -30.66 9.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.98 1.516 . . . . 0.0 110.178 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.486 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.75 -179.38 44.76 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.502 ' CD1' ' HB3' ' B' ' 176' ' ' ALA . 3.6 tt -123.4 150.81 43.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -1.187 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' B' ' 183' ' ' SER . 4.5 mt -107.52 100.79 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.485 ' OH ' ' ND1' ' B' ' 179' ' ' HIS . 0.6 OUTLIER -89.62 103.88 16.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.262 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' B' ' 202' ' ' ILE . 22.2 mtm180 -92.36 79.51 4.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.505 ' CE ' HG12 ' B' ' 230' ' ' ILE . 34.3 ttm -43.53 146.28 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 110.589 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.14 -34.61 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 110.079 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.8 116.05 2.24 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.54 147.42 89.56 Favored 'Cis proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.89 -2.129 . . . . 0.0 110.377 0.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.432 ' O ' HD12 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -59.27 101.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.51 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 37.9 mm -138.85 153.55 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.343 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.71 100.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.516 HD22 ' CD2' ' B' ' 214' ' ' LEU . 6.2 mp -94.67 127.25 40.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.46 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.514 ' CB ' ' HB ' ' B' ' 213' ' ' VAL . 0.1 OUTLIER -92.54 111.12 22.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.466 ' HB ' HD23 ' B' ' 172' ' ' LEU . 10.9 mm -96.68 139.32 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -128.81 136.41 50.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.141 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 54.8 t -49.19 -36.35 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.938 . . . . 0.0 110.215 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.6 m -53.3 -30.0 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.47 16.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.465 ' HA ' ' OD1' ' B' ' 165' ' ' ASP . 8.8 mttt -92.26 133.97 35.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.13 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 163' ' ' SER . 12.9 mm -117.54 135.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.371 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.514 ' HB ' ' CB ' ' B' ' 205' ' ' LEU . 69.3 t -123.06 113.68 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.812 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.516 ' CD2' HD22 ' B' ' 204' ' ' LEU . 3.5 mp -103.74 117.37 34.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.462 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.9 t -147.8 165.64 29.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.183 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.456 ' HA3' ' HE3' ' A' ' 67' ' ' MET . . . 92.49 21.76 30.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -100.32 141.57 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -1.099 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -16.0 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 109.94 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.12 145.72 24.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 110.027 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' B' ' 220' ' ' ARG . 0.6 OUTLIER -53.03 -25.73 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.244 -0.91 . . . . 0.0 110.329 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -38.68 91.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' B' ' 217' ' ' ALA . 82.0 mt-10 -67.59 -52.09 42.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.292 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' B' ' 224' ' ' TYR . 0.0 OUTLIER -53.08 -56.64 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.553 ' N ' ' CG2' ' B' ' 223' ' ' ILE . 1.7 m-30 -47.56 -31.07 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.004 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' B' ' 228' ' ' GLU . 2.8 mt-30 -78.42 -41.97 31.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.465 ' HB3' HD12 ' B' ' 204' ' ' LEU . . . -45.88 -44.36 14.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.868 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -69.5 -45.18 69.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.812 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . 0.413 ' OE1' ' HA ' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -53.28 -28.77 29.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.08 19.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 109.789 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.505 HG12 ' CE ' ' B' ' 197' ' ' MET . 5.9 mm -97.58 -13.4 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 109.821 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 41.7 t80 -52.46 -44.95 95.48 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.924 . . . . 0.0 110.694 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -74.28 -26.73 12.15 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.39 1.205 . . . . 0.0 110.315 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 25.0 t -66.23 -39.48 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 109.785 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.449 HD11 HG23 ' B' ' 166' ' ' VAL . 67.6 mt -68.5 -45.62 71.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 110.018 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 94.9 p -64.94 -44.58 88.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.87 . . . . 0.0 110.04 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.62 -37.33 49.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.927 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -110.62 36.59 3.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.968 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' B' ' 238' ' ' ARG . 0.2 OUTLIER -74.55 163.46 27.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -121.37 -30.68 4.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.106 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.699 ' HB2' ' CG ' ' B' ' 99' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.379 0.609 . . . . 0.0 110.032 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.538 ' N ' ' CD1' ' A' ' 18' ' ' LEU . 37.0 t0 -68.28 67.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.753 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.614 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -84.28 -4.42 58.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 110.397 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.594 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 31.1 m -43.48 -36.45 2.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 110.289 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.507 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -92.41 -36.45 6.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.601 ' N ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -49.93 -45.46 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -1.213 . . . . 0.0 108.82 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' CD2' ' HB3' ' A' ' 67' ' ' MET . 3.8 pp -79.74 6.35 11.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 109.607 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.547 ' CZ ' HD12 ' B' ' 205' ' ' LEU . 1.3 t80 -114.94 -13.89 11.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 111.232 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 164.73 46.9 0.02 OUTLIER Glycine 0 N--CA 1.496 2.649 0 C-N-CA 118.861 -1.638 . . . . 0.0 110.746 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.539 ' HB2' ' CG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 44.96 112.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.307 1.051 . . . . 0.0 111.784 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -145.0 158.24 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.528 ' N ' HG12 ' A' ' 28' ' ' ILE . 44.8 m-20 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.547 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 13.7 p -38.66 -28.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.475 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.8 tt0 -54.02 -17.02 2.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 110.233 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.53 28.22 5.5 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.502 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -123.97 125.87 45.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.003 -1.293 . . . . 0.0 110.359 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.688 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.31 153.16 17.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 110.706 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.539 ' CG ' ' HB2' ' A' ' 27' ' ' ASN . 4.3 pp . . . . . 0 N--CA 1.494 1.753 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.784 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.187 0.518 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 13.8 pt-20 -95.53 -23.73 16.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.81 -43.7 7.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.016 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -45.23 -45.16 11.64 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.967 -179.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.98 -30.26 70.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.547 ' HB3' ' CE1' ' B' ' 190' ' ' PHE . 91.2 m-20 -80.69 -37.8 30.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.713 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.558 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 7.7 mt -49.28 -46.22 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.355 -0.841 . . . . 0.0 109.54 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.77 -17.12 26.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.441 ' HB3' HD13 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -119.46 7.75 11.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -1.143 . . . . 0.0 110.315 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' A' ' 56' ' ' ILE . 1.8 mt -86.76 31.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.524 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -118.2 39.07 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.204 -0.935 . . . . 0.0 110.49 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HE3' HD12 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -162.42 31.43 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.522 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -145.22 -26.65 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 111.256 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.519 ' N ' HD11 ' A' ' 62' ' ' LEU . . . 177.47 -44.52 0.1 OUTLIER Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.157 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -53.4 -17.7 2.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -1.188 . . . . 0.0 110.67 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 80.6 m-20 -46.42 -39.82 11.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.085 -1.009 . . . . 0.0 110.116 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -62.26 -57.05 12.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.877 . . . . 0.0 110.098 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.505 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . 4.9 tpp -64.32 -11.01 27.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 21' ' ' THR . 1.3 tm? -68.0 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.974 0.892 . . . . 0.0 109.024 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.82 -2.46 17.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.307 0.575 . . . . 0.0 110.222 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.404 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 13.3 tt0 -85.8 0.53 52.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.229 -0.919 . . . . 0.0 111.53 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.592 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.2 t -137.92 3.24 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.265 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.614 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 6.0 tp -149.85 70.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -75.83 57.33 1.02 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.631 ' HB3' ' CZ ' ' B' ' 99' ' ' PHE . 6.1 mt . . . . . 0 C--N 1.303 -1.444 0 CA-C-O 121.681 0.753 . . . . 0.0 110.382 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.29 0.567 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.402 ' O ' ' SG ' ' B' ' 164' ' ' CYS . 55.8 t -92.47 140.07 24.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.876 . . . . 0.0 110.248 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.458 ' HG3' ' HB2' ' B' ' 227' ' ' PHE . 44.5 Cg_endo -71.29 138.45 33.1 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.011 1.532 . . . . 0.0 110.476 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.463 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 17.0 m -106.67 141.35 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.523 HD12 ' CG2' ' B' ' 160' ' ' ILE . 40.6 mt -78.66 122.24 25.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.521 ' O ' ' ND2' ' B' ' 69' ' ' ASN . 19.7 mm-40 -110.16 -15.71 13.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 110.383 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.533 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 10.4 m120 -160.94 121.7 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.299 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.514 HG23 ' N ' ' B' ' 71' ' ' VAL . 10.1 mt -122.54 171.33 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.902 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 7.6 t -144.79 134.31 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.64 133.29 54.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 38.7 m -92.14 127.33 37.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.093 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' B' ' 155' ' ' PHE . 40.6 t -131.12 133.04 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.385 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 4.4 m -101.27 139.98 36.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 110.056 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.46 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 29.2 mt -87.16 -67.25 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 143.32 -17.75 2.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 30.1 p -141.7 141.08 33.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.423 ' C ' ' HG ' ' B' ' 80' ' ' LEU . 1.5 ptt85 -57.9 163.56 2.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.446 HD13 ' CD1' ' B' ' 76' ' ' LEU . 18.0 mt -139.86 155.98 46.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 110.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 3.7 m-20 -89.75 102.59 15.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 13.6 mt -48.39 -31.44 6.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.333 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -67.25 -38.59 85.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 110.255 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 31.7 p -81.9 -41.96 20.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' B' ' 89' ' ' ALA . 24.2 t -58.66 -42.46 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.44 ' HB3' HG12 ' B' ' 102' ' ' VAL . . . -81.03 -18.39 46.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 87' ' ' LEU . 13.4 tp -87.08 -31.38 20.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -95.59 -29.3 14.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.397 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.41 ' CB ' ' HB1' ' B' ' 92' ' ' ALA . . . -63.35 133.37 53.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -25.45 59.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 110.383 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 2.4 m120 -132.25 79.42 1.86 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.41 ' HB1' ' CB ' ' B' ' 89' ' ' ALA . . . -148.75 158.41 44.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -129.78 147.34 51.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -147.6 111.14 4.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.925 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -135.35 122.85 15.07 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 110.41 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.72 -17.3 26.11 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.916 1.482 . . . . 0.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -21.6 62.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 110.208 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.435 ' HG3' ' NH1' ' B' ' 98' ' ' ARG . 0.0 OUTLIER -101.9 -56.95 2.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.606 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.699 ' CG ' ' HB2' ' A' ' 18' ' ' LEU 0.257 62.6 t80 -170.18 -179.14 3.02 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.866 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.448 ' O ' HD11 ' A' ' 74' ' ' LEU . . . -99.41 70.72 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.5 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -155.43 149.67 25.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.558 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' B' ' 86' ' ' ALA . 44.7 t -102.03 117.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' B' ' 113' ' ' ALA . 1.3 mp -89.55 111.38 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.483 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.529 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.6 OUTLIER -89.93 153.01 20.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.774 179.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -149.53 118.05 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.047 -1.033 . . . . 0.0 110.728 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.567 HG21 ' CE1' ' B' ' 139' ' ' TYR . 34.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 109.706 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -104.03 35.59 2.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 110.39 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -171.82 81.49 0.48 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.461 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.469 ' O ' HG13 ' B' ' 106' ' ' ILE . 50.3 Cg_endo -79.63 165.35 80.08 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.538 -0.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 8.4 tptt -70.24 94.17 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' B' ' 124' ' ' THR . 18.4 p -139.59 177.66 7.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.713 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' B' ' 113' ' ' ALA . 0.9 OUTLIER -119.7 173.43 7.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.451 -0.78 . . . . 0.0 109.383 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.548 ' N ' ' CG2' ' B' ' 112' ' ' THR . . . -146.93 133.97 20.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.509 HD13 ' CD1' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -107.22 97.18 6.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.521 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 68.8 mt -97.34 150.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.101 -0.999 . . . . 0.0 111.274 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 72' ' ' ILE . 2.3 m-85 -118.81 174.13 6.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 109.861 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -87.4 -3.29 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 109.907 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.88 -22.34 24.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.46 ' O ' ' CD1' ' B' ' 76' ' ' LEU . . . 126.57 -38.98 2.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.63 153.46 2.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -1.157 . . . . 0.0 110.026 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.453 ' HG3' HG12 ' B' ' 115' ' ' ILE . 1.9 ttm -140.76 148.77 41.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' B' ' 114' ' ' LEU . 1.4 t -129.02 142.21 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.49 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 21.7 t -132.04 112.41 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 27' ' ' ASN . 1.7 t -104.86 165.37 11.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.382 -0.824 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.464 ' HA2' ' CG ' ' A' ' 27' ' ' ASN . . . 107.87 -28.26 12.67 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -51.5 144.91 9.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -1.222 . . . . 0.0 110.241 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' B' ' 128' ' ' SER . 17.0 pttm -112.62 -23.54 10.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.422 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -137.25 -153.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.79 -39.27 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.319 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.9 -42.45 90.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.62 -47.21 79.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 110.204 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 35.7 t -52.27 -46.96 66.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.241 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -36.86 80.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 110.212 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.82 -50.39 36.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.73 -50.27 66.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -54.34 41.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.009 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.431 ' HD3' ' HD3' ' B' ' 138' ' ' LYS . 0.0 OUTLIER -46.5 -39.37 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.961 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.431 ' HD3' ' HD3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -61.29 -53.73 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.945 . . . . 0.0 110.052 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.567 ' CE1' HG21 ' B' ' 106' ' ' ILE . 40.5 m-85 -54.21 -52.72 60.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.257 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.37 -31.93 16.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -35.98 81.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 13.8 mt -63.97 -48.62 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.526 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.493 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 20.4 mm -61.66 -49.32 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -68.95 -27.56 65.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.085 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -77.35 -20.6 54.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.237 -0.914 . . . . 0.0 108.75 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.468 HG22 HD11 ' B' ' 146' ' ' ILE . 6.8 mt -87.57 -19.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.697 -0.627 . . . . 0.0 109.34 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.45 -29.41 5.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.493 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 6.8 m-85 -47.88 159.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.032 -1.275 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.12 42.07 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.651 -0.655 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.457 ' HB1' HG23 ' B' ' 143' ' ' ILE . . . -71.33 154.87 41.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.601 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -144.42 120.52 10.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 109.768 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 63.3 t80 -60.89 111.46 1.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.452 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -158.16 163.25 37.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 0.4 OUTLIER 63.43 13.95 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' B' ' 156' ' ' LYS . 19.8 t80 -61.41 126.41 27.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.972 -1.08 . . . . 0.0 109.838 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 155' ' ' PHE . 27.5 mtpt -160.77 133.35 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.548 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.419 HG22 HG22 ' B' ' 70' ' ' ILE . 2.9 mp -79.49 127.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.755 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -129.33 -25.69 2.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.209 -0.932 . . . . 0.0 110.88 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.515 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.1 OUTLIER -113.54 96.88 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.793 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.523 ' CG2' HD12 ' B' ' 67' ' ' LEU . 44.5 mt -107.85 111.36 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.552 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.466 HG21 ' OG1' ' B' ' 215' ' ' THR . 25.2 t -94.8 107.66 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.789 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -111.5 167.52 12.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.8 t -169.16 159.72 9.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.923 -1.339 . . . . 0.0 110.63 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' B' ' 64' ' ' VAL . 0.0 OUTLIER -169.85 170.11 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.845 . . . . 0.0 109.928 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.89 161.05 14.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.969 . . . . 0.0 110.281 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.54 -83.8 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.89 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.484 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 7.0 p90 -137.49 166.31 27.59 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.7 Cg_endo -71.18 149.42 57.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.782 1.412 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.39 160.57 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.301 -0.874 . . . . 0.0 110.376 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.07 91.42 6.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 83.0 mt -48.34 -26.37 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.38 -58.57 4.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -51.22 -31.82 27.68 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.442 HD12 ' ND1' ' B' ' 179' ' ' HIS . 0.1 OUTLIER -72.97 -42.89 62.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -1.165 . . . . 0.0 110.229 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.423 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -68.09 -13.46 62.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.143 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.6 t80 -92.8 -37.52 12.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' SER . . . . . 0.474 ' HB2' ' CZ ' ' B' ' 237' ' ' PHE . 46.6 t -83.82 -50.27 8.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.442 ' ND1' HD12 ' B' ' 175' ' ' LEU . 20.0 m80 -105.4 19.4 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.887 . . . . 0.0 110.225 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' B' ' 176' ' ' ALA . . . -54.36 -25.74 34.72 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.07 -24.31 62.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -1.145 . . . . 0.0 110.263 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.57 ' CZ ' HG23 ' B' ' 198' ' ' VAL . 0.9 OUTLIER -134.66 12.04 3.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 48.6 m -120.15 159.47 24.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 0.0 110.373 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 16.9 m -134.84 126.81 29.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.174 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -136.55 120.03 17.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 110.41 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -132.25 105.17 13.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.818 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.96 -2.86 12.17 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.084 1.571 . . . . 0.0 110.346 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.0 5.86 45.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.875 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 58' ' ' SER . 0.4 OUTLIER -157.82 -41.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 110.266 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 55' ' ' ASN . 3.0 t80 -126.35 114.15 23.42 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -17.82 28.02 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.838 1.441 . . . . 0.0 110.49 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -94.31 179.79 37.84 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.439 HD21 HD11 ' B' ' 206' ' ' ILE . 9.5 tt -120.41 126.99 51.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.334 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.436 ' CG1' HD22 ' B' ' 205' ' ' LEU . 6.5 mt -90.95 107.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.4 t80 -96.44 116.7 29.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 87.55 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.0 ttm -59.53 144.07 48.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.57 HG23 ' CZ ' ' B' ' 182' ' ' PHE . 65.2 t -88.26 -40.37 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 110.436 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.93 107.49 6.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.365 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.96 166.31 83.26 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.049 -2.063 . . . . 0.0 110.55 -0.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.0 OUTLIER -76.31 95.73 3.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 33.4 mm -134.91 160.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.45 107.04 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.506 HD22 ' CD2' ' B' ' 214' ' ' LEU . 1.5 mp -100.07 134.63 42.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.547 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 2.8 mt -110.83 116.26 30.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.439 HD11 HD21 ' B' ' 193' ' ' LEU . 3.6 mp -100.48 136.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.273 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' B' ' 208' ' ' VAL . 49.0 m-85 -119.92 131.23 55.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 0.0 110.069 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 22.0 t -42.79 -27.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 207' ' ' PHE . 98.3 p -64.51 -26.58 68.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 110.75 9.02 23.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.426 ' C ' ' CD1' ' B' ' 212' ' ' ILE . 0.1 OUTLIER -98.2 121.93 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -1.185 . . . . 0.0 110.153 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' B' ' 212' ' ' ILE . 1.2 mp -109.97 146.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.248 -0.907 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 27.6 t -127.81 146.65 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 110.08 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.506 ' CD2' HD22 ' B' ' 204' ' ' LEU . 4.4 mp -133.2 109.51 9.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.466 ' OG1' HG21 ' B' ' 161' ' ' VAL . 14.7 t -130.23 152.04 50.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.149 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.486 ' CA ' ' HE2' ' A' ' 67' ' ' MET . . . 109.03 -11.92 34.31 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -68.77 144.57 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.165 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -90.04 -17.37 27.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.173 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.408 ' N ' ' CD1' ' B' ' 160' ' ' ILE . 1.7 mt-30 -147.95 168.94 20.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -14.54 62.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.138 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' B' ' 221' ' ' GLU . 8.5 mp0 -68.73 -42.19 77.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 110.081 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -63.78 -51.15 66.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.456 HG21 HD11 ' B' ' 223' ' ' ILE . 45.8 mm -56.0 -37.2 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.05 -42.87 93.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 226' ' ' ALA . 0.0 OUTLIER -75.9 -44.11 42.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.296 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 225' ' ' GLN . . . -45.3 -41.38 8.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.458 ' HB2' ' HG3' ' B' ' 65' ' ' PRO . 10.2 t80 -78.39 -50.26 12.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 109.88 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -18.62 33.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.982 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -97.86 -32.61 11.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' B' ' 232' ' ' PRO . 5.8 tp -92.98 -17.79 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.3 t80 -50.88 -44.99 87.24 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 111.107 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.7 Cg_endo -71.93 -32.65 10.95 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.205 1.108 . . . . 0.0 110.496 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.37 -30.41 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 109.893 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.438 HD23 HG12 ' B' ' 206' ' ' ILE . 89.7 mt -70.91 -56.49 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.993 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -25.3 17.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -48.88 62.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' B' ' 178' ' ' SER . 92.4 m-85 -106.87 37.51 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.38 -0.825 . . . . 0.0 109.87 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -163.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' B' ' 169' ' ' PRO . 1.7 ttmm -126.7 -81.12 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 1.8 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.314 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.655 ' N ' ' CZ ' ' B' ' 99' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.26 75.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 0.0 110.25 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.607 ' CD1' ' HB ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -91.14 -7.53 51.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 91.9 m -43.38 -30.7 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.43 -31.48 6.44 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.553 HG13 HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -52.79 -41.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.316 . . . . 0.0 109.333 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.537 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.4 pp -84.51 -18.94 34.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.742 -1.223 . . . . 0.0 108.652 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -99.6 14.57 29.55 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 141.18 93.27 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.532 ' CB ' ' CG2' ' B' ' 124' ' ' THR . 4.9 p30 -28.42 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.69 0.757 . . . . 0.0 112.066 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.79 169.1 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.599 ' N ' HG12 ' A' ' 28' ' ' ILE . 94.9 m-20 -86.41 123.92 32.17 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.515 ' HB3' ' CG1' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -36.56 -29.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.923 -177.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.5 tt0 -50.26 -21.16 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 109.87 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.82 25.45 4.23 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.672 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.57 135.19 52.94 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.808 -1.407 . . . . 0.0 110.988 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.639 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -103.43 154.01 19.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 111.235 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.531 ' CD2' ' OD1' ' A' ' 27' ' ' ASN . 3.0 pp . . . . . 0 N--CA 1.492 1.645 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.156 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.231 0.539 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.5 tt0 -100.65 -24.29 14.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' ASN . 3.9 mt -99.61 -44.37 6.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.73 -44.38 4.32 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.395 -0.816 . . . . 0.0 109.931 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.26 -27.25 65.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 52' ' ' LEU . 29.2 m-80 -81.45 -36.03 29.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 6.8 mt -55.54 -44.05 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 0.0 109.541 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.42 -17.09 31.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -129.75 18.83 5.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -1.089 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' B' ' 190' ' ' PHE . 3.0 mt -80.93 -5.1 57.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 97.9 p -90.08 37.88 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 0.0 109.691 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 58' ' ' SER . 13.7 mtpp -121.17 6.66 10.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.61 -85.02 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.48 28.9 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.307 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.54 HD13 ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -100.69 -27.96 13.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.024 -1.28 . . . . 0.0 109.005 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 50.2 t0 -45.21 -38.28 5.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.5 ' HA ' ' CD2' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -53.9 -30.63 46.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.991 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.479 ' SD ' ' CA ' ' B' ' 216' ' ' GLY . 0.9 OUTLIER -78.17 -25.63 47.29 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 109.803 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 7.9 mp -61.93 -58.66 7.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.5 ' CD2' ' HA ' ' A' ' 66' ' ' SER . 2.1 pp -52.75 -19.1 2.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.555 -0.716 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 35.3 tt0 -75.33 -2.98 30.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 110.356 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.607 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 1.4 t -132.77 1.46 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.118 -0.989 . . . . 0.0 109.875 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.559 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 7.5 tp -146.82 67.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.638 -0.664 . . . . 0.0 109.918 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 46.4 t0 -76.8 57.84 1.35 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.617 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 6.0 mt . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 121.577 0.703 . . . . 0.0 110.85 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' B' ' 64' ' ' VAL . 3.4 mt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.124 0.488 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' B' ' 63' ' ' ILE . 38.8 t 58.55 137.79 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 0.0 110.514 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.484 ' HD3' ' CD2' ' B' ' 227' ' ' PHE . 44.6 Cg_endo -73.27 124.74 9.7 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.859 1.452 . . . . 0.0 110.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.496 ' O ' ' CA ' ' B' ' 162' ' ' GLY . 2.3 m -89.97 156.4 18.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.96 137.97 31.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.213 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -126.91 -10.74 6.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.511 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.476 ' OD1' ' HA2' ' B' ' 125' ' ' GLY . 0.5 OUTLIER -168.02 131.0 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.474 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 124' ' ' THR . 4.1 mt -129.74 165.75 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.454 HG21 ' CB ' ' B' ' 124' ' ' THR . 42.5 t -139.89 144.76 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 110.568 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.97 162.31 35.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.055 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 42.1 p -110.76 141.64 43.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.067 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.505 ' CG1' ' HE3' ' B' ' 121' ' ' MET . 60.6 t -131.92 146.6 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 110.173 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' B' ' 154' ' ' ASP . 2.3 m -118.84 129.1 55.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' B' ' 151' ' ' LYS . 64.2 mt -89.67 -40.72 12.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 110.102 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.04 22.18 20.98 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.86 146.55 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -1.191 . . . . 0.0 110.381 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -77.16 148.58 35.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.418 HD12 HD11 ' B' ' 76' ' ' LEU . 13.7 mt -129.37 149.31 51.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.7 OUTLIER -90.07 94.74 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.733 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.459 HD21 ' CG2' ' B' ' 102' ' ' VAL . 13.1 mt -40.24 -55.23 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 0.0 110.462 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -47.25 -39.72 14.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 99.3 m -76.35 -41.04 49.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.54 -56.76 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 110.448 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.81 55.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.324 -0.86 . . . . 0.0 110.734 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 0.9 OUTLIER -72.13 -51.26 22.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.543 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -72.77 -42.23 64.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 0.0 110.482 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -42.7 122.34 2.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.429 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -73.53 -26.07 60.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.094 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 1.8 m120 -130.05 78.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -170.28 170.23 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.429 -0.794 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.466 ' HG3' HD11 ' B' ' 103' ' ' ILE . 9.6 pt-20 -160.2 137.2 9.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -108.54 116.47 32.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 110.088 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.23 107.12 55.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.314 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -23.13 18.95 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.895 1.471 . . . . 0.0 110.089 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -24.38 63.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.099 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.45 -69.32 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.031 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.655 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.36 166.23 26.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.4 44.85 1.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.617 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -122.83 146.83 47.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.459 ' CG2' HD21 ' B' ' 82' ' ' LEU . 30.9 t -89.97 122.15 41.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.325 -0.86 . . . . 0.0 109.05 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.521 HG22 ' CA ' ' A' ' 29' ' ' ASP . 4.1 mp -89.3 110.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.893 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.428 ' HB2' ' CD1' ' B' ' 115' ' ' ILE . 7.2 ttm -103.93 163.95 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' B' ' 111' ' ' THR . 0.4 OUTLIER -163.6 127.38 2.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 110.587 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.53 HG22 ' CE1' ' B' ' 139' ' ' TYR . 7.2 pt -112.08 170.94 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 109.895 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 12.1 ptt180 -114.09 18.06 17.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.1 -1.0 . . . . 0.0 110.536 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 9.6 tt0 -177.67 94.02 0.23 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.478 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.471 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.6 Cg_endo -77.8 139.54 57.63 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.957 -2.101 . . . . 0.0 110.484 -0.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.453 ' O ' HG21 ' B' ' 111' ' ' THR . 18.9 mttp -56.65 118.98 5.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 0.7 OUTLIER -163.59 178.33 8.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 110.419 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -131.91 172.4 12.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.82 . . . . 0.0 109.149 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.505 ' N ' ' CG2' ' B' ' 112' ' ' THR . . . -166.1 137.24 3.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.487 ' CD1' HG13 ' B' ' 122' ' ' VAL . 0.3 OUTLIER -97.91 102.52 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' B' ' 104' ' ' MET . 2.3 mp -89.65 126.15 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 2.6 m-85 -101.32 157.44 16.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 109.913 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.444 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -73.56 -23.02 59.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 1.5 t -58.18 -18.91 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.184 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.11 -17.79 16.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -96.71 147.25 24.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 110.142 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.505 ' HE3' ' CG1' ' B' ' 74' ' ' VAL . 4.3 ptt? -138.5 169.24 18.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.487 HG13 ' CD1' ' B' ' 114' ' ' LEU . 5.1 t -127.12 142.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 11.2 t -119.63 149.67 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.794 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.532 ' CG2' ' CB ' ' A' ' 27' ' ' ASN . 3.0 t -162.36 160.21 26.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.877 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.524 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 104.25 -1.56 43.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' B' ' 69' ' ' ASN . . . -75.53 -179.0 4.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.249 . . . . 0.0 110.09 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -135.28 0.39 2.8 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.994 -1.066 . . . . 0.0 110.731 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -160.41 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.081 -1.012 . . . . 0.0 110.319 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -87.84 -34.12 18.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.67 -34.94 60.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -53.49 53.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 3.1 m -55.0 -42.8 72.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.992 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.43 78.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.926 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.458 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -71.49 -56.69 5.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.062 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.44 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.309 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 21.0 t -65.77 -63.14 1.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.1 ptm180 -52.06 -31.15 28.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.485 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -62.99 -47.47 82.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.666 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.53 ' CE1' HG22 ' B' ' 106' ' ' ILE . 20.9 m-85 -63.73 -53.42 51.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.632 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.37 -22.94 13.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.33 -47.53 49.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.783 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.466 ' O ' HG13 ' B' ' 146' ' ' ILE . 1.8 mt -50.4 -43.3 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.527 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 3.1 mp -73.08 -59.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.918 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 3.0 mm-40 -54.45 -34.82 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.617 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -73.22 -30.15 63.29 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.466 HG13 ' O ' ' B' ' 142' ' ' ILE . 3.4 mt -72.68 -16.16 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.1 -20.58 19.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.522 ' CB ' HG22 ' B' ' 143' ' ' ILE . 3.1 m-85 -49.8 171.13 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.961 -1.317 . . . . 0.0 110.548 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.7 43.55 1.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 110.097 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.527 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -85.68 151.97 23.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.579 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 6.6 mttp -120.98 -158.53 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 110.206 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.03 86.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -146.53 177.19 9.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.536 ' CB ' ' OG1' ' B' ' 75' ' ' THR . 2.8 t0 69.29 6.57 5.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.352 -0.842 . . . . 0.0 110.704 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -51.23 127.73 20.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.026 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 126.3 5.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.54 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 6.5 mt -82.67 117.16 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.752 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -117.98 2.5 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 110.602 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.449 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.4 OUTLIER -147.67 121.9 9.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.448 ' HA ' HG12 ' B' ' 70' ' ' ILE . 57.6 mt -130.93 126.14 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.716 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 15.0 t -105.16 140.05 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' B' ' 66' ' ' THR . . . -139.96 -179.81 18.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.9 OUTLIER -170.38 154.99 4.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.315 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.464 ' HB2' HG23 ' B' ' 63' ' ' ILE . 18.0 p -170.18 163.47 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -106.24 133.73 50.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.974 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.58 ' O ' ' CD2' ' B' ' 168' ' ' PHE . 12.8 m -83.48 7.43 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -0.931 . . . . 0.0 110.595 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 45.7 tttt 70.68 12.43 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 110.809 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 16.0 p90 -169.35 145.6 2.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.048 -1.032 . . . . 0.0 110.425 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.66 154.77 54.65 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.092 1.575 . . . . 0.0 110.648 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.11 151.18 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 110.152 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 5.8 ptm180 -88.51 98.51 11.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.115 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' B' ' 185' ' ' TYR . 30.3 mt -54.81 -42.06 71.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.011 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 16.1 pt-20 -55.65 -44.51 77.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.999 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . 0.467 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -66.77 -37.89 92.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.44 HD22 HG13 ' B' ' 233' ' ' VAL . 0.2 OUTLIER -67.19 -38.6 85.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.942 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.64 60.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.933 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.91 -29.35 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.903 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 3.1 t -97.18 -30.89 12.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.949 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' B' ' 183' ' ' SER . 24.7 m170 -130.44 31.71 4.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -66.69 -10.88 56.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.9 m -64.71 -36.63 84.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.0 -14.77 11.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.83 . . . . 0.0 110.303 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.57 ' HB2' ' CD2' ' B' ' 195' ' ' TYR . 0.9 OUTLIER -104.38 149.0 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.404 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 2.3 p -128.95 133.91 48.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.078 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.51 ' CE1' HD11 ' B' ' 172' ' ' LEU . 34.5 t80 -133.3 124.17 26.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.286 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -122.81 104.78 35.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 110.074 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.29 -2.52 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.97 1.511 . . . . 0.0 110.23 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.44 0.42 39.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.853 . . . . 0.0 110.398 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . . . . . . . . . 2.2 tt -161.13 -47.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.572 ' CD2' HD13 ' B' ' 194' ' ' ILE . 1.1 t80 -100.92 110.94 62.4 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.443 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.93 -25.64 16.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.994 1.523 . . . . 0.0 110.266 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.17 -179.68 34.07 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' B' ' 205' ' ' LEU . 7.5 tt -115.91 127.25 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -1.226 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.572 HD13 ' CD2' ' B' ' 190' ' ' PHE . 4.2 mt -90.07 111.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.57 ' CD2' ' HB2' ' B' ' 183' ' ' SER . 10.2 t80 -108.92 113.32 26.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.347 -0.846 . . . . 0.0 110.144 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.1 91.63 5.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 28.0 ttm -60.3 131.34 50.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' B' ' 201' ' ' LYS . 38.5 t -70.71 -42.29 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 1.7 mttt -139.66 112.24 7.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.385 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.9 Cg_endo -73.23 169.94 71.42 Favored 'Cis proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.974 -2.094 . . . . 0.0 110.462 -0.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 8.6 mtmt -79.42 80.02 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.511 HD13 ' CB ' ' B' ' 217' ' ' ALA . 44.7 mm -121.97 150.82 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.527 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.425 ' N ' HG21 ' B' ' 202' ' ' ILE . 79.6 t -101.81 104.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.904 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.3 mp -97.17 141.51 30.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.392 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' B' ' 193' ' ' LEU . 2.5 mt -120.9 131.95 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.422 HD12 ' C ' ' B' ' 205' ' ' LEU . 5.0 mm -115.41 139.51 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -121.38 145.21 48.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.482 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 74.9 t -50.09 -33.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.119 -0.988 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.2 t -63.72 -35.22 79.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 110.082 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 119.03 30.02 1.69 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.98 129.31 46.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 110.312 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' B' ' 163' ' ' SER . 19.2 mm -114.72 132.79 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 6.1 t -124.73 140.31 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.933 . . . . 0.0 110.213 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 3.1 mp -130.75 112.49 13.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.419 ' O ' HG21 ' B' ' 215' ' ' THR . 5.3 t -136.34 151.43 49.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.479 ' CA ' ' SD ' ' A' ' 67' ' ' MET . . . 103.85 7.05 42.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.511 ' CB ' HD13 ' B' ' 202' ' ' ILE . . . -82.19 159.46 23.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -1.197 . . . . 0.0 110.165 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -99.57 -17.58 17.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 0.0 110.171 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.421 ' CA ' HD13 ' B' ' 160' ' ' ILE . 0.5 OUTLIER -147.44 -162.59 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -95.75 -21.08 18.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.23 -24.09 65.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.833 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -79.92 -52.68 7.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.906 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 22.5 mm -52.94 -39.35 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.865 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.24 -43.84 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.008 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.61 82.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.287 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.84 88.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.208 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.484 ' CD2' ' HD3' ' B' ' 65' ' ' PRO . 53.1 t80 -70.0 -49.0 55.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -24.5 67.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.63 -31.33 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.945 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.491 HG21 ' N ' ' B' ' 231' ' ' TYR . 2.1 tp -96.96 -16.62 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.937 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.568 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.1 t80 -46.97 -46.34 53.15 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 110.827 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -72.67 -50.57 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.329 1.173 . . . . 0.0 110.427 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.44 HG13 HD22 ' B' ' 175' ' ' LEU . 25.5 t -44.26 -38.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.62 -42.46 64.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.888 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.53 34.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.461 ' CA ' ' HD3' ' B' ' 171' ' ' ARG . 86.6 m-85 -121.44 38.77 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.78 167.07 21.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -104.8 -36.92 7.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.263 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.644 ' N ' ' CE1' ' B' ' 99' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.545 ' N ' ' CD1' ' A' ' 18' ' ' LEU . 6.2 t70 -65.86 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.605 ' CD1' ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -84.4 -17.2 40.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.525 -0.734 . . . . 0.0 111.02 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.533 ' N ' HD22 ' A' ' 68' ' ' LEU . 8.8 m -44.65 -25.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.045 -1.034 . . . . 0.0 110.349 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -100.16 -34.57 4.78 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.557 ' N ' HG21 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -48.5 -40.35 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.216 -1.167 . . . . 0.0 109.688 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.427 ' HB2' ' ND2' ' B' ' 159' ' ' ASN . 1.4 pp -83.42 -18.24 39.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.943 -1.098 . . . . 0.0 108.724 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -98.68 6.32 47.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.631 -0.668 . . . . 0.0 109.381 179.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 151.26 89.96 0.08 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.553 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 12.5 p-10 -19.54 81.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.662 0.744 . . . . 0.0 112.896 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.637 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -89.44 164.54 2.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 28' ' ' ILE . 70.3 m-20 -86.49 132.77 33.84 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -42.29 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.178 -178.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.1 tm-20 -62.77 -7.48 5.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.44 5.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LEU . 1.1 tpp180 -127.12 128.95 47.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.096 -1.238 . . . . 0.0 110.376 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.637 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -98.75 150.94 21.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.937 -1.102 . . . . 0.0 110.33 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.541 HD12 ' ND2' ' A' ' 27' ' ' ASN . 4.5 pp . . . . . 0 N--CA 1.49 1.562 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.262 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.095 0.474 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.3 tt0 -100.37 -22.01 15.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.061 -1.025 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 56' ' ' ILE . 5.1 mt -101.19 -51.39 3.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.533 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -47.4 -51.26 20.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.394 -0.817 . . . . 0.0 109.889 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -68.73 -15.29 63.47 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.729 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.581 ' HB3' ' CE2' ' B' ' 190' ' ' PHE . 1.9 m-80 -92.63 -35.0 13.77 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 7.5 mt -55.56 -42.44 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.416 -0.802 . . . . 0.0 109.309 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.4 -21.22 12.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.19 28.23 5.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -1.133 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 56' ' ' ILE . 5.0 mt -92.12 10.44 29.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.59 34.82 1.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.845 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HG3' ' CD2' ' A' ' 62' ' ' LEU . 11.6 ptpt -135.55 26.03 3.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.436 -0.79 . . . . 0.0 109.969 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.468 ' CD2' ' HG3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -142.96 -56.86 0.42 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.553 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . -164.0 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.4 mm? -42.07 -29.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.331 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.6 -33.65 33.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.739 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -68.9 -56.98 6.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.515 ' SD ' ' CA ' ' B' ' 216' ' ' GLY . 0.0 OUTLIER -67.3 -8.54 33.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.341 -0.849 . . . . 0.0 109.208 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.581 ' CD2' ' CB ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -67.98 -63.84 0.98 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.805 0.812 . . . . 0.0 109.035 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.418 HD11 ' C ' ' A' ' 69' ' ' LEU . 3.4 pp -68.9 -5.95 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.215 0.531 . . . . 0.0 110.075 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 22.4 tt0 -80.92 3.37 23.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.605 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.1 t -143.27 4.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.816 -1.178 . . . . 0.0 110.656 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.581 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 5.9 tp -149.14 71.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.553 -0.717 . . . . 0.0 109.367 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t0 -76.52 57.34 1.21 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.62 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 5.6 mt . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.66 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.2 mp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.209 0.528 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 57.0 t 59.62 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.466 -0.771 . . . . 0.0 110.385 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.5 Cg_endo -75.53 149.61 34.82 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.928 1.489 . . . . 0.0 110.631 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.441 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.1 m -113.93 143.08 45.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.909 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 67.6 mt -80.44 117.61 21.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -108.3 -10.69 15.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.278 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.528 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 6.3 t30 -165.76 160.13 16.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 110.299 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 10.2 mt -157.45 166.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.936 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.459 ' N ' HG23 ' B' ' 70' ' ' ILE . 16.6 t -135.41 132.85 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.488 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -121.2 136.51 54.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.9 m -97.11 134.06 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 0.0 110.125 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' B' ' 155' ' ' PHE . 8.4 t -133.63 169.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 56.2 m -144.11 133.66 23.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.387 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.503 ' CD1' HD12 ' B' ' 80' ' ' LEU . 82.9 mt -88.56 -14.39 37.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.67 -0.54 70.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 22.1 p -138.55 137.0 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -1.164 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' B' ' 118' ' ' SER . 5.7 mtp85 -62.48 158.72 17.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.503 HD12 ' CD1' ' B' ' 76' ' ' LEU . 15.5 mt -130.36 150.45 51.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.271 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 1.0 OUTLIER -99.12 93.54 6.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.456 HD23 HG21 ' B' ' 102' ' ' VAL . 9.1 mt -39.16 -46.49 1.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.465 -0.772 . . . . 0.0 110.68 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.63 -43.56 76.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.51 HG21 ' CD2' ' B' ' 88' ' ' HIS . 84.8 m -83.58 -35.77 24.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.99 . . . . 0.0 110.22 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 30.4 t -65.96 -57.25 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.53 -36.59 80.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.493 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.03 -48.03 83.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.51 ' CD2' HG21 ' B' ' 84' ' ' THR . 45.2 m-70 -78.61 -42.95 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -0.951 . . . . 0.0 110.542 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.437 ' HB2' ' HB1' ' B' ' 92' ' ' ALA . . . -43.82 124.95 3.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 109.997 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.92 -18.01 62.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 3.3 m-20 -137.42 79.8 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -165.84 152.27 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.54 164.61 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 110.044 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.52 120.82 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 110.435 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.44 112.09 21.11 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.99 -18.8 30.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.932 1.491 . . . . 0.0 110.268 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -71.95 -17.13 62.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -105.54 -69.72 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.644 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -152.09 -178.93 7.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.494 -0.754 . . . . 0.0 109.953 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -99.48 49.89 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.915 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.62 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -130.95 149.84 52.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.946 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.458 ' HB ' ' HB ' ' B' ' 115' ' ' ILE . 99.4 t -92.27 124.07 44.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 5.0 mp -88.76 107.35 17.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.419 ' HE3' HG23 ' B' ' 142' ' ' ILE . 0.9 OUTLIER -93.27 161.39 14.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.482 -0.761 . . . . 0.0 109.844 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -163.85 123.31 2.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 0.0 110.832 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 4.6 pt -122.59 155.56 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 109.696 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 5.3 mtt180 -103.49 30.86 4.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 4.3 tm-20 -177.9 87.8 0.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.49 159.58 96.24 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.351 -0.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' B' ' 111' ' ' THR . 0.1 OUTLIER -73.12 115.37 12.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.037 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' B' ' 110' ' ' LYS . 0.8 OUTLIER -165.99 175.26 8.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.319 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.532 HG21 ' CG2' ' B' ' 124' ' ' THR . 0.5 OUTLIER -134.53 157.87 45.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.128 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -147.34 158.81 44.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -115.3 107.37 15.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.486 -0.758 . . . . 0.0 109.375 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.505 ' N ' HD11 ' B' ' 115' ' ' ILE . 3.0 mp -89.93 131.47 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.618 ' CD1' ' CD1' ' A' ' 74' ' ' LEU . 4.5 m-30 -106.95 149.9 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.795 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' B' ' 80' ' ' LEU . . . -61.36 -20.06 62.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 110.342 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' B' ' 79' ' ' ARG . 12.2 t -62.86 -33.76 75.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.343 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.462 ' HA2' ' HG ' ' B' ' 80' ' ' LEU . . . 126.19 -13.77 7.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -76.16 171.57 14.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 6.7 ttp -155.99 135.0 12.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.158 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.525 ' CG1' HG11 ' A' ' 71' ' ' VAL . 12.6 t -115.51 119.02 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 18.7 t -105.24 144.49 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.538 HG21 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -146.78 165.96 28.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.542 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 101.55 -24.27 32.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.61 156.51 0.66 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -1.219 . . . . 0.0 110.607 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -109.4 -14.5 14.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 4.3 m -163.71 -178.49 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.244 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . 0.407 ' HG2' HD13 ' B' ' 157' ' ' ILE . 93.3 mt-10 -58.18 -65.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.052 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.35 -30.44 2.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.079 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -71.33 -53.71 13.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.0 110.226 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -54.81 -37.85 66.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -48.86 79.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.051 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 39.5 mt -61.57 -49.56 76.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.847 . . . . 0.0 110.054 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -58.05 -35.65 71.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 13.5 t -70.57 -65.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 110.022 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -46.79 -34.42 5.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.017 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' B' ' 138' ' ' LYS . 42.5 mmtt -63.86 -49.61 72.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.475 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 18.4 m-85 -66.6 -54.91 18.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.916 . . . . 0.0 109.959 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.98 -35.61 59.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 3.3 ttp180 -58.77 -41.71 87.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.99 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.419 HG23 ' HE3' ' B' ' 104' ' ' MET . 27.6 mt -59.0 -47.05 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' B' ' 143' ' ' ILE . 1.5 mp -60.46 -46.83 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.069 -1.02 . . . . 0.0 109.396 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 68.5 mt-30 -67.27 -31.89 72.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.452 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 3.1 mmtt -74.49 -28.71 61.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.94 -22.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.2 -22.85 7.0 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.479 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -51.63 175.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.349 . . . . 0.0 110.756 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.16 36.03 3.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.478 -0.764 . . . . 0.0 110.542 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.484 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -62.47 131.09 48.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' B' ' 152' ' ' PHE . 2.0 ptpt -111.31 25.08 12.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.011 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.486 ' C ' ' O ' ' B' ' 151' ' ' LYS . 3.7 t80 31.55 95.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.124 0.488 . . . . 0.0 111.2 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.426 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 1.9 p -153.23 174.41 14.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 153' ' ' THR . 1.6 t0 65.2 27.22 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.409 -0.807 . . . . 0.0 110.554 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.432 ' HA ' HG21 ' B' ' 74' ' ' VAL . 41.3 t80 -73.25 133.52 43.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.89 . . . . 0.0 109.903 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -166.7 135.52 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 110.48 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 44.8 mt -78.9 133.66 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.432 -0.792 . . . . 0.0 109.638 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' B' ' 218' ' ' LYS . 23.2 mt-30 -125.53 -40.0 2.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 110.939 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.461 ' ND2' ' HA2' ' B' ' 216' ' ' GLY . 0.7 OUTLIER -114.06 109.27 18.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.066 -1.021 . . . . 0.0 110.959 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.458 HG12 HD12 ' B' ' 70' ' ' ILE . 30.1 mt -105.94 123.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.486 HG22 ' ND2' ' B' ' 69' ' ' ASN . 79.8 t -98.36 138.98 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 110.574 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -140.49 167.27 25.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 155.08 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.265 . . . . 0.0 110.708 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.459 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 5.5 p -169.4 171.63 7.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.418 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 7.9 m-20 -128.57 140.39 51.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.0 110.419 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 22.6 m -119.34 8.66 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.936 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt 52.03 29.9 6.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 110.179 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' ' 238' ' ' ARG . 1.2 t80 -121.0 115.86 31.58 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.26 120.16 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.904 1.476 . . . . 0.0 110.223 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.464 HG22 HD21 ' B' ' 234' ' ' LEU . 3.3 mt -101.49 145.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.568 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.64 84.86 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.981 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.52 ' O ' ' CB ' ' B' ' 176' ' ' ALA . 15.1 mt -48.04 -23.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.98 -53.13 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.25 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.82 -38.61 96.26 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 11.7 tp -74.81 -38.58 62.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 109.968 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 172' ' ' LEU . . . -65.87 -38.66 89.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -0.924 . . . . 0.0 110.291 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -72.38 -24.41 61.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.178 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -89.24 -48.9 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' B' ' 183' ' ' SER . 53.1 m170 -103.16 34.94 2.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.08 -33.63 51.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -19.09 44.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -1.095 . . . . 0.0 110.141 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.519 ' CE1' HG22 ' B' ' 198' ' ' VAL . 36.2 m-85 -136.37 6.02 3.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.447 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' B' ' 179' ' ' HIS . 0.2 OUTLIER -133.64 135.57 44.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 0.0 110.67 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.98 122.17 37.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 109.792 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -124.49 129.42 50.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 110.597 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 190' ' ' PHE . 9.3 mt-10 -136.23 102.85 9.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.453 -0.779 . . . . 0.0 109.653 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -2.45 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.932 1.49 . . . . 0.0 110.825 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -100.43 -6.02 26.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 0.0 110.324 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -143.91 -50.37 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.327 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 55' ' ' ASN . 2.7 t80 -111.26 121.49 40.28 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . 0.449 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.4 Cg_endo -73.54 -35.55 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.923 1.486 . . . . 0.0 110.631 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.39 175.83 42.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.484 ' N ' HD12 ' B' ' 172' ' ' LEU . 8.7 tt -106.83 138.19 43.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -1.163 . . . . 0.0 110.251 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.455 HD12 HD12 ' A' ' 62' ' ' LEU . 2.6 mt -98.35 96.74 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.499 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 7.6 t80 -93.89 120.37 34.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.469 ' HG2' ' CG2' ' B' ' 203' ' ' VAL . 17.0 mtp85 -108.2 97.82 7.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.328 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 45.3 tpp -52.88 148.34 7.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.051 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.519 HG22 ' CE1' ' B' ' 182' ' ' PHE . 86.2 t -91.48 -40.91 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.905 . . . . 0.0 110.394 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.7 107.79 6.48 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.491 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.92 165.45 84.97 Favored 'Cis proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.952 -2.103 . . . . 0.0 110.395 -0.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 16.9 mtmt -75.05 97.31 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' B' ' 222' ' ' GLU . 23.9 mm -129.24 158.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.582 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.469 ' CG2' ' HG2' ' B' ' 196' ' ' ARG . 46.0 t -111.63 124.37 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' B' ' 204' ' ' LEU . 3.9 mp -123.9 135.85 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.171 -0.956 . . . . 0.0 110.623 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.42 ' HB3' ' CE1' ' B' ' 207' ' ' PHE . 3.8 mm? -101.33 125.23 47.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.83 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.499 ' CD1' ' HB2' ' B' ' 195' ' ' TYR . 2.8 mt -120.32 133.68 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' B' ' 207' ' ' PHE . 57.8 m-85 -119.46 154.22 34.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 52.7 t -60.44 -22.57 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.074 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.5 t -64.52 -36.17 83.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 121.29 11.04 6.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' B' ' 165' ' ' ASP . 2.2 mptm? -92.51 141.65 28.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.105 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 24.6 mm -131.78 132.7 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.4 t -123.08 140.08 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.226 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 5.6 mp -121.47 145.03 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 6.6 t -165.3 157.3 15.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.187 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.515 ' CA ' ' SD ' ' A' ' 67' ' ' MET . . . 98.02 -15.78 61.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.525 ' CB ' HD12 ' B' ' 223' ' ' ILE . . . -65.83 141.7 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' B' ' 158' ' ' GLN . 0.3 OUTLIER -92.56 -25.93 18.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.109 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.86 151.37 47.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -47.05 -33.23 4.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -38.47 70.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.434 ' HB3' HD13 ' B' ' 202' ' ' ILE . 0.2 OUTLIER -60.66 -49.68 76.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.525 HD12 ' CB ' ' B' ' 217' ' ' ALA . 47.2 mm -56.03 -38.65 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 110.342 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.34 -40.38 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 110.326 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.86 94.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.3 -56.45 21.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.134 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -58.64 -44.49 90.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.131 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.9 -36.19 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.14 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . 0.402 ' O ' HG22 ' B' ' 233' ' ' VAL . . . -91.48 -11.31 37.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 9.8 mm -97.77 -23.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.784 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -50.22 -48.45 79.93 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 110.758 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.72 -41.73 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.515 1.271 . . . . 0.0 110.376 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 229' ' ' ALA . 57.1 t -50.53 -39.39 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.645 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.464 HD21 HG22 ' B' ' 170' ' ' ILE . 15.8 mt -68.65 -48.43 64.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.824 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 40.8 t -60.78 -31.99 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.845 . . . . 0.0 109.87 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -37.94 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.494 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 76.6 m-85 -116.23 38.04 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.95 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.414 ' HB3' ' CE2' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -60.85 145.89 48.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 110.086 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -93.71 -39.2 10.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.918 . . . . 0.0 110.167 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.218 179.926 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' HB2' ' A' ' 30' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.22 0.534 . . . . 0.0 110.247 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -63.43 81.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.641 ' CD1' ' CG1' ' A' ' 23' ' ' ILE . 4.1 tp -120.22 62.03 0.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.776 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 1.2 m -92.05 -3.6 55.56 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.504 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -101.62 -31.51 5.46 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.563 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.641 ' CG1' ' CD1' ' A' ' 20' ' ' LEU . 2.2 mm -46.15 -44.12 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.416 -1.638 . . . . 0.0 109.171 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.552 ' HG ' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -83.94 -23.44 31.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.057 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -85.26 10.64 11.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.499 -0.75 . . . . 0.0 109.16 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 135.55 104.83 0.78 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.571 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 7.5 p-10 -21.74 118.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.944 0.878 . . . . 0.0 111.438 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -140.37 161.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.546 0.688 . . . . 0.0 109.461 -178.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.541 ' N ' HG12 ' A' ' 28' ' ' ILE . 1.2 m-20 -87.58 119.32 27.77 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.588 ' OG ' ' CE2' ' B' ' 99' ' ' PHE . 26.7 p -39.15 -25.8 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.3 tt0 -66.3 -3.49 6.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.948 -1.095 . . . . 0.0 111.306 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 29.11 5.83 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.023 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -121.03 117.18 26.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.916 -1.343 . . . . 0.0 109.534 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.593 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.8 OUTLIER -87.27 162.82 17.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.229 . . . . 0.0 111.906 -178.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.558 0.694 . . . . 0.0 111.67 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.291 0.567 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.6 pt-20 -97.47 -31.36 12.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.848 . . . . 0.0 110.29 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 3.1 mt -90.99 -41.29 11.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.532 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -48.81 -52.96 21.26 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.98 -26.53 67.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.368 -0.833 . . . . 0.0 109.524 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 1.9 m-80 -79.97 -42.9 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.459 -0.776 . . . . 0.0 110.05 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -48.43 -45.71 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.81 0.74 64.8 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.71 -44.47 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -1.197 . . . . 0.0 110.884 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.553 ' CD2' ' CE2' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -85.59 34.84 0.59 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 110.698 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.69 34.38 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.894 -1.129 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.9 1.55 0.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 111.106 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.503 ' N ' HD21 ' A' ' 62' ' ' LEU . 5.7 mt -86.65 -67.62 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.661 -1.274 . . . . 0.0 109.93 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.63 -35.66 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -54.24 -39.76 67.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.21 -1.17 . . . . 0.0 110.343 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' HA ' HD11 ' A' ' 68' ' ' LEU . 16.4 t0 -43.91 -33.89 1.49 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 1.5 m -60.7 -62.88 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.523 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 1.1 ttp -72.01 -3.14 21.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.292 -0.88 . . . . 0.0 109.792 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.525 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -67.69 -54.98 15.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 108.933 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 66' ' ' SER . 0.6 OUTLIER -69.92 0.28 6.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.72 -0.613 . . . . 0.0 109.953 179.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -91.83 -11.47 36.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -0.845 . . . . 0.0 110.577 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.564 ' CG1' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.58 -17.59 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.084 -1.01 . . . . 0.0 108.797 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.551 ' HB ' ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -146.57 78.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.845 -0.534 . . . . 0.0 110.148 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.46 53.24 1.51 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.885 -1.134 . . . . 0.0 109.049 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.603 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 8.0 mt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.675 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.47 HD12 ' O ' ' B' ' 165' ' ' ASP . 33.4 mt . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.216 0.531 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 2.7 t 67.2 125.19 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 46.5 Cg_endo -73.43 146.96 40.56 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.856 1.451 . . . . 0.0 110.617 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.401 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 3.3 m -105.4 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 110.07 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.527 HD23 ' CG2' ' B' ' 160' ' ' ILE . 27.3 mt -77.01 134.68 38.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -123.25 -18.39 6.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.419 ' OD1' ' HA2' ' B' ' 125' ' ' GLY . 5.4 t30 -169.88 154.24 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.399 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.458 ' CD1' HG12 ' B' ' 160' ' ' ILE . 5.0 mt -145.26 147.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 110.025 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.521 HG12 ' CG1' ' A' ' 71' ' ' VAL . 53.3 t -115.83 142.83 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.95 . . . . 0.0 110.582 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.402 ' N ' HG11 ' B' ' 71' ' ' VAL . . . -135.31 162.04 33.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 0.0 110.172 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 0.3 OUTLIER -116.48 135.0 54.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.319 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.403 HG13 ' HE3' ' B' ' 121' ' ' MET . 91.5 t -132.04 171.21 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.871 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.517 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 46.1 m -148.03 151.63 36.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.494 ' N ' HG21 ' B' ' 75' ' ' THR . 33.7 mt -104.77 -57.5 2.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.837 . . . . 0.0 110.195 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.95 21.54 6.3 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.68 142.76 12.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -1.205 . . . . 0.0 110.282 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 146.86 53.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.045 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.447 HD13 HD11 ' B' ' 76' ' ' LEU . 15.5 mt -127.48 153.23 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.124 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.1 OUTLIER -90.37 88.12 7.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 110.017 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.473 HD21 ' CG2' ' B' ' 102' ' ' VAL . 10.7 mt -41.14 -44.04 2.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 110.277 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.4 OUTLIER -56.3 -42.28 77.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 110.092 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -83.96 -43.94 14.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.423 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' B' ' 148' ' ' PHE . 86.4 t -55.15 -48.2 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.244 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' B' ' 92' ' ' ALA . . . -72.96 -28.94 62.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 9.5 tp -77.21 -34.6 56.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.59 -25.71 22.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.96 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.52 143.09 57.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -72.06 -27.59 62.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.061 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' B' ' 104' ' ' MET . 71.7 m-20 -134.78 79.44 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 110.007 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' B' ' 86' ' ' ALA . . . -152.32 130.83 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.613 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -124.34 142.78 51.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -118.24 137.94 52.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 0.0 110.811 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' B' ' 95' ' ' ASN . 8.5 p30 -133.66 109.97 12.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.939 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 -26.9 12.79 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.99 1.521 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.28 -7.46 59.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' B' ' 95' ' ' ASN . 0.0 OUTLIER -102.45 -75.91 0.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.588 ' CE2' ' OG ' ' A' ' 30' ' ' SER . 32.4 p90 -145.68 -178.86 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 110.075 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.455 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -99.2 56.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.051 -1.03 . . . . 0.0 112.099 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.603 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -152.53 166.32 32.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.867 -1.146 . . . . 0.0 110.524 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.473 ' CG2' HD21 ' B' ' 82' ' ' LEU . 21.3 t -97.39 157.74 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.469 HD12 ' OG ' ' A' ' 30' ' ' SER . 2.0 mt -118.25 100.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.99 . . . . 0.0 110.429 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.503 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 2.2 ttm -92.39 145.2 24.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.58 118.67 8.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.257 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 109' ' ' PRO . 30.8 pt -116.81 164.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 110.063 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 1.1 ptm180 -120.04 42.44 2.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER 179.26 80.29 0.17 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 0.0 110.256 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.444 ' O ' HG13 ' B' ' 106' ' ' ILE . 49.4 Cg_endo -78.13 159.81 92.66 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.436 -0.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' B' ' 107' ' ' ARG . 2.1 tppt? -71.27 113.18 8.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.441 HG21 ' HA3' ' B' ' 125' ' ' GLY . 0.3 OUTLIER -154.47 164.8 38.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.687 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.9 m -114.84 146.45 41.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.502 -0.748 . . . . 0.0 109.325 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' B' ' 139' ' ' TYR . . . -149.53 140.82 23.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.102 . . . . 0.0 111.305 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' B' ' 114' ' ' LEU . 0.2 OUTLIER -119.37 126.65 51.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.555 -0.716 . . . . 0.0 109.223 179.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 5.8 mt -108.36 136.65 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.935 . . . . 0.0 111.111 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 4.5 m-85 -93.81 161.43 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.58 -1.19 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.972 -1.08 . . . . 0.0 110.296 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 35.9 t -91.19 -7.67 50.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.348 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.1 -30.72 8.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -74.12 151.78 40.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -1.138 . . . . 0.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.403 ' HE3' HG13 ' B' ' 74' ' ' VAL . 7.2 ptt? -153.64 169.45 23.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.201 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.522 HG12 ' CG1' ' A' ' 71' ' ' VAL . 24.8 t -133.38 147.98 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 23.3 t -126.67 170.04 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.511 HG21 ' CB ' ' A' ' 27' ' ' ASN . 10.1 t -170.04 154.18 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.881 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.555 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 111.43 8.3 23.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.479 ' CB ' ' HB2' ' B' ' 132' ' ' SER . . . -82.41 141.21 32.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.154 . . . . 0.0 110.046 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.64 -0.04 41.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.873 . . . . 0.0 110.283 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.79 -159.9 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.209 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.68 -49.09 9.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.55 -28.98 65.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.076 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -43.82 96.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.034 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.479 ' HB2' ' CB ' ' B' ' 126' ' ' ALA . 44.9 t -68.33 -36.64 79.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.79 -38.22 81.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.205 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.438 ' O ' ' HD2' ' B' ' 138' ' ' LYS . 6.1 mt -69.94 -45.41 67.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.31 -52.12 67.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 72.3 m -60.55 -50.85 71.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -39.66 69.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.998 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -59.41 -40.4 86.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' B' ' 113' ' ' ALA . 26.8 m-85 -65.62 -52.08 54.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.71 -36.16 56.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.955 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -59.94 -43.33 95.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 -35.26 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.516 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 39.8 mm -73.9 -57.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.65 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.14 -28.32 69.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 1.7 tttt -75.71 -19.27 59.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.97 -23.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.72 -0.613 . . . . 0.0 109.371 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.4 -29.37 4.8 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' B' ' 85' ' ' VAL . 12.2 m-85 -46.4 163.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -1.214 . . . . 0.0 110.937 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.2 38.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.559 -0.713 . . . . 0.0 109.942 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -73.55 136.41 44.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 5.1 tttt -112.44 157.65 20.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 110.338 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -99.69 89.95 4.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.474 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -148.92 172.8 14.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.387 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.517 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t0 67.78 26.12 7.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 6.8 t80 -84.62 129.16 34.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.077 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -163.62 131.82 3.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 mt -79.88 123.74 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.666 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -119.69 -10.93 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.801 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 26.1 t30 -140.12 122.1 15.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.527 ' CG2' HD23 ' B' ' 67' ' ' LEU . 3.9 mt -113.25 160.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.152 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -138.67 126.35 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.714 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -130.95 176.2 19.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.1 p -158.33 154.54 27.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.438 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.9 p -170.2 174.21 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.818 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.47 ' O ' HD12 ' B' ' 63' ' ' ILE . 14.9 t0 -121.59 136.11 54.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' B' ' 168' ' ' PHE . 26.8 m -85.47 2.54 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.888 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.12 23.72 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.254 -0.904 . . . . 0.0 110.925 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.583 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 8.4 p90 -177.93 148.19 0.65 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.406 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.63 161.15 44.77 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.093 1.575 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.448 HG21 ' O ' ' B' ' 237' ' ' PHE . 4.0 mt -131.08 150.84 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.408 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.0 OUTLIER -84.37 90.62 7.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.511 ' CD1' HG21 ' B' ' 208' ' ' VAL . 22.2 mt -48.2 -29.13 3.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -64.14 -60.22 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.35 -34.15 25.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -47.71 79.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 110.17 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.54 -30.03 67.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.886 . . . . 0.0 110.414 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -69.26 -27.35 65.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.279 -0.888 . . . . 0.0 110.583 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 11.3 p -99.14 -57.75 2.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.14 -0.975 . . . . 0.0 110.357 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' B' ' 183' ' ' SER . 26.6 m80 -100.54 38.26 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -62.85 -30.18 76.37 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' THR . . . . . 0.434 HG22 ' CG ' ' B' ' 182' ' ' PHE . 9.3 t -62.46 -33.47 74.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 110.362 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.434 ' CG ' HG22 ' B' ' 181' ' ' THR . 21.4 m-85 -113.16 -12.2 13.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.493 ' N ' ' O ' ' B' ' 179' ' ' HIS . 37.7 m -104.77 171.29 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.266 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.6 m -155.88 109.87 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.825 . . . . 0.0 110.053 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.5 ' HB2' ' CD1' ' B' ' 193' ' ' LEU . 17.8 t80 -113.49 114.51 26.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 110.23 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 3.2 mm-40 -125.55 102.52 29.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.44 -0.15 8.85 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.083 1.57 . . . . 0.0 110.325 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -98.42 -20.03 17.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.886 . . . . 0.0 110.035 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.51 ' O ' ' CG ' ' B' ' 189' ' ' LEU . 2.6 tt -142.11 8.13 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.3 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.553 ' CE2' ' CD2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -169.94 108.54 0.46 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.264 -0.897 . . . . 0.0 110.419 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -4.36 13.32 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.849 1.447 . . . . 0.0 110.516 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -117.47 162.96 12.76 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.5 ' CD1' ' HB2' ' B' ' 185' ' ' TYR . 2.4 tt -100.72 143.46 30.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 110.129 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.463 HD12 ' CE2' ' B' ' 190' ' ' PHE . 31.7 mt -104.78 106.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' B' ' 183' ' ' SER . 0.3 OUTLIER -97.95 111.88 24.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -0.98 . . . . 0.0 109.87 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.77 80.99 5.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 110.41 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.9 ttm -50.83 141.68 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.23 -43.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 110.56 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -141.32 110.6 6.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.146 -0.971 . . . . 0.0 110.31 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.459 ' O ' HG12 ' B' ' 202' ' ' ILE . 47.5 Cg_endo -73.21 149.95 94.94 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.443 -0.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.8 OUTLIER -64.22 95.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.898 . . . . 0.0 109.967 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 11.4 mm -134.1 151.62 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 110.621 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -107.37 109.37 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 109.667 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mp -100.98 134.93 43.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 110.913 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.72 117.79 35.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 109.473 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.508 ' N ' HD11 ' B' ' 206' ' ' ILE . 4.4 mp -107.87 137.31 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.488 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -118.29 135.25 54.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.048 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.511 HG21 ' CD1' ' B' ' 172' ' ' LEU . 69.0 t -45.21 -24.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -35.06 78.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . 0.452 ' O ' HG23 ' B' ' 166' ' ' VAL . . . 124.95 -12.45 7.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.28 154.76 37.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.414 HG13 HG12 ' B' ' 166' ' ' VAL . 12.2 mm -138.78 137.15 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 110.083 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.442 HG11 ' N ' ' B' ' 214' ' ' LEU . 96.7 t -120.98 149.25 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.442 ' N ' HG11 ' B' ' 213' ' ' VAL . 1.1 mt -133.35 102.14 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 14.2 t -131.53 153.65 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.388 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.479 ' CA ' ' HE2' ' A' ' 67' ' ' MET . . . 100.81 20.25 15.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.532 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -100.03 131.23 46.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -1.199 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.422 ' N ' ' OE1' ' B' ' 222' ' ' GLU . 4.6 tttt -75.75 -13.98 60.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.91 173.46 15.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -32.23 70.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.117 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -55.98 -51.32 68.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' B' ' 218' ' ' LYS . 1.1 mt-10 -52.74 -42.28 64.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 109.943 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.513 HG22 HD11 ' B' ' 223' ' ' ILE . 18.4 mm -60.13 -45.83 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -68.63 -33.25 73.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -71.79 -46.25 58.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 109.966 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.427 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -54.48 -51.49 64.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.848 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.52 ' HA ' ' CG2' ' B' ' 230' ' ' ILE . 20.0 t80 -57.27 -37.34 72.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.78 . . . . 0.0 109.93 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.48 -18.2 63.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.037 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.97 -18.28 17.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.52 ' CG2' ' HA ' ' B' ' 227' ' ' PHE . 9.1 tp -100.03 -25.53 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 110.323 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.577 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 31.9 t80 -51.99 -44.18 91.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.02 -31.09 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.354 1.187 . . . . 0.0 110.555 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 30.7 t -70.06 -38.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.166 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 37.0 mt -67.87 -42.99 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.168 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.8 -39.22 88.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.91 -31.37 72.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.448 ' O ' HG21 ' B' ' 170' ' ' ILE . 46.1 m-85 -117.32 42.65 2.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.213 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -96.65 -176.03 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.59 -38.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.157 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' N ' ' CE1' ' B' ' 99' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.561 ' N ' ' CD1' ' A' ' 18' ' ' LEU . 2.7 t70 -66.54 60.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.091 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.627 ' CD1' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -80.68 -17.23 51.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 110.691 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.547 ' N ' HD22 ' A' ' 68' ' ' LEU . 64.9 m -41.31 -28.96 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.94 -37.1 4.0 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.608 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -48.59 -40.39 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.277 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.472 HD21 ' HG2' ' A' ' 67' ' ' MET . 3.5 pp -82.97 -27.81 30.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.978 -1.076 . . . . 0.0 108.92 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CE1' HD12 ' A' ' 52' ' ' LEU . 1.7 t80 -90.58 9.95 27.51 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 141.18 95.33 0.25 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 6.8 p-10 -20.06 116.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.976 0.893 . . . . 0.0 112.315 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.671 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.33 163.79 27.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 31' ' ' GLU . 75.7 m-20 -87.45 121.73 30.26 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.545 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 2.9 p -36.78 -28.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.471 0.653 . . . . 0.0 109.69 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.8 tt0 -51.64 -18.48 1.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 0.0 110.575 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.75 27.97 3.87 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.645 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -129.38 147.86 51.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.94 -1.33 . . . . 0.0 109.573 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.671 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.72 165.88 12.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 0.0 111.872 -178.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.528 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.928 0.871 . . . . 0.0 111.552 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.24 0.543 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 0.4 OUTLIER -89.31 -26.66 21.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 109.074 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.582 HD12 ' CE1' ' A' ' 25' ' ' PHE . 2.1 mt -88.81 -38.57 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.621 -0.674 . . . . 0.0 109.451 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.527 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -57.26 -57.49 12.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.362 -0.836 . . . . 0.0 109.913 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.12 -31.36 71.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 58' ' ' SER . 3.4 m-20 -73.21 -43.13 61.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.53 HG22 ' CA ' ' A' ' 22' ' ' GLY . 16.1 mt -46.26 -45.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.328 -0.857 . . . . 0.0 109.245 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.92 -26.48 18.77 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -136.51 44.19 2.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 110.232 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.606 ' CD2' ' CE1' ' B' ' 190' ' ' PHE . 6.7 mt -99.41 13.14 34.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.22 47.21 1.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.79 . . . . 0.0 109.864 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -135.99 1.93 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 110.102 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 1.5 mt -88.69 -38.96 14.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 109.743 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 3.35 4.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.0 0.59 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.092 -1.24 . . . . 0.0 110.064 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.9 t70 -44.05 -32.91 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.914 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -56.75 -49.73 74.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.017 -1.052 . . . . 0.0 109.478 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.479 ' SD ' ' ND2' ' B' ' 159' ' ' ASN . 12.7 ttp -65.96 -12.62 56.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 21' ' ' THR . 1.3 tm? -70.09 -65.66 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.09 -6.33 22.34 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -79.45 -4.77 52.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 110.646 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -129.65 -6.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 110.371 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.575 ' CG2' ' HG ' ' A' ' 20' ' ' LEU . 5.8 tp -140.74 72.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 110.166 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.8 t70 -79.79 56.19 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.587 HD13 ' CE1' ' B' ' 116' ' ' PHE . 6.4 mt . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.634 0.731 . . . . 0.0 110.746 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.45 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.21 0.528 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 4.8 t 62.1 132.09 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 109.961 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.417 ' HD2' HG11 ' B' ' 64' ' ' VAL . 49.3 Cg_endo -74.48 152.53 43.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.006 1.53 . . . . 0.0 110.778 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -118.92 129.86 55.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 109.865 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.442 HD12 HG23 ' B' ' 160' ' ' ILE . 29.2 mt -69.93 132.23 45.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 110.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.82 -16.36 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.421 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.416 ' OD1' ' HA2' ' B' ' 125' ' ' GLY . 0.9 OUTLIER -152.49 111.6 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.577 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' B' ' 124' ' ' THR . 20.0 mm -91.95 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' B' ' 159' ' ' ASN . 50.7 t -148.77 114.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.915 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' B' ' 157' ' ' ILE . . . -132.56 165.34 24.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.534 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 69.5 p -120.71 141.44 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.685 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' B' ' 121' ' ' MET . 3.3 t -140.23 156.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.042 . . . . 0.0 110.722 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.461 ' O ' ' O ' ' B' ' 151' ' ' LYS . 24.2 m -106.18 144.44 32.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' B' ' 151' ' ' LYS . 93.5 mt -94.73 -6.29 43.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.447 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . 0.512 ' HA3' ' CB ' ' B' ' 151' ' ' LYS . . . 103.59 -38.8 3.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . 0.461 ' HB2' ' HA ' ' B' ' 149' ' ' ALA . 0.0 OUTLIER -142.47 -174.5 4.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.113 -1.228 . . . . 0.0 110.836 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.468 ' O ' HD21 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -78.7 178.86 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 110.222 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.549 ' CD1' HD11 ' B' ' 76' ' ' LEU . 10.4 mt -140.89 165.01 28.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.422 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.49 ' CB ' ' OG1' ' B' ' 84' ' ' THR . 1.1 m-20 -110.27 83.27 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.459 HD21 HG22 ' B' ' 102' ' ' VAL . 8.4 mt -38.11 -49.1 1.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.39 -51.62 58.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.697 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.518 ' HA ' ' CD2' ' B' ' 87' ' ' LEU . 43.3 p -76.87 -41.9 42.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 110.077 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.549 HG21 ' CZ ' ' B' ' 148' ' ' PHE . 43.9 t -60.49 -37.02 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.121 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.27 78.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.518 ' CD2' ' HA ' ' B' ' 84' ' ' THR . 0.7 OUTLIER -90.74 -23.04 20.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.5 ' CD2' ' HB ' ' B' ' 84' ' ' THR . 6.7 m-70 -82.97 -35.38 25.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.684 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.52 ' HB3' ' CE ' ' B' ' 104' ' ' MET . . . -72.06 145.15 48.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.387 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -73.94 -27.13 60.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 1.7 m120 -133.69 79.29 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.938 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' B' ' 89' ' ' ALA . . . -138.07 159.64 41.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.416 ' HG3' ' C ' ' B' ' 92' ' ' ALA . 73.9 mt-10 -147.83 120.34 8.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.244 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -113.52 113.4 25.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.121 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -119.8 111.72 35.72 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.15 -19.77 29.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.009 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -17.86 61.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -105.28 -76.46 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.444 -0.785 . . . . 0.0 110.027 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.658 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.25 173.15 11.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.891 . . . . 0.0 110.433 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.3 43.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.234 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.527 ' CB ' HD12 ' A' ' 74' ' ' LEU . . . -132.22 151.97 51.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 110.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.459 HG22 HD21 ' B' ' 82' ' ' LEU . 55.8 t -96.95 126.58 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 109.526 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.449 HD12 ' OG ' ' A' ' 30' ' ' SER . 3.3 mp -89.72 118.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 110.478 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.52 ' CE ' ' HB3' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -95.56 165.32 12.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.455 ' O ' ' ND2' ' B' ' 91' ' ' ASN . 10.3 mtp180 -163.8 116.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.783 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.473 HG22 ' CE1' ' B' ' 139' ' ' TYR . 37.7 pt -120.71 150.19 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.466 -0.771 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.5 OUTLIER -91.6 28.32 1.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.519 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 7.0 pt-20 -161.96 83.9 1.69 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.716 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' B' ' 111' ' ' THR . 51.1 Cg_endo -85.47 148.76 46.47 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.172 -0.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -51.54 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 109' ' ' PRO . 13.2 p -146.62 -179.46 6.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.899 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.503 ' CG2' ' HB2' ' A' ' 27' ' ' ASN . 1.2 t -131.57 179.22 6.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 110.208 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.469 ' HB1' ' CE2' ' B' ' 139' ' ' TYR . . . -166.85 137.82 3.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 0.0 110.312 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.481 HD23 HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -95.22 105.94 17.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.59 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 33.8 mt -90.21 128.34 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.361 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 2.8 m-30 -99.84 162.31 13.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 79' ' ' ARG . . . -76.57 -11.09 59.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.699 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 m -83.05 -5.68 59.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.027 . . . . 0.0 110.211 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' B' ' 78' ' ' CYS . . . 107.14 -39.16 2.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.93 135.21 55.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.114 . . . . 0.0 109.987 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -133.01 168.34 18.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.356 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 71' ' ' VAL . 10.3 t -130.37 143.64 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.16 144.38 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.958 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.535 HG22 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -153.08 165.58 35.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.538 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 108.72 -36.45 4.35 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.464 ' HB1' ' HB ' ' B' ' 70' ' ' ILE . . . -47.25 167.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -1.161 . . . . 0.0 110.416 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -118.77 -12.09 9.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.504 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m -154.43 173.65 15.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.062 -1.024 . . . . 0.0 110.406 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.96 -49.74 75.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.08 -35.3 73.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.69 -41.78 83.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 110.202 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -58.42 -54.61 45.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.164 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -50.17 -37.54 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.09 -39.21 75.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 0.0 110.376 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -70.1 -35.37 74.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.14 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 50.7 m -72.28 -60.56 2.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 5.7 ptm180 -47.51 -30.11 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.294 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 57.7 mmtt -66.89 -48.16 69.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.014 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 28.6 m-85 -64.79 -52.79 54.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.79 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.503 ' CB ' ' NE2' ' B' ' 144' ' ' GLN . . . -50.01 -37.09 31.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.864 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.85 85.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 mt -64.2 -25.44 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.771 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' B' ' 148' ' ' PHE . 0.3 OUTLIER -84.43 -25.12 7.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.385 -0.822 . . . . 0.0 109.029 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.541 ' CG ' ' HB3' ' B' ' 150' ' ' ALA . 24.2 mt-30 -89.17 -22.3 22.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.452 -0.78 . . . . 0.0 109.763 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -82.18 -27.81 32.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.55 ' CG2' ' CE2' ' B' ' 148' ' ' PHE . 25.7 mt -83.48 -37.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.655 -0.653 . . . . 0.0 109.806 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 117.74 20.2 4.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.55 ' CE2' ' CG2' ' B' ' 146' ' ' ILE . 13.8 m-85 -86.19 -160.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.088 -1.242 . . . . 0.0 110.335 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' B' ' 76' ' ' LEU . . . -34.66 -71.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.304 0.573 . . . . 0.0 110.501 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.541 ' HB3' ' CG ' ' B' ' 144' ' ' GLN . . . 64.88 72.72 0.43 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 112.002 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' B' ' 76' ' ' LEU . 0.4 OUTLIER -162.92 101.56 1.0 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.167 -0.958 . . . . 0.0 110.057 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.463 ' O ' HG22 ' B' ' 153' ' ' THR . 2.7 t80 -72.18 103.22 3.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.0 110.353 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.7 OUTLIER -159.22 158.27 32.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' B' ' 153' ' ' THR . 2.7 t70 70.45 18.5 6.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.885 . . . . 0.0 110.669 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.522 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 4.2 t80 -69.05 135.4 50.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.046 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.0 131.82 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -0.956 . . . . 0.0 110.704 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.45 ' HA ' ' HB3' ' B' ' 72' ' ' ALA . 51.5 mt -80.39 122.68 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 109.644 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -111.93 -3.6 14.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.119 -0.988 . . . . 0.0 110.972 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.479 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 11.2 m120 -155.8 140.42 16.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.855 -1.153 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.442 HG23 HD12 ' B' ' 67' ' ' LEU . 48.4 mt -133.88 123.97 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.388 -0.82 . . . . 0.0 109.655 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 8.0 t -101.6 131.1 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 110.627 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.73 172.15 18.97 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.99 152.24 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -1.197 . . . . 0.0 110.362 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.01 159.95 7.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' B' ' 166' ' ' VAL . 22.6 t0 -101.81 166.3 10.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.485 ' N ' ' OD1' ' B' ' 165' ' ' ASP . 0.0 OUTLIER -114.32 -83.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.347 -0.846 . . . . 0.0 110.291 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -177.84 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.636 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.465 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 2.2 p90 -137.6 166.7 24.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.1 Cg_endo -70.97 171.63 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.82 1.431 . . . . 0.0 110.527 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.95 139.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 110.601 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.13 88.07 2.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' B' ' 185' ' ' TYR . 71.9 mt -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.625 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -43.02 76.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.182 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.26 -31.03 66.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' B' ' 193' ' ' LEU . 11.5 tp -75.45 -35.24 60.95 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -1.112 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' B' ' 172' ' ' LEU . . . -69.89 -27.36 64.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.3 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -75.44 -40.82 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.328 -0.857 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 2.1 t -78.3 -55.85 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.183 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.437 ' HB2' HD13 ' B' ' 175' ' ' LEU . 14.2 m80 -91.67 27.07 2.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.71 45.92 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -12.48 52.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.145 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -115.38 -23.99 8.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' B' ' 195' ' ' TYR . 0.1 OUTLIER -125.04 171.28 10.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.7 m -132.33 147.77 52.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.241 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' B' ' 172' ' ' LEU . 33.6 t80 -149.64 104.54 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.913 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' B' ' 190' ' ' PHE . 6.5 mt-10 -113.67 103.94 55.3 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.81 -1.87 10.58 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.068 1.562 . . . . 0.0 110.113 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' B' ' 186' ' ' GLU . 1.7 pm0 -85.74 -18.21 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.7 -38.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.606 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 4.5 t80 -113.82 108.61 51.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.425 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.96 -20.52 19.42 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.031 1.543 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.446 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.55 178.43 44.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.462 ' CB ' HD21 ' B' ' 172' ' ' LEU . 9.7 tt -118.73 125.75 50.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -1.116 . . . . 0.0 110.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.522 ' CD1' HD11 ' A' ' 62' ' ' LEU . 4.7 mt -101.66 111.0 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.431 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 6.5 t80 -96.39 124.38 40.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.523 ' CZ ' ' CB ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -104.91 101.19 10.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 110.24 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.508 ' CE ' HG12 ' B' ' 230' ' ' ILE . 16.8 ttm -69.58 128.51 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.922 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.7 -51.38 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 119.05 10.36 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.103 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.69 150.28 95.25 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.91 -2.121 . . . . 0.0 110.427 -0.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' B' ' 197' ' ' MET . 3.2 tttt -63.04 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.483 HG21 HD11 ' B' ' 202' ' ' ILE . 47.1 mm -128.96 150.96 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.62 128.71 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.044 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.463 HD22 ' CD2' ' B' ' 214' ' ' LEU . 3.7 mp -120.36 135.05 55.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 110.548 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.524 HD13 ' CZ ' ' B' ' 190' ' ' PHE . 1.9 mm? -102.97 126.66 50.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 109.795 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.443 HG12 HD22 ' B' ' 234' ' ' LEU . 3.7 mt -119.5 127.19 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 110.434 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.446 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 83.7 m-85 -118.23 143.67 46.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 110.241 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 25.4 t -48.06 -30.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.38 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.25 -45.74 68.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . 0.446 ' O ' HG23 ' B' ' 166' ' ' VAL . . . 128.24 3.25 5.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.453 ' O ' HD12 ' B' ' 212' ' ' ILE . 0.5 OUTLIER -92.57 135.98 33.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -1.2 . . . . 0.0 110.301 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.453 HD12 ' O ' ' B' ' 211' ' ' LYS . 46.1 mm -121.09 125.3 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.348 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 24.7 t -107.07 154.78 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.961 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.463 ' CD2' HD22 ' B' ' 204' ' ' LEU . 4.1 mp -135.36 135.73 40.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 5.1 t -157.84 142.14 16.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.909 . . . . 0.0 110.204 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 111.39 21.78 6.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.472 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -108.82 126.92 53.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -1.136 . . . . 0.0 110.179 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -75.23 -25.69 58.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -132.56 -178.57 4.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.12 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 28.4 ttp-105 -85.5 -37.42 19.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -52.49 -26.71 13.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.131 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -76.35 -44.56 36.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.828 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.434 HG22 HD11 ' B' ' 223' ' ' ILE . 28.2 mm -60.36 -38.23 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.64 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -64.99 -47.3 78.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -36.16 81.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.316 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.407 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -53.84 -52.86 59.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.465 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 25.5 t80 -71.57 -44.34 64.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.34 -32.36 2.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.51 -11.67 20.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.508 HG12 ' CE ' ' B' ' 197' ' ' MET . 8.6 mm -100.03 -23.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.59 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 25.0 t80 -52.34 -48.22 90.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -70.31 -33.4 14.58 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.397 1.209 . . . . 0.0 110.391 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.84 -40.36 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.456 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.443 HD22 HG12 ' B' ' 206' ' ' ILE . 66.5 mt -68.11 -45.48 73.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.128 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -27.6 64.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.6 OUTLIER -66.49 -39.49 88.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.34 40.5 2.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.1 ptt85 -66.72 -170.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.441 ' HB2' ' HG2' ' B' ' 169' ' ' PRO . 1.3 mttp -123.33 -61.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.128 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.171 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.685 ' HB2' ' CG ' ' B' ' 99' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.577 ' N ' HD13 ' A' ' 18' ' ' LEU . 14.4 t70 -81.22 98.68 8.2 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 111.123 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.569 ' CD1' ' HB ' ' A' ' 71' ' ' VAL . 4.9 mt -97.71 4.93 49.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.253 -0.904 . . . . 0.0 109.697 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 18.7 m -39.81 -28.61 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.104 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -100.19 -38.26 3.6 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -52.86 -46.87 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -1.073 . . . . 0.0 109.022 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.457 ' CD1' ' HG2' ' A' ' 67' ' ' MET . 3.4 pp -80.51 -3.92 51.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 21' ' ' THR . 1.4 t80 -112.75 -4.76 13.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.421 -0.799 . . . . 0.0 110.895 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 162.19 69.08 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.517 -1.801 . . . . 0.0 111.337 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.589 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 20.37 111.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.15 0.976 . . . . 0.0 113.301 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.714 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -149.0 156.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.53 ' N ' HG12 ' A' ' 28' ' ' ILE . 5.4 m-20 -88.85 138.3 31.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.533 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -41.77 -26.55 0.08 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.407 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -55.47 -14.99 2.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 110.74 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.26 32.88 5.63 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.21 123.88 51.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.28 -1.13 . . . . 0.0 109.607 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.714 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER -90.39 131.79 35.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.442 -0.786 . . . . 0.0 110.339 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 120.985 -1.072 . . . . 0.0 109.693 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.324 0.583 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.429 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.8 tt0 -79.3 -31.8 43.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.593 ' HB3' ' CZ ' ' B' ' 190' ' ' PHE . 0.0 OUTLIER -117.16 -9.17 11.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.483 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.574 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 5.7 tpt180 -62.82 -54.25 41.84 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.64 -20.5 33.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' LEU . 85.7 m-20 -88.43 -25.45 22.64 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 40.7 mt -51.2 -38.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.34 -13.29 42.9 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 55' ' ' ASN . 18.0 m -138.15 11.59 2.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.241 -1.152 . . . . 0.0 110.808 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.549 HD11 ' N ' ' A' ' 56' ' ' ILE . 0.5 OUTLIER -83.54 19.83 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 0.0 110.669 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 p -104.21 31.41 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 110.301 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -130.64 11.24 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.472 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -124.86 -2.2 7.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.016 -1.053 . . . . 0.0 110.979 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.498 ' N ' HD23 ' A' ' 62' ' ' LEU . . . 150.71 -47.27 0.6 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 3.1 mm? -41.83 -31.74 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -1.206 . . . . 0.0 110.718 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' CA ' ' HG ' ' A' ' 68' ' ' LEU . 36.0 t70 -41.02 -35.93 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.515 -0.741 . . . . 0.0 110.286 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.466 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.3 m -66.53 -43.64 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.832 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.486 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 5.2 tpp -70.32 -22.71 62.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . 4.7 mt -62.74 -61.25 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.973 -1.079 . . . . 0.0 108.904 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.8 pp -62.48 -9.51 8.76 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.018 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.15 -17.23 37.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 111.274 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.569 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -115.68 -20.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.688 -1.258 . . . . 0.0 109.319 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 3.9 tp -130.36 71.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.646 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.52 57.73 1.26 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.854 -1.154 . . . . 0.0 108.154 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.634 ' CB ' ' CE2' ' B' ' 99' ' ' PHE . 5.1 mt . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 121.534 0.683 . . . . 0.0 110.502 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' B' ' 166' ' ' VAL . 5.2 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.346 0.593 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.37 132.19 23.72 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.857 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.34 148.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.922 1.485 . . . . 0.0 110.627 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 17.9 m -108.07 127.01 53.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.855 . . . . 0.0 110.245 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.92 131.06 43.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -123.26 -7.86 8.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.594 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.473 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.9 OUTLIER -163.47 110.16 1.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.466 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.527 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 19.4 mm -100.96 146.69 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 47.4 t -136.75 131.16 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.969 -1.082 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.95 156.78 44.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' THR . . . . . 0.415 ' C ' HG21 ' B' ' 74' ' ' VAL . 24.3 m -109.98 137.86 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' HE3' ' B' ' 121' ' ' MET . 90.2 t -134.12 171.01 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 50.9 m -146.14 144.4 29.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.314 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.5 HD23 ' CB ' ' B' ' 150' ' ' ALA . 71.3 mt -97.27 -71.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.84 -5.91 5.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . 0.415 ' O ' ' SG ' ' B' ' 78' ' ' CYS . 31.0 p -129.29 130.5 46.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -1.159 . . . . 0.0 110.165 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.456 ' O ' HD22 ' B' ' 80' ' ' LEU . 0.7 OUTLIER -53.5 151.84 5.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 0.0 110.261 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.557 HD21 ' CD1' ' B' ' 148' ' ' PHE . 25.5 mt -131.13 159.59 37.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' B' ' 82' ' ' LEU . 31.9 t70 -105.58 92.03 4.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.846 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.447 HD21 HG22 ' B' ' 102' ' ' VAL . 16.3 mt -40.64 -34.39 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.1 OUTLIER -61.2 -49.04 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.052 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 41.3 m -80.24 -33.42 37.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.256 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.41 -50.1 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.45 -25.36 54.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 12.3 tp -68.39 -43.5 77.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 110.286 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -40.7 18.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -48.78 110.71 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -63.26 -11.35 20.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 0.8 OUTLIER -139.93 79.79 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.336 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.32 168.92 25.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.25 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.16 142.08 35.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.224 -0.923 . . . . 0.0 110.121 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -140.21 102.56 4.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.69 124.84 26.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.86 -20.98 21.79 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 110.74 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.34 59.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 6.0 mpt_? -93.18 -60.1 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.95 . . . . 0.0 110.723 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.685 ' CG ' ' HB2' ' A' ' 18' ' ' LEU . 64.3 t80 -170.32 179.97 3.25 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.523 -177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' LEU . . . -100.9 69.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.005 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.597 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -154.24 142.84 20.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.567 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.447 HG22 HD21 ' B' ' 82' ' ' LEU . 12.5 t -96.69 117.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 30' ' ' SER . 3.4 mt -89.58 105.82 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.411 ' SD ' HD11 ' B' ' 142' ' ' ILE . 4.0 ttm -91.72 148.94 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.043 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 30.4 mtm180 -142.78 144.16 32.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 19.4 pt -131.27 179.16 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.882 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.45 34.99 4.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.129 -0.982 . . . . 0.0 110.514 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 179.25 81.05 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.456 ' HG3' ' OD1' ' B' ' 131' ' ' ASP . 50.0 Cg_endo -77.06 162.35 91.54 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.364 -0.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.5 ' O ' ' CG2' ' B' ' 111' ' ' THR . 3.5 tttp -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.898 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' B' ' 110' ' ' LYS . 61.8 p -156.26 -179.63 8.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.295 -0.878 . . . . 0.0 110.485 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.534 ' CG2' HG21 ' B' ' 124' ' ' THR . 4.9 t -125.58 172.7 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.511 ' HB3' ' CE2' ' B' ' 139' ' ' TYR . . . -150.79 136.21 17.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.906 -1.121 . . . . 0.0 111.416 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.541 HD13 ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -92.54 95.81 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.43 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 73.9 mt -89.69 139.26 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.069 . . . . 0.0 111.116 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.547 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 2.0 m-85 -111.28 162.79 14.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.407 ' HB3' ' HG ' ' B' ' 82' ' ' LEU . . . -79.08 -15.59 57.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 8.2 m -76.85 -17.66 58.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.298 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.406 ' HA2' HD13 ' B' ' 80' ' ' LEU . . . 120.14 -26.22 7.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' B' ' 75' ' ' THR . 3.4 mttt -77.75 163.02 26.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -1.114 . . . . 0.0 110.189 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.442 ' HE3' ' CG1' ' B' ' 74' ' ' VAL . 5.2 ptt? -160.99 170.27 20.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -135.9 127.27 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.355 -0.84 . . . . 0.0 109.744 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 26.3 t -105.2 133.89 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.968 -1.083 . . . . 0.0 110.796 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.534 HG21 ' CG2' ' B' ' 112' ' ' THR . 2.4 t -140.64 159.03 43.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.616 -0.677 . . . . 0.0 109.23 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.554 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 112.58 -17.03 23.66 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.527 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -60.42 173.27 0.71 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -1.199 . . . . 0.0 110.191 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -120.47 -18.77 7.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.998 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.41 ' N ' HG13 ' B' ' 70' ' ' ILE . 14.5 t -146.7 -172.32 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -70.59 -59.23 2.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.214 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -52.53 -33.41 45.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' B' ' 109' ' ' PRO . 1.5 t0 -63.59 -46.4 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 4.0 t -63.27 -34.84 78.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.321 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . 0.507 ' HA ' ' CZ ' ' B' ' 155' ' ' PHE . 6.4 ttpt -66.37 -43.51 85.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.141 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -70.36 -58.27 3.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.51 -26.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.121 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -77.52 -59.07 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 110.23 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' B' ' 134' ' ' LEU . 1.2 ptm180 -53.07 -26.01 14.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.003 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -70.65 -46.9 62.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.799 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.511 ' CE2' ' HB3' ' B' ' 113' ' ' ALA . 17.4 m-85 -60.76 -44.13 97.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.797 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.95 -27.79 67.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.766 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.497 ' HG3' ' NH1' ' B' ' 141' ' ' ARG . 0.2 OUTLIER -68.69 -37.4 79.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.8 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.411 HD11 ' SD ' ' B' ' 104' ' ' MET . 11.2 mt -61.5 -48.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.511 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 3.2 mp -63.66 -44.09 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 109.666 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -70.97 -33.81 70.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -71.73 -22.25 61.65 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.7 -22.87 10.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.35 -34.65 2.75 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.557 ' CD1' HD21 ' B' ' 80' ' ' LEU . 11.8 m-85 -47.18 161.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.159 -1.201 . . . . 0.0 110.962 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.16 42.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 0.0 109.707 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.511 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -59.98 158.34 11.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 110.692 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 2.4 mttm -120.8 -156.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.539 -0.726 . . . . 0.0 109.688 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -153.0 71.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 110.211 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -142.85 -178.79 5.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 153' ' ' THR . 0.6 OUTLIER 69.04 11.75 8.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.507 ' CZ ' ' HA ' ' B' ' 133' ' ' LYS . 40.4 t80 -68.67 132.25 46.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -169.83 131.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 1.9 mp -79.97 118.93 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.836 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.434 ' OE1' ' HG3' ' B' ' 218' ' ' LYS . 17.4 mm-40 -122.49 3.36 9.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.071 -1.018 . . . . 0.0 110.849 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.474 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 8.2 t-20 -149.83 95.91 2.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.894 -1.129 . . . . 0.0 110.768 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.519 HD13 ' CA ' ' B' ' 219' ' ' GLN . 88.1 mt -100.71 141.91 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.668 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.5 ' CG2' ' OG1' ' B' ' 215' ' ' THR . 26.5 t -122.31 132.8 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.775 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -134.98 -179.92 17.0 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.04 143.23 3.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -1.213 . . . . 0.0 110.369 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 26.9 p -170.23 175.41 4.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -119.35 173.82 6.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 209' ' ' SER . 0.0 OUTLIER -112.84 -85.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 110.098 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 166.97 -22.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.142 -0.974 . . . . 0.0 110.672 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' B' ' 170' ' ' ILE . 28.7 p90 -121.33 152.44 57.57 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.093 -1.005 . . . . 0.0 109.705 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.472 ' HA ' ' OG ' ' B' ' 209' ' ' SER . 50.9 Cg_endo -79.78 158.44 24.64 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.908 1.478 . . . . 0.0 110.619 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.64 ' CD1' ' CB ' ' B' ' 209' ' ' SER . 5.7 mt -133.95 164.92 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 0.0 110.293 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.17 93.2 5.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.934 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.525 ' CD1' ' HA ' ' B' ' 208' ' ' VAL . 55.5 mt -47.45 -49.99 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 110.063 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 172' ' ' LEU . 1.5 mt-10 -44.61 -36.73 3.2 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.496 -0.752 . . . . 0.0 109.797 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.06 -38.57 63.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' B' ' 195' ' ' TYR . 0.1 OUTLIER -66.73 -38.06 85.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -1.125 . . . . 0.0 110.011 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.14 -13.74 59.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -89.18 -37.9 14.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -52.13 4.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' B' ' 183' ' ' SER . 28.7 m80 -93.05 21.73 5.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 0.0 110.084 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' B' ' 179' ' ' HIS . . . -43.13 -65.29 1.48 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 9.3 t -48.71 -21.73 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -1.186 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.564 ' CZ ' HG22 ' B' ' 198' ' ' VAL . 1.1 m-30 -114.08 15.48 18.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' B' ' 179' ' ' HIS . 0.5 OUTLIER -151.52 153.45 34.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' SER . . . . . 0.419 ' O ' HD22 ' B' ' 193' ' ' LEU . 1.0 OUTLIER -127.77 141.23 51.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.875 . . . . 0.0 109.943 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -132.66 107.91 8.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.445 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 2.0 mm-40 -114.31 94.49 35.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.05 -8.94 24.67 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 110.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.37 -3.91 27.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.42 -35.22 0.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 52' ' ' LEU . 2.5 t80 -126.48 128.97 24.25 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.146 -0.971 . . . . 0.0 110.4 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.88 -38.6 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.927 1.488 . . . . 0.0 110.65 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.71 -179.98 44.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.419 HD22 ' O ' ' B' ' 184' ' ' SER . 4.9 tt -106.53 131.92 53.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -1.157 . . . . 0.0 110.269 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' B' ' 205' ' ' LEU . 23.8 mt -90.31 105.94 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.525 ' CD2' HD13 ' B' ' 175' ' ' LEU . 2.1 t80 -90.35 116.26 28.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 79.87 1.77 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -67.5 161.02 26.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.564 HG22 ' CZ ' ' B' ' 182' ' ' PHE . 53.0 t -111.8 -31.08 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.83 94.16 29.37 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.36 165.66 83.9 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.787 -2.172 . . . . 0.0 110.471 0.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' B' ' 197' ' ' MET . 35.2 tttm -88.72 93.11 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' B' ' 217' ' ' ALA . 13.7 mt -144.39 148.5 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.422 ' N ' HG21 ' B' ' 202' ' ' ILE . 14.4 t -94.86 142.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.463 HD13 ' O ' ' B' ' 202' ' ' ILE . 5.2 mp -135.27 148.9 49.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.526 ' HB2' ' CG2' ' B' ' 213' ' ' VAL . 69.7 mt -105.76 110.64 23.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.901 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.518 HD11 HG22 ' B' ' 206' ' ' ILE . 18.5 mm -94.79 96.15 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.477 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.533 ' O ' ' HB ' ' B' ' 208' ' ' VAL . 12.8 m-85 -70.31 58.93 0.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' B' ' 209' ' ' SER . 5.8 t 80.37 -37.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.937 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.64 ' CB ' ' CD1' ' B' ' 170' ' ' ILE . 2.9 p 156.74 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.937 0.875 . . . . 0.0 110.163 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.76 -67.66 1.89 Allowed Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.698 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.452 ' O ' HD12 ' B' ' 212' ' ' ILE . 4.8 mttp -100.74 139.92 35.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -1.15 . . . . 0.0 111.142 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.452 HD12 ' O ' ' B' ' 211' ' ' LYS . 27.1 mm -123.15 140.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.308 -0.87 . . . . 0.0 110.032 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' B' ' 205' ' ' LEU . 12.0 t -123.63 152.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.185 -0.947 . . . . 0.0 110.492 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' B' ' 213' ' ' VAL . 3.4 mp -144.08 123.65 13.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.322 -0.862 . . . . 0.0 110.545 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.5 ' OG1' ' CG2' ' B' ' 161' ' ' VAL . 2.9 t -147.21 144.42 28.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.088 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 116.88 1.16 19.49 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.515 ' CB ' HD12 ' B' ' 202' ' ' ILE . . . -75.59 152.41 37.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -1.124 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.434 ' HG3' ' OE1' ' B' ' 158' ' ' GLN . 8.6 tttt -100.49 -2.53 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.519 ' CA ' HD13 ' B' ' 160' ' ' ILE . 0.0 OUTLIER -165.3 164.93 19.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.086 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.28 -24.77 65.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.466 ' CA ' ' OE1' ' B' ' 221' ' ' GLU . 0.1 OUTLIER -69.1 -37.98 78.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.912 . . . . 0.0 109.964 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' B' ' 217' ' ' ALA . 2.9 mt-10 -63.66 -46.92 83.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.07 -1.019 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.485 HG12 ' CB ' ' B' ' 217' ' ' ALA . 10.7 mm -58.46 -48.37 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.922 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -55.68 -26.8 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.078 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -48.72 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.456 ' HB2' HD21 ' B' ' 214' ' ' LEU . . . -45.26 -35.95 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.17 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.45 -47.43 12.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.345 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -25.97 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.509 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -83.37 -36.57 24.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.46 ' O ' HD11 ' B' ' 230' ' ' ILE . 0.3 OUTLIER -88.19 -29.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 109.906 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.588 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 6.7 t80 -44.21 -49.55 23.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.409 -0.807 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 41.1 Cg_endo -68.17 -45.11 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.35 1.184 . . . . 0.0 110.355 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.457 ' HB ' HD12 ' B' ' 230' ' ' ILE . 4.3 t -47.18 -37.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 108.981 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' B' ' 170' ' ' ILE . 57.3 mt -65.41 -53.0 49.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.84 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.91 -38.17 15.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.981 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -60.08 -45.43 92.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -97.63 34.38 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.931 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -52.01 146.71 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 110.276 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -29.94 9.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.37 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.327 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.599 ' CD2' ' CD1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.65 95.32 5.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.038 -1.039 . . . . 0.0 111.552 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.601 HD21 ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -107.94 9.43 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.978 . . . . 0.0 110.81 179.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.567 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 24.0 m -48.85 -23.79 1.21 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.857 -1.152 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.468 ' HA3' HG23 ' A' ' 28' ' ' ILE . . . -100.2 -29.0 6.95 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.601 ' CG1' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -44.99 -44.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.294 . . . . 0.0 108.848 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.431 ' O ' HG23 ' B' ' 161' ' ' VAL . 1.6 pp -84.41 -22.32 30.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.924 -1.11 . . . . 0.0 109.294 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.12 2.82 45.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.35 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 149.98 101.03 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 13.6 p-10 -22.08 84.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.813 0.816 . . . . 0.0 111.878 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.592 ' CG1' HG12 ' A' ' 23' ' ' ILE . 1.2 pp -88.49 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' GLU . 66.0 m-20 -88.22 126.52 35.19 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.538 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 1.1 p -39.71 -25.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.758 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' ASP . 16.2 tt0 -59.77 -10.62 3.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.09 -1.006 . . . . 0.0 110.202 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.59 29.84 5.78 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.478 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -117.36 119.65 35.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.306 -1.114 . . . . 0.0 110.519 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.535 HD21 HG21 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -90.81 143.55 26.61 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.051 -1.03 . . . . 0.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 27' ' ' ASN . 4.5 pp . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.786 -1.196 . . . . 0.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.345 0.593 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.39 -19.51 16.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.518 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mt -100.28 -45.79 5.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.775 . . . . 0.0 110.331 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.535 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -53.2 -57.56 10.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.274 -0.891 . . . . 0.0 109.738 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 3.0 pp20? -62.77 -19.99 64.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.78 . . . . 0.0 109.416 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 7.7 m-20 -84.15 -35.79 23.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.5 -0.75 . . . . 0.0 109.211 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 4.5 mt -53.09 -41.51 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.394 -0.817 . . . . 0.0 109.141 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.54 -23.88 44.69 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p -118.52 12.8 13.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -1.182 . . . . 0.0 110.567 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.506 ' CD1' ' HA ' ' A' ' 56' ' ' ILE . 4.0 mt -87.81 26.46 1.32 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.098 -1.001 . . . . 0.0 110.369 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 52.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.504 ' HE2' ' CD2' ' B' ' 189' ' ' LEU . 0.7 OUTLIER -173.35 26.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 110.364 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -148.09 12.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.186 -0.947 . . . . 0.0 110.393 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.94 -58.49 0.51 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 4.1 mm? -50.34 -20.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -1.116 . . . . 0.0 110.928 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 t70 -45.43 -43.03 11.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.443 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -66.78 -50.45 62.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.391 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.457 ' O ' HG22 ' A' ' 71' ' ' VAL . 2.0 tpp -68.27 -7.67 32.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.296 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.3 tm? -70.05 -59.63 2.79 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 122.061 0.934 . . . . 0.0 108.631 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.3 pp -75.74 0.56 17.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -92.49 13.93 18.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 112.222 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.528 ' CG1' ' CG2' ' A' ' 23' ' ' ILE . 2.0 t -140.58 3.7 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.743 -1.223 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.599 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 1.5 tp -148.99 76.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.6 t70 -77.73 55.43 1.36 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.12 -0.988 . . . . 0.0 108.455 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.558 ' CD1' ' HB2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.531 0.681 . . . . 0.0 110.629 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.574 ' O ' ' CE2' ' B' ' 227' ' ' PHE . 89.8 mt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.179 0.514 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.474 ' CG1' ' OH ' ' B' ' 224' ' ' TYR . 6.6 t -70.96 140.14 85.83 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.321 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.9 Cg_endo -73.85 130.0 14.06 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.011 1.532 . . . . 0.0 110.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -91.17 135.57 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 49.9 mt -80.06 124.29 28.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.02 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -106.49 -18.76 13.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.487 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.9 163.94 11.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.178 -0.951 . . . . 0.0 110.447 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.497 HG21 ' N ' ' B' ' 71' ' ' VAL . 5.6 mt -151.27 165.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.381 -0.824 . . . . 0.0 109.959 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.497 ' N ' HG21 ' B' ' 70' ' ' ILE . 3.4 t -148.17 142.09 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.48 152.28 48.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.986 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.29 132.2 45.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 110.342 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.518 ' HB ' ' CG ' ' B' ' 121' ' ' MET . 94.1 t -123.88 158.34 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.922 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.483 ' CB ' ' HB2' ' B' ' 154' ' ' ASP . 7.7 m -133.39 144.27 49.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.454 ' CD2' ' HB3' ' B' ' 150' ' ' ALA . 96.1 mt -101.4 -32.44 10.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.852 . . . . 0.0 110.032 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.93 18.36 59.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.73 144.91 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -1.212 . . . . 0.0 110.313 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 4.2 ttp85 -75.23 152.18 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 110.005 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.437 HD13 HD13 ' B' ' 76' ' ' LEU . 39.7 mt -132.93 163.09 29.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.406 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.424 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 97.7 m-20 -98.21 113.7 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.423 ' HA ' HG22 ' B' ' 102' ' ' VAL . 13.4 mt -56.25 -53.93 51.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -0.966 . . . . 0.0 110.174 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 8.6 tppt? -51.42 -47.2 63.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.997 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 84.8 m -72.93 -45.71 56.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.08 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.04 -47.95 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.963 . . . . 0.0 109.999 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.01 -10.24 59.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 7.7 tp -98.12 -24.78 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.451 ' O ' ' NH2' ' B' ' 90' ' ' ARG . 2.1 m-70 -98.67 -30.42 12.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.458 ' HB3' ' CE ' ' B' ' 104' ' ' MET . . . -62.28 146.36 51.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.139 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' B' ' 88' ' ' HIS . 5.2 mmt-85 -76.07 -33.57 59.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -134.37 79.3 1.8 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.319 -0.863 . . . . 0.0 109.989 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.455 ' HB1' ' CB ' ' B' ' 89' ' ' ALA . . . -127.13 156.71 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.406 -0.808 . . . . 0.0 110.174 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.424 ' HB2' ' HB ' ' B' ' 103' ' ' ILE . 1.5 mm-40 -134.1 126.05 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -134.93 111.89 10.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.441 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -128.59 126.19 23.34 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.58 -25.55 14.87 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 0.0 110.8 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -68.4 -17.04 64.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 0.0 110.299 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.6 -50.37 3.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.621 ' CE2' ' CB ' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -173.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.436 -0.79 . . . . 0.0 111.582 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.24 56.46 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.837 . . . . 0.0 110.947 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.621 ' CB ' ' CE2' ' B' ' 99' ' ' PHE . . . -145.07 152.82 40.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.523 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' B' ' 115' ' ' ILE . 23.8 t -98.46 135.74 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 30' ' ' SER . 25.4 mm -109.62 120.66 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.043 . . . . 0.0 110.887 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.577 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.9 OUTLIER -90.76 162.93 14.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.667 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.447 ' NH2' ' HG2' ' B' ' 105' ' ' ARG . 0.0 OUTLIER -155.96 126.76 6.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.076 -1.015 . . . . 0.0 110.44 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.571 HG22 ' CE1' ' B' ' 139' ' ' TYR . 43.9 pt -128.47 149.45 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -99.74 26.94 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -162.62 83.0 1.59 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.88 163.76 79.58 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.977 -2.093 . . . . 0.0 110.635 -0.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -68.78 103.93 1.89 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' B' ' 124' ' ' THR . 13.9 p -148.97 169.61 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 111.149 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.488 HG21 ' N ' ' B' ' 113' ' ' ALA . 1.7 m -117.73 153.99 32.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.488 ' N ' HG21 ' B' ' 112' ' ' THR . . . -143.6 132.89 23.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.057 -1.027 . . . . 0.0 110.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.48 ' CD1' HD12 ' A' ' 20' ' ' LEU . 7.2 mt -96.35 137.05 36.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' B' ' 102' ' ' VAL . 46.5 mt -125.83 118.52 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 0.8 OUTLIER -99.89 141.24 32.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -51.83 -20.52 2.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.207 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -21.44 64.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.403 ' O ' HD13 ' B' ' 76' ' ' LEU . . . 113.7 -23.34 13.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -72.66 177.22 4.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -1.162 . . . . 0.0 110.383 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.518 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 6.0 ptm -168.83 140.96 2.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' B' ' 114' ' ' LEU . 4.2 t -115.1 132.98 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.92 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.31 167.88 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 110.091 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.519 HG21 ' CB ' ' A' ' 27' ' ' ASN . 4.7 t -169.16 160.25 9.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.954 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.463 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 113.2 -4.75 25.28 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' B' ' 132' ' ' SER . . . -76.8 146.64 37.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -1.188 . . . . 0.0 110.309 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.69 -21.45 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.252 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' B' ' 129' ' ' GLU . 0.3 OUTLIER -127.23 32.34 5.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . 0.499 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.1 tt0 66.6 -68.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 128' ' ' SER . 7.3 t70 -44.07 -31.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -0.84 . . . . 0.0 110.363 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -63.02 -58.99 5.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.517 ' N ' ' HB3' ' B' ' 126' ' ' ALA . 0.1 OUTLIER -52.48 -31.53 35.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -46.41 75.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.958 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.35 -45.9 71.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.257 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.01 -48.69 67.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.942 . . . . 0.0 110.083 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.415 ' OG ' HG22 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -57.29 -53.63 55.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -51.83 -36.86 49.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.959 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -48.28 65.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' B' ' 104' ' ' MET . 21.8 m-85 -61.78 -55.71 27.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.093 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.28 -21.65 9.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.877 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -78.99 -29.34 43.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 110.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.462 HD11 ' SD ' ' B' ' 104' ' ' MET . 49.0 mt -68.62 -43.69 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.528 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 52.1 mt -70.66 -50.5 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.098 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 90.0 mt-30 -60.15 -37.2 79.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 109.693 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -32.64 68.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.451 HG13 ' O ' ' B' ' 142' ' ' ILE . 5.2 mt -66.6 -17.93 23.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.6 -23.45 12.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -52.34 169.01 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.007 -1.29 . . . . 0.0 110.745 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.53 50.42 0.81 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 110.308 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -80.32 144.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.419 ' O ' ' OG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -126.01 106.37 9.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 0.0 110.331 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -55.78 101.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -162.08 -178.91 6.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.483 ' HB2' ' CB ' ' B' ' 75' ' ' THR . 3.4 m-20 57.8 26.47 13.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 110.445 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.529 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 5.7 t80 -78.99 133.14 36.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.073 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -161.91 130.52 4.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.609 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.499 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 30.0 mt -79.86 126.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 109.826 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' B' ' 218' ' ' LYS . 6.5 mt-30 -134.36 4.68 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 0.0 110.455 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.472 ' HB2' ' HB ' ' B' ' 71' ' ' VAL . 16.1 m120 -147.5 90.8 1.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.816 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.405 HG21 HG12 ' B' ' 70' ' ' ILE . 96.7 mt -99.72 141.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.903 . . . . 0.0 109.863 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 24' ' ' LEU . 11.4 t -109.36 135.44 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.526 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.437 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.19 172.79 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 5.1 m -164.13 150.13 10.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -1.164 . . . . 0.0 110.159 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 21.0 p -170.62 157.78 5.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.456 ' O ' HD11 ' B' ' 63' ' ' ILE . 2.7 p30 -113.6 175.22 5.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 109.796 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.44 -84.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.39 -27.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.426 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 30.7 p90 -129.69 164.67 38.51 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.768 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 48.0 Cg_endo -76.86 156.55 34.86 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.023 1.539 . . . . 0.0 110.488 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.413 HG12 HD21 ' B' ' 234' ' ' LEU . 2.2 mp -121.79 147.84 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -82.62 101.2 10.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.472 HD23 ' O ' ' B' ' 206' ' ' ILE . 20.8 mt -58.65 -52.03 67.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' B' ' 177' ' ' PHE . 1.1 mt-10 -50.44 -45.71 56.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.93 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.12 70.59 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -51.95 10.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.46 -1.023 . . . . 0.0 109.83 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.436 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -63.78 -11.69 28.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.76 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' B' ' 173' ' ' GLU . 3.4 t80 -88.89 -49.36 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 110.125 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' SER . . . . . 0.466 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 36.4 t -88.38 -35.56 17.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -112.36 18.73 18.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.444 ' HA2' ' OG ' ' B' ' 183' ' ' SER . . . -59.38 -18.77 44.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' THR . . . . . 0.444 HG21 ' N ' ' B' ' 182' ' ' PHE . 5.6 t -64.95 -20.61 66.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -1.17 . . . . 0.0 110.21 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.444 ' N ' HG21 ' B' ' 181' ' ' THR . 15.2 m-85 -131.85 5.53 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.897 . . . . 0.0 110.228 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' B' ' 194' ' ' ILE . 37.2 p -124.35 153.54 41.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -125.91 137.42 53.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.456 ' OH ' HD11 ' B' ' 172' ' ' LEU . 4.3 t80 -129.69 101.09 5.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.77 111.85 27.37 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.917 . . . . 0.0 109.908 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 -2.03 10.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.881 1.464 . . . . 0.0 110.377 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.73 -22.51 50.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.305 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.504 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 2.6 pp -159.37 24.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -170.07 106.9 0.44 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.475 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.66 -31.42 6.82 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.97 1.51 . . . . 0.0 109.986 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.78 171.33 37.58 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' B' ' 176' ' ' ALA . 5.1 tt -101.01 140.06 35.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.237 -1.155 . . . . 0.0 110.463 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' B' ' 205' ' ' LEU . 65.0 mt -96.04 123.22 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.854 . . . . 0.0 110.109 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.439 ' HB2' HD13 ' B' ' 206' ' ' ILE . 7.4 t80 -107.94 124.15 49.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.367 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -99.66 90.95 4.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.439 ' HE2' ' HB ' ' B' ' 230' ' ' ILE . 29.7 tpp -47.11 134.51 10.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.349 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 56.5 t -65.62 -58.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.403 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -138.72 118.55 9.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.462 ' HG3' ' HA ' ' B' ' 222' ' ' GLU . 48.4 Cg_endo -75.66 163.22 90.82 Favored 'Cis proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.962 -2.099 . . . . 0.0 110.377 -0.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' B' ' 197' ' ' MET . 6.3 mmtt -69.1 94.27 0.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 36.4 mm -126.43 146.29 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.95 . . . . 0.0 110.497 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.403 ' C ' HD13 ' B' ' 204' ' ' LEU . 71.5 t -98.28 134.63 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.848 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.479 HD13 ' N ' ' B' ' 204' ' ' LEU . 3.5 mp -136.34 136.83 40.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 110.542 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 67.4 mt -99.12 145.2 27.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 110.08 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.472 ' O ' HD23 ' B' ' 172' ' ' LEU . 6.6 mt -125.39 103.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -87.17 135.43 33.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 110.307 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 42.5 t -48.15 -24.45 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.2 p -66.38 -44.15 83.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 135.26 -3.43 4.02 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 137.16 34.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -1.226 . . . . 0.0 110.492 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.442 HG22 HD11 ' B' ' 212' ' ' ILE . 13.5 mm -121.66 152.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.28 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 33.4 t -124.77 162.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.056 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 213' ' ' VAL . 3.2 mp -148.29 135.41 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.404 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 4.8 t -166.6 141.17 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 110.082 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 112.9 14.59 9.99 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -90.23 160.35 16.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -1.195 . . . . 0.0 110.361 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' B' ' 158' ' ' GLN . 3.7 mmmm -106.12 -5.34 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -168.59 159.46 10.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.353 -0.842 . . . . 0.0 110.109 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -56.62 -17.79 9.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.337 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -25.63 59.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 109.776 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.462 ' HA ' ' HG3' ' B' ' 200' ' ' PRO . 3.6 mt-10 -80.02 -44.76 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.4 ' HA ' HD11 ' B' ' 223' ' ' ILE . 28.4 mm -61.34 -40.43 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.474 ' OH ' ' CG1' ' B' ' 64' ' ' VAL . 2.4 m-85 -66.77 -37.26 84.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.887 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -72.54 -38.97 67.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.411 ' HB2' HD22 ' B' ' 204' ' ' LEU . . . -58.91 -33.98 71.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.574 ' CE2' ' O ' ' B' ' 63' ' ' ILE . 33.0 t80 -77.84 -54.23 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -17.73 5.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.09 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.39 -37.63 11.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.312 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.467 HG21 ' HA ' ' B' ' 227' ' ' PHE . 3.9 tp -84.47 -24.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.586 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.55 -49.24 56.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.887 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.1 Cg_endo -71.4 -36.47 6.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.547 1.288 . . . . 0.0 110.339 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.67 -35.83 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.653 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.413 HD21 HG12 ' B' ' 170' ' ' ILE . 8.2 mt -71.27 -48.51 50.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.039 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -22.66 53.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.177 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.2 -35.39 41.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 110.269 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.466 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 64.3 m-85 -113.75 40.77 2.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.343 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.5 ' NH2' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -63.67 172.58 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -117.88 -55.62 2.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.159 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 32.3 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.22 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.662 ' N ' ' CZ ' ' B' ' 99' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.499 ' O ' HD13 ' A' ' 28' ' ' ILE . 2.0 t70 -57.62 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.856 -1.153 . . . . 0.0 110.049 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.558 HD22 ' CD2' ' A' ' 18' ' ' LEU . 1.4 mm? -107.21 -20.55 13.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 111.025 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.512 HG22 ' CB ' ' A' ' 59' ' ' LEU . 13.5 m -43.31 -26.83 0.2 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -95.59 -27.11 10.87 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.59 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 4.6 mm -59.43 -50.99 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -1.104 . . . . 0.0 108.942 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 67' ' ' MET . 0.6 OUTLIER -77.56 1.76 18.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -104.78 -21.49 13.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 110.74 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA2' ' ND2' ' B' ' 69' ' ' ASN . . . 159.86 48.32 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.999 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.54 ' HB3' ' CD2' ' A' ' 35' ' ' LEU . 1.4 t-20 56.33 151.67 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -1.112 . . . . 0.0 111.039 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.685 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -171.06 156.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 31' ' ' GLU . 96.7 m-20 -86.18 116.1 24.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.553 ' HB3' ' CD1' ' B' ' 103' ' ' ILE . 0.5 OUTLIER -35.34 -28.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.306 0.574 . . . . 0.0 110.318 -177.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 29' ' ' ASP . 21.3 tt0 -51.77 -18.5 1.27 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.325 -0.86 . . . . 0.0 110.061 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.74 26.59 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.082 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.505 ' O ' ' CA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.44 132.13 54.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.089 -1.242 . . . . 0.0 110.438 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.685 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 1.6 tt -102.9 152.65 21.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.848 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.54 ' CD2' ' HB3' ' A' ' 27' ' ' ASN . 3.0 pp . . . . . 0 N--CA 1.493 1.707 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.688 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.333 0.587 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.73 -19.01 16.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 56' ' ' ILE . 4.4 mt -94.59 -47.65 6.43 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.3 -48.87 18.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.434 -0.791 . . . . 0.0 109.593 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.35 -26.28 66.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 6.7 m-20 -79.85 -40.46 28.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.517 ' N ' HD13 ' A' ' 59' ' ' LEU . 5.9 mt -50.97 -39.97 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 0.0 109.141 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -22.75 48.91 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 p -129.67 18.85 5.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -1.224 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.548 ' CD2' ' CE2' ' B' ' 190' ' ' PHE . 4.3 mt -84.14 5.21 27.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.4 m -89.53 45.36 1.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.118 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 11.3 ttpt -147.52 12.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.147 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' B' ' 194' ' ' ILE . 0.8 OUTLIER -131.06 -27.17 2.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.622 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.31 -42.77 0.14 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.497 HD21 ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -44.85 -36.99 3.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -1.202 . . . . 0.0 110.54 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 15.3 t0 -42.39 -35.38 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 14.8 m -65.17 -46.8 79.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.335 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.543 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 6.4 tpp -66.76 -16.63 64.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.54 ' CD1' ' HA ' ' A' ' 65' ' ' ASP . 6.5 mt -70.48 -61.42 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.953 -1.092 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.1 pp -66.45 -2.66 4.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.58 -0.7 . . . . 0.0 110.808 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -91.51 -13.55 31.95 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.151 -0.968 . . . . 0.0 111.241 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 67' ' ' MET . 0.0 OUTLIER -119.05 -26.72 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.938 -1.101 . . . . 0.0 110.045 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.585 HG12 ' CE2' ' B' ' 99' ' ' PHE . 0.4 OUTLIER -128.23 67.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 73' ' ' ASP . 16.5 t70 -70.09 59.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.612 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 3.0 mt . . . . . 0 C--N 1.299 -1.615 0 CA-C-O 121.612 0.72 . . . . 0.0 110.97 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.197 0.522 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.438 HG11 ' HD2' ' B' ' 65' ' ' PRO . 39.5 t -97.93 139.45 21.3 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.329 -0.857 . . . . 0.0 109.916 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.481 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 45.5 Cg_endo -71.58 130.12 16.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.94 1.495 . . . . 0.0 110.62 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.461 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 94.1 m -93.45 132.08 38.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.123 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 mt -70.17 128.61 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' B' ' 163' ' ' SER . 2.0 mt-30 -106.86 -18.33 13.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 110.219 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.527 ' ND2' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -170.17 153.59 4.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.532 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 37.7 mm -129.28 153.74 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' B' ' 124' ' ' THR . 22.4 t -141.76 129.9 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.341 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -137.9 157.19 46.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 41.6 p -104.04 146.19 29.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.251 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.447 HG23 ' OG ' ' B' ' 136' ' ' SER . 54.7 t -137.8 132.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 110.163 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.438 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 5.9 m -114.62 128.24 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.518 HD23 ' CB ' ' B' ' 150' ' ' ALA . 70.3 mt -83.25 -71.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.79 -11.11 3.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . 0.426 ' SG ' HD22 ' B' ' 80' ' ' LEU . 31.6 p -129.68 134.16 47.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -1.219 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' B' ' 117' ' ' ALA . 5.8 ttt180 -58.16 155.26 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.544 HD21 ' CD1' ' B' ' 148' ' ' PHE . 14.6 mt -137.38 153.19 50.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 40.7 t0 -93.9 101.11 13.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.808 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' B' ' 100' ' ' ALA . 17.8 mt -41.36 -49.33 3.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.185 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -54.23 -34.57 61.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.002 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 85.9 m -80.24 -40.35 27.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.568 HG23 ' CE2' ' B' ' 148' ' ' PHE . 24.8 t -71.9 -37.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.065 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' B' ' 82' ' ' LEU . . . -79.99 -19.02 48.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 110.192 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 13.1 tp -91.54 -30.63 16.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.6 m80 -92.51 -17.77 24.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.339 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' B' ' 85' ' ' VAL . . . -74.7 133.4 42.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -70.32 -21.43 62.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.885 . . . . 0.0 110.351 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -139.44 79.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.083 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -160.2 154.29 23.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 8.2 pt-20 -141.27 171.59 13.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.482 ' CZ ' HD11 ' B' ' 82' ' ' LEU . 21.5 t80 -140.46 124.89 17.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 110.568 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 31' ' ' GLU . 7.5 m-20 -114.27 98.83 49.68 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.88 -24.01 21.56 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.076 1.566 . . . . 0.0 110.357 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -74.15 -20.78 60.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.384 -0.822 . . . . 0.0 110.298 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.24 -74.03 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 110.363 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -133.25 178.19 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -104.39 40.13 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.612 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -117.96 149.18 41.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -0.949 . . . . 0.0 110.766 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.448 ' CG2' HD23 ' B' ' 82' ' ' LEU . 40.6 t -89.99 124.51 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.044 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 30' ' ' SER . 3.8 mm -89.28 111.77 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.04 . . . . 0.0 110.224 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' B' ' 112' ' ' THR . 2.1 ttm -107.72 155.77 19.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.701 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.42 ' CG ' ' C ' ' B' ' 104' ' ' MET . 56.5 mtm180 -146.33 148.01 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 110.567 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 9.8 pt -131.44 157.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.465 -0.772 . . . . 0.0 109.656 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.07 -28.19 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' B' ' 108' ' ' GLU . 0.5 OUTLIER -156.69 118.69 2.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.168 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.475 ' HG2' ' CB ' ' B' ' 135' ' ' ALA . 47.1 Cg_endo -73.63 122.36 7.71 Favored 'Cis proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.881 -2.133 . . . . 0.0 110.36 -0.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.518 ' O ' ' CG2' ' B' ' 111' ' ' THR . 24.2 tttp -43.25 108.16 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' B' ' 110' ' ' LYS . 18.8 p -158.67 -178.92 7.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.703 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.484 ' HB ' ' ND2' ' A' ' 27' ' ' ASN . 1.2 m -135.23 154.79 51.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.775 . . . . 0.0 109.096 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.481 ' N ' HG21 ' B' ' 112' ' ' THR . . . -136.48 123.92 22.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.836 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.519 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.1 OUTLIER -95.71 97.62 9.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.412 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 9.3 mt -89.51 140.54 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.09 -1.006 . . . . 0.0 110.912 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 72' ' ' ILE . 1.9 m-30 -106.51 150.89 25.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 109.878 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.457 ' N ' HD22 ' B' ' 82' ' ' LEU . . . -65.25 -17.86 64.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 0.0 110.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.6 m -67.52 -18.93 65.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.282 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.56 -13.49 15.39 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -87.95 164.61 15.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -1.196 . . . . 0.0 110.224 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.425 ' HG3' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -163.18 161.74 25.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 0.0 110.251 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.503 ' HB ' ' CD1' ' B' ' 114' ' ' LEU . 24.8 t -129.98 154.39 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.41 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 14.3 t -133.11 104.11 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.527 HG21 ' ND2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -112.04 172.62 6.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.36 -0.837 . . . . 0.0 110.167 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.508 ' CA ' ' HB2' ' A' ' 27' ' ' ASN . . . 97.31 -15.95 61.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -60.21 166.11 3.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -1.226 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -26.46 10.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.764 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.502 ' N ' HG13 ' B' ' 70' ' ' ILE . 40.0 m -153.68 166.44 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.429 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 128' ' ' SER . 3.8 mt-10 -43.64 -48.41 7.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.15 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.62 -50.63 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.46 -45.34 69.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -36.66 78.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -33.64 72.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.139 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -42.91 64.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.475 ' CB ' ' HG2' ' B' ' 109' ' ' PRO . . . -66.9 -39.81 87.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.194 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.447 ' OG ' HG23 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -60.24 -57.4 12.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.964 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -44.75 -52.2 8.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -53.74 -47.75 70.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.418 ' O ' HD11 ' B' ' 143' ' ' ILE . 15.4 m-85 -61.68 -57.74 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.77 -26.91 2.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 9.0 ttm180 -73.84 -49.29 25.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.836 . . . . 0.0 110.092 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 42.2 mt -47.12 -39.2 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.938 . . . . 0.0 110.052 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' B' ' 143' ' ' ILE . 1.8 mp -72.21 -53.04 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 3.5 mt-30 -66.92 -28.28 68.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.65 -24.85 60.05 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 0.0 108.436 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 7.1 mt -82.33 -24.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 130.35 -23.11 4.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.568 ' CE2' HG23 ' B' ' 85' ' ' VAL . 7.3 m-85 -49.32 165.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.293 . . . . 0.0 110.746 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.62 36.82 2.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.452 -0.78 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.518 ' CB ' HD23 ' B' ' 76' ' ' LEU . . . -62.83 152.69 35.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 13.6 ptpt -136.99 24.07 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.124 -0.985 . . . . 0.0 110.462 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' B' ' 151' ' ' LYS . 2.7 t80 27.25 98.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.211 0.529 . . . . 0.0 111.795 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -151.86 169.5 22.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 110.369 179.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.438 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 7.3 t0 65.45 30.12 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 7.1 t80 -71.85 122.87 21.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.924 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.36 131.19 8.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 3.3 mp -79.53 123.91 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -110.91 -14.99 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.486 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.4 t30 -142.49 135.96 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.711 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' B' ' 70' ' ' ILE . 29.8 mt -131.26 129.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.447 HG21 ' OG1' ' B' ' 215' ' ' THR . 10.2 t -96.8 134.72 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -141.97 168.74 25.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.505 ' HB2' ' NE2' ' B' ' 68' ' ' GLN . 0.3 OUTLIER -161.76 153.05 18.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.285 . . . . 0.0 110.711 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.441 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 7.5 p -165.95 155.65 12.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.13 153.08 21.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.348 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.579 ' HB ' ' CZ ' ' B' ' 168' ' ' PHE . 13.2 m -105.91 3.46 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.56 -2.8 2.52 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.361 -0.837 . . . . 0.0 111.262 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.579 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 15.3 p90 -150.24 149.84 27.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.797 -1.189 . . . . 0.0 110.38 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.478 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 47.4 Cg_endo -73.64 160.62 43.67 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.135 1.597 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.489 HG21 ' N ' ' B' ' 171' ' ' ARG . 3.1 mt -131.34 150.83 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.872 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.489 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.0 OUTLIER -79.66 103.03 9.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.875 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.452 ' O ' HD11 ' B' ' 193' ' ' LEU . 15.5 mt -63.37 -34.68 78.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.662 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 9.4 pt-20 -78.3 -32.44 49.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.385 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . 0.521 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -64.16 -48.02 79.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.53 HD23 ' CD2' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -60.63 -42.2 96.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -1.106 . . . . 0.0 110.296 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.76 64.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.451 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -83.23 -27.78 29.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 67.0 m -95.13 -44.72 7.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -123.72 49.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.09 -20.59 79.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 32.6 m -60.32 -23.58 64.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -1.146 . . . . 0.0 110.208 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.432 ' O ' ' HG2' ' B' ' 196' ' ' ARG . 17.7 m-85 -123.5 -5.37 8.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.43 ' HB2' HD22 ' B' ' 193' ' ' LEU . 0.4 OUTLIER -123.31 152.93 40.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 8.5 p -131.8 139.33 48.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -127.16 113.46 16.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' B' ' 190' ' ' PHE . 8.6 mt-10 -117.72 92.15 40.55 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.127 -0.983 . . . . 0.0 109.921 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.64 -3.78 13.29 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.001 1.527 . . . . 0.0 110.167 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.57 -13.58 18.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.89 . . . . 0.0 110.014 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 tt -138.54 -35.11 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.462 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.548 ' CE2' ' CD2' ' A' ' 59' ' ' LEU . 2.7 t80 -125.49 114.04 25.4 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.39 -10.32 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.897 1.472 . . . . 0.0 110.457 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.99 172.81 18.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.452 HD11 ' O ' ' B' ' 172' ' ' LEU . 6.1 tt -105.15 121.53 44.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.522 ' CD1' HD11 ' A' ' 62' ' ' LEU . 6.4 mt -90.3 106.27 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.214 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' B' ' 204' ' ' LEU . 5.7 t80 -101.58 122.32 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -111.67 80.06 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.405 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.5 OUTLIER -68.34 166.09 17.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.883 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' B' ' 201' ' ' LYS . 63.1 t -111.02 -31.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.97 . . . . 0.0 110.704 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 7.0 tttt -134.78 97.14 14.22 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.585 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -72.37 150.18 94.55 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.8 -2.167 . . . . 0.0 110.401 -0.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' B' ' 198' ' ' VAL . 0.0 OUTLIER -77.39 92.69 3.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.969 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' B' ' 217' ' ' ALA . 27.6 mm -140.33 153.53 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.07 103.8 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 109.844 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.435 HD22 HD22 ' B' ' 214' ' ' LEU . 3.3 mp -95.01 142.45 27.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.463 ' CD1' ' HB ' ' B' ' 213' ' ' VAL . 4.4 mt -118.87 116.01 25.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.663 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.441 HG13 HG13 ' B' ' 212' ' ' ILE . 2.6 mt -108.71 119.87 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' B' ' 208' ' ' VAL . 10.0 m-85 -99.29 147.83 24.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.443 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.478 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 67.7 t -44.42 -25.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.021 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.406 ' N ' ' O ' ' B' ' 207' ' ' PHE . 3.8 p -66.11 -39.73 90.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.055 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . 0.444 ' O ' HG23 ' B' ' 166' ' ' VAL . . . 120.75 17.27 4.28 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.462 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.1 OUTLIER -91.36 130.77 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.123 . . . . 0.0 110.135 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.492 ' N ' HD11 ' B' ' 212' ' ' ILE . 1.2 mp -116.35 121.68 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 110.028 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.463 ' HB ' ' CD1' ' B' ' 205' ' ' LEU . 27.0 t -107.69 113.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 110.139 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' B' ' 214' ' ' LEU . 3.7 mp -101.23 103.5 14.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 5.0 t -130.31 142.95 50.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.971 . . . . 0.0 110.105 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.41 ' CA ' ' HE2' ' A' ' 67' ' ' MET . . . 114.14 14.05 9.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.533 ' CB ' HD13 ' B' ' 202' ' ' ILE . . . -90.96 145.55 24.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.157 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -85.33 -13.76 48.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.348 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.509 ' CA ' ' CD1' ' B' ' 160' ' ' ILE . 1.3 tt0 -151.51 -173.44 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.066 -1.021 . . . . 0.0 110.539 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -79.77 -52.97 7.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.408 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.451 ' OE2' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -45.7 -25.72 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 110.538 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -69.83 -54.34 14.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.467 HD12 ' HB1' ' B' ' 217' ' ' ALA . 18.9 mm -58.6 -39.81 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.481 ' CE1' ' HG2' ' B' ' 65' ' ' PRO . 5.5 m-85 -67.35 -33.15 74.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.491 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -78.24 -37.09 46.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.956 . . . . 0.0 110.145 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.3 80.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 2.3 t80 -67.85 -50.12 58.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.92 -15.19 7.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -95.88 -34.57 11.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.484 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.441 ' C ' ' HD2' ' B' ' 232' ' ' PRO . 3.6 tp -95.48 -16.21 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 18.8 t80 -50.09 -45.3 81.77 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.3 Cg_endo -73.13 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.327 1.172 . . . . 0.0 110.497 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' B' ' 232' ' ' PRO . 14.1 t -44.36 -37.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.761 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.4 -47.64 32.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 13.2 m -55.74 -33.21 64.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.03 -29.34 61.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.317 -0.864 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.53 ' CD2' HD23 ' B' ' 175' ' ' LEU . 52.5 m-85 -118.78 40.56 3.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.093 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 -170.74 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -46.31 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.279 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.675 ' CB ' ' CG ' ' B' ' 99' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.42 0.628 . . . . 0.0 111.29 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 4.5 m-20 79.84 76.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.482 0.658 . . . . 0.0 110.749 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.564 ' HG ' ' CG2' ' A' ' 72' ' ' ILE . 1.1 mt -97.87 25.92 5.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.411 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.579 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 24.3 m -54.59 -19.55 6.19 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 109.533 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.547 ' HA3' HG22 ' A' ' 28' ' ' ILE . . . -100.37 -36.68 4.02 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.564 HG12 ' CG1' ' A' ' 28' ' ' ILE . 7.8 mm -43.93 -45.13 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.981 -1.305 . . . . 0.0 108.857 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.52 ' CD1' ' SD ' ' A' ' 67' ' ' MET . 1.2 pp -80.81 -21.92 40.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -101.14 13.84 33.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.545 -0.722 . . . . 0.0 109.757 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 28' ' ' ILE . . . 139.24 83.61 0.1 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.54 ' CB ' ' CG2' ' B' ' 124' ' ' THR . 20.6 p-10 -15.18 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.698 0.761 . . . . 0.0 112.755 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.564 ' CG1' HG12 ' A' ' 23' ' ' ILE . 1.2 pp -88.55 171.65 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 31' ' ' GLU . 71.2 m-20 -86.81 119.38 26.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.2 -27.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.024 -177.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.2 tt0 -57.36 -13.29 3.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.21 27.32 4.55 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -116.25 116.77 28.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.085 -1.244 . . . . 0.0 110.778 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.554 ' HA ' ' CG2' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -88.94 143.58 26.77 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.822 -1.174 . . . . 0.0 109.83 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 34' ' ' LEU . 4.5 pp . . . . . 0 N--CA 1.494 1.75 0 O-C-N 120.614 -1.304 . . . . 0.0 111.312 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.188 0.518 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' CD ' ' HG3' ' B' ' 191' ' ' PRO . 2.5 tp10 -101.03 -20.41 15.4 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.138 -0.977 . . . . 0.0 109.319 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.48 HD23 ' CD1' ' B' ' 205' ' ' LEU . 3.0 mt -95.5 -44.59 7.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 110.149 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -53.88 -59.05 5.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.243 -0.911 . . . . 0.0 109.595 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.52 -13.38 30.0 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.497 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.437 ' HB3' HD13 ' A' ' 59' ' ' LEU . 2.8 m-20 -91.02 -39.15 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -0.797 . . . . 0.0 109.278 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.489 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 4.5 mt -51.97 -39.38 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.531 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 -16.19 41.83 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.47 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -133.15 9.87 4.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.243 -1.151 . . . . 0.0 110.781 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 1.2 mt -79.31 7.05 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.507 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -94.09 43.27 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.311 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 58' ' ' SER . 3.3 ptmm? -143.67 15.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -131.42 -60.43 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 65' ' ' ASP . . . -146.84 -44.93 0.03 OUTLIER Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.486 ' CD1' HD12 ' A' ' 24' ' ' LEU . 3.4 mm? -42.06 -26.14 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -1.17 . . . . 0.0 110.394 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 63' ' ' GLY . 10.1 t70 -44.5 -37.7 3.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -71.11 -54.19 11.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.699 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.52 ' SD ' ' CD1' ' A' ' 24' ' ' LEU . 10.6 ttm -72.65 -3.7 26.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.553 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.9 tm? -75.81 -59.04 2.93 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.87 0.843 . . . . 0.0 108.975 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.404 HD21 ' O ' ' A' ' 65' ' ' ASP . 1.3 pp -78.48 1.01 23.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.246 0.546 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.53 9.32 27.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 111.446 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.514 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 1.6 t -135.73 2.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.866 -1.146 . . . . 0.0 109.809 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.564 ' CG2' ' HG ' ' A' ' 20' ' ' LEU . 3.5 tp -149.86 75.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.4 t70 -77.84 57.47 1.71 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 108.26 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.629 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 8.0 mt . . . . . 0 C--N 1.305 -1.348 0 CA-C-O 121.716 0.769 . . . . 0.0 110.727 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 4.0 mt . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.1 0.476 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 14.0 t 61.07 128.91 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.76 120.42 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.894 1.47 . . . . 0.0 110.193 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 90.5 m -89.68 135.11 33.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.91 123.85 22.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 110.064 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' B' ' 127' ' ' LYS . 1.4 mm-40 -109.31 -7.1 15.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.473 ' ND2' ' HA2' ' A' ' 26' ' ' GLY . 4.1 t-20 -164.43 156.72 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' B' ' 126' ' ' ALA . 23.5 mm -137.47 147.2 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 14.6 t -137.02 138.44 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.05 159.3 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.459 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.09 138.85 44.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.842 . . . . 0.0 109.875 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.437 HG11 ' N ' ' B' ' 75' ' ' THR . 92.9 t -135.64 154.65 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.112 -0.992 . . . . 0.0 110.649 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.454 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 33.6 m -129.7 131.91 46.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 109.932 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.446 HD11 HD12 ' B' ' 80' ' ' LEU . 57.4 mt -89.43 -27.65 20.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.38 80.38 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' B' ' 150' ' ' ALA . 24.8 p -137.12 139.16 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -1.228 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -69.26 152.27 45.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.516 ' N ' ' HG2' ' B' ' 79' ' ' ARG . 16.6 mt -131.17 150.92 51.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.352 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.461 ' HB3' HG22 ' B' ' 84' ' ' THR . 1.1 t0 -91.12 97.71 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' B' ' 100' ' ' ALA . 13.0 mt -41.16 -36.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.604 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -62.01 -40.7 96.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 110.475 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.461 HG22 ' HB3' ' B' ' 81' ' ' ASP . 26.7 p -85.83 -39.34 17.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.963 . . . . 0.0 110.425 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' B' ' 80' ' ' LEU . 56.7 t -62.55 -30.17 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 110.083 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.54 -23.93 21.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -0.859 . . . . 0.0 110.12 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 1.0 OUTLIER -76.98 -47.98 19.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.32 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -77.28 -39.16 49.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.375 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.415 ' HB2' ' HB1' ' B' ' 92' ' ' ALA . . . -50.23 113.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.357 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -26.32 62.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' B' ' 91' ' ' ASN . 31.7 p30 -130.11 79.12 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.764 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -161.03 145.81 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -134.85 136.65 42.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.285 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.406 ' CE1' HD11 ' B' ' 82' ' ' LEU . 28.8 t80 -114.58 110.75 20.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -106.51 112.69 63.65 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.98 -16.56 29.02 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.022 1.538 . . . . 0.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.61 -22.07 24.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 5.3 mpt_? -91.8 -73.28 0.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.675 ' CG ' ' CB ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -153.6 164.14 38.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.43 -0.794 . . . . 0.0 110.253 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -81.7 47.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.889 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.629 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -129.61 146.49 51.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 111.087 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.424 HG22 HD23 ' B' ' 82' ' ' LEU . 20.1 t -93.28 122.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.447 -0.783 . . . . 0.0 108.997 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.554 HG22 ' CA ' ' A' ' 29' ' ' ASP . 3.1 mp -89.18 115.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 110.52 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.55 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.4 OUTLIER -97.37 147.97 23.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.966 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.73 95.01 2.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.541 HG22 ' CE1' ' B' ' 139' ' ' TYR . 16.5 pt -94.81 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -129.3 43.89 3.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.456 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 176.47 78.58 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.391 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.463 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.7 Cg_endo -79.66 157.03 89.34 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.455 -0.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.476 ' O ' HG21 ' B' ' 111' ' ' THR . 45.8 tttp -65.65 109.41 2.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.888 . . . . 0.0 109.945 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.518 HG23 ' N ' ' B' ' 126' ' ' ALA . 1.3 p -148.29 177.77 9.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.64 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.533 HG21 ' CG2' ' B' ' 124' ' ' THR . 0.4 OUTLIER -130.04 171.5 12.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -164.19 140.17 6.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.795 -1.191 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.574 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.4 OUTLIER -105.54 100.02 9.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.422 -0.799 . . . . 0.0 108.849 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.445 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt -89.21 137.31 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.091 -1.006 . . . . 0.0 110.569 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.596 ' CE1' HD13 ' A' ' 74' ' ' LEU . 1.9 m-30 -108.45 166.15 10.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.25 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -53.72 -20.02 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.06 -18.32 16.36 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.25 162.99 18.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -1.166 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -159.97 149.4 17.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.081 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.47 HG12 HG11 ' A' ' 71' ' ' VAL . 21.0 t -112.74 135.1 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.39 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 16.8 t -110.22 148.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 109.882 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.54 ' CG2' ' CB ' ' A' ' 27' ' ' ASN . 3.5 t -156.11 162.51 40.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.788 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.528 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 112.65 -37.1 3.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.518 ' N ' HG23 ' B' ' 111' ' ' THR . . . -46.1 160.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -1.142 . . . . 0.0 110.256 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' B' ' 68' ' ' GLN . 1.3 mmmt -115.92 -2.31 12.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.193 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.452 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.5 OUTLIER -158.78 162.85 37.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.24 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.91 -31.79 67.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.34 -50.95 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.11 -44.13 97.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.904 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 46.6 t -53.7 -47.45 70.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.964 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -54.85 -46.74 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.39 -52.76 29.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.304 -0.872 . . . . 0.0 110.033 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.405 ' O ' ' C ' ' B' ' 137' ' ' ARG . 1.6 p -71.65 -60.08 2.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.583 ' HD2' ' CE2' ' B' ' 152' ' ' PHE . 4.7 mtp180 -43.54 -46.22 6.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -51.38 65.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.098 -1.001 . . . . 0.0 109.966 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' B' ' 104' ' ' MET . 15.4 m-85 -50.33 -48.8 55.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 109.863 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.24 -24.86 67.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.821 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -71.0 -31.44 67.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 110.064 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.438 ' O ' HG13 ' B' ' 146' ' ' ILE . 23.1 mt -69.64 -47.02 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.529 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 1.7 mp -65.3 -49.52 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 1.5 mt-30 -64.39 -39.34 93.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.025 -1.047 . . . . 0.0 110.017 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -68.23 -21.68 64.82 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.44 HG22 HD11 ' B' ' 146' ' ' ILE . 9.2 mt -81.15 -24.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.52 -35.34 2.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.521 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 13.5 m-85 -51.03 165.86 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.138 -1.213 . . . . 0.0 110.89 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.99 48.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.674 -0.641 . . . . 0.0 109.975 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.529 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -71.55 134.88 46.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.27 -153.9 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.583 ' CE2' ' HD2' ' B' ' 137' ' ' ARG . 22.3 t80 -149.46 78.3 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.267 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 1.1 p -141.66 179.55 6.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.454 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 8.7 t0 66.31 13.93 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.952 . . . . 0.0 110.351 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -66.76 136.72 55.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.887 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -168.57 124.12 0.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.584 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.7 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.453 ' HA ' ' HG3' ' B' ' 218' ' ' LYS . 1.6 mt-30 -122.98 -11.86 8.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.036 . . . . 0.0 111.042 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.46 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.2 t30 -136.69 130.4 32.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.082 . . . . 0.0 111.061 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.56 122.53 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 58.1 t -94.27 125.58 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -131.51 162.99 23.75 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 93.4 p -164.4 151.08 11.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.099 -1.236 . . . . 0.0 110.403 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 26.5 p -167.59 146.75 4.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.236 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 11.4 p-10 -91.26 163.36 14.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -102.43 -71.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 165.43 -23.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.72 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' B' ' 168' ' ' PHE . 16.2 p90 -136.32 163.18 51.88 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.6 Cg_endo -72.04 142.09 37.73 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.8 1.421 . . . . 0.0 110.555 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.442 HG22 HD21 ' B' ' 234' ' ' LEU . 3.8 mt -101.83 149.82 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.32 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.58 98.5 10.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.489 ' CD1' HG21 ' B' ' 208' ' ' VAL . 91.4 mt -56.9 -30.01 63.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 110.391 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -49.1 33.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.882 . . . . 0.0 110.419 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.79 -28.78 68.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.448 ' HB3' HD12 ' B' ' 193' ' ' LEU . 0.1 OUTLIER -71.19 -44.94 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 0.0 110.195 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.63 -13.77 59.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.024 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.22 -34.71 37.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.778 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.03 -35.08 9.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.785 . . . . 0.0 109.888 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -115.63 37.51 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.351 -0.843 . . . . 0.0 110.135 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.56 -9.96 82.4 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' THR . . . . . 0.492 HG21 ' N ' ' B' ' 182' ' ' PHE . 7.0 t -76.11 -24.79 54.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -1.197 . . . . 0.0 110.061 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.529 ' CE2' HG23 ' B' ' 198' ' ' VAL . 0.2 OUTLIER -127.81 -2.44 5.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.519 ' OG ' ' CD2' ' B' ' 193' ' ' LEU . 0.9 OUTLIER -114.97 140.99 48.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.107 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 3.8 t -111.56 136.75 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -145.32 91.28 2.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -108.44 110.21 61.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.89 1.08 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.959 1.505 . . . . 0.0 110.462 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.9 -13.92 28.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.528 ' O ' ' CG ' ' B' ' 189' ' ' LEU . 2.1 tt -155.71 16.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.278 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.45 ' CE2' HD22 ' A' ' 59' ' ' LEU . 1.7 t80 -170.18 106.16 0.44 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.762 -1.211 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . 0.442 ' O ' HD12 ' B' ' 172' ' ' LEU . 45.5 Cg_endo -73.85 -23.41 16.5 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.987 1.519 . . . . 0.0 110.238 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.93 -179.88 42.96 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.519 ' CD2' ' OG ' ' B' ' 183' ' ' SER . 1.9 tt -115.11 146.69 41.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.451 ' HA ' HD22 ' B' ' 205' ' ' LEU . 77.0 mt -113.45 103.82 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 109.943 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.5 t80 -102.14 118.21 36.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.892 . . . . 0.0 110.351 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.452 ' HG2' ' NH1' ' B' ' 196' ' ' ARG . 3.3 tpp85 -92.41 92.72 8.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 56.4 tpp -50.8 125.65 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.354 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.529 HG23 ' CE2' ' B' ' 182' ' ' PHE . 30.8 t -64.23 -43.31 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.292 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -149.43 117.16 3.72 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.89 166.96 79.81 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.916 -2.118 . . . . 0.0 110.304 -0.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.455 ' O ' ' CG1' ' B' ' 202' ' ' ILE . 4.9 mttm -75.35 108.38 8.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.481 HG21 ' N ' ' B' ' 203' ' ' VAL . 13.3 mt -154.67 151.76 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.481 ' N ' HG21 ' B' ' 202' ' ' ILE . 20.0 t -96.98 127.71 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 109.991 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.483 HD22 ' CD2' ' B' ' 214' ' ' LEU . 2.3 mp -112.53 125.7 54.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.48 ' CD1' HD23 ' A' ' 52' ' ' LEU . 13.1 mt -102.58 120.19 40.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.438 ' O ' HD22 ' B' ' 172' ' ' LEU . 12.3 mt -114.84 115.17 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.07 154.84 16.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 110.245 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.489 HG21 ' CD1' ' B' ' 172' ' ' LEU . 52.9 t -49.98 -35.42 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.52 90.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 110.498 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . 0.441 ' HA2' ' CD1' ' B' ' 170' ' ' ILE . . . 130.93 32.4 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' B' ' 163' ' ' SER . 0.0 OUTLIER -95.97 117.08 29.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -1.183 . . . . 0.0 109.828 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' B' ' 212' ' ' ILE . 1.2 mp -107.08 111.14 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 75.9 t -104.91 150.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.928 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.483 ' CD2' HD22 ' B' ' 204' ' ' LEU . 4.1 mp -142.33 107.96 5.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 10.1 t -129.61 157.58 41.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.45 ' HA2' ' OD1' ' B' ' 159' ' ' ASN . . . 102.85 11.75 33.99 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' B' ' 222' ' ' GLU . . . -91.77 155.1 18.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.31 -1.112 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' B' ' 218' ' ' LYS . 22.4 tttt -104.79 0.71 28.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.375 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.2 137.78 5.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.028 . . . . 0.0 110.432 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' B' ' 220' ' ' ARG . 10.4 ttm180 -45.18 -26.62 0.5 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -34.03 77.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.989 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 217' ' ' ALA . 1.4 mm-40 -67.82 -55.13 14.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.432 HG12 ' CB ' ' B' ' 217' ' ' ALA . 14.3 mm -51.08 -47.53 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.786 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.05 -27.58 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.778 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.16 -43.4 24.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 110.107 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.16 88.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.401 ' HA ' HG21 ' B' ' 230' ' ' ILE . 46.8 t80 -70.28 -42.58 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -20.09 66.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.84 -22.99 18.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 110.318 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.418 ' C ' ' HD2' ' B' ' 232' ' ' PRO . 7.5 tp -100.36 -28.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.584 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 30.6 t80 -44.08 -49.52 22.24 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.4 Cg_endo -69.45 -40.49 5.73 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.36 1.189 . . . . 0.0 110.606 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.7 -39.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.881 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.442 HD21 HG22 ' B' ' 170' ' ' ILE . 95.1 mt -64.87 -55.16 21.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.115 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -50.69 -28.81 9.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.95 -32.92 65.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 110.446 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -113.66 41.4 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.393 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -160.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -144.47 -54.73 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.187 -0.946 . . . . 0.0 110.236 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.599 HD21 ' CD2' ' B' ' 99' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.806 0.812 . . . . 0.0 110.664 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 5.9 t0 75.5 90.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 111.529 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.564 HD23 ' CD2' ' A' ' 18' ' ' LEU . 2.3 mt -107.27 35.45 3.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.787 . . . . 0.0 110.034 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.58 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 20.2 m -56.6 -25.45 52.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.24 -27.49 8.69 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.239 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 28' ' ' ILE . 14.8 mm -46.46 -46.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.801 -1.411 . . . . 0.0 108.849 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.523 ' CD2' ' HG2' ' A' ' 67' ' ' MET . 1.1 pp -82.66 -25.65 32.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 109.137 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' B' ' 205' ' ' LEU . 0.1 OUTLIER -90.6 14.65 12.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' HG21 ' A' ' 28' ' ' ILE . . . 135.88 98.32 0.54 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.595 ' HB3' ' N ' ' B' ' 125' ' ' GLY . 25.8 p-10 -33.9 93.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.519 -0.989 . . . . 0.0 111.737 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -90.63 175.57 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 31' ' ' GLU . 21.4 m-20 -87.86 126.19 34.89 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.508 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -40.13 -25.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -178.442 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -64.12 -6.81 7.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.986 -1.071 . . . . 0.0 110.408 178.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 102.35 29.43 6.01 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.685 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.511 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -119.44 111.33 17.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.9 -1.353 . . . . 0.0 110.6 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 1.0 OUTLIER -89.47 149.14 23.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.535 ' CD1' ' C ' ' A' ' 35' ' ' LEU . 3.4 pp . . . . . 0 N--CA 1.492 1.643 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.594 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.263 0.554 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -97.13 -20.97 17.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.291 -0.881 . . . . 0.0 109.08 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 25' ' ' PHE . 3.5 mt -98.95 -42.66 7.03 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.683 . . . . 0.0 110.094 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.71 -55.69 18.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.43 -0.794 . . . . 0.0 109.534 -179.522 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -61.79 -14.04 29.18 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.499 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 58' ' ' SER . 3.6 m-20 -92.75 -39.86 11.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.293 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 2.9 mt -47.7 -41.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 0.0 108.922 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.93 -20.05 12.65 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 55' ' ' ASN . 50.2 m -113.44 0.64 14.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -1.123 . . . . 0.0 110.371 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 56' ' ' ILE . 29.8 mt -88.91 33.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -115.88 23.15 12.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.391 -0.818 . . . . 0.0 110.501 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.87 50.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' CD1' HD12 ' B' ' 194' ' ' ILE . 0.4 OUTLIER -152.19 -29.11 0.16 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.354 -0.841 . . . . 0.0 111.0 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.515 ' N ' HD11 ' A' ' 62' ' ' LEU . . . -175.8 -42.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 2.8 mm? -69.46 -3.53 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -46.14 -41.8 13.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 110.129 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 p -65.99 -48.83 69.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 0.0 109.907 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.523 ' HG2' ' CD2' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.87 -3.36 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.4 tm? -80.6 -60.49 2.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.284 -0.885 . . . . 0.0 109.343 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.74 0.3 27.36 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.444 0.64 . . . . 0.0 109.794 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 22.9 tt0 -93.01 10.47 31.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.384 -0.822 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.465 ' O ' HD13 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -133.2 -4.26 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 120.954 -1.091 . . . . 0.0 110.072 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.598 HG12 ' CD2' ' A' ' 18' ' ' LEU . 2.6 tp -138.69 74.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.0 t0 -83.34 52.41 2.21 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.034 -1.041 . . . . 0.0 108.615 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.544 HD23 HG13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.528 -0.733 . . . . 0.0 111.766 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 5.1 mt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.202 0.525 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 45.4 t 58.77 119.63 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 0.0 110.363 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 44.6 Cg_endo -72.02 137.88 30.0 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.781 1.411 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.461 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 15.8 m -93.31 153.43 18.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 110.437 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 88.2 mt -86.52 133.06 33.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.432 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 2.9 mm-40 -116.06 -19.45 10.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.529 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 4.4 m120 -167.63 167.76 13.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.362 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 9.2 mt -158.11 158.17 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.22 144.42 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 110.351 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.04 155.44 48.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.87 141.56 42.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.505 ' HB ' ' CE ' ' B' ' 121' ' ' MET . 86.2 t -133.07 135.88 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 0.0 110.211 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -105.71 123.01 47.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.223 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.498 HD11 ' CD1' ' B' ' 80' ' ' LEU . 71.4 mt -78.45 -43.5 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.83 9.71 42.27 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.53 150.24 21.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -1.189 . . . . 0.0 110.359 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.534 ' O ' ' CD2' ' B' ' 80' ' ' LEU . 9.6 mtp180 -70.65 164.94 23.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.163 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' B' ' 79' ' ' ARG . 20.6 mt -140.39 160.22 40.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.331 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.3 OUTLIER -96.27 92.46 6.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.533 HD23 ' CG2' ' B' ' 102' ' ' VAL . 13.8 mt -42.35 -46.72 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.26 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 3.8 tptm -52.62 -46.57 67.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.444 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 18.6 p -86.89 -38.96 16.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.26 -37.51 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.798 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.65 -31.84 23.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 14.1 tp -76.8 -27.87 55.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.772 . . . . 0.0 109.97 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -47.62 9.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 110.098 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.448 ' HB3' ' CE ' ' B' ' 104' ' ' MET . . . -48.49 135.86 13.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -71.69 -24.59 61.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 10.1 p30 -136.14 79.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.111 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -151.6 153.56 34.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.389 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' OE1' ' B' ' 93' ' ' GLU . 52.7 mm-40 -134.49 141.54 46.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 110.108 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -134.41 117.79 16.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.5 125.3 26.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.55 -34.13 7.7 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.845 1.445 . . . . 0.0 110.098 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.021 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.5 ' N ' ' HD2' ' B' ' 98' ' ' ARG . 5.6 mpt_? -98.15 -59.76 1.69 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.375 -0.828 . . . . 0.0 110.202 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.656 ' CE2' ' CB ' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.57 175.0 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.629 -0.67 . . . . 0.0 111.375 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.41 55.89 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 111.298 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.656 ' CB ' ' CE2' ' B' ' 99' ' ' PHE . . . -147.87 160.23 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.533 ' CG2' HD23 ' B' ' 82' ' ' LEU . 84.6 t -92.61 162.27 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.543 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 30' ' ' SER . 9.9 mt -131.57 125.32 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 109.711 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.457 ' HE3' HG23 ' B' ' 142' ' ' ILE . 0.0 OUTLIER -103.85 162.85 12.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -160.01 130.07 5.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.443 HG21 ' O ' ' B' ' 105' ' ' ARG . 5.6 pt -139.72 167.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.44 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -125.28 37.14 4.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 110.224 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.88 80.05 0.23 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.461 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.93 165.82 84.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.483 -2.299 . . . . 0.0 110.3 -0.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' B' ' 107' ' ' ARG . 0.1 OUTLIER -78.58 109.47 12.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 110.334 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.473 HG21 ' O ' ' B' ' 124' ' ' THR . 0.2 OUTLIER -157.27 171.33 20.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.908 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 27' ' ' ASN . 6.5 t -137.12 155.35 49.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.8 167.22 28.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.508 ' CD2' HD12 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -140.86 113.56 8.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 0.0 109.507 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.532 HG13 ' CG ' ' B' ' 121' ' ' MET . 2.9 mp -98.22 149.85 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.432 -0.792 . . . . 0.0 111.02 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.582 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.1 m-85 -95.68 -177.65 4.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.491 -0.756 . . . . 0.0 109.511 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -84.96 -15.65 43.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.728 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' B' ' 79' ' ' ARG . 66.7 p -73.09 -18.53 61.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.17 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 6.72 22.28 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . 0.551 ' HB3' ' CD2' ' B' ' 116' ' ' PHE . 2.4 mttt -87.85 157.82 18.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -1.168 . . . . 0.0 110.015 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.532 ' CG ' HG13 ' B' ' 115' ' ' ILE . 7.2 tmm? -147.35 133.95 19.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.816 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 t -113.68 132.93 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.837 . . . . 0.0 109.759 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.476 ' CG2' ' SD ' ' B' ' 121' ' ' MET . 12.7 t -112.96 138.12 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.551 ' CG2' ' HB2' ' A' ' 27' ' ' ASN . 9.0 t -147.02 146.58 30.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.824 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.595 ' N ' ' HB3' ' A' ' 27' ' ' ASN . . . 119.42 -9.51 11.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -75.75 151.45 37.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.218 . . . . 0.0 110.167 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.499 ' HG3' ' N ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -117.88 -23.32 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.881 . . . . 0.0 110.145 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.499 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.1 OUTLIER -123.02 -173.66 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -82.62 -48.68 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.294 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -65.77 -16.58 63.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.63 -46.54 14.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' B' ' 136' ' ' SER . 2.0 t -65.75 -30.36 71.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.13 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -71.18 -51.27 25.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.3 -50.05 74.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.32 -0.862 . . . . 0.0 110.182 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.06 75.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' B' ' 132' ' ' SER . 0.3 OUTLIER -60.87 -58.61 7.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 110.05 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.55 -36.94 25.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.761 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -49.66 77.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.423 ' OH ' HG12 ' B' ' 106' ' ' ILE . 25.2 m-85 -58.8 -50.07 75.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 109.97 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.65 71.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.064 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 1.3 mmt85 -60.38 -40.88 92.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 110.039 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.457 HG23 ' HE3' ' B' ' 104' ' ' MET . 38.6 mt -54.71 -48.14 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.487 HG22 HD11 ' B' ' 143' ' ' ILE . 57.5 mt -66.56 -49.77 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -61.24 -36.9 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.0 OUTLIER -71.84 -27.58 62.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.442 HD11 HG22 ' B' ' 146' ' ' ILE . 6.1 mt -72.8 -18.54 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.44 -27.07 7.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.421 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 12.1 m-85 -46.79 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.25 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.78 29.97 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.532 -0.73 . . . . 0.0 109.815 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' B' ' 76' ' ' LEU . . . -66.38 151.59 46.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.513 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.97 107.53 6.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.95 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.485 ' CD1' HG12 ' B' ' 74' ' ' VAL . 77.1 t80 -53.3 102.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.902 . . . . 0.0 110.308 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.8 p -148.39 172.21 14.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 t0 60.85 15.88 6.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -60.62 134.53 57.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.966 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -170.08 134.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.352 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.96 126.81 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.365 -0.835 . . . . 0.0 109.665 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -115.67 -12.48 11.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.851 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.3 112.05 5.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.054 -1.029 . . . . 0.0 111.047 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' B' ' 215' ' ' THR . 11.0 mt -105.52 148.48 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 0.0 109.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' B' ' 69' ' ' ASN . 6.4 t -117.09 142.4 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.037 . . . . 0.0 111.079 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -159.9 164.81 34.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.0 OUTLIER -168.49 164.17 12.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.845 -1.385 . . . . 0.0 111.029 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -170.01 175.81 4.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.846 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -108.03 149.02 28.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 16.1 m -97.22 4.34 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 110.224 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.69 12.92 6.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.259 -0.901 . . . . 0.0 110.722 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.544 ' CE1' HG13 ' B' ' 170' ' ' ILE . 10.3 p90 -171.43 139.82 1.19 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.133 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.0 Cg_endo -71.31 153.62 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.104 1.581 . . . . 0.0 111.007 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.544 HG13 ' CE1' ' B' ' 168' ' ' PHE . 3.2 mt -125.42 150.65 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -80.25 92.79 5.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.462 HD23 ' O ' ' B' ' 206' ' ' ILE . 97.9 mt -52.73 -32.38 42.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.406 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.69 -59.82 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.946 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.61 -37.18 33.15 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.445 ' CD2' ' HB2' ' B' ' 237' ' ' PHE . 0.2 OUTLIER -64.89 -53.69 42.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -1.101 . . . . 0.0 109.98 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.46 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -58.1 -20.98 44.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 0.0 110.075 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.66 -56.31 4.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 0.0 109.878 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.7 t -69.9 -46.03 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 0.0 110.043 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -105.89 41.57 1.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.018 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.36 -16.89 63.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 68.0 p -85.82 -31.74 22.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -1.209 . . . . 0.0 110.378 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.419 ' CZ ' HG22 ' B' ' 198' ' ' VAL . 6.8 m-30 -104.63 -10.36 17.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.416 ' HB2' HD23 ' B' ' 193' ' ' LEU . 1.2 p -140.88 123.41 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.57 165.89 11.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.866 . . . . 0.0 110.083 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -160.66 126.89 4.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 110.28 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -130.97 107.9 15.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.273 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.996 1.524 . . . . 0.0 110.087 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -95.75 4.42 52.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 58' ' ' SER . 0.9 OUTLIER -159.78 -51.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' B' ' 192' ' ' GLY . 26.6 t80 -113.19 109.95 51.41 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 0.0 110.374 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.69 -20.8 22.59 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.975 1.513 . . . . 0.0 110.152 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' B' ' 190' ' ' PHE . . . -90.74 -179.94 43.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' B' ' 205' ' ' LEU . 6.0 tt -123.79 131.8 53.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -1.18 . . . . 0.0 110.321 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.526 HD12 ' CD1' ' A' ' 62' ' ' LEU . 4.6 mt -96.32 111.26 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 20.5 t80 -95.31 111.57 23.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.259 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -94.98 86.85 4.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 20.6 ttm -65.27 135.1 54.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 110.169 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.419 HG22 ' CZ ' ' B' ' 182' ' ' PHE . 74.2 t -86.11 -28.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.878 . . . . 0.0 110.307 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' B' ' 199' ' ' LYS . 0.0 OUTLIER -149.4 110.15 3.41 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.432 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.42 ' HB2' ' OE2' ' B' ' 222' ' ' GLU . 48.5 Cg_endo -73.72 171.28 67.23 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.035 -2.069 . . . . 0.0 110.485 -0.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.417 ' C ' HG12 ' B' ' 202' ' ' ILE . 11.8 tptt -74.46 92.57 2.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.87 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.595 ' CD1' ' CB ' ' B' ' 217' ' ' ALA . 24.6 mm -140.16 153.63 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.741 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.34 116.69 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.714 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' B' ' 214' ' ' LEU . 3.4 mp -110.71 131.21 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -110.59 122.65 48.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.19 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' B' ' 211' ' ' LYS . 2.8 mp -113.68 145.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.108 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -121.15 156.32 32.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 12.8 t -47.97 -27.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.421 -0.8 . . . . 0.0 110.137 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 4.7 m -71.54 -31.92 67.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.927 . . . . 0.0 110.303 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.39 5.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.2 OUTLIER -87.77 133.65 33.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' B' ' 163' ' ' SER . 36.5 mm -117.49 132.93 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.441 ' HA ' ' HB3' ' B' ' 163' ' ' SER . 76.0 t -125.85 114.52 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 110.393 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.519 ' CD2' HD22 ' B' ' 204' ' ' LEU . 1.9 mp -97.69 104.19 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 110.172 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.8 t -132.56 142.29 49.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.953 . . . . 0.0 110.235 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.452 ' HA3' ' HE2' ' A' ' 67' ' ' MET . . . 108.0 19.21 9.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.595 ' CB ' ' CD1' ' B' ' 202' ' ' ILE . . . -99.99 164.43 12.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.288 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.15 -29.97 8.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.77 154.0 44.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.865 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -53.8 -18.69 3.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -59.44 -45.51 91.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -0.92 . . . . 0.0 110.461 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.42 ' OE2' ' HB2' ' B' ' 200' ' ' PRO . 30.6 mt-10 -72.43 -46.4 55.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.45 HD12 ' HB1' ' B' ' 217' ' ' ALA . 13.6 mm -51.57 -44.71 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.418 ' OH ' ' CG1' ' B' ' 64' ' ' VAL . 2.2 m-30 -71.38 -48.98 46.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.49 -33.91 73.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 110.446 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.444 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -61.44 -59.77 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.867 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 35.8 t80 -56.27 -26.83 53.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.836 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -32.26 73.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.871 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . 0.431 ' O ' HG22 ' B' ' 233' ' ' VAL . . . -94.75 -13.17 25.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.465 HG13 HD21 ' B' ' 204' ' ' LEU . 6.0 mm -96.77 -23.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.36 -0.837 . . . . 0.0 109.83 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.577 ' N ' ' CD ' ' B' ' 232' ' ' PRO . 10.3 t80 -58.43 -42.3 93.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 0.0 110.966 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 48.2 Cg_endo -76.33 -31.17 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.416 1.219 . . . . 0.0 110.755 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.431 HG22 ' O ' ' B' ' 229' ' ' ALA . 39.5 t -67.27 -35.89 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.412 HD23 HD11 ' B' ' 170' ' ' ILE . 18.3 mt -71.88 -39.72 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.057 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.51 80.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.87 -39.92 91.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.006 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' B' ' 175' ' ' LEU . 84.4 m-85 -110.04 37.78 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 177.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -121.54 -51.42 2.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 110.094 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.225 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.667 ' HB3' ' CD2' ' B' ' 99' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 2.6 m-20 -63.7 71.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.052 -1.03 . . . . 0.0 110.207 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.642 HD23 ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -86.65 8.98 20.09 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.35 -0.844 . . . . 0.0 111.322 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 10.4 m -54.96 -18.87 5.59 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.467 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' HG23 ' A' ' 28' ' ' ILE . . . -100.43 -36.2 4.16 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.573 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.642 ' CG1' HD23 ' A' ' 20' ' ' LEU . 1.1 mm -46.68 -47.42 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.802 -1.411 . . . . 0.0 108.985 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 2.0 pp -82.91 -28.06 30.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' HD12 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -86.97 8.71 22.07 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.565 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 141.57 98.54 0.33 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.565 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -16.75 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.91 0.862 . . . . 0.0 111.436 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.578 ' CG1' HG12 ' A' ' 23' ' ' ILE . 2.3 pp -138.07 166.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 121.464 -0.773 . . . . 0.0 109.443 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 31' ' ' GLU . 80.6 m-20 -87.11 116.71 25.35 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.515 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -36.28 -28.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.484 0.659 . . . . 0.0 110.157 -177.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.9 tt0 -57.04 -13.03 2.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 110.544 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.28 24.37 5.7 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.052 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.54 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -109.83 124.23 50.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -1.155 . . . . 0.0 109.235 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.533 HD21 ' CG2' ' A' ' 28' ' ' ILE . 3.2 tm? -87.55 150.57 23.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 111.066 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.544 ' CG ' ' OD1' ' A' ' 27' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 111.23 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.211 0.529 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.7 tt0 -93.42 -33.7 13.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 25' ' ' PHE . 1.8 mt -90.97 -41.2 11.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.361 -0.837 . . . . 0.0 110.064 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.536 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.51 -50.26 17.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.54 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.29 -29.48 68.27 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.702 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 8.4 m-80 -77.82 -40.58 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 23.0 mt -49.97 -47.38 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.32 0.07 69.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.33 -46.57 3.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -1.143 . . . . 0.0 110.437 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -85.98 44.54 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 0.0 110.421 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -84.86 22.36 1.39 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.739 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HG2' HD22 ' A' ' 62' ' ' LEU . 1.8 pttt -152.68 8.04 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 111.195 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.528 ' CD1' ' HB2' ' A' ' 59' ' ' LEU . 3.0 mt -86.37 -34.68 20.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.621 -1.299 . . . . 0.0 109.852 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.48 -35.25 0.04 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 3.8 mm? -56.92 -28.25 61.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -1.171 . . . . 0.0 110.709 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' LEU . 11.5 t0 -43.67 -38.67 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.464 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.0 m -70.73 -51.01 30.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.374 -0.828 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.506 ' SD ' ' ND2' ' B' ' 159' ' ' ASN . 3.5 tpp -65.38 -12.73 55.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -72.69 -64.03 1.04 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 109.719 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -60.85 -12.15 10.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.583 -0.698 . . . . 0.0 110.022 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.62 2.69 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.536 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 1.5 t -140.04 3.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.046 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.649 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 2.6 tp -148.64 67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.396 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 11.1 t0 -77.1 53.54 0.98 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.975 -1.078 . . . . 0.0 109.359 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD1' ' CE1' ' B' ' 116' ' ' PHE . 1.5 mt . . . . . 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' B' ' 64' ' ' VAL . 2.9 mp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.155 0.502 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' B' ' 63' ' ' ILE . 91.5 t 58.03 119.62 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 110.25 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' B' ' 223' ' ' ILE . 43.4 Cg_endo -71.13 134.46 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.793 1.417 . . . . 0.0 110.407 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.448 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.6 m -96.82 137.5 35.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.379 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 33.2 mt -70.67 139.36 51.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.453 ' OE1' ' HA ' ' B' ' 68' ' ' GLN . 22.1 mm-40 -126.48 -5.64 6.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.655 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.478 ' ND2' ' C ' ' B' ' 69' ' ' ASN . 0.4 OUTLIER -168.41 124.53 1.0 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.0 -1.063 . . . . 0.0 110.755 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' B' ' 124' ' ' THR . 11.5 mm -108.89 147.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 109.311 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 25.5 t -134.61 135.7 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.956 -1.09 . . . . 0.0 110.456 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -141.52 155.43 45.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.316 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 60.6 m -104.47 126.93 52.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.227 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 t -126.67 138.54 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.926 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 9.5 m -109.65 145.86 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.531 ' CD1' HD13 ' B' ' 80' ' ' LEU . 59.3 mt -96.53 -30.13 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 109.751 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' B' ' 78' ' ' CYS . . . 80.52 32.48 34.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' B' ' 77' ' ' GLY . 1.2 m -166.29 164.88 17.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 110.273 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 0.1 OUTLIER -91.82 152.71 20.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.113 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' B' ' 76' ' ' LEU . 22.5 mt -138.95 163.88 31.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.422 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 2.8 t70 -108.74 97.92 7.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.526 -0.734 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.452 ' HB3' HG21 ' B' ' 102' ' ' VAL . 14.3 mt -40.94 -35.78 0.57 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -48.2 73.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 60.8 m -66.18 -37.78 86.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' B' ' 89' ' ' ALA . 22.7 t -72.88 -46.12 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.978 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.71 -13.01 61.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tp -99.27 -29.64 12.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.857 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.2 OUTLIER -99.81 -20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.285 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' B' ' 85' ' ' VAL . . . -61.74 151.65 33.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.144 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -85.65 -37.8 19.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.219 -0.926 . . . . 0.0 110.195 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -131.38 78.76 1.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.593 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -146.92 160.51 42.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.865 . . . . 0.0 110.725 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -137.35 157.62 46.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 109.939 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -147.44 101.48 3.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.222 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.523 ' O ' ' HG3' ' B' ' 98' ' ' ARG . 1.5 m-20 -109.86 121.16 42.8 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.63 -10.83 20.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.704 1.37 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -87.21 10.74 16.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 111.155 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' B' ' 95' ' ' ASN . 1.0 OUTLIER -139.68 -43.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.826 -1.172 . . . . 0.0 110.799 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.667 ' CD2' ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -170.35 168.89 7.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.25 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.39 55.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.538 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -136.24 158.51 44.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 111.155 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.452 HG21 ' HB3' ' B' ' 82' ' ' LEU . 49.0 t -102.58 122.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.473 -0.767 . . . . 0.0 109.184 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 3.6 mp -89.36 109.18 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.402 ' SD ' HD13 ' B' ' 115' ' ' ILE . 3.2 ttm -91.57 160.89 15.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.2 112.0 3.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.989 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.468 HG12 ' OH ' ' B' ' 139' ' ' TYR . 44.5 pt -101.91 167.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -125.64 33.08 5.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 3.3 tt0 -178.89 83.35 0.22 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.5 Cg_endo -78.79 151.44 88.32 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.786 -2.173 . . . . 0.0 110.33 -0.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.452 ' O ' HG21 ' B' ' 111' ' ' THR . 7.1 mttt -61.53 110.15 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.8 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.452 HG21 ' O ' ' B' ' 110' ' ' LYS . 74.0 p -148.57 175.17 11.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.582 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 28' ' ' ILE . 1.0 OUTLIER -126.67 162.81 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.755 . . . . 0.0 109.416 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -156.35 133.4 10.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.569 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.2 OUTLIER -97.92 105.8 18.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.463 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 9.7 mt -90.78 140.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.957 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.614 ' CE1' ' CD1' ' A' ' 74' ' ' LEU . 1.4 m-85 -111.31 159.42 17.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.585 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -77.94 -4.59 47.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 45.7 p -83.47 -15.2 50.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.45 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . 0.404 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 114.02 -18.66 18.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -84.11 154.32 23.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 110.009 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 50.9 ttp -149.42 149.2 30.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.958 . . . . 0.0 110.333 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.525 ' CG1' HD13 ' B' ' 114' ' ' LEU . 7.3 t -116.21 141.18 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 109.723 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 22.9 t -114.12 157.18 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 110.789 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 27' ' ' ASN . 14.6 t -167.73 147.76 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.652 -0.655 . . . . 0.0 109.433 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.545 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 123.09 -25.97 6.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.472 ' HB2' ' HB ' ' B' ' 70' ' ' ILE . . . -66.18 160.59 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -1.207 . . . . 0.0 110.336 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -120.15 4.38 10.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 131' ' ' ASP . 0.5 OUTLIER -158.1 162.55 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.361 -0.837 . . . . 0.0 110.034 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -56.12 -48.65 75.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 110.178 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.57 -29.27 70.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.375 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' B' ' 128' ' ' SER . 88.7 m-20 -65.81 -60.75 2.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.42 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 60.3 p -61.68 -33.31 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -44.64 75.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 110.23 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.78 -54.16 6.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.408 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.96 -39.64 9.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.978 . . . . 0.0 109.829 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.8 m -63.1 -56.3 18.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -54.06 -32.94 56.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.841 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' B' ' 138' ' ' LYS . 9.3 mptt -69.14 -42.09 76.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.952 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.468 ' OH ' HG12 ' B' ' 106' ' ' ILE . 22.3 m-85 -61.98 -47.66 83.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.15 75.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.933 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.65 -40.92 88.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 59.0 mt -54.02 -45.79 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.593 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.42 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 21.0 mm -65.37 -46.83 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -66.63 -28.79 68.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.845 . . . . 0.0 109.525 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -23.37 55.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 1.5 mt -81.47 -25.02 10.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.13 -32.66 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.474 ' CD1' HD21 ' B' ' 80' ' ' LEU . 12.5 m-85 -46.62 162.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.247 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.93 44.48 1.03 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.42 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -81.44 154.56 26.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 -166.55 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.471 ' O ' ' CG2' ' B' ' 153' ' ' THR . 73.3 t80 -129.87 118.38 21.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -0.975 . . . . 0.0 110.141 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' B' ' 152' ' ' PHE . 0.6 OUTLIER -167.8 174.0 7.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.529 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.431 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 4.0 m-20 52.15 42.48 30.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.614 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 155' ' ' PHE . 8.4 t80 -90.13 132.71 35.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.9 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.33 134.84 1.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 110.39 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 4.4 mt -78.9 124.24 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.72 -4.11 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.506 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 28.6 t-20 -152.8 131.46 12.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.86 -1.15 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' B' ' 161' ' ' VAL . 7.0 mt -124.37 171.55 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.508 -0.745 . . . . 0.0 109.672 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.496 ' N ' ' CG2' ' B' ' 160' ' ' ILE . 72.8 t -144.11 128.89 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.053 . . . . 0.0 110.884 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -134.02 165.18 24.37 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.8 t -165.45 149.85 8.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.028 -1.277 . . . . 0.0 110.37 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.0 OUTLIER -170.2 173.99 5.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.281 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.468 ' O ' HG22 ' B' ' 63' ' ' ILE . 14.7 t70 -113.92 168.83 9.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.74 -80.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.279 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? 177.96 -27.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.019 -1.051 . . . . 0.0 110.682 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' B' ' 168' ' ' PHE . 13.7 p90 -131.29 158.09 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.981 . . . . 0.0 109.705 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 44.8 Cg_endo -72.74 152.71 53.33 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.85 1.447 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.448 HG22 HD21 ' B' ' 234' ' ' LEU . 4.0 mt -119.84 158.08 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.503 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.451 ' NE ' ' HG3' ' B' ' 239' ' ' LYS . 6.5 mtt-85 -95.82 99.27 11.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 45.9 mt -50.08 -33.03 17.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 174' ' ' GLY . 4.3 mt-10 -68.08 -56.38 9.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.165 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' B' ' 173' ' ' GLU . . . -44.35 -30.25 1.95 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.86 -59.04 2.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 110.254 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.14 -24.39 17.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.47 -46.82 18.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.046 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 5.0 t -79.63 -58.43 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -92.63 36.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.48 -13.54 37.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.97 -14.64 38.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -1.2 . . . . 0.0 110.306 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 -6.37 8.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.276 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.431 ' HB2' HD22 ' B' ' 193' ' ' LEU . 82.6 p -133.66 164.19 27.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 184' ' ' SER . . . . . 0.462 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 14.7 m -135.13 147.43 49.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.98 . . . . 0.0 110.07 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -133.77 115.98 15.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.163 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' B' ' 190' ' ' PHE . 9.3 mm-40 -115.87 92.75 35.59 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.89 -9.91 26.62 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.993 1.522 . . . . 0.0 110.356 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -9.57 21.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 110.053 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' B' ' 189' ' ' LEU . 2.7 tt -153.08 19.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.482 ' CE1' HD13 ' B' ' 205' ' ' LEU . 0.9 OUTLIER -170.07 113.54 0.48 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.992 . . . . 0.0 110.317 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -37.28 4.96 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.048 1.552 . . . . 0.0 110.552 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.511 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -91.32 179.32 42.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 184' ' ' SER . 3.1 tt -116.32 138.64 51.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.121 . . . . 0.0 110.225 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.439 HD12 ' CE2' ' B' ' 190' ' ' PHE . 25.1 mt -93.51 111.06 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -101.35 117.21 34.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.12 89.24 7.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.378 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.409 ' HB2' ' HE1' ' B' ' 197' ' ' MET . 52.0 tpp -53.22 128.44 27.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.6 -47.28 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.29 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.28 123.83 6.09 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.941 . . . . 0.0 110.246 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.44 155.2 99.8 Favored 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.891 -2.129 . . . . 0.0 110.321 -0.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.471 ' O ' ' CG1' ' B' ' 202' ' ' ILE . 16.2 tttt -56.64 112.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.484 HD12 ' CB ' ' B' ' 217' ' ' ALA . 4.7 mt -158.58 154.72 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 0.0 110.471 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.6 114.99 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.479 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.493 HD13 ' N ' ' B' ' 204' ' ' LEU . 6.2 mp -101.53 135.09 43.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 110.95 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.482 HD13 ' CE1' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -103.24 119.14 38.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 109.535 179.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.505 HD11 HG22 ' B' ' 206' ' ' ILE . 13.7 mm -105.16 147.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 0.0 110.566 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.511 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 21.0 m-85 -132.53 141.14 48.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.063 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 0.8 OUTLIER -46.48 -54.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 110.105 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 208' ' ' VAL . 68.2 m -39.2 -36.9 0.36 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.317 0.579 . . . . 0.0 110.187 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 118.01 24.23 3.36 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -97.53 134.61 40.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -1.223 . . . . 0.0 110.099 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.421 HG21 HD11 ' B' ' 212' ' ' ILE . 15.8 mm -119.82 138.45 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 59.6 t -128.41 132.32 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.233 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.472 ' CB ' HD11 ' B' ' 223' ' ' ILE . 2.6 mp -118.77 119.14 33.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 110.16 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.468 ' OG1' HG21 ' B' ' 161' ' ' VAL . 12.6 t -139.0 157.67 45.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 110.241 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.71 14.38 55.34 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.484 ' CB ' HD12 ' B' ' 202' ' ' ILE . . . -83.92 144.42 29.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -1.09 . . . . 0.0 110.276 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -81.44 -7.28 59.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.462 ' HA ' HD13 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -169.37 -176.69 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -73.98 -45.42 50.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.437 ' HG3' ' OE1' ' B' ' 222' ' ' GLU . 24.0 pt-20 -49.74 -32.76 14.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.478 ' HB3' HD13 ' B' ' 202' ' ' ILE . 8.7 mm-40 -61.17 -49.14 78.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.942 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.523 HG21 ' CG ' ' B' ' 65' ' ' PRO . 47.8 mm -59.43 -36.14 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -65.28 -35.54 81.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.47 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -82.08 -41.46 20.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.418 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.84 -34.4 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 110.247 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.428 ' O ' HG21 ' B' ' 230' ' ' ILE . 18.1 t80 -76.18 -49.45 17.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.366 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -23.04 40.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.479 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.18 -24.78 19.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.992 . . . . 0.0 110.255 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.428 HG21 ' O ' ' B' ' 227' ' ' PHE . 6.6 tp -100.28 -17.98 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.341 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.6 t80 -55.1 -43.63 99.17 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 111.144 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -72.87 -42.68 1.01 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.312 1.164 . . . . 0.0 110.343 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 40.6 t -53.97 -42.69 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.972 . . . . 0.0 109.682 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.448 HD21 HG22 ' B' ' 170' ' ' ILE . 81.9 mt -65.01 -58.16 6.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 109.966 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -52.9 -30.94 37.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.035 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.71 -36.85 84.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -113.04 41.47 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' B' ' 235' ' ' SER . 1.5 ptt180 -74.56 -176.14 2.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 6.2 ttmt -125.33 -29.46 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 109.979 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' MET . . . . . 0.451 ' OXT' ' HB2' ' B' ' 168' ' ' PHE . 10.8 mtp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.139 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.656 ' N ' ' CZ ' ' B' ' 99' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 121.033 0.444 . . . . 0.0 109.974 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.428 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 4.8 t70 -76.1 96.27 3.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.049 -1.032 . . . . 0.0 111.1 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.536 HD21 HG13 ' A' ' 23' ' ' ILE . 2.0 mt -99.06 12.2 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.078 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.528 ' CG2' HG21 ' A' ' 56' ' ' ILE . 1.3 t -40.93 -33.63 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.635 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.51 -31.55 6.38 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.607 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -47.39 -44.38 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.685 -1.479 . . . . 0.0 109.084 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.529 ' HB2' ' ND2' ' B' ' 159' ' ' ASN . 0.6 OUTLIER -82.84 -22.56 34.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.022 -1.049 . . . . 0.0 109.0 178.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CE1' HD12 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -92.77 11.09 28.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 143.64 98.67 0.28 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.546 ' CB ' HG21 ' B' ' 124' ' ' THR . 12.7 p-10 -30.73 90.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.05 0.928 . . . . 0.0 111.832 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -92.6 164.16 2.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.555 ' N ' HG12 ' A' ' 28' ' ' ILE . 26.0 m-20 -85.59 123.85 31.47 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.497 ' C ' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -37.03 -29.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.363 0.601 . . . . 0.0 109.825 -178.143 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.9 tt0 -54.85 -16.13 2.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.09 27.97 4.61 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.589 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -123.27 126.41 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.998 -1.295 . . . . 0.0 110.557 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.636 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -98.95 155.34 17.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.688 -1.257 . . . . 0.0 110.645 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.53 ' CD1' ' OD1' ' A' ' 27' ' ' ASN . 3.3 pp . . . . . 0 N--CA 1.493 1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.117 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.286 0.565 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 41.8 tt0 -100.59 -29.86 12.1 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD12 ' CE1' ' A' ' 25' ' ' PHE . 3.4 mt -98.58 -45.31 6.13 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 110.009 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.564 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -45.04 -49.05 11.7 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.763 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -64.14 -20.7 66.17 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.719 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 76.5 m-20 -91.34 -38.12 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.653 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 3.2 mt -47.71 -43.49 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.95 -17.18 28.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -138.39 35.54 2.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -1.195 . . . . 0.0 110.468 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.56 ' CD2' ' CD1' ' A' ' 62' ' ' LEU . 12.2 mt -102.58 21.18 15.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.159 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.11 45.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 21.7 ttpt -150.28 15.84 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.56 ' CD1' ' CD2' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -93.75 -31.83 14.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.28 -0.888 . . . . 0.0 109.768 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.53 1.77 7.64 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -95.28 0.19 53.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.2 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 22.6 m-20 -46.2 -41.93 13.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.662 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.451 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -60.61 -35.36 75.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.894 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.467 ' HG2' HD23 ' A' ' 24' ' ' LEU . 4.9 ttp -69.0 -18.98 64.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 65' ' ' ASP . 7.4 mt -71.96 -60.18 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.526 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -62.61 -9.02 7.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -85.58 5.74 30.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.124 -0.985 . . . . 0.0 110.619 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -132.49 0.93 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.756 179.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.644 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -150.94 66.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.3 p-10 -76.72 54.67 0.99 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.622 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.605 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.751 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.212 0.53 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.413 HG11 ' HD2' ' B' ' 65' ' ' PRO . 91.4 t -143.2 139.55 16.79 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.413 ' HD2' HG11 ' B' ' 64' ' ' VAL . 46.2 Cg_endo -73.12 122.57 8.16 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 67.7 m -91.07 132.38 36.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.507 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -70.27 133.82 47.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 109.89 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -121.18 -15.99 8.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.662 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.45 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -161.38 119.53 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.595 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.519 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 13.8 mm -104.25 157.07 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 30.8 t -135.9 136.85 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.8 166.29 28.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.208 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -119.01 151.93 37.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.51 151.3 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.292 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -118.34 142.35 47.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.022 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.531 HD11 ' CD1' ' B' ' 80' ' ' LEU . 49.4 mt -89.84 -61.1 1.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.77 4.75 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 1.3 m -162.3 151.28 15.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -1.172 . . . . 0.0 110.167 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 18.1 ttp85 -71.46 155.55 40.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.531 ' CD1' HD11 ' B' ' 76' ' ' LEU . 44.6 mt -138.07 148.91 45.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 29.9 t70 -89.81 95.59 10.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.013 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' B' ' 102' ' ' VAL . 14.5 mt -42.68 -48.61 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.181 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -46.13 61.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.864 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 9.0 m -76.46 -48.37 19.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 95.8 t -54.62 -50.42 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.236 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.401 ' HB1' HG23 ' B' ' 102' ' ' VAL . . . -69.08 -20.54 64.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 110.005 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.27 -37.62 15.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.246 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.71 -26.78 29.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.485 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.31 140.27 58.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 110.375 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -76.07 -27.05 57.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.402 -0.811 . . . . 0.0 109.983 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 0.7 OUTLIER -132.54 79.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.946 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -163.89 167.75 20.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -161.27 141.04 10.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 110.135 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -114.06 105.4 13.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.274 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -102.67 105.35 43.98 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.73 -16.58 33.48 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.986 1.519 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -73.07 -27.54 61.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.811 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.71 -72.09 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.986 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.656 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -138.55 -177.28 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.31 44.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.116 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . -131.18 165.02 24.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 110.563 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' B' ' 82' ' ' LEU . 57.9 t -102.97 123.64 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.354 -0.841 . . . . 0.0 109.586 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.5 mp -89.29 122.47 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.865 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.402 ' HG3' ' HB3' ' B' ' 92' ' ' ALA . 9.8 ttm -115.81 166.09 12.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 110.514 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' B' ' 111' ' ' THR . 3.9 ttt85 -164.71 118.98 1.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 12.9 pt -112.71 170.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 110.376 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.89 38.16 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.808 . . . . 0.0 109.799 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -174.17 79.33 0.36 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.507 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' B' ' 135' ' ' ALA . 53.0 Cg_endo -83.65 162.47 70.67 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.795 -2.169 . . . . 0.0 110.444 -0.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 21.5 mttt -61.81 106.7 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.933 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' B' ' 110' ' ' LYS . 20.7 p -156.45 173.33 17.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.465 HG21 HG21 ' B' ' 124' ' ' THR . 0.4 OUTLIER -121.97 -179.51 4.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.357 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -167.19 122.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 0.0 111.218 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.453 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.5 OUTLIER -89.87 103.29 15.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 178.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.428 ' HA ' ' HB3' ' B' ' 121' ' ' MET . 15.8 mt -91.05 141.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 111.468 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.592 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 1.8 m-85 -110.6 151.46 27.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.46 66.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.295 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 p -71.04 -3.94 22.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.38 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.18 -28.36 16.27 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -73.2 163.99 27.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -1.068 . . . . 0.0 110.099 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.428 ' HB3' ' HA ' ' B' ' 115' ' ' ILE . 0.0 OUTLIER -167.44 176.02 6.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.274 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' B' ' 113' ' ' ALA . 9.3 t -132.15 160.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.412 ' N ' HG11 ' B' ' 122' ' ' VAL . 81.8 t -140.46 131.79 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.386 -0.821 . . . . 0.0 110.049 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.546 HG21 ' CB ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -142.15 173.28 11.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.534 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 100.33 -18.82 54.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -54.81 162.77 1.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -1.158 . . . . 0.0 110.456 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.46 13.33 16.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.192 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.66 -164.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.452 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.76 -43.91 16.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.17 -28.94 69.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.42 -53.41 12.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 110.187 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 88.8 p -49.97 -37.37 32.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.356 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -66.71 -40.41 88.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.298 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' B' ' 138' ' ' LYS . 0.3 OUTLIER -70.85 -50.65 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.342 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' B' ' 109' ' ' PRO . . . -53.21 -34.46 57.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.4 m -68.71 -56.52 7.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -48.08 -37.0 14.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.97 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.471 ' O ' HG12 ' B' ' 142' ' ' ILE . 9.8 mmtp -59.6 -51.62 69.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.433 ' CZ ' ' HB1' ' B' ' 113' ' ' ALA . 26.2 m-85 -58.3 -54.72 43.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.54 -24.42 8.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 109.83 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.458 ' HG2' ' HE3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -79.23 -39.66 32.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.976 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.471 HG12 ' O ' ' B' ' 138' ' ' LYS . 25.1 mm -54.03 -47.34 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.881 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.588 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 51.0 mt -71.59 -41.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.452 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 27.5 mt-30 -68.25 -38.92 82.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.852 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.458 ' HE3' ' HG2' ' B' ' 141' ' ' ARG . 0.5 OUTLIER -70.44 -20.74 62.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.9 mt -81.99 -16.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 111.75 -23.03 18.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.588 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 8.6 m-85 -50.13 176.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 110.859 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.67 42.64 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.735 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.473 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -88.23 125.94 34.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' B' ' 76' ' ' LEU . 0.0 OUTLIER -100.73 -152.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.887 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -151.33 110.91 4.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.276 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.26 -173.4 2.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 110.319 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.04 27.81 7.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.399 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' B' ' 73' ' ' THR . 10.6 t80 -74.06 136.63 43.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 109.92 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.06 133.98 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.978 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 31.9 mt -79.84 135.29 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -121.77 -18.87 6.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 110.516 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 2.7 t-20 -142.69 130.53 21.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.138 -0.976 . . . . 0.0 110.622 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.455 HD11 HG22 ' B' ' 160' ' ' ILE . 32.5 mt -120.47 142.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.637 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 94.7 t -116.5 125.72 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.38 171.01 18.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.2 OUTLIER -162.35 146.33 11.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -1.223 . . . . 0.0 110.427 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 7.7 p -168.94 159.9 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.429 ' OD1' ' HG2' ' B' ' 211' ' ' LYS . 5.6 t70 -103.55 154.78 19.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.573 ' O ' ' CD2' ' B' ' 168' ' ' PHE . 22.5 m -97.48 11.88 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.42 -2.06 2.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.408 -0.808 . . . . 0.0 111.214 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 11.6 p90 -155.22 157.3 31.74 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.869 -1.144 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.0 Cg_endo -72.05 160.03 48.55 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.147 1.604 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.503 HG21 ' N ' ' B' ' 171' ' ' ARG . 1.5 mp -131.85 153.92 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 110.314 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.503 ' N ' HG21 ' B' ' 170' ' ' ILE . 12.5 ttm180 -87.51 110.18 20.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.931 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.46 HD23 ' O ' ' B' ' 206' ' ' ILE . 15.6 mt -66.39 -64.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.331 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -25.95 64.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.08 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -72.56 -48.21 24.14 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.552 HD11 ' CD2' ' B' ' 237' ' ' PHE . 9.6 tp -74.77 -33.76 62.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.343 -1.093 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.73 71.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.947 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -80.44 -28.31 37.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.992 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 178' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' B' ' 175' ' ' LEU . 1.2 p -83.58 -58.6 2.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -0.802 . . . . 0.0 110.097 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -96.28 32.65 1.92 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.021 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 181' ' ' THR . . . -52.75 -26.49 25.35 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 181' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 180' ' ' GLY . 22.6 p -42.37 -55.27 3.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -1.174 . . . . 0.0 110.133 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.621 ' CZ ' ' CG2' ' B' ' 198' ' ' VAL . 3.2 m-85 -115.49 -3.24 12.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' B' ' 195' ' ' TYR . 9.4 t -92.11 140.78 29.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.99 130.46 41.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.406 ' HB2' ' HG ' ' B' ' 193' ' ' LEU . 5.6 t80 -146.52 101.42 3.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 110.272 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.16 116.99 46.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.152 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.73 -0.24 9.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.945 1.497 . . . . 0.0 110.525 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.87 -6.67 28.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' B' ' 190' ' ' PHE . 3.8 tt -143.13 -57.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 110.425 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.512 ' HB2' ' CD2' ' B' ' 189' ' ' LEU . 7.4 t80 -105.74 124.92 34.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' B' ' 190' ' ' PHE . 46.3 Cg_endo -73.84 -35.77 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.905 1.477 . . . . 0.0 110.351 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.518 ' HA3' ' CD1' ' B' ' 207' ' ' PHE . . . -90.3 174.85 40.57 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' B' ' 194' ' ' ILE . 9.1 tt -94.11 159.75 15.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -1.137 . . . . 0.0 110.272 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.532 ' N ' ' CD2' ' B' ' 193' ' ' LEU . 75.9 mt -130.82 107.58 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 12.5 t80 -98.56 119.65 37.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.002 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.51 ' NH2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -91.96 117.73 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 110.457 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.424 ' HE3' ' HB2' ' B' ' 229' ' ' ALA . 30.1 ttm -93.45 144.26 25.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.937 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.621 ' CG2' ' CZ ' ' B' ' 182' ' ' PHE . 84.7 t -92.34 -50.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.965 . . . . 0.0 110.274 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.44 106.41 17.43 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.861 . . . . 0.0 110.314 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.54 171.14 67.74 Favored 'Cis proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.359 -0.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -85.14 98.58 10.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.502 HG21 ' N ' ' B' ' 203' ' ' VAL . 29.2 mt -145.82 149.68 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.682 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.502 ' N ' HG21 ' B' ' 202' ' ' ILE . 75.0 t -103.7 117.68 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.477 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' B' ' 204' ' ' LEU . 4.8 mp -104.54 152.06 22.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.724 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.52 ' CD1' HD23 ' A' ' 52' ' ' LEU . 18.5 mt -117.13 143.51 45.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.371 -0.83 . . . . 0.0 110.013 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.46 ' O ' HD23 ' B' ' 172' ' ' LEU . 6.5 mt -132.49 103.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.518 ' CD1' ' HA3' ' B' ' 192' ' ' GLY . 14.2 m-30 -94.48 145.74 24.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.111 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 37.6 t -45.46 -28.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.892 . . . . 0.0 110.467 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -16.19 56.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.447 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.67 -4.36 61.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.429 ' HG2' ' OD1' ' B' ' 165' ' ' ASP . 8.7 mttm -73.22 131.96 42.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 110.166 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' B' ' 163' ' ' SER . 17.0 mm -119.73 143.98 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.429 ' C ' HD13 ' B' ' 214' ' ' LEU . 12.0 t -124.76 157.38 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.461 HD22 HD22 ' B' ' 204' ' ' LEU . 4.8 mp -144.46 107.38 4.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 1.6 t -128.95 137.19 51.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 0.0 110.144 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.443 ' C ' HG12 ' B' ' 202' ' ' ILE . . . 119.8 9.74 8.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.455 ' HB3' HD13 ' B' ' 202' ' ' ILE . . . -88.19 154.89 20.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.308 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.56 -12.26 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.505 ' CG ' ' HG2' ' B' ' 221' ' ' GLU . 9.4 tp60 -150.32 150.1 31.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.059 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.18 -38.72 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 16.0 pt-20 -54.45 -34.51 61.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.511 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 16.8 mt-10 -65.16 -58.73 5.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.11 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.424 HG13 HG23 ' B' ' 160' ' ' ILE . 29.5 mm -50.67 -45.2 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.992 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -65.7 -33.14 75.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.67 -46.05 23.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.018 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.417 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -55.66 -27.61 50.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.89 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' B' ' 231' ' ' TYR . 16.9 t80 -78.78 -46.65 18.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -59.5 -22.61 61.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.087 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . 0.424 ' HB2' ' HE3' ' B' ' 197' ' ' MET . . . -88.25 -30.54 19.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 5.8 tp -99.82 -9.65 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.069 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.588 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.7 t80 -63.14 -46.73 86.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -71.51 -25.95 20.62 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.229 1.12 . . . . 0.0 110.065 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.63 -36.69 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.768 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.465 HD21 HG22 ' B' ' 170' ' ' ILE . 54.7 mt -71.4 -40.93 70.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 109.972 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -19.94 66.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.314 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -82.7 -41.8 18.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.552 ' CD2' HD11 ' B' ' 175' ' ' LEU . 60.4 m-85 -109.04 38.54 2.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.385 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -75.22 176.01 7.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.277 -0.89 . . . . 0.0 110.078 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -128.93 -36.86 1.76 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.953 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.216 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.438 ' N ' ' CD1' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -88.38 78.26 7.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 111.565 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.626 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 4.2 mt -86.3 30.11 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.576 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 1.8 m -77.76 -6.01 52.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.24 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.97 -41.73 2.79 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.002 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.674 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 17.2 pt -51.93 -46.17 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.651 -1.5 . . . . 0.0 109.601 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.568 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 1.3 pp -75.27 0.33 16.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 0.0 109.272 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -120.27 -13.99 8.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.327 -0.858 . . . . 0.0 110.721 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 157.31 45.47 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.622 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 52.87 147.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.368 -1.078 . . . . 0.0 111.43 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.674 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.49 161.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.461 -0.775 . . . . 0.0 109.284 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 28' ' ' ILE . 81.1 m-20 -88.57 135.02 33.7 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.502 ' C ' ' O ' ' A' ' 29' ' ' ASP . 1.1 p -36.27 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.904 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -49.2 -21.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 110.007 179.121 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.87 21.1 7.99 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.85 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -114.48 130.84 56.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.805 -1.409 . . . . 0.0 109.586 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.628 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -102.77 151.02 22.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 111.703 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 27' ' ' ASN . 4.0 pp . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 110.367 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.193 0.52 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -100.22 -25.53 14.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 56' ' ' ILE . 3.5 mt -96.43 -40.83 8.9 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.399 -0.813 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.531 ' CD ' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -47.98 -52.29 20.37 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.231 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.38 -40.51 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.393 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' LEU . 3.9 m-80 -63.75 -45.36 90.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.664 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 39.2 mt -46.75 -44.61 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -0.847 . . . . 0.0 109.777 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.96 -22.65 60.5 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.17 39.04 1.59 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.31 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' ASN . 1.8 tp -104.05 -9.74 18.56 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.413 -0.805 . . . . 0.0 109.718 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 p -75.83 48.15 0.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 109.835 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -134.49 -19.4 1.89 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 110.325 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.629 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.25 22.73 4.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.673 -1.267 . . . . 0.0 111.19 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.91 -69.77 0.13 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.397 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 4.0 mm? -69.97 -2.09 11.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.239 . . . . 0.0 111.274 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.467 ' O ' HD22 ' A' ' 69' ' ' LEU . 65.8 t0 -52.66 -49.62 64.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 109.837 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.3 p -67.56 -45.42 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.943 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.402 ' HG2' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.66 -4.41 19.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.777 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.586 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.7 tm? -82.0 -60.49 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.891 . . . . 0.0 109.735 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 65' ' ' ASP . 1.1 pp -75.54 2.02 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.906 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 3.3 tt0 -97.32 16.94 18.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 111.109 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 4.2 t -136.62 -1.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.243 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.626 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -151.73 76.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 1.9 p-10 -75.04 57.6 0.83 Allowed 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.739 -1.226 . . . . 0.0 108.563 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.5 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 8.7 mt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.622 0.725 . . . . 0.0 110.815 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.455 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 1.9 mp . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.289 0.566 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.628 ' CG1' ' CZ ' ' B' ' 224' ' ' TYR . 3.4 t 64.05 123.14 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 46.1 Cg_endo -72.72 145.93 42.19 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.938 1.494 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.41 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.5 m -96.72 136.72 36.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.477 HD13 ' NH1' ' B' ' 220' ' ' ARG . 39.7 mt -70.0 121.36 17.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.897 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -95.34 -29.52 14.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -170.37 -179.49 3.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.557 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' B' ' 126' ' ' ALA . 21.0 mt -153.93 164.45 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.971 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 24' ' ' LEU . 25.8 t -130.6 133.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.24 169.74 15.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.289 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' THR . . . . . 0.435 HG22 ' HG3' ' B' ' 158' ' ' GLN . 28.1 p -122.48 144.19 49.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.303 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' B' ' 121' ' ' MET . 47.8 t -136.08 142.4 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.365 -0.835 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' B' ' 120' ' ' LYS . 1.3 m -123.99 132.75 53.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.729 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -100.42 -26.09 13.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 109.963 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 51.78 39.36 47.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 79' ' ' ARG . 89.0 m -134.67 -0.22 2.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' B' ' 80' ' ' LEU . 4.9 mmm180 59.77 139.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.026 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' B' ' 79' ' ' ARG . 24.1 mt -139.54 151.01 45.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.961 -1.087 . . . . 0.0 110.6 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' B' ' 81' ' ' ASP . 2.0 m-20 -89.83 89.25 7.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.527 HD21 ' CG2' ' B' ' 102' ' ' VAL . 32.3 mt -40.84 -43.07 1.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 110.689 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -54.59 -47.21 73.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.638 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -80.44 -40.87 25.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.713 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.465 HG21 ' CE2' ' B' ' 148' ' ' PHE . 55.9 t -52.56 -42.87 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.124 -0.985 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.406 ' HA ' ' HB2' ' B' ' 92' ' ' ALA . . . -80.28 -23.53 40.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.067 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.91 -27.26 43.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.368 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -100.43 -38.92 8.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.503 ' CB ' ' HB1' ' B' ' 92' ' ' ALA . . . -53.21 134.27 39.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.204 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -73.96 -22.9 59.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.444 ' O ' ' SD ' ' B' ' 104' ' ' MET . 1.4 m120 -134.79 79.52 1.8 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.829 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.514 ' CB ' ' SD ' ' B' ' 104' ' ' MET . . . -150.43 162.42 40.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -143.07 171.87 13.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.004 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.28 104.68 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.11 112.84 59.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.56 -17.48 23.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.911 1.479 . . . . 0.0 110.619 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -82.22 -17.7 45.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.158 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -55.55 2.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.586 ' CE2' ' HB1' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -160.41 -164.65 1.29 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 111.397 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.38 54.39 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.935 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.586 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -143.9 167.45 22.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 110.382 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.527 ' CG2' HD21 ' B' ' 82' ' ' LEU . 49.7 t -100.58 139.91 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 110.159 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' B' ' 114' ' ' LEU . 4.8 mp -106.52 113.43 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.514 ' SD ' ' CB ' ' B' ' 92' ' ' ALA . 21.0 tpp -104.65 162.07 13.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 110.224 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.42 131.65 11.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.555 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 7.4 pt -125.8 169.68 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' B' ' 108' ' ' GLU . 1.1 mtt180 -115.16 22.61 13.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' B' ' 107' ' ' ARG . 3.1 mt-10 -166.1 93.14 0.81 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.455 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' B' ' 135' ' ' ALA . 47.5 Cg_endo -75.22 159.57 97.59 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.818 -2.159 . . . . 0.0 110.423 -0.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 98.21 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.917 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -153.17 -179.29 7.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.853 . . . . 0.0 110.113 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.542 ' CG2' HG21 ' B' ' 124' ' ' THR . 15.1 t -134.38 162.47 32.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.102 -0.999 . . . . 0.0 110.062 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' B' ' 104' ' ' MET . . . -161.51 156.76 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.913 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.529 ' CG ' ' HB ' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -132.05 115.12 15.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.522 -0.736 . . . . 0.0 109.422 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' B' ' 102' ' ' VAL . 50.6 mt -90.77 137.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.867 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 2.6 m-30 -90.53 -171.04 2.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.347 -0.846 . . . . 0.0 109.515 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' B' ' 79' ' ' ARG . . . -93.01 -10.25 36.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.52 -28.55 18.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.19 -38.65 1.78 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . 0.517 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 5.0 tttt -61.24 139.83 58.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 110.139 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.438 ' HE2' ' HB2' ' B' ' 139' ' ' TYR . 3.7 ptt? -144.69 157.13 44.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 71' ' ' VAL . 31.3 t -104.37 154.01 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.49 ' N ' HG11 ' B' ' 122' ' ' VAL . 7.5 t -147.27 101.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 110.711 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.542 HG21 ' CG2' ' B' ' 112' ' ' THR . 0.2 OUTLIER -104.92 179.88 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 0.0 109.001 178.599 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.586 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 98.46 -29.74 10.91 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.53 ' CB ' ' OG ' ' B' ' 132' ' ' SER . . . -48.19 131.62 16.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 109.991 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' B' ' 128' ' ' SER . 0.2 OUTLIER -101.09 13.67 34.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.382 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' B' ' 127' ' ' LYS . 0.3 OUTLIER 178.93 -169.67 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -74.21 -45.92 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.57 -27.03 64.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.474 ' O ' ' HB1' ' B' ' 135' ' ' ALA . 0.7 OUTLIER -64.68 -45.82 85.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.269 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 39.2 m -65.2 -48.52 73.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 10.8 ttpp -53.37 -41.28 65.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 110.47 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 138' ' ' LYS . 0.7 OUTLIER -77.63 -43.76 30.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 110.444 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' B' ' 131' ' ' ASP . . . -64.38 -36.75 85.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.277 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 11.8 p -68.78 -59.93 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.121 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.436 ' CZ ' ' HB2' ' B' ' 137' ' ' ARG . 8.5 ptm85 -51.82 -26.41 9.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.896 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -67.1 -48.55 67.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.555 ' CZ ' HG12 ' B' ' 106' ' ' ILE . 35.7 m-85 -62.56 -47.3 84.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -55.6 -28.36 54.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.91 . . . . 0.0 109.69 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -70.95 -51.57 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 110.003 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.437 ' O ' HG13 ' B' ' 146' ' ' ILE . 6.4 mt -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.045 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 49.3 mm -73.64 -53.77 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.82 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 28.0 mt-30 -64.72 -29.95 70.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 109.989 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -74.09 -22.61 59.44 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.437 HG13 ' O ' ' B' ' 142' ' ' ILE . 4.2 mt -81.04 -22.16 10.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.94 4.85 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.465 ' CE2' HG21 ' B' ' 85' ' ' VAL . 24.2 m-85 -63.99 175.02 1.3 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.007 -1.29 . . . . 0.0 111.416 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.15 24.32 11.77 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.458 0.647 . . . . 0.0 109.679 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.482 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -46.24 150.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 110.598 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -124.44 101.53 7.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 110.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.95 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.304 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.9 OUTLIER -151.74 173.09 15.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 110.395 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' B' ' 153' ' ' THR . 0.1 OUTLIER 65.39 21.46 11.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.341 -0.849 . . . . 0.0 110.436 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -65.67 135.13 54.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.989 . . . . 0.0 110.09 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -166.04 136.71 3.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 110.35 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 7.3 mt -79.04 154.23 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.897 . . . . 0.0 109.653 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.435 ' HG3' HG22 ' B' ' 73' ' ' THR . 8.8 mm-40 -137.06 -23.8 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.005 -1.059 . . . . 0.0 111.63 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.522 ' ND2' ' HA2' ' B' ' 216' ' ' GLY . 13.7 t-20 -149.51 122.19 8.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.712 -1.243 . . . . 0.0 111.523 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' B' ' 215' ' ' THR . 84.8 mt -106.92 144.89 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 108.903 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 48.6 t -118.06 142.5 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.827 -1.17 . . . . 0.0 111.435 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -139.72 162.03 26.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 54.5 p -161.2 143.93 12.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.314 . . . . 0.0 110.676 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.5 OUTLIER -170.36 171.72 6.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.374 -0.829 . . . . 0.0 110.144 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.444 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 0.8 OUTLIER -114.83 131.53 56.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.042 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' B' ' 167' ' ' LYS . 5.1 m -67.62 -61.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.121 -0.987 . . . . 0.0 110.957 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 169.59 -31.42 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.033 . . . . 0.0 110.441 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 17.0 p90 -134.34 165.78 34.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.2 Cg_endo -71.81 147.39 50.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.975 1.513 . . . . 0.0 110.26 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.462 HG22 HD21 ' B' ' 234' ' ' LEU . 4.1 mt -110.49 152.91 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -93.8 105.18 17.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.695 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.467 HD23 ' O ' ' B' ' 206' ' ' ILE . 8.5 mt -63.37 -43.95 96.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 110.615 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.4 -49.62 75.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 110.424 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -62.0 -38.07 95.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.538 HD21 ' CG ' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -74.37 -36.73 63.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -1.168 . . . . 0.0 110.451 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.64 67.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.271 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -92.39 -42.3 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.052 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 178' ' ' SER . . . . . 0.414 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -63.36 -52.78 60.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -115.38 40.2 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.098 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.6 -19.8 49.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.0 m -58.03 -35.85 71.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -1.162 . . . . 0.0 110.257 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.6 ' CE1' ' CG2' ' B' ' 198' ' ' VAL . 44.1 m-85 -125.19 12.15 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 50.6 m -114.72 143.91 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 0.0 110.226 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.09 114.2 16.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 110.25 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -125.7 91.42 3.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.93 113.98 60.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.25 5.04 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.908 1.478 . . . . 0.0 110.937 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.87 -9.19 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.025 . . . . 0.0 110.248 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.459 HD22 ' OD1' ' A' ' 55' ' ' ASN . 3.8 tt -152.51 -40.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.403 ' CE2' HD12 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -117.76 107.81 43.81 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.405 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.61 -23.69 19.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.029 1.542 . . . . 0.0 110.279 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.23 177.87 39.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' B' ' 205' ' ' LEU . 7.4 tt -108.05 128.42 54.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.166 . . . . 0.0 110.402 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.47 ' HA ' HD22 ' B' ' 205' ' ' LEU . 22.2 mt -101.72 108.04 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -95.77 113.1 24.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.236 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.417 ' CB ' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -90.6 88.29 7.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.44 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 22.9 ttm -59.28 139.11 57.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 110.161 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.6 ' CG2' ' CE1' ' B' ' 182' ' ' PHE . 3.0 t -77.3 -46.09 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 109.949 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' B' ' 199' ' ' LYS . 34.2 pttt -142.21 118.56 7.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 0.0 109.863 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.32 145.99 85.68 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.971 -2.096 . . . . 0.0 110.513 0.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.454 ' O ' HD12 ' B' ' 202' ' ' ILE . 1.4 tptm -57.34 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.115 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.522 HD13 ' CB ' ' B' ' 217' ' ' ALA . 42.5 mm -138.34 165.16 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.581 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.91 125.24 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.472 HD22 ' CB ' ' B' ' 226' ' ' ALA . 1.6 mp -121.94 140.5 52.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.508 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' B' ' 194' ' ' ILE . 12.5 mt -103.96 156.0 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.854 . . . . 0.0 109.952 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.469 HG13 ' CD1' ' B' ' 212' ' ' ILE . 2.8 mt -140.05 105.69 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -97.62 152.05 19.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 62.0 t -49.23 -34.11 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 97.5 p -55.66 -31.85 62.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 110.1 12.86 16.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.444 ' HG3' ' OD1' ' B' ' 165' ' ' ASP . 29.1 tttt -89.7 131.86 35.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.029 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.485 HD13 HG22 ' B' ' 212' ' ' ILE . 34.1 mm -118.12 122.14 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 16.1 t -92.39 154.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 4.2 mp -143.17 100.95 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.979 . . . . 0.0 110.716 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 0.9 OUTLIER -136.84 170.72 15.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.204 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . 0.522 ' HA2' ' ND2' ' B' ' 159' ' ' ASN . . . 92.28 13.33 57.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.522 ' CB ' HD13 ' B' ' 202' ' ' ILE . . . -98.48 157.15 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -1.131 . . . . 0.0 110.297 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -36.58 13.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.28 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.416 ' CA ' HD13 ' B' ' 160' ' ' ILE . 0.1 OUTLIER -128.86 -158.8 0.91 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 110.165 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . 0.477 ' NH1' HD13 ' B' ' 67' ' ' LEU . 15.5 ttm-85 -97.08 -22.52 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.48 -38.04 82.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.52 -48.82 65.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 23.9 mm -52.79 -41.64 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.628 ' CZ ' ' CG1' ' B' ' 64' ' ' VAL . 3.8 m-85 -70.51 -28.15 64.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -45.53 21.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.472 ' CB ' HD22 ' B' ' 204' ' ' LEU . . . -56.21 -35.16 67.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.354 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.441 ' HA ' HG21 ' B' ' 230' ' ' ILE . 21.5 t80 -72.47 -49.69 31.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -18.63 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.29 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.16 -28.41 17.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 110.079 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' B' ' 227' ' ' PHE . 7.4 tp -99.59 -16.32 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 110.161 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.595 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 3.9 t80 -55.92 -43.25 99.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.9 Cg_endo -74.21 -31.24 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.449 1.237 . . . . 0.0 110.255 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.43 HG11 HD23 ' B' ' 175' ' ' LEU . 8.8 t -67.36 -43.84 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.707 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.462 HD21 HG22 ' B' ' 170' ' ' ILE . 71.2 mt -58.46 -44.24 89.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.967 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' SER . . . . . 0.42 ' HA ' ' CZ ' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -67.71 -28.02 67.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.151 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -74.31 -24.41 59.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.113 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.538 ' CG ' HD21 ' B' ' 175' ' ' LEU . 86.8 m-85 -125.12 45.57 2.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -63.26 -162.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -42.45 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 110.145 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.216 179.871 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 HD21 ' CD2' ' B' ' 99' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.526 ' N ' HD13 ' A' ' 18' ' ' LEU . 55.6 t0 -90.01 89.26 7.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 111.018 -178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.61 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 2.4 mt -87.93 -5.4 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.042 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.52 ' N ' HD21 ' A' ' 68' ' ' LEU . 96.0 m -39.38 -38.85 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.292 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -91.59 -32.34 8.74 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.618 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -51.25 -44.28 30.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.198 -1.178 . . . . 0.0 109.46 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.523 ' HG ' ' N ' ' A' ' 25' ' ' PHE . 1.6 pp -83.02 -25.98 31.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.892 -1.13 . . . . 0.0 109.417 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.523 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 1.9 t80 -87.22 0.4 55.42 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.723 0.773 . . . . 0.0 109.101 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 150.1 98.68 0.19 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 8.3 p-10 -21.99 119.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.095 0.95 . . . . 0.0 112.849 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.693 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -130.21 165.47 30.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.535 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.557 ' N ' HG12 ' A' ' 28' ' ' ILE . 77.2 m-20 -86.18 125.95 33.89 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.545 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -39.47 -24.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 -178.484 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 29' ' ' ASP . 65.0 mt-10 -64.61 -4.91 4.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.018 . . . . 0.0 111.142 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.55 38.07 4.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.8 tpp180 -126.54 130.08 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -1.142 . . . . 0.0 109.511 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.693 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -89.01 158.69 17.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.589 -1.32 . . . . 0.0 111.429 -179.046 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.52 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.611 0.72 . . . . 0.0 111.504 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.189 0.519 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -95.45 -32.93 12.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 0.0 108.631 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.514 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 1.7 mt -88.87 -34.62 16.93 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.08 -49.51 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.38 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.0 -29.53 68.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.593 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.471 ' OD1' ' HD2' ' B' ' 191' ' ' PRO . 20.8 m-80 -76.28 -41.06 50.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.613 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.548 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 45.7 mt -49.96 -47.08 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.58 0.52 60.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.51 -41.73 3.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.536 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -86.57 36.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.13 -0.981 . . . . 0.0 110.458 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -80.21 17.12 1.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.112 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.99 11.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 62' ' ' LEU . 3.5 mt -90.32 -26.07 20.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.744 -1.223 . . . . 0.0 109.47 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.54 -38.71 0.04 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.7 mm? -62.93 -12.14 23.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 110.537 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -48.03 -41.1 24.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.981 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -42.75 76.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.484 ' O ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -81.86 -1.92 49.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.995 179.739 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.52 HD21 ' N ' ' A' ' 21' ' ' THR . 2.8 tm? -82.29 -47.2 12.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.413 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -90.26 0.28 57.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 110.176 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.445 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 3.1 tt0 -90.9 15.85 10.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.322 -0.861 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.577 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 45.0 t -145.67 5.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.328 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' CE2' ' B' ' 116' ' ' PHE . 4.0 tp -150.52 77.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.881 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.6 t70 -84.29 49.3 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.016 -1.053 . . . . 0.0 108.523 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.623 ' HB2' ' CE1' ' B' ' 99' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.402 HD13 ' OH ' ' B' ' 231' ' ' TYR . 2.5 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.215 0.531 . . . . 0.0 110.407 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.531 ' CG1' ' HD2' ' B' ' 65' ' ' PRO . 15.5 t -57.9 145.51 71.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.006 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.531 ' HD2' ' CG1' ' B' ' 64' ' ' VAL . 44.1 Cg_endo -71.69 138.43 31.94 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.806 1.424 . . . . 0.0 110.377 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.454 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 72.8 m -105.17 135.19 46.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -75.03 122.04 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.91 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -113.38 -3.66 13.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.649 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.4 142.47 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 110.574 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.511 ' CD1' HG22 ' B' ' 160' ' ' ILE . 13.3 mm -126.99 161.16 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.355 -0.841 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' B' ' 158' ' ' GLN . 47.8 t -141.74 121.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.126 -0.984 . . . . 0.0 110.233 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' B' ' 157' ' ' ILE . . . -134.9 168.5 18.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 73' ' ' THR . . . . . 0.436 HG21 HG21 ' B' ' 122' ' ' VAL . 0.2 OUTLIER -124.71 153.5 42.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.461 HG11 ' N ' ' B' ' 75' ' ' THR . 53.2 t -143.91 155.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 110.303 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.461 ' N ' HG11 ' B' ' 74' ' ' VAL . 9.1 m -124.72 133.13 53.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' B' ' 150' ' ' ALA . 67.6 mt -87.56 -65.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.88 -20.83 2.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 40.6 m -135.18 143.78 46.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.247 . . . . 0.0 110.471 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 7.3 ptm85 -59.54 163.37 4.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.913 . . . . 0.0 109.816 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.446 HD12 ' CD1' ' B' ' 76' ' ' LEU . 25.6 mt -131.43 153.6 49.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 42.3 t0 -89.64 89.02 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' B' ' 101' ' ' ALA . 15.1 mt -38.52 -36.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 110.666 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -66.18 -42.51 88.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.44 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.49 HG23 ' CE2' ' B' ' 148' ' ' PHE . 16.0 m -79.34 -25.73 42.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.159 -0.963 . . . . 0.0 110.543 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.53 HG21 ' CE2' ' B' ' 148' ' ' PHE . 22.9 t -75.26 -40.39 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.13 -21.19 43.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.1 tp -88.9 -18.49 27.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -100.03 -41.13 7.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 110.362 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.421 ' HB2' ' HB1' ' B' ' 92' ' ' ALA . . . -64.48 140.42 58.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.855 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -77.55 -14.43 59.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.096 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -137.7 79.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 110.138 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -162.02 154.0 19.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.286 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -143.34 155.63 44.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -119.3 135.74 54.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.83 101.57 3.43 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.178 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.87 -16.19 26.2 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.044 1.549 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -72.66 -6.58 45.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.95 -65.72 1.04 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 110.377 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.673 ' CZ ' ' CB ' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -146.86 133.18 19.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.365 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.478 ' N ' ' CD1' ' B' ' 99' ' ' PHE . . . -60.62 57.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.989 -177.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.673 ' CB ' ' CZ ' ' B' ' 99' ' ' PHE . . . -152.48 169.02 23.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.872 -1.142 . . . . 0.0 111.159 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.447 HG22 HD21 ' B' ' 82' ' ' LEU . 17.2 t -102.23 130.39 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.609 -0.682 . . . . 0.0 109.303 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.4 mp -89.3 118.29 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 110.2 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 27.2 ttm -104.16 164.62 11.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 110.236 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.508 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 9.0 ptm180 -156.03 122.41 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.555 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 10.4 pt -108.68 151.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.509 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 23.77 8.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 109.931 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.0 OUTLIER -175.9 94.92 0.26 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.88 . . . . 0.0 110.114 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' B' ' 106' ' ' ILE . 46.4 Cg_endo -72.8 162.22 91.72 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.546 0.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.402 ' C ' ' CG2' ' B' ' 111' ' ' THR . 6.6 tppt? -71.5 89.83 0.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 109.918 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' B' ' 124' ' ' THR . 21.9 p -145.32 -179.83 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.293 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 27' ' ' ASN . 6.1 t -133.69 176.06 8.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -170.5 177.58 3.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.04 . . . . 0.0 111.049 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.585 HD11 ' CE1' ' B' ' 116' ' ' PHE . 0.3 OUTLIER -145.7 123.44 11.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.432 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' B' ' 101' ' ' ALA . 18.0 mt -94.04 134.55 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.935 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.636 ' CE2' HD13 ' A' ' 72' ' ' ILE . 8.3 m-85 -87.41 134.21 33.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.611 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' B' ' 82' ' ' LEU . . . -52.24 -19.69 2.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 55.0 m -79.41 -29.6 42.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.256 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.09 -31.28 2.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.42 163.3 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.225 -1.162 . . . . 0.0 110.135 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.433 ' HE2' HG13 ' B' ' 74' ' ' VAL . 8.1 tmm? -160.89 128.18 4.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 71' ' ' VAL . 22.6 t -107.94 154.64 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.417 ' CG2' ' SD ' ' B' ' 121' ' ' MET . 25.7 t -146.37 131.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.469 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.528 HG21 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -139.04 167.01 23.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.337 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.578 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 117.36 -37.48 3.31 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -53.52 173.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -1.086 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.448 ' HA ' HG12 ' B' ' 70' ' ' ILE . 8.5 mtmm -135.34 5.8 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -147.23 163.18 37.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . 0.521 ' HG2' ' CD1' ' B' ' 157' ' ' ILE . 3.8 mt-10 -57.73 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.173 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.92 -36.17 11.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.847 . . . . 0.0 110.345 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' B' ' 128' ' ' SER . 9.3 t0 -53.89 -49.57 68.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.128 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 57.0 m -56.23 -42.04 76.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' B' ' 137' ' ' ARG . 3.7 mttt -53.86 -38.43 64.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 1.4 mt -66.25 -41.1 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.133 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.59 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.409 ' HA ' HG23 ' B' ' 123' ' ' VAL . 0.3 OUTLIER -60.38 -51.53 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' B' ' 133' ' ' LYS . 0.2 OUTLIER -53.41 -37.43 62.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.924 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' B' ' 134' ' ' LEU . 4.8 mmtt -68.15 -50.78 52.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.898 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.555 ' CZ ' HG12 ' B' ' 106' ' ' ILE . 28.2 m-85 -52.75 -54.18 37.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.941 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.63 58.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.49 -46.25 55.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 57.0 mt -51.69 -41.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.475 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 23.5 mm -64.37 -49.95 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.531 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.75 -31.45 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.376 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 2.7 tmtt? -74.23 -21.17 59.91 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.467 HG23 ' CD2' ' B' ' 148' ' ' PHE . 5.4 mt -84.58 -17.13 10.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.97 -21.88 9.33 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.53 ' CE2' HG21 ' B' ' 85' ' ' VAL . 15.3 m-85 -53.94 174.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 110.958 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.65 36.56 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.515 -0.74 . . . . 0.0 110.193 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' B' ' 76' ' ' LEU . . . -71.06 144.47 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.467 ' O ' ' OG1' ' B' ' 153' ' ' THR . 4.2 tttp -128.74 104.52 7.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.452 ' O ' HG21 ' B' ' 153' ' ' THR . 54.9 t80 -53.41 102.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 110.319 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.6 OUTLIER -154.09 172.09 18.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.164 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.0 33.61 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -72.35 138.22 47.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -161.74 136.14 6.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.521 ' CD1' ' HG2' ' B' ' 129' ' ' GLU . 37.2 mt -80.23 140.77 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.853 . . . . 0.0 110.139 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.439 ' HB2' HG13 ' B' ' 71' ' ' VAL . 25.6 mm-40 -92.77 -61.76 1.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.425 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -145.75 168.77 19.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.511 HG22 ' CD1' ' B' ' 70' ' ' ILE . 67.1 mt -119.54 144.4 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 24' ' ' LEU . 12.4 t -112.0 121.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -132.64 172.28 21.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 28.3 t -166.1 161.16 16.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.173 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.428 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 29.5 p -167.88 139.5 2.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -92.69 161.69 14.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.1 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.489 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.0 OUTLIER -110.94 -81.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.182 -0.948 . . . . 0.0 110.198 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 6.1 mtpt 170.01 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 0.0 110.407 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' B' ' 168' ' ' PHE . 10.5 p90 -129.56 155.99 79.37 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.201 -0.937 . . . . 0.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 44.6 Cg_endo -71.45 161.27 46.07 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.859 1.452 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.477 HG21 ' N ' ' B' ' 171' ' ' ARG . 1.7 mp -126.93 149.67 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.154 -0.967 . . . . 0.0 110.663 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.477 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.2 OUTLIER -86.46 110.59 19.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.848 179.591 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' B' ' 193' ' ' LEU . 11.9 mt -65.61 -32.21 73.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 110.612 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.13 -28.96 67.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 110.175 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.79 65.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -45.46 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 110.227 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.53 -13.63 62.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -90.31 -32.45 16.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 178' ' ' SER . . . . . 0.508 ' OG ' ' ND1' ' B' ' 179' ' ' HIS . 37.6 p -98.27 -30.53 12.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.907 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.508 ' ND1' ' OG ' ' B' ' 178' ' ' SER . 76.1 m80 -123.94 44.38 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -65.34 -27.68 72.72 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 181' ' ' THR . . . . . 0.4 HG21 ' N ' ' B' ' 182' ' ' PHE . 2.2 t -54.16 -26.22 26.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.151 . . . . 0.0 110.221 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.565 ' CE2' ' CG2' ' B' ' 198' ' ' VAL . 31.4 m-85 -136.17 8.77 3.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.895 . . . . 0.0 110.196 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' B' ' 179' ' ' HIS . 22.9 t -110.96 120.72 43.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.969 . . . . 0.0 110.632 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 40.2 t -111.55 103.98 12.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.53 105.9 15.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' B' ' 190' ' ' PHE . 1.6 mm-40 -113.62 99.19 49.23 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.946 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.19 -4.66 15.35 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.052 1.554 . . . . 0.0 110.49 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.13 -13.02 19.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.952 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.493 ' O ' ' CG ' ' B' ' 189' ' ' LEU . 2.4 tt -146.43 11.2 1.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 110.263 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.617 ' CE2' ' CG1' ' B' ' 194' ' ' ILE . 2.2 t80 -166.2 112.6 0.74 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . 0.471 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.7 Cg_endo -74.43 -26.89 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.898 1.472 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.99 178.28 37.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' B' ' 172' ' ' LEU . 8.3 tt -110.6 132.82 53.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -1.103 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.617 ' CG1' ' CE2' ' B' ' 190' ' ' PHE . 93.8 mt -100.46 118.39 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -120.85 128.95 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -108.42 89.38 2.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.152 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 32.9 ttm -50.74 141.13 13.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.075 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.565 ' CG2' ' CE2' ' B' ' 182' ' ' PHE . 31.3 t -71.35 -59.27 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -127.13 117.18 21.84 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.952 . . . . 0.0 110.304 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.08 156.46 99.72 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.92 -2.117 . . . . 0.0 110.277 -0.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' B' ' 198' ' ' VAL . 0.6 OUTLIER -69.8 85.43 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.978 . . . . 0.0 110.106 179.848 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.471 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 25.3 mm -130.27 163.07 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 12.6 t -109.57 120.38 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.281 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' B' ' 204' ' ' LEU . 4.5 mp -114.76 124.49 51.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.161 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.522 HD12 ' CE2' ' A' ' 25' ' ' PHE . 1.8 mt -102.63 148.67 25.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' B' ' 211' ' ' LYS . 4.1 mp -139.56 127.16 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.327 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.441 ' N ' ' CD1' ' B' ' 207' ' ' PHE . 26.0 m-85 -105.13 155.61 18.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 72.6 t -51.33 -24.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 0.0 110.306 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -24.32 62.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 110.421 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 107.54 24.92 6.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.0 OUTLIER -91.15 126.18 36.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -1.114 . . . . 0.0 110.204 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' B' ' 163' ' ' SER . 23.8 mm -114.37 116.17 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.507 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 29.0 t -107.61 143.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.063 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.479 ' N ' HD13 ' B' ' 214' ' ' LEU . 3.1 mp -135.58 112.36 10.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 13.2 t -135.95 153.68 51.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.15 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.05 -5.59 34.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' B' ' 223' ' ' ILE . . . -81.99 127.47 33.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -1.194 . . . . 0.0 110.051 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -71.19 -38.61 72.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 110.432 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.423 ' CA ' HD13 ' B' ' 160' ' ' ILE . 3.7 mt-30 -117.69 -173.01 2.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.274 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . 0.55 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 35.5 ttp180 -88.48 -24.66 22.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.277 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 3.4 pt-20 -63.96 -22.47 66.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.21 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 33.2 mt-10 -76.39 -53.75 7.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 110.07 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.525 HG12 ' CB ' ' B' ' 217' ' ' ALA . 27.8 mm -56.59 -37.7 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 110.035 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.55 ' CE1' ' HG2' ' B' ' 220' ' ' ARG . 5.5 m-85 -66.11 -40.54 90.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 110.134 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.434 ' O ' ' HB1' ' B' ' 229' ' ' ALA . 7.2 tt0 -80.02 -22.48 42.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.872 . . . . 0.0 110.087 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.444 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -67.68 -47.49 69.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.46 ' HA ' ' CG2' ' B' ' 230' ' ' ILE . 19.6 t80 -76.92 -34.21 57.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' B' ' 224' ' ' TYR . 35.9 mm-40 -65.68 -18.48 65.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.213 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' B' ' 225' ' ' GLN . . . -97.04 -25.91 15.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.065 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.46 ' CG2' ' HA ' ' B' ' 227' ' ' PHE . 2.9 tp -96.21 -11.3 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.05 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.578 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 2.4 t80 -53.89 -44.03 97.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.72 -43.74 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.468 1.246 . . . . 0.0 110.68 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 30.5 t -56.92 -36.51 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.428 ' CD2' HG22 ' B' ' 206' ' ' ILE . 20.2 mt -63.44 -62.13 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 43.1 m -53.79 -20.31 5.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.512 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.69 -40.25 84.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.452 -0.78 . . . . 0.0 110.044 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -116.14 41.68 2.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 110.516 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -168.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.145 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -141.35 -41.38 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 30.2 mtp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.18 179.852 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.605 ' CD1' ' CB ' ' A' ' 30' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.471 ' O ' HD21 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -100.55 128.07 46.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.764 -179.481 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.579 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 43.4 mt -123.92 22.69 8.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.54 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.589 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 6.4 m -43.7 -37.41 2.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.49 -32.02 5.89 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.666 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -46.62 -41.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.392 -1.064 . . . . 0.0 108.644 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.492 ' CD2' ' HG2' ' A' ' 67' ' ' MET . 3.1 pp -84.29 -26.22 28.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.033 -1.042 . . . . 0.0 108.539 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.447 ' HB3' ' HA2' ' A' ' 22' ' ' GLY . 1.7 t80 -85.85 7.03 25.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 142.23 99.66 0.35 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 6.4 p-10 -20.84 115.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.912 0.863 . . . . 0.0 112.357 -178.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -136.42 158.81 38.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.568 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.533 ' N ' HG12 ' A' ' 28' ' ' ILE . 4.4 m-20 -88.12 123.57 32.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.605 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . 17.3 p -39.41 -26.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.588 -0.695 . . . . 0.0 110.145 -178.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.0 mt-10 -55.9 -14.32 2.38 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.65 26.56 6.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 28' ' ' ILE . 11.7 mmt-85 -116.55 123.88 48.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -1.149 . . . . 0.0 109.501 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.673 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.39 160.95 16.56 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 111.163 -178.954 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.513 HD21 ' N ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 0.0 111.272 -178.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.237 0.541 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.65 -20.31 15.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.107 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 3.5 mt -96.31 -43.78 7.53 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.702 . . . . 0.0 110.303 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.6 -52.96 34.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.577 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.13 -27.24 67.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.429 -0.794 . . . . 0.0 109.559 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.568 ' OD1' ' CD1' ' B' ' 190' ' ' PHE . 1.6 m-80 -77.8 -31.62 51.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.195 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -56.81 -47.41 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.386 -0.821 . . . . 0.0 109.195 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.54 -25.95 14.75 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.03 25.63 7.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -1.114 . . . . 0.0 110.136 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' B' ' 190' ' ' PHE . 2.6 mt -82.08 -21.2 36.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.891 . . . . 0.0 110.069 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.454 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.41 40.36 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 110.548 -179.817 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -132.81 -4.61 3.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.957 . . . . 0.0 110.521 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.626 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -129.39 -2.96 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 111.331 -179.752 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.506 ' N ' HD23 ' A' ' 62' ' ' LEU . . . 168.8 -55.43 0.21 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 4.0 mm? -42.92 -24.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -1.205 . . . . 0.0 110.933 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t70 -44.05 -41.96 5.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 109.716 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.9 m -67.23 -51.19 56.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.435 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.492 ' HG2' ' CD2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -71.12 -4.47 25.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 178.86 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 21' ' ' THR . 1.8 tm? -72.32 -62.09 1.56 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.858 0.837 . . . . 0.0 109.032 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.7 0.69 12.18 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.24 0.543 . . . . 0.0 110.298 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 37.3 tt0 -84.36 8.12 17.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 111.196 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.575 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 6.0 t -140.69 2.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.121 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.579 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 3.1 tp -151.01 81.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.78 . . . . 0.0 109.232 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 8.6 t0 -83.98 49.78 1.7 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.095 -1.003 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.343 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' B' ' 64' ' ' VAL . 1.3 mp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.011 0.434 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' B' ' 63' ' ' ILE . 90.3 t 58.61 125.13 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 110.583 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.7 Cg_endo -74.43 144.05 31.93 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.825 1.434 . . . . 0.0 110.589 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -107.19 129.76 54.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.493 HD21 ' CG2' ' B' ' 160' ' ' ILE . 73.4 mt -69.66 127.1 31.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' B' ' 68' ' ' GLN . 5.6 mm-40 -106.25 -20.28 13.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' B' ' 161' ' ' VAL . 7.3 m120 -161.42 137.02 7.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.074 -1.016 . . . . 0.0 110.567 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' B' ' 124' ' ' THR . 13.1 mm -115.73 148.39 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.492 HG21 ' CB ' ' B' ' 124' ' ' THR . 27.6 t -137.89 129.18 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.505 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.58 155.55 46.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 65.0 p -111.34 139.26 46.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.182 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.565 HG12 ' CE1' ' B' ' 152' ' ' PHE . 22.6 t -123.9 148.78 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.837 . . . . 0.0 110.13 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' B' ' 154' ' ' ASP . 4.7 m -119.06 127.52 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.487 ' CD2' ' HB3' ' B' ' 150' ' ' ALA . 70.2 mt -92.02 -42.94 9.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.004 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.72 68.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 52.9 m -132.84 151.14 52.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -1.198 . . . . 0.0 110.365 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 39.2 mtp-105 -79.32 155.2 28.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 110.075 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 18.7 mt -127.74 161.0 29.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.454 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 8.6 m-20 -94.63 82.11 3.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.81 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' B' ' 101' ' ' ALA . 92.6 mt -42.01 -27.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.241 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' B' ' 81' ' ' ASP . 18.9 mmmt -67.01 -44.99 78.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 10.9 p -85.41 -38.5 18.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.871 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.495 HG21 ' CE2' ' B' ' 148' ' ' PHE . 43.3 t -52.36 -44.61 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.416 ' HB3' HG23 ' B' ' 102' ' ' VAL . . . -77.81 -30.36 51.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' B' ' 87' ' ' LEU . 14.1 tp -80.53 -18.9 47.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' B' ' 84' ' ' THR . 1.2 m-70 -99.91 -32.87 10.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.338 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 150.48 45.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -87.15 -26.13 23.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' B' ' 104' ' ' MET . 90.6 m-20 -127.74 78.82 1.85 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.532 ' HB3' ' CG1' ' B' ' 102' ' ' VAL . . . -145.49 158.35 43.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 110.136 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.07 141.12 44.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.67 109.31 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 110.095 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . 0.413 ' OD1' ' NH1' ' B' ' 98' ' ' ARG . 2.6 t-20 -129.35 128.31 23.19 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.83 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -16.16 31.79 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.842 1.443 . . . . 0.0 110.186 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.513 ' HE2' ' NH2' ' B' ' 98' ' ' ARG . 7.3 tttt -86.32 -16.92 35.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.86 . . . . 0.0 110.066 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.513 ' NH2' ' HE2' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -92.21 -67.0 0.88 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.486 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.668 ' CE2' ' CB ' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.08 161.67 8.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.288 -0.883 . . . . 0.0 111.225 -179.389 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.83 54.06 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.532 -0.73 . . . . 0.0 111.677 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.668 ' CB ' ' CE2' ' B' ' 99' ' ' PHE . . . -161.85 173.27 14.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.941 -1.099 . . . . 0.0 110.258 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.532 ' CG1' ' HB3' ' B' ' 92' ' ' ALA . 38.0 t -108.06 155.82 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.477 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 16.1 mt -113.51 110.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.504 ' HE2' ' CD1' ' B' ' 115' ' ' ILE . 12.0 ttm -94.19 151.07 19.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.624 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -149.56 120.88 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 109' ' ' PRO . 25.1 pt -107.57 156.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.116 -0.99 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -106.88 37.81 2.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.847 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.63 82.19 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.592 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.459 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.0 Cg_endo -80.64 161.49 83.41 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.801 -2.166 . . . . 0.0 110.472 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -64.24 104.74 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 109.995 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.427 HG22 ' O ' ' B' ' 109' ' ' PRO . 30.5 p -146.63 166.1 27.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.66 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' B' ' 113' ' ' ALA . 1.8 m -112.52 164.8 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -167.2 146.07 5.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.524 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.578 HD13 ' CZ ' ' B' ' 116' ' ' PHE . 0.2 OUTLIER -124.28 119.4 29.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.726 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.504 ' CD1' ' HE2' ' B' ' 104' ' ' MET . 78.6 mt -95.41 131.46 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.638 ' CD1' ' CD1' ' A' ' 74' ' ' LEU . 8.5 m-30 -90.13 155.19 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.99 -11.61 61.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 110.152 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 3.9 m -85.7 -40.48 16.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.27 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 148.06 -34.79 1.2 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -67.8 150.19 48.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -1.218 . . . . 0.0 110.508 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.466 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -150.14 159.3 44.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.534 HG12 ' CG1' ' A' ' 71' ' ' VAL . 99.0 t -124.51 137.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 88.6 t -121.89 140.95 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.868 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.533 HG21 ' CB ' ' A' ' 27' ' ' ASN . 3.9 t -145.55 160.83 41.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.444 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.577 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 114.32 -35.26 4.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' B' ' 131' ' ' ASP . . . -42.42 147.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -1.191 . . . . 0.0 110.083 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . 0.47 ' HB2' ' OD2' ' B' ' 131' ' ' ASP . 13.1 mmtt -96.11 0.74 51.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.63 -165.19 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.39 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.13 -40.38 74.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.04 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -44.64 92.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' B' ' 127' ' ' LYS . 8.8 m-20 -56.31 -53.51 56.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 0.0 109.964 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.427 ' HB3' HG23 ' B' ' 70' ' ' ILE . 1.5 p -57.81 -32.5 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.848 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . 0.438 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -67.69 -44.69 77.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 109.999 179.691 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -59.73 2.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.043 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.13 3.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.025 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' B' ' 152' ' ' PHE . 18.4 m -65.98 -58.69 4.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.138 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -46.2 -44.03 15.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.004 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -53.29 -47.12 69.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.452 ' CE2' ' HB1' ' B' ' 113' ' ' ALA . 31.7 m-85 -65.62 -55.05 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 0.0 109.912 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -17.66 8.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -47.02 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 42.0 mt -52.74 -38.06 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.535 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 34.0 mm -71.7 -55.63 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.098 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.26 -27.3 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.942 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -75.54 -21.71 57.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.94 . . . . 0.0 108.613 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.449 HG22 HD11 ' B' ' 146' ' ' ILE . 5.7 mt -86.17 -21.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.27 -18.86 6.86 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.495 ' CE2' HG21 ' B' ' 85' ' ' VAL . 11.0 m-85 -53.84 165.98 0.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.286 . . . . 0.0 110.882 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.56 23.8 13.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.552 -0.717 . . . . 0.0 109.823 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.535 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -54.94 148.3 13.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.83 . . . . 0.0 110.552 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -123.35 114.77 20.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 110.04 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.565 ' CE1' HG12 ' B' ' 74' ' ' VAL . 36.2 t80 -69.89 90.9 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 1.4 p -145.6 171.89 14.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.438 ' HB3' ' OG1' ' B' ' 75' ' ' THR . 1.1 t0 63.21 29.79 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.438 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.9 t80 -77.36 136.73 38.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.88 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 134.17 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.404 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.68 121.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.862 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -119.68 -4.33 10.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.452 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 3.3 m120 -138.29 115.3 10.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.0 . . . . 0.0 110.616 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.493 ' CG2' HD21 ' B' ' 67' ' ' LEU . 68.9 mt -122.65 125.58 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 24' ' ' LEU . 26.0 t -100.26 130.75 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.524 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.05 169.86 24.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 2.3 m -162.89 164.53 25.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -1.147 . . . . 0.0 110.119 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.488 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.6 p -170.34 166.93 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 0.0 110.607 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.67 137.45 50.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 109.74 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.575 HG22 ' CE1' ' B' ' 168' ' ' PHE . 20.9 m -89.71 12.07 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.423 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.1 OUTLIER 70.82 3.63 4.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.281 -0.887 . . . . 0.0 110.711 179.662 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.575 ' CE1' HG22 ' B' ' 166' ' ' VAL . 8.1 p90 -162.58 150.98 12.13 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.386 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.468 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 45.1 Cg_endo -71.84 165.66 31.87 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.998 1.525 . . . . 0.0 110.512 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.449 HD13 HG23 ' B' ' 166' ' ' VAL . 3.7 mt -133.25 158.09 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.934 . . . . 0.0 110.79 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.453 ' HD3' ' HG3' ' B' ' 173' ' ' GLU . 3.4 ttm180 -89.3 98.81 11.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.685 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.66 -55.24 27.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.19 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . 0.453 ' HG3' ' HD3' ' B' ' 171' ' ' ARG . 15.4 pt-20 -54.02 -26.54 26.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.725 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.55 -37.14 53.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -44.58 64.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -1.166 . . . . 0.0 110.056 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -59.38 -38.3 80.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -65.5 -32.69 74.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -58.66 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' B' ' 183' ' ' SER . 37.3 m80 -101.74 30.38 4.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.343 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -60.1 -14.71 33.42 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -30.38 64.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -1.19 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' B' ' 198' ' ' VAL . 60.4 m-85 -119.77 0.68 10.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' B' ' 179' ' ' HIS . 0.1 OUTLIER -120.59 174.07 6.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.074 179.873 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.29 152.98 35.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.265 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.411 ' HB2' HD13 ' B' ' 193' ' ' LEU . 75.0 t80 -148.75 100.94 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' B' ' 190' ' ' PHE . 23.5 mt-10 -101.31 103.5 27.0 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.936 . . . . 0.0 110.02 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.68 -6.32 18.89 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.938 1.493 . . . . 0.0 110.146 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -99.95 -2.92 33.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.71 -41.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 0.0 110.626 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.568 ' CD1' ' OD1' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -111.24 110.8 55.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 110.675 -179.524 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.46 -25.35 15.34 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.115 1.587 . . . . 0.0 110.07 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.492 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -95.64 -179.91 36.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' B' ' 205' ' ' LEU . 0.7 OUTLIER -113.22 140.62 47.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -1.163 . . . . 0.0 110.359 -179.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.519 HG12 ' CD2' ' B' ' 205' ' ' LEU . 67.9 mt -104.87 104.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -96.78 137.21 36.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.546 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -115.66 83.6 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.456 ' HE2' HD12 ' B' ' 204' ' ' LEU . 30.4 ttm -51.87 139.84 21.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' B' ' 182' ' ' PHE . 25.6 t -82.4 -42.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.216 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -140.41 114.51 7.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.893 . . . . 0.0 110.019 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.49 168.68 75.51 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.968 -2.097 . . . . 0.0 110.607 0.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.423 ' C ' HG12 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -72.69 87.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 0.0 110.005 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 19.1 mm -137.76 153.29 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 110.51 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.73 126.85 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.0 mp -116.55 136.82 52.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 110.277 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.519 ' CD2' HG12 ' B' ' 194' ' ' ILE . 1.2 mt -119.32 132.69 55.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.329 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.58 159.98 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.492 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 2.9 m-85 -135.75 147.74 48.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 37.9 t -45.87 -24.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -76.12 -22.65 55.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.438 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 107.24 4.31 35.4 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -77.84 141.43 39.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 110.139 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' B' ' 163' ' ' SER . 15.2 mm -124.53 142.14 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.102 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 11.1 t -124.24 151.9 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.199 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' B' ' 213' ' ' VAL . 3.1 mp -141.35 119.24 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 12.8 t -135.52 166.17 23.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 110.314 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.38 79.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.519 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -79.39 132.64 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -1.171 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' B' ' 218' ' ' LYS . 2.1 ttmt -79.24 -26.31 42.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.485 ' HB3' ' CG ' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -144.87 162.23 37.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.375 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -59.44 -26.56 65.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.806 . . . . 0.0 110.552 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.485 ' CG ' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -63.85 -27.55 69.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 -179.824 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.444 ' OE1' HD12 ' B' ' 202' ' ' ILE . 4.5 mt-10 -74.57 -42.27 59.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 109.879 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.416 HD11 HG22 ' B' ' 223' ' ' ILE . 32.0 mm -63.75 -40.35 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.37 -39.88 94.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.08 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -74.62 -31.45 62.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.444 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -63.92 -38.3 90.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.856 . . . . 0.0 110.156 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.466 ' HA ' ' CG2' ' B' ' 230' ' ' ILE . 27.5 t80 -79.55 -42.32 25.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 110.221 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' B' ' 228' ' ' GLU . 0.3 OUTLIER -61.83 -17.04 54.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.972 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . 0.444 ' HB2' ' HE3' ' B' ' 197' ' ' MET . . . -96.06 -32.96 12.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.466 ' CG2' ' HA ' ' B' ' 227' ' ' PHE . 5.3 tp -89.59 -16.34 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.995 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.564 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.4 t80 -53.86 -43.39 96.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.379 -0.825 . . . . 0.0 111.083 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 46.1 Cg_endo -74.58 -36.87 2.64 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.356 1.188 . . . . 0.0 110.613 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.11 -40.72 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.869 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.436 HD13 HG22 ' B' ' 230' ' ' ILE . 26.3 mt -62.66 -48.81 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 110.233 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -42.54 84.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.988 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . 0.441 ' CA ' ' OE1' ' B' ' 236' ' ' GLU . 0.0 OUTLIER -61.73 -30.0 70.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 110.156 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -119.58 39.58 3.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.447 ' HG2' ' N ' ' B' ' 239' ' ' LYS . 7.1 tmm_? -69.75 148.49 49.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.235 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.447 ' N ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -91.7 -56.19 3.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.343 -179.895 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 36.5 ttm . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.253 -179.998 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' CD1' ' HB2' ' A' ' 30' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.227 0.537 . . . . 0.0 109.952 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.509 ' N ' HD13 ' A' ' 18' ' ' LEU . 5.6 p-10 -86.68 93.12 9.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 111.024 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.623 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 2.9 mt -99.21 2.62 45.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.317 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 42.3 m -42.33 -39.29 2.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -89.41 -35.25 8.08 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.614 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -51.19 -45.44 31.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.459 -1.024 . . . . 0.0 109.076 -179.49 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' CD2' ' HG2' ' A' ' 67' ' ' MET . 3.8 pp -82.88 -19.62 37.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 109.827 178.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -100.22 11.62 38.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.246 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.559 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 146.58 89.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.587 ' ND2' ' CD1' ' A' ' 35' ' ' LEU . 4.3 p30 -16.06 124.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.075 0.941 . . . . 0.0 112.506 -179.264 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.69 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -145.67 161.13 12.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.854 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.555 ' N ' HG12 ' A' ' 28' ' ' ILE . 68.9 m-20 -86.8 134.33 33.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.563 ' OG ' ' CE1' ' B' ' 99' ' ' PHE . 9.7 p -39.35 -27.36 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.598 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 10.3 tt0 -55.57 -15.41 2.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 178.275 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 31.26 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.526 ' O ' ' CA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.72 129.32 49.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.957 -1.32 . . . . 0.0 110.571 179.83 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.69 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.35 150.58 20.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.299 -0.876 . . . . 0.0 110.698 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.587 ' CD1' ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.522 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.172 0.51 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -22.8 14.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.192 -0.943 . . . . 0.0 108.833 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.528 HD23 ' CD1' ' B' ' 205' ' ' LEU . 4.0 mt -103.51 -40.06 6.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.591 -0.693 . . . . 0.0 110.435 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.75 -56.01 16.34 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.721 -179.16 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -64.88 -24.53 67.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.643 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 2.2 m-20 -80.04 -37.03 34.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.466 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 8.0 mt -53.71 -43.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.65 -22.46 46.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.6 p -127.21 17.83 7.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -1.117 . . . . 0.0 110.31 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 55' ' ' ASN . 4.8 mt -79.02 -11.47 60.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.53 38.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.537 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 24.8 ttpt -137.16 12.99 3.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.996 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' B' ' 194' ' ' ILE . 0.9 OUTLIER -136.96 -29.77 0.9 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 110.948 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.9 -44.35 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.112 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.8 mm? -44.83 -23.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -1.231 . . . . 0.0 110.793 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 64' ' ' LEU . 7.8 t0 -43.93 -41.65 5.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.022 . . . . 0.0 109.744 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.7 -45.82 74.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.428 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.439 ' HG2' ' CD2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -72.22 -8.73 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.388 179.17 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.461 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 2.2 tm? -71.17 -60.89 1.99 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.948 0.88 . . . . 0.0 108.88 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -72.57 0.4 10.59 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.328 0.585 . . . . 0.0 110.14 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 44.8 tt0 -84.3 1.18 46.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -0.918 . . . . 0.0 111.171 -179.179 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.603 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 3.4 t -138.36 -2.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.128 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.623 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 4.4 tp -150.85 77.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.444 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.7 p-10 -78.57 55.35 1.62 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.962 -1.086 . . . . 0.0 108.851 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 8.7 mt . . . . . 0 C--N 1.306 -1.294 0 CA-C-O 121.672 0.748 . . . . 0.0 110.668 -179.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' B' ' 64' ' ' VAL . 1.5 mp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.317 0.58 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.456 HG11 ' HD2' ' B' ' 65' ' ' PRO . 4.3 t 61.04 130.65 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 0.0 110.318 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.457 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 45.6 Cg_endo -74.03 137.44 24.1 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.973 1.512 . . . . 0.0 110.388 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -99.06 128.51 45.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 69.9 mt -70.42 114.6 8.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 110.121 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -102.82 -9.62 19.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.291 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.498 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 0.6 OUTLIER -168.27 157.86 9.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 -179.857 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 126' ' ' ALA . 8.1 mt -156.9 159.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.965 . . . . 0.0 109.853 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' B' ' 123' ' ' VAL . 50.7 t -139.47 143.02 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.442 ' N ' HG11 ' B' ' 71' ' ' VAL . . . -132.82 151.55 51.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 14.8 p -108.58 120.77 43.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.427 HG21 ' HA ' ' B' ' 155' ' ' PHE . 65.4 t -116.76 151.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.165 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 75' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 27.5 m -122.8 152.24 40.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.508 ' CD1' HD13 ' B' ' 80' ' ' LEU . 14.0 mt -105.14 -44.52 4.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.95 -11.22 34.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 176.35 8.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -1.124 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -93.73 160.95 14.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.508 HD13 ' CD1' ' B' ' 76' ' ' LEU . 13.5 mt -134.84 149.41 50.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.979 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 2.7 m-20 -95.45 100.44 12.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.423 ' O ' ' HB1' ' B' ' 86' ' ' ALA . 21.2 mt -50.66 -39.4 50.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.042 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -42.28 84.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 84' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 4.2 m -87.64 -44.24 11.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.025 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.564 HG21 ' CE2' ' B' ' 148' ' ' PHE . 19.8 t -53.72 -37.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.969 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' B' ' 82' ' ' LEU . . . -83.67 -28.95 27.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' B' ' 87' ' ' LEU . 1.9 tp -84.14 -23.63 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' B' ' 84' ' ' THR . 8.2 m80 -94.03 -32.49 13.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.489 ' CB ' ' HB1' ' B' ' 92' ' ' ALA . . . -64.02 139.41 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.044 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -73.47 -27.74 61.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.955 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.443 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 10.6 t-20 -134.69 79.48 1.8 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' B' ' 89' ' ' ALA . . . -149.38 154.72 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . 0.527 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 16.2 pt-20 -136.24 165.49 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -139.86 113.76 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.099 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -115.67 96.23 45.79 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.363 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -16.27 25.82 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.974 1.512 . . . . 0.0 110.412 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -3.94 44.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.424 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -126.54 -34.45 2.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.141 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.604 ' CE2' ' HB1' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.49 -171.59 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.402 -0.811 . . . . 0.0 110.842 -179.301 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.96 57.03 0.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 111.542 -178.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.604 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -147.84 155.82 42.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.959 -1.088 . . . . 0.0 110.775 179.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' B' ' 93' ' ' GLU . 73.0 t -97.79 126.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.919 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.527 ' HB ' ' CG ' ' B' ' 93' ' ' GLU . 20.0 mm -90.29 129.51 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.358 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 1.3 ttt -102.4 162.54 12.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.443 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 0.6 OUTLIER -154.36 124.3 6.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 110.601 -179.773 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.519 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 8.7 pt -129.06 155.62 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.631 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.4 OUTLIER -102.41 34.28 2.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.435 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.473 ' O ' ' CD ' ' B' ' 138' ' ' LYS . 1.0 OUTLIER -177.06 87.45 0.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.8 Cg_endo -79.08 149.31 83.84 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.21 -0.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 3.9 tttt -62.05 97.69 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.153 -0.967 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' B' ' 124' ' ' THR . 23.8 p -149.67 170.95 17.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 110.749 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.472 ' OG1' HD22 ' A' ' 35' ' ' LEU . 1.2 m -110.79 156.55 20.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' B' ' 139' ' ' TYR . . . -136.82 143.64 43.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 110.938 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.517 ' HB3' ' CE1' ' B' ' 116' ' ' PHE . 2.8 mm? -104.87 125.39 50.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.4 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.459 ' CD1' ' HG3' ' B' ' 121' ' ' MET . 31.4 mm -110.13 121.56 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 0.0 110.868 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' B' ' 114' ' ' LEU . 6.8 m-85 -106.24 128.43 53.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.301 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.25 -24.3 4.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.219 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.83 -26.47 3.81 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -71.61 149.96 45.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.459 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.9 OUTLIER -139.86 140.91 36.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -115.29 157.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.949 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 33.6 t -142.46 153.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.489 ' O ' ' HB ' ' B' ' 111' ' ' THR . 1.8 t -149.71 163.12 38.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.539 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 112.0 -30.42 7.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -56.0 147.62 19.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -1.07 . . . . 0.0 110.253 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -119.41 -22.08 7.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m -121.88 -141.32 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.814 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.91 -41.92 5.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 131' ' ' ASP . 6.4 p30 -72.07 -21.87 61.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.204 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 73.9 m-20 -70.95 -35.16 72.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 110.434 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 132' ' ' SER . . . . . 0.481 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 12.1 m -79.27 -32.59 43.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.278 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -74.82 -42.95 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 110.151 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' B' ' 130' ' ' ASP . 0.2 OUTLIER -64.12 -37.59 88.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.418 ' HB2' HG12 ' B' ' 123' ' ' VAL . . . -67.76 -60.79 2.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 2.8 m -51.08 -46.63 61.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -45.08 88.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.8 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.473 ' CD ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -58.93 -41.4 87.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.903 179.746 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.572 ' CZ ' ' HB1' ' B' ' 113' ' ' ALA . 37.5 m-85 -66.79 -55.45 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.985 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . 0.521 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -48.57 -33.77 10.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 8.3 mmt180 -64.73 -41.32 96.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 28.1 mt -54.63 -49.75 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.49 HG21 ' CB ' ' B' ' 148' ' ' PHE . 9.0 mt -69.25 -54.23 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' B' ' 140' ' ' ALA . 0.9 OUTLIER -59.56 -32.89 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.94 . . . . 0.0 109.925 179.719 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 0.6 OUTLIER -72.92 -27.24 61.75 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.069 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.474 HG23 ' CD2' ' B' ' 148' ' ' PHE . 2.6 mt -76.28 -15.71 15.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 117.17 -27.34 7.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.564 ' CE2' HG21 ' B' ' 85' ' ' VAL . 9.6 m-85 -41.99 154.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.258 . . . . 0.0 110.765 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.52 24.63 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.512 ' HB2' ' NE2' ' B' ' 144' ' ' GLN . . . -72.42 165.59 24.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.11 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -142.78 169.48 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.374 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.434 ' O ' ' CD1' ' B' ' 152' ' ' PHE . 60.6 t80 -101.1 91.47 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.161 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.5 p -153.52 176.6 11.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.259 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . 0.5 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 20.5 t0 60.84 24.11 14.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.092 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 3.3 t80 -80.54 133.12 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -163.74 132.17 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 110.151 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.503 HG22 ' CG2' ' B' ' 70' ' ' ILE . 1.9 mp -79.96 109.4 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 109.917 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -103.47 -3.04 25.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 110.838 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.91 108.5 4.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.036 -1.04 . . . . 0.0 110.904 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.463 ' HA ' HG12 ' B' ' 70' ' ' ILE . 95.6 mt -113.21 120.03 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.177 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 3.5 t -95.37 140.37 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.637 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.45 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.75 177.04 20.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 163' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 73.7 m -166.05 140.6 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -1.178 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.457 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 8.9 p -170.23 136.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.95 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 59.2 p30 -103.41 179.81 4.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.024 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.519 HG22 ' CE2' ' B' ' 168' ' ' PHE . 0.2 OUTLIER -124.44 -86.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.213 -0.929 . . . . 0.0 110.3 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 173.97 33.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' B' ' 168' ' ' PHE . 11.8 p90 -166.32 149.32 6.41 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.64 145.49 46.83 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.098 1.578 . . . . 0.0 110.484 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.427 HD11 ' CG2' ' B' ' 206' ' ' ILE . 6.0 mt -112.2 142.62 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 0.0 110.514 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -82.1 92.83 6.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -0.834 . . . . 0.0 109.793 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.455 HD12 ' HA2' ' B' ' 192' ' ' GLY . 11.5 mt -51.23 -47.48 62.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.72 -50.12 74.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.937 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -49.79 -34.09 21.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' B' ' 179' ' ' HIS . 0.4 OUTLIER -71.32 -59.44 2.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 109.92 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.452 ' HA ' ' HA2' ' B' ' 180' ' ' GLY . . . -58.63 -19.49 39.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.07 -51.09 23.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.33 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 -32.72 11.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.463 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' B' ' 183' ' ' SER . 54.5 m80 -108.75 19.98 19.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' B' ' 176' ' ' ALA . . . -45.3 -51.6 9.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 55.5 m -62.09 -18.58 61.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -1.135 . . . . 0.0 109.931 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' B' ' 179' ' ' HIS . 1.4 m-85 -105.4 -10.5 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.058 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.478 ' N ' ' O ' ' B' ' 179' ' ' HIS . 13.9 p -154.07 154.96 34.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 184' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 0.5 OUTLIER -126.7 164.74 20.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 110.06 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' B' ' 185' ' ' TYR . 1.7 t80 -164.1 86.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -92.11 110.04 41.57 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 110.135 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -7.18 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.9 1.474 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.34 -6.43 56.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' B' ' 190' ' ' PHE . 1.9 tt -146.97 -35.61 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.483 ' CD2' ' OD1' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -118.47 130.38 24.81 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.992 . . . . 0.0 110.609 -179.888 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.45 -42.09 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.949 1.499 . . . . 0.0 110.376 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.455 ' HA2' HD12 ' B' ' 172' ' ' LEU . . . -89.69 -179.55 44.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' B' ' 206' ' ' ILE . 0.9 OUTLIER -96.46 147.49 23.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -1.156 . . . . 0.0 110.297 -179.92 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.478 HG22 ' CD1' ' A' ' 62' ' ' LEU . 63.4 mt -109.82 104.93 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -97.58 128.66 44.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.474 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' B' ' 203' ' ' VAL . 12.2 ttt-85 -110.92 80.74 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.456 ' N ' ' O ' ' B' ' 202' ' ' ILE . 37.1 tpp -45.81 134.59 7.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 75.3 t -88.17 -34.72 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.359 -0.838 . . . . 0.0 109.975 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' B' ' 199' ' ' LYS . 0.1 OUTLIER -143.58 108.34 5.17 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 110.049 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.44 169.46 69.37 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.94 -2.109 . . . . 0.0 110.786 0.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.448 ' O ' HD11 ' B' ' 202' ' ' ILE . 5.6 mtmp? -75.22 81.56 2.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.34 -0.85 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 10.4 mm -130.41 148.22 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' B' ' 196' ' ' ARG . 10.5 t -108.42 137.46 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.019 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.581 ' N ' ' CD1' ' B' ' 204' ' ' LEU . 3.6 mp -131.51 151.82 51.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.925 . . . . 0.0 110.571 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.528 ' CD1' HD23 ' A' ' 52' ' ' LEU . 25.1 mt -110.13 144.9 38.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.473 179.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' B' ' 193' ' ' LEU . 11.8 mm -127.81 104.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.989 -1.07 . . . . 0.0 110.302 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' B' ' 209' ' ' SER . 66.8 m-85 -91.05 133.99 34.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 36.1 t -42.24 -26.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 110.416 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.439 ' N ' ' O ' ' B' ' 207' ' ' PHE . 0.0 OUTLIER -59.34 -38.63 80.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' B' ' 165' ' ' ASP . . . 121.35 15.86 4.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 124.98 41.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.031 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.453 HD13 HD11 ' B' ' 206' ' ' ILE . 21.1 mm -108.89 125.6 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.538 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 17.1 t -105.77 159.4 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.395 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.508 ' CD2' HD22 ' B' ' 204' ' ' LEU . 4.1 mp -143.05 146.17 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.428 HG21 ' O ' ' B' ' 215' ' ' THR . 5.5 t -169.8 145.09 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 110.18 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.62 10.74 26.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -91.3 158.74 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -1.198 . . . . 0.0 110.227 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -103.39 -23.75 13.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.471 ' N ' ' HG2' ' B' ' 218' ' ' LYS . 0.0 OUTLIER -137.65 179.35 6.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . 0.438 ' HG3' ' CE1' ' B' ' 224' ' ' TYR . 1.6 ttt180 -75.88 -27.75 57.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.363 -0.836 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -61.05 -41.17 96.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.496 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -61.43 -52.16 65.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 0.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.459 HD12 ' O ' ' B' ' 160' ' ' ILE . 22.6 mm -58.05 -43.8 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.438 ' CE1' ' HG3' ' B' ' 220' ' ' ARG . 10.5 m-85 -70.98 -34.16 71.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.204 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 3.4 tp60 -80.48 -44.16 19.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 110.047 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.14 -38.42 68.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.471 ' O ' HG21 ' B' ' 230' ' ' ILE . 15.7 t80 -68.92 -52.72 26.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.995 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -54.29 -24.21 18.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.783 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.81 -30.82 45.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 110.039 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.471 HG21 ' O ' ' B' ' 227' ' ' PHE . 6.0 tp -93.38 -17.37 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.891 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.72 -47.88 60.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 111.015 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.77 -40.44 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.593 1.312 . . . . 0.0 110.612 -179.404 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 40.8 t -58.52 -42.32 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.907 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.439 ' CD2' HG22 ' B' ' 206' ' ' ILE . 77.5 mt -66.67 -40.22 88.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.34 -25.4 63.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.36 -27.15 59.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 59.9 m-85 -117.16 42.74 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.508 ' HG2' ' CD1' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -68.16 -172.01 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -35.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.142 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 240' ' ' MET . . . . . 0.407 ' HG3' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.141 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.622 HD21 ' CD2' ' B' ' 99' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.537 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 12.0 t0 -101.04 118.38 36.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.919 -1.113 . . . . 0.0 111.117 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.601 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 6.6 mt -113.78 12.79 18.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 110.641 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.458 ' OG1' HD21 ' A' ' 68' ' ' LEU . 3.1 m -42.43 -27.74 0.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 110.187 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.482 ' CA ' HD13 ' A' ' 34' ' ' LEU . . . -91.36 -30.2 11.2 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.604 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 16.3 mm -50.65 -53.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.295 . . . . 0.0 108.771 -179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.499 ' HB2' ' ND2' ' B' ' 159' ' ' ASN . 1.1 pp -78.97 5.7 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.468 -0.77 . . . . 0.0 110.004 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CD1' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -107.99 -17.61 14.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.177 -0.952 . . . . 0.0 111.14 -179.516 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 151.79 48.74 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.252 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.535 ' HB3' ' HG ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER 63.86 139.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.012 -1.287 . . . . 0.0 111.275 178.524 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -170.35 157.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 68.1 m-20 -90.08 122.52 33.13 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 177.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.515 ' HB2' HD23 ' A' ' 18' ' ' LEU . 1.5 p -39.8 -26.67 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.727 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.1 tt0 -57.48 -13.53 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.447 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.92 26.3 5.58 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.98 117.43 26.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.076 -1.249 . . . . 0.0 109.814 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.636 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 2.8 tt -88.36 156.9 18.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.778 -1.201 . . . . 0.0 110.244 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' A' ' 27' ' ' ASN . 4.2 pp . . . . . 0 N--CA 1.491 1.622 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.043 -179.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.113 0.482 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.01 -25.5 14.04 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.57 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 2.7 mt -92.54 -42.28 9.78 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.552 -0.718 . . . . 0.0 110.139 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.66 -51.22 16.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 0.0 109.609 -179.627 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -66.53 -13.83 61.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.825 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 52' ' ' LEU . 9.7 m-80 -96.23 -40.19 9.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.825 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 53' ' ' ARG . 1.2 mp -51.42 -40.65 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.399 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.39 -14.54 49.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 p -134.53 18.11 3.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 110.39 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 6.7 mt -98.04 16.27 21.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.2 m -90.95 42.97 1.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 110.433 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -151.78 -30.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -0.971 . . . . 0.0 110.954 179.854 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.554 HD11 ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -74.37 6.15 3.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.977 -1.077 . . . . 0.0 111.271 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.554 ' N ' HD11 ' A' ' 62' ' ' LEU . . . 144.03 -46.92 0.8 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.484 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.6 mm? -52.0 -18.15 1.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 110.678 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 66' ' ' SER . 2.7 p30 -43.0 -39.65 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 10.9 m -67.67 -55.92 11.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.387 -0.821 . . . . 0.0 109.976 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.446 ' HG2' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.52 -6.6 26.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.602 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.458 HD21 ' OG1' ' A' ' 21' ' ' THR . 1.2 tm? -71.02 -62.89 1.23 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.179 0.99 . . . . 0.0 108.848 179.301 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.48 1.69 13.46 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.164 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 66' ' ' SER . 15.4 tt0 -91.24 11.36 23.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 111.696 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 3.2 t -138.4 0.42 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.601 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.0 tp -152.0 74.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 110.233 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 56.9 t0 -79.74 56.65 2.32 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.923 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 5.8 mt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.719 0.771 . . . . 0.0 110.716 -179.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' B' ' 64' ' ' VAL . 2.0 mp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.152 0.501 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' B' ' 63' ' ' ILE . 14.5 t 60.54 126.93 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.301 -0.874 . . . . 0.0 110.057 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 44.2 Cg_endo -70.95 150.31 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.85 1.447 . . . . 0.0 110.484 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' B' ' 68' ' ' GLN . 18.1 m -122.04 128.02 50.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.447 HD13 ' HG3' ' B' ' 220' ' ' ARG . 21.7 mt -70.29 117.53 11.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 110.211 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.457 ' O ' ' OD1' ' B' ' 69' ' ' ASN . 19.8 mm-40 -112.35 -13.63 13.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.351 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.521 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 4.5 m120 -153.53 158.03 40.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.497 ' N ' ' O ' ' B' ' 126' ' ' ALA . 8.4 mt -154.96 169.2 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.987 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 27.0 t -139.23 130.48 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.94 143.96 50.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 94.7 m -93.62 128.93 40.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.89 . . . . 0.0 110.355 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.63 146.07 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.2 m -125.49 145.68 49.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.513 ' CD1' HD12 ' B' ' 80' ' ' LEU . 91.8 mt -97.08 -41.85 8.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.11 54.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 7.3 t -148.43 153.87 39.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -1.181 . . . . 0.0 110.335 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -77.52 149.21 34.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.097 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.513 HD12 ' CD1' ' B' ' 76' ' ' LEU . 68.9 mt -124.69 155.66 38.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -0.97 . . . . 0.0 110.505 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' B' ' 82' ' ' LEU . 4.9 m-20 -92.69 83.64 4.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 109.455 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.502 ' HB3' ' CE1' ' B' ' 94' ' ' TYR . 94.6 mt -40.1 -35.6 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.723 . . . . 0.0 110.536 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -50.12 73.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 110.008 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -77.47 -43.28 32.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.573 HG21 ' CE2' ' B' ' 148' ' ' PHE . 85.2 t -50.38 -43.96 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.142 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.96 -21.72 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 tp -86.2 -37.22 18.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -87.74 -24.95 23.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.478 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' B' ' 85' ' ' VAL . . . -70.63 136.34 49.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.145 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -24.08 58.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 9.6 t-20 -135.63 79.45 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.096 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' B' ' 89' ' ' ALA . . . -137.85 149.97 46.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -0.859 . . . . 0.0 109.955 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -125.78 119.36 27.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.341 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.502 ' CE1' ' HB3' ' B' ' 82' ' ' LEU . 8.1 t80 -114.37 118.96 35.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 109.929 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -129.05 110.22 18.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.277 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.47 -22.1 18.85 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.969 1.51 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -17.94 56.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -102.02 -45.34 5.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.622 ' CD2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -170.54 -162.42 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.913 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.414 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -122.12 54.86 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 111.043 -179.357 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.61 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -143.14 172.16 13.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 110.095 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.494 ' CG2' HD21 ' B' ' 82' ' ' LEU . 42.1 t -114.56 123.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.36 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.496 ' CD1' HD12 ' B' ' 114' ' ' LEU . 15.2 mm -93.67 108.6 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.979 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 104' ' ' MET . . . . . 0.56 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 1.4 ttm -89.81 146.54 24.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.417 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 3.8 ttt85 -135.63 118.66 16.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.439 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.485 ' CG2' ' CE1' ' B' ' 139' ' ' TYR . 18.2 pt -114.71 165.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.934 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.7 ptm180 -110.59 22.9 14.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.389 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.51 ' O ' ' NZ ' ' B' ' 138' ' ' LYS . 2.4 tt0 -176.9 94.74 0.24 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.267 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.1 Cg_endo -76.73 143.93 77.33 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.477 -0.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.12 108.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.0 109.926 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.449 HG21 ' HA3' ' B' ' 125' ' ' GLY . 0.7 OUTLIER -161.76 -179.14 6.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.753 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.449 HG21 ' N ' ' B' ' 113' ' ' ALA . 1.3 m -126.54 158.74 35.4 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.564 ' HB1' ' CZ ' ' B' ' 139' ' ' TYR . . . -132.82 124.98 29.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 111.103 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.509 ' HB3' ' CZ ' ' B' ' 116' ' ' PHE . 3.9 mm? -92.24 89.83 7.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.489 HG12 ' CG ' ' B' ' 121' ' ' MET . 41.1 mt -90.28 128.61 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.168 -178.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.56 ' CE1' HD13 ' A' ' 72' ' ' ILE . 4.0 m-30 -110.19 144.75 38.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 109.593 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -54.36 -19.88 6.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 110.408 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -7.18 37.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.55 -25.93 26.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -56.23 173.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -1.206 . . . . 0.0 110.082 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.489 ' CG ' HG12 ' B' ' 115' ' ' ILE . 3.2 tmm? -169.05 119.89 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.521 HG12 ' CG1' ' A' ' 71' ' ' VAL . 3.8 t -109.4 138.98 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.378 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.42 124.01 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 110.766 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.484 ' C ' ' ND2' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -117.44 170.63 8.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 109.801 179.656 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.449 ' HA3' HG21 ' B' ' 111' ' ' THR . . . 102.81 -35.67 4.83 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -50.04 157.09 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -1.187 . . . . 0.0 110.387 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -121.76 -25.39 5.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 164.82 27.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.88 -63.01 1.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.189 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -45.44 -37.48 5.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -70.4 -42.02 72.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.159 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -55.48 -40.64 71.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . 0.474 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -69.1 -49.05 60.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.328 -179.918 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.44 ' HB3' ' HG3' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -55.0 -51.66 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 110.168 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.3 -47.55 65.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.218 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -69.31 -47.24 65.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.07 -42.36 65.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.391 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -63.73 -36.73 84.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.564 ' CZ ' ' HB1' ' B' ' 113' ' ' ALA . 13.4 m-85 -72.01 -56.95 4.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.61 -22.95 0.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.766 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . 0.452 ' HD3' ' HD3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -73.58 -50.53 20.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 110.073 179.803 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 46.4 mt -50.75 -38.83 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.466 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 38.8 mm -72.54 -58.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 110.039 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 56.7 mt-30 -61.39 -27.63 68.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 109.961 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.452 ' HD3' ' HD3' ' B' ' 141' ' ' ARG . 27.5 ttpt -75.39 -23.45 57.08 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.179 -0.95 . . . . 0.0 108.504 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.6 mt -83.79 -21.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.87 -16.23 7.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.573 ' CE2' HG21 ' B' ' 85' ' ' VAL . 14.9 m-85 -54.4 172.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.077 -1.249 . . . . 0.0 110.865 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.27 32.06 5.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.631 -0.668 . . . . 0.0 109.747 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' B' ' 76' ' ' LEU . . . -77.16 144.24 38.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 110.504 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.18 51.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -71.94 97.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.172 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 176.24 9.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.56 33.98 23.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.659 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . 0.474 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.0 t80 -76.16 127.91 33.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 109.927 179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -161.43 129.64 4.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.123 -0.985 . . . . 0.0 110.709 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 20.3 mt -87.65 131.0 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.73 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . 0.432 ' HA ' ' HG2' ' B' ' 218' ' ' LYS . 4.5 mt-30 -135.31 0.56 2.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.046 -1.034 . . . . 0.0 110.95 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.515 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.2 OUTLIER -142.53 96.85 3.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.01 -1.056 . . . . 0.0 110.932 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.477 HD13 ' CA ' ' B' ' 219' ' ' GLN . 75.4 mt -98.71 153.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 15.8 t -134.15 131.12 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.031 . . . . 0.0 110.571 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.43 175.7 18.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.14 148.63 8.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -1.21 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.3 p -169.45 170.71 8.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . 0.452 ' OD1' ' HA ' ' B' ' 211' ' ' LYS . 6.2 m-20 -116.29 155.77 27.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.294 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' B' ' 168' ' ' PHE . 10.2 m -103.87 11.5 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.9 OUTLIER 71.89 3.46 4.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.368 -0.832 . . . . 0.0 110.789 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.56 ' CD1' HG22 ' B' ' 166' ' ' VAL . 8.3 p90 -162.02 156.04 18.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 110.495 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.472 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 45.3 Cg_endo -74.24 161.87 39.74 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.103 1.581 . . . . 0.0 110.357 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.528 HG21 ' N ' ' B' ' 171' ' ' ARG . 3.0 mt -127.07 148.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.528 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.4 OUTLIER -86.38 104.6 16.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 179.55 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.483 HD21 ' CB ' ' B' ' 193' ' ' LEU . 26.9 mt -61.7 -48.51 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.44 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.69 -51.45 69.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.599 -179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.8 -51.08 55.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' B' ' 237' ' ' PHE . 8.0 tp -68.4 -36.25 78.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -1.141 . . . . 0.0 110.676 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -61.11 -30.65 70.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 7.0 t80 -76.93 -44.59 30.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.6 t -68.73 -48.94 62.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.273 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . 0.401 ' ND1' ' OH ' ' B' ' 195' ' ' TYR . 54.8 m170 -110.87 37.44 2.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -54.14 -34.32 52.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -15.92 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.191 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -111.32 -0.75 16.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.888 . . . . 0.0 110.283 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' B' ' 195' ' ' TYR . 1.1 p -140.86 168.92 18.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 110.429 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 69.1 m -139.95 130.64 25.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.032 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -132.75 120.31 21.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.128 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 190' ' ' PHE . 99.2 mt-10 -121.19 100.71 45.13 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.46 -0.71 9.15 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.932 1.49 . . . . 0.0 110.4 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.82 -18.62 17.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.151 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' B' ' 189' ' ' LEU . 2.6 tt -147.34 9.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.604 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.466 ' CZ ' HD13 ' B' ' 205' ' ' LEU . 19.0 t80 -167.97 107.63 0.57 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.874 -1.141 . . . . 0.0 110.421 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.79 -15.77 23.82 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.916 1.482 . . . . 0.0 110.165 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.61 44.13 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.483 ' CB ' HD21 ' B' ' 172' ' ' LEU . 7.3 tt -124.53 134.29 53.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -1.169 . . . . 0.0 110.433 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . 0.412 HG22 HD22 ' A' ' 62' ' ' LEU . 3.3 mt -104.74 113.85 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 109.886 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.538 ' CD2' HD12 ' B' ' 230' ' ' ILE . 4.5 t80 -93.32 127.06 38.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.442 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . 0.415 ' NH2' ' HA3' ' A' ' 63' ' ' GLY . 65.0 mtt180 -99.12 103.15 15.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.108 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 197' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 47.4 tpp -75.97 131.1 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.096 -1.003 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.51 -32.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.587 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -147.39 108.26 3.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.47 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.9 172.32 62.09 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.96 -2.1 . . . . 0.0 110.328 -0.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.5 OUTLIER -78.2 81.47 4.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.004 179.835 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.528 HG22 HD13 ' B' ' 202' ' ' ILE . 35.3 mm -126.04 154.01 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.29 111.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 110.295 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.461 HD22 ' CB ' ' B' ' 226' ' ' ALA . 4.9 mp -99.71 133.13 44.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.927 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.466 HD13 ' CZ ' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -93.69 147.31 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . 0.413 ' O ' HD23 ' B' ' 172' ' ' LEU . 5.1 mt -137.86 120.14 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -110.72 150.11 29.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 93.2 t -52.16 -27.14 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.382 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -37.44 84.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 110.253 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . 0.461 ' HA2' HD13 ' B' ' 170' ' ' ILE . . . 119.81 1.92 13.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . 0.452 ' HA ' ' OD1' ' B' ' 165' ' ' ASP . 11.2 tttm -81.21 140.48 34.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 110.049 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . 0.406 ' HA ' HD11 ' B' ' 212' ' ' ILE . 22.0 mm -123.13 132.38 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.405 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 2.3 t -120.04 148.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.24 -0.912 . . . . 0.0 109.694 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.0 mp -135.17 127.76 30.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.077 -1.014 . . . . 0.0 110.654 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 215' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 3.4 t -150.42 174.46 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.58 -0.42 77.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.516 ' CB ' HD13 ' B' ' 202' ' ' ILE . . . -94.24 142.54 27.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 110.183 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' B' ' 158' ' ' GLN . 3.2 mttm -87.27 -25.34 24.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.477 ' CA ' HD13 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -127.41 168.45 14.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . 0.447 ' HG3' HD13 ' B' ' 67' ' ' LEU . 2.2 ttt180 -73.93 -27.53 61.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.331 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -57.37 -42.53 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.45 -46.81 87.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 109.871 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' B' ' 224' ' ' TYR . 0.9 OUTLIER -56.49 -56.96 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -0.821 . . . . 0.0 109.42 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . 0.566 ' N ' ' CG2' ' B' ' 223' ' ' ILE . 1.1 m-85 -53.09 -33.61 52.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 110.273 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -79.03 -40.69 30.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.005 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . 0.461 ' CB ' HD22 ' B' ' 204' ' ' LEU . . . -58.77 -42.59 89.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.462 ' O ' HG21 ' B' ' 230' ' ' ILE . 79.4 t80 -68.51 -55.98 9.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.05 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.21 -29.87 10.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.886 . . . . 0.0 110.064 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' B' ' 232' ' ' PRO . . . -81.49 -36.0 29.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 110.165 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.538 HD12 ' CD2' ' B' ' 195' ' ' TYR . 3.6 tp -88.14 -13.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 110.025 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.58 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 64.3 t80 -59.63 -43.21 95.12 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.852 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -75.9 -23.37 12.43 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.396 1.209 . . . . 0.0 110.24 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.476 ' CG1' HD12 ' B' ' 175' ' ' LEU . 37.7 t -72.59 -40.89 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . 0.457 ' HB3' HG12 ' B' ' 170' ' ' ILE . 35.8 mt -67.0 -50.25 62.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -33.13 65.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 110.357 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.24 -40.89 90.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . 0.527 ' CD2' HD11 ' B' ' 175' ' ' LEU . 51.7 m-85 -113.72 38.81 2.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.17 -0.956 . . . . 0.0 110.194 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -179.99 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.472 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 4.3 tptt -116.87 -35.45 4.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.223 179.897 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.523 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -82.56 63.18 6.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 0.0 111.917 -178.628 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -83.9 -3.16 57.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.964 -1.085 . . . . 0.0 109.604 178.627 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.51 ' N ' HD21 ' A' ' 68' ' ' LEU . 3.4 m -52.95 -21.55 4.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.281 -0.887 . . . . 0.0 109.638 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -97.23 -37.9 4.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.615 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -46.09 -46.33 5.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.22 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' CD1' ' HG2' ' A' ' 67' ' ' MET . 0.9 OUTLIER -79.5 -19.48 49.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.144 -0.972 . . . . 0.0 108.944 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -85.94 -17.44 35.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.395 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 158.34 93.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.066 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.574 ' CB ' ' HG ' ' A' ' 35' ' ' LEU . 4.5 t-20 2.53 112.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.001 0.905 . . . . 0.0 113.043 178.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.693 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -138.41 159.66 31.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.799 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 28' ' ' ILE . 39.5 m-20 -86.76 125.99 34.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.581 ' OG ' ' CZ ' ' B' ' 99' ' ' PHE . 3.0 p -37.99 -28.03 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.433 0.635 . . . . 0.0 109.895 -178.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 29' ' ' ASP . 8.7 tt0 -57.04 -13.43 2.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.449 178.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.56 34.5 3.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.08 129.65 53.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -1.131 . . . . 0.0 110.069 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.693 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 5.6 tt -89.02 155.37 19.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 111.067 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.574 ' HG ' ' CB ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 122.073 0.939 . . . . 0.0 111.304 -179.112 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.209 0.528 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -101.19 -26.34 13.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.079 -1.013 . . . . 0.0 110.141 -179.969 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.504 HD12 ' CE1' ' A' ' 25' ' ' PHE . 5.2 mt -105.31 -44.99 4.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 110.898 -179.352 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -51.76 -55.53 19.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.1 pp20? -65.82 -15.45 62.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.635 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 3.9 m-20 -87.61 -39.57 14.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.508 -0.745 . . . . 0.0 109.28 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.499 ' HA ' ' CD1' ' A' ' 59' ' ' LEU . 7.0 mt -52.26 -43.65 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.481 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.76 13.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -126.52 7.84 6.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -1.153 . . . . 0.0 110.669 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 56' ' ' ILE . 7.4 mt -72.02 -8.45 54.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 110.332 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -80.65 50.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.318 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -148.77 -39.62 0.16 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' B' ' 184' ' ' SER . 0.1 OUTLIER -71.24 -70.12 0.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.341 -0.849 . . . . 0.0 110.519 -179.904 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.38 -35.07 0.08 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -51.22 -20.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -1.179 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.1 t0 -44.33 -40.62 5.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.95 . . . . 0.0 109.955 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.8 OUTLIER -65.36 -48.41 73.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.525 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.89 -4.26 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.732 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.51 HD21 ' N ' ' A' ' 21' ' ' THR . 3.4 tm? -78.23 -54.91 5.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.73 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -83.64 1.34 42.81 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.46 0.648 . . . . 0.0 109.695 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 1.5 tt0 -88.31 -1.71 58.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 111.643 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.585 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.2 t -131.74 -1.04 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 118.527 -1.269 . . . . 0.0 109.688 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.584 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -151.23 67.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.504 -0.747 . . . . 0.0 110.042 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.6 58.65 0.43 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.993 -1.067 . . . . 0.0 108.622 179.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.598 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 27.9 mt . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 121.571 0.701 . . . . 0.0 110.907 -178.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.463 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.5 mt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.187 0.517 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 8.2 t 61.06 128.2 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.934 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 65' ' ' PRO . . . . . 0.458 ' HG2' HG23 ' B' ' 223' ' ' ILE . 44.1 Cg_endo -70.14 161.55 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.8 1.421 . . . . 0.0 110.556 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 66' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.4 m -121.39 133.28 55.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.888 . . . . 0.0 110.161 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.497 HD21 ' CG2' ' B' ' 160' ' ' ILE . 80.9 mt -74.6 108.38 7.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 41.6 mm-40 -89.98 -15.04 32.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 69' ' ' ASN . . . . . 0.408 ' CG ' ' O ' ' B' ' 68' ' ' GLN . 2.1 m120 -167.84 164.51 14.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' B' ' 126' ' ' ALA . 7.4 mt -154.82 164.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.435 ' N ' HG21 ' B' ' 70' ' ' ILE . 71.5 t -141.49 132.97 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.265 -0.897 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.02 154.44 39.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.77 121.76 41.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.497 HG12 ' CD1' ' B' ' 152' ' ' PHE . 66.2 t -121.63 134.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -122.79 131.25 53.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 110.16 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.52 ' CD1' HD13 ' B' ' 80' ' ' LEU . 15.0 mt -83.14 -51.27 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.88 27.4 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.0 134.73 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.266 . . . . 0.0 110.446 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -56.62 152.24 12.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.52 HD13 ' CD1' ' B' ' 76' ' ' LEU . 18.3 mt -133.65 158.63 42.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.416 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -102.05 94.01 5.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.029 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' B' ' 102' ' ' VAL . 16.0 mt -43.57 -37.53 2.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 110.341 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 83' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.5 OUTLIER -58.3 -38.88 77.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.183 -179.882 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 27.2 p -89.1 -43.08 11.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.202 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' B' ' 148' ' ' PHE . 63.2 t -56.37 -39.89 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.466 ' HB1' HG23 ' B' ' 102' ' ' VAL . . . -83.89 -26.37 29.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.399 -0.813 . . . . 0.0 109.934 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 25.9 tp -80.13 -43.83 20.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 88' ' ' HIS . . . . . 0.4 ' HB3' HG12 ' B' ' 146' ' ' ILE . 65.2 m80 -77.55 -28.81 51.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 89' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 85' ' ' VAL . . . -69.8 139.88 53.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.067 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -23.46 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 110.334 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 91' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' B' ' 105' ' ' ARG . 3.2 t-20 -134.88 79.67 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' B' ' 86' ' ' ALA . . . -141.8 152.58 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.12 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -130.75 131.54 44.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.79 103.59 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.95 104.8 52.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.67 -23.76 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.107 1.582 . . . . 0.0 110.26 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.33 60.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.547 ' HB3' ' CD1' ' B' ' 99' ' ' PHE . 4.2 tpm_? -112.66 -66.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 109.864 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 99' ' ' PHE . . . . . 0.581 ' CZ ' ' OG ' ' A' ' 30' ' ' SER . 30.5 p90 -141.55 -170.77 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 110.12 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.49 62.34 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -0.966 . . . . 0.0 110.652 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.598 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -152.02 170.4 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.083 -1.01 . . . . 0.0 110.649 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 102' ' ' VAL . . . . . 0.519 ' CG2' HD21 ' B' ' 82' ' ' LEU . 24.5 t -106.98 132.63 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.561 179.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.47 HG13 ' OG ' ' A' ' 30' ' ' SER . 12.8 mm -99.85 97.47 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.135 -0.978 . . . . 0.0 110.507 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 23.4 ttm -90.01 158.68 17.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.953 . . . . 0.0 109.824 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.438 ' HA ' ' OH ' ' B' ' 139' ' ' TYR . 0.1 OUTLIER -157.3 155.84 31.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.753 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 3.9 pt -136.09 162.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 107' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -102.0 25.11 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 110.083 179.973 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 3.6 tt0 -177.97 90.01 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.95 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 109' ' ' PRO . . . . . 0.449 ' HG2' ' HB3' ' B' ' 135' ' ' ALA . 50.8 Cg_endo -83.11 155.5 73.97 Favored 'Cis proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.181 -2.008 . . . . 0.0 110.345 -0.097 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 5.3 ttmt -61.34 104.01 0.36 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.057 -1.027 . . . . 0.0 109.619 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 111' ' ' THR . . . . . 0.413 HG21 ' O ' ' B' ' 110' ' ' LYS . 29.3 p -144.89 179.49 7.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.754 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -138.64 128.97 25.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.556 -0.715 . . . . 0.0 109.228 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 113' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' B' ' 139' ' ' TYR . . . -106.0 123.69 48.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 111.063 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 114' ' ' LEU . . . . . 0.484 HD13 HD11 ' A' ' 72' ' ' ILE . 4.2 mm? -89.58 92.55 9.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 115' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' B' ' 101' ' ' ALA . 10.5 mt -92.66 127.11 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.162 -0.961 . . . . 0.0 111.33 -178.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 116' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 2.8 m-85 -100.77 160.26 14.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 109.649 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.4 2.52 21.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.996 -1.065 . . . . 0.0 110.111 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.3 t -90.58 -21.71 21.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.97 -33.9 3.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -63.48 172.14 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 109.901 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 121' ' ' MET . . . . . 0.453 ' N ' ' O ' ' B' ' 74' ' ' VAL . 2.5 ttm -164.63 149.65 9.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.587 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . 0.488 HG13 HG11 ' A' ' 71' ' ' VAL . 1.2 t -125.4 145.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.183 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.2 t -129.81 100.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.038 . . . . 0.0 111.029 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 124' ' ' THR . . . . . 0.526 ' CG2' HG22 ' A' ' 23' ' ' ILE . 1.2 t -99.62 165.28 11.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 108.908 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 125' ' ' GLY . . . . . 0.522 ' HA2' ' HB2' ' A' ' 27' ' ' ASN . . . 101.92 -3.51 52.35 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 126' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' B' ' 70' ' ' ILE . . . -73.22 133.79 44.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.262 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.42 -6.65 27.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 110.438 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 128' ' ' SER . . . . . 0.409 ' HB2' ' CG ' ' B' ' 131' ' ' ASP . 0.4 OUTLIER -160.25 -168.2 2.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 0.0 110.367 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.5 -56.03 4.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.187 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 130' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 7.9 m-20 -63.82 -22.45 66.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.878 . . . . 0.0 110.389 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' B' ' 128' ' ' SER . 5.0 m-20 -68.18 -48.8 64.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.99 . . . . 0.0 110.313 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -36.59 83.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.217 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -58.7 -42.16 87.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.56 -50.78 11.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.449 ' HB3' ' HG2' ' B' ' 109' ' ' PRO . . . -54.13 -50.49 66.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 136' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' B' ' 137' ' ' ARG . 20.6 p -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.771 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 137' ' ' ARG . . . . . 0.424 ' N ' ' OG ' ' B' ' 136' ' ' SER . 5.4 mtp180 -48.25 -43.23 32.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.363 -0.836 . . . . 0.0 109.95 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -57.25 -45.69 83.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.842 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 139' ' ' TYR . . . . . 0.462 ' CZ ' ' HB1' ' B' ' 113' ' ' ALA . 11.8 m-85 -57.03 -53.23 60.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.77 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.55 -20.14 64.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.85 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -31.96 58.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' B' ' 139' ' ' TYR . 6.3 mt -70.29 -41.36 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 33.7 mt -68.31 -42.27 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -68.4 -33.98 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -71.47 -22.37 61.82 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' B' ' 88' ' ' HIS . 1.3 mt -81.21 -20.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 122.51 -32.15 4.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 148' ' ' PHE . . . . . 0.581 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 7.7 m-85 -40.85 150.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.132 . . . . 0.0 110.964 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.39 28.68 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.525 -0.734 . . . . 0.0 109.859 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.412 ' HB3' ' CD2' ' B' ' 76' ' ' LEU . . . -67.14 148.69 51.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.512 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . 0.447 ' O ' ' OG1' ' B' ' 153' ' ' THR . 0.0 OUTLIER -136.73 117.86 14.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 152' ' ' PHE . . . . . 0.497 ' CD1' HG12 ' B' ' 74' ' ' VAL . 61.7 t80 -56.02 100.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.179 -0.951 . . . . 0.0 110.087 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.2 OUTLIER -144.19 166.17 25.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.63 35.33 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 110.435 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -78.36 130.86 36.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -165.75 129.19 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 110.607 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 40.5 mt -79.51 129.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.598 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -125.56 -13.17 6.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.056 -1.028 . . . . 0.0 110.933 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 159' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 24' ' ' LEU . 2.2 t30 -139.27 98.02 3.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.878 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 160' ' ' ILE . . . . . 0.497 ' CG2' HD21 ' B' ' 67' ' ' LEU . 53.1 mt -97.47 134.08 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.518 179.192 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 5.9 t -101.71 133.96 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.665 -179.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 162' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -148.47 163.21 28.97 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 43.2 p -167.56 159.79 12.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 164' ' ' CYS . . . . . 0.427 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 11.0 p -168.51 158.44 9.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.7 130.97 54.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 210' ' ' GLY . 35.1 m -105.25 12.21 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.181 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 48.79 41.59 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.969 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 168' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' B' ' 238' ' ' ARG . 0.1 OUTLIER -136.55 115.6 10.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 110.206 -179.953 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 169' ' ' PRO . . . . . 0.474 ' HB2' ' CB ' ' B' ' 239' ' ' LYS . 46.4 Cg_endo -72.28 140.21 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.904 1.476 . . . . 0.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . 0.501 ' CD1' ' HA2' ' B' ' 210' ' ' GLY . 2.8 mp -130.17 151.43 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.616 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 171' ' ' ARG . . . . . 0.413 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.4 OUTLIER -85.5 88.32 7.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.803 179.715 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' B' ' 185' ' ' TYR . 68.9 mt -51.01 -23.69 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -55.37 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.202 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.63 -46.56 74.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.416 ' O ' HD11 ' B' ' 175' ' ' LEU . 10.3 tp -62.92 -36.95 85.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -1.155 . . . . 0.0 110.446 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 176' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' B' ' 172' ' ' LEU . . . -66.51 -19.87 65.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.277 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -93.84 -35.27 12.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 p -81.36 -26.71 35.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.046 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -122.83 12.82 9.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -0.853 . . . . 0.0 110.041 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.09 -36.59 5.3 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -26.1 65.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -1.144 . . . . 0.0 110.499 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -122.48 -18.89 6.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 110.344 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' B' ' 195' ' ' TYR . 57.8 m -115.83 165.61 12.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.432 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 184' ' ' SER . . . . . 0.415 ' HB2' HD22 ' A' ' 62' ' ' LEU . 2.5 p -141.46 143.2 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.403 -0.811 . . . . 0.0 109.987 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 185' ' ' TYR . . . . . 0.533 ' CD1' ' HB3' ' B' ' 172' ' ' LEU . 78.4 t80 -133.15 94.54 3.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 186' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' B' ' 190' ' ' PHE . 27.4 mt-10 -100.59 102.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.763 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.5 -6.94 20.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.687 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.75 -13.99 18.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 189' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' B' ' 189' ' ' LEU . 2.4 tt -137.03 3.64 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 190' ' ' PHE . . . . . 0.45 ' HB2' HD22 ' B' ' 189' ' ' LEU . 1.4 t80 -169.73 113.4 0.49 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.211 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -19.66 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.923 1.486 . . . . 0.0 110.176 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 192' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -99.64 176.6 28.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 193' ' ' LEU . . . . . 0.456 ' CB ' HD21 ' B' ' 172' ' ' LEU . 5.7 tt -110.69 132.97 53.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 194' ' ' ILE . . . . . . . . . . . . . 6.8 mt -93.69 106.6 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.302 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 195' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' B' ' 183' ' ' SER . 3.9 t80 -101.33 107.48 18.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.12 99.72 12.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 110.103 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 41.5 ttm -70.31 145.05 51.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.266 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.66 -39.14 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 199' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 199' ' ' LYS . 1.0 OUTLIER -139.7 114.72 8.0 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.91 179.976 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 200' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -72.2 167.32 77.39 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.946 -2.106 . . . . 0.0 110.639 0.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -76.27 93.58 3.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 202' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' B' ' 217' ' ' ALA . 4.5 mt -146.21 165.91 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.914 . . . . 0.0 110.342 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.457 ' N ' ' CG2' ' B' ' 202' ' ' ILE . 26.0 t -111.09 119.32 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.43 -0.793 . . . . 0.0 109.661 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.0 mp -106.37 117.95 35.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.511 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 3.4 mt -97.18 119.9 36.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 17.9 mm -98.5 141.22 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.381 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.43 144.98 47.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.035 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 75.5 t -51.66 -24.72 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.291 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.9 t -78.16 -19.37 54.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.096 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . 0.501 ' HA2' ' CD1' ' B' ' 170' ' ' ILE . . . 108.68 5.82 31.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.24 137.71 45.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 109.951 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 17.2 mm -125.37 131.55 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.557 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 21.8 t -114.3 150.28 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.821 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . 0.443 HD11 ' N ' ' B' ' 214' ' ' LEU . 4.2 mp -141.81 111.69 6.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 110.381 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 15.2 t -134.12 151.61 51.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.125 -0.984 . . . . 0.0 110.155 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.54 -5.4 48.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 217' ' ' ALA . . . . . 0.531 ' CB ' HD13 ' B' ' 202' ' ' ILE . . . -64.71 172.94 2.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -1.143 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -116.57 -16.44 10.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 219' ' ' GLN . . . . . 0.444 ' N ' HD13 ' B' ' 160' ' ' ILE . 1.6 tt0 -167.42 163.14 14.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -51.85 -21.9 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.303 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -68.75 -35.93 77.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.45 ' HB3' HD13 ' B' ' 202' ' ' ILE . 3.2 mp0 -72.54 -53.63 11.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 110.322 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.458 HG23 ' HG2' ' B' ' 65' ' ' PRO . 32.8 mm -50.53 -44.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.63 -34.71 77.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -36.31 59.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.88 -35.7 71.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.298 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 227' ' ' PHE . . . . . 0.464 ' O ' HG21 ' B' ' 230' ' ' ILE . 20.7 t80 -80.85 -46.3 15.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -58.71 -27.61 65.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -83.05 -36.78 24.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.464 HG21 ' O ' ' B' ' 227' ' ' PHE . 0.8 OUTLIER -89.65 -11.94 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.916 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 231' ' ' TYR . . . . . 0.553 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -43.14 -50.53 14.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.799 . . . . 0.0 110.783 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 232' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.8 Cg_endo -73.27 -44.35 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.599 1.316 . . . . 0.0 110.624 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.65 -30.62 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 109.986 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 9.8 mt -77.09 -47.67 19.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.187 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -21.15 63.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 236' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.2 OUTLIER -70.61 -54.3 12.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.83 . . . . 0.0 110.011 179.838 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.99 34.42 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.424 ' HB2' ' CE1' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -64.43 -178.23 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.516 -0.74 . . . . 0.0 110.571 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 239' ' ' LYS . . . . . 0.474 ' CB ' ' HB2' ' B' ' 169' ' ' PRO . 1.2 tttp -114.92 -33.74 5.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.139 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 15.7 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.262 -179.834 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.256 0.55 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.51 -163.44 22.5 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.2 t -118.54 163.33 16.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -1.159 . . . . 0.0 110.096 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mt -106.0 115.76 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.73 85.17 1.6 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.485 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 2.2 m120 -80.41 155.09 27.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.32 -1.106 . . . . 0.0 110.228 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.59 162.88 11.68 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.585 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -108.05 170.01 8.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -1.146 . . . . 0.0 109.756 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.61 93.08 9.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 111.233 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.585 ' CD2' ' CD2' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -99.79 23.14 10.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.587 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 3.4 m -52.22 -31.47 32.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.919 -1.113 . . . . 0.0 109.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.493 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -91.9 -26.4 19.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.616 HG12 ' CG1' ' A' ' 28' ' ' ILE . 1.8 mm -50.74 -48.8 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.332 . . . . 0.0 108.944 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.509 ' CD1' ' HG2' ' A' ' 67' ' ' MET . 0.7 OUTLIER -78.69 -10.68 59.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 0.0 110.193 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.46 ' HB2' ' HA2' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -87.99 -15.22 37.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 110.859 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 148.78 81.78 0.04 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.116 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.574 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 33.04 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.067 0.937 . . . . 0.0 112.719 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.616 ' CG1' HG12 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -139.78 165.02 22.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.767 -1.208 . . . . 0.0 109.765 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' GLU . 69.8 m-20 -88.71 126.63 35.41 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.523 ' HB2' HD23 ' A' ' 18' ' ' LEU . 60.0 p -37.74 -28.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.113 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' ASP . 31.0 mt-10 -57.59 -12.7 2.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 110.447 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 13.88 17.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -96.33 115.5 27.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -1.149 . . . . 0.0 109.515 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -89.05 138.72 31.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 109.431 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.59 ' N ' ' CD2' ' A' ' 34' ' ' LEU . 0.9 OUTLIER -131.72 -178.96 5.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.897 -1.127 . . . . 0.0 111.506 -179.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -136.17 122.5 20.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.66 . . . . 0.0 109.864 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 36' ' ' GLN . 1.3 t70 -41.68 -37.07 1.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.309 -0.869 . . . . 0.0 110.425 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -98.98 170.11 8.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 110.078 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -119.02 151.43 38.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.98 122.95 2.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -106.4 27.06 9.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -1.173 . . . . 0.0 110.354 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.14 170.56 14.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 7.6 ttm180 -86.57 11.34 12.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -1.088 . . . . 0.0 110.306 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.32 106.85 0.2 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 46' ' ' THR . . . -159.84 -160.14 10.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' GLY . 3.9 t -43.48 131.55 4.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -1.147 . . . . 0.0 110.298 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.4 164.87 13.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.87 141.87 28.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -1.121 . . . . 0.0 110.246 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -62.97 -147.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -0.933 . . . . 0.0 109.841 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -99.53 31.1 3.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.15 -0.969 . . . . 0.0 110.049 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 26.8 pt-20 -100.85 -21.12 15.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.828 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.438 ' C ' HD13 ' A' ' 56' ' ' ILE . 5.1 mt -102.1 -45.04 5.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 110.694 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.29 -54.36 21.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.381 -0.824 . . . . 0.0 110.056 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -68.52 -19.86 64.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 44.6 m-20 -86.62 -37.88 17.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.53 ' CG2' HG21 ' A' ' 21' ' ' THR . 11.3 mt -52.56 -48.32 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.423 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.11 -22.02 4.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -124.53 8.97 8.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.515 HD23 ' CE1' ' B' ' 190' ' ' PHE . 12.3 mt -75.17 -2.23 26.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.047 . . . . 0.0 110.272 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.72 42.42 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -143.89 13.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.431 HD23 ' CD1' ' B' ' 194' ' ' ILE . 3.7 pp -133.32 -31.9 1.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 110.655 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -175.37 -40.11 0.05 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.479 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.7 mm? -49.84 -20.53 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -1.226 . . . . 0.0 110.531 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -46.89 -39.9 13.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 109.916 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.9 -51.0 60.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.509 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -72.37 -1.98 17.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 21' ' ' THR . 1.5 tm? -76.46 -60.56 2.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.967 0.889 . . . . 0.0 108.944 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -78.87 0.53 26.87 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.251 0.548 . . . . 0.0 109.993 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.415 ' C ' HG21 ' A' ' 71' ' ' VAL . 5.2 tt0 -88.16 8.55 26.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 111.364 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.54 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.1 t -138.19 1.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.941 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.541 HG12 ' CD2' ' A' ' 18' ' ' LEU . 4.1 tp -149.08 73.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 6.8 p-10 -75.96 55.77 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.173 -0.954 . . . . 0.0 108.843 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.537 ' CD1' ' HB1' ' B' ' 101' ' ' ALA . 6.0 mt -85.88 59.49 5.67 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.583 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' HG3' ' CB ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -139.91 37.32 1.97 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.719 -0.613 . . . . 0.0 109.985 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -141.92 24.95 1.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 110.423 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.175 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.208 0.528 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.74 63.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 35.6 mm -126.83 -55.79 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 110.015 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 5.3 t 62.11 129.28 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.58 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.47 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 49.8 Cg_endo -77.57 135.46 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 124.026 1.54 . . . . 0.0 110.253 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -97.59 137.77 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.68 135.22 45.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 110.114 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -114.64 -29.96 6.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 1.8 m120 -170.0 171.78 6.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 110.119 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.497 ' N ' ' O ' ' B' ' 126' ' ' ALA . 0.5 OUTLIER -144.6 160.6 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.081 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 20.5 t -134.96 132.37 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.851 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.29 156.21 48.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.33 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' THR . . . . . 0.456 HG21 ' N ' ' B' ' 74' ' ' VAL . 13.5 m -108.7 144.25 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.456 ' N ' HG21 ' B' ' 73' ' ' THR . 8.1 t -132.18 156.89 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 109.961 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -130.15 130.56 44.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' B' ' 80' ' ' LEU . 53.3 mt -82.31 -19.65 38.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . 0.418 ' C ' ' SG ' ' B' ' 78' ' ' CYS . . . 79.75 4.53 89.44 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . 0.418 ' SG ' ' C ' ' B' ' 77' ' ' GLY . 23.1 m -143.66 146.72 33.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -1.181 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.95 153.02 30.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.476 ' CD1' HD11 ' B' ' 76' ' ' LEU . 14.4 mt -132.42 167.62 19.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 2.8 t70 -99.88 94.77 6.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.43 HD21 HG22 ' B' ' 102' ' ' VAL . 26.2 mt -40.94 -46.15 2.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -0.837 . . . . 0.0 110.827 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -54.51 -48.84 71.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.498 HG22 ' CE1' ' B' ' 88' ' ' HIS . 20.1 m -77.57 -38.54 48.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 110.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.435 ' O ' ' HB1' ' B' ' 89' ' ' ALA . 55.3 t -54.73 -47.9 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.062 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.37 -29.56 63.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.023 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 28.5 tp -78.21 -30.16 48.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 109.987 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.498 ' CE1' HG22 ' B' ' 84' ' ' THR . 0.7 OUTLIER -91.5 -25.76 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.945 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' B' ' 85' ' ' VAL . . . -71.01 131.82 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 110.071 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 -69.53 -29.74 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -133.5 79.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -143.31 152.79 42.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -130.3 136.97 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.149 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -125.89 101.54 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 110.386 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.21 110.33 63.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.861 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.82 -15.38 26.67 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.057 1.556 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.45 -15.29 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.651 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -102.65 -43.09 5.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.081 -1.012 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.594 ' CE2' ' HB1' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -165.19 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 111.314 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.29 54.0 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.143 -0.973 . . . . 0.0 111.128 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.594 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -149.42 166.14 29.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.43 HG22 HD21 ' B' ' 82' ' ' LEU . 66.8 t -99.43 166.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.93 . . . . 0.0 109.985 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.526 ' CD1' ' HB3' ' B' ' 114' ' ' LEU . 23.1 mm -129.84 107.45 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.38 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.535 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.0 OUTLIER -89.67 164.72 14.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.009 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.71 135.24 6.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . . . . . . . . . 19.0 pt -133.58 159.48 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.795 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' B' ' 108' ' ' GLU . 1.4 ptt180 -102.62 17.65 23.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.523 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' B' ' 107' ' ' ARG . 0.5 OUTLIER -161.05 88.94 1.63 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 110.446 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.3 Cg_endo -75.88 162.37 92.4 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.35 -0.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.36 83.54 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.055 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 124' ' ' THR . 14.6 p -134.05 178.4 6.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 110.272 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.466 HG21 ' CG2' ' B' ' 124' ' ' THR . 5.2 t -131.82 159.24 39.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.428 ' HB1' ' CZ ' ' B' ' 139' ' ' TYR . . . -152.8 155.44 37.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.966 -1.084 . . . . 0.0 110.868 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.533 ' CD1' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -131.66 115.1 15.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.739 . . . . 0.0 109.611 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 10.8 mt -96.37 146.08 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.946 . . . . 0.0 110.753 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 3.5 m-30 -104.51 157.81 16.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.374 -0.829 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.91 -15.43 30.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.353 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 60.2 p -84.8 4.5 32.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.09 -28.59 7.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 3.6 ttmt -67.88 127.91 34.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -1.169 . . . . 0.0 110.116 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' B' ' 74' ' ' VAL . 0.2 OUTLIER -136.03 157.72 46.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.49 HG12 ' CG1' ' A' ' 71' ' ' VAL . 11.4 t -123.06 129.86 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.366 -0.834 . . . . 0.0 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.2 t -113.85 139.55 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.476 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 27' ' ' ASN . 10.2 t -142.6 156.83 45.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.523 ' CA ' ' HB3' ' A' ' 27' ' ' ASN . . . 123.83 -13.89 8.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -76.87 158.71 30.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.117 . . . . 0.0 110.029 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.414 ' C ' ' OG ' ' B' ' 128' ' ' SER . 25.2 mtmt -109.47 -1.15 18.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.278 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -163.89 -170.12 2.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . 0.455 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.0 OUTLIER -68.44 -60.58 2.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -55.86 -31.95 63.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -65.04 -42.1 94.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' B' ' 136' ' ' SER . 0.4 OUTLIER -79.72 -38.69 32.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . 0.423 ' CG ' ' CE2' ' B' ' 155' ' ' PHE . 10.8 mttm -53.1 -39.5 63.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.118 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.4 -47.04 29.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.421 ' HB3' ' HG2' ' B' ' 109' ' ' PRO . . . -53.97 -43.59 70.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.438 ' HB3' HG23 ' B' ' 74' ' ' VAL . 0.9 OUTLIER -62.01 -55.71 26.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -46.21 -44.8 16.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 110.082 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -57.79 -51.35 69.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.535 ' CE1' ' HB3' ' B' ' 104' ' ' MET . 22.7 m-85 -58.2 -57.63 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.463 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -50.28 -31.68 14.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.11 62.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.312 -0.868 . . . . 0.0 109.855 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.425 HD11 ' SD ' ' B' ' 104' ' ' MET . 50.5 mt -45.03 -38.86 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.478 ' CG2' ' CB ' ' B' ' 150' ' ' ALA . 41.0 mm -69.37 -52.73 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.676 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.463 ' NE2' ' O ' ' B' ' 140' ' ' ALA . 16.1 mt-30 -64.97 -28.48 69.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -75.1 -21.2 59.06 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.435 HG22 HD11 ' B' ' 146' ' ' ILE . 3.8 mt -84.29 -21.24 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.74 -22.26 5.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -64.41 179.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.312 . . . . 0.0 111.199 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -113.76 36.35 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.592 -0.692 . . . . 0.0 110.304 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.478 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . . . -60.46 148.33 37.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.97 . . . . 0.0 110.201 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -113.47 -157.97 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.227 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' B' ' 152' ' ' PHE . 1.0 OUTLIER -147.09 77.93 1.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 110.077 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -144.75 178.95 7.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' B' ' 153' ' ' THR . 15.1 t0 66.97 22.3 10.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 110.298 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.423 ' CE2' ' CG ' ' B' ' 133' ' ' LYS . 8.4 t80 -77.38 132.74 38.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -164.97 133.48 3.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.149 -0.969 . . . . 0.0 110.731 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.455 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 33.9 mt -81.2 108.37 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.721 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.09 -2.04 32.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.746 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 8.9 t-20 -152.24 120.36 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.936 -1.103 . . . . 0.0 110.983 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.495 HD13 ' N ' ' B' ' 219' ' ' GLN . 70.8 mt -114.38 137.76 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 109.428 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -106.99 135.28 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 110.798 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.78 177.08 20.77 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.1 OUTLIER -169.65 153.33 4.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.246 . . . . 0.0 110.722 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.47 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 24.6 p -169.11 165.46 11.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 109.824 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 22.4 p-10 -115.94 134.05 55.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.328 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.571 ' HB ' ' CE2' ' B' ' 168' ' ' PHE . 33.6 m -80.06 4.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 110.089 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.59 -4.51 2.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.49 -0.756 . . . . 0.0 111.138 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.571 ' CE2' ' HB ' ' B' ' 166' ' ' VAL . 22.4 p90 -145.91 153.11 49.47 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.9 -1.125 . . . . 0.0 110.532 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 44.0 Cg_endo -71.51 159.72 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.072 1.564 . . . . 0.0 110.329 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.455 HG21 ' N ' ' B' ' 171' ' ' ARG . 2.1 mp -128.38 152.93 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.514 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.455 ' N ' HG21 ' B' ' 170' ' ' ILE . 7.1 mmt180 -82.11 101.45 10.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.81 . . . . 0.0 109.998 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 18.8 mt -55.0 -42.03 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 110.512 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.92 -21.61 59.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.14 -45.52 31.27 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.518 ' HB3' ' CD1' ' B' ' 193' ' ' LEU . 0.1 OUTLIER -67.84 -36.67 80.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.88 61.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.303 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -91.12 -16.37 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' SER . . . . . 0.563 ' OG ' ' CZ ' ' B' ' 237' ' ' PHE . 0.3 OUTLIER -99.59 -33.37 10.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -120.89 37.06 4.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.42 -21.2 6.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' THR . . . . . 0.461 ' O ' ' CG ' ' B' ' 182' ' ' PHE . 16.2 p -87.53 23.47 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' B' ' 181' ' ' THR . 0.9 OUTLIER -169.82 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.282 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 13.5 p -89.98 151.07 21.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.276 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.9 m -128.69 148.73 50.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -158.1 112.6 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.55 104.02 53.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.94 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.35 -3.17 12.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.467 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.8 -7.32 30.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.464 HD21 ' HB2' ' B' ' 190' ' ' PHE . 2.5 tt -148.66 -44.02 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 110.551 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.515 ' CE1' HD23 ' A' ' 59' ' ' LEU . 12.6 t80 -117.12 110.17 41.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . 0.511 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 45.6 Cg_endo -74.79 -12.81 22.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.924 1.486 . . . . 0.0 110.21 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -92.9 179.52 39.77 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' B' ' 175' ' ' LEU . 3.7 tt -115.18 148.34 39.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 110.102 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.431 ' CD1' HD23 ' A' ' 62' ' ' LEU . 4.3 mt -123.3 103.37 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.279 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.496 ' CD1' HD11 ' B' ' 230' ' ' ILE . 27.0 t80 -95.03 120.47 35.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 197' ' ' MET . 1.8 ttp180 -90.03 82.62 6.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.427 ' C ' ' O ' ' B' ' 196' ' ' ARG . 31.2 tpp -42.63 130.16 4.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 14.9 t -70.51 -52.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -143.68 117.11 5.92 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.98 171.89 59.82 Favored 'Cis proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.025 -2.073 . . . . 0.0 110.601 -0.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -82.31 108.69 15.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.138 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' B' ' 222' ' ' GLU . 9.2 mt -150.8 155.95 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 70.0 t -105.39 131.21 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 109.671 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.491 ' N ' HD11 ' B' ' 204' ' ' LEU . 5.3 mp -119.19 123.04 43.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.445 ' CD2' ' N ' ' B' ' 205' ' ' LEU . 4.4 mm? -94.12 124.04 37.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.448 HG12 HD13 ' B' ' 212' ' ' ILE . 2.5 mp -124.55 122.44 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 95.6 m-85 -110.36 149.84 29.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.47 HG22 HD13 ' B' ' 172' ' ' LEU . 40.8 t -45.73 -24.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.096 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -29.23 70.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.363 -0.836 . . . . 0.0 110.331 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 109.85 2.91 30.31 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 123.61 27.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -1.156 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.494 HD13 HG22 ' B' ' 212' ' ' ILE . 19.4 mm -116.56 125.43 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 4.0 t -110.62 154.82 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.052 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 5.2 mp -141.87 103.35 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -0.884 . . . . 0.0 110.481 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.401 ' O ' HG22 ' B' ' 202' ' ' ILE . 13.3 t -126.66 152.57 46.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.984 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.45 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 106.64 -4.41 36.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' B' ' 223' ' ' ILE . . . -68.87 162.67 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -1.193 . . . . 0.0 110.013 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -114.68 -6.9 12.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.15 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.495 ' N ' HD13 ' B' ' 160' ' ' ILE . 1.9 tt0 -159.66 147.44 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' B' ' 219' ' ' GLN . 20.7 ttm180 -43.85 -37.25 2.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -61.43 -34.07 74.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 110.156 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.461 ' HB3' HD13 ' B' ' 202' ' ' ILE . 6.2 mt-10 -63.73 -53.31 53.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 110.254 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.512 HG12 ' CB ' ' B' ' 217' ' ' ALA . 18.7 mm -57.71 -42.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.408 ' CD1' ' HG2' ' B' ' 65' ' ' PRO . 2.7 m-85 -66.56 -28.84 68.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.107 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 2.6 tt0 -82.4 -50.06 9.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.153 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' B' ' 225' ' ' GLN . . . -45.51 -43.59 11.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.728 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 26.2 t80 -69.69 -41.46 75.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -15.38 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.174 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -92.53 -42.0 9.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 110.027 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.496 HD11 ' CD1' ' B' ' 195' ' ' TYR . 1.5 tp -90.55 -14.74 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.57 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.5 t80 -49.28 -49.72 68.72 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.3 Cg_endo -70.39 -45.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.47 1.247 . . . . 0.0 110.272 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' B' ' 175' ' ' LEU . 22.4 t -49.96 -39.24 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.705 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.33 -50.75 20.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.744 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 14.0 t -55.93 -33.16 64.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.17 -32.38 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.77 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.563 ' CZ ' ' OG ' ' B' ' 178' ' ' SER . 22.5 m-85 -117.36 37.72 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 110.092 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -61.31 171.95 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.127 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.407 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 5.7 tptm -102.49 -47.14 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 110.111 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.93 67.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 p -58.24 174.29 0.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.124 . . . . 0.0 110.251 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 tp -111.76 -18.98 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.467 ' HA3' ' HD2' ' A' ' 75' ' ' LYS . . . 85.46 120.22 1.02 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -107.22 -41.5 5.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -1.134 . . . . 0.0 110.485 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' C ' ' CZ ' ' B' ' 99' ' ' PHE . . . 101.78 147.15 19.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.662 ' N ' ' CZ ' ' B' ' 99' ' ' PHE . 0.3 OUTLIER -65.24 171.54 3.72 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.058 -1.26 . . . . 0.0 109.825 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.51 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -66.91 82.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.174 -0.954 . . . . 0.0 110.762 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.598 ' CD1' ' HB ' ' A' ' 71' ' ' VAL . 0.4 OUTLIER -98.59 -0.16 43.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.08 -1.013 . . . . 0.0 110.706 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.591 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 8.2 m -45.98 -29.34 1.41 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.57 -32.26 5.78 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.63 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -55.81 -43.07 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 108.738 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.471 ' CD1' ' SD ' ' A' ' 67' ' ' MET . 3.4 pp -82.4 -28.71 31.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.545 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -93.36 13.12 22.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.397 -0.814 . . . . 0.0 108.871 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 142.85 94.46 0.2 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.588 ' ND2' ' CD1' ' A' ' 35' ' ' LEU . 7.0 p30 -20.27 132.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.031 0.919 . . . . 0.0 112.39 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.724 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -147.11 163.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 31' ' ' GLU . 80.3 m-20 -87.3 124.2 33.1 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.565 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 5.3 p -37.96 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.793 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.4 mm-40 -55.1 -15.99 2.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 110.164 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.86 27.49 5.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.492 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -123.33 121.22 35.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.098 -1.236 . . . . 0.0 110.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.724 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -94.24 157.8 15.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.759 -1.213 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.588 ' CD1' ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp -136.38 -179.19 5.53 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.997 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.512 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 11.5 mt-30 -152.65 13.91 0.55 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -0.901 . . . . 0.0 110.399 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 36' ' ' GLN . 1.4 m-20 71.74 -53.17 0.69 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.256 -0.902 . . . . 0.0 110.382 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.5 t70 60.54 30.55 19.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.863 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 40' ' ' GLY . 0.3 OUTLIER -145.69 70.05 1.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.802 . . . . 0.0 109.945 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' ASP . . . -41.83 -90.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -125.86 -32.46 2.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.31 -52.42 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -167.96 56.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -1.173 . . . . 0.0 110.368 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.33 153.81 23.14 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.08 140.53 2.95 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.7 -80.03 0.59 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.317 -1.108 . . . . 0.0 110.076 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.93 153.7 9.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 49' ' ' ASP . 5.4 m-85 -73.71 141.59 46.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -1.164 . . . . 0.0 110.168 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 48' ' ' PHE . 25.8 t0 -48.65 178.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.102 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.17 26.05 1.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 110.324 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -100.87 -17.73 16.71 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' ILE . 4.0 mt -99.26 -44.24 6.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.436 -0.79 . . . . 0.0 110.384 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.555 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.21 -54.25 42.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 110.085 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -67.41 -22.47 65.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.475 -0.765 . . . . 0.0 110.211 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.58 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 7.0 m-80 -87.4 -28.65 22.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.31 -0.869 . . . . 0.0 109.186 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 12.6 mt -56.93 -48.3 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.462 -0.773 . . . . 0.0 108.981 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.49 -22.09 5.11 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.07 25.76 5.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.847 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.532 ' CB ' HG22 ' A' ' 21' ' ' THR . 6.2 mt -92.79 22.63 4.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.01 . . . . 0.0 109.88 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.38 52.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HG3' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -169.82 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD13 HD21 ' A' ' 59' ' ' LEU . 3.4 mt -112.79 -50.03 2.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 109.805 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.85 -31.11 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER -75.2 0.92 14.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.787 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' LEU . 10.5 t70 -43.71 -41.34 4.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.777 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -46.23 78.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.414 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.471 ' SD ' ' CD1' ' A' ' 24' ' ' LEU . 15.9 ttm -65.99 -9.61 31.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 109.417 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.0 tm? -71.41 -61.73 1.67 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.987 0.899 . . . . 0.0 108.687 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.61 -1.74 26.0 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 11.9 tt0 -85.9 11.59 11.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.272 -0.893 . . . . 0.0 111.347 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.598 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.2 t -144.88 3.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.963 -1.085 . . . . 0.0 110.565 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.595 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 4.1 tp -147.33 74.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.7 54.38 1.8 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.144 -0.972 . . . . 0.0 108.553 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.645 ' CD1' ' CD1' ' B' ' 116' ' ' PHE . 7.5 mt -103.96 66.94 0.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.564 0.697 . . . . 0.0 110.397 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 3.5 pttm -147.11 70.03 1.18 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.634 -0.666 . . . . 0.0 110.178 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 48.1 35.46 5.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.237 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.271 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.201 0.524 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' B' ' 64' ' ' VAL . . . 117.94 85.45 1.06 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' B' ' 62' ' ' GLY . 2.3 mp 64.57 -56.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.57 -0.959 . . . . 0.0 111.024 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' B' ' 62' ' ' GLY . 5.9 t 63.76 139.4 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 109.987 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.489 ' CB ' HD12 ' B' ' 214' ' ' LEU . 45.1 Cg_endo -72.32 135.67 25.06 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.115 1.587 . . . . 0.0 110.856 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 51.6 m -100.18 136.84 39.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.489 HD21 ' CG2' ' B' ' 160' ' ' ILE . 84.6 mt -70.4 133.79 47.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -130.82 -3.29 4.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 110.348 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.443 ' CB ' ' HB ' ' B' ' 161' ' ' VAL . 0.4 OUTLIER -162.51 126.41 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.332 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.489 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 14.1 mm -115.21 157.17 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 7.7 t -141.82 121.53 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 109.692 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.5 162.88 26.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 110.549 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.1 p -121.85 135.4 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.527 HG12 ' CE1' ' B' ' 152' ' ' PHE . 13.0 t -125.23 148.45 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 17.5 m -118.08 142.19 47.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' B' ' 150' ' ' ALA . 40.6 mt -101.29 -50.86 3.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.075 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.56 -12.5 23.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.46 172.46 9.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' B' ' 117' ' ' ALA . 0.5 OUTLIER -101.71 150.53 23.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.184 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.518 HD21 ' CD1' ' B' ' 148' ' ' PHE . 17.4 mt -126.23 175.78 7.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -0.908 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.59 96.85 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.049 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.571 HD11 ' CE1' ' B' ' 94' ' ' TYR . 17.7 mt -43.87 -41.13 4.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.875 . . . . 0.0 110.329 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.416 ' HE3' ' CD2' ' B' ' 94' ' ' TYR . 12.8 mmtp -55.55 -47.45 76.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 110.343 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -79.91 -41.24 26.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 54.4 t -54.8 -54.59 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.933 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.71 69.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.927 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 34.9 tp -81.84 -25.1 35.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -98.34 -42.27 7.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.127 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -47.6 133.2 13.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.066 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . 0.515 ' HG3' ' N ' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -70.63 -25.28 62.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.515 ' N ' ' HG3' ' B' ' 90' ' ' ARG . 1.2 m-20 -138.7 79.18 1.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.345 -0.847 . . . . 0.0 109.794 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.13 171.9 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.531 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.52 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -157.23 172.01 19.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 110.051 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.571 ' CE1' HD11 ' B' ' 82' ' ' LEU . 18.6 t80 -135.7 129.21 32.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' B' ' 95' ' ' ASN . 6.7 p30 -123.17 102.34 37.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.095 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.32 -26.06 17.83 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.015 1.534 . . . . 0.0 110.479 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -75.43 -20.94 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -100.07 -71.64 0.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -149.3 163.5 37.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 110.402 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.51 47.96 1.24 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 109.305 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.641 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -126.35 144.5 50.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.904 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.518 ' CG2' HD21 ' B' ' 82' ' ' LEU . 6.8 t -90.02 124.95 42.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.52 ' HB ' ' CG ' ' B' ' 93' ' ' GLU . 8.8 mm -88.27 110.35 20.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.857 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.429 ' HB2' HD11 ' B' ' 115' ' ' ILE . 3.1 ttm -106.49 161.08 14.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 110.387 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 0.5 OUTLIER -162.29 126.6 3.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.893 . . . . 0.0 110.293 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.41 HG12 ' OH ' ' B' ' 139' ' ' TYR . 37.4 pt -107.85 176.37 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.981 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -120.04 42.05 3.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.473 ' CB ' ' O ' ' B' ' 107' ' ' ARG . 0.3 OUTLIER 170.7 85.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 48.8 Cg_endo -78.3 160.23 91.81 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.723 -2.199 . . . . 0.0 110.467 -0.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.485 ' CB ' ' HB3' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -67.56 105.25 1.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.95 . . . . 0.0 109.777 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' B' ' 124' ' ' THR . 11.2 p -152.85 176.67 11.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.615 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.537 HG21 ' CG2' ' B' ' 124' ' ' THR . 5.3 t -131.37 171.42 13.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -156.74 141.61 17.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.991 -1.068 . . . . 0.0 110.642 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.493 HD13 ' CG1' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -98.53 103.78 15.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.449 -0.782 . . . . 0.0 109.048 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.464 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 4.4 mt -89.76 135.74 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.119 -0.988 . . . . 0.0 110.61 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 74' ' ' LEU . 3.0 m-30 -110.35 150.72 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.102 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.514 ' O ' ' CG ' ' B' ' 79' ' ' ARG . . . -70.05 -10.9 60.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.274 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -7.37 53.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.77 -18.61 40.23 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -88.32 160.07 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -1.183 . . . . 0.0 110.246 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 3.3 ptm -156.69 164.44 38.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.252 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.513 HG13 ' CG1' ' A' ' 71' ' ' VAL . 35.7 t -128.57 161.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 110.485 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.443 ' N ' HG11 ' B' ' 122' ' ' VAL . 53.3 t -138.76 151.23 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.015 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.537 ' CG2' HG21 ' B' ' 112' ' ' THR . 1.2 t -157.23 164.26 37.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 110.344 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.43 ' HA3' HG21 ' B' ' 111' ' ' THR . . . 110.79 -39.2 2.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.489 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -42.48 158.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -1.106 . . . . 0.0 110.317 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -124.05 -6.02 7.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.6 175.44 9.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.146 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.59 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.22 -16.71 5.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.264 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -49.66 32.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -25.06 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 110.422 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -78.91 -26.09 43.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.521 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 7.4 mt -79.12 -49.82 12.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -65.79 -30.83 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 51.0 p -67.97 -60.57 2.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.198 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' B' ' 134' ' ' LEU . 1.4 ptm180 -54.68 -33.19 60.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.006 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.416 ' O ' HG13 ' B' ' 142' ' ' ILE . 0.1 OUTLIER -65.91 -40.78 91.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 0.0 110.074 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.474 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 11.7 m-85 -65.98 -49.25 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.489 ' CB ' ' HB2' ' B' ' 152' ' ' PHE . . . -55.62 -30.58 61.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -71.94 -31.68 66.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.48 HG23 HD11 ' B' ' 142' ' ' ILE . 34.5 mt -61.79 -42.7 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.528 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 1.8 mp -67.51 -44.5 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -72.94 -30.05 63.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.655 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -20.11 61.52 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.436 HD12 HG22 ' B' ' 146' ' ' ILE . 3.6 mt -86.14 -24.07 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.72 -26.27 3.65 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.535 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.518 ' CD1' HD21 ' B' ' 80' ' ' LEU . 12.3 m-85 -52.27 158.16 1.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.943 -1.328 . . . . 0.0 110.988 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.65 34.72 2.16 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -68.57 169.6 10.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.352 -0.842 . . . . 0.0 110.421 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.91 112.74 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 110.264 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.527 ' CE1' HG12 ' B' ' 74' ' ' VAL . 83.5 t80 -58.97 108.34 0.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.441 HG21 ' O ' ' B' ' 152' ' ' PHE . 1.4 p -156.18 169.37 24.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' B' ' 153' ' ' THR . 4.2 t70 62.41 28.84 17.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.217 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -70.91 134.02 46.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.953 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.91 131.41 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.496 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.427 ' C ' ' HG2' ' B' ' 158' ' ' GLN . 14.7 mt -82.91 131.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.427 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 3.6 mt-30 -128.76 0.32 5.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.781 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.472 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 2.1 t-20 -147.79 110.11 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.921 -1.112 . . . . 0.0 110.709 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.489 ' CG2' HD21 ' B' ' 67' ' ' LEU . 66.4 mt -113.26 141.35 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.589 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' B' ' 69' ' ' ASN . 72.8 t -115.93 130.05 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.13 -0.981 . . . . 0.0 110.645 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.97 168.3 19.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' B' ' 213' ' ' VAL . 1.0 OUTLIER -166.57 149.44 6.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.262 . . . . 0.0 110.545 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.8 OUTLIER -170.07 170.18 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.021 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 164.08 12.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.032 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.583 ' O ' ' CD2' ' B' ' 168' ' ' PHE . 32.6 m -113.2 11.97 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.279 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.53 -2.25 2.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 26.1 p90 -161.37 150.09 13.09 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.987 -1.071 . . . . 0.0 110.568 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.508 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 47.8 Cg_endo -73.88 170.24 20.53 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.133 1.596 . . . . 0.0 110.732 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.47 HG21 ' N ' ' B' ' 171' ' ' ARG . 4.4 mp -140.36 151.28 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 110.378 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.47 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.3 OUTLIER -80.76 80.27 7.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 109.946 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.468 HD13 ' N ' ' B' ' 208' ' ' VAL . 18.9 mt -47.07 -37.97 10.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 110.42 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.17 -55.27 22.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.24 92.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.469 HD12 ' CG1' ' B' ' 233' ' ' VAL . 18.3 tp -70.12 -39.67 75.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -1.169 . . . . 0.0 110.373 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.64 -26.69 67.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.955 . . . . 0.0 110.18 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -77.01 -30.05 55.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 1.3 p -87.42 -44.64 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -105.72 26.51 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 110.259 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.55 54.85 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.7 m -53.8 -39.03 65.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -1.188 . . . . 0.0 110.433 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.497 ' CE1' HG21 ' B' ' 198' ' ' VAL . 19.9 m-85 -108.26 -26.97 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.401 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 47.9 p -96.05 158.05 15.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.624 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.2 m -132.43 119.75 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.677 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -125.42 112.13 15.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 110.565 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -118.94 102.55 49.11 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 109.666 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.61 -1.18 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.93 1.489 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -98.95 -3.64 34.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.036 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.415 HD21 ' HB2' ' B' ' 190' ' ' PHE . 0.3 OUTLIER -150.93 -37.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.586 ' CZ ' HD13 ' B' ' 205' ' ' LEU . 7.8 t80 -127.95 110.98 20.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.86 -17.64 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.888 1.467 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.87 -179.94 44.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' B' ' 172' ' ' LEU . 7.6 tt -118.38 130.07 55.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -1.143 . . . . 0.0 110.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.44 HG13 HD12 ' B' ' 205' ' ' LEU . 5.7 mt -102.96 100.94 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 109.914 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -91.79 120.26 32.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.471 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.428 ' HG2' HG21 ' B' ' 203' ' ' VAL . 1.1 mtp180 -92.54 83.45 4.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.457 ' HB2' ' CD1' ' B' ' 204' ' ' LEU . 33.7 tpp -42.11 126.81 3.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.935 . . . . 0.0 110.189 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.497 HG21 ' CE1' ' B' ' 182' ' ' PHE . 61.9 t -63.17 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -137.4 118.13 10.65 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.16 169.54 73.53 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.986 -2.089 . . . . 0.0 110.369 -0.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -76.85 95.35 4.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.044 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.448 HD13 ' HB1' ' B' ' 217' ' ' ALA . 31.8 mm -130.96 149.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.428 HG21 ' HG2' ' B' ' 196' ' ' ARG . 71.4 t -101.83 105.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.032 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' B' ' 197' ' ' MET . 4.5 mp -95.82 118.5 32.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.45 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.586 HD13 ' CZ ' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -89.65 117.41 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 109.935 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.468 HG23 ' CD2' ' B' ' 172' ' ' LEU . 3.2 mt -113.0 136.0 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.351 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.496 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 44.7 m-85 -119.62 145.2 46.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 64.3 t -49.19 -24.36 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -62.67 -38.65 91.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 110.133 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 123.36 8.77 6.29 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -90.06 145.22 25.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.241 . . . . 0.0 110.232 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' B' ' 163' ' ' SER . 30.3 mm -130.05 121.69 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.335 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 57.4 t -113.86 155.74 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.051 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.489 HD12 ' CB ' ' B' ' 65' ' ' PRO . 2.6 mp -140.12 121.94 15.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 110.629 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 6.2 t -137.02 146.48 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.886 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 111.18 3.9 27.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.448 ' HB1' HD13 ' B' ' 202' ' ' ILE . . . -82.99 138.45 33.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -29.27 32.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.45 ' O ' HD13 ' B' ' 160' ' ' ILE . 3.2 tt0 -136.17 -152.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 110.029 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -100.11 -36.89 9.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.432 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -54.69 -27.38 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.119 -0.988 . . . . 0.0 110.518 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.61 -47.43 54.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.242 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.496 HG22 HD11 ' B' ' 223' ' ' ILE . 40.8 mm -62.63 -37.61 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.29 -29.19 67.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.923 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -37.63 41.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.321 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.365 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.505 ' HA ' ' CG2' ' B' ' 230' ' ' ILE . 27.9 t80 -64.81 -46.54 81.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.394 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.42 -32.68 71.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -85.14 -25.94 27.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.426 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.505 ' CG2' ' HA ' ' B' ' 227' ' ' PHE . 8.7 tp -97.2 -17.94 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.595 ' N ' ' CD ' ' B' ' 232' ' ' PRO . 14.3 t80 -59.63 -41.34 85.76 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.943 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -77.93 -47.22 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.36 1.189 . . . . 0.0 110.384 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.469 ' CG1' HD12 ' B' ' 175' ' ' LEU . 18.4 t -53.49 -50.8 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.724 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.497 ' CD1' HG13 ' B' ' 230' ' ' ILE . 95.7 mt -59.14 -38.13 78.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.833 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 3.4 t -65.53 -39.39 91.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.392 -0.818 . . . . 0.0 109.816 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . 0.508 ' HG2' ' CE1' ' B' ' 237' ' ' PHE . 0.8 OUTLIER -60.14 -33.85 72.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.677 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.508 ' CE1' ' HG2' ' B' ' 236' ' ' GLU . 65.2 m-85 -115.39 37.41 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.827 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -62.52 168.64 3.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 0.0 110.257 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.413 ' HB2' ' C ' ' B' ' 169' ' ' PRO . 0.0 OUTLIER -111.84 -33.32 6.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 110.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.196 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.417 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.201 0.524 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.89 165.94 23.28 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.21 37.33 28.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -1.143 . . . . 0.0 110.209 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.0 mt 47.58 90.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.17 172.67 12.64 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 11' ' ' GLU . 1.9 t30 -146.19 -68.73 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -1.095 . . . . 0.0 110.145 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.27 165.24 41.09 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.602 HD21 ' CD2' ' B' ' 99' ' ' PHE . 0.0 OUTLIER -107.7 156.68 18.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.227 -1.161 . . . . 0.0 108.94 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 19' ' ' ASP . 1.9 p30 -86.19 109.12 18.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.614 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 3.4 mt -101.17 18.45 19.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.519 ' HA ' ' CD2' ' A' ' 68' ' ' LEU . 1.3 m -45.19 -29.86 1.05 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.057 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.441 ' C ' HG23 ' A' ' 28' ' ' ILE . . . -98.44 -27.8 8.4 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.495 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.608 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 1.1 mm -52.36 -45.87 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.912 -1.346 . . . . 0.0 109.359 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 68' ' ' LEU . 2.0 pp -85.86 -26.51 25.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.608 -1.308 . . . . 0.0 109.665 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CD1' HG23 ' B' ' 215' ' ' THR . 0.5 OUTLIER -83.88 7.41 18.22 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 142.61 106.04 0.57 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 6.4 p-10 -24.49 135.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.784 0.802 . . . . 0.0 111.396 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.664 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -150.42 161.77 3.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.553 ' N ' HG12 ' A' ' 28' ' ' ILE . 5.3 m-20 -87.48 119.2 27.52 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.553 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 1.3 p -39.53 -26.69 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.898 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.1 tt0 -57.55 -13.37 3.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.117 -0.989 . . . . 0.0 110.43 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.23 27.71 4.67 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.416 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.5 mmt-85 -120.77 122.19 39.83 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.085 -1.244 . . . . 0.0 109.861 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.664 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 3.1 tt -87.67 162.07 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.933 -1.105 . . . . 0.0 111.738 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.498 HD21 ' N ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -87.49 101.97 14.12 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.472 -0.767 . . . . 0.0 111.355 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -101.29 12.21 37.88 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 49.12 65.98 1.23 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.703 -0.623 . . . . 0.0 110.332 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 24.8 t70 -54.01 125.88 20.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.232 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 59.6 m-20 -156.9 162.59 39.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.9 . . . . 0.0 110.327 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.56 -0.43 84.3 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -161.54 170.5 19.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -1.147 . . . . 0.0 110.12 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.68 103.63 1.0 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.71 35.8 4.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -1.105 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.08 30.35 4.37 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.53 92.18 2.25 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.71 114.18 15.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.233 -1.157 . . . . 0.0 110.113 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.87 173.54 4.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.59 ' CD1' HD13 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -95.43 -170.98 2.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -1.17 . . . . 0.0 110.301 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -89.88 -177.67 5.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.285 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.8 14.03 11.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 110.072 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.503 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -100.28 -22.13 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.349 -0.844 . . . . 0.0 109.469 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 48' ' ' PHE . 3.7 mt -95.39 -45.21 7.22 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.546 -0.721 . . . . 0.0 110.157 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.544 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -49.5 -52.47 29.21 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.152 -0.968 . . . . 0.0 109.6 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.79 -23.21 66.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 12.5 m-20 -85.83 -33.99 21.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.544 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 15.6 mt -54.22 -42.14 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 109.372 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.35 -14.89 35.96 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.444 ' HB3' ' CD1' ' B' ' 189' ' ' LEU . 49.7 m -122.07 0.05 9.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.12 -1.223 . . . . 0.0 110.297 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 1.2 mt -81.38 8.32 9.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -91.18 43.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.494 ' CG ' HD22 ' A' ' 62' ' ' LEU . 5.9 pttt -172.88 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' B' ' 194' ' ' ILE . 3.7 mt -105.15 -43.82 4.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.03 -28.3 0.09 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.525 ' CD1' HD23 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -84.53 0.19 50.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -1.212 . . . . 0.0 110.108 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' HA ' ' HG ' ' A' ' 68' ' ' LEU . 4.7 t70 -50.36 -39.69 47.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 109.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.47 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -58.7 -32.2 68.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.895 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.485 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.45 -26.79 63.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.885 . . . . 0.0 109.74 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.533 ' CD2' HD22 ' A' ' 24' ' ' LEU . 7.4 mt -64.43 -61.7 2.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.725 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.3 pp -58.04 -12.63 3.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.676 -0.64 . . . . 0.0 110.341 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' C ' HG21 ' A' ' 71' ' ' VAL . 2.9 tt0 -87.05 2.75 48.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 110.592 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.58 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.8 t -127.74 -0.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.393 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.614 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.8 tp -150.51 68.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -73.43 56.95 0.52 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.849 -1.157 . . . . 0.0 108.975 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.619 ' CD1' ' CD2' ' B' ' 99' ' ' PHE . 5.6 mt -84.18 57.82 4.43 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.693 0.759 . . . . 0.0 110.472 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 -173.27 2.25 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.923 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.98 106.73 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 110.2 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.235 179.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.177 0.513 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.454 ' O ' HG13 ' B' ' 63' ' ' ILE . . . 155.64 -52.87 0.43 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.487 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 4.2 mt -140.63 -39.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -1.124 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 91.8 t 59.34 142.22 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.436 -0.79 . . . . 0.0 110.301 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.453 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.3 Cg_endo -72.97 123.96 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.844 1.444 . . . . 0.0 110.745 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.433 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 9.3 m -92.06 135.0 34.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.476 ' HG ' ' NH2' ' B' ' 220' ' ' ARG . 19.0 mt -69.95 125.41 26.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 110.323 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.423 ' NE2' HG23 ' B' ' 66' ' ' THR . 78.1 mm-40 -101.4 -27.29 13.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.147 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -156.14 162.73 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.425 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.517 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 17.0 mm -136.48 150.64 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.794 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 24.1 t -136.76 140.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -143.99 149.4 36.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.909 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.38 128.32 45.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -0.954 . . . . 0.0 110.539 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.417 HG11 ' N ' ' B' ' 75' ' ' THR . 59.0 t -119.67 151.2 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 109.955 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 23.5 m -129.49 142.91 50.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.535 ' CD1' ' CD1' ' B' ' 80' ' ' LEU . 49.4 mt -100.05 -46.2 5.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.18 55.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.5 158.65 43.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -1.178 . . . . 0.0 110.212 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.451 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -80.13 142.96 34.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.535 ' CD1' ' CD1' ' B' ' 76' ' ' LEU . 25.7 mt -116.65 153.68 31.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.423 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' B' ' 82' ' ' LEU . 8.2 t0 -96.93 86.9 4.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.45 HD23 HG22 ' B' ' 102' ' ' VAL . 8.6 mt -40.66 -43.62 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.845 . . . . 0.0 110.362 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -54.13 -45.45 71.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.94 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 14.7 m -81.02 -44.5 17.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.96 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.567 HG21 ' CE2' ' B' ' 148' ' ' PHE . 40.8 t -54.94 -43.08 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 110.159 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.86 -25.59 48.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.69 -33.49 20.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.213 -0.929 . . . . 0.0 110.124 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.0 m80 -83.22 -44.83 14.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' B' ' 85' ' ' VAL . . . -53.31 141.84 22.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.089 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . 0.41 ' O ' ' OD1' ' B' ' 91' ' ' ASN . 21.7 mtt85 -81.05 -15.44 56.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.483 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' B' ' 104' ' ' MET . 16.0 m-20 -139.54 79.94 1.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' B' ' 93' ' ' GLU . . . -152.95 161.91 41.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' B' ' 92' ' ' ALA . 37.7 mt-10 -142.46 161.61 37.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 110.132 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -152.04 130.56 12.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.928 . . . . 0.0 110.324 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.41 122.99 6.28 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.11 -16.71 28.56 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.908 1.478 . . . . 0.0 110.343 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -77.78 -9.73 59.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -109.3 -59.94 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.261 -0.899 . . . . 0.0 110.137 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.619 ' CD2' ' CD1' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -163.07 -159.23 0.53 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.496 -0.753 . . . . 0.0 110.704 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.489 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -121.38 49.8 1.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 111.602 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.608 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -143.57 163.77 32.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.45 HG22 HD23 ' B' ' 82' ' ' LEU . 90.0 t -101.41 136.93 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.509 HD13 ' CZ ' ' B' ' 99' ' ' PHE . 3.1 mp -106.03 111.34 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.369 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.481 ' HE2' ' CD1' ' B' ' 115' ' ' ILE . 14.6 ttm -94.53 170.52 9.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.323 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -157.56 113.15 2.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.502 HG21 ' CE1' ' B' ' 139' ' ' TYR . 48.3 pt -101.29 170.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' B' ' 108' ' ' GLU . 5.3 mmt85 -124.93 46.32 2.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 0.0 110.291 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' B' ' 107' ' ' ARG . 0.0 OUTLIER 175.27 79.21 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 0.0 110.338 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -81.63 161.56 79.77 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.756 -2.185 . . . . 0.0 110.473 -0.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.15 106.38 1.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -147.27 177.5 9.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.645 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.7 m -124.57 159.14 31.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.474 ' HB3' ' CE2' ' B' ' 139' ' ' TYR . . . -147.48 138.35 23.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 110.41 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' B' ' 121' ' ' MET . 8.0 mt -98.46 120.51 39.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 109.723 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.481 ' CD1' ' HE2' ' B' ' 104' ' ' MET . 3.6 mt -111.97 115.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.985 . . . . 0.0 110.375 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 3.6 m-30 -94.93 168.32 10.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.451 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -78.41 -13.52 59.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.4 t -81.05 -7.81 59.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.79 -26.27 20.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -56.2 149.74 15.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -1.135 . . . . 0.0 110.096 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.463 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 1.7 tmm? -148.66 128.82 13.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.533 ' CG1' HG13 ' A' ' 71' ' ' VAL . 73.4 t -114.91 128.1 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.501 HG11 ' N ' ' B' ' 124' ' ' THR . 97.2 t -112.86 151.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.349 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.501 ' N ' HG11 ' B' ' 123' ' ' VAL . 1.8 t -155.09 164.42 38.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 109.983 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.569 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 110.83 -34.84 5.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.528 ' HB3' ' CA ' ' B' ' 132' ' ' SER . . . -42.24 149.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -1.148 . . . . 0.0 110.442 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -3.19 30.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.475 ' N ' HG13 ' B' ' 70' ' ' ILE . 3.0 m -167.17 -163.23 0.51 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . 0.401 ' HA ' HD13 ' B' ' 157' ' ' ILE . 3.1 mt-10 -78.24 -44.65 24.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.316 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.11 -26.1 66.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 110.387 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.93 -58.29 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.885 . . . . 0.0 110.286 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.528 ' CA ' ' HB3' ' B' ' 126' ' ' ALA . 2.2 m -47.57 -40.01 18.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 12.2 mttt -60.24 -51.06 71.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.467 ' O ' ' HG3' ' B' ' 137' ' ' ARG . 39.6 mt -62.88 -32.81 74.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -74.3 -41.1 61.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.271 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 3.6 p -65.7 -52.09 54.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.499 ' HB2' ' CZ ' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -55.15 -34.1 63.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.449 ' HD3' ' HD2' ' B' ' 137' ' ' ARG . 7.0 mptt -65.42 -36.67 84.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 110.032 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.502 ' CE1' HG21 ' B' ' 106' ' ' ILE . 31.4 m-85 -71.41 -52.3 19.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.875 . . . . 0.0 110.04 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.74 64.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.087 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -40.71 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.447 HD11 ' SD ' ' B' ' 104' ' ' MET . 24.6 mt -59.37 -54.93 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.517 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 10.0 mt -55.73 -46.61 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 35.0 mt-30 -66.26 -35.24 79.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' B' ' 145' ' ' LYS . 10.1 tttm -71.55 -21.05 61.94 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mt -83.31 -18.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.88 -21.37 12.43 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.567 ' CE2' HG21 ' B' ' 85' ' ' VAL . 12.3 m-85 -57.55 172.6 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.278 . . . . 0.0 111.016 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.54 54.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.75 . . . . 0.0 110.328 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.517 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -90.74 130.57 36.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 110.423 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -121.85 119.28 31.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 17.0 t80 -60.79 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -140.6 171.35 14.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 110.227 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' B' ' 153' ' ' THR . 56.5 m-20 58.37 19.32 6.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.367 -0.833 . . . . 0.0 110.559 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.49 ' HB2' ' CE1' ' B' ' 152' ' ' PHE . 15.1 t80 -68.69 136.79 53.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.92 136.5 1.93 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 70.7 mt -79.29 124.51 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -118.5 -8.81 10.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.114 -0.991 . . . . 0.0 110.992 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 30.4 t30 -148.98 134.42 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.783 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.402 HG12 ' CD1' ' B' ' 70' ' ' ILE . 60.0 mt -129.4 142.85 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.747 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.1 135.75 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.985 . . . . 0.0 110.55 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -136.94 173.11 22.32 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.3 t -164.82 151.18 10.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -1.184 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.453 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.0 p -170.21 146.57 2.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.03 169.53 9.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.962 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.31 -83.33 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -176.01 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' B' ' 238' ' ' ARG . 14.8 p90 -131.8 159.45 71.92 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.363 -0.836 . . . . 0.0 109.576 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.474 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -71.34 152.19 60.74 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.873 1.46 . . . . 0.0 110.146 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.26 148.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.561 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -86.88 106.45 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.934 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.505 HD21 ' CB ' ' B' ' 193' ' ' LEU . 21.9 mt -63.23 -59.91 4.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.342 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 23.5 pt-20 -50.19 -33.85 20.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . 0.456 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -72.96 -41.57 48.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' B' ' 179' ' ' HIS . 9.7 tp -80.23 -32.28 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -1.119 . . . . 0.0 110.23 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -73.95 -24.3 59.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 110.178 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -79.14 -42.61 25.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 t -78.74 -52.19 8.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.14 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.443 ' HB2' HD13 ' B' ' 175' ' ' LEU . 29.7 m170 -93.41 13.48 21.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.072 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -46.42 -32.97 5.63 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.8 t -54.08 -24.15 16.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -1.221 . . . . 0.0 110.378 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.567 ' CE1' ' CG2' ' B' ' 198' ' ' VAL . 26.4 m-85 -133.05 13.63 4.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 58.8 m -129.65 150.38 51.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.281 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.92 133.94 53.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.495 ' O ' ' CD2' ' B' ' 185' ' ' TYR . 26.4 t80 -150.45 102.61 3.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.101 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' B' ' 190' ' ' PHE . 1.3 mt-10 -113.31 115.26 47.56 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 110.091 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.82 -1.49 10.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.403 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -100.27 6.82 44.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 58' ' ' SER . 0.4 OUTLIER -166.36 -38.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 110.386 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.516 ' CZ ' HD22 ' A' ' 59' ' ' LEU . 1.8 t80 -118.65 114.05 36.08 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.4 -31.12 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.863 1.454 . . . . 0.0 110.568 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.449 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.96 -179.72 44.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.505 ' CB ' HD21 ' B' ' 172' ' ' LEU . 8.5 tt -113.42 133.78 55.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -1.125 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.581 ' CD1' ' CD1' ' A' ' 62' ' ' LEU . 53.0 mt -100.68 109.11 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.491 ' CD2' HD12 ' B' ' 230' ' ' ILE . 15.4 t80 -99.69 114.15 27.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -90.63 98.47 11.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.104 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' B' ' 226' ' ' ALA . 0.5 OUTLIER -56.73 131.09 48.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.419 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.567 ' CG2' ' CE1' ' B' ' 182' ' ' PHE . 13.2 t -70.82 -48.75 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.061 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 6.9 tttm -144.29 117.03 5.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.7 Cg_endo -72.79 163.18 89.58 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.931 -2.112 . . . . 0.0 110.63 0.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.492 ' O ' ' CD1' ' B' ' 202' ' ' ILE . 0.0 OUTLIER -70.94 99.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.492 ' CD1' ' O ' ' B' ' 201' ' ' LYS . 37.6 mm -143.65 145.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.06 141.47 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.704 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 133.99 50.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.042 -1.036 . . . . 0.0 110.716 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.466 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 2.6 mm? -103.32 116.6 32.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.449 HG13 HD11 ' B' ' 212' ' ' ILE . 3.5 mp -114.3 120.73 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.09 -1.006 . . . . 0.0 110.406 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' B' ' 209' ' ' SER . 66.9 m-85 -110.88 143.76 40.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 110.208 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.474 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 17.2 t -44.11 -25.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 207' ' ' PHE . 25.2 m -59.94 -38.33 82.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.31 -0.869 . . . . 0.0 110.36 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 115.83 13.91 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.61 133.39 44.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.023 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.449 HD11 HG13 ' B' ' 206' ' ' ILE . 29.0 mm -118.52 136.68 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.941 . . . . 0.0 110.429 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 4.6 t -119.93 155.51 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 109.921 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.435 HD11 ' N ' ' B' ' 214' ' ' LEU . 4.9 mp -134.34 123.2 23.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.975 . . . . 0.0 110.376 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.584 HG23 ' CD1' ' A' ' 25' ' ' PHE . 8.3 t -141.27 147.57 38.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.07 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.92 5.82 43.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.453 ' HB1' HD12 ' B' ' 223' ' ' ILE . . . -89.08 134.6 33.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -1.124 . . . . 0.0 110.119 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -27.34 48.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.363 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.22 163.0 33.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.267 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . 0.505 ' CG ' ' CE1' ' B' ' 224' ' ' TYR . 4.9 ttm180 -65.54 -20.58 66.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 110.119 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -54.67 -44.32 73.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 226' ' ' ALA . 30.1 mt-10 -72.71 -39.98 66.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.911 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.453 HD12 ' HB1' ' B' ' 217' ' ' ALA . 34.0 mm -57.91 -41.51 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.891 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' B' ' 220' ' ' ARG . 10.1 m-85 -79.04 -47.22 16.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.103 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -65.54 -42.72 91.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' B' ' 222' ' ' GLU . . . -57.47 -44.54 84.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.606 ' CZ ' ' CE2' ' B' ' 231' ' ' TYR . 32.6 t80 -67.6 -28.66 67.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.145 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.27 -19.18 61.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.108 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.77 -31.86 15.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.491 HD12 ' CD2' ' B' ' 195' ' ' TYR . 9.2 tp -85.51 -22.61 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.606 ' CE2' ' CZ ' ' B' ' 227' ' ' PHE . 0.3 OUTLIER -40.89 -50.95 7.45 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.963 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.1 Cg_endo -69.22 -42.2 4.19 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.428 1.225 . . . . 0.0 110.633 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.43 ' CG1' HD13 ' B' ' 230' ' ' ILE . 24.4 t -53.66 -40.36 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.551 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 74.0 mt -61.25 -45.02 96.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 22.9 t -64.64 -46.71 81.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -35.91 49.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -108.58 38.56 2.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.467 ' HB3' ' CE1' ' B' ' 168' ' ' PHE . 1.0 OUTLIER -89.05 149.31 23.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -94.21 -60.16 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.5 mmm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.225 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.294 0.568 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' SER . . . -157.68 55.92 0.37 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' ILE . 6.5 t -44.27 167.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 110.173 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' SER . 5.3 mt 46.27 94.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 16' ' ' ASN . . . -101.32 15.8 57.32 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER 65.44 59.29 0.8 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -1.21 . . . . 0.0 110.119 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.54 145.73 4.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HB2' ' CD2' ' B' ' 99' ' ' PHE . 0.0 OUTLIER -98.62 159.75 14.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -1.164 . . . . 0.0 109.477 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.41 105.42 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 111.194 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.553 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 6.8 mt -117.97 3.64 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.958 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.529 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 6.2 m -38.44 -30.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.679 0.752 . . . . 0.0 109.549 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.515 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -100.55 -31.49 5.78 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.559 ' CA ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -56.32 -43.36 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.074 -1.251 . . . . 0.0 108.762 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.518 ' CD1' ' HG2' ' A' ' 67' ' ' MET . 1.8 pp -80.78 6.34 13.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 108.977 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -110.65 -18.08 13.24 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.544 -0.723 . . . . 0.0 111.034 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 158.3 67.02 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 C-N-CA 118.448 -1.834 . . . . 0.0 111.59 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' B' ' 125' ' ' GLY . 4.0 m120 41.28 111.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.943 . . . . 0.0 113.271 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.769 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -156.02 151.44 9.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLU . 12.6 m-20 -89.06 137.09 32.63 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.584 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . 83.3 p -39.81 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.241 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -48.6 -21.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.6 29.5 5.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.33 131.5 54.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.122 -1.222 . . . . 0.0 110.085 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.769 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -101.86 139.16 37.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.546 ' CG ' ' HB3' ' A' ' 27' ' ' ASN . 2.8 pp -124.57 -179.75 4.62 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.419 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.513 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 7.5 mt-30 -135.02 144.95 47.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 110.143 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -50.71 -37.97 44.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.92 . . . . 0.0 110.733 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.82 145.21 35.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.597 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -134.07 140.28 46.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 110.047 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.11 33.09 5.33 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.42 79.63 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -1.137 . . . . 0.0 110.314 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.82 -23.34 69.78 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 52.94 2.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -1.155 . . . . 0.0 110.21 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.25 -33.83 0.75 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.39 -141.24 15.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 p -91.13 -173.75 3.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 110.185 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.89 135.88 5.22 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -88.6 16.58 6.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -1.157 . . . . 0.0 110.24 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 5.0 t70 -47.16 -53.09 13.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.9 . . . . 0.0 110.423 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.38 -4.96 24.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.414 -0.804 . . . . 0.0 110.463 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 18.3 tp10 -97.49 -25.46 15.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.014 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.45 ' C ' HD13 ' A' ' 56' ' ' ILE . 5.9 mt -110.01 -44.94 3.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.626 -0.672 . . . . 0.0 110.055 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.02 -45.77 3.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.578 0.704 . . . . 0.0 109.984 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.27 -50.62 63.09 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 58' ' ' SER . 64.0 m-20 -58.72 -38.77 79.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 109.174 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' N ' HD11 ' A' ' 59' ' ' LEU . 8.0 mt -50.91 -40.14 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.096 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -12.97 48.71 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -125.09 -0.24 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -1.12 . . . . 0.0 110.344 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.541 HD11 ' N ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -80.52 51.86 1.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 24.3 t -134.06 50.24 2.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.887 . . . . 0.0 110.273 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 60' ' ' SER . 5.3 pttp 179.34 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.087 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.52 HD11 ' N ' ' A' ' 63' ' ' GLY . 1.1 pp -140.26 -29.54 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.054 -1.029 . . . . 0.0 111.146 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.52 ' N ' HD11 ' A' ' 62' ' ' LEU . . . 178.5 -48.99 0.09 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.461 HD22 HD12 ' A' ' 62' ' ' LEU . 1.1 pp -82.95 -5.27 58.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.264 . . . . 0.0 110.812 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.7 t70 -44.47 -35.35 2.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.66 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -63.8 -47.04 82.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 0.0 109.619 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.518 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 7.1 ttp -65.02 -10.92 33.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.692 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.529 ' HG ' ' N ' ' A' ' 21' ' ' THR . 4.9 tt -73.35 -61.27 1.88 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 65' ' ' ASP . 1.1 pp -73.78 0.86 11.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 109.939 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -91.78 15.28 13.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 0.0 110.796 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.517 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 1.6 t -130.43 0.35 2.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.917 0.865 . . . . 0.0 109.016 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.58 HG12 ' HB3' ' A' ' 18' ' ' LEU . 1.3 tp -151.0 76.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 5.4 t0 -75.09 57.09 0.81 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.383 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.608 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 8.5 mt -89.83 30.28 1.07 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.469 -0.769 . . . . 0.0 110.572 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 77' ' ' ALA . 32.6 pttt -118.64 -157.39 0.68 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.505 -0.747 . . . . 0.0 110.419 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.438 ' N ' ' HG3' ' A' ' 75' ' ' LYS . 1.4 tp10 -50.92 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.818 . . . . 0.0 110.274 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.302 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.228 0.537 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.93 64.79 0.72 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.468 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 29.6 mt -99.5 -40.56 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -1.125 . . . . 0.0 110.044 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.528 HG13 ' CE1' ' B' ' 224' ' ' TYR . 3.0 t 65.8 142.64 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 110.383 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.47 ' HG3' ' O ' ' B' ' 223' ' ' ILE . 46.8 Cg_endo -75.96 137.88 20.17 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.098 1.578 . . . . 0.0 110.317 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.427 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 49.1 m -97.66 132.61 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 44.4 mt -69.72 120.61 15.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.961 . . . . 0.0 109.826 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' B' ' 66' ' ' THR . 25.2 mm-40 -110.4 -14.04 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.443 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 1.7 t30 -162.56 144.52 10.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.987 . . . . 0.0 110.812 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.55 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 6.0 mm -126.35 150.75 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 109.333 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.74 126.29 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.011 -1.056 . . . . 0.0 110.549 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.83 170.75 15.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 110.05 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -141.2 145.26 35.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 t -127.97 155.74 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 25.9 m -106.0 129.64 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.458 ' CD2' ' HB2' ' B' ' 150' ' ' ALA . 72.8 mt -84.29 -69.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.89 28.39 2.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . 0.45 ' SG ' ' HB1' ' B' ' 149' ' ' ALA . 39.8 t -164.02 152.1 12.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.455 ' O ' HD22 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -73.23 139.81 46.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.455 HD22 ' O ' ' B' ' 79' ' ' ARG . 28.9 mt -118.28 140.21 50.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 110.385 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 94.92 9.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.881 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.486 HD21 ' CG2' ' B' ' 102' ' ' VAL . 14.4 mt -44.05 -52.67 6.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.365 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -49.86 -43.46 49.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.028 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 28.0 m -76.27 -48.84 18.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 0.0 110.129 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.84 -47.81 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.402 ' HB3' HG12 ' B' ' 102' ' ' VAL . . . -67.36 -23.56 65.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 tp -75.61 -42.22 52.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -88.26 -31.79 18.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' B' ' 92' ' ' ALA . . . -57.05 109.84 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.87 -22.35 66.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.052 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.48 ' ND2' ' HG3' ' B' ' 105' ' ' ARG . 2.4 t-20 -134.08 79.63 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' B' ' 89' ' ' ALA . . . -149.0 163.07 38.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -144.91 127.05 15.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.187 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -114.6 125.58 53.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.218 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.75 106.0 20.73 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.231 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.94 -21.78 20.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.033 1.544 . . . . 0.0 110.241 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -82.4 8.38 11.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.085 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.522 ' HB3' ' CD2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER -131.27 -70.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 18' ' ' LEU . 24.4 p90 -134.74 -173.62 3.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.046 . . . . 0.0 110.436 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 64.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.608 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -159.29 177.0 11.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.298 -0.876 . . . . 0.0 110.566 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.486 ' CG2' HD21 ' B' ' 82' ' ' LEU . 92.2 t -119.13 124.93 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.563 HD13 ' CZ ' ' B' ' 99' ' ' PHE . 5.5 mt -89.66 107.36 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.504 ' HB3' ' CD1' ' B' ' 115' ' ' ILE . 37.8 ttm -108.31 151.14 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.48 ' HG3' ' ND2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -139.23 145.36 39.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.552 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 15.0 pt -111.66 175.35 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.136 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.6 mtt180 -116.73 26.73 9.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 110.408 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 1.5 tm-20 -175.88 87.13 0.29 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.752 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.45 153.38 91.59 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.759 -2.184 . . . . 0.0 110.242 -0.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.6 OUTLIER -67.11 104.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 0.0 109.915 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' B' ' 124' ' ' THR . 68.0 p -146.75 176.87 9.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.925 . . . . 0.0 110.566 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.448 HG23 HD12 ' A' ' 23' ' ' ILE . 1.2 m -115.76 144.18 44.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.558 ' HB3' ' CE2' ' B' ' 139' ' ' TYR . . . -135.21 129.58 33.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.959 -1.088 . . . . 0.0 110.885 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.575 ' N ' ' CD2' ' B' ' 114' ' ' LEU . 3.5 mm? -89.59 120.49 30.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.044 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.504 ' CD1' ' HB3' ' B' ' 104' ' ' MET . 1.6 mp -108.92 122.92 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' B' ' 120' ' ' LYS . 3.6 m-30 -96.49 149.04 22.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.71 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.51 -6.0 27.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.961 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.4 p -86.91 -16.77 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.424 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 119.31 -26.88 7.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 4.0 mttt -78.44 145.45 35.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -1.194 . . . . 0.0 110.157 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 7.3 ptt? -152.26 151.51 31.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 110.204 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.487 HG23 ' CG1' ' A' ' 71' ' ' VAL . 0.5 OUTLIER -110.47 162.38 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.902 . . . . 0.0 109.771 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.453 HG21 ' O ' ' B' ' 122' ' ' VAL . 12.7 t -145.2 119.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.52 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 10.2 t -113.56 151.33 31.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.91 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.563 ' N ' ' OD1' ' A' ' 27' ' ' ASN . . . 118.45 -31.48 5.58 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.407 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.55 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -39.92 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.0 110.305 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -104.4 -16.13 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.185 -0.947 . . . . 0.0 109.741 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 7.2 t -169.22 175.24 5.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.92 . . . . 0.0 110.043 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.07 -40.63 73.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.3 -47.12 65.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.456 ' OD2' ' HB3' ' B' ' 127' ' ' LYS . 15.8 t0 -58.17 -55.01 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 110.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' B' ' 126' ' ' ALA . 8.7 t -49.46 -47.43 48.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' B' ' 133' ' ' LYS . 1.3 tppt? -49.83 -40.48 42.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.41 -46.26 41.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.38 53.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -53.35 44.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.812 . . . . 0.0 110.067 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.09 -38.7 5.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.116 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -62.93 -56.39 17.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' B' ' 113' ' ' ALA . 51.6 m-85 -56.03 -47.54 77.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.855 . . . . 0.0 109.976 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.94 -24.72 54.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.012 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 19.0 ttt180 -77.32 -51.84 10.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.436 ' O ' HG13 ' B' ' 146' ' ' ILE . 7.1 mt -45.75 -36.79 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' B' ' 150' ' ' ALA . 34.8 mm -76.48 -52.79 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.82 -32.0 73.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.62 -26.15 60.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.436 HG13 ' O ' ' B' ' 142' ' ' ILE . 11.3 mt -77.71 -24.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.86 -21.16 6.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -57.82 178.6 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.277 . . . . 0.0 110.944 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . 0.45 ' HB1' ' SG ' ' B' ' 78' ' ' CYS . . . -113.89 45.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.528 -0.733 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' B' ' 76' ' ' LEU . . . -81.59 109.84 16.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 110.475 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.453 ' O ' HD21 ' B' ' 76' ' ' LEU . 6.2 tttp -85.34 -170.28 3.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.136 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -136.75 103.53 5.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.0 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -166.41 169.5 13.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.875 . . . . 0.0 110.308 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' B' ' 153' ' ' THR . 8.2 t0 69.58 10.99 7.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.818 . . . . 0.0 110.63 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.406 ' CE2' ' HD3' ' B' ' 133' ' ' LYS . 39.8 t80 -48.25 151.64 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 142.85 3.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.539 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.444 HG22 HD11 ' B' ' 157' ' ' ILE . 42.7 mm -79.75 149.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 109.951 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -118.87 -60.18 1.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -143.07 169.28 17.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 110.643 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.518 HD13 ' CA ' ' B' ' 219' ' ' GLN . 45.4 mt -140.87 138.01 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 109.775 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 26.1 t -110.47 129.42 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.06 174.82 18.22 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.38 146.21 3.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -1.209 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.5 OUTLIER -170.65 150.46 3.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.94 165.46 12.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -110.11 -83.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 179.65 -29.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.232 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 3.5 p90 -134.43 158.22 75.66 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.464 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.3 Cg_endo -71.88 159.91 49.2 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.998 1.525 . . . . 0.0 110.588 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.0 151.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.459 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 2.1 ptm180 -87.61 103.66 15.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.505 ' HB3' ' CE1' ' B' ' 185' ' ' TYR . 12.7 mt -53.54 -33.16 53.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.28 -43.35 95.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.66 -29.32 73.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' B' ' 179' ' ' HIS . 0.1 OUTLIER -79.32 -32.03 43.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -1.096 . . . . 0.0 110.068 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.499 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -87.0 -25.53 24.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.91 -39.6 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 29.9 t -84.73 -38.84 19.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' B' ' 175' ' ' LEU . 69.4 m80 -107.27 15.4 25.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -44.61 -35.89 4.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.55 4.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -138.95 9.7 2.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 110.264 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.437 ' OG ' HD23 ' B' ' 193' ' ' LEU . 1.8 t -122.19 122.31 38.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.12 127.84 45.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.942 . . . . 0.0 110.234 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' B' ' 172' ' ' LEU . 23.0 t80 -126.13 120.5 30.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -137.68 102.33 8.64 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 110.054 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.32 0.1 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.13 1.594 . . . . 0.0 110.365 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -99.88 -4.78 29.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -148.44 -38.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 110.472 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.469 ' HB2' HD21 ' B' ' 189' ' ' LEU . 6.7 t80 -124.39 113.78 27.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.382 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.04 -19.27 26.71 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.956 1.503 . . . . 0.0 110.079 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -97.72 179.92 33.14 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.437 HD23 ' OG ' ' B' ' 183' ' ' SER . 0.9 OUTLIER -113.19 145.99 40.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -1.185 . . . . 0.0 110.533 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.445 HD12 HD23 ' A' ' 62' ' ' LEU . 5.8 mt -109.09 110.36 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -107.54 120.53 42.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.33 93.08 6.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.934 . . . . 0.0 110.046 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 52.9 tpp -49.64 136.04 17.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.437 ' O ' ' HE2' ' B' ' 201' ' ' LYS . 73.0 t -73.12 -50.71 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -142.3 115.91 6.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.152 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.415 ' CB ' ' HG2' ' B' ' 222' ' ' GLU . 48.8 Cg_endo -73.73 165.21 85.44 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.994 -2.086 . . . . 0.0 110.541 -0.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' B' ' 198' ' ' VAL . 0.0 OUTLIER -74.75 98.86 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.992 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 31.7 mm -139.76 144.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.498 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 90.4 t -93.45 118.61 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' B' ' 204' ' ' LEU . 6.1 mp -115.58 123.77 49.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.568 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' B' ' 193' ' ' LEU . 5.7 mt -94.83 129.37 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.914 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.467 HG22 ' CD2' ' B' ' 234' ' ' LEU . 3.7 mp -118.8 129.47 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.549 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.475 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 96.6 m-85 -114.26 149.72 35.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 110.062 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 65.1 t -55.19 -24.8 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.0 p -64.36 -26.48 68.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.328 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 108.06 19.9 8.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -1.162 . . . . 0.0 110.274 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.72 132.99 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.384 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 21.2 t -125.79 130.97 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' B' ' 214' ' ' LEU . 4.7 mp -118.42 126.28 51.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.403 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.444 ' OG1' HG21 ' B' ' 161' ' ' VAL . 1.1 t -147.3 136.03 22.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.968 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.452 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 120.45 7.55 8.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.523 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -86.87 134.36 33.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -1.213 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -78.36 -21.19 49.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.518 ' CA ' HD13 ' B' ' 160' ' ' ILE . 0.0 OUTLIER -139.1 -170.38 2.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -89.94 -36.54 14.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.133 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -52.79 -31.31 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.174 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.415 ' HG2' ' CB ' ' B' ' 200' ' ' PRO . 24.1 mt-10 -70.45 -56.99 5.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 110.109 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.511 HG12 ' CB ' ' B' ' 217' ' ' ALA . 31.0 mm -50.93 -38.73 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.528 ' CE1' HG13 ' B' ' 64' ' ' VAL . 1.1 m-30 -67.79 -50.97 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -27.47 67.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.044 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.447 ' HB2' HD21 ' B' ' 214' ' ' LEU . . . -58.43 -52.48 65.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.655 ' CZ ' ' CD1' ' B' ' 231' ' ' TYR . 41.9 t80 -61.93 -42.33 98.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.946 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -18.17 52.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 110.306 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -96.7 -28.57 14.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.455 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 4.2 tp -98.29 -10.66 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.655 ' CD1' ' CZ ' ' B' ' 227' ' ' PHE . 14.9 t80 -59.18 -42.52 93.71 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 111.013 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 47.3 Cg_endo -76.23 -44.0 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.381 1.2 . . . . 0.0 110.353 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 7.7 t -55.27 -38.51 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.873 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.467 ' CD2' HG22 ' B' ' 206' ' ' ILE . 40.4 mt -67.27 -50.65 59.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -0.831 . . . . 0.0 110.201 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 1.6 m -58.4 -29.48 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.85 -35.42 76.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.99 39.44 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.8 176.71 1.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.115 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 -59.53 1.7 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.213 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.176 0.512 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.43 85.56 0.15 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.424 ' O ' HD12 ' A' ' 14' ' ' ILE . 69.4 m -139.99 43.95 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -1.125 . . . . 0.0 110.156 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 13' ' ' SER . 21.1 mm -135.51 64.8 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 110.245 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.53 172.98 15.54 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -83.09 -104.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.159 . . . . 0.0 110.239 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.48 142.31 12.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.578 ' CD2' ' CD1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -112.66 175.25 5.51 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.374 -1.074 . . . . 0.0 109.288 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.49 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.6 OUTLIER -93.7 97.4 10.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.063 -1.023 . . . . 0.0 111.004 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.599 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -108.06 6.36 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.976 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.513 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 5.6 m -43.19 -26.77 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.483 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' CA ' HG22 ' A' ' 56' ' ' ILE . . . -98.55 -19.26 23.28 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.624 HG12 ' CG1' ' A' ' 28' ' ' ILE . 1.3 mm -57.07 -46.79 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.67 -1.488 . . . . 0.0 109.0 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 25' ' ' PHE . 1.1 pp -83.53 -24.43 31.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.922 -1.111 . . . . 0.0 109.976 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.463 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -83.82 9.25 12.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 137.34 103.71 0.66 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.561 ' C ' ' O ' ' A' ' 26' ' ' GLY . 20.0 p-10 -18.56 129.77 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.717 0.77 . . . . 0.0 111.827 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.624 ' CG1' HG12 ' A' ' 23' ' ' ILE . 1.5 pp -138.93 170.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.726 -0.609 . . . . 0.0 109.533 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 31' ' ' GLU . 77.5 m-20 -88.17 120.34 29.43 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.557 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 4.6 p -35.33 -31.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.594 0.711 . . . . 0.0 109.662 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.9 tt0 -47.14 -23.35 0.49 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.23 21.78 5.1 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.38 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.528 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.98 134.27 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.315 . . . . 0.0 109.351 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.553 ' HA ' HG21 ' A' ' 28' ' ' ILE . 5.4 tt -87.82 162.06 17.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.895 -1.128 . . . . 0.0 111.157 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.529 ' CD1' ' ND2' ' A' ' 27' ' ' ASN . 3.1 pp -139.05 -179.64 5.97 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.846 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.484 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 22.2 mt-30 -125.89 145.4 50.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.467 -0.771 . . . . 0.0 109.842 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -98.73 -29.35 13.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.101 -0.999 . . . . 0.0 110.591 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 38' ' ' ASP . 58.2 p30 -156.37 -146.36 0.17 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 110.513 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -157.71 161.14 38.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -104.52 78.87 0.28 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -17.19 47.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -1.122 . . . . 0.0 110.281 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.78 -88.66 1.02 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -92.66 45.57 1.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -1.167 . . . . 0.0 109.988 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 40' ' ' GLY . . . -108.84 104.67 2.0 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.89 -102.45 1.06 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 46' ' ' THR . 15.1 t -85.05 137.24 33.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -1.164 . . . . 0.0 109.802 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.81 177.38 28.88 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' ASP . 26.0 p90 -99.73 36.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -1.097 . . . . 0.0 110.014 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' PHE . 2.0 m-20 -41.24 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.714 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.82 26.62 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -0.915 . . . . 0.0 110.668 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.4 tp10 -100.24 -26.51 13.89 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.089 -1.007 . . . . 0.0 108.693 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.462 ' HB3' HD13 ' A' ' 56' ' ' ILE . 2.8 mt -98.32 -39.01 9.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.402 0.62 . . . . 0.0 109.689 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -44.38 -46.71 9.56 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.29 -32.6 74.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 109.553 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 59' ' ' LEU . 92.4 m-20 -76.76 -39.07 52.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.409 -0.807 . . . . 0.0 109.676 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.526 HG22 ' CA ' ' A' ' 22' ' ' GLY . 1.0 OUTLIER -53.46 -34.38 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.384 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.31 -27.12 72.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.48 ' O ' ' CD1' ' B' ' 189' ' ' LEU . 11.5 t -117.82 8.94 12.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 62' ' ' LEU . 6.0 mt -96.16 13.8 26.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.44 41.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.23 -0.919 . . . . 0.0 110.306 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HG3' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.57 19.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD1' HD21 ' A' ' 59' ' ' LEU . 6.0 mt -118.06 -58.64 1.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.361 -0.837 . . . . 0.0 109.232 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.4 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.5 mm? -52.13 -26.0 10.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -1.19 . . . . 0.0 110.57 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -45.95 -36.77 5.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.46 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.4 m -70.04 -59.5 2.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 110.048 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.477 ' SD ' ' HA2' ' B' ' 216' ' ' GLY . 0.2 OUTLIER -64.77 -11.96 42.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.03 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 20' ' ' LEU . 6.1 tt -69.39 -62.17 1.49 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.391 -0.818 . . . . 0.0 109.292 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.8 pp -66.78 -6.3 15.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.427 ' O ' HG21 ' A' ' 71' ' ' VAL . 2.1 tt0 -84.58 16.37 3.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.619 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.504 ' O ' HD13 ' B' ' 114' ' ' LEU . 2.9 t -141.37 4.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.932 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.599 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 1.4 tp -147.3 77.2 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.579 -0.701 . . . . 0.0 109.359 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.8 t70 -82.83 50.64 1.74 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 108.908 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.536 ' CD1' ' HB2' ' B' ' 99' ' ' PHE . 0.4 OUTLIER -75.89 43.47 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.74 -0.6 . . . . 0.0 111.657 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -170.91 2.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.825 -1.172 . . . . 0.0 110.193 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' O ' ' OE2' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -64.16 129.49 40.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.331 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.216 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.233 0.539 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.04 64.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -62.03 103.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 110.349 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.445 HG11 ' HD2' ' B' ' 65' ' ' PRO . 45.3 t -71.77 134.75 83.61 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.445 ' HD2' HG11 ' B' ' 64' ' ' VAL . 44.4 Cg_endo -71.55 135.66 26.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.937 1.493 . . . . 0.0 110.318 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.6 m -96.44 130.58 43.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.361 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 33.2 mt -74.76 123.35 24.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.867 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -113.95 -3.66 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -0.887 . . . . 0.0 110.705 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.525 ' CB ' ' HB ' ' B' ' 161' ' ' VAL . 0.2 OUTLIER -156.36 142.83 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.914 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.53 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 19.9 mm -132.13 150.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.829 . . . . 0.0 109.809 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.523 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 22.0 t -141.44 134.65 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' B' ' 157' ' ' ILE . . . -141.64 165.27 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.252 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 68.1 p -110.15 145.65 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.72 131.21 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 41.4 m -111.84 128.59 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.457 ' HB3' ' HA ' ' B' ' 150' ' ' ALA . 49.0 mt -88.07 -17.33 31.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -2.31 84.26 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 3.6 t -137.33 151.14 48.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.339 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.447 ' O ' ' CD2' ' B' ' 80' ' ' LEU . 0.9 OUTLIER -78.46 164.15 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.447 ' CD2' ' O ' ' B' ' 79' ' ' ARG . 23.8 mt -140.48 153.38 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 82' ' ' LEU . 34.8 t0 -92.77 100.59 13.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.463 HD23 HG22 ' B' ' 102' ' ' VAL . 18.0 mt -44.23 -34.95 2.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 1.9 tmtm? -66.14 -36.12 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 20.8 m -89.25 -40.13 13.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.561 HG21 ' CE2' ' B' ' 148' ' ' PHE . 91.1 t -58.29 -50.48 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 110.272 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.78 63.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.139 -0.976 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 27.6 tp -57.74 -28.48 63.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.453 ' HB2' HD12 ' B' ' 146' ' ' ILE . 3.7 m-70 -98.94 -40.37 8.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.319 -0.863 . . . . 0.0 110.081 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.481 ' HB3' ' CE ' ' B' ' 104' ' ' MET . . . -47.38 124.3 6.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 20.9 mtt180 -67.28 -21.35 65.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.42 79.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -158.13 165.18 35.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.19 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -145.24 152.93 40.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.154 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -139.52 122.53 16.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.265 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.73 134.72 10.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.87 . . . . 0.0 110.228 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.85 -41.04 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.948 1.499 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -50.37 -23.2 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -98.32 -65.44 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.585 ' CE1' ' O ' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.79 167.15 7.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.469 -0.77 . . . . 0.0 111.295 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.92 56.07 3.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.684 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.585 ' O ' ' CE1' ' B' ' 99' ' ' PHE . . . -148.88 159.62 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.977 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.463 HG22 HD23 ' B' ' 82' ' ' LEU . 30.8 t -101.02 132.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.848 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.468 HG12 ' OG ' ' A' ' 30' ' ' SER . 6.5 mt -95.74 112.46 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.481 ' CE ' ' HB3' ' B' ' 89' ' ' ALA . 2.8 ttm -102.29 157.76 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 110.014 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -161.66 131.58 4.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.137 -0.977 . . . . 0.0 110.439 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 26.7 pt -115.64 172.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.463 ' HA ' ' HG2' ' B' ' 110' ' ' LYS . 7.7 mtp180 -115.45 29.53 7.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -174.63 86.16 0.33 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.503 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' B' ' 111' ' ' THR . 51.0 Cg_endo -78.23 148.77 85.4 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.777 -2.176 . . . . 0.0 110.319 -0.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' B' ' 107' ' ' ARG . 12.0 mtmm -58.25 86.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.879 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.47 HG21 ' HA3' ' B' ' 125' ' ' GLY . 11.3 p -130.45 168.64 16.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.519 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.525 ' HB ' ' CD2' ' A' ' 35' ' ' LEU . 4.0 t -130.38 164.22 25.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.61 166.26 30.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.01 -1.057 . . . . 0.0 110.903 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.516 ' CD1' HD12 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -113.17 107.88 16.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.525 ' CD1' ' HG3' ' B' ' 121' ' ' MET . 13.8 mm -91.75 125.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 111.186 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 4.6 m-30 -103.57 166.06 10.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.479 -0.763 . . . . 0.0 109.64 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.05 -14.85 58.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.263 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' B' ' 79' ' ' ARG . 1.1 p -73.53 -30.27 62.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.305 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.75 -23.43 5.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -65.94 163.6 16.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.178 . . . . 0.0 110.049 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.525 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.8 OUTLIER -159.05 124.88 4.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 110.766 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.477 HG12 ' CG1' ' A' ' 71' ' ' VAL . 2.9 t -101.8 136.22 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 0.0 109.655 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.418 HG13 ' N ' ' B' ' 124' ' ' THR . 76.9 t -115.71 165.42 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.156 -0.965 . . . . 0.0 110.662 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.515 HG22 ' HA ' ' A' ' 27' ' ' ASN . 5.9 t -169.52 155.89 6.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.439 -0.788 . . . . 0.0 110.014 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.522 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 113.8 -4.06 24.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -84.21 168.99 15.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.192 -1.181 . . . . 0.0 110.502 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.439 ' C ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -121.89 -19.21 6.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 110.292 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' B' ' 129' ' ' GLU . 1.0 OUTLIER -139.86 -178.92 5.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -68.74 -43.59 75.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -33.5 72.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -50.64 37.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.251 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' B' ' 136' ' ' SER . 5.2 t -61.21 -22.21 64.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.942 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.5 -49.53 18.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.843 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -45.47 74.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -50.68 -49.01 58.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.832 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 132' ' ' SER . 0.6 OUTLIER -66.85 -49.5 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.682 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -54.05 -29.68 44.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' B' ' 141' ' ' ARG . 27.4 mmtt -70.86 -55.84 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.702 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 47.0 m-85 -49.47 -48.49 47.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -57.01 -36.54 70.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.395 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 65.6 ttt180 -57.51 -38.36 74.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.425 -0.797 . . . . 0.0 109.949 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.464 HG23 HD13 ' B' ' 146' ' ' ILE . 12.2 mt -66.76 -59.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.477 HG22 HD11 ' B' ' 143' ' ' ILE . 89.3 mt -56.6 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' B' ' 140' ' ' ALA . 20.5 mt-30 -67.55 -40.57 84.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 109.715 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -70.32 -21.29 62.94 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.464 HD13 HG23 ' B' ' 142' ' ' ILE . 6.5 mt -75.72 -29.46 20.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 125.07 -29.84 4.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.561 ' CE2' HG21 ' B' ' 85' ' ' VAL . 9.8 m-85 -43.89 156.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.014 -1.286 . . . . 0.0 110.637 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.62 48.58 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.129 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' B' ' 76' ' ' LEU . . . -84.42 171.49 12.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.403 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' B' ' 153' ' ' THR . 16.2 tttt -160.78 108.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.193 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.414 ' O ' ' CD2' ' B' ' 152' ' ' PHE . 47.7 t80 -49.7 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.265 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.9 OUTLIER -145.65 168.43 20.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.332 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.523 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t70 63.37 24.02 14.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -67.72 132.98 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 110.023 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -166.24 134.69 2.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.481 HG22 HD11 ' B' ' 157' ' ' ILE . 18.0 mt -79.38 122.85 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.59 6.38 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.523 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 1.1 m120 -154.51 123.08 6.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.374 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' B' ' 215' ' ' THR . 30.8 mt -122.64 149.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.525 ' HB ' ' CB ' ' B' ' 69' ' ' ASN . 58.6 t -130.35 138.38 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.572 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.37 171.57 25.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.34 152.85 5.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.938 -1.33 . . . . 0.0 110.697 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.475 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 31.0 p -166.79 166.4 15.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.53 171.31 8.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.75 -83.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt 178.1 -23.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.036 -1.04 . . . . 0.0 111.109 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -125.48 153.67 72.5 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.979 -1.076 . . . . 0.0 109.703 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.407 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 44.3 Cg_endo -72.34 147.29 46.87 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.943 1.496 . . . . 0.0 110.248 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.449 HG22 ' CD2' ' B' ' 234' ' ' LEU . 2.0 mp -108.23 156.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 110.599 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 14.2 mtt180 -91.29 101.97 14.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.775 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 25.2 mt -63.9 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.27 -34.29 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -64.97 -51.11 54.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.463 HD12 ' CG1' ' B' ' 233' ' ' VAL . 16.6 tp -65.71 -41.83 91.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -1.074 . . . . 0.0 109.907 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 180' ' ' GLY . . . -58.46 -43.53 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.8 t80 -59.76 -30.11 68.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -59.56 2.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.42 ' O ' ' N ' ' B' ' 183' ' ' SER . 41.5 m170 -97.98 32.53 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.338 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 176' ' ' ALA . . . -47.93 -62.74 3.97 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' THR . . . . . 0.559 HG22 ' CE1' ' B' ' 182' ' ' PHE . 10.3 t -45.85 -24.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -1.195 . . . . 0.0 110.272 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.559 ' CE1' HG22 ' B' ' 181' ' ' THR . 20.7 m-85 -102.43 -14.19 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.469 ' O ' ' O ' ' B' ' 180' ' ' GLY . 0.3 OUTLIER -140.86 149.04 41.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.931 . . . . 0.0 110.089 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -121.01 137.58 54.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.588 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -134.71 109.43 8.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 0.0 109.79 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.03 121.63 33.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.19 -11.98 25.32 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.891 1.469 . . . . 0.0 110.279 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.73 -23.85 22.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.113 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.48 ' CD1' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -89.84 -63.21 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.591 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 0.1 OUTLIER -169.68 161.07 7.18 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.43 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.9 Cg_endo -69.82 0.37 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.136 1.598 . . . . 0.0 111.842 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.591 ' HA3' ' CE2' ' B' ' 190' ' ' PHE . . . -89.25 149.41 20.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' B' ' 205' ' ' LEU . 10.3 tt -110.33 130.83 55.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -1.171 . . . . 0.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . . . . . . . . . 3.3 mt -95.63 111.21 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.225 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -100.89 113.7 26.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.297 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -91.1 88.58 7.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 110.145 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.42 ' HE3' ' HB2' ' B' ' 197' ' ' MET . 46.1 tpp -57.55 125.2 21.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.867 . . . . 0.0 110.377 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 34.7 t -57.52 -49.62 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.57 124.73 5.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.997 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.8 148.68 92.39 Favored 'Cis proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.011 -2.079 . . . . 0.0 110.424 -0.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -56.22 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.335 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' B' ' 222' ' ' GLU . 36.6 mm -136.84 153.5 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.17 112.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.925 . . . . 0.0 110.297 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' B' ' 226' ' ' ALA . 1.7 mp -107.42 149.13 28.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 0.2 OUTLIER -114.85 115.8 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.445 HD13 ' N ' ' B' ' 206' ' ' ILE . 4.6 mp -104.85 139.58 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -122.69 155.6 36.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.43 HG21 HD13 ' B' ' 172' ' ' LEU . 63.9 t -59.13 -31.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.348 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.3 t -57.04 -39.13 74.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.099 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.22 10.88 5.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.426 ' O ' HD12 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -89.66 135.45 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.426 HD12 ' O ' ' B' ' 211' ' ' LYS . 25.5 mm -113.74 134.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.3 t -114.32 163.45 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 1.4 mp -145.92 129.8 17.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.915 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 15.1 t -158.83 149.05 19.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 110.333 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.477 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 101.95 5.17 50.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.94 33.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -1.191 . . . . 0.0 110.161 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -93.18 -6.12 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.123 -0.985 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -154.68 -179.99 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.143 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -79.05 -25.34 43.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 110.22 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.79 -23.89 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.424 ' HB3' HD13 ' B' ' 202' ' ' ILE . 0.5 OUTLIER -78.13 -50.37 12.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 110.19 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 20.3 mm -58.8 -38.13 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.432 ' OH ' HG12 ' B' ' 64' ' ' VAL . 3.0 m-85 -70.6 -38.53 74.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.311 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -30.3 59.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.551 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.457 ' O ' HG12 ' B' ' 230' ' ' ILE . . . -64.72 -49.85 69.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -0.962 . . . . 0.0 110.417 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.475 ' CE1' ' SG ' ' B' ' 164' ' ' CYS . 16.1 t80 -69.07 -41.22 77.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.479 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -51.57 -38.19 53.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.82 -10.1 35.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.294 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.457 HG12 ' O ' ' B' ' 226' ' ' ALA . 10.5 mm -96.22 -17.73 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.58 ' N ' ' CD ' ' B' ' 232' ' ' PRO . 4.9 t80 -61.73 -42.1 81.41 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 48.5 Cg_endo -76.71 -49.26 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.346 1.182 . . . . 0.0 110.21 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.463 ' CG1' HD12 ' B' ' 175' ' ' LEU . 21.3 t -44.87 -40.48 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.764 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.449 ' CD2' HG22 ' B' ' 170' ' ' ILE . 74.0 mt -70.75 -63.36 1.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.779 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -46.9 -33.2 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.33 -34.19 77.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.403 -0.811 . . . . 0.0 110.014 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 57.3 m-85 -120.89 39.63 3.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.269 -0.894 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.49 ' NH2' ' O ' ' B' ' 239' ' ' LYS . 0.0 OUTLIER -71.57 -173.72 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.927 . . . . 0.0 110.175 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.49 ' O ' ' NH2' ' B' ' 238' ' ' ARG . 2.4 ttpt -125.68 -39.55 2.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.21 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.264 0.554 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.67 -88.59 1.21 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.05 89.63 2.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -1.12 . . . . 0.0 110.142 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 16' ' ' ASN . 2.9 mp -52.52 97.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.312 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.06 69.98 0.32 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 14' ' ' ILE . 20.1 p-10 -124.04 145.87 48.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -1.172 . . . . 0.0 110.373 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.04 132.95 4.94 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' B' ' 99' ' ' PHE . 0.0 OUTLIER -120.78 160.93 22.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.492 -1.005 . . . . 0.0 109.509 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.93 76.85 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.045 -1.034 . . . . 0.0 110.615 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -93.99 -0.32 55.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 111.253 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 9.0 m -45.91 -24.25 0.38 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.889 -1.132 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.454 ' C ' HG22 ' A' ' 28' ' ' ILE . . . -97.04 -31.93 6.7 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.607 ' CG1' HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -47.94 -47.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.403 . . . . 0.0 109.132 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.513 ' HB2' ' ND2' ' B' ' 159' ' ' ASN . 1.8 pp -83.51 -26.74 29.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.969 -1.082 . . . . 0.0 110.549 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -80.96 6.92 11.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.096 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 138.33 106.58 0.74 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.553 ' C ' ' O ' ' A' ' 26' ' ' GLY . 5.9 p30 -16.94 133.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.915 0.864 . . . . 0.0 112.186 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.565 ' CG1' HG12 ' A' ' 23' ' ' ILE . 2.0 pp -146.44 167.29 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.487 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.8 m-20 -87.88 121.14 29.93 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.542 ' OG ' ' CD1' ' B' ' 103' ' ' ILE . 9.3 p -36.93 -28.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.145 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.6 tt0 -58.51 -11.95 3.47 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.181 -0.949 . . . . 0.0 110.446 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.64 23.94 6.34 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.531 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.4 tpp180 -107.34 120.45 42.19 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.045 -1.268 . . . . 0.0 109.644 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' HA ' HG21 ' A' ' 28' ' ' ILE . 2.5 tm? -88.59 134.07 33.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.405 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 36' ' ' GLN . 1.1 pp -129.53 176.83 7.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.03 . . . . 0.0 109.993 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.559 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 4.5 mt-30 -134.87 -76.73 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.967 . . . . 0.0 110.572 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 36' ' ' GLN . 9.3 p-10 178.4 -44.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.161 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.96 -173.75 3.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.344 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.83 71.48 1.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 110.125 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.33 143.09 16.17 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -175.79 153.89 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -1.086 . . . . 0.0 110.174 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.95 63.15 3.36 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -170.57 84.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -1.122 . . . . 0.0 110.038 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.62 -123.71 27.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.55 79.98 0.34 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.34 2.54 56.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -1.185 . . . . 0.0 110.278 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.73 148.76 5.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.503 ' CD2' HD13 ' A' ' 52' ' ' LEU . 6.9 p90 -50.76 176.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -1.079 . . . . 0.0 110.029 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -97.39 -137.66 0.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 110.037 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.96 33.4 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.965 . . . . 0.0 110.224 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -100.46 -17.67 17.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.901 . . . . 0.0 109.591 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 48' ' ' PHE . 4.0 mt -95.32 -47.06 6.47 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.513 -0.742 . . . . 0.0 109.977 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.575 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.58 -50.89 52.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -63.75 -25.82 68.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.795 . . . . 0.0 110.06 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 3.5 m-80 -83.29 -33.88 25.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 4.3 mt -51.93 -46.03 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.292 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.28 -19.93 26.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.73 9.9 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -1.191 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 3.0 mt -84.76 15.85 3.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.141 -0.974 . . . . 0.0 110.419 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.0 p -105.94 39.78 1.71 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 110.221 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 29.31 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 63' ' ' GLY . 2.1 pp -147.5 -35.44 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.103 -0.998 . . . . 0.0 111.152 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' N ' HD11 ' A' ' 62' ' ' LEU . . . -170.14 -51.29 0.04 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.294 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.4 mm? -42.83 -24.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -1.232 . . . . 0.0 110.572 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 63' ' ' GLY . 1.8 t70 -42.79 -38.97 2.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.854 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 58.5 m -66.84 -56.88 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.406 -0.809 . . . . 0.0 109.809 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.451 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -65.22 -10.54 32.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.486 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.554 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -67.92 -63.93 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.745 0.783 . . . . 0.0 109.298 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -68.57 -5.12 18.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.808 -0.557 . . . . 0.0 110.226 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' C ' HG21 ' A' ' 71' ' ' VAL . 31.6 tt0 -83.17 5.68 21.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 111.201 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.575 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.3 t -140.22 4.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.173 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.562 HD12 ' CD2' ' A' ' 18' ' ' LEU . 5.2 tp -145.48 73.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.779 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t70 -81.8 51.77 1.79 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.528 HD12 ' CG1' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -78.01 45.1 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.528 -0.732 . . . . 0.0 111.46 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 76' ' ' GLU . 9.2 mtmt -100.23 153.45 19.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.056 -1.027 . . . . 0.0 110.069 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.52 ' CA ' ' OE1' ' A' ' 76' ' ' GLU . 0.0 OUTLIER 64.24 28.17 13.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.271 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.193 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.21 0.529 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 63' ' ' ILE . . . 167.51 41.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' B' ' 62' ' ' GLY . 2.1 mp -43.7 126.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -1.19 . . . . 0.0 110.089 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 70.2 t -89.82 142.2 28.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 110.505 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.2 Cg_endo -75.35 134.54 17.36 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.052 1.554 . . . . 0.0 110.417 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -90.71 127.17 36.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 mt -73.03 132.65 43.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.125 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -98.05 -41.08 8.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.101 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -170.03 179.07 3.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' B' ' 126' ' ' ALA . 9.5 mt -150.53 167.8 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.125 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.466 ' N ' ' CG2' ' B' ' 70' ' ' ILE . 52.8 t -137.4 140.64 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.131 -0.981 . . . . 0.0 110.426 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.55 50.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.426 -0.797 . . . . 0.0 110.068 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' THR . . . . . 0.409 HG21 ' O ' ' B' ' 73' ' ' THR . 1.8 t -115.24 133.85 55.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.422 HG22 ' OG ' ' B' ' 136' ' ' SER . 66.2 t -126.71 146.76 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 57.5 m -110.13 141.26 43.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.559 ' O ' ' CB ' ' B' ' 151' ' ' LYS . 7.4 mt -105.2 -72.93 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.485 -0.759 . . . . 0.0 109.898 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.33 -10.18 10.83 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' B' ' 148' ' ' PHE . 68.5 m -109.31 119.92 40.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.034 -1.274 . . . . 0.0 109.354 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.48 ' O ' HD22 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -44.02 147.94 0.45 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 110.032 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' B' ' 148' ' ' PHE . 27.0 mt -116.73 144.59 44.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 111.173 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' LYS . 0.2 OUTLIER -101.28 83.04 2.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.486 -0.758 . . . . 0.0 109.152 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' B' ' 81' ' ' ASP . 10.3 mt -37.09 -30.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.636 -0.665 . . . . 0.0 110.933 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' B' ' 81' ' ' ASP . 0.0 OUTLIER -70.28 -46.04 65.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 109.937 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 97.9 m -82.21 -31.41 30.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.382 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.5 -43.04 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.77 51.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 tp -85.24 -43.23 13.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.261 -0.9 . . . . 0.0 110.452 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.516 ' HB3' ' CG1' ' B' ' 146' ' ' ILE . 0.3 OUTLIER -74.43 -44.84 50.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 110.591 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.88 128.48 33.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.438 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -66.55 -24.93 66.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 9.0 p30 -135.22 79.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.077 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -160.07 137.04 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -117.39 171.18 8.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.448 ' HB2' HG21 ' B' ' 102' ' ' VAL . 13.3 t80 -164.2 102.2 0.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 110.301 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.437 ' HB3' ' HD3' ' B' ' 98' ' ' ARG . 0.7 OUTLIER -119.1 136.95 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.272 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -21.01 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.996 1.524 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -76.65 -17.3 59.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' B' ' 98' ' ' ARG . 3.2 mpt_? -96.45 -63.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.649 ' CE2' ' CB ' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.86 166.69 11.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.494 -0.754 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.97 53.43 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 111.909 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.649 ' CB ' ' CE2' ' B' ' 99' ' ' PHE . . . -153.19 154.25 34.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.143 . . . . 0.0 110.463 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' B' ' 114' ' ' LEU . 39.7 t -89.81 139.08 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.542 ' CD1' ' OG ' ' A' ' 30' ' ' SER . 8.4 mt -100.35 114.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 109.845 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.447 ' SD ' HD13 ' B' ' 115' ' ' ILE . 1.7 ttm -99.8 170.86 8.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 0.1 OUTLIER -169.99 132.42 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 0.0 110.046 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.467 HG12 ' OH ' ' B' ' 139' ' ' TYR . 22.8 pt -128.45 163.56 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.352 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -110.64 26.23 10.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.258 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER -172.76 86.28 0.41 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.267 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.465 ' O ' HG13 ' B' ' 106' ' ' ILE . 47.3 Cg_endo -74.85 161.52 94.6 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.564 -0.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -72.28 82.9 1.03 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' B' ' 124' ' ' THR . 37.0 p -132.46 176.3 8.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 110.518 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.571 ' CG2' ' CG2' ' B' ' 124' ' ' THR . 5.8 t -135.68 174.07 11.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.6 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' B' ' 122' ' ' VAL . . . -170.25 176.45 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.967 -1.083 . . . . 0.0 111.091 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.465 HD13 ' HB ' ' B' ' 122' ' ' VAL . 0.4 OUTLIER -143.17 122.89 13.35 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.491 HG21 ' N ' ' B' ' 116' ' ' PHE . 20.4 mt -100.35 160.34 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.006 . . . . 0.0 111.479 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 72' ' ' ILE . 34.8 m-85 -119.42 156.17 30.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 110.246 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -64.8 -16.45 63.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 4.4 p -71.29 -36.73 71.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.482 ' O ' HD13 ' B' ' 76' ' ' LEU . . . 129.41 4.24 4.96 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . 0.419 ' C ' ' HG3' ' B' ' 121' ' ' MET . 0.5 OUTLIER -100.4 138.89 36.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -1.175 . . . . 0.0 110.003 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.515 ' SD ' ' CG ' ' B' ' 76' ' ' LEU . 0.0 OUTLIER -128.03 129.45 46.72 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.04 . . . . 0.0 110.163 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.534 HG12 ' CG1' ' A' ' 71' ' ' VAL . 18.3 t -97.44 132.36 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 0.0 109.713 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.451 ' HA ' ' HB3' ' B' ' 113' ' ' ALA . 29.7 t -114.95 149.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 110.574 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.571 ' CG2' ' CG2' ' B' ' 112' ' ' THR . 6.2 t -149.54 156.48 42.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.521 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 110.04 -32.81 6.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.498 ' HB3' ' CA ' ' B' ' 132' ' ' SER . . . -45.35 125.13 5.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -1.115 . . . . 0.0 110.089 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -92.29 -17.92 24.09 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.23 -0.919 . . . . 0.0 109.802 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 42.0 t -142.44 151.87 42.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.387 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.16 -49.88 11.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -40.87 98.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.056 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -38.67 77.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.498 ' CA ' ' HB3' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -69.06 -44.43 72.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.161 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -25.56 65.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.23 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 0.6 OUTLIER -85.25 -36.26 21.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.338 -0.851 . . . . 0.0 110.287 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' B' ' 109' ' ' PRO . . . -70.49 -36.11 73.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.047 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.422 ' OG ' HG22 ' B' ' 74' ' ' VAL . 28.8 t -71.64 -59.8 2.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.507 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.0 ptm180 -46.19 -37.36 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.507 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 8.8 mttt -64.72 -45.98 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.467 ' OH ' HG12 ' B' ' 106' ' ' ILE . 9.5 m-85 -57.47 -56.95 15.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.516 ' HB2' ' NE2' ' B' ' 144' ' ' GLN . . . -49.04 -40.77 32.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.475 ' HA ' ' OE1' ' B' ' 144' ' ' GLN . 2.4 ttt-85 -53.4 -47.29 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.085 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 83.2 mt -61.81 -25.44 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 110.349 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.62 ' CG2' ' CB ' ' B' ' 149' ' ' ALA . 0.5 OUTLIER -83.83 -51.2 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 109.397 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.682 ' HG3' ' HA ' ' B' ' 150' ' ' ALA . 19.9 mt-30 -46.96 -36.5 7.79 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -72.16 -31.65 66.14 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' B' ' 143' ' ' ILE . 0.1 OUTLIER -74.71 -45.02 45.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.41 -26.16 1.37 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.15 -1.5 . . . . 0.0 112.033 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.565 ' O ' HG23 ' B' ' 143' ' ' ILE . 0.1 OUTLIER -142.31 -154.61 0.53 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.291 -1.711 . . . . 0.0 112.598 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . 0.62 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . . . 41.22 29.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.54 1.162 . . . . 0.0 107.889 -178.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.682 ' HA ' ' HG3' ' B' ' 144' ' ' GLN . . . -89.74 -19.06 25.21 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.814 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' B' ' 76' ' ' LEU . 1.9 mptt -71.03 133.21 46.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.568 -1.333 . . . . 0.0 110.33 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -115.19 75.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.858 . . . . 0.0 110.269 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -137.79 -174.05 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.229 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 1.9 t0 56.39 16.77 2.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -68.57 125.85 27.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.215 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -160.24 131.93 6.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 110.259 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.431 ' C ' ' HG2' ' B' ' 158' ' ' GLN . 21.4 mt -79.43 132.01 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.857 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.431 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 38.3 mm-40 -130.7 1.16 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 110.652 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -148.33 108.53 4.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.977 -1.077 . . . . 0.0 111.236 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' B' ' 219' ' ' GLN . 69.8 mt -117.67 137.26 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.837 . . . . 0.0 109.209 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 88.9 t -114.37 139.13 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 111.031 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -147.02 171.18 27.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.4 p -155.84 163.42 39.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.257 . . . . 0.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 17.6 p -165.65 169.84 14.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.843 . . . . 0.0 110.223 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 15.5 p-10 -120.55 144.01 48.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 109.988 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.592 ' HB ' ' CZ ' ' B' ' 168' ' ' PHE . 25.3 m -94.02 2.7 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.988 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 28.2 tttp 71.86 10.16 6.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 110.917 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 9.3 p90 -166.23 154.58 9.79 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 110.416 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.65 158.02 51.35 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.996 1.524 . . . . 0.0 110.784 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.47 HD13 ' HA2' ' B' ' 210' ' ' GLY . 2.4 mp -131.07 147.86 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.229 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.422 ' N ' HG21 ' B' ' 170' ' ' ILE . 7.5 ttm180 -76.93 92.05 3.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.924 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.469 HD12 ' N ' ' B' ' 208' ' ' VAL . 13.6 mt -50.57 -37.25 38.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.39 -43.49 60.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.245 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.39 80.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.36 -51.77 22.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -1.123 . . . . 0.0 110.12 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.498 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -57.84 -29.71 65.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.114 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -72.38 -36.54 68.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.13 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.59 -27.4 17.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.959 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -129.15 34.9 4.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 110.004 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.22 -18.29 64.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' THR . . . . . 0.51 HG21 ' N ' ' B' ' 182' ' ' PHE . 8.9 t -69.31 -21.43 63.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -1.137 . . . . 0.0 110.31 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.51 ' N ' HG21 ' B' ' 181' ' ' THR . 41.3 m-85 -129.57 3.14 5.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' B' ' 195' ' ' TYR . 0.9 OUTLIER -139.47 135.42 33.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 154.98 29.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.071 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -147.08 105.72 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.342 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 190' ' ' PHE . 7.4 mt-10 -108.75 105.27 56.71 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.74 -2.07 10.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.981 1.516 . . . . 0.0 110.599 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -19.88 16.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.074 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' B' ' 190' ' ' PHE . 4.7 tt -132.91 -29.73 1.44 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 110.551 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.488 ' HB2' HD21 ' B' ' 189' ' ' LEU . 1.9 t80 -131.8 111.29 14.7 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.32 -7.92 21.79 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.867 1.456 . . . . 0.0 110.231 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.97 179.98 21.89 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.454 HD11 ' O ' ' B' ' 172' ' ' LEU . 3.5 tt -113.74 125.95 54.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.398 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.463 HG12 HD21 ' B' ' 205' ' ' LEU . 44.2 mt -91.77 112.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.96 . . . . 0.0 109.953 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 2.2 t80 -108.49 124.61 50.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.381 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.454 ' HB2' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -105.82 79.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.057 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 32.1 ttm -49.11 134.72 17.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 40.5 t -73.01 -43.1 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.3 OUTLIER -143.2 116.43 6.05 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.113 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.1 Cg_endo -73.54 156.02 99.67 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.99 -2.087 . . . . 0.0 110.529 -0.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.511 ' O ' ' CD1' ' B' ' 202' ' ' ILE . 2.9 tptt -67.37 94.87 0.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.511 ' CD1' ' O ' ' B' ' 201' ' ' LYS . 11.2 mm -141.09 158.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.215 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 62.2 t -105.54 116.22 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.943 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.472 ' CD2' HG23 ' B' ' 230' ' ' ILE . 5.2 mp -108.12 108.67 19.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.497 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.463 HD21 HG12 ' B' ' 194' ' ' ILE . 0.9 OUTLIER -95.08 118.88 32.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.447 ' O ' HD23 ' B' ' 172' ' ' LEU . 3.2 mp -116.76 120.9 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.162 -0.962 . . . . 0.0 110.486 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' B' ' 207' ' ' PHE . 30.1 m-85 -93.33 172.22 8.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.469 ' N ' HD12 ' B' ' 172' ' ' LEU . 27.2 t -60.32 -39.83 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.327 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 50.6 m -53.16 -42.28 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.455 -0.778 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' B' ' 170' ' ' ILE . . . 125.81 4.34 6.75 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.31 136.45 44.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 110.089 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.456 ' HB ' ' SG ' ' B' ' 164' ' ' CYS . 14.6 mm -119.41 136.49 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.328 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 84.0 t -121.88 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.939 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 2.2 mp -127.03 117.16 21.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 13.6 t -135.57 160.53 38.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.105 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.57 -5.88 64.91 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' B' ' 222' ' ' GLU . . . -73.54 136.18 44.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.16 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.425 ' N ' ' OE2' ' B' ' 222' ' ' GLU . 0.0 OUTLIER -84.57 -8.69 58.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.092 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.467 ' HA ' ' CD1' ' B' ' 160' ' ' ILE . 1.0 OUTLIER -156.89 -174.02 4.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -82.15 -32.63 29.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 1.0 OUTLIER -52.44 -29.61 25.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.052 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.425 ' OE2' ' N ' ' B' ' 218' ' ' LYS . 21.1 mt-10 -76.85 -48.0 19.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.3 -39.03 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -69.88 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -83.59 -46.77 12.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.265 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.71 -40.65 20.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.441 ' O ' HG21 ' B' ' 230' ' ' ILE . 14.6 t80 -74.37 -48.33 28.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.0 -17.38 62.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.007 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -86.4 -32.92 20.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 109.922 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.472 HG23 ' CD2' ' B' ' 204' ' ' LEU . 1.0 OUTLIER -99.12 -17.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.846 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.589 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 51.9 t80 -47.71 -46.96 62.22 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.2 Cg_endo -71.43 -49.36 0.36 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.387 1.204 . . . . 0.0 110.18 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 9.3 t -47.71 -43.28 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.642 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.453 HD21 HG23 ' B' ' 170' ' ' ILE . 91.0 mt -63.12 -51.22 67.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' B' ' 232' ' ' PRO . 59.6 p -54.11 -27.76 35.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.65 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.82 -38.47 79.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.919 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -110.15 37.77 2.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -63.21 163.21 10.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.202 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.61 -28.83 6.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.877 . . . . 0.0 110.218 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.256 0.55 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.49 80.02 1.28 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.1 p -157.23 67.59 0.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.175 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 mt -83.3 148.74 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.235 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.72 -91.25 0.64 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -78.26 172.45 13.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.324 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 168.5 20.24 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD23 ' CE2' ' B' ' 99' ' ' PHE . 0.1 OUTLIER -128.82 158.63 38.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.447 -1.031 . . . . 0.0 109.196 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.433 ' O ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -93.8 128.38 40.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.122 -0.987 . . . . 0.0 111.497 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.57 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 9.6 mt -124.64 24.98 7.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 110.47 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.544 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 8.4 m -49.01 -36.6 18.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.464 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -85.67 -24.66 41.54 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.497 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.611 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 9.5 mm -50.37 -54.22 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.883 -1.363 . . . . 0.0 109.011 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.519 HD12 ' CD1' ' A' ' 64' ' ' LEU . 1.6 pp -79.33 8.89 5.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 110.023 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.413 ' HB2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -111.75 -15.41 13.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.006 -1.059 . . . . 0.0 111.026 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 156.99 44.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.531 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.556 ' HA ' ' CG2' ' B' ' 124' ' ' THR . 0.7 OUTLIER 61.72 132.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.929 -1.336 . . . . 0.0 110.185 178.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.611 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -162.2 158.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.818 0.818 . . . . 0.0 109.524 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLU . 77.1 m-20 -88.49 118.36 28.08 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.549 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -39.68 -26.82 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.992 -179.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 18.0 pt-20 -55.16 -16.33 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.043 -1.035 . . . . 0.0 109.991 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.98 14.29 10.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.52 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.69 115.88 28.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.074 -1.25 . . . . 0.0 109.939 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.587 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 1.2 tt -87.67 158.85 18.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.918 -1.114 . . . . 0.0 110.872 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 27' ' ' ASN . 4.0 pp -127.47 -179.57 4.98 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.711 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.428 ' N ' HD11 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -146.98 103.32 3.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.502 -0.749 . . . . 0.0 110.35 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 9.9 p-10 -46.45 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -0.825 . . . . 0.0 110.264 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 39' ' ' ASP . 7.2 t0 63.23 -158.75 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 110.129 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 15.3 m-20 59.84 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.6 -113.24 0.65 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -123.82 109.73 14.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -1.14 . . . . 0.0 110.253 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 46.28 10.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.52 -29.0 3.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -1.191 . . . . 0.0 110.273 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.81 0.1 10.91 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.04 150.67 46.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -136.79 146.11 45.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.137 . . . . 0.0 110.214 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 48' ' ' PHE . . . 135.68 171.26 12.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 49.7 p90 -43.47 122.07 2.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -1.139 . . . . 0.0 110.013 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.58 -127.75 0.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 110.379 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -99.79 23.23 9.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.957 -1.09 . . . . 0.0 110.348 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 1.6 tp10 -88.67 -52.04 5.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.519 ' CD1' HD12 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -93.5 -11.6 31.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.546 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -56.7 -54.05 50.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -0.996 . . . . 0.0 108.784 178.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.63 -23.34 64.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 58' ' ' SER . 45.8 m-80 -80.06 -33.31 39.1 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.546 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 24.6 mt -50.01 -41.98 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.51 -14.61 28.74 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -116.99 -7.1 11.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.89 179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.574 HD12 ' CE1' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -76.88 53.99 0.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.95 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m -126.81 32.59 5.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.786 . . . . 0.0 110.365 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HG3' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.19 17.87 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.322 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.486 ' CD2' ' HG3' ' A' ' 61' ' ' LYS . 6.9 mt -112.89 -63.09 1.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.561 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.5 -39.96 0.03 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.519 ' CD1' HD12 ' A' ' 24' ' ' LEU . 3.5 mm? -53.3 -19.4 3.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -1.117 . . . . 0.0 110.644 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' HD22 ' A' ' 69' ' ' LEU . 4.8 p-10 -46.07 -40.75 11.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 110.068 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -59.49 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.51 ' SD ' ' CD1' ' A' ' 24' ' ' LEU . 12.6 ttm -70.75 -3.49 19.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.766 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.5 tm? -69.43 -58.29 4.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 65' ' ' ASP . 1.6 pp -77.92 1.42 20.66 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.478 0.656 . . . . 0.0 109.613 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.441 ' CB ' ' HA ' ' A' ' 67' ' ' MET . 3.9 tt0 -87.94 15.5 7.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 3.8 t -138.93 -0.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.729 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.584 ' CD1' HD21 ' A' ' 18' ' ' LEU . 2.9 tp -151.17 84.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.515 -0.741 . . . . 0.0 109.32 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 2.1 p-10 -87.4 49.19 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.964 -1.085 . . . . 0.0 108.486 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.547 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 9.9 mt -90.88 62.27 4.93 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.675 0.75 . . . . 0.0 110.872 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -168.32 110.86 0.58 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.618 -0.676 . . . . 0.0 110.211 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 77' ' ' ALA . 1.2 mt-10 47.55 -112.7 0.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.149 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.853 -1.154 . . . . 0.0 110.318 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.177 0.513 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.87 39.72 62.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' B' ' 64' ' ' VAL . 6.3 mt -74.84 -40.54 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -1.124 . . . . 0.0 110.291 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' B' ' 63' ' ' ILE . 56.6 t 58.46 126.34 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.595 -0.691 . . . . 0.0 110.223 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 45.9 Cg_endo -73.49 151.53 47.68 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.858 1.451 . . . . 0.0 110.568 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.405 ' O ' ' CA ' ' B' ' 162' ' ' GLY . 98.1 m -101.47 164.79 11.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt -89.48 128.67 36.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.28 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.33 -32.62 10.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.507 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 7.6 m-20 -170.05 171.62 6.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.525 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 16.5 mm -131.77 155.52 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 110.149 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 37.6 t -138.29 113.7 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.864 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.505 ' CB ' ' HA ' ' B' ' 157' ' ' ILE . . . -128.42 156.46 43.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 110.587 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 26.1 p -105.69 114.16 28.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.93 120.64 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.455 ' O ' ' OG1' ' B' ' 153' ' ' THR . 52.5 m -97.08 160.68 14.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.52 ' CD1' ' CD1' ' B' ' 80' ' ' LEU . 22.0 mt -107.32 -59.89 1.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.237 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.86 -0.1 6.65 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 21.6 p -142.37 170.18 16.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -1.152 . . . . 0.0 110.187 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.453 ' HG2' ' N ' ' B' ' 80' ' ' LEU . 0.1 OUTLIER -83.34 154.32 24.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.52 ' CD1' ' CD1' ' B' ' 76' ' ' LEU . 70.8 mt -128.32 144.49 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.093 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 5.7 m-20 -89.86 94.6 9.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.501 ' HB3' ' CE1' ' B' ' 94' ' ' TYR . 12.3 mt -46.63 -45.17 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -54.78 -45.06 74.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 110.106 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 7.0 m -82.5 -38.68 23.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.7 t -61.44 -48.06 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' B' ' 82' ' ' LEU . . . -73.43 -24.24 60.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.277 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 19.7 tp -85.98 -23.8 26.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.498 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.4 OUTLIER -96.75 -42.91 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.181 -0.95 . . . . 0.0 110.378 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.471 ' HB2' ' HB1' ' B' ' 92' ' ' ALA . . . -45.92 123.49 4.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.129 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -24.05 64.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.25 -0.906 . . . . 0.0 110.293 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -137.14 79.59 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' B' ' 89' ' ' ALA . . . -164.96 161.24 19.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 0.0 109.856 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' B' ' 92' ' ' ALA . 58.6 mm-40 -152.78 138.38 17.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 110.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' B' ' 82' ' ' LEU . 19.8 t80 -93.17 148.24 22.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.725 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.444 ' HB3' ' HB2' ' B' ' 98' ' ' ARG . 0.1 OUTLIER -138.44 103.9 7.82 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 110.628 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.37 -17.71 16.44 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.045 1.55 . . . . 0.0 110.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.07 -4.23 58.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 0.0 110.269 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -116.55 -65.39 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.61 ' CE2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -153.67 -168.07 2.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.356 -0.84 . . . . 0.0 111.294 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.18 53.7 0.68 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.61 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -145.33 164.21 32.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 0.0 110.93 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.415 HG12 ' HB3' ' B' ' 86' ' ' ALA . 86.2 t -102.27 127.0 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.818 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -94.61 108.78 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 3.4 ttm -93.63 170.75 9.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.01 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.6 119.66 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.5 HG22 ' CE1' ' B' ' 139' ' ' TYR . 8.7 pt -122.58 149.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.32 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 2.3 ptt180 -99.12 33.13 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.1 tt0 -171.93 84.2 0.46 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 47.7 Cg_endo -76.51 162.1 92.49 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.657 -2.226 . . . . 0.0 110.463 -0.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -70.36 79.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.008 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.427 HG23 ' C ' ' B' ' 125' ' ' GLY . 67.7 p -131.12 -179.7 5.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.532 HG21 ' CG2' ' B' ' 124' ' ' THR . 13.4 t -138.58 158.48 44.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.427 ' HB1' ' CE2' ' B' ' 139' ' ' TYR . . . -149.77 154.96 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.934 -1.104 . . . . 0.0 111.162 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.477 HD12 HD12 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -124.16 111.61 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.13 136.96 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 111.483 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 5.2 m-30 -96.84 169.33 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.77 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.06 -0.96 42.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 110.097 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.7 -7.31 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.08 -2.49 40.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . 0.521 ' HB3' ' CD2' ' B' ' 116' ' ' PHE . 0.1 OUTLIER -85.42 146.11 27.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.111 -1.229 . . . . 0.0 110.024 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 29.2 ttp -149.51 125.55 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 71' ' ' VAL . 48.7 t -97.38 148.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.95 107.72 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 111.355 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.556 ' CG2' ' HA ' ' A' ' 27' ' ' ASN . 9.7 t -108.53 144.44 36.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.094 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.52 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 126.5 -27.2 5.03 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -52.92 149.01 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.03 -1.277 . . . . 0.0 109.719 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.0 OUTLIER -94.66 -19.97 19.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.027 -1.046 . . . . 0.0 109.862 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.416 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -161.99 -159.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -75.34 -36.83 60.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.07 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.48 -38.94 92.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.086 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.61 -52.8 22.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.299 -0.876 . . . . 0.0 110.231 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 30.3 t -45.91 -36.4 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.203 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -73.83 -31.93 63.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 50.5 mt -80.95 -46.63 14.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.47 -29.57 61.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.143 -0.973 . . . . 0.0 109.88 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.438 ' O ' ' C ' ' B' ' 137' ' ' ARG . 23.4 t -76.3 -64.43 1.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 110.243 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.581 ' HA ' ' CE1' ' B' ' 152' ' ' PHE . 14.6 ptm180 -41.79 -31.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.526 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 4.9 mmtm -67.83 -50.99 53.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.471 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.5 ' CE1' HG22 ' B' ' 106' ' ' ILE . 18.1 m-85 -60.03 -52.13 66.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.342 -0.849 . . . . 0.0 109.673 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.33 62.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.639 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -52.26 -40.44 61.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.646 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.448 ' O ' HG13 ' B' ' 146' ' ' ILE . 84.2 mt -63.34 -43.0 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.835 . . . . 0.0 110.195 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.532 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 52.0 mt -75.5 -49.06 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.71 -37.43 84.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' B' ' 141' ' ' ARG . 32.5 tttp -71.82 -27.03 62.64 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 142' ' ' ILE . 6.2 mt -74.01 -10.64 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.67 -19.3 28.66 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.532 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 6.4 m-85 -55.18 157.98 3.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -1.222 . . . . 0.0 111.057 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.41 49.72 0.99 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.62 -0.675 . . . . 0.0 109.742 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' B' ' 76' ' ' LEU . . . -96.26 144.78 26.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 110.835 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.427 ' O ' HD21 ' B' ' 76' ' ' LEU . 9.2 ptpt -142.28 -157.6 0.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.45 -0.781 . . . . 0.0 109.551 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.581 ' CE1' ' HA ' ' B' ' 137' ' ' ARG . 33.8 m-85 -106.09 117.39 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.016 . . . . 0.0 110.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' B' ' 75' ' ' THR . 0.8 OUTLIER -151.27 163.28 39.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' B' ' 75' ' ' THR . 13.8 t0 42.65 26.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 110.438 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 1.4 t80 -76.63 124.05 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 110.023 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . 0.443 ' N ' ' CD1' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -163.75 131.57 3.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.366 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.505 ' HA ' ' CB ' ' B' ' 72' ' ' ALA . 31.5 mt -78.78 107.87 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -110.45 12.01 23.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.657 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.526 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 6.2 m120 -153.46 115.44 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.548 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.495 HD11 HG22 ' B' ' 160' ' ' ILE . 31.2 mt -117.73 162.7 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.667 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.34 128.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.033 . . . . 0.0 110.624 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' B' ' 66' ' ' THR . . . -133.53 175.18 20.36 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 3.3 m -167.49 154.11 8.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -1.223 . . . . 0.0 110.456 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.432 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -169.95 161.9 9.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.122 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' B' ' 211' ' ' LYS . 4.2 m-20 -106.65 157.54 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.569 HG13 ' CZ ' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -110.46 3.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 3.8 tmtm? 74.34 -4.06 2.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.504 -0.748 . . . . 0.0 111.166 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.569 ' CZ ' HG13 ' B' ' 166' ' ' VAL . 38.5 p90 -149.57 144.91 18.31 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.009 -1.057 . . . . 0.0 110.278 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.468 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.7 Cg_endo -71.92 157.64 54.41 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.174 1.618 . . . . 0.0 110.714 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.18 154.35 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 110.284 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.34 90.4 8.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 109.994 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.486 ' CD1' ' HA2' ' B' ' 192' ' ' GLY . 24.3 mt -52.17 -34.25 44.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.518 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -62.86 -58.91 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -56.34 -42.24 88.66 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' B' ' 179' ' ' HIS . 14.5 tp -71.88 -38.37 70.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.185 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' B' ' 193' ' ' LEU . . . -71.13 -17.31 62.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -83.09 -40.86 19.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.123 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 15.3 t -81.61 -45.63 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.533 ' CD2' HD13 ' B' ' 175' ' ' LEU . 52.2 m-70 -95.4 14.93 20.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.33 -29.97 5.52 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 92.2 m -71.95 -25.44 61.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.3 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -106.1 -21.32 13.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' B' ' 194' ' ' ILE . 1.1 m -124.86 171.61 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.5 t -137.95 135.39 35.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.894 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.494 ' CD2' ' HD3' ' B' ' 187' ' ' PRO . 64.4 t80 -128.55 135.59 49.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.578 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' B' ' 190' ' ' PHE . 12.3 mm-40 -131.94 93.79 26.28 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.494 ' HD3' ' CD2' ' B' ' 185' ' ' TYR . 42.0 Cg_endo -68.99 -7.08 19.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.034 1.544 . . . . 0.0 110.365 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -100.41 -1.68 35.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.411 HD22 ' HB2' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -153.48 -48.33 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.134 -0.979 . . . . 0.0 110.565 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.574 ' CE1' HD12 ' A' ' 59' ' ' LEU . 3.0 t80 -108.76 117.56 53.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 110.514 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.53 -30.66 9.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.98 1.516 . . . . 0.0 110.178 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.486 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.75 -179.38 44.76 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.502 ' CD1' ' HB3' ' B' ' 176' ' ' ALA . 3.6 tt -123.4 150.81 43.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -1.187 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' B' ' 183' ' ' SER . 4.5 mt -107.52 100.79 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.485 ' OH ' ' ND1' ' B' ' 179' ' ' HIS . 0.6 OUTLIER -89.62 103.88 16.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.262 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' B' ' 202' ' ' ILE . 22.2 mtm180 -92.36 79.51 4.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.505 ' CE ' HG12 ' B' ' 230' ' ' ILE . 34.3 ttm -43.53 146.28 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 110.589 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.14 -34.61 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 110.079 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.8 116.05 2.24 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.54 147.42 89.56 Favored 'Cis proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.89 -2.129 . . . . 0.0 110.377 0.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.432 ' O ' HD12 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -59.27 101.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.51 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 37.9 mm -138.85 153.55 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.343 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.71 100.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.516 HD22 ' CD2' ' B' ' 214' ' ' LEU . 6.2 mp -94.67 127.25 40.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.46 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.514 ' CB ' ' HB ' ' B' ' 213' ' ' VAL . 0.1 OUTLIER -92.54 111.12 22.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.466 ' HB ' HD23 ' B' ' 172' ' ' LEU . 10.9 mm -96.68 139.32 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -128.81 136.41 50.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.141 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 54.8 t -49.19 -36.35 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.938 . . . . 0.0 110.215 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.6 m -53.3 -30.0 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.47 16.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.465 ' HA ' ' OD1' ' B' ' 165' ' ' ASP . 8.8 mttt -92.26 133.97 35.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.13 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 163' ' ' SER . 12.9 mm -117.54 135.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.371 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.514 ' HB ' ' CB ' ' B' ' 205' ' ' LEU . 69.3 t -123.06 113.68 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.812 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.516 ' CD2' HD22 ' B' ' 204' ' ' LEU . 3.5 mp -103.74 117.37 34.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.462 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.9 t -147.8 165.64 29.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.183 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.456 ' HA3' ' HE3' ' A' ' 67' ' ' MET . . . 92.49 21.76 30.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -100.32 141.57 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -1.099 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -16.0 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 109.94 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.12 145.72 24.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 110.027 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' B' ' 220' ' ' ARG . 0.6 OUTLIER -53.03 -25.73 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.244 -0.91 . . . . 0.0 110.329 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -38.68 91.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' B' ' 217' ' ' ALA . 82.0 mt-10 -67.59 -52.09 42.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.292 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' B' ' 224' ' ' TYR . 0.0 OUTLIER -53.08 -56.64 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.553 ' N ' ' CG2' ' B' ' 223' ' ' ILE . 1.7 m-30 -47.56 -31.07 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.004 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' B' ' 228' ' ' GLU . 2.8 mt-30 -78.42 -41.97 31.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.465 ' HB3' HD12 ' B' ' 204' ' ' LEU . . . -45.88 -44.36 14.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.868 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -69.5 -45.18 69.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.812 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . 0.413 ' OE1' ' HA ' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -53.28 -28.77 29.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.08 19.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 109.789 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.505 HG12 ' CE ' ' B' ' 197' ' ' MET . 5.9 mm -97.58 -13.4 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 109.821 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 41.7 t80 -52.46 -44.95 95.48 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.924 . . . . 0.0 110.694 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -74.28 -26.73 12.15 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.39 1.205 . . . . 0.0 110.315 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 25.0 t -66.23 -39.48 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 109.785 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.449 HD11 HG23 ' B' ' 166' ' ' VAL . 67.6 mt -68.5 -45.62 71.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 110.018 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 94.9 p -64.94 -44.58 88.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.87 . . . . 0.0 110.04 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.62 -37.33 49.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.927 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -110.62 36.59 3.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.968 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' B' ' 238' ' ' ARG . 0.2 OUTLIER -74.55 163.46 27.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -121.37 -30.68 4.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.106 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.261 0.553 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.63 130.77 4.78 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.87 55.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 110.447 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.532 HG22 HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -63.44 -27.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.101 -0.999 . . . . 0.0 110.156 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.9 138.35 5.54 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' GLY . 6.2 m120 -86.02 140.37 30.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -1.157 . . . . 0.0 110.343 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' ASN . . . 53.33 170.48 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.699 ' HB2' ' CG ' ' B' ' 99' ' ' PHE . 0.1 OUTLIER -60.29 159.57 9.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -1.144 . . . . 0.0 110.032 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.538 ' N ' ' CD1' ' A' ' 18' ' ' LEU . 37.0 t0 -68.28 67.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.753 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.614 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -84.28 -4.42 58.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 110.397 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.594 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 31.1 m -43.48 -36.45 2.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 110.289 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.507 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -92.41 -36.45 6.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.601 ' N ' HG22 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -49.93 -45.46 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -1.213 . . . . 0.0 108.82 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' CD2' ' HB3' ' A' ' 67' ' ' MET . 3.8 pp -79.74 6.35 11.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 109.607 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.547 ' CZ ' HD12 ' B' ' 205' ' ' LEU . 1.3 t80 -114.94 -13.89 11.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 111.232 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 164.73 46.9 0.02 OUTLIER Glycine 0 N--CA 1.496 2.649 0 C-N-CA 118.861 -1.638 . . . . 0.0 110.746 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.539 ' HB2' ' CG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 44.96 112.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.307 1.051 . . . . 0.0 111.784 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.688 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -145.0 158.24 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.528 ' N ' HG12 ' A' ' 28' ' ' ILE . 44.8 m-20 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.547 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 13.7 p -38.66 -28.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.475 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.8 tt0 -54.02 -17.02 2.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 110.233 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.53 28.22 5.5 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.502 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -123.97 125.87 45.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.003 -1.293 . . . . 0.0 110.359 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.688 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.31 153.16 17.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 110.706 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.539 ' CG ' ' HB2' ' A' ' 27' ' ' ASN . 4.3 pp -128.34 -178.88 4.74 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.784 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -131.42 122.8 26.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.639 -0.663 . . . . 0.0 110.101 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' B' ' 110' ' ' LYS . 10.8 t0 -63.02 -11.84 22.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.359 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -58.39 163.94 2.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -118.18 8.96 12.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 110.383 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.57 116.55 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.87 -174.5 2.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -1.144 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.55 -64.15 2.32 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -59.84 117.47 5.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -1.12 . . . . 0.0 110.201 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.64 146.07 8.04 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.69 -157.3 32.61 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -124.2 120.13 31.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -1.168 . . . . 0.0 110.285 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.42 -163.69 26.36 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' A' ' 48' ' ' PHE . 25.1 p90 -78.47 149.33 33.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.166 . . . . 0.0 110.228 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -96.75 -114.87 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.73 34.94 2.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.141 . . . . 0.0 110.295 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 13.8 pt-20 -95.53 -23.73 16.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mt -96.81 -43.7 7.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.016 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -45.23 -45.16 11.64 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.967 -179.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.98 -30.26 70.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.547 ' HB3' ' CE1' ' B' ' 190' ' ' PHE . 91.2 m-20 -80.69 -37.8 30.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.713 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.558 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 7.7 mt -49.28 -46.22 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.355 -0.841 . . . . 0.0 109.54 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.77 -17.12 26.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.441 ' HB3' HD13 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -119.46 7.75 11.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -1.143 . . . . 0.0 110.315 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.535 ' CD1' ' HA ' ' A' ' 56' ' ' ILE . 1.8 mt -86.76 31.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.524 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -118.2 39.07 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.204 -0.935 . . . . 0.0 110.49 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HE3' HD12 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -162.42 31.43 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.522 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD11 ' N ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -145.22 -26.65 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 111.256 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.519 ' N ' HD11 ' A' ' 62' ' ' LEU . . . 177.47 -44.52 0.1 OUTLIER Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.157 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -53.4 -17.7 2.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -1.188 . . . . 0.0 110.67 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 80.6 m-20 -46.42 -39.82 11.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.085 -1.009 . . . . 0.0 110.116 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -62.26 -57.05 12.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.877 . . . . 0.0 110.098 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.505 ' HB3' ' CD2' ' A' ' 24' ' ' LEU . 4.9 tpp -64.32 -11.01 27.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 21' ' ' THR . 1.3 tm? -68.0 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.974 0.892 . . . . 0.0 109.024 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.82 -2.46 17.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.307 0.575 . . . . 0.0 110.222 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.404 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 13.3 tt0 -85.8 0.53 52.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.229 -0.919 . . . . 0.0 111.53 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.592 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.2 t -137.92 3.24 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.265 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.614 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 6.0 tp -149.85 70.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -75.83 57.33 1.02 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.631 ' HB3' ' CZ ' ' B' ' 99' ' ' PHE . 6.1 mt -107.09 67.2 0.69 Allowed 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.681 0.753 . . . . 0.0 110.382 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 76' ' ' GLU . 0.9 OUTLIER -129.83 60.64 1.59 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.529 -0.732 . . . . 0.0 110.019 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.1 tt0 66.27 31.38 8.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -0.885 . . . . 0.0 110.183 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.25 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.306 0.574 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.13 69.45 0.05 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.79 136.99 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -1.15 . . . . 0.0 110.219 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.402 ' O ' ' SG ' ' B' ' 164' ' ' CYS . 55.8 t -92.47 140.07 24.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.876 . . . . 0.0 110.248 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.458 ' HG3' ' HB2' ' B' ' 227' ' ' PHE . 44.5 Cg_endo -71.29 138.45 33.1 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.011 1.532 . . . . 0.0 110.476 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.463 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 17.0 m -106.67 141.35 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.523 HD12 ' CG2' ' B' ' 160' ' ' ILE . 40.6 mt -78.66 122.24 25.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.521 ' O ' ' ND2' ' B' ' 69' ' ' ASN . 19.7 mm-40 -110.16 -15.71 13.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 110.383 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.533 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 10.4 m120 -160.94 121.7 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.299 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.514 HG23 ' N ' ' B' ' 71' ' ' VAL . 10.1 mt -122.54 171.33 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.902 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 7.6 t -144.79 134.31 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.64 133.29 54.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 38.7 m -92.14 127.33 37.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.093 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' B' ' 155' ' ' PHE . 40.6 t -131.12 133.04 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.385 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 4.4 m -101.27 139.98 36.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 110.056 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.46 ' CD1' ' O ' ' B' ' 119' ' ' GLY . 29.2 mt -87.16 -67.25 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 143.32 -17.75 2.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 30.1 p -141.7 141.08 33.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.423 ' C ' ' HG ' ' B' ' 80' ' ' LEU . 1.5 ptt85 -57.9 163.56 2.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.446 HD13 ' CD1' ' B' ' 76' ' ' LEU . 18.0 mt -139.86 155.98 46.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 110.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 3.7 m-20 -89.75 102.59 15.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 13.6 mt -48.39 -31.44 6.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.333 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -67.25 -38.59 85.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 110.255 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 31.7 p -81.9 -41.96 20.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' B' ' 89' ' ' ALA . 24.2 t -58.66 -42.46 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.44 ' HB3' HG12 ' B' ' 102' ' ' VAL . . . -81.03 -18.39 46.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 87' ' ' LEU . 13.4 tp -87.08 -31.38 20.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -95.59 -29.3 14.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.397 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.41 ' CB ' ' HB1' ' B' ' 92' ' ' ALA . . . -63.35 133.37 53.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -25.45 59.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 110.383 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 2.4 m120 -132.25 79.42 1.86 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.41 ' HB1' ' CB ' ' B' ' 89' ' ' ALA . . . -148.75 158.41 44.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -129.78 147.34 51.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -147.6 111.14 4.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.925 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -135.35 122.85 15.07 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 110.41 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.72 -17.3 26.11 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.916 1.482 . . . . 0.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -21.6 62.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 110.208 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.435 ' HG3' ' NH1' ' B' ' 98' ' ' ARG . 0.0 OUTLIER -101.9 -56.95 2.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.606 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.699 ' CG ' ' HB2' ' A' ' 18' ' ' LEU 0.257 62.6 t80 -170.18 -179.14 3.02 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.866 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.448 ' O ' HD11 ' A' ' 74' ' ' LEU . . . -99.41 70.72 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.5 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -155.43 149.67 25.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.558 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' B' ' 86' ' ' ALA . 44.7 t -102.03 117.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' B' ' 113' ' ' ALA . 1.3 mp -89.55 111.38 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.483 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.529 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.6 OUTLIER -89.93 153.01 20.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.774 179.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -149.53 118.05 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.047 -1.033 . . . . 0.0 110.728 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.567 HG21 ' CE1' ' B' ' 139' ' ' TYR . 34.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 109.706 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -104.03 35.59 2.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 110.39 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -171.82 81.49 0.48 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.461 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.469 ' O ' HG13 ' B' ' 106' ' ' ILE . 50.3 Cg_endo -79.63 165.35 80.08 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.538 -0.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 8.4 tptt -70.24 94.17 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' B' ' 124' ' ' THR . 18.4 p -139.59 177.66 7.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.713 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' B' ' 113' ' ' ALA . 0.9 OUTLIER -119.7 173.43 7.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.451 -0.78 . . . . 0.0 109.383 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.548 ' N ' ' CG2' ' B' ' 112' ' ' THR . . . -146.93 133.97 20.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.509 HD13 ' CD1' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -107.22 97.18 6.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.521 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 68.8 mt -97.34 150.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.101 -0.999 . . . . 0.0 111.274 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 72' ' ' ILE . 2.3 m-85 -118.81 174.13 6.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 109.861 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -87.4 -3.29 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 109.907 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.88 -22.34 24.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.46 ' O ' ' CD1' ' B' ' 76' ' ' LEU . . . 126.57 -38.98 2.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.63 153.46 2.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -1.157 . . . . 0.0 110.026 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.453 ' HG3' HG12 ' B' ' 115' ' ' ILE . 1.9 ttm -140.76 148.77 41.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' B' ' 114' ' ' LEU . 1.4 t -129.02 142.21 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.49 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 21.7 t -132.04 112.41 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 27' ' ' ASN . 1.7 t -104.86 165.37 11.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.382 -0.824 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.464 ' HA2' ' CG ' ' A' ' 27' ' ' ASN . . . 107.87 -28.26 12.67 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -51.5 144.91 9.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -1.222 . . . . 0.0 110.241 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' B' ' 128' ' ' SER . 17.0 pttm -112.62 -23.54 10.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.422 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -137.25 -153.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.79 -39.27 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.319 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.9 -42.45 90.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.62 -47.21 79.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 110.204 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 35.7 t -52.27 -46.96 66.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.241 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -36.86 80.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 110.212 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.82 -50.39 36.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.73 -50.27 66.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -54.34 41.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.009 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.431 ' HD3' ' HD3' ' B' ' 138' ' ' LYS . 0.0 OUTLIER -46.5 -39.37 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.961 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.431 ' HD3' ' HD3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -61.29 -53.73 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.945 . . . . 0.0 110.052 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.567 ' CE1' HG21 ' B' ' 106' ' ' ILE . 40.5 m-85 -54.21 -52.72 60.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.257 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.37 -31.93 16.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -35.98 81.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 13.8 mt -63.97 -48.62 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.526 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.493 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 20.4 mm -61.66 -49.32 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -68.95 -27.56 65.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.085 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -77.35 -20.6 54.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.237 -0.914 . . . . 0.0 108.75 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.468 HG22 HD11 ' B' ' 146' ' ' ILE . 6.8 mt -87.57 -19.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.697 -0.627 . . . . 0.0 109.34 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.45 -29.41 5.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.493 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 6.8 m-85 -47.88 159.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.032 -1.275 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.12 42.07 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.651 -0.655 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.457 ' HB1' HG23 ' B' ' 143' ' ' ILE . . . -71.33 154.87 41.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.601 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -144.42 120.52 10.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 109.768 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 63.3 t80 -60.89 111.46 1.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.452 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -158.16 163.25 37.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 0.4 OUTLIER 63.43 13.95 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' B' ' 156' ' ' LYS . 19.8 t80 -61.41 126.41 27.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.972 -1.08 . . . . 0.0 109.838 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 155' ' ' PHE . 27.5 mtpt -160.77 133.35 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.548 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.419 HG22 HG22 ' B' ' 70' ' ' ILE . 2.9 mp -79.49 127.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.755 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -129.33 -25.69 2.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.209 -0.932 . . . . 0.0 110.88 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.515 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.1 OUTLIER -113.54 96.88 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.793 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.523 ' CG2' HD12 ' B' ' 67' ' ' LEU . 44.5 mt -107.85 111.36 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.552 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.466 HG21 ' OG1' ' B' ' 215' ' ' THR . 25.2 t -94.8 107.66 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.789 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -111.5 167.52 12.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.8 t -169.16 159.72 9.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.923 -1.339 . . . . 0.0 110.63 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' B' ' 64' ' ' VAL . 0.0 OUTLIER -169.85 170.11 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.845 . . . . 0.0 109.928 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.89 161.05 14.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.969 . . . . 0.0 110.281 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.54 -83.8 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.89 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 110.8 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.484 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 7.0 p90 -137.49 166.31 27.59 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.7 Cg_endo -71.18 149.42 57.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.782 1.412 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.39 160.57 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.301 -0.874 . . . . 0.0 110.376 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.07 91.42 6.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 83.0 mt -48.34 -26.37 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.38 -58.57 4.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -51.22 -31.82 27.68 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.442 HD12 ' ND1' ' B' ' 179' ' ' HIS . 0.1 OUTLIER -72.97 -42.89 62.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -1.165 . . . . 0.0 110.229 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.423 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -68.09 -13.46 62.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.143 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.6 t80 -92.8 -37.52 12.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' SER . . . . . 0.474 ' HB2' ' CZ ' ' B' ' 237' ' ' PHE . 46.6 t -83.82 -50.27 8.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.442 ' ND1' HD12 ' B' ' 175' ' ' LEU . 20.0 m80 -105.4 19.4 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.887 . . . . 0.0 110.225 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' B' ' 176' ' ' ALA . . . -54.36 -25.74 34.72 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.07 -24.31 62.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -1.145 . . . . 0.0 110.263 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.57 ' CZ ' HG23 ' B' ' 198' ' ' VAL . 0.9 OUTLIER -134.66 12.04 3.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 48.6 m -120.15 159.47 24.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 0.0 110.373 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 16.9 m -134.84 126.81 29.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.174 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -136.55 120.03 17.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 110.41 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -132.25 105.17 13.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.818 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.96 -2.86 12.17 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.084 1.571 . . . . 0.0 110.346 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.0 5.86 45.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.875 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.441 HD13 ' HB3' ' A' ' 58' ' ' SER . 0.4 OUTLIER -157.82 -41.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 110.266 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 55' ' ' ASN . 3.0 t80 -126.35 114.15 23.42 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -17.82 28.02 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.838 1.441 . . . . 0.0 110.49 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -94.31 179.79 37.84 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.439 HD21 HD11 ' B' ' 206' ' ' ILE . 9.5 tt -120.41 126.99 51.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.334 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.436 ' CG1' HD22 ' B' ' 205' ' ' LEU . 6.5 mt -90.95 107.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.4 t80 -96.44 116.7 29.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 87.55 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.0 ttm -59.53 144.07 48.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.57 HG23 ' CZ ' ' B' ' 182' ' ' PHE . 65.2 t -88.26 -40.37 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 110.436 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.93 107.49 6.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.365 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.96 166.31 83.26 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.049 -2.063 . . . . 0.0 110.55 -0.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.0 OUTLIER -76.31 95.73 3.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 33.4 mm -134.91 160.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.45 107.04 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.506 HD22 ' CD2' ' B' ' 214' ' ' LEU . 1.5 mp -100.07 134.63 42.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.547 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 2.8 mt -110.83 116.26 30.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.439 HD11 HD21 ' B' ' 193' ' ' LEU . 3.6 mp -100.48 136.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.273 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' B' ' 208' ' ' VAL . 49.0 m-85 -119.92 131.23 55.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 0.0 110.069 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 22.0 t -42.79 -27.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 207' ' ' PHE . 98.3 p -64.51 -26.58 68.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 110.75 9.02 23.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.426 ' C ' ' CD1' ' B' ' 212' ' ' ILE . 0.1 OUTLIER -98.2 121.93 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -1.185 . . . . 0.0 110.153 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' B' ' 212' ' ' ILE . 1.2 mp -109.97 146.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.248 -0.907 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 27.6 t -127.81 146.65 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 110.08 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.506 ' CD2' HD22 ' B' ' 204' ' ' LEU . 4.4 mp -133.2 109.51 9.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.466 ' OG1' HG21 ' B' ' 161' ' ' VAL . 14.7 t -130.23 152.04 50.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.149 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.486 ' CA ' ' HE2' ' A' ' 67' ' ' MET . . . 109.03 -11.92 34.31 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -68.77 144.57 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.165 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -90.04 -17.37 27.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.173 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.408 ' N ' ' CD1' ' B' ' 160' ' ' ILE . 1.7 mt-30 -147.95 168.94 20.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -14.54 62.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.138 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' B' ' 221' ' ' GLU . 8.5 mp0 -68.73 -42.19 77.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 110.081 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -63.78 -51.15 66.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.456 HG21 HD11 ' B' ' 223' ' ' ILE . 45.8 mm -56.0 -37.2 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.05 -42.87 93.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 226' ' ' ALA . 0.0 OUTLIER -75.9 -44.11 42.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.296 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 225' ' ' GLN . . . -45.3 -41.38 8.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.458 ' HB2' ' HG3' ' B' ' 65' ' ' PRO . 10.2 t80 -78.39 -50.26 12.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 109.88 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -18.62 33.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.982 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -97.86 -32.61 11.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' B' ' 232' ' ' PRO . 5.8 tp -92.98 -17.79 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.583 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.3 t80 -50.88 -44.99 87.24 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 111.107 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.7 Cg_endo -71.93 -32.65 10.95 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.205 1.108 . . . . 0.0 110.496 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.37 -30.41 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 109.893 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.438 HD23 HG12 ' B' ' 206' ' ' ILE . 89.7 mt -70.91 -56.49 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.993 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -25.3 17.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -48.88 62.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' B' ' 178' ' ' SER . 92.4 m-85 -106.87 37.51 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.38 -0.825 . . . . 0.0 109.87 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -163.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' B' ' 169' ' ' PRO . 1.7 ttmm -126.7 -81.12 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 1.8 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.314 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.274 0.559 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.11 -36.21 92.67 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 m -168.66 152.21 5.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -1.204 . . . . 0.0 110.403 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.7 tt -172.33 159.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.24 -0.913 . . . . 0.0 110.175 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.26 83.89 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.83 -68.25 0.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -1.181 . . . . 0.0 109.977 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' C ' ' CZ ' ' B' ' 99' ' ' PHE . . . 78.81 139.14 1.57 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.655 ' N ' ' CZ ' ' B' ' 99' ' ' PHE . 0.2 OUTLIER -65.02 173.88 2.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.325 -1.103 . . . . 0.0 109.647 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.26 75.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 0.0 110.25 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.607 ' CD1' ' HB ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -91.14 -7.53 51.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 91.9 m -43.38 -30.7 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.43 -31.48 6.44 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.553 HG13 HD21 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -52.79 -41.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.316 . . . . 0.0 109.333 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.537 ' CD2' HD13 ' A' ' 68' ' ' LEU . 1.4 pp -84.51 -18.94 34.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.742 -1.223 . . . . 0.0 108.652 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -99.6 14.57 29.55 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 141.18 93.27 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.532 ' CB ' ' CG2' ' B' ' 124' ' ' THR . 4.9 p30 -28.42 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.69 0.757 . . . . 0.0 112.066 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.79 169.1 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.599 ' N ' HG12 ' A' ' 28' ' ' ILE . 94.9 m-20 -86.41 123.92 32.17 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.515 ' HB3' ' CG1' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -36.56 -29.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.923 -177.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.5 tt0 -50.26 -21.16 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 109.87 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.82 25.45 4.23 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.672 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.57 135.19 52.94 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.808 -1.407 . . . . 0.0 110.988 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.639 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -103.43 154.01 19.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 111.235 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.531 ' CD2' ' OD1' ' A' ' 27' ' ' ASN . 3.0 pp -126.66 -178.88 4.54 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.156 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 11.5 mt-30 -145.4 13.11 1.38 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.494 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' B' ' 110' ' ' LYS . 1.2 m-20 50.34 50.61 18.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 0.0 110.216 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 61.63 -178.2 0.12 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 110.147 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -118.73 -169.15 1.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.934 . . . . 0.0 110.232 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.13 133.77 10.08 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -116.2 -169.59 1.64 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -1.146 . . . . 0.0 110.12 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.42 -88.5 1.3 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -21.76 66.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.324 -1.103 . . . . 0.0 110.245 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.98 171.28 40.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.21 -105.15 0.27 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.8 m 60.04 72.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -1.154 . . . . 0.0 110.19 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.92 -161.62 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 48' ' ' PHE . 23.2 p90 -45.92 126.19 7.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -1.132 . . . . 0.0 110.203 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -100.26 -84.14 0.43 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.071 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.23 33.84 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 110.144 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.5 tt0 -100.65 -24.29 14.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' ASN . 3.9 mt -99.61 -44.37 6.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.73 -44.38 4.32 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.395 -0.816 . . . . 0.0 109.931 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.26 -27.25 65.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 52' ' ' LEU . 29.2 m-80 -81.45 -36.03 29.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 6.8 mt -55.54 -44.05 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 0.0 109.541 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.42 -17.09 31.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -129.75 18.83 5.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -1.089 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' B' ' 190' ' ' PHE . 3.0 mt -80.93 -5.1 57.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 97.9 p -90.08 37.88 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 0.0 109.691 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 58' ' ' SER . 13.7 mtpp -121.17 6.66 10.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.61 -85.02 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.48 28.9 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.307 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.54 HD13 ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -100.69 -27.96 13.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.024 -1.28 . . . . 0.0 109.005 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 50.2 t0 -45.21 -38.28 5.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.5 ' HA ' ' CD2' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -53.9 -30.63 46.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.991 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.479 ' SD ' ' CA ' ' B' ' 216' ' ' GLY . 0.9 OUTLIER -78.17 -25.63 47.29 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 109.803 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 7.9 mp -61.93 -58.66 7.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.5 ' CD2' ' HA ' ' A' ' 66' ' ' SER . 2.1 pp -52.75 -19.1 2.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.555 -0.716 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 35.3 tt0 -75.33 -2.98 30.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 110.356 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.607 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 1.4 t -132.77 1.46 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.118 -0.989 . . . . 0.0 109.875 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.559 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 7.5 tp -146.82 67.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.638 -0.664 . . . . 0.0 109.918 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 46.4 t0 -76.8 57.84 1.35 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.617 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 6.0 mt -105.12 66.94 0.77 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.577 0.703 . . . . 0.0 110.85 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 58.47 0.82 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.531 -0.731 . . . . 0.0 110.184 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 178.47 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.141 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.878 -1.139 . . . . 0.0 110.162 179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.332 0.587 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.02 67.28 0.34 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' B' ' 64' ' ' VAL . 3.4 mt -81.07 -27.23 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -1.162 . . . . 0.0 110.116 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' B' ' 63' ' ' ILE . 38.8 t 58.55 137.79 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 0.0 110.514 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.484 ' HD3' ' CD2' ' B' ' 227' ' ' PHE . 44.6 Cg_endo -73.27 124.74 9.7 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.859 1.452 . . . . 0.0 110.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.496 ' O ' ' CA ' ' B' ' 162' ' ' GLY . 2.3 m -89.97 156.4 18.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.96 137.97 31.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.213 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -126.91 -10.74 6.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.511 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.476 ' OD1' ' HA2' ' B' ' 125' ' ' GLY . 0.5 OUTLIER -168.02 131.0 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.474 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 124' ' ' THR . 4.1 mt -129.74 165.75 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.454 HG21 ' CB ' ' B' ' 124' ' ' THR . 42.5 t -139.89 144.76 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 110.568 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.97 162.31 35.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.055 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 42.1 p -110.76 141.64 43.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.067 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.505 ' CG1' ' HE3' ' B' ' 121' ' ' MET . 60.6 t -131.92 146.6 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 110.173 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' B' ' 154' ' ' ASP . 2.3 m -118.84 129.1 55.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' B' ' 151' ' ' LYS . 64.2 mt -89.67 -40.72 12.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 110.102 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.04 22.18 20.98 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.86 146.55 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -1.191 . . . . 0.0 110.381 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -77.16 148.58 35.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.418 HD12 HD11 ' B' ' 76' ' ' LEU . 13.7 mt -129.37 149.31 51.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.7 OUTLIER -90.07 94.74 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.733 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.459 HD21 ' CG2' ' B' ' 102' ' ' VAL . 13.1 mt -40.24 -55.23 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 0.0 110.462 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -47.25 -39.72 14.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 99.3 m -76.35 -41.04 49.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.54 -56.76 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 110.448 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.81 55.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.324 -0.86 . . . . 0.0 110.734 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 0.9 OUTLIER -72.13 -51.26 22.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.543 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -72.77 -42.23 64.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 0.0 110.482 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -42.7 122.34 2.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.429 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -73.53 -26.07 60.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.094 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 1.8 m120 -130.05 78.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -170.28 170.23 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.429 -0.794 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.466 ' HG3' HD11 ' B' ' 103' ' ' ILE . 9.6 pt-20 -160.2 137.2 9.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -108.54 116.47 32.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 110.088 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.23 107.12 55.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.314 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -23.13 18.95 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.895 1.471 . . . . 0.0 110.089 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -24.38 63.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.099 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.45 -69.32 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.031 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.655 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.36 166.23 26.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.4 44.85 1.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.617 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -122.83 146.83 47.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.459 ' CG2' HD21 ' B' ' 82' ' ' LEU . 30.9 t -89.97 122.15 41.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.325 -0.86 . . . . 0.0 109.05 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.521 HG22 ' CA ' ' A' ' 29' ' ' ASP . 4.1 mp -89.3 110.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.893 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.428 ' HB2' ' CD1' ' B' ' 115' ' ' ILE . 7.2 ttm -103.93 163.95 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' B' ' 111' ' ' THR . 0.4 OUTLIER -163.6 127.38 2.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 110.587 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.53 HG22 ' CE1' ' B' ' 139' ' ' TYR . 7.2 pt -112.08 170.94 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 109.895 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 12.1 ptt180 -114.09 18.06 17.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.1 -1.0 . . . . 0.0 110.536 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 9.6 tt0 -177.67 94.02 0.23 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.478 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.471 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.6 Cg_endo -77.8 139.54 57.63 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.957 -2.101 . . . . 0.0 110.484 -0.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.453 ' O ' HG21 ' B' ' 111' ' ' THR . 18.9 mttp -56.65 118.98 5.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' B' ' 105' ' ' ARG . 0.7 OUTLIER -163.59 178.33 8.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 110.419 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -131.91 172.4 12.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.82 . . . . 0.0 109.149 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.505 ' N ' ' CG2' ' B' ' 112' ' ' THR . . . -166.1 137.24 3.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.487 ' CD1' HG13 ' B' ' 122' ' ' VAL . 0.3 OUTLIER -97.91 102.52 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' B' ' 104' ' ' MET . 2.3 mp -89.65 126.15 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 2.6 m-85 -101.32 157.44 16.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 109.913 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.444 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -73.56 -23.02 59.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 1.5 t -58.18 -18.91 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.184 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.11 -17.79 16.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -96.71 147.25 24.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 110.142 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.505 ' HE3' ' CG1' ' B' ' 74' ' ' VAL . 4.3 ptt? -138.5 169.24 18.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.487 HG13 ' CD1' ' B' ' 114' ' ' LEU . 5.1 t -127.12 142.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 11.2 t -119.63 149.67 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.794 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.532 ' CG2' ' CB ' ' A' ' 27' ' ' ASN . 3.0 t -162.36 160.21 26.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.877 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.524 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 104.25 -1.56 43.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' B' ' 69' ' ' ASN . . . -75.53 -179.0 4.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.249 . . . . 0.0 110.09 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -135.28 0.39 2.8 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.994 -1.066 . . . . 0.0 110.731 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -160.41 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.081 -1.012 . . . . 0.0 110.319 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -87.84 -34.12 18.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.67 -34.94 60.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -53.49 53.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 3.1 m -55.0 -42.8 72.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.992 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.43 78.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.926 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.458 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -71.49 -56.69 5.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.062 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.44 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.309 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 21.0 t -65.77 -63.14 1.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.485 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.1 ptm180 -52.06 -31.15 28.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.485 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -62.99 -47.47 82.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.666 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.53 ' CE1' HG22 ' B' ' 106' ' ' ILE . 20.9 m-85 -63.73 -53.42 51.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.632 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.37 -22.94 13.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.33 -47.53 49.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.783 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.466 ' O ' HG13 ' B' ' 146' ' ' ILE . 1.8 mt -50.4 -43.3 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.527 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 3.1 mp -73.08 -59.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.918 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 3.0 mm-40 -54.45 -34.82 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.617 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -73.22 -30.15 63.29 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.466 HG13 ' O ' ' B' ' 142' ' ' ILE . 3.4 mt -72.68 -16.16 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.1 -20.58 19.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.522 ' CB ' HG22 ' B' ' 143' ' ' ILE . 3.1 m-85 -49.8 171.13 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.961 -1.317 . . . . 0.0 110.548 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.7 43.55 1.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 110.097 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.527 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -85.68 151.97 23.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.579 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 6.6 mttp -120.98 -158.53 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 110.206 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.03 86.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -146.53 177.19 9.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.536 ' CB ' ' OG1' ' B' ' 75' ' ' THR . 2.8 t0 69.29 6.57 5.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.352 -0.842 . . . . 0.0 110.704 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -51.23 127.73 20.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.026 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 126.3 5.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.54 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 6.5 mt -82.67 117.16 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.752 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -117.98 2.5 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 110.602 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.449 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.4 OUTLIER -147.67 121.9 9.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.448 ' HA ' HG12 ' B' ' 70' ' ' ILE . 57.6 mt -130.93 126.14 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.716 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 15.0 t -105.16 140.05 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' B' ' 66' ' ' THR . . . -139.96 -179.81 18.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.9 OUTLIER -170.38 154.99 4.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.315 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.464 ' HB2' HG23 ' B' ' 63' ' ' ILE . 18.0 p -170.18 163.47 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -106.24 133.73 50.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.974 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.58 ' O ' ' CD2' ' B' ' 168' ' ' PHE . 12.8 m -83.48 7.43 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -0.931 . . . . 0.0 110.595 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 45.7 tttt 70.68 12.43 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 110.809 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 16.0 p90 -169.35 145.6 2.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.048 -1.032 . . . . 0.0 110.425 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.66 154.77 54.65 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.092 1.575 . . . . 0.0 110.648 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.11 151.18 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 110.152 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 5.8 ptm180 -88.51 98.51 11.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.115 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' B' ' 185' ' ' TYR . 30.3 mt -54.81 -42.06 71.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.011 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 16.1 pt-20 -55.65 -44.51 77.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.999 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . 0.467 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -66.77 -37.89 92.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.44 HD22 HG13 ' B' ' 233' ' ' VAL . 0.2 OUTLIER -67.19 -38.6 85.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.942 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.64 60.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.933 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.91 -29.35 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.903 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 3.1 t -97.18 -30.89 12.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.949 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' B' ' 183' ' ' SER . 24.7 m170 -130.44 31.71 4.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -66.69 -10.88 56.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.9 m -64.71 -36.63 84.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.0 -14.77 11.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.83 . . . . 0.0 110.303 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.57 ' HB2' ' CD2' ' B' ' 195' ' ' TYR . 0.9 OUTLIER -104.38 149.0 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.404 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 2.3 p -128.95 133.91 48.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.078 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.51 ' CE1' HD11 ' B' ' 172' ' ' LEU . 34.5 t80 -133.3 124.17 26.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.286 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -122.81 104.78 35.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 110.074 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.29 -2.52 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.97 1.511 . . . . 0.0 110.23 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.44 0.42 39.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.853 . . . . 0.0 110.398 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . . . . . . . . . 2.2 tt -161.13 -47.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.572 ' CD2' HD13 ' B' ' 194' ' ' ILE . 1.1 t80 -100.92 110.94 62.4 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.443 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.93 -25.64 16.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.994 1.523 . . . . 0.0 110.266 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.17 -179.68 34.07 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' B' ' 205' ' ' LEU . 7.5 tt -115.91 127.25 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -1.226 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.572 HD13 ' CD2' ' B' ' 190' ' ' PHE . 4.2 mt -90.07 111.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.57 ' CD2' ' HB2' ' B' ' 183' ' ' SER . 10.2 t80 -108.92 113.32 26.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.347 -0.846 . . . . 0.0 110.144 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.1 91.63 5.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 28.0 ttm -60.3 131.34 50.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' B' ' 201' ' ' LYS . 38.5 t -70.71 -42.29 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 1.7 mttt -139.66 112.24 7.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.385 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.9 Cg_endo -73.23 169.94 71.42 Favored 'Cis proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.974 -2.094 . . . . 0.0 110.462 -0.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 8.6 mtmt -79.42 80.02 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.511 HD13 ' CB ' ' B' ' 217' ' ' ALA . 44.7 mm -121.97 150.82 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.527 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.425 ' N ' HG21 ' B' ' 202' ' ' ILE . 79.6 t -101.81 104.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.904 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.3 mp -97.17 141.51 30.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.392 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' B' ' 193' ' ' LEU . 2.5 mt -120.9 131.95 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.422 HD12 ' C ' ' B' ' 205' ' ' LEU . 5.0 mm -115.41 139.51 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -121.38 145.21 48.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.482 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 74.9 t -50.09 -33.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.119 -0.988 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.2 t -63.72 -35.22 79.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 110.082 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 119.03 30.02 1.69 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.98 129.31 46.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 110.312 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' B' ' 163' ' ' SER . 19.2 mm -114.72 132.79 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 6.1 t -124.73 140.31 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.933 . . . . 0.0 110.213 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 3.1 mp -130.75 112.49 13.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.419 ' O ' HG21 ' B' ' 215' ' ' THR . 5.3 t -136.34 151.43 49.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.479 ' CA ' ' SD ' ' A' ' 67' ' ' MET . . . 103.85 7.05 42.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.511 ' CB ' HD13 ' B' ' 202' ' ' ILE . . . -82.19 159.46 23.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -1.197 . . . . 0.0 110.165 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -99.57 -17.58 17.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 0.0 110.171 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.421 ' CA ' HD13 ' B' ' 160' ' ' ILE . 0.5 OUTLIER -147.44 -162.59 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -95.75 -21.08 18.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.23 -24.09 65.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.833 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -79.92 -52.68 7.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.906 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 22.5 mm -52.94 -39.35 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.865 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.24 -43.84 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.008 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.61 82.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.287 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.84 88.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.208 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.484 ' CD2' ' HD3' ' B' ' 65' ' ' PRO . 53.1 t80 -70.0 -49.0 55.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -24.5 67.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.63 -31.33 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.945 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.491 HG21 ' N ' ' B' ' 231' ' ' TYR . 2.1 tp -96.96 -16.62 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.937 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.568 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.1 t80 -46.97 -46.34 53.15 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 110.827 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -72.67 -50.57 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.329 1.173 . . . . 0.0 110.427 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.44 HG13 HD22 ' B' ' 175' ' ' LEU . 25.5 t -44.26 -38.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.62 -42.46 64.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.888 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.53 34.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.461 ' CA ' ' HD3' ' B' ' 171' ' ' ARG . 86.6 m-85 -121.44 38.77 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.78 167.07 21.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -104.8 -36.92 7.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.263 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.308 0.575 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.62 31.28 3.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.23 100.41 5.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -1.209 . . . . 0.0 110.243 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 15' ' ' GLY . 22.8 pt -108.93 -36.05 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 14' ' ' ILE . . . 78.06 99.62 0.2 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.94 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -1.143 . . . . 0.0 110.145 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.512 ' C ' ' CE1' ' B' ' 99' ' ' PHE . . . -132.47 -145.54 5.49 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.644 ' N ' ' CE1' ' B' ' 99' ' ' PHE . 0.1 OUTLIER -69.43 161.0 30.34 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.354 -1.086 . . . . 0.0 109.705 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.545 ' N ' ' CD1' ' A' ' 18' ' ' LEU . 6.2 t70 -65.86 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.605 ' CD1' ' HB ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -84.4 -17.2 40.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.525 -0.734 . . . . 0.0 111.02 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.533 ' N ' HD22 ' A' ' 68' ' ' LEU . 8.8 m -44.65 -25.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.045 -1.034 . . . . 0.0 110.349 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -100.16 -34.57 4.78 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.557 ' N ' HG21 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -48.5 -40.35 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.216 -1.167 . . . . 0.0 109.688 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.427 ' HB2' ' ND2' ' B' ' 159' ' ' ASN . 1.4 pp -83.42 -18.24 39.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.943 -1.098 . . . . 0.0 108.724 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -98.68 6.32 47.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.631 -0.668 . . . . 0.0 109.381 179.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 151.26 89.96 0.08 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.553 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 12.5 p-10 -19.54 81.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.662 0.744 . . . . 0.0 112.896 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.637 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -89.44 164.54 2.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.568 ' N ' HG12 ' A' ' 28' ' ' ILE . 70.3 m-20 -86.49 132.77 33.84 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -42.29 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.178 -178.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.1 tm-20 -62.77 -7.48 5.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.44 5.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.522 ' HD3' ' N ' ' A' ' 34' ' ' LEU . 1.1 tpp180 -127.12 128.95 47.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.096 -1.238 . . . . 0.0 110.376 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.637 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -98.75 150.94 21.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.937 -1.102 . . . . 0.0 110.33 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.541 HD12 ' ND2' ' A' ' 27' ' ' ASN . 4.5 pp -135.57 -178.08 4.96 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.262 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.441 ' N ' HD11 ' A' ' 35' ' ' LEU . 5.5 mt-30 -125.1 -69.1 0.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.815 . . . . 0.0 110.315 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 36' ' ' GLN . 0.2 OUTLIER 175.58 -63.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.09 58.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -108.84 97.27 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.917 . . . . 0.0 110.264 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.29 86.7 0.49 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 50.71 66.6 1.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.217 -1.167 . . . . 0.0 110.207 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 44' ' ' GLY . . . -139.27 106.23 0.5 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 44' ' ' GLY . 5.9 ttt-85 53.83 -88.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.191 -1.182 . . . . 0.0 110.072 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 42' ' ' GLY . . . -58.28 -163.53 0.07 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.94 -103.93 0.18 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.2 p -143.71 100.19 3.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -1.144 . . . . 0.0 110.31 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.73 -88.47 0.86 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.525 ' CD1' HD11 ' A' ' 52' ' ' LEU . 25.4 p90 -83.94 -0.95 53.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -1.152 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 48' ' ' PHE . 22.4 t70 -41.54 -62.64 0.84 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.67 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.75 -6.12 35.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.326 -0.859 . . . . 0.0 110.776 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.3 tt0 -100.37 -22.01 15.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.061 -1.025 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.525 HD11 ' CD1' ' A' ' 48' ' ' PHE . 5.1 mt -101.19 -51.39 3.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.533 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -47.4 -51.26 20.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.394 -0.817 . . . . 0.0 109.889 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -68.73 -15.29 63.47 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.729 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.581 ' HB3' ' CE2' ' B' ' 190' ' ' PHE . 1.9 m-80 -92.63 -35.0 13.77 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 7.5 mt -55.56 -42.44 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.416 -0.802 . . . . 0.0 109.309 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.4 -21.22 12.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.19 28.23 5.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -1.133 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 56' ' ' ILE . 5.0 mt -92.12 10.44 29.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.59 34.82 1.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.845 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HG3' ' CD2' ' A' ' 62' ' ' LEU . 11.6 ptpt -135.55 26.03 3.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.436 -0.79 . . . . 0.0 109.969 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.468 ' CD2' ' HG3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -142.96 -56.86 0.42 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.553 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . -164.0 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.4 mm? -42.07 -29.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.331 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.6 -33.65 33.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.739 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -68.9 -56.98 6.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.515 ' SD ' ' CA ' ' B' ' 216' ' ' GLY . 0.0 OUTLIER -67.3 -8.54 33.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.341 -0.849 . . . . 0.0 109.208 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.581 ' CD2' ' CB ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -67.98 -63.84 0.98 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.805 0.812 . . . . 0.0 109.035 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.418 HD11 ' C ' ' A' ' 69' ' ' LEU . 3.4 pp -68.9 -5.95 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.215 0.531 . . . . 0.0 110.075 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 22.4 tt0 -80.92 3.37 23.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.605 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.1 t -143.27 4.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.816 -1.178 . . . . 0.0 110.656 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.581 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 5.9 tp -149.14 71.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.553 -0.717 . . . . 0.0 109.367 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t0 -76.52 57.34 1.21 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.62 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 5.6 mt -107.51 67.39 0.69 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.66 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -153.44 29.28 0.49 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 109.872 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -174.33 74.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.463 -0.773 . . . . 0.0 110.221 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.236 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 95.4 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.91 76.8 1.28 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.2 mp -90.86 -22.87 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -1.118 . . . . 0.0 110.342 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 57.0 t 59.62 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.466 -0.771 . . . . 0.0 110.385 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.5 Cg_endo -75.53 149.61 34.82 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.928 1.489 . . . . 0.0 110.631 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.441 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.1 m -113.93 143.08 45.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.909 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 67.6 mt -80.44 117.61 21.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -108.3 -10.69 15.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.278 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.528 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 6.3 t30 -165.76 160.13 16.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 110.299 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 10.2 mt -157.45 166.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.936 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.459 ' N ' HG23 ' B' ' 70' ' ' ILE . 16.6 t -135.41 132.85 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.488 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -121.2 136.51 54.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.9 m -97.11 134.06 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 0.0 110.125 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' B' ' 155' ' ' PHE . 8.4 t -133.63 169.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 56.2 m -144.11 133.66 23.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.387 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.503 ' CD1' HD12 ' B' ' 80' ' ' LEU . 82.9 mt -88.56 -14.39 37.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.67 -0.54 70.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 22.1 p -138.55 137.0 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -1.164 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' B' ' 118' ' ' SER . 5.7 mtp85 -62.48 158.72 17.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.503 HD12 ' CD1' ' B' ' 76' ' ' LEU . 15.5 mt -130.36 150.45 51.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.271 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 1.0 OUTLIER -99.12 93.54 6.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.456 HD23 HG21 ' B' ' 102' ' ' VAL . 9.1 mt -39.16 -46.49 1.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.465 -0.772 . . . . 0.0 110.68 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.63 -43.56 76.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.51 HG21 ' CD2' ' B' ' 88' ' ' HIS . 84.8 m -83.58 -35.77 24.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.99 . . . . 0.0 110.22 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 30.4 t -65.96 -57.25 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.53 -36.59 80.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.493 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.03 -48.03 83.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.51 ' CD2' HG21 ' B' ' 84' ' ' THR . 45.2 m-70 -78.61 -42.95 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -0.951 . . . . 0.0 110.542 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.437 ' HB2' ' HB1' ' B' ' 92' ' ' ALA . . . -43.82 124.95 3.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 109.997 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.92 -18.01 62.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 3.3 m-20 -137.42 79.8 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -165.84 152.27 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.54 164.61 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 110.044 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.52 120.82 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 110.435 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.44 112.09 21.11 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.99 -18.8 30.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.932 1.491 . . . . 0.0 110.268 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -71.95 -17.13 62.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -105.54 -69.72 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.644 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -152.09 -178.93 7.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.494 -0.754 . . . . 0.0 109.953 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -99.48 49.89 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.915 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.62 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -130.95 149.84 52.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.946 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.458 ' HB ' ' HB ' ' B' ' 115' ' ' ILE . 99.4 t -92.27 124.07 44.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 5.0 mp -88.76 107.35 17.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.419 ' HE3' HG23 ' B' ' 142' ' ' ILE . 0.9 OUTLIER -93.27 161.39 14.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.482 -0.761 . . . . 0.0 109.844 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -163.85 123.31 2.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 0.0 110.832 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 4.6 pt -122.59 155.56 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 109.696 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 5.3 mtt180 -103.49 30.86 4.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 4.3 tm-20 -177.9 87.8 0.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.49 159.58 96.24 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.351 -0.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' B' ' 111' ' ' THR . 0.1 OUTLIER -73.12 115.37 12.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.037 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' B' ' 110' ' ' LYS . 0.8 OUTLIER -165.99 175.26 8.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.319 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.532 HG21 ' CG2' ' B' ' 124' ' ' THR . 0.5 OUTLIER -134.53 157.87 45.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.128 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -147.34 158.81 44.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -115.3 107.37 15.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.486 -0.758 . . . . 0.0 109.375 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.505 ' N ' HD11 ' B' ' 115' ' ' ILE . 3.0 mp -89.93 131.47 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.618 ' CD1' ' CD1' ' A' ' 74' ' ' LEU . 4.5 m-30 -106.95 149.9 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.795 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' B' ' 80' ' ' LEU . . . -61.36 -20.06 62.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 110.342 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' B' ' 79' ' ' ARG . 12.2 t -62.86 -33.76 75.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.343 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.462 ' HA2' ' HG ' ' B' ' 80' ' ' LEU . . . 126.19 -13.77 7.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -76.16 171.57 14.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 6.7 ttp -155.99 135.0 12.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.158 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.525 ' CG1' HG11 ' A' ' 71' ' ' VAL . 12.6 t -115.51 119.02 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 18.7 t -105.24 144.49 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.538 HG21 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -146.78 165.96 28.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.542 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 101.55 -24.27 32.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.61 156.51 0.66 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -1.219 . . . . 0.0 110.607 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -109.4 -14.5 14.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 4.3 m -163.71 -178.49 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.244 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . 0.407 ' HG2' HD13 ' B' ' 157' ' ' ILE . 93.3 mt-10 -58.18 -65.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.052 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.35 -30.44 2.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.079 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -71.33 -53.71 13.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.0 110.226 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -54.81 -37.85 66.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -48.86 79.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.051 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 39.5 mt -61.57 -49.56 76.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.847 . . . . 0.0 110.054 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -58.05 -35.65 71.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 13.5 t -70.57 -65.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 110.022 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -46.79 -34.42 5.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.017 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' B' ' 138' ' ' LYS . 42.5 mmtt -63.86 -49.61 72.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.475 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 18.4 m-85 -66.6 -54.91 18.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.916 . . . . 0.0 109.959 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.98 -35.61 59.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 3.3 ttp180 -58.77 -41.71 87.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.99 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.419 HG23 ' HE3' ' B' ' 104' ' ' MET . 27.6 mt -59.0 -47.05 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' B' ' 143' ' ' ILE . 1.5 mp -60.46 -46.83 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.069 -1.02 . . . . 0.0 109.396 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 68.5 mt-30 -67.27 -31.89 72.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.452 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 3.1 mmtt -74.49 -28.71 61.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.94 -22.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.2 -22.85 7.0 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.479 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -51.63 175.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.349 . . . . 0.0 110.756 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.16 36.03 3.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.478 -0.764 . . . . 0.0 110.542 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.484 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -62.47 131.09 48.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' B' ' 152' ' ' PHE . 2.0 ptpt -111.31 25.08 12.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.011 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.486 ' C ' ' O ' ' B' ' 151' ' ' LYS . 3.7 t80 31.55 95.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.124 0.488 . . . . 0.0 111.2 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.426 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 1.9 p -153.23 174.41 14.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 153' ' ' THR . 1.6 t0 65.2 27.22 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.409 -0.807 . . . . 0.0 110.554 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.432 ' HA ' HG21 ' B' ' 74' ' ' VAL . 41.3 t80 -73.25 133.52 43.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.89 . . . . 0.0 109.903 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -166.7 135.52 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 110.48 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 44.8 mt -78.9 133.66 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.432 -0.792 . . . . 0.0 109.638 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' B' ' 218' ' ' LYS . 23.2 mt-30 -125.53 -40.0 2.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 110.939 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.461 ' ND2' ' HA2' ' B' ' 216' ' ' GLY . 0.7 OUTLIER -114.06 109.27 18.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.066 -1.021 . . . . 0.0 110.959 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.458 HG12 HD12 ' B' ' 70' ' ' ILE . 30.1 mt -105.94 123.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.486 HG22 ' ND2' ' B' ' 69' ' ' ASN . 79.8 t -98.36 138.98 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 110.574 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -140.49 167.27 25.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 155.08 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.265 . . . . 0.0 110.708 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.459 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 5.5 p -169.4 171.63 7.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.418 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 7.9 m-20 -128.57 140.39 51.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.0 110.419 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 22.6 m -119.34 8.66 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.936 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt 52.03 29.9 6.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 110.179 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' B' ' 238' ' ' ARG . 1.2 t80 -121.0 115.86 31.58 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.26 120.16 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.904 1.476 . . . . 0.0 110.223 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.464 HG22 HD21 ' B' ' 234' ' ' LEU . 3.3 mt -101.49 145.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.568 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.64 84.86 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.981 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.52 ' O ' ' CB ' ' B' ' 176' ' ' ALA . 15.1 mt -48.04 -23.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.98 -53.13 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.25 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.82 -38.61 96.26 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 11.7 tp -74.81 -38.58 62.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 109.968 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 172' ' ' LEU . . . -65.87 -38.66 89.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -0.924 . . . . 0.0 110.291 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -72.38 -24.41 61.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.178 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -89.24 -48.9 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' B' ' 183' ' ' SER . 53.1 m170 -103.16 34.94 2.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.08 -33.63 51.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -19.09 44.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -1.095 . . . . 0.0 110.141 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.519 ' CE1' HG22 ' B' ' 198' ' ' VAL . 36.2 m-85 -136.37 6.02 3.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.447 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' B' ' 179' ' ' HIS . 0.2 OUTLIER -133.64 135.57 44.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 0.0 110.67 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.98 122.17 37.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 109.792 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -124.49 129.42 50.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 110.597 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 190' ' ' PHE . 9.3 mt-10 -136.23 102.85 9.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.453 -0.779 . . . . 0.0 109.653 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -2.45 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.932 1.49 . . . . 0.0 110.825 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -100.43 -6.02 26.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 0.0 110.324 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -143.91 -50.37 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.327 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 55' ' ' ASN . 2.7 t80 -111.26 121.49 40.28 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . 0.449 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.4 Cg_endo -73.54 -35.55 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.923 1.486 . . . . 0.0 110.631 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.39 175.83 42.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.484 ' N ' HD12 ' B' ' 172' ' ' LEU . 8.7 tt -106.83 138.19 43.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -1.163 . . . . 0.0 110.251 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.455 HD12 HD12 ' A' ' 62' ' ' LEU . 2.6 mt -98.35 96.74 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.499 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 7.6 t80 -93.89 120.37 34.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.469 ' HG2' ' CG2' ' B' ' 203' ' ' VAL . 17.0 mtp85 -108.2 97.82 7.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.328 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 45.3 tpp -52.88 148.34 7.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.051 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.519 HG22 ' CE1' ' B' ' 182' ' ' PHE . 86.2 t -91.48 -40.91 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.905 . . . . 0.0 110.394 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.7 107.79 6.48 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.491 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.92 165.45 84.97 Favored 'Cis proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.952 -2.103 . . . . 0.0 110.395 -0.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 16.9 mtmt -75.05 97.31 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.434 HD13 ' HB3' ' B' ' 222' ' ' GLU . 23.9 mm -129.24 158.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.582 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.469 ' CG2' ' HG2' ' B' ' 196' ' ' ARG . 46.0 t -111.63 124.37 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' B' ' 204' ' ' LEU . 3.9 mp -123.9 135.85 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.171 -0.956 . . . . 0.0 110.623 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.42 ' HB3' ' CE1' ' B' ' 207' ' ' PHE . 3.8 mm? -101.33 125.23 47.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.83 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.499 ' CD1' ' HB2' ' B' ' 195' ' ' TYR . 2.8 mt -120.32 133.68 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' B' ' 207' ' ' PHE . 57.8 m-85 -119.46 154.22 34.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 52.7 t -60.44 -22.57 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.074 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.5 t -64.52 -36.17 83.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 121.29 11.04 6.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.418 ' HG3' ' OD1' ' B' ' 165' ' ' ASP . 2.2 mptm? -92.51 141.65 28.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.105 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 24.6 mm -131.78 132.7 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.4 t -123.08 140.08 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.226 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 5.6 mp -121.47 145.03 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 6.6 t -165.3 157.3 15.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.187 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.515 ' CA ' ' SD ' ' A' ' 67' ' ' MET . . . 98.02 -15.78 61.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.525 ' CB ' HD12 ' B' ' 223' ' ' ILE . . . -65.83 141.7 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' B' ' 158' ' ' GLN . 0.3 OUTLIER -92.56 -25.93 18.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.109 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.86 151.37 47.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -47.05 -33.23 4.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -38.47 70.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.434 ' HB3' HD13 ' B' ' 202' ' ' ILE . 0.2 OUTLIER -60.66 -49.68 76.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.525 HD12 ' CB ' ' B' ' 217' ' ' ALA . 47.2 mm -56.03 -38.65 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 110.342 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.34 -40.38 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 110.326 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.86 94.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.3 -56.45 21.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.134 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -58.64 -44.49 90.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.131 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.9 -36.19 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.14 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . 0.402 ' O ' HG22 ' B' ' 233' ' ' VAL . . . -91.48 -11.31 37.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 9.8 mm -97.77 -23.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.784 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -50.22 -48.45 79.93 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 110.758 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.72 -41.73 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.515 1.271 . . . . 0.0 110.376 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.402 HG22 ' O ' ' B' ' 229' ' ' ALA . 57.1 t -50.53 -39.39 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.645 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.464 HD21 HG22 ' B' ' 170' ' ' ILE . 15.8 mt -68.65 -48.43 64.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.824 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 40.8 t -60.78 -31.99 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.845 . . . . 0.0 109.87 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -37.94 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.494 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 76.6 m-85 -116.23 38.04 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.95 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.414 ' HB3' ' CE2' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -60.85 145.89 48.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 110.086 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -93.71 -39.2 10.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.918 . . . . 0.0 110.167 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.218 179.926 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.214 0.53 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.24 -22.98 2.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.19 24.8 1.03 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -1.116 . . . . 0.0 110.043 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 mt 48.36 61.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.313 -0.867 . . . . 0.0 110.08 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.18 156.81 28.06 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.507 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 13.6 p-10 -175.41 64.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -1.144 . . . . 0.0 110.489 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.04 -176.83 54.55 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.549 ' CD1' ' HB2' ' A' ' 30' ' ' SER . 0.0 OUTLIER -132.33 166.09 22.73 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.058 -1.26 . . . . 0.0 110.247 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -63.43 81.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.641 ' CD1' ' CG1' ' A' ' 23' ' ' ILE . 4.1 tp -120.22 62.03 0.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.776 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 1.2 m -92.05 -3.6 55.56 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.504 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -101.62 -31.51 5.46 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.563 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.641 ' CG1' ' CD1' ' A' ' 20' ' ' LEU . 2.2 mm -46.15 -44.12 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.416 -1.638 . . . . 0.0 109.171 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.552 ' HG ' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -83.94 -23.44 31.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.057 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -85.26 10.64 11.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.499 -0.75 . . . . 0.0 109.16 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 135.55 104.83 0.78 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.571 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 7.5 p-10 -21.74 118.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.944 0.878 . . . . 0.0 111.438 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -140.37 161.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.546 0.688 . . . . 0.0 109.461 -178.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.541 ' N ' HG12 ' A' ' 28' ' ' ILE . 1.2 m-20 -87.58 119.32 27.77 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.588 ' OG ' ' CE2' ' B' ' 99' ' ' PHE . 26.7 p -39.15 -25.8 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.3 tt0 -66.3 -3.49 6.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.948 -1.095 . . . . 0.0 111.306 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 29.11 5.83 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.023 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -121.03 117.18 26.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.916 -1.343 . . . . 0.0 109.534 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.593 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.8 OUTLIER -87.27 162.82 17.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.229 . . . . 0.0 111.906 -178.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -88.75 108.33 19.43 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.558 0.694 . . . . 0.0 111.67 -178.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 38' ' ' ASP . 3.6 pt20 -89.69 -5.37 57.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 49.02 -88.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.717 -0.614 . . . . 0.0 110.861 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' GLN . 36.8 m-20 -79.51 -178.38 6.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.647 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -133.93 -35.67 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.398 -0.814 . . . . 0.0 110.102 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.11 -107.16 1.45 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 51.53 29.69 5.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -1.182 . . . . 0.0 109.943 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.02 -74.43 0.09 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -158.67 49.7 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -1.188 . . . . 0.0 110.379 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.41 51.09 60.76 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.87 -173.86 50.01 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -167.85 72.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -1.076 . . . . 0.0 110.206 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 36' ' ' GLN . . . 66.04 -151.43 52.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 49' ' ' ASP . 1.9 m-85 -60.94 144.5 53.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.361 -1.082 . . . . 0.0 110.246 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' PHE . 1.6 m-20 -50.57 -176.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.978 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.71 25.52 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -0.962 . . . . 0.0 109.935 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.6 pt-20 -97.47 -31.36 12.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.848 . . . . 0.0 110.29 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 3.1 mt -90.99 -41.29 11.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.532 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -48.81 -52.96 21.26 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.98 -26.53 67.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.368 -0.833 . . . . 0.0 109.524 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 1.9 m-80 -79.97 -42.9 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.459 -0.776 . . . . 0.0 110.05 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -48.43 -45.71 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.81 0.74 64.8 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.71 -44.47 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -1.197 . . . . 0.0 110.884 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.553 ' CD2' ' CE2' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -85.59 34.84 0.59 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 110.698 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.69 34.38 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.894 -1.129 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.9 1.55 0.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 111.106 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.503 ' N ' HD21 ' A' ' 62' ' ' LEU . 5.7 mt -86.65 -67.62 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.661 -1.274 . . . . 0.0 109.93 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.63 -35.66 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -54.24 -39.76 67.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.21 -1.17 . . . . 0.0 110.343 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' HA ' HD11 ' A' ' 68' ' ' LEU . 16.4 t0 -43.91 -33.89 1.49 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 1.5 m -60.7 -62.88 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.523 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 1.1 ttp -72.01 -3.14 21.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.292 -0.88 . . . . 0.0 109.792 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.525 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -67.69 -54.98 15.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 108.933 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 66' ' ' SER . 0.6 OUTLIER -69.92 0.28 6.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.72 -0.613 . . . . 0.0 109.953 179.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -91.83 -11.47 36.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -0.845 . . . . 0.0 110.577 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.564 ' CG1' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.58 -17.59 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.084 -1.01 . . . . 0.0 108.797 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.551 ' HB ' ' CD2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -146.57 78.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.845 -0.534 . . . . 0.0 110.148 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.46 53.24 1.51 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.885 -1.134 . . . . 0.0 109.049 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.603 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 8.0 mt -84.08 59.03 5.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.675 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 16' ' ' ASN . 1.8 tttm -121.38 81.31 1.78 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.667 -0.646 . . . . 0.0 110.085 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 77' ' ' ALA . 1.9 mt-10 50.21 53.1 13.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.263 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.199 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.273 0.558 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.41 ' O ' HG22 ' B' ' 64' ' ' VAL . . . 137.28 60.42 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.47 HD12 ' O ' ' B' ' 165' ' ' ASP . 33.4 mt -65.35 -52.29 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.28 -1.129 . . . . 0.0 110.375 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 2.7 t 67.2 125.19 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 46.5 Cg_endo -73.43 146.96 40.56 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.856 1.451 . . . . 0.0 110.617 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.401 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 3.3 m -105.4 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 110.07 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.527 HD23 ' CG2' ' B' ' 160' ' ' ILE . 27.3 mt -77.01 134.68 38.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -123.25 -18.39 6.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.419 ' OD1' ' HA2' ' B' ' 125' ' ' GLY . 5.4 t30 -169.88 154.24 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.399 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.458 ' CD1' HG12 ' B' ' 160' ' ' ILE . 5.0 mt -145.26 147.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 110.025 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.521 HG12 ' CG1' ' A' ' 71' ' ' VAL . 53.3 t -115.83 142.83 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.95 . . . . 0.0 110.582 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.402 ' N ' HG11 ' B' ' 71' ' ' VAL . . . -135.31 162.04 33.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 0.0 110.172 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 0.3 OUTLIER -116.48 135.0 54.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.319 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.403 HG13 ' HE3' ' B' ' 121' ' ' MET . 91.5 t -132.04 171.21 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.871 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.517 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 46.1 m -148.03 151.63 36.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.494 ' N ' HG21 ' B' ' 75' ' ' THR . 33.7 mt -104.77 -57.5 2.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.837 . . . . 0.0 110.195 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.95 21.54 6.3 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.68 142.76 12.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -1.205 . . . . 0.0 110.282 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 146.86 53.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.045 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.447 HD13 HD11 ' B' ' 76' ' ' LEU . 15.5 mt -127.48 153.23 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.124 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.1 OUTLIER -90.37 88.12 7.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 110.017 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.473 HD21 ' CG2' ' B' ' 102' ' ' VAL . 10.7 mt -41.14 -44.04 2.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 110.277 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.4 OUTLIER -56.3 -42.28 77.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 110.092 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -83.96 -43.94 14.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.423 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.463 HG21 ' CE2' ' B' ' 148' ' ' PHE . 86.4 t -55.15 -48.2 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.244 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' B' ' 92' ' ' ALA . . . -72.96 -28.94 62.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 9.5 tp -77.21 -34.6 56.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.59 -25.71 22.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.96 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.52 143.09 57.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -72.06 -27.59 62.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.061 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' B' ' 104' ' ' MET . 71.7 m-20 -134.78 79.44 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 110.007 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' B' ' 86' ' ' ALA . . . -152.32 130.83 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.613 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -124.34 142.78 51.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -118.24 137.94 52.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 0.0 110.811 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' B' ' 95' ' ' ASN . 8.5 p30 -133.66 109.97 12.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.939 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 -26.9 12.79 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.99 1.521 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.28 -7.46 59.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' B' ' 95' ' ' ASN . 0.0 OUTLIER -102.45 -75.91 0.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.588 ' CE2' ' OG ' ' A' ' 30' ' ' SER . 32.4 p90 -145.68 -178.86 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 110.075 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.455 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -99.2 56.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.051 -1.03 . . . . 0.0 112.099 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.603 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -152.53 166.32 32.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.867 -1.146 . . . . 0.0 110.524 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.473 ' CG2' HD21 ' B' ' 82' ' ' LEU . 21.3 t -97.39 157.74 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.469 HD12 ' OG ' ' A' ' 30' ' ' SER . 2.0 mt -118.25 100.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.99 . . . . 0.0 110.429 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.503 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 2.2 ttm -92.39 145.2 24.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.58 118.67 8.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.257 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 109' ' ' PRO . 30.8 pt -116.81 164.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 110.063 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 1.1 ptm180 -120.04 42.44 2.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER 179.26 80.29 0.17 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 0.0 110.256 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.444 ' O ' HG13 ' B' ' 106' ' ' ILE . 49.4 Cg_endo -78.13 159.81 92.66 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.436 -0.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' B' ' 107' ' ' ARG . 2.1 tppt? -71.27 113.18 8.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.441 HG21 ' HA3' ' B' ' 125' ' ' GLY . 0.3 OUTLIER -154.47 164.8 38.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.687 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.9 m -114.84 146.45 41.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.502 -0.748 . . . . 0.0 109.325 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' B' ' 139' ' ' TYR . . . -149.53 140.82 23.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.102 . . . . 0.0 111.305 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' B' ' 114' ' ' LEU . 0.2 OUTLIER -119.37 126.65 51.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.555 -0.716 . . . . 0.0 109.223 179.178 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 5.8 mt -108.36 136.65 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.935 . . . . 0.0 111.111 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 4.5 m-85 -93.81 161.43 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.58 -1.19 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.972 -1.08 . . . . 0.0 110.296 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 35.9 t -91.19 -7.67 50.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.348 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.1 -30.72 8.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -74.12 151.78 40.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -1.138 . . . . 0.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.403 ' HE3' HG13 ' B' ' 74' ' ' VAL . 7.2 ptt? -153.64 169.45 23.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.201 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.522 HG12 ' CG1' ' A' ' 71' ' ' VAL . 24.8 t -133.38 147.98 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 23.3 t -126.67 170.04 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.511 HG21 ' CB ' ' A' ' 27' ' ' ASN . 10.1 t -170.04 154.18 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.881 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.555 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 111.43 8.3 23.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.479 ' CB ' ' HB2' ' B' ' 132' ' ' SER . . . -82.41 141.21 32.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.154 . . . . 0.0 110.046 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.64 -0.04 41.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.873 . . . . 0.0 110.283 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.79 -159.9 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.209 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.68 -49.09 9.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.55 -28.98 65.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.076 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -43.82 96.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.034 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.479 ' HB2' ' CB ' ' B' ' 126' ' ' ALA . 44.9 t -68.33 -36.64 79.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.79 -38.22 81.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.205 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.438 ' O ' ' HD2' ' B' ' 138' ' ' LYS . 6.1 mt -69.94 -45.41 67.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.31 -52.12 67.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 72.3 m -60.55 -50.85 71.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -39.66 69.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.998 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -59.41 -40.4 86.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' B' ' 113' ' ' ALA . 26.8 m-85 -65.62 -52.08 54.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.71 -36.16 56.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.955 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -59.94 -43.33 95.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 -35.26 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.516 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 39.8 mm -73.9 -57.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.65 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.14 -28.32 69.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 1.7 tttt -75.71 -19.27 59.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.97 -23.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.72 -0.613 . . . . 0.0 109.371 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.4 -29.37 4.8 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.463 ' CE2' HG21 ' B' ' 85' ' ' VAL . 12.2 m-85 -46.4 163.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -1.214 . . . . 0.0 110.937 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.2 38.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.559 -0.713 . . . . 0.0 109.942 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.516 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -73.55 136.41 44.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 5.1 tttt -112.44 157.65 20.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 110.338 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -99.69 89.95 4.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.474 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -148.92 172.8 14.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.387 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.517 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t0 67.78 26.12 7.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 6.8 t80 -84.62 129.16 34.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.077 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -163.62 131.82 3.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 3.1 mt -79.88 123.74 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.666 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -119.69 -10.93 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.801 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 26.1 t30 -140.12 122.1 15.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.527 ' CG2' HD23 ' B' ' 67' ' ' LEU . 3.9 mt -113.25 160.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.152 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 54.7 t -138.67 126.35 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.714 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -130.95 176.2 19.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.1 p -158.33 154.54 27.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.438 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.9 p -170.2 174.21 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.818 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.47 ' O ' HD12 ' B' ' 63' ' ' ILE . 14.9 t0 -121.59 136.11 54.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' B' ' 168' ' ' PHE . 26.8 m -85.47 2.54 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.888 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.12 23.72 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.254 -0.904 . . . . 0.0 110.925 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.583 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 8.4 p90 -177.93 148.19 0.65 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.406 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.63 161.15 44.77 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.093 1.575 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.448 HG21 ' O ' ' B' ' 237' ' ' PHE . 4.0 mt -131.08 150.84 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.408 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.0 OUTLIER -84.37 90.62 7.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.511 ' CD1' HG21 ' B' ' 208' ' ' VAL . 22.2 mt -48.2 -29.13 3.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -64.14 -60.22 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.35 -34.15 25.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -47.71 79.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 110.17 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.54 -30.03 67.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.886 . . . . 0.0 110.414 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -69.26 -27.35 65.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.279 -0.888 . . . . 0.0 110.583 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 11.3 p -99.14 -57.75 2.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.14 -0.975 . . . . 0.0 110.357 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' B' ' 183' ' ' SER . 26.6 m80 -100.54 38.26 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -62.85 -30.18 76.37 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' THR . . . . . 0.434 HG22 ' CG ' ' B' ' 182' ' ' PHE . 9.3 t -62.46 -33.47 74.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 110.362 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.434 ' CG ' HG22 ' B' ' 181' ' ' THR . 21.4 m-85 -113.16 -12.2 13.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.493 ' N ' ' O ' ' B' ' 179' ' ' HIS . 37.7 m -104.77 171.29 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.266 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.6 m -155.88 109.87 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.825 . . . . 0.0 110.053 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.5 ' HB2' ' CD1' ' B' ' 193' ' ' LEU . 17.8 t80 -113.49 114.51 26.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 110.23 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 3.2 mm-40 -125.55 102.52 29.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.44 -0.15 8.85 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.083 1.57 . . . . 0.0 110.325 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -98.42 -20.03 17.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.886 . . . . 0.0 110.035 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.51 ' O ' ' CG ' ' B' ' 189' ' ' LEU . 2.6 tt -142.11 8.13 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.3 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.553 ' CE2' ' CD2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -169.94 108.54 0.46 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.264 -0.897 . . . . 0.0 110.419 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -4.36 13.32 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.849 1.447 . . . . 0.0 110.516 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -117.47 162.96 12.76 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.5 ' CD1' ' HB2' ' B' ' 185' ' ' TYR . 2.4 tt -100.72 143.46 30.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 110.129 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.463 HD12 ' CE2' ' B' ' 190' ' ' PHE . 31.7 mt -104.78 106.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' B' ' 183' ' ' SER . 0.3 OUTLIER -97.95 111.88 24.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -0.98 . . . . 0.0 109.87 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.77 80.99 5.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 110.41 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.452 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.9 ttm -50.83 141.68 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.23 -43.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 110.56 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -141.32 110.6 6.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.146 -0.971 . . . . 0.0 110.31 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.459 ' O ' HG12 ' B' ' 202' ' ' ILE . 47.5 Cg_endo -73.21 149.95 94.94 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.443 -0.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.8 OUTLIER -64.22 95.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.898 . . . . 0.0 109.967 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 11.4 mm -134.1 151.62 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 110.621 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -107.37 109.37 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 109.667 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mp -100.98 134.93 43.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 110.913 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.72 117.79 35.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 109.473 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.508 ' N ' HD11 ' B' ' 206' ' ' ILE . 4.4 mp -107.87 137.31 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.488 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -118.29 135.25 54.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.048 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.511 HG21 ' CD1' ' B' ' 172' ' ' LEU . 69.0 t -45.21 -24.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -35.06 78.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . 0.452 ' O ' HG23 ' B' ' 166' ' ' VAL . . . 124.95 -12.45 7.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.28 154.76 37.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.414 HG13 HG12 ' B' ' 166' ' ' VAL . 12.2 mm -138.78 137.15 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 110.083 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.442 HG11 ' N ' ' B' ' 214' ' ' LEU . 96.7 t -120.98 149.25 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.442 ' N ' HG11 ' B' ' 213' ' ' VAL . 1.1 mt -133.35 102.14 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 14.2 t -131.53 153.65 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.388 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.479 ' CA ' ' HE2' ' A' ' 67' ' ' MET . . . 100.81 20.25 15.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.532 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -100.03 131.23 46.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -1.199 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.422 ' N ' ' OE1' ' B' ' 222' ' ' GLU . 4.6 tttt -75.75 -13.98 60.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.91 173.46 15.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -32.23 70.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.117 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -55.98 -51.32 68.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' B' ' 218' ' ' LYS . 1.1 mt-10 -52.74 -42.28 64.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 109.943 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.513 HG22 HD11 ' B' ' 223' ' ' ILE . 18.4 mm -60.13 -45.83 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -68.63 -33.25 73.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -71.79 -46.25 58.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 109.966 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.427 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -54.48 -51.49 64.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.848 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.52 ' HA ' ' CG2' ' B' ' 230' ' ' ILE . 20.0 t80 -57.27 -37.34 72.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.78 . . . . 0.0 109.93 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.48 -18.2 63.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.037 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.97 -18.28 17.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.52 ' CG2' ' HA ' ' B' ' 227' ' ' PHE . 9.1 tp -100.03 -25.53 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 110.323 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.577 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 31.9 t80 -51.99 -44.18 91.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.02 -31.09 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.354 1.187 . . . . 0.0 110.555 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 30.7 t -70.06 -38.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.166 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 37.0 mt -67.87 -42.99 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.168 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.8 -39.22 88.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.91 -31.37 72.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.448 ' O ' HG21 ' B' ' 170' ' ' ILE . 46.1 m-85 -117.32 42.65 2.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.213 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -96.65 -176.03 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.59 -38.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.157 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.288 0.566 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.0 -147.97 5.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -123.68 -15.21 7.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.163 . . . . 0.0 110.44 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 mt 51.2 94.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.134 -0.979 . . . . 0.0 110.258 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.33 -119.79 1.03 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -54.05 173.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -1.152 . . . . 0.0 110.087 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' C ' ' CE1' ' B' ' 99' ' ' PHE . . . -96.55 -133.22 7.58 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' N ' ' CE1' ' B' ' 99' ' ' PHE . 0.3 OUTLIER -65.64 176.33 1.55 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.107 -1.231 . . . . 0.0 109.731 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.561 ' N ' ' CD1' ' A' ' 18' ' ' LEU . 2.7 t70 -66.54 60.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.091 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.627 ' CD1' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -80.68 -17.23 51.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 110.691 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.547 ' N ' HD22 ' A' ' 68' ' ' LEU . 64.9 m -41.31 -28.96 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.94 -37.1 4.0 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.608 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -48.59 -40.39 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.277 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.472 HD21 ' HG2' ' A' ' 67' ' ' MET . 3.5 pp -82.97 -27.81 30.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.978 -1.076 . . . . 0.0 108.92 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CE1' HD12 ' A' ' 52' ' ' LEU . 1.7 t80 -90.58 9.95 27.51 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 141.18 95.33 0.25 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 6.8 p-10 -20.06 116.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.976 0.893 . . . . 0.0 112.315 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.671 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.33 163.79 27.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 31' ' ' GLU . 75.7 m-20 -87.45 121.73 30.26 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.545 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 2.9 p -36.78 -28.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.471 0.653 . . . . 0.0 109.69 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.8 tt0 -51.64 -18.48 1.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 0.0 110.575 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.75 27.97 3.87 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.645 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -129.38 147.86 51.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.94 -1.33 . . . . 0.0 109.573 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.671 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.72 165.88 12.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 0.0 111.872 -178.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.528 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -88.31 113.69 24.17 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.928 0.871 . . . . 0.0 111.552 -178.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.02 17.72 2.28 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.93 86.99 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.798 -0.564 . . . . 0.0 109.987 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -70.35 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.323 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.13 -77.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.359 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.52 -144.88 24.7 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 20.3 tt0 -92.38 19.67 6.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -1.195 . . . . 0.0 110.168 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.39 -59.86 0.51 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.24 158.78 15.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -1.109 . . . . 0.0 110.032 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.94 159.03 26.91 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.39 100.21 2.44 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.9 -36.11 0.84 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 0.0 110.098 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 48' ' ' PHE . . . -69.13 -146.86 0.2 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 47' ' ' GLY . 6.3 p90 -49.48 179.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -1.191 . . . . 0.0 110.267 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -91.9 -144.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.349 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -100.55 35.8 2.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.393 -0.817 . . . . 0.0 110.071 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 0.4 OUTLIER -89.31 -26.66 21.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 109.074 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.582 HD12 ' CE1' ' A' ' 25' ' ' PHE . 2.1 mt -88.81 -38.57 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.621 -0.674 . . . . 0.0 109.451 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.527 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -57.26 -57.49 12.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.362 -0.836 . . . . 0.0 109.913 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.12 -31.36 71.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 58' ' ' SER . 3.4 m-20 -73.21 -43.13 61.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.53 HG22 ' CA ' ' A' ' 22' ' ' GLY . 16.1 mt -46.26 -45.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.328 -0.857 . . . . 0.0 109.245 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.92 -26.48 18.77 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -136.51 44.19 2.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 110.232 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.606 ' CD2' ' CE1' ' B' ' 190' ' ' PHE . 6.7 mt -99.41 13.14 34.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.22 47.21 1.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.79 . . . . 0.0 109.864 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -135.99 1.93 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 110.102 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 1.5 mt -88.69 -38.96 14.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 109.743 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 3.35 4.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.0 0.59 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.092 -1.24 . . . . 0.0 110.064 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.9 t70 -44.05 -32.91 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.914 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -56.75 -49.73 74.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.017 -1.052 . . . . 0.0 109.478 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.479 ' SD ' ' ND2' ' B' ' 159' ' ' ASN . 12.7 ttp -65.96 -12.62 56.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 21' ' ' THR . 1.3 tm? -70.09 -65.66 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.09 -6.33 22.34 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -79.45 -4.77 52.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 110.646 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -129.65 -6.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 110.371 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.575 ' CG2' ' HG ' ' A' ' 20' ' ' LEU . 5.8 tp -140.74 72.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 110.166 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.8 t70 -79.79 56.19 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.587 HD13 ' CE1' ' B' ' 116' ' ' PHE . 6.4 mt -110.48 69.01 0.68 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.634 0.731 . . . . 0.0 110.746 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -133.96 -164.81 1.55 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.563 -0.711 . . . . 0.0 110.064 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.0 114.05 6.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.302 -0.874 . . . . 0.0 110.165 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.218 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.25 0.548 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.15 75.64 1.3 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.45 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt -96.84 -51.58 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -1.163 . . . . 0.0 110.237 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 4.8 t 62.1 132.09 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 109.961 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.417 ' HD2' HG11 ' B' ' 64' ' ' VAL . 49.3 Cg_endo -74.48 152.53 43.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.006 1.53 . . . . 0.0 110.778 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -118.92 129.86 55.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 109.865 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.442 HD12 HG23 ' B' ' 160' ' ' ILE . 29.2 mt -69.93 132.23 45.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 110.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.82 -16.36 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.421 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.416 ' OD1' ' HA2' ' B' ' 125' ' ' GLY . 0.9 OUTLIER -152.49 111.6 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.577 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' B' ' 124' ' ' THR . 20.0 mm -91.95 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' B' ' 159' ' ' ASN . 50.7 t -148.77 114.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.915 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' B' ' 157' ' ' ILE . . . -132.56 165.34 24.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.534 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 69.5 p -120.71 141.44 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.685 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.444 ' O ' ' HG3' ' B' ' 121' ' ' MET . 3.3 t -140.23 156.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.042 . . . . 0.0 110.722 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.461 ' O ' ' O ' ' B' ' 151' ' ' LYS . 24.2 m -106.18 144.44 32.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' B' ' 151' ' ' LYS . 93.5 mt -94.73 -6.29 43.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.447 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . 0.512 ' HA3' ' CB ' ' B' ' 151' ' ' LYS . . . 103.59 -38.8 3.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . 0.461 ' HB2' ' HA ' ' B' ' 149' ' ' ALA . 0.0 OUTLIER -142.47 -174.5 4.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.113 -1.228 . . . . 0.0 110.836 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.468 ' O ' HD21 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -78.7 178.86 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 110.222 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.549 ' CD1' HD11 ' B' ' 76' ' ' LEU . 10.4 mt -140.89 165.01 28.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.422 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.49 ' CB ' ' OG1' ' B' ' 84' ' ' THR . 1.1 m-20 -110.27 83.27 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.459 HD21 HG22 ' B' ' 102' ' ' VAL . 8.4 mt -38.11 -49.1 1.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.39 -51.62 58.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.697 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.518 ' HA ' ' CD2' ' B' ' 87' ' ' LEU . 43.3 p -76.87 -41.9 42.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 110.077 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.549 HG21 ' CZ ' ' B' ' 148' ' ' PHE . 43.9 t -60.49 -37.02 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.121 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.27 78.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.518 ' CD2' ' HA ' ' B' ' 84' ' ' THR . 0.7 OUTLIER -90.74 -23.04 20.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.5 ' CD2' ' HB ' ' B' ' 84' ' ' THR . 6.7 m-70 -82.97 -35.38 25.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.684 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.52 ' HB3' ' CE ' ' B' ' 104' ' ' MET . . . -72.06 145.15 48.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.387 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -73.94 -27.13 60.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 1.7 m120 -133.69 79.29 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.938 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' B' ' 89' ' ' ALA . . . -138.07 159.64 41.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.416 ' HG3' ' C ' ' B' ' 92' ' ' ALA . 73.9 mt-10 -147.83 120.34 8.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.244 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -113.52 113.4 25.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.121 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -119.8 111.72 35.72 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.15 -19.77 29.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.009 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -17.86 61.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -105.28 -76.46 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.444 -0.785 . . . . 0.0 110.027 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.658 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.25 173.15 11.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.891 . . . . 0.0 110.433 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.3 43.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.234 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.527 ' CB ' HD12 ' A' ' 74' ' ' LEU . . . -132.22 151.97 51.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 110.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.459 HG22 HD21 ' B' ' 82' ' ' LEU . 55.8 t -96.95 126.58 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 109.526 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.449 HD12 ' OG ' ' A' ' 30' ' ' SER . 3.3 mp -89.72 118.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 110.478 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.52 ' CE ' ' HB3' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -95.56 165.32 12.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.455 ' O ' ' ND2' ' B' ' 91' ' ' ASN . 10.3 mtp180 -163.8 116.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.783 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.473 HG22 ' CE1' ' B' ' 139' ' ' TYR . 37.7 pt -120.71 150.19 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.466 -0.771 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.5 OUTLIER -91.6 28.32 1.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.519 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 7.0 pt-20 -161.96 83.9 1.69 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.716 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' B' ' 111' ' ' THR . 51.1 Cg_endo -85.47 148.76 46.47 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.172 -0.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -51.54 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 109' ' ' PRO . 13.2 p -146.62 -179.46 6.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.899 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.503 ' CG2' ' HB2' ' A' ' 27' ' ' ASN . 1.2 t -131.57 179.22 6.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 110.208 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.469 ' HB1' ' CE2' ' B' ' 139' ' ' TYR . . . -166.85 137.82 3.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 0.0 110.312 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.481 HD23 HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -95.22 105.94 17.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.59 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 33.8 mt -90.21 128.34 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.361 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 2.8 m-30 -99.84 162.31 13.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 79' ' ' ARG . . . -76.57 -11.09 59.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.699 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 m -83.05 -5.68 59.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.027 . . . . 0.0 110.211 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' B' ' 78' ' ' CYS . . . 107.14 -39.16 2.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.93 135.21 55.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.114 . . . . 0.0 109.987 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -133.01 168.34 18.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.356 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 71' ' ' VAL . 10.3 t -130.37 143.64 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.16 144.38 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.958 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.535 HG22 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -153.08 165.58 35.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.538 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 108.72 -36.45 4.35 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.464 ' HB1' ' HB ' ' B' ' 70' ' ' ILE . . . -47.25 167.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -1.161 . . . . 0.0 110.416 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -118.77 -12.09 9.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.504 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m -154.43 173.65 15.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.062 -1.024 . . . . 0.0 110.406 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -57.96 -49.74 75.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.08 -35.3 73.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.69 -41.78 83.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 110.202 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -58.42 -54.61 45.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.164 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -50.17 -37.54 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.09 -39.21 75.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 0.0 110.376 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -70.1 -35.37 74.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.14 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 50.7 m -72.28 -60.56 2.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 5.7 ptm180 -47.51 -30.11 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.294 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 57.7 mmtt -66.89 -48.16 69.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.014 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 28.6 m-85 -64.79 -52.79 54.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.79 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.503 ' CB ' ' NE2' ' B' ' 144' ' ' GLN . . . -50.01 -37.09 31.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.864 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.85 85.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 mt -64.2 -25.44 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.771 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' B' ' 148' ' ' PHE . 0.3 OUTLIER -84.43 -25.12 7.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.385 -0.822 . . . . 0.0 109.029 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.541 ' CG ' ' HB3' ' B' ' 150' ' ' ALA . 24.2 mt-30 -89.17 -22.3 22.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.452 -0.78 . . . . 0.0 109.763 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -82.18 -27.81 32.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.55 ' CG2' ' CE2' ' B' ' 148' ' ' PHE . 25.7 mt -83.48 -37.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.655 -0.653 . . . . 0.0 109.806 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 117.74 20.2 4.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.55 ' CE2' ' CG2' ' B' ' 146' ' ' ILE . 13.8 m-85 -86.19 -160.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.088 -1.242 . . . . 0.0 110.335 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' B' ' 76' ' ' LEU . . . -34.66 -71.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.304 0.573 . . . . 0.0 110.501 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.541 ' HB3' ' CG ' ' B' ' 144' ' ' GLN . . . 64.88 72.72 0.43 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 112.002 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' B' ' 76' ' ' LEU . 0.4 OUTLIER -162.92 101.56 1.0 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.167 -0.958 . . . . 0.0 110.057 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.463 ' O ' HG22 ' B' ' 153' ' ' THR . 2.7 t80 -72.18 103.22 3.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.0 110.353 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.7 OUTLIER -159.22 158.27 32.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' B' ' 153' ' ' THR . 2.7 t70 70.45 18.5 6.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.885 . . . . 0.0 110.669 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.522 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 4.2 t80 -69.05 135.4 50.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.046 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.0 131.82 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -0.956 . . . . 0.0 110.704 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.45 ' HA ' ' HB3' ' B' ' 72' ' ' ALA . 51.5 mt -80.39 122.68 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 109.644 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -111.93 -3.6 14.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.119 -0.988 . . . . 0.0 110.972 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.479 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 11.2 m120 -155.8 140.42 16.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.855 -1.153 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.442 HG23 HD12 ' B' ' 67' ' ' LEU . 48.4 mt -133.88 123.97 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.388 -0.82 . . . . 0.0 109.655 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 8.0 t -101.6 131.1 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 110.627 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.73 172.15 18.97 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.99 152.24 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -1.197 . . . . 0.0 110.362 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.01 159.95 7.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' B' ' 166' ' ' VAL . 22.6 t0 -101.81 166.3 10.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.485 ' N ' ' OD1' ' B' ' 165' ' ' ASP . 0.0 OUTLIER -114.32 -83.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.347 -0.846 . . . . 0.0 110.291 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -177.84 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.636 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.465 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 2.2 p90 -137.6 166.7 24.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.1 Cg_endo -70.97 171.63 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.82 1.431 . . . . 0.0 110.527 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.95 139.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 110.601 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.13 88.07 2.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' B' ' 185' ' ' TYR . 71.9 mt -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.625 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -43.02 76.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.182 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.26 -31.03 66.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.455 ' HG ' HD12 ' B' ' 193' ' ' LEU . 11.5 tp -75.45 -35.24 60.95 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -1.112 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' B' ' 172' ' ' LEU . . . -69.89 -27.36 64.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.3 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -75.44 -40.82 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.328 -0.857 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 2.1 t -78.3 -55.85 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.183 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.437 ' HB2' HD13 ' B' ' 175' ' ' LEU . 14.2 m80 -91.67 27.07 2.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.71 45.92 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -12.48 52.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.145 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -115.38 -23.99 8.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' B' ' 195' ' ' TYR . 0.1 OUTLIER -125.04 171.28 10.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.7 m -132.33 147.77 52.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.241 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' B' ' 172' ' ' LEU . 33.6 t80 -149.64 104.54 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.913 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' B' ' 190' ' ' PHE . 6.5 mt-10 -113.67 103.94 55.3 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.81 -1.87 10.58 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.068 1.562 . . . . 0.0 110.113 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' B' ' 186' ' ' GLU . 1.7 pm0 -85.74 -18.21 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.7 -38.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.606 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 4.5 t80 -113.82 108.61 51.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.425 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.96 -20.52 19.42 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.031 1.543 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.446 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.55 178.43 44.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.462 ' CB ' HD21 ' B' ' 172' ' ' LEU . 9.7 tt -118.73 125.75 50.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -1.116 . . . . 0.0 110.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.522 ' CD1' HD11 ' A' ' 62' ' ' LEU . 4.7 mt -101.66 111.0 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.431 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 6.5 t80 -96.39 124.38 40.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.523 ' CZ ' ' CB ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -104.91 101.19 10.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 110.24 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.508 ' CE ' HG12 ' B' ' 230' ' ' ILE . 16.8 ttm -69.58 128.51 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.922 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.7 -51.38 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.06 119.05 10.36 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.103 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.69 150.28 95.25 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.91 -2.121 . . . . 0.0 110.427 -0.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' B' ' 197' ' ' MET . 3.2 tttt -63.04 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.483 HG21 HD11 ' B' ' 202' ' ' ILE . 47.1 mm -128.96 150.96 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.62 128.71 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.044 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.463 HD22 ' CD2' ' B' ' 214' ' ' LEU . 3.7 mp -120.36 135.05 55.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 110.548 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.524 HD13 ' CZ ' ' B' ' 190' ' ' PHE . 1.9 mm? -102.97 126.66 50.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 109.795 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.443 HG12 HD22 ' B' ' 234' ' ' LEU . 3.7 mt -119.5 127.19 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 110.434 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.446 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 83.7 m-85 -118.23 143.67 46.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 110.241 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 25.4 t -48.06 -30.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.38 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.25 -45.74 68.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . 0.446 ' O ' HG23 ' B' ' 166' ' ' VAL . . . 128.24 3.25 5.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.453 ' O ' HD12 ' B' ' 212' ' ' ILE . 0.5 OUTLIER -92.57 135.98 33.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -1.2 . . . . 0.0 110.301 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.453 HD12 ' O ' ' B' ' 211' ' ' LYS . 46.1 mm -121.09 125.3 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.348 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 24.7 t -107.07 154.78 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.961 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.463 ' CD2' HD22 ' B' ' 204' ' ' LEU . 4.1 mp -135.36 135.73 40.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 5.1 t -157.84 142.14 16.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.909 . . . . 0.0 110.204 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 111.39 21.78 6.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.472 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -108.82 126.92 53.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -1.136 . . . . 0.0 110.179 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -75.23 -25.69 58.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -132.56 -178.57 4.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.12 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 28.4 ttp-105 -85.5 -37.42 19.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -52.49 -26.71 13.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.131 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -76.35 -44.56 36.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.828 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.434 HG22 HD11 ' B' ' 223' ' ' ILE . 28.2 mm -60.36 -38.23 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.64 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -64.99 -47.3 78.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -36.16 81.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.316 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.407 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -53.84 -52.86 59.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.465 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 25.5 t80 -71.57 -44.34 64.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.34 -32.36 2.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.51 -11.67 20.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.508 HG12 ' CE ' ' B' ' 197' ' ' MET . 8.6 mm -100.03 -23.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.59 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 25.0 t80 -52.34 -48.22 90.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -70.31 -33.4 14.58 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.397 1.209 . . . . 0.0 110.391 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.84 -40.36 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.456 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.443 HD22 HG12 ' B' ' 206' ' ' ILE . 66.5 mt -68.11 -45.48 73.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.128 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -27.6 64.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.6 OUTLIER -66.49 -39.49 88.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.34 40.5 2.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.1 ptt85 -66.72 -170.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.441 ' HB2' ' HG2' ' B' ' 169' ' ' PRO . 1.3 mttp -123.33 -61.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.128 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.171 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.175 0.512 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.7 -82.33 0.21 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 m -72.83 142.26 48.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -1.101 . . . . 0.0 110.057 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 14' ' ' ILE . 11.8 pt -108.63 144.7 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.204 -0.935 . . . . 0.0 110.518 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 16' ' ' ASN . . . 49.44 -173.08 0.07 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER 174.03 -152.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -1.141 . . . . 0.0 110.133 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.31 -172.28 23.53 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.685 ' HB2' ' CG ' ' B' ' 99' ' ' PHE . 0.1 OUTLIER -63.01 156.38 24.84 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.988 -1.301 . . . . 0.0 109.101 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.577 ' N ' HD13 ' A' ' 18' ' ' LEU . 14.4 t70 -81.22 98.68 8.2 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 111.123 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.569 ' CD1' ' HB ' ' A' ' 71' ' ' VAL . 4.9 mt -97.71 4.93 49.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.253 -0.904 . . . . 0.0 109.697 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 18.7 m -39.81 -28.61 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.104 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -100.19 -38.26 3.6 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -52.86 -46.87 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -1.073 . . . . 0.0 109.022 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.457 ' CD1' ' HG2' ' A' ' 67' ' ' MET . 3.4 pp -80.51 -3.92 51.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 21' ' ' THR . 1.4 t80 -112.75 -4.76 13.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.421 -0.799 . . . . 0.0 110.895 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 162.19 69.08 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.517 -1.801 . . . . 0.0 111.337 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.589 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 20.37 111.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.15 0.976 . . . . 0.0 113.301 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.714 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -149.0 156.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.53 ' N ' HG12 ' A' ' 28' ' ' ILE . 5.4 m-20 -88.85 138.3 31.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.533 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -41.77 -26.55 0.08 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.407 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -55.47 -14.99 2.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 110.74 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.26 32.88 5.63 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.21 123.88 51.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.28 -1.13 . . . . 0.0 109.607 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.714 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.7 OUTLIER -90.39 131.79 35.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.442 -0.786 . . . . 0.0 110.339 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 27' ' ' ASN . 0.6 OUTLIER -130.18 179.93 5.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.985 -1.072 . . . . 0.0 109.693 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.474 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 1.4 mt-30 -125.77 -102.15 0.37 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 110.179 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 36' ' ' GLN . 8.9 p30 176.62 43.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.584 -1.323 . . . . 0.0 110.084 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.436 ' N ' ' HD3' ' B' ' 110' ' ' LYS . 0.2 OUTLIER -85.83 84.73 7.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 0.0 110.481 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 20.3 p-10 -82.71 -147.76 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.898 . . . . 0.0 109.994 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.19 -46.56 85.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -121.97 106.34 11.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.154 . . . . 0.0 110.358 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.46 -71.47 0.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.75 44.33 23.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -1.118 . . . . 0.0 110.265 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.79 -150.97 0.02 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.97 -121.71 0.65 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -48.3 151.93 0.96 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -1.112 . . . . 0.0 110.358 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.41 138.3 2.47 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 48' ' ' PHE . 13.3 p90 -58.07 161.37 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -1.123 . . . . 0.0 110.463 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.12 -137.5 0.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.391 -0.818 . . . . 0.0 110.215 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . . . -100.92 36.04 2.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.815 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.8 tt0 -79.3 -31.8 43.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.593 ' HB3' ' CZ ' ' B' ' 190' ' ' PHE . 0.0 OUTLIER -117.16 -9.17 11.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.483 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.574 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 5.7 tpt180 -62.82 -54.25 41.84 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.64 -20.5 33.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' LEU . 85.7 m-20 -88.43 -25.45 22.64 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 40.7 mt -51.2 -38.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.34 -13.29 42.9 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 55' ' ' ASN . 18.0 m -138.15 11.59 2.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.241 -1.152 . . . . 0.0 110.808 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.549 HD11 ' N ' ' A' ' 56' ' ' ILE . 0.5 OUTLIER -83.54 19.83 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 0.0 110.669 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 p -104.21 31.41 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 110.301 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -130.64 11.24 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.472 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -124.86 -2.2 7.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.016 -1.053 . . . . 0.0 110.979 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.498 ' N ' HD23 ' A' ' 62' ' ' LEU . . . 150.71 -47.27 0.6 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.485 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 3.1 mm? -41.83 -31.74 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -1.206 . . . . 0.0 110.718 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' CA ' ' HG ' ' A' ' 68' ' ' LEU . 36.0 t70 -41.02 -35.93 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.515 -0.741 . . . . 0.0 110.286 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.466 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.3 m -66.53 -43.64 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.832 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.486 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 5.2 tpp -70.32 -22.71 62.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . 4.7 mt -62.74 -61.25 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.973 -1.079 . . . . 0.0 108.904 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.8 pp -62.48 -9.51 8.76 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.018 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.15 -17.23 37.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 111.274 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.569 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -115.68 -20.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.688 -1.258 . . . . 0.0 109.319 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.55 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 3.9 tp -130.36 71.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.646 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.52 57.73 1.26 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.854 -1.154 . . . . 0.0 108.154 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.634 ' CB ' ' CE2' ' B' ' 99' ' ' PHE . 5.1 mt -102.23 65.65 0.97 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.534 0.683 . . . . 0.0 110.502 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -110.39 128.17 55.45 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.334 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 75' ' ' LYS . 16.1 mm-40 43.02 75.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.242 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.182 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.325 0.583 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -159.37 58.36 0.33 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' B' ' 166' ' ' VAL . 5.2 mt -61.81 138.68 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.133 . . . . 0.0 110.38 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.37 132.19 23.72 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.857 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.34 148.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.922 1.485 . . . . 0.0 110.627 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 17.9 m -108.07 127.01 53.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.855 . . . . 0.0 110.245 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.92 131.06 43.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -123.26 -7.86 8.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.594 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.473 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.9 OUTLIER -163.47 110.16 1.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.466 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.527 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 19.4 mm -100.96 146.69 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.474 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 47.4 t -136.75 131.16 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.969 -1.082 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.95 156.78 44.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' THR . . . . . 0.415 ' C ' HG21 ' B' ' 74' ' ' VAL . 24.3 m -109.98 137.86 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.442 ' CG1' ' HE3' ' B' ' 121' ' ' MET . 90.2 t -134.12 171.01 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 50.9 m -146.14 144.4 29.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.314 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.5 HD23 ' CB ' ' B' ' 150' ' ' ALA . 71.3 mt -97.27 -71.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.84 -5.91 5.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . 0.415 ' O ' ' SG ' ' B' ' 78' ' ' CYS . 31.0 p -129.29 130.5 46.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -1.159 . . . . 0.0 110.165 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.456 ' O ' HD22 ' B' ' 80' ' ' LEU . 0.7 OUTLIER -53.5 151.84 5.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 0.0 110.261 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.557 HD21 ' CD1' ' B' ' 148' ' ' PHE . 25.5 mt -131.13 159.59 37.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' B' ' 82' ' ' LEU . 31.9 t70 -105.58 92.03 4.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.846 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.447 HD21 HG22 ' B' ' 102' ' ' VAL . 16.3 mt -40.64 -34.39 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.1 OUTLIER -61.2 -49.04 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.052 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 41.3 m -80.24 -33.42 37.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.256 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 t -61.41 -50.1 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.45 -25.36 54.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 12.3 tp -68.39 -43.5 77.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 110.286 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -40.7 18.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -48.78 110.71 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -63.26 -11.35 20.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 0.8 OUTLIER -139.93 79.79 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.336 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.32 168.92 25.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.25 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.16 142.08 35.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.224 -0.923 . . . . 0.0 110.121 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -140.21 102.56 4.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.69 124.84 26.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.86 -20.98 21.79 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 110.74 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.34 59.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 6.0 mpt_? -93.18 -60.1 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.95 . . . . 0.0 110.723 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.685 ' CG ' ' HB2' ' A' ' 18' ' ' LEU . 64.3 t80 -170.32 179.97 3.25 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.523 -177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.456 ' O ' ' CD1' ' A' ' 74' ' ' LEU . . . -100.9 69.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.005 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.597 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -154.24 142.84 20.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.567 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.447 HG22 HD21 ' B' ' 82' ' ' LEU . 12.5 t -96.69 117.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 30' ' ' SER . 3.4 mt -89.58 105.82 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.411 ' SD ' HD11 ' B' ' 142' ' ' ILE . 4.0 ttm -91.72 148.94 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.043 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.422 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 30.4 mtm180 -142.78 144.16 32.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 19.4 pt -131.27 179.16 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.882 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.45 34.99 4.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.129 -0.982 . . . . 0.0 110.514 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 179.25 81.05 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.456 ' HG3' ' OD1' ' B' ' 131' ' ' ASP . 50.0 Cg_endo -77.06 162.35 91.54 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.364 -0.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.5 ' O ' ' CG2' ' B' ' 111' ' ' THR . 3.5 tttp -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.898 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' B' ' 110' ' ' LYS . 61.8 p -156.26 -179.63 8.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.295 -0.878 . . . . 0.0 110.485 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.534 ' CG2' HG21 ' B' ' 124' ' ' THR . 4.9 t -125.58 172.7 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.511 ' HB3' ' CE2' ' B' ' 139' ' ' TYR . . . -150.79 136.21 17.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.906 -1.121 . . . . 0.0 111.416 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.541 HD13 ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -92.54 95.81 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.43 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 73.9 mt -89.69 139.26 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.069 . . . . 0.0 111.116 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.547 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 2.0 m-85 -111.28 162.79 14.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.407 ' HB3' ' HG ' ' B' ' 82' ' ' LEU . . . -79.08 -15.59 57.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 8.2 m -76.85 -17.66 58.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.298 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.406 ' HA2' HD13 ' B' ' 80' ' ' LEU . . . 120.14 -26.22 7.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' B' ' 75' ' ' THR . 3.4 mttt -77.75 163.02 26.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -1.114 . . . . 0.0 110.189 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.442 ' HE3' ' CG1' ' B' ' 74' ' ' VAL . 5.2 ptt? -160.99 170.27 20.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -135.9 127.27 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.355 -0.84 . . . . 0.0 109.744 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 26.3 t -105.2 133.89 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.968 -1.083 . . . . 0.0 110.796 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.534 HG21 ' CG2' ' B' ' 112' ' ' THR . 2.4 t -140.64 159.03 43.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.616 -0.677 . . . . 0.0 109.23 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.554 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 112.58 -17.03 23.66 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.527 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -60.42 173.27 0.71 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -1.199 . . . . 0.0 110.191 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -120.47 -18.77 7.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.998 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.41 ' N ' HG13 ' B' ' 70' ' ' ILE . 14.5 t -146.7 -172.32 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -70.59 -59.23 2.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.214 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -52.53 -33.41 45.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' B' ' 109' ' ' PRO . 1.5 t0 -63.59 -46.4 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 4.0 t -63.27 -34.84 78.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.321 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . 0.507 ' HA ' ' CZ ' ' B' ' 155' ' ' PHE . 6.4 ttpt -66.37 -43.51 85.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.141 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.469 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -70.36 -58.27 3.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.51 -26.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.121 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 47.7 t -77.52 -59.07 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 110.23 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' B' ' 134' ' ' LEU . 1.2 ptm180 -53.07 -26.01 14.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.003 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -70.65 -46.9 62.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.799 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.511 ' CE2' ' HB3' ' B' ' 113' ' ' ALA . 17.4 m-85 -60.76 -44.13 97.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.797 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.95 -27.79 67.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.766 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.497 ' HG3' ' NH1' ' B' ' 141' ' ' ARG . 0.2 OUTLIER -68.69 -37.4 79.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.8 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.411 HD11 ' SD ' ' B' ' 104' ' ' MET . 11.2 mt -61.5 -48.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.991 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.511 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 3.2 mp -63.66 -44.09 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 109.666 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -70.97 -33.81 70.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -71.73 -22.25 61.65 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.7 -22.87 10.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.35 -34.65 2.75 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.557 ' CD1' HD21 ' B' ' 80' ' ' LEU . 11.8 m-85 -47.18 161.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.159 -1.201 . . . . 0.0 110.962 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.16 42.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 0.0 109.707 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.511 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -59.98 158.34 11.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 110.692 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 2.4 mttm -120.8 -156.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.539 -0.726 . . . . 0.0 109.688 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -153.0 71.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 110.211 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -142.85 -178.79 5.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 153' ' ' THR . 0.6 OUTLIER 69.04 11.75 8.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.507 ' CZ ' ' HA ' ' B' ' 133' ' ' LYS . 40.4 t80 -68.67 132.25 46.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -169.83 131.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 1.9 mp -79.97 118.93 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.836 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.434 ' OE1' ' HG3' ' B' ' 218' ' ' LYS . 17.4 mm-40 -122.49 3.36 9.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.071 -1.018 . . . . 0.0 110.849 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.474 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 8.2 t-20 -149.83 95.91 2.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.894 -1.129 . . . . 0.0 110.768 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.519 HD13 ' CA ' ' B' ' 219' ' ' GLN . 88.1 mt -100.71 141.91 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.668 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.5 ' CG2' ' OG1' ' B' ' 215' ' ' THR . 26.5 t -122.31 132.8 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.775 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -134.98 -179.92 17.0 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.04 143.23 3.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -1.213 . . . . 0.0 110.369 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 26.9 p -170.23 175.41 4.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -119.35 173.82 6.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 209' ' ' SER . 0.0 OUTLIER -112.84 -85.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 110.098 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 166.97 -22.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.142 -0.974 . . . . 0.0 110.672 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' B' ' 170' ' ' ILE . 28.7 p90 -121.33 152.44 57.57 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.093 -1.005 . . . . 0.0 109.705 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.472 ' HA ' ' OG ' ' B' ' 209' ' ' SER . 50.9 Cg_endo -79.78 158.44 24.64 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.908 1.478 . . . . 0.0 110.619 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.64 ' CD1' ' CB ' ' B' ' 209' ' ' SER . 5.7 mt -133.95 164.92 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 0.0 110.293 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.17 93.2 5.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.934 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.525 ' CD1' ' HA ' ' B' ' 208' ' ' VAL . 55.5 mt -47.45 -49.99 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 110.063 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 172' ' ' LEU . 1.5 mt-10 -44.61 -36.73 3.2 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.496 -0.752 . . . . 0.0 109.797 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.06 -38.57 63.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' B' ' 195' ' ' TYR . 0.1 OUTLIER -66.73 -38.06 85.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -1.125 . . . . 0.0 110.011 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.14 -13.74 59.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -89.18 -37.9 14.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -52.13 4.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' B' ' 183' ' ' SER . 28.7 m80 -93.05 21.73 5.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 0.0 110.084 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' B' ' 179' ' ' HIS . . . -43.13 -65.29 1.48 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 9.3 t -48.71 -21.73 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -1.186 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.564 ' CZ ' HG22 ' B' ' 198' ' ' VAL . 1.1 m-30 -114.08 15.48 18.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' B' ' 179' ' ' HIS . 0.5 OUTLIER -151.52 153.45 34.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' SER . . . . . 0.419 ' O ' HD22 ' B' ' 193' ' ' LEU . 1.0 OUTLIER -127.77 141.23 51.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.875 . . . . 0.0 109.943 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -132.66 107.91 8.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.445 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 2.0 mm-40 -114.31 94.49 35.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.05 -8.94 24.67 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 110.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.37 -3.91 27.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.42 -35.22 0.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 52' ' ' LEU . 2.5 t80 -126.48 128.97 24.25 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.146 -0.971 . . . . 0.0 110.4 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.88 -38.6 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.927 1.488 . . . . 0.0 110.65 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.71 -179.98 44.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.419 HD22 ' O ' ' B' ' 184' ' ' SER . 4.9 tt -106.53 131.92 53.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -1.157 . . . . 0.0 110.269 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' B' ' 205' ' ' LEU . 23.8 mt -90.31 105.94 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.525 ' CD2' HD13 ' B' ' 175' ' ' LEU . 2.1 t80 -90.35 116.26 28.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 79.87 1.77 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -67.5 161.02 26.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.564 HG22 ' CZ ' ' B' ' 182' ' ' PHE . 53.0 t -111.8 -31.08 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.83 94.16 29.37 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.36 165.66 83.9 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.787 -2.172 . . . . 0.0 110.471 0.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' B' ' 197' ' ' MET . 35.2 tttm -88.72 93.11 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' B' ' 217' ' ' ALA . 13.7 mt -144.39 148.5 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.422 ' N ' HG21 ' B' ' 202' ' ' ILE . 14.4 t -94.86 142.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.463 HD13 ' O ' ' B' ' 202' ' ' ILE . 5.2 mp -135.27 148.9 49.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.526 ' HB2' ' CG2' ' B' ' 213' ' ' VAL . 69.7 mt -105.76 110.64 23.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.901 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.518 HD11 HG22 ' B' ' 206' ' ' ILE . 18.5 mm -94.79 96.15 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.477 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.533 ' O ' ' HB ' ' B' ' 208' ' ' VAL . 12.8 m-85 -70.31 58.93 0.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.579 ' O ' ' CB ' ' B' ' 209' ' ' SER . 5.8 t 80.37 -37.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.937 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.64 ' CB ' ' CD1' ' B' ' 170' ' ' ILE . 2.9 p 156.74 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.937 0.875 . . . . 0.0 110.163 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.76 -67.66 1.89 Allowed Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.698 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.452 ' O ' HD12 ' B' ' 212' ' ' ILE . 4.8 mttp -100.74 139.92 35.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -1.15 . . . . 0.0 111.142 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.452 HD12 ' O ' ' B' ' 211' ' ' LYS . 27.1 mm -123.15 140.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.308 -0.87 . . . . 0.0 110.032 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' B' ' 205' ' ' LEU . 12.0 t -123.63 152.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.185 -0.947 . . . . 0.0 110.492 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' B' ' 213' ' ' VAL . 3.4 mp -144.08 123.65 13.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.322 -0.862 . . . . 0.0 110.545 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.5 ' OG1' ' CG2' ' B' ' 161' ' ' VAL . 2.9 t -147.21 144.42 28.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.088 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 116.88 1.16 19.49 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.515 ' CB ' HD12 ' B' ' 202' ' ' ILE . . . -75.59 152.41 37.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -1.124 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.434 ' HG3' ' OE1' ' B' ' 158' ' ' GLN . 8.6 tttt -100.49 -2.53 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.519 ' CA ' HD13 ' B' ' 160' ' ' ILE . 0.0 OUTLIER -165.3 164.93 19.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.086 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.28 -24.77 65.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.466 ' CA ' ' OE1' ' B' ' 221' ' ' GLU . 0.1 OUTLIER -69.1 -37.98 78.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.912 . . . . 0.0 109.964 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' B' ' 217' ' ' ALA . 2.9 mt-10 -63.66 -46.92 83.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.07 -1.019 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.485 HG12 ' CB ' ' B' ' 217' ' ' ALA . 10.7 mm -58.46 -48.37 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.922 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -55.68 -26.8 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.078 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -48.72 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.456 ' HB2' HD21 ' B' ' 214' ' ' LEU . . . -45.26 -35.95 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.17 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.45 -47.43 12.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.345 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -25.97 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.509 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -83.37 -36.57 24.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.46 ' O ' HD11 ' B' ' 230' ' ' ILE . 0.3 OUTLIER -88.19 -29.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 109.906 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.588 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 6.7 t80 -44.21 -49.55 23.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.409 -0.807 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 41.1 Cg_endo -68.17 -45.11 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.35 1.184 . . . . 0.0 110.355 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.457 ' HB ' HD12 ' B' ' 230' ' ' ILE . 4.3 t -47.18 -37.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 108.981 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' B' ' 170' ' ' ILE . 57.3 mt -65.41 -53.0 49.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.84 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.91 -38.17 15.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.981 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -60.08 -45.43 92.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -97.63 34.38 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.931 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -52.01 146.71 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 110.276 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -29.94 9.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.37 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.327 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.293 0.568 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.29 -144.44 17.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.4 p -147.78 68.86 1.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -1.141 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.86 -158.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.15 -41.15 1.74 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.76 99.39 3.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -1.098 . . . . 0.0 109.82 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.15 136.98 5.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.599 ' CD2' ' CD1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -96.4 157.58 15.83 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.136 -1.214 . . . . 0.0 109.235 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.65 95.32 5.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.038 -1.039 . . . . 0.0 111.552 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.601 HD21 ' CG1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -107.94 9.43 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.978 . . . . 0.0 110.81 179.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.567 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 24.0 m -48.85 -23.79 1.21 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.857 -1.152 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.468 ' HA3' HG23 ' A' ' 28' ' ' ILE . . . -100.2 -29.0 6.95 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.601 ' CG1' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -44.99 -44.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.294 . . . . 0.0 108.848 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.431 ' O ' HG23 ' B' ' 161' ' ' VAL . 1.6 pp -84.41 -22.32 30.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.924 -1.11 . . . . 0.0 109.294 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.12 2.82 45.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.35 178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 149.98 101.03 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.54 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 13.6 p-10 -22.08 84.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.813 0.816 . . . . 0.0 111.878 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.592 ' CG1' HG12 ' A' ' 23' ' ' ILE . 1.2 pp -88.49 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 31' ' ' GLU . 66.0 m-20 -88.22 126.52 35.19 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.538 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 1.1 p -39.71 -25.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.758 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' ASP . 16.2 tt0 -59.77 -10.62 3.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.09 -1.006 . . . . 0.0 110.202 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.59 29.84 5.78 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.478 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -117.36 119.65 35.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.306 -1.114 . . . . 0.0 110.519 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.535 HD21 HG21 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -90.81 143.55 26.61 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.051 -1.03 . . . . 0.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 27' ' ' ASN . 4.5 pp -132.48 -178.77 5.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.786 -1.196 . . . . 0.0 110.959 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -128.49 139.36 52.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 110.152 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 23.9 p-10 -78.28 67.21 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.877 . . . . 0.0 110.179 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -160.13 146.05 15.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.888 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -150.19 92.26 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.24 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.62 102.41 1.01 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -65.13 94.44 0.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -1.159 . . . . 0.0 110.19 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.83 -80.38 1.39 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.96 162.87 39.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 110.314 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.21 -157.03 40.33 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.54 101.3 0.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.22 128.32 33.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 110.206 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.77 130.88 1.86 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 48' ' ' PHE . 28.1 p90 -46.54 137.58 6.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -1.138 . . . . 0.0 110.3 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.73 -138.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 110.106 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -93.31 30.37 1.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 110.163 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.39 -19.51 16.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.518 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.572 HD11 ' CD2' ' A' ' 48' ' ' PHE . 4.0 mt -100.28 -45.79 5.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.775 . . . . 0.0 110.331 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.535 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -53.2 -57.56 10.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.274 -0.891 . . . . 0.0 109.738 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 3.0 pp20? -62.77 -19.99 64.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.78 . . . . 0.0 109.416 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 7.7 m-20 -84.15 -35.79 23.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.5 -0.75 . . . . 0.0 109.211 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 4.5 mt -53.09 -41.51 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.394 -0.817 . . . . 0.0 109.141 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.54 -23.88 44.69 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p -118.52 12.8 13.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -1.182 . . . . 0.0 110.567 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.506 ' CD1' ' HA ' ' A' ' 56' ' ' ILE . 4.0 mt -87.81 26.46 1.32 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.098 -1.001 . . . . 0.0 110.369 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 52.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.504 ' HE2' ' CD2' ' B' ' 189' ' ' LEU . 0.7 OUTLIER -173.35 26.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 110.364 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -148.09 12.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.186 -0.947 . . . . 0.0 110.393 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.94 -58.49 0.51 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 4.1 mm? -50.34 -20.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -1.116 . . . . 0.0 110.928 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 t70 -45.43 -43.03 11.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.443 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -66.78 -50.45 62.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.391 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.457 ' O ' HG22 ' A' ' 71' ' ' VAL . 2.0 tpp -68.27 -7.67 32.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.296 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.3 tm? -70.05 -59.63 2.79 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 122.061 0.934 . . . . 0.0 108.631 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.3 pp -75.74 0.56 17.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -92.49 13.93 18.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 112.222 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.528 ' CG1' ' CG2' ' A' ' 23' ' ' ILE . 2.0 t -140.58 3.7 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.743 -1.223 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.599 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 1.5 tp -148.99 76.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.6 t70 -77.73 55.43 1.36 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.12 -0.988 . . . . 0.0 108.455 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.558 ' CD1' ' HB2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER -85.54 34.57 0.59 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.531 0.681 . . . . 0.0 110.629 -178.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.77 162.78 14.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 0.0 110.354 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 58.84 40.15 23.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.4 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.143 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.199 0.524 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.55 65.37 0.97 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.574 ' O ' ' CE2' ' B' ' 227' ' ' PHE . 89.8 mt -93.51 115.28 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -1.161 . . . . 0.0 110.196 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.474 ' CG1' ' OH ' ' B' ' 224' ' ' TYR . 6.6 t -70.96 140.14 85.83 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.321 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.9 Cg_endo -73.85 130.0 14.06 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.011 1.532 . . . . 0.0 110.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -91.17 135.57 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 49.9 mt -80.06 124.29 28.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.02 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -106.49 -18.76 13.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.487 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.9 163.94 11.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.178 -0.951 . . . . 0.0 110.447 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.497 HG21 ' N ' ' B' ' 71' ' ' VAL . 5.6 mt -151.27 165.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.381 -0.824 . . . . 0.0 109.959 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.497 ' N ' HG21 ' B' ' 70' ' ' ILE . 3.4 t -148.17 142.09 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.48 152.28 48.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.986 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.29 132.2 45.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 110.342 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.518 ' HB ' ' CG ' ' B' ' 121' ' ' MET . 94.1 t -123.88 158.34 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.922 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.483 ' CB ' ' HB2' ' B' ' 154' ' ' ASP . 7.7 m -133.39 144.27 49.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.454 ' CD2' ' HB3' ' B' ' 150' ' ' ALA . 96.1 mt -101.4 -32.44 10.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.852 . . . . 0.0 110.032 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.93 18.36 59.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.73 144.91 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -1.212 . . . . 0.0 110.313 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 4.2 ttp85 -75.23 152.18 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 110.005 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.437 HD13 HD13 ' B' ' 76' ' ' LEU . 39.7 mt -132.93 163.09 29.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.406 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.424 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 97.7 m-20 -98.21 113.7 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.423 ' HA ' HG22 ' B' ' 102' ' ' VAL . 13.4 mt -56.25 -53.93 51.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -0.966 . . . . 0.0 110.174 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 8.6 tppt? -51.42 -47.2 63.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.997 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 84.8 m -72.93 -45.71 56.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.08 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.04 -47.95 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.963 . . . . 0.0 109.999 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.01 -10.24 59.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 7.7 tp -98.12 -24.78 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.451 ' O ' ' NH2' ' B' ' 90' ' ' ARG . 2.1 m-70 -98.67 -30.42 12.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.458 ' HB3' ' CE ' ' B' ' 104' ' ' MET . . . -62.28 146.36 51.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.139 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' B' ' 88' ' ' HIS . 5.2 mmt-85 -76.07 -33.57 59.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -134.37 79.3 1.8 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.319 -0.863 . . . . 0.0 109.989 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.455 ' HB1' ' CB ' ' B' ' 89' ' ' ALA . . . -127.13 156.71 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.406 -0.808 . . . . 0.0 110.174 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.424 ' HB2' ' HB ' ' B' ' 103' ' ' ILE . 1.5 mm-40 -134.1 126.05 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -134.93 111.89 10.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.441 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -128.59 126.19 23.34 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.58 -25.55 14.87 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 0.0 110.8 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -68.4 -17.04 64.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 0.0 110.299 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.6 -50.37 3.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.621 ' CE2' ' CB ' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -173.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.436 -0.79 . . . . 0.0 111.582 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.24 56.46 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.837 . . . . 0.0 110.947 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.621 ' CB ' ' CE2' ' B' ' 99' ' ' PHE . . . -145.07 152.82 40.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.523 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' B' ' 115' ' ' ILE . 23.8 t -98.46 135.74 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 30' ' ' SER . 25.4 mm -109.62 120.66 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.043 . . . . 0.0 110.887 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.577 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.9 OUTLIER -90.76 162.93 14.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.667 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.447 ' NH2' ' HG2' ' B' ' 105' ' ' ARG . 0.0 OUTLIER -155.96 126.76 6.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.076 -1.015 . . . . 0.0 110.44 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.571 HG22 ' CE1' ' B' ' 139' ' ' TYR . 43.9 pt -128.47 149.45 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -99.74 26.94 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -162.62 83.0 1.59 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.88 163.76 79.58 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.977 -2.093 . . . . 0.0 110.635 -0.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -68.78 103.93 1.89 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' B' ' 124' ' ' THR . 13.9 p -148.97 169.61 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 111.149 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.488 HG21 ' N ' ' B' ' 113' ' ' ALA . 1.7 m -117.73 153.99 32.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.488 ' N ' HG21 ' B' ' 112' ' ' THR . . . -143.6 132.89 23.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.057 -1.027 . . . . 0.0 110.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.48 ' CD1' HD12 ' A' ' 20' ' ' LEU . 7.2 mt -96.35 137.05 36.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' B' ' 102' ' ' VAL . 46.5 mt -125.83 118.52 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 0.8 OUTLIER -99.89 141.24 32.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -51.83 -20.52 2.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.207 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -21.44 64.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.403 ' O ' HD13 ' B' ' 76' ' ' LEU . . . 113.7 -23.34 13.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -72.66 177.22 4.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -1.162 . . . . 0.0 110.383 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.518 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 6.0 ptm -168.83 140.96 2.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' B' ' 114' ' ' LEU . 4.2 t -115.1 132.98 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.92 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.31 167.88 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 110.091 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.519 HG21 ' CB ' ' A' ' 27' ' ' ASN . 4.7 t -169.16 160.25 9.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.954 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.463 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 113.2 -4.75 25.28 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' B' ' 132' ' ' SER . . . -76.8 146.64 37.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -1.188 . . . . 0.0 110.309 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.69 -21.45 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.252 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' B' ' 129' ' ' GLU . 0.3 OUTLIER -127.23 32.34 5.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . 0.499 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.1 tt0 66.6 -68.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 128' ' ' SER . 7.3 t70 -44.07 -31.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -0.84 . . . . 0.0 110.363 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -63.02 -58.99 5.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.517 ' N ' ' HB3' ' B' ' 126' ' ' ALA . 0.1 OUTLIER -52.48 -31.53 35.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -46.41 75.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.958 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.35 -45.9 71.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.257 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.01 -48.69 67.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.942 . . . . 0.0 110.083 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.415 ' OG ' HG22 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -57.29 -53.63 55.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -51.83 -36.86 49.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.959 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -48.28 65.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' B' ' 104' ' ' MET . 21.8 m-85 -61.78 -55.71 27.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.093 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.28 -21.65 9.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.877 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -78.99 -29.34 43.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 110.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.462 HD11 ' SD ' ' B' ' 104' ' ' MET . 49.0 mt -68.62 -43.69 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.528 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 52.1 mt -70.66 -50.5 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.098 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 90.0 mt-30 -60.15 -37.2 79.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 109.693 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -32.64 68.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.451 HG13 ' O ' ' B' ' 142' ' ' ILE . 5.2 mt -66.6 -17.93 23.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.6 -23.45 12.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -52.34 169.01 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.007 -1.29 . . . . 0.0 110.745 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.53 50.42 0.81 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 110.308 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -80.32 144.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.419 ' O ' ' OG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -126.01 106.37 9.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 0.0 110.331 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -55.78 101.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -162.08 -178.91 6.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.483 ' HB2' ' CB ' ' B' ' 75' ' ' THR . 3.4 m-20 57.8 26.47 13.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 110.445 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.529 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 5.7 t80 -78.99 133.14 36.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.073 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -161.91 130.52 4.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.609 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.499 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 30.0 mt -79.86 126.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 109.826 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' B' ' 218' ' ' LYS . 6.5 mt-30 -134.36 4.68 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 0.0 110.455 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.472 ' HB2' ' HB ' ' B' ' 71' ' ' VAL . 16.1 m120 -147.5 90.8 1.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.816 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.405 HG21 HG12 ' B' ' 70' ' ' ILE . 96.7 mt -99.72 141.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.903 . . . . 0.0 109.863 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 24' ' ' LEU . 11.4 t -109.36 135.44 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.526 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.437 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.19 172.79 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 5.1 m -164.13 150.13 10.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -1.164 . . . . 0.0 110.159 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 21.0 p -170.62 157.78 5.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.456 ' O ' HD11 ' B' ' 63' ' ' ILE . 2.7 p30 -113.6 175.22 5.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 109.796 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.44 -84.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.39 -27.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.426 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 30.7 p90 -129.69 164.67 38.51 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.768 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 48.0 Cg_endo -76.86 156.55 34.86 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.023 1.539 . . . . 0.0 110.488 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.413 HG12 HD21 ' B' ' 234' ' ' LEU . 2.2 mp -121.79 147.84 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -82.62 101.2 10.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.472 HD23 ' O ' ' B' ' 206' ' ' ILE . 20.8 mt -58.65 -52.03 67.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' B' ' 177' ' ' PHE . 1.1 mt-10 -50.44 -45.71 56.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.93 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.12 70.59 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.33 -51.95 10.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.46 -1.023 . . . . 0.0 109.83 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.436 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -63.78 -11.69 28.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.76 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' B' ' 173' ' ' GLU . 3.4 t80 -88.89 -49.36 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 110.125 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' SER . . . . . 0.466 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 36.4 t -88.38 -35.56 17.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -112.36 18.73 18.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.444 ' HA2' ' OG ' ' B' ' 183' ' ' SER . . . -59.38 -18.77 44.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' THR . . . . . 0.444 HG21 ' N ' ' B' ' 182' ' ' PHE . 5.6 t -64.95 -20.61 66.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -1.17 . . . . 0.0 110.21 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.444 ' N ' HG21 ' B' ' 181' ' ' THR . 15.2 m-85 -131.85 5.53 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.897 . . . . 0.0 110.228 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' B' ' 194' ' ' ILE . 37.2 p -124.35 153.54 41.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -125.91 137.42 53.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.456 ' OH ' HD11 ' B' ' 172' ' ' LEU . 4.3 t80 -129.69 101.09 5.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.77 111.85 27.37 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.917 . . . . 0.0 109.908 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 -2.03 10.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.881 1.464 . . . . 0.0 110.377 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.73 -22.51 50.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.305 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.504 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 2.6 pp -159.37 24.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -170.07 106.9 0.44 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.475 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.66 -31.42 6.82 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.97 1.51 . . . . 0.0 109.986 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.78 171.33 37.58 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.412 HD13 ' HB3' ' B' ' 176' ' ' ALA . 5.1 tt -101.01 140.06 35.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.237 -1.155 . . . . 0.0 110.463 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' B' ' 205' ' ' LEU . 65.0 mt -96.04 123.22 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.854 . . . . 0.0 110.109 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.439 ' HB2' HD13 ' B' ' 206' ' ' ILE . 7.4 t80 -107.94 124.15 49.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.367 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -99.66 90.95 4.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.439 ' HE2' ' HB ' ' B' ' 230' ' ' ILE . 29.7 tpp -47.11 134.51 10.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.349 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 56.5 t -65.62 -58.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.403 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -138.72 118.55 9.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.462 ' HG3' ' HA ' ' B' ' 222' ' ' GLU . 48.4 Cg_endo -75.66 163.22 90.82 Favored 'Cis proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.962 -2.099 . . . . 0.0 110.377 -0.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' B' ' 197' ' ' MET . 6.3 mmtt -69.1 94.27 0.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 36.4 mm -126.43 146.29 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.95 . . . . 0.0 110.497 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.403 ' C ' HD13 ' B' ' 204' ' ' LEU . 71.5 t -98.28 134.63 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.848 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.479 HD13 ' N ' ' B' ' 204' ' ' LEU . 3.5 mp -136.34 136.83 40.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 110.542 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 67.4 mt -99.12 145.2 27.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 110.08 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.472 ' O ' HD23 ' B' ' 172' ' ' LEU . 6.6 mt -125.39 103.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -87.17 135.43 33.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 110.307 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 42.5 t -48.15 -24.45 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.2 p -66.38 -44.15 83.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 135.26 -3.43 4.02 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 137.16 34.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -1.226 . . . . 0.0 110.492 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.442 HG22 HD11 ' B' ' 212' ' ' ILE . 13.5 mm -121.66 152.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.28 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 33.4 t -124.77 162.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.056 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 213' ' ' VAL . 3.2 mp -148.29 135.41 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.404 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 4.8 t -166.6 141.17 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 110.082 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 112.9 14.59 9.99 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -90.23 160.35 16.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -1.195 . . . . 0.0 110.361 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' B' ' 158' ' ' GLN . 3.7 mmmm -106.12 -5.34 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -168.59 159.46 10.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.353 -0.842 . . . . 0.0 110.109 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -56.62 -17.79 9.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.337 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -25.63 59.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 109.776 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.462 ' HA ' ' HG3' ' B' ' 200' ' ' PRO . 3.6 mt-10 -80.02 -44.76 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.4 ' HA ' HD11 ' B' ' 223' ' ' ILE . 28.4 mm -61.34 -40.43 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.474 ' OH ' ' CG1' ' B' ' 64' ' ' VAL . 2.4 m-85 -66.77 -37.26 84.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.887 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -72.54 -38.97 67.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.411 ' HB2' HD22 ' B' ' 204' ' ' LEU . . . -58.91 -33.98 71.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.574 ' CE2' ' O ' ' B' ' 63' ' ' ILE . 33.0 t80 -77.84 -54.23 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -17.73 5.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.09 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.39 -37.63 11.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.312 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.467 HG21 ' HA ' ' B' ' 227' ' ' PHE . 3.9 tp -84.47 -24.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.586 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.55 -49.24 56.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.887 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.1 Cg_endo -71.4 -36.47 6.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.547 1.288 . . . . 0.0 110.339 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.67 -35.83 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.653 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.413 HD21 HG12 ' B' ' 170' ' ' ILE . 8.2 mt -71.27 -48.51 50.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.039 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -22.66 53.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.177 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.2 -35.39 41.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 110.269 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.466 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 64.3 m-85 -113.75 40.77 2.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.343 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.5 ' NH2' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -63.67 172.58 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -117.88 -55.62 2.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.159 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 32.3 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.22 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' A' ' 12' ' ' GLY . 52.0 tt0 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.302 0.572 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 11' ' ' GLU . . . -171.11 53.22 0.19 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 t -111.51 53.27 0.72 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.29 -1.124 . . . . 0.0 110.132 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 mm -130.11 -33.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.288 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.406 ' HA2' ' OD2' ' A' ' 65' ' ' ASP . . . 114.82 110.12 2.8 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 17' ' ' GLY . 57.3 m-20 -127.0 -158.69 0.88 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -1.166 . . . . 0.0 110.353 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 16' ' ' ASN . . . 62.07 125.72 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.662 ' N ' ' CZ ' ' B' ' 99' ' ' PHE . 0.0 OUTLIER -60.0 -172.9 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.196 -1.179 . . . . 0.0 109.19 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.499 ' O ' HD13 ' A' ' 28' ' ' ILE . 2.0 t70 -57.62 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.856 -1.153 . . . . 0.0 110.049 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.558 HD22 ' CD2' ' A' ' 18' ' ' LEU . 1.4 mm? -107.21 -20.55 13.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 111.025 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.512 HG22 ' CB ' ' A' ' 59' ' ' LEU . 13.5 m -43.31 -26.83 0.2 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -95.59 -27.11 10.87 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.59 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 4.6 mm -59.43 -50.99 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -1.104 . . . . 0.0 108.942 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 67' ' ' MET . 0.6 OUTLIER -77.56 1.76 18.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.1 OUTLIER -104.78 -21.49 13.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 110.74 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.527 ' HA2' ' ND2' ' B' ' 69' ' ' ASN . . . 159.86 48.32 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.999 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.54 ' HB3' ' CD2' ' A' ' 35' ' ' LEU . 1.4 t-20 56.33 151.67 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -1.112 . . . . 0.0 111.039 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.685 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -171.06 156.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 31' ' ' GLU . 96.7 m-20 -86.18 116.1 24.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.553 ' HB3' ' CD1' ' B' ' 103' ' ' ILE . 0.5 OUTLIER -35.34 -28.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.306 0.574 . . . . 0.0 110.318 -177.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 29' ' ' ASP . 21.3 tt0 -51.77 -18.5 1.27 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.325 -0.86 . . . . 0.0 110.061 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.74 26.59 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.082 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.505 ' O ' ' CA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.44 132.13 54.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.089 -1.242 . . . . 0.0 110.438 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.685 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 1.6 tt -102.9 152.65 21.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.848 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' CD2' ' HB3' ' A' ' 27' ' ' ASN . 3.0 pp -127.88 -179.62 5.05 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.688 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.47 ' N ' HD13 ' A' ' 35' ' ' LEU . 7.2 mt-30 -132.24 110.78 10.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 110.231 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' GLN . 12.5 t0 -43.17 -34.88 1.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.275 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -94.82 70.2 3.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.384 -0.823 . . . . 0.0 110.33 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 20.4 p-10 -92.54 45.47 1.2 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.44 68.85 1.17 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' GLY . 3.2 mt-10 53.29 28.34 7.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -1.197 . . . . 0.0 110.251 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 43' ' ' ARG . . . 44.88 -101.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER 43.45 92.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -1.131 . . . . 0.0 110.258 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.45 -118.76 4.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.27 -142.0 46.79 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.2 m -145.91 146.58 31.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.129 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.06 -166.6 39.83 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.66 127.26 34.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -1.133 . . . . 0.0 110.117 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -171.81 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.143 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.54 22.62 5.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.923 . . . . 0.0 110.153 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.73 -19.01 16.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 56' ' ' ILE . 4.4 mt -94.59 -47.65 6.43 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.3 -48.87 18.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.434 -0.791 . . . . 0.0 109.593 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.35 -26.28 66.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 6.7 m-20 -79.85 -40.46 28.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.517 ' N ' HD13 ' A' ' 59' ' ' LEU . 5.9 mt -50.97 -39.97 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 0.0 109.141 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -22.75 48.91 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 p -129.67 18.85 5.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -1.224 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.548 ' CD2' ' CE2' ' B' ' 190' ' ' PHE . 4.3 mt -84.14 5.21 27.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.4 m -89.53 45.36 1.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.118 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 11.3 ttpt -147.52 12.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.147 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' B' ' 194' ' ' ILE . 0.8 OUTLIER -131.06 -27.17 2.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.622 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.31 -42.77 0.14 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.497 HD21 ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -44.85 -36.99 3.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -1.202 . . . . 0.0 110.54 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 15.3 t0 -42.39 -35.38 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 14.8 m -65.17 -46.8 79.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.335 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.543 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 6.4 tpp -66.76 -16.63 64.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.54 ' CD1' ' HA ' ' A' ' 65' ' ' ASP . 6.5 mt -70.48 -61.42 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.953 -1.092 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.1 pp -66.45 -2.66 4.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.58 -0.7 . . . . 0.0 110.808 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -91.51 -13.55 31.95 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.151 -0.968 . . . . 0.0 111.241 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 67' ' ' MET . 0.0 OUTLIER -119.05 -26.72 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.938 -1.101 . . . . 0.0 110.045 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.585 HG12 ' CE2' ' B' ' 99' ' ' PHE . 0.4 OUTLIER -128.23 67.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 73' ' ' ASP . 16.5 t70 -70.09 59.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.612 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 3.0 mt -91.84 62.05 4.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.612 0.72 . . . . 0.0 110.97 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.26 132.11 56.76 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.12 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 57.98 18.72 5.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.228 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.2 0.524 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -146.87 18.17 1.6 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 87.5 mt -137.61 117.81 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.237 -1.155 . . . . 0.0 110.287 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.438 HG11 ' HD2' ' B' ' 65' ' ' PRO . 39.5 t -97.93 139.45 21.3 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.329 -0.857 . . . . 0.0 109.916 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.481 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 45.5 Cg_endo -71.58 130.12 16.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.94 1.495 . . . . 0.0 110.62 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.461 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 94.1 m -93.45 132.08 38.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.123 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 mt -70.17 128.61 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.505 ' NE2' ' HB2' ' B' ' 163' ' ' SER . 2.0 mt-30 -106.86 -18.33 13.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 110.219 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.527 ' ND2' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -170.17 153.59 4.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.532 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 37.7 mm -129.28 153.74 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' B' ' 124' ' ' THR . 22.4 t -141.76 129.9 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.341 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -137.9 157.19 46.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 41.6 p -104.04 146.19 29.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.251 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.447 HG23 ' OG ' ' B' ' 136' ' ' SER . 54.7 t -137.8 132.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 110.163 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.438 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 5.9 m -114.62 128.24 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.518 HD23 ' CB ' ' B' ' 150' ' ' ALA . 70.3 mt -83.25 -71.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.79 -11.11 3.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . 0.426 ' SG ' HD22 ' B' ' 80' ' ' LEU . 31.6 p -129.68 134.16 47.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -1.219 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' B' ' 117' ' ' ALA . 5.8 ttt180 -58.16 155.26 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.544 HD21 ' CD1' ' B' ' 148' ' ' PHE . 14.6 mt -137.38 153.19 50.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.453 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 40.7 t0 -93.9 101.11 13.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.808 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' B' ' 100' ' ' ALA . 17.8 mt -41.36 -49.33 3.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.185 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -54.23 -34.57 61.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.002 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 85.9 m -80.24 -40.35 27.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.568 HG23 ' CE2' ' B' ' 148' ' ' PHE . 24.8 t -71.9 -37.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.065 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' B' ' 82' ' ' LEU . . . -79.99 -19.02 48.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 110.192 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 13.1 tp -91.54 -30.63 16.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.6 m80 -92.51 -17.77 24.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.339 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' B' ' 85' ' ' VAL . . . -74.7 133.4 42.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -70.32 -21.43 62.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.885 . . . . 0.0 110.351 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -139.44 79.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.083 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -160.2 154.29 23.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.456 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 8.2 pt-20 -141.27 171.59 13.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.482 ' CZ ' HD11 ' B' ' 82' ' ' LEU . 21.5 t80 -140.46 124.89 17.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 110.568 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 31' ' ' GLU . 7.5 m-20 -114.27 98.83 49.68 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.88 -24.01 21.56 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.076 1.566 . . . . 0.0 110.357 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -74.15 -20.78 60.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.384 -0.822 . . . . 0.0 110.298 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.24 -74.03 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 110.363 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -133.25 178.19 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -104.39 40.13 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.612 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -117.96 149.18 41.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -0.949 . . . . 0.0 110.766 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.448 ' CG2' HD23 ' B' ' 82' ' ' LEU . 40.6 t -89.99 124.51 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.044 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 30' ' ' SER . 3.8 mm -89.28 111.77 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.04 . . . . 0.0 110.224 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' B' ' 112' ' ' THR . 2.1 ttm -107.72 155.77 19.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.701 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.42 ' CG ' ' C ' ' B' ' 104' ' ' MET . 56.5 mtm180 -146.33 148.01 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 110.567 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 9.8 pt -131.44 157.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.465 -0.772 . . . . 0.0 109.656 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.07 -28.19 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' B' ' 108' ' ' GLU . 0.5 OUTLIER -156.69 118.69 2.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.168 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.475 ' HG2' ' CB ' ' B' ' 135' ' ' ALA . 47.1 Cg_endo -73.63 122.36 7.71 Favored 'Cis proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.881 -2.133 . . . . 0.0 110.36 -0.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.518 ' O ' ' CG2' ' B' ' 111' ' ' THR . 24.2 tttp -43.25 108.16 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' B' ' 110' ' ' LYS . 18.8 p -158.67 -178.92 7.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.703 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.484 ' HB ' ' ND2' ' A' ' 27' ' ' ASN . 1.2 m -135.23 154.79 51.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.775 . . . . 0.0 109.096 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.481 ' N ' HG21 ' B' ' 112' ' ' THR . . . -136.48 123.92 22.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.836 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.519 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.1 OUTLIER -95.71 97.62 9.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.412 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 9.3 mt -89.51 140.54 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.09 -1.006 . . . . 0.0 110.912 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 72' ' ' ILE . 1.9 m-30 -106.51 150.89 25.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 109.878 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.457 ' N ' HD22 ' B' ' 82' ' ' LEU . . . -65.25 -17.86 64.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 0.0 110.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.6 m -67.52 -18.93 65.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.282 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.56 -13.49 15.39 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -87.95 164.61 15.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -1.196 . . . . 0.0 110.224 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.425 ' HG3' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -163.18 161.74 25.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 0.0 110.251 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.503 ' HB ' ' CD1' ' B' ' 114' ' ' LEU . 24.8 t -129.98 154.39 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.41 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 14.3 t -133.11 104.11 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.527 HG21 ' ND2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -112.04 172.62 6.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.36 -0.837 . . . . 0.0 110.167 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.508 ' CA ' ' HB2' ' A' ' 27' ' ' ASN . . . 97.31 -15.95 61.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.532 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -60.21 166.11 3.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -1.226 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -26.46 10.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.764 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.502 ' N ' HG13 ' B' ' 70' ' ' ILE . 40.0 m -153.68 166.44 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.429 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 128' ' ' SER . 3.8 mt-10 -43.64 -48.41 7.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.15 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.62 -50.63 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.46 -45.34 69.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -36.66 78.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -33.64 72.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.139 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -42.91 64.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.475 ' CB ' ' HG2' ' B' ' 109' ' ' PRO . . . -66.9 -39.81 87.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.194 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.447 ' OG ' HG23 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -60.24 -57.4 12.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.964 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -44.75 -52.2 8.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -53.74 -47.75 70.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.418 ' O ' HD11 ' B' ' 143' ' ' ILE . 15.4 m-85 -61.68 -57.74 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.77 -26.91 2.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 9.0 ttm180 -73.84 -49.29 25.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.836 . . . . 0.0 110.092 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 42.2 mt -47.12 -39.2 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.938 . . . . 0.0 110.052 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' B' ' 143' ' ' ILE . 1.8 mp -72.21 -53.04 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 3.5 mt-30 -66.92 -28.28 68.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.65 -24.85 60.05 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 0.0 108.436 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 7.1 mt -82.33 -24.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 130.35 -23.11 4.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.568 ' CE2' HG23 ' B' ' 85' ' ' VAL . 7.3 m-85 -49.32 165.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.293 . . . . 0.0 110.746 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.62 36.82 2.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.452 -0.78 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.518 ' CB ' HD23 ' B' ' 76' ' ' LEU . . . -62.83 152.69 35.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 13.6 ptpt -136.99 24.07 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.124 -0.985 . . . . 0.0 110.462 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' B' ' 151' ' ' LYS . 2.7 t80 27.25 98.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.211 0.529 . . . . 0.0 111.795 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -151.86 169.5 22.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 110.369 179.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.438 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 7.3 t0 65.45 30.12 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 7.1 t80 -71.85 122.87 21.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.924 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.36 131.19 8.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 3.3 mp -79.53 123.91 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -110.91 -14.99 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.486 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.4 t30 -142.49 135.96 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.711 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' B' ' 70' ' ' ILE . 29.8 mt -131.26 129.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.447 HG21 ' OG1' ' B' ' 215' ' ' THR . 10.2 t -96.8 134.72 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -141.97 168.74 25.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.505 ' HB2' ' NE2' ' B' ' 68' ' ' GLN . 0.3 OUTLIER -161.76 153.05 18.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.285 . . . . 0.0 110.711 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.441 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 7.5 p -165.95 155.65 12.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.13 153.08 21.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.348 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.579 ' HB ' ' CZ ' ' B' ' 168' ' ' PHE . 13.2 m -105.91 3.46 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.56 -2.8 2.52 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.361 -0.837 . . . . 0.0 111.262 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.579 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 15.3 p90 -150.24 149.84 27.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.797 -1.189 . . . . 0.0 110.38 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.478 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 47.4 Cg_endo -73.64 160.62 43.67 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.135 1.597 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.489 HG21 ' N ' ' B' ' 171' ' ' ARG . 3.1 mt -131.34 150.83 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.872 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.489 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.0 OUTLIER -79.66 103.03 9.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.875 179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.452 ' O ' HD11 ' B' ' 193' ' ' LEU . 15.5 mt -63.37 -34.68 78.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.662 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 9.4 pt-20 -78.3 -32.44 49.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.385 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . 0.521 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -64.16 -48.02 79.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.53 HD23 ' CD2' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -60.63 -42.2 96.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -1.106 . . . . 0.0 110.296 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.76 64.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.451 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -83.23 -27.78 29.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 67.0 m -95.13 -44.72 7.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -123.72 49.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.09 -20.59 79.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 32.6 m -60.32 -23.58 64.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -1.146 . . . . 0.0 110.208 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.432 ' O ' ' HG2' ' B' ' 196' ' ' ARG . 17.7 m-85 -123.5 -5.37 8.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.43 ' HB2' HD22 ' B' ' 193' ' ' LEU . 0.4 OUTLIER -123.31 152.93 40.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 8.5 p -131.8 139.33 48.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -127.16 113.46 16.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' B' ' 190' ' ' PHE . 8.6 mt-10 -117.72 92.15 40.55 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.127 -0.983 . . . . 0.0 109.921 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.64 -3.78 13.29 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.001 1.527 . . . . 0.0 110.167 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.57 -13.58 18.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.89 . . . . 0.0 110.014 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 tt -138.54 -35.11 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.462 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.548 ' CE2' ' CD2' ' A' ' 59' ' ' LEU . 2.7 t80 -125.49 114.04 25.4 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.39 -10.32 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.897 1.472 . . . . 0.0 110.457 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.99 172.81 18.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.452 HD11 ' O ' ' B' ' 172' ' ' LEU . 6.1 tt -105.15 121.53 44.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.522 ' CD1' HD11 ' A' ' 62' ' ' LEU . 6.4 mt -90.3 106.27 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.214 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' B' ' 204' ' ' LEU . 5.7 t80 -101.58 122.32 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -111.67 80.06 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.405 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.5 OUTLIER -68.34 166.09 17.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.883 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' B' ' 201' ' ' LYS . 63.1 t -111.02 -31.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.97 . . . . 0.0 110.704 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 7.0 tttt -134.78 97.14 14.22 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.585 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -72.37 150.18 94.55 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.8 -2.167 . . . . 0.0 110.401 -0.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' B' ' 198' ' ' VAL . 0.0 OUTLIER -77.39 92.69 3.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.969 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.533 HD13 ' CB ' ' B' ' 217' ' ' ALA . 27.6 mm -140.33 153.53 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.07 103.8 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 109.844 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.435 HD22 HD22 ' B' ' 214' ' ' LEU . 3.3 mp -95.01 142.45 27.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.463 ' CD1' ' HB ' ' B' ' 213' ' ' VAL . 4.4 mt -118.87 116.01 25.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.663 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.441 HG13 HG13 ' B' ' 212' ' ' ILE . 2.6 mt -108.71 119.87 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' B' ' 208' ' ' VAL . 10.0 m-85 -99.29 147.83 24.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.443 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.478 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 67.7 t -44.42 -25.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.021 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.406 ' N ' ' O ' ' B' ' 207' ' ' PHE . 3.8 p -66.11 -39.73 90.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.055 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . 0.444 ' O ' HG23 ' B' ' 166' ' ' VAL . . . 120.75 17.27 4.28 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.462 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.1 OUTLIER -91.36 130.77 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.123 . . . . 0.0 110.135 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.492 ' N ' HD11 ' B' ' 212' ' ' ILE . 1.2 mp -116.35 121.68 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 110.028 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.463 ' HB ' ' CD1' ' B' ' 205' ' ' LEU . 27.0 t -107.69 113.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 110.139 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' B' ' 214' ' ' LEU . 3.7 mp -101.23 103.5 14.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 5.0 t -130.31 142.95 50.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.971 . . . . 0.0 110.105 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.41 ' CA ' ' HE2' ' A' ' 67' ' ' MET . . . 114.14 14.05 9.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.533 ' CB ' HD13 ' B' ' 202' ' ' ILE . . . -90.96 145.55 24.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.157 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -85.33 -13.76 48.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.348 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.509 ' CA ' ' CD1' ' B' ' 160' ' ' ILE . 1.3 tt0 -151.51 -173.44 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.066 -1.021 . . . . 0.0 110.539 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -79.77 -52.97 7.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.408 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.451 ' OE2' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -45.7 -25.72 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 110.538 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -69.83 -54.34 14.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.467 HD12 ' HB1' ' B' ' 217' ' ' ALA . 18.9 mm -58.6 -39.81 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.481 ' CE1' ' HG2' ' B' ' 65' ' ' PRO . 5.5 m-85 -67.35 -33.15 74.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.491 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -78.24 -37.09 46.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.956 . . . . 0.0 110.145 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.3 80.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 2.3 t80 -67.85 -50.12 58.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.92 -15.19 7.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -95.88 -34.57 11.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.484 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.441 ' C ' ' HD2' ' B' ' 232' ' ' PRO . 3.6 tp -95.48 -16.21 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.579 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 18.8 t80 -50.09 -45.3 81.77 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.3 Cg_endo -73.13 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.327 1.172 . . . . 0.0 110.497 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' B' ' 232' ' ' PRO . 14.1 t -44.36 -37.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.761 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.4 -47.64 32.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 13.2 m -55.74 -33.21 64.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.03 -29.34 61.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.317 -0.864 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.53 ' CD2' HD23 ' B' ' 175' ' ' LEU . 52.5 m-85 -118.78 40.56 3.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.093 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.29 -170.74 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -46.31 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.279 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.248 0.547 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.6 77.37 1.76 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -104.29 74.71 1.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 110.483 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.413 HG23 ' OD1' ' A' ' 19' ' ' ASP . 18.0 mt -97.55 143.02 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.17 29.13 2.07 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.092 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.13 109.92 16.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.084 -1.245 . . . . 0.0 109.924 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.463 ' C ' ' CE1' ' B' ' 99' ' ' PHE . . . 63.65 165.26 0.73 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.675 ' CB ' ' CG ' ' B' ' 99' ' ' PHE . 0.2 OUTLIER -70.53 0.64 6.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.903 -1.351 . . . . 0.0 111.29 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 4.5 m-20 79.84 76.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.482 0.658 . . . . 0.0 110.749 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.564 ' HG ' ' CG2' ' A' ' 72' ' ' ILE . 1.1 mt -97.87 25.92 5.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.411 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.579 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 24.3 m -54.59 -19.55 6.19 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 109.533 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.547 ' HA3' HG22 ' A' ' 28' ' ' ILE . . . -100.37 -36.68 4.02 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.564 HG12 ' CG1' ' A' ' 28' ' ' ILE . 7.8 mm -43.93 -45.13 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.981 -1.305 . . . . 0.0 108.857 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.52 ' CD1' ' SD ' ' A' ' 67' ' ' MET . 1.2 pp -80.81 -21.92 40.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -101.14 13.84 33.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.545 -0.722 . . . . 0.0 109.757 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.537 ' O ' HG21 ' A' ' 28' ' ' ILE . . . 139.24 83.61 0.1 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.54 ' CB ' ' CG2' ' B' ' 124' ' ' THR . 20.6 p-10 -15.18 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.698 0.761 . . . . 0.0 112.755 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.564 ' CG1' HG12 ' A' ' 23' ' ' ILE . 1.2 pp -88.55 171.65 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.567 ' O ' ' N ' ' A' ' 31' ' ' GLU . 71.2 m-20 -86.81 119.38 26.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.2 -27.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.024 -177.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.2 tt0 -57.36 -13.29 3.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.21 27.32 4.55 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -116.25 116.77 28.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.085 -1.244 . . . . 0.0 110.778 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.554 ' HA ' ' CG2' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -88.94 143.58 26.77 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.822 -1.174 . . . . 0.0 109.83 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 34' ' ' LEU . 4.5 pp -130.91 -178.97 5.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.614 -1.304 . . . . 0.0 111.312 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.517 ' N ' HD11 ' A' ' 35' ' ' LEU . 3.1 mt-30 -130.56 133.01 45.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.578 -0.701 . . . . 0.0 109.726 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.69 75.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.206 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 36' ' ' GLN . 0.5 OUTLIER 58.22 -166.87 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.365 -0.835 . . . . 0.0 110.345 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.64 80.58 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.163 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.31 105.09 0.2 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -132.94 72.48 1.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 110.161 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.66 -119.32 8.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -104.4 104.1 13.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 0.0 110.069 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.88 -125.49 1.8 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.16 114.59 2.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.8 -85.59 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -1.117 . . . . 0.0 110.282 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.42 157.33 33.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -78.51 137.88 38.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -1.159 . . . . 0.0 110.262 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -77.22 -169.59 1.43 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 109.935 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -88.56 25.11 1.78 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.112 -0.992 . . . . 0.0 110.356 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' CD ' ' HG3' ' B' ' 191' ' ' PRO . 2.5 tp10 -101.03 -20.41 15.4 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.138 -0.977 . . . . 0.0 109.319 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.48 HD23 ' CD1' ' B' ' 205' ' ' LEU . 3.0 mt -95.5 -44.59 7.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 110.149 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.3 OUTLIER -53.88 -59.05 5.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.243 -0.911 . . . . 0.0 109.595 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.52 -13.38 30.0 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.497 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.437 ' HB3' HD13 ' A' ' 59' ' ' LEU . 2.8 m-20 -91.02 -39.15 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -0.797 . . . . 0.0 109.278 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.489 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 4.5 mt -51.97 -39.38 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.531 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 -16.19 41.83 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.47 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -133.15 9.87 4.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.243 -1.151 . . . . 0.0 110.781 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 1.2 mt -79.31 7.05 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.507 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -94.09 43.27 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.311 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 58' ' ' SER . 3.3 ptmm? -143.67 15.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -131.42 -60.43 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 65' ' ' ASP . . . -146.84 -44.93 0.03 OUTLIER Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.486 ' CD1' HD12 ' A' ' 24' ' ' LEU . 3.4 mm? -42.06 -26.14 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -1.17 . . . . 0.0 110.394 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 63' ' ' GLY . 10.1 t70 -44.5 -37.7 3.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -71.11 -54.19 11.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.699 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.52 ' SD ' ' CD1' ' A' ' 24' ' ' LEU . 10.6 ttm -72.65 -3.7 26.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.553 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.9 tm? -75.81 -59.04 2.93 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.87 0.843 . . . . 0.0 108.975 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.404 HD21 ' O ' ' A' ' 65' ' ' ASP . 1.3 pp -78.48 1.01 23.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.246 0.546 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.53 9.32 27.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 111.446 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.514 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 1.6 t -135.73 2.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.866 -1.146 . . . . 0.0 109.809 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.564 ' CG2' ' HG ' ' A' ' 20' ' ' LEU . 3.5 tp -149.86 75.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.4 t70 -77.84 57.47 1.71 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 108.26 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.629 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 8.0 mt -105.44 67.97 0.79 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.716 0.769 . . . . 0.0 110.727 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -169.05 131.57 1.26 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.775 -0.578 . . . . 0.0 110.124 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 52.9 43.98 30.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.254 179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.318 0.58 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 64' ' ' VAL . . . -146.14 -67.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' B' ' 62' ' ' GLY . 4.0 mt 60.61 -72.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.553 -0.969 . . . . 0.0 110.483 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 62' ' ' GLY . 14.0 t 61.07 128.91 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.76 120.42 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.894 1.47 . . . . 0.0 110.193 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 90.5 m -89.68 135.11 33.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.91 123.85 22.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 110.064 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' B' ' 127' ' ' LYS . 1.4 mm-40 -109.31 -7.1 15.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.473 ' ND2' ' HA2' ' A' ' 26' ' ' GLY . 4.1 t-20 -164.43 156.72 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' B' ' 126' ' ' ALA . 23.5 mm -137.47 147.2 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 14.6 t -137.02 138.44 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.05 159.3 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.459 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.09 138.85 44.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.842 . . . . 0.0 109.875 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.437 HG11 ' N ' ' B' ' 75' ' ' THR . 92.9 t -135.64 154.65 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.112 -0.992 . . . . 0.0 110.649 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.454 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 33.6 m -129.7 131.91 46.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 109.932 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.446 HD11 HD12 ' B' ' 80' ' ' LEU . 57.4 mt -89.43 -27.65 20.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.38 80.38 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' B' ' 150' ' ' ALA . 24.8 p -137.12 139.16 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -1.228 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -69.26 152.27 45.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.516 ' N ' ' HG2' ' B' ' 79' ' ' ARG . 16.6 mt -131.17 150.92 51.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.352 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.461 ' HB3' HG22 ' B' ' 84' ' ' THR . 1.1 t0 -91.12 97.71 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' B' ' 100' ' ' ALA . 13.0 mt -41.16 -36.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.604 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -62.01 -40.7 96.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 110.475 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.461 HG22 ' HB3' ' B' ' 81' ' ' ASP . 26.7 p -85.83 -39.34 17.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.963 . . . . 0.0 110.425 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.42 HG22 ' HB3' ' B' ' 80' ' ' LEU . 56.7 t -62.55 -30.17 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 110.083 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.54 -23.93 21.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -0.859 . . . . 0.0 110.12 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 1.0 OUTLIER -76.98 -47.98 19.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.32 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -77.28 -39.16 49.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.375 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.415 ' HB2' ' HB1' ' B' ' 92' ' ' ALA . . . -50.23 113.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.357 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -26.32 62.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.464 ' O ' ' OD1' ' B' ' 91' ' ' ASN . 31.7 p30 -130.11 79.12 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.764 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -161.03 145.81 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -134.85 136.65 42.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.285 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.406 ' CE1' HD11 ' B' ' 82' ' ' LEU . 28.8 t80 -114.58 110.75 20.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -106.51 112.69 63.65 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.98 -16.56 29.02 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.022 1.538 . . . . 0.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.61 -22.07 24.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 5.3 mpt_? -91.8 -73.28 0.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.675 ' CG ' ' CB ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -153.6 164.14 38.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.43 -0.794 . . . . 0.0 110.253 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -81.7 47.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.889 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.629 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -129.61 146.49 51.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 111.087 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.424 HG22 HD23 ' B' ' 82' ' ' LEU . 20.1 t -93.28 122.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.447 -0.783 . . . . 0.0 108.997 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.554 HG22 ' CA ' ' A' ' 29' ' ' ASP . 3.1 mp -89.18 115.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 110.52 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.55 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.4 OUTLIER -97.37 147.97 23.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.966 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.73 95.01 2.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.541 HG22 ' CE1' ' B' ' 139' ' ' TYR . 16.5 pt -94.81 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -129.3 43.89 3.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.456 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 176.47 78.58 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.391 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.463 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.7 Cg_endo -79.66 157.03 89.34 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.455 -0.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.476 ' O ' HG21 ' B' ' 111' ' ' THR . 45.8 tttp -65.65 109.41 2.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.888 . . . . 0.0 109.945 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.518 HG23 ' N ' ' B' ' 126' ' ' ALA . 1.3 p -148.29 177.77 9.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.64 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.533 HG21 ' CG2' ' B' ' 124' ' ' THR . 0.4 OUTLIER -130.04 171.5 12.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -164.19 140.17 6.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.795 -1.191 . . . . 0.0 110.876 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.574 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.4 OUTLIER -105.54 100.02 9.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.422 -0.799 . . . . 0.0 108.849 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.445 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt -89.21 137.31 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.091 -1.006 . . . . 0.0 110.569 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.596 ' CE1' HD13 ' A' ' 74' ' ' LEU . 1.9 m-30 -108.45 166.15 10.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.25 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -53.72 -20.02 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.06 -18.32 16.36 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.25 162.99 18.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -1.166 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -159.97 149.4 17.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.081 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.47 HG12 HG11 ' A' ' 71' ' ' VAL . 21.0 t -112.74 135.1 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.39 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 16.8 t -110.22 148.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 109.882 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.54 ' CG2' ' CB ' ' A' ' 27' ' ' ASN . 3.5 t -156.11 162.51 40.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.788 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.528 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 112.65 -37.1 3.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.518 ' N ' HG23 ' B' ' 111' ' ' THR . . . -46.1 160.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -1.142 . . . . 0.0 110.256 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' B' ' 68' ' ' GLN . 1.3 mmmt -115.92 -2.31 12.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.193 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.452 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.5 OUTLIER -158.78 162.85 37.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.24 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.91 -31.79 67.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.34 -50.95 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.11 -44.13 97.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.904 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 46.6 t -53.7 -47.45 70.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.964 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -54.85 -46.74 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.39 -52.76 29.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.304 -0.872 . . . . 0.0 110.033 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.405 ' O ' ' C ' ' B' ' 137' ' ' ARG . 1.6 p -71.65 -60.08 2.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.583 ' HD2' ' CE2' ' B' ' 152' ' ' PHE . 4.7 mtp180 -43.54 -46.22 6.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -51.38 65.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.098 -1.001 . . . . 0.0 109.966 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.55 ' CE1' ' HB3' ' B' ' 104' ' ' MET . 15.4 m-85 -50.33 -48.8 55.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 109.863 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.24 -24.86 67.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.821 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -71.0 -31.44 67.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 110.064 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.438 ' O ' HG13 ' B' ' 146' ' ' ILE . 23.1 mt -69.64 -47.02 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.529 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 1.7 mp -65.3 -49.52 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 1.5 mt-30 -64.39 -39.34 93.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.025 -1.047 . . . . 0.0 110.017 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -68.23 -21.68 64.82 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.44 HG22 HD11 ' B' ' 146' ' ' ILE . 9.2 mt -81.15 -24.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.52 -35.34 2.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.521 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 13.5 m-85 -51.03 165.86 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.138 -1.213 . . . . 0.0 110.89 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.99 48.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.674 -0.641 . . . . 0.0 109.975 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.529 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -71.55 134.88 46.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.27 -153.9 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.583 ' CE2' ' HD2' ' B' ' 137' ' ' ARG . 22.3 t80 -149.46 78.3 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.267 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 1.1 p -141.66 179.55 6.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.454 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 8.7 t0 66.31 13.93 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.952 . . . . 0.0 110.351 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -66.76 136.72 55.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.887 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -168.57 124.12 0.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.584 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.7 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.453 ' HA ' ' HG3' ' B' ' 218' ' ' LYS . 1.6 mt-30 -122.98 -11.86 8.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.036 . . . . 0.0 111.042 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.46 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.2 t30 -136.69 130.4 32.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.082 . . . . 0.0 111.061 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 7.9 mt -129.56 122.53 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 58.1 t -94.27 125.58 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -131.51 162.99 23.75 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 93.4 p -164.4 151.08 11.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.099 -1.236 . . . . 0.0 110.403 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 26.5 p -167.59 146.75 4.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.236 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 11.4 p-10 -91.26 163.36 14.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -102.43 -71.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 165.43 -23.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.72 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' B' ' 168' ' ' PHE . 16.2 p90 -136.32 163.18 51.88 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.6 Cg_endo -72.04 142.09 37.73 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.8 1.421 . . . . 0.0 110.555 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.442 HG22 HD21 ' B' ' 234' ' ' LEU . 3.8 mt -101.83 149.82 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.32 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.58 98.5 10.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.489 ' CD1' HG21 ' B' ' 208' ' ' VAL . 91.4 mt -56.9 -30.01 63.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 110.391 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -49.1 33.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.882 . . . . 0.0 110.419 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.79 -28.78 68.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.448 ' HB3' HD12 ' B' ' 193' ' ' LEU . 0.1 OUTLIER -71.19 -44.94 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 0.0 110.195 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.63 -13.77 59.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.024 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.22 -34.71 37.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.778 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.03 -35.08 9.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.785 . . . . 0.0 109.888 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -115.63 37.51 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.351 -0.843 . . . . 0.0 110.135 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.56 -9.96 82.4 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' THR . . . . . 0.492 HG21 ' N ' ' B' ' 182' ' ' PHE . 7.0 t -76.11 -24.79 54.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -1.197 . . . . 0.0 110.061 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.529 ' CE2' HG23 ' B' ' 198' ' ' VAL . 0.2 OUTLIER -127.81 -2.44 5.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.519 ' OG ' ' CD2' ' B' ' 193' ' ' LEU . 0.9 OUTLIER -114.97 140.99 48.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.107 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 3.8 t -111.56 136.75 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -145.32 91.28 2.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -108.44 110.21 61.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.89 1.08 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.959 1.505 . . . . 0.0 110.462 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.9 -13.92 28.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.528 ' O ' ' CG ' ' B' ' 189' ' ' LEU . 2.1 tt -155.71 16.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.278 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.45 ' CE2' HD22 ' A' ' 59' ' ' LEU . 1.7 t80 -170.18 106.16 0.44 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.762 -1.211 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . 0.442 ' O ' HD12 ' B' ' 172' ' ' LEU . 45.5 Cg_endo -73.85 -23.41 16.5 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.987 1.519 . . . . 0.0 110.238 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.93 -179.88 42.96 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.519 ' CD2' ' OG ' ' B' ' 183' ' ' SER . 1.9 tt -115.11 146.69 41.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.451 ' HA ' HD22 ' B' ' 205' ' ' LEU . 77.0 mt -113.45 103.82 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 109.943 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.5 t80 -102.14 118.21 36.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.892 . . . . 0.0 110.351 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.452 ' HG2' ' NH1' ' B' ' 196' ' ' ARG . 3.3 tpp85 -92.41 92.72 8.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 56.4 tpp -50.8 125.65 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.354 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.529 HG23 ' CE2' ' B' ' 182' ' ' PHE . 30.8 t -64.23 -43.31 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.292 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -149.43 117.16 3.72 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.89 166.96 79.81 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.916 -2.118 . . . . 0.0 110.304 -0.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.455 ' O ' ' CG1' ' B' ' 202' ' ' ILE . 4.9 mttm -75.35 108.38 8.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.481 HG21 ' N ' ' B' ' 203' ' ' VAL . 13.3 mt -154.67 151.76 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.481 ' N ' HG21 ' B' ' 202' ' ' ILE . 20.0 t -96.98 127.71 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 109.991 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.483 HD22 ' CD2' ' B' ' 214' ' ' LEU . 2.3 mp -112.53 125.7 54.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.48 ' CD1' HD23 ' A' ' 52' ' ' LEU . 13.1 mt -102.58 120.19 40.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.438 ' O ' HD22 ' B' ' 172' ' ' LEU . 12.3 mt -114.84 115.17 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.07 154.84 16.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 110.245 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.489 HG21 ' CD1' ' B' ' 172' ' ' LEU . 52.9 t -49.98 -35.42 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.52 90.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 110.498 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . 0.441 ' HA2' ' CD1' ' B' ' 170' ' ' ILE . . . 130.93 32.4 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' B' ' 163' ' ' SER . 0.0 OUTLIER -95.97 117.08 29.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -1.183 . . . . 0.0 109.828 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' B' ' 212' ' ' ILE . 1.2 mp -107.08 111.14 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 75.9 t -104.91 150.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.928 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.483 ' CD2' HD22 ' B' ' 204' ' ' LEU . 4.1 mp -142.33 107.96 5.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 10.1 t -129.61 157.58 41.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.45 ' HA2' ' OD1' ' B' ' 159' ' ' ASN . . . 102.85 11.75 33.99 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' B' ' 222' ' ' GLU . . . -91.77 155.1 18.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.31 -1.112 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' B' ' 218' ' ' LYS . 22.4 tttt -104.79 0.71 28.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.375 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.2 137.78 5.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.028 . . . . 0.0 110.432 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' B' ' 220' ' ' ARG . 10.4 ttm180 -45.18 -26.62 0.5 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -34.03 77.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.989 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 217' ' ' ALA . 1.4 mm-40 -67.82 -55.13 14.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.432 HG12 ' CB ' ' B' ' 217' ' ' ALA . 14.3 mm -51.08 -47.53 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.786 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.05 -27.58 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.778 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.16 -43.4 24.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 110.107 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.16 88.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.401 ' HA ' HG21 ' B' ' 230' ' ' ILE . 46.8 t80 -70.28 -42.58 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -20.09 66.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.84 -22.99 18.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 110.318 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.418 ' C ' ' HD2' ' B' ' 232' ' ' PRO . 7.5 tp -100.36 -28.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.584 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 30.6 t80 -44.08 -49.52 22.24 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.4 Cg_endo -69.45 -40.49 5.73 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.36 1.189 . . . . 0.0 110.606 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.7 -39.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.881 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.442 HD21 HG22 ' B' ' 170' ' ' ILE . 95.1 mt -64.87 -55.16 21.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.115 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -50.69 -28.81 9.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.95 -32.92 65.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 110.446 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -113.66 41.4 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.393 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -160.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -144.47 -54.73 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.187 -0.946 . . . . 0.0 110.236 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.259 0.552 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.89 43.57 97.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.8 -51.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.149 . . . . 0.0 110.2 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.9 tt -125.97 16.6 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.152 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.8 83.97 0.33 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -118.72 99.25 6.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -1.158 . . . . 0.0 109.965 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.57 115.94 1.7 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.599 HD21 ' CD2' ' B' ' 99' ' ' PHE . 0.2 OUTLIER -80.64 2.29 26.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -1.206 . . . . 0.0 110.664 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 5.9 t0 75.5 90.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 111.529 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.564 HD23 ' CD2' ' A' ' 18' ' ' LEU . 2.3 mt -107.27 35.45 3.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.787 . . . . 0.0 110.034 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.58 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 20.2 m -56.6 -25.45 52.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.24 -27.49 8.69 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.239 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 28' ' ' ILE . 14.8 mm -46.46 -46.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.801 -1.411 . . . . 0.0 108.849 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.523 ' CD2' ' HG2' ' A' ' 67' ' ' MET . 1.1 pp -82.66 -25.65 32.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 109.137 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' B' ' 205' ' ' LEU . 0.1 OUTLIER -90.6 14.65 12.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' HG21 ' A' ' 28' ' ' ILE . . . 135.88 98.32 0.54 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.595 ' HB3' ' N ' ' B' ' 125' ' ' GLY . 25.8 p-10 -33.9 93.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.519 -0.989 . . . . 0.0 111.737 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -90.63 175.57 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 31' ' ' GLU . 21.4 m-20 -87.86 126.19 34.89 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.508 ' HB2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -40.13 -25.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -178.442 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -64.12 -6.81 7.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.986 -1.071 . . . . 0.0 110.408 178.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 102.35 29.43 6.01 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.685 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.511 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -119.44 111.33 17.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.9 -1.353 . . . . 0.0 110.6 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 1.0 OUTLIER -89.47 149.14 23.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.535 ' CD1' ' C ' ' A' ' 35' ' ' LEU . 3.4 pp -127.47 -179.01 4.68 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.594 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.469 ' N ' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -128.61 -41.88 1.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 109.958 -179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.33 -75.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.473 -0.767 . . . . 0.0 109.979 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 38' ' ' ASP . 6.9 p30 -132.48 164.15 27.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 110.025 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -139.08 168.42 19.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.989 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.69 -150.79 20.01 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 158.68 18.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.9 -100.06 0.27 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -122.41 -48.12 2.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 0.0 110.169 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.32 158.33 16.5 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.57 167.54 5.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -135.76 28.76 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 110.139 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.66 -162.2 10.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -51.8 153.31 2.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 110.247 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 20.4 p30 -86.07 -128.84 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.506 ' N ' ' OD1' ' A' ' 49' ' ' ASP . . . -99.89 36.54 1.8 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.955 -1.091 . . . . 0.0 110.146 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -97.13 -20.97 17.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.291 -0.881 . . . . 0.0 109.08 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 25' ' ' PHE . 3.5 mt -98.95 -42.66 7.03 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.683 . . . . 0.0 110.094 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.71 -55.69 18.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.43 -0.794 . . . . 0.0 109.534 -179.522 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -61.79 -14.04 29.18 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.499 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 58' ' ' SER . 3.6 m-20 -92.75 -39.86 11.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.293 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 2.9 mt -47.7 -41.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 0.0 108.922 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.93 -20.05 12.65 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 55' ' ' ASN . 50.2 m -113.44 0.64 14.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -1.123 . . . . 0.0 110.371 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 56' ' ' ILE . 29.8 mt -88.91 33.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -115.88 23.15 12.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.391 -0.818 . . . . 0.0 110.501 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.87 50.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' CD1' HD12 ' B' ' 194' ' ' ILE . 0.4 OUTLIER -152.19 -29.11 0.16 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.354 -0.841 . . . . 0.0 111.0 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.515 ' N ' HD11 ' A' ' 62' ' ' LEU . . . -175.8 -42.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 2.8 mm? -69.46 -3.53 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -46.14 -41.8 13.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 110.129 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 p -65.99 -48.83 69.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 0.0 109.907 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.523 ' HG2' ' CD2' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.87 -3.36 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.4 tm? -80.6 -60.49 2.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.284 -0.885 . . . . 0.0 109.343 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.74 0.3 27.36 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.444 0.64 . . . . 0.0 109.794 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 22.9 tt0 -93.01 10.47 31.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.384 -0.822 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.465 ' O ' HD13 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -133.2 -4.26 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 120.954 -1.091 . . . . 0.0 110.072 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.598 HG12 ' CD2' ' A' ' 18' ' ' LEU . 2.6 tp -138.69 74.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.0 t0 -83.34 52.41 2.21 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.034 -1.041 . . . . 0.0 108.615 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.544 HD23 HG13 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -77.36 40.46 0.28 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.528 -0.733 . . . . 0.0 111.766 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -70.31 159.81 33.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.904 -1.123 . . . . 0.0 110.035 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.35 -31.51 22.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 110.267 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.519 ' CB ' ' HB3' ' B' ' 118' ' ' SER . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.181 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.329 0.585 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.59 -44.92 0.33 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 5.1 mt -79.56 -23.47 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -1.13 . . . . 0.0 110.254 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 45.4 t 58.77 119.63 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 0.0 110.363 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 44.6 Cg_endo -72.02 137.88 30.0 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.781 1.411 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.461 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 15.8 m -93.31 153.43 18.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 110.437 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 88.2 mt -86.52 133.06 33.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.432 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 2.9 mm-40 -116.06 -19.45 10.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.529 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 4.4 m120 -167.63 167.76 13.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.362 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 9.2 mt -158.11 158.17 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 61.5 t -134.22 144.42 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 110.351 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.04 155.44 48.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.87 141.56 42.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.505 ' HB ' ' CE ' ' B' ' 121' ' ' MET . 86.2 t -133.07 135.88 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 0.0 110.211 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -105.71 123.01 47.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.223 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.498 HD11 ' CD1' ' B' ' 80' ' ' LEU . 71.4 mt -78.45 -43.5 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.83 9.71 42.27 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.53 150.24 21.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -1.189 . . . . 0.0 110.359 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.534 ' O ' ' CD2' ' B' ' 80' ' ' LEU . 9.6 mtp180 -70.65 164.94 23.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.163 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' B' ' 79' ' ' ARG . 20.6 mt -140.39 160.22 40.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.331 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.3 OUTLIER -96.27 92.46 6.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.533 HD23 ' CG2' ' B' ' 102' ' ' VAL . 13.8 mt -42.35 -46.72 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.26 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 3.8 tptm -52.62 -46.57 67.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.444 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 18.6 p -86.89 -38.96 16.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 53.6 t -54.26 -37.51 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.798 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.65 -31.84 23.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 14.1 tp -76.8 -27.87 55.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.772 . . . . 0.0 109.97 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -47.62 9.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 110.098 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.448 ' HB3' ' CE ' ' B' ' 104' ' ' MET . . . -48.49 135.86 13.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -71.69 -24.59 61.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 10.1 p30 -136.14 79.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.111 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -151.6 153.56 34.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.389 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.443 ' HA ' ' OE1' ' B' ' 93' ' ' GLU . 52.7 mm-40 -134.49 141.54 46.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 110.108 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -134.41 117.79 16.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.5 125.3 26.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.55 -34.13 7.7 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.845 1.445 . . . . 0.0 110.098 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.021 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.5 ' N ' ' HD2' ' B' ' 98' ' ' ARG . 5.6 mpt_? -98.15 -59.76 1.69 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.375 -0.828 . . . . 0.0 110.202 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.656 ' CE2' ' CB ' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.57 175.0 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.629 -0.67 . . . . 0.0 111.375 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.41 55.89 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 111.298 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.656 ' CB ' ' CE2' ' B' ' 99' ' ' PHE . . . -147.87 160.23 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.533 ' CG2' HD23 ' B' ' 82' ' ' LEU . 84.6 t -92.61 162.27 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.543 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 30' ' ' SER . 9.9 mt -131.57 125.32 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 109.711 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.457 ' HE3' HG23 ' B' ' 142' ' ' ILE . 0.0 OUTLIER -103.85 162.85 12.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -160.01 130.07 5.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.443 HG21 ' O ' ' B' ' 105' ' ' ARG . 5.6 pt -139.72 167.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.44 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -125.28 37.14 4.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 110.224 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.88 80.05 0.23 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.461 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.93 165.82 84.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.483 -2.299 . . . . 0.0 110.3 -0.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' B' ' 107' ' ' ARG . 0.1 OUTLIER -78.58 109.47 12.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 110.334 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.473 HG21 ' O ' ' B' ' 124' ' ' THR . 0.2 OUTLIER -157.27 171.33 20.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.908 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 27' ' ' ASN . 6.5 t -137.12 155.35 49.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.8 167.22 28.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.508 ' CD2' HD12 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -140.86 113.56 8.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 0.0 109.507 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.532 HG13 ' CG ' ' B' ' 121' ' ' MET . 2.9 mp -98.22 149.85 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.432 -0.792 . . . . 0.0 111.02 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.582 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.1 m-85 -95.68 -177.65 4.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.491 -0.756 . . . . 0.0 109.511 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -84.96 -15.65 43.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.728 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.519 ' HB3' ' CB ' ' A' ' 77' ' ' ALA . 66.7 p -73.09 -18.53 61.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.17 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 6.72 22.28 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . 0.551 ' HB3' ' CD2' ' B' ' 116' ' ' PHE . 2.4 mttt -87.85 157.82 18.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -1.168 . . . . 0.0 110.015 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.532 ' CG ' HG13 ' B' ' 115' ' ' ILE . 7.2 tmm? -147.35 133.95 19.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.816 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 t -113.68 132.93 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.837 . . . . 0.0 109.759 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.476 ' CG2' ' SD ' ' B' ' 121' ' ' MET . 12.7 t -112.96 138.12 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.551 ' CG2' ' HB2' ' A' ' 27' ' ' ASN . 9.0 t -147.02 146.58 30.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.824 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.595 ' N ' ' HB3' ' A' ' 27' ' ' ASN . . . 119.42 -9.51 11.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -75.75 151.45 37.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.218 . . . . 0.0 110.167 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.499 ' HG3' ' N ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -117.88 -23.32 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.881 . . . . 0.0 110.145 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.499 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.1 OUTLIER -123.02 -173.66 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -82.62 -48.68 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.294 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -65.77 -16.58 63.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.63 -46.54 14.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' B' ' 136' ' ' SER . 2.0 t -65.75 -30.36 71.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.13 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -71.18 -51.27 25.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.3 -50.05 74.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.32 -0.862 . . . . 0.0 110.182 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.99 -46.06 75.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' B' ' 132' ' ' SER . 0.3 OUTLIER -60.87 -58.61 7.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 110.05 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.55 -36.94 25.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.761 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -49.66 77.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.423 ' OH ' HG12 ' B' ' 106' ' ' ILE . 25.2 m-85 -58.8 -50.07 75.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 109.97 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.65 71.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.064 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 1.3 mmt85 -60.38 -40.88 92.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 110.039 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.457 HG23 ' HE3' ' B' ' 104' ' ' MET . 38.6 mt -54.71 -48.14 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.487 HG22 HD11 ' B' ' 143' ' ' ILE . 57.5 mt -66.56 -49.77 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -61.24 -36.9 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.0 OUTLIER -71.84 -27.58 62.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.442 HD11 HG22 ' B' ' 146' ' ' ILE . 6.1 mt -72.8 -18.54 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.44 -27.07 7.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.421 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 12.1 m-85 -46.79 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.25 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.78 29.97 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.532 -0.73 . . . . 0.0 109.815 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' B' ' 76' ' ' LEU . . . -66.38 151.59 46.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.513 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.97 107.53 6.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.95 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.485 ' CD1' HG12 ' B' ' 74' ' ' VAL . 77.1 t80 -53.3 102.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.902 . . . . 0.0 110.308 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.8 p -148.39 172.21 14.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 t0 60.85 15.88 6.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -60.62 134.53 57.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.966 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -170.08 134.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.352 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.96 126.81 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.365 -0.835 . . . . 0.0 109.665 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -115.67 -12.48 11.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.851 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.3 112.05 5.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.054 -1.029 . . . . 0.0 111.047 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' B' ' 215' ' ' THR . 11.0 mt -105.52 148.48 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 0.0 109.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' B' ' 69' ' ' ASN . 6.4 t -117.09 142.4 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.037 . . . . 0.0 111.079 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -159.9 164.81 34.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.0 OUTLIER -168.49 164.17 12.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.845 -1.385 . . . . 0.0 111.029 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -170.01 175.81 4.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.846 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -108.03 149.02 28.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.501 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 16.1 m -97.22 4.34 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 110.224 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.69 12.92 6.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.259 -0.901 . . . . 0.0 110.722 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.544 ' CE1' HG13 ' B' ' 170' ' ' ILE . 10.3 p90 -171.43 139.82 1.19 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.133 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.0 Cg_endo -71.31 153.62 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.104 1.581 . . . . 0.0 111.007 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.544 HG13 ' CE1' ' B' ' 168' ' ' PHE . 3.2 mt -125.42 150.65 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -80.25 92.79 5.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.462 HD23 ' O ' ' B' ' 206' ' ' ILE . 97.9 mt -52.73 -32.38 42.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.406 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.69 -59.82 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.946 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.61 -37.18 33.15 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.445 ' CD2' ' HB2' ' B' ' 237' ' ' PHE . 0.2 OUTLIER -64.89 -53.69 42.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -1.101 . . . . 0.0 109.98 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.46 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -58.1 -20.98 44.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 0.0 110.075 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.66 -56.31 4.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 0.0 109.878 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.7 t -69.9 -46.03 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 0.0 110.043 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -105.89 41.57 1.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.018 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.36 -16.89 63.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 68.0 p -85.82 -31.74 22.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -1.209 . . . . 0.0 110.378 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.419 ' CZ ' HG22 ' B' ' 198' ' ' VAL . 6.8 m-30 -104.63 -10.36 17.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.416 ' HB2' HD23 ' B' ' 193' ' ' LEU . 1.2 p -140.88 123.41 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.57 165.89 11.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.866 . . . . 0.0 110.083 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -160.66 126.89 4.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 110.28 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -130.97 107.9 15.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.273 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.996 1.524 . . . . 0.0 110.087 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -95.75 4.42 52.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 58' ' ' SER . 0.9 OUTLIER -159.78 -51.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.482 ' CD2' ' O ' ' B' ' 192' ' ' GLY . 26.6 t80 -113.19 109.95 51.41 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 0.0 110.374 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.69 -20.8 22.59 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.975 1.513 . . . . 0.0 110.152 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' B' ' 190' ' ' PHE . . . -90.74 -179.94 43.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' B' ' 205' ' ' LEU . 6.0 tt -123.79 131.8 53.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -1.18 . . . . 0.0 110.321 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.526 HD12 ' CD1' ' A' ' 62' ' ' LEU . 4.6 mt -96.32 111.26 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.429 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 20.5 t80 -95.31 111.57 23.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.259 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -94.98 86.85 4.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 20.6 ttm -65.27 135.1 54.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 110.169 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.419 HG22 ' CZ ' ' B' ' 182' ' ' PHE . 74.2 t -86.11 -28.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.878 . . . . 0.0 110.307 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' B' ' 199' ' ' LYS . 0.0 OUTLIER -149.4 110.15 3.41 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.432 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.42 ' HB2' ' OE2' ' B' ' 222' ' ' GLU . 48.5 Cg_endo -73.72 171.28 67.23 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.035 -2.069 . . . . 0.0 110.485 -0.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.417 ' C ' HG12 ' B' ' 202' ' ' ILE . 11.8 tptt -74.46 92.57 2.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.87 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.595 ' CD1' ' CB ' ' B' ' 217' ' ' ALA . 24.6 mm -140.16 153.63 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.741 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 48.4 t -114.34 116.69 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.714 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' B' ' 214' ' ' LEU . 3.4 mp -110.71 131.21 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -110.59 122.65 48.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.19 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' B' ' 211' ' ' LYS . 2.8 mp -113.68 145.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.108 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -121.15 156.32 32.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.462 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 12.8 t -47.97 -27.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.421 -0.8 . . . . 0.0 110.137 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 4.7 m -71.54 -31.92 67.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.927 . . . . 0.0 110.303 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.39 5.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.2 OUTLIER -87.77 133.65 33.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' B' ' 163' ' ' SER . 36.5 mm -117.49 132.93 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.441 ' HA ' ' HB3' ' B' ' 163' ' ' SER . 76.0 t -125.85 114.52 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 110.393 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.519 ' CD2' HD22 ' B' ' 204' ' ' LEU . 1.9 mp -97.69 104.19 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 110.172 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.8 t -132.56 142.29 49.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.953 . . . . 0.0 110.235 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.452 ' HA3' ' HE2' ' A' ' 67' ' ' MET . . . 108.0 19.21 9.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.595 ' CB ' ' CD1' ' B' ' 202' ' ' ILE . . . -99.99 164.43 12.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.288 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.15 -29.97 8.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.77 154.0 44.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.865 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -53.8 -18.69 3.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -59.44 -45.51 91.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -0.92 . . . . 0.0 110.461 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.42 ' OE2' ' HB2' ' B' ' 200' ' ' PRO . 30.6 mt-10 -72.43 -46.4 55.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.45 HD12 ' HB1' ' B' ' 217' ' ' ALA . 13.6 mm -51.57 -44.71 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.418 ' OH ' ' CG1' ' B' ' 64' ' ' VAL . 2.2 m-30 -71.38 -48.98 46.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.49 -33.91 73.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 110.446 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.444 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -61.44 -59.77 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.867 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 35.8 t80 -56.27 -26.83 53.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.836 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -32.26 73.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.871 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . 0.431 ' O ' HG22 ' B' ' 233' ' ' VAL . . . -94.75 -13.17 25.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.465 HG13 HD21 ' B' ' 204' ' ' LEU . 6.0 mm -96.77 -23.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.36 -0.837 . . . . 0.0 109.83 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.577 ' N ' ' CD ' ' B' ' 232' ' ' PRO . 10.3 t80 -58.43 -42.3 93.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 0.0 110.966 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 48.2 Cg_endo -76.33 -31.17 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.416 1.219 . . . . 0.0 110.755 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.431 HG22 ' O ' ' B' ' 229' ' ' ALA . 39.5 t -67.27 -35.89 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.412 HD23 HD11 ' B' ' 170' ' ' ILE . 18.3 mt -71.88 -39.72 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.057 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.51 80.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.87 -39.92 91.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.006 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' B' ' 175' ' ' LEU . 84.4 m-85 -110.04 37.78 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 177.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -121.54 -51.42 2.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 110.094 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.225 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.18 0.514 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.71 -56.49 0.03 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.97 59.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -1.163 . . . . 0.0 110.276 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.88 56.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.149 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . 162.86 -37.14 0.34 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 53.7 t-20 60.78 127.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -1.102 . . . . 0.0 110.339 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.518 ' CA ' ' CZ ' ' B' ' 99' ' ' PHE . . . -72.57 -148.97 0.91 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.667 ' HB3' ' CD2' ' B' ' 99' ' ' PHE . 0.0 OUTLIER -77.49 161.61 27.8 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.186 -1.185 . . . . 0.0 109.701 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 2.6 m-20 -63.7 71.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.052 -1.03 . . . . 0.0 110.207 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.642 HD23 ' CG1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -86.65 8.98 20.09 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.35 -0.844 . . . . 0.0 111.322 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 10.4 m -54.96 -18.87 5.59 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.467 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' HA3' HG23 ' A' ' 28' ' ' ILE . . . -100.43 -36.2 4.16 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.573 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.642 ' CG1' HD23 ' A' ' 20' ' ' LEU . 1.1 mm -46.68 -47.42 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.802 -1.411 . . . . 0.0 108.985 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 2.0 pp -82.91 -28.06 30.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' HD12 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -86.97 8.71 22.07 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.565 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 141.57 98.54 0.33 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.565 ' C ' ' O ' ' A' ' 26' ' ' GLY . 0.2 OUTLIER -16.75 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.91 0.862 . . . . 0.0 111.436 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.578 ' CG1' HG12 ' A' ' 23' ' ' ILE . 2.3 pp -138.07 166.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 121.464 -0.773 . . . . 0.0 109.443 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 31' ' ' GLU . 80.6 m-20 -87.11 116.71 25.35 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.515 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -36.28 -28.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.484 0.659 . . . . 0.0 110.157 -177.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.9 tt0 -57.04 -13.03 2.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 110.544 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.28 24.37 5.7 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.052 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.54 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -109.83 124.23 50.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -1.155 . . . . 0.0 109.235 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.533 HD21 ' CG2' ' A' ' 28' ' ' ILE . 3.2 tm? -87.55 150.57 23.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 111.066 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.544 ' CG ' ' OD1' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -86.72 106.46 17.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 111.23 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -90.05 8.38 32.93 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 t70 50.92 -165.86 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.729 -0.607 . . . . 0.0 110.483 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.14 52.14 1.91 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -0.974 . . . . 0.0 110.34 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.79 41.67 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.22 58.8 0.62 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -96.43 75.5 2.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -1.132 . . . . 0.0 110.206 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.44 22.97 4.6 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 47.18 -168.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -1.171 . . . . 0.0 110.202 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.45 5.67 8.44 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.17 70.12 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.0 p -59.8 159.97 8.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -1.155 . . . . 0.0 110.125 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.53 -99.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.523 ' CE1' HD13 ' A' ' 52' ' ' LEU . 9.5 m-85 -85.79 101.66 12.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -1.121 . . . . 0.0 109.944 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -68.47 -158.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.74 23.25 2.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.158 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.7 tt0 -93.42 -33.7 13.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 25' ' ' PHE . 1.8 mt -90.97 -41.2 11.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.361 -0.837 . . . . 0.0 110.064 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.536 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.51 -50.26 17.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.54 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.29 -29.48 68.27 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.702 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 8.4 m-80 -77.82 -40.58 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 23.0 mt -49.97 -47.38 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.32 0.07 69.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.33 -46.57 3.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -1.143 . . . . 0.0 110.437 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -85.98 44.54 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 0.0 110.421 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -84.86 22.36 1.39 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.739 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.465 ' HG2' HD22 ' A' ' 62' ' ' LEU . 1.8 pttt -152.68 8.04 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 111.195 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' CD1' ' HB2' ' A' ' 59' ' ' LEU . 3.0 mt -86.37 -34.68 20.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.621 -1.299 . . . . 0.0 109.852 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.48 -35.25 0.04 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 3.8 mm? -56.92 -28.25 61.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -1.171 . . . . 0.0 110.709 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' LEU . 11.5 t0 -43.67 -38.67 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.464 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.0 m -70.73 -51.01 30.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.374 -0.828 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.506 ' SD ' ' ND2' ' B' ' 159' ' ' ASN . 3.5 tpp -65.38 -12.73 55.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -72.69 -64.03 1.04 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 109.719 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -60.85 -12.15 10.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.583 -0.698 . . . . 0.0 110.022 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.62 2.69 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.536 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 1.5 t -140.04 3.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.046 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.649 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 2.6 tp -148.64 67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.396 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 11.1 t0 -77.1 53.54 0.98 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.975 -1.078 . . . . 0.0 109.359 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.614 ' CD1' ' CE1' ' B' ' 116' ' ' PHE . 1.5 mt -97.72 53.6 1.13 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -78.96 165.8 23.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.0 110.257 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -72.16 74.64 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.938 . . . . 0.0 110.272 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.205 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.295 0.569 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.55 25.8 0.25 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' B' ' 64' ' ' VAL . 2.9 mp -121.77 -65.63 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -1.156 . . . . 0.0 110.29 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' B' ' 63' ' ' ILE . 91.5 t 58.03 119.62 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 110.25 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.523 ' CG ' HG21 ' B' ' 223' ' ' ILE . 43.4 Cg_endo -71.13 134.46 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.793 1.417 . . . . 0.0 110.407 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.448 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.6 m -96.82 137.5 35.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.379 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 33.2 mt -70.67 139.36 51.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.453 ' OE1' ' HA ' ' B' ' 68' ' ' GLN . 22.1 mm-40 -126.48 -5.64 6.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.655 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.478 ' ND2' ' C ' ' B' ' 69' ' ' ASN . 0.4 OUTLIER -168.41 124.53 1.0 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.0 -1.063 . . . . 0.0 110.755 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' B' ' 124' ' ' THR . 11.5 mm -108.89 147.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 109.311 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 25.5 t -134.61 135.7 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.956 -1.09 . . . . 0.0 110.456 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -141.52 155.43 45.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.316 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 60.6 m -104.47 126.93 52.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.227 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 t -126.67 138.54 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.926 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 9.5 m -109.65 145.86 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.531 ' CD1' HD13 ' B' ' 80' ' ' LEU . 59.3 mt -96.53 -30.13 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 109.751 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' B' ' 78' ' ' CYS . . . 80.52 32.48 34.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' B' ' 77' ' ' GLY . 1.2 m -166.29 164.88 17.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 110.273 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 0.1 OUTLIER -91.82 152.71 20.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.113 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' B' ' 76' ' ' LEU . 22.5 mt -138.95 163.88 31.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.422 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 2.8 t70 -108.74 97.92 7.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.526 -0.734 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.452 ' HB3' HG21 ' B' ' 102' ' ' VAL . 14.3 mt -40.94 -35.78 0.57 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -48.2 73.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 60.8 m -66.18 -37.78 86.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.471 ' O ' ' CB ' ' B' ' 89' ' ' ALA . 22.7 t -72.88 -46.12 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.978 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.71 -13.01 61.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tp -99.27 -29.64 12.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.857 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.2 OUTLIER -99.81 -20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.285 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' B' ' 85' ' ' VAL . . . -61.74 151.65 33.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.144 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -85.65 -37.8 19.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.219 -0.926 . . . . 0.0 110.195 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -131.38 78.76 1.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.593 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -146.92 160.51 42.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.865 . . . . 0.0 110.725 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -137.35 157.62 46.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 109.939 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -147.44 101.48 3.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.222 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.523 ' O ' ' HG3' ' B' ' 98' ' ' ARG . 1.5 m-20 -109.86 121.16 42.8 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.63 -10.83 20.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.704 1.37 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -87.21 10.74 16.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 111.155 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' B' ' 95' ' ' ASN . 1.0 OUTLIER -139.68 -43.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.826 -1.172 . . . . 0.0 110.799 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.667 ' CD2' ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -170.35 168.89 7.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.25 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.39 55.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.538 ' HB1' ' CD1' ' A' ' 74' ' ' LEU . . . -136.24 158.51 44.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 111.155 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.452 HG21 ' HB3' ' B' ' 82' ' ' LEU . 49.0 t -102.58 122.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.473 -0.767 . . . . 0.0 109.184 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 3.6 mp -89.36 109.18 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.402 ' SD ' HD13 ' B' ' 115' ' ' ILE . 3.2 ttm -91.57 160.89 15.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.2 112.0 3.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.989 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.468 HG12 ' OH ' ' B' ' 139' ' ' TYR . 44.5 pt -101.91 167.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -125.64 33.08 5.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 3.3 tt0 -178.89 83.35 0.22 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.5 Cg_endo -78.79 151.44 88.32 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.786 -2.173 . . . . 0.0 110.33 -0.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.452 ' O ' HG21 ' B' ' 111' ' ' THR . 7.1 mttt -61.53 110.15 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.8 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.452 HG21 ' O ' ' B' ' 110' ' ' LYS . 74.0 p -148.57 175.17 11.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.582 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 28' ' ' ILE . 1.0 OUTLIER -126.67 162.81 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.755 . . . . 0.0 109.416 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -156.35 133.4 10.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.569 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.2 OUTLIER -97.92 105.8 18.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.463 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 9.7 mt -90.78 140.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.957 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.614 ' CE1' ' CD1' ' A' ' 74' ' ' LEU . 1.4 m-85 -111.31 159.42 17.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.585 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -77.94 -4.59 47.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 45.7 p -83.47 -15.2 50.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.45 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . 0.404 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 114.02 -18.66 18.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -84.11 154.32 23.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 110.009 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 50.9 ttp -149.42 149.2 30.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.958 . . . . 0.0 110.333 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.525 ' CG1' HD13 ' B' ' 114' ' ' LEU . 7.3 t -116.21 141.18 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 109.723 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 22.9 t -114.12 157.18 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 110.789 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 27' ' ' ASN . 14.6 t -167.73 147.76 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.652 -0.655 . . . . 0.0 109.433 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.545 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 123.09 -25.97 6.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.472 ' HB2' ' HB ' ' B' ' 70' ' ' ILE . . . -66.18 160.59 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -1.207 . . . . 0.0 110.336 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -120.15 4.38 10.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 131' ' ' ASP . 0.5 OUTLIER -158.1 162.55 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.361 -0.837 . . . . 0.0 110.034 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -56.12 -48.65 75.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 110.178 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.57 -29.27 70.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.375 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' B' ' 128' ' ' SER . 88.7 m-20 -65.81 -60.75 2.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.42 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 60.3 p -61.68 -33.31 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -44.64 75.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 110.23 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.78 -54.16 6.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.408 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.96 -39.64 9.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.978 . . . . 0.0 109.829 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.8 m -63.1 -56.3 18.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -54.06 -32.94 56.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.841 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.489 ' N ' ' HD2' ' B' ' 138' ' ' LYS . 9.3 mptt -69.14 -42.09 76.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.952 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.468 ' OH ' HG12 ' B' ' 106' ' ' ILE . 22.3 m-85 -61.98 -47.66 83.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.15 75.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.933 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.65 -40.92 88.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 59.0 mt -54.02 -45.79 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.593 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.42 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 21.0 mm -65.37 -46.83 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -66.63 -28.79 68.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.845 . . . . 0.0 109.525 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -23.37 55.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 1.5 mt -81.47 -25.02 10.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.13 -32.66 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.474 ' CD1' HD21 ' B' ' 80' ' ' LEU . 12.5 m-85 -46.62 162.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.247 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.93 44.48 1.03 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.42 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -81.44 154.56 26.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 -166.55 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.471 ' O ' ' CG2' ' B' ' 153' ' ' THR . 73.3 t80 -129.87 118.38 21.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -0.975 . . . . 0.0 110.141 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' B' ' 152' ' ' PHE . 0.6 OUTLIER -167.8 174.0 7.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.529 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.431 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 4.0 m-20 52.15 42.48 30.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.614 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 155' ' ' PHE . 8.4 t80 -90.13 132.71 35.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.9 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.33 134.84 1.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 110.39 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 4.4 mt -78.9 124.24 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.72 -4.11 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.506 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 28.6 t-20 -152.8 131.46 12.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.86 -1.15 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' B' ' 161' ' ' VAL . 7.0 mt -124.37 171.55 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.508 -0.745 . . . . 0.0 109.672 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.496 ' N ' ' CG2' ' B' ' 160' ' ' ILE . 72.8 t -144.11 128.89 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.053 . . . . 0.0 110.884 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -134.02 165.18 24.37 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.8 t -165.45 149.85 8.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.028 -1.277 . . . . 0.0 110.37 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.0 OUTLIER -170.2 173.99 5.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.281 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.468 ' O ' HG22 ' B' ' 63' ' ' ILE . 14.7 t70 -113.92 168.83 9.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.74 -80.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.279 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? 177.96 -27.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.019 -1.051 . . . . 0.0 110.682 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' B' ' 168' ' ' PHE . 13.7 p90 -131.29 158.09 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.981 . . . . 0.0 109.705 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.474 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 44.8 Cg_endo -72.74 152.71 53.33 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.85 1.447 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.448 HG22 HD21 ' B' ' 234' ' ' LEU . 4.0 mt -119.84 158.08 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.503 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.451 ' NE ' ' HG3' ' B' ' 239' ' ' LYS . 6.5 mtt-85 -95.82 99.27 11.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 45.9 mt -50.08 -33.03 17.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 174' ' ' GLY . 4.3 mt-10 -68.08 -56.38 9.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.165 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' B' ' 173' ' ' GLU . . . -44.35 -30.25 1.95 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.86 -59.04 2.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 110.254 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.14 -24.39 17.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.47 -46.82 18.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.046 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 5.0 t -79.63 -58.43 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -92.63 36.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.48 -13.54 37.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.97 -14.64 38.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -1.2 . . . . 0.0 110.306 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 -6.37 8.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.276 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.431 ' HB2' HD22 ' B' ' 193' ' ' LEU . 82.6 p -133.66 164.19 27.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' SER . . . . . 0.462 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 14.7 m -135.13 147.43 49.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.98 . . . . 0.0 110.07 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -133.77 115.98 15.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.163 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' B' ' 190' ' ' PHE . 9.3 mm-40 -115.87 92.75 35.59 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.89 -9.91 26.62 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.993 1.522 . . . . 0.0 110.356 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -9.57 21.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 110.053 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' B' ' 189' ' ' LEU . 2.7 tt -153.08 19.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.482 ' CE1' HD13 ' B' ' 205' ' ' LEU . 0.9 OUTLIER -170.07 113.54 0.48 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.992 . . . . 0.0 110.317 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -37.28 4.96 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.048 1.552 . . . . 0.0 110.552 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.511 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -91.32 179.32 42.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 184' ' ' SER . 3.1 tt -116.32 138.64 51.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.121 . . . . 0.0 110.225 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.439 HD12 ' CE2' ' B' ' 190' ' ' PHE . 25.1 mt -93.51 111.06 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -101.35 117.21 34.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.12 89.24 7.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.378 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.409 ' HB2' ' HE1' ' B' ' 197' ' ' MET . 52.0 tpp -53.22 128.44 27.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.6 -47.28 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.29 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.28 123.83 6.09 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.941 . . . . 0.0 110.246 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.44 155.2 99.8 Favored 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.891 -2.129 . . . . 0.0 110.321 -0.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.471 ' O ' ' CG1' ' B' ' 202' ' ' ILE . 16.2 tttt -56.64 112.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.484 HD12 ' CB ' ' B' ' 217' ' ' ALA . 4.7 mt -158.58 154.72 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 0.0 110.471 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.6 114.99 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.479 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.493 HD13 ' N ' ' B' ' 204' ' ' LEU . 6.2 mp -101.53 135.09 43.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 110.95 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.482 HD13 ' CE1' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -103.24 119.14 38.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 109.535 179.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.505 HD11 HG22 ' B' ' 206' ' ' ILE . 13.7 mm -105.16 147.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 0.0 110.566 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.511 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 21.0 m-85 -132.53 141.14 48.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.063 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 0.8 OUTLIER -46.48 -54.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 110.105 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 208' ' ' VAL . 68.2 m -39.2 -36.9 0.36 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.317 0.579 . . . . 0.0 110.187 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 118.01 24.23 3.36 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -97.53 134.61 40.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -1.223 . . . . 0.0 110.099 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.421 HG21 HD11 ' B' ' 212' ' ' ILE . 15.8 mm -119.82 138.45 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 59.6 t -128.41 132.32 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.233 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.472 ' CB ' HD11 ' B' ' 223' ' ' ILE . 2.6 mp -118.77 119.14 33.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 110.16 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.468 ' OG1' HG21 ' B' ' 161' ' ' VAL . 12.6 t -139.0 157.67 45.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 110.241 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.71 14.38 55.34 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.484 ' CB ' HD12 ' B' ' 202' ' ' ILE . . . -83.92 144.42 29.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -1.09 . . . . 0.0 110.276 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -81.44 -7.28 59.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.462 ' HA ' HD13 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -169.37 -176.69 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -73.98 -45.42 50.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.437 ' HG3' ' OE1' ' B' ' 222' ' ' GLU . 24.0 pt-20 -49.74 -32.76 14.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.478 ' HB3' HD13 ' B' ' 202' ' ' ILE . 8.7 mm-40 -61.17 -49.14 78.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.942 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.523 HG21 ' CG ' ' B' ' 65' ' ' PRO . 47.8 mm -59.43 -36.14 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -65.28 -35.54 81.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.47 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -82.08 -41.46 20.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.418 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.84 -34.4 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 110.247 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.428 ' O ' HG21 ' B' ' 230' ' ' ILE . 18.1 t80 -76.18 -49.45 17.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.366 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -23.04 40.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.479 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.18 -24.78 19.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.992 . . . . 0.0 110.255 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.428 HG21 ' O ' ' B' ' 227' ' ' PHE . 6.6 tp -100.28 -17.98 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.341 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.6 t80 -55.1 -43.63 99.17 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 111.144 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -72.87 -42.68 1.01 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.312 1.164 . . . . 0.0 110.343 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 40.6 t -53.97 -42.69 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.972 . . . . 0.0 109.682 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.448 HD21 HG22 ' B' ' 170' ' ' ILE . 81.9 mt -65.01 -58.16 6.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 109.966 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -52.9 -30.94 37.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.035 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.71 -36.85 84.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -113.04 41.47 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' B' ' 235' ' ' SER . 1.5 ptt180 -74.56 -176.14 2.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 6.2 ttmt -125.33 -29.46 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 109.979 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' MET . . . . . 0.451 ' OXT' ' HB2' ' B' ' 168' ' ' PHE . 10.8 mtp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.139 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.306 0.574 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.62 -109.76 0.46 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 0.6 OUTLIER -166.89 -49.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -1.111 . . . . 0.0 110.03 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 13' ' ' SER . 30.8 mm 57.68 84.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 16' ' ' ASN . . . 128.97 31.76 0.62 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 27.9 m-20 -167.44 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -1.217 . . . . 0.0 110.216 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.496 ' HA3' HG21 ' A' ' 72' ' ' ILE . . . -145.52 158.8 27.77 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.656 ' N ' ' CZ ' ' B' ' 99' ' ' PHE . 0.0 OUTLIER -67.8 -176.12 0.62 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.132 -1.216 . . . . 0.0 109.974 -179.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 4.8 t70 -76.1 96.27 3.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.049 -1.032 . . . . 0.0 111.1 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.536 HD21 HG13 ' A' ' 23' ' ' ILE . 2.0 mt -99.06 12.2 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.078 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.528 ' CG2' HG21 ' A' ' 56' ' ' ILE . 1.3 t -40.93 -33.63 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.635 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.51 -31.55 6.38 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.607 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -47.39 -44.38 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.685 -1.479 . . . . 0.0 109.084 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.529 ' HB2' ' ND2' ' B' ' 159' ' ' ASN . 0.6 OUTLIER -82.84 -22.56 34.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.022 -1.049 . . . . 0.0 109.0 178.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CE1' HD12 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -92.77 11.09 28.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 143.64 98.67 0.28 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.546 ' CB ' HG21 ' B' ' 124' ' ' THR . 12.7 p-10 -30.73 90.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.05 0.928 . . . . 0.0 111.832 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -92.6 164.16 2.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.555 ' N ' HG12 ' A' ' 28' ' ' ILE . 26.0 m-20 -85.59 123.85 31.47 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.497 ' C ' ' O ' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -37.03 -29.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.363 0.601 . . . . 0.0 109.825 -178.143 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.9 tt0 -54.85 -16.13 2.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.09 27.97 4.61 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.589 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -123.27 126.41 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.998 -1.295 . . . . 0.0 110.557 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.636 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -98.95 155.34 17.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.688 -1.257 . . . . 0.0 110.645 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.53 ' CD1' ' OD1' ' A' ' 27' ' ' ASN . 3.3 pp -124.66 -179.29 4.44 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.117 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.448 ' OE1' ' HB2' ' A' ' 49' ' ' ASP . 5.8 mt-30 -118.06 135.48 54.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.679 -0.638 . . . . 0.0 109.778 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.427 ' OD2' ' HA2' ' B' ' 125' ' ' GLY . 47.0 m-20 -108.02 -16.25 14.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.581 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -97.79 172.05 7.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 110.316 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -69.11 173.93 5.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.955 . . . . 0.0 109.885 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.95 105.47 3.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -144.8 23.86 1.54 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -1.132 . . . . 0.0 110.105 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.72 -121.57 0.18 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -128.9 65.45 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -1.203 . . . . 0.0 110.295 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.94 -129.08 20.86 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.19 -99.15 0.69 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.29 101.86 13.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -1.189 . . . . 0.0 110.272 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.95 127.42 1.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 16.4 p90 -82.89 2.92 32.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -1.14 . . . . 0.0 110.217 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 13.0 p-10 -48.17 -42.37 29.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.194 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 49' ' ' ASP . . . -96.57 10.37 38.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.423 -0.798 . . . . 0.0 110.073 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 41.8 tt0 -100.59 -29.86 12.1 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD12 ' CE1' ' A' ' 25' ' ' PHE . 3.4 mt -98.58 -45.31 6.13 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 110.009 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.564 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -45.04 -49.05 11.7 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.763 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -64.14 -20.7 66.17 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.719 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 76.5 m-20 -91.34 -38.12 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.653 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 3.2 mt -47.71 -43.49 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.95 -17.18 28.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -138.39 35.54 2.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -1.195 . . . . 0.0 110.468 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.56 ' CD2' ' CD1' ' A' ' 62' ' ' LEU . 12.2 mt -102.58 21.18 15.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.159 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.11 45.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 21.7 ttpt -150.28 15.84 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.56 ' CD1' ' CD2' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -93.75 -31.83 14.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.28 -0.888 . . . . 0.0 109.768 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.53 1.77 7.64 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -95.28 0.19 53.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.2 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 22.6 m-20 -46.2 -41.93 13.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.662 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.451 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -60.61 -35.36 75.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.894 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.467 ' HG2' HD23 ' A' ' 24' ' ' LEU . 4.9 ttp -69.0 -18.98 64.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 65' ' ' ASP . 7.4 mt -71.96 -60.18 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.526 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -62.61 -9.02 7.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -85.58 5.74 30.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.124 -0.985 . . . . 0.0 110.619 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -132.49 0.93 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.756 179.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.644 ' CD1' ' CD2' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -150.94 66.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.3 p-10 -76.72 54.67 0.99 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.622 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.605 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -89.75 54.77 2.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.751 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -96.59 121.24 38.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.078 -1.014 . . . . 0.0 110.16 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 77' ' ' ALA . 1.7 mt-10 59.61 -157.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.928 . . . . 0.0 110.124 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.309 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.245 0.545 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -169.87 -41.0 0.03 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 92.4 mt -90.15 169.79 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -1.141 . . . . 0.0 110.147 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.413 HG11 ' HD2' ' B' ' 65' ' ' PRO . 91.4 t -143.2 139.55 16.79 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.413 ' HD2' HG11 ' B' ' 64' ' ' VAL . 46.2 Cg_endo -73.12 122.57 8.16 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 67.7 m -91.07 132.38 36.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.507 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -70.27 133.82 47.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 109.89 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -121.18 -15.99 8.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.662 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.45 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -161.38 119.53 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.595 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.519 ' HB ' ' CB ' ' B' ' 126' ' ' ALA . 13.8 mm -104.25 157.07 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 30.8 t -135.9 136.85 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.8 166.29 28.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.208 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -119.01 151.93 37.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.51 151.3 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.292 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -118.34 142.35 47.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.022 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.531 HD11 ' CD1' ' B' ' 80' ' ' LEU . 49.4 mt -89.84 -61.1 1.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.77 4.75 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 1.3 m -162.3 151.28 15.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -1.172 . . . . 0.0 110.167 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 18.1 ttp85 -71.46 155.55 40.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.531 ' CD1' HD11 ' B' ' 76' ' ' LEU . 44.6 mt -138.07 148.91 45.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 29.9 t70 -89.81 95.59 10.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.013 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' B' ' 102' ' ' VAL . 14.5 mt -42.68 -48.61 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.181 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -46.13 61.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.864 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 9.0 m -76.46 -48.37 19.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 95.8 t -54.62 -50.42 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.236 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.401 ' HB1' HG23 ' B' ' 102' ' ' VAL . . . -69.08 -20.54 64.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 110.005 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.27 -37.62 15.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.246 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.71 -26.78 29.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.485 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.31 140.27 58.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 110.375 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -76.07 -27.05 57.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.402 -0.811 . . . . 0.0 109.983 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 0.7 OUTLIER -132.54 79.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.946 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -163.89 167.75 20.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -161.27 141.04 10.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 110.135 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -114.06 105.4 13.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.274 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -102.67 105.35 43.98 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.73 -16.58 33.48 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.986 1.519 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -73.07 -27.54 61.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.811 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.71 -72.09 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.986 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.656 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -138.55 -177.28 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.31 44.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.116 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 74' ' ' LEU . . . -131.18 165.02 24.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 110.563 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' B' ' 82' ' ' LEU . 57.9 t -102.97 123.64 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.354 -0.841 . . . . 0.0 109.586 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.5 mp -89.29 122.47 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.865 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.402 ' HG3' ' HB3' ' B' ' 92' ' ' ALA . 9.8 ttm -115.81 166.09 12.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 110.514 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' B' ' 111' ' ' THR . 3.9 ttt85 -164.71 118.98 1.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 12.9 pt -112.71 170.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 110.376 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.89 38.16 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.808 . . . . 0.0 109.799 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -174.17 79.33 0.36 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.507 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' B' ' 135' ' ' ALA . 53.0 Cg_endo -83.65 162.47 70.67 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.795 -2.169 . . . . 0.0 110.444 -0.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 21.5 mttt -61.81 106.7 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.933 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' B' ' 110' ' ' LYS . 20.7 p -156.45 173.33 17.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.465 HG21 HG21 ' B' ' 124' ' ' THR . 0.4 OUTLIER -121.97 -179.51 4.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.357 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -167.19 122.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 0.0 111.218 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.453 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.5 OUTLIER -89.87 103.29 15.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 178.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.428 ' HA ' ' HB3' ' B' ' 121' ' ' MET . 15.8 mt -91.05 141.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 111.468 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.592 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 1.8 m-85 -110.6 151.46 27.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.46 66.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.295 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 p -71.04 -3.94 22.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.38 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.18 -28.36 16.27 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -73.2 163.99 27.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -1.068 . . . . 0.0 110.099 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.428 ' HB3' ' HA ' ' B' ' 115' ' ' ILE . 0.0 OUTLIER -167.44 176.02 6.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.274 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' B' ' 113' ' ' ALA . 9.3 t -132.15 160.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.412 ' N ' HG11 ' B' ' 122' ' ' VAL . 81.8 t -140.46 131.79 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.386 -0.821 . . . . 0.0 110.049 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.546 HG21 ' CB ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -142.15 173.28 11.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.534 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 100.33 -18.82 54.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HB ' ' B' ' 70' ' ' ILE . . . -54.81 162.77 1.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -1.158 . . . . 0.0 110.456 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.46 13.33 16.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.192 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.66 -164.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.452 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.76 -43.91 16.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.17 -28.94 69.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.42 -53.41 12.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 110.187 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 88.8 p -49.97 -37.37 32.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.356 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -66.71 -40.41 88.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.298 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.43 ' O ' ' HG2' ' B' ' 138' ' ' LYS . 0.3 OUTLIER -70.85 -50.65 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.342 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.457 ' HA ' ' HD2' ' B' ' 109' ' ' PRO . . . -53.21 -34.46 57.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.4 m -68.71 -56.52 7.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -48.08 -37.0 14.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.97 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.471 ' O ' HG12 ' B' ' 142' ' ' ILE . 9.8 mmtp -59.6 -51.62 69.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.433 ' CZ ' ' HB1' ' B' ' 113' ' ' ALA . 26.2 m-85 -58.3 -54.72 43.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.54 -24.42 8.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 109.83 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.458 ' HG2' ' HE3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -79.23 -39.66 32.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.976 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.471 HG12 ' O ' ' B' ' 138' ' ' LYS . 25.1 mm -54.03 -47.34 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.881 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.588 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 51.0 mt -71.59 -41.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.452 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 27.5 mt-30 -68.25 -38.92 82.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.852 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.458 ' HE3' ' HG2' ' B' ' 141' ' ' ARG . 0.5 OUTLIER -70.44 -20.74 62.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.9 mt -81.99 -16.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 111.75 -23.03 18.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.588 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 8.6 m-85 -50.13 176.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 110.859 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.67 42.64 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.735 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.473 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -88.23 125.94 34.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' B' ' 76' ' ' LEU . 0.0 OUTLIER -100.73 -152.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.887 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -151.33 110.91 4.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.276 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.26 -173.4 2.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 110.319 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.04 27.81 7.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.399 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' B' ' 73' ' ' THR . 10.6 t80 -74.06 136.63 43.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 109.92 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.06 133.98 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.978 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 31.9 mt -79.84 135.29 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -121.77 -18.87 6.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 110.516 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 2.7 t-20 -142.69 130.53 21.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.138 -0.976 . . . . 0.0 110.622 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.455 HD11 HG22 ' B' ' 160' ' ' ILE . 32.5 mt -120.47 142.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.637 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 94.7 t -116.5 125.72 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.38 171.01 18.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.2 OUTLIER -162.35 146.33 11.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -1.223 . . . . 0.0 110.427 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 7.7 p -168.94 159.9 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.429 ' OD1' ' HG2' ' B' ' 211' ' ' LYS . 5.6 t70 -103.55 154.78 19.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.573 ' O ' ' CD2' ' B' ' 168' ' ' PHE . 22.5 m -97.48 11.88 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.42 -2.06 2.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.408 -0.808 . . . . 0.0 111.214 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 11.6 p90 -155.22 157.3 31.74 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.869 -1.144 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.0 Cg_endo -72.05 160.03 48.55 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.147 1.604 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.503 HG21 ' N ' ' B' ' 171' ' ' ARG . 1.5 mp -131.85 153.92 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 110.314 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.503 ' N ' HG21 ' B' ' 170' ' ' ILE . 12.5 ttm180 -87.51 110.18 20.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.931 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.46 HD23 ' O ' ' B' ' 206' ' ' ILE . 15.6 mt -66.39 -64.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.331 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -25.95 64.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.08 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -72.56 -48.21 24.14 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.552 HD11 ' CD2' ' B' ' 237' ' ' PHE . 9.6 tp -74.77 -33.76 62.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.343 -1.093 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.73 71.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.947 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -80.44 -28.31 37.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.992 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' B' ' 175' ' ' LEU . 1.2 p -83.58 -58.6 2.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -0.802 . . . . 0.0 110.097 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -96.28 32.65 1.92 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.021 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 181' ' ' THR . . . -52.75 -26.49 25.35 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 180' ' ' GLY . 22.6 p -42.37 -55.27 3.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -1.174 . . . . 0.0 110.133 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.621 ' CZ ' ' CG2' ' B' ' 198' ' ' VAL . 3.2 m-85 -115.49 -3.24 12.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' B' ' 195' ' ' TYR . 9.4 t -92.11 140.78 29.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.99 130.46 41.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.406 ' HB2' ' HG ' ' B' ' 193' ' ' LEU . 5.6 t80 -146.52 101.42 3.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 110.272 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.16 116.99 46.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.152 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.73 -0.24 9.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.945 1.497 . . . . 0.0 110.525 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.87 -6.67 28.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' B' ' 190' ' ' PHE . 3.8 tt -143.13 -57.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 110.425 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.512 ' HB2' ' CD2' ' B' ' 189' ' ' LEU . 7.4 t80 -105.74 124.92 34.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . 0.487 ' HD2' ' CD1' ' B' ' 190' ' ' PHE . 46.3 Cg_endo -73.84 -35.77 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.905 1.477 . . . . 0.0 110.351 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.518 ' HA3' ' CD1' ' B' ' 207' ' ' PHE . . . -90.3 174.85 40.57 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' B' ' 194' ' ' ILE . 9.1 tt -94.11 159.75 15.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -1.137 . . . . 0.0 110.272 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.532 ' N ' ' CD2' ' B' ' 193' ' ' LEU . 75.9 mt -130.82 107.58 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 12.5 t80 -98.56 119.65 37.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.002 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.51 ' NH2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -91.96 117.73 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 110.457 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.424 ' HE3' ' HB2' ' B' ' 229' ' ' ALA . 30.1 ttm -93.45 144.26 25.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.937 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.621 ' CG2' ' CZ ' ' B' ' 182' ' ' PHE . 84.7 t -92.34 -50.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.965 . . . . 0.0 110.274 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.44 106.41 17.43 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.861 . . . . 0.0 110.314 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.54 171.14 67.74 Favored 'Cis proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.359 -0.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -85.14 98.58 10.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.502 HG21 ' N ' ' B' ' 203' ' ' VAL . 29.2 mt -145.82 149.68 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.682 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.502 ' N ' HG21 ' B' ' 202' ' ' ILE . 75.0 t -103.7 117.68 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.477 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.567 ' N ' ' CD1' ' B' ' 204' ' ' LEU . 4.8 mp -104.54 152.06 22.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.724 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.52 ' CD1' HD23 ' A' ' 52' ' ' LEU . 18.5 mt -117.13 143.51 45.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.371 -0.83 . . . . 0.0 110.013 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.46 ' O ' HD23 ' B' ' 172' ' ' LEU . 6.5 mt -132.49 103.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.518 ' CD1' ' HA3' ' B' ' 192' ' ' GLY . 14.2 m-30 -94.48 145.74 24.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.111 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 37.6 t -45.46 -28.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.892 . . . . 0.0 110.467 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -16.19 56.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.447 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.67 -4.36 61.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.429 ' HG2' ' OD1' ' B' ' 165' ' ' ASP . 8.7 mttm -73.22 131.96 42.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 110.166 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' B' ' 163' ' ' SER . 17.0 mm -119.73 143.98 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.429 ' C ' HD13 ' B' ' 214' ' ' LEU . 12.0 t -124.76 157.38 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.461 HD22 HD22 ' B' ' 204' ' ' LEU . 4.8 mp -144.46 107.38 4.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 1.6 t -128.95 137.19 51.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 0.0 110.144 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.443 ' C ' HG12 ' B' ' 202' ' ' ILE . . . 119.8 9.74 8.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.455 ' HB3' HD13 ' B' ' 202' ' ' ILE . . . -88.19 154.89 20.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.308 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.56 -12.26 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.505 ' CG ' ' HG2' ' B' ' 221' ' ' GLU . 9.4 tp60 -150.32 150.1 31.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.059 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.18 -38.72 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 16.0 pt-20 -54.45 -34.51 61.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.511 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 16.8 mt-10 -65.16 -58.73 5.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.11 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.424 HG13 HG23 ' B' ' 160' ' ' ILE . 29.5 mm -50.67 -45.2 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.992 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -65.7 -33.14 75.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.67 -46.05 23.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.018 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.417 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -55.66 -27.61 50.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.89 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' B' ' 231' ' ' TYR . 16.9 t80 -78.78 -46.65 18.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -59.5 -22.61 61.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.087 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . 0.424 ' HB2' ' HE3' ' B' ' 197' ' ' MET . . . -88.25 -30.54 19.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 5.8 tp -99.82 -9.65 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.069 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.588 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.7 t80 -63.14 -46.73 86.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -71.51 -25.95 20.62 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.229 1.12 . . . . 0.0 110.065 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.63 -36.69 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.768 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.465 HD21 HG22 ' B' ' 170' ' ' ILE . 54.7 mt -71.4 -40.93 70.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 109.972 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -19.94 66.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.314 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -82.7 -41.8 18.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.552 ' CD2' HD11 ' B' ' 175' ' ' LEU . 60.4 m-85 -109.04 38.54 2.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.385 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -75.22 176.01 7.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.277 -0.89 . . . . 0.0 110.078 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -128.93 -36.86 1.76 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.953 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.216 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.316 0.579 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.09 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -175.14 89.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -1.127 . . . . 0.0 110.139 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -94.42 19.96 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.935 . . . . 0.0 110.222 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.92 66.31 2.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -121.8 89.65 3.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -1.094 . . . . 0.0 110.089 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.05 121.15 2.33 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -99.75 161.25 13.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -1.159 . . . . 0.0 109.166 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.438 ' N ' ' CD1' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -88.38 78.26 7.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 111.565 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.626 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 4.2 mt -86.3 30.11 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.576 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 1.8 m -77.76 -6.01 52.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.24 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.97 -41.73 2.79 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.002 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.674 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 17.2 pt -51.93 -46.17 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.651 -1.5 . . . . 0.0 109.601 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.568 ' CD1' ' CD1' ' A' ' 64' ' ' LEU . 1.3 pp -75.27 0.33 16.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 0.0 109.272 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -120.27 -13.99 8.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.327 -0.858 . . . . 0.0 110.721 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 157.31 45.47 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.622 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 52.87 147.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.368 -1.078 . . . . 0.0 111.43 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.674 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.49 161.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.461 -0.775 . . . . 0.0 109.284 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.531 ' N ' HG12 ' A' ' 28' ' ' ILE . 81.1 m-20 -88.57 135.02 33.7 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.502 ' C ' ' O ' ' A' ' 29' ' ' ASP . 1.1 p -36.27 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.904 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -49.2 -21.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 110.007 179.121 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.87 21.1 7.99 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.85 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -114.48 130.84 56.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.805 -1.409 . . . . 0.0 109.586 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.628 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -102.77 151.02 22.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 111.703 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 4.0 pp -112.87 -178.86 3.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 110.367 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 13.1 mt-30 -146.11 75.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.596 -0.69 . . . . 0.0 109.999 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 46.23 44.81 12.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.55 -177.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 110.091 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.39 141.35 57.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.166 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.59 -136.13 2.65 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -172.04 145.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -1.11 . . . . 0.0 110.15 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.8 -104.69 0.81 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -152.96 -66.95 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 109.924 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.49 22.06 42.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.48 -168.69 36.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.28 67.66 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.14 . . . . 0.0 110.273 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' PHE . . . 98.72 -174.08 27.63 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 47' ' ' GLY . 5.1 m-30 -43.72 147.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -1.162 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -72.86 -172.1 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.862 . . . . 0.0 110.28 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.45 27.28 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.087 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -100.22 -25.53 14.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 56' ' ' ILE . 3.5 mt -96.43 -40.83 8.9 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.399 -0.813 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.531 ' CD ' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -47.98 -52.29 20.37 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.231 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.38 -40.51 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.393 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' LEU . 3.9 m-80 -63.75 -45.36 90.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.664 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.497 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 39.2 mt -46.75 -44.61 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -0.847 . . . . 0.0 109.777 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.96 -22.65 60.5 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.17 39.04 1.59 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.31 . . . . 0.0 109.34 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 55' ' ' ASN . 1.8 tp -104.05 -9.74 18.56 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.413 -0.805 . . . . 0.0 109.718 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 p -75.83 48.15 0.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 109.835 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -134.49 -19.4 1.89 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 110.325 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.629 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.25 22.73 4.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.673 -1.267 . . . . 0.0 111.19 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.91 -69.77 0.13 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.397 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 4.0 mm? -69.97 -2.09 11.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.239 . . . . 0.0 111.274 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.467 ' O ' HD22 ' A' ' 69' ' ' LEU . 65.8 t0 -52.66 -49.62 64.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 109.837 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.3 p -67.56 -45.42 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.943 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.402 ' HG2' HD23 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.66 -4.41 19.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.777 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.586 ' CD2' ' N ' ' A' ' 20' ' ' LEU . 2.7 tm? -82.0 -60.49 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.891 . . . . 0.0 109.735 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 65' ' ' ASP . 1.1 pp -75.54 2.02 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.906 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 3.3 tt0 -97.32 16.94 18.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 111.109 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 4.2 t -136.62 -1.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.243 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.626 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -151.73 76.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 1.9 p-10 -75.04 57.6 0.83 Allowed 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.739 -1.226 . . . . 0.0 108.563 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.5 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 8.7 mt -93.12 64.34 3.82 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.622 0.725 . . . . 0.0 110.815 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -135.07 -177.28 4.57 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.652 -0.655 . . . . 0.0 110.214 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -55.1 96.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 110.183 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.213 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.29 0.567 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.86 76.74 1.2 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.455 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 1.9 mp -76.52 -48.58 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -1.141 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.628 ' CG1' ' CZ ' ' B' ' 224' ' ' TYR . 3.4 t 64.05 123.14 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 46.1 Cg_endo -72.72 145.93 42.19 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.938 1.494 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.41 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.5 m -96.72 136.72 36.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.477 HD13 ' NH1' ' B' ' 220' ' ' ARG . 39.7 mt -70.0 121.36 17.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.897 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -95.34 -29.52 14.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -170.37 -179.49 3.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.557 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' B' ' 126' ' ' ALA . 21.0 mt -153.93 164.45 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.971 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 24' ' ' LEU . 25.8 t -130.6 133.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.24 169.74 15.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.289 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' THR . . . . . 0.435 HG22 ' HG3' ' B' ' 158' ' ' GLN . 28.1 p -122.48 144.19 49.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.303 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.412 ' HB ' ' HG3' ' B' ' 121' ' ' MET . 47.8 t -136.08 142.4 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.365 -0.835 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' B' ' 120' ' ' LYS . 1.3 m -123.99 132.75 53.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.729 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -100.42 -26.09 13.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 109.963 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 51.78 39.36 47.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 79' ' ' ARG . 89.0 m -134.67 -0.22 2.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.524 ' O ' ' CD2' ' B' ' 80' ' ' LEU . 4.9 mmm180 59.77 139.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.026 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' B' ' 79' ' ' ARG . 24.1 mt -139.54 151.01 45.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.961 -1.087 . . . . 0.0 110.6 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' B' ' 81' ' ' ASP . 2.0 m-20 -89.83 89.25 7.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.527 HD21 ' CG2' ' B' ' 102' ' ' VAL . 32.3 mt -40.84 -43.07 1.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 110.689 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -54.59 -47.21 73.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.638 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 12.0 p -80.44 -40.87 25.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.713 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.465 HG21 ' CE2' ' B' ' 148' ' ' PHE . 55.9 t -52.56 -42.87 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.124 -0.985 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.406 ' HA ' ' HB2' ' B' ' 92' ' ' ALA . . . -80.28 -23.53 40.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.067 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.91 -27.26 43.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.368 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -100.43 -38.92 8.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.503 ' CB ' ' HB1' ' B' ' 92' ' ' ALA . . . -53.21 134.27 39.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.204 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -73.96 -22.9 59.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.444 ' O ' ' SD ' ' B' ' 104' ' ' MET . 1.4 m120 -134.79 79.52 1.8 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.829 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.514 ' CB ' ' SD ' ' B' ' 104' ' ' MET . . . -150.43 162.42 40.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -143.07 171.87 13.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.004 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.28 104.68 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.11 112.84 59.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.56 -17.48 23.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.911 1.479 . . . . 0.0 110.619 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -82.22 -17.7 45.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.158 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -55.55 2.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.586 ' CE2' ' HB1' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -160.41 -164.65 1.29 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 111.397 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.38 54.39 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.935 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.586 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -143.9 167.45 22.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 110.382 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.527 ' CG2' HD21 ' B' ' 82' ' ' LEU . 49.7 t -100.58 139.91 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 110.159 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' B' ' 114' ' ' LEU . 4.8 mp -106.52 113.43 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.514 ' SD ' ' CB ' ' B' ' 92' ' ' ALA . 21.0 tpp -104.65 162.07 13.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 110.224 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.42 131.65 11.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.555 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 7.4 pt -125.8 169.68 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' B' ' 108' ' ' GLU . 1.1 mtt180 -115.16 22.61 13.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' B' ' 107' ' ' ARG . 3.1 mt-10 -166.1 93.14 0.81 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.455 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' B' ' 135' ' ' ALA . 47.5 Cg_endo -75.22 159.57 97.59 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.818 -2.159 . . . . 0.0 110.423 -0.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 98.21 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.917 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' THR . . . . . . . . . . . . . 38.3 p -153.17 -179.29 7.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.853 . . . . 0.0 110.113 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.542 ' CG2' HG21 ' B' ' 124' ' ' THR . 15.1 t -134.38 162.47 32.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.102 -0.999 . . . . 0.0 110.062 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' B' ' 104' ' ' MET . . . -161.51 156.76 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.913 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.529 ' CG ' ' HB ' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -132.05 115.12 15.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.522 -0.736 . . . . 0.0 109.422 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' B' ' 102' ' ' VAL . 50.6 mt -90.77 137.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.867 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 2.6 m-30 -90.53 -171.04 2.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.347 -0.846 . . . . 0.0 109.515 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' B' ' 79' ' ' ARG . . . -93.01 -10.25 36.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.52 -28.55 18.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.19 -38.65 1.78 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . 0.517 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 5.0 tttt -61.24 139.83 58.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 110.139 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.438 ' HE2' ' HB2' ' B' ' 139' ' ' TYR . 3.7 ptt? -144.69 157.13 44.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.549 ' CG2' ' O ' ' A' ' 71' ' ' VAL . 31.3 t -104.37 154.01 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.49 ' N ' HG11 ' B' ' 122' ' ' VAL . 7.5 t -147.27 101.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 110.711 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.542 HG21 ' CG2' ' B' ' 112' ' ' THR . 0.2 OUTLIER -104.92 179.88 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 0.0 109.001 178.599 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.586 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 98.46 -29.74 10.91 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.53 ' CB ' ' OG ' ' B' ' 132' ' ' SER . . . -48.19 131.62 16.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 109.991 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' B' ' 128' ' ' SER . 0.2 OUTLIER -101.09 13.67 34.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.382 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' B' ' 127' ' ' LYS . 0.3 OUTLIER 178.93 -169.67 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -74.21 -45.92 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.57 -27.03 64.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.474 ' O ' ' HB1' ' B' ' 135' ' ' ALA . 0.7 OUTLIER -64.68 -45.82 85.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.269 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 39.2 m -65.2 -48.52 73.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 10.8 ttpp -53.37 -41.28 65.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 110.47 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 138' ' ' LYS . 0.7 OUTLIER -77.63 -43.76 30.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 110.444 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' B' ' 131' ' ' ASP . . . -64.38 -36.75 85.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.277 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 11.8 p -68.78 -59.93 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.121 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.436 ' CZ ' ' HB2' ' B' ' 137' ' ' ARG . 8.5 ptm85 -51.82 -26.41 9.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.896 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -67.1 -48.55 67.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.555 ' CZ ' HG12 ' B' ' 106' ' ' ILE . 35.7 m-85 -62.56 -47.3 84.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -55.6 -28.36 54.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.91 . . . . 0.0 109.69 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -70.95 -51.57 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 110.003 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.437 ' O ' HG13 ' B' ' 146' ' ' ILE . 6.4 mt -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.045 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 49.3 mm -73.64 -53.77 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.82 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 28.0 mt-30 -64.72 -29.95 70.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 109.989 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -74.09 -22.61 59.44 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.437 HG13 ' O ' ' B' ' 142' ' ' ILE . 4.2 mt -81.04 -22.16 10.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.94 4.85 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.465 ' CE2' HG21 ' B' ' 85' ' ' VAL . 24.2 m-85 -63.99 175.02 1.3 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.007 -1.29 . . . . 0.0 111.416 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.15 24.32 11.77 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.458 0.647 . . . . 0.0 109.679 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.482 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -46.24 150.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 110.598 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -124.44 101.53 7.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 110.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.95 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.304 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.437 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.9 OUTLIER -151.74 173.09 15.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 110.395 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' B' ' 153' ' ' THR . 0.1 OUTLIER 65.39 21.46 11.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.341 -0.849 . . . . 0.0 110.436 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -65.67 135.13 54.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.989 . . . . 0.0 110.09 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -166.04 136.71 3.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 110.35 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 7.3 mt -79.04 154.23 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.897 . . . . 0.0 109.653 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.435 ' HG3' HG22 ' B' ' 73' ' ' THR . 8.8 mm-40 -137.06 -23.8 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.005 -1.059 . . . . 0.0 111.63 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.522 ' ND2' ' HA2' ' B' ' 216' ' ' GLY . 13.7 t-20 -149.51 122.19 8.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.712 -1.243 . . . . 0.0 111.523 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' B' ' 215' ' ' THR . 84.8 mt -106.92 144.89 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 108.903 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 48.6 t -118.06 142.5 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.827 -1.17 . . . . 0.0 111.435 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -139.72 162.03 26.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 54.5 p -161.2 143.93 12.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.314 . . . . 0.0 110.676 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.454 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.5 OUTLIER -170.36 171.72 6.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.374 -0.829 . . . . 0.0 110.144 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.444 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 0.8 OUTLIER -114.83 131.53 56.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.042 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' B' ' 167' ' ' LYS . 5.1 m -67.62 -61.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.121 -0.987 . . . . 0.0 110.957 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 169.59 -31.42 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.033 . . . . 0.0 110.441 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 17.0 p90 -134.34 165.78 34.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.2 Cg_endo -71.81 147.39 50.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.975 1.513 . . . . 0.0 110.26 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.462 HG22 HD21 ' B' ' 234' ' ' LEU . 4.1 mt -110.49 152.91 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -93.8 105.18 17.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.695 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.467 HD23 ' O ' ' B' ' 206' ' ' ILE . 8.5 mt -63.37 -43.95 96.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 110.615 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.4 -49.62 75.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 110.424 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -62.0 -38.07 95.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.538 HD21 ' CG ' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -74.37 -36.73 63.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -1.168 . . . . 0.0 110.451 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.64 67.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.271 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -92.39 -42.3 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.052 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' SER . . . . . 0.414 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -63.36 -52.78 60.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -115.38 40.2 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.098 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.6 -19.8 49.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.0 m -58.03 -35.85 71.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -1.162 . . . . 0.0 110.257 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.6 ' CE1' ' CG2' ' B' ' 198' ' ' VAL . 44.1 m-85 -125.19 12.15 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 50.6 m -114.72 143.91 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 0.0 110.226 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.09 114.2 16.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 110.25 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -125.7 91.42 3.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.93 113.98 60.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.25 5.04 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.908 1.478 . . . . 0.0 110.937 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.87 -9.19 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.025 . . . . 0.0 110.248 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.459 HD22 ' OD1' ' A' ' 55' ' ' ASN . 3.8 tt -152.51 -40.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.403 ' CE2' HD12 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -117.76 107.81 43.81 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.405 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.61 -23.69 19.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.029 1.542 . . . . 0.0 110.279 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.23 177.87 39.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' B' ' 205' ' ' LEU . 7.4 tt -108.05 128.42 54.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.166 . . . . 0.0 110.402 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.47 ' HA ' HD22 ' B' ' 205' ' ' LEU . 22.2 mt -101.72 108.04 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -95.77 113.1 24.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.236 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.417 ' CB ' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -90.6 88.29 7.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.44 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 22.9 ttm -59.28 139.11 57.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 110.161 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.6 ' CG2' ' CE1' ' B' ' 182' ' ' PHE . 3.0 t -77.3 -46.09 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 109.949 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' B' ' 199' ' ' LYS . 34.2 pttt -142.21 118.56 7.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 0.0 109.863 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.32 145.99 85.68 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.971 -2.096 . . . . 0.0 110.513 0.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.454 ' O ' HD12 ' B' ' 202' ' ' ILE . 1.4 tptm -57.34 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.115 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.522 HD13 ' CB ' ' B' ' 217' ' ' ALA . 42.5 mm -138.34 165.16 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.581 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 45.1 t -121.91 125.24 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.472 HD22 ' CB ' ' B' ' 226' ' ' ALA . 1.6 mp -121.94 140.5 52.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.508 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' B' ' 194' ' ' ILE . 12.5 mt -103.96 156.0 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.854 . . . . 0.0 109.952 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.469 HG13 ' CD1' ' B' ' 212' ' ' ILE . 2.8 mt -140.05 105.69 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -97.62 152.05 19.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 62.0 t -49.23 -34.11 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 97.5 p -55.66 -31.85 62.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 110.1 12.86 16.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.444 ' HG3' ' OD1' ' B' ' 165' ' ' ASP . 29.1 tttt -89.7 131.86 35.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.029 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.485 HD13 HG22 ' B' ' 212' ' ' ILE . 34.1 mm -118.12 122.14 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 16.1 t -92.39 154.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 4.2 mp -143.17 100.95 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.979 . . . . 0.0 110.716 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 0.9 OUTLIER -136.84 170.72 15.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.204 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . 0.522 ' HA2' ' ND2' ' B' ' 159' ' ' ASN . . . 92.28 13.33 57.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.522 ' CB ' HD13 ' B' ' 202' ' ' ILE . . . -98.48 157.15 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -1.131 . . . . 0.0 110.297 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -36.58 13.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.28 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.416 ' CA ' HD13 ' B' ' 160' ' ' ILE . 0.1 OUTLIER -128.86 -158.8 0.91 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 110.165 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . 0.477 ' NH1' HD13 ' B' ' 67' ' ' LEU . 15.5 ttm-85 -97.08 -22.52 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.48 -38.04 82.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.52 -48.82 65.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 23.9 mm -52.79 -41.64 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.628 ' CZ ' ' CG1' ' B' ' 64' ' ' VAL . 3.8 m-85 -70.51 -28.15 64.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -45.53 21.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.472 ' CB ' HD22 ' B' ' 204' ' ' LEU . . . -56.21 -35.16 67.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.354 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.441 ' HA ' HG21 ' B' ' 230' ' ' ILE . 21.5 t80 -72.47 -49.69 31.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -18.63 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.29 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.16 -28.41 17.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 110.079 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.441 HG21 ' HA ' ' B' ' 227' ' ' PHE . 7.4 tp -99.59 -16.32 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 110.161 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.595 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 3.9 t80 -55.92 -43.25 99.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.9 Cg_endo -74.21 -31.24 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.449 1.237 . . . . 0.0 110.255 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.43 HG11 HD23 ' B' ' 175' ' ' LEU . 8.8 t -67.36 -43.84 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.707 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.462 HD21 HG22 ' B' ' 170' ' ' ILE . 71.2 mt -58.46 -44.24 89.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.967 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' SER . . . . . 0.42 ' HA ' ' CZ ' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -67.71 -28.02 67.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.151 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -74.31 -24.41 59.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.113 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.538 ' CG ' HD21 ' B' ' 175' ' ' LEU . 86.8 m-85 -125.12 45.57 2.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -63.26 -162.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -42.45 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 110.145 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.216 179.871 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.18 0.514 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.97 -171.69 12.99 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.4 p -133.95 23.1 3.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.101 . . . . 0.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 14' ' ' ILE . 29.0 mm -108.87 49.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 110.272 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.95 -158.13 17.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.53 -71.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -1.174 . . . . 0.0 110.374 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . -137.44 -52.49 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 HD21 ' CD2' ' B' ' 99' ' ' PHE . 0.1 OUTLIER -114.58 160.95 18.69 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.362 -1.081 . . . . 0.0 109.281 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.526 ' N ' HD13 ' A' ' 18' ' ' LEU . 55.6 t0 -90.01 89.26 7.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 111.018 -178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.61 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 2.4 mt -87.93 -5.4 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.042 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.52 ' N ' HD21 ' A' ' 68' ' ' LEU . 96.0 m -39.38 -38.85 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.292 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -91.59 -32.34 8.74 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.618 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -51.25 -44.28 30.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.198 -1.178 . . . . 0.0 109.46 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.523 ' HG ' ' N ' ' A' ' 25' ' ' PHE . 1.6 pp -83.02 -25.98 31.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.892 -1.13 . . . . 0.0 109.417 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.523 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 1.9 t80 -87.22 0.4 55.42 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.723 0.773 . . . . 0.0 109.101 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 150.1 98.68 0.19 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 8.3 p-10 -21.99 119.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.095 0.95 . . . . 0.0 112.849 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.693 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -130.21 165.47 30.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.535 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.557 ' N ' HG12 ' A' ' 28' ' ' ILE . 77.2 m-20 -86.18 125.95 33.89 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.545 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -39.47 -24.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 -178.484 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 29' ' ' ASP . 65.0 mt-10 -64.61 -4.91 4.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.018 . . . . 0.0 111.142 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.55 38.07 4.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.8 tpp180 -126.54 130.08 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -1.142 . . . . 0.0 109.511 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.693 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -89.01 158.69 17.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.589 -1.32 . . . . 0.0 111.429 -179.046 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.52 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -87.37 108.55 19.04 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.611 0.72 . . . . 0.0 111.504 -178.583 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' ASP . 14.0 mt-30 -91.0 -12.98 34.2 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 36' ' ' GLN . 2.8 m-20 65.65 -60.1 0.28 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.759 -0.588 . . . . 0.0 110.155 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 33.8 p-10 -147.45 143.92 28.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 109.89 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -72.1 142.88 49.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -0.945 . . . . 0.0 110.406 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -103.98 121.88 7.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 -36.47 11.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -1.168 . . . . 0.0 110.501 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.27 60.41 0.42 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 54.08 98.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -1.124 . . . . 0.0 110.148 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.58 -114.05 0.25 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 155.27 -37.07 0.64 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.1 p -82.14 68.41 8.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -1.087 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.93 117.29 0.59 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -47.2 156.78 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.182 . . . . 0.0 110.239 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -90.73 -154.1 0.33 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 28.91 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -95.45 -32.93 12.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 0.0 108.631 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.514 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 1.7 mt -88.87 -34.62 16.93 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.08 -49.51 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.38 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.0 -29.53 68.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.593 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' OD1' ' HD2' ' B' ' 191' ' ' PRO . 20.8 m-80 -76.28 -41.06 50.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.613 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.548 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 45.7 mt -49.96 -47.08 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.58 0.52 60.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.51 -41.73 3.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.536 ' CD1' ' O ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -86.57 36.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.13 -0.981 . . . . 0.0 110.458 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -80.21 17.12 1.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.112 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.99 11.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 62' ' ' LEU . 3.5 mt -90.32 -26.07 20.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.744 -1.223 . . . . 0.0 109.47 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.54 -38.71 0.04 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.7 mm? -62.93 -12.14 23.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 110.537 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -48.03 -41.1 24.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.981 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -42.75 76.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.484 ' O ' HD21 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -81.86 -1.92 49.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.995 179.739 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.52 HD21 ' N ' ' A' ' 21' ' ' THR . 2.8 tm? -82.29 -47.2 12.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.413 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -90.26 0.28 57.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 110.176 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.445 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 3.1 tt0 -90.9 15.85 10.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.322 -0.861 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.577 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 45.0 t -145.67 5.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.328 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.636 HD13 ' CE2' ' B' ' 116' ' ' PHE . 4.0 tp -150.52 77.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.881 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.6 t70 -84.29 49.3 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.016 -1.053 . . . . 0.0 108.523 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.623 ' HB2' ' CE1' ' B' ' 99' ' ' PHE . 0.1 OUTLIER -74.91 47.29 0.33 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.319 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -148.17 41.13 0.98 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.989 -1.07 . . . . 0.0 110.129 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.96 24.63 2.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.397 -0.815 . . . . 0.0 109.956 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.115 -179.99 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.187 0.518 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.16 -53.85 0.07 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.402 HD13 ' OH ' ' B' ' 231' ' ' TYR . 2.5 mt -123.44 88.9 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -1.129 . . . . 0.0 110.407 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.531 ' CG1' ' HD2' ' B' ' 65' ' ' PRO . 15.5 t -57.9 145.51 71.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.006 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.531 ' HD2' ' CG1' ' B' ' 64' ' ' VAL . 44.1 Cg_endo -71.69 138.43 31.94 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.806 1.424 . . . . 0.0 110.377 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.454 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 72.8 m -105.17 135.19 46.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -75.03 122.04 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.91 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -113.38 -3.66 13.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.649 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.4 142.47 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 110.574 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.511 ' CD1' HG22 ' B' ' 160' ' ' ILE . 13.3 mm -126.99 161.16 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.355 -0.841 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' B' ' 158' ' ' GLN . 47.8 t -141.74 121.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.126 -0.984 . . . . 0.0 110.233 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' B' ' 157' ' ' ILE . . . -134.9 168.5 18.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 73' ' ' THR . . . . . 0.436 HG21 HG21 ' B' ' 122' ' ' VAL . 0.2 OUTLIER -124.71 153.5 42.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.461 HG11 ' N ' ' B' ' 75' ' ' THR . 53.2 t -143.91 155.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 110.303 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.461 ' N ' HG11 ' B' ' 74' ' ' VAL . 9.1 m -124.72 133.13 53.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' B' ' 150' ' ' ALA . 67.6 mt -87.56 -65.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.88 -20.83 2.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 40.6 m -135.18 143.78 46.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.247 . . . . 0.0 110.471 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 7.3 ptm85 -59.54 163.37 4.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.913 . . . . 0.0 109.816 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.446 HD12 ' CD1' ' B' ' 76' ' ' LEU . 25.6 mt -131.43 153.6 49.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 42.3 t0 -89.64 89.02 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' B' ' 101' ' ' ALA . 15.1 mt -38.52 -36.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 110.666 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -66.18 -42.51 88.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.44 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.49 HG23 ' CE2' ' B' ' 148' ' ' PHE . 16.0 m -79.34 -25.73 42.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.159 -0.963 . . . . 0.0 110.543 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.53 HG21 ' CE2' ' B' ' 148' ' ' PHE . 22.9 t -75.26 -40.39 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.13 -21.19 43.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.1 tp -88.9 -18.49 27.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -100.03 -41.13 7.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 110.362 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.421 ' HB2' ' HB1' ' B' ' 92' ' ' ALA . . . -64.48 140.42 58.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.855 . . . . 0.0 110.2 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -77.55 -14.43 59.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.096 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -137.7 79.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 110.138 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -162.02 154.0 19.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.286 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -143.34 155.63 44.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -119.3 135.74 54.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.83 101.57 3.43 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.178 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.87 -16.19 26.2 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.044 1.549 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -72.66 -6.58 45.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.95 -65.72 1.04 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 110.377 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.673 ' CZ ' ' CB ' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -146.86 133.18 19.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.365 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.478 ' N ' ' CD1' ' B' ' 99' ' ' PHE . . . -60.62 57.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.989 -177.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.673 ' CB ' ' CZ ' ' B' ' 99' ' ' PHE . . . -152.48 169.02 23.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.872 -1.142 . . . . 0.0 111.159 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.447 HG22 HD21 ' B' ' 82' ' ' LEU . 17.2 t -102.23 130.39 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.609 -0.682 . . . . 0.0 109.303 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.4 mp -89.3 118.29 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 110.2 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 27.2 ttm -104.16 164.62 11.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 110.236 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.508 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 9.0 ptm180 -156.03 122.41 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.555 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 10.4 pt -108.68 151.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.509 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 23.77 8.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 109.931 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.0 OUTLIER -175.9 94.92 0.26 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.88 . . . . 0.0 110.114 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.449 ' HD2' ' CD1' ' B' ' 106' ' ' ILE . 46.4 Cg_endo -72.8 162.22 91.72 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.546 0.146 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.402 ' C ' ' CG2' ' B' ' 111' ' ' THR . 6.6 tppt? -71.5 89.83 0.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 109.918 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' B' ' 124' ' ' THR . 21.9 p -145.32 -179.83 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.293 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 27' ' ' ASN . 6.1 t -133.69 176.06 8.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -170.5 177.58 3.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.04 . . . . 0.0 111.049 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.585 HD11 ' CE1' ' B' ' 116' ' ' PHE . 0.3 OUTLIER -145.7 123.44 11.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.432 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' B' ' 101' ' ' ALA . 18.0 mt -94.04 134.55 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.935 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.636 ' CE2' HD13 ' A' ' 72' ' ' ILE . 8.3 m-85 -87.41 134.21 33.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.611 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' B' ' 82' ' ' LEU . . . -52.24 -19.69 2.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 55.0 m -79.41 -29.6 42.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.256 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.09 -31.28 2.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.42 163.3 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.225 -1.162 . . . . 0.0 110.135 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.433 ' HE2' HG13 ' B' ' 74' ' ' VAL . 8.1 tmm? -160.89 128.18 4.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 71' ' ' VAL . 22.6 t -107.94 154.64 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.417 ' CG2' ' SD ' ' B' ' 121' ' ' MET . 25.7 t -146.37 131.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.469 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.528 HG21 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -139.04 167.01 23.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.337 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.578 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 117.36 -37.48 3.31 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -53.52 173.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -1.086 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.448 ' HA ' HG12 ' B' ' 70' ' ' ILE . 8.5 mtmm -135.34 5.8 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -147.23 163.18 37.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . 0.521 ' HG2' ' CD1' ' B' ' 157' ' ' ILE . 3.8 mt-10 -57.73 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.173 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.92 -36.17 11.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.847 . . . . 0.0 110.345 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' B' ' 128' ' ' SER . 9.3 t0 -53.89 -49.57 68.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.128 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 57.0 m -56.23 -42.04 76.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' B' ' 137' ' ' ARG . 3.7 mttt -53.86 -38.43 64.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 1.4 mt -66.25 -41.1 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.133 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.59 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.409 ' HA ' HG23 ' B' ' 123' ' ' VAL . 0.3 OUTLIER -60.38 -51.53 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.962 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' B' ' 133' ' ' LYS . 0.2 OUTLIER -53.41 -37.43 62.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.924 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' B' ' 134' ' ' LEU . 4.8 mmtt -68.15 -50.78 52.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.898 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.555 ' CZ ' HG12 ' B' ' 106' ' ' ILE . 28.2 m-85 -52.75 -54.18 37.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.941 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.63 58.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.49 -46.25 55.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 57.0 mt -51.69 -41.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.475 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 23.5 mm -64.37 -49.95 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.531 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.75 -31.45 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.376 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 2.7 tmtt? -74.23 -21.17 59.91 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.467 HG23 ' CD2' ' B' ' 148' ' ' PHE . 5.4 mt -84.58 -17.13 10.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.97 -21.88 9.33 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.53 ' CE2' HG21 ' B' ' 85' ' ' VAL . 15.3 m-85 -53.94 174.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 110.958 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.65 36.56 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.515 -0.74 . . . . 0.0 110.193 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' B' ' 76' ' ' LEU . . . -71.06 144.47 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.467 ' O ' ' OG1' ' B' ' 153' ' ' THR . 4.2 tttp -128.74 104.52 7.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.452 ' O ' HG21 ' B' ' 153' ' ' THR . 54.9 t80 -53.41 102.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 110.319 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.6 OUTLIER -154.09 172.09 18.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.164 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.0 33.61 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -72.35 138.22 47.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -161.74 136.14 6.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.521 ' CD1' ' HG2' ' B' ' 129' ' ' GLU . 37.2 mt -80.23 140.77 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.853 . . . . 0.0 110.139 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.439 ' HB2' HG13 ' B' ' 71' ' ' VAL . 25.6 mm-40 -92.77 -61.76 1.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.425 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -145.75 168.77 19.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.511 HG22 ' CD1' ' B' ' 70' ' ' ILE . 67.1 mt -119.54 144.4 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 24' ' ' LEU . 12.4 t -112.0 121.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -132.64 172.28 21.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 28.3 t -166.1 161.16 16.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.173 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.428 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 29.5 p -167.88 139.5 2.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -92.69 161.69 14.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.1 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.489 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.0 OUTLIER -110.94 -81.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.182 -0.948 . . . . 0.0 110.198 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 6.1 mtpt 170.01 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 0.0 110.407 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' B' ' 168' ' ' PHE . 10.5 p90 -129.56 155.99 79.37 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.201 -0.937 . . . . 0.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.445 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 44.6 Cg_endo -71.45 161.27 46.07 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.859 1.452 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.477 HG21 ' N ' ' B' ' 171' ' ' ARG . 1.7 mp -126.93 149.67 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.154 -0.967 . . . . 0.0 110.663 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.477 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.2 OUTLIER -86.46 110.59 19.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.848 179.591 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' B' ' 193' ' ' LEU . 11.9 mt -65.61 -32.21 73.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 110.612 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.13 -28.96 67.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 110.175 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.79 65.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -45.46 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 110.227 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.53 -13.63 62.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -90.31 -32.45 16.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 178' ' ' SER . . . . . 0.508 ' OG ' ' ND1' ' B' ' 179' ' ' HIS . 37.6 p -98.27 -30.53 12.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.907 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.508 ' ND1' ' OG ' ' B' ' 178' ' ' SER . 76.1 m80 -123.94 44.38 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -65.34 -27.68 72.72 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 181' ' ' THR . . . . . 0.4 HG21 ' N ' ' B' ' 182' ' ' PHE . 2.2 t -54.16 -26.22 26.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.151 . . . . 0.0 110.221 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.565 ' CE2' ' CG2' ' B' ' 198' ' ' VAL . 31.4 m-85 -136.17 8.77 3.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.895 . . . . 0.0 110.196 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' B' ' 179' ' ' HIS . 22.9 t -110.96 120.72 43.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.969 . . . . 0.0 110.632 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 40.2 t -111.55 103.98 12.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.53 105.9 15.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' B' ' 190' ' ' PHE . 1.6 mm-40 -113.62 99.19 49.23 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.946 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.19 -4.66 15.35 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.052 1.554 . . . . 0.0 110.49 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.13 -13.02 19.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.952 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.493 ' O ' ' CG ' ' B' ' 189' ' ' LEU . 2.4 tt -146.43 11.2 1.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 110.263 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.617 ' CE2' ' CG1' ' B' ' 194' ' ' ILE . 2.2 t80 -166.2 112.6 0.74 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . 0.471 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.7 Cg_endo -74.43 -26.89 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.898 1.472 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.99 178.28 37.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' B' ' 172' ' ' LEU . 8.3 tt -110.6 132.82 53.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -1.103 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.617 ' CG1' ' CE2' ' B' ' 190' ' ' PHE . 93.8 mt -100.46 118.39 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -120.85 128.95 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -108.42 89.38 2.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.152 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.444 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 32.9 ttm -50.74 141.13 13.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.075 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.565 ' CG2' ' CE2' ' B' ' 182' ' ' PHE . 31.3 t -71.35 -59.27 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -127.13 117.18 21.84 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.952 . . . . 0.0 110.304 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.08 156.46 99.72 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.92 -2.117 . . . . 0.0 110.277 -0.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' B' ' 198' ' ' VAL . 0.6 OUTLIER -69.8 85.43 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.978 . . . . 0.0 110.106 179.848 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.471 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 25.3 mm -130.27 163.07 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 12.6 t -109.57 120.38 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.281 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' B' ' 204' ' ' LEU . 4.5 mp -114.76 124.49 51.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.161 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.522 HD12 ' CE2' ' A' ' 25' ' ' PHE . 1.8 mt -102.63 148.67 25.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' B' ' 211' ' ' LYS . 4.1 mp -139.56 127.16 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.327 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.441 ' N ' ' CD1' ' B' ' 207' ' ' PHE . 26.0 m-85 -105.13 155.61 18.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.445 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 72.6 t -51.33 -24.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 0.0 110.306 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -24.32 62.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 110.421 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 107.54 24.92 6.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.0 OUTLIER -91.15 126.18 36.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -1.114 . . . . 0.0 110.204 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' B' ' 163' ' ' SER . 23.8 mm -114.37 116.17 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.507 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 29.0 t -107.61 143.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.063 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.479 ' N ' HD13 ' B' ' 214' ' ' LEU . 3.1 mp -135.58 112.36 10.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 13.2 t -135.95 153.68 51.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.15 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.05 -5.59 34.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.525 ' CB ' HG12 ' B' ' 223' ' ' ILE . . . -81.99 127.47 33.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -1.194 . . . . 0.0 110.051 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -71.19 -38.61 72.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 110.432 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.423 ' CA ' HD13 ' B' ' 160' ' ' ILE . 3.7 mt-30 -117.69 -173.01 2.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.274 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . 0.55 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 35.5 ttp180 -88.48 -24.66 22.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.277 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 3.4 pt-20 -63.96 -22.47 66.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.21 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.492 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 33.2 mt-10 -76.39 -53.75 7.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 110.07 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.525 HG12 ' CB ' ' B' ' 217' ' ' ALA . 27.8 mm -56.59 -37.7 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 110.035 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.55 ' CE1' ' HG2' ' B' ' 220' ' ' ARG . 5.5 m-85 -66.11 -40.54 90.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 110.134 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.434 ' O ' ' HB1' ' B' ' 229' ' ' ALA . 7.2 tt0 -80.02 -22.48 42.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.872 . . . . 0.0 110.087 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.444 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -67.68 -47.49 69.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.46 ' HA ' ' CG2' ' B' ' 230' ' ' ILE . 19.6 t80 -76.92 -34.21 57.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' B' ' 224' ' ' TYR . 35.9 mm-40 -65.68 -18.48 65.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.213 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' B' ' 225' ' ' GLN . . . -97.04 -25.91 15.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.065 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.46 ' CG2' ' HA ' ' B' ' 227' ' ' PHE . 2.9 tp -96.21 -11.3 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.05 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.578 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 2.4 t80 -53.89 -44.03 97.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.72 -43.74 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.468 1.246 . . . . 0.0 110.68 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 30.5 t -56.92 -36.51 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.428 ' CD2' HG22 ' B' ' 206' ' ' ILE . 20.2 mt -63.44 -62.13 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 43.1 m -53.79 -20.31 5.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.512 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -67.69 -40.25 84.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.452 -0.78 . . . . 0.0 110.044 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -116.14 41.68 2.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 110.516 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -168.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.145 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -141.35 -41.38 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 30.2 mtp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.18 179.852 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.255 0.55 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.04 -133.38 10.6 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 p -138.04 -179.51 5.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -1.113 . . . . 0.0 110.273 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.0 tt -117.23 28.32 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 110.032 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.42 47.3 1.03 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.525 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 2.2 t-20 -138.34 166.77 23.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -1.16 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 74' ' ' LEU . . . 95.33 159.11 32.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.605 ' CD1' ' CB ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -80.18 165.27 22.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -1.108 . . . . 0.0 109.534 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.471 ' O ' HD21 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -100.55 128.07 46.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.764 -179.481 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.579 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 43.4 mt -123.92 22.69 8.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.54 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.589 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 6.4 m -43.7 -37.41 2.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.49 -32.02 5.89 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.666 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -46.62 -41.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.392 -1.064 . . . . 0.0 108.644 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.492 ' CD2' ' HG2' ' A' ' 67' ' ' MET . 3.1 pp -84.29 -26.22 28.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.033 -1.042 . . . . 0.0 108.539 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.447 ' HB3' ' HA2' ' A' ' 22' ' ' GLY . 1.7 t80 -85.85 7.03 25.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.535 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 142.23 99.66 0.35 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 6.4 p-10 -20.84 115.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.912 0.863 . . . . 0.0 112.357 -178.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -136.42 158.81 38.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.568 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.533 ' N ' HG12 ' A' ' 28' ' ' ILE . 4.4 m-20 -88.12 123.57 32.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.605 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . 17.3 p -39.41 -26.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.588 -0.695 . . . . 0.0 110.145 -178.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.0 mt-10 -55.9 -14.32 2.38 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.65 26.56 6.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 28' ' ' ILE . 11.7 mmt-85 -116.55 123.88 48.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -1.149 . . . . 0.0 109.501 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.673 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.39 160.95 16.56 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 111.163 -178.954 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.513 HD21 ' N ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -88.15 116.14 26.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 0.0 111.272 -178.78 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -88.94 6.42 39.52 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 38' ' ' ASP . 8.9 t70 50.16 20.25 0.6 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.759 -0.588 . . . . 0.0 110.485 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' ASP . 0.7 OUTLIER 42.78 39.26 1.62 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -105.89 176.06 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.324 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.86 98.54 1.74 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 143.26 36.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -1.148 . . . . 0.0 110.263 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.53 -112.97 5.44 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -94.77 -164.41 1.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 110.269 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.49 -172.79 41.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.71 -45.25 0.26 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -79.44 101.49 8.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -1.113 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.14 -74.5 0.29 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -63.24 148.79 47.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -1.138 . . . . 0.0 110.372 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -175.14 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 110.315 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.63 21.02 7.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.294 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.65 -20.31 15.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.107 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 3.5 mt -96.31 -43.78 7.53 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.702 . . . . 0.0 110.303 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.6 -52.96 34.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.577 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.13 -27.24 67.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.429 -0.794 . . . . 0.0 109.559 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.568 ' OD1' ' CD1' ' B' ' 190' ' ' PHE . 1.6 m-80 -77.8 -31.62 51.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.195 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -56.81 -47.41 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.386 -0.821 . . . . 0.0 109.195 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.54 -25.95 14.75 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.03 25.63 7.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -1.114 . . . . 0.0 110.136 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' B' ' 190' ' ' PHE . 2.6 mt -82.08 -21.2 36.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.891 . . . . 0.0 110.069 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.454 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.41 40.36 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 110.548 -179.817 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -132.81 -4.61 3.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.957 . . . . 0.0 110.521 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.626 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -129.39 -2.96 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 111.331 -179.752 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.506 ' N ' HD23 ' A' ' 62' ' ' LEU . . . 168.8 -55.43 0.21 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 4.0 mm? -42.92 -24.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -1.205 . . . . 0.0 110.933 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t70 -44.05 -41.96 5.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 109.716 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.9 m -67.23 -51.19 56.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.435 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.492 ' HG2' ' CD2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -71.12 -4.47 25.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 178.86 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 21' ' ' THR . 1.8 tm? -72.32 -62.09 1.56 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.858 0.837 . . . . 0.0 109.032 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.7 0.69 12.18 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.24 0.543 . . . . 0.0 110.298 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 37.3 tt0 -84.36 8.12 17.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 111.196 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.575 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 6.0 t -140.69 2.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.121 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.579 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 3.1 tp -151.01 81.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.78 . . . . 0.0 109.232 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 8.6 t0 -83.98 49.78 1.7 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.095 -1.003 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.638 ' CD1' ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt -101.82 62.32 0.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.343 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' A' ' 16' ' ' ASN . 11.5 mtmt -112.94 -173.01 2.16 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 110.321 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 5.8 mt-10 58.61 -79.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.435 -0.79 . . . . 0.0 110.458 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.32 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.201 0.524 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -164.1 25.18 0.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' B' ' 64' ' ' VAL . 1.3 mp -130.13 -48.78 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -1.183 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' B' ' 63' ' ' ILE . 90.3 t 58.61 125.13 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 110.583 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.7 Cg_endo -74.43 144.05 31.93 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.825 1.434 . . . . 0.0 110.589 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -107.19 129.76 54.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.493 HD21 ' CG2' ' B' ' 160' ' ' ILE . 73.4 mt -69.66 127.1 31.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' B' ' 68' ' ' GLN . 5.6 mm-40 -106.25 -20.28 13.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' B' ' 161' ' ' VAL . 7.3 m120 -161.42 137.02 7.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.074 -1.016 . . . . 0.0 110.567 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' B' ' 124' ' ' THR . 13.1 mm -115.73 148.39 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.492 HG21 ' CB ' ' B' ' 124' ' ' THR . 27.6 t -137.89 129.18 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.505 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.58 155.55 46.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 65.0 p -111.34 139.26 46.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.182 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.565 HG12 ' CE1' ' B' ' 152' ' ' PHE . 22.6 t -123.9 148.78 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.837 . . . . 0.0 110.13 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.438 ' OG1' ' HB3' ' B' ' 154' ' ' ASP . 4.7 m -119.06 127.52 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.487 ' CD2' ' HB3' ' B' ' 150' ' ' ALA . 70.2 mt -92.02 -42.94 9.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.004 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.72 68.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 52.9 m -132.84 151.14 52.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -1.198 . . . . 0.0 110.365 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 39.2 mtp-105 -79.32 155.2 28.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 110.075 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 18.7 mt -127.74 161.0 29.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.27 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.454 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 8.6 m-20 -94.63 82.11 3.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.81 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' B' ' 101' ' ' ALA . 92.6 mt -42.01 -27.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.241 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' B' ' 81' ' ' ASP . 18.9 mmmt -67.01 -44.99 78.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 10.9 p -85.41 -38.5 18.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.871 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.495 HG21 ' CE2' ' B' ' 148' ' ' PHE . 43.3 t -52.36 -44.61 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.416 ' HB3' HG23 ' B' ' 102' ' ' VAL . . . -77.81 -30.36 51.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' B' ' 87' ' ' LEU . 14.1 tp -80.53 -18.9 47.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' B' ' 84' ' ' THR . 1.2 m-70 -99.91 -32.87 10.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.338 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 150.48 45.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -87.15 -26.13 23.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' B' ' 104' ' ' MET . 90.6 m-20 -127.74 78.82 1.85 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.532 ' HB3' ' CG1' ' B' ' 102' ' ' VAL . . . -145.49 158.35 43.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 110.136 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.07 141.12 44.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.67 109.31 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 110.095 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . 0.413 ' OD1' ' NH1' ' B' ' 98' ' ' ARG . 2.6 t-20 -129.35 128.31 23.19 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.83 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -16.16 31.79 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.842 1.443 . . . . 0.0 110.186 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.513 ' HE2' ' NH2' ' B' ' 98' ' ' ARG . 7.3 tttt -86.32 -16.92 35.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.86 . . . . 0.0 110.066 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.513 ' NH2' ' HE2' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -92.21 -67.0 0.88 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.486 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.668 ' CE2' ' CB ' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.08 161.67 8.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.288 -0.883 . . . . 0.0 111.225 -179.389 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.83 54.06 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.532 -0.73 . . . . 0.0 111.677 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.668 ' CB ' ' CE2' ' B' ' 99' ' ' PHE . . . -161.85 173.27 14.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.941 -1.099 . . . . 0.0 110.258 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.532 ' CG1' ' HB3' ' B' ' 92' ' ' ALA . 38.0 t -108.06 155.82 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.477 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 16.1 mt -113.51 110.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.504 ' HE2' ' CD1' ' B' ' 115' ' ' ILE . 12.0 ttm -94.19 151.07 19.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.624 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -149.56 120.88 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 109' ' ' PRO . 25.1 pt -107.57 156.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.116 -0.99 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -106.88 37.81 2.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.847 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.63 82.19 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.592 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.459 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.0 Cg_endo -80.64 161.49 83.41 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.801 -2.166 . . . . 0.0 110.472 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -64.24 104.74 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 109.995 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.427 HG22 ' O ' ' B' ' 109' ' ' PRO . 30.5 p -146.63 166.1 27.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.66 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' B' ' 113' ' ' ALA . 1.8 m -112.52 164.8 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -167.2 146.07 5.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.524 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.578 HD13 ' CZ ' ' B' ' 116' ' ' PHE . 0.2 OUTLIER -124.28 119.4 29.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.726 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.504 ' CD1' ' HE2' ' B' ' 104' ' ' MET . 78.6 mt -95.41 131.46 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.638 ' CD1' ' CD1' ' A' ' 74' ' ' LEU . 8.5 m-30 -90.13 155.19 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.99 -11.61 61.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 110.152 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 3.9 m -85.7 -40.48 16.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.27 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 148.06 -34.79 1.2 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -67.8 150.19 48.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -1.218 . . . . 0.0 110.508 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.466 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -150.14 159.3 44.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.534 HG12 ' CG1' ' A' ' 71' ' ' VAL . 99.0 t -124.51 137.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 88.6 t -121.89 140.95 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.868 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.533 HG21 ' CB ' ' A' ' 27' ' ' ASN . 3.9 t -145.55 160.83 41.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.444 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.577 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 114.32 -35.26 4.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' B' ' 131' ' ' ASP . . . -42.42 147.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -1.191 . . . . 0.0 110.083 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . 0.47 ' HB2' ' OD2' ' B' ' 131' ' ' ASP . 13.1 mmtt -96.11 0.74 51.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.63 -165.19 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.39 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.13 -40.38 74.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.04 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -44.64 92.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.47 ' OD2' ' HB2' ' B' ' 127' ' ' LYS . 8.8 m-20 -56.31 -53.51 56.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 0.0 109.964 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.427 ' HB3' HG23 ' B' ' 70' ' ' ILE . 1.5 p -57.81 -32.5 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.848 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . 0.438 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -67.69 -44.69 77.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 109.999 179.691 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -59.73 2.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.043 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.13 3.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.025 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' B' ' 152' ' ' PHE . 18.4 m -65.98 -58.69 4.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.138 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -46.2 -44.03 15.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.004 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -53.29 -47.12 69.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.452 ' CE2' ' HB1' ' B' ' 113' ' ' ALA . 31.7 m-85 -65.62 -55.05 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 0.0 109.912 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -17.66 8.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -47.02 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 42.0 mt -52.74 -38.06 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.535 ' CG2' ' HB1' ' B' ' 150' ' ' ALA . 34.0 mm -71.7 -55.63 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.098 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.26 -27.3 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.942 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -75.54 -21.71 57.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.94 . . . . 0.0 108.613 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.449 HG22 HD11 ' B' ' 146' ' ' ILE . 5.7 mt -86.17 -21.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.27 -18.86 6.86 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.495 ' CE2' HG21 ' B' ' 85' ' ' VAL . 11.0 m-85 -53.84 165.98 0.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.286 . . . . 0.0 110.882 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.56 23.8 13.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.552 -0.717 . . . . 0.0 109.823 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.535 ' HB1' ' CG2' ' B' ' 143' ' ' ILE . . . -54.94 148.3 13.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.83 . . . . 0.0 110.552 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -123.35 114.77 20.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 110.04 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.565 ' CE1' HG12 ' B' ' 74' ' ' VAL . 36.2 t80 -69.89 90.9 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 1.4 p -145.6 171.89 14.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.438 ' HB3' ' OG1' ' B' ' 75' ' ' THR . 1.1 t0 63.21 29.79 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.438 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.9 t80 -77.36 136.73 38.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.88 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 134.17 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.404 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.68 121.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.862 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -119.68 -4.33 10.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.452 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 3.3 m120 -138.29 115.3 10.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.0 . . . . 0.0 110.616 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.493 ' CG2' HD21 ' B' ' 67' ' ' LEU . 68.9 mt -122.65 125.58 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 24' ' ' LEU . 26.0 t -100.26 130.75 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.524 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.05 169.86 24.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 2.3 m -162.89 164.53 25.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -1.147 . . . . 0.0 110.119 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.488 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.6 p -170.34 166.93 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 0.0 110.607 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.67 137.45 50.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 109.74 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.575 HG22 ' CE1' ' B' ' 168' ' ' PHE . 20.9 m -89.71 12.07 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.423 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.1 OUTLIER 70.82 3.63 4.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.281 -0.887 . . . . 0.0 110.711 179.662 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.575 ' CE1' HG22 ' B' ' 166' ' ' VAL . 8.1 p90 -162.58 150.98 12.13 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.386 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.468 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 45.1 Cg_endo -71.84 165.66 31.87 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.998 1.525 . . . . 0.0 110.512 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.449 HD13 HG23 ' B' ' 166' ' ' VAL . 3.7 mt -133.25 158.09 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.934 . . . . 0.0 110.79 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.453 ' HD3' ' HG3' ' B' ' 173' ' ' GLU . 3.4 ttm180 -89.3 98.81 11.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.685 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.66 -55.24 27.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.19 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . 0.453 ' HG3' ' HD3' ' B' ' 171' ' ' ARG . 15.4 pt-20 -54.02 -26.54 26.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.725 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.55 -37.14 53.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -44.58 64.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -1.166 . . . . 0.0 110.056 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -59.38 -38.3 80.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -65.5 -32.69 74.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -58.66 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' B' ' 183' ' ' SER . 37.3 m80 -101.74 30.38 4.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.343 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -60.1 -14.71 33.42 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -30.38 64.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -1.19 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' B' ' 198' ' ' VAL . 60.4 m-85 -119.77 0.68 10.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' B' ' 179' ' ' HIS . 0.1 OUTLIER -120.59 174.07 6.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.074 179.873 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.29 152.98 35.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.265 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.411 ' HB2' HD13 ' B' ' 193' ' ' LEU . 75.0 t80 -148.75 100.94 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' B' ' 190' ' ' PHE . 23.5 mt-10 -101.31 103.5 27.0 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.936 . . . . 0.0 110.02 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.68 -6.32 18.89 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.938 1.493 . . . . 0.0 110.146 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -99.95 -2.92 33.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.71 -41.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 0.0 110.626 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.568 ' CD1' ' OD1' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -111.24 110.8 55.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 110.675 -179.524 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.46 -25.35 15.34 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.115 1.587 . . . . 0.0 110.07 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.492 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -95.64 -179.91 36.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' B' ' 205' ' ' LEU . 0.7 OUTLIER -113.22 140.62 47.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -1.163 . . . . 0.0 110.359 -179.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.519 HG12 ' CD2' ' B' ' 205' ' ' LEU . 67.9 mt -104.87 104.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -96.78 137.21 36.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.546 -179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -115.66 83.6 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.456 ' HE2' HD12 ' B' ' 204' ' ' LEU . 30.4 ttm -51.87 139.84 21.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' B' ' 182' ' ' PHE . 25.6 t -82.4 -42.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.216 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 9.7 tttp -140.41 114.51 7.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.893 . . . . 0.0 110.019 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.49 168.68 75.51 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.968 -2.097 . . . . 0.0 110.607 0.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.423 ' C ' HG12 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -72.69 87.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 0.0 110.005 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 19.1 mm -137.76 153.29 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 110.51 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.73 126.85 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.0 mp -116.55 136.82 52.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 110.277 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.519 ' CD2' HG12 ' B' ' 194' ' ' ILE . 1.2 mt -119.32 132.69 55.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.329 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.58 159.98 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.492 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 2.9 m-85 -135.75 147.74 48.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 37.9 t -45.87 -24.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -76.12 -22.65 55.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.438 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 107.24 4.31 35.4 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -77.84 141.43 39.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 110.139 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' B' ' 163' ' ' SER . 15.2 mm -124.53 142.14 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.102 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 11.1 t -124.24 151.9 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.199 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' B' ' 213' ' ' VAL . 3.1 mp -141.35 119.24 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 12.8 t -135.52 166.17 23.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 110.314 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.38 79.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.519 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -79.39 132.64 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -1.171 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' B' ' 218' ' ' LYS . 2.1 ttmt -79.24 -26.31 42.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.485 ' HB3' ' CG ' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -144.87 162.23 37.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.375 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -59.44 -26.56 65.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.806 . . . . 0.0 110.552 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.485 ' CG ' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -63.85 -27.55 69.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 -179.824 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.444 ' OE1' HD12 ' B' ' 202' ' ' ILE . 4.5 mt-10 -74.57 -42.27 59.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 109.879 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.416 HD11 HG22 ' B' ' 223' ' ' ILE . 32.0 mm -63.75 -40.35 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.37 -39.88 94.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.08 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -74.62 -31.45 62.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.444 ' HA ' ' SD ' ' B' ' 197' ' ' MET . . . -63.92 -38.3 90.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.856 . . . . 0.0 110.156 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.466 ' HA ' ' CG2' ' B' ' 230' ' ' ILE . 27.5 t80 -79.55 -42.32 25.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 110.221 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' B' ' 228' ' ' GLU . 0.3 OUTLIER -61.83 -17.04 54.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.972 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . 0.444 ' HB2' ' HE3' ' B' ' 197' ' ' MET . . . -96.06 -32.96 12.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.466 ' CG2' ' HA ' ' B' ' 227' ' ' PHE . 5.3 tp -89.59 -16.34 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.995 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.564 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.4 t80 -53.86 -43.39 96.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.379 -0.825 . . . . 0.0 111.083 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 46.1 Cg_endo -74.58 -36.87 2.64 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.356 1.188 . . . . 0.0 110.613 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 40.9 t -63.11 -40.72 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.869 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.436 HD13 HG22 ' B' ' 230' ' ' ILE . 26.3 mt -62.66 -48.81 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 110.233 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -42.54 84.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.988 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . 0.441 ' CA ' ' OE1' ' B' ' 236' ' ' GLU . 0.0 OUTLIER -61.73 -30.0 70.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 110.156 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -119.58 39.58 3.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.447 ' HG2' ' N ' ' B' ' 239' ' ' LYS . 7.1 tmm_? -69.75 148.49 49.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.235 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.447 ' N ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -91.7 -56.19 3.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.343 -179.895 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 36.5 ttm . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.253 -179.998 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.222 0.534 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' SER . . . 63.3 -117.83 12.21 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 12' ' ' GLY . 5.5 t 56.86 112.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -1.101 . . . . 0.0 110.191 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 14' ' ' ILE . 9.6 pt -105.88 48.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.13 -72.31 1.19 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -67.78 -162.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.17 -1.194 . . . . 0.0 110.11 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 64.63 147.6 0.04 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' CD1' ' HB2' ' A' ' 30' ' ' SER . 0.1 OUTLIER -111.18 166.88 10.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -1.196 . . . . 0.0 109.952 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.509 ' N ' HD13 ' A' ' 18' ' ' LEU . 5.6 p-10 -86.68 93.12 9.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 111.024 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.623 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 2.9 mt -99.21 2.62 45.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.317 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 42.3 m -42.33 -39.29 2.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -89.41 -35.25 8.08 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.614 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -51.19 -45.44 31.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.459 -1.024 . . . . 0.0 109.076 -179.49 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' CD2' ' HG2' ' A' ' 67' ' ' MET . 3.8 pp -82.88 -19.62 37.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 109.827 178.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -100.22 11.62 38.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.246 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.559 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 146.58 89.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.587 ' ND2' ' CD1' ' A' ' 35' ' ' LEU . 4.3 p30 -16.06 124.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.075 0.941 . . . . 0.0 112.506 -179.264 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.69 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -145.67 161.13 12.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.854 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.555 ' N ' HG12 ' A' ' 28' ' ' ILE . 68.9 m-20 -86.8 134.33 33.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.563 ' OG ' ' CE1' ' B' ' 99' ' ' PHE . 9.7 p -39.35 -27.36 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.598 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 10.3 tt0 -55.57 -15.41 2.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 178.275 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 31.26 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.526 ' O ' ' CA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.72 129.32 49.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.957 -1.32 . . . . 0.0 110.571 179.83 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.69 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.35 150.58 20.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.299 -0.876 . . . . 0.0 110.698 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.587 ' CD1' ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp -123.35 -178.79 4.1 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.522 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -122.48 136.79 54.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.425 -0.797 . . . . 0.0 110.357 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.517 ' OD1' ' ND2' ' A' ' 27' ' ' ASN . 10.3 m-20 -64.79 -40.28 94.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 110.227 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.8 152.02 16.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 110.076 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 19.6 t0 -117.0 -23.18 8.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 110.263 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.63 -158.25 2.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.55 21.13 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -1.118 . . . . 0.0 110.189 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.74 87.11 0.14 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.1 8.55 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -1.184 . . . . 0.0 110.357 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.93 8.08 14.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.97 48.81 7.43 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m -68.66 170.31 9.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 110.301 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' PHE . . . 106.99 124.61 5.27 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 47' ' ' GLY . 4.9 m-85 -43.8 151.69 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -1.108 . . . . 0.0 110.28 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -79.92 -159.39 0.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 110.255 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -98.48 31.77 2.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.403 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -22.8 14.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.192 -0.943 . . . . 0.0 108.833 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.528 HD23 ' CD1' ' B' ' 205' ' ' LEU . 4.0 mt -103.51 -40.06 6.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.591 -0.693 . . . . 0.0 110.435 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.75 -56.01 16.34 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.721 -179.16 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -64.88 -24.53 67.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.643 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 2.2 m-20 -80.04 -37.03 34.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.466 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 8.0 mt -53.71 -43.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.65 -22.46 46.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.6 p -127.21 17.83 7.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -1.117 . . . . 0.0 110.31 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 55' ' ' ASN . 4.8 mt -79.02 -11.47 60.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.53 38.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.537 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 24.8 ttpt -137.16 12.99 3.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.996 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.478 ' CD1' HG22 ' B' ' 194' ' ' ILE . 0.9 OUTLIER -136.96 -29.77 0.9 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 110.948 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.9 -44.35 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.112 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.8 mm? -44.83 -23.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -1.231 . . . . 0.0 110.793 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 64' ' ' LEU . 7.8 t0 -43.93 -41.65 5.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.022 . . . . 0.0 109.744 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.7 -45.82 74.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.428 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.439 ' HG2' ' CD2' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -72.22 -8.73 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.388 179.17 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.461 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 2.2 tm? -71.17 -60.89 1.99 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.948 0.88 . . . . 0.0 108.88 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -72.57 0.4 10.59 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.328 0.585 . . . . 0.0 110.14 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 44.8 tt0 -84.3 1.18 46.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -0.918 . . . . 0.0 111.171 -179.179 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.603 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 3.4 t -138.36 -2.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.128 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.623 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 4.4 tp -150.85 77.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.444 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.7 p-10 -78.57 55.35 1.62 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.962 -1.086 . . . . 0.0 108.851 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.586 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 8.7 mt -99.78 65.44 1.33 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.672 0.748 . . . . 0.0 110.668 -179.109 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -156.25 155.06 31.69 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.696 -0.628 . . . . 0.0 110.006 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 52.84 44.13 30.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 110.064 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.343 -179.977 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.46 ' HA ' ' OH ' ' B' ' 231' ' ' TYR . 3.7 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.305 0.574 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.29 37.96 0.09 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' B' ' 64' ' ' VAL . 1.5 mp -84.81 -25.23 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -1.188 . . . . 0.0 109.971 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.456 HG11 ' HD2' ' B' ' 65' ' ' PRO . 4.3 t 61.04 130.65 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 0.0 110.318 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.457 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 45.6 Cg_endo -74.03 137.44 24.1 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.973 1.512 . . . . 0.0 110.388 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -99.06 128.51 45.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 69.9 mt -70.42 114.6 8.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 110.121 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -102.82 -9.62 19.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.291 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.498 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 0.6 OUTLIER -168.27 157.86 9.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 -179.857 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 126' ' ' ALA . 8.1 mt -156.9 159.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.965 . . . . 0.0 109.853 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' B' ' 123' ' ' VAL . 50.7 t -139.47 143.02 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.442 ' N ' HG11 ' B' ' 71' ' ' VAL . . . -132.82 151.55 51.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 14.8 p -108.58 120.77 43.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.427 HG21 ' HA ' ' B' ' 155' ' ' PHE . 65.4 t -116.76 151.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.165 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 75' ' ' THR . . . . . 0.5 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 27.5 m -122.8 152.24 40.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.508 ' CD1' HD13 ' B' ' 80' ' ' LEU . 14.0 mt -105.14 -44.52 4.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.95 -11.22 34.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 176.35 8.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -1.124 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -93.73 160.95 14.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.508 HD13 ' CD1' ' B' ' 76' ' ' LEU . 13.5 mt -134.84 149.41 50.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.979 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.419 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 2.7 m-20 -95.45 100.44 12.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.423 ' O ' ' HB1' ' B' ' 86' ' ' ALA . 21.2 mt -50.66 -39.4 50.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.042 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -42.28 84.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 4.2 m -87.64 -44.24 11.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.025 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.564 HG21 ' CE2' ' B' ' 148' ' ' PHE . 19.8 t -53.72 -37.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.969 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' B' ' 82' ' ' LEU . . . -83.67 -28.95 27.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' B' ' 87' ' ' LEU . 1.9 tp -84.14 -23.63 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' B' ' 84' ' ' THR . 8.2 m80 -94.03 -32.49 13.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.489 ' CB ' ' HB1' ' B' ' 92' ' ' ALA . . . -64.02 139.41 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.044 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -73.47 -27.74 61.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.955 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.443 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 10.6 t-20 -134.69 79.48 1.8 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.489 ' HB1' ' CB ' ' B' ' 89' ' ' ALA . . . -149.38 154.72 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . 0.527 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 16.2 pt-20 -136.24 165.49 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -139.86 113.76 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.099 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -115.67 96.23 45.79 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.363 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -16.27 25.82 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.974 1.512 . . . . 0.0 110.412 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -3.94 44.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.424 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -126.54 -34.45 2.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.141 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.604 ' CE2' ' HB1' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.49 -171.59 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.402 -0.811 . . . . 0.0 110.842 -179.301 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.96 57.03 0.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 111.542 -178.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.604 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -147.84 155.82 42.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.959 -1.088 . . . . 0.0 110.775 179.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' B' ' 93' ' ' GLU . 73.0 t -97.79 126.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.919 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.527 ' HB ' ' CG ' ' B' ' 93' ' ' GLU . 20.0 mm -90.29 129.51 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.358 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 1.3 ttt -102.4 162.54 12.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.443 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 0.6 OUTLIER -154.36 124.3 6.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 110.601 -179.773 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.519 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 8.7 pt -129.06 155.62 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.631 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.4 OUTLIER -102.41 34.28 2.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.435 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.473 ' O ' ' CD ' ' B' ' 138' ' ' LYS . 1.0 OUTLIER -177.06 87.45 0.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.8 Cg_endo -79.08 149.31 83.84 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.21 -0.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 3.9 tttt -62.05 97.69 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.153 -0.967 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' B' ' 124' ' ' THR . 23.8 p -149.67 170.95 17.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 110.749 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.472 ' OG1' HD22 ' A' ' 35' ' ' LEU . 1.2 m -110.79 156.55 20.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 179.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' B' ' 139' ' ' TYR . . . -136.82 143.64 43.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 110.938 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.517 ' HB3' ' CE1' ' B' ' 116' ' ' PHE . 2.8 mm? -104.87 125.39 50.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.4 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.459 ' CD1' ' HG3' ' B' ' 121' ' ' MET . 31.4 mm -110.13 121.56 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 0.0 110.868 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' B' ' 114' ' ' LEU . 6.8 m-85 -106.24 128.43 53.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.301 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.25 -24.3 4.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.219 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.83 -26.47 3.81 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -71.61 149.96 45.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.459 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.9 OUTLIER -139.86 140.91 36.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.484 HG13 HG13 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -115.29 157.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.949 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 33.6 t -142.46 153.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.489 ' O ' ' HB ' ' B' ' 111' ' ' THR . 1.8 t -149.71 163.12 38.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.539 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 112.0 -30.42 7.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -56.0 147.62 19.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -1.07 . . . . 0.0 110.253 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -119.41 -22.08 7.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m -121.88 -141.32 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.814 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.91 -41.92 5.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 131' ' ' ASP . 6.4 p30 -72.07 -21.87 61.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.204 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 73.9 m-20 -70.95 -35.16 72.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 110.434 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 132' ' ' SER . . . . . 0.481 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 12.1 m -79.27 -32.59 43.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.278 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -74.82 -42.95 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 110.151 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' B' ' 130' ' ' ASP . 0.2 OUTLIER -64.12 -37.59 88.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.418 ' HB2' HG12 ' B' ' 123' ' ' VAL . . . -67.76 -60.79 2.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 2.8 m -51.08 -46.63 61.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -45.08 88.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.8 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.473 ' CD ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -58.93 -41.4 87.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.903 179.746 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.572 ' CZ ' ' HB1' ' B' ' 113' ' ' ALA . 37.5 m-85 -66.79 -55.45 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.985 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . 0.521 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -48.57 -33.77 10.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 8.3 mmt180 -64.73 -41.32 96.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 28.1 mt -54.63 -49.75 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.49 HG21 ' CB ' ' B' ' 148' ' ' PHE . 9.0 mt -69.25 -54.23 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' B' ' 140' ' ' ALA . 0.9 OUTLIER -59.56 -32.89 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.94 . . . . 0.0 109.925 179.719 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 0.6 OUTLIER -72.92 -27.24 61.75 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.069 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.474 HG23 ' CD2' ' B' ' 148' ' ' PHE . 2.6 mt -76.28 -15.71 15.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 117.17 -27.34 7.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.564 ' CE2' HG21 ' B' ' 85' ' ' VAL . 9.6 m-85 -41.99 154.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.258 . . . . 0.0 110.765 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.52 24.63 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.512 ' HB2' ' NE2' ' B' ' 144' ' ' GLN . . . -72.42 165.59 24.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.11 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -142.78 169.48 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.374 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.434 ' O ' ' CD1' ' B' ' 152' ' ' PHE . 60.6 t80 -101.1 91.47 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.161 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.5 p -153.52 176.6 11.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.259 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.5 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 20.5 t0 60.84 24.11 14.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.092 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 3.3 t80 -80.54 133.12 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -163.74 132.17 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 110.151 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.503 HG22 ' CG2' ' B' ' 70' ' ' ILE . 1.9 mp -79.96 109.4 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 109.917 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -103.47 -3.04 25.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 110.838 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.91 108.5 4.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.036 -1.04 . . . . 0.0 110.904 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.463 ' HA ' HG12 ' B' ' 70' ' ' ILE . 95.6 mt -113.21 120.03 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.177 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 3.5 t -95.37 140.37 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.637 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.45 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.75 177.04 20.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 163' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 73.7 m -166.05 140.6 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -1.178 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.457 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 8.9 p -170.23 136.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.95 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 59.2 p30 -103.41 179.81 4.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.024 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.519 HG22 ' CE2' ' B' ' 168' ' ' PHE . 0.2 OUTLIER -124.44 -86.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.213 -0.929 . . . . 0.0 110.3 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 173.97 33.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' B' ' 168' ' ' PHE . 11.8 p90 -166.32 149.32 6.41 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.64 145.49 46.83 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.098 1.578 . . . . 0.0 110.484 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.427 HD11 ' CG2' ' B' ' 206' ' ' ILE . 6.0 mt -112.2 142.62 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 0.0 110.514 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -82.1 92.83 6.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -0.834 . . . . 0.0 109.793 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.455 HD12 ' HA2' ' B' ' 192' ' ' GLY . 11.5 mt -51.23 -47.48 62.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.72 -50.12 74.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.937 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -49.79 -34.09 21.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' B' ' 179' ' ' HIS . 0.4 OUTLIER -71.32 -59.44 2.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 109.92 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.452 ' HA ' ' HA2' ' B' ' 180' ' ' GLY . . . -58.63 -19.49 39.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.07 -51.09 23.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.33 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 -32.72 11.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.463 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' B' ' 183' ' ' SER . 54.5 m80 -108.75 19.98 19.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' B' ' 176' ' ' ALA . . . -45.3 -51.6 9.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 55.5 m -62.09 -18.58 61.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -1.135 . . . . 0.0 109.931 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' B' ' 179' ' ' HIS . 1.4 m-85 -105.4 -10.5 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.058 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.478 ' N ' ' O ' ' B' ' 179' ' ' HIS . 13.9 p -154.07 154.96 34.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 184' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 0.5 OUTLIER -126.7 164.74 20.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 110.06 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.447 ' C ' ' CD1' ' B' ' 185' ' ' TYR . 1.7 t80 -164.1 86.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -92.11 110.04 41.57 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 110.135 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -7.18 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.9 1.474 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.34 -6.43 56.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.459 HD21 ' HB2' ' B' ' 190' ' ' PHE . 1.9 tt -146.97 -35.61 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.483 ' CD2' ' OD1' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -118.47 130.38 24.81 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.992 . . . . 0.0 110.609 -179.888 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.45 -42.09 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.949 1.499 . . . . 0.0 110.376 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.455 ' HA2' HD12 ' B' ' 172' ' ' LEU . . . -89.69 -179.55 44.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' B' ' 206' ' ' ILE . 0.9 OUTLIER -96.46 147.49 23.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -1.156 . . . . 0.0 110.297 -179.92 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.478 HG22 ' CD1' ' A' ' 62' ' ' LEU . 63.4 mt -109.82 104.93 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -97.58 128.66 44.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.474 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' B' ' 203' ' ' VAL . 12.2 ttt-85 -110.92 80.74 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.456 ' N ' ' O ' ' B' ' 202' ' ' ILE . 37.1 tpp -45.81 134.59 7.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 75.3 t -88.17 -34.72 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.359 -0.838 . . . . 0.0 109.975 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' B' ' 199' ' ' LYS . 0.1 OUTLIER -143.58 108.34 5.17 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 110.049 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.44 169.46 69.37 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.94 -2.109 . . . . 0.0 110.786 0.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.448 ' O ' HD11 ' B' ' 202' ' ' ILE . 5.6 mtmp? -75.22 81.56 2.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.34 -0.85 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 10.4 mm -130.41 148.22 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' B' ' 196' ' ' ARG . 10.5 t -108.42 137.46 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.019 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.581 ' N ' ' CD1' ' B' ' 204' ' ' LEU . 3.6 mp -131.51 151.82 51.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.925 . . . . 0.0 110.571 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.528 ' CD1' HD23 ' A' ' 52' ' ' LEU . 25.1 mt -110.13 144.9 38.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.473 179.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' B' ' 193' ' ' LEU . 11.8 mm -127.81 104.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.989 -1.07 . . . . 0.0 110.302 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' B' ' 209' ' ' SER . 66.8 m-85 -91.05 133.99 34.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 36.1 t -42.24 -26.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 110.416 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.439 ' N ' ' O ' ' B' ' 207' ' ' PHE . 0.0 OUTLIER -59.34 -38.63 80.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' B' ' 165' ' ' ASP . . . 121.35 15.86 4.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 124.98 41.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.031 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.453 HD13 HD11 ' B' ' 206' ' ' ILE . 21.1 mm -108.89 125.6 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.538 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 17.1 t -105.77 159.4 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.395 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.508 ' CD2' HD22 ' B' ' 204' ' ' LEU . 4.1 mp -143.05 146.17 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.428 HG21 ' O ' ' B' ' 215' ' ' THR . 5.5 t -169.8 145.09 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 110.18 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.62 10.74 26.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -91.3 158.74 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -1.198 . . . . 0.0 110.227 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -103.39 -23.75 13.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.471 ' N ' ' HG2' ' B' ' 218' ' ' LYS . 0.0 OUTLIER -137.65 179.35 6.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . 0.438 ' HG3' ' CE1' ' B' ' 224' ' ' TYR . 1.6 ttt180 -75.88 -27.75 57.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.363 -0.836 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -61.05 -41.17 96.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.496 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -61.43 -52.16 65.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 0.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.459 HD12 ' O ' ' B' ' 160' ' ' ILE . 22.6 mm -58.05 -43.8 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.438 ' CE1' ' HG3' ' B' ' 220' ' ' ARG . 10.5 m-85 -70.98 -34.16 71.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.204 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 3.4 tp60 -80.48 -44.16 19.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 110.047 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.14 -38.42 68.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.471 ' O ' HG21 ' B' ' 230' ' ' ILE . 15.7 t80 -68.92 -52.72 26.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.995 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -54.29 -24.21 18.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.783 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.81 -30.82 45.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 110.039 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.471 HG21 ' O ' ' B' ' 227' ' ' PHE . 6.0 tp -93.38 -17.37 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.891 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.72 -47.88 60.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 111.015 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.77 -40.44 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.593 1.312 . . . . 0.0 110.612 -179.404 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 40.8 t -58.52 -42.32 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.907 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.439 ' CD2' HG22 ' B' ' 206' ' ' ILE . 77.5 mt -66.67 -40.22 88.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.34 -25.4 63.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.36 -27.15 59.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 59.9 m-85 -117.16 42.74 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.508 ' HG2' ' CD1' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -68.16 -172.01 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -35.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.142 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 240' ' ' MET . . . . . 0.407 ' HG3' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.141 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.177 0.513 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.77 62.78 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.451 ' OG ' ' N ' ' A' ' 14' ' ' ILE . 96.7 p -172.13 -70.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 110.243 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.451 ' N ' ' OG ' ' A' ' 13' ' ' SER . 2.6 mp -90.52 164.86 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.25 168.02 34.78 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -60.55 163.51 5.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 110.146 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.76 154.86 30.08 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.622 HD21 ' CD2' ' B' ' 99' ' ' PHE . 0.0 OUTLIER -113.2 172.18 7.11 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.33 -1.1 . . . . 0.0 108.747 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.537 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 12.0 t0 -101.04 118.38 36.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.919 -1.113 . . . . 0.0 111.117 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.601 ' CD1' ' HB ' ' A' ' 72' ' ' ILE . 6.6 mt -113.78 12.79 18.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 110.641 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.458 ' OG1' HD21 ' A' ' 68' ' ' LEU . 3.1 m -42.43 -27.74 0.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 110.187 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.482 ' CA ' HD13 ' A' ' 34' ' ' LEU . . . -91.36 -30.2 11.2 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.604 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 16.3 mm -50.65 -53.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.295 . . . . 0.0 108.771 -179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.499 ' HB2' ' ND2' ' B' ' 159' ' ' ASN . 1.1 pp -78.97 5.7 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.468 -0.77 . . . . 0.0 110.004 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CD1' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -107.99 -17.61 14.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.177 -0.952 . . . . 0.0 111.14 -179.516 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.521 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 151.79 48.74 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.252 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.535 ' HB3' ' HG ' ' A' ' 35' ' ' LEU . 0.9 OUTLIER 63.86 139.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.012 -1.287 . . . . 0.0 111.275 178.524 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.636 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -170.35 157.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 68.1 m-20 -90.08 122.52 33.13 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 177.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.515 ' HB2' HD23 ' A' ' 18' ' ' LEU . 1.5 p -39.8 -26.67 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.727 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.1 tt0 -57.48 -13.53 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.447 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.92 26.3 5.58 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.98 117.43 26.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.076 -1.249 . . . . 0.0 109.814 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.636 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 2.8 tt -88.36 156.9 18.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.778 -1.201 . . . . 0.0 110.244 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' A' ' 27' ' ' ASN . 4.2 pp -136.68 -178.77 5.33 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.043 -179.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.435 ' O ' ' HB3' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -163.94 23.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.611 -0.68 . . . . 0.0 110.23 -179.324 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 36' ' ' GLN . 20.5 t0 61.5 97.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.143 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.77 134.3 39.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 110.311 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.54 -158.47 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.77 -120.59 3.4 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.14 97.06 2.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -1.167 . . . . 0.0 110.334 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.86 -63.01 0.07 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -74.88 -7.4 53.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -1.175 . . . . 0.0 110.139 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.52 12.19 15.57 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.08 144.32 4.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.3 m -152.72 139.81 19.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -1.214 . . . . 0.0 110.288 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.08 -170.99 29.4 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 49' ' ' ASP . 28.0 m-85 -90.0 121.02 31.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -1.08 . . . . 0.0 110.235 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 48' ' ' PHE . 23.3 p30 -56.79 -166.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.731 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.07 28.64 4.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.028 . . . . 0.0 110.321 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.01 -25.5 14.04 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.57 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 2.7 mt -92.54 -42.28 9.78 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.552 -0.718 . . . . 0.0 110.139 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.66 -51.22 16.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 0.0 109.609 -179.627 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -66.53 -13.83 61.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.825 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 52' ' ' LEU . 9.7 m-80 -96.23 -40.19 9.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.825 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 53' ' ' ARG . 1.2 mp -51.42 -40.65 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.399 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.39 -14.54 49.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 p -134.53 18.11 3.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 110.39 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 6.7 mt -98.04 16.27 21.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.2 m -90.95 42.97 1.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 110.433 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HG3' ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -151.78 -30.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -0.971 . . . . 0.0 110.954 179.854 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.554 HD11 ' N ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -74.37 6.15 3.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.977 -1.077 . . . . 0.0 111.271 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.554 ' N ' HD11 ' A' ' 62' ' ' LEU . . . 144.03 -46.92 0.8 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.484 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.6 mm? -52.0 -18.15 1.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 110.678 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 66' ' ' SER . 2.7 p30 -43.0 -39.65 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 10.9 m -67.67 -55.92 11.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.387 -0.821 . . . . 0.0 109.976 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.446 ' HG2' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.52 -6.6 26.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.602 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.458 HD21 ' OG1' ' A' ' 21' ' ' THR . 1.2 tm? -71.02 -62.89 1.23 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.179 0.99 . . . . 0.0 108.848 179.301 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.48 1.69 13.46 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.164 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 66' ' ' SER . 15.4 tt0 -91.24 11.36 23.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 111.696 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 3.2 t -138.4 0.42 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.601 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.0 tp -152.0 74.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 110.233 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 56.9 t0 -79.74 56.65 2.32 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.923 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 5.8 mt -82.11 59.56 4.48 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.719 0.771 . . . . 0.0 110.716 -179.193 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -126.45 37.63 4.28 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.758 -0.588 . . . . 0.0 110.134 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.88 88.0 1.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 110.197 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.167 -179.899 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.306 0.574 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' B' ' 231' ' ' TYR . . . -148.94 -68.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' B' ' 64' ' ' VAL . 2.0 mp -115.01 -6.51 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -1.188 . . . . 0.0 110.148 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.47 ' O ' ' O ' ' B' ' 63' ' ' ILE . 14.5 t 60.54 126.93 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.301 -0.874 . . . . 0.0 110.057 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 44.2 Cg_endo -70.95 150.31 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.85 1.447 . . . . 0.0 110.484 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.425 ' O ' ' HG2' ' B' ' 68' ' ' GLN . 18.1 m -122.04 128.02 50.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.447 HD13 ' HG3' ' B' ' 220' ' ' ARG . 21.7 mt -70.29 117.53 11.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 110.211 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.457 ' O ' ' OD1' ' B' ' 69' ' ' ASN . 19.8 mm-40 -112.35 -13.63 13.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.351 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.521 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 4.5 m120 -153.53 158.03 40.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.497 ' N ' ' O ' ' B' ' 126' ' ' ALA . 8.4 mt -154.96 169.2 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.987 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 27.0 t -139.23 130.48 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.94 143.96 50.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 94.7 m -93.62 128.93 40.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.89 . . . . 0.0 110.355 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.63 146.07 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.2 m -125.49 145.68 49.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.513 ' CD1' HD12 ' B' ' 80' ' ' LEU . 91.8 mt -97.08 -41.85 8.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.11 54.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 7.3 t -148.43 153.87 39.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -1.181 . . . . 0.0 110.335 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -77.52 149.21 34.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.097 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.513 HD12 ' CD1' ' B' ' 76' ' ' LEU . 68.9 mt -124.69 155.66 38.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -0.97 . . . . 0.0 110.505 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' B' ' 82' ' ' LEU . 4.9 m-20 -92.69 83.64 4.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 109.455 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.502 ' HB3' ' CE1' ' B' ' 94' ' ' TYR . 94.6 mt -40.1 -35.6 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.723 . . . . 0.0 110.536 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -50.12 73.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 110.008 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -77.47 -43.28 32.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.573 HG21 ' CE2' ' B' ' 148' ' ' PHE . 85.2 t -50.38 -43.96 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.142 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.96 -21.72 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 tp -86.2 -37.22 18.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -87.74 -24.95 23.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.478 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' B' ' 85' ' ' VAL . . . -70.63 136.34 49.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.145 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -24.08 58.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 9.6 t-20 -135.63 79.45 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.096 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' B' ' 89' ' ' ALA . . . -137.85 149.97 46.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -0.859 . . . . 0.0 109.955 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -125.78 119.36 27.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.341 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.502 ' CE1' ' HB3' ' B' ' 82' ' ' LEU . 8.1 t80 -114.37 118.96 35.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 109.929 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -129.05 110.22 18.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.277 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.47 -22.1 18.85 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.969 1.51 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -17.94 56.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -102.02 -45.34 5.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.622 ' CD2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -170.54 -162.42 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.913 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.414 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -122.12 54.86 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 111.043 -179.357 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.61 ' HB1' ' CE2' ' B' ' 99' ' ' PHE . . . -143.14 172.16 13.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 110.095 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.494 ' CG2' HD21 ' B' ' 82' ' ' LEU . 42.1 t -114.56 123.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.36 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.496 ' CD1' HD12 ' B' ' 114' ' ' LEU . 15.2 mm -93.67 108.6 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.979 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 104' ' ' MET . . . . . 0.56 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 1.4 ttm -89.81 146.54 24.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.417 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 3.8 ttt85 -135.63 118.66 16.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.439 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.485 ' CG2' ' CE1' ' B' ' 139' ' ' TYR . 18.2 pt -114.71 165.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.934 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.7 ptm180 -110.59 22.9 14.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.389 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.51 ' O ' ' NZ ' ' B' ' 138' ' ' LYS . 2.4 tt0 -176.9 94.74 0.24 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.267 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.1 Cg_endo -76.73 143.93 77.33 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.477 -0.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.404 ' HD3' ' CG ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -57.12 108.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.0 109.926 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.449 HG21 ' HA3' ' B' ' 125' ' ' GLY . 0.7 OUTLIER -161.76 -179.14 6.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.753 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.449 HG21 ' N ' ' B' ' 113' ' ' ALA . 1.3 m -126.54 158.74 35.4 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.564 ' HB1' ' CZ ' ' B' ' 139' ' ' TYR . . . -132.82 124.98 29.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 111.103 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.509 ' HB3' ' CZ ' ' B' ' 116' ' ' PHE . 3.9 mm? -92.24 89.83 7.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.489 HG12 ' CG ' ' B' ' 121' ' ' MET . 41.1 mt -90.28 128.61 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.168 -178.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.56 ' CE1' HD13 ' A' ' 72' ' ' ILE . 4.0 m-30 -110.19 144.75 38.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 109.593 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -54.36 -19.88 6.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 110.408 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -7.18 37.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 101.55 -25.93 26.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -56.23 173.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -1.206 . . . . 0.0 110.082 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.489 ' CG ' HG12 ' B' ' 115' ' ' ILE . 3.2 tmm? -169.05 119.89 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.521 HG12 ' CG1' ' A' ' 71' ' ' VAL . 3.8 t -109.4 138.98 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.378 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.42 124.01 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 110.766 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.484 ' C ' ' ND2' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -117.44 170.63 8.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 109.801 179.656 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.449 ' HA3' HG21 ' B' ' 111' ' ' THR . . . 102.81 -35.67 4.83 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -50.04 157.09 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -1.187 . . . . 0.0 110.387 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -121.76 -25.39 5.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 164.82 27.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.88 -63.01 1.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.189 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -45.44 -37.48 5.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -70.4 -42.02 72.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.159 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -55.48 -40.64 71.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . 0.474 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -69.1 -49.05 60.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.328 -179.918 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.44 ' HB3' ' HG3' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -55.0 -51.66 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 110.168 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.3 -47.55 65.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.218 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -69.31 -47.24 65.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.07 -42.36 65.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.391 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -63.73 -36.73 84.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.564 ' CZ ' ' HB1' ' B' ' 113' ' ' ALA . 13.4 m-85 -72.01 -56.95 4.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.61 -22.95 0.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.766 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . 0.452 ' HD3' ' HD3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -73.58 -50.53 20.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 110.073 179.803 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 46.4 mt -50.75 -38.83 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.466 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 38.8 mm -72.54 -58.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 110.039 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 56.7 mt-30 -61.39 -27.63 68.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 109.961 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.452 ' HD3' ' HD3' ' B' ' 141' ' ' ARG . 27.5 ttpt -75.39 -23.45 57.08 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.179 -0.95 . . . . 0.0 108.504 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.6 mt -83.79 -21.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.87 -16.23 7.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.573 ' CE2' HG21 ' B' ' 85' ' ' VAL . 14.9 m-85 -54.4 172.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.077 -1.249 . . . . 0.0 110.865 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.27 32.06 5.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.631 -0.668 . . . . 0.0 109.747 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.502 ' HB2' ' CD2' ' B' ' 76' ' ' LEU . . . -77.16 144.24 38.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 110.504 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.18 51.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -71.94 97.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.172 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 176.24 9.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.56 33.98 23.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.659 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . 0.474 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.0 t80 -76.16 127.91 33.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 109.927 179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -161.43 129.64 4.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.123 -0.985 . . . . 0.0 110.709 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 20.3 mt -87.65 131.0 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.73 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . 0.432 ' HA ' ' HG2' ' B' ' 218' ' ' LYS . 4.5 mt-30 -135.31 0.56 2.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.046 -1.034 . . . . 0.0 110.95 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.515 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.2 OUTLIER -142.53 96.85 3.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.01 -1.056 . . . . 0.0 110.932 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.477 HD13 ' CA ' ' B' ' 219' ' ' GLN . 75.4 mt -98.71 153.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 15.8 t -134.15 131.12 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.031 . . . . 0.0 110.571 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.43 175.7 18.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.14 148.63 8.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -1.21 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.3 p -169.45 170.71 8.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . 0.452 ' OD1' ' HA ' ' B' ' 211' ' ' LYS . 6.2 m-20 -116.29 155.77 27.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.294 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.56 HG22 ' CD1' ' B' ' 168' ' ' PHE . 10.2 m -103.87 11.5 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.9 OUTLIER 71.89 3.46 4.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.368 -0.832 . . . . 0.0 110.789 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.56 ' CD1' HG22 ' B' ' 166' ' ' VAL . 8.3 p90 -162.02 156.04 18.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 110.495 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.472 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 45.3 Cg_endo -74.24 161.87 39.74 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.103 1.581 . . . . 0.0 110.357 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.528 HG21 ' N ' ' B' ' 171' ' ' ARG . 3.0 mt -127.07 148.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.528 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.4 OUTLIER -86.38 104.6 16.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 179.55 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.483 HD21 ' CB ' ' B' ' 193' ' ' LEU . 26.9 mt -61.7 -48.51 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.44 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.69 -51.45 69.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.599 -179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.8 -51.08 55.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' B' ' 237' ' ' PHE . 8.0 tp -68.4 -36.25 78.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -1.141 . . . . 0.0 110.676 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -61.11 -30.65 70.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 7.0 t80 -76.93 -44.59 30.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.6 t -68.73 -48.94 62.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.273 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . 0.401 ' ND1' ' OH ' ' B' ' 195' ' ' TYR . 54.8 m170 -110.87 37.44 2.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -54.14 -34.32 52.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -15.92 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.191 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -111.32 -0.75 16.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.888 . . . . 0.0 110.283 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' B' ' 195' ' ' TYR . 1.1 p -140.86 168.92 18.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 110.429 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 69.1 m -139.95 130.64 25.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.032 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -132.75 120.31 21.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.128 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 190' ' ' PHE . 99.2 mt-10 -121.19 100.71 45.13 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.46 -0.71 9.15 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.932 1.49 . . . . 0.0 110.4 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.82 -18.62 17.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.151 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' B' ' 189' ' ' LEU . 2.6 tt -147.34 9.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.604 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.466 ' CZ ' HD13 ' B' ' 205' ' ' LEU . 19.0 t80 -167.97 107.63 0.57 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.874 -1.141 . . . . 0.0 110.421 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.79 -15.77 23.82 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.916 1.482 . . . . 0.0 110.165 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.61 44.13 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.483 ' CB ' HD21 ' B' ' 172' ' ' LEU . 7.3 tt -124.53 134.29 53.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -1.169 . . . . 0.0 110.433 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . 0.412 HG22 HD22 ' A' ' 62' ' ' LEU . 3.3 mt -104.74 113.85 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 109.886 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.538 ' CD2' HD12 ' B' ' 230' ' ' ILE . 4.5 t80 -93.32 127.06 38.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.442 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . 0.415 ' NH2' ' HA3' ' A' ' 63' ' ' GLY . 65.0 mtt180 -99.12 103.15 15.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.108 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 197' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 47.4 tpp -75.97 131.1 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.096 -1.003 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.51 -32.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.587 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -147.39 108.26 3.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.47 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.9 172.32 62.09 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.96 -2.1 . . . . 0.0 110.328 -0.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.5 OUTLIER -78.2 81.47 4.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.004 179.835 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.528 HG22 HD13 ' B' ' 202' ' ' ILE . 35.3 mm -126.04 154.01 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.29 111.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 110.295 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.461 HD22 ' CB ' ' B' ' 226' ' ' ALA . 4.9 mp -99.71 133.13 44.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.927 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.466 HD13 ' CZ ' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -93.69 147.31 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . 0.413 ' O ' HD23 ' B' ' 172' ' ' LEU . 5.1 mt -137.86 120.14 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -110.72 150.11 29.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 93.2 t -52.16 -27.14 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.382 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -37.44 84.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 110.253 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . 0.461 ' HA2' HD13 ' B' ' 170' ' ' ILE . . . 119.81 1.92 13.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . 0.452 ' HA ' ' OD1' ' B' ' 165' ' ' ASP . 11.2 tttm -81.21 140.48 34.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 110.049 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . 0.406 ' HA ' HD11 ' B' ' 212' ' ' ILE . 22.0 mm -123.13 132.38 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.405 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 2.3 t -120.04 148.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.24 -0.912 . . . . 0.0 109.694 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.0 mp -135.17 127.76 30.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.077 -1.014 . . . . 0.0 110.654 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 215' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 3.4 t -150.42 174.46 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.58 -0.42 77.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.516 ' CB ' HD13 ' B' ' 202' ' ' ILE . . . -94.24 142.54 27.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 110.183 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' B' ' 158' ' ' GLN . 3.2 mttm -87.27 -25.34 24.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.477 ' CA ' HD13 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -127.41 168.45 14.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . 0.447 ' HG3' HD13 ' B' ' 67' ' ' LEU . 2.2 ttt180 -73.93 -27.53 61.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.331 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -57.37 -42.53 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -59.45 -46.81 87.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 109.871 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.566 ' CG2' ' N ' ' B' ' 224' ' ' TYR . 0.9 OUTLIER -56.49 -56.96 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -0.821 . . . . 0.0 109.42 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . 0.566 ' N ' ' CG2' ' B' ' 223' ' ' ILE . 1.1 m-85 -53.09 -33.61 52.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 110.273 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -79.03 -40.69 30.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.005 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . 0.461 ' CB ' HD22 ' B' ' 204' ' ' LEU . . . -58.77 -42.59 89.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.462 ' O ' HG21 ' B' ' 230' ' ' ILE . 79.4 t80 -68.51 -55.98 9.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.05 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.21 -29.87 10.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.886 . . . . 0.0 110.064 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' B' ' 232' ' ' PRO . . . -81.49 -36.0 29.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 110.165 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.538 HD12 ' CD2' ' B' ' 195' ' ' TYR . 3.6 tp -88.14 -13.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 110.025 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.58 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 64.3 t80 -59.63 -43.21 95.12 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.852 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -75.9 -23.37 12.43 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.396 1.209 . . . . 0.0 110.24 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.476 ' CG1' HD12 ' B' ' 175' ' ' LEU . 37.7 t -72.59 -40.89 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . 0.457 ' HB3' HG12 ' B' ' 170' ' ' ILE . 35.8 mt -67.0 -50.25 62.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -33.13 65.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 110.357 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.24 -40.89 90.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . 0.527 ' CD2' HD11 ' B' ' 175' ' ' LEU . 51.7 m-85 -113.72 38.81 2.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.17 -0.956 . . . . 0.0 110.194 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -179.99 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.472 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 4.3 tptt -116.87 -35.45 4.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.223 179.897 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.302 0.573 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.97 -108.77 0.41 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.95 98.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -1.168 . . . . 0.0 110.272 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.49 148.93 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.108 179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.35 172.29 45.27 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -106.22 108.41 19.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -1.085 . . . . 0.0 110.118 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.39 159.97 10.05 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -116.35 174.75 5.89 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.088 -1.242 . . . . 0.0 109.031 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.523 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -82.56 63.18 6.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 0.0 111.917 -178.628 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.594 ' CD2' ' CD2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -83.9 -3.16 57.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.964 -1.085 . . . . 0.0 109.604 178.627 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.51 ' N ' HD21 ' A' ' 68' ' ' LEU . 3.4 m -52.95 -21.55 4.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.281 -0.887 . . . . 0.0 109.638 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -97.23 -37.9 4.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.615 ' N ' ' CG2' ' A' ' 28' ' ' ILE . 0.6 OUTLIER -46.09 -46.33 5.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.22 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' CD1' ' HG2' ' A' ' 67' ' ' MET . 0.9 OUTLIER -79.5 -19.48 49.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.144 -0.972 . . . . 0.0 108.944 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -85.94 -17.44 35.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.395 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 158.34 93.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.066 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.574 ' CB ' ' HG ' ' A' ' 35' ' ' LEU . 4.5 t-20 2.53 112.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.001 0.905 . . . . 0.0 113.043 178.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.693 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -138.41 159.66 31.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.799 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 28' ' ' ILE . 39.5 m-20 -86.76 125.99 34.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.581 ' OG ' ' CZ ' ' B' ' 99' ' ' PHE . 3.0 p -37.99 -28.03 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.433 0.635 . . . . 0.0 109.895 -178.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 29' ' ' ASP . 8.7 tt0 -57.04 -13.43 2.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.449 178.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.56 34.5 3.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.08 129.65 53.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -1.131 . . . . 0.0 110.069 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.693 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 5.6 tt -89.02 155.37 19.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 111.067 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.574 ' HG ' ' CB ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -86.98 107.34 18.36 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 122.073 0.939 . . . . 0.0 111.304 -179.112 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 38' ' ' ASP . 10.6 pt20 -120.59 10.34 11.05 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.323 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.418 ' OD1' ' HD2' ' B' ' 110' ' ' LYS . 0.7 OUTLIER 53.81 -84.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.721 -0.612 . . . . 0.0 110.371 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' GLN . 0.3 OUTLIER -95.05 148.89 21.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.953 . . . . 0.0 110.405 -179.723 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.36 108.27 7.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.68 69.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -89.97 57.94 4.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -1.096 . . . . 0.0 110.291 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.75 -48.28 0.04 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 16.8 ttt180 -115.01 10.35 16.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 110.118 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.42 -51.62 5.17 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.4 -117.5 2.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.03 170.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.69 150.37 25.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -76.69 145.57 38.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -1.171 . . . . 0.0 110.245 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.0 -141.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 109.892 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -89.57 25.83 1.89 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.132 -0.98 . . . . 0.0 110.097 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -101.19 -26.34 13.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.079 -1.013 . . . . 0.0 110.141 -179.969 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.504 HD12 ' CE1' ' A' ' 25' ' ' PHE . 5.2 mt -105.31 -44.99 4.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 110.898 -179.352 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -51.76 -55.53 19.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.1 pp20? -65.82 -15.45 62.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.635 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 3.9 m-20 -87.61 -39.57 14.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.508 -0.745 . . . . 0.0 109.28 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.499 ' HA ' ' CD1' ' A' ' 59' ' ' LEU . 7.0 mt -52.26 -43.65 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.481 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.76 13.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -126.52 7.84 6.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -1.153 . . . . 0.0 110.669 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 56' ' ' ILE . 7.4 mt -72.02 -8.45 54.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 110.332 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -80.65 50.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.318 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -148.77 -39.62 0.16 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' B' ' 184' ' ' SER . 0.1 OUTLIER -71.24 -70.12 0.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.341 -0.849 . . . . 0.0 110.519 -179.904 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.38 -35.07 0.08 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -51.22 -20.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -1.179 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.1 t0 -44.33 -40.62 5.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.95 . . . . 0.0 109.955 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.8 OUTLIER -65.36 -48.41 73.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.525 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.89 -4.26 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.732 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.51 HD21 ' N ' ' A' ' 21' ' ' THR . 3.4 tm? -78.23 -54.91 5.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.73 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -83.64 1.34 42.81 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.46 0.648 . . . . 0.0 109.695 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 1.5 tt0 -88.31 -1.71 58.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 111.643 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.585 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 2.2 t -131.74 -1.04 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 118.527 -1.269 . . . . 0.0 109.688 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.584 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -151.23 67.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.504 -0.747 . . . . 0.0 110.042 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.6 58.65 0.43 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.993 -1.067 . . . . 0.0 108.622 179.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.598 ' CD1' ' CB ' ' B' ' 101' ' ' ALA . 27.9 mt -91.59 61.46 4.28 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.571 0.701 . . . . 0.0 110.907 -178.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -100.43 58.59 0.96 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.488 -0.758 . . . . 0.0 110.146 179.763 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 75' ' ' LYS . 18.6 pt-20 37.05 51.66 1.02 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.724 -0.61 . . . . 0.0 110.797 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.361 -179.88 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 61' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' B' ' 62' ' ' GLY . 2.5 t . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.239 0.542 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 62' ' ' GLY . . . . . 0.401 ' N ' ' OG ' ' B' ' 61' ' ' SER . . . -112.77 -42.99 0.9 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.463 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.5 mt -115.14 -27.21 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -1.206 . . . . 0.0 110.202 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 8.2 t 61.06 128.2 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.934 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.458 ' HG2' HG23 ' B' ' 223' ' ' ILE . 44.1 Cg_endo -70.14 161.55 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.8 1.421 . . . . 0.0 110.556 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 66' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.4 m -121.39 133.28 55.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.888 . . . . 0.0 110.161 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.497 HD21 ' CG2' ' B' ' 160' ' ' ILE . 80.9 mt -74.6 108.38 7.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 41.6 mm-40 -89.98 -15.04 32.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.408 ' CG ' ' O ' ' B' ' 68' ' ' GLN . 2.1 m120 -167.84 164.51 14.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' B' ' 126' ' ' ALA . 7.4 mt -154.82 164.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.435 ' N ' HG21 ' B' ' 70' ' ' ILE . 71.5 t -141.49 132.97 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.265 -0.897 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.02 154.44 39.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.77 121.76 41.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.497 HG12 ' CD1' ' B' ' 152' ' ' PHE . 66.2 t -121.63 134.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -122.79 131.25 53.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 110.16 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.52 ' CD1' HD13 ' B' ' 80' ' ' LEU . 15.0 mt -83.14 -51.27 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.88 27.4 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.0 134.73 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.266 . . . . 0.0 110.446 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -56.62 152.24 12.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.52 HD13 ' CD1' ' B' ' 76' ' ' LEU . 18.3 mt -133.65 158.63 42.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.416 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -102.05 94.01 5.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.029 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' B' ' 102' ' ' VAL . 16.0 mt -43.57 -37.53 2.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 110.341 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 83' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.5 OUTLIER -58.3 -38.88 77.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.183 -179.882 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 27.2 p -89.1 -43.08 11.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.202 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' B' ' 148' ' ' PHE . 63.2 t -56.37 -39.89 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.466 ' HB1' HG23 ' B' ' 102' ' ' VAL . . . -83.89 -26.37 29.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.399 -0.813 . . . . 0.0 109.934 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 25.9 tp -80.13 -43.83 20.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . 0.4 ' HB3' HG12 ' B' ' 146' ' ' ILE . 65.2 m80 -77.55 -28.81 51.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 89' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 85' ' ' VAL . . . -69.8 139.88 53.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.067 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -23.46 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 110.334 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' B' ' 105' ' ' ARG . 3.2 t-20 -134.88 79.67 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' B' ' 86' ' ' ALA . . . -141.8 152.58 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.12 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -130.75 131.54 44.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.79 103.59 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.95 104.8 52.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.67 -23.76 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.107 1.582 . . . . 0.0 110.26 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.33 60.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.547 ' HB3' ' CD1' ' B' ' 99' ' ' PHE . 4.2 tpm_? -112.66 -66.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 109.864 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 99' ' ' PHE . . . . . 0.581 ' CZ ' ' OG ' ' A' ' 30' ' ' SER . 30.5 p90 -141.55 -170.77 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 110.12 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.49 62.34 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -0.966 . . . . 0.0 110.652 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.598 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . . . -152.02 170.4 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.083 -1.01 . . . . 0.0 110.649 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 102' ' ' VAL . . . . . 0.519 ' CG2' HD21 ' B' ' 82' ' ' LEU . 24.5 t -106.98 132.63 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.561 179.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.47 HG13 ' OG ' ' A' ' 30' ' ' SER . 12.8 mm -99.85 97.47 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.135 -0.978 . . . . 0.0 110.507 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 23.4 ttm -90.01 158.68 17.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.953 . . . . 0.0 109.824 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.438 ' HA ' ' OH ' ' B' ' 139' ' ' TYR . 0.1 OUTLIER -157.3 155.84 31.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.753 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 3.9 pt -136.09 162.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 107' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -102.0 25.11 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 110.083 179.973 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 3.6 tt0 -177.97 90.01 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.95 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 109' ' ' PRO . . . . . 0.449 ' HG2' ' HB3' ' B' ' 135' ' ' ALA . 50.8 Cg_endo -83.11 155.5 73.97 Favored 'Cis proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.181 -2.008 . . . . 0.0 110.345 -0.097 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 5.3 ttmt -61.34 104.01 0.36 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.057 -1.027 . . . . 0.0 109.619 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 111' ' ' THR . . . . . 0.413 HG21 ' O ' ' B' ' 110' ' ' LYS . 29.3 p -144.89 179.49 7.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.754 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -138.64 128.97 25.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.556 -0.715 . . . . 0.0 109.228 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 113' ' ' ALA . . . . . 0.462 ' HB1' ' CZ ' ' B' ' 139' ' ' TYR . . . -106.0 123.69 48.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 111.063 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 114' ' ' LEU . . . . . 0.484 HD13 HD11 ' A' ' 72' ' ' ILE . 4.2 mm? -89.58 92.55 9.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 115' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' B' ' 101' ' ' ALA . 10.5 mt -92.66 127.11 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.162 -0.961 . . . . 0.0 111.33 -178.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 116' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 2.8 m-85 -100.77 160.26 14.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 109.649 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.4 2.52 21.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.996 -1.065 . . . . 0.0 110.111 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.3 t -90.58 -21.71 21.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.97 -33.9 3.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -63.48 172.14 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 109.901 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 121' ' ' MET . . . . . 0.453 ' N ' ' O ' ' B' ' 74' ' ' VAL . 2.5 ttm -164.63 149.65 9.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.587 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . 0.488 HG13 HG11 ' A' ' 71' ' ' VAL . 1.2 t -125.4 145.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.183 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.2 t -129.81 100.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.038 . . . . 0.0 111.029 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 124' ' ' THR . . . . . 0.526 ' CG2' HG22 ' A' ' 23' ' ' ILE . 1.2 t -99.62 165.28 11.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 108.908 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . 0.522 ' HA2' ' HB2' ' A' ' 27' ' ' ASN . . . 101.92 -3.51 52.35 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' B' ' 70' ' ' ILE . . . -73.22 133.79 44.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.262 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.42 -6.65 27.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 110.438 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 128' ' ' SER . . . . . 0.409 ' HB2' ' CG ' ' B' ' 131' ' ' ASP . 0.4 OUTLIER -160.25 -168.2 2.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 0.0 110.367 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.5 -56.03 4.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.187 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 130' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 7.9 m-20 -63.82 -22.45 66.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.878 . . . . 0.0 110.389 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' B' ' 128' ' ' SER . 5.0 m-20 -68.18 -48.8 64.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.99 . . . . 0.0 110.313 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -36.59 83.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.217 -179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -58.7 -42.16 87.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.56 -50.78 11.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.449 ' HB3' ' HG2' ' B' ' 109' ' ' PRO . . . -54.13 -50.49 66.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 136' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' B' ' 137' ' ' ARG . 20.6 p -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.771 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 137' ' ' ARG . . . . . 0.424 ' N ' ' OG ' ' B' ' 136' ' ' SER . 5.4 mtp180 -48.25 -43.23 32.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.363 -0.836 . . . . 0.0 109.95 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -57.25 -45.69 83.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.842 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 139' ' ' TYR . . . . . 0.462 ' CZ ' ' HB1' ' B' ' 113' ' ' ALA . 11.8 m-85 -57.03 -53.23 60.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.77 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.55 -20.14 64.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.85 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -31.96 58.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' B' ' 139' ' ' TYR . 6.3 mt -70.29 -41.36 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 33.7 mt -68.31 -42.27 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -68.4 -33.98 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -71.47 -22.37 61.82 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.4 HG12 ' HB3' ' B' ' 88' ' ' HIS . 1.3 mt -81.21 -20.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 122.51 -32.15 4.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 148' ' ' PHE . . . . . 0.581 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 7.7 m-85 -40.85 150.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.132 . . . . 0.0 110.964 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.39 28.68 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.525 -0.734 . . . . 0.0 109.859 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.412 ' HB3' ' CD2' ' B' ' 76' ' ' LEU . . . -67.14 148.69 51.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.512 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . 0.447 ' O ' ' OG1' ' B' ' 153' ' ' THR . 0.0 OUTLIER -136.73 117.86 14.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . 0.497 ' CD1' HG12 ' B' ' 74' ' ' VAL . 61.7 t80 -56.02 100.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.179 -0.951 . . . . 0.0 110.087 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.2 OUTLIER -144.19 166.17 25.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.63 35.33 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 110.435 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -78.36 130.86 36.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -165.75 129.19 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 110.607 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 40.5 mt -79.51 129.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.598 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -125.56 -13.17 6.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.056 -1.028 . . . . 0.0 110.933 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 159' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 24' ' ' LEU . 2.2 t30 -139.27 98.02 3.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.878 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 160' ' ' ILE . . . . . 0.497 ' CG2' HD21 ' B' ' 67' ' ' LEU . 53.1 mt -97.47 134.08 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.518 179.192 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 5.9 t -101.71 133.96 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.665 -179.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 162' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -148.47 163.21 28.97 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 43.2 p -167.56 159.79 12.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 164' ' ' CYS . . . . . 0.427 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 11.0 p -168.51 158.44 9.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.7 130.97 54.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 210' ' ' GLY . 35.1 m -105.25 12.21 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.181 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 48.79 41.59 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.969 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 168' ' ' PHE . . . . . 0.424 ' CE1' ' HB2' ' B' ' 238' ' ' ARG . 0.1 OUTLIER -136.55 115.6 10.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 110.206 -179.953 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 169' ' ' PRO . . . . . 0.474 ' HB2' ' CB ' ' B' ' 239' ' ' LYS . 46.4 Cg_endo -72.28 140.21 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.904 1.476 . . . . 0.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . 0.501 ' CD1' ' HA2' ' B' ' 210' ' ' GLY . 2.8 mp -130.17 151.43 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.616 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 171' ' ' ARG . . . . . 0.413 ' N ' HG21 ' B' ' 170' ' ' ILE . 0.4 OUTLIER -85.5 88.32 7.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.803 179.715 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' B' ' 185' ' ' TYR . 68.9 mt -51.01 -23.69 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -55.37 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.202 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.63 -46.56 74.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.416 ' O ' HD11 ' B' ' 175' ' ' LEU . 10.3 tp -62.92 -36.95 85.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -1.155 . . . . 0.0 110.446 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 176' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' B' ' 172' ' ' LEU . . . -66.51 -19.87 65.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.277 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -93.84 -35.27 12.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 p -81.36 -26.71 35.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.046 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -122.83 12.82 9.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -0.853 . . . . 0.0 110.041 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.09 -36.59 5.3 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -26.1 65.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -1.144 . . . . 0.0 110.499 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -122.48 -18.89 6.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 110.344 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' B' ' 195' ' ' TYR . 57.8 m -115.83 165.61 12.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.432 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 184' ' ' SER . . . . . 0.415 ' HB2' HD22 ' A' ' 62' ' ' LEU . 2.5 p -141.46 143.2 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.403 -0.811 . . . . 0.0 109.987 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 185' ' ' TYR . . . . . 0.533 ' CD1' ' HB3' ' B' ' 172' ' ' LEU . 78.4 t80 -133.15 94.54 3.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 186' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' B' ' 190' ' ' PHE . 27.4 mt-10 -100.59 102.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.763 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.5 -6.94 20.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.687 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.75 -13.99 18.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 189' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' B' ' 189' ' ' LEU . 2.4 tt -137.03 3.64 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.45 ' HB2' HD22 ' B' ' 189' ' ' LEU . 1.4 t80 -169.73 113.4 0.49 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.211 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -19.66 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.923 1.486 . . . . 0.0 110.176 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -99.64 176.6 28.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 193' ' ' LEU . . . . . 0.456 ' CB ' HD21 ' B' ' 172' ' ' LEU . 5.7 tt -110.69 132.97 53.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 194' ' ' ILE . . . . . . . . . . . . . 6.8 mt -93.69 106.6 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.302 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 195' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' B' ' 183' ' ' SER . 3.9 t80 -101.33 107.48 18.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.12 99.72 12.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 110.103 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 41.5 ttm -70.31 145.05 51.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.266 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.66 -39.14 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 199' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 199' ' ' LYS . 1.0 OUTLIER -139.7 114.72 8.0 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.91 179.976 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 200' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -72.2 167.32 77.39 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.946 -2.106 . . . . 0.0 110.639 0.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -76.27 93.58 3.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 202' ' ' ILE . . . . . 0.531 HD13 ' CB ' ' B' ' 217' ' ' ALA . 4.5 mt -146.21 165.91 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.914 . . . . 0.0 110.342 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.457 ' N ' ' CG2' ' B' ' 202' ' ' ILE . 26.0 t -111.09 119.32 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.43 -0.793 . . . . 0.0 109.661 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.0 mp -106.37 117.95 35.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.511 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 3.4 mt -97.18 119.9 36.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 17.9 mm -98.5 141.22 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.381 -179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.43 144.98 47.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.035 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 75.5 t -51.66 -24.72 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.291 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.9 t -78.16 -19.37 54.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.096 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . 0.501 ' HA2' ' CD1' ' B' ' 170' ' ' ILE . . . 108.68 5.82 31.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.24 137.71 45.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 109.951 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 17.2 mm -125.37 131.55 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.557 -179.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 21.8 t -114.3 150.28 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.821 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . 0.443 HD11 ' N ' ' B' ' 214' ' ' LEU . 4.2 mp -141.81 111.69 6.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 110.381 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 15.2 t -134.12 151.61 51.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.125 -0.984 . . . . 0.0 110.155 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.54 -5.4 48.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 217' ' ' ALA . . . . . 0.531 ' CB ' HD13 ' B' ' 202' ' ' ILE . . . -64.71 172.94 2.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -1.143 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -116.57 -16.44 10.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.444 ' N ' HD13 ' B' ' 160' ' ' ILE . 1.6 tt0 -167.42 163.14 14.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -51.85 -21.9 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.303 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -68.75 -35.93 77.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.45 ' HB3' HD13 ' B' ' 202' ' ' ILE . 3.2 mp0 -72.54 -53.63 11.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 110.322 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.458 HG23 ' HG2' ' B' ' 65' ' ' PRO . 32.8 mm -50.53 -44.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.63 -34.71 77.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -36.31 59.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.88 -35.7 71.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.298 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 227' ' ' PHE . . . . . 0.464 ' O ' HG21 ' B' ' 230' ' ' ILE . 20.7 t80 -80.85 -46.3 15.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -58.71 -27.61 65.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -83.05 -36.78 24.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.464 HG21 ' O ' ' B' ' 227' ' ' PHE . 0.8 OUTLIER -89.65 -11.94 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.916 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 231' ' ' TYR . . . . . 0.553 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -43.14 -50.53 14.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.799 . . . . 0.0 110.783 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 232' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.8 Cg_endo -73.27 -44.35 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.599 1.316 . . . . 0.0 110.624 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.65 -30.62 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 109.986 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 9.8 mt -77.09 -47.67 19.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.187 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -21.15 63.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 236' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.2 OUTLIER -70.61 -54.3 12.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.83 . . . . 0.0 110.011 179.838 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.99 34.42 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.424 ' HB2' ' CE1' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -64.43 -178.23 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.516 -0.74 . . . . 0.0 110.571 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . 0.474 ' CB ' ' HB2' ' B' ' 169' ' ' PRO . 1.2 tttp -114.92 -33.74 5.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.139 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 15.7 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.262 -179.834 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.952 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.55 ' HA ' HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -88.61 93.08 9.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 111.233 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.952 HD21 HD21 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -99.79 23.14 10.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 1.025 HG22 HG23 ' A' ' 56' ' ' ILE . 3.4 m -52.22 -31.47 32.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.919 -1.113 . . . . 0.0 109.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.74 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -91.9 -26.4 19.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.824 HG13 HD22 ' A' ' 20' ' ' LEU . 1.8 mm -50.74 -48.8 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.332 . . . . 0.0 108.944 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.7 OUTLIER -78.69 -10.68 59.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 0.0 110.193 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.482 ' HB2' ' HA2' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -87.99 -15.22 37.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 110.859 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 148.78 81.78 0.04 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.116 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.635 ' HB2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 33.04 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.067 0.937 . . . . 0.0 112.719 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.0 OUTLIER -139.78 165.02 22.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.767 -1.208 . . . . 0.0 109.765 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.877 ' O ' HD12 ' A' ' 28' ' ' ILE . 69.8 m-20 -88.71 126.63 35.41 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 60.0 p -37.74 -28.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.113 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' ASP . 31.0 mt-10 -57.59 -12.7 2.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 110.447 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 13.88 17.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -96.33 115.5 27.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -1.149 . . . . 0.0 109.515 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.109 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -89.05 138.72 31.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 109.431 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.109 ' N ' HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.897 -1.127 . . . . 0.0 111.506 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.132 0.491 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 26.8 pt-20 -100.85 -21.12 15.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.828 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 52' ' ' LEU . 5.1 mt -102.1 -45.04 5.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 110.694 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.843 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.29 -54.36 21.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.381 -0.824 . . . . 0.0 110.056 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -68.52 -19.86 64.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 44.6 m-20 -86.62 -37.88 17.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 21' ' ' THR . 11.3 mt -52.56 -48.32 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.423 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.11 -22.02 4.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -124.53 8.97 8.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 56' ' ' ILE . 12.3 mt -75.17 -2.23 26.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.047 . . . . 0.0 110.272 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.72 42.42 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -143.89 13.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.779 ' CD1' HG21 ' B' ' 194' ' ' ILE . 3.7 pp -133.32 -31.9 1.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 110.655 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.527 ' N ' HD12 ' A' ' 62' ' ' LEU . . . -175.37 -40.11 0.05 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.637 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.7 mm? -49.84 -20.53 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -1.226 . . . . 0.0 110.531 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -46.89 -39.9 13.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 109.916 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.9 -51.0 60.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.81 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -72.37 -1.98 17.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.623 HD23 ' OG1' ' A' ' 21' ' ' THR . 1.5 tm? -76.46 -60.56 2.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.967 0.889 . . . . 0.0 108.944 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -78.87 0.53 26.87 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.251 0.548 . . . . 0.0 109.993 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 66' ' ' SER . 5.2 tt0 -88.16 8.55 26.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 111.364 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.013 HG12 HG11 ' B' ' 122' ' ' VAL . 2.1 t -138.19 1.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.941 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.019 HD11 ' CD1' ' A' ' 74' ' ' LEU . 4.1 tp -149.08 73.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 6.8 p-10 -75.96 55.77 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.173 -0.954 . . . . 0.0 108.843 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.019 ' CD1' HD11 ' A' ' 72' ' ' ILE . 6.0 mt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.583 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 35.6 mm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.191 0.52 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 5.3 t 62.11 129.28 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.58 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 49.8 Cg_endo -77.57 135.46 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 124.026 1.54 . . . . 0.0 110.253 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -97.59 137.77 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' B' ' 67' ' ' LEU . 20.2 mt -72.68 135.22 45.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -114.64 -29.96 6.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 1.8 m120 -170.0 171.78 6.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 110.119 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.834 HG22 ' HB3' ' B' ' 126' ' ' ALA . 0.5 OUTLIER -144.6 160.6 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.081 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.575 HG22 ' OG1' ' B' ' 124' ' ' THR . 20.5 t -134.96 132.37 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.851 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.29 156.21 48.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.33 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 13.5 m -108.7 144.25 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' B' ' 121' ' ' MET . 8.1 t -132.18 156.89 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 109.961 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -130.15 130.56 44.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.981 HD22 ' HB1' ' B' ' 150' ' ' ALA . 53.3 mt -82.31 -19.65 38.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLY . . . . . 0.418 ' C ' ' SG ' ' B' ' 78' ' ' CYS . . . 79.75 4.53 89.44 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' CYS . . . . . 0.418 ' SG ' ' C ' ' B' ' 77' ' ' GLY . 23.1 m -143.66 146.72 33.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -1.181 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.682 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -78.95 153.02 30.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' B' ' 76' ' ' LEU . 14.4 mt -132.42 167.62 19.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 2.8 t70 -99.88 94.77 6.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.628 HD22 HG23 ' B' ' 102' ' ' VAL . 26.2 mt -40.94 -46.15 2.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -0.837 . . . . 0.0 110.827 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -54.51 -48.84 71.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.549 HG23 ' CE1' ' B' ' 88' ' ' HIS . 20.1 m -77.57 -38.54 48.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 110.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 55.3 t -54.73 -47.9 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.062 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.37 -29.56 63.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.023 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 28.5 tp -78.21 -30.16 48.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 109.987 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.549 ' CE1' HG23 ' B' ' 84' ' ' THR . 0.7 OUTLIER -91.5 -25.76 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.945 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.01 131.82 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 110.071 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 -69.53 -29.74 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -133.5 79.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -143.31 152.79 42.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -130.3 136.97 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.149 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -125.89 101.54 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 110.386 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.21 110.33 63.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.861 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.82 -15.38 26.67 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.057 1.556 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.45 -15.29 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.651 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -102.65 -43.09 5.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.081 -1.012 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.762 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -165.19 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 111.314 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.29 54.0 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.143 -0.973 . . . . 0.0 111.128 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.935 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -149.42 166.14 29.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.628 HG23 HD22 ' B' ' 82' ' ' LEU . 66.8 t -99.43 166.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.93 . . . . 0.0 109.985 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.55 ' CD1' ' HB3' ' B' ' 114' ' ' LEU . 23.1 mm -129.84 107.45 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.38 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.54 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.0 OUTLIER -89.67 164.72 14.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.009 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.71 135.24 6.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 19.0 pt -133.58 159.48 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.795 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' B' ' 108' ' ' GLU . 1.4 ptt180 -102.62 17.65 23.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.523 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.5 OUTLIER -161.05 88.94 1.63 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 110.446 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.3 Cg_endo -75.88 162.37 92.4 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.35 -0.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -74.36 83.54 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.055 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' B' ' 124' ' ' THR . 14.6 p -134.05 178.4 6.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 110.272 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.513 HG22 HG23 ' B' ' 124' ' ' THR . 5.2 t -131.82 159.24 39.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -152.8 155.44 37.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.966 -1.084 . . . . 0.0 110.868 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.55 ' HB3' ' CD1' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -131.66 115.1 15.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.739 . . . . 0.0 109.611 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' B' ' 121' ' ' MET . 10.8 mt -96.37 146.08 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.946 . . . . 0.0 110.753 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 3.5 m-30 -104.51 157.81 16.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.374 -0.829 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.91 -15.43 30.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.353 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 60.2 p -84.8 4.5 32.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.09 -28.59 7.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 3.6 ttmt -67.88 127.91 34.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -1.169 . . . . 0.0 110.116 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.425 ' HB3' HG12 ' B' ' 115' ' ' ILE . 0.2 OUTLIER -136.03 157.72 46.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 1.013 HG11 HG12 ' A' ' 71' ' ' VAL . 11.4 t -123.06 129.86 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.366 -0.834 . . . . 0.0 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' B' ' 139' ' ' TYR . 60.2 t -113.85 139.55 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.476 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.575 ' OG1' HG22 ' B' ' 71' ' ' VAL . 10.2 t -142.6 156.83 45.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.524 ' CA ' ' HB3' ' A' ' 27' ' ' ASN . . . 123.83 -13.89 8.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.834 ' HB3' HG22 ' B' ' 70' ' ' ILE . . . -76.87 158.71 30.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.117 . . . . 0.0 110.029 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.414 ' C ' ' OG ' ' B' ' 128' ' ' SER . 25.2 mtmt -109.47 -1.15 18.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.278 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -163.89 -170.12 2.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 129' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.0 OUTLIER -68.44 -60.58 2.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -55.86 -31.95 63.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.409 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 9.9 m-20 -65.04 -42.1 94.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.72 -38.69 32.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' LYS . . . . . 0.423 ' CG ' ' CE2' ' B' ' 155' ' ' PHE . 10.8 mttm -53.1 -39.5 63.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.118 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.4 -47.04 29.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.97 -43.59 70.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.01 -55.71 26.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -46.21 -44.8 16.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 110.082 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -57.79 -51.35 69.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' B' ' 104' ' ' MET . 22.7 m-85 -58.2 -57.63 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.28 -31.68 14.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.11 62.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.312 -0.868 . . . . 0.0 109.855 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.423 HG21 ' SD ' ' B' ' 104' ' ' MET . 50.5 mt -45.03 -38.86 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.985 HG21 ' HB2' ' B' ' 150' ' ' ALA . 41.0 mm -69.37 -52.73 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.676 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -64.97 -28.48 69.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -75.1 -21.2 59.06 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.29 -21.24 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.74 -22.26 5.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' B' ' 143' ' ' ILE . 23.2 m-85 -64.41 179.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.312 . . . . 0.0 111.199 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -113.76 36.35 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.592 -0.692 . . . . 0.0 110.304 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.985 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -60.46 148.33 37.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.97 . . . . 0.0 110.201 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -113.47 -157.97 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.227 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' B' ' 152' ' ' PHE . 1.0 OUTLIER -147.09 77.93 1.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 110.077 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -144.75 178.95 7.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' B' ' 153' ' ' THR . 15.1 t0 66.97 22.3 10.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 110.298 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' B' ' 73' ' ' THR . 8.4 t80 -77.38 132.74 38.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -164.97 133.48 3.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.149 -0.969 . . . . 0.0 110.731 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.461 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 33.9 mt -81.2 108.37 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.721 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -101.09 -2.04 32.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.746 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.47 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 0.7 OUTLIER -152.24 120.36 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.936 -1.103 . . . . 0.0 110.983 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.38 137.76 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 109.428 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -106.99 135.28 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 110.798 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.78 177.08 20.77 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.1 OUTLIER -169.65 153.33 4.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.246 . . . . 0.0 110.722 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 24.6 p -169.11 165.46 11.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 109.824 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 22.4 p-10 -115.94 134.05 55.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.328 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.846 HG21 HD11 ' B' ' 170' ' ' ILE . 33.6 m -80.06 4.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 110.089 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.59 -4.51 2.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.49 -0.756 . . . . 0.0 111.138 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.732 ' H ' HG23 ' B' ' 166' ' ' VAL . 22.4 p90 -145.91 153.11 49.47 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.9 -1.125 . . . . 0.0 110.532 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.51 159.72 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.072 1.564 . . . . 0.0 110.329 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.846 HD11 HG21 ' B' ' 166' ' ' VAL . 2.1 mp -128.38 152.93 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.514 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -82.11 101.45 10.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.81 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.521 HD22 ' HB2' ' B' ' 193' ' ' LEU . 18.8 mt -55.0 -42.03 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 110.512 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.92 -21.61 59.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.14 -45.52 31.27 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 1.015 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -67.84 -36.67 80.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.88 61.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.303 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -91.12 -16.37 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 178' ' ' SER . . . . . 0.534 ' OG ' ' CZ ' ' B' ' 237' ' ' PHE . 0.3 OUTLIER -99.59 -33.37 10.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -120.89 37.06 4.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.42 -21.2 6.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' THR . . . . . 0.461 ' O ' ' CG ' ' B' ' 182' ' ' PHE . 16.2 p -87.53 23.47 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.506 ' CZ ' HG22 ' B' ' 198' ' ' VAL . 0.9 OUTLIER -169.82 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.282 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 13.5 p -89.98 151.07 21.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.276 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.9 m -128.69 148.73 50.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -158.1 112.6 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.55 104.02 53.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.94 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.35 -3.17 12.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.467 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.8 -7.32 30.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' B' ' 190' ' ' PHE . 2.5 tt -148.66 -44.02 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 110.551 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.699 ' HB2' HD23 ' B' ' 189' ' ' LEU . 12.6 t80 -117.12 110.17 41.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 191' ' ' PRO . . . . . 0.513 ' O ' HD13 ' B' ' 172' ' ' LEU . 45.6 Cg_endo -74.79 -12.81 22.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.924 1.486 . . . . 0.0 110.21 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.514 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -92.9 179.52 39.77 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.863 HD23 ' N ' ' B' ' 194' ' ' ILE . 3.7 tt -115.18 148.34 39.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 110.102 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.863 ' N ' HD23 ' B' ' 193' ' ' LEU . 4.3 mt -123.3 103.37 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.279 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.503 ' CD1' HD13 ' B' ' 230' ' ' ILE . 27.0 t80 -95.03 120.47 35.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 197' ' ' MET . 1.8 ttp180 -90.03 82.62 6.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.427 ' C ' ' O ' ' B' ' 196' ' ' ARG . 31.2 tpp -42.63 130.16 4.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.506 HG22 ' CZ ' ' B' ' 182' ' ' PHE . 14.9 t -70.51 -52.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 8.5 ttpp -143.68 117.11 5.92 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.1 Cg_endo -71.98 171.89 59.82 Favored 'Cis proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.025 -2.073 . . . . 0.0 110.601 -0.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -82.31 108.69 15.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.138 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' B' ' 217' ' ' ALA . 9.2 mt -150.8 155.95 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.496 HG13 HG23 ' B' ' 194' ' ' ILE . 70.0 t -105.39 131.21 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 109.671 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.506 HD22 HG21 ' B' ' 230' ' ' ILE . 5.3 mp -119.19 123.04 43.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.508 HD22 ' N ' ' B' ' 205' ' ' LEU . 4.4 mm? -94.12 124.04 37.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.517 HG12 HD12 ' B' ' 212' ' ' ILE . 2.5 mp -124.55 122.44 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.514 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 95.6 m-85 -110.36 149.84 29.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 40.8 t -45.73 -24.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -29.23 70.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.363 -0.836 . . . . 0.0 110.331 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 109.85 2.91 30.31 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 123.61 27.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -1.156 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.517 HD12 HG12 ' B' ' 206' ' ' ILE . 19.4 mm -116.56 125.43 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.64 ' C ' HD12 ' B' ' 214' ' ' LEU . 4.0 t -110.62 154.82 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.052 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.64 HD12 ' C ' ' B' ' 213' ' ' VAL . 5.2 mp -141.87 103.35 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -0.884 . . . . 0.0 110.481 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.476 ' O ' HG23 ' B' ' 202' ' ' ILE . 13.3 t -126.66 152.57 46.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.984 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.473 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 106.64 -4.41 36.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' B' ' 202' ' ' ILE . . . -68.87 162.67 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -1.193 . . . . 0.0 110.013 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -114.68 -6.9 12.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.15 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' B' ' 222' ' ' GLU . 1.9 tt0 -159.66 147.44 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 220' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' B' ' 219' ' ' GLN . 20.7 ttm180 -43.85 -37.25 2.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -61.43 -34.07 74.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 110.156 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.593 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 6.2 mt-10 -63.73 -53.31 53.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 110.254 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.518 HG12 ' CB ' ' B' ' 217' ' ' ALA . 18.7 mm -57.71 -42.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.46 ' CE2' HG13 ' B' ' 64' ' ' VAL . 2.7 m-85 -66.56 -28.84 68.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.107 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 2.6 tt0 -82.4 -50.06 9.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.153 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' B' ' 225' ' ' GLN . . . -45.51 -43.59 11.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.728 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 26.2 t80 -69.69 -41.46 75.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -15.38 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.174 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -92.53 -42.0 9.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 110.027 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.506 HG21 HD22 ' B' ' 204' ' ' LEU . 1.5 tp -90.55 -14.74 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.5 t80 -49.28 -49.72 68.72 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.3 Cg_endo -70.39 -45.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.47 1.247 . . . . 0.0 110.272 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 1.015 HG12 HD21 ' B' ' 175' ' ' LEU . 22.4 t -49.96 -39.24 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.705 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.403 HD22 HG21 ' B' ' 170' ' ' ILE . 96.5 mt -73.33 -50.75 20.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.744 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 14.0 t -55.93 -33.16 64.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.17 -32.38 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.77 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.546 ' HD2' HD22 ' B' ' 175' ' ' LEU . 22.5 m-85 -117.36 37.72 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 110.092 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -61.31 171.95 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.127 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -102.49 -47.14 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 110.111 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.023 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.235 0.541 . . . . 0.0 109.825 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.896 ' N ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -66.91 82.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.174 -0.954 . . . . 0.0 110.762 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.92 HD21 HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -98.59 -0.16 43.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.08 -1.013 . . . . 0.0 110.706 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 59' ' ' LEU . 8.2 m -45.98 -29.34 1.41 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.57 -32.26 5.78 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.875 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -55.81 -43.07 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 108.738 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.009 HD13 ' SD ' ' A' ' 67' ' ' MET . 3.4 pp -82.4 -28.71 31.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.545 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.2 OUTLIER -93.36 13.12 22.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.397 -0.814 . . . . 0.0 108.871 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.587 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 142.85 94.46 0.2 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 1.008 ' ND2' HD11 ' A' ' 35' ' ' LEU . 7.0 p30 -20.27 132.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.031 0.919 . . . . 0.0 112.39 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.714 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -147.11 163.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 31' ' ' GLU . 80.3 m-20 -87.3 124.2 33.1 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.023 ' HB2' HD13 ' A' ' 18' ' ' LEU . 5.3 p -37.96 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.793 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.4 mm-40 -55.1 -15.99 2.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 110.164 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.86 27.49 5.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.492 ' CD ' ' C ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -123.33 121.22 35.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.098 -1.236 . . . . 0.0 110.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -94.24 157.8 15.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.759 -1.213 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.008 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.997 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.274 0.559 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -100.87 -17.73 16.71 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 52' ' ' LEU . 4.0 mt -99.26 -44.24 6.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.436 -0.79 . . . . 0.0 110.384 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.008 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.21 -54.25 42.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 110.085 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -67.41 -22.47 65.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.475 -0.765 . . . . 0.0 110.211 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.58 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 7.0 m-80 -87.4 -28.65 22.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.31 -0.869 . . . . 0.0 109.186 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' A' ' 53' ' ' ARG . 12.6 mt -56.93 -48.3 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.462 -0.773 . . . . 0.0 108.981 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.49 -22.09 5.11 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.413 ' HB3' HD11 ' B' ' 189' ' ' LEU . 0.5 OUTLIER -130.07 25.76 5.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.847 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.789 HD21 ' CE2' ' B' ' 190' ' ' PHE . 6.2 mt -92.79 22.63 4.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.01 . . . . 0.0 109.88 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.38 52.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.687 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -169.82 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.697 ' CD1' HD23 ' A' ' 59' ' ' LEU . 3.4 mt -112.79 -50.03 2.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 109.805 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.85 -31.11 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -75.2 0.92 14.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.787 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' LEU . 10.5 t70 -43.71 -41.34 4.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.777 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -46.23 78.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.414 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . 1.009 ' SD ' HD13 ' A' ' 24' ' ' LEU . 15.9 ttm -65.99 -9.61 31.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 109.417 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.0 tm? -71.41 -61.73 1.67 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.987 0.899 . . . . 0.0 108.687 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.61 -1.74 26.0 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.528 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 11.9 tt0 -85.9 11.59 11.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.272 -0.893 . . . . 0.0 111.347 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.953 ' O ' HG21 ' B' ' 122' ' ' VAL . 2.2 t -144.88 3.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.963 -1.085 . . . . 0.0 110.565 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.002 ' CD1' HD23 ' A' ' 18' ' ' LEU . 4.1 tp -147.33 74.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.7 54.38 1.8 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.144 -0.972 . . . . 0.0 108.553 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.133 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 7.5 mt . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 121.564 0.697 . . . . 0.0 110.397 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.641 HG22 ' SG ' ' B' ' 164' ' ' CYS . 2.3 mp . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 120.927 0.394 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 5.9 t 63.76 139.4 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 109.987 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.744 ' HG2' HG22 ' B' ' 223' ' ' ILE . 45.1 Cg_endo -72.32 135.67 25.06 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.115 1.587 . . . . 0.0 110.856 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 51.6 m -100.18 136.84 39.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.663 HD22 ' CG2' ' B' ' 160' ' ' ILE . 84.6 mt -70.4 133.79 47.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -130.82 -3.29 4.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 110.348 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.7 OUTLIER -162.51 126.41 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.332 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.971 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 14.1 mm -115.21 157.17 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.504 HG22 ' HB ' ' B' ' 124' ' ' THR . 7.7 t -141.82 121.53 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 109.692 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.5 162.88 26.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 110.549 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' THR . . . . . 0.587 HG22 HG22 ' B' ' 122' ' ' VAL . 18.1 p -121.85 135.4 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.538 HG11 ' CD1' ' B' ' 152' ' ' PHE . 13.0 t -125.23 148.45 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 17.5 m -118.08 142.19 47.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.888 HD22 ' HB1' ' B' ' 150' ' ' ALA . 40.6 mt -101.29 -50.86 3.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.075 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.56 -12.5 23.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.46 172.46 9.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.623 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.5 OUTLIER -101.71 150.53 23.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.184 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.623 HD23 ' O ' ' B' ' 79' ' ' ARG . 17.4 mt -126.23 175.78 7.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -0.908 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.59 96.85 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.049 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.612 HD22 HG23 ' B' ' 102' ' ' VAL . 17.7 mt -43.87 -41.13 4.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.875 . . . . 0.0 110.329 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' B' ' 94' ' ' TYR . 12.8 mmtp -55.55 -47.45 76.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 110.343 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -79.91 -41.24 26.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 54.4 t -54.8 -54.59 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.933 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.71 69.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.927 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 34.9 tp -81.84 -25.1 35.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -98.34 -42.27 7.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.127 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -47.6 133.2 13.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.066 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ARG . . . . . 0.506 ' HG3' ' N ' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -70.63 -25.28 62.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.506 ' N ' ' HG3' ' B' ' 90' ' ' ARG . 1.2 m-20 -138.7 79.18 1.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.345 -0.847 . . . . 0.0 109.794 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.814 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -159.13 171.9 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.531 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.529 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -157.23 172.01 19.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 110.051 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.435 ' CD2' ' HE3' ' B' ' 83' ' ' LYS . 18.6 t80 -135.7 129.21 32.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' B' ' 95' ' ' ASN . 6.7 p30 -123.17 102.34 37.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.095 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.32 -26.06 17.83 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.015 1.534 . . . . 0.0 110.479 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -75.43 -20.94 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -100.07 -71.64 0.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -149.3 163.5 37.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 110.402 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.411 ' O ' HD11 ' B' ' 82' ' ' LEU . . . -82.51 47.96 1.24 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 109.305 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.133 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -126.35 144.5 50.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.904 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.612 HG23 HD22 ' B' ' 82' ' ' LEU . 6.8 t -90.02 124.95 42.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.529 ' HB ' ' CG ' ' B' ' 93' ' ' GLU . 8.8 mm -88.27 110.35 20.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.857 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.814 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 3.1 ttm -106.49 161.08 14.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 110.387 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' B' ' 111' ' ' THR . 0.5 OUTLIER -162.29 126.6 3.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.893 . . . . 0.0 110.293 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.64 HG23 ' CE1' ' B' ' 139' ' ' TYR . 37.4 pt -107.85 176.37 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.981 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.475 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -120.04 42.05 3.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER 170.7 85.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 48.8 Cg_endo -78.3 160.23 91.81 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.723 -2.199 . . . . 0.0 110.467 -0.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.476 ' O ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -67.56 105.25 1.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.95 . . . . 0.0 109.777 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.666 HG22 ' HA3' ' B' ' 125' ' ' GLY . 11.2 p -152.85 176.67 11.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.615 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.85 HG22 HG23 ' B' ' 124' ' ' THR . 5.3 t -131.37 171.42 13.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -156.74 141.61 17.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.991 -1.068 . . . . 0.0 110.642 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.818 HD22 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -98.53 103.78 15.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.449 -0.782 . . . . 0.0 109.048 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' B' ' 104' ' ' MET . 4.4 mt -89.76 135.74 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.119 -0.988 . . . . 0.0 110.61 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.905 ' CD1' HD11 ' A' ' 74' ' ' LEU . 3.0 m-30 -110.35 150.72 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.102 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.514 ' O ' ' CG ' ' B' ' 79' ' ' ARG . . . -70.05 -10.9 60.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.274 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -7.37 53.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.508 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 105.77 -18.61 40.23 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -88.32 160.07 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -1.183 . . . . 0.0 110.246 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 3.3 ptm -156.69 164.44 38.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.252 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.953 HG21 ' O ' ' A' ' 71' ' ' VAL . 35.7 t -128.57 161.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 110.485 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.418 ' N ' HG12 ' B' ' 122' ' ' VAL . 53.3 t -138.76 151.23 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.015 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.85 HG23 HG22 ' B' ' 112' ' ' THR . 1.2 t -157.23 164.26 37.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 110.344 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.666 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 110.79 -39.2 2.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.971 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.48 158.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -1.106 . . . . 0.0 110.317 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -124.05 -6.02 7.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.6 175.44 9.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.146 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.59 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.22 -16.71 5.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.264 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.678 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 0.3 OUTLIER -72.3 -49.66 32.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -25.06 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 110.422 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -78.91 -26.09 43.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.521 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.473 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 7.4 mt -79.12 -49.82 12.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -65.79 -30.83 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 51.0 p -67.97 -60.57 2.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.198 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' B' ' 134' ' ' LEU . 1.4 ptm180 -54.68 -33.19 60.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.006 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.422 ' O ' HG13 ' B' ' 142' ' ' ILE . 0.1 OUTLIER -65.91 -40.78 91.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 0.0 110.074 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.64 ' CE1' HG23 ' B' ' 106' ' ' ILE . 11.7 m-85 -65.98 -49.25 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 140' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' B' ' 152' ' ' PHE . . . -55.62 -30.58 61.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -71.94 -31.68 66.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 138' ' ' LYS . 34.5 mt -61.79 -42.7 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.626 HD12 ' N ' ' B' ' 143' ' ' ILE . 1.8 mp -67.51 -44.5 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -72.94 -30.05 63.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.655 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -20.11 61.52 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.412 HD13 HG21 ' B' ' 146' ' ' ILE . 3.6 mt -86.14 -24.07 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.72 -26.27 3.65 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.535 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.497 ' CD1' HD22 ' B' ' 80' ' ' LEU . 12.3 m-85 -52.27 158.16 1.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.943 -1.328 . . . . 0.0 110.988 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.65 34.72 2.16 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.888 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -68.57 169.6 10.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.352 -0.842 . . . . 0.0 110.421 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.9 OUTLIER -148.91 112.74 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 110.264 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.573 ' O ' HG23 ' B' ' 153' ' ' THR . 83.5 t80 -58.97 108.34 0.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 152' ' ' PHE . 1.4 p -156.18 169.37 24.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' B' ' 153' ' ' THR . 4.2 t70 62.41 28.84 17.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.217 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -70.91 134.02 46.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.953 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.91 131.41 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.496 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.435 ' C ' ' HG2' ' B' ' 158' ' ' GLN . 14.7 mt -82.91 131.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.435 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 3.6 mt-30 -128.76 0.32 5.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.781 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.462 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 2.1 t-20 -147.79 110.11 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.921 -1.112 . . . . 0.0 110.709 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.663 ' CG2' HD22 ' B' ' 67' ' ' LEU . 66.4 mt -113.26 141.35 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.589 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.575 HG22 ' OG1' ' B' ' 215' ' ' THR . 72.8 t -115.93 130.05 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.13 -0.981 . . . . 0.0 110.645 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.97 168.3 19.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 1.0 OUTLIER -166.57 149.44 6.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.262 . . . . 0.0 110.545 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.641 ' SG ' HG22 ' B' ' 63' ' ' ILE . 0.8 OUTLIER -170.07 170.18 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.021 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 164.08 12.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.032 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.797 HG21 HD11 ' B' ' 170' ' ' ILE . 32.6 m -113.2 11.97 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.279 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.53 -2.25 2.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.585 ' O ' HG23 ' B' ' 166' ' ' VAL . 26.1 p90 -161.37 150.09 13.09 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.987 -1.071 . . . . 0.0 110.568 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.508 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 47.8 Cg_endo -73.88 170.24 20.53 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.133 1.596 . . . . 0.0 110.732 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.797 HD11 HG21 ' B' ' 166' ' ' VAL . 4.4 mp -140.36 151.28 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 110.378 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.76 80.27 7.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 109.946 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.792 HD21 HG22 ' B' ' 206' ' ' ILE . 18.9 mt -47.07 -37.97 10.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 110.42 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.17 -55.27 22.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.24 92.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 18.3 tp -70.12 -39.67 75.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -1.169 . . . . 0.0 110.373 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.64 -26.69 67.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.955 . . . . 0.0 110.18 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -77.01 -30.05 55.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 1.3 p -87.42 -44.64 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -105.72 26.51 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 110.259 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.55 54.85 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.7 m -53.8 -39.03 65.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -1.188 . . . . 0.0 110.433 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' B' ' 198' ' ' VAL . 19.9 m-85 -108.26 -26.97 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.401 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.797 ' HB2' HD21 ' B' ' 193' ' ' LEU . 47.9 p -96.05 158.05 15.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.624 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.2 m -132.43 119.75 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.677 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -125.42 112.13 15.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 110.565 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -118.94 102.55 49.11 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 109.666 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.61 -1.18 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.93 1.489 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -98.95 -3.64 34.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.036 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.509 HD13 ' HE3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -150.93 -37.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.789 ' CE2' HD21 ' A' ' 59' ' ' LEU . 7.8 t80 -127.95 110.98 20.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.86 -17.64 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.888 1.467 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.87 -179.94 44.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' B' ' 183' ' ' SER . 7.6 tt -118.38 130.07 55.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -1.143 . . . . 0.0 110.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.482 HD13 ' CD1' ' A' ' 62' ' ' LEU . 5.7 mt -102.96 100.94 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 109.914 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -91.79 120.26 32.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.471 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' B' ' 203' ' ' VAL . 1.1 mtp180 -92.54 83.45 4.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.475 ' HB2' ' CD1' ' B' ' 204' ' ' LEU . 33.7 tpp -42.11 126.81 3.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.935 . . . . 0.0 110.189 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.507 HG22 ' CE1' ' B' ' 182' ' ' PHE . 61.9 t -63.17 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 8.8 mtmt -137.4 118.13 10.65 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.6 Cg_endo -74.16 169.54 73.53 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.986 -2.089 . . . . 0.0 110.369 -0.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' B' ' 197' ' ' MET . 37.2 mttt -76.85 95.35 4.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.044 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' B' ' 217' ' ' ALA . 31.8 mm -130.96 149.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' B' ' 196' ' ' ARG . 71.4 t -101.83 105.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.032 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.749 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.5 mp -95.82 118.5 32.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.45 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.5 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 0.5 OUTLIER -89.65 117.41 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 109.935 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.792 HG22 HD21 ' B' ' 172' ' ' LEU . 3.2 mt -113.0 136.0 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.351 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.544 ' HA ' HD11 ' B' ' 172' ' ' LEU . 44.7 m-85 -119.62 145.2 46.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 64.3 t -49.19 -24.36 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -62.67 -38.65 91.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 110.133 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.483 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 123.36 8.77 6.29 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -90.06 145.22 25.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.241 . . . . 0.0 110.232 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' B' ' 163' ' ' SER . 30.3 mm -130.05 121.69 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.335 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.516 HG11 ' HE1' ' A' ' 25' ' ' PHE . 57.4 t -113.86 155.74 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.051 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.487 HD12 ' N ' ' B' ' 214' ' ' LEU . 2.6 mp -140.12 121.94 15.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 110.629 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.575 ' OG1' HG22 ' B' ' 161' ' ' VAL . 6.2 t -137.02 146.48 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.886 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 111.18 3.9 27.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -82.99 138.45 33.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -29.27 32.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.582 ' O ' HD12 ' B' ' 160' ' ' ILE . 3.2 tt0 -136.17 -152.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 110.029 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -100.11 -36.89 9.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.432 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 16.0 pt-20 -54.69 -27.38 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.119 -0.988 . . . . 0.0 110.518 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 0.8 OUTLIER -71.61 -47.43 54.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.242 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.744 HG22 ' HG2' ' B' ' 65' ' ' PRO . 40.8 mm -62.63 -37.61 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.29 -29.19 67.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.923 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -37.63 41.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.321 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.749 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -61.32 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.365 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' B' ' 230' ' ' ILE . 27.9 t80 -64.81 -46.54 81.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.394 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.42 -32.68 71.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -85.14 -25.94 27.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.426 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' B' ' 227' ' ' PHE . 8.7 tp -97.2 -17.94 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.595 ' N ' ' CD ' ' B' ' 232' ' ' PRO . 14.3 t80 -59.63 -41.34 85.76 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.943 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -77.93 -47.22 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.36 1.189 . . . . 0.0 110.384 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.49 -50.8 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.724 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.522 ' CD1' HG13 ' B' ' 230' ' ' ILE . 95.7 mt -59.14 -38.13 78.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.833 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 3.4 t -65.53 -39.39 91.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.392 -0.818 . . . . 0.0 109.816 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' GLU . . . . . 0.519 ' HG2' ' CE1' ' B' ' 237' ' ' PHE . 0.8 OUTLIER -60.14 -33.85 72.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.677 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.519 ' CE1' ' HG2' ' B' ' 236' ' ' GLU . 65.2 m-85 -115.39 37.41 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.827 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -62.52 168.64 3.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 0.0 110.257 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.429 ' HB2' ' C ' ' B' ' 169' ' ' PRO . 0.0 OUTLIER -111.84 -33.32 6.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 110.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.196 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.095 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 19' ' ' ASP . 1.9 p30 -86.19 109.12 18.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.095 HD21 HD21 ' A' ' 18' ' ' LEU . 3.4 mt -101.17 18.45 19.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.89 HG22 HG23 ' A' ' 56' ' ' ILE . 1.3 m -45.19 -29.86 1.05 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.057 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -98.44 -27.8 8.4 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.495 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.934 HG13 HD22 ' A' ' 20' ' ' LEU . 1.1 mm -52.36 -45.87 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.912 -1.346 . . . . 0.0 109.359 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 67' ' ' MET . 2.0 pp -85.86 -26.51 25.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.608 -1.308 . . . . 0.0 109.665 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CD1' HG21 ' B' ' 215' ' ' THR . 0.5 OUTLIER -83.88 7.41 18.22 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 142.61 106.04 0.57 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 27' ' ' ASN . 6.4 p-10 -24.49 135.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.784 0.802 . . . . 0.0 111.396 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.749 HG23 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -150.42 161.77 3.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.546 ' N ' HG12 ' A' ' 28' ' ' ILE . 5.3 m-20 -87.48 119.2 27.52 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.572 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 1.3 p -39.53 -26.69 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.898 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.543 ' OE2' ' ND2' ' B' ' 95' ' ' ASN . 3.1 tt0 -57.55 -13.37 3.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.117 -0.989 . . . . 0.0 110.43 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.23 27.71 4.67 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.416 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.555 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.5 mmt-85 -120.77 122.19 39.83 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.085 -1.244 . . . . 0.0 109.861 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 35' ' ' LEU . 3.1 tt -87.67 162.07 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.933 -1.105 . . . . 0.0 111.738 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.691 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 O-C-N 121.472 -0.767 . . . . 0.0 111.355 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.14 0.495 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.503 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -100.28 -22.13 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.349 -0.844 . . . . 0.0 109.469 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.7 mt -95.39 -45.21 7.22 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.546 -0.721 . . . . 0.0 110.157 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.999 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -49.5 -52.47 29.21 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.152 -0.968 . . . . 0.0 109.6 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.79 -23.21 66.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 12.5 m-20 -85.83 -33.99 21.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.999 HD12 ' HA ' ' A' ' 53' ' ' ARG . 15.6 mt -54.22 -42.14 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 109.372 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.35 -14.89 35.96 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.976 ' HB3' HD11 ' B' ' 189' ' ' LEU . 49.7 m -122.07 0.05 9.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.12 -1.223 . . . . 0.0 110.297 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.897 HD23 HD12 ' A' ' 62' ' ' LEU . 1.2 mt -81.38 8.32 9.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -91.18 43.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.697 ' C ' HD23 ' A' ' 62' ' ' LEU . 5.9 pttt -172.88 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.897 HD12 HD23 ' A' ' 59' ' ' LEU . 3.7 mt -105.15 -43.82 4.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.03 -28.3 0.09 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.719 HD12 HD21 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -84.53 0.19 50.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -1.212 . . . . 0.0 110.108 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.546 ' HA ' ' HG ' ' A' ' 68' ' ' LEU . 4.7 t70 -50.36 -39.69 47.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 109.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.76 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -58.7 -32.2 68.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.895 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.704 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -70.45 -26.79 63.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.885 . . . . 0.0 109.74 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.719 HD21 HD12 ' A' ' 64' ' ' LEU . 7.4 mt -64.43 -61.7 2.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.725 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.76 HD21 ' HA ' ' A' ' 66' ' ' SER . 3.3 pp -58.04 -12.63 3.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.676 -0.64 . . . . 0.0 110.341 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -87.05 2.75 48.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 110.592 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.018 HG12 HG11 ' B' ' 122' ' ' VAL . 2.8 t -127.74 -0.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.393 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.054 HD11 HD12 ' A' ' 74' ' ' LEU . 2.8 tp -150.51 68.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -73.43 56.95 0.52 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.849 -1.157 . . . . 0.0 108.975 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.095 HD11 ' CB ' ' B' ' 101' ' ' ALA . 5.6 mt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.693 0.759 . . . . 0.0 110.472 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.495 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 4.2 mt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.156 0.503 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' B' ' 65' ' ' PRO . 91.8 t 59.34 142.22 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.436 -0.79 . . . . 0.0 110.301 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' B' ' 64' ' ' VAL . 47.3 Cg_endo -72.97 123.96 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.844 1.444 . . . . 0.0 110.745 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.447 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 9.3 m -92.06 135.0 34.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.484 ' HG ' ' NH2' ' B' ' 220' ' ' ARG . 19.0 mt -69.95 125.41 26.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 110.323 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -101.4 -27.29 13.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.147 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' HB ' ' B' ' 161' ' ' VAL . 5.6 m120 -156.14 162.73 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.861 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 17.0 mm -136.48 150.64 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.794 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' B' ' 124' ' ' THR . 24.1 t -136.76 140.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.99 149.4 36.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.909 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.38 128.32 45.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -0.954 . . . . 0.0 110.539 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' B' ' 121' ' ' MET . 59.0 t -119.67 151.2 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 109.955 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 23.5 m -129.49 142.91 50.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' B' ' 150' ' ' ALA . 49.4 mt -100.05 -46.2 5.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.18 55.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.5 158.65 43.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -1.178 . . . . 0.0 110.212 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -80.13 142.96 34.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 1.028 HD11 ' CD1' ' B' ' 76' ' ' LEU . 25.7 mt -116.65 153.68 31.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.423 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' B' ' 82' ' ' LEU . 8.2 t0 -96.93 86.9 4.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.468 ' HA ' HG21 ' B' ' 102' ' ' VAL . 8.6 mt -40.66 -43.62 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.845 . . . . 0.0 110.362 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -54.13 -45.45 71.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.94 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 14.7 m -81.02 -44.5 17.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.96 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 40.8 t -54.94 -43.08 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 110.159 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.86 -25.59 48.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.69 -33.49 20.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.213 -0.929 . . . . 0.0 110.124 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.0 m80 -83.22 -44.83 14.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.31 141.84 22.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.089 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ARG . . . . . 0.41 ' O ' ' OD1' ' B' ' 91' ' ' ASN . 21.7 mtt85 -81.05 -15.44 56.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.483 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' B' ' 104' ' ' MET . 16.0 m-20 -139.54 79.94 1.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' B' ' 93' ' ' GLU . . . -152.95 161.91 41.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' B' ' 92' ' ' ALA . 37.7 mt-10 -142.46 161.61 37.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 110.132 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -152.04 130.56 12.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.928 . . . . 0.0 110.324 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.543 ' ND2' ' OE2' ' A' ' 31' ' ' GLU . 3.1 m-20 -145.41 122.99 6.28 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.11 -16.71 28.56 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.908 1.478 . . . . 0.0 110.343 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -77.78 -9.73 59.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -109.3 -59.94 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.261 -0.899 . . . . 0.0 110.137 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.666 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -163.07 -159.23 0.53 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.496 -0.753 . . . . 0.0 110.704 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.47 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -121.38 49.8 1.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 111.602 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.095 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -143.57 163.77 32.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' B' ' 82' ' ' LEU . 90.0 t -101.41 136.93 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 29' ' ' ASP . 3.1 mp -106.03 111.34 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.369 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.501 ' HB2' ' HE3' ' B' ' 104' ' ' MET . 14.6 ttm -94.53 170.52 9.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.323 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -157.56 113.15 2.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.841 HG23 ' CE1' ' B' ' 139' ' ' TYR . 48.3 pt -101.29 170.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' B' ' 108' ' ' GLU . 5.3 mmt85 -124.93 46.32 2.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 0.0 110.291 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 175.27 79.21 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 0.0 110.338 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 52.5 Cg_endo -81.63 161.56 79.77 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.756 -2.185 . . . . 0.0 110.473 -0.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.15 106.38 1.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.556 HG22 ' HA3' ' B' ' 125' ' ' GLY . 1.7 p -147.27 177.5 9.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.645 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.7 m -124.57 159.14 31.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -147.48 138.35 23.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 110.41 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 121' ' ' MET . 8.0 mt -98.46 120.51 39.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 109.723 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.421 HG13 ' HG2' ' B' ' 121' ' ' MET . 3.6 mt -111.97 115.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.985 . . . . 0.0 110.375 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 3.6 m-30 -94.93 168.32 10.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -78.41 -13.52 59.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.4 t -81.05 -7.81 59.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.79 -26.27 20.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -56.2 149.74 15.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -1.135 . . . . 0.0 110.096 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 1.7 tmm? -148.66 128.82 13.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 1.018 HG11 HG12 ' A' ' 71' ' ' VAL . 73.4 t -114.91 128.1 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.2 t -112.86 151.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.349 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.559 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.8 t -155.09 164.42 38.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 109.983 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.569 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 110.83 -34.84 5.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.861 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.24 149.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -1.148 . . . . 0.0 110.442 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -3.19 30.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.492 ' N ' HG13 ' B' ' 70' ' ' ILE . 3.0 m -167.17 -163.23 0.51 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' GLU . . . . . 0.451 ' HA ' HD11 ' B' ' 157' ' ' ILE . 3.1 mt-10 -78.24 -44.65 24.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.316 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.11 -26.1 66.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 110.387 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.93 -58.29 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.885 . . . . 0.0 110.286 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' SER . . . . . 0.652 ' OG ' HG21 ' B' ' 70' ' ' ILE . 2.2 m -47.57 -40.01 18.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 12.2 mttt -60.24 -51.06 71.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' B' ' 137' ' ' ARG . 39.6 mt -62.88 -32.81 74.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -74.3 -41.1 61.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.271 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 3.6 p -65.7 -52.09 54.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.509 ' CZ ' ' HB2' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -55.15 -34.1 63.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.493 ' HD3' ' HD2' ' B' ' 137' ' ' ARG . 7.0 mptt -65.42 -36.67 84.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 110.032 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.877 ' HA ' HD12 ' B' ' 142' ' ' ILE . 31.4 m-85 -71.41 -52.3 19.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.875 . . . . 0.0 110.04 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.74 64.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.087 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -40.71 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' B' ' 139' ' ' TYR . 24.6 mt -59.37 -54.93 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.723 HG21 ' HB2' ' B' ' 150' ' ' ALA . 10.0 mt -55.73 -46.61 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 35.0 mt-30 -66.26 -35.24 79.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' B' ' 145' ' ' LYS . 10.1 tttm -71.55 -21.05 61.94 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mt -83.31 -18.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.88 -21.37 12.43 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.533 ' HB2' HG22 ' B' ' 143' ' ' ILE . 12.3 m-85 -57.55 172.6 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.278 . . . . 0.0 111.016 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.54 54.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.75 . . . . 0.0 110.328 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -90.74 130.57 36.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 110.423 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -121.85 119.28 31.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 17.0 t80 -60.79 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -140.6 171.35 14.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 110.227 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.474 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 56.5 m-20 58.37 19.32 6.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.367 -0.833 . . . . 0.0 110.559 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' B' ' 152' ' ' PHE . 15.1 t80 -68.69 136.79 53.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.92 136.5 1.93 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.451 HD11 ' HA ' ' B' ' 129' ' ' GLU . 70.7 mt -79.29 124.51 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -118.5 -8.81 10.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.114 -0.991 . . . . 0.0 110.992 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 30.4 t30 -148.98 134.42 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.783 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.414 ' CG2' HD22 ' B' ' 67' ' ' LEU . 60.0 mt -129.4 142.85 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.747 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 41.6 t -113.1 135.75 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.985 . . . . 0.0 110.55 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -136.94 173.11 22.32 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.3 t -164.82 151.18 10.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -1.184 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.478 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.0 p -170.21 146.57 2.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.406 ' O ' HD13 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -98.03 169.53 9.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.962 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.0 OUTLIER -113.31 -83.33 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -176.01 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' B' ' 238' ' ' ARG . 14.8 p90 -131.8 159.45 71.92 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.363 -0.836 . . . . 0.0 109.576 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -71.34 152.19 60.74 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.873 1.46 . . . . 0.0 110.146 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.26 148.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.561 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -86.88 106.45 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.934 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.51 HD22 ' CB ' ' B' ' 193' ' ' LEU . 21.9 mt -63.23 -59.91 4.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.342 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 173' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 23.5 pt-20 -50.19 -33.85 20.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -72.96 -41.57 48.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.457 ' O ' HD12 ' B' ' 175' ' ' LEU . 9.7 tp -80.23 -32.28 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -1.119 . . . . 0.0 110.23 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.808 ' HB2' ' CD1' ' B' ' 193' ' ' LEU . . . -73.95 -24.3 59.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 110.178 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -79.14 -42.61 25.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 t -78.74 -52.19 8.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.14 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -93.41 13.48 21.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.072 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -46.42 -32.97 5.63 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' THR . . . . . 0.552 HG23 ' HD2' ' B' ' 182' ' ' PHE . 1.8 t -54.08 -24.15 16.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -1.221 . . . . 0.0 110.378 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.829 ' CE1' HG22 ' B' ' 198' ' ' VAL . 26.4 m-85 -133.05 13.63 4.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.497 ' HB3' HD21 ' B' ' 193' ' ' LEU . 58.8 m -129.65 150.38 51.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.281 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.92 133.94 53.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' B' ' 185' ' ' TYR . 26.4 t80 -150.45 102.61 3.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.101 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' B' ' 190' ' ' PHE . 1.3 mt-10 -113.31 115.26 47.56 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 110.091 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.82 -1.49 10.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.403 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -100.27 6.82 44.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.976 HD11 ' HB3' ' A' ' 58' ' ' SER . 0.4 OUTLIER -166.36 -38.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 110.386 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.544 ' CZ ' HD11 ' B' ' 205' ' ' LEU . 1.8 t80 -118.65 114.05 36.08 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.4 -31.12 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.863 1.454 . . . . 0.0 110.568 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.96 -179.72 44.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.808 ' CD1' ' HB2' ' B' ' 176' ' ' ALA . 8.5 tt -113.42 133.78 55.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -1.125 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.666 ' CD1' HD13 ' A' ' 62' ' ' LEU . 53.0 mt -100.68 109.11 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.737 ' CD2' HD13 ' B' ' 230' ' ' ILE . 15.4 t80 -99.69 114.15 27.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -90.63 98.47 11.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.104 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.416 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 0.5 OUTLIER -56.73 131.09 48.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.419 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.829 HG22 ' CE1' ' B' ' 182' ' ' PHE . 13.2 t -70.82 -48.75 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.061 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 6.9 tttm -144.29 117.03 5.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.7 Cg_endo -72.79 163.18 89.58 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.931 -2.112 . . . . 0.0 110.63 0.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.788 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -70.94 99.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.788 HD13 ' O ' ' B' ' 201' ' ' LYS . 37.6 mm -143.65 145.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.06 141.47 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.704 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 133.99 50.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.042 -1.036 . . . . 0.0 110.716 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.544 HD11 ' CZ ' ' B' ' 190' ' ' PHE . 2.6 mm? -103.32 116.6 32.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.714 HG13 HD12 ' B' ' 212' ' ' ILE . 3.5 mp -114.3 120.73 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.09 -1.006 . . . . 0.0 110.406 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.407 ' CD1' ' HA3' ' B' ' 192' ' ' GLY . 66.9 m-85 -110.88 143.76 40.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 110.208 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 17.2 t -44.11 -25.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 207' ' ' PHE . 25.2 m -59.94 -38.33 82.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.31 -0.869 . . . . 0.0 110.36 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.438 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 115.83 13.91 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.475 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -99.61 133.39 44.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.023 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.714 HD12 HG13 ' B' ' 206' ' ' ILE . 29.0 mm -118.52 136.68 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.941 . . . . 0.0 110.429 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 4.6 t -119.93 155.51 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 109.921 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.455 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.9 mp -134.34 123.2 23.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.975 . . . . 0.0 110.376 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 25' ' ' PHE . 8.3 t -141.27 147.57 38.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.07 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.42 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 103.92 5.82 43.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -89.08 134.6 33.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -1.124 . . . . 0.0 110.119 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -27.34 48.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.363 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.22 163.0 33.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.267 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 220' ' ' ARG . . . . . 0.505 ' CG ' ' CE1' ' B' ' 224' ' ' TYR . 4.9 ttm180 -65.54 -20.58 66.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 110.119 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -54.67 -44.32 73.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 226' ' ' ALA . 30.1 mt-10 -72.71 -39.98 66.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.911 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.411 HD12 HG23 ' B' ' 223' ' ' ILE . 34.0 mm -57.91 -41.51 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.891 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' B' ' 220' ' ' ARG . 10.1 m-85 -79.04 -47.22 16.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.103 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -65.54 -42.72 91.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' B' ' 222' ' ' GLU . . . -57.47 -44.54 84.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.606 ' CZ ' ' CE2' ' B' ' 231' ' ' TYR . 32.6 t80 -67.6 -28.66 67.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.145 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.27 -19.18 61.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.108 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.77 -31.86 15.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.737 HD13 ' CD2' ' B' ' 195' ' ' TYR . 9.2 tp -85.51 -22.61 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.606 ' CE2' ' CZ ' ' B' ' 227' ' ' PHE . 0.3 OUTLIER -40.89 -50.95 7.45 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.963 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.1 Cg_endo -69.22 -42.2 4.19 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.428 1.225 . . . . 0.0 110.633 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.66 -40.36 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.551 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 74.0 mt -61.25 -45.02 96.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 235' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 22.9 t -64.64 -46.71 81.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -35.91 49.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -108.58 38.56 2.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.494 ' HB3' ' CE1' ' B' ' 168' ' ' PHE . 1.0 OUTLIER -89.05 149.31 23.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -94.21 -60.16 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.5 mmm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.225 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.119 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.601 ' O ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -83.41 105.42 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 111.194 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.119 HD21 HD21 ' A' ' 18' ' ' LEU . 6.8 mt -117.97 3.64 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.958 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.72 HG21 ' O ' ' A' ' 56' ' ' ILE . 6.2 m -38.44 -30.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.679 0.752 . . . . 0.0 109.549 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.577 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -100.55 -31.49 5.78 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.87 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.32 -43.36 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.074 -1.251 . . . . 0.0 108.762 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.812 HD13 ' HG2' ' A' ' 67' ' ' MET . 1.8 pp -80.78 6.34 13.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 108.977 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE1' HD13 ' A' ' 52' ' ' LEU . 4.3 t80 -110.65 -18.08 13.24 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.544 -0.723 . . . . 0.0 111.034 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 158.3 67.02 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 C-N-CA 118.448 -1.834 . . . . 0.0 111.59 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.579 ' HB3' ' CG ' ' A' ' 35' ' ' LEU . 4.0 m120 41.28 111.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.943 . . . . 0.0 113.271 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -156.02 151.44 9.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.172 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLU . 12.6 m-20 -89.06 137.09 32.63 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.596 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 83.3 p -39.81 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.241 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -48.6 -21.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.6 29.5 5.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.33 131.5 54.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.122 -1.222 . . . . 0.0 110.085 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.765 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -101.86 139.16 37.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 35' ' ' LEU . 2.8 pp . . . . . 0 N--CA 1.491 1.593 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.419 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.184 0.516 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 18.3 tp10 -97.49 -25.46 15.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.014 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.643 HD13 ' CE1' ' A' ' 25' ' ' PHE . 5.9 mt -110.01 -44.94 3.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.626 -0.672 . . . . 0.0 110.055 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.79 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.02 -45.77 3.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.578 0.704 . . . . 0.0 109.984 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.27 -50.62 63.09 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.497 ' C ' HD12 ' A' ' 59' ' ' LEU . 64.0 m-20 -58.72 -38.77 79.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 109.174 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 53' ' ' ARG . 8.0 mt -50.91 -40.14 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.096 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -12.97 48.71 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.68 ' HB2' HD11 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -125.09 -0.24 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -1.12 . . . . 0.0 110.344 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.886 HD23 HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -80.52 51.86 1.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 24.3 t -134.06 50.24 2.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.887 . . . . 0.0 110.273 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 60' ' ' SER . 5.3 pttp 179.34 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.087 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.952 HD12 ' N ' ' A' ' 63' ' ' GLY . 1.1 pp -140.26 -29.54 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.054 -1.029 . . . . 0.0 111.146 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.952 ' N ' HD12 ' A' ' 62' ' ' LEU . . . 178.5 -48.99 0.09 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 62' ' ' LEU . 1.1 pp -82.95 -5.27 58.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.264 . . . . 0.0 110.812 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.7 t70 -44.47 -35.35 2.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.66 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -63.8 -47.04 82.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 0.0 109.619 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.812 ' HG2' HD13 ' A' ' 24' ' ' LEU . 7.1 ttp -65.02 -10.92 33.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.692 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.758 HD21 ' H ' ' A' ' 20' ' ' LEU . 4.9 tt -73.35 -61.27 1.88 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.78 0.86 11.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 109.939 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 25.4 tt0 -91.78 15.28 13.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 0.0 110.796 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.574 ' HB ' HD12 ' A' ' 20' ' ' LEU . 1.6 t -130.43 0.35 2.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.917 0.865 . . . . 0.0 109.016 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.975 HD11 HD12 ' A' ' 74' ' ' LEU . 1.3 tp -151.0 76.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 5.4 t0 -75.09 57.09 0.81 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.383 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.04 HD11 ' CB ' ' B' ' 101' ' ' ALA . 8.5 mt . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.469 -0.769 . . . . 0.0 110.572 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.669 HG22 ' SG ' ' B' ' 164' ' ' CYS . 29.6 mt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.262 0.553 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.506 HG23 ' C ' ' B' ' 63' ' ' ILE . 3.0 t 65.8 142.64 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 110.383 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.556 ' HG2' HG22 ' B' ' 223' ' ' ILE . 46.8 Cg_endo -75.96 137.88 20.17 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.098 1.578 . . . . 0.0 110.317 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.444 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 49.1 m -97.66 132.61 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.719 HD11 ' HG3' ' B' ' 220' ' ' ARG . 44.4 mt -69.72 120.61 15.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.961 . . . . 0.0 109.826 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 66' ' ' THR . 25.2 mm-40 -110.4 -14.04 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -162.56 144.52 10.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.987 . . . . 0.0 110.812 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.84 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 6.0 mm -126.35 150.75 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 109.333 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.74 126.29 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.011 -1.056 . . . . 0.0 110.549 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.83 170.75 15.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 110.05 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -141.2 145.26 35.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' B' ' 136' ' ' SER . 3.8 t -127.97 155.74 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 25.9 m -106.0 129.64 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.835 HD22 ' HB1' ' B' ' 150' ' ' ALA . 72.8 mt -84.29 -69.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.89 28.39 2.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' CYS . . . . . 0.949 ' SG ' ' HB3' ' B' ' 149' ' ' ALA . 39.8 t -164.02 152.1 12.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.457 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -73.23 139.81 46.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.707 HD11 ' CD1' ' B' ' 76' ' ' LEU . 28.9 mt -118.28 140.21 50.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 110.385 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 94.92 9.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.881 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.672 HD22 HG23 ' B' ' 102' ' ' VAL . 14.4 mt -44.05 -52.67 6.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.365 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -49.86 -43.46 49.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.028 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 28.0 m -76.27 -48.84 18.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 0.0 110.129 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.84 -47.81 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.56 65.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 tp -75.61 -42.22 52.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -88.26 -31.79 18.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' B' ' 92' ' ' ALA . . . -57.05 109.84 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.87 -22.35 66.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.052 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.491 ' ND2' ' HG3' ' B' ' 105' ' ' ARG . 2.4 t-20 -134.08 79.63 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.517 ' HB2' ' HB1' ' B' ' 89' ' ' ALA . . . -149.0 163.07 38.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -144.91 127.05 15.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.187 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -114.6 125.58 53.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.218 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.75 106.0 20.73 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.231 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.94 -21.78 20.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.033 1.544 . . . . 0.0 110.241 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -82.4 8.38 11.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.085 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.546 ' HB3' ' CD2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER -131.27 -70.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.594 ' HE2' ' HG ' ' A' ' 30' ' ' SER . 24.4 p90 -134.74 -173.62 3.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.046 . . . . 0.0 110.436 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 64.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.04 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -159.29 177.0 11.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.298 -0.876 . . . . 0.0 110.566 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.672 HG23 HD22 ' B' ' 82' ' ' LEU . 92.2 t -119.13 124.93 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.543 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 5.5 mt -89.66 107.36 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.663 ' SD ' HD13 ' B' ' 142' ' ' ILE . 37.8 ttm -108.31 151.14 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.491 ' HG3' ' ND2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -139.23 145.36 39.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.554 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 15.0 pt -111.66 175.35 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.136 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.6 mtt180 -116.73 26.73 9.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 110.408 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.5 tm-20 -175.88 87.13 0.29 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.752 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.0 Cg_endo -78.45 153.38 91.59 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.759 -2.184 . . . . 0.0 110.242 -0.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.6 OUTLIER -67.11 104.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 0.0 109.915 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.47 ' HA ' ' ND2' ' A' ' 27' ' ' ASN . 68.0 p -146.75 176.87 9.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.925 . . . . 0.0 110.566 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -115.76 144.18 44.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.604 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -135.21 129.58 33.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.959 -1.088 . . . . 0.0 110.885 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.647 ' HB2' HG12 ' B' ' 122' ' ' VAL . 3.5 mm? -89.59 120.49 30.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.044 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.56 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 1.6 mp -108.92 122.92 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' B' ' 120' ' ' LYS . 3.6 m-30 -96.49 149.04 22.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.71 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.51 -6.0 27.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.961 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.4 p -86.91 -16.77 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.427 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 119.31 -26.88 7.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 4.0 mttt -78.44 145.45 35.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -1.194 . . . . 0.0 110.157 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 7.3 ptt? -152.26 151.51 31.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 110.204 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' B' ' 114' ' ' LEU . 0.5 OUTLIER -110.47 162.38 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.902 . . . . 0.0 109.771 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.403 HG23 ' C ' ' B' ' 122' ' ' VAL . 12.7 t -145.2 119.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.52 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 10.2 t -113.56 151.33 31.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.91 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.563 ' N ' ' OD1' ' A' ' 27' ' ' ASN . . . 118.45 -31.48 5.58 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.407 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.84 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -39.92 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.0 110.305 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -104.4 -16.13 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.185 -0.947 . . . . 0.0 109.741 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 7.2 t -169.22 175.24 5.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.92 . . . . 0.0 110.043 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.07 -40.63 73.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.3 -47.12 65.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' B' ' 127' ' ' LYS . 15.8 t0 -58.17 -55.01 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 110.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' SER . . . . . 0.403 ' HB2' ' HB1' ' B' ' 126' ' ' ALA . 8.7 t -49.46 -47.43 48.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' B' ' 133' ' ' LYS . 1.3 tppt? -49.83 -40.48 42.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.41 -46.26 41.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.38 53.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.785 ' HB3' HG21 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -65.43 -53.35 44.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.812 . . . . 0.0 110.067 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.09 -38.7 5.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.116 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -62.93 -56.39 17.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 51.6 m-85 -56.03 -47.54 77.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.855 . . . . 0.0 109.976 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.94 -24.72 54.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.012 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 19.0 ttt180 -77.32 -51.84 10.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.663 HD13 ' SD ' ' B' ' 104' ' ' MET . 7.1 mt -45.75 -36.79 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.754 HG21 ' HB2' ' B' ' 150' ' ' ALA . 34.8 mm -76.48 -52.79 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.82 -32.0 73.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.62 -26.15 60.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' B' ' 142' ' ' ILE . 11.3 mt -77.71 -24.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.86 -21.16 6.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.578 ' HB2' HG22 ' B' ' 143' ' ' ILE . 17.8 m-85 -57.82 178.6 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.277 . . . . 0.0 110.944 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.949 ' HB3' ' SG ' ' B' ' 78' ' ' CYS . . . -113.89 45.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.528 -0.733 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.835 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -81.59 109.84 16.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 110.475 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.505 ' O ' HD23 ' B' ' 76' ' ' LEU . 6.2 tttp -85.34 -170.28 3.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.136 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.427 ' HD1' HG11 ' B' ' 74' ' ' VAL . 9.7 t80 -136.75 103.53 5.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.0 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -166.41 169.5 13.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.875 . . . . 0.0 110.308 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' B' ' 153' ' ' THR . 8.2 t0 69.58 10.99 7.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.818 . . . . 0.0 110.63 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.636 ' HD1' HG22 ' B' ' 74' ' ' VAL . 39.8 t80 -48.25 151.64 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 142.85 3.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.539 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.75 149.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 109.951 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -118.87 -60.18 1.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' B' ' 217' ' ' ALA . 51.9 m-80 -143.07 169.28 17.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 110.643 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.77 HD12 ' O ' ' B' ' 219' ' ' GLN . 45.4 mt -140.87 138.01 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 109.775 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.946 HG22 ' OG1' ' B' ' 215' ' ' THR . 26.1 t -110.47 129.42 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.06 174.82 18.22 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.38 146.21 3.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -1.209 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.669 ' SG ' HG22 ' B' ' 63' ' ' ILE . 0.5 OUTLIER -170.65 150.46 3.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.94 165.46 12.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.489 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -110.11 -83.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.489 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 179.65 -29.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.232 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 3.5 p90 -134.43 158.22 75.66 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.464 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.3 Cg_endo -71.88 159.91 49.2 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.998 1.525 . . . . 0.0 110.588 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.0 151.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.459 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' B' ' 171' ' ' ARG . 2.1 ptm180 -87.61 103.66 15.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.53 ' HB3' ' CE1' ' B' ' 185' ' ' TYR . 12.7 mt -53.54 -33.16 53.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.28 -43.35 95.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.66 -29.32 73.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.553 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -79.32 -32.03 43.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -1.096 . . . . 0.0 110.068 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.929 ' HB2' HD11 ' B' ' 193' ' ' LEU . . . -87.0 -25.53 24.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.91 -39.6 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 29.9 t -84.73 -38.84 19.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.511 ' CE1' HG13 ' B' ' 233' ' ' VAL . 69.4 m80 -107.27 15.4 25.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -44.61 -35.89 4.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.55 4.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -138.95 9.7 2.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 110.264 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.615 ' OG ' HD21 ' B' ' 193' ' ' LEU . 1.8 t -122.19 122.31 38.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.12 127.84 45.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.942 . . . . 0.0 110.234 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 0.573 ' CD1' HD12 ' B' ' 193' ' ' LEU . 23.0 t80 -126.13 120.5 30.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -137.68 102.33 8.64 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 110.054 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.32 0.1 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.13 1.594 . . . . 0.0 110.365 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -99.88 -4.78 29.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 58' ' ' SER . 0.5 OUTLIER -148.44 -38.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 110.472 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.572 ' HB2' HD23 ' B' ' 189' ' ' LEU . 6.7 t80 -124.39 113.78 27.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.382 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.04 -19.27 26.71 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.956 1.503 . . . . 0.0 110.079 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -97.72 179.92 33.14 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.929 HD11 ' HB2' ' B' ' 176' ' ' ALA . 0.9 OUTLIER -113.19 145.99 40.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -1.185 . . . . 0.0 110.533 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.505 ' CD1' HD22 ' A' ' 62' ' ' LEU . 5.8 mt -109.09 110.36 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -107.54 120.53 42.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.33 93.08 6.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.934 . . . . 0.0 110.046 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 52.9 tpp -49.64 136.04 17.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.426 ' O ' ' HE2' ' B' ' 201' ' ' LYS . 73.0 t -73.12 -50.71 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 7.9 tttp -142.3 115.91 6.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.451 ' HG3' ' HA ' ' B' ' 222' ' ' GLU . 48.8 Cg_endo -73.73 165.21 85.44 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.994 -2.086 . . . . 0.0 110.541 -0.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.445 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -74.75 98.86 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.992 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' B' ' 217' ' ' ALA . 31.7 mm -139.76 144.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.498 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.602 ' C ' HD12 ' B' ' 204' ' ' LEU . 90.4 t -93.45 118.61 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.738 ' N ' HD12 ' B' ' 204' ' ' LEU . 6.1 mp -115.58 123.77 49.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.568 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.502 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 5.7 mt -94.83 129.37 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.914 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.547 HG12 HD21 ' B' ' 234' ' ' LEU . 3.7 mp -118.8 129.47 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.549 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.492 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 96.6 m-85 -114.26 149.72 35.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 110.062 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 65.1 t -55.19 -24.8 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.0 p -64.36 -26.48 68.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.328 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.427 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 108.06 19.9 8.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -1.162 . . . . 0.0 110.274 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.72 132.99 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.384 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.586 ' C ' HD12 ' B' ' 214' ' ' LEU . 21.2 t -125.79 130.97 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.826 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.7 mp -118.42 126.28 51.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.403 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.946 ' OG1' HG22 ' B' ' 161' ' ' VAL . 1.1 t -147.3 136.03 22.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.968 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.468 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 120.45 7.55 8.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -86.87 134.36 33.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -1.213 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -78.36 -21.19 49.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.77 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.0 OUTLIER -139.1 -170.38 2.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 220' ' ' ARG . . . . . 0.719 ' HG3' HD11 ' B' ' 67' ' ' LEU . 2.9 ttt180 -89.94 -36.54 14.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.133 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -52.79 -31.31 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.174 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' B' ' 200' ' ' PRO . 24.1 mt-10 -70.45 -56.99 5.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 110.109 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.556 HG22 ' HG2' ' B' ' 65' ' ' PRO . 31.0 mm -50.93 -38.73 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' B' ' 64' ' ' VAL . 1.1 m-30 -67.79 -50.97 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -27.47 67.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.044 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.43 -52.48 65.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.672 ' HA ' HG22 ' B' ' 230' ' ' ILE . 41.9 t80 -61.93 -42.33 98.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.946 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -18.17 52.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 110.306 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -96.7 -28.57 14.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.455 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' B' ' 227' ' ' PHE . 4.2 tp -98.29 -10.66 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.655 ' CD1' ' CZ ' ' B' ' 227' ' ' PHE . 14.9 t80 -59.18 -42.52 93.71 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 111.013 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 47.3 Cg_endo -76.23 -44.0 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.381 1.2 . . . . 0.0 110.353 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.553 HG12 HD21 ' B' ' 175' ' ' LEU . 7.7 t -55.27 -38.51 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.873 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.547 HD21 HG12 ' B' ' 206' ' ' ILE . 40.4 mt -67.27 -50.65 59.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -0.831 . . . . 0.0 110.201 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 1.6 m -58.4 -29.48 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.85 -35.42 76.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.99 39.44 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.8 176.71 1.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.115 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 -59.53 1.7 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.213 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.066 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -93.7 97.4 10.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.063 -1.023 . . . . 0.0 111.004 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.066 HD21 HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -108.06 6.36 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.976 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.783 ' OG1' HD12 ' A' ' 68' ' ' LEU . 5.6 m -43.19 -26.77 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.483 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.523 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -98.55 -19.26 23.28 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.865 HG13 HD22 ' A' ' 20' ' ' LEU . 1.3 mm -57.07 -46.79 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.67 -1.488 . . . . 0.0 109.0 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.871 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.1 pp -83.53 -24.43 31.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.922 -1.111 . . . . 0.0 109.976 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -83.82 9.25 12.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 137.34 103.71 0.66 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.843 ' ND2' HD11 ' A' ' 35' ' ' LEU . 20.0 p-10 -18.56 129.77 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.717 0.77 . . . . 0.0 111.827 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 29' ' ' ASP . 1.5 pp -138.93 170.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.726 -0.609 . . . . 0.0 109.533 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.806 ' C ' HD12 ' A' ' 28' ' ' ILE . 77.5 m-20 -88.17 120.34 29.43 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.732 ' O ' HD11 ' A' ' 18' ' ' LEU . 4.6 p -35.33 -31.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.594 0.711 . . . . 0.0 109.662 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.9 tt0 -47.14 -23.35 0.49 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.23 21.78 5.1 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.38 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.98 134.27 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.315 . . . . 0.0 109.351 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.542 ' HA ' HG22 ' A' ' 28' ' ' ILE . 5.4 tt -87.82 162.06 17.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.895 -1.128 . . . . 0.0 111.157 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.843 HD11 ' ND2' ' A' ' 27' ' ' ASN . 3.1 pp . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.846 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.086 0.469 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -100.24 -26.51 13.89 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.089 -1.007 . . . . 0.0 108.693 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 56' ' ' ILE . 2.8 mt -98.32 -39.01 9.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.402 0.62 . . . . 0.0 109.689 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -44.38 -46.71 9.56 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.29 -32.6 74.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 109.553 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.553 ' ND2' ' HB3' ' B' ' 190' ' ' PHE . 13.6 m120 -76.76 -39.07 52.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.409 -0.807 . . . . 0.0 109.676 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -53.46 -34.38 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.384 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.31 -27.12 72.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.975 ' O ' HD11 ' B' ' 189' ' ' LEU . 11.5 t -117.82 8.94 12.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.856 HD23 HD12 ' A' ' 62' ' ' LEU . 6.0 mt -96.16 13.8 26.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.44 41.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.23 -0.919 . . . . 0.0 110.306 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.586 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.57 19.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.856 HD12 HD23 ' A' ' 59' ' ' LEU . 6.0 mt -118.06 -58.64 1.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.361 -0.837 . . . . 0.0 109.232 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.4 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.871 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.5 mm? -52.13 -26.0 10.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -1.19 . . . . 0.0 110.57 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -45.95 -36.77 5.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.4 m -70.04 -59.5 2.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 110.048 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.558 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -64.77 -11.96 42.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.03 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.783 HD12 ' OG1' ' A' ' 21' ' ' THR . 6.1 tt -69.39 -62.17 1.49 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.391 -0.818 . . . . 0.0 109.292 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.8 pp -66.78 -6.3 15.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -84.58 16.37 3.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.619 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.919 HG12 HG11 ' B' ' 122' ' ' VAL . 2.9 t -141.37 4.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.932 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.779 ' HB ' HD11 ' A' ' 20' ' ' LEU . 1.4 tp -147.3 77.2 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.579 -0.701 . . . . 0.0 109.359 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.8 t70 -82.83 50.64 1.74 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 108.908 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.74 -0.6 . . . . 0.0 111.657 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.77 134.75 83.61 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.55 135.66 26.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.937 1.493 . . . . 0.0 110.318 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.6 m -96.44 130.58 43.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.361 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' B' ' 161' ' ' VAL . 33.2 mt -74.76 123.35 24.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.867 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -113.95 -3.66 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -0.887 . . . . 0.0 110.705 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.532 ' CB ' ' HB ' ' B' ' 161' ' ' VAL . 0.2 OUTLIER -156.36 142.83 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.914 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.844 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 19.9 mm -132.13 150.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.829 . . . . 0.0 109.809 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' B' ' 124' ' ' THR . 22.0 t -141.44 134.65 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.64 165.27 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.252 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 68.1 p -110.15 145.65 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.72 131.21 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 41.4 m -111.84 128.59 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.855 HD22 ' HB1' ' B' ' 150' ' ' ALA . 49.0 mt -88.07 -17.33 31.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -2.31 84.26 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' B' ' 149' ' ' ALA . 3.6 t -137.33 151.14 48.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.339 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.828 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.9 OUTLIER -78.46 164.15 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.828 HD23 ' O ' ' B' ' 79' ' ' ARG . 23.8 mt -140.48 153.38 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 82' ' ' LEU . 34.8 t0 -92.77 100.59 13.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.519 ' HB3' HG23 ' B' ' 102' ' ' VAL . 18.0 mt -44.23 -34.95 2.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 1.9 tmtm? -66.14 -36.12 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 20.8 m -89.25 -40.13 13.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.29 -50.48 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 110.272 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.78 63.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.139 -0.976 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 27.6 tp -57.74 -28.48 63.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -98.94 -40.37 8.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.319 -0.863 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -47.38 124.3 6.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 20.9 mtt180 -67.28 -21.35 65.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.42 79.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -158.13 165.18 35.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.19 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -145.24 152.93 40.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.154 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -139.52 122.53 16.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.265 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.73 134.72 10.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.87 . . . . 0.0 110.228 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.85 -41.04 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.948 1.499 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -50.37 -23.2 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -98.32 -65.44 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 1.012 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.79 167.15 7.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.469 -0.77 . . . . 0.0 111.295 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.92 56.07 3.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.684 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.012 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -148.88 159.62 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.977 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' B' ' 82' ' ' LEU . 30.8 t -101.02 132.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.848 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.476 HG12 ' OG ' ' A' ' 30' ' ' SER . 6.5 mt -95.74 112.46 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 2.8 ttm -102.29 157.76 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 110.014 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -161.66 131.58 4.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.137 -0.977 . . . . 0.0 110.439 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 26.7 pt -115.64 172.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' B' ' 110' ' ' LYS . 7.7 mtp180 -115.45 29.53 7.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -174.63 86.16 0.33 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.503 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 51.0 Cg_endo -78.23 148.77 85.4 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.777 -2.176 . . . . 0.0 110.319 -0.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' B' ' 107' ' ' ARG . 12.0 mtmm -58.25 86.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.879 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.47 HG22 ' C ' ' B' ' 125' ' ' GLY . 11.3 p -130.45 168.64 16.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.519 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.696 HG22 HG23 ' B' ' 124' ' ' THR . 4.0 t -130.38 164.22 25.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.61 166.26 30.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.01 -1.057 . . . . 0.0 110.903 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.575 HD13 HD11 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -113.17 107.88 16.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.549 ' CD1' ' HG3' ' B' ' 121' ' ' MET . 13.8 mm -91.75 125.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 111.186 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 4.6 m-30 -103.57 166.06 10.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.479 -0.763 . . . . 0.0 109.64 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.05 -14.85 58.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.263 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 1.1 p -73.53 -30.27 62.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.305 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.75 -23.43 5.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -65.94 163.6 16.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.178 . . . . 0.0 110.049 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.549 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.8 OUTLIER -159.05 124.88 4.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 110.766 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.919 HG11 HG12 ' A' ' 71' ' ' VAL . 2.9 t -101.8 136.22 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 0.0 109.655 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.483 HG12 ' N ' ' B' ' 124' ' ' THR . 76.9 t -115.71 165.42 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.156 -0.965 . . . . 0.0 110.662 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.696 HG23 HG22 ' B' ' 112' ' ' THR . 5.9 t -169.52 155.89 6.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.439 -0.788 . . . . 0.0 110.014 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.544 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 113.8 -4.06 24.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.844 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -84.21 168.99 15.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.192 -1.181 . . . . 0.0 110.502 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.465 ' C ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -121.89 -19.21 6.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 110.292 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' B' ' 129' ' ' GLU . 1.0 OUTLIER -139.86 -178.92 5.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 129' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -68.74 -43.59 75.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -33.5 72.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.734 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 0.2 OUTLIER -70.24 -50.64 37.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.251 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 132' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' B' ' 136' ' ' SER . 5.2 t -61.21 -22.21 64.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.942 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.5 -49.53 18.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.843 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -45.47 74.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -50.68 -49.01 58.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.832 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 132' ' ' SER . 0.6 OUTLIER -66.85 -49.5 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.682 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -54.05 -29.68 44.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' B' ' 141' ' ' ARG . 27.4 mmtt -70.86 -55.84 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.702 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 47.0 m-85 -49.47 -48.49 47.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 140' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -57.01 -36.54 70.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.395 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 65.6 ttt180 -57.51 -38.36 74.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.425 -0.797 . . . . 0.0 109.949 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.407 ' O ' HG13 ' B' ' 146' ' ' ILE . 12.2 mt -66.76 -59.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.53 HD13 HD13 ' B' ' 80' ' ' LEU . 89.3 mt -56.6 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' B' ' 140' ' ' ALA . 20.5 mt-30 -67.55 -40.57 84.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 109.715 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -70.32 -21.29 62.94 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' B' ' 143' ' ' ILE . 6.5 mt -75.72 -29.46 20.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 125.07 -29.84 4.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' B' ' 147' ' ' GLY . 9.8 m-85 -43.89 156.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.014 -1.286 . . . . 0.0 110.637 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.513 ' HB3' ' SG ' ' B' ' 78' ' ' CYS . . . -91.62 48.58 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.129 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.855 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -84.42 171.49 12.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.403 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' B' ' 153' ' ' THR . 16.2 tttt -160.78 108.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.193 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' B' ' 152' ' ' PHE . 47.7 t80 -49.7 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.265 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.9 OUTLIER -145.65 168.43 20.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.332 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t70 63.37 24.02 14.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' B' ' 73' ' ' THR . 43.5 t80 -67.72 132.98 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 110.023 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -166.24 134.69 2.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.413 HG21 HD13 ' B' ' 157' ' ' ILE . 18.0 mt -79.38 122.85 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -119.59 6.38 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.532 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 1.1 m120 -154.51 123.08 6.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.374 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' B' ' 215' ' ' THR . 30.8 mt -122.64 149.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.532 ' HB ' ' CB ' ' B' ' 69' ' ' ASN . 58.6 t -130.35 138.38 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.572 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.37 171.57 25.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.34 152.85 5.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.938 -1.33 . . . . 0.0 110.697 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.475 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 31.0 p -166.79 166.4 15.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.53 171.31 8.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.521 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -121.75 -83.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.521 ' H ' HG23 ' B' ' 166' ' ' VAL . 3.0 mmtt 178.1 -23.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.036 -1.04 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -125.48 153.67 72.5 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.979 -1.076 . . . . 0.0 109.703 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.34 147.29 46.87 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.943 1.496 . . . . 0.0 110.248 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.691 HG12 HD22 ' B' ' 234' ' ' LEU . 2.0 mp -108.23 156.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 110.599 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 14.2 mtt180 -91.29 101.97 14.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.775 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 25.2 mt -63.9 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.27 -34.29 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -64.97 -51.11 54.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.71 -41.83 91.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -1.074 . . . . 0.0 109.907 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 180' ' ' GLY . . . -58.46 -43.53 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 177' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.8 t80 -59.76 -30.11 68.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -59.56 2.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.42 ' O ' ' N ' ' B' ' 183' ' ' SER . 41.5 m170 -97.98 32.53 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.338 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 176' ' ' ALA . . . -47.93 -62.74 3.97 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 181' ' ' THR . . . . . 0.585 HG23 ' CD1' ' B' ' 182' ' ' PHE . 10.3 t -45.85 -24.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -1.195 . . . . 0.0 110.272 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.585 ' CD1' HG23 ' B' ' 181' ' ' THR . 20.7 m-85 -102.43 -14.19 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.469 ' O ' ' O ' ' B' ' 180' ' ' GLY . 0.3 OUTLIER -140.86 149.04 41.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.931 . . . . 0.0 110.089 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -121.01 137.58 54.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.588 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -134.71 109.43 8.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 0.0 109.79 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.03 121.63 33.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.19 -11.98 25.32 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.891 1.469 . . . . 0.0 110.279 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.73 -23.85 22.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.113 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.975 HD11 ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -89.84 -63.21 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.689 ' HZ ' HD11 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -169.68 161.07 7.18 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.43 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 191' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.9 Cg_endo -69.82 0.37 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.136 1.598 . . . . 0.0 111.842 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.584 ' HA3' ' CE2' ' B' ' 190' ' ' PHE . . . -89.25 149.41 20.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.897 ' O ' HD13 ' B' ' 205' ' ' LEU . 10.3 tt -110.33 130.83 55.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -1.171 . . . . 0.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 194' ' ' ILE . . . . . . . . . . . . . 3.3 mt -95.63 111.21 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.225 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -100.89 113.7 26.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.297 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -91.1 88.58 7.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 110.145 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 46.1 tpp -57.55 125.2 21.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.867 . . . . 0.0 110.377 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.41 HG23 ' H ' ' B' ' 198' ' ' VAL . 34.7 t -57.52 -49.62 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.57 124.73 5.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.997 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.405 ' O ' HG12 ' B' ' 202' ' ' ILE . 48.0 Cg_endo -74.8 148.68 92.39 Favored 'Cis proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.011 -2.079 . . . . 0.0 110.424 -0.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.414 ' O ' HD13 ' B' ' 202' ' ' ILE . 10.9 tptt -56.22 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.335 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.414 HD13 ' O ' ' B' ' 201' ' ' LYS . 36.6 mm -136.84 153.5 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.17 112.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.925 . . . . 0.0 110.297 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.859 HD21 ' HB1' ' B' ' 226' ' ' ALA . 1.7 mp -107.42 149.13 28.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.897 HD13 ' O ' ' B' ' 193' ' ' LEU . 0.2 OUTLIER -114.85 115.8 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.568 ' N ' HD12 ' B' ' 206' ' ' ILE . 4.6 mp -104.85 139.58 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -122.69 155.6 36.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 63.9 t -59.13 -31.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.3 t -57.04 -39.13 74.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.099 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.22 10.88 5.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.437 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -89.66 135.45 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.437 HD13 ' O ' ' B' ' 211' ' ' LYS . 25.5 mm -113.74 134.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.3 t -114.32 163.45 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 1.4 mp -145.92 129.8 17.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.915 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 15.1 t -158.83 149.05 19.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 110.333 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.505 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 101.95 5.17 50.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.94 33.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -1.191 . . . . 0.0 110.161 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -93.18 -6.12 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.123 -0.985 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -154.68 -179.99 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.143 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -79.05 -25.34 43.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 110.22 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.79 -23.89 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.13 -50.37 12.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 110.19 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.499 HG23 HD22 ' B' ' 214' ' ' LEU . 20.3 mm -58.8 -38.13 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -70.6 -38.53 74.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.311 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -30.3 59.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.551 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.859 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -64.72 -49.85 69.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -0.962 . . . . 0.0 110.417 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.513 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 16.1 t80 -69.07 -41.22 77.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.479 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -51.57 -38.19 53.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.82 -10.1 35.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.294 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.556 HG13 HD22 ' B' ' 204' ' ' LEU . 10.5 mm -96.22 -17.73 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.9 t80 -61.73 -42.1 81.41 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.5 Cg_endo -76.71 -49.26 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.346 1.182 . . . . 0.0 110.21 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 21.3 t -44.87 -40.48 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.764 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.691 HD22 HG12 ' B' ' 170' ' ' ILE . 74.0 mt -70.75 -63.36 1.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.779 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -46.9 -33.2 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.33 -34.19 77.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.403 -0.811 . . . . 0.0 110.014 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 57.3 m-85 -120.89 39.63 3.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.269 -0.894 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.49 ' NH2' ' O ' ' B' ' 239' ' ' LYS . 0.0 OUTLIER -71.57 -173.72 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.927 . . . . 0.0 110.175 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.49 ' O ' ' NH2' ' B' ' 238' ' ' ARG . 2.4 ttpt -125.68 -39.55 2.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.21 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.93 76.85 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.045 -1.034 . . . . 0.0 110.615 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.947 HD13 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -93.99 -0.32 55.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 111.253 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.719 ' N ' HD21 ' A' ' 68' ' ' LEU . 9.0 m -45.91 -24.25 0.38 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.889 -1.132 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.487 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -97.04 -31.93 6.7 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.947 HG21 HD13 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -47.94 -47.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.403 . . . . 0.0 109.132 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.833 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.8 pp -83.51 -26.74 29.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.969 -1.082 . . . . 0.0 110.549 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.689 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.3 OUTLIER -80.96 6.92 11.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.096 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 28' ' ' ILE . . . 138.33 106.58 0.74 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.858 ' ND2' HD11 ' A' ' 35' ' ' LEU . 5.9 p30 -16.94 133.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.915 0.864 . . . . 0.0 112.186 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 29' ' ' ASP . 2.0 pp -146.44 167.29 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.487 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.806 ' C ' HD12 ' A' ' 28' ' ' ILE . 10.8 m-20 -87.88 121.14 29.93 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.542 ' OG ' ' CD1' ' B' ' 103' ' ' ILE . 9.3 p -36.93 -28.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.145 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.6 tt0 -58.51 -11.95 3.47 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.181 -0.949 . . . . 0.0 110.446 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.64 23.94 6.34 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.4 tpp180 -107.34 120.45 42.19 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.045 -1.268 . . . . 0.0 109.644 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.805 ' C ' HD13 ' A' ' 34' ' ' LEU . 2.5 tm? -88.59 134.07 33.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.405 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.858 HD11 ' ND2' ' A' ' 27' ' ' ASN . 1.1 pp . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.03 . . . . 0.0 109.993 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.23 0.538 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.46 -17.67 17.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.901 . . . . 0.0 109.591 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 25' ' ' PHE . 4.0 mt -95.32 -47.06 6.47 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.513 -0.742 . . . . 0.0 109.977 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.922 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.58 -50.89 52.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -63.75 -25.82 68.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.795 . . . . 0.0 110.06 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -83.29 -33.88 25.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.922 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.3 mt -51.93 -46.03 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.292 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.28 -19.93 26.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.73 9.9 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -1.191 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.654 HD23 HD21 ' A' ' 62' ' ' LEU . 3.0 mt -84.76 15.85 3.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.141 -0.974 . . . . 0.0 110.419 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.0 p -105.94 39.78 1.71 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 110.221 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 29.31 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 63' ' ' GLY . 2.1 pp -147.5 -35.44 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.103 -0.998 . . . . 0.0 111.152 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.915 ' N ' HD12 ' A' ' 62' ' ' LEU . . . -170.14 -51.29 0.04 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.294 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.833 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.4 mm? -42.83 -24.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -1.232 . . . . 0.0 110.572 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 1.8 t70 -42.79 -38.97 2.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.854 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.43 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 58.5 m -66.84 -56.88 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.406 -0.809 . . . . 0.0 109.809 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.641 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -65.22 -10.54 32.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.486 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.719 HD21 ' N ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -67.92 -63.93 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.745 0.783 . . . . 0.0 109.298 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -68.57 -5.12 18.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.808 -0.557 . . . . 0.0 110.226 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -83.17 5.68 21.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 111.201 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.835 HG12 HG11 ' B' ' 122' ' ' VAL . 2.3 t -140.22 4.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.173 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.882 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.2 tp -145.48 73.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.779 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t70 -81.8 51.77 1.79 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.528 -0.732 . . . . 0.0 111.46 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.243 0.544 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.536 HG13 ' HD2' ' B' ' 65' ' ' PRO . 70.2 t -89.82 142.2 28.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 110.505 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.536 ' HD2' HG13 ' B' ' 64' ' ' VAL . 47.2 Cg_endo -75.35 134.54 17.36 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.052 1.554 . . . . 0.0 110.417 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -90.71 127.17 36.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' B' ' 67' ' ' LEU . 17.6 mt -73.03 132.65 43.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.125 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -98.05 -41.08 8.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.101 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -170.03 179.07 3.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.561 HG12 HG23 ' B' ' 160' ' ' ILE . 9.5 mt -150.53 167.8 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.125 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.542 HG13 ' O ' ' B' ' 123' ' ' VAL . 52.8 t -137.4 140.64 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.131 -0.981 . . . . 0.0 110.426 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.55 50.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.426 -0.797 . . . . 0.0 110.068 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 133.85 55.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.451 HG21 ' OG ' ' B' ' 136' ' ' SER . 66.2 t -126.71 146.76 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 57.5 m -110.13 141.26 43.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.941 HD22 ' C ' ' B' ' 149' ' ' ALA . 7.4 mt -105.2 -72.93 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.485 -0.759 . . . . 0.0 109.898 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.33 -10.18 10.83 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 148' ' ' PHE . 68.5 m -109.31 119.92 40.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.034 -1.274 . . . . 0.0 109.354 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -44.02 147.94 0.45 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 110.032 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.701 ' CD2' ' HB2' ' B' ' 149' ' ' ALA . 27.0 mt -116.73 144.59 44.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 111.173 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' LYS . 0.2 OUTLIER -101.28 83.04 2.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.486 -0.758 . . . . 0.0 109.152 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' B' ' 81' ' ' ASP . 10.3 mt -37.09 -30.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.636 -0.665 . . . . 0.0 110.933 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' B' ' 81' ' ' ASP . 0.0 OUTLIER -70.28 -46.04 65.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 109.937 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 97.9 m -82.21 -31.41 30.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.382 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.5 -43.04 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.77 51.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 tp -85.24 -43.23 13.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.261 -0.9 . . . . 0.0 110.452 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.767 ' HB2' HD11 ' B' ' 146' ' ' ILE . 7.6 m170 -74.43 -44.84 50.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 110.591 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -54.88 128.48 33.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.438 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -66.55 -24.93 66.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 9.0 p30 -135.22 79.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.077 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -160.07 137.04 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -117.39 171.18 8.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' B' ' 102' ' ' VAL . 13.3 t80 -164.2 102.2 0.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 110.301 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' B' ' 98' ' ' ARG . 0.7 OUTLIER -119.1 136.95 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.272 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -21.01 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.996 1.524 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -76.65 -17.3 59.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' B' ' 98' ' ' ARG . 3.2 mpt_? -96.45 -63.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 1.168 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.86 166.69 11.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.494 -0.754 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.97 53.43 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 111.909 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.168 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -153.19 154.25 34.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.143 . . . . 0.0 110.463 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.692 HG22 ' HB2' ' B' ' 94' ' ' TYR . 39.7 t -89.81 139.08 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.542 ' CD1' ' OG ' ' A' ' 30' ' ' SER . 8.4 mt -100.35 114.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 109.845 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.609 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 1.7 ttm -99.8 170.86 8.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 0.1 OUTLIER -169.99 132.42 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 0.0 110.046 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.558 HG23 ' CE1' ' B' ' 139' ' ' TYR . 22.8 pt -128.45 163.56 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.352 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -110.64 26.23 10.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.258 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER -172.76 86.28 0.41 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.267 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.731 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.3 Cg_endo -74.85 161.52 94.6 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.564 -0.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -72.28 82.9 1.03 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' B' ' 124' ' ' THR . 37.0 p -132.46 176.3 8.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 110.518 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.823 HG22 HG23 ' B' ' 124' ' ' THR . 5.8 t -135.68 174.07 11.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.6 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -170.25 176.45 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.967 -1.083 . . . . 0.0 111.091 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.832 HD13 HD13 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -143.17 122.89 13.35 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.423 ' CG2' ' CD1' ' B' ' 80' ' ' LEU . 20.4 mt -100.35 160.34 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.006 . . . . 0.0 111.479 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.72 ' CZ ' HD12 ' B' ' 114' ' ' LEU . 34.8 m-85 -119.42 156.17 30.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 110.246 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -64.8 -16.45 63.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 4.4 p -71.29 -36.73 71.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.629 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 129.41 4.24 4.96 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' LYS . . . . . 0.413 ' C ' ' HG3' ' B' ' 121' ' ' MET . 0.5 OUTLIER -100.4 138.89 36.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -1.175 . . . . 0.0 110.003 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.752 ' CG ' HD11 ' B' ' 76' ' ' LEU . 0.0 OUTLIER -128.03 129.45 46.72 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.04 . . . . 0.0 110.163 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.835 HG11 HG12 ' A' ' 71' ' ' VAL . 18.3 t -97.44 132.36 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 0.0 109.713 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.542 ' O ' HG13 ' B' ' 71' ' ' VAL . 29.7 t -114.95 149.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 110.574 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.823 HG23 HG22 ' B' ' 112' ' ' THR . 6.2 t -149.54 156.48 42.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.543 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 110.04 -32.81 6.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -45.35 125.13 5.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -1.115 . . . . 0.0 110.089 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -92.29 -17.92 24.09 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.23 -0.919 . . . . 0.0 109.802 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 42.0 t -142.44 151.87 42.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.387 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.16 -49.88 11.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -40.87 98.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.056 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -38.67 77.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -44.43 72.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.161 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -25.56 65.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.23 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.498 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 0.6 OUTLIER -85.25 -36.26 21.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.338 -0.851 . . . . 0.0 110.287 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.731 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -70.49 -36.11 73.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.047 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.451 ' OG ' HG21 ' B' ' 74' ' ' VAL . 28.8 t -71.64 -59.8 2.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.527 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.0 ptm180 -46.19 -37.36 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.527 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 8.8 mttt -64.72 -45.98 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.558 ' CE1' HG23 ' B' ' 106' ' ' ILE . 9.5 m-85 -57.47 -56.95 15.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 140' ' ' ALA . . . . . 0.53 ' HA ' HG12 ' B' ' 143' ' ' ILE . . . -49.04 -40.77 32.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.616 ' HA ' ' NE2' ' B' ' 144' ' ' GLN . 2.4 ttt-85 -53.4 -47.29 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.085 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.439 ' C ' HD13 ' B' ' 143' ' ' ILE . 83.2 mt -61.81 -25.44 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 110.349 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 1.152 ' CG2' ' HB3' ' B' ' 149' ' ' ALA . 0.5 OUTLIER -83.83 -51.2 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 109.397 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.878 ' HG2' ' HB1' ' B' ' 150' ' ' ALA . 4.2 mt-30 -46.96 -36.5 7.79 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -72.16 -31.65 66.14 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' B' ' 88' ' ' HIS . 0.1 OUTLIER -74.71 -45.02 45.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.41 -26.16 1.37 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.15 -1.5 . . . . 0.0 112.033 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.534 ' HB2' ' CD2' ' B' ' 80' ' ' LEU . 0.1 OUTLIER -142.31 -154.61 0.53 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.291 -1.711 . . . . 0.0 112.598 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 1.152 ' HB3' ' CG2' ' B' ' 143' ' ' ILE . . . 41.22 29.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.54 1.162 . . . . 0.0 107.889 -178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.878 ' HB1' ' HG2' ' B' ' 144' ' ' GLN . . . -89.74 -19.06 25.21 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.814 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.83 ' O ' HD23 ' B' ' 76' ' ' LEU . 1.9 mptt -71.03 133.21 46.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.568 -1.333 . . . . 0.0 110.33 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -115.19 75.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.858 . . . . 0.0 110.269 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -137.79 -174.05 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.229 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 1.9 t0 56.39 16.77 2.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -68.57 125.85 27.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.215 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -160.24 131.93 6.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 110.259 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.498 HD13 HG21 ' B' ' 70' ' ' ILE . 21.4 mt -79.43 132.01 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.857 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.419 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 38.3 mm-40 -130.7 1.16 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 110.652 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.471 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.5 OUTLIER -148.33 108.53 4.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.977 -1.077 . . . . 0.0 111.236 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.682 HD12 ' N ' ' B' ' 219' ' ' GLN . 69.8 mt -117.67 137.26 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.837 . . . . 0.0 109.209 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.547 HG22 ' OG1' ' B' ' 215' ' ' THR . 88.9 t -114.37 139.13 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 111.031 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -147.02 171.18 27.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.4 p -155.84 163.42 39.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.257 . . . . 0.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' B' ' 212' ' ' ILE . 17.6 p -165.65 169.84 14.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.843 . . . . 0.0 110.223 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 15.5 p-10 -120.55 144.01 48.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 109.988 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 1.129 HG21 HD11 ' B' ' 170' ' ' ILE . 25.3 m -94.02 2.7 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.988 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 28.2 tttp 71.86 10.16 6.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 110.917 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.602 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 9.3 p90 -166.23 154.58 9.79 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 110.416 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.65 158.02 51.35 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.996 1.524 . . . . 0.0 110.784 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 1.129 HD11 HG21 ' B' ' 166' ' ' VAL . 2.4 mp -131.07 147.86 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.229 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -76.93 92.05 3.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.924 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.514 HD11 ' N ' ' B' ' 208' ' ' VAL . 13.6 mt -50.57 -37.25 38.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.39 -43.49 60.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.245 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.39 80.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.727 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -71.36 -51.77 22.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -1.123 . . . . 0.0 110.12 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.498 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -57.84 -29.71 65.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.114 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -72.38 -36.54 68.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.13 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.59 -27.4 17.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.959 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -129.15 34.9 4.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 110.004 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.22 -18.29 64.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 181' ' ' THR . . . . . 0.864 HG23 ' CD2' ' B' ' 182' ' ' PHE . 8.9 t -69.31 -21.43 63.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -1.137 . . . . 0.0 110.31 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.864 ' CD2' HG23 ' B' ' 181' ' ' THR . 41.3 m-85 -129.57 3.14 5.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.662 ' HB2' HD21 ' B' ' 193' ' ' LEU . 0.9 OUTLIER -139.47 135.42 33.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 154.98 29.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.071 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 0.479 ' HB2' HD12 ' B' ' 193' ' ' LEU . 82.8 t80 -147.08 105.72 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.342 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 190' ' ' PHE . 7.4 mt-10 -108.75 105.27 56.71 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 187' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.0 Cg_endo -71.74 -2.07 10.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.981 1.516 . . . . 0.0 110.599 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -19.88 16.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.074 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.533 ' C ' HD23 ' B' ' 189' ' ' LEU . 4.7 tt -132.91 -29.73 1.44 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 110.551 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.627 ' CE2' HD21 ' A' ' 59' ' ' LEU . 1.9 t80 -131.8 111.29 14.7 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.32 -7.92 21.79 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.867 1.456 . . . . 0.0 110.231 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' B' ' 172' ' ' LEU . . . -107.97 179.98 21.89 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' B' ' 183' ' ' SER . 3.5 tt -113.74 125.95 54.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.398 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.678 HD13 HD13 ' A' ' 62' ' ' LEU . 44.2 mt -91.77 112.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.96 . . . . 0.0 109.953 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 2.2 t80 -108.49 124.61 50.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.381 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.458 ' HB2' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -105.82 79.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.057 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 32.1 ttm -49.11 134.72 17.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 40.5 t -73.01 -43.1 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.3 OUTLIER -143.2 116.43 6.05 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.113 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.1 Cg_endo -73.54 156.02 99.67 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.99 -2.087 . . . . 0.0 110.529 -0.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.926 ' O ' HD13 ' B' ' 202' ' ' ILE . 2.9 tptt -67.37 94.87 0.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.926 HD13 ' O ' ' B' ' 201' ' ' LYS . 11.2 mm -141.09 158.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.215 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.415 HG22 ' HG3' ' B' ' 196' ' ' ARG . 62.2 t -105.54 116.22 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.943 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.2 mp -108.12 108.67 19.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.497 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.689 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -95.08 118.88 32.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.614 HG23 ' CD1' ' B' ' 212' ' ' ILE . 3.2 mp -116.76 120.9 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.162 -0.962 . . . . 0.0 110.486 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' B' ' 207' ' ' PHE . 30.1 m-85 -93.33 172.22 8.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.514 ' N ' HD11 ' B' ' 172' ' ' LEU . 27.2 t -60.32 -39.83 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.327 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 50.6 m -53.16 -42.28 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.455 -0.778 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.655 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 125.81 4.34 6.75 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.31 136.45 44.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 110.089 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.614 ' CD1' HG23 ' B' ' 206' ' ' ILE . 14.6 mm -119.41 136.49 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.328 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 84.0 t -121.88 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.939 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.452 HD12 ' N ' ' B' ' 214' ' ' LEU . 2.2 mp -127.03 117.16 21.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.547 ' OG1' HG22 ' B' ' 161' ' ' VAL . 13.6 t -135.57 160.53 38.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.105 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.57 -5.88 64.91 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.62 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -73.54 136.18 44.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.16 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.425 ' N ' ' OE2' ' B' ' 222' ' ' GLU . 0.0 OUTLIER -84.57 -8.69 58.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.092 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.682 ' N ' HD12 ' B' ' 160' ' ' ILE . 1.0 OUTLIER -156.89 -174.02 4.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -82.15 -32.63 29.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 1.0 OUTLIER -52.44 -29.61 25.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.052 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.62 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 21.1 mt-10 -76.85 -48.0 19.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.3 -39.03 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -69.88 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -83.59 -46.77 12.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.265 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.442 ' O ' HG22 ' B' ' 230' ' ' ILE . . . -47.71 -40.65 20.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -74.37 -48.33 28.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.0 -17.38 62.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.007 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -86.4 -32.92 20.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 109.922 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.442 HG22 ' O ' ' B' ' 226' ' ' ALA . 1.0 OUTLIER -99.12 -17.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.846 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.616 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 51.9 t80 -47.71 -46.96 62.22 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.2 Cg_endo -71.43 -49.36 0.36 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.387 1.204 . . . . 0.0 110.18 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.727 HG12 HD21 ' B' ' 175' ' ' LEU . 9.3 t -47.71 -43.28 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.642 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.609 ' CD2' HG21 ' B' ' 170' ' ' ILE . 91.0 mt -63.12 -51.22 67.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 59.6 p -54.11 -27.76 35.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.65 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.82 -38.47 79.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.919 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.501 ' CD2' HD22 ' B' ' 175' ' ' LEU . 50.0 m-85 -110.15 37.77 2.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -63.21 163.21 10.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.202 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.61 -28.83 6.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.877 . . . . 0.0 110.218 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.925 HD22 ' CD2' ' B' ' 99' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.847 ' O ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -93.8 128.38 40.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.122 -0.987 . . . . 0.0 111.497 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.968 HD11 ' HB ' ' A' ' 72' ' ' ILE . 9.6 mt -124.64 24.98 7.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 110.47 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.59 ' OG1' HD23 ' A' ' 68' ' ' LEU . 8.4 m -49.01 -36.6 18.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.61 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -85.67 -24.66 41.54 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.497 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.831 HG21 HG11 ' A' ' 71' ' ' VAL . 9.5 mm -50.37 -54.22 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.883 -1.363 . . . . 0.0 109.011 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.961 HD13 ' SD ' ' A' ' 67' ' ' MET . 1.6 pp -79.33 8.89 5.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 110.023 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.742 ' HE2' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -111.75 -15.41 13.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.006 -1.059 . . . . 0.0 111.026 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 156.99 44.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.531 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB2' ' CG ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER 61.72 132.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.929 -1.336 . . . . 0.0 110.185 178.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.757 HG21 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -162.2 158.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.818 0.818 . . . . 0.0 109.524 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLU . 77.1 m-20 -88.49 118.36 28.08 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.623 ' HB2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -39.68 -26.82 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.992 -179.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 18.0 pt-20 -55.16 -16.33 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.043 -1.035 . . . . 0.0 109.991 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.98 14.29 10.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.536 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.69 115.88 28.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.074 -1.25 . . . . 0.0 109.939 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.61 HD12 ' HA3' ' A' ' 22' ' ' GLY . 1.2 tt -87.67 158.85 18.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.918 -1.114 . . . . 0.0 110.872 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 35' ' ' LEU . 4.0 pp . . . . . 0 N--CA 1.492 1.631 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.711 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.211 0.529 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 1.6 tp10 -88.67 -52.04 5.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.742 HD21 ' HE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -93.5 -11.6 31.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.025 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -56.7 -54.05 50.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -0.996 . . . . 0.0 108.784 178.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.63 -23.34 64.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 45.8 m-80 -80.06 -33.31 39.1 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.025 HD12 ' HA ' ' A' ' 53' ' ' ARG . 24.6 mt -50.01 -41.98 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.51 -14.61 28.74 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.99 -7.1 11.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.89 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.732 HD11 ' CE1' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -76.88 53.99 0.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.95 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m -126.81 32.59 5.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.786 . . . . 0.0 110.365 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.569 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.19 17.87 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.322 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 61' ' ' LYS . 6.9 mt -112.89 -63.09 1.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.561 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.5 -39.96 0.03 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.847 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.5 mm? -53.3 -19.4 3.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -1.117 . . . . 0.0 110.644 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 4.8 p-10 -46.07 -40.75 11.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 110.068 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -59.49 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.961 ' SD ' HD13 ' A' ' 24' ' ' LEU . 12.6 ttm -70.75 -3.49 19.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.766 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.69 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.5 tm? -69.43 -58.29 4.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pp -77.92 1.42 20.66 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.478 0.656 . . . . 0.0 109.613 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 3.9 tt0 -87.94 15.5 7.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.898 ' HB ' HD12 ' A' ' 20' ' ' LEU . 3.8 t -138.93 -0.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.729 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.072 HD11 HD12 ' A' ' 74' ' ' LEU . 2.9 tp -151.17 84.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.515 -0.741 . . . . 0.0 109.32 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 2.1 p-10 -87.4 49.19 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.964 -1.085 . . . . 0.0 108.486 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.072 HD12 HD11 ' A' ' 72' ' ' ILE . 9.9 mt . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.675 0.75 . . . . 0.0 110.872 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 6.3 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.07 0.462 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 56.6 t 58.46 126.34 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.595 -0.691 . . . . 0.0 110.223 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.437 ' HA ' ' SG ' ' B' ' 164' ' ' CYS . 45.9 Cg_endo -73.49 151.53 47.68 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.858 1.451 . . . . 0.0 110.568 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.443 HG22 ' N ' ' B' ' 67' ' ' LEU . 98.1 m -101.47 164.79 11.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.443 ' N ' HG22 ' B' ' 66' ' ' THR . 19.4 mt -89.48 128.67 36.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.28 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.33 -32.62 10.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.507 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 7.6 m-20 -170.05 171.62 6.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.939 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 16.5 mm -131.77 155.52 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 110.149 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.53 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 37.6 t -138.29 113.7 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.864 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.51 ' HB2' ' CG1' ' B' ' 157' ' ' ILE . . . -128.42 156.46 43.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 110.587 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 26.1 p -105.69 114.16 28.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.55 HG22 ' CD1' ' B' ' 155' ' ' PHE . 21.6 t -107.93 120.64 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 52.5 m -97.08 160.68 14.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' B' ' 150' ' ' ALA . 22.0 mt -107.32 -59.89 1.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.237 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.86 -0.1 6.65 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 21.6 p -142.37 170.18 16.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -1.152 . . . . 0.0 110.187 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.533 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -83.34 154.32 24.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 1.025 HD11 ' CD1' ' B' ' 76' ' ' LEU . 70.8 mt -128.32 144.49 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.093 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.463 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 5.7 m-20 -89.86 94.6 9.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.631 HD22 HG23 ' B' ' 102' ' ' VAL . 12.3 mt -46.63 -45.17 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -54.78 -45.06 74.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 110.106 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 7.0 m -82.5 -38.68 23.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.465 HG12 HG11 ' B' ' 102' ' ' VAL . 19.7 t -61.44 -48.06 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.526 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -73.43 -24.24 60.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.277 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 19.7 tp -85.98 -23.8 26.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.498 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.4 OUTLIER -96.75 -42.91 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.181 -0.95 . . . . 0.0 110.378 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.701 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -45.92 123.49 4.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.129 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -24.05 64.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.25 -0.906 . . . . 0.0 110.293 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -137.14 79.59 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.737 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -164.96 161.24 19.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 0.0 109.856 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' B' ' 92' ' ' ALA . 58.6 mm-40 -152.78 138.38 17.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 110.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.535 ' HE1' HD13 ' B' ' 82' ' ' LEU . 19.8 t80 -93.17 148.24 22.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.725 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' B' ' 98' ' ' ARG . 0.1 OUTLIER -138.44 103.9 7.82 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 110.628 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.37 -17.71 16.44 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.045 1.55 . . . . 0.0 110.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.07 -4.23 58.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 0.0 110.269 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -116.55 -65.39 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 1.07 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -153.67 -168.07 2.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.356 -0.84 . . . . 0.0 111.294 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.18 53.7 0.68 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.07 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -145.33 164.21 32.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 0.0 110.93 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.631 HG23 HD22 ' B' ' 82' ' ' LEU . 86.2 t -102.27 127.0 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.818 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -94.61 108.78 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.737 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 3.4 ttm -93.63 170.75 9.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.01 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.6 119.66 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.465 HG23 ' CE1' ' B' ' 139' ' ' TYR . 8.7 pt -122.58 149.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.32 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 2.3 ptt180 -99.12 33.13 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.1 tt0 -171.93 84.2 0.46 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 47.7 Cg_endo -76.51 162.1 92.49 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.657 -2.226 . . . . 0.0 110.463 -0.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -70.36 79.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.008 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.51 HG22 ' HA3' ' B' ' 125' ' ' GLY . 67.7 p -131.12 -179.7 5.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.51 HG22 HG23 ' B' ' 124' ' ' THR . 13.4 t -138.58 158.48 44.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.77 154.96 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.934 -1.104 . . . . 0.0 111.162 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.477 ' N ' HD23 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -124.16 111.61 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.591 ' N ' HD12 ' B' ' 115' ' ' ILE . 5.2 mp -93.13 136.96 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 111.483 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 5.2 m-30 -96.84 169.33 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.77 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.06 -0.96 42.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 110.097 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.7 -7.31 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.08 -2.49 40.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' LYS . . . . . 0.541 ' HB3' ' CD2' ' B' ' 116' ' ' PHE . 0.1 OUTLIER -85.42 146.11 27.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.111 -1.229 . . . . 0.0 110.024 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 29.2 ttp -149.51 125.55 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.814 HG11 ' CG1' ' A' ' 71' ' ' VAL . 48.7 t -97.38 148.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.95 107.72 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 111.355 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.552 ' CG2' ' HA ' ' A' ' 27' ' ' ASN . 9.7 t -108.53 144.44 36.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.094 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.524 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 126.5 -27.2 5.03 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.939 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -52.92 149.01 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.03 -1.277 . . . . 0.0 109.719 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.0 OUTLIER -94.66 -19.97 19.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.027 -1.046 . . . . 0.0 109.862 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.436 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -161.99 -159.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -75.34 -36.83 60.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.07 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.48 -38.94 92.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.086 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.61 -52.8 22.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.299 -0.876 . . . . 0.0 110.231 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 30.3 t -45.91 -36.4 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.203 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -73.83 -31.93 63.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.686 HD23 ' HD3' ' B' ' 137' ' ' ARG . 50.5 mt -80.95 -46.63 14.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.47 -29.57 61.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.143 -0.973 . . . . 0.0 109.88 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.438 ' O ' ' C ' ' B' ' 137' ' ' ARG . 23.4 t -76.3 -64.43 1.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 110.243 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.686 ' HD3' HD23 ' B' ' 134' ' ' LEU . 14.6 ptm180 -41.79 -31.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.537 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 4.9 mmtm -67.83 -50.99 53.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.471 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.465 ' CE1' HG23 ' B' ' 106' ' ' ILE . 18.1 m-85 -60.03 -52.13 66.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.342 -0.849 . . . . 0.0 109.673 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.33 62.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.639 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -52.26 -40.44 61.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.646 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' B' ' 139' ' ' TYR . 84.2 mt -63.34 -43.0 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.835 . . . . 0.0 110.195 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.532 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 52.0 mt -75.5 -49.06 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.71 -37.43 84.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' B' ' 141' ' ' ARG . 32.5 tttp -71.82 -27.03 62.64 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.427 HG13 ' O ' ' B' ' 142' ' ' ILE . 6.2 mt -74.01 -10.64 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.67 -19.3 28.66 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.532 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 6.4 m-85 -55.18 157.98 3.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -1.222 . . . . 0.0 111.057 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.41 49.72 0.99 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.62 -0.675 . . . . 0.0 109.742 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -96.26 144.78 26.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 110.835 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.509 ' O ' HD23 ' B' ' 76' ' ' LEU . 9.2 ptpt -142.28 -157.6 0.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.45 -0.781 . . . . 0.0 109.551 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' B' ' 137' ' ' ARG . 33.8 m-85 -106.09 117.39 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.016 . . . . 0.0 110.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' B' ' 75' ' ' THR . 0.8 OUTLIER -151.27 163.28 39.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' B' ' 75' ' ' THR . 13.8 t0 42.65 26.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 110.438 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' B' ' 74' ' ' VAL . 1.4 t80 -76.63 124.05 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 110.023 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 156' ' ' LYS . . . . . 0.443 ' N ' ' CD1' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -163.75 131.57 3.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.366 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.51 ' CG1' ' HB2' ' B' ' 72' ' ' ALA . 31.5 mt -78.78 107.87 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -110.45 12.01 23.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.657 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.53 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 49.3 m-20 -153.46 115.44 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.548 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 215' ' ' THR . 31.2 mt -117.73 162.7 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.667 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.418 ' N ' HG22 ' B' ' 160' ' ' ILE . 21.5 t -137.34 128.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.033 . . . . 0.0 110.624 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' B' ' 66' ' ' THR . . . -133.53 175.18 20.36 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 3.3 m -167.49 154.11 8.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -1.223 . . . . 0.0 110.456 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -169.95 161.9 9.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.122 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.432 ' OD1' ' HA ' ' B' ' 211' ' ' LYS . 4.2 m-20 -106.65 157.54 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.0 OUTLIER -110.46 3.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 3.8 tmtm? 74.34 -4.06 2.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.504 -0.748 . . . . 0.0 111.166 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 38.5 p90 -149.57 144.91 18.31 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.009 -1.057 . . . . 0.0 110.278 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.468 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.7 Cg_endo -71.92 157.64 54.41 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.174 1.618 . . . . 0.0 110.714 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.18 154.35 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 110.284 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.34 90.4 8.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 109.994 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' B' ' 193' ' ' LEU . 24.3 mt -52.17 -34.25 44.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.518 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -62.86 -58.91 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -56.34 -42.24 88.66 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.527 HD12 ' CD2' ' B' ' 179' ' ' HIS . 14.5 tp -71.88 -38.37 70.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.185 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.662 ' HB2' HD12 ' B' ' 193' ' ' LEU . . . -71.13 -17.31 62.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -83.09 -40.86 19.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.123 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 15.3 t -81.61 -45.63 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.527 ' CD2' HD12 ' B' ' 175' ' ' LEU . 52.2 m-70 -95.4 14.93 20.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.33 -29.97 5.52 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 92.2 m -71.95 -25.44 61.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.3 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -106.1 -21.32 13.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.891 ' HB3' HD21 ' B' ' 193' ' ' LEU . 1.1 m -124.86 171.61 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.5 t -137.95 135.39 35.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.894 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 0.491 ' CD2' ' HD3' ' B' ' 187' ' ' PRO . 64.4 t80 -128.55 135.59 49.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.578 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' B' ' 190' ' ' PHE . 12.3 mm-40 -131.94 93.79 26.28 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 187' ' ' PRO . . . . . 0.491 ' HD3' ' CD2' ' B' ' 185' ' ' TYR . 42.0 Cg_endo -68.99 -7.08 19.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.034 1.544 . . . . 0.0 110.365 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -100.41 -1.68 35.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -153.48 -48.33 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.134 -0.979 . . . . 0.0 110.565 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.816 ' HE2' HD11 ' B' ' 205' ' ' LEU . 3.0 t80 -108.76 117.56 53.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 110.514 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.53 -30.66 9.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.98 1.516 . . . . 0.0 110.178 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.75 -179.38 44.76 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.891 HD21 ' HB3' ' B' ' 183' ' ' SER . 3.6 tt -123.4 150.81 43.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -1.187 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' B' ' 183' ' ' SER . 4.5 mt -107.52 100.79 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.48 ' OH ' ' ND1' ' B' ' 179' ' ' HIS . 0.6 OUTLIER -89.62 103.88 16.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.262 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' B' ' 202' ' ' ILE . 22.2 mtm180 -92.36 79.51 4.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.523 ' CE ' HG12 ' B' ' 230' ' ' ILE . 34.3 ttm -43.53 146.28 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 110.589 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.14 -34.61 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 110.079 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -155.8 116.05 2.24 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.3 Cg_endo -73.54 147.42 89.56 Favored 'Cis proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.89 -2.129 . . . . 0.0 110.377 0.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' B' ' 197' ' ' MET . 0.0 OUTLIER -59.27 101.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' B' ' 217' ' ' ALA . 37.9 mm -138.85 153.55 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.343 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.71 100.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.925 HD22 HG13 ' B' ' 230' ' ' ILE . 6.2 mp -94.67 127.25 40.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.46 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.816 HD11 ' HE2' ' B' ' 190' ' ' PHE . 0.1 OUTLIER -92.54 111.12 22.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.45 HD12 HD21 ' B' ' 234' ' ' LEU . 10.9 mm -96.68 139.32 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' B' ' 205' ' ' LEU . 33.4 m-85 -128.81 136.41 50.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.141 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 54.8 t -49.19 -36.35 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.938 . . . . 0.0 110.215 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.6 m -53.3 -30.0 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.47 16.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.624 ' O ' HD13 ' B' ' 212' ' ' ILE . 8.8 mttt -92.26 133.97 35.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.13 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.624 HD13 ' O ' ' B' ' 211' ' ' LYS . 12.9 mm -117.54 135.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.371 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' B' ' 205' ' ' LEU . 69.3 t -123.06 113.68 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.812 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.533 HD12 ' H ' ' B' ' 214' ' ' LEU . 3.5 mp -103.74 117.37 34.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.462 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.9 t -147.8 165.64 29.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.183 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.447 ' HA3' ' HE1' ' A' ' 67' ' ' MET . . . 92.49 21.76 30.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.895 ' HB3' HD12 ' B' ' 223' ' ' ILE . . . -100.32 141.57 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -1.099 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -16.0 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 109.94 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -153.12 145.72 24.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 110.027 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' B' ' 67' ' ' LEU . 0.6 OUTLIER -53.03 -25.73 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.244 -0.91 . . . . 0.0 110.329 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -38.68 91.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.407 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 82.0 mt-10 -67.59 -52.09 42.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.292 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' B' ' 217' ' ' ALA . 0.0 OUTLIER -53.08 -56.64 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.685 ' N ' HG22 ' B' ' 223' ' ' ILE . 1.7 m-30 -47.56 -31.07 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.004 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' B' ' 228' ' ' GLU . 2.8 mt-30 -78.42 -41.97 31.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.801 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -45.88 -44.36 14.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.868 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -69.5 -45.18 69.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.812 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -53.28 -28.77 29.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.08 19.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 109.789 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.925 HG13 HD22 ' B' ' 204' ' ' LEU . 5.9 mm -97.58 -13.4 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 109.821 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 41.7 t80 -52.46 -44.95 95.48 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.924 . . . . 0.0 110.694 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -74.28 -26.73 12.15 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.39 1.205 . . . . 0.0 110.315 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.41 HG13 HD13 ' B' ' 175' ' ' LEU . 25.0 t -66.23 -39.48 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 109.785 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.45 HD21 HD12 ' B' ' 206' ' ' ILE . 67.6 mt -68.5 -45.62 71.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 110.018 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 94.9 p -64.94 -44.58 88.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.87 . . . . 0.0 110.04 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.62 -37.33 49.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.927 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -110.62 36.59 3.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.968 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.488 ' CD ' ' C ' ' B' ' 238' ' ' ARG . 0.2 OUTLIER -74.55 163.46 27.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -121.37 -30.68 4.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.106 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.052 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.379 0.609 . . . . 0.0 110.032 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 1.02 ' N ' HD12 ' A' ' 18' ' ' LEU . 37.0 t0 -68.28 67.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.753 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.985 HD21 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -84.28 -4.42 58.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 110.397 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.594 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 31.1 m -43.48 -36.45 2.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 110.289 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.507 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -92.41 -36.45 6.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.755 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -49.93 -45.46 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -1.213 . . . . 0.0 108.82 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.891 HD22 ' HB3' ' A' ' 67' ' ' MET . 3.8 pp -79.74 6.35 11.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 109.607 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.786 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.3 t80 -114.94 -13.89 11.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 111.232 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 164.73 46.9 0.02 OUTLIER Glycine 0 N--CA 1.496 2.649 0 C-N-CA 118.861 -1.638 . . . . 0.0 110.746 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.702 HD21 ' CD1' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 44.96 112.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.307 1.051 . . . . 0.0 111.784 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -145.0 158.24 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.777 ' HA ' HG21 ' B' ' 103' ' ' ILE . 44.8 m-20 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.052 ' HB2' HD13 ' A' ' 18' ' ' LEU . 13.7 p -38.66 -28.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.475 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.8 tt0 -54.02 -17.02 2.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 110.233 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.53 28.22 5.5 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -123.97 125.87 45.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.003 -1.293 . . . . 0.0 110.359 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.673 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.31 153.16 17.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 110.706 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.747 HD12 ' C ' ' A' ' 35' ' ' LEU . 4.3 pp . . . . . 0 N--CA 1.494 1.753 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.784 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.187 0.518 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -95.53 -23.73 16.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.668 HD21 ' HZ ' ' B' ' 207' ' ' PHE . 4.4 mt -96.81 -43.7 7.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.016 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.904 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -45.23 -45.16 11.64 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.967 -179.304 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.98 -30.26 70.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.564 ' HB3' ' CE1' ' B' ' 190' ' ' PHE . 13.7 m120 -80.69 -37.8 30.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.713 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.7 mt -49.28 -46.22 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.355 -0.841 . . . . 0.0 109.54 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.77 -17.12 26.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -119.46 7.75 11.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -1.143 . . . . 0.0 110.315 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 56' ' ' ILE . 1.8 mt -86.76 31.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.524 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -118.2 39.07 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.204 -0.935 . . . . 0.0 110.49 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' HD13 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -162.42 31.43 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.522 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -145.22 -26.65 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 111.256 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.999 ' N ' HD12 ' A' ' 62' ' ' LEU . . . 177.47 -44.52 0.1 OUTLIER Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.157 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.86 HD12 HD11 ' A' ' 24' ' ' LEU . 3.9 mm? -53.4 -17.7 2.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -1.188 . . . . 0.0 110.67 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 80.6 m-20 -46.42 -39.82 11.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.085 -1.009 . . . . 0.0 110.116 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -62.26 -57.05 12.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.877 . . . . 0.0 110.098 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.891 ' HB3' HD22 ' A' ' 24' ' ' LEU . 4.9 tpp -64.32 -11.01 27.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 21' ' ' THR . 1.3 tm? -68.0 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.974 0.892 . . . . 0.0 109.024 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.82 -2.46 17.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.307 0.575 . . . . 0.0 110.222 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 13.3 tt0 -85.8 0.53 52.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.229 -0.919 . . . . 0.0 111.53 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.778 HG12 HG11 ' B' ' 122' ' ' VAL . 2.2 t -137.92 3.24 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.265 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 74' ' ' LEU . 6.0 tp -149.85 70.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -75.83 57.33 1.02 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.933 HD12 HD11 ' A' ' 72' ' ' ILE . 6.1 mt . . . . . 0 C--N 1.303 -1.444 0 CA-C-O 121.681 0.753 . . . . 0.0 110.382 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.29 0.567 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.459 HG13 ' HD2' ' B' ' 65' ' ' PRO . 55.8 t -92.47 140.07 24.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.876 . . . . 0.0 110.248 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.467 ' HG3' ' HB2' ' B' ' 227' ' ' PHE . 44.5 Cg_endo -71.29 138.45 33.1 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.011 1.532 . . . . 0.0 110.476 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.479 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 17.0 m -106.67 141.35 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.826 HD22 HG22 ' B' ' 160' ' ' ILE . 40.6 mt -78.66 122.24 25.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 19.7 mm-40 -110.16 -15.71 13.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 110.383 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.544 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 71.9 m-20 -160.94 121.7 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.299 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.716 HD11 HD13 ' B' ' 67' ' ' LEU . 10.1 mt -122.54 171.33 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.902 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.579 ' N ' HG22 ' B' ' 70' ' ' ILE . 7.6 t -144.79 134.31 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.64 133.29 54.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 38.7 m -92.14 127.33 37.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.093 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.727 HG21 ' OG ' ' B' ' 136' ' ' SER . 40.6 t -131.12 133.04 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.385 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 4.4 m -101.27 139.98 36.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 110.056 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.831 HD22 ' HB1' ' B' ' 150' ' ' ALA . 29.2 mt -87.16 -67.25 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 143.32 -17.75 2.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 30.1 p -141.7 141.08 33.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.775 ' O ' HD23 ' B' ' 80' ' ' LEU . 1.5 ptt85 -57.9 163.56 2.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.775 HD23 ' O ' ' B' ' 79' ' ' ARG . 18.0 mt -139.86 155.98 46.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 110.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 3.7 m-20 -89.75 102.59 15.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' B' ' 102' ' ' VAL . 13.6 mt -48.39 -31.44 6.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.333 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -67.25 -38.59 85.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 110.255 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 31.7 p -81.9 -41.96 20.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.543 HG12 HG11 ' B' ' 102' ' ' VAL . 24.2 t -58.66 -42.46 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.404 ' CB ' ' HB2' ' B' ' 94' ' ' TYR . . . -81.03 -18.39 46.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.452 ' O ' HD12 ' B' ' 87' ' ' LEU . 13.4 tp -87.08 -31.38 20.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -95.59 -29.3 14.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.397 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -63.35 133.37 53.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -25.45 59.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 110.383 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 2.4 m120 -132.25 79.42 1.86 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.75 158.41 44.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' B' ' 102' ' ' VAL . 1.7 mm-40 -129.78 147.34 51.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.404 ' HB2' ' CB ' ' B' ' 86' ' ' ALA . 28.8 t80 -147.6 111.14 4.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.925 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -135.35 122.85 15.07 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 110.41 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.72 -17.3 26.11 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.916 1.482 . . . . 0.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -21.6 62.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 110.208 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.452 ' HG3' ' NH1' ' B' ' 98' ' ' ARG . 0.0 OUTLIER -101.9 -56.95 2.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.606 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.731 ' CG ' ' HB2' ' A' ' 18' ' ' LEU 0.257 62.6 t80 -170.18 -179.14 3.02 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.866 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.773 ' O ' HD13 ' A' ' 74' ' ' LEU . . . -99.41 70.72 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.869 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -155.43 149.67 25.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.558 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.543 HG11 HG12 ' B' ' 85' ' ' VAL . 44.7 t -102.03 117.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.777 HG21 ' HA ' ' A' ' 29' ' ' ASP . 1.3 mp -89.55 111.38 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.483 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.568 ' CB ' ' HB3' ' B' ' 113' ' ' ALA . 0.6 OUTLIER -89.93 153.01 20.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.774 179.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -149.53 118.05 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.047 -1.033 . . . . 0.0 110.728 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.584 HG23 ' CE1' ' B' ' 139' ' ' TYR . 34.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 109.706 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -104.03 35.59 2.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 110.39 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 5.9 tt0 -171.82 81.49 0.48 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.461 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.483 ' O ' HG13 ' B' ' 106' ' ' ILE . 50.3 Cg_endo -79.63 165.35 80.08 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.538 -0.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 8.4 tptt -70.24 94.17 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.518 HG22 ' HA3' ' B' ' 125' ' ' GLY . 18.4 p -139.59 177.66 7.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.713 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.58 ' HB ' HG23 ' B' ' 124' ' ' THR . 0.9 OUTLIER -119.7 173.43 7.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.451 -0.78 . . . . 0.0 109.383 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' B' ' 104' ' ' MET . . . -146.93 133.97 20.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.22 97.18 6.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.521 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 68.8 mt -97.34 150.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.101 -0.999 . . . . 0.0 111.274 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.3 m-85 -118.81 174.13 6.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 109.861 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -87.4 -3.29 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 109.907 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.88 -22.34 24.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.531 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 126.57 -38.98 2.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.63 153.46 2.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -1.157 . . . . 0.0 110.026 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.545 ' HE2' HD21 ' B' ' 76' ' ' LEU . 1.9 ttm -140.76 148.77 41.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.778 HG11 HG12 ' A' ' 71' ' ' VAL . 1.4 t -129.02 142.21 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.49 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.482 HG13 ' HE2' ' B' ' 139' ' ' TYR . 21.7 t -132.04 112.41 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.636 HG21 HD13 ' A' ' 23' ' ' ILE . 1.7 t -104.86 165.37 11.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.382 -0.824 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.518 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 107.87 -28.26 12.67 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -51.5 144.91 9.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -1.222 . . . . 0.0 110.241 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' B' ' 128' ' ' SER . 17.0 pttm -112.62 -23.54 10.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.442 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -137.25 -153.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.79 -39.27 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.319 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.9 -42.45 90.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.62 -47.21 79.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 110.204 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 35.7 t -52.27 -46.96 66.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.241 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -36.86 80.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 110.212 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.82 -50.39 36.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.73 -50.27 66.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.727 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -62.35 -54.34 41.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.009 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' B' ' 138' ' ' LYS . 0.0 OUTLIER -46.5 -39.37 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.961 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.469 ' HD3' ' HD3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -61.29 -53.73 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.945 . . . . 0.0 110.052 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.721 ' HA ' HD12 ' B' ' 142' ' ' ILE . 40.5 m-85 -54.21 -52.72 60.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.257 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.37 -31.93 16.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -35.98 81.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.721 HD12 ' HA ' ' B' ' 139' ' ' TYR . 13.8 mt -63.97 -48.62 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.526 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.84 HG21 ' HB2' ' B' ' 150' ' ' ALA . 20.4 mm -61.66 -49.32 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -68.95 -27.56 65.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.085 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -77.35 -20.6 54.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.237 -0.914 . . . . 0.0 108.75 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.8 mt -87.57 -19.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.697 -0.627 . . . . 0.0 109.34 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.45 -29.41 5.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.499 ' CB ' HG22 ' B' ' 143' ' ' ILE . 6.8 m-85 -47.88 159.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.032 -1.275 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.12 42.07 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.651 -0.655 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.84 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -71.33 154.87 41.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.601 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -144.42 120.52 10.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 109.768 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 63.3 t80 -60.89 111.46 1.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.452 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.466 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.1 OUTLIER -158.16 163.25 37.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 0.4 OUTLIER 63.43 13.95 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.649 ' HA ' HG22 ' B' ' 74' ' ' VAL . 19.8 t80 -61.41 126.41 27.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.972 -1.08 . . . . 0.0 109.838 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 156' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 155' ' ' PHE . 27.5 mtpt -160.77 133.35 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.548 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.479 HG23 ' CG2' ' B' ' 70' ' ' ILE . 2.9 mp -79.49 127.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.755 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -129.33 -25.69 2.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.209 -0.932 . . . . 0.0 110.88 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -113.54 96.88 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.793 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.826 HG22 HD22 ' B' ' 67' ' ' LEU . 44.5 mt -107.85 111.36 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.552 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.874 HG22 ' OG1' ' B' ' 215' ' ' THR . 25.2 t -94.8 107.66 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.789 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -111.5 167.52 12.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.8 t -169.16 159.72 9.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.923 -1.339 . . . . 0.0 110.63 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -169.85 170.11 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.845 . . . . 0.0 109.928 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.89 161.05 14.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.969 . . . . 0.0 110.281 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.548 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.1 OUTLIER -111.54 -83.8 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.489 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER -173.89 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 110.8 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.489 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 7.0 p90 -137.49 166.31 27.59 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.7 Cg_endo -71.18 149.42 57.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.782 1.412 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.39 160.57 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.301 -0.874 . . . . 0.0 110.376 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.07 91.42 6.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' B' ' 193' ' ' LEU . 83.0 mt -48.34 -26.37 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.38 -58.57 4.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -51.22 -31.82 27.68 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.571 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -72.97 -42.89 62.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -1.165 . . . . 0.0 110.229 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -68.09 -13.46 62.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.143 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 177' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.6 t80 -92.8 -37.52 12.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 178' ' ' SER . . . . . 0.491 ' HB2' ' CZ ' ' B' ' 237' ' ' PHE . 46.6 t -83.82 -50.27 8.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -105.4 19.4 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.887 . . . . 0.0 110.225 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 176' ' ' ALA . . . -54.36 -25.74 34.72 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.07 -24.31 62.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -1.145 . . . . 0.0 110.263 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.706 ' CE1' HG22 ' B' ' 198' ' ' VAL . 0.9 OUTLIER -134.66 12.04 3.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.466 ' HB3' HD21 ' B' ' 193' ' ' LEU . 48.6 m -120.15 159.47 24.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 0.0 110.373 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 16.9 m -134.84 126.81 29.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.174 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -136.55 120.03 17.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 110.41 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -132.25 105.17 13.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.818 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.96 -2.86 12.17 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.084 1.571 . . . . 0.0 110.346 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.0 5.86 45.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.875 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.446 HD13 ' HE3' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -157.82 -41.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 110.266 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 55' ' ' ASN . 3.0 t80 -126.35 114.15 23.42 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 191' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -17.82 28.02 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.838 1.441 . . . . 0.0 110.49 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -94.31 179.79 37.84 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.9 ' HB2' HD22 ' B' ' 172' ' ' LEU . 9.5 tt -120.41 126.99 51.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.334 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.782 HD13 HD13 ' A' ' 62' ' ' LEU . 6.5 mt -90.95 107.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.4 t80 -96.44 116.7 29.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 87.55 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.0 ttm -59.53 144.07 48.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.706 HG22 ' CE1' ' B' ' 182' ' ' PHE . 65.2 t -88.26 -40.37 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 110.436 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.2 OUTLIER -140.93 107.49 6.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.365 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.9 Cg_endo -75.96 166.31 83.26 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.049 -2.063 . . . . 0.0 110.55 -0.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.0 OUTLIER -76.31 95.73 3.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.784 HD11 ' OE1' ' B' ' 222' ' ' GLU . 33.4 mm -134.91 160.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.45 107.04 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' B' ' 195' ' ' TYR . 1.5 mp -100.07 134.63 42.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.786 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 2.8 mt -110.83 116.26 30.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.489 HG12 HD21 ' B' ' 234' ' ' LEU . 3.6 mp -100.48 136.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.273 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.668 ' HZ ' HD21 ' A' ' 52' ' ' LEU . 49.0 m-85 -119.92 131.23 55.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 0.0 110.069 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 22.0 t -42.79 -27.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 207' ' ' PHE . 98.3 p -64.51 -26.58 68.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.548 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 110.75 9.02 23.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.62 ' C ' HD12 ' B' ' 212' ' ' ILE . 0.1 OUTLIER -98.2 121.93 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -1.185 . . . . 0.0 110.153 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.62 HD12 ' C ' ' B' ' 211' ' ' LYS . 1.2 mp -109.97 146.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.248 -0.907 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.652 ' C ' HD12 ' B' ' 214' ' ' LEU . 27.6 t -127.81 146.65 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 110.08 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.765 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.4 mp -133.2 109.51 9.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.874 ' OG1' HG22 ' B' ' 161' ' ' VAL . 14.7 t -130.23 152.04 50.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.149 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.413 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 109.03 -11.92 34.31 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -68.77 144.57 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.165 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -90.04 -17.37 27.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.173 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.528 ' NE2' ' OE1' ' B' ' 221' ' ' GLU . 0.6 OUTLIER -147.95 168.94 20.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -14.54 62.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.138 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.528 ' OE1' ' NE2' ' B' ' 219' ' ' GLN . 8.5 mp0 -68.73 -42.19 77.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 110.081 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.784 ' OE1' HD11 ' B' ' 202' ' ' ILE . 13.9 mt-10 -63.78 -51.15 66.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.449 HG22 ' HG2' ' B' ' 65' ' ' PRO . 45.8 mm -56.0 -37.2 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.419 ' CZ ' HG11 ' B' ' 64' ' ' VAL . 0.9 OUTLIER -65.05 -42.87 93.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 226' ' ' ALA . 0.0 OUTLIER -75.9 -44.11 42.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.296 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.478 ' O ' HG22 ' B' ' 230' ' ' ILE . . . -45.3 -41.38 8.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.72 ' HA ' HG22 ' B' ' 230' ' ' ILE . 10.2 t80 -78.39 -50.26 12.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 109.88 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -18.62 33.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.982 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -97.86 -32.61 11.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.72 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.8 tp -92.98 -17.79 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.605 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.3 t80 -50.88 -44.99 87.24 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 111.107 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.7 Cg_endo -71.93 -32.65 10.95 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.205 1.108 . . . . 0.0 110.496 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.571 HG12 HD21 ' B' ' 175' ' ' LEU . 25.2 t -64.37 -30.41 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 109.893 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.489 HD21 HG12 ' B' ' 206' ' ' ILE . 89.7 mt -70.91 -56.49 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.993 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -25.3 17.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -48.88 62.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' B' ' 178' ' ' SER . 92.4 m-85 -106.87 37.51 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.38 -0.825 . . . . 0.0 109.87 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -163.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' B' ' 169' ' ' PRO . 1.7 ttmm -126.7 -81.12 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 1.8 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.314 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.883 HD23 ' CG1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.493 ' N ' HD12 ' A' ' 18' ' ' LEU . 29.1 t0 -61.26 75.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 0.0 110.25 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -91.14 -7.53 51.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.86 ' OG1' HD21 ' A' ' 68' ' ' LEU . 91.9 m -43.38 -30.7 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.43 -31.48 6.44 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.762 HD12 HD11 ' B' ' 114' ' ' LEU . 0.3 OUTLIER -52.79 -41.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.316 . . . . 0.0 109.333 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.496 ' CD2' HD12 ' A' ' 68' ' ' LEU . 1.4 pp -84.51 -18.94 34.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.742 -1.223 . . . . 0.0 108.652 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.688 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -99.6 14.57 29.55 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 141.18 93.27 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.934 ' HB2' HG23 ' B' ' 124' ' ' THR . 4.9 p30 -28.42 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.69 0.757 . . . . 0.0 112.066 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.77 HG22 HD12 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.79 169.1 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.629 ' HB3' HG21 ' B' ' 103' ' ' ILE . 94.9 m-20 -86.41 123.92 32.17 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.628 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -36.56 -29.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.923 -177.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.5 tt0 -50.26 -21.16 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 109.87 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.82 25.45 4.23 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.672 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.57 135.19 52.94 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.808 -1.407 . . . . 0.0 110.988 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.77 HD12 HG22 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -103.43 154.01 19.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 111.235 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.9 HD21 ' OD1' ' A' ' 27' ' ' ASN . 3.0 pp . . . . . 0 N--CA 1.492 1.645 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.156 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.231 0.539 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.5 tt0 -100.65 -24.29 14.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' ASN . 3.9 mt -99.61 -44.37 6.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.856 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.73 -44.38 4.32 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.395 -0.816 . . . . 0.0 109.931 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.26 -27.25 65.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 52' ' ' LEU . 29.2 m-80 -81.45 -36.03 29.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 53' ' ' ARG . 6.8 mt -55.54 -44.05 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 0.0 109.541 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.42 -17.09 31.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -129.75 18.83 5.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -1.089 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' A' ' 56' ' ' ILE . 3.0 mt -80.93 -5.1 57.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 97.9 p -90.08 37.88 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 0.0 109.691 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 58' ' ' SER . 13.7 mtpp -121.17 6.66 10.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 194' ' ' ILE . 0.1 OUTLIER -118.61 -85.02 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.48 28.9 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.307 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.621 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -100.69 -27.96 13.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.024 -1.28 . . . . 0.0 109.005 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.694 ' HA ' HD22 ' A' ' 68' ' ' LEU . 50.2 t0 -45.21 -38.28 5.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.846 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -53.9 -30.63 46.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.991 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.556 ' HB3' HD12 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -78.17 -25.63 47.29 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 109.803 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.86 HD21 ' OG1' ' A' ' 21' ' ' THR . 7.9 mp -61.93 -58.66 7.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.846 HD21 ' HA ' ' A' ' 66' ' ' SER . 2.1 pp -52.75 -19.1 2.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.555 -0.716 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 67' ' ' MET . 35.3 tt0 -75.33 -2.98 30.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 110.356 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.959 ' O ' HG21 ' B' ' 122' ' ' VAL . 1.4 t -132.77 1.46 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.118 -0.989 . . . . 0.0 109.875 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.883 ' CG1' HD23 ' A' ' 18' ' ' LEU . 7.5 tp -146.82 67.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.638 -0.664 . . . . 0.0 109.918 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 46.4 t0 -76.8 57.84 1.35 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.145 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 6.0 mt . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 121.577 0.703 . . . . 0.0 110.85 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.605 HD13 ' O ' ' B' ' 165' ' ' ASP . 3.4 mt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.124 0.488 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' B' ' 63' ' ' ILE . 38.8 t 58.55 137.79 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 0.0 110.514 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.5 ' HD3' ' CD2' ' B' ' 227' ' ' PHE . 44.6 Cg_endo -73.27 124.74 9.7 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.859 1.452 . . . . 0.0 110.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.5 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 2.3 m -89.97 156.4 18.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.96 137.97 31.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.213 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -126.91 -10.74 6.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.511 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.5 OUTLIER -168.02 131.0 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.474 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.744 HG12 HG23 ' B' ' 160' ' ' ILE . 4.1 mt -129.74 165.75 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.884 HG22 ' HB ' ' B' ' 124' ' ' THR . 42.5 t -139.89 144.76 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 110.568 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' B' ' 156' ' ' LYS . . . -139.97 162.31 35.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.055 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 42.1 p -110.76 141.64 43.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.067 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.92 146.6 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 110.173 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' B' ' 154' ' ' ASP . 2.3 m -118.84 129.1 55.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.592 HD22 ' HB1' ' B' ' 150' ' ' ALA . 64.2 mt -89.67 -40.72 12.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 110.102 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.04 22.18 20.98 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.86 146.55 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -1.191 . . . . 0.0 110.381 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.631 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -77.16 148.58 35.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.8 HD22 ' HD2' ' B' ' 148' ' ' PHE . 13.7 mt -129.37 149.31 51.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.407 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 0.7 OUTLIER -90.07 94.74 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.733 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.582 HD22 HG23 ' B' ' 102' ' ' VAL . 13.1 mt -40.24 -55.23 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 0.0 110.462 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -47.25 -39.72 14.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 99.3 m -76.35 -41.04 49.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.54 -56.76 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 110.448 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.81 55.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.324 -0.86 . . . . 0.0 110.734 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 0.9 OUTLIER -72.13 -51.26 22.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.543 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -72.77 -42.23 64.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 0.0 110.482 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -42.7 122.34 2.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.429 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -73.53 -26.07 60.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.094 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 1.8 m120 -130.05 78.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -170.28 170.23 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.429 -0.794 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.623 ' O ' HD12 ' B' ' 103' ' ' ILE . 9.6 pt-20 -160.2 137.2 9.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -108.54 116.47 32.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 110.088 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.23 107.12 55.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.314 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -23.13 18.95 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.895 1.471 . . . . 0.0 110.089 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -24.38 63.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.099 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.45 -69.32 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.031 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.655 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.36 166.23 26.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.4 44.85 1.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.145 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -122.83 146.83 47.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.582 HG23 HD22 ' B' ' 82' ' ' LEU . 30.9 t -89.97 122.15 41.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.325 -0.86 . . . . 0.0 109.05 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.629 HG21 ' HB3' ' A' ' 29' ' ' ASP . 4.1 mp -89.3 110.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.893 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.58 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 7.2 ttm -103.93 163.95 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' B' ' 111' ' ' THR . 0.4 OUTLIER -163.6 127.38 2.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 110.587 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.643 HG23 ' CE1' ' B' ' 139' ' ' TYR . 7.2 pt -112.08 170.94 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 109.895 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.519 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 12.1 ptt180 -114.09 18.06 17.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.1 -1.0 . . . . 0.0 110.536 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 9.6 tt0 -177.67 94.02 0.23 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.478 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 51.6 Cg_endo -77.8 139.54 57.63 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.957 -2.101 . . . . 0.0 110.484 -0.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.74 ' O ' HG23 ' B' ' 111' ' ' THR . 18.9 mttp -56.65 118.98 5.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.74 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -163.59 178.33 8.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 110.419 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -131.91 172.4 12.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.82 . . . . 0.0 109.149 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.505 ' N ' ' CG2' ' B' ' 112' ' ' THR . . . -166.1 137.24 3.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.824 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -97.91 102.52 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' B' ' 104' ' ' MET . 2.3 mp -89.65 126.15 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' A' ' 74' ' ' LEU . 2.6 m-85 -101.32 157.44 16.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 109.913 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.485 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -73.56 -23.02 59.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 1.5 t -58.18 -18.91 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.184 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.11 -17.79 16.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -96.71 147.25 24.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 110.142 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -138.5 169.24 18.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.959 HG21 ' O ' ' A' ' 71' ' ' VAL . 5.1 t -127.12 142.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 71' ' ' VAL . 11.2 t -119.63 149.67 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.794 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.934 HG23 ' HB2' ' A' ' 27' ' ' ASN . 3.0 t -162.36 160.21 26.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.877 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.686 ' C ' HG22 ' B' ' 111' ' ' THR . . . 104.25 -1.56 43.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' B' ' 69' ' ' ASN . . . -75.53 -179.0 4.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.249 . . . . 0.0 110.09 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -135.28 0.39 2.8 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.994 -1.066 . . . . 0.0 110.731 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -160.41 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.081 -1.012 . . . . 0.0 110.319 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -87.84 -34.12 18.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.67 -34.94 60.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -53.49 53.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 3.1 m -55.0 -42.8 72.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.992 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.43 78.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.926 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -71.49 -56.69 5.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.062 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.603 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -58.88 -31.44 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 21.0 t -65.77 -63.14 1.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.1 ptm180 -52.06 -31.15 28.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.499 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -62.99 -47.47 82.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.666 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.643 ' CE1' HG23 ' B' ' 106' ' ' ILE . 20.9 m-85 -63.73 -53.42 51.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.632 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.37 -22.94 13.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.33 -47.53 49.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.783 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 146' ' ' ILE . 1.8 mt -50.4 -43.3 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.643 HD12 ' N ' ' B' ' 143' ' ' ILE . 3.1 mp -73.08 -59.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.918 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 3.0 mm-40 -54.45 -34.82 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.617 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -73.22 -30.15 63.29 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 142' ' ' ILE . 3.4 mt -72.68 -16.16 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.1 -20.58 19.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.8 ' HD2' HD22 ' B' ' 80' ' ' LEU . 3.1 m-85 -49.8 171.13 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.961 -1.317 . . . . 0.0 110.548 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.7 43.55 1.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 110.097 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.592 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -85.68 151.97 23.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.579 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 6.6 mttp -120.98 -158.53 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 110.206 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.03 86.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -146.53 177.19 9.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.536 ' CB ' ' OG1' ' B' ' 75' ' ' THR . 2.8 t0 69.29 6.57 5.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.352 -0.842 . . . . 0.0 110.704 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -51.23 127.73 20.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.026 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 156' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -158.33 126.3 5.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.54 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 6.5 mt -82.67 117.16 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.752 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -117.98 2.5 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 110.602 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.466 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 0.4 OUTLIER -147.67 121.9 9.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.744 HG23 HG12 ' B' ' 70' ' ' ILE . 57.6 mt -130.93 126.14 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.716 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.9 HG22 ' OG1' ' B' ' 215' ' ' THR . 15.0 t -105.16 140.05 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -139.96 -179.81 18.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.9 OUTLIER -170.38 154.99 4.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.315 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.481 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 18.0 p -170.18 163.47 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.605 ' O ' HD13 ' B' ' 63' ' ' ILE . 4.3 t0 -106.24 133.73 50.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.974 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.775 HG21 HD11 ' B' ' 170' ' ' ILE . 12.8 m -83.48 7.43 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -0.931 . . . . 0.0 110.595 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 45.7 tttt 70.68 12.43 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 110.809 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 16.0 p90 -169.35 145.6 2.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.048 -1.032 . . . . 0.0 110.425 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.66 154.77 54.65 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.092 1.575 . . . . 0.0 110.648 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.775 HD11 HG21 ' B' ' 166' ' ' VAL . 2.7 mp -125.11 151.18 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 110.152 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' B' ' 171' ' ' ARG . 5.8 ptm180 -88.51 98.51 11.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.115 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.509 HD22 ' CB ' ' B' ' 193' ' ' LEU . 30.3 mt -54.81 -42.06 71.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.011 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 173' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 16.1 pt-20 -55.65 -44.51 77.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.999 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 174' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -66.77 -37.89 92.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.821 HD21 HG12 ' B' ' 233' ' ' VAL . 0.2 OUTLIER -67.19 -38.6 85.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.942 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.64 60.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.933 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.91 -29.35 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.903 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 3.1 t -97.18 -30.89 12.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.949 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 183' ' ' SER . 24.7 m170 -130.44 31.71 4.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -66.69 -10.88 56.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.9 m -64.71 -36.63 84.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.0 -14.77 11.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.83 . . . . 0.0 110.303 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.592 ' HB2' ' CD2' ' B' ' 195' ' ' TYR . 0.9 OUTLIER -104.38 149.0 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.404 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 2.3 p -128.95 133.91 48.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.078 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -133.3 124.17 26.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.286 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' B' ' 187' ' ' PRO . 2.3 mt-10 -122.81 104.78 35.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 110.074 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 187' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.3 Cg_endo -72.29 -2.52 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.97 1.511 . . . . 0.0 110.23 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.44 0.42 39.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.853 . . . . 0.0 110.398 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.476 HD23 ' N ' ' B' ' 190' ' ' PHE . 2.2 tt -161.13 -47.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' B' ' 194' ' ' ILE . 1.1 t80 -100.92 110.94 62.4 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.443 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.93 -25.64 16.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.994 1.523 . . . . 0.0 110.266 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.17 -179.68 34.07 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.719 HD23 ' C ' ' B' ' 193' ' ' LEU . 7.5 tt -115.91 127.25 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -1.226 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.893 HD13 HD13 ' A' ' 62' ' ' LEU . 4.2 mt -90.07 111.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' B' ' 183' ' ' SER . 10.2 t80 -108.92 113.32 26.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.347 -0.846 . . . . 0.0 110.144 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.1 91.63 5.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 28.0 ttm -60.3 131.34 50.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' B' ' 201' ' ' LYS . 38.5 t -70.71 -42.29 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 1.7 mttt -139.66 112.24 7.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.385 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.9 Cg_endo -73.23 169.94 71.42 Favored 'Cis proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.974 -2.094 . . . . 0.0 110.462 -0.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 8.6 mtmt -79.42 80.02 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' B' ' 217' ' ' ALA . 44.7 mm -121.97 150.82 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.527 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 79.6 t -101.81 104.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.904 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.3 mp -97.17 141.51 30.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.392 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.798 ' C ' HD13 ' B' ' 206' ' ' ILE . 2.5 mt -120.9 131.95 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.798 HD13 ' C ' ' B' ' 205' ' ' LEU . 5.0 mm -115.41 139.51 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -121.38 145.21 48.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.482 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 74.9 t -50.09 -33.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.119 -0.988 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.2 t -63.72 -35.22 79.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 110.082 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.426 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 119.03 30.02 1.69 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.98 129.31 46.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 110.312 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.546 HD12 HD12 ' B' ' 206' ' ' ILE . 19.2 mm -114.72 132.79 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.598 ' HB ' HD12 ' B' ' 205' ' ' LEU . 6.1 t -124.73 140.31 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.933 . . . . 0.0 110.213 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.566 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.1 mp -130.75 112.49 13.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.9 ' OG1' HG22 ' B' ' 161' ' ' VAL . 5.3 t -136.34 151.43 49.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.484 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 103.85 7.05 42.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -82.19 159.46 23.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -1.197 . . . . 0.0 110.165 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -99.57 -17.58 17.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 0.0 110.171 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.654 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.5 OUTLIER -147.44 -162.59 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -95.75 -21.08 18.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.23 -24.09 65.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.833 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.43 ' HB3' HD11 ' B' ' 202' ' ' ILE . 21.0 mt-10 -79.92 -52.68 7.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.906 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 22.5 mm -52.94 -39.35 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.865 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.24 -43.84 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.008 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.61 82.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.287 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.84 88.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.208 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.5 ' CD2' ' HD3' ' B' ' 65' ' ' PRO . 53.1 t80 -70.0 -49.0 55.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -24.5 67.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.63 -31.33 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.945 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' B' ' 232' ' ' PRO . 2.1 tp -96.96 -16.62 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.937 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.594 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.1 t80 -46.97 -46.34 53.15 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 110.827 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -72.67 -50.57 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.329 1.173 . . . . 0.0 110.427 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.821 HG12 HD21 ' B' ' 175' ' ' LEU . 25.5 t -44.26 -38.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.62 -42.46 64.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.888 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.53 34.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.491 ' CA ' ' HD3' ' B' ' 171' ' ' ARG . 86.6 m-85 -121.44 38.77 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.78 167.07 21.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -104.8 -36.92 7.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.263 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.967 HD12 ' N ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.967 ' N ' HD12 ' A' ' 18' ' ' LEU . 6.2 t70 -65.86 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.833 HD21 HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -84.4 -17.2 40.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.525 -0.734 . . . . 0.0 111.02 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.721 ' N ' HD21 ' A' ' 68' ' ' LEU . 8.8 m -44.65 -25.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.045 -1.034 . . . . 0.0 110.349 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -100.16 -34.57 4.78 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.808 HD12 HD11 ' B' ' 114' ' ' LEU . 0.3 OUTLIER -48.5 -40.35 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.216 -1.167 . . . . 0.0 109.688 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.4 pp -83.42 -18.24 39.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.943 -1.098 . . . . 0.0 108.724 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -98.68 6.32 47.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.631 -0.668 . . . . 0.0 109.381 179.107 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 151.26 89.96 0.08 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 1.001 ' ND2' HD11 ' A' ' 35' ' ' LEU . 12.5 p-10 -19.54 81.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.662 0.744 . . . . 0.0 112.896 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -89.44 164.54 2.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' HG12 ' A' ' 28' ' ' ILE . 70.3 m-20 -86.49 132.77 33.84 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.546 ' OG ' HD11 ' B' ' 103' ' ' ILE . 1.0 OUTLIER -42.29 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.178 -178.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.1 tm-20 -62.77 -7.48 5.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.44 5.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HD3' ' N ' ' A' ' 34' ' ' LEU . 1.1 tpp180 -127.12 128.95 47.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.096 -1.238 . . . . 0.0 110.376 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.639 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -98.75 150.94 21.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.937 -1.102 . . . . 0.0 110.33 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.001 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.5 pp . . . . . 0 N--CA 1.49 1.562 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.262 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.095 0.474 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.3 tt0 -100.37 -22.01 15.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.061 -1.025 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 52' ' ' LEU . 5.1 mt -101.19 -51.39 3.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.947 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -47.4 -51.26 20.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.394 -0.817 . . . . 0.0 109.889 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -68.73 -15.29 63.47 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.729 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.592 ' HB3' ' CE2' ' B' ' 190' ' ' PHE . 1.9 m-80 -92.63 -35.0 13.77 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.947 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.5 mt -55.56 -42.44 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.416 -0.802 . . . . 0.0 109.309 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.4 -21.22 12.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.19 28.23 5.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -1.133 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' A' ' 56' ' ' ILE . 5.0 mt -92.12 10.44 29.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.59 34.82 1.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.845 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.953 ' HG3' HD23 ' A' ' 62' ' ' LEU . 11.6 ptpt -135.55 26.03 3.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.436 -0.79 . . . . 0.0 109.969 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.953 HD23 ' HG3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -142.96 -56.86 0.42 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.553 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . -164.0 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.4 mm? -42.07 -29.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.331 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -51.6 -33.65 33.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.739 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -68.9 -56.98 6.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.515 ' SD ' ' CA ' ' B' ' 216' ' ' GLY . 0.0 OUTLIER -67.3 -8.54 33.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.341 -0.849 . . . . 0.0 109.208 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.721 HD21 ' N ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -67.98 -63.84 0.98 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.805 0.812 . . . . 0.0 109.035 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.4 HD12 ' C ' ' A' ' 69' ' ' LEU . 3.4 pp -68.9 -5.95 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.215 0.531 . . . . 0.0 110.075 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 22.4 tt0 -80.92 3.37 23.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.981 HG12 HG11 ' B' ' 122' ' ' VAL . 2.1 t -143.27 4.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.816 -1.178 . . . . 0.0 110.656 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.867 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.9 tp -149.14 71.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.553 -0.717 . . . . 0.0 109.367 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t0 -76.52 57.34 1.21 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.157 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 5.6 mt . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.66 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.2 mp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.209 0.528 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 57.0 t 59.62 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.466 -0.771 . . . . 0.0 110.385 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.5 Cg_endo -75.53 149.61 34.82 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.928 1.489 . . . . 0.0 110.631 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.457 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.1 m -113.93 143.08 45.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.909 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.484 HD22 ' CG2' ' B' ' 160' ' ' ILE . 67.6 mt -80.44 117.61 21.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -108.3 -10.69 15.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.278 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.569 HD22 HG21 ' B' ' 161' ' ' VAL . 6.3 t30 -165.76 160.13 16.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 110.299 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 10.2 mt -157.45 166.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.936 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.503 ' N ' HG22 ' B' ' 70' ' ' ILE . 16.6 t -135.41 132.85 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.488 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -121.2 136.51 54.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.9 m -97.11 134.06 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 0.0 110.125 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' B' ' 155' ' ' PHE . 8.4 t -133.63 169.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 56.2 m -144.11 133.66 23.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.387 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 1.103 HD12 HD11 ' B' ' 80' ' ' LEU . 82.9 mt -88.56 -14.39 37.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.67 -0.54 70.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 22.1 p -138.55 137.0 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -1.164 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 5.7 mtp85 -62.48 158.72 17.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 1.103 HD11 HD12 ' B' ' 76' ' ' LEU . 15.5 mt -130.36 150.45 51.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.271 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 1.0 OUTLIER -99.12 93.54 6.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.623 HD22 HG23 ' B' ' 102' ' ' VAL . 9.1 mt -39.16 -46.49 1.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.465 -0.772 . . . . 0.0 110.68 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.63 -43.56 76.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 84.8 m -83.58 -35.77 24.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.99 . . . . 0.0 110.22 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' B' ' 80' ' ' LEU . 30.4 t -65.96 -57.25 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.53 -36.59 80.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.493 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.03 -48.03 83.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.416 ' O ' ' C ' ' B' ' 89' ' ' ALA . 32.6 m170 -78.61 -42.95 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -0.951 . . . . 0.0 110.542 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -43.82 124.95 3.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 109.997 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.92 -18.01 62.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 3.3 m-20 -137.42 79.8 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.573 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -165.84 152.27 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.54 164.61 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 110.044 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.52 120.82 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 110.435 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.44 112.09 21.11 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.99 -18.8 30.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.932 1.491 . . . . 0.0 110.268 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -71.95 -17.13 62.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 11.1 mpt_? -105.54 -69.72 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.644 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -152.09 -178.93 7.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.494 -0.754 . . . . 0.0 109.953 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -99.48 49.89 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.915 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.157 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -130.95 149.84 52.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.946 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.623 HG23 HD22 ' B' ' 82' ' ' LEU . 99.4 t -92.27 124.07 44.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.71 ' H ' HD12 ' B' ' 103' ' ' ILE . 5.0 mp -88.76 107.35 17.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.573 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 0.9 OUTLIER -93.27 161.39 14.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.482 -0.761 . . . . 0.0 109.844 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -163.85 123.31 2.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 0.0 110.832 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 4.6 pt -122.59 155.56 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 109.696 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 5.3 mtt180 -103.49 30.86 4.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 4.3 tm-20 -177.9 87.8 0.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.5 Cg_endo -76.49 159.58 96.24 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.351 -0.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.835 ' O ' HG23 ' B' ' 111' ' ' THR . 0.1 OUTLIER -73.12 115.37 12.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.037 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.835 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.8 OUTLIER -165.99 175.26 8.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.319 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.593 HG22 HG23 ' B' ' 124' ' ' THR . 0.5 OUTLIER -134.53 157.87 45.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.128 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -147.34 158.81 44.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.808 HD11 HD12 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -115.3 107.37 15.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.486 -0.758 . . . . 0.0 109.375 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' B' ' 102' ' ' VAL . 3.0 mp -89.93 131.47 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.735 ' CD1' HD11 ' A' ' 74' ' ' LEU . 4.5 m-30 -106.95 149.9 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.795 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' B' ' 80' ' ' LEU . . . -61.36 -20.06 62.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 110.342 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' B' ' 79' ' ' ARG . 12.2 t -62.86 -33.76 75.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.343 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.475 ' HA2' ' HG ' ' B' ' 80' ' ' LEU . . . 126.19 -13.77 7.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -76.16 171.57 14.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.411 ' SD ' HG13 ' B' ' 115' ' ' ILE . 6.7 ttp -155.99 135.0 12.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.158 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.981 HG11 HG12 ' A' ' 71' ' ' VAL . 12.6 t -115.51 119.02 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.694 HG13 ' HE2' ' B' ' 139' ' ' TYR . 18.7 t -105.24 144.49 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.707 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -146.78 165.96 28.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.571 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 101.55 -24.27 32.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.61 156.51 0.66 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -1.219 . . . . 0.0 110.607 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -109.4 -14.5 14.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 4.3 m -163.71 -178.49 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.244 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' GLU . . . . . 0.405 ' HG2' HD11 ' B' ' 157' ' ' ILE . 93.3 mt-10 -58.18 -65.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.052 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.35 -30.44 2.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.079 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -71.33 -53.71 13.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.0 110.226 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -54.81 -37.85 66.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -48.86 79.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.051 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 39.5 mt -61.57 -49.56 76.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.847 . . . . 0.0 110.054 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -58.05 -35.65 71.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 13.5 t -70.57 -65.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 110.022 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -46.79 -34.42 5.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.017 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -63.86 -49.61 72.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.694 ' HE2' HG13 ' B' ' 123' ' ' VAL . 18.4 m-85 -66.6 -54.91 18.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.916 . . . . 0.0 109.959 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 140' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.98 -35.61 59.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 3.3 ttp180 -58.77 -41.71 87.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.99 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 139' ' ' TYR . 27.6 mt -59.0 -47.05 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.731 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.5 mp -60.46 -46.83 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.069 -1.02 . . . . 0.0 109.396 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 68.5 mt-30 -67.27 -31.89 72.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.452 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 3.1 mmtt -74.49 -28.71 61.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.94 -22.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.2 -22.85 7.0 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.479 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.484 ' HB2' HG23 ' B' ' 143' ' ' ILE . 15.5 m-85 -51.63 175.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.349 . . . . 0.0 110.756 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.16 36.03 3.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.478 -0.764 . . . . 0.0 110.542 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.909 ' CB ' HD22 ' B' ' 76' ' ' LEU . . . -62.47 131.09 48.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.569 ' O ' HG23 ' B' ' 153' ' ' THR . 2.0 ptpt -111.31 25.08 12.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.011 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.498 ' O ' HG23 ' B' ' 153' ' ' THR . 3.7 t80 31.55 95.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.124 0.488 . . . . 0.0 111.2 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.569 HG23 ' O ' ' B' ' 151' ' ' LYS . 1.9 p -153.23 174.41 14.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 153' ' ' THR . 1.6 t0 65.2 27.22 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.409 -0.807 . . . . 0.0 110.554 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.412 ' HA ' HG22 ' B' ' 74' ' ' VAL . 41.3 t80 -73.25 133.52 43.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.89 . . . . 0.0 109.903 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -166.7 135.52 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 110.48 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 44.8 mt -78.9 133.66 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.432 -0.792 . . . . 0.0 109.638 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' B' ' 218' ' ' LYS . 23.2 mt-30 -125.53 -40.0 2.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 110.939 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.452 ' HB2' ' HB ' ' B' ' 71' ' ' VAL . 0.3 OUTLIER -114.06 109.27 18.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.066 -1.021 . . . . 0.0 110.959 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.484 ' CG2' HD22 ' B' ' 67' ' ' LEU . 30.1 mt -105.94 123.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.7 HG22 ' OG1' ' B' ' 215' ' ' THR . 79.8 t -98.36 138.98 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 110.574 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -140.49 167.27 25.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 155.08 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.265 . . . . 0.0 110.708 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 5.5 p -169.4 171.63 7.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.426 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 7.9 m-20 -128.57 140.39 51.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.0 110.419 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' B' ' 63' ' ' ILE . 22.6 m -119.34 8.66 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.936 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt 52.03 29.9 6.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 110.179 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.458 ' H ' HG23 ' B' ' 166' ' ' VAL . 1.2 t80 -121.0 115.86 31.58 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.26 120.16 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.904 1.476 . . . . 0.0 110.223 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.805 HD13 ' CG2' ' B' ' 206' ' ' ILE . 3.3 mt -101.49 145.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.568 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.64 84.86 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.981 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.719 HD22 ' HB2' ' B' ' 193' ' ' LEU . 15.1 mt -48.04 -23.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.98 -53.13 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.25 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.82 -38.61 96.26 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.499 HD23 HD13 ' B' ' 193' ' ' LEU . 11.7 tp -74.81 -38.58 62.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 109.968 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' B' ' 172' ' ' LEU . . . -65.87 -38.66 89.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -0.924 . . . . 0.0 110.291 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -72.38 -24.41 61.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.178 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 178' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -89.24 -48.9 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' B' ' 183' ' ' SER . 4.6 m-70 -103.16 34.94 2.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.08 -33.63 51.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -19.09 44.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -1.095 . . . . 0.0 110.141 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' B' ' 198' ' ' VAL . 36.2 m-85 -136.37 6.02 3.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.447 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.664 ' OG ' HD21 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -133.64 135.57 44.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 0.0 110.67 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.98 122.17 37.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 109.792 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -124.49 129.42 50.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 110.597 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 190' ' ' PHE . 9.3 mt-10 -136.23 102.85 9.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.453 -0.779 . . . . 0.0 109.653 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -2.45 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.932 1.49 . . . . 0.0 110.825 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -100.43 -6.02 26.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 0.0 110.324 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -143.91 -50.37 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.327 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.675 ' HB2' HD23 ' B' ' 189' ' ' LEU . 2.7 t80 -111.26 121.49 40.28 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 191' ' ' PRO . . . . . 0.474 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.4 Cg_endo -73.54 -35.55 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.923 1.486 . . . . 0.0 110.631 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.39 175.83 42.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.719 ' HB2' HD22 ' B' ' 172' ' ' LEU . 8.7 tt -106.83 138.19 43.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -1.163 . . . . 0.0 110.251 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.615 ' N ' HD23 ' B' ' 193' ' ' LEU . 2.6 mt -98.35 96.74 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.523 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 7.6 t80 -93.89 120.37 34.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.856 ' HG2' HG22 ' B' ' 203' ' ' VAL . 17.0 mtp85 -108.2 97.82 7.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.328 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 45.3 tpp -52.88 148.34 7.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.051 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.618 HG21 ' CE1' ' B' ' 182' ' ' PHE . 86.2 t -91.48 -40.91 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.905 . . . . 0.0 110.394 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.1 OUTLIER -140.7 107.79 6.48 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.491 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -73.92 165.45 84.97 Favored 'Cis proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.952 -2.103 . . . . 0.0 110.395 -0.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 16.9 mtmt -75.05 97.31 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.795 HD11 ' HG2' ' B' ' 222' ' ' GLU . 23.9 mm -129.24 158.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.582 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.856 HG22 ' HG2' ' B' ' 196' ' ' ARG . 46.0 t -111.63 124.37 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 1.069 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.9 mp -123.9 135.85 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.171 -0.956 . . . . 0.0 110.623 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' B' ' 205' ' ' LEU . 3.8 mm? -101.33 125.23 47.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.83 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.805 ' CG2' HD13 ' B' ' 170' ' ' ILE . 2.8 mt -120.32 133.68 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' B' ' 207' ' ' PHE . 57.8 m-85 -119.46 154.22 34.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 52.7 t -60.44 -22.57 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.074 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.5 t -64.52 -36.17 83.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 121.29 11.04 6.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.851 ' O ' HD13 ' B' ' 212' ' ' ILE . 2.2 mptm? -92.51 141.65 28.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.105 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.851 HD13 ' O ' ' B' ' 211' ' ' LYS . 24.6 mm -131.78 132.7 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.4 t -123.08 140.08 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.226 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 5.6 mp -121.47 145.03 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.7 ' OG1' HG22 ' B' ' 161' ' ' VAL . 6.6 t -165.3 157.3 15.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.187 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.515 ' CA ' ' SD ' ' A' ' 67' ' ' MET . . . 98.02 -15.78 61.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' B' ' 222' ' ' GLU . . . -65.83 141.7 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' B' ' 158' ' ' GLN . 0.3 OUTLIER -92.56 -25.93 18.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.109 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.86 151.37 47.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -47.05 -33.23 4.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -38.47 70.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.795 ' HG2' HD11 ' B' ' 202' ' ' ILE . 0.2 OUTLIER -60.66 -49.68 76.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.419 HG23 HD22 ' B' ' 214' ' ' LEU . 47.2 mm -56.03 -38.65 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 110.342 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.34 -40.38 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 110.326 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.86 94.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 1.069 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -60.3 -56.45 21.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.134 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.453 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 2.9 t80 -58.64 -44.49 90.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.131 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.9 -36.19 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.14 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.48 -11.31 37.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.669 HG13 HD22 ' B' ' 204' ' ' LEU . 9.8 mm -97.77 -23.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.784 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -50.22 -48.45 79.93 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 110.758 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.72 -41.73 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.515 1.271 . . . . 0.0 110.376 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.443 ' CG1' HD13 ' B' ' 175' ' ' LEU . 57.1 t -50.53 -39.39 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.645 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.529 HD11 HG22 ' B' ' 230' ' ' ILE . 15.8 mt -68.65 -48.43 64.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.824 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 40.8 t -60.78 -31.99 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.845 . . . . 0.0 109.87 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -37.94 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.494 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 76.6 m-85 -116.23 38.04 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.95 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.44 ' HB3' ' CE2' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -60.85 145.89 48.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 110.086 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -93.71 -39.2 10.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.918 . . . . 0.0 110.167 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.218 179.926 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.981 ' CD2' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.22 0.534 . . . . 0.0 110.247 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -63.43 81.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.981 HD22 ' CD2' ' A' ' 18' ' ' LEU . 4.1 tp -120.22 62.03 0.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.776 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.708 HG23 ' HB3' ' A' ' 64' ' ' LEU . 1.2 m -92.05 -3.6 55.56 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.544 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -101.62 -31.51 5.46 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.563 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.931 ' CG1' HD11 ' A' ' 20' ' ' LEU . 2.2 mm -46.15 -44.12 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.416 -1.638 . . . . 0.0 109.171 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.826 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.6 OUTLIER -83.94 -23.44 31.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.057 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.594 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -85.26 10.64 11.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.499 -0.75 . . . . 0.0 109.16 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 135.55 104.83 0.78 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.596 ' ND2' HD12 ' A' ' 35' ' ' LEU . 7.5 p-10 -21.74 118.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.944 0.878 . . . . 0.0 111.438 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -140.37 161.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.546 0.688 . . . . 0.0 109.461 -178.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 28' ' ' ILE . 1.2 m-20 -87.58 119.32 27.77 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.571 ' OG ' ' CE2' ' B' ' 99' ' ' PHE . 26.7 p -39.15 -25.8 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.3 tt0 -66.3 -3.49 6.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.948 -1.095 . . . . 0.0 111.306 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 29.11 5.83 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.023 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.556 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -121.03 117.18 26.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.916 -1.343 . . . . 0.0 109.534 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -87.27 162.82 17.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.229 . . . . 0.0 111.906 -178.303 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.558 0.694 . . . . 0.0 111.67 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.291 0.567 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.6 pt-20 -97.47 -31.36 12.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.848 . . . . 0.0 110.29 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 3.1 mt -90.99 -41.29 11.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.002 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -48.81 -52.96 21.26 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.98 -26.53 67.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.368 -0.833 . . . . 0.0 109.524 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.537 ' HB3' HD23 ' A' ' 59' ' ' LEU . 1.9 m-80 -79.97 -42.9 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.459 -0.776 . . . . 0.0 110.05 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.002 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -48.43 -45.71 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.81 0.74 64.8 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.494 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.3 OUTLIER -120.71 -44.47 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -1.197 . . . . 0.0 110.884 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.057 HD22 ' CE2' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -85.59 34.84 0.59 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 110.698 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.69 34.38 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.894 -1.129 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.9 1.55 0.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 111.106 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 62' ' ' LEU . 5.7 mt -86.65 -67.62 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.661 -1.274 . . . . 0.0 109.93 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.63 -35.66 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.708 ' HB3' HG23 ' A' ' 21' ' ' THR . 3.9 mm? -54.24 -39.76 67.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.21 -1.17 . . . . 0.0 110.343 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 69' ' ' LEU . 16.4 t0 -43.91 -33.89 1.49 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 1.5 m -60.7 -62.88 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.826 ' HG2' HD13 ' A' ' 24' ' ' LEU . 1.1 ttp -72.01 -3.14 21.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.292 -0.88 . . . . 0.0 109.792 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -67.69 -54.98 15.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 108.933 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 65' ' ' ASP . 0.6 OUTLIER -69.92 0.28 6.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.72 -0.613 . . . . 0.0 109.953 179.249 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -91.83 -11.47 36.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -0.845 . . . . 0.0 110.577 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.921 HG11 HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.58 -17.59 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.084 -1.01 . . . . 0.0 108.797 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.065 HD11 HD12 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -146.57 78.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.845 -0.534 . . . . 0.0 110.148 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.46 53.24 1.51 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.885 -1.134 . . . . 0.0 109.049 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.126 HD11 ' CB ' ' B' ' 101' ' ' ALA . 8.0 mt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.675 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.579 ' C ' HG23 ' B' ' 64' ' ' VAL . 33.4 mt . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.216 0.531 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.579 HG23 ' C ' ' B' ' 63' ' ' ILE . 2.7 t 67.2 125.19 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 46.5 Cg_endo -73.43 146.96 40.56 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.856 1.451 . . . . 0.0 110.617 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 3.3 m -105.4 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 110.07 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.448 HD22 HG23 ' B' ' 160' ' ' ILE . 27.3 mt -77.01 134.68 38.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -123.25 -18.39 6.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.405 ' OD1' ' HA2' ' B' ' 125' ' ' GLY . 5.4 t30 -169.88 154.24 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.399 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' B' ' 160' ' ' ILE . 5.0 mt -145.26 147.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 110.025 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.595 HG11 ' CG1' ' A' ' 71' ' ' VAL . 53.3 t -115.83 142.83 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.95 . . . . 0.0 110.582 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.31 162.04 33.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 0.0 110.172 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 0.3 OUTLIER -116.48 135.0 54.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.319 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.567 HG12 ' N ' ' B' ' 75' ' ' THR . 91.5 t -132.04 171.21 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.871 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.567 ' N ' HG12 ' B' ' 74' ' ' VAL . 46.1 m -148.03 151.63 36.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.95 HD22 ' HB1' ' B' ' 150' ' ' ALA . 33.7 mt -104.77 -57.5 2.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.837 . . . . 0.0 110.195 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.95 21.54 6.3 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.68 142.76 12.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -1.205 . . . . 0.0 110.282 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 146.86 53.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.045 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.741 HD11 ' CD1' ' B' ' 76' ' ' LEU . 15.5 mt -127.48 153.23 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.124 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.1 OUTLIER -90.37 88.12 7.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 110.017 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.659 HD22 HG23 ' B' ' 102' ' ' VAL . 10.7 mt -41.14 -44.04 2.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 110.277 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.4 OUTLIER -56.3 -42.28 77.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 110.092 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -83.96 -43.94 14.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.423 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 86.4 t -55.15 -48.2 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.244 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.625 ' HB2' HG13 ' B' ' 102' ' ' VAL . . . -72.96 -28.94 62.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 9.5 tp -77.21 -34.6 56.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.59 -25.71 22.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.96 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -65.52 143.09 57.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -72.06 -27.59 62.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.061 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' B' ' 104' ' ' MET . 71.7 m-20 -134.78 79.44 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 110.007 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -152.32 130.83 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.613 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -124.34 142.78 51.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -118.24 137.94 52.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 0.0 110.811 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' B' ' 95' ' ' ASN . 8.5 p30 -133.66 109.97 12.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.939 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 -26.9 12.79 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.99 1.521 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.28 -7.46 59.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' B' ' 95' ' ' ASN . 0.0 OUTLIER -102.45 -75.91 0.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.666 ' CE1' ' HB3' ' B' ' 101' ' ' ALA . 32.4 p90 -145.68 -178.86 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 110.075 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.612 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -99.2 56.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.051 -1.03 . . . . 0.0 112.099 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.126 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -152.53 166.32 32.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.867 -1.146 . . . . 0.0 110.524 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.659 HG23 HD22 ' B' ' 82' ' ' LEU . 21.3 t -97.39 157.74 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.47 HD13 ' OG ' ' A' ' 30' ' ' SER . 2.0 mt -118.25 100.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.99 . . . . 0.0 110.429 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.501 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 2.2 ttm -92.39 145.2 24.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.58 118.67 8.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.257 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 30.8 pt -116.81 164.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 110.063 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 1.1 ptm180 -120.04 42.44 2.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER 179.26 80.29 0.17 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 0.0 110.256 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.455 ' O ' HG13 ' B' ' 106' ' ' ILE . 49.4 Cg_endo -78.13 159.81 92.66 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.436 -0.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 2.1 tppt? -71.27 113.18 8.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.489 HG22 ' HA3' ' B' ' 125' ' ' GLY . 0.3 OUTLIER -154.47 164.8 38.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.687 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.616 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.9 m -114.84 146.45 41.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.502 -0.748 . . . . 0.0 109.325 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.717 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -149.53 140.82 23.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.102 . . . . 0.0 111.305 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.653 ' N ' HD23 ' B' ' 114' ' ' LEU . 0.2 OUTLIER -119.37 126.65 51.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.555 -0.716 . . . . 0.0 109.223 179.178 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 5.8 mt -108.36 136.65 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.935 . . . . 0.0 111.111 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 4.5 m-85 -93.81 161.43 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.58 -1.19 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.972 -1.08 . . . . 0.0 110.296 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 35.9 t -91.19 -7.67 50.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.348 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.1 -30.72 8.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -74.12 151.78 40.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -1.138 . . . . 0.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -153.64 169.45 23.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.201 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.89 HG11 HG12 ' A' ' 71' ' ' VAL . 24.8 t -133.38 147.98 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.478 HG12 ' N ' ' B' ' 124' ' ' THR . 23.3 t -126.67 170.04 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.588 HG23 ' CB ' ' A' ' 27' ' ' ASN . 10.1 t -170.04 154.18 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.881 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.583 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 111.43 8.3 23.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.472 ' CB ' ' HB2' ' B' ' 132' ' ' SER . . . -82.41 141.21 32.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.154 . . . . 0.0 110.046 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.64 -0.04 41.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.873 . . . . 0.0 110.283 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.79 -159.9 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.209 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.68 -49.09 9.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.55 -28.98 65.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.076 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -43.82 96.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.034 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 132' ' ' SER . . . . . 0.472 ' HB2' ' CB ' ' B' ' 126' ' ' ALA . 44.9 t -68.33 -36.64 79.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.79 -38.22 81.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.205 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.45 ' O ' ' HD2' ' B' ' 138' ' ' LYS . 6.1 mt -69.94 -45.41 67.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.31 -52.12 67.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 72.3 m -60.55 -50.85 71.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -39.66 69.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.998 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -59.41 -40.4 86.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.717 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 26.8 m-85 -65.62 -52.08 54.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.71 -36.16 56.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.955 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -59.94 -43.33 95.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 -35.26 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.853 HG21 ' HB2' ' B' ' 150' ' ' ALA . 39.8 mm -73.9 -57.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.65 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.14 -28.32 69.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 1.7 tttt -75.71 -19.27 59.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.97 -23.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.72 -0.613 . . . . 0.0 109.371 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.4 -29.37 4.8 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.534 ' CB ' HG22 ' B' ' 143' ' ' ILE . 12.2 m-85 -46.4 163.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -1.214 . . . . 0.0 110.937 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.2 38.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.559 -0.713 . . . . 0.0 109.942 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.95 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -73.55 136.41 44.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.627 ' O ' HD23 ' B' ' 76' ' ' LEU . 5.1 tttt -112.44 157.65 20.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 110.338 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -99.69 89.95 4.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.474 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -148.92 172.8 14.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.387 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.525 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t0 67.78 26.12 7.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 6.8 t80 -84.62 129.16 34.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.077 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -163.62 131.82 3.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.42 HG23 ' CG2' ' B' ' 70' ' ' ILE . 3.1 mt -79.88 123.74 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.666 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -119.69 -10.93 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.801 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 26.1 t30 -140.12 122.1 15.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' B' ' 215' ' ' THR . 3.9 mt -113.25 160.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.152 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.456 HG22 ' OG1' ' B' ' 215' ' ' THR . 54.7 t -138.67 126.35 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.714 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -130.95 176.2 19.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.1 p -158.33 154.54 27.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.447 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.9 p -170.2 174.21 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.818 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.484 ' O ' HD13 ' B' ' 63' ' ' ILE . 14.9 t0 -121.59 136.11 54.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.686 HG21 HD11 ' B' ' 170' ' ' ILE . 26.8 m -85.47 2.54 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.888 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.12 23.72 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.254 -0.904 . . . . 0.0 110.925 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.594 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 8.4 p90 -177.93 148.19 0.65 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.406 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.63 161.15 44.77 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.093 1.575 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.686 HD11 HG21 ' B' ' 166' ' ' VAL . 4.0 mt -131.08 150.84 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.37 90.62 7.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.533 HD21 HG22 ' B' ' 206' ' ' ILE . 22.2 mt -48.2 -29.13 3.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -64.14 -60.22 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.35 -34.15 25.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.573 ' HB3' HD13 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -63.99 -47.71 79.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 110.17 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.54 -30.03 67.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.886 . . . . 0.0 110.414 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -69.26 -27.35 65.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.279 -0.888 . . . . 0.0 110.583 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 11.3 p -99.14 -57.75 2.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.14 -0.975 . . . . 0.0 110.357 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' B' ' 183' ' ' SER . 26.6 m80 -100.54 38.26 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -62.85 -30.18 76.37 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 181' ' ' THR . . . . . 0.437 HG23 ' CG ' ' B' ' 182' ' ' PHE . 9.3 t -62.46 -33.47 74.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 110.362 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.437 ' CG ' HG23 ' B' ' 181' ' ' THR . 21.4 m-85 -113.16 -12.2 13.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.493 ' N ' ' O ' ' B' ' 179' ' ' HIS . 37.7 m -104.77 171.29 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.266 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.6 m -155.88 109.87 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.825 . . . . 0.0 110.053 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 1.019 ' HB2' HD12 ' B' ' 193' ' ' LEU . 17.8 t80 -113.49 114.51 26.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 110.23 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 3.2 mm-40 -125.55 102.52 29.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.44 -0.15 8.85 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.083 1.57 . . . . 0.0 110.325 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -98.42 -20.03 17.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.886 . . . . 0.0 110.035 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.602 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.6 tt -142.11 8.13 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.3 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 1.057 ' CE2' HD22 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -169.94 108.54 0.46 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.264 -0.897 . . . . 0.0 110.419 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -4.36 13.32 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.849 1.447 . . . . 0.0 110.516 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -117.47 162.96 12.76 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' B' ' 185' ' ' TYR . 2.4 tt -100.72 143.46 30.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 110.129 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.55 HD11 ' CE2' ' B' ' 190' ' ' PHE . 31.7 mt -104.78 106.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' B' ' 179' ' ' HIS . 0.3 OUTLIER -97.95 111.88 24.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -0.98 . . . . 0.0 109.87 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.77 80.99 5.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 110.41 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.9 ttm -50.83 141.68 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.23 -43.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 110.56 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 4.5 mttp -141.32 110.6 6.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.146 -0.971 . . . . 0.0 110.31 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.475 ' O ' HG12 ' B' ' 202' ' ' ILE . 47.5 Cg_endo -73.21 149.95 94.94 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.443 -0.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.8 OUTLIER -64.22 95.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.898 . . . . 0.0 109.967 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.519 HD12 ' HB2' ' B' ' 217' ' ' ALA . 11.4 mm -134.1 151.62 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 110.621 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -107.37 109.37 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 109.667 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.483 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.9 mp -100.98 134.93 43.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 110.913 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' B' ' 205' ' ' LEU . 0.2 OUTLIER -108.72 117.79 35.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 109.473 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.533 HG22 HD21 ' B' ' 172' ' ' LEU . 4.4 mp -107.87 137.31 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.488 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -118.29 135.25 54.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.048 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' B' ' 172' ' ' LEU . 69.0 t -45.21 -24.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -35.06 78.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.594 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 124.95 -12.45 7.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.28 154.76 37.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' B' ' 212' ' ' ILE . 12.2 mm -138.78 137.15 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 110.083 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.594 HG11 ' HE1' ' A' ' 25' ' ' PHE . 96.7 t -120.98 149.25 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 1.1 mt -133.35 102.14 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 14.2 t -131.53 153.65 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.388 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.25 15.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.519 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -100.03 131.23 46.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -1.199 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.422 ' N ' ' OE1' ' B' ' 222' ' ' GLU . 4.6 tttt -75.75 -13.98 60.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.434 ' C ' HD13 ' B' ' 160' ' ' ILE . 0.2 OUTLIER -152.91 173.46 15.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -32.23 70.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.117 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -55.98 -51.32 68.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.505 ' HB3' HD11 ' B' ' 202' ' ' ILE . 1.1 mt-10 -52.74 -42.28 64.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 109.943 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.444 HG12 ' CB ' ' B' ' 217' ' ' ALA . 18.4 mm -60.13 -45.83 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -68.63 -33.25 73.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -71.79 -46.25 58.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 109.966 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.483 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -54.48 -51.49 64.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.848 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.712 ' HA ' HG22 ' B' ' 230' ' ' ILE . 20.0 t80 -57.27 -37.34 72.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.78 . . . . 0.0 109.93 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.48 -18.2 63.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.037 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.97 -18.28 17.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.712 HG22 ' HA ' ' B' ' 227' ' ' PHE . 9.1 tp -100.03 -25.53 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 110.323 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 31.9 t80 -51.99 -44.18 91.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.02 -31.09 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.354 1.187 . . . . 0.0 110.555 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 30.7 t -70.06 -38.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.166 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 37.0 mt -67.87 -42.99 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.168 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.8 -39.22 88.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.91 -31.37 72.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -117.32 42.65 2.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.213 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -96.65 -176.03 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.59 -38.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.157 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.047 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.993 ' N ' HD12 ' A' ' 18' ' ' LEU . 2.7 t70 -66.54 60.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.091 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.895 HD21 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -80.68 -17.23 51.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 110.691 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.551 ' N ' HD21 ' A' ' 68' ' ' LEU . 64.9 m -41.31 -28.96 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.94 -37.1 4.0 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.75 HD12 HD11 ' B' ' 114' ' ' LEU . 0.4 OUTLIER -48.59 -40.39 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.277 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.601 HD13 ' CE ' ' A' ' 67' ' ' MET . 3.5 pp -82.97 -27.81 30.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.978 -1.076 . . . . 0.0 108.92 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 52' ' ' LEU . 1.7 t80 -90.58 9.95 27.51 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 141.18 95.33 0.25 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.709 ' HB2' HG22 ' B' ' 112' ' ' THR . 6.8 p-10 -20.06 116.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.976 0.893 . . . . 0.0 112.315 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.689 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.33 163.79 27.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.133 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.774 ' HA ' HG21 ' B' ' 103' ' ' ILE . 75.7 m-20 -87.45 121.73 30.26 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.047 ' HB2' HD13 ' A' ' 18' ' ' LEU . 2.9 p -36.78 -28.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.471 0.653 . . . . 0.0 109.69 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.8 tt0 -51.64 -18.48 1.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 0.0 110.575 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.75 27.97 3.87 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.645 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -129.38 147.86 51.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.94 -1.33 . . . . 0.0 109.573 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.689 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.72 165.88 12.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 0.0 111.872 -178.341 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.651 HD12 ' ND2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.928 0.871 . . . . 0.0 111.552 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.24 0.543 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 0.4 OUTLIER -89.31 -26.66 21.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 109.074 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.508 HD13 ' CE1' ' A' ' 25' ' ' PHE . 2.1 mt -88.81 -38.57 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.621 -0.674 . . . . 0.0 109.451 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.001 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -57.26 -57.49 12.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.362 -0.836 . . . . 0.0 109.913 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.12 -31.36 71.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 3.4 m-20 -73.21 -43.13 61.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.001 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.1 mt -46.26 -45.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.328 -0.857 . . . . 0.0 109.245 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.92 -26.48 18.77 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -136.51 44.19 2.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 110.232 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.156 HD21 ' CE1' ' B' ' 190' ' ' PHE . 6.7 mt -99.41 13.14 34.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.22 47.21 1.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.79 . . . . 0.0 109.864 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.523 ' C ' HD23 ' A' ' 62' ' ' LEU . 17.7 mtpp -135.99 1.93 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 110.102 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.908 HD11 HD22 ' A' ' 59' ' ' LEU . 1.5 mt -88.69 -38.96 14.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 109.743 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 3.35 4.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 62' ' ' LEU . 1.5 pp -87.0 0.59 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.092 -1.24 . . . . 0.0 110.064 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.9 t70 -44.05 -32.91 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.914 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -56.75 -49.73 74.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.017 -1.052 . . . . 0.0 109.478 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.601 ' CE ' HD13 ' A' ' 24' ' ' LEU . 12.7 ttp -65.96 -12.62 56.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.644 ' C ' HD13 ' A' ' 68' ' ' LEU . 1.3 tm? -70.09 -65.66 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.09 -6.33 22.34 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -79.45 -4.77 52.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 110.646 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.914 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.1 OUTLIER -129.65 -6.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 110.371 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.929 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.8 tp -140.74 72.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 110.166 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.8 t70 -79.79 56.19 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.016 HD13 ' HB2' ' B' ' 101' ' ' ALA . 6.4 mt . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.634 0.731 . . . . 0.0 110.746 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.453 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.21 0.528 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 4.8 t 62.1 132.09 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 109.961 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.523 ' HG2' HG22 ' B' ' 223' ' ' ILE . 49.3 Cg_endo -74.48 152.53 43.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.006 1.53 . . . . 0.0 110.778 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -118.92 129.86 55.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 109.865 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.787 HD22 HG22 ' B' ' 160' ' ' ILE . 29.2 mt -69.93 132.23 45.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 110.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.82 -16.36 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.421 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -152.49 111.6 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.577 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 20.0 mm -91.95 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' B' ' 159' ' ' ASN . 50.7 t -148.77 114.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.915 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.56 165.34 24.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.534 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' THR . . . . . 0.725 HG22 HG22 ' B' ' 122' ' ' VAL . 69.5 p -120.71 141.44 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.685 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' B' ' 121' ' ' MET . 3.3 t -140.23 156.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.042 . . . . 0.0 110.722 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.665 HG22 ' H ' ' B' ' 77' ' ' GLY . 24.2 m -106.18 144.44 32.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.965 HD12 HD11 ' B' ' 80' ' ' LEU . 93.5 mt -94.73 -6.29 43.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.447 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLY . . . . . 0.665 ' H ' HG22 ' B' ' 75' ' ' THR . . . 103.59 -38.8 3.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' CYS . . . . . 0.724 ' H ' ' HB1' ' B' ' 149' ' ' ALA . 0.0 OUTLIER -142.47 -174.5 4.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.113 -1.228 . . . . 0.0 110.836 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.688 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -78.7 178.86 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 110.222 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.965 HD11 HD12 ' B' ' 76' ' ' LEU . 10.4 mt -140.89 165.01 28.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.422 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.634 ' O ' HG23 ' B' ' 85' ' ' VAL . 1.1 m-20 -110.27 83.27 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' B' ' 81' ' ' ASP . 8.4 mt -38.11 -49.1 1.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.39 -51.62 58.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.697 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.544 ' HA ' ' CD2' ' B' ' 87' ' ' LEU . 43.3 p -76.87 -41.9 42.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 110.077 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.851 HG22 ' CE2' ' B' ' 148' ' ' PHE . 43.9 t -60.49 -37.02 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.121 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.27 78.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' B' ' 84' ' ' THR . 0.7 OUTLIER -90.74 -23.04 20.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.517 ' HB3' ' CD1' ' B' ' 146' ' ' ILE . 20.7 m170 -82.97 -35.38 25.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.684 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.527 ' HB2' ' HE1' ' B' ' 104' ' ' MET . . . -72.06 145.15 48.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.387 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -73.94 -27.13 60.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 1.7 m120 -133.69 79.29 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.938 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 89' ' ' ALA . . . -138.07 159.64 41.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.83 ' O ' HD12 ' B' ' 103' ' ' ILE . 73.9 mt-10 -147.83 120.34 8.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.244 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.475 ' HB2' HG22 ' B' ' 102' ' ' VAL . 24.8 t80 -113.52 113.4 25.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.121 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -119.8 111.72 35.72 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.15 -19.77 29.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.009 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -17.86 61.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -105.28 -76.46 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.444 -0.785 . . . . 0.0 110.027 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.658 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.25 173.15 11.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.891 . . . . 0.0 110.433 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.3 43.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.234 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.016 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -132.22 151.97 51.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 110.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' B' ' 94' ' ' TYR . 55.8 t -96.95 126.58 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 109.526 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.83 HD12 ' O ' ' B' ' 93' ' ' GLU . 3.3 mp -89.72 118.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 110.478 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.527 ' HE1' ' HB2' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -95.56 165.32 12.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.455 ' O ' ' ND2' ' B' ' 91' ' ' ASN . 10.3 mtp180 -163.8 116.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.783 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' B' ' 138' ' ' LYS . 37.7 pt -120.71 150.19 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.466 -0.771 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.5 OUTLIER -91.6 28.32 1.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.519 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 7.0 pt-20 -161.96 83.9 1.69 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.716 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' B' ' 111' ' ' THR . 51.1 Cg_endo -85.47 148.76 46.47 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.172 -0.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -51.54 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 109' ' ' PRO . 13.2 p -146.62 -179.46 6.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.899 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.81 HG22 HG23 ' B' ' 124' ' ' THR . 1.2 t -131.57 179.22 6.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 110.208 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -166.85 137.82 3.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 0.0 110.312 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.882 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -95.22 105.94 17.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.59 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.44 HD12 ' SD ' ' B' ' 104' ' ' MET . 33.8 mt -90.21 128.34 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.361 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.834 ' CD1' HD11 ' A' ' 74' ' ' LEU . 2.8 m-30 -99.84 162.31 13.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 79' ' ' ARG . . . -76.57 -11.09 59.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.699 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 m -83.05 -5.68 59.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.027 . . . . 0.0 110.211 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' B' ' 78' ' ' CYS . . . 107.14 -39.16 2.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.93 135.21 55.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.114 . . . . 0.0 109.987 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -133.01 168.34 18.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.356 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.914 HG21 ' O ' ' A' ' 71' ' ' VAL . 10.3 t -130.37 143.64 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.16 144.38 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.958 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.81 HG23 HG22 ' B' ' 112' ' ' THR . 1.2 t -153.08 165.58 35.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.568 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 108.72 -36.45 4.35 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -47.25 167.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -1.161 . . . . 0.0 110.416 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -118.77 -12.09 9.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.504 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m -154.43 173.65 15.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.062 -1.024 . . . . 0.0 110.406 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.2 mt-10 -57.96 -49.74 75.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.08 -35.3 73.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.69 -41.78 83.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 110.202 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -58.42 -54.61 45.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.164 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -50.17 -37.54 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' B' ' 138' ' ' LYS . 0.2 OUTLIER -70.09 -39.21 75.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 0.0 110.376 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -70.1 -35.37 74.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.14 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 50.7 m -72.28 -60.56 2.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 5.7 ptm180 -47.51 -30.11 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.294 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.569 ' HB3' HD13 ' B' ' 106' ' ' ILE . 57.7 mmtt -66.89 -48.16 69.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.014 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 28.6 m-85 -64.79 -52.79 54.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.79 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 140' ' ' ALA . . . . . 0.853 ' HB1' ' NE2' ' B' ' 144' ' ' GLN . . . -50.01 -37.09 31.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.864 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.85 85.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 mt -64.2 -25.44 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.771 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.456 HG23 ' HB2' ' B' ' 148' ' ' PHE . 0.3 OUTLIER -84.43 -25.12 7.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.385 -0.822 . . . . 0.0 109.029 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.853 ' NE2' ' HB1' ' B' ' 140' ' ' ALA . 24.2 mt-30 -89.17 -22.3 22.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.452 -0.78 . . . . 0.0 109.763 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -82.18 -27.81 32.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.975 HG21 ' CE2' ' B' ' 148' ' ' PHE . 25.7 mt -83.48 -37.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.655 -0.653 . . . . 0.0 109.806 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 117.74 20.2 4.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.975 ' CE2' HG21 ' B' ' 146' ' ' ILE . 13.8 m-85 -86.19 -160.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.088 -1.242 . . . . 0.0 110.335 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 149' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' B' ' 76' ' ' LEU . . . -34.66 -71.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.304 0.573 . . . . 0.0 110.501 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' B' ' 149' ' ' ALA . . . 64.88 72.72 0.43 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 112.002 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' B' ' 76' ' ' LEU . 0.4 OUTLIER -162.92 101.56 1.0 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.167 -0.958 . . . . 0.0 110.057 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.639 ' O ' HG23 ' B' ' 153' ' ' THR . 2.7 t80 -72.18 103.22 3.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.0 110.353 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.639 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.7 OUTLIER -159.22 158.27 32.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' B' ' 153' ' ' THR . 2.7 t70 70.45 18.5 6.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.885 . . . . 0.0 110.669 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.522 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 4.2 t80 -69.05 135.4 50.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.046 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.0 131.82 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -0.956 . . . . 0.0 110.704 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.402 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 51.5 mt -80.39 122.68 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 109.644 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -111.93 -3.6 14.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.119 -0.988 . . . . 0.0 110.972 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.479 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 11.2 m120 -155.8 140.42 16.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.855 -1.153 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.787 HG22 HD22 ' B' ' 67' ' ' LEU . 48.4 mt -133.88 123.97 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.388 -0.82 . . . . 0.0 109.655 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 8.0 t -101.6 131.1 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 110.627 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.73 172.15 18.97 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.99 152.24 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -1.197 . . . . 0.0 110.362 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.01 159.95 7.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' B' ' 166' ' ' VAL . 22.6 t0 -101.81 166.3 10.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.493 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.0 OUTLIER -114.32 -83.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.347 -0.846 . . . . 0.0 110.291 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -177.84 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.636 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.475 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 2.2 p90 -137.6 166.7 24.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.1 Cg_endo -70.97 171.63 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.82 1.431 . . . . 0.0 110.527 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.95 139.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 110.601 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 171' ' ' ARG . . . . . 0.428 ' CG ' ' H ' ' B' ' 174' ' ' GLY . 0.5 OUTLIER -75.13 88.07 2.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.607 HD22 ' CB ' ' B' ' 193' ' ' LEU . 71.9 mt -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.625 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -43.02 76.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.182 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 174' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' B' ' 171' ' ' ARG . . . -71.26 -31.03 66.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.459 ' O ' HD12 ' B' ' 175' ' ' LEU . 11.5 tp -75.45 -35.24 60.95 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -1.112 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.89 -27.36 64.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.3 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -75.44 -40.82 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.328 -0.857 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 2.1 t -78.3 -55.85 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.183 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -91.67 27.07 2.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.71 45.92 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -12.48 52.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.145 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -115.38 -23.99 8.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.04 171.28 10.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.7 m -132.33 147.77 52.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.241 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' B' ' 172' ' ' LEU . 33.6 t80 -149.64 104.54 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.913 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' B' ' 190' ' ' PHE . 6.5 mt-10 -113.67 103.94 55.3 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.81 -1.87 10.58 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.068 1.562 . . . . 0.0 110.113 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 188' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' B' ' 189' ' ' LEU . 1.7 pm0 -85.74 -18.21 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -148.7 -38.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 1.156 ' CE1' HD21 ' A' ' 59' ' ' LEU . 4.5 t80 -113.82 108.61 51.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.425 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.96 -20.52 19.42 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.031 1.543 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.55 178.43 44.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.607 ' CB ' HD22 ' B' ' 172' ' ' LEU . 9.7 tt -118.73 125.75 50.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -1.116 . . . . 0.0 110.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.767 HD13 HD22 ' A' ' 62' ' ' LEU . 4.7 mt -101.66 111.0 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.431 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 6.5 t80 -96.39 124.38 40.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.523 ' CB ' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -104.91 101.19 10.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 110.24 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.54 ' HE1' HG12 ' B' ' 230' ' ' ILE . 16.8 ttm -69.58 128.51 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.922 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.7 -51.38 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -138.06 119.05 10.36 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.103 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -74.69 150.28 95.25 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.91 -2.121 . . . . 0.0 110.427 -0.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' B' ' 197' ' ' MET . 3.2 tttt -63.04 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' B' ' 217' ' ' ALA . 47.1 mm -128.96 150.96 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.62 128.71 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.044 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.64 HD22 HG13 ' B' ' 230' ' ' ILE . 3.7 mp -120.36 135.05 55.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 110.548 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 1.9 mm? -102.97 126.66 50.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 109.795 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.556 HG12 HD21 ' B' ' 234' ' ' LEU . 3.7 mt -119.5 127.19 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 110.434 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.461 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 83.7 m-85 -118.23 143.67 46.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 110.241 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 25.4 t -48.06 -30.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.38 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.25 -45.74 68.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.493 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 128.24 3.25 5.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.438 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.5 OUTLIER -92.57 135.98 33.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -1.2 . . . . 0.0 110.301 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.438 HD13 ' O ' ' B' ' 211' ' ' LYS . 46.1 mm -121.09 125.3 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.348 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 24.7 t -107.07 154.78 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.961 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.1 mp -135.36 135.73 40.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 5.1 t -157.84 142.14 16.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.909 . . . . 0.0 110.204 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.406 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 111.39 21.78 6.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.742 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -108.82 126.92 53.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -1.136 . . . . 0.0 110.179 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -75.23 -25.69 58.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.415 ' HB3' ' HG2' ' B' ' 221' ' ' GLU . 1.2 tt0 -132.56 -178.57 4.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.12 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 28.4 ttp-105 -85.5 -37.42 19.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' B' ' 219' ' ' GLN . 13.2 pt-20 -52.49 -26.71 13.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -76.35 -44.56 36.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.828 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.523 HG22 ' HG2' ' B' ' 65' ' ' PRO . 28.2 mm -60.36 -38.23 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.64 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -64.99 -47.3 78.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -36.16 81.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.316 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.589 ' HB1' HD11 ' B' ' 204' ' ' LEU . . . -53.84 -52.86 59.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.524 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 25.5 t80 -71.57 -44.34 64.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.34 -32.36 2.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.51 -11.67 20.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.64 HG13 HD22 ' B' ' 204' ' ' LEU . 8.6 mm -100.03 -23.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.612 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 25.0 t80 -52.34 -48.22 90.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -70.31 -33.4 14.58 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.397 1.209 . . . . 0.0 110.391 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.84 -40.36 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.456 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.556 HD21 HG12 ' B' ' 206' ' ' ILE . 66.5 mt -68.11 -45.48 73.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.128 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -27.6 64.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.6 OUTLIER -66.49 -39.49 88.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.34 40.5 2.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.1 ptt85 -66.72 -170.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.466 ' HB2' ' HG2' ' B' ' 169' ' ' PRO . 1.3 mttp -123.33 -61.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.128 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.171 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.968 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.671 ' N ' HD12 ' A' ' 18' ' ' LEU . 14.4 t70 -81.22 98.68 8.2 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 111.123 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.968 HD21 HD21 ' A' ' 18' ' ' LEU . 4.9 mt -97.71 4.93 49.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.253 -0.904 . . . . 0.0 109.697 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.601 HG21 ' CB ' ' A' ' 59' ' ' LEU . 18.7 m -39.81 -28.61 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.104 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -100.19 -38.26 3.6 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.944 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -52.86 -46.87 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -1.073 . . . . 0.0 109.022 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.767 HD13 ' HG2' ' A' ' 67' ' ' MET . 3.4 pp -80.51 -3.92 51.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' O ' ' A' ' 21' ' ' THR . 1.4 t80 -112.75 -4.76 13.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.421 -0.799 . . . . 0.0 110.895 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 162.19 69.08 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.517 -1.801 . . . . 0.0 111.337 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.589 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 20.37 111.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.15 0.976 . . . . 0.0 113.301 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.738 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -149.0 156.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.876 ' HA ' HG21 ' B' ' 103' ' ' ILE . 5.4 m-20 -88.85 138.3 31.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.749 ' HB3' HD11 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -41.77 -26.55 0.08 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.407 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HA ' ' HG2' ' B' ' 98' ' ' ARG . 0.0 OUTLIER -55.47 -14.99 2.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 110.74 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.26 32.88 5.63 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.21 123.88 51.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.28 -1.13 . . . . 0.0 109.607 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -90.39 131.79 35.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.442 -0.786 . . . . 0.0 110.339 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.853 ' N ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 120.985 -1.072 . . . . 0.0 109.693 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.324 0.583 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' CG ' ' HG3' ' B' ' 191' ' ' PRO . 2.8 tt0 -79.3 -31.8 43.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.84 HD22 ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -117.16 -9.17 11.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.483 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.84 ' N ' HD22 ' A' ' 52' ' ' LEU . 5.7 tpt180 -62.82 -54.25 41.84 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.559 ' OE2' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -57.64 -20.5 33.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.035 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.575 ' C ' HD12 ' A' ' 59' ' ' LEU . 9.3 m120 -88.43 -25.45 22.64 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 53' ' ' ARG . 40.7 mt -51.2 -38.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.34 -13.29 42.9 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 55' ' ' ASN . 18.0 m -138.15 11.59 2.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.241 -1.152 . . . . 0.0 110.808 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 56' ' ' ILE . 0.5 OUTLIER -83.54 19.83 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 0.0 110.669 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 p -104.21 31.41 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 110.301 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.662 ' H ' HD13 ' A' ' 62' ' ' LEU . 5.7 pttt -130.64 11.24 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.472 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -124.86 -2.2 7.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.016 -1.053 . . . . 0.0 110.979 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.762 ' N ' HD22 ' A' ' 62' ' ' LEU . . . 150.71 -47.27 0.6 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.581 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.1 mm? -41.83 -31.74 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -1.206 . . . . 0.0 110.718 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.517 ' CA ' ' HG ' ' A' ' 68' ' ' LEU . 36.0 t70 -41.02 -35.93 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.515 -0.741 . . . . 0.0 110.286 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.3 m -66.53 -43.64 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.832 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.767 ' HG2' HD13 ' A' ' 24' ' ' LEU . 5.2 tpp -70.32 -22.71 62.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.803 ' O ' HG22 ' A' ' 72' ' ' ILE . 4.7 mt -62.74 -61.25 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.973 -1.079 . . . . 0.0 108.904 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 69' ' ' LEU . 3.8 pp -62.48 -9.51 8.76 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.018 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.15 -17.23 37.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 111.274 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.68 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.1 OUTLIER -115.68 -20.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.688 -1.258 . . . . 0.0 109.319 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.913 HD11 HD12 ' A' ' 74' ' ' LEU . 3.9 tp -130.36 71.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.646 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.52 57.73 1.26 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.854 -1.154 . . . . 0.0 108.154 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.995 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 5.1 mt . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 121.534 0.683 . . . . 0.0 110.502 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' B' ' 166' ' ' VAL . 5.2 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.346 0.593 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.37 132.19 23.72 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.857 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.34 148.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.922 1.485 . . . . 0.0 110.627 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 17.9 m -108.07 127.01 53.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.855 . . . . 0.0 110.245 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.92 131.06 43.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -123.26 -7.86 8.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.594 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.477 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.9 OUTLIER -163.47 110.16 1.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.466 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.931 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 19.4 mm -100.96 146.69 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.778 HG22 ' CB ' ' B' ' 124' ' ' THR . 47.4 t -136.75 131.16 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.969 -1.082 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.95 156.78 44.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' THR . . . . . 0.406 ' O ' ' O ' ' B' ' 154' ' ' ASP . 24.3 m -109.98 137.86 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.657 HG21 ' OG ' ' B' ' 136' ' ' SER . 90.2 t -134.12 171.01 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.764 HG23 ' HG3' ' B' ' 120' ' ' LYS . 50.9 m -146.14 144.4 29.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.314 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.901 HD22 ' HB1' ' B' ' 150' ' ' ALA . 71.3 mt -97.27 -71.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.84 -5.91 5.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' CYS . . . . . 0.465 ' SG ' HD21 ' B' ' 80' ' ' LEU . 31.0 p -129.29 130.5 46.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -1.159 . . . . 0.0 110.165 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.655 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.7 OUTLIER -53.5 151.84 5.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 0.0 110.261 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.691 HD11 HD12 ' B' ' 76' ' ' LEU . 25.5 mt -131.13 159.59 37.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' B' ' 82' ' ' LEU . 31.9 t70 -105.58 92.03 4.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.846 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' B' ' 81' ' ' ASP . 16.3 mt -40.64 -34.39 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.1 OUTLIER -61.2 -49.04 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.052 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 41.3 m -80.24 -33.42 37.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.256 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.615 HG12 HG11 ' B' ' 102' ' ' VAL . 5.7 t -61.41 -50.1 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -76.45 -25.36 54.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 12.3 tp -68.39 -43.5 77.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 110.286 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -40.7 18.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -48.78 110.71 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -63.26 -11.35 20.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 0.8 OUTLIER -139.93 79.79 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.336 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.32 168.92 25.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.25 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.16 142.08 35.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.224 -0.923 . . . . 0.0 110.121 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -140.21 102.56 4.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.69 124.84 26.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.86 -20.98 21.79 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 110.74 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.34 59.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 6.0 mpt_? -93.18 -60.1 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.95 . . . . 0.0 110.723 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.713 ' CG ' ' HB2' ' A' ' 18' ' ' LEU . 64.3 t80 -170.32 179.97 3.25 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.523 -177.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.813 ' O ' HD13 ' A' ' 74' ' ' LEU . . . -100.9 69.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.005 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.995 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -154.24 142.84 20.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.567 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.615 HG11 HG12 ' B' ' 85' ' ' VAL . 12.5 t -96.69 117.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.876 HG21 ' HA ' ' A' ' 29' ' ' ASP . 3.4 mt -89.58 105.82 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 4.0 ttm -91.72 148.94 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.043 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.447 ' HD3' ' OD1' ' A' ' 29' ' ' ASP . 30.4 mtm180 -142.78 144.16 32.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 19.4 pt -131.27 179.16 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.882 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.45 34.99 4.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.129 -0.982 . . . . 0.0 110.514 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 179.25 81.05 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.0 Cg_endo -77.06 162.35 91.54 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.364 -0.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.573 ' C ' HG23 ' B' ' 111' ' ' THR . 3.5 tttp -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.898 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.622 HG22 ' C ' ' B' ' 125' ' ' GLY . 61.8 p -156.26 -179.63 8.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.295 -0.878 . . . . 0.0 110.485 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.844 HG22 HG23 ' B' ' 124' ' ' THR . 4.9 t -125.58 172.7 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.545 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -150.79 136.21 17.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.906 -1.121 . . . . 0.0 111.416 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.72 HD23 HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -92.54 95.81 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.43 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 73.9 mt -89.69 139.26 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.069 . . . . 0.0 111.116 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.643 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.0 m-85 -111.28 162.79 14.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.08 -15.59 57.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 8.2 m -76.85 -17.66 58.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.298 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 120.14 -26.22 7.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' LYS . . . . . 0.764 ' HG3' HG23 ' B' ' 75' ' ' THR . 3.4 mttt -77.75 163.02 26.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -1.114 . . . . 0.0 110.189 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 5.2 ptt? -160.99 170.27 20.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.68 HG21 ' O ' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -135.9 127.27 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.355 -0.84 . . . . 0.0 109.744 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 26.3 t -105.2 133.89 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.968 -1.083 . . . . 0.0 110.796 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.844 HG23 HG22 ' B' ' 112' ' ' THR . 2.4 t -140.64 159.03 43.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.616 -0.677 . . . . 0.0 109.23 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.622 ' C ' HG22 ' B' ' 111' ' ' THR . . . 112.58 -17.03 23.66 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -60.42 173.27 0.71 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -1.199 . . . . 0.0 110.191 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -120.47 -18.77 7.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.998 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.427 ' N ' HG13 ' B' ' 70' ' ' ILE . 14.5 t -146.7 -172.32 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -70.59 -59.23 2.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.214 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -52.53 -33.41 45.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.535 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 1.5 t0 -63.59 -46.4 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 4.0 t -63.27 -34.84 78.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.321 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' LYS . . . . . 0.472 ' HA ' ' CE1' ' B' ' 155' ' ' PHE . 6.4 ttpt -66.37 -43.51 85.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.141 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -70.36 -58.27 3.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.51 -26.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.121 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.657 ' OG ' HG21 ' B' ' 74' ' ' VAL . 47.7 t -77.52 -59.07 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' B' ' 134' ' ' LEU . 1.2 ptm180 -53.07 -26.01 14.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.003 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -70.65 -46.9 62.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.799 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.545 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 17.4 m-85 -60.76 -44.13 97.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.797 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.95 -27.79 67.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.766 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.502 ' HG3' ' NH1' ' B' ' 141' ' ' ARG . 0.2 OUTLIER -68.69 -37.4 79.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.8 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 11.2 mt -61.5 -48.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.991 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.789 HG21 ' HB2' ' B' ' 150' ' ' ALA . 3.2 mp -63.66 -44.09 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 109.666 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.768 ' HG3' ' HB3' ' B' ' 150' ' ' ALA . 35.4 mt-30 -70.97 -33.81 70.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -71.73 -22.25 61.65 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.7 -22.87 10.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.35 -34.65 2.75 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.468 ' CE1' ' HA ' ' B' ' 80' ' ' LEU . 11.8 m-85 -47.18 161.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.159 -1.201 . . . . 0.0 110.962 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.16 42.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 0.0 109.707 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.901 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -59.98 158.34 11.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 110.692 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 2.4 mttm -120.8 -156.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.539 -0.726 . . . . 0.0 109.688 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -153.0 71.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 110.211 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -142.85 -178.79 5.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 153' ' ' THR . 0.6 OUTLIER 69.04 11.75 8.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.606 ' HA ' HG22 ' B' ' 74' ' ' VAL . 40.4 t80 -68.67 132.25 46.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -169.83 131.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 1.9 mp -79.97 118.93 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.836 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.443 ' OE1' ' HG3' ' B' ' 218' ' ' LYS . 17.4 mm-40 -122.49 3.36 9.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.071 -1.018 . . . . 0.0 110.849 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.47 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 8.2 t-20 -149.83 95.91 2.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.894 -1.129 . . . . 0.0 110.768 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' B' ' 217' ' ' ALA . 88.1 mt -100.71 141.91 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.668 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 1.022 HG22 ' OG1' ' B' ' 215' ' ' THR . 26.5 t -122.31 132.8 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.775 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -134.98 -179.92 17.0 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.04 143.23 3.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -1.213 . . . . 0.0 110.369 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 26.9 p -170.23 175.41 4.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -119.35 173.82 6.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 209' ' ' SER . 0.0 OUTLIER -112.84 -85.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 110.098 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 166.97 -22.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.142 -0.974 . . . . 0.0 110.672 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.443 ' CE2' HG12 ' B' ' 170' ' ' ILE . 28.7 p90 -121.33 152.44 57.57 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.093 -1.005 . . . . 0.0 109.705 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.535 ' HA ' ' OG ' ' B' ' 209' ' ' SER . 50.9 Cg_endo -79.78 158.44 24.64 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.908 1.478 . . . . 0.0 110.619 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.991 HD12 ' CB ' ' B' ' 209' ' ' SER . 5.7 mt -133.95 164.92 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 0.0 110.293 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 171' ' ' ARG . . . . . 0.486 ' N ' HG22 ' B' ' 170' ' ' ILE . 0.0 OUTLIER -100.17 93.2 5.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.934 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.935 HD22 ' HB2' ' B' ' 193' ' ' LEU . 55.5 mt -47.45 -49.99 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 110.063 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 173' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 172' ' ' LEU . 1.5 mt-10 -44.61 -36.73 3.2 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.496 -0.752 . . . . 0.0 109.797 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.06 -38.57 63.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.66 HD11 ' HE2' ' B' ' 195' ' ' TYR . 0.1 OUTLIER -66.73 -38.06 85.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -1.125 . . . . 0.0 110.011 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.14 -13.74 59.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -89.18 -37.9 14.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -52.13 4.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.563 ' HB2' HD13 ' B' ' 175' ' ' LEU . 28.7 m80 -93.05 21.73 5.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 0.0 110.084 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' B' ' 179' ' ' HIS . . . -43.13 -65.29 1.48 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 9.3 t -48.71 -21.73 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -1.186 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.413 ' CZ ' ' CG2' ' B' ' 198' ' ' VAL . 1.1 m-30 -114.08 15.48 18.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' B' ' 179' ' ' HIS . 0.5 OUTLIER -151.52 153.45 34.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.77 141.23 51.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.875 . . . . 0.0 109.943 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -132.66 107.91 8.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.445 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 2.0 mm-40 -114.31 94.49 35.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.05 -8.94 24.67 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 110.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.37 -3.91 27.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.432 HD13 ' CE ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -140.42 -35.22 0.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.651 ' CZ ' HD22 ' B' ' 205' ' ' LEU . 2.5 t80 -126.48 128.97 24.25 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.146 -0.971 . . . . 0.0 110.4 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 191' ' ' PRO . . . . . 0.412 ' HG3' ' CG ' ' A' ' 51' ' ' GLU . 47.9 Cg_endo -75.88 -38.6 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.927 1.488 . . . . 0.0 110.65 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.71 -179.98 44.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.935 ' HB2' HD22 ' B' ' 172' ' ' LEU . 4.9 tt -106.53 131.92 53.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -1.157 . . . . 0.0 110.269 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.655 ' N ' HD23 ' B' ' 193' ' ' LEU . 23.8 mt -90.31 105.94 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.66 ' HE2' HD11 ' B' ' 175' ' ' LEU . 2.1 t80 -90.35 116.26 28.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 79.87 1.77 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -67.5 161.02 26.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.413 ' CG2' ' CZ ' ' B' ' 182' ' ' PHE . 53.0 t -111.8 -31.08 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -130.83 94.16 29.37 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.5 Cg_endo -73.36 165.66 83.9 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.787 -2.172 . . . . 0.0 110.471 0.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' B' ' 197' ' ' MET . 35.2 tttm -88.72 93.11 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.485 ' CD1' ' HB2' ' B' ' 217' ' ' ALA . 13.7 mt -144.39 148.5 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.521 ' C ' HD12 ' B' ' 204' ' ' LEU . 14.4 t -94.86 142.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.566 ' N ' HD12 ' B' ' 204' ' ' LEU . 5.2 mp -135.27 148.9 49.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.651 HD22 ' CZ ' ' B' ' 190' ' ' PHE . 69.7 mt -105.76 110.64 23.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.901 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' B' ' 208' ' ' VAL . 18.5 mm -94.79 96.15 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.477 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.633 ' C ' HG23 ' B' ' 208' ' ' VAL . 12.8 m-85 -70.31 58.93 0.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.633 HG23 ' C ' ' B' ' 207' ' ' PHE . 5.8 t 80.37 -37.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.937 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.991 ' CB ' HD12 ' B' ' 170' ' ' ILE . 2.9 p 156.74 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.937 0.875 . . . . 0.0 110.163 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.76 -67.66 1.89 Allowed Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.698 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 212' ' ' ILE . 4.8 mttp -100.74 139.92 35.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -1.15 . . . . 0.0 111.142 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.648 HD13 ' O ' ' B' ' 211' ' ' LYS . 27.1 mm -123.15 140.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.308 -0.87 . . . . 0.0 110.032 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.564 ' C ' HD12 ' B' ' 214' ' ' LEU . 12.0 t -123.63 152.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.185 -0.947 . . . . 0.0 110.492 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.643 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.4 mp -144.08 123.65 13.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.322 -0.862 . . . . 0.0 110.545 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 215' ' ' THR . . . . . 1.022 ' OG1' HG22 ' B' ' 161' ' ' VAL . 2.9 t -147.21 144.42 28.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.088 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 116.88 1.16 19.49 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -75.59 152.41 37.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -1.124 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.443 ' HG3' ' OE1' ' B' ' 158' ' ' GLN . 8.6 tttt -100.49 -2.53 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.3 164.93 19.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.086 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.28 -24.77 65.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.466 ' OE1' ' CA ' ' B' ' 221' ' ' GLU . 0.1 OUTLIER -69.1 -37.98 78.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.912 . . . . 0.0 109.964 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 2.9 mt-10 -63.66 -46.92 83.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.07 -1.019 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.489 HG12 ' CB ' ' B' ' 217' ' ' ALA . 10.7 mm -58.46 -48.37 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.922 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -55.68 -26.8 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.078 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -48.72 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.26 -35.95 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.45 -47.43 12.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.345 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -25.97 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.509 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -83.37 -36.57 24.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.584 HD13 ' O ' ' B' ' 230' ' ' ILE . 0.3 OUTLIER -88.19 -29.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 109.906 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.606 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 6.7 t80 -44.21 -49.55 23.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.409 -0.807 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 41.1 Cg_endo -68.17 -45.11 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.35 1.184 . . . . 0.0 110.355 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.571 ' HB ' HD13 ' B' ' 230' ' ' ILE . 4.3 t -47.18 -37.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 108.981 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.814 HD22 HD13 ' B' ' 170' ' ' ILE . 57.3 mt -65.41 -53.0 49.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.84 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.91 -38.17 15.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.981 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -60.08 -45.43 92.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -97.63 34.38 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.931 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -52.01 146.71 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 110.276 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -29.94 9.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.37 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.327 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.073 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.65 95.32 5.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.038 -1.039 . . . . 0.0 111.552 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.073 HD21 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -107.94 9.43 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.978 . . . . 0.0 110.81 179.417 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.662 ' OG1' HD23 ' A' ' 68' ' ' LEU . 24.0 m -48.85 -23.79 1.21 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.857 -1.152 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.2 -29.0 6.95 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.8 ' CG2' HG11 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -44.99 -44.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.294 . . . . 0.0 108.848 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.864 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.6 pp -84.41 -22.32 30.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.924 -1.11 . . . . 0.0 109.294 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.743 ' HZ ' HD11 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -86.12 2.82 45.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.35 178.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 149.98 101.03 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.744 ' ND2' HD11 ' A' ' 35' ' ' LEU . 13.6 p-10 -22.08 84.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.813 0.816 . . . . 0.0 111.878 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.2 pp -88.49 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.907 ' O ' HD12 ' A' ' 28' ' ' ILE . 66.0 m-20 -88.22 126.52 35.19 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.549 ' HB3' ' CD1' ' B' ' 103' ' ' ILE . 1.1 p -39.71 -25.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.758 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' ASP . 16.2 tt0 -59.77 -10.62 3.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.09 -1.006 . . . . 0.0 110.202 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.59 29.84 5.78 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -117.36 119.65 35.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.306 -1.114 . . . . 0.0 110.519 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.96 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -90.81 143.55 26.61 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.051 -1.03 . . . . 0.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.96 ' N ' HD22 ' A' ' 34' ' ' LEU . 4.5 pp . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.786 -1.196 . . . . 0.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.345 0.593 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.39 -19.51 16.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.518 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD21 HD13 ' B' ' 205' ' ' LEU . 4.0 mt -100.28 -45.79 5.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.775 . . . . 0.0 110.331 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.898 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -53.2 -57.56 10.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.274 -0.891 . . . . 0.0 109.738 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 3.0 pp20? -62.77 -19.99 64.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.78 . . . . 0.0 109.416 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 7.7 m-20 -84.15 -35.79 23.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.5 -0.75 . . . . 0.0 109.211 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.898 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.5 mt -53.09 -41.51 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.394 -0.817 . . . . 0.0 109.141 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.54 -23.88 44.69 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p -118.52 12.8 13.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -1.182 . . . . 0.0 110.567 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.044 HD23 HD11 ' A' ' 62' ' ' LEU . 4.0 mt -87.81 26.46 1.32 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.098 -1.001 . . . . 0.0 110.369 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 52.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.527 ' HG3' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -173.35 26.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 110.364 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.044 HD11 HD23 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -148.09 12.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.186 -0.947 . . . . 0.0 110.393 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.94 -58.49 0.51 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 4.1 mm? -50.34 -20.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -1.116 . . . . 0.0 110.928 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 t70 -45.43 -43.03 11.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -66.78 -50.45 62.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.391 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.864 ' HG2' HD22 ' A' ' 24' ' ' LEU . 2.0 tpp -68.27 -7.67 32.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.296 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.662 HD23 ' OG1' ' A' ' 21' ' ' THR . 2.3 tm? -70.05 -59.63 2.79 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 122.061 0.934 . . . . 0.0 108.631 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.3 pp -75.74 0.56 17.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 4.1 tt0 -92.49 13.93 18.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 112.222 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.893 HG12 HG11 ' B' ' 122' ' ' VAL . 2.0 t -140.58 3.7 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.743 -1.223 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.838 ' CG1' HD23 ' A' ' 18' ' ' LEU . 1.5 tp -148.99 76.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.6 t70 -77.73 55.43 1.36 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.12 -0.988 . . . . 0.0 108.455 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.577 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.531 0.681 . . . . 0.0 110.629 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.597 HD13 ' O ' ' B' ' 165' ' ' ASP . 89.8 mt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.179 0.514 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.474 ' CG1' ' OH ' ' B' ' 224' ' ' TYR . 6.6 t -70.96 140.14 85.83 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.321 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.9 Cg_endo -73.85 130.0 14.06 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.011 1.532 . . . . 0.0 110.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.406 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 2.3 m -91.17 135.57 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' B' ' 67' ' ' LEU . 49.9 mt -80.06 124.29 28.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.02 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -106.49 -18.76 13.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.487 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.9 163.94 11.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.178 -0.951 . . . . 0.0 110.447 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.591 HG12 HG23 ' B' ' 160' ' ' ILE . 5.6 mt -151.27 165.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.381 -0.824 . . . . 0.0 109.959 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.772 HG22 ' HB ' ' B' ' 124' ' ' THR . 3.4 t -148.17 142.09 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.48 152.28 48.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.986 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.29 132.2 45.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 110.342 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.658 HG21 ' OG ' ' B' ' 136' ' ' SER . 94.1 t -123.88 158.34 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.922 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.496 ' CB ' ' HB2' ' B' ' 154' ' ' ASP . 7.7 m -133.39 144.27 49.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' B' ' 150' ' ' ALA . 96.1 mt -101.4 -32.44 10.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.852 . . . . 0.0 110.032 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.93 18.36 59.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.73 144.91 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -1.212 . . . . 0.0 110.313 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.571 ' O ' HD23 ' B' ' 80' ' ' LEU . 4.2 ttp85 -75.23 152.18 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 110.005 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.571 HD23 ' O ' ' B' ' 79' ' ' ARG . 39.7 mt -132.93 163.09 29.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.406 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.454 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 97.7 m-20 -98.21 113.7 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.25 -53.93 51.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -0.966 . . . . 0.0 110.174 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 8.6 tppt? -51.42 -47.2 63.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.997 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 84.8 m -72.93 -45.71 56.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.08 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.638 HG12 HG11 ' B' ' 102' ' ' VAL . 25.2 t -58.04 -47.95 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.963 . . . . 0.0 109.999 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.578 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -75.01 -10.24 59.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 7.7 tp -98.12 -24.78 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.451 ' O ' ' NH2' ' B' ' 90' ' ' ARG . 2.1 m-70 -98.67 -30.42 12.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.448 ' HB1' ' HE2' ' B' ' 104' ' ' MET . . . -62.28 146.36 51.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.139 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' B' ' 88' ' ' HIS . 5.2 mmt-85 -76.07 -33.57 59.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -134.37 79.3 1.8 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.319 -0.863 . . . . 0.0 109.989 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.431 ' C ' ' HG2' ' B' ' 93' ' ' GLU . . . -127.13 156.71 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.406 -0.808 . . . . 0.0 110.174 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' B' ' 103' ' ' ILE . 1.5 mm-40 -134.1 126.05 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.594 ' HB2' HG22 ' B' ' 102' ' ' VAL . 9.6 t80 -134.93 111.89 10.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.441 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -128.59 126.19 23.34 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.58 -25.55 14.87 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 0.0 110.8 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -68.4 -17.04 64.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 0.0 110.299 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.6 -50.37 3.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 1.181 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -173.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.436 -0.79 . . . . 0.0 111.582 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.24 56.46 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.837 . . . . 0.0 110.947 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.181 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -145.07 152.82 40.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.523 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.638 HG11 HG12 ' B' ' 85' ' ' VAL . 23.8 t -98.46 135.74 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.57 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 25.4 mm -109.62 120.66 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.043 . . . . 0.0 110.887 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.572 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.9 OUTLIER -90.76 162.93 14.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.667 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.438 ' NH2' ' HG2' ' B' ' 105' ' ' ARG . 0.0 OUTLIER -155.96 126.76 6.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.076 -1.015 . . . . 0.0 110.44 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.577 HG23 ' CE1' ' B' ' 139' ' ' TYR . 43.9 pt -128.47 149.45 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -99.74 26.94 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 2.0 tt0 -162.62 83.0 1.59 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 51.3 Cg_endo -80.88 163.76 79.58 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.977 -2.093 . . . . 0.0 110.635 -0.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -68.78 103.93 1.89 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.661 HG22 ' HA3' ' B' ' 125' ' ' GLY . 13.9 p -148.97 169.61 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 111.149 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.7 m -117.73 153.99 32.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.579 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -143.6 132.89 23.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.057 -1.027 . . . . 0.0 110.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.55 HD23 HD12 ' B' ' 103' ' ' ILE . 7.2 mt -96.35 137.05 36.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' B' ' 102' ' ' VAL . 46.5 mt -125.83 118.52 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 0.8 OUTLIER -99.89 141.24 32.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -51.83 -20.52 2.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.207 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -21.44 64.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.7 -23.34 13.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' LYS . . . . . 0.481 ' HG3' HG23 ' B' ' 75' ' ' THR . 3.9 ttmt -72.66 177.22 4.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -1.162 . . . . 0.0 110.383 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.526 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 6.0 ptm -168.83 140.96 2.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.893 HG11 HG12 ' A' ' 71' ' ' VAL . 4.2 t -115.1 132.98 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.92 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.31 167.88 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 110.091 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.772 ' HB ' HG22 ' B' ' 71' ' ' VAL . 4.7 t -169.16 160.25 9.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.954 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 113.2 -4.75 25.28 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -76.8 146.64 37.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -1.188 . . . . 0.0 110.309 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.69 -21.45 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.252 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' B' ' 129' ' ' GLU . 0.3 OUTLIER -127.23 32.34 5.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 129' ' ' GLU . . . . . 0.524 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.1 tt0 66.6 -68.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 128' ' ' SER . 7.3 t70 -44.07 -31.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -0.84 . . . . 0.0 110.363 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.487 ' HB3' ' HA ' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -63.02 -58.99 5.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 132' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' B' ' 126' ' ' ALA . 0.1 OUTLIER -52.48 -31.53 35.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -46.41 75.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.958 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.35 -45.9 71.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.257 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.484 ' HA ' HD11 ' B' ' 106' ' ' ILE . . . -53.01 -48.69 67.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.942 . . . . 0.0 110.083 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.658 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -57.29 -53.63 55.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -51.83 -36.86 49.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.959 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -48.28 65.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 21.8 m-85 -61.78 -55.71 27.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.093 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.28 -21.65 9.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.877 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -78.99 -29.34 43.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 110.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.435 ' O ' HG13 ' B' ' 146' ' ' ILE . 49.0 mt -68.62 -43.69 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' B' ' 150' ' ' ALA . 52.1 mt -70.66 -50.5 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.098 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 90.0 mt-30 -60.15 -37.2 79.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 109.693 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -32.64 68.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.435 HG13 ' O ' ' B' ' 142' ' ' ILE . 5.2 mt -66.6 -17.93 23.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.6 -23.45 12.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.42 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 13.1 m-85 -52.34 169.01 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.007 -1.29 . . . . 0.0 110.745 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.53 50.42 0.81 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 110.308 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -80.32 144.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.419 ' O ' ' OG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -126.01 106.37 9.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 0.0 110.331 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -55.78 101.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -162.08 -178.91 6.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.496 ' HB2' ' CB ' ' B' ' 75' ' ' THR . 3.4 m-20 57.8 26.47 13.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 110.445 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.529 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 5.7 t80 -78.99 133.14 36.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.073 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -161.91 130.52 4.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.609 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.524 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 30.0 mt -79.86 126.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 109.826 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' B' ' 218' ' ' LYS . 6.5 mt-30 -134.36 4.68 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 0.0 110.455 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.511 ' HB2' ' HB ' ' B' ' 71' ' ' VAL . 77.3 m-20 -147.5 90.8 1.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.816 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.591 HG23 HG12 ' B' ' 70' ' ' ILE . 96.7 mt -99.72 141.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.903 . . . . 0.0 109.863 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 11.4 t -109.36 135.44 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.526 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.436 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.19 172.79 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 5.1 m -164.13 150.13 10.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -1.164 . . . . 0.0 110.159 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.493 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 21.0 p -170.62 157.78 5.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.597 ' O ' HD13 ' B' ' 63' ' ' ILE . 2.7 p30 -113.6 175.22 5.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 109.796 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.575 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.1 OUTLIER -119.44 -84.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.486 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.3 OUTLIER 178.39 -27.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.435 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 30.7 p90 -129.69 164.67 38.51 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.768 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 48.0 Cg_endo -76.86 156.55 34.86 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.023 1.539 . . . . 0.0 110.488 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.79 147.84 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -82.62 101.2 10.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.408 ' CD1' ' HA2' ' B' ' 192' ' ' GLY . 20.8 mt -58.65 -52.03 67.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 173' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' B' ' 177' ' ' PHE . 1.1 mt-10 -50.44 -45.71 56.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.93 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.12 70.59 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.488 ' HB3' HD13 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -76.33 -51.95 10.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.46 -1.023 . . . . 0.0 109.83 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.454 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -63.78 -11.69 28.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.76 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 177' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' B' ' 173' ' ' GLU . 3.4 t80 -88.89 -49.36 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 110.125 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 178' ' ' SER . . . . . 0.466 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 36.4 t -88.38 -35.56 17.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -112.36 18.73 18.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' B' ' 176' ' ' ALA . . . -59.38 -18.77 44.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 5.6 t -64.95 -20.61 66.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -1.17 . . . . 0.0 110.21 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -131.85 5.53 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.897 . . . . 0.0 110.228 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.75 ' HB2' HD21 ' B' ' 193' ' ' LEU . 37.2 p -124.35 153.54 41.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -125.91 137.42 53.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -129.69 101.09 5.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.77 111.85 27.37 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.917 . . . . 0.0 109.908 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 -2.03 10.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.881 1.464 . . . . 0.0 110.377 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.73 -22.51 50.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.305 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.517 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 2.6 pp -159.37 24.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.727 ' CZ ' HD22 ' B' ' 205' ' ' LEU . 0.6 OUTLIER -170.07 106.9 0.44 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.475 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.66 -31.42 6.82 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.97 1.51 . . . . 0.0 109.986 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.78 171.33 37.58 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' B' ' 183' ' ' SER . 5.1 tt -101.01 140.06 35.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.237 -1.155 . . . . 0.0 110.463 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' B' ' 183' ' ' SER . 65.0 mt -96.04 123.22 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.854 . . . . 0.0 110.109 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.51 ' O ' HD12 ' B' ' 204' ' ' LEU . 7.4 t80 -107.94 124.15 49.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.367 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -99.66 90.95 4.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.539 ' HE1' ' HB ' ' B' ' 230' ' ' ILE . 29.7 tpp -47.11 134.51 10.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.349 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 56.5 t -65.62 -58.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.403 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -138.72 118.55 9.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -75.66 163.22 90.82 Favored 'Cis proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.962 -2.099 . . . . 0.0 110.377 -0.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' B' ' 197' ' ' MET . 6.3 mmtt -69.1 94.27 0.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.431 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 36.4 mm -126.43 146.29 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.95 . . . . 0.0 110.497 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 71.5 t -98.28 134.63 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.848 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.866 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.5 mp -136.34 136.83 40.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 110.542 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.743 HD11 ' HZ ' ' A' ' 25' ' ' PHE . 67.4 mt -99.12 145.2 27.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 110.08 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.507 HG12 HD21 ' B' ' 234' ' ' LEU . 6.6 mt -125.39 103.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -87.17 135.43 33.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 110.307 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 42.5 t -48.15 -24.45 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.2 p -66.38 -44.15 83.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.575 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 135.26 -3.43 4.02 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 137.16 34.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -1.226 . . . . 0.0 110.492 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 13.5 mm -121.66 152.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.28 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.496 ' C ' HD12 ' B' ' 214' ' ' LEU . 33.4 t -124.77 162.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.056 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.496 HD12 ' C ' ' B' ' 213' ' ' VAL . 3.2 mp -148.29 135.41 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.404 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 4.8 t -166.6 141.17 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 110.082 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 112.9 14.59 9.99 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -90.23 160.35 16.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -1.195 . . . . 0.0 110.361 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' B' ' 158' ' ' GLN . 3.7 mmmm -106.12 -5.34 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -168.59 159.46 10.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.353 -0.842 . . . . 0.0 110.109 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -56.62 -17.79 9.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.337 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -25.63 59.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 109.776 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.667 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 3.6 mt-10 -80.02 -44.76 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.34 -40.43 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.474 ' OH ' ' CG1' ' B' ' 64' ' ' VAL . 2.4 m-85 -66.77 -37.26 84.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.887 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -72.54 -38.97 67.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.866 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.91 -33.98 71.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.631 ' HA ' HG22 ' B' ' 230' ' ' ILE . 33.0 t80 -77.84 -54.23 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -17.73 5.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.09 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.404 ' C ' ' HD2' ' B' ' 232' ' ' PRO . . . -93.39 -37.63 11.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.312 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.9 tp -84.47 -24.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.55 -49.24 56.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.887 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.1 Cg_endo -71.4 -36.47 6.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.547 1.288 . . . . 0.0 110.339 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.67 -35.83 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.653 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.507 HD21 HG12 ' B' ' 206' ' ' ILE . 8.2 mt -71.27 -48.51 50.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.039 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -22.66 53.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.177 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.2 -35.39 41.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 110.269 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.466 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 64.3 m-85 -113.75 40.77 2.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.343 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.497 ' HG2' ' NH2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -63.67 172.58 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -117.88 -55.62 2.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.159 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 32.3 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.22 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.808 HD11 ' CA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.543 ' H ' HD12 ' A' ' 18' ' ' LEU . 2.0 t70 -57.62 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.856 -1.153 . . . . 0.0 110.049 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.812 HD13 ' CB ' ' A' ' 23' ' ' ILE . 1.4 mm? -107.21 -20.55 13.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 111.025 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.817 HG21 ' HB2' ' A' ' 59' ' ' LEU . 13.5 m -43.31 -26.83 0.2 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.782 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -95.59 -27.11 10.87 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.989 HG23 HG21 ' B' ' 124' ' ' THR . 4.6 mm -59.43 -50.99 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -1.104 . . . . 0.0 108.942 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.87 HD11 ' CD1' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -77.56 1.76 18.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -104.78 -21.49 13.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 110.74 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.536 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 159.86 48.32 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.999 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.886 ' OD1' HD21 ' A' ' 35' ' ' LEU . 1.4 t-20 56.33 151.67 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -1.112 . . . . 0.0 111.039 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.944 HD12 HG12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -171.06 156.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 31' ' ' GLU . 96.7 m-20 -86.18 116.1 24.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.808 ' CA ' HD11 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -35.34 -28.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.306 0.574 . . . . 0.0 110.318 -177.45 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 29' ' ' ASP . 21.3 tt0 -51.77 -18.5 1.27 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.325 -0.86 . . . . 0.0 110.061 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.74 26.59 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.082 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' HD3' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -121.44 132.13 54.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.089 -1.242 . . . . 0.0 110.438 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 56' ' ' ILE . 1.6 tt -102.9 152.65 21.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.848 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.886 HD21 ' OD1' ' A' ' 27' ' ' ASN . 3.0 pp . . . . . 0 N--CA 1.493 1.707 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.688 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.333 0.587 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.73 -19.01 16.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 52' ' ' LEU . 4.4 mt -94.59 -47.65 6.43 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.774 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.3 -48.87 18.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.434 -0.791 . . . . 0.0 109.593 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.35 -26.28 66.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 6.7 m-20 -79.85 -40.46 28.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.965 HD13 HD13 ' A' ' 34' ' ' LEU . 5.9 mt -50.97 -39.97 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 0.0 109.141 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -22.75 48.91 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 p -129.67 18.85 5.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -1.224 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.02 HD21 ' CE2' ' B' ' 190' ' ' PHE . 4.3 mt -84.14 5.21 27.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.4 m -89.53 45.36 1.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.118 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 11.3 ttpt -147.52 12.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.147 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.985 HD13 HD13 ' B' ' 194' ' ' ILE . 0.8 OUTLIER -131.06 -27.17 2.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.622 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.31 -42.77 0.14 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.87 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.9 mm? -44.85 -36.99 3.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -1.202 . . . . 0.0 110.54 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.561 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 15.3 t0 -42.39 -35.38 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 14.8 m -65.17 -46.8 79.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.335 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.613 ' HG2' HD13 ' A' ' 24' ' ' LEU . 6.4 tpp -66.76 -16.63 64.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 72' ' ' ILE . 6.5 mt -70.48 -61.42 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.953 -1.092 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.1 pp -66.45 -2.66 4.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.58 -0.7 . . . . 0.0 110.808 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -91.51 -13.55 31.95 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.151 -0.968 . . . . 0.0 111.241 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.0 OUTLIER -119.05 -26.72 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.938 -1.101 . . . . 0.0 110.045 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 HD12 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -128.23 67.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 73' ' ' ASP . 16.5 t70 -70.09 59.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.092 HD22 ' HB3' ' B' ' 100' ' ' ALA . 3.0 mt . . . . . 0 C--N 1.299 -1.615 0 CA-C-O 121.612 0.72 . . . . 0.0 110.97 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.197 0.522 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' B' ' 65' ' ' PRO . 39.5 t -97.93 139.45 21.3 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.329 -0.857 . . . . 0.0 109.916 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.49 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 45.5 Cg_endo -71.58 130.12 16.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.94 1.495 . . . . 0.0 110.62 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.471 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 94.1 m -93.45 132.08 38.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.123 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 mt -70.17 128.61 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.532 ' NE2' ' HB2' ' B' ' 163' ' ' SER . 2.0 mt-30 -106.86 -18.33 13.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 110.219 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.536 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -170.17 153.59 4.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.909 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 37.7 mm -129.28 153.74 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.972 HG22 ' HB ' ' B' ' 124' ' ' THR . 22.4 t -141.76 129.9 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.341 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.535 ' HB2' HG13 ' B' ' 157' ' ' ILE . . . -137.9 157.19 46.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 41.6 p -104.04 146.19 29.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.251 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.462 HG21 ' OG ' ' B' ' 136' ' ' SER . 54.7 t -137.8 132.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 110.163 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.449 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 5.9 m -114.62 128.24 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.925 HD22 ' HB1' ' B' ' 150' ' ' ALA . 70.3 mt -83.25 -71.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.79 -11.11 3.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' CYS . . . . . 0.523 ' SG ' HD21 ' B' ' 80' ' ' LEU . 31.6 p -129.68 134.16 47.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -1.219 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.666 ' O ' HD23 ' B' ' 80' ' ' LEU . 5.8 ttt180 -58.16 155.26 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.666 HD23 ' O ' ' B' ' 79' ' ' ARG . 14.6 mt -137.38 153.19 50.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 40.7 t0 -93.9 101.11 13.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.808 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.766 HD22 HG23 ' B' ' 102' ' ' VAL . 17.8 mt -41.36 -49.33 3.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.185 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -54.23 -34.57 61.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.002 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 85.9 m -80.24 -40.35 27.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.913 HG22 ' CE2' ' B' ' 148' ' ' PHE . 24.8 t -71.9 -37.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.065 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.99 -19.02 48.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 110.192 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 13.1 tp -91.54 -30.63 16.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.6 m80 -92.51 -17.77 24.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.339 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -74.7 133.4 42.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -70.32 -21.43 62.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.885 . . . . 0.0 110.351 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -139.44 79.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.083 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.784 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -160.2 154.29 23.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.48 ' HG2' ' HB ' ' B' ' 103' ' ' ILE . 8.2 pt-20 -141.27 171.59 13.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.447 ' CE1' HD13 ' B' ' 82' ' ' LEU . 21.5 t80 -140.46 124.89 17.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 110.568 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.467 ' ND2' ' HB2' ' A' ' 31' ' ' GLU . 7.5 m-20 -114.27 98.83 49.68 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' B' ' 95' ' ' ASN . 47.5 Cg_endo -71.88 -24.01 21.56 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.076 1.566 . . . . 0.0 110.357 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -74.15 -20.78 60.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.384 -0.822 . . . . 0.0 110.298 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.24 -74.03 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 110.363 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -133.25 178.19 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 1.092 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -104.39 40.13 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.047 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -117.96 149.18 41.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -0.949 . . . . 0.0 110.766 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.766 HG23 HD22 ' B' ' 82' ' ' LEU . 40.6 t -89.99 124.51 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.044 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 30' ' ' SER . 3.8 mm -89.28 111.77 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.04 . . . . 0.0 110.224 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 2.1 ttm -107.72 155.77 19.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.701 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.42 ' CG ' ' C ' ' B' ' 104' ' ' MET . 56.5 mtm180 -146.33 148.01 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 110.567 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.696 HD11 ' OG1' ' B' ' 111' ' ' THR . 9.8 pt -131.44 157.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.465 -0.772 . . . . 0.0 109.656 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.07 -28.19 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 108' ' ' GLU . 0.5 OUTLIER -156.69 118.69 2.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.168 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.915 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.1 Cg_endo -73.63 122.36 7.71 Favored 'Cis proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.881 -2.133 . . . . 0.0 110.36 -0.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.667 ' O ' HG23 ' B' ' 111' ' ' THR . 24.2 tttp -43.25 108.16 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.696 ' OG1' HD11 ' B' ' 106' ' ' ILE . 18.8 p -158.67 -178.92 7.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.703 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' B' ' 104' ' ' MET . 1.2 m -135.23 154.79 51.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.775 . . . . 0.0 109.096 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -136.48 123.92 22.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.836 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.788 HD12 ' HB ' ' B' ' 122' ' ' VAL . 0.1 OUTLIER -95.71 97.62 9.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.412 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 9.3 mt -89.51 140.54 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.09 -1.006 . . . . 0.0 110.912 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 1.9 m-30 -106.51 150.89 25.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 109.878 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.571 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -65.25 -17.86 64.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 0.0 110.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.6 m -67.52 -18.93 65.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.282 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.56 -13.49 15.39 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -87.95 164.61 15.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -1.196 . . . . 0.0 110.224 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.44 ' HG3' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -163.18 161.74 25.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 0.0 110.251 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.788 ' HB ' HD12 ' B' ' 114' ' ' LEU . 24.8 t -129.98 154.39 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.41 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 14.3 t -133.11 104.11 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.989 HG21 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -112.04 172.62 6.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.36 -0.837 . . . . 0.0 110.167 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.592 ' C ' HG22 ' B' ' 111' ' ' THR . . . 97.31 -15.95 61.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.909 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -60.21 166.11 3.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -1.226 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -26.46 10.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.764 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.526 ' N ' HG13 ' B' ' 70' ' ' ILE . 40.0 m -153.68 166.44 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.429 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 129' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 128' ' ' SER . 3.8 mt-10 -43.64 -48.41 7.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.15 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.62 -50.63 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.46 -45.34 69.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -36.66 78.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -33.64 72.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.139 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -42.91 64.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.915 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -66.9 -39.81 87.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.194 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.462 ' OG ' HG21 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -60.24 -57.4 12.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.964 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -44.75 -52.2 8.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -53.74 -47.75 70.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.913 ' HA ' HD12 ' B' ' 142' ' ' ILE . 15.4 m-85 -61.68 -57.74 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 140' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' B' ' 152' ' ' PHE . . . -48.77 -26.91 2.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.453 ' HG2' ' HG3' ' B' ' 145' ' ' LYS . 9.0 ttm180 -73.84 -49.29 25.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.836 . . . . 0.0 110.092 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.913 HD12 ' HA ' ' B' ' 139' ' ' TYR . 42.2 mt -47.12 -39.2 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.938 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.758 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.8 mp -72.21 -53.04 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -28.28 68.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.65 -24.85 60.05 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 0.0 108.436 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 7.1 mt -82.33 -24.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 130.35 -23.11 4.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.913 ' CE2' HG22 ' B' ' 85' ' ' VAL . 7.3 m-85 -49.32 165.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.293 . . . . 0.0 110.746 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.62 36.82 2.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.452 -0.78 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.925 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -62.83 152.69 35.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 13.6 ptpt -136.99 24.07 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.124 -0.985 . . . . 0.0 110.462 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' B' ' 151' ' ' LYS . 2.7 t80 27.25 98.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.211 0.529 . . . . 0.0 111.795 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -151.86 169.5 22.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 110.369 179.65 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.449 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 7.3 t0 65.45 30.12 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 7.1 t80 -71.85 122.87 21.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.924 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.36 131.19 8.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' B' ' 72' ' ' ALA . 3.3 mp -79.53 123.91 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -110.91 -14.99 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.4 t30 -142.49 135.96 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.711 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.722 HG23 ' CD1' ' B' ' 70' ' ' ILE . 29.8 mt -131.26 129.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 24' ' ' LEU . 10.2 t -96.8 134.72 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -141.97 168.74 25.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.532 ' HB2' ' NE2' ' B' ' 68' ' ' GLN . 0.3 OUTLIER -161.76 153.05 18.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.285 . . . . 0.0 110.711 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.438 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 7.5 p -165.95 155.65 12.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.13 153.08 21.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.348 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.621 HG21 HD11 ' B' ' 170' ' ' ILE . 13.2 m -105.91 3.46 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.56 -2.8 2.52 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.361 -0.837 . . . . 0.0 111.262 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.588 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 15.3 p90 -150.24 149.84 27.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.797 -1.189 . . . . 0.0 110.38 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.479 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 47.4 Cg_endo -73.64 160.62 43.67 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.135 1.597 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.621 HD11 HG21 ' B' ' 166' ' ' VAL . 3.1 mt -131.34 150.83 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.872 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.66 103.03 9.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.875 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.454 ' O ' HD12 ' B' ' 193' ' ' LEU . 15.5 mt -63.37 -34.68 78.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.662 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 173' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 9.4 pt-20 -78.3 -32.44 49.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.385 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 174' ' ' GLY . . . . . 0.533 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -64.16 -48.02 79.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -60.63 -42.2 96.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -1.106 . . . . 0.0 110.296 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.76 64.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.451 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -83.23 -27.78 29.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 67.0 m -95.13 -44.72 7.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -123.72 49.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.09 -20.59 79.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 32.6 m -60.32 -23.58 64.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -1.146 . . . . 0.0 110.208 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' B' ' 196' ' ' ARG . 17.7 m-85 -123.5 -5.37 8.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.31 152.93 40.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 8.5 p -131.8 139.33 48.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -127.16 113.46 16.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' B' ' 190' ' ' PHE . 8.6 mt-10 -117.72 92.15 40.55 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.127 -0.983 . . . . 0.0 109.921 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.64 -3.78 13.29 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.001 1.527 . . . . 0.0 110.167 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.57 -13.58 18.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.89 . . . . 0.0 110.014 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.491 HD23 ' HB2' ' B' ' 190' ' ' PHE . 4.3 tt -138.54 -35.11 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.462 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 1.02 ' CE2' HD21 ' A' ' 59' ' ' LEU . 2.7 t80 -125.49 114.04 25.4 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.39 -10.32 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.897 1.472 . . . . 0.0 110.457 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.99 172.81 18.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.454 HD12 ' O ' ' B' ' 172' ' ' LEU . 6.1 tt -105.15 121.53 44.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.985 HD13 HD13 ' A' ' 62' ' ' LEU . 6.4 mt -90.3 106.27 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.214 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' B' ' 204' ' ' LEU . 5.7 t80 -101.58 122.32 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -111.67 80.06 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.405 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.5 OUTLIER -68.34 166.09 17.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.883 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' B' ' 201' ' ' LYS . 63.1 t -111.02 -31.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.97 . . . . 0.0 110.704 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 7.0 tttt -134.78 97.14 14.22 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.585 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -72.37 150.18 94.55 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.8 -2.167 . . . . 0.0 110.401 -0.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.54 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -77.39 92.69 3.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.969 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' B' ' 217' ' ' ALA . 27.6 mm -140.33 153.53 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.07 103.8 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 109.844 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.442 HD12 ' H ' ' B' ' 204' ' ' LEU . 3.3 mp -95.01 142.45 27.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.881 HD12 ' HB ' ' B' ' 213' ' ' VAL . 4.4 mt -118.87 116.01 25.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.663 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.462 HG13 HG13 ' B' ' 212' ' ' ILE . 2.6 mt -108.71 119.87 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' B' ' 208' ' ' VAL . 10.0 m-85 -99.29 147.83 24.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.443 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 67.7 t -44.42 -25.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.021 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.406 ' N ' ' O ' ' B' ' 207' ' ' PHE . 3.8 p -66.11 -39.73 90.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.055 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.582 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 120.75 17.27 4.28 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.7 ' O ' HD12 ' B' ' 212' ' ' ILE . 0.1 OUTLIER -91.36 130.77 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.123 . . . . 0.0 110.135 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.855 HG22 HD11 ' B' ' 214' ' ' LEU . 1.2 mp -116.35 121.68 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 110.028 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.881 ' HB ' HD12 ' B' ' 205' ' ' LEU . 27.0 t -107.69 113.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 110.139 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.855 HD11 HG22 ' B' ' 212' ' ' ILE . 3.7 mp -101.23 103.5 14.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 5.0 t -130.31 142.95 50.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.971 . . . . 0.0 110.105 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 114.14 14.05 9.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.707 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -90.96 145.55 24.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.157 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -85.33 -13.76 48.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.348 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.509 ' CA ' ' CD1' ' B' ' 160' ' ' ILE . 1.3 tt0 -151.51 -173.44 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.066 -1.021 . . . . 0.0 110.539 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -79.77 -52.97 7.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.408 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.449 ' OE2' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -45.7 -25.72 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 110.538 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.543 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 56.3 mm-40 -69.83 -54.34 14.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.6 -39.81 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.49 ' CE1' ' HG2' ' B' ' 65' ' ' PRO . 5.5 m-85 -67.35 -33.15 74.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.491 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.438 ' HB3' ' HG3' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -78.24 -37.09 46.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.956 . . . . 0.0 110.145 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.3 80.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.515 ' HA ' HG22 ' B' ' 230' ' ' ILE . 2.3 t80 -67.85 -50.12 58.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.92 -15.19 7.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -95.88 -34.57 11.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.484 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.6 tp -95.48 -16.21 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.601 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 18.8 t80 -50.09 -45.3 81.77 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.3 Cg_endo -73.13 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.327 1.172 . . . . 0.0 110.497 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' B' ' 232' ' ' PRO . 14.1 t -44.36 -37.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.761 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.4 -47.64 32.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 13.2 m -55.74 -33.21 64.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.03 -29.34 61.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.317 -0.864 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' B' ' 175' ' ' LEU . 52.5 m-85 -118.78 40.56 3.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.093 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -78.29 -170.74 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -46.31 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' MET . . . . . 0.422 ' OXT' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.279 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.117 HD21 HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.42 0.628 . . . . 0.0 111.29 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 4.5 m-20 79.84 76.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.482 0.658 . . . . 0.0 110.749 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.117 HD21 HD21 ' A' ' 18' ' ' LEU . 1.1 mt -97.87 25.92 5.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.411 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.579 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 24.3 m -54.59 -19.55 6.19 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 109.533 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.664 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.37 -36.68 4.02 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.769 HG13 HD22 ' A' ' 20' ' ' LEU . 7.8 mm -43.93 -45.13 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.981 -1.305 . . . . 0.0 108.857 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.013 HD13 ' SD ' ' A' ' 67' ' ' MET . 1.2 pp -80.81 -21.92 40.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.73 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -101.14 13.84 33.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.545 -0.722 . . . . 0.0 109.757 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 139.24 83.61 0.1 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.86 ' OD1' HD11 ' A' ' 35' ' ' LEU . 20.6 p-10 -15.18 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.698 0.761 . . . . 0.0 112.755 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.2 pp -88.55 171.65 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.803 ' O ' HD12 ' A' ' 28' ' ' ILE . 71.2 m-20 -86.81 119.38 26.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.564 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.2 -27.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.024 -177.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.2 tt0 -57.36 -13.29 3.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 110.21 27.32 4.55 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.25 116.77 28.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.085 -1.244 . . . . 0.0 110.778 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.988 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -88.94 143.58 26.77 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.822 -1.174 . . . . 0.0 109.83 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.988 ' N ' HD22 ' A' ' 34' ' ' LEU . 4.5 pp . . . . . 0 N--CA 1.494 1.75 0 O-C-N 120.614 -1.304 . . . . 0.0 111.312 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.188 0.518 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' CD ' ' HG3' ' B' ' 191' ' ' PRO . 2.5 tp10 -101.03 -20.41 15.4 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.138 -0.977 . . . . 0.0 109.319 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.687 HD21 ' CD1' ' B' ' 205' ' ' LEU . 3.0 mt -95.5 -44.59 7.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 110.149 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.816 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -53.88 -59.05 5.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.243 -0.911 . . . . 0.0 109.595 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.52 -13.38 30.0 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.497 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 2.8 m-20 -91.02 -39.15 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -0.797 . . . . 0.0 109.278 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.816 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.5 mt -51.97 -39.38 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.531 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 -16.19 41.83 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.531 ' HB3' HD11 ' B' ' 189' ' ' LEU . 0.1 OUTLIER -133.15 9.87 4.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.243 -1.151 . . . . 0.0 110.781 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.563 HD21 ' CE2' ' B' ' 190' ' ' PHE . 1.2 mt -79.31 7.05 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.507 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -94.09 43.27 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.311 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 58' ' ' SER . 3.3 ptmm? -143.67 15.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.64 HD22 HD12 ' B' ' 194' ' ' ILE . 0.0 OUTLIER -131.42 -60.43 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 65' ' ' ASP . . . -146.84 -44.93 0.03 OUTLIER Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.709 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.4 mm? -42.06 -26.14 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -1.17 . . . . 0.0 110.394 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.472 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.1 t70 -44.5 -37.7 3.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -71.11 -54.19 11.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.699 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' MET . . . . . 1.013 ' SD ' HD13 ' A' ' 24' ' ' LEU . 10.6 ttm -72.65 -3.7 26.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.553 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.653 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.9 tm? -75.81 -59.04 2.93 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.87 0.843 . . . . 0.0 108.975 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 65' ' ' ASP . 1.3 pp -78.48 1.01 23.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.246 0.546 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.53 9.32 27.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 111.446 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.021 HG12 HG11 ' B' ' 122' ' ' VAL . 1.6 t -135.73 2.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.866 -1.146 . . . . 0.0 109.809 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.103 HD11 HD12 ' A' ' 74' ' ' LEU . 3.5 tp -149.86 75.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.4 t70 -77.84 57.47 1.71 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 108.26 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.114 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 8.0 mt . . . . . 0 C--N 1.305 -1.348 0 CA-C-O 121.716 0.769 . . . . 0.0 110.727 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 4.0 mt . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.1 0.476 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 14.0 t 61.07 128.91 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.4 ' CG ' HG22 ' B' ' 223' ' ' ILE . 44.5 Cg_endo -71.76 120.42 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.894 1.47 . . . . 0.0 110.193 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.48 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 90.5 m -89.68 135.11 33.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.59 HD22 ' CG2' ' B' ' 160' ' ' ILE . 32.4 mt -69.91 123.85 22.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 110.064 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.485 ' HA ' ' HD3' ' B' ' 127' ' ' LYS . 1.4 mm-40 -109.31 -7.1 15.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.479 ' ND2' ' HA2' ' A' ' 26' ' ' GLY . 4.1 t-20 -164.43 156.72 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 23.5 mm -137.47 147.2 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 14.6 t -137.02 138.44 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.05 159.3 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.459 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.09 138.85 44.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.842 . . . . 0.0 109.875 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 92.9 t -135.64 154.65 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.112 -0.992 . . . . 0.0 110.649 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.518 ' HG1' ' CG ' ' B' ' 154' ' ' ASP . 33.6 m -129.7 131.91 46.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 109.932 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.796 HD22 ' HB1' ' B' ' 150' ' ' ALA . 57.4 mt -89.43 -27.65 20.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.38 80.38 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' CYS . . . . . 0.429 ' SG ' ' HA ' ' B' ' 150' ' ' ALA . 24.8 p -137.12 139.16 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -1.228 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -69.26 152.27 45.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.682 HD11 ' CD1' ' B' ' 76' ' ' LEU . 16.6 mt -131.17 150.92 51.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.352 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' B' ' 82' ' ' LEU . 1.1 t0 -91.12 97.71 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' B' ' 100' ' ' ALA . 13.0 mt -41.16 -36.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.604 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.552 ' O ' HD23 ' B' ' 87' ' ' LEU . 0.0 OUTLIER -62.01 -40.7 96.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 110.475 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 26.7 p -85.83 -39.34 17.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.963 . . . . 0.0 110.425 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.596 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 56.7 t -62.55 -30.17 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 110.083 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.518 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -89.54 -23.93 21.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -0.859 . . . . 0.0 110.12 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.552 HD23 ' O ' ' B' ' 83' ' ' LYS . 1.0 OUTLIER -76.98 -47.98 19.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.32 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -77.28 -39.16 49.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.375 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -50.23 113.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.357 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -26.32 62.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.499 ' ND2' HG22 ' B' ' 106' ' ' ILE . 31.7 p30 -130.11 79.12 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.764 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -161.03 145.81 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.709 ' O ' HD12 ' B' ' 103' ' ' ILE . 12.5 mt-10 -134.85 136.65 42.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.285 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -114.58 110.75 20.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -106.51 112.69 63.65 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.98 -16.56 29.02 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.022 1.538 . . . . 0.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.61 -22.07 24.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 5.3 mpt_? -91.8 -73.28 0.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.675 ' CG ' ' CB ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -153.6 164.14 38.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.43 -0.794 . . . . 0.0 110.253 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -81.7 47.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.889 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.114 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -129.61 146.49 51.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 111.087 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' B' ' 86' ' ' ALA . 20.1 t -93.28 122.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.447 -0.783 . . . . 0.0 108.997 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.709 HD12 ' O ' ' B' ' 93' ' ' GLU . 3.1 mp -89.18 115.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 110.52 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.555 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.4 OUTLIER -97.37 147.97 23.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.966 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.73 95.01 2.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.499 HG22 ' ND2' ' B' ' 91' ' ' ASN . 16.5 pt -94.81 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -129.3 43.89 3.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.456 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.2 tt0 176.47 78.58 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.391 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.474 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.7 Cg_endo -79.66 157.03 89.34 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.455 -0.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 45.8 tttp -65.65 109.41 2.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.888 . . . . 0.0 109.945 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.462 HG22 ' C ' ' B' ' 125' ' ' GLY . 1.3 p -148.29 177.77 9.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.64 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.668 HG22 ' CG2' ' B' ' 124' ' ' THR . 0.4 OUTLIER -130.04 171.5 12.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.434 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -164.19 140.17 6.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.795 -1.191 . . . . 0.0 110.876 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.574 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.4 OUTLIER -105.54 100.02 9.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.422 -0.799 . . . . 0.0 108.849 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.445 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt -89.21 137.31 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.091 -1.006 . . . . 0.0 110.569 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.726 ' CD1' HD11 ' A' ' 74' ' ' LEU . 1.9 m-30 -108.45 166.15 10.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.25 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -53.72 -20.02 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.06 -18.32 16.36 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.25 162.99 18.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -1.166 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.422 ' HB2' HG12 ' B' ' 115' ' ' ILE . 4.0 ptt? -159.97 149.4 17.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.081 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 1.021 HG11 HG12 ' A' ' 71' ' ' VAL . 21.0 t -112.74 135.1 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.39 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.577 HG13 ' HE2' ' B' ' 139' ' ' TYR . 16.8 t -110.22 148.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 109.882 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.854 HG23 ' CB ' ' A' ' 27' ' ' ASN . 3.5 t -156.11 162.51 40.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.788 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.556 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 112.65 -37.1 3.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.72 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -46.1 160.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -1.142 . . . . 0.0 110.256 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' B' ' 68' ' ' GLN . 1.3 mmmt -115.92 -2.31 12.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.193 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.473 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.5 OUTLIER -158.78 162.85 37.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.24 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.91 -31.79 67.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.34 -50.95 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.11 -44.13 97.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.904 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 132' ' ' SER . . . . . 0.539 ' HB2' HG21 ' B' ' 70' ' ' ILE . 46.6 t -53.7 -47.45 70.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.964 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -54.85 -46.74 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.39 -52.76 29.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.304 -0.872 . . . . 0.0 110.033 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.405 ' O ' ' C ' ' B' ' 137' ' ' ARG . 1.6 p -71.65 -60.08 2.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.592 ' HD2' ' CE2' ' B' ' 152' ' ' PHE . 4.7 mtp180 -43.54 -46.22 6.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -51.38 65.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.098 -1.001 . . . . 0.0 109.966 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.577 ' HE2' HG13 ' B' ' 123' ' ' VAL . 15.4 m-85 -50.33 -48.8 55.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 109.863 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.24 -24.86 67.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.821 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -71.0 -31.44 67.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 110.064 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 146' ' ' ILE . 23.1 mt -69.64 -47.02 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.647 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.7 mp -65.3 -49.52 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 1.5 mt-30 -64.39 -39.34 93.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.025 -1.047 . . . . 0.0 110.017 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -68.23 -21.68 64.82 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' B' ' 143' ' ' ILE . 9.2 mt -81.15 -24.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.52 -35.34 2.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.546 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 13.5 m-85 -51.03 165.86 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.138 -1.213 . . . . 0.0 110.89 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.99 48.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.674 -0.641 . . . . 0.0 109.975 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.796 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -71.55 134.88 46.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.27 -153.9 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.592 ' CE2' ' HD2' ' B' ' 137' ' ' ARG . 22.3 t80 -149.46 78.3 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.267 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' B' ' 154' ' ' ASP . 1.1 p -141.66 179.55 6.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.518 ' CG ' ' HG1' ' B' ' 75' ' ' THR . 8.7 t0 66.31 13.93 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.952 . . . . 0.0 110.351 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -66.76 136.72 55.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.887 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -168.57 124.12 0.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.584 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.7 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.475 ' HA ' ' HG3' ' B' ' 218' ' ' LYS . 1.6 mt-30 -122.98 -11.86 8.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.036 . . . . 0.0 111.042 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.494 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.2 t30 -136.69 130.4 32.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.082 . . . . 0.0 111.061 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.59 ' CG2' HD22 ' B' ' 67' ' ' LEU . 7.9 mt -129.56 122.53 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 58.1 t -94.27 125.58 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -131.51 162.99 23.75 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 93.4 p -164.4 151.08 11.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.099 -1.236 . . . . 0.0 110.403 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.425 ' HB2' HG22 ' B' ' 63' ' ' ILE . 26.5 p -167.59 146.75 4.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.236 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 11.4 p-10 -91.26 163.36 14.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -102.43 -71.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 165.43 -23.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.72 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' B' ' 168' ' ' PHE . 16.2 p90 -136.32 163.18 51.88 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.6 Cg_endo -72.04 142.09 37.73 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.8 1.421 . . . . 0.0 110.555 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.702 HD12 ' HA2' ' B' ' 210' ' ' GLY . 3.8 mt -101.83 149.82 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.32 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.58 98.5 10.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.775 HD11 HG23 ' B' ' 208' ' ' VAL . 91.4 mt -56.9 -30.01 63.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 110.391 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -49.1 33.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.882 . . . . 0.0 110.419 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.79 -28.78 68.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' B' ' 175' ' ' LEU . 0.1 OUTLIER -71.19 -44.94 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 0.0 110.195 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.63 -13.77 59.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.024 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.22 -34.71 37.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.778 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 178' ' ' SER . . . . . 0.404 ' HB2' ' CZ ' ' B' ' 237' ' ' PHE . 0.3 OUTLIER -100.03 -35.08 9.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.785 . . . . 0.0 109.888 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' B' ' 183' ' ' SER . 34.0 m170 -115.63 37.51 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.351 -0.843 . . . . 0.0 110.135 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.56 -9.96 82.4 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 7.0 t -76.11 -24.79 54.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -1.197 . . . . 0.0 110.061 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.435 ' CE2' HG22 ' B' ' 198' ' ' VAL . 0.2 OUTLIER -127.81 -2.44 5.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 183' ' ' SER . . . . . 1.017 ' OG ' HD21 ' B' ' 193' ' ' LEU . 0.9 OUTLIER -114.97 140.99 48.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.107 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 3.8 t -111.56 136.75 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -145.32 91.28 2.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -108.44 110.21 61.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.89 1.08 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.959 1.505 . . . . 0.0 110.462 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.9 -13.92 28.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.644 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.1 tt -155.71 16.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.278 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.563 ' CE2' HD21 ' A' ' 59' ' ' LEU . 1.7 t80 -170.18 106.16 0.44 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.762 -1.211 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 191' ' ' PRO . . . . . 0.466 ' HG3' ' CD ' ' A' ' 51' ' ' GLU . 45.5 Cg_endo -73.85 -23.41 16.5 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.987 1.519 . . . . 0.0 110.238 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.93 -179.88 42.96 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 1.017 HD21 ' OG ' ' B' ' 183' ' ' SER . 1.9 tt -115.11 146.69 41.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.787 HG12 HD21 ' B' ' 205' ' ' LEU . 77.0 mt -113.45 103.82 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 109.943 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.5 t80 -102.14 118.21 36.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.892 . . . . 0.0 110.351 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.876 ' HD3' HG22 ' B' ' 203' ' ' VAL . 3.3 tpp85 -92.41 92.72 8.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 56.4 tpp -50.8 125.65 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.354 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.435 HG22 ' CE2' ' B' ' 182' ' ' PHE . 30.8 t -64.23 -43.31 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.292 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 21.6 tttm -149.43 117.16 3.72 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.7 Cg_endo -72.89 166.96 79.81 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.916 -2.118 . . . . 0.0 110.304 -0.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.455 ' O ' ' CG1' ' B' ' 202' ' ' ILE . 4.9 mttm -75.35 108.38 8.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.755 ' CD1' ' HB2' ' B' ' 217' ' ' ALA . 13.3 mt -154.67 151.76 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.876 HG22 ' HD3' ' B' ' 196' ' ' ARG . 20.0 t -96.98 127.71 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 109.991 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 2.3 mp -112.53 125.7 54.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.787 HD21 HG12 ' B' ' 194' ' ' ILE . 13.1 mt -102.58 120.19 40.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.667 HG23 HD13 ' B' ' 170' ' ' ILE . 12.3 mt -114.84 115.17 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.07 154.84 16.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 110.245 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.775 HG23 HD11 ' B' ' 172' ' ' LEU . 52.9 t -49.98 -35.42 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.52 90.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 110.498 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.702 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 130.93 32.4 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.609 ' C ' HD12 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -95.97 117.08 29.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -1.183 . . . . 0.0 109.828 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.746 HG22 HD11 ' B' ' 214' ' ' LEU . 1.2 mp -107.08 111.14 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.73 HG11 ' HE1' ' A' ' 25' ' ' PHE . 75.9 t -104.91 150.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.928 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.746 HD11 HG22 ' B' ' 212' ' ' ILE . 4.1 mp -142.33 107.96 5.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.549 ' O ' HG23 ' B' ' 202' ' ' ILE . 10.1 t -129.61 157.58 41.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.455 ' HA2' ' OD1' ' B' ' 159' ' ' ASN . . . 102.85 11.75 33.99 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.755 ' HB2' ' CD1' ' B' ' 202' ' ' ILE . . . -91.77 155.1 18.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.31 -1.112 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' B' ' 218' ' ' LYS . 22.4 tttt -104.79 0.71 28.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.375 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.2 137.78 5.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.028 . . . . 0.0 110.432 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 220' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 220' ' ' ARG . 10.4 ttm180 -45.18 -26.62 0.5 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -34.03 77.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.989 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.604 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 1.4 mm-40 -67.82 -55.13 14.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' B' ' 217' ' ' ALA . 14.3 mm -51.08 -47.53 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.786 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.05 -27.58 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.778 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.16 -43.4 24.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 110.107 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' B' ' 204' ' ' LEU . . . -60.12 -40.16 88.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.15 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.533 ' HA ' HG22 ' B' ' 230' ' ' ILE . 46.8 t80 -70.28 -42.58 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -20.09 66.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.84 -22.99 18.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 110.318 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' B' ' 227' ' ' PHE . 7.5 tp -100.36 -28.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 30.6 t80 -44.08 -49.52 22.24 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.4 Cg_endo -69.45 -40.49 5.73 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.36 1.189 . . . . 0.0 110.606 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.7 -39.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.881 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.42 HD21 HD13 ' B' ' 206' ' ' ILE . 95.1 mt -64.87 -55.16 21.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.115 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -50.69 -28.81 9.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.95 -32.92 65.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 110.446 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' B' ' 178' ' ' SER . 49.6 m-85 -113.66 41.4 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.393 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -160.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -144.47 -54.73 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.187 -0.946 . . . . 0.0 110.236 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.009 HD23 ' CG1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.806 0.812 . . . . 0.0 110.664 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.729 ' HA ' HD11 ' A' ' 68' ' ' LEU . 5.9 t0 75.5 90.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 111.529 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 18' ' ' LEU . 2.3 mt -107.27 35.45 3.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.787 . . . . 0.0 110.034 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.708 ' OG1' HD23 ' A' ' 68' ' ' LEU . 20.2 m -56.6 -25.45 52.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.595 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -98.24 -27.49 8.69 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.239 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.781 HG13 HD13 ' A' ' 20' ' ' LEU . 14.8 mm -46.46 -46.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.801 -1.411 . . . . 0.0 108.849 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.874 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.1 pp -82.66 -25.65 32.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 109.137 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.013 ' CZ ' HD13 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -90.6 14.65 12.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 135.88 98.32 0.54 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 1.033 ' HB2' HG23 ' B' ' 124' ' ' THR . 25.8 p-10 -33.9 93.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.519 -0.989 . . . . 0.0 111.737 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.779 ' O ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -90.63 175.57 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 31' ' ' GLU . 21.4 m-20 -87.86 126.19 34.89 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.49 ' HB3' HG12 ' B' ' 103' ' ' ILE . 0.0 OUTLIER -40.13 -25.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -178.442 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -64.12 -6.81 7.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.986 -1.071 . . . . 0.0 110.408 178.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 102.35 29.43 6.01 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.685 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.511 ' CD ' ' C ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -119.44 111.33 17.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.9 -1.353 . . . . 0.0 110.6 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.921 HD13 HD13 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -89.47 149.14 23.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.945 HD11 ' OD1' ' A' ' 27' ' ' ASN . 3.4 pp . . . . . 0 N--CA 1.492 1.643 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.594 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.263 0.554 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -97.13 -20.97 17.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.291 -0.881 . . . . 0.0 109.08 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.614 HD21 ' HZ ' ' B' ' 207' ' ' PHE . 3.5 mt -98.95 -42.66 7.03 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.683 . . . . 0.0 110.094 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.758 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.71 -55.69 18.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.43 -0.794 . . . . 0.0 109.534 -179.522 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -61.79 -14.04 29.18 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.499 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 58' ' ' SER . 3.6 m-20 -92.75 -39.86 11.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.293 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.921 HD13 HD13 ' A' ' 34' ' ' LEU . 2.9 mt -47.7 -41.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 0.0 108.922 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.93 -20.05 12.65 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.422 ' HB3' HD11 ' B' ' 189' ' ' LEU . 50.2 m -113.44 0.64 14.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -1.123 . . . . 0.0 110.371 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 56' ' ' ILE . 29.8 mt -88.91 33.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -115.88 23.15 12.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.391 -0.818 . . . . 0.0 110.501 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.87 50.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -152.19 -29.11 0.16 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.354 -0.841 . . . . 0.0 111.0 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.859 ' H ' HD12 ' A' ' 62' ' ' LEU . . . -175.8 -42.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.869 HD12 HD11 ' A' ' 24' ' ' LEU . 2.8 mm? -69.46 -3.53 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -46.14 -41.8 13.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 110.129 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 p -65.99 -48.83 69.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 0.0 109.907 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.874 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.87 -3.36 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.729 HD11 ' HA ' ' A' ' 19' ' ' ASP . 2.4 tm? -80.6 -60.49 2.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.284 -0.885 . . . . 0.0 109.343 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.448 HD12 ' C ' ' A' ' 69' ' ' LEU . 3.5 pp -78.74 0.3 27.36 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.444 0.64 . . . . 0.0 109.794 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 22.9 tt0 -93.01 10.47 31.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.384 -0.822 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.804 ' HB ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -133.2 -4.26 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 120.954 -1.091 . . . . 0.0 110.072 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.009 ' CG1' HD23 ' A' ' 18' ' ' LEU . 2.6 tp -138.69 74.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.0 t0 -83.34 52.41 2.21 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.034 -1.041 . . . . 0.0 108.615 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.612 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.528 -0.733 . . . . 0.0 111.766 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 5.1 mt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.202 0.525 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 45.4 t 58.77 119.63 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 0.0 110.363 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 44.6 Cg_endo -72.02 137.88 30.0 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.781 1.411 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.479 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 15.8 m -93.31 153.43 18.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 110.437 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 88.2 mt -86.52 133.06 33.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.432 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 2.9 mm-40 -116.06 -19.45 10.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.529 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 14.5 m-80 -167.63 167.76 13.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.362 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 9.2 mt -158.11 158.17 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' B' ' 123' ' ' VAL . 61.5 t -134.22 144.42 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 110.351 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.04 155.44 48.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.87 141.56 42.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.725 HG21 ' OG ' ' B' ' 136' ' ' SER . 86.2 t -133.07 135.88 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 0.0 110.211 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -105.71 123.01 47.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.223 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.867 HD22 ' HB1' ' B' ' 150' ' ' ALA . 71.4 mt -78.45 -43.5 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.83 9.71 42.27 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.53 150.24 21.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -1.189 . . . . 0.0 110.359 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.922 ' O ' HD23 ' B' ' 80' ' ' LEU . 9.6 mtp180 -70.65 164.94 23.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.163 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.922 HD23 ' O ' ' B' ' 79' ' ' ARG . 20.6 mt -140.39 160.22 40.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.331 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.3 OUTLIER -96.27 92.46 6.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 1.041 HD22 HG23 ' B' ' 102' ' ' VAL . 13.8 mt -42.35 -46.72 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.26 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 3.8 tptm -52.62 -46.57 67.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.444 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 18.6 p -86.89 -38.96 16.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.441 HG12 HG11 ' B' ' 102' ' ' VAL . 53.6 t -54.26 -37.51 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.798 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.65 -31.84 23.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 14.1 tp -76.8 -27.87 55.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.772 . . . . 0.0 109.97 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -47.62 9.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 110.098 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -48.49 135.86 13.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -71.69 -24.59 61.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 10.1 p30 -136.14 79.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.111 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -151.6 153.56 34.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.389 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.418 ' OE1' ' HA ' ' B' ' 93' ' ' GLU . 52.7 mm-40 -134.49 141.54 46.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 110.108 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -134.41 117.79 16.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.5 125.3 26.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.55 -34.13 7.7 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.845 1.445 . . . . 0.0 110.098 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.021 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' B' ' 98' ' ' ARG . 5.6 mpt_? -98.15 -59.76 1.69 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.375 -0.828 . . . . 0.0 110.202 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 1.201 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.57 175.0 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.629 -0.67 . . . . 0.0 111.375 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.41 55.89 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 111.298 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.201 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -147.87 160.23 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 1.041 HG23 HD22 ' B' ' 82' ' ' LEU . 84.6 t -92.61 162.27 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.543 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 30' ' ' SER . 9.9 mt -131.57 125.32 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 109.711 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.85 162.85 12.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -160.01 130.07 5.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 5.6 pt -139.72 167.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.44 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -125.28 37.14 4.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 110.224 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.4 OUTLIER -177.88 80.05 0.23 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.461 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.8 Cg_endo -75.93 165.82 84.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.483 -2.299 . . . . 0.0 110.3 -0.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -78.58 109.47 12.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 110.334 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.563 HG22 ' O ' ' B' ' 124' ' ' THR . 0.2 OUTLIER -157.27 171.33 20.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.908 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.546 HG22 HG23 ' B' ' 124' ' ' THR . 6.5 t -137.12 155.35 49.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -150.8 167.22 28.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.745 HD13 HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -140.86 113.56 8.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 0.0 109.507 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.723 HG23 ' O ' ' B' ' 120' ' ' LYS . 2.9 mp -98.22 149.85 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.432 -0.792 . . . . 0.0 111.02 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.623 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.1 m-85 -95.68 -177.65 4.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.491 -0.756 . . . . 0.0 109.511 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -84.96 -15.65 43.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.728 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' SER . . . . . 0.493 ' HA ' ' HG2' ' B' ' 79' ' ' ARG . 66.7 p -73.09 -18.53 61.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.17 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 6.72 22.28 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' LYS . . . . . 0.723 ' O ' HG23 ' B' ' 115' ' ' ILE . 2.4 mttt -87.85 157.82 18.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -1.168 . . . . 0.0 110.015 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.551 ' CG ' HG13 ' B' ' 115' ' ' ILE . 7.2 tmm? -147.35 133.95 19.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.816 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.786 HG11 HG12 ' A' ' 71' ' ' VAL . 7.0 t -113.68 132.93 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.837 . . . . 0.0 109.759 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.561 HG13 ' HE2' ' B' ' 139' ' ' TYR . 12.7 t -112.96 138.12 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 124' ' ' THR . . . . . 1.033 HG23 ' HB2' ' A' ' 27' ' ' ASN . 9.0 t -147.02 146.58 30.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.824 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.617 ' N ' ' HB3' ' A' ' 27' ' ' ASN . . . 119.42 -9.51 11.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -75.75 151.45 37.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.218 . . . . 0.0 110.167 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -117.88 -23.32 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.881 . . . . 0.0 110.145 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.1 OUTLIER -123.02 -173.66 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -82.62 -48.68 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.294 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -65.77 -16.58 63.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.63 -46.54 14.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 132' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 136' ' ' SER . 2.0 t -65.75 -30.36 71.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.13 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -71.18 -51.27 25.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.3 -50.05 74.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.32 -0.862 . . . . 0.0 110.182 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.611 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -54.99 -46.06 75.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.725 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -60.87 -58.61 7.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 110.05 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.55 -36.94 25.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.761 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -49.66 77.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.561 ' HE2' HG13 ' B' ' 123' ' ' VAL . 25.2 m-85 -58.8 -50.07 75.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 109.97 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.65 71.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.064 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 1.3 mmt85 -60.38 -40.88 92.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 110.039 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' B' ' 139' ' ' TYR . 38.6 mt -54.71 -48.14 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.514 HD13 HD13 ' B' ' 80' ' ' LEU . 57.5 mt -66.56 -49.77 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -61.24 -36.9 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.0 OUTLIER -71.84 -27.58 62.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.1 mt -72.8 -18.54 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.44 -27.07 7.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' B' ' 143' ' ' ILE . 12.1 m-85 -46.79 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.25 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.78 29.97 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.532 -0.73 . . . . 0.0 109.815 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.867 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -66.38 151.59 46.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.513 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.97 107.53 6.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.95 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -53.3 102.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.902 . . . . 0.0 110.308 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.8 p -148.39 172.21 14.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 t0 60.85 15.88 6.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -60.62 134.53 57.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.966 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -170.08 134.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.352 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.96 126.81 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.365 -0.835 . . . . 0.0 109.665 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -115.67 -12.48 11.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.851 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.3 112.05 5.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.054 -1.029 . . . . 0.0 111.047 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' ' 215' ' ' THR . 11.0 mt -105.52 148.48 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 0.0 109.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' B' ' 69' ' ' ASN . 6.4 t -117.09 142.4 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.037 . . . . 0.0 111.079 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -159.9 164.81 34.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.0 OUTLIER -168.49 164.17 12.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.845 -1.385 . . . . 0.0 111.029 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.432 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -170.01 175.81 4.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.846 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -108.03 149.02 28.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.743 HG21 HD11 ' B' ' 170' ' ' ILE . 16.1 m -97.22 4.34 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 110.224 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.69 12.92 6.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.259 -0.901 . . . . 0.0 110.722 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.569 ' CE1' HG13 ' B' ' 170' ' ' ILE . 10.3 p90 -171.43 139.82 1.19 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.133 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.0 Cg_endo -71.31 153.62 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.104 1.581 . . . . 0.0 111.007 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 1.022 HD13 HD22 ' B' ' 234' ' ' LEU . 3.2 mt -125.42 150.65 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -80.25 92.79 5.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.633 HD11 ' HA ' ' B' ' 207' ' ' PHE . 97.9 mt -52.73 -32.38 42.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.406 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.69 -59.82 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.946 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.61 -37.18 33.15 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.566 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.2 OUTLIER -64.89 -53.69 42.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -1.101 . . . . 0.0 109.98 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.46 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -58.1 -20.98 44.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 0.0 110.075 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.66 -56.31 4.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 0.0 109.878 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.7 t -69.9 -46.03 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 0.0 110.043 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -105.89 41.57 1.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.018 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.36 -16.89 63.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 68.0 p -85.82 -31.74 22.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -1.209 . . . . 0.0 110.378 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -104.63 -10.36 17.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.792 ' HB2' HD21 ' B' ' 193' ' ' LEU . 1.2 p -140.88 123.41 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.57 165.89 11.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.866 . . . . 0.0 110.083 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -160.66 126.89 4.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 110.28 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' B' ' 187' ' ' PRO . 81.3 mt-10 -130.97 107.9 15.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.273 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 187' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.9 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.996 1.524 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -95.75 4.42 52.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.686 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -159.78 -51.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.686 ' HB2' HD23 ' B' ' 189' ' ' LEU . 26.6 t80 -113.19 109.95 51.41 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 0.0 110.374 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.69 -20.8 22.59 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.975 1.513 . . . . 0.0 110.152 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' B' ' 190' ' ' PHE . . . -90.74 -179.94 43.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' B' ' 183' ' ' SER . 6.0 tt -123.79 131.8 53.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -1.18 . . . . 0.0 110.321 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.837 HD13 HD13 ' A' ' 62' ' ' LEU . 4.6 mt -96.32 111.26 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 20.5 t80 -95.31 111.57 23.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.259 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -94.98 86.85 4.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.562 ' HE1' HG12 ' B' ' 230' ' ' ILE . 20.6 ttm -65.27 135.1 54.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 110.169 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 74.2 t -86.11 -28.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.878 . . . . 0.0 110.307 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' B' ' 199' ' ' LYS . 0.0 OUTLIER -149.4 110.15 3.41 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.432 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.446 ' HB2' ' OE2' ' B' ' 222' ' ' GLU . 48.5 Cg_endo -73.72 171.28 67.23 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.035 -2.069 . . . . 0.0 110.485 -0.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.404 ' C ' HG12 ' B' ' 202' ' ' ILE . 11.8 tptt -74.46 92.57 2.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.87 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' B' ' 217' ' ' ALA . 24.6 mm -140.16 153.63 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.741 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' B' ' 195' ' ' TYR . 48.4 t -114.34 116.69 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.714 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.755 HD22 HG13 ' B' ' 230' ' ' ILE . 3.4 mp -110.71 131.21 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 1.013 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -110.59 122.65 48.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.19 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.51 HG12 HD21 ' B' ' 234' ' ' LEU . 2.8 mp -113.68 145.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.108 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.633 ' HA ' HD11 ' B' ' 172' ' ' LEU . 84.2 m-85 -121.15 156.32 32.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.462 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 12.8 t -47.97 -27.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.421 -0.8 . . . . 0.0 110.137 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 4.7 m -71.54 -31.92 67.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.927 . . . . 0.0 110.303 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.39 5.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.2 OUTLIER -87.77 133.65 33.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' B' ' 163' ' ' SER . 36.5 mm -117.49 132.93 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 25' ' ' PHE . 76.0 t -125.85 114.52 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 110.393 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.69 104.19 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 110.172 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.8 t -132.56 142.29 49.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.953 . . . . 0.0 110.235 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.428 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 108.0 19.21 9.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.827 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -99.99 164.43 12.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.288 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.15 -29.97 8.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.77 154.0 44.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.865 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -53.8 -18.69 3.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -59.44 -45.51 91.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -0.92 . . . . 0.0 110.461 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' B' ' 200' ' ' PRO . 30.6 mt-10 -72.43 -46.4 55.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 13.6 mm -51.57 -44.71 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 110.025 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.462 ' CZ ' HG13 ' B' ' 64' ' ' VAL . 2.2 m-30 -71.38 -48.98 46.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.49 -33.91 73.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 110.446 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.585 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -61.44 -59.77 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.867 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 35.8 t80 -56.27 -26.83 53.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.836 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -32.26 73.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.871 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -94.75 -13.17 25.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.755 HG13 HD22 ' B' ' 204' ' ' LEU . 6.0 mm -96.77 -23.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.36 -0.837 . . . . 0.0 109.83 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.591 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 10.3 t80 -58.43 -42.3 93.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 0.0 110.966 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.2 Cg_endo -76.33 -31.17 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.416 1.219 . . . . 0.0 110.755 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.566 ' CG1' HD11 ' B' ' 175' ' ' LEU . 39.5 t -67.27 -35.89 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 1.022 HD22 HD13 ' B' ' 170' ' ' ILE . 18.3 mt -71.88 -39.72 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.057 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.51 80.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.87 -39.92 91.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.006 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.458 ' HB2' ' CD2' ' B' ' 175' ' ' LEU . 84.4 m-85 -110.04 37.78 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 177.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -121.54 -51.42 2.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 110.094 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.225 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.731 HD21 ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 2.6 m-20 -63.7 71.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.052 -1.03 . . . . 0.0 110.207 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.731 ' CD2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -86.65 8.98 20.09 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.35 -0.844 . . . . 0.0 111.322 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.871 HG22 HG23 ' A' ' 56' ' ' ILE . 10.4 m -54.96 -18.87 5.59 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.467 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.645 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.43 -36.2 4.16 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.573 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 28' ' ' ILE . 1.1 mm -46.68 -47.42 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.802 -1.411 . . . . 0.0 108.985 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.072 HD11 ' CD1' ' A' ' 64' ' ' LEU . 2.0 pp -82.91 -28.06 30.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CE1' ' CD1' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -86.97 8.71 22.07 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.653 ' O ' HG23 ' A' ' 28' ' ' ILE . . . 141.57 98.54 0.33 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.72 ' HB3' HG23 ' B' ' 124' ' ' THR . 0.2 OUTLIER -16.75 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.91 0.862 . . . . 0.0 111.436 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.897 HG22 HD22 ' A' ' 34' ' ' LEU . 2.3 pp -138.07 166.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 121.464 -0.773 . . . . 0.0 109.443 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.743 ' C ' HD12 ' A' ' 28' ' ' ILE . 80.6 m-20 -87.11 116.71 25.35 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.529 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -36.28 -28.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.484 0.659 . . . . 0.0 110.157 -177.365 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.9 tt0 -57.04 -13.03 2.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 110.544 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.28 24.37 5.7 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.052 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.565 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -109.83 124.23 50.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -1.155 . . . . 0.0 109.235 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.03 HD13 ' N ' ' A' ' 35' ' ' LEU . 3.2 tm? -87.55 150.57 23.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 111.066 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 1.03 ' N ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 111.23 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.211 0.529 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.7 tt0 -93.42 -33.7 13.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.533 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 1.8 mt -90.97 -41.2 11.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.361 -0.837 . . . . 0.0 110.064 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.974 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.51 -50.26 17.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.54 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.29 -29.48 68.27 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.702 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.53 ' C ' HD23 ' A' ' 59' ' ' LEU . 8.4 m-80 -77.82 -40.58 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.974 HD12 ' HA ' ' A' ' 53' ' ' ARG . 23.0 mt -49.97 -47.38 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.32 0.07 69.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.33 -46.57 3.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -1.143 . . . . 0.0 110.437 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.785 HD22 ' CE2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -85.98 44.54 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 0.0 110.421 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -84.86 22.36 1.39 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.739 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.447 ' C ' HD23 ' A' ' 62' ' ' LEU . 1.8 pttt -152.68 8.04 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 111.195 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 62' ' ' LEU . 3.0 mt -86.37 -34.68 20.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.621 -1.299 . . . . 0.0 109.852 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.48 -35.25 0.04 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.072 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.8 mm? -56.92 -28.25 61.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -1.171 . . . . 0.0 110.709 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' LEU . 11.5 t0 -43.67 -38.67 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.471 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.0 m -70.73 -51.01 30.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.374 -0.828 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.827 ' HG2' HD13 ' A' ' 24' ' ' LEU . 3.5 tpp -65.38 -12.73 55.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -72.69 -64.03 1.04 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 109.719 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -60.85 -12.15 10.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.583 -0.698 . . . . 0.0 110.022 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.62 2.69 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.065 HG12 HG11 ' B' ' 122' ' ' VAL . 1.5 t -140.04 3.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.046 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 72' ' ' ILE . 2.6 tp -148.64 67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.396 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 11.1 t0 -77.1 53.54 0.98 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.975 -1.078 . . . . 0.0 109.359 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.959 HD11 ' CE1' ' B' ' 116' ' ' PHE . 1.5 mt . . . . . 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' B' ' 64' ' ' VAL . 2.9 mp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.155 0.502 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' B' ' 63' ' ' ILE . 91.5 t 58.03 119.62 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 110.25 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.604 ' HG2' HG22 ' B' ' 223' ' ' ILE . 43.4 Cg_endo -71.13 134.46 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.793 1.417 . . . . 0.0 110.407 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.6 m -96.82 137.5 35.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.379 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' B' ' 161' ' ' VAL . 33.2 mt -70.67 139.36 51.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -126.48 -5.64 6.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.655 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.609 ' ND2' HG21 ' B' ' 161' ' ' VAL . 1.8 t30 -168.41 124.53 1.0 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.0 -1.063 . . . . 0.0 110.755 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' B' ' 124' ' ' THR . 11.5 mm -108.89 147.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 109.311 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 25.5 t -134.61 135.7 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.956 -1.09 . . . . 0.0 110.456 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -141.52 155.43 45.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.316 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 60.6 m -104.47 126.93 52.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.227 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 t -126.67 138.54 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.926 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 9.5 m -109.65 145.86 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.553 ' CD1' HD11 ' B' ' 80' ' ' LEU . 59.3 mt -96.53 -30.13 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 109.751 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' B' ' 78' ' ' CYS . . . 80.52 32.48 34.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' B' ' 77' ' ' GLY . 1.2 m -166.29 164.88 17.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 110.273 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.811 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -91.82 152.71 20.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.113 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.811 HD23 ' O ' ' B' ' 79' ' ' ARG . 22.5 mt -138.95 163.88 31.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.422 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 2.8 t70 -108.74 97.92 7.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.526 -0.734 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.46 HD22 HG23 ' B' ' 102' ' ' VAL . 14.3 mt -40.94 -35.78 0.57 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -48.2 73.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 60.8 m -66.18 -37.78 86.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.622 HG12 HG11 ' B' ' 102' ' ' VAL . 22.7 t -72.88 -46.12 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.978 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.71 -13.01 61.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tp -99.27 -29.64 12.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.857 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.2 OUTLIER -99.81 -20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.285 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -61.74 151.65 33.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.144 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -85.65 -37.8 19.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.219 -0.926 . . . . 0.0 110.195 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -131.38 78.76 1.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.593 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -146.92 160.51 42.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.865 . . . . 0.0 110.725 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.533 ' O ' HD12 ' B' ' 103' ' ' ILE . 3.0 mt-10 -137.35 157.62 46.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 109.939 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -147.44 101.48 3.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.222 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.539 ' O ' ' HG3' ' B' ' 98' ' ' ARG . 1.5 m-20 -109.86 121.16 42.8 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.63 -10.83 20.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.704 1.37 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -87.21 10.74 16.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 111.155 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 95' ' ' ASN . 1.0 OUTLIER -139.68 -43.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.826 -1.172 . . . . 0.0 110.799 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.698 ' CD2' ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -170.35 168.89 7.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.25 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.39 55.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.83 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -136.24 158.51 44.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 111.155 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.622 HG11 HG12 ' B' ' 85' ' ' VAL . 49.0 t -102.58 122.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.473 -0.767 . . . . 0.0 109.184 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.695 ' H ' HD12 ' B' ' 103' ' ' ILE . 3.6 mp -89.36 109.18 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.471 ' SD ' HD11 ' B' ' 115' ' ' ILE . 3.2 ttm -91.57 160.89 15.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.2 112.0 3.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.989 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.676 HD11 ' OG1' ' B' ' 111' ' ' THR . 44.5 pt -101.91 167.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -125.64 33.08 5.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 3.3 tt0 -178.89 83.35 0.22 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.5 Cg_endo -78.79 151.44 88.32 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.786 -2.173 . . . . 0.0 110.33 -0.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.455 ' C ' HG23 ' B' ' 111' ' ' THR . 7.1 mttt -61.53 110.15 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.8 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.676 ' OG1' HD11 ' B' ' 106' ' ' ILE . 74.0 p -148.57 175.17 11.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.582 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.0 OUTLIER -126.67 162.81 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.755 . . . . 0.0 109.416 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -156.35 133.4 10.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.805 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.2 OUTLIER -97.92 105.8 18.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.471 HD11 ' SD ' ' B' ' 104' ' ' MET . 9.7 mt -90.78 140.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.957 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.959 ' CE1' HD11 ' A' ' 74' ' ' LEU . 1.4 m-85 -111.31 159.42 17.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.585 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -77.94 -4.59 47.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 45.7 p -83.47 -15.2 50.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.45 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 114.02 -18.66 18.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -84.11 154.32 23.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 110.009 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 50.9 ttp -149.42 149.2 30.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.958 . . . . 0.0 110.333 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 1.065 HG11 HG12 ' A' ' 71' ' ' VAL . 7.3 t -116.21 141.18 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 109.723 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 22.9 t -114.12 157.18 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 110.789 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 27' ' ' ASN . 14.6 t -167.73 147.76 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.652 -0.655 . . . . 0.0 109.433 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.546 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 123.09 -25.97 6.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -66.18 160.59 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -1.207 . . . . 0.0 110.336 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -120.15 4.38 10.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 131' ' ' ASP . 0.5 OUTLIER -158.1 162.55 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.361 -0.837 . . . . 0.0 110.034 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -56.12 -48.65 75.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 110.178 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.57 -29.27 70.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.375 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' B' ' 128' ' ' SER . 88.7 m-20 -65.81 -60.75 2.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.42 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 60.3 p -61.68 -33.31 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -44.64 75.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 110.23 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.78 -54.16 6.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.408 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.96 -39.64 9.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.978 . . . . 0.0 109.829 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.8 m -63.1 -56.3 18.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -54.06 -32.94 56.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.841 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' B' ' 138' ' ' LYS . 9.3 mptt -69.14 -42.09 76.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.952 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.834 ' HA ' HD12 ' B' ' 142' ' ' ILE . 22.3 m-85 -61.98 -47.66 83.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.15 75.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.933 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.65 -40.92 88.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' B' ' 139' ' ' TYR . 59.0 mt -54.02 -45.79 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.593 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' B' ' 150' ' ' ALA . 21.0 mm -65.37 -46.83 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' B' ' 150' ' ' ALA . 29.4 mt-30 -66.63 -28.79 68.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.845 . . . . 0.0 109.525 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -23.37 55.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 1.5 mt -81.47 -25.02 10.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.13 -32.66 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' B' ' 80' ' ' LEU . 12.5 m-85 -46.62 162.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.247 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.93 44.48 1.03 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.608 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -81.44 154.56 26.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 -166.55 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.845 ' O ' HG23 ' B' ' 153' ' ' THR . 73.3 t80 -129.87 118.38 21.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -0.975 . . . . 0.0 110.141 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.6 OUTLIER -167.8 174.0 7.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.529 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.463 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 4.0 m-20 52.15 42.48 30.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.614 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 155' ' ' PHE . 8.4 t80 -90.13 132.71 35.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.9 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.33 134.84 1.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 110.39 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 4.4 mt -78.9 124.24 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.72 -4.11 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.506 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 28.6 t-20 -152.8 131.46 12.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.86 -1.15 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.572 HG22 ' N ' ' B' ' 161' ' ' VAL . 7.0 mt -124.37 171.55 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.508 -0.745 . . . . 0.0 109.672 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.644 HG22 ' OG1' ' B' ' 215' ' ' THR . 72.8 t -144.11 128.89 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.053 . . . . 0.0 110.884 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -134.02 165.18 24.37 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.8 t -165.45 149.85 8.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.028 -1.277 . . . . 0.0 110.37 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.0 OUTLIER -170.2 173.99 5.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.281 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -113.92 168.83 9.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.598 HG12 ' HE1' ' B' ' 231' ' ' TYR . 0.0 OUTLIER -112.74 -80.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.279 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.456 ' H ' HG23 ' B' ' 166' ' ' VAL . 4.7 tmtt? 177.96 -27.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.019 -1.051 . . . . 0.0 110.682 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.477 ' HB2' ' OXT' ' B' ' 240' ' ' MET . 13.7 p90 -131.29 158.09 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.981 . . . . 0.0 109.705 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.8 Cg_endo -72.74 152.71 53.33 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.85 1.447 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.472 HD13 HD22 ' B' ' 234' ' ' LEU . 4.0 mt -119.84 158.08 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.503 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 171' ' ' ARG . . . . . 0.467 ' NE ' ' HG3' ' B' ' 239' ' ' LYS . 6.5 mtt-85 -95.82 99.27 11.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 45.9 mt -50.08 -33.03 17.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 173' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 174' ' ' GLY . 4.3 mt-10 -68.08 -56.38 9.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.165 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 174' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' B' ' 173' ' ' GLU . . . -44.35 -30.25 1.95 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.856 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.2 OUTLIER -80.86 -59.04 2.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 110.254 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' B' ' 185' ' ' TYR . . . -54.14 -24.39 17.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.47 -46.82 18.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.046 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 5.0 t -79.63 -58.43 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -92.63 36.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.48 -13.54 37.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.97 -14.64 38.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -1.2 . . . . 0.0 110.306 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 -6.37 8.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.276 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.674 ' HB2' HD21 ' B' ' 193' ' ' LEU . 82.6 p -133.66 164.19 27.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 184' ' ' SER . . . . . 0.471 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 14.7 m -135.13 147.43 49.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.98 . . . . 0.0 110.07 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' B' ' 176' ' ' ALA . 16.1 t80 -133.77 115.98 15.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.163 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 190' ' ' PHE . 9.3 mm-40 -115.87 92.75 35.59 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.89 -9.91 26.62 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.993 1.522 . . . . 0.0 110.356 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -9.57 21.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 110.053 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.632 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.7 tt -153.08 19.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.785 ' CE2' HD22 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -170.07 113.54 0.48 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.992 . . . . 0.0 110.317 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 191' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -37.28 4.96 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.048 1.552 . . . . 0.0 110.552 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -91.32 179.32 42.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' B' ' 183' ' ' SER . 3.1 tt -116.32 138.64 51.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.121 . . . . 0.0 110.225 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.469 HD11 ' CE2' ' B' ' 190' ' ' PHE . 25.1 mt -93.51 111.06 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -101.35 117.21 34.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.12 89.24 7.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.378 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.403 ' HB2' HD13 ' B' ' 204' ' ' LEU . 52.0 tpp -53.22 128.44 27.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.6 -47.28 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.29 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.5 OUTLIER -146.28 123.83 6.09 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.941 . . . . 0.0 110.246 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.8 Cg_endo -73.44 155.2 99.8 Favored 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.891 -2.129 . . . . 0.0 110.321 -0.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.482 ' O ' HG13 ' B' ' 202' ' ' ILE . 16.2 tttt -56.64 112.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.482 HG13 ' O ' ' B' ' 201' ' ' LYS . 4.7 mt -158.58 154.72 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 0.0 110.471 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.6 114.99 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.479 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.538 ' N ' HD12 ' B' ' 204' ' ' LEU . 6.2 mp -101.53 135.09 43.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 110.95 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' B' ' 205' ' ' LEU . 0.9 OUTLIER -103.24 119.14 38.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 109.535 179.363 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 13.7 mm -105.16 147.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 0.0 110.566 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.521 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 21.0 m-85 -132.53 141.14 48.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.063 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.607 HG23 ' H ' ' B' ' 209' ' ' SER . 0.8 OUTLIER -46.48 -54.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 110.105 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.607 ' H ' HG23 ' B' ' 208' ' ' VAL . 68.2 m -39.2 -36.9 0.36 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.317 0.579 . . . . 0.0 110.187 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 118.01 24.23 3.36 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.528 ' O ' HD13 ' B' ' 212' ' ' ILE . 1.9 mttm -97.53 134.61 40.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -1.223 . . . . 0.0 110.099 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 211' ' ' LYS . 15.8 mm -119.82 138.45 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 59.6 t -128.41 132.32 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.233 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.48 ' HB2' HD12 ' B' ' 223' ' ' ILE . 2.6 mp -118.77 119.14 33.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 110.16 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.644 ' OG1' HG22 ' B' ' 161' ' ' VAL . 12.6 t -139.0 157.67 45.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 110.241 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.71 14.38 55.34 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.659 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -83.92 144.42 29.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -1.09 . . . . 0.0 110.276 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -81.44 -7.28 59.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.567 ' C ' HD12 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -169.37 -176.69 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -73.98 -45.42 50.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.449 ' HG3' ' OE1' ' B' ' 222' ' ' GLU . 24.0 pt-20 -49.74 -32.76 14.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.659 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 8.7 mm-40 -61.17 -49.14 78.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.942 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.604 HG22 ' HG2' ' B' ' 65' ' ' PRO . 47.8 mm -59.43 -36.14 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -65.28 -35.54 81.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.47 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -82.08 -41.46 20.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.418 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.84 -34.4 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 110.247 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.685 ' HA ' HG22 ' B' ' 230' ' ' ILE . 18.1 t80 -76.18 -49.45 17.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.366 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -23.04 40.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.479 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.18 -24.78 19.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.992 . . . . 0.0 110.255 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' B' ' 227' ' ' PHE . 6.6 tp -100.28 -17.98 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.341 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.632 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.6 t80 -55.1 -43.63 99.17 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 111.144 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -72.87 -42.68 1.01 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.312 1.164 . . . . 0.0 110.343 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.856 ' CG1' HD11 ' B' ' 175' ' ' LEU . 40.6 t -53.97 -42.69 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.972 . . . . 0.0 109.682 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.472 HD22 HD13 ' B' ' 170' ' ' ILE . 81.9 mt -65.01 -58.16 6.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 109.966 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 235' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -52.9 -30.94 37.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.035 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.71 -36.85 84.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.441 ' CD2' HD22 ' B' ' 175' ' ' LEU . 94.8 m-85 -113.04 41.47 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' B' ' 235' ' ' SER . 1.5 ptt180 -74.56 -176.14 2.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.499 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 6.2 ttmt -125.33 -29.46 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 109.979 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 240' ' ' MET . . . . . 0.477 ' OXT' ' HB2' ' B' ' 168' ' ' PHE . 10.8 mtp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.139 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.97 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 121.033 0.444 . . . . 0.0 109.974 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 4.8 t70 -76.1 96.27 3.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.049 -1.032 . . . . 0.0 111.1 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.043 HD13 HG21 ' A' ' 23' ' ' ILE . 2.0 mt -99.06 12.2 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.078 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.718 HG23 HG23 ' A' ' 56' ' ' ILE . 1.3 t -40.93 -33.63 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.635 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.51 -31.55 6.38 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.043 HG21 HD13 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -47.39 -44.38 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.685 -1.479 . . . . 0.0 109.084 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.68 HD21 ' CD2' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -82.84 -22.56 34.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.022 -1.049 . . . . 0.0 109.0 178.258 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.594 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -92.77 11.09 28.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 143.64 98.67 0.28 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.995 ' OD1' HD11 ' A' ' 35' ' ' LEU . 12.7 p-10 -30.73 90.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.05 0.928 . . . . 0.0 111.832 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.631 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -92.6 164.16 2.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 28' ' ' ILE . 26.0 m-20 -85.59 123.85 31.47 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.698 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -37.03 -29.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.363 0.601 . . . . 0.0 109.825 -178.143 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.9 tt0 -54.85 -16.13 2.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.09 27.97 4.61 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.589 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -123.27 126.41 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.998 -1.295 . . . . 0.0 110.557 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.86 HD13 HD13 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -98.95 155.34 17.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.688 -1.257 . . . . 0.0 110.645 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.995 HD11 ' OD1' ' A' ' 27' ' ' ASN . 3.3 pp . . . . . 0 N--CA 1.493 1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.117 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.286 0.565 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 41.8 tt0 -100.59 -29.86 12.1 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.633 HD21 ' CD1' ' B' ' 205' ' ' LEU . 3.4 mt -98.58 -45.31 6.13 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 110.009 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -45.04 -49.05 11.7 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.763 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -64.14 -20.7 66.17 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.719 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 76.5 m-20 -91.34 -38.12 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.653 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.86 HD13 HD13 ' A' ' 34' ' ' LEU . 3.2 mt -47.71 -43.49 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.95 -17.18 28.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.7 OUTLIER -138.39 35.54 2.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -1.195 . . . . 0.0 110.468 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.065 ' CD2' HD11 ' A' ' 62' ' ' LEU . 12.2 mt -102.58 21.18 15.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.159 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.11 45.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.548 ' C ' HD23 ' A' ' 62' ' ' LEU . 21.7 ttpt -150.28 15.84 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.065 HD11 ' CD2' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -93.75 -31.83 14.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.28 -0.888 . . . . 0.0 109.768 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.53 1.77 7.64 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.949 HD12 HD21 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -95.28 0.19 53.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.2 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.539 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 22.6 m-20 -46.2 -41.93 13.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.662 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.666 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -60.61 -35.36 75.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.894 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.526 ' HE3' ' HB2' ' A' ' 64' ' ' LEU . 4.9 ttp -69.0 -18.98 64.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.949 HD21 HD12 ' A' ' 64' ' ' LEU . 7.4 mt -71.96 -60.18 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.526 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 66' ' ' SER . 2.7 pp -62.61 -9.02 7.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -85.58 5.74 30.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.124 -0.985 . . . . 0.0 110.619 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.866 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.7 OUTLIER -132.49 0.93 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.756 179.552 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.956 ' HB ' HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -150.94 66.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.3 p-10 -76.72 54.67 0.99 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.622 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.932 ' CD2' ' HB2' ' B' ' 101' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.751 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.552 HG22 ' N ' ' B' ' 64' ' ' VAL . 92.4 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.212 0.53 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.552 ' N ' HG22 ' B' ' 63' ' ' ILE . 91.4 t -143.2 139.55 16.79 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.41 ' HD2' HG13 ' B' ' 64' ' ' VAL . 46.2 Cg_endo -73.12 122.57 8.16 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 67.7 m -91.07 132.38 36.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.507 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.848 HD11 ' HD2' ' B' ' 220' ' ' ARG . 34.2 mt -70.27 133.82 47.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 109.89 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -121.18 -15.99 8.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.662 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.448 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -161.38 119.53 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.595 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.951 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 13.8 mm -104.25 157.07 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 30.8 t -135.9 136.85 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.8 166.29 28.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.208 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' THR . . . . . 0.701 HG23 HG22 ' B' ' 122' ' ' VAL . 0.0 OUTLIER -119.01 151.93 37.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.51 151.3 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.292 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -118.34 142.35 47.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.022 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.789 HD13 ' HB1' ' B' ' 150' ' ' ALA . 49.4 mt -89.84 -61.1 1.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.77 4.75 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 1.3 m -162.3 151.28 15.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -1.172 . . . . 0.0 110.167 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.761 ' O ' HD23 ' B' ' 80' ' ' LEU . 18.1 ttp85 -71.46 155.55 40.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' B' ' 76' ' ' LEU . 44.6 mt -138.07 148.91 45.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 29.9 t70 -89.81 95.59 10.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.013 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.453 HD22 HG23 ' B' ' 102' ' ' VAL . 14.5 mt -42.68 -48.61 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.181 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -46.13 61.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.864 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 9.0 m -76.46 -48.37 19.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.445 HG22 ' CE2' ' B' ' 148' ' ' PHE . 95.8 t -54.62 -50.42 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.236 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.08 -20.54 64.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 110.005 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.27 -37.62 15.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.246 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.71 -26.78 29.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.485 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -65.31 140.27 58.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 110.375 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -76.07 -27.05 57.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.402 -0.811 . . . . 0.0 109.983 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 0.7 OUTLIER -132.54 79.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.946 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.818 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -163.89 167.75 20.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.407 ' O ' HD12 ' B' ' 103' ' ' ILE . 17.3 pt-20 -161.27 141.04 10.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 110.135 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.405 ' HB2' HG22 ' B' ' 102' ' ' VAL . 30.3 t80 -114.06 105.4 13.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.274 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -102.67 105.35 43.98 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.73 -16.58 33.48 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.986 1.519 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -73.07 -27.54 61.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.811 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.71 -72.09 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.986 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.656 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -138.55 -177.28 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.31 44.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.116 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . . . -131.18 165.02 24.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 110.563 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.453 HG23 HD22 ' B' ' 82' ' ' LEU . 57.9 t -102.97 123.64 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.354 -0.841 . . . . 0.0 109.586 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.5 mp -89.29 122.47 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.865 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.818 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 9.8 ttm -115.81 166.09 12.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 110.514 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' B' ' 111' ' ' THR . 3.9 ttt85 -164.71 118.98 1.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 12.9 pt -112.71 170.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 110.376 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.89 38.16 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.808 . . . . 0.0 109.799 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.2 tt0 -174.17 79.33 0.36 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.507 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 53.0 Cg_endo -83.65 162.47 70.67 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.795 -2.169 . . . . 0.0 110.444 -0.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.569 ' O ' HG23 ' B' ' 111' ' ' THR . 21.5 mttt -61.81 106.7 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.933 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.569 HG23 ' O ' ' B' ' 110' ' ' LYS . 20.7 p -156.45 173.33 17.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.607 HG22 HG23 ' B' ' 124' ' ' THR . 0.4 OUTLIER -121.97 -179.51 4.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.357 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.674 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -167.19 122.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 0.0 111.218 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.638 HD22 HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -89.87 103.29 15.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 178.817 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.442 ' HA ' ' HB3' ' B' ' 121' ' ' MET . 15.8 mt -91.05 141.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 111.468 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.898 ' CE1' HD11 ' A' ' 74' ' ' LEU . 1.8 m-85 -110.6 151.46 27.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.46 66.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.295 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 p -71.04 -3.94 22.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.38 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.18 -28.36 16.27 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -73.2 163.99 27.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -1.068 . . . . 0.0 110.099 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.442 ' HB3' ' HA ' ' B' ' 115' ' ' ILE . 0.0 OUTLIER -167.44 176.02 6.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.274 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.866 HG21 ' O ' ' A' ' 71' ' ' VAL . 9.3 t -132.15 160.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.623 HG13 ' HE2' ' B' ' 139' ' ' TYR . 81.8 t -140.46 131.79 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.386 -0.821 . . . . 0.0 110.049 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.76 HG23 ' CB ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -142.15 173.28 11.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.559 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 100.33 -18.82 54.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.951 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -54.81 162.77 1.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -1.158 . . . . 0.0 110.456 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.46 13.33 16.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.192 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.66 -164.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.452 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.76 -43.91 16.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.17 -28.94 69.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.42 -53.41 12.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 110.187 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 88.8 p -49.97 -37.37 32.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.356 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -66.71 -40.41 88.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.298 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' B' ' 138' ' ' LYS . 0.3 OUTLIER -70.85 -50.65 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.342 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' B' ' 109' ' ' PRO . . . -53.21 -34.46 57.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.4 m -68.71 -56.52 7.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -48.08 -37.0 14.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.97 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.475 ' O ' HG12 ' B' ' 142' ' ' ILE . 9.8 mmtp -59.6 -51.62 69.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 26.2 m-85 -58.3 -54.72 43.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 140' ' ' ALA . . . . . 0.425 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.54 -24.42 8.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 109.83 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.509 ' HG2' ' HE3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -79.23 -39.66 32.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.976 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.475 HG12 ' O ' ' B' ' 138' ' ' LYS . 25.1 mm -54.03 -47.34 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.881 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.754 HD13 HD13 ' B' ' 80' ' ' LEU . 51.0 mt -71.59 -41.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.452 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 27.5 mt-30 -68.25 -38.92 82.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.852 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.509 ' HE3' ' HG2' ' B' ' 141' ' ' ARG . 0.5 OUTLIER -70.44 -20.74 62.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.9 mt -81.99 -16.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 111.75 -23.03 18.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.702 ' CB ' HG22 ' B' ' 143' ' ' ILE . 8.6 m-85 -50.13 176.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 110.859 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.67 42.64 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.735 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.789 ' HB1' HD13 ' B' ' 76' ' ' LEU . . . -88.23 125.94 34.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.596 ' O ' HD23 ' B' ' 76' ' ' LEU . 0.0 OUTLIER -100.73 -152.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.887 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.546 ' O ' HG23 ' B' ' 153' ' ' THR . 18.9 t80 -151.33 110.91 4.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.546 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.0 OUTLIER -165.26 -173.4 2.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 110.319 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.04 27.81 7.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.399 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' B' ' 73' ' ' THR . 10.6 t80 -74.06 136.63 43.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 109.92 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.06 133.98 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.978 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 31.9 mt -79.84 135.29 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.401 ' HA ' ' HG2' ' B' ' 218' ' ' LYS . 31.9 mm-40 -121.77 -18.87 6.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 110.516 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.543 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 2.7 t-20 -142.69 130.53 21.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.138 -0.976 . . . . 0.0 110.622 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' B' ' 217' ' ' ALA . 32.5 mt -120.47 142.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.637 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.791 HG22 ' OG1' ' B' ' 215' ' ' THR . 94.7 t -116.5 125.72 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.38 171.01 18.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.2 OUTLIER -162.35 146.33 11.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -1.223 . . . . 0.0 110.427 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 7.7 p -168.94 159.9 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' B' ' 211' ' ' LYS . 5.6 t70 -103.55 154.78 19.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 1.061 HG21 HD11 ' B' ' 170' ' ' ILE . 22.5 m -97.48 11.88 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.42 -2.06 2.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.408 -0.808 . . . . 0.0 111.214 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 11.6 p90 -155.22 157.3 31.74 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.869 -1.144 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.0 Cg_endo -72.05 160.03 48.55 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.147 1.604 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 1.061 HD11 HG21 ' B' ' 166' ' ' VAL . 1.5 mp -131.85 153.92 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 110.314 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -87.51 110.18 20.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.931 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.39 -64.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.331 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -25.95 64.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.08 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -72.56 -48.21 24.14 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.501 ' HA ' ' OG ' ' B' ' 178' ' ' SER . 9.6 tp -74.77 -33.76 62.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.343 -1.093 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.73 71.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.947 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -80.44 -28.31 37.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.992 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 178' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' B' ' 175' ' ' LEU . 1.2 p -83.58 -58.6 2.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -0.802 . . . . 0.0 110.097 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -96.28 32.65 1.92 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.021 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 181' ' ' THR . . . -52.75 -26.49 25.35 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 181' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 180' ' ' GLY . 22.6 p -42.37 -55.27 3.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -1.174 . . . . 0.0 110.133 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.621 ' CZ ' ' CG2' ' B' ' 198' ' ' VAL . 3.2 m-85 -115.49 -3.24 12.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.611 ' OG ' HD21 ' B' ' 193' ' ' LEU . 9.4 t -92.11 140.78 29.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.99 130.46 41.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 0.414 ' HB2' ' HG ' ' B' ' 193' ' ' LEU . 5.6 t80 -146.52 101.42 3.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 110.272 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.16 116.99 46.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.152 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.73 -0.24 9.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.945 1.497 . . . . 0.0 110.525 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.87 -6.67 28.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.824 HD23 ' N ' ' B' ' 190' ' ' PHE . 3.8 tt -143.13 -57.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 110.425 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.824 ' N ' HD23 ' B' ' 189' ' ' LEU . 7.4 t80 -105.74 124.92 34.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 191' ' ' PRO . . . . . 0.497 ' HD2' ' CD1' ' B' ' 190' ' ' PHE . 46.3 Cg_endo -73.84 -35.77 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.905 1.477 . . . . 0.0 110.351 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.544 ' HA3' ' CD1' ' B' ' 207' ' ' PHE . . . -90.3 174.85 40.57 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.977 HD23 ' N ' ' B' ' 194' ' ' ILE . 9.1 tt -94.11 159.75 15.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -1.137 . . . . 0.0 110.272 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.977 ' N ' HD23 ' B' ' 193' ' ' LEU . 75.9 mt -130.82 107.58 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 12.5 t80 -98.56 119.65 37.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.002 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.51 ' NH2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -91.96 117.73 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 110.457 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.428 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 30.1 ttm -93.45 144.26 25.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.937 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.621 ' CG2' ' CZ ' ' B' ' 182' ' ' PHE . 84.7 t -92.34 -50.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.965 . . . . 0.0 110.274 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -129.44 106.41 17.43 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.861 . . . . 0.0 110.314 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.1 Cg_endo -73.54 171.14 67.74 Favored 'Cis proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.359 -0.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' B' ' 197' ' ' MET . 4.2 tptt -85.14 98.58 10.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' B' ' 217' ' ' ALA . 29.2 mt -145.82 149.68 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.682 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' B' ' 196' ' ' ARG . 75.0 t -103.7 117.68 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.477 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.826 ' N ' HD12 ' B' ' 204' ' ' LEU . 4.8 mp -104.54 152.06 22.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.724 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.633 ' CD1' HD21 ' A' ' 52' ' ' LEU . 18.5 mt -117.13 143.51 45.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.371 -0.83 . . . . 0.0 110.013 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.601 HG12 HD21 ' B' ' 234' ' ' LEU . 6.5 mt -132.49 103.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.544 ' CD1' ' HA3' ' B' ' 192' ' ' GLY . 14.2 m-30 -94.48 145.74 24.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.111 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 37.6 t -45.46 -28.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.892 . . . . 0.0 110.467 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -16.19 56.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.447 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.442 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 97.67 -4.36 61.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.44 ' HG2' ' OD1' ' B' ' 165' ' ' ASP . 8.7 mttm -73.22 131.96 42.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 110.166 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' B' ' 163' ' ' SER . 17.0 mm -119.73 143.98 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.594 HG11 ' HE1' ' A' ' 25' ' ' PHE . 12.0 t -124.76 157.38 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.526 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.8 mp -144.46 107.38 4.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.791 ' OG1' HG22 ' B' ' 161' ' ' VAL . 1.6 t -128.95 137.19 51.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 0.0 110.144 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.461 ' C ' HG12 ' B' ' 202' ' ' ILE . . . 119.8 9.74 8.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.631 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -88.19 154.89 20.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.308 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' B' ' 158' ' ' GLN . 0.8 OUTLIER -106.56 -12.26 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.512 ' CG ' ' HG2' ' B' ' 221' ' ' GLU . 9.4 tp60 -150.32 150.1 31.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.059 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 220' ' ' ARG . . . . . 0.848 ' HD2' HD11 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -49.18 -38.72 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 110.368 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 16.0 pt-20 -54.45 -34.51 61.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 16.8 mt-10 -65.16 -58.73 5.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.11 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.403 HG23 HD12 ' B' ' 223' ' ' ILE . 29.5 mm -50.67 -45.2 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.992 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -65.7 -33.14 75.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.67 -46.05 23.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.018 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.496 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -55.66 -27.61 50.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.89 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.572 ' HA ' HG22 ' B' ' 230' ' ' ILE . 16.9 t80 -78.78 -46.65 18.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -59.5 -22.61 61.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.087 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -88.25 -30.54 19.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.8 tp -99.82 -9.65 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.069 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.7 t80 -63.14 -46.73 86.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -71.51 -25.95 20.62 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.229 1.12 . . . . 0.0 110.065 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.63 -36.69 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.768 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.958 HD13 HG11 ' B' ' 166' ' ' VAL . 54.7 mt -71.4 -40.93 70.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 109.972 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -19.94 66.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.314 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -82.7 -41.8 18.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -109.04 38.54 2.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.385 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -75.22 176.01 7.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.277 -0.89 . . . . 0.0 110.078 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -128.93 -36.86 1.76 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.953 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.216 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.084 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.845 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -88.38 78.26 7.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 111.565 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.084 HD21 HD21 ' A' ' 18' ' ' LEU . 4.2 mt -86.3 30.11 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.836 HG22 HG23 ' A' ' 56' ' ' ILE . 1.8 m -77.76 -6.01 52.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.24 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.776 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -99.97 -41.73 2.79 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.002 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.679 HG22 HG21 ' B' ' 124' ' ' THR . 17.2 pt -51.93 -46.17 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.651 -1.5 . . . . 0.0 109.601 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.809 ' CD1' HD12 ' A' ' 64' ' ' LEU . 1.3 pp -75.27 0.33 16.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 0.0 109.272 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -120.27 -13.99 8.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.327 -0.858 . . . . 0.0 110.721 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 157.31 45.47 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB3' HG22 ' B' ' 112' ' ' THR . 0.0 OUTLIER 52.87 147.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.368 -1.078 . . . . 0.0 111.43 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.776 ' O ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -170.49 161.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.461 -0.775 . . . . 0.0 109.284 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 31' ' ' GLU . 81.1 m-20 -88.57 135.02 33.7 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.502 ' C ' ' O ' ' A' ' 29' ' ' ASP . 1.1 p -36.27 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.904 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -49.2 -21.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 110.007 179.121 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.87 21.1 7.99 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.85 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -114.48 130.84 56.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.805 -1.409 . . . . 0.0 109.586 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.875 HD22 ' C ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -102.77 151.02 22.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 111.703 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.664 HD11 ' OD1' ' A' ' 27' ' ' ASN . 4.0 pp . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 110.367 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.193 0.52 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -100.22 -25.53 14.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.521 HD21 ' CZ ' ' B' ' 190' ' ' PHE . 3.5 mt -96.43 -40.83 8.9 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.399 -0.813 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.958 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -47.98 -52.29 20.37 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.231 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.38 -40.51 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.393 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' LEU . 3.9 m-80 -63.75 -45.36 90.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.664 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 53' ' ' ARG . 39.2 mt -46.75 -44.61 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -0.847 . . . . 0.0 109.777 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.96 -22.65 60.5 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.7 OUTLIER -142.17 39.04 1.59 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.31 . . . . 0.0 109.34 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.774 ' CD1' HD21 ' A' ' 62' ' ' LEU . 1.8 tp -104.05 -9.74 18.56 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.413 -0.805 . . . . 0.0 109.718 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 p -75.83 48.15 0.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 109.835 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -134.49 -19.4 1.89 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 110.325 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.89 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.25 22.73 4.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.673 -1.267 . . . . 0.0 111.19 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.91 -69.77 0.13 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.397 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.809 HD12 ' CD1' ' A' ' 24' ' ' LEU . 4.0 mm? -69.97 -2.09 11.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.239 . . . . 0.0 111.274 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -52.66 -49.62 64.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 109.837 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 54.3 p -67.56 -45.42 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.943 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.5 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.66 -4.41 19.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.777 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.881 HD11 ' O ' ' A' ' 18' ' ' LEU . 2.7 tm? -82.0 -60.49 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.891 . . . . 0.0 109.735 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.54 2.02 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.906 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 3.3 tt0 -97.32 16.94 18.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 111.109 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' A' ' 20' ' ' LEU . 4.2 t -136.62 -1.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.243 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.928 HD11 ' CD1' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -151.73 76.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 1.9 p-10 -75.04 57.6 0.83 Allowed 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.739 -1.226 . . . . 0.0 108.563 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.928 ' CD1' HD11 ' A' ' 72' ' ' ILE . 8.7 mt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.622 0.725 . . . . 0.0 110.815 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.462 ' C ' HG23 ' B' ' 64' ' ' VAL . 1.9 mp . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.289 0.566 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.628 ' CG1' ' CZ ' ' B' ' 224' ' ' TYR . 3.4 t 64.05 123.14 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 46.1 Cg_endo -72.72 145.93 42.19 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.938 1.494 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.5 m -96.72 136.72 36.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.512 HD22 ' CG2' ' B' ' 160' ' ' ILE . 39.7 mt -70.0 121.36 17.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.897 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -95.34 -29.52 14.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.481 HD21 HG21 ' B' ' 161' ' ' VAL . 1.5 p-10 -170.37 -179.49 3.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.557 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.599 HG12 HG23 ' B' ' 160' ' ' ILE . 21.0 mt -153.93 164.45 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.971 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.708 HG21 ' HA ' ' A' ' 24' ' ' LEU . 25.8 t -130.6 133.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.24 169.74 15.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.289 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 28.1 p -122.48 144.19 49.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.303 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' B' ' 136' ' ' SER . 47.8 t -136.08 142.4 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.365 -0.835 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' B' ' 120' ' ' LYS . 1.3 m -123.99 132.75 53.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.729 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.997 HD22 ' HB1' ' B' ' 150' ' ' ALA . 11.7 mt -100.42 -26.09 13.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 109.963 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 51.78 39.36 47.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 79' ' ' ARG . 89.0 m -134.67 -0.22 2.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.938 ' O ' HD23 ' B' ' 80' ' ' LEU . 4.9 mmm180 59.77 139.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.026 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.938 HD23 ' O ' ' B' ' 79' ' ' ARG . 24.1 mt -139.54 151.01 45.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.961 -1.087 . . . . 0.0 110.6 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' B' ' 81' ' ' ASP . 2.0 m-20 -89.83 89.25 7.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.84 HD22 HG23 ' B' ' 102' ' ' VAL . 32.3 mt -40.84 -43.07 1.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 110.689 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -54.59 -47.21 73.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.638 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.401 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 12.0 p -80.44 -40.87 25.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.713 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.405 HG12 HG11 ' B' ' 102' ' ' VAL . 55.9 t -52.56 -42.87 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.124 -0.985 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.28 -23.53 40.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.067 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.91 -27.26 43.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.368 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -100.43 -38.92 8.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.479 ' HB1' ' SD ' ' B' ' 104' ' ' MET . . . -53.21 134.27 39.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.204 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -73.96 -22.9 59.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.444 ' O ' ' SD ' ' B' ' 104' ' ' MET . 1.4 m120 -134.79 79.52 1.8 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.829 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 1.006 ' HB2' ' SD ' ' B' ' 104' ' ' MET . . . -150.43 162.42 40.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -143.07 171.87 13.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.004 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.28 104.68 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.11 112.84 59.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.56 -17.48 23.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.911 1.479 . . . . 0.0 110.619 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -82.22 -17.7 45.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.158 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -55.55 2.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 1.124 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -160.41 -164.65 1.29 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 111.397 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.38 54.39 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.935 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.124 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -143.9 167.45 22.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 110.382 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.84 HG23 HD22 ' B' ' 82' ' ' LEU . 49.7 t -100.58 139.91 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 110.159 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.527 ' N ' HD12 ' B' ' 103' ' ' ILE . 4.8 mp -106.52 113.43 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' MET . . . . . 1.006 ' SD ' ' HB2' ' B' ' 92' ' ' ALA . 21.0 tpp -104.65 162.07 13.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 110.224 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.42 131.65 11.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.566 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 7.4 pt -125.8 169.68 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' B' ' 108' ' ' GLU . 1.1 mtt180 -115.16 22.61 13.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' B' ' 107' ' ' ARG . 3.1 mt-10 -166.1 93.14 0.81 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.455 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.697 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.5 Cg_endo -75.22 159.57 97.59 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.818 -2.159 . . . . 0.0 110.423 -0.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.49 ' C ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -65.84 98.21 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.917 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.49 HG23 ' C ' ' B' ' 110' ' ' LYS . 38.3 p -153.17 -179.29 7.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.853 . . . . 0.0 110.113 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.704 HG22 ' HB3' ' A' ' 27' ' ' ASN . 15.1 t -134.38 162.47 32.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.102 -0.999 . . . . 0.0 110.062 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -161.51 156.76 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.913 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.742 HD12 ' HE1' ' B' ' 116' ' ' PHE . 0.3 OUTLIER -132.05 115.12 15.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.522 -0.736 . . . . 0.0 109.422 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' B' ' 102' ' ' VAL . 50.6 mt -90.77 137.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.867 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.742 ' HE1' HD12 ' B' ' 114' ' ' LEU . 2.6 m-30 -90.53 -171.04 2.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.347 -0.846 . . . . 0.0 109.515 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.485 ' O ' ' HD2' ' B' ' 79' ' ' ARG . . . -93.01 -10.25 36.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.52 -28.55 18.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.466 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 135.19 -38.65 1.78 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 120' ' ' LYS . . . . . 0.517 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 5.0 tttt -61.24 139.83 58.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 110.139 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.442 ' HG3' ' HB ' ' B' ' 74' ' ' VAL . 3.7 ptt? -144.69 157.13 44.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 71' ' ' VAL . 31.3 t -104.37 154.01 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.438 HG23 ' C ' ' B' ' 122' ' ' VAL . 7.5 t -147.27 101.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 110.711 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.679 HG21 HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -104.92 179.88 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 0.0 109.001 178.599 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.592 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 98.46 -29.74 10.91 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.53 ' CB ' ' OG ' ' B' ' 132' ' ' SER . . . -48.19 131.62 16.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 109.991 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' B' ' 128' ' ' SER . 0.2 OUTLIER -101.09 13.67 34.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.382 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' B' ' 127' ' ' LYS . 0.3 OUTLIER 178.93 -169.67 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -74.21 -45.92 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.57 -27.03 64.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.68 -45.82 85.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.269 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 132' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 39.2 m -65.2 -48.52 73.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 133' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 10.8 ttpp -53.37 -41.28 65.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 110.47 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' B' ' 138' ' ' LYS . 0.7 OUTLIER -77.63 -43.76 30.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 110.444 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.697 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -64.38 -36.75 85.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.277 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.458 ' HB2' HG21 ' B' ' 74' ' ' VAL . 11.8 p -68.78 -59.93 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.121 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' B' ' 137' ' ' ARG . 8.5 ptm85 -51.82 -26.41 9.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.896 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -67.1 -48.55 67.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.657 ' HA ' HD12 ' B' ' 142' ' ' ILE . 35.7 m-85 -62.56 -47.3 84.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 140' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -55.6 -28.36 54.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.91 . . . . 0.0 109.69 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -70.95 -51.57 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 110.003 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' B' ' 139' ' ' TYR . 6.4 mt -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.045 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.705 HG22 ' HB2' ' B' ' 148' ' ' PHE . 49.3 mm -73.64 -53.77 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.82 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 28.0 mt-30 -64.72 -29.95 70.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 109.989 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -74.09 -22.61 59.44 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 142' ' ' ILE . 4.2 mt -81.04 -22.16 10.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.94 4.85 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.705 ' HB2' HG22 ' B' ' 143' ' ' ILE . 24.2 m-85 -63.99 175.02 1.3 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.007 -1.29 . . . . 0.0 111.416 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.15 24.32 11.77 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.458 0.647 . . . . 0.0 109.679 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.997 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -46.24 150.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 110.598 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -124.44 101.53 7.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 110.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.434 ' O ' HG23 ' B' ' 153' ' ' THR . 23.6 t80 -57.95 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.304 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.9 OUTLIER -151.74 173.09 15.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 110.395 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' B' ' 153' ' ' THR . 0.1 OUTLIER 65.39 21.46 11.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.341 -0.849 . . . . 0.0 110.436 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -65.67 135.13 54.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.989 . . . . 0.0 110.09 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -166.04 136.71 3.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 110.35 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 7.3 mt -79.04 154.23 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.897 . . . . 0.0 109.653 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -137.06 -23.8 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.005 -1.059 . . . . 0.0 111.63 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' B' ' 217' ' ' ALA . 13.7 t-20 -149.51 122.19 8.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.712 -1.243 . . . . 0.0 111.523 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.599 HG23 HG12 ' B' ' 70' ' ' ILE . 84.8 mt -106.92 144.89 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 108.903 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.481 HG21 HD21 ' B' ' 69' ' ' ASN . 48.6 t -118.06 142.5 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.827 -1.17 . . . . 0.0 111.435 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -139.72 162.03 26.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 54.5 p -161.2 143.93 12.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.314 . . . . 0.0 110.676 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.5 OUTLIER -170.36 171.72 6.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.374 -0.829 . . . . 0.0 110.144 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.455 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 0.8 OUTLIER -114.83 131.53 56.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.042 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.709 HG23 ' H ' ' B' ' 167' ' ' LYS . 5.1 m -67.62 -61.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.121 -0.987 . . . . 0.0 110.957 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.709 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 169.59 -31.42 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.033 . . . . 0.0 110.441 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 17.0 p90 -134.34 165.78 34.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.2 Cg_endo -71.81 147.39 50.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.975 1.513 . . . . 0.0 110.26 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.641 HD12 ' HA2' ' B' ' 210' ' ' GLY . 4.1 mt -110.49 152.91 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -93.8 105.18 17.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.695 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.446 ' N ' HD23 ' B' ' 172' ' ' LEU . 8.5 mt -63.37 -43.95 96.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 110.615 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.4 -49.62 75.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 110.424 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -62.0 -38.07 95.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -74.37 -36.73 63.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -1.168 . . . . 0.0 110.451 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.64 67.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.271 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -92.39 -42.3 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.052 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 178' ' ' SER . . . . . 0.414 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -63.36 -52.78 60.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -115.38 40.2 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.098 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.6 -19.8 49.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.0 m -58.03 -35.85 71.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -1.162 . . . . 0.0 110.257 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.858 ' CE1' HG22 ' B' ' 198' ' ' VAL . 44.1 m-85 -125.19 12.15 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.51 ' HB3' HD21 ' B' ' 193' ' ' LEU . 50.6 m -114.72 143.91 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 0.0 110.226 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.09 114.2 16.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 110.25 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -125.7 91.42 3.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.93 113.98 60.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.25 5.04 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.908 1.478 . . . . 0.0 110.937 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.87 -9.19 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.025 . . . . 0.0 110.248 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.579 ' C ' HD23 ' B' ' 189' ' ' LEU . 3.8 tt -152.51 -40.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.682 ' CE2' HD13 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -117.76 107.81 43.81 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.405 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.61 -23.69 19.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.029 1.542 . . . . 0.0 110.279 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.23 177.87 39.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' B' ' 183' ' ' SER . 7.4 tt -108.05 128.42 54.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.166 . . . . 0.0 110.402 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.543 ' HA ' HD23 ' B' ' 205' ' ' LEU . 22.2 mt -101.72 108.04 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.49 ' CD2' HD13 ' B' ' 230' ' ' ILE . 17.0 t80 -95.77 113.1 24.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.236 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.417 ' CB ' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -90.6 88.29 7.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.445 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 22.9 ttm -59.28 139.11 57.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 110.161 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.858 HG22 ' CE1' ' B' ' 182' ' ' PHE . 3.0 t -77.3 -46.09 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 109.949 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' B' ' 199' ' ' LYS . 34.2 pttt -142.21 118.56 7.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 0.0 109.863 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.4 Cg_endo -73.32 145.99 85.68 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.971 -2.096 . . . . 0.0 110.513 0.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.496 ' O ' HD13 ' B' ' 202' ' ' ILE . 1.4 tptm -57.34 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.115 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' B' ' 217' ' ' ALA . 42.5 mm -138.34 165.16 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.581 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.461 ' N ' HG22 ' B' ' 202' ' ' ILE . 45.1 t -121.91 125.24 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 1.101 HD21 ' HB1' ' B' ' 226' ' ' ALA . 1.6 mp -121.94 140.5 52.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.508 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' B' ' 194' ' ' ILE . 12.5 mt -103.96 156.0 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.854 . . . . 0.0 109.952 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.704 HG12 HD21 ' B' ' 234' ' ' LEU . 2.8 mt -140.05 105.69 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -97.62 152.05 19.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 62.0 t -49.23 -34.11 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 97.5 p -55.66 -31.85 62.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 110.1 12.86 16.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.455 ' HG3' ' OD1' ' B' ' 165' ' ' ASP . 29.1 tttt -89.7 131.86 35.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.029 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' B' ' 206' ' ' ILE . 34.1 mm -118.12 122.14 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.749 HG11 ' HE1' ' A' ' 25' ' ' PHE . 16.1 t -92.39 154.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.435 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.2 mp -143.17 100.95 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.979 . . . . 0.0 110.716 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 0.9 OUTLIER -136.84 170.72 15.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.204 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 216' ' ' GLY . . . . . 0.515 ' HA2' ' ND2' ' B' ' 159' ' ' ASN . . . 92.28 13.33 57.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -98.48 157.15 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -1.131 . . . . 0.0 110.297 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -36.58 13.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.28 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.51 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.1 OUTLIER -128.86 -158.8 0.91 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 110.165 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -97.08 -22.52 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.48 -38.04 82.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.52 -48.82 65.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 23.9 mm -52.79 -41.64 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.628 ' CZ ' ' CG1' ' B' ' 64' ' ' VAL . 3.8 m-85 -70.51 -28.15 64.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -45.53 21.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 1.101 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -56.21 -35.16 67.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.354 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.532 ' HA ' HG22 ' B' ' 230' ' ' ILE . 21.5 t80 -72.47 -49.69 31.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -18.63 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.29 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.16 -28.41 17.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 110.079 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' B' ' 227' ' ' PHE . 7.4 tp -99.59 -16.32 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 110.161 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.621 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 3.9 t80 -55.92 -43.25 99.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.9 Cg_endo -74.21 -31.24 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.449 1.237 . . . . 0.0 110.255 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' B' ' 175' ' ' LEU . 8.8 t -67.36 -43.84 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.707 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.704 HD21 HG12 ' B' ' 206' ' ' ILE . 71.2 mt -58.46 -44.24 89.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.967 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -28.02 67.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.151 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -74.31 -24.41 59.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.113 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.582 ' HB2' HD23 ' B' ' 175' ' ' LEU . 86.8 m-85 -125.12 45.57 2.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -63.26 -162.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -42.45 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 110.145 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.216 179.871 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.08 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.716 ' N ' HD12 ' A' ' 18' ' ' LEU . 55.6 t0 -90.01 89.26 7.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 111.018 -178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.08 HD21 HD21 ' A' ' 18' ' ' LEU . 2.4 mt -87.93 -5.4 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.042 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.663 ' N ' HD23 ' A' ' 68' ' ' LEU . 96.0 m -39.38 -38.85 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.292 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -91.59 -32.34 8.74 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.734 HG12 HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -51.25 -44.28 30.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.198 -1.178 . . . . 0.0 109.46 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.94 ' HA ' HG21 ' B' ' 71' ' ' VAL . 1.6 pp -83.02 -25.98 31.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.892 -1.13 . . . . 0.0 109.417 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.799 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.9 t80 -87.22 0.4 55.42 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.723 0.773 . . . . 0.0 109.101 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 150.1 98.68 0.19 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.84 ' HB2' HG22 ' B' ' 112' ' ' THR . 8.3 p-10 -21.99 119.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.095 0.95 . . . . 0.0 112.849 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.734 HG23 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -130.21 165.47 30.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.535 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 28' ' ' ILE . 77.2 m-20 -86.18 125.95 33.89 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.959 ' HB2' HD13 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -39.47 -24.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 -178.484 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.648 ' HG3' HD13 ' B' ' 103' ' ' ILE . 65.0 mt-10 -64.61 -4.91 4.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.018 . . . . 0.0 111.142 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.55 38.07 4.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.525 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.8 tpp180 -126.54 130.08 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -1.142 . . . . 0.0 109.511 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.716 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -89.01 158.69 17.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.589 -1.32 . . . . 0.0 111.429 -179.046 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.52 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.611 0.72 . . . . 0.0 111.504 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.189 0.519 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -95.45 -32.93 12.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 0.0 108.631 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.53 HD13 ' CE1' ' A' ' 25' ' ' PHE . 1.7 mt -88.87 -34.62 16.93 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.08 -49.51 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.38 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.0 -29.53 68.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.593 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.501 ' OD1' ' HD2' ' B' ' 191' ' ' PRO . 20.8 m-80 -76.28 -41.06 50.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.613 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 53' ' ' ARG . 45.7 mt -49.96 -47.08 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.58 0.52 60.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.51 -41.73 3.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -86.57 36.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.13 -0.981 . . . . 0.0 110.458 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -80.21 17.12 1.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.112 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.556 ' HE2' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -152.99 11.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 -179.697 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.851 HD11 ' CD2' ' B' ' 189' ' ' LEU . 3.5 mt -90.32 -26.07 20.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.744 -1.223 . . . . 0.0 109.47 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.54 -38.71 0.04 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.724 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.7 mm? -62.93 -12.14 23.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 110.537 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -48.03 -41.1 24.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.981 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -42.75 76.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.568 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -81.86 -1.92 49.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.995 179.739 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.763 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.8 tm? -82.29 -47.2 12.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.413 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -90.26 0.28 57.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 110.176 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.505 ' C ' HG23 ' A' ' 71' ' ' VAL . 3.1 tt0 -90.9 15.85 10.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.322 -0.861 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.643 ' HB ' HD12 ' A' ' 20' ' ' LEU . 45.0 t -145.67 5.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.328 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.951 ' CD1' HD23 ' A' ' 18' ' ' LEU . 4.0 tp -150.52 77.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.881 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.6 t70 -84.29 49.3 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.016 -1.053 . . . . 0.0 108.523 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.912 HD13 ' CG1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.319 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.215 0.531 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.531 ' CG1' ' HD2' ' B' ' 65' ' ' PRO . 15.5 t -57.9 145.51 71.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.006 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.617 ' CG ' HG22 ' B' ' 223' ' ' ILE . 44.1 Cg_endo -71.69 138.43 31.94 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.806 1.424 . . . . 0.0 110.377 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.472 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 72.8 m -105.17 135.19 46.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -75.03 122.04 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.91 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -113.38 -3.66 13.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.649 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.4 142.47 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 110.574 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.541 ' CD1' HG23 ' B' ' 160' ' ' ILE . 13.3 mm -126.99 161.16 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.355 -0.841 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.94 HG21 ' HA ' ' A' ' 24' ' ' LEU . 47.8 t -141.74 121.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.126 -0.984 . . . . 0.0 110.233 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 157' ' ' ILE . . . -134.9 168.5 18.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 73' ' ' THR . . . . . 0.774 HG23 HG22 ' B' ' 122' ' ' VAL . 0.2 OUTLIER -124.71 153.5 42.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 53.2 t -143.91 155.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 110.303 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 9.1 m -124.72 133.13 53.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.842 HD22 ' HB1' ' B' ' 150' ' ' ALA . 67.6 mt -87.56 -65.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.88 -20.83 2.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 40.6 m -135.18 143.78 46.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.247 . . . . 0.0 110.471 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.504 ' O ' HD23 ' B' ' 80' ' ' LEU . 7.3 ptm85 -59.54 163.37 4.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.913 . . . . 0.0 109.816 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.681 HD11 HD12 ' B' ' 76' ' ' LEU . 25.6 mt -131.43 153.6 49.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 42.3 t0 -89.64 89.02 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.495 HD11 ' O ' ' B' ' 100' ' ' ALA . 15.1 mt -38.52 -36.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 110.666 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -66.18 -42.51 88.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.44 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 16.0 m -79.34 -25.73 42.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.159 -0.963 . . . . 0.0 110.543 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.478 HG12 HG11 ' B' ' 102' ' ' VAL . 22.9 t -75.26 -40.39 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.13 -21.19 43.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.1 tp -88.9 -18.49 27.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -100.03 -41.13 7.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 110.362 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.48 140.42 58.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.855 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -77.55 -14.43 59.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.096 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.427 ' HB3' ' HG2' ' B' ' 105' ' ' ARG . 8.6 m-20 -137.7 79.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -162.02 154.0 19.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.286 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -143.34 155.63 44.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -119.3 135.74 54.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -148.83 101.57 3.43 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.178 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.87 -16.19 26.2 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.044 1.549 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -72.66 -6.58 45.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -123.95 -65.72 1.04 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 110.377 -179.814 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -146.86 133.18 19.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.365 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.495 ' O ' HD11 ' B' ' 82' ' ' LEU . . . -60.62 57.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.989 -177.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.905 ' HB1' ' O ' ' B' ' 115' ' ' ILE . . . -152.48 169.02 23.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.872 -1.142 . . . . 0.0 111.159 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' B' ' 82' ' ' LEU . 17.2 t -102.23 130.39 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.609 -0.682 . . . . 0.0 109.303 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.648 HD13 ' HG3' ' A' ' 31' ' ' GLU . 2.4 mp -89.3 118.29 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 110.2 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 27.2 ttm -104.16 164.62 11.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 110.236 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.508 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 9.0 ptm180 -156.03 122.41 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.818 HG23 ' CE1' ' B' ' 139' ' ' TYR . 10.4 pt -108.68 151.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.509 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 23.77 8.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 109.931 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.0 OUTLIER -175.9 94.92 0.26 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.88 . . . . 0.0 110.114 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 46.4 Cg_endo -72.8 162.22 91.72 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.546 0.146 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.412 ' C ' HG23 ' B' ' 111' ' ' THR . 6.6 tppt? -71.5 89.83 0.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 109.918 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' B' ' 124' ' ' THR . 21.9 p -145.32 -179.83 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.293 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.84 HG22 ' HB2' ' A' ' 27' ' ' ASN . 6.1 t -133.69 176.06 8.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -170.5 177.58 3.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.04 . . . . 0.0 111.049 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.68 HD12 ' CE1' ' B' ' 116' ' ' PHE . 0.3 OUTLIER -145.7 123.44 11.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.432 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.905 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 18.0 mt -94.04 134.55 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.935 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.773 ' CZ ' HD12 ' A' ' 72' ' ' ILE . 8.3 m-85 -87.41 134.21 33.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.611 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' B' ' 82' ' ' LEU . . . -52.24 -19.69 2.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 55.0 m -79.41 -29.6 42.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.256 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.09 -31.28 2.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.42 163.3 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.225 -1.162 . . . . 0.0 110.135 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.417 ' SD ' ' CG2' ' B' ' 123' ' ' VAL . 8.1 tmm? -160.89 128.18 4.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.774 HG22 HG23 ' B' ' 73' ' ' THR . 22.6 t -107.94 154.64 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.442 HG23 ' C ' ' B' ' 122' ' ' VAL . 25.7 t -146.37 131.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.469 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.617 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -139.04 167.01 23.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.337 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.578 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 117.36 -37.48 3.31 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -53.52 173.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -1.086 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.507 ' HA ' HG12 ' B' ' 70' ' ' ILE . 8.5 mtmm -135.34 5.8 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -147.23 163.18 37.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 129' ' ' GLU . . . . . 0.536 ' HG2' ' CD1' ' B' ' 157' ' ' ILE . 3.8 mt-10 -57.73 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.173 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' B' ' 133' ' ' LYS . 0.4 OUTLIER -47.92 -36.17 11.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.847 . . . . 0.0 110.345 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' B' ' 128' ' ' SER . 9.3 t0 -53.89 -49.57 68.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.128 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 57.0 m -56.23 -42.04 76.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 133' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' B' ' 137' ' ' ARG . 3.7 mttt -53.86 -38.43 64.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 1.4 mt -66.25 -41.1 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.133 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.59 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -51.53 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' B' ' 133' ' ' LYS . 0.2 OUTLIER -53.41 -37.43 62.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.924 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' B' ' 134' ' ' LEU . 4.8 mmtt -68.15 -50.78 52.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.898 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.818 ' CE1' HG23 ' B' ' 106' ' ' ILE . 28.2 m-85 -52.75 -54.18 37.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.941 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.63 58.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.49 -46.25 55.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 57.0 mt -51.69 -41.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' B' ' 148' ' ' PHE . 23.5 mm -64.37 -49.95 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.531 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.75 -31.45 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.376 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 2.7 tmtt? -74.23 -21.17 59.91 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 5.4 mt -84.58 -17.13 10.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.97 -21.88 9.33 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.672 ' HB2' HG22 ' B' ' 143' ' ' ILE . 15.3 m-85 -53.94 174.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 110.958 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.65 36.56 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.515 -0.74 . . . . 0.0 110.193 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.842 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -71.06 144.47 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.451 ' O ' ' OG1' ' B' ' 153' ' ' THR . 4.2 tttp -128.74 104.52 7.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.459 ' O ' HG23 ' B' ' 153' ' ' THR . 54.9 t80 -53.41 102.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 110.319 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.459 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.6 OUTLIER -154.09 172.09 18.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.164 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.0 33.61 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -72.35 138.22 47.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -161.74 136.14 6.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.536 ' CD1' ' HG2' ' B' ' 129' ' ' GLU . 37.2 mt -80.23 140.77 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.853 . . . . 0.0 110.139 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -92.77 -61.76 1.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.425 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -145.75 168.77 19.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.568 HD12 ' O ' ' B' ' 219' ' ' GLN . 67.1 mt -119.54 144.4 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 12.4 t -112.0 121.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -132.64 172.28 21.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 28.3 t -166.1 161.16 16.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.173 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.452 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 29.5 p -167.88 139.5 2.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -92.69 161.69 14.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.1 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.489 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.0 OUTLIER -110.94 -81.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.182 -0.948 . . . . 0.0 110.198 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 6.1 mtpt 170.01 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 0.0 110.407 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' B' ' 168' ' ' PHE . 10.5 p90 -129.56 155.99 79.37 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.201 -0.937 . . . . 0.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 44.6 Cg_endo -71.45 161.27 46.07 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.859 1.452 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 1.7 mp -126.93 149.67 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.154 -0.967 . . . . 0.0 110.663 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.46 110.59 19.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.848 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' B' ' 193' ' ' LEU . 11.9 mt -65.61 -32.21 73.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 110.612 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.13 -28.96 67.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 110.175 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.79 65.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' B' ' 175' ' ' LEU . 0.2 OUTLIER -71.41 -45.46 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 110.227 179.898 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.53 -13.63 62.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -90.31 -32.45 16.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 178' ' ' SER . . . . . 0.508 ' OG ' ' ND1' ' B' ' 179' ' ' HIS . 37.6 p -98.27 -30.53 12.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.907 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.508 ' ND1' ' OG ' ' B' ' 178' ' ' SER . 76.1 m80 -123.94 44.38 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -65.34 -27.68 72.72 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 2.2 t -54.16 -26.22 26.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.151 . . . . 0.0 110.221 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.565 ' CE2' ' CG2' ' B' ' 198' ' ' VAL . 31.4 m-85 -136.17 8.77 3.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.895 . . . . 0.0 110.196 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.718 ' OG ' HD21 ' B' ' 193' ' ' LEU . 22.9 t -110.96 120.72 43.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.969 . . . . 0.0 110.632 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 40.2 t -111.55 103.98 12.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.53 105.9 15.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' B' ' 190' ' ' PHE . 1.6 mm-40 -113.62 99.19 49.23 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.946 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.19 -4.66 15.35 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.052 1.554 . . . . 0.0 110.49 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.13 -13.02 19.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.952 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.851 ' CD2' HD11 ' A' ' 62' ' ' LEU . 2.4 tt -146.43 11.2 1.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 110.263 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.617 ' CE2' ' CG1' ' B' ' 194' ' ' ILE . 2.2 t80 -166.2 112.6 0.74 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 191' ' ' PRO . . . . . 0.501 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.7 Cg_endo -74.43 -26.89 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.898 1.472 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.99 178.28 37.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.718 HD21 ' OG ' ' B' ' 183' ' ' SER . 8.3 tt -110.6 132.82 53.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -1.103 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.617 ' CG1' ' CE2' ' B' ' 190' ' ' PHE . 93.8 mt -100.46 118.39 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -120.85 128.95 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' B' ' 203' ' ' VAL . 7.6 mtp-105 -108.42 89.38 2.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.483 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 32.9 ttm -50.74 141.13 13.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.075 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.565 ' CG2' ' CE2' ' B' ' 182' ' ' PHE . 31.3 t -71.35 -59.27 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 20.5 tttp -127.13 117.18 21.84 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.952 . . . . 0.0 110.304 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.6 Cg_endo -74.08 156.46 99.72 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.92 -2.117 . . . . 0.0 110.277 -0.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 85.43 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.978 . . . . 0.0 110.106 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' B' ' 217' ' ' ALA . 25.3 mm -130.27 163.07 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' B' ' 196' ' ' ARG . 12.6 t -109.57 120.38 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.863 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.5 mp -114.76 124.49 51.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.161 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.799 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 1.8 mt -102.63 148.67 25.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.57 HG23 ' CD1' ' B' ' 212' ' ' ILE . 4.1 mp -139.56 127.16 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.327 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.509 ' HZ ' HD21 ' A' ' 52' ' ' LEU . 26.0 m-85 -105.13 155.61 18.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 72.6 t -51.33 -24.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 0.0 110.306 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -24.32 62.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 110.421 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 107.54 24.92 6.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.0 OUTLIER -91.15 126.18 36.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -1.114 . . . . 0.0 110.204 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.57 ' CD1' HG23 ' B' ' 206' ' ' ILE . 23.8 mm -114.37 116.17 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.507 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 29.0 t -107.61 143.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.063 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.594 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.1 mp -135.58 112.36 10.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 13.2 t -135.95 153.68 51.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.15 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.05 -5.59 34.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.621 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -81.99 127.47 33.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -1.194 . . . . 0.0 110.051 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -71.19 -38.61 72.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 110.432 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.568 ' O ' HD12 ' B' ' 160' ' ' ILE . 3.7 mt-30 -117.69 -173.01 2.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.274 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 220' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 35.5 ttp180 -88.48 -24.66 22.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.277 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.503 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 3.4 pt-20 -63.96 -22.47 66.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.21 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.621 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 33.2 mt-10 -76.39 -53.75 7.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 110.07 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.617 HG22 ' CG ' ' B' ' 65' ' ' PRO . 27.8 mm -56.59 -37.7 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 110.035 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.571 ' CE1' ' HG2' ' B' ' 220' ' ' ARG . 5.5 m-85 -66.11 -40.54 90.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 110.134 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -80.02 -22.48 42.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.872 . . . . 0.0 110.087 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.863 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -67.68 -47.49 69.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.747 ' HA ' HG22 ' B' ' 230' ' ' ILE . 19.6 t80 -76.92 -34.21 57.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 228' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' B' ' 224' ' ' TYR . 35.9 mm-40 -65.68 -18.48 65.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.213 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.443 ' HB3' ' SD ' ' B' ' 197' ' ' MET . . . -97.04 -25.91 15.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.065 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' B' ' 227' ' ' PHE . 2.9 tp -96.21 -11.3 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.05 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 2.4 t80 -53.89 -44.03 97.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.72 -43.74 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.468 1.246 . . . . 0.0 110.68 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.413 HG12 HD21 ' B' ' 175' ' ' LEU . 30.5 t -56.92 -36.51 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.455 HD21 HG12 ' B' ' 206' ' ' ILE . 20.2 mt -63.44 -62.13 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 43.1 m -53.79 -20.31 5.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.512 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 236' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 233' ' ' VAL . 2.0 tt0 -67.69 -40.25 84.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.452 -0.78 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -116.14 41.68 2.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 110.516 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -168.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.145 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -141.35 -41.38 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 30.2 mtp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.18 179.852 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.035 HD23 HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.522 ' HA ' HD11 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -100.55 128.07 46.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.764 -179.481 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.839 HD11 ' HB ' ' A' ' 72' ' ' ILE . 43.4 mt -123.92 22.69 8.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.54 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.642 ' OG1' HD23 ' A' ' 68' ' ' LEU . 6.4 m -43.7 -37.41 2.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.49 -32.02 5.89 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.674 HG12 HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -46.62 -41.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.392 -1.064 . . . . 0.0 108.644 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.869 HD22 ' HG2' ' A' ' 67' ' ' MET . 3.1 pp -84.29 -26.22 28.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.033 -1.042 . . . . 0.0 108.539 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.704 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.7 t80 -85.85 7.03 25.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 142.23 99.66 0.35 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.218 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.723 ' ND2' HD12 ' A' ' 35' ' ' LEU . 6.4 p-10 -20.84 115.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.912 0.863 . . . . 0.0 112.357 -178.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.676 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -136.42 158.81 38.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.568 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 31' ' ' GLU . 4.4 m-20 -88.12 123.57 32.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.605 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . 17.3 p -39.41 -26.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.588 -0.695 . . . . 0.0 110.145 -178.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.0 mt-10 -55.9 -14.32 2.38 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.65 26.56 6.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 28' ' ' ILE . 11.7 mmt-85 -116.55 123.88 48.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -1.149 . . . . 0.0 109.501 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.676 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.39 160.95 16.56 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 111.163 -178.954 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.723 HD12 ' ND2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 0.0 111.272 -178.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.237 0.541 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.65 -20.31 15.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.107 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 52' ' ' LEU . 3.5 mt -96.31 -43.78 7.53 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.702 . . . . 0.0 110.303 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.029 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.6 -52.96 34.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.577 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.13 -27.24 67.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.429 -0.794 . . . . 0.0 109.559 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.568 ' OD1' ' CD1' ' B' ' 190' ' ' PHE . 1.6 m-80 -77.8 -31.62 51.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.195 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.029 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -56.81 -47.41 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.386 -0.821 . . . . 0.0 109.195 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.54 -25.95 14.75 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB2' HD11 ' B' ' 189' ' ' LEU . 0.8 OUTLIER -124.03 25.63 7.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -1.114 . . . . 0.0 110.136 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 56' ' ' ILE . 2.6 mt -82.08 -21.2 36.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.891 . . . . 0.0 110.069 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.47 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.41 40.36 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 110.548 -179.817 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' HD13 ' A' ' 62' ' ' LEU . 3.4 ttpp -132.81 -4.61 3.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.957 . . . . 0.0 110.521 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -129.39 -2.96 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 111.331 -179.752 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.783 ' N ' HD22 ' A' ' 62' ' ' LEU . . . 168.8 -55.43 0.21 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 4.0 mm? -42.92 -24.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -1.205 . . . . 0.0 110.933 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t70 -44.05 -41.96 5.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 109.716 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.9 m -67.23 -51.19 56.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.435 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.869 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -71.12 -4.47 25.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 178.86 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.663 ' C ' HD13 ' A' ' 68' ' ' LEU . 1.8 tm? -72.32 -62.09 1.56 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.858 0.837 . . . . 0.0 109.032 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.7 0.69 12.18 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.24 0.543 . . . . 0.0 110.298 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 37.3 tt0 -84.36 8.12 17.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 111.196 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.951 HG12 HG11 ' B' ' 122' ' ' VAL . 6.0 t -140.69 2.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.121 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.035 HD13 HD23 ' A' ' 18' ' ' LEU . 3.1 tp -151.01 81.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.78 . . . . 0.0 109.232 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 8.6 t0 -83.98 49.78 1.7 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.095 -1.003 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.974 HD11 ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.343 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.569 HD13 ' CE2' ' B' ' 231' ' ' TYR . 1.3 mp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.011 0.434 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 90.3 t 58.61 125.13 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 110.583 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.7 Cg_endo -74.43 144.05 31.93 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.825 1.434 . . . . 0.0 110.589 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -107.19 129.76 54.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.532 HD22 ' CG2' ' B' ' 160' ' ' ILE . 73.4 mt -69.66 127.1 31.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' B' ' 68' ' ' GLN . 5.6 mm-40 -106.25 -20.28 13.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.441 ' HB2' ' HB ' ' B' ' 161' ' ' VAL . 43.3 m-20 -161.42 137.02 7.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.074 -1.016 . . . . 0.0 110.567 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 13.1 mm -115.73 148.39 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.917 HG22 ' CB ' ' B' ' 124' ' ' THR . 27.6 t -137.89 129.18 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.505 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.58 155.55 46.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 65.0 p -111.34 139.26 46.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.182 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.476 ' HB ' ' CG ' ' B' ' 121' ' ' MET . 22.6 t -123.9 148.78 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.837 . . . . 0.0 110.13 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' B' ' 154' ' ' ASP . 4.7 m -119.06 127.52 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.977 HD22 ' HB1' ' B' ' 150' ' ' ALA . 70.2 mt -92.02 -42.94 9.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.004 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.72 68.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 52.9 m -132.84 151.14 52.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -1.198 . . . . 0.0 110.365 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.523 ' O ' HD23 ' B' ' 80' ' ' LEU . 39.2 mtp-105 -79.32 155.2 28.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 110.075 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.523 HD23 ' O ' ' B' ' 79' ' ' ARG . 18.7 mt -127.74 161.0 29.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 8.6 m-20 -94.63 82.11 3.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.81 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.727 ' CD1' ' HB2' ' B' ' 117' ' ' ALA . 92.6 mt -42.01 -27.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.241 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' B' ' 81' ' ' ASP . 18.9 mmmt -67.01 -44.99 78.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 10.9 p -85.41 -38.5 18.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.871 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 43.3 t -52.36 -44.61 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' B' ' 102' ' ' VAL . . . -77.81 -30.36 51.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' B' ' 87' ' ' LEU . 14.1 tp -80.53 -18.9 47.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' B' ' 84' ' ' THR . 1.2 m-70 -99.91 -32.87 10.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.338 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 150.48 45.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -87.15 -26.13 23.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' B' ' 104' ' ' MET . 90.6 m-20 -127.74 78.82 1.85 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.541 ' HB1' ' CG1' ' B' ' 102' ' ' VAL . . . -145.49 158.35 43.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 110.136 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.07 141.12 44.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.67 109.31 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 110.095 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.413 ' OD1' ' NH1' ' B' ' 98' ' ' ARG . 2.6 t-20 -129.35 128.31 23.19 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.83 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -16.16 31.79 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.842 1.443 . . . . 0.0 110.186 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.493 ' HE2' ' NH2' ' B' ' 98' ' ' ARG . 7.3 tttt -86.32 -16.92 35.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.86 . . . . 0.0 110.066 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.493 ' NH2' ' HE2' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -92.21 -67.0 0.88 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.486 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 1.18 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.08 161.67 8.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.288 -0.883 . . . . 0.0 111.225 -179.389 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.83 54.06 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.532 -0.73 . . . . 0.0 111.677 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.18 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -161.85 173.27 14.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.941 -1.099 . . . . 0.0 110.258 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.541 ' CG1' ' HB1' ' B' ' 92' ' ' ALA . 38.0 t -108.06 155.82 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.477 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.519 HD11 ' OG ' ' A' ' 30' ' ' SER . 16.1 mt -113.51 110.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' B' ' 91' ' ' ASN . 12.0 ttm -94.19 151.07 19.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.624 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -149.56 120.88 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.677 HG23 ' CE1' ' B' ' 139' ' ' TYR . 25.1 pt -107.57 156.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.116 -0.99 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -106.88 37.81 2.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.847 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER -175.63 82.19 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.592 -179.78 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.474 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.0 Cg_endo -80.64 161.49 83.41 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.801 -2.166 . . . . 0.0 110.472 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -64.24 104.74 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 109.995 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.435 HG23 ' C ' ' B' ' 110' ' ' LYS . 30.5 p -146.63 166.1 27.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.66 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' B' ' 113' ' ' ALA . 1.8 m -112.52 164.8 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -167.2 146.07 5.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.524 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.886 HD12 ' CE1' ' B' ' 116' ' ' PHE . 0.2 OUTLIER -124.28 119.4 29.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.726 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.566 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 78.6 mt -95.41 131.46 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.974 ' CD1' HD11 ' A' ' 74' ' ' LEU . 8.5 m-30 -90.13 155.19 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.727 ' HB2' ' CD1' ' B' ' 82' ' ' LEU . . . -69.99 -11.61 61.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 110.152 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 118' ' ' SER . . . . . 0.413 ' HA ' ' HG2' ' B' ' 79' ' ' ARG . 3.9 m -85.7 -40.48 16.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.27 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.633 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 148.06 -34.79 1.2 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -67.8 150.19 48.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -1.218 . . . . 0.0 110.508 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.476 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -150.14 159.3 44.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.951 HG11 HG12 ' A' ' 71' ' ' VAL . 99.0 t -124.51 137.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 88.6 t -121.89 140.95 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.868 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.917 ' CB ' HG22 ' B' ' 71' ' ' VAL . 3.9 t -145.55 160.83 41.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.444 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.577 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 114.32 -35.26 4.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.42 147.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -1.191 . . . . 0.0 110.083 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.467 ' HB2' ' OD2' ' B' ' 131' ' ' ASP . 13.1 mmtt -96.11 0.74 51.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.63 -165.19 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.39 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.13 -40.38 74.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.04 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -44.64 92.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.482 ' CB ' ' HB1' ' B' ' 126' ' ' ALA . 8.8 m-20 -56.31 -53.51 56.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 0.0 109.964 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 1.5 p -57.81 -32.5 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.848 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 133' ' ' LYS . . . . . 0.438 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -67.69 -44.69 77.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 109.999 179.691 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -59.73 2.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.043 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.13 3.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.025 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' B' ' 152' ' ' PHE . 18.4 m -65.98 -58.69 4.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.138 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -46.2 -44.03 15.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.004 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -53.29 -47.12 69.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.677 ' CE1' HG23 ' B' ' 106' ' ' ILE . 31.7 m-85 -65.62 -55.05 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 0.0 109.912 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -17.66 8.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -47.02 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 42.0 mt -52.74 -38.06 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' B' ' 150' ' ' ALA . 34.0 mm -71.7 -55.63 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.098 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.26 -27.3 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.942 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -75.54 -21.71 57.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.94 . . . . 0.0 108.613 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 5.7 mt -86.17 -21.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.27 -18.86 6.86 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.569 ' HB2' HG22 ' B' ' 143' ' ' ILE . 11.0 m-85 -53.84 165.98 0.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.286 . . . . 0.0 110.882 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.56 23.8 13.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.552 -0.717 . . . . 0.0 109.823 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.977 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -54.94 148.3 13.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.83 . . . . 0.0 110.552 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -123.35 114.77 20.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 110.04 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' B' ' 136' ' ' SER . 36.2 t80 -69.89 90.9 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 1.4 p -145.6 171.89 14.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' B' ' 75' ' ' THR . 1.1 t0 63.21 29.79 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.438 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.9 t80 -77.36 136.73 38.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.88 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 134.17 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.404 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.68 121.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.862 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -119.68 -4.33 10.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.459 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 3.3 m120 -138.29 115.3 10.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.0 . . . . 0.0 110.616 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.532 ' CG2' HD22 ' B' ' 67' ' ' LEU . 68.9 mt -122.65 125.58 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' B' ' 69' ' ' ASN . 26.0 t -100.26 130.75 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.524 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.05 169.86 24.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 2.3 m -162.89 164.53 25.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -1.147 . . . . 0.0 110.119 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.486 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.6 p -170.34 166.93 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 0.0 110.607 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.67 137.45 50.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 109.74 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.74 HG21 HD11 ' B' ' 170' ' ' ILE . 20.9 m -89.71 12.07 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.423 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.1 OUTLIER 70.82 3.63 4.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.281 -0.887 . . . . 0.0 110.711 179.662 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.61 ' O ' HG23 ' B' ' 166' ' ' VAL . 8.1 p90 -162.58 150.98 12.13 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.386 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 45.1 Cg_endo -71.84 165.66 31.87 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.998 1.525 . . . . 0.0 110.512 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.74 HD11 HG21 ' B' ' 166' ' ' VAL . 3.7 mt -133.25 158.09 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.934 . . . . 0.0 110.79 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 171' ' ' ARG . . . . . 0.493 ' HD3' ' HG3' ' B' ' 173' ' ' GLU . 3.4 ttm180 -89.3 98.81 11.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.685 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' B' ' 193' ' ' LEU . 92.6 mt -53.66 -55.24 27.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.19 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 173' ' ' GLU . . . . . 0.493 ' HG3' ' HD3' ' B' ' 171' ' ' ARG . 15.4 pt-20 -54.02 -26.54 26.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.725 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 174' ' ' GLY . . . . . 0.413 ' HA3' ' HD2' ' B' ' 171' ' ' ARG . . . -73.55 -37.14 53.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.494 ' HA ' HD13 ' B' ' 175' ' ' LEU . 0.1 OUTLIER -71.54 -44.58 64.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -1.166 . . . . 0.0 110.056 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -59.38 -38.3 80.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -65.5 -32.69 74.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -58.66 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' B' ' 183' ' ' SER . 37.3 m80 -101.74 30.38 4.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.343 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -60.1 -14.71 33.42 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -30.38 64.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -1.19 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' B' ' 198' ' ' VAL . 60.4 m-85 -119.77 0.68 10.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' B' ' 194' ' ' ILE . 0.1 OUTLIER -120.59 174.07 6.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.074 179.873 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.29 152.98 35.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.265 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 0.76 ' HB2' HD12 ' B' ' 193' ' ' LEU . 75.0 t80 -148.75 100.94 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' B' ' 190' ' ' PHE . 23.5 mt-10 -101.31 103.5 27.0 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.936 . . . . 0.0 110.02 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.68 -6.32 18.89 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.938 1.493 . . . . 0.0 110.146 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -99.95 -2.92 33.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 58' ' ' SER . 0.8 OUTLIER -154.71 -41.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 0.0 110.626 -179.846 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.645 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -111.24 110.8 55.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 110.675 -179.524 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.46 -25.35 15.34 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.115 1.587 . . . . 0.0 110.07 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -95.64 -179.91 36.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.76 HD12 ' HB2' ' B' ' 185' ' ' TYR . 0.7 OUTLIER -113.22 140.62 47.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -1.163 . . . . 0.0 110.359 -179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.529 HG12 ' CD2' ' B' ' 205' ' ' LEU . 67.9 mt -104.87 104.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' B' ' 203' ' ' VAL . 17.9 t80 -96.78 137.21 36.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.546 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -115.66 83.6 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 30.4 ttm -51.87 139.84 21.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' B' ' 182' ' ' PHE . 25.6 t -82.4 -42.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.216 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 9.7 tttp -140.41 114.51 7.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.893 . . . . 0.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.9 Cg_endo -73.49 168.68 75.51 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.968 -2.097 . . . . 0.0 110.607 0.157 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.407 ' C ' HG12 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -72.69 87.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 0.0 110.005 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 19.1 mm -137.76 153.29 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 110.51 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 195' ' ' TYR . 43.0 t -105.73 126.85 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.573 HD21 ' HB1' ' B' ' 226' ' ' ALA . 5.0 mp -116.55 136.82 52.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 110.277 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.704 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 1.2 mt -119.32 132.69 55.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.329 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.654 HG13 HD12 ' B' ' 212' ' ' ILE . 3.5 mp -112.58 159.98 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.508 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 2.9 m-85 -135.75 147.74 48.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 37.9 t -45.87 -24.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -76.12 -22.65 55.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.438 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.689 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 107.24 4.31 35.4 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.592 ' O ' HD13 ' B' ' 212' ' ' ILE . 22.1 tttt -77.84 141.43 39.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.654 HD12 HG13 ' B' ' 206' ' ' ILE . 15.2 mm -124.53 142.14 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.102 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 11.1 t -124.24 151.9 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.199 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' B' ' 213' ' ' VAL . 3.1 mp -141.35 119.24 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 12.8 t -135.52 166.17 23.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 110.314 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.38 79.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -79.39 132.64 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -1.171 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' B' ' 218' ' ' LYS . 2.1 ttmt -79.24 -26.31 42.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.516 ' HB3' ' HG3' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -144.87 162.23 37.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.375 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -59.44 -26.56 65.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.806 . . . . 0.0 110.552 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -63.85 -27.55 69.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 -179.824 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.43 ' OE1' HD11 ' B' ' 202' ' ' ILE . 4.5 mt-10 -74.57 -42.27 59.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 109.879 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' B' ' 214' ' ' LEU . 32.0 mm -63.75 -40.35 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.37 -39.88 94.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.08 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -74.62 -31.45 62.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -63.92 -38.3 90.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.856 . . . . 0.0 110.156 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.689 ' HA ' HG22 ' B' ' 230' ' ' ILE . 27.5 t80 -79.55 -42.32 25.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 110.221 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 228' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' B' ' 228' ' ' GLU . 0.3 OUTLIER -61.83 -17.04 54.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.972 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -96.06 -32.96 12.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.3 tp -89.59 -16.34 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.995 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.594 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.4 t80 -53.86 -43.39 96.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.379 -0.825 . . . . 0.0 111.083 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 46.1 Cg_endo -74.58 -36.87 2.64 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.356 1.188 . . . . 0.0 110.613 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.42 HG12 HD21 ' B' ' 175' ' ' LEU . 40.9 t -63.11 -40.72 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.869 179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.547 HD13 HG11 ' B' ' 166' ' ' VAL . 26.3 mt -62.66 -48.81 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 110.233 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -42.54 84.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.988 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 236' ' ' GLU . . . . . 0.441 ' OE1' ' CA ' ' B' ' 236' ' ' GLU . 0.0 OUTLIER -61.73 -30.0 70.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 110.156 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -119.58 39.58 3.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' B' ' 239' ' ' LYS . 7.1 tmm_? -69.75 148.49 49.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.235 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.433 ' N ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -91.7 -56.19 3.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.343 -179.895 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 36.5 ttm . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.253 -179.998 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.011 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.227 0.537 . . . . 0.0 109.952 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.885 ' N ' HD12 ' A' ' 18' ' ' LEU . 5.6 p-10 -86.68 93.12 9.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 111.024 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.011 HD21 HD21 ' A' ' 18' ' ' LEU . 2.9 mt -99.21 2.62 45.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.317 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 59' ' ' LEU . 42.3 m -42.33 -39.29 2.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -89.41 -35.25 8.08 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.689 HG12 HG23 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -51.19 -45.44 31.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.459 -1.024 . . . . 0.0 109.076 -179.49 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.769 HD22 ' HG2' ' A' ' 67' ' ' MET . 3.8 pp -82.88 -19.62 37.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 109.827 178.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -100.22 11.62 38.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.246 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 146.58 89.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.986 ' ND2' HD11 ' A' ' 35' ' ' LEU . 4.3 p30 -16.06 124.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.075 0.941 . . . . 0.0 112.506 -179.264 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.689 HG23 HG12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -145.67 161.13 12.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.854 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 28' ' ' ILE . 68.9 m-20 -86.8 134.33 33.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . 1.01 ' HB2' HD13 ' A' ' 18' ' ' LEU . 9.7 p -39.35 -27.36 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.598 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 10.3 tt0 -55.57 -15.41 2.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 178.275 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 31.26 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.72 129.32 49.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.957 -1.32 . . . . 0.0 110.571 179.83 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.35 150.58 20.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.299 -0.876 . . . . 0.0 110.698 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.986 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.522 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.172 0.51 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -22.8 14.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.192 -0.943 . . . . 0.0 108.833 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.644 HD21 ' CD1' ' B' ' 205' ' ' LEU . 4.0 mt -103.51 -40.06 6.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.591 -0.693 . . . . 0.0 110.435 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.924 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.75 -56.01 16.34 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.721 -179.16 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -64.88 -24.53 67.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.643 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 2.2 m-20 -80.04 -37.03 34.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.466 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.924 HD12 ' HA ' ' A' ' 53' ' ' ARG . 8.0 mt -53.71 -43.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.65 -22.46 46.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.6 p -127.21 17.83 7.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -1.117 . . . . 0.0 110.31 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.857 HD23 HD21 ' A' ' 62' ' ' LEU . 4.8 mt -79.02 -11.47 60.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.53 38.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.537 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 24.8 ttpt -137.16 12.99 3.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.996 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.857 HD21 HD23 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -136.96 -29.77 0.9 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 110.948 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.9 -44.35 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.112 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.8 mm? -44.83 -23.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -1.231 . . . . 0.0 110.793 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 64' ' ' LEU . 7.8 t0 -43.93 -41.65 5.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.022 . . . . 0.0 109.744 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.7 -45.82 74.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.428 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.769 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -72.22 -8.73 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.388 179.17 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.654 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.2 tm? -71.17 -60.89 1.99 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.948 0.88 . . . . 0.0 108.88 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -72.57 0.4 10.59 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.328 0.585 . . . . 0.0 110.14 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 44.8 tt0 -84.3 1.18 46.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -0.918 . . . . 0.0 111.171 -179.179 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.759 HG12 HG11 ' B' ' 122' ' ' VAL . 3.4 t -138.36 -2.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.128 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.98 HD11 HD12 ' A' ' 74' ' ' LEU . 4.4 tp -150.85 77.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.444 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.7 p-10 -78.57 55.35 1.62 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.962 -1.086 . . . . 0.0 108.851 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.042 HD11 ' HB2' ' B' ' 101' ' ' ALA . 8.7 mt . . . . . 0 C--N 1.306 -1.294 0 CA-C-O 121.672 0.748 . . . . 0.0 110.668 -179.109 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' B' ' 64' ' ' VAL . 1.5 mp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.317 0.58 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' B' ' 63' ' ' ILE . 4.3 t 61.04 130.65 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 0.0 110.318 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 45.6 Cg_endo -74.03 137.44 24.1 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.973 1.512 . . . . 0.0 110.388 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -99.06 128.51 45.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.537 HD22 HG22 ' B' ' 160' ' ' ILE . 69.9 mt -70.42 114.6 8.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 110.121 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -102.82 -9.62 19.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.291 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.498 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 1.1 m-80 -168.27 157.86 9.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 126' ' ' ALA . 8.1 mt -156.9 159.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.965 . . . . 0.0 109.853 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.631 HG22 ' HB ' ' B' ' 124' ' ' THR . 50.7 t -139.47 143.02 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' B' ' 157' ' ' ILE . . . -132.82 151.55 51.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 14.8 p -108.58 120.77 43.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 65.4 t -116.76 151.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.165 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 27.5 m -122.8 152.24 40.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 1.006 HD22 ' HB1' ' B' ' 150' ' ' ALA . 14.0 mt -105.14 -44.52 4.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.95 -11.22 34.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 176.35 8.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -1.124 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.738 ' O ' HD23 ' B' ' 80' ' ' LEU . 9.6 ttt180 -93.73 160.95 14.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.999 HD11 ' CD1' ' B' ' 76' ' ' LEU . 13.5 mt -134.84 149.41 50.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.979 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 2.7 m-20 -95.45 100.44 12.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 21.2 mt -50.66 -39.4 50.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.042 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -42.28 84.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 84' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 4.2 m -87.64 -44.24 11.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.025 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -53.72 -37.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.551 ' HB2' ' CG2' ' B' ' 102' ' ' VAL . . . -83.67 -28.95 27.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' B' ' 87' ' ' LEU . 1.9 tp -84.14 -23.63 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' B' ' 84' ' ' THR . 8.2 m80 -94.03 -32.49 13.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -64.02 139.41 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.044 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -73.47 -27.74 61.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.955 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 10.6 t-20 -134.69 79.48 1.8 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -149.38 154.72 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 93' ' ' GLU . . . . . 0.537 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 16.2 pt-20 -136.24 165.49 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -139.86 113.76 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.099 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -115.67 96.23 45.79 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.363 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -16.27 25.82 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.974 1.512 . . . . 0.0 110.412 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -3.94 44.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.406 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -126.54 -34.45 2.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.141 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.957 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.49 -171.59 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.402 -0.811 . . . . 0.0 110.842 -179.301 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.96 57.03 0.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 111.542 -178.636 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -147.84 155.82 42.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.959 -1.088 . . . . 0.0 110.775 179.22 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' B' ' 86' ' ' ALA . 73.0 t -97.79 126.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.919 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 20.0 mm -90.29 129.51 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.358 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 1.3 ttt -102.4 162.54 12.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.449 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 0.6 OUTLIER -154.36 124.3 6.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 110.601 -179.773 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.529 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 8.7 pt -129.06 155.62 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.631 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.457 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 0.4 OUTLIER -102.41 34.28 2.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.435 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.0 OUTLIER -177.06 87.45 0.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.8 Cg_endo -79.08 149.31 83.84 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.21 -0.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 3.9 tttt -62.05 97.69 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.153 -0.967 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' B' ' 124' ' ' THR . 23.8 p -149.67 170.95 17.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 110.749 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -110.79 156.55 20.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.557 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -136.82 143.64 43.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 110.938 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.53 ' HB3' ' CZ ' ' B' ' 116' ' ' PHE . 2.8 mm? -104.87 125.39 50.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.4 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.582 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 31.4 mm -110.13 121.56 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 0.0 110.868 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.53 ' CZ ' ' HB3' ' B' ' 114' ' ' LEU . 6.8 m-85 -106.24 128.43 53.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.301 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.25 -24.3 4.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.219 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.472 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 131.83 -26.47 3.81 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -71.61 149.96 45.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.481 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.9 OUTLIER -139.86 140.91 36.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -115.29 157.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.949 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 71' ' ' VAL . 33.6 t -142.46 153.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.672 HG21 HD13 ' A' ' 23' ' ' ILE . 1.8 t -149.71 163.12 38.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.562 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 112.0 -30.42 7.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -56.0 147.62 19.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -1.07 . . . . 0.0 110.253 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 127' ' ' LYS . . . . . 0.401 ' HG2' ' OD2' ' B' ' 131' ' ' ASP . 10.9 ptmt -119.41 -22.08 7.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m -121.88 -141.32 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.814 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.91 -41.92 5.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 131' ' ' ASP . 6.4 p30 -72.07 -21.87 61.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.204 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 73.9 m-20 -70.95 -35.16 72.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 110.434 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 132' ' ' SER . . . . . 0.481 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 12.1 m -79.27 -32.59 43.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.278 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -74.82 -42.95 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 110.151 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' B' ' 130' ' ' ASP . 0.2 OUTLIER -64.12 -37.59 88.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.76 -60.79 2.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.518 ' OG ' HG21 ' B' ' 123' ' ' VAL . 2.8 m -51.08 -46.63 61.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -45.08 88.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.8 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.473 ' CD ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -58.93 -41.4 87.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.903 179.746 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.723 ' HA ' HD12 ' B' ' 142' ' ' ILE . 37.5 m-85 -66.79 -55.45 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.985 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 140' ' ' ALA . . . . . 0.521 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -48.57 -33.77 10.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 8.3 mmt180 -64.73 -41.32 96.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' B' ' 139' ' ' TYR . 28.1 mt -54.63 -49.75 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.624 HD13 HD13 ' B' ' 80' ' ' LEU . 9.0 mt -69.25 -54.23 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.579 HE21 ' HB3' ' B' ' 150' ' ' ALA . 0.9 OUTLIER -59.56 -32.89 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.94 . . . . 0.0 109.925 179.719 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 0.6 OUTLIER -72.92 -27.24 61.75 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.069 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.6 mt -76.28 -15.71 15.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 117.17 -27.34 7.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.481 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 9.6 m-85 -41.99 154.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.258 . . . . 0.0 110.765 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.52 24.63 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 1.006 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -72.42 165.59 24.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.11 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.533 ' O ' HD23 ' B' ' 76' ' ' LEU . 19.0 tttt -142.78 169.48 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.374 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 152' ' ' PHE . . . . . 0.503 ' O ' HG23 ' B' ' 153' ' ' THR . 60.6 t80 -101.1 91.47 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.161 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.503 HG23 ' O ' ' B' ' 152' ' ' PHE . 1.5 p -153.52 176.6 11.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.259 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 154' ' ' ASP . . . . . 0.506 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 20.5 t0 60.84 24.11 14.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.092 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 3.3 t80 -80.54 133.12 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -163.74 132.17 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 110.151 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' B' ' 72' ' ' ALA . 1.9 mp -79.96 109.4 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 109.917 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -103.47 -3.04 25.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 110.838 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.91 108.5 4.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.036 -1.04 . . . . 0.0 110.904 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.537 HG22 HD22 ' B' ' 67' ' ' LEU . 95.6 mt -113.21 120.03 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.177 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.589 HG22 ' OG1' ' B' ' 215' ' ' THR . 3.5 t -95.37 140.37 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.637 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.75 177.04 20.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 163' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 73.7 m -166.05 140.6 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -1.178 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.505 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 8.9 p -170.23 136.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.95 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 59.2 p30 -103.41 179.81 4.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.024 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.553 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.2 OUTLIER -124.44 -86.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.213 -0.929 . . . . 0.0 110.3 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.553 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 173.97 33.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.53 ' CD1' ' HG2' ' B' ' 238' ' ' ARG . 11.8 p90 -166.32 149.32 6.41 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.64 145.49 46.83 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.098 1.578 . . . . 0.0 110.484 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.43 HD13 ' CG2' ' B' ' 206' ' ' ILE . 6.0 mt -112.2 142.62 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 0.0 110.514 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 171' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -82.1 92.83 6.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -0.834 . . . . 0.0 109.793 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' B' ' 193' ' ' LEU . 11.5 mt -51.23 -47.48 62.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.72 -50.12 74.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.937 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -49.79 -34.09 21.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.4 OUTLIER -71.32 -59.44 2.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 109.92 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' B' ' 180' ' ' GLY . . . -58.63 -19.49 39.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.07 -51.09 23.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.33 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 -32.72 11.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.463 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' B' ' 183' ' ' SER . 54.5 m80 -108.75 19.98 19.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' B' ' 176' ' ' ALA . . . -45.3 -51.6 9.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 55.5 m -62.09 -18.58 61.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -1.135 . . . . 0.0 109.931 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 182' ' ' PHE . . . . . 0.446 ' N ' ' O ' ' B' ' 179' ' ' HIS . 1.4 m-85 -105.4 -10.5 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.058 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.478 ' N ' ' O ' ' B' ' 179' ' ' HIS . 13.9 p -154.07 154.96 34.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 184' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 0.5 OUTLIER -126.7 164.74 20.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 110.06 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 0.578 ' HB2' HD12 ' B' ' 193' ' ' LEU . 1.7 t80 -164.1 86.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -92.11 110.04 41.57 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 110.135 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -7.18 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.9 1.474 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.34 -6.43 56.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 189' ' ' LEU . 1.9 tt -146.97 -35.61 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.569 ' CD2' HD11 ' B' ' 194' ' ' ILE . 0.8 OUTLIER -118.47 130.38 24.81 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.992 . . . . 0.0 110.609 -179.888 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.45 -42.09 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.949 1.499 . . . . 0.0 110.376 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.69 -179.55 44.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' B' ' 185' ' ' TYR . 0.9 OUTLIER -96.46 147.49 23.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -1.156 . . . . 0.0 110.297 -179.92 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.691 HG21 HD13 ' A' ' 62' ' ' LEU . 63.4 mt -109.82 104.93 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -97.58 128.66 44.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.474 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' B' ' 203' ' ' VAL . 12.2 ttt-85 -110.92 80.74 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.456 ' N ' ' O ' ' B' ' 202' ' ' ILE . 37.1 tpp -45.81 134.59 7.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 75.3 t -88.17 -34.72 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.359 -0.838 . . . . 0.0 109.975 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.1 OUTLIER -143.58 108.34 5.17 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 110.049 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.2 Cg_endo -71.44 169.46 69.37 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.94 -2.109 . . . . 0.0 110.786 0.046 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.553 ' O ' HD13 ' B' ' 202' ' ' ILE . 5.6 mtmp? -75.22 81.56 2.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.34 -0.85 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.553 HD13 ' O ' ' B' ' 201' ' ' LYS . 10.4 mm -130.41 148.22 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.708 ' C ' HD12 ' B' ' 204' ' ' LEU . 10.5 t -108.42 137.46 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.019 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.83 ' N ' HD12 ' B' ' 204' ' ' LEU . 3.6 mp -131.51 151.82 51.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.925 . . . . 0.0 110.571 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.698 ' O ' HD13 ' B' ' 206' ' ' ILE . 25.1 mt -110.13 144.9 38.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.473 179.26 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.698 HD13 ' O ' ' B' ' 205' ' ' LEU . 11.8 mm -127.81 104.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.989 -1.07 . . . . 0.0 110.302 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' B' ' 209' ' ' SER . 66.8 m-85 -91.05 133.99 34.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 36.1 t -42.24 -26.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 110.416 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.439 ' N ' ' O ' ' B' ' 207' ' ' PHE . 0.0 OUTLIER -59.34 -38.63 80.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' B' ' 165' ' ' ASP . . . 121.35 15.86 4.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 124.98 41.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.031 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.577 HD12 HD12 ' B' ' 206' ' ' ILE . 21.1 mm -108.89 125.6 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.538 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.522 ' C ' HD12 ' B' ' 214' ' ' LEU . 17.1 t -105.77 159.4 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.395 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.1 mp -143.05 146.17 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.589 ' OG1' HG22 ' B' ' 161' ' ' VAL . 5.5 t -169.8 145.09 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 110.18 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.62 10.74 26.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -91.3 158.74 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -1.198 . . . . 0.0 110.227 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -103.39 -23.75 13.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.479 ' N ' ' HG2' ' B' ' 218' ' ' LYS . 0.0 OUTLIER -137.65 179.35 6.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 220' ' ' ARG . . . . . 0.454 ' HG3' ' CE1' ' B' ' 224' ' ' TYR . 1.6 ttt180 -75.88 -27.75 57.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.363 -0.836 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 221' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -61.05 -41.17 96.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.496 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -61.43 -52.16 65.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 0.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.468 HD11 ' O ' ' B' ' 160' ' ' ILE . 22.6 mm -58.05 -43.8 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' B' ' 220' ' ' ARG . 10.5 m-85 -70.98 -34.16 71.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.204 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 3.4 tp60 -80.48 -44.16 19.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 110.047 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.14 -38.42 68.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.627 ' O ' HG22 ' B' ' 230' ' ' ILE . 15.7 t80 -68.92 -52.72 26.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.995 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -54.29 -24.21 18.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.783 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.81 -30.82 45.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 110.039 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.627 HG22 ' O ' ' B' ' 227' ' ' PHE . 6.0 tp -93.38 -17.37 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.891 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.72 -47.88 60.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 111.015 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.77 -40.44 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.593 1.312 . . . . 0.0 110.612 -179.404 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.494 ' CG1' HD11 ' B' ' 175' ' ' LEU . 40.8 t -58.52 -42.32 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.907 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 77.5 mt -66.67 -40.22 88.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.34 -25.4 63.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.36 -27.15 59.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 59.9 m-85 -117.16 42.74 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.53 ' HG2' ' CD1' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -68.16 -172.01 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -35.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.142 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 240' ' ' MET . . . . . 0.462 ' HG3' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.141 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.06 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.799 ' HA ' HD11 ' A' ' 68' ' ' LEU . 12.0 t0 -101.04 118.38 36.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.919 -1.113 . . . . 0.0 111.117 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.06 HD21 HD21 ' A' ' 18' ' ' LEU . 6.6 mt -113.78 12.79 18.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 110.641 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.687 ' OG1' HD23 ' A' ' 68' ' ' LEU . 3.1 m -42.43 -27.74 0.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 110.187 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.567 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -91.36 -30.2 11.2 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 20' ' ' LEU . 16.3 mm -50.65 -53.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.295 . . . . 0.0 108.771 -179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.1 pp -78.97 5.7 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.468 -0.77 . . . . 0.0 110.004 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CD1' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -107.99 -17.61 14.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.177 -0.952 . . . . 0.0 111.14 -179.516 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 151.79 48.74 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.252 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.988 ' OD1' HD21 ' A' ' 35' ' ' LEU . 0.9 OUTLIER 63.86 139.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.012 -1.287 . . . . 0.0 111.275 178.524 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.763 HG23 HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.35 157.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 68.1 m-20 -90.08 122.52 33.13 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 177.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.479 ' OG ' HG13 ' B' ' 103' ' ' ILE . 1.5 p -39.8 -26.67 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.727 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.1 tt0 -57.48 -13.53 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.447 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.92 26.3 5.58 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.98 117.43 26.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.076 -1.249 . . . . 0.0 109.814 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 35' ' ' LEU . 2.8 tt -88.36 156.9 18.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.778 -1.201 . . . . 0.0 110.244 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.988 HD21 ' OD1' ' A' ' 27' ' ' ASN . 4.2 pp . . . . . 0 N--CA 1.491 1.622 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.043 -179.055 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.113 0.482 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.01 -25.5 14.04 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.973 ' O ' HD12 ' A' ' 56' ' ' ILE . 2.7 mt -92.54 -42.28 9.78 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.552 -0.718 . . . . 0.0 110.139 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.66 -51.22 16.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 0.0 109.609 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -66.53 -13.83 61.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.825 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' A' ' 59' ' ' LEU . 9.7 m-80 -96.23 -40.19 9.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.825 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.973 HD12 ' O ' ' A' ' 52' ' ' LEU . 1.2 mp -51.42 -40.65 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.399 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.39 -14.54 49.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 p -134.53 18.11 3.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 110.39 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 6.7 mt -98.04 16.27 21.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.2 m -90.95 42.97 1.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 110.433 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HG3' ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -151.78 -30.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -0.971 . . . . 0.0 110.954 179.854 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -74.37 6.15 3.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.977 -1.077 . . . . 0.0 111.271 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.586 ' N ' HD13 ' A' ' 62' ' ' LEU . . . 144.03 -46.92 0.8 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.751 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.6 mm? -52.0 -18.15 1.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 110.678 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 66' ' ' SER . 2.7 p30 -43.0 -39.65 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 10.9 m -67.67 -55.92 11.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.387 -0.821 . . . . 0.0 109.976 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.461 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.52 -6.6 26.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.602 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.799 HD11 ' HA ' ' A' ' 19' ' ' ASP . 1.2 tm? -71.02 -62.89 1.23 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.179 0.99 . . . . 0.0 108.848 179.301 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.48 1.69 13.46 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.164 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 66' ' ' SER . 15.4 tt0 -91.24 11.36 23.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 111.696 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 20' ' ' LEU . 3.2 t -138.4 0.42 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.042 HD11 ' CD1' ' A' ' 74' ' ' LEU . 2.0 tp -152.0 74.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 110.233 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 56.9 t0 -79.74 56.65 2.32 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.923 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.042 ' CD1' HD11 ' A' ' 72' ' ' ILE . 5.8 mt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.719 0.771 . . . . 0.0 110.716 -179.193 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.0 mp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.152 0.501 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 14.5 t 60.54 126.93 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.301 -0.874 . . . . 0.0 110.057 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.475 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 44.2 Cg_endo -70.95 150.31 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.85 1.447 . . . . 0.0 110.484 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' B' ' 68' ' ' GLN . 18.1 m -122.04 128.02 50.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.486 HD21 HG21 ' B' ' 223' ' ' ILE . 21.7 mt -70.29 117.53 11.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 110.211 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.609 ' O ' ' ND2' ' B' ' 69' ' ' ASN . 19.8 mm-40 -112.35 -13.63 13.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.351 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' B' ' 68' ' ' GLN . 4.6 m-80 -153.53 158.03 40.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.562 HG22 ' N ' ' B' ' 71' ' ' VAL . 8.4 mt -154.96 169.2 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.987 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' B' ' 124' ' ' THR . 27.0 t -139.23 130.48 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.94 143.96 50.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 94.7 m -93.62 128.93 40.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.89 . . . . 0.0 110.355 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.63 146.07 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.2 m -125.49 145.68 49.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 1.133 HD22 ' HB1' ' B' ' 150' ' ' ALA . 91.8 mt -97.08 -41.85 8.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.11 54.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 7.3 t -148.43 153.87 39.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -1.181 . . . . 0.0 110.335 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -77.52 149.21 34.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.097 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.938 HD11 ' CD1' ' B' ' 76' ' ' LEU . 68.9 mt -124.69 155.66 38.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -0.97 . . . . 0.0 110.505 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' B' ' 82' ' ' LEU . 4.9 m-20 -92.69 83.64 4.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 109.455 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.786 HD22 HG23 ' B' ' 102' ' ' VAL . 94.6 mt -40.1 -35.6 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.723 . . . . 0.0 110.536 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -50.12 73.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 110.008 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -77.47 -43.28 32.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.495 HG22 ' CE2' ' B' ' 148' ' ' PHE . 85.2 t -50.38 -43.96 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.142 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.96 -21.72 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 tp -86.2 -37.22 18.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -87.74 -24.95 23.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.478 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -70.63 136.34 49.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.145 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -24.08 58.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 9.6 t-20 -135.63 79.45 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.096 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.85 149.97 46.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -0.859 . . . . 0.0 109.955 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -125.78 119.36 27.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.341 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.525 ' CE1' ' HB3' ' B' ' 82' ' ' LEU . 8.1 t80 -114.37 118.96 35.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 109.929 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -129.05 110.22 18.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.277 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.47 -22.1 18.85 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.969 1.51 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -17.94 56.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -102.02 -45.34 5.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.752 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.54 -162.42 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.913 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.414 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -122.12 54.86 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 111.043 -179.357 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.997 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -143.14 172.16 13.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 110.095 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.786 HG23 HD22 ' B' ' 82' ' ' LEU . 42.1 t -114.56 123.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.36 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.81 ' CD1' HD13 ' B' ' 114' ' ' LEU . 15.2 mm -93.67 108.6 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.979 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.562 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 1.4 ttm -89.81 146.54 24.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.428 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 3.8 ttt85 -135.63 118.66 16.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.439 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.757 HG23 ' CE1' ' B' ' 139' ' ' TYR . 18.2 pt -114.71 165.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.934 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.7 ptm180 -110.59 22.9 14.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.389 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 2.4 tt0 -176.9 94.74 0.24 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.267 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.1 Cg_endo -76.73 143.93 77.33 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.477 -0.243 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.721 ' O ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -57.12 108.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.0 109.926 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.721 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -161.76 -179.14 6.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.753 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -126.54 158.74 35.4 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.7 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -132.82 124.98 29.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 111.103 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.81 HD13 ' CD1' ' B' ' 103' ' ' ILE . 3.9 mm? -92.24 89.83 7.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.711 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 41.1 mt -90.28 128.61 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.168 -178.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.787 ' CZ ' HD12 ' A' ' 72' ' ' ILE . 4.0 m-30 -110.19 144.75 38.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 109.593 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -54.36 -19.88 6.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 110.408 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -7.18 37.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 119' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 101.55 -25.93 26.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -56.23 173.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -1.206 . . . . 0.0 110.082 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.51 ' CG ' HG12 ' B' ' 115' ' ' ILE . 3.2 tmm? -169.05 119.89 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 71' ' ' VAL . 3.8 t -109.4 138.98 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.378 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.42 124.01 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 110.766 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.694 HG23 ' ND2' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -117.44 170.63 8.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 109.801 179.656 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 102.81 -35.67 4.83 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -50.04 157.09 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -1.187 . . . . 0.0 110.387 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -121.76 -25.39 5.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 164.82 27.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.88 -63.01 1.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.189 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -45.44 -37.48 5.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -70.4 -42.02 72.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.159 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -55.48 -40.64 71.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 133' ' ' LYS . . . . . 0.474 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -69.1 -49.05 60.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.328 -179.918 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.455 ' HB3' ' HG3' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -55.0 -51.66 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 110.168 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.3 -47.55 65.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.218 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -69.31 -47.24 65.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.07 -42.36 65.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.391 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.478 ' NZ ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -63.73 -36.73 84.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.757 ' CE1' HG23 ' B' ' 106' ' ' ILE . 13.4 m-85 -72.01 -56.95 4.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.61 -22.95 0.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.766 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 141' ' ' ARG . . . . . 0.451 ' HD3' ' HD3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -73.58 -50.53 20.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 110.073 179.803 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' B' ' 139' ' ' TYR . 46.4 mt -50.75 -38.83 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.69 HG22 ' HB2' ' B' ' 148' ' ' PHE . 38.8 mm -72.54 -58.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 110.039 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 144' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 33.3 mt-30 -61.39 -27.63 68.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 109.961 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.451 ' HD3' ' HD3' ' B' ' 141' ' ' ARG . 27.5 ttpt -75.39 -23.45 57.08 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.179 -0.95 . . . . 0.0 108.504 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.6 mt -83.79 -21.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.87 -16.23 7.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.438 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.69 ' HB2' HG22 ' B' ' 143' ' ' ILE . 14.9 m-85 -54.4 172.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.077 -1.249 . . . . 0.0 110.865 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.27 32.06 5.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.631 -0.668 . . . . 0.0 109.747 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 1.133 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -77.16 144.24 38.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 110.504 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.18 51.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -71.94 97.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.172 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 176.24 9.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.56 33.98 23.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.659 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 155' ' ' PHE . . . . . 0.474 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.0 t80 -76.16 127.91 33.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 109.927 179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -161.43 129.64 4.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.123 -0.985 . . . . 0.0 110.709 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 20.3 mt -87.65 131.0 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.73 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 158' ' ' GLN . . . . . 0.447 ' HA ' ' HG2' ' B' ' 218' ' ' LYS . 4.5 mt-30 -135.31 0.56 2.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.046 -1.034 . . . . 0.0 110.95 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.525 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.2 OUTLIER -142.53 96.85 3.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.01 -1.056 . . . . 0.0 110.932 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' B' ' 215' ' ' THR . 75.4 mt -98.71 153.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 15.8 t -134.15 131.12 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.031 . . . . 0.0 110.571 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.43 175.7 18.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.14 148.63 8.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -1.21 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.475 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.3 p -169.45 170.71 8.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 165' ' ' ASP . . . . . 0.417 ' O ' HD13 ' B' ' 63' ' ' ILE . 6.2 m-20 -116.29 155.77 27.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.294 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.56 ' O ' ' CD2' ' B' ' 168' ' ' PHE . 10.2 m -103.87 11.5 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 167' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.9 OUTLIER 71.89 3.46 4.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.368 -0.832 . . . . 0.0 110.789 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 8.3 p90 -162.02 156.04 18.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 110.495 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.494 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 45.3 Cg_endo -74.24 161.87 39.74 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.103 1.581 . . . . 0.0 110.357 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.485 HD11 HG21 ' B' ' 166' ' ' VAL . 3.0 mt -127.07 148.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.38 104.6 16.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.825 HD22 ' CB ' ' B' ' 193' ' ' LEU . 26.9 mt -61.7 -48.51 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.44 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.69 -51.45 69.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.599 -179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.8 -51.08 55.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' B' ' 237' ' ' PHE . 8.0 tp -68.4 -36.25 78.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -1.141 . . . . 0.0 110.676 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -61.11 -30.65 70.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 177' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 7.0 t80 -76.93 -44.59 30.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.6 t -68.73 -48.94 62.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.273 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -110.87 37.44 2.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 180' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -54.14 -34.32 52.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -15.92 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.191 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -111.32 -0.75 16.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.888 . . . . 0.0 110.283 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.563 ' HB2' HD21 ' B' ' 193' ' ' LEU . 1.1 p -140.86 168.92 18.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 110.429 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 69.1 m -139.95 130.64 25.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.032 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -132.75 120.31 21.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.128 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 190' ' ' PHE . 99.2 mt-10 -121.19 100.71 45.13 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.46 -0.71 9.15 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.932 1.49 . . . . 0.0 110.4 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.82 -18.62 17.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.151 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.646 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.6 tt -147.34 9.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.604 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.489 ' HB2' HD23 ' B' ' 189' ' ' LEU . 19.0 t80 -167.97 107.63 0.57 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.874 -1.141 . . . . 0.0 110.421 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.79 -15.77 23.82 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.916 1.482 . . . . 0.0 110.165 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.61 44.13 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.825 ' CB ' HD22 ' B' ' 172' ' ' LEU . 7.3 tt -124.53 134.29 53.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -1.169 . . . . 0.0 110.433 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.765 HD13 HD23 ' A' ' 62' ' ' LEU . 3.3 mt -104.74 113.85 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 109.886 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.633 ' CD2' HD11 ' B' ' 230' ' ' ILE . 4.5 t80 -93.32 127.06 38.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.442 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.442 ' NH2' ' HA3' ' A' ' 63' ' ' GLY . 65.0 mtt180 -99.12 103.15 15.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.108 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 47.4 tpp -75.97 131.1 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.096 -1.003 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 198' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' B' ' 199' ' ' LYS . 39.4 t -80.51 -32.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.587 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 10.2 mttt -147.39 108.26 3.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.47 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -73.9 172.32 62.09 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.96 -2.1 . . . . 0.0 110.328 -0.223 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 201' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.5 OUTLIER -78.2 81.47 4.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.004 179.835 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' B' ' 217' ' ' ALA . 35.3 mm -126.04 154.01 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.29 111.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 110.295 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.713 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.9 mp -99.71 133.13 44.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.927 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 0.5 OUTLIER -93.69 147.31 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 179.984 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.451 HG22 HD21 ' B' ' 172' ' ' LEU . 5.1 mt -137.86 120.14 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -110.72 150.11 29.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 93.2 t -52.16 -27.14 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.382 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -37.44 84.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 110.253 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 119.81 1.92 13.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.413 ' HA ' ' OD1' ' B' ' 165' ' ' ASP . 11.2 tttm -81.21 140.48 34.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 110.049 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.408 HD13 ' O ' ' B' ' 211' ' ' LYS . 22.0 mm -123.13 132.38 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.405 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 2.3 t -120.04 148.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.24 -0.912 . . . . 0.0 109.694 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.0 mp -135.17 127.76 30.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.077 -1.014 . . . . 0.0 110.654 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 3.4 t -150.42 174.46 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.557 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.58 -0.42 77.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.813 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -94.24 142.54 27.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 110.183 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' B' ' 158' ' ' GLN . 3.2 mttm -87.27 -25.34 24.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 219' ' ' GLN . . . . . 0.426 ' C ' HD12 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -127.41 168.45 14.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -73.93 -27.53 61.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.331 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -57.37 -42.53 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.446 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 31.3 mt-10 -59.45 -46.81 87.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 109.871 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.682 HG22 ' N ' ' B' ' 224' ' ' TYR . 0.9 OUTLIER -56.49 -56.96 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -0.821 . . . . 0.0 109.42 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 224' ' ' TYR . . . . . 0.682 ' N ' HG22 ' B' ' 223' ' ' ILE . 1.1 m-85 -53.09 -33.61 52.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 110.273 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -79.03 -40.69 30.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.005 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.713 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.77 -42.59 89.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.662 ' HA ' HG22 ' B' ' 230' ' ' ILE . 79.4 t80 -68.51 -55.98 9.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.05 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 228' ' ' GLU . . . . . 0.429 ' O ' ' HD3' ' B' ' 232' ' ' PRO . 0.4 OUTLIER -50.21 -29.87 10.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.886 . . . . 0.0 110.064 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.452 ' O ' ' HD2' ' B' ' 232' ' ' PRO . . . -81.49 -36.0 29.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 110.165 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.6 tp -88.14 -13.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 110.025 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.603 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 64.3 t80 -59.63 -43.21 95.12 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.852 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -75.9 -23.37 12.43 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.396 1.209 . . . . 0.0 110.24 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 37.7 t -72.59 -40.89 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.461 ' HB3' HG12 ' B' ' 170' ' ' ILE . 35.8 mt -67.0 -50.25 62.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -33.13 65.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 110.357 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.24 -40.89 90.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 237' ' ' PHE . . . . . 0.462 ' CD2' HD13 ' B' ' 175' ' ' LEU . 51.7 m-85 -113.72 38.81 2.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.17 -0.956 . . . . 0.0 110.194 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -179.99 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.494 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 4.3 tptt -116.87 -35.45 4.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.223 179.897 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.825 ' CD2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.543 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -82.56 63.18 6.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 0.0 111.917 -178.628 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.822 HD21 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -83.9 -3.16 57.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.964 -1.085 . . . . 0.0 109.604 178.627 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.632 ' OG1' HD23 ' A' ' 68' ' ' LEU . 3.4 m -52.95 -21.55 4.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.281 -0.887 . . . . 0.0 109.638 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -97.23 -37.9 4.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.629 HD11 HD21 ' B' ' 114' ' ' LEU . 0.6 OUTLIER -46.09 -46.33 5.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.22 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.914 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.9 OUTLIER -79.5 -19.48 49.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.144 -0.972 . . . . 0.0 108.944 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.5 OUTLIER -85.94 -17.44 35.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.395 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 158.34 93.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.066 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.688 ' ND2' HG23 ' B' ' 124' ' ' THR . 4.5 t-20 2.53 112.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.001 0.905 . . . . 0.0 113.043 178.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.703 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -138.41 159.66 31.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.799 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 31' ' ' GLU . 39.5 m-20 -86.76 125.99 34.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.565 ' CA ' HD11 ' A' ' 18' ' ' LEU . 3.0 p -37.99 -28.03 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.433 0.635 . . . . 0.0 109.895 -178.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 29' ' ' ASP . 8.7 tt0 -57.04 -13.43 2.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.449 178.535 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.56 34.5 3.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.08 129.65 53.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -1.131 . . . . 0.0 110.069 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.838 HD23 ' N ' ' A' ' 35' ' ' LEU . 5.6 tt -89.02 155.37 19.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 111.067 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.838 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 122.073 0.939 . . . . 0.0 111.304 -179.112 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.209 0.528 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -101.19 -26.34 13.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.079 -1.013 . . . . 0.0 110.141 -179.969 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.473 HD13 ' CE1' ' A' ' 25' ' ' PHE . 5.2 mt -105.31 -44.99 4.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 110.898 -179.352 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.91 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -51.76 -55.53 19.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.1 pp20? -65.82 -15.45 62.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.635 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 3.9 m-20 -87.61 -39.57 14.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.508 -0.745 . . . . 0.0 109.28 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.91 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.0 mt -52.26 -43.65 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.481 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.76 13.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -126.52 7.84 6.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -1.153 . . . . 0.0 110.669 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 56' ' ' ILE . 7.4 mt -72.02 -8.45 54.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 110.332 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -80.65 50.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.318 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -148.77 -39.62 0.16 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.812 HD22 HD12 ' B' ' 194' ' ' ILE . 0.1 OUTLIER -71.24 -70.12 0.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.341 -0.849 . . . . 0.0 110.519 -179.904 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.38 -35.07 0.08 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 64' ' ' LEU . 3.9 mm? -51.22 -20.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -1.179 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.1 t0 -44.33 -40.62 5.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.95 . . . . 0.0 109.955 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.8 OUTLIER -65.36 -48.41 73.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.914 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.89 -4.26 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.732 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.725 ' C ' HD13 ' A' ' 68' ' ' LEU . 3.4 tm? -78.23 -54.91 5.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.73 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -83.64 1.34 42.81 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.46 0.648 . . . . 0.0 109.695 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 1.5 tt0 -88.31 -1.71 58.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 111.643 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 20' ' ' LEU . 2.2 t -131.74 -1.04 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 118.527 -1.269 . . . . 0.0 109.688 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.036 HD11 HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -151.23 67.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.504 -0.747 . . . . 0.0 110.042 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.6 58.65 0.43 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.993 -1.067 . . . . 0.0 108.622 179.473 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.036 HD12 HD11 ' A' ' 72' ' ' ILE . 27.9 mt . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 121.571 0.701 . . . . 0.0 110.907 -178.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.5 mt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.187 0.517 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 8.2 t 61.06 128.2 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.934 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 65' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 44.1 Cg_endo -70.14 161.55 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.8 1.421 . . . . 0.0 110.556 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 66' ' ' THR . . . . . 0.483 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.4 m -121.39 133.28 55.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.888 . . . . 0.0 110.161 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.746 HD22 ' CG2' ' B' ' 160' ' ' ILE . 80.9 mt -74.6 108.38 7.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 41.6 mm-40 -89.98 -15.04 32.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 69' ' ' ASN . . . . . 0.425 ' O ' HG13 ' B' ' 70' ' ' ILE . 2.1 m120 -167.84 164.51 14.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.528 HG12 HG23 ' B' ' 160' ' ' ILE . 7.4 mt -154.82 164.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.556 HG22 ' HB ' ' B' ' 124' ' ' THR . 71.5 t -141.49 132.97 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.265 -0.897 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.02 154.44 39.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.77 121.76 41.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' B' ' 121' ' ' MET . 66.2 t -121.63 134.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -122.79 131.25 53.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 110.16 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' B' ' 150' ' ' ALA . 15.0 mt -83.14 -51.27 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.88 27.4 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.0 134.73 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.266 . . . . 0.0 110.446 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.483 ' O ' HD23 ' B' ' 80' ' ' LEU . 71.6 ttt-85 -56.62 152.24 12.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.612 HD11 HD12 ' B' ' 76' ' ' LEU . 18.3 mt -133.65 158.63 42.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.416 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -102.05 94.01 5.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.029 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.714 HD22 HG23 ' B' ' 102' ' ' VAL . 16.0 mt -43.57 -37.53 2.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 110.341 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 83' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.5 OUTLIER -58.3 -38.88 77.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.183 -179.882 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 27.2 p -89.1 -43.08 11.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.202 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 63.2 t -56.37 -39.89 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -83.89 -26.37 29.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.399 -0.813 . . . . 0.0 109.934 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 25.9 tp -80.13 -43.83 20.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 88' ' ' HIS . . . . . 0.421 ' HB3' HG12 ' B' ' 146' ' ' ILE . 65.2 m80 -77.55 -28.81 51.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 89' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -69.8 139.88 53.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.067 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -23.46 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 110.334 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 91' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' B' ' 105' ' ' ARG . 3.2 t-20 -134.88 79.67 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 86' ' ' ALA . . . -141.8 152.58 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.12 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -130.75 131.54 44.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.79 103.59 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 0.5 OUTLIER -115.95 104.8 52.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 96' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' B' ' 95' ' ' ASN . 44.3 Cg_endo -70.67 -23.76 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.107 1.582 . . . . 0.0 110.26 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.33 60.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.545 ' HB3' ' CD1' ' B' ' 99' ' ' PHE . 4.2 tpm_? -112.66 -66.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 109.864 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 99' ' ' PHE . . . . . 0.696 ' CD1' HD13 ' A' ' 18' ' ' LEU . 30.5 p90 -141.55 -170.77 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 110.12 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.46 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -117.49 62.34 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -0.966 . . . . 0.0 110.652 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.883 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -152.02 170.4 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.083 -1.01 . . . . 0.0 110.649 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 102' ' ' VAL . . . . . 0.714 HG23 HD22 ' B' ' 82' ' ' LEU . 24.5 t -106.98 132.63 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.561 179.506 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.648 HD12 HD13 ' B' ' 114' ' ' LEU . 12.8 mm -99.85 97.47 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.135 -0.978 . . . . 0.0 110.507 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 104' ' ' MET . . . . . 0.46 ' HB2' ' HE3' ' B' ' 104' ' ' MET . 23.4 ttm -90.01 158.68 17.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.953 . . . . 0.0 109.824 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' OH ' ' B' ' 139' ' ' TYR . 0.1 OUTLIER -157.3 155.84 31.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.753 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 3.9 pt -136.09 162.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 107' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -102.0 25.11 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 110.083 179.973 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 3.6 tt0 -177.97 90.01 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.95 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 109' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 50.8 Cg_endo -83.11 155.5 73.97 Favored 'Cis proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.181 -2.008 . . . . 0.0 110.345 -0.097 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 5.3 ttmt -61.34 104.01 0.36 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.057 -1.027 . . . . 0.0 109.619 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 111' ' ' THR . . . . . 0.423 HG22 ' C ' ' B' ' 125' ' ' GLY . 29.3 p -144.89 179.49 7.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.754 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -138.64 128.97 25.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.556 -0.715 . . . . 0.0 109.228 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 113' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -106.0 123.69 48.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 111.063 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 114' ' ' LEU . . . . . 0.648 HD13 HD12 ' B' ' 103' ' ' ILE . 4.2 mm? -89.58 92.55 9.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 115' ' ' ILE . . . . . 0.613 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 10.5 mt -92.66 127.11 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.162 -0.961 . . . . 0.0 111.33 -178.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 116' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 2.8 m-85 -100.77 160.26 14.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 109.649 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -79.4 2.52 21.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.996 -1.065 . . . . 0.0 110.111 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.3 t -90.58 -21.71 21.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.97 -33.9 3.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -63.48 172.14 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 109.901 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 121' ' ' MET . . . . . 0.453 ' N ' ' O ' ' B' ' 74' ' ' VAL . 2.5 ttm -164.63 149.65 9.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.587 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.719 HG21 HG12 ' A' ' 71' ' ' VAL . 1.2 t -125.4 145.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.183 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.2 t -129.81 100.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.038 . . . . 0.0 111.029 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 124' ' ' THR . . . . . 0.688 HG23 ' ND2' ' A' ' 27' ' ' ASN . 1.2 t -99.62 165.28 11.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 108.908 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 125' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 27' ' ' ASN . . . 101.92 -3.51 52.35 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 126' ' ' ALA . . . . . 0.552 ' HB1' ' OG ' ' B' ' 132' ' ' SER . . . -73.22 133.79 44.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.262 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.42 -6.65 27.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 110.438 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 128' ' ' SER . . . . . 0.432 ' HB2' ' CG ' ' B' ' 131' ' ' ASP . 0.4 OUTLIER -160.25 -168.2 2.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 0.0 110.367 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.5 -56.03 4.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.187 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 130' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 7.9 m-20 -63.82 -22.45 66.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.878 . . . . 0.0 110.389 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' B' ' 128' ' ' SER . 5.0 m-20 -68.18 -48.8 64.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.99 . . . . 0.0 110.313 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 132' ' ' SER . . . . . 0.552 ' OG ' ' HB1' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -66.2 -36.59 83.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.217 -179.884 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -58.7 -42.16 87.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.56 -50.78 11.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.44 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -54.13 -50.49 66.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 136' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' B' ' 137' ' ' ARG . 20.6 p -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.771 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 137' ' ' ARG . . . . . 0.424 ' N ' ' OG ' ' B' ' 136' ' ' SER . 5.4 mtp180 -48.25 -43.23 32.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.363 -0.836 . . . . 0.0 109.95 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -57.25 -45.69 83.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.842 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 139' ' ' TYR . . . . . 0.838 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 11.8 m-85 -57.03 -53.23 60.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.77 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.55 -20.14 64.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.85 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -31.96 58.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' B' ' 139' ' ' TYR . 6.3 mt -70.29 -41.36 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 143' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 33.7 mt -68.31 -42.27 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -68.4 -33.98 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -71.47 -22.37 61.82 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' B' ' 88' ' ' HIS . 1.3 mt -81.21 -20.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 122.51 -32.15 4.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 148' ' ' PHE . . . . . 0.581 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 7.7 m-85 -40.85 150.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.132 . . . . 0.0 110.964 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.39 28.68 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.525 -0.734 . . . . 0.0 109.859 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -67.14 148.69 51.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.512 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.0 OUTLIER -136.73 117.86 14.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -56.02 100.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.179 -0.951 . . . . 0.0 110.087 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.2 OUTLIER -144.19 166.17 25.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.845 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.63 35.33 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 110.435 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -78.36 130.86 36.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -165.75 129.19 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 110.607 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 40.5 mt -79.51 129.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.598 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -125.56 -13.17 6.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.056 -1.028 . . . . 0.0 110.933 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 159' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' A' ' 24' ' ' LEU . 2.2 t30 -139.27 98.02 3.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.878 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 160' ' ' ILE . . . . . 0.746 ' CG2' HD22 ' B' ' 67' ' ' LEU . 53.1 mt -97.47 134.08 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.518 179.192 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 24' ' ' LEU . 5.9 t -101.71 133.96 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.665 -179.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 162' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -148.47 163.21 28.97 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 43.2 p -167.56 159.79 12.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 164' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 11.0 p -168.51 158.44 9.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.7 130.97 54.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.578 HG22 ' O ' ' B' ' 210' ' ' GLY . 35.1 m -105.25 12.21 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.181 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 48.79 41.59 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.969 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 168' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' B' ' 238' ' ' ARG . 0.1 OUTLIER -136.55 115.6 10.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 110.206 -179.953 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 169' ' ' PRO . . . . . 0.464 ' HB2' ' CB ' ' B' ' 239' ' ' LYS . 46.4 Cg_endo -72.28 140.21 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.904 1.476 . . . . 0.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.51 ' CD1' ' HA2' ' B' ' 210' ' ' GLY . 2.8 mp -130.17 151.43 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.616 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.5 88.32 7.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.803 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.579 ' CD1' HG23 ' B' ' 208' ' ' VAL . 68.9 mt -51.01 -23.69 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -55.37 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.202 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.63 -46.56 74.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.451 ' O ' HD12 ' B' ' 175' ' ' LEU . 10.3 tp -62.92 -36.95 85.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -1.155 . . . . 0.0 110.446 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 176' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' B' ' 185' ' ' TYR . . . -66.51 -19.87 65.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.277 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -93.84 -35.27 12.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 p -81.36 -26.71 35.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.046 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 179' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' B' ' 183' ' ' SER . 26.4 m-70 -122.83 12.82 9.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -0.853 . . . . 0.0 110.041 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.09 -36.59 5.3 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -26.1 65.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -1.144 . . . . 0.0 110.499 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -122.48 -18.89 6.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 110.344 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' B' ' 195' ' ' TYR . 57.8 m -115.83 165.61 12.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.432 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 2.5 p -141.46 143.2 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.403 -0.811 . . . . 0.0 109.987 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 185' ' ' TYR . . . . . 0.557 ' CD1' ' HB3' ' B' ' 172' ' ' LEU . 78.4 t80 -133.15 94.54 3.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 186' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' B' ' 190' ' ' PHE . 27.4 mt-10 -100.59 102.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.763 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 187' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' B' ' 185' ' ' TYR . 45.4 Cg_endo -71.5 -6.94 20.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.687 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.75 -13.99 18.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 189' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' B' ' 189' ' ' LEU . 2.4 tt -137.03 3.64 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 190' ' ' PHE . . . . . 0.478 ' HB2' HD23 ' B' ' 189' ' ' LEU . 1.4 t80 -169.73 113.4 0.49 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.211 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -19.66 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.923 1.486 . . . . 0.0 110.176 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 192' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' B' ' 172' ' ' LEU . . . -99.64 176.6 28.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 193' ' ' LEU . . . . . 0.457 ' CB ' HD22 ' B' ' 172' ' ' LEU . 5.7 tt -110.69 132.97 53.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 194' ' ' ILE . . . . . 0.812 HD12 HD22 ' A' ' 62' ' ' LEU . 6.8 mt -93.69 106.6 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.302 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 195' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' B' ' 183' ' ' SER . 3.9 t80 -101.33 107.48 18.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 196' ' ' ARG . . . . . 0.51 ' CG ' HG22 ' B' ' 203' ' ' VAL . 1.0 OUTLIER -92.12 99.72 12.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 110.103 -179.974 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 197' ' ' MET . . . . . 0.542 ' HE1' ' HB3' ' B' ' 229' ' ' ALA . 41.5 ttm -70.31 145.05 51.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.266 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.66 -39.14 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 199' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 1.0 OUTLIER -139.7 114.72 8.0 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.91 179.976 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 200' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -72.2 167.32 77.39 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.946 -2.106 . . . . 0.0 110.639 0.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -76.27 93.58 3.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 202' ' ' ILE . . . . . 0.833 HD11 ' CB ' ' B' ' 217' ' ' ALA . 4.5 mt -146.21 165.91 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.914 . . . . 0.0 110.342 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.51 HG22 ' CG ' ' B' ' 196' ' ' ARG . 26.0 t -111.09 119.32 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.43 -0.793 . . . . 0.0 109.661 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 204' ' ' LEU . . . . . 0.573 HD21 ' HB1' ' B' ' 226' ' ' ALA . 5.0 mp -106.37 117.95 35.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.662 HD12 ' HB ' ' B' ' 213' ' ' VAL . 3.4 mt -97.18 119.9 36.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 206' ' ' ILE . . . . . 0.597 HG23 HD21 ' B' ' 234' ' ' LEU . 17.9 mm -98.5 141.22 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.381 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.43 144.98 47.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.035 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.579 HG23 ' CD1' ' B' ' 172' ' ' LEU . 75.5 t -51.66 -24.72 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.291 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.9 t -78.16 -19.37 54.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.096 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.578 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 108.68 5.82 31.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 211' ' ' LYS . . . . . 0.788 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.5 OUTLIER -73.24 137.71 45.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 109.951 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 212' ' ' ILE . . . . . 0.788 HD13 ' O ' ' B' ' 211' ' ' LYS . 17.2 mm -125.37 131.55 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.557 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.662 ' HB ' HD12 ' B' ' 205' ' ' LEU . 21.8 t -114.3 150.28 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.821 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.523 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.2 mp -141.81 111.69 6.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 110.381 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 215' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 15.2 t -134.12 151.61 51.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.125 -0.984 . . . . 0.0 110.155 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.54 -5.4 48.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 217' ' ' ALA . . . . . 0.833 ' CB ' HD11 ' B' ' 202' ' ' ILE . . . -64.71 172.94 2.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -1.143 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -116.57 -16.44 10.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -167.42 163.14 14.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -51.85 -21.9 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.303 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -68.75 -35.93 77.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.54 -53.63 11.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 110.322 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.416 HG22 ' CG ' ' B' ' 65' ' ' PRO . 32.8 mm -50.53 -44.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.63 -34.71 77.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -36.31 59.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 226' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -57.88 -35.7 71.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.298 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 227' ' ' PHE . . . . . 0.643 ' HA ' HG22 ' B' ' 230' ' ' ILE . 20.7 t80 -80.85 -46.3 15.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -58.71 -27.61 65.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' B' ' 197' ' ' MET . . . -83.05 -36.78 24.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.643 HG22 ' HA ' ' B' ' 227' ' ' PHE . 0.8 OUTLIER -89.65 -11.94 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.916 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 231' ' ' TYR . . . . . 0.566 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -43.14 -50.53 14.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.799 . . . . 0.0 110.783 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 232' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.8 Cg_endo -73.27 -44.35 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.599 1.316 . . . . 0.0 110.624 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.65 -30.62 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 109.986 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 234' ' ' LEU . . . . . 0.597 HD21 HG23 ' B' ' 206' ' ' ILE . 9.8 mt -77.09 -47.67 19.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.187 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -21.15 63.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 236' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.2 OUTLIER -70.61 -54.3 12.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.83 . . . . 0.0 110.011 179.838 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.99 34.42 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -64.43 -178.23 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.516 -0.74 . . . . 0.0 110.571 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 239' ' ' LYS . . . . . 0.464 ' CB ' ' HB2' ' B' ' 169' ' ' PRO . 1.2 tttp -114.92 -33.74 5.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.139 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 15.7 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.262 -179.834 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.256 0.55 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.51 -163.44 22.5 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.2 t -118.54 163.33 16.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -1.159 . . . . 0.0 110.096 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mt -106.0 115.76 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.73 85.17 1.6 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.511 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 2.2 m120 -80.41 155.09 27.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.32 -1.106 . . . . 0.0 110.228 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.59 162.88 11.68 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.952 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -108.05 170.01 8.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -1.146 . . . . 0.0 109.756 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.55 ' HA ' HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -88.61 93.08 9.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 111.233 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.952 HD21 HD21 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -99.79 23.14 10.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 1.025 HG22 HG23 ' A' ' 56' ' ' ILE . 3.4 m -52.22 -31.47 32.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.919 -1.113 . . . . 0.0 109.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.74 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -91.9 -26.4 19.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.824 HG13 HD22 ' A' ' 20' ' ' LEU . 1.8 mm -50.74 -48.8 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.332 . . . . 0.0 108.944 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.7 OUTLIER -78.69 -10.68 59.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 0.0 110.193 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.482 ' HB2' ' HA2' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -87.99 -15.22 37.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 110.859 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 148.78 81.78 0.04 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.116 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.635 ' HB2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 33.04 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.067 0.937 . . . . 0.0 112.719 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.0 OUTLIER -139.78 165.02 22.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.767 -1.208 . . . . 0.0 109.765 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.877 ' O ' HD12 ' A' ' 28' ' ' ILE . 69.8 m-20 -88.71 126.63 35.41 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 60.0 p -37.74 -28.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.113 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' ASP . 31.0 mt-10 -57.59 -12.7 2.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 110.447 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 13.88 17.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -96.33 115.5 27.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -1.149 . . . . 0.0 109.515 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.109 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -89.05 138.72 31.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 109.431 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.109 ' N ' HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -131.72 -178.96 5.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.897 -1.127 . . . . 0.0 111.506 -179.119 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.544 ' N ' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -136.17 122.5 20.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.66 . . . . 0.0 109.864 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 36' ' ' GLN . 1.3 t70 -41.68 -37.07 1.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.309 -0.869 . . . . 0.0 110.425 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -98.98 170.11 8.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 110.078 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -119.02 151.43 38.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.98 122.95 2.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -106.4 27.06 9.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -1.173 . . . . 0.0 110.354 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.14 170.56 14.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 7.6 ttm180 -86.57 11.34 12.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -1.088 . . . . 0.0 110.306 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.32 106.85 0.2 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 46' ' ' THR . . . -159.84 -160.14 10.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' GLY . 3.9 t -43.48 131.55 4.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -1.147 . . . . 0.0 110.298 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.4 164.87 13.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.87 141.87 28.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -1.121 . . . . 0.0 110.246 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -62.97 -147.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -0.933 . . . . 0.0 109.841 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -99.53 31.1 3.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.15 -0.969 . . . . 0.0 110.049 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 26.8 pt-20 -100.85 -21.12 15.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.828 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 52' ' ' LEU . 5.1 mt -102.1 -45.04 5.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 110.694 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.843 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.29 -54.36 21.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.381 -0.824 . . . . 0.0 110.056 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -68.52 -19.86 64.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 44.6 m-20 -86.62 -37.88 17.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 21' ' ' THR . 11.3 mt -52.56 -48.32 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.423 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.11 -22.02 4.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -124.53 8.97 8.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 56' ' ' ILE . 12.3 mt -75.17 -2.23 26.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.047 . . . . 0.0 110.272 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.72 42.42 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -143.89 13.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.779 ' CD1' HG21 ' B' ' 194' ' ' ILE . 3.7 pp -133.32 -31.9 1.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 110.655 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.527 ' N ' HD12 ' A' ' 62' ' ' LEU . . . -175.37 -40.11 0.05 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.637 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.7 mm? -49.84 -20.53 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -1.226 . . . . 0.0 110.531 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -46.89 -39.9 13.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 109.916 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.9 -51.0 60.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.81 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -72.37 -1.98 17.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.623 HD23 ' OG1' ' A' ' 21' ' ' THR . 1.5 tm? -76.46 -60.56 2.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.967 0.889 . . . . 0.0 108.944 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -78.87 0.53 26.87 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.251 0.548 . . . . 0.0 109.993 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 66' ' ' SER . 5.2 tt0 -88.16 8.55 26.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 111.364 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.013 HG12 HG11 ' B' ' 122' ' ' VAL . 2.1 t -138.19 1.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.941 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.019 HD11 ' CD1' ' A' ' 74' ' ' LEU . 4.1 tp -149.08 73.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 6.8 p-10 -75.96 55.77 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.173 -0.954 . . . . 0.0 108.843 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.019 ' CD1' HD11 ' A' ' 72' ' ' ILE . 6.0 mt -85.88 59.49 5.67 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.583 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.511 ' HG3' ' CB ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -139.91 37.32 1.97 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.719 -0.613 . . . . 0.0 109.985 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -141.92 24.95 1.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 110.423 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.175 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.208 0.528 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.74 63.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 35.6 mm -126.83 -55.79 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 110.015 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 5.3 t 62.11 129.28 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.58 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 49.8 Cg_endo -77.57 135.46 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 124.026 1.54 . . . . 0.0 110.253 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -97.59 137.77 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' B' ' 67' ' ' LEU . 20.2 mt -72.68 135.22 45.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -114.64 -29.96 6.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 1.8 m120 -170.0 171.78 6.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 110.119 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.834 HG22 ' HB3' ' B' ' 126' ' ' ALA . 0.5 OUTLIER -144.6 160.6 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.081 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.575 HG22 ' OG1' ' B' ' 124' ' ' THR . 20.5 t -134.96 132.37 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.851 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.29 156.21 48.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.33 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 13.5 m -108.7 144.25 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' B' ' 121' ' ' MET . 8.1 t -132.18 156.89 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 109.961 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -130.15 130.56 44.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.981 HD22 ' HB1' ' B' ' 150' ' ' ALA . 53.3 mt -82.31 -19.65 38.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLY . . . . . 0.418 ' C ' ' SG ' ' B' ' 78' ' ' CYS . . . 79.75 4.53 89.44 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' CYS . . . . . 0.418 ' SG ' ' C ' ' B' ' 77' ' ' GLY . 23.1 m -143.66 146.72 33.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -1.181 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.682 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -78.95 153.02 30.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' B' ' 76' ' ' LEU . 14.4 mt -132.42 167.62 19.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 2.8 t70 -99.88 94.77 6.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.628 HD22 HG23 ' B' ' 102' ' ' VAL . 26.2 mt -40.94 -46.15 2.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -0.837 . . . . 0.0 110.827 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -54.51 -48.84 71.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.549 HG23 ' CE1' ' B' ' 88' ' ' HIS . 20.1 m -77.57 -38.54 48.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 110.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 55.3 t -54.73 -47.9 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.062 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.37 -29.56 63.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.023 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 28.5 tp -78.21 -30.16 48.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 109.987 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.549 ' CE1' HG23 ' B' ' 84' ' ' THR . 0.7 OUTLIER -91.5 -25.76 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.945 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.01 131.82 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 110.071 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 -69.53 -29.74 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -133.5 79.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -143.31 152.79 42.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -130.3 136.97 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.149 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -125.89 101.54 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 110.386 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.21 110.33 63.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.861 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.82 -15.38 26.67 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.057 1.556 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.45 -15.29 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.651 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -102.65 -43.09 5.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.081 -1.012 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.762 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -165.19 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 111.314 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.29 54.0 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.143 -0.973 . . . . 0.0 111.128 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.935 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -149.42 166.14 29.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.628 HG23 HD22 ' B' ' 82' ' ' LEU . 66.8 t -99.43 166.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.93 . . . . 0.0 109.985 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.55 ' CD1' ' HB3' ' B' ' 114' ' ' LEU . 23.1 mm -129.84 107.45 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.38 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.54 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.0 OUTLIER -89.67 164.72 14.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.009 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.71 135.24 6.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 19.0 pt -133.58 159.48 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.795 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' B' ' 108' ' ' GLU . 1.4 ptt180 -102.62 17.65 23.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.523 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.5 OUTLIER -161.05 88.94 1.63 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 110.446 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.3 Cg_endo -75.88 162.37 92.4 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.35 -0.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -74.36 83.54 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.055 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' B' ' 124' ' ' THR . 14.6 p -134.05 178.4 6.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 110.272 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.513 HG22 HG23 ' B' ' 124' ' ' THR . 5.2 t -131.82 159.24 39.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -152.8 155.44 37.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.966 -1.084 . . . . 0.0 110.868 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.55 ' HB3' ' CD1' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -131.66 115.1 15.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.739 . . . . 0.0 109.611 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' B' ' 121' ' ' MET . 10.8 mt -96.37 146.08 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.946 . . . . 0.0 110.753 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 3.5 m-30 -104.51 157.81 16.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.374 -0.829 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.91 -15.43 30.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.353 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 60.2 p -84.8 4.5 32.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.09 -28.59 7.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 3.6 ttmt -67.88 127.91 34.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -1.169 . . . . 0.0 110.116 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.425 ' HB3' HG12 ' B' ' 115' ' ' ILE . 0.2 OUTLIER -136.03 157.72 46.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 1.013 HG11 HG12 ' A' ' 71' ' ' VAL . 11.4 t -123.06 129.86 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.366 -0.834 . . . . 0.0 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' B' ' 139' ' ' TYR . 60.2 t -113.85 139.55 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.476 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.575 ' OG1' HG22 ' B' ' 71' ' ' VAL . 10.2 t -142.6 156.83 45.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.524 ' CA ' ' HB3' ' A' ' 27' ' ' ASN . . . 123.83 -13.89 8.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.834 ' HB3' HG22 ' B' ' 70' ' ' ILE . . . -76.87 158.71 30.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.117 . . . . 0.0 110.029 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.414 ' C ' ' OG ' ' B' ' 128' ' ' SER . 25.2 mtmt -109.47 -1.15 18.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.278 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -163.89 -170.12 2.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 129' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.0 OUTLIER -68.44 -60.58 2.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -55.86 -31.95 63.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.409 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 9.9 m-20 -65.04 -42.1 94.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.72 -38.69 32.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' LYS . . . . . 0.423 ' CG ' ' CE2' ' B' ' 155' ' ' PHE . 10.8 mttm -53.1 -39.5 63.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.118 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.4 -47.04 29.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.97 -43.59 70.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.01 -55.71 26.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -46.21 -44.8 16.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 110.082 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -57.79 -51.35 69.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' B' ' 104' ' ' MET . 22.7 m-85 -58.2 -57.63 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.28 -31.68 14.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.11 62.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.312 -0.868 . . . . 0.0 109.855 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.423 HG21 ' SD ' ' B' ' 104' ' ' MET . 50.5 mt -45.03 -38.86 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.985 HG21 ' HB2' ' B' ' 150' ' ' ALA . 41.0 mm -69.37 -52.73 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.676 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -64.97 -28.48 69.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -75.1 -21.2 59.06 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.29 -21.24 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.74 -22.26 5.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' B' ' 143' ' ' ILE . 23.2 m-85 -64.41 179.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.312 . . . . 0.0 111.199 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -113.76 36.35 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.592 -0.692 . . . . 0.0 110.304 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.985 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -60.46 148.33 37.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.97 . . . . 0.0 110.201 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -113.47 -157.97 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.227 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' B' ' 152' ' ' PHE . 1.0 OUTLIER -147.09 77.93 1.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 110.077 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -144.75 178.95 7.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' B' ' 153' ' ' THR . 15.1 t0 66.97 22.3 10.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 110.298 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' B' ' 73' ' ' THR . 8.4 t80 -77.38 132.74 38.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -164.97 133.48 3.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.149 -0.969 . . . . 0.0 110.731 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.461 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 33.9 mt -81.2 108.37 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.721 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -101.09 -2.04 32.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.746 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.47 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 0.7 OUTLIER -152.24 120.36 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.936 -1.103 . . . . 0.0 110.983 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.38 137.76 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 109.428 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -106.99 135.28 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 110.798 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.78 177.08 20.77 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.1 OUTLIER -169.65 153.33 4.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.246 . . . . 0.0 110.722 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 24.6 p -169.11 165.46 11.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 109.824 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 22.4 p-10 -115.94 134.05 55.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.328 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.846 HG21 HD11 ' B' ' 170' ' ' ILE . 33.6 m -80.06 4.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 110.089 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.59 -4.51 2.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.49 -0.756 . . . . 0.0 111.138 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.732 ' H ' HG23 ' B' ' 166' ' ' VAL . 22.4 p90 -145.91 153.11 49.47 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.9 -1.125 . . . . 0.0 110.532 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.51 159.72 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.072 1.564 . . . . 0.0 110.329 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.846 HD11 HG21 ' B' ' 166' ' ' VAL . 2.1 mp -128.38 152.93 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.514 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -82.11 101.45 10.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.81 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.521 HD22 ' HB2' ' B' ' 193' ' ' LEU . 18.8 mt -55.0 -42.03 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 110.512 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.92 -21.61 59.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.14 -45.52 31.27 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 1.015 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -67.84 -36.67 80.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.88 61.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.303 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -91.12 -16.37 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' SER . . . . . 0.534 ' OG ' ' CZ ' ' B' ' 237' ' ' PHE . 0.3 OUTLIER -99.59 -33.37 10.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -120.89 37.06 4.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.42 -21.2 6.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' THR . . . . . 0.461 ' O ' ' CG ' ' B' ' 182' ' ' PHE . 16.2 p -87.53 23.47 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.506 ' CZ ' HG22 ' B' ' 198' ' ' VAL . 0.9 OUTLIER -169.82 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.282 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 13.5 p -89.98 151.07 21.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.276 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.9 m -128.69 148.73 50.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -158.1 112.6 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.55 104.02 53.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.94 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.35 -3.17 12.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.467 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.8 -7.32 30.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' B' ' 190' ' ' PHE . 2.5 tt -148.66 -44.02 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 110.551 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.699 ' HB2' HD23 ' B' ' 189' ' ' LEU . 12.6 t80 -117.12 110.17 41.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 191' ' ' PRO . . . . . 0.513 ' O ' HD13 ' B' ' 172' ' ' LEU . 45.6 Cg_endo -74.79 -12.81 22.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.924 1.486 . . . . 0.0 110.21 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.514 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -92.9 179.52 39.77 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.863 HD23 ' N ' ' B' ' 194' ' ' ILE . 3.7 tt -115.18 148.34 39.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 110.102 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.863 ' N ' HD23 ' B' ' 193' ' ' LEU . 4.3 mt -123.3 103.37 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.279 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.503 ' CD1' HD13 ' B' ' 230' ' ' ILE . 27.0 t80 -95.03 120.47 35.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 197' ' ' MET . 1.8 ttp180 -90.03 82.62 6.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.427 ' C ' ' O ' ' B' ' 196' ' ' ARG . 31.2 tpp -42.63 130.16 4.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.506 HG22 ' CZ ' ' B' ' 182' ' ' PHE . 14.9 t -70.51 -52.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 8.5 ttpp -143.68 117.11 5.92 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.1 Cg_endo -71.98 171.89 59.82 Favored 'Cis proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.025 -2.073 . . . . 0.0 110.601 -0.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -82.31 108.69 15.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.138 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' B' ' 217' ' ' ALA . 9.2 mt -150.8 155.95 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.496 HG13 HG23 ' B' ' 194' ' ' ILE . 70.0 t -105.39 131.21 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 109.671 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.506 HD22 HG21 ' B' ' 230' ' ' ILE . 5.3 mp -119.19 123.04 43.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.508 HD22 ' N ' ' B' ' 205' ' ' LEU . 4.4 mm? -94.12 124.04 37.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.517 HG12 HD12 ' B' ' 212' ' ' ILE . 2.5 mp -124.55 122.44 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.514 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 95.6 m-85 -110.36 149.84 29.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 40.8 t -45.73 -24.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -29.23 70.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.363 -0.836 . . . . 0.0 110.331 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 109.85 2.91 30.31 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 123.61 27.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -1.156 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.517 HD12 HG12 ' B' ' 206' ' ' ILE . 19.4 mm -116.56 125.43 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.64 ' C ' HD12 ' B' ' 214' ' ' LEU . 4.0 t -110.62 154.82 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.052 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.64 HD12 ' C ' ' B' ' 213' ' ' VAL . 5.2 mp -141.87 103.35 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -0.884 . . . . 0.0 110.481 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.476 ' O ' HG23 ' B' ' 202' ' ' ILE . 13.3 t -126.66 152.57 46.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.984 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.473 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 106.64 -4.41 36.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' B' ' 202' ' ' ILE . . . -68.87 162.67 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -1.193 . . . . 0.0 110.013 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -114.68 -6.9 12.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.15 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' B' ' 222' ' ' GLU . 1.9 tt0 -159.66 147.44 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' B' ' 219' ' ' GLN . 20.7 ttm180 -43.85 -37.25 2.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -61.43 -34.07 74.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 110.156 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.593 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 6.2 mt-10 -63.73 -53.31 53.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 110.254 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.518 HG12 ' CB ' ' B' ' 217' ' ' ALA . 18.7 mm -57.71 -42.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.46 ' CE2' HG13 ' B' ' 64' ' ' VAL . 2.7 m-85 -66.56 -28.84 68.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.107 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 2.6 tt0 -82.4 -50.06 9.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.153 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' B' ' 225' ' ' GLN . . . -45.51 -43.59 11.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.728 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 26.2 t80 -69.69 -41.46 75.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -15.38 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.174 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -92.53 -42.0 9.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 110.027 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.506 HG21 HD22 ' B' ' 204' ' ' LEU . 1.5 tp -90.55 -14.74 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.5 t80 -49.28 -49.72 68.72 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.3 Cg_endo -70.39 -45.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.47 1.247 . . . . 0.0 110.272 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 1.015 HG12 HD21 ' B' ' 175' ' ' LEU . 22.4 t -49.96 -39.24 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.705 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.403 HD22 HG21 ' B' ' 170' ' ' ILE . 96.5 mt -73.33 -50.75 20.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.744 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 14.0 t -55.93 -33.16 64.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.17 -32.38 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.77 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.546 ' HD2' HD22 ' B' ' 175' ' ' LEU . 22.5 m-85 -117.36 37.72 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 110.092 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -61.31 171.95 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.127 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -102.49 -47.14 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 110.111 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.93 67.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 p -58.24 174.29 0.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.124 . . . . 0.0 110.251 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 tp -111.76 -18.98 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' HA3' ' HD2' ' A' ' 75' ' ' LYS . . . 85.46 120.22 1.02 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -107.22 -41.5 5.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -1.134 . . . . 0.0 110.485 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' C ' ' CZ ' ' B' ' 99' ' ' PHE . . . 101.78 147.15 19.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.023 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.3 OUTLIER -65.24 171.54 3.72 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.058 -1.26 . . . . 0.0 109.825 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.896 ' N ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -66.91 82.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.174 -0.954 . . . . 0.0 110.762 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.92 HD21 HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -98.59 -0.16 43.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.08 -1.013 . . . . 0.0 110.706 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 59' ' ' LEU . 8.2 m -45.98 -29.34 1.41 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.57 -32.26 5.78 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.875 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -55.81 -43.07 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 108.738 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.009 HD13 ' SD ' ' A' ' 67' ' ' MET . 3.4 pp -82.4 -28.71 31.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.545 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.2 OUTLIER -93.36 13.12 22.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.397 -0.814 . . . . 0.0 108.871 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.587 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 142.85 94.46 0.2 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 1.008 ' ND2' HD11 ' A' ' 35' ' ' LEU . 7.0 p30 -20.27 132.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.031 0.919 . . . . 0.0 112.39 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.714 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -147.11 163.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 31' ' ' GLU . 80.3 m-20 -87.3 124.2 33.1 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.023 ' HB2' HD13 ' A' ' 18' ' ' LEU . 5.3 p -37.96 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.793 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.4 mm-40 -55.1 -15.99 2.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 110.164 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.86 27.49 5.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.492 ' CD ' ' C ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -123.33 121.22 35.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.098 -1.236 . . . . 0.0 110.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -94.24 157.8 15.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.759 -1.213 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.008 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp -136.38 -179.19 5.53 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.997 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.636 ' N ' HD12 ' A' ' 35' ' ' LEU . 11.5 mt-30 -152.65 13.91 0.55 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -0.901 . . . . 0.0 110.399 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 36' ' ' GLN . 1.4 m-20 71.74 -53.17 0.69 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.256 -0.902 . . . . 0.0 110.382 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.5 t70 60.54 30.55 19.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.863 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.469 ' HB2' ' HD3' ' B' ' 110' ' ' LYS . 0.3 OUTLIER -145.69 70.05 1.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.802 . . . . 0.0 109.945 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' ASP . . . -41.83 -90.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -125.86 -32.46 2.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.31 -52.42 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -167.96 56.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -1.173 . . . . 0.0 110.368 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.33 153.81 23.14 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.08 140.53 2.95 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.7 -80.03 0.59 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.317 -1.108 . . . . 0.0 110.076 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.93 153.7 9.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 49' ' ' ASP . 5.4 m-85 -73.71 141.59 46.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -1.164 . . . . 0.0 110.168 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 48' ' ' PHE . 25.8 t0 -48.65 178.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.102 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.17 26.05 1.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 110.324 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -100.87 -17.73 16.71 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 52' ' ' LEU . 4.0 mt -99.26 -44.24 6.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.436 -0.79 . . . . 0.0 110.384 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.008 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.21 -54.25 42.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 110.085 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -67.41 -22.47 65.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.475 -0.765 . . . . 0.0 110.211 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.58 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 7.0 m-80 -87.4 -28.65 22.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.31 -0.869 . . . . 0.0 109.186 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' A' ' 53' ' ' ARG . 12.6 mt -56.93 -48.3 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.462 -0.773 . . . . 0.0 108.981 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.49 -22.09 5.11 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.413 ' HB3' HD11 ' B' ' 189' ' ' LEU . 0.5 OUTLIER -130.07 25.76 5.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.847 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.789 HD21 ' CE2' ' B' ' 190' ' ' PHE . 6.2 mt -92.79 22.63 4.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.01 . . . . 0.0 109.88 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.38 52.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.687 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -169.82 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.697 ' CD1' HD23 ' A' ' 59' ' ' LEU . 3.4 mt -112.79 -50.03 2.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 109.805 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.85 -31.11 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -75.2 0.92 14.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.787 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' LEU . 10.5 t70 -43.71 -41.34 4.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.777 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -46.23 78.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.414 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . 1.009 ' SD ' HD13 ' A' ' 24' ' ' LEU . 15.9 ttm -65.99 -9.61 31.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 109.417 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.0 tm? -71.41 -61.73 1.67 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.987 0.899 . . . . 0.0 108.687 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.61 -1.74 26.0 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.528 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 11.9 tt0 -85.9 11.59 11.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.272 -0.893 . . . . 0.0 111.347 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.953 ' O ' HG21 ' B' ' 122' ' ' VAL . 2.2 t -144.88 3.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.963 -1.085 . . . . 0.0 110.565 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.002 ' CD1' HD23 ' A' ' 18' ' ' LEU . 4.1 tp -147.33 74.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.7 54.38 1.8 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.144 -0.972 . . . . 0.0 108.553 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.133 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 7.5 mt -103.96 66.94 0.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.564 0.697 . . . . 0.0 110.397 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 3.5 pttm -147.11 70.03 1.18 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.634 -0.666 . . . . 0.0 110.178 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 48.1 35.46 5.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.237 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.271 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.201 0.524 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' B' ' 64' ' ' VAL . . . 117.94 85.45 1.06 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.641 HG22 ' SG ' ' B' ' 164' ' ' CYS . 2.3 mp 64.57 -56.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.57 -0.959 . . . . 0.0 111.024 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' B' ' 62' ' ' GLY . 5.9 t 63.76 139.4 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 109.987 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.744 ' HG2' HG22 ' B' ' 223' ' ' ILE . 45.1 Cg_endo -72.32 135.67 25.06 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.115 1.587 . . . . 0.0 110.856 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 51.6 m -100.18 136.84 39.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.663 HD22 ' CG2' ' B' ' 160' ' ' ILE . 84.6 mt -70.4 133.79 47.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -130.82 -3.29 4.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 110.348 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.7 OUTLIER -162.51 126.41 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.332 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.971 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 14.1 mm -115.21 157.17 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.504 HG22 ' HB ' ' B' ' 124' ' ' THR . 7.7 t -141.82 121.53 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 109.692 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.5 162.88 26.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 110.549 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' THR . . . . . 0.587 HG22 HG22 ' B' ' 122' ' ' VAL . 18.1 p -121.85 135.4 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.538 HG11 ' CD1' ' B' ' 152' ' ' PHE . 13.0 t -125.23 148.45 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 17.5 m -118.08 142.19 47.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.888 HD22 ' HB1' ' B' ' 150' ' ' ALA . 40.6 mt -101.29 -50.86 3.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.075 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.56 -12.5 23.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.46 172.46 9.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.623 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.5 OUTLIER -101.71 150.53 23.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.184 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.623 HD23 ' O ' ' B' ' 79' ' ' ARG . 17.4 mt -126.23 175.78 7.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -0.908 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.59 96.85 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.049 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.612 HD22 HG23 ' B' ' 102' ' ' VAL . 17.7 mt -43.87 -41.13 4.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.875 . . . . 0.0 110.329 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' B' ' 94' ' ' TYR . 12.8 mmtp -55.55 -47.45 76.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 110.343 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -79.91 -41.24 26.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 54.4 t -54.8 -54.59 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.933 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.71 69.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.927 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 34.9 tp -81.84 -25.1 35.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -98.34 -42.27 7.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.127 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -47.6 133.2 13.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.066 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ARG . . . . . 0.506 ' HG3' ' N ' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -70.63 -25.28 62.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.506 ' N ' ' HG3' ' B' ' 90' ' ' ARG . 1.2 m-20 -138.7 79.18 1.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.345 -0.847 . . . . 0.0 109.794 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.814 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -159.13 171.9 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.531 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.529 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -157.23 172.01 19.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 110.051 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.435 ' CD2' ' HE3' ' B' ' 83' ' ' LYS . 18.6 t80 -135.7 129.21 32.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' B' ' 95' ' ' ASN . 6.7 p30 -123.17 102.34 37.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.095 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.32 -26.06 17.83 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.015 1.534 . . . . 0.0 110.479 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -75.43 -20.94 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -100.07 -71.64 0.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -149.3 163.5 37.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 110.402 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.411 ' O ' HD11 ' B' ' 82' ' ' LEU . . . -82.51 47.96 1.24 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 109.305 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.133 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -126.35 144.5 50.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.904 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.612 HG23 HD22 ' B' ' 82' ' ' LEU . 6.8 t -90.02 124.95 42.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.529 ' HB ' ' CG ' ' B' ' 93' ' ' GLU . 8.8 mm -88.27 110.35 20.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.857 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.814 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 3.1 ttm -106.49 161.08 14.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 110.387 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' B' ' 111' ' ' THR . 0.5 OUTLIER -162.29 126.6 3.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.893 . . . . 0.0 110.293 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.64 HG23 ' CE1' ' B' ' 139' ' ' TYR . 37.4 pt -107.85 176.37 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.981 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.475 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -120.04 42.05 3.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER 170.7 85.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 48.8 Cg_endo -78.3 160.23 91.81 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.723 -2.199 . . . . 0.0 110.467 -0.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.476 ' O ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -67.56 105.25 1.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.95 . . . . 0.0 109.777 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.666 HG22 ' HA3' ' B' ' 125' ' ' GLY . 11.2 p -152.85 176.67 11.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.615 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.85 HG22 HG23 ' B' ' 124' ' ' THR . 5.3 t -131.37 171.42 13.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -156.74 141.61 17.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.991 -1.068 . . . . 0.0 110.642 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.818 HD22 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -98.53 103.78 15.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.449 -0.782 . . . . 0.0 109.048 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' B' ' 104' ' ' MET . 4.4 mt -89.76 135.74 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.119 -0.988 . . . . 0.0 110.61 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.905 ' CD1' HD11 ' A' ' 74' ' ' LEU . 3.0 m-30 -110.35 150.72 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.102 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.514 ' O ' ' CG ' ' B' ' 79' ' ' ARG . . . -70.05 -10.9 60.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.274 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -7.37 53.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.508 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 105.77 -18.61 40.23 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -88.32 160.07 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -1.183 . . . . 0.0 110.246 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 3.3 ptm -156.69 164.44 38.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.252 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.953 HG21 ' O ' ' A' ' 71' ' ' VAL . 35.7 t -128.57 161.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 110.485 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.418 ' N ' HG12 ' B' ' 122' ' ' VAL . 53.3 t -138.76 151.23 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.015 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.85 HG23 HG22 ' B' ' 112' ' ' THR . 1.2 t -157.23 164.26 37.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 110.344 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.666 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 110.79 -39.2 2.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.971 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.48 158.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -1.106 . . . . 0.0 110.317 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -124.05 -6.02 7.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.6 175.44 9.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.146 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.59 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.22 -16.71 5.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.264 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.678 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 0.3 OUTLIER -72.3 -49.66 32.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -25.06 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 110.422 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -78.91 -26.09 43.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.521 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.473 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 7.4 mt -79.12 -49.82 12.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -65.79 -30.83 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 51.0 p -67.97 -60.57 2.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.198 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' B' ' 134' ' ' LEU . 1.4 ptm180 -54.68 -33.19 60.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.006 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.422 ' O ' HG13 ' B' ' 142' ' ' ILE . 0.1 OUTLIER -65.91 -40.78 91.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 0.0 110.074 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.64 ' CE1' HG23 ' B' ' 106' ' ' ILE . 11.7 m-85 -65.98 -49.25 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' B' ' 152' ' ' PHE . . . -55.62 -30.58 61.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -71.94 -31.68 66.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 138' ' ' LYS . 34.5 mt -61.79 -42.7 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.626 HD12 ' N ' ' B' ' 143' ' ' ILE . 1.8 mp -67.51 -44.5 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -72.94 -30.05 63.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.655 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -20.11 61.52 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.412 HD13 HG21 ' B' ' 146' ' ' ILE . 3.6 mt -86.14 -24.07 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.72 -26.27 3.65 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.535 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.497 ' CD1' HD22 ' B' ' 80' ' ' LEU . 12.3 m-85 -52.27 158.16 1.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.943 -1.328 . . . . 0.0 110.988 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.65 34.72 2.16 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.888 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -68.57 169.6 10.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.352 -0.842 . . . . 0.0 110.421 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.9 OUTLIER -148.91 112.74 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 110.264 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.573 ' O ' HG23 ' B' ' 153' ' ' THR . 83.5 t80 -58.97 108.34 0.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 152' ' ' PHE . 1.4 p -156.18 169.37 24.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' B' ' 153' ' ' THR . 4.2 t70 62.41 28.84 17.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.217 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -70.91 134.02 46.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.953 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.91 131.41 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.496 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.435 ' C ' ' HG2' ' B' ' 158' ' ' GLN . 14.7 mt -82.91 131.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.435 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 3.6 mt-30 -128.76 0.32 5.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.781 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.462 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 2.1 t-20 -147.79 110.11 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.921 -1.112 . . . . 0.0 110.709 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.663 ' CG2' HD22 ' B' ' 67' ' ' LEU . 66.4 mt -113.26 141.35 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.589 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.575 HG22 ' OG1' ' B' ' 215' ' ' THR . 72.8 t -115.93 130.05 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.13 -0.981 . . . . 0.0 110.645 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.97 168.3 19.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 1.0 OUTLIER -166.57 149.44 6.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.262 . . . . 0.0 110.545 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.641 ' SG ' HG22 ' B' ' 63' ' ' ILE . 0.8 OUTLIER -170.07 170.18 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.021 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 164.08 12.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.032 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.797 HG21 HD11 ' B' ' 170' ' ' ILE . 32.6 m -113.2 11.97 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.279 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.53 -2.25 2.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.585 ' O ' HG23 ' B' ' 166' ' ' VAL . 26.1 p90 -161.37 150.09 13.09 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.987 -1.071 . . . . 0.0 110.568 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.508 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 47.8 Cg_endo -73.88 170.24 20.53 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.133 1.596 . . . . 0.0 110.732 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.797 HD11 HG21 ' B' ' 166' ' ' VAL . 4.4 mp -140.36 151.28 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 110.378 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.76 80.27 7.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 109.946 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.792 HD21 HG22 ' B' ' 206' ' ' ILE . 18.9 mt -47.07 -37.97 10.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 110.42 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.17 -55.27 22.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.24 92.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 18.3 tp -70.12 -39.67 75.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -1.169 . . . . 0.0 110.373 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.64 -26.69 67.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.955 . . . . 0.0 110.18 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -77.01 -30.05 55.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 1.3 p -87.42 -44.64 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -105.72 26.51 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 110.259 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.55 54.85 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.7 m -53.8 -39.03 65.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -1.188 . . . . 0.0 110.433 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' B' ' 198' ' ' VAL . 19.9 m-85 -108.26 -26.97 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.401 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.797 ' HB2' HD21 ' B' ' 193' ' ' LEU . 47.9 p -96.05 158.05 15.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.624 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.2 m -132.43 119.75 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.677 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -125.42 112.13 15.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 110.565 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -118.94 102.55 49.11 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 109.666 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.61 -1.18 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.93 1.489 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -98.95 -3.64 34.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.036 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.509 HD13 ' HE3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -150.93 -37.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.789 ' CE2' HD21 ' A' ' 59' ' ' LEU . 7.8 t80 -127.95 110.98 20.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.86 -17.64 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.888 1.467 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.87 -179.94 44.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' B' ' 183' ' ' SER . 7.6 tt -118.38 130.07 55.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -1.143 . . . . 0.0 110.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.482 HD13 ' CD1' ' A' ' 62' ' ' LEU . 5.7 mt -102.96 100.94 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 109.914 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -91.79 120.26 32.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.471 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' B' ' 203' ' ' VAL . 1.1 mtp180 -92.54 83.45 4.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.475 ' HB2' ' CD1' ' B' ' 204' ' ' LEU . 33.7 tpp -42.11 126.81 3.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.935 . . . . 0.0 110.189 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.507 HG22 ' CE1' ' B' ' 182' ' ' PHE . 61.9 t -63.17 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 8.8 mtmt -137.4 118.13 10.65 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.6 Cg_endo -74.16 169.54 73.53 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.986 -2.089 . . . . 0.0 110.369 -0.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' B' ' 197' ' ' MET . 37.2 mttt -76.85 95.35 4.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.044 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' B' ' 217' ' ' ALA . 31.8 mm -130.96 149.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' B' ' 196' ' ' ARG . 71.4 t -101.83 105.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.032 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.749 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.5 mp -95.82 118.5 32.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.45 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.5 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 0.5 OUTLIER -89.65 117.41 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 109.935 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.792 HG22 HD21 ' B' ' 172' ' ' LEU . 3.2 mt -113.0 136.0 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.351 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.544 ' HA ' HD11 ' B' ' 172' ' ' LEU . 44.7 m-85 -119.62 145.2 46.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 64.3 t -49.19 -24.36 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -62.67 -38.65 91.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 110.133 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.483 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 123.36 8.77 6.29 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -90.06 145.22 25.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.241 . . . . 0.0 110.232 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' B' ' 163' ' ' SER . 30.3 mm -130.05 121.69 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.335 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.516 HG11 ' HE1' ' A' ' 25' ' ' PHE . 57.4 t -113.86 155.74 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.051 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.487 HD12 ' N ' ' B' ' 214' ' ' LEU . 2.6 mp -140.12 121.94 15.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 110.629 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.575 ' OG1' HG22 ' B' ' 161' ' ' VAL . 6.2 t -137.02 146.48 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.886 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 111.18 3.9 27.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -82.99 138.45 33.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -29.27 32.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.582 ' O ' HD12 ' B' ' 160' ' ' ILE . 3.2 tt0 -136.17 -152.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 110.029 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -100.11 -36.89 9.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.432 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 16.0 pt-20 -54.69 -27.38 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.119 -0.988 . . . . 0.0 110.518 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 0.8 OUTLIER -71.61 -47.43 54.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.242 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.744 HG22 ' HG2' ' B' ' 65' ' ' PRO . 40.8 mm -62.63 -37.61 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.29 -29.19 67.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.923 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -37.63 41.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.321 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.749 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -61.32 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.365 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' B' ' 230' ' ' ILE . 27.9 t80 -64.81 -46.54 81.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.394 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.42 -32.68 71.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -85.14 -25.94 27.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.426 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' B' ' 227' ' ' PHE . 8.7 tp -97.2 -17.94 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.595 ' N ' ' CD ' ' B' ' 232' ' ' PRO . 14.3 t80 -59.63 -41.34 85.76 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.943 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -77.93 -47.22 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.36 1.189 . . . . 0.0 110.384 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.49 -50.8 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.724 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.522 ' CD1' HG13 ' B' ' 230' ' ' ILE . 95.7 mt -59.14 -38.13 78.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.833 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 3.4 t -65.53 -39.39 91.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.392 -0.818 . . . . 0.0 109.816 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' GLU . . . . . 0.519 ' HG2' ' CE1' ' B' ' 237' ' ' PHE . 0.8 OUTLIER -60.14 -33.85 72.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.677 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.519 ' CE1' ' HG2' ' B' ' 236' ' ' GLU . 65.2 m-85 -115.39 37.41 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.827 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -62.52 168.64 3.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 0.0 110.257 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.429 ' HB2' ' C ' ' B' ' 169' ' ' PRO . 0.0 OUTLIER -111.84 -33.32 6.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 110.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.196 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.417 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.201 0.524 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.89 165.94 23.28 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.21 37.33 28.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -1.143 . . . . 0.0 110.209 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.0 mt 47.58 90.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.17 172.67 12.64 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 11' ' ' GLU . 1.9 t30 -146.19 -68.73 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -1.095 . . . . 0.0 110.145 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.27 165.24 41.09 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.095 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -107.7 156.68 18.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.227 -1.161 . . . . 0.0 108.94 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 19' ' ' ASP . 1.9 p30 -86.19 109.12 18.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.095 HD21 HD21 ' A' ' 18' ' ' LEU . 3.4 mt -101.17 18.45 19.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.89 HG22 HG23 ' A' ' 56' ' ' ILE . 1.3 m -45.19 -29.86 1.05 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.057 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -98.44 -27.8 8.4 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.495 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.934 HG13 HD22 ' A' ' 20' ' ' LEU . 1.1 mm -52.36 -45.87 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.912 -1.346 . . . . 0.0 109.359 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 67' ' ' MET . 2.0 pp -85.86 -26.51 25.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.608 -1.308 . . . . 0.0 109.665 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CD1' HG21 ' B' ' 215' ' ' THR . 0.5 OUTLIER -83.88 7.41 18.22 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 142.61 106.04 0.57 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 27' ' ' ASN . 6.4 p-10 -24.49 135.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.784 0.802 . . . . 0.0 111.396 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.749 HG23 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -150.42 161.77 3.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.546 ' N ' HG12 ' A' ' 28' ' ' ILE . 5.3 m-20 -87.48 119.2 27.52 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.572 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 1.3 p -39.53 -26.69 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.898 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.543 ' OE2' ' ND2' ' B' ' 95' ' ' ASN . 3.1 tt0 -57.55 -13.37 3.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.117 -0.989 . . . . 0.0 110.43 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.23 27.71 4.67 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.416 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.5 mmt-85 -120.77 122.19 39.83 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.085 -1.244 . . . . 0.0 109.861 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 35' ' ' LEU . 3.1 tt -87.67 162.07 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.933 -1.105 . . . . 0.0 111.738 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.691 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -87.49 101.97 14.12 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.472 -0.767 . . . . 0.0 111.355 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -101.29 12.21 37.88 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 49.12 65.98 1.23 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.703 -0.623 . . . . 0.0 110.332 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 24.8 t70 -54.01 125.88 20.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.232 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 59.6 m-20 -156.9 162.59 39.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.9 . . . . 0.0 110.327 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.56 -0.43 84.3 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -161.54 170.5 19.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -1.147 . . . . 0.0 110.12 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.68 103.63 1.0 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.71 35.8 4.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -1.105 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.08 30.35 4.37 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.53 92.18 2.25 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.71 114.18 15.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.233 -1.157 . . . . 0.0 110.113 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.87 173.54 4.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.604 ' CD1' HD12 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -95.43 -170.98 2.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -1.17 . . . . 0.0 110.301 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -89.88 -177.67 5.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.285 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.8 14.03 11.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 110.072 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.503 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -100.28 -22.13 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.349 -0.844 . . . . 0.0 109.469 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.604 HD12 ' CD1' ' A' ' 48' ' ' PHE . 3.7 mt -95.39 -45.21 7.22 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.546 -0.721 . . . . 0.0 110.157 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.999 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -49.5 -52.47 29.21 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.152 -0.968 . . . . 0.0 109.6 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.79 -23.21 66.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 12.5 m-20 -85.83 -33.99 21.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.999 HD12 ' HA ' ' A' ' 53' ' ' ARG . 15.6 mt -54.22 -42.14 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 109.372 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.35 -14.89 35.96 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.976 ' HB3' HD11 ' B' ' 189' ' ' LEU . 49.7 m -122.07 0.05 9.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.12 -1.223 . . . . 0.0 110.297 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.897 HD23 HD12 ' A' ' 62' ' ' LEU . 1.2 mt -81.38 8.32 9.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -91.18 43.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.697 ' C ' HD23 ' A' ' 62' ' ' LEU . 5.9 pttt -172.88 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.897 HD12 HD23 ' A' ' 59' ' ' LEU . 3.7 mt -105.15 -43.82 4.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.03 -28.3 0.09 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.719 HD12 HD21 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -84.53 0.19 50.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -1.212 . . . . 0.0 110.108 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.546 ' HA ' ' HG ' ' A' ' 68' ' ' LEU . 4.7 t70 -50.36 -39.69 47.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 109.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.76 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -58.7 -32.2 68.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.895 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.704 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -70.45 -26.79 63.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.885 . . . . 0.0 109.74 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.719 HD21 HD12 ' A' ' 64' ' ' LEU . 7.4 mt -64.43 -61.7 2.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.725 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.76 HD21 ' HA ' ' A' ' 66' ' ' SER . 3.3 pp -58.04 -12.63 3.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.676 -0.64 . . . . 0.0 110.341 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -87.05 2.75 48.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 110.592 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.018 HG12 HG11 ' B' ' 122' ' ' VAL . 2.8 t -127.74 -0.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.393 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.054 HD11 HD12 ' A' ' 74' ' ' LEU . 2.8 tp -150.51 68.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -73.43 56.95 0.52 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.849 -1.157 . . . . 0.0 108.975 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.095 HD11 ' CB ' ' B' ' 101' ' ' ALA . 5.6 mt -84.18 57.82 4.43 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.693 0.759 . . . . 0.0 110.472 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 -173.27 2.25 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.923 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.98 106.73 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 110.2 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.235 179.98 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.177 0.513 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.455 ' O ' HG13 ' B' ' 63' ' ' ILE . . . 155.64 -52.87 0.43 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.495 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 4.2 mt -140.63 -39.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -1.124 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' B' ' 65' ' ' PRO . 91.8 t 59.34 142.22 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.436 -0.79 . . . . 0.0 110.301 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' B' ' 64' ' ' VAL . 47.3 Cg_endo -72.97 123.96 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.844 1.444 . . . . 0.0 110.745 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.447 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 9.3 m -92.06 135.0 34.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.484 ' HG ' ' NH2' ' B' ' 220' ' ' ARG . 19.0 mt -69.95 125.41 26.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 110.323 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -101.4 -27.29 13.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.147 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' HB ' ' B' ' 161' ' ' VAL . 5.6 m120 -156.14 162.73 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.861 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 17.0 mm -136.48 150.64 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.794 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' B' ' 124' ' ' THR . 24.1 t -136.76 140.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.99 149.4 36.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.909 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.38 128.32 45.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -0.954 . . . . 0.0 110.539 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' B' ' 121' ' ' MET . 59.0 t -119.67 151.2 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 109.955 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 23.5 m -129.49 142.91 50.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' B' ' 150' ' ' ALA . 49.4 mt -100.05 -46.2 5.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.18 55.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.5 158.65 43.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -1.178 . . . . 0.0 110.212 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -80.13 142.96 34.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 1.028 HD11 ' CD1' ' B' ' 76' ' ' LEU . 25.7 mt -116.65 153.68 31.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.423 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' B' ' 82' ' ' LEU . 8.2 t0 -96.93 86.9 4.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.468 ' HA ' HG21 ' B' ' 102' ' ' VAL . 8.6 mt -40.66 -43.62 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.845 . . . . 0.0 110.362 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -54.13 -45.45 71.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.94 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 14.7 m -81.02 -44.5 17.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.96 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 40.8 t -54.94 -43.08 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 110.159 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.86 -25.59 48.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.69 -33.49 20.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.213 -0.929 . . . . 0.0 110.124 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.0 m80 -83.22 -44.83 14.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.31 141.84 22.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.089 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ARG . . . . . 0.41 ' O ' ' OD1' ' B' ' 91' ' ' ASN . 21.7 mtt85 -81.05 -15.44 56.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.483 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' B' ' 104' ' ' MET . 16.0 m-20 -139.54 79.94 1.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' B' ' 93' ' ' GLU . . . -152.95 161.91 41.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' B' ' 92' ' ' ALA . 37.7 mt-10 -142.46 161.61 37.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 110.132 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -152.04 130.56 12.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.928 . . . . 0.0 110.324 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.543 ' ND2' ' OE2' ' A' ' 31' ' ' GLU . 3.1 m-20 -145.41 122.99 6.28 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.11 -16.71 28.56 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.908 1.478 . . . . 0.0 110.343 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -77.78 -9.73 59.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -109.3 -59.94 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.261 -0.899 . . . . 0.0 110.137 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.666 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -163.07 -159.23 0.53 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.496 -0.753 . . . . 0.0 110.704 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.47 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -121.38 49.8 1.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 111.602 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.095 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -143.57 163.77 32.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' B' ' 82' ' ' LEU . 90.0 t -101.41 136.93 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 29' ' ' ASP . 3.1 mp -106.03 111.34 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.369 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.501 ' HB2' ' HE3' ' B' ' 104' ' ' MET . 14.6 ttm -94.53 170.52 9.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.323 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -157.56 113.15 2.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.841 HG23 ' CE1' ' B' ' 139' ' ' TYR . 48.3 pt -101.29 170.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' B' ' 108' ' ' GLU . 5.3 mmt85 -124.93 46.32 2.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 0.0 110.291 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 175.27 79.21 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 0.0 110.338 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 52.5 Cg_endo -81.63 161.56 79.77 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.756 -2.185 . . . . 0.0 110.473 -0.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.15 106.38 1.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.556 HG22 ' HA3' ' B' ' 125' ' ' GLY . 1.7 p -147.27 177.5 9.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.645 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.7 m -124.57 159.14 31.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -147.48 138.35 23.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 110.41 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 121' ' ' MET . 8.0 mt -98.46 120.51 39.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 109.723 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.421 HG13 ' HG2' ' B' ' 121' ' ' MET . 3.6 mt -111.97 115.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.985 . . . . 0.0 110.375 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 3.6 m-30 -94.93 168.32 10.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -78.41 -13.52 59.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.4 t -81.05 -7.81 59.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.79 -26.27 20.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -56.2 149.74 15.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -1.135 . . . . 0.0 110.096 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 1.7 tmm? -148.66 128.82 13.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 1.018 HG11 HG12 ' A' ' 71' ' ' VAL . 73.4 t -114.91 128.1 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.2 t -112.86 151.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.349 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.559 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.8 t -155.09 164.42 38.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 109.983 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.569 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 110.83 -34.84 5.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.861 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.24 149.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -1.148 . . . . 0.0 110.442 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -3.19 30.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.492 ' N ' HG13 ' B' ' 70' ' ' ILE . 3.0 m -167.17 -163.23 0.51 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' GLU . . . . . 0.451 ' HA ' HD11 ' B' ' 157' ' ' ILE . 3.1 mt-10 -78.24 -44.65 24.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.316 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.11 -26.1 66.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 110.387 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.93 -58.29 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.885 . . . . 0.0 110.286 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.652 ' OG ' HG21 ' B' ' 70' ' ' ILE . 2.2 m -47.57 -40.01 18.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 12.2 mttt -60.24 -51.06 71.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' B' ' 137' ' ' ARG . 39.6 mt -62.88 -32.81 74.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -74.3 -41.1 61.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.271 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 3.6 p -65.7 -52.09 54.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.509 ' CZ ' ' HB2' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -55.15 -34.1 63.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.493 ' HD3' ' HD2' ' B' ' 137' ' ' ARG . 7.0 mptt -65.42 -36.67 84.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 110.032 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.877 ' HA ' HD12 ' B' ' 142' ' ' ILE . 31.4 m-85 -71.41 -52.3 19.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.875 . . . . 0.0 110.04 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.74 64.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.087 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -40.71 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' B' ' 139' ' ' TYR . 24.6 mt -59.37 -54.93 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.723 HG21 ' HB2' ' B' ' 150' ' ' ALA . 10.0 mt -55.73 -46.61 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 35.0 mt-30 -66.26 -35.24 79.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' B' ' 145' ' ' LYS . 10.1 tttm -71.55 -21.05 61.94 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mt -83.31 -18.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.88 -21.37 12.43 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.533 ' HB2' HG22 ' B' ' 143' ' ' ILE . 12.3 m-85 -57.55 172.6 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.278 . . . . 0.0 111.016 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.54 54.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.75 . . . . 0.0 110.328 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -90.74 130.57 36.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 110.423 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -121.85 119.28 31.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 17.0 t80 -60.79 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -140.6 171.35 14.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 110.227 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.474 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 56.5 m-20 58.37 19.32 6.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.367 -0.833 . . . . 0.0 110.559 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' B' ' 152' ' ' PHE . 15.1 t80 -68.69 136.79 53.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.92 136.5 1.93 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.451 HD11 ' HA ' ' B' ' 129' ' ' GLU . 70.7 mt -79.29 124.51 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -118.5 -8.81 10.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.114 -0.991 . . . . 0.0 110.992 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 30.4 t30 -148.98 134.42 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.783 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.414 ' CG2' HD22 ' B' ' 67' ' ' LEU . 60.0 mt -129.4 142.85 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.747 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 41.6 t -113.1 135.75 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.985 . . . . 0.0 110.55 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -136.94 173.11 22.32 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.3 t -164.82 151.18 10.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -1.184 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.478 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.0 p -170.21 146.57 2.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.406 ' O ' HD13 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -98.03 169.53 9.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.962 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.0 OUTLIER -113.31 -83.33 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -176.01 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' B' ' 238' ' ' ARG . 14.8 p90 -131.8 159.45 71.92 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.363 -0.836 . . . . 0.0 109.576 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -71.34 152.19 60.74 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.873 1.46 . . . . 0.0 110.146 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.26 148.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.561 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -86.88 106.45 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.934 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.51 HD22 ' CB ' ' B' ' 193' ' ' LEU . 21.9 mt -63.23 -59.91 4.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.342 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 23.5 pt-20 -50.19 -33.85 20.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -72.96 -41.57 48.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.457 ' O ' HD12 ' B' ' 175' ' ' LEU . 9.7 tp -80.23 -32.28 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -1.119 . . . . 0.0 110.23 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.808 ' HB2' ' CD1' ' B' ' 193' ' ' LEU . . . -73.95 -24.3 59.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 110.178 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -79.14 -42.61 25.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 t -78.74 -52.19 8.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.14 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -93.41 13.48 21.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.072 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -46.42 -32.97 5.63 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' THR . . . . . 0.552 HG23 ' HD2' ' B' ' 182' ' ' PHE . 1.8 t -54.08 -24.15 16.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -1.221 . . . . 0.0 110.378 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.829 ' CE1' HG22 ' B' ' 198' ' ' VAL . 26.4 m-85 -133.05 13.63 4.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.497 ' HB3' HD21 ' B' ' 193' ' ' LEU . 58.8 m -129.65 150.38 51.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.281 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.92 133.94 53.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' B' ' 185' ' ' TYR . 26.4 t80 -150.45 102.61 3.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.101 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' B' ' 190' ' ' PHE . 1.3 mt-10 -113.31 115.26 47.56 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 110.091 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.82 -1.49 10.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.403 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -100.27 6.82 44.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.976 HD11 ' HB3' ' A' ' 58' ' ' SER . 0.4 OUTLIER -166.36 -38.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 110.386 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.544 ' CZ ' HD11 ' B' ' 205' ' ' LEU . 1.8 t80 -118.65 114.05 36.08 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.4 -31.12 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.863 1.454 . . . . 0.0 110.568 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.96 -179.72 44.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.808 ' CD1' ' HB2' ' B' ' 176' ' ' ALA . 8.5 tt -113.42 133.78 55.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -1.125 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.666 ' CD1' HD13 ' A' ' 62' ' ' LEU . 53.0 mt -100.68 109.11 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.737 ' CD2' HD13 ' B' ' 230' ' ' ILE . 15.4 t80 -99.69 114.15 27.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -90.63 98.47 11.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.104 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.416 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 0.5 OUTLIER -56.73 131.09 48.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.419 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.829 HG22 ' CE1' ' B' ' 182' ' ' PHE . 13.2 t -70.82 -48.75 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.061 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 6.9 tttm -144.29 117.03 5.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.7 Cg_endo -72.79 163.18 89.58 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.931 -2.112 . . . . 0.0 110.63 0.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.788 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -70.94 99.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.788 HD13 ' O ' ' B' ' 201' ' ' LYS . 37.6 mm -143.65 145.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.06 141.47 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.704 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 133.99 50.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.042 -1.036 . . . . 0.0 110.716 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.544 HD11 ' CZ ' ' B' ' 190' ' ' PHE . 2.6 mm? -103.32 116.6 32.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.714 HG13 HD12 ' B' ' 212' ' ' ILE . 3.5 mp -114.3 120.73 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.09 -1.006 . . . . 0.0 110.406 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.407 ' CD1' ' HA3' ' B' ' 192' ' ' GLY . 66.9 m-85 -110.88 143.76 40.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 110.208 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 17.2 t -44.11 -25.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 207' ' ' PHE . 25.2 m -59.94 -38.33 82.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.31 -0.869 . . . . 0.0 110.36 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.438 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 115.83 13.91 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.475 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -99.61 133.39 44.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.023 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.714 HD12 HG13 ' B' ' 206' ' ' ILE . 29.0 mm -118.52 136.68 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.941 . . . . 0.0 110.429 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 4.6 t -119.93 155.51 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 109.921 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.455 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.9 mp -134.34 123.2 23.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.975 . . . . 0.0 110.376 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 25' ' ' PHE . 8.3 t -141.27 147.57 38.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.07 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.42 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 103.92 5.82 43.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -89.08 134.6 33.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -1.124 . . . . 0.0 110.119 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -27.34 48.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.363 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.22 163.0 33.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.267 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ARG . . . . . 0.505 ' CG ' ' CE1' ' B' ' 224' ' ' TYR . 4.9 ttm180 -65.54 -20.58 66.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 110.119 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -54.67 -44.32 73.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 226' ' ' ALA . 30.1 mt-10 -72.71 -39.98 66.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.911 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.411 HD12 HG23 ' B' ' 223' ' ' ILE . 34.0 mm -57.91 -41.51 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.891 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' B' ' 220' ' ' ARG . 10.1 m-85 -79.04 -47.22 16.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.103 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -65.54 -42.72 91.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' B' ' 222' ' ' GLU . . . -57.47 -44.54 84.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.606 ' CZ ' ' CE2' ' B' ' 231' ' ' TYR . 32.6 t80 -67.6 -28.66 67.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.145 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.27 -19.18 61.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.108 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.77 -31.86 15.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.737 HD13 ' CD2' ' B' ' 195' ' ' TYR . 9.2 tp -85.51 -22.61 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.606 ' CE2' ' CZ ' ' B' ' 227' ' ' PHE . 0.3 OUTLIER -40.89 -50.95 7.45 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.963 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.1 Cg_endo -69.22 -42.2 4.19 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.428 1.225 . . . . 0.0 110.633 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.66 -40.36 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.551 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 74.0 mt -61.25 -45.02 96.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 235' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 22.9 t -64.64 -46.71 81.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -35.91 49.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -108.58 38.56 2.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.494 ' HB3' ' CE1' ' B' ' 168' ' ' PHE . 1.0 OUTLIER -89.05 149.31 23.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -94.21 -60.16 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.5 mmm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.225 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.294 0.568 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' SER . . . -157.68 55.92 0.37 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' ILE . 6.5 t -44.27 167.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 110.173 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' SER . 5.3 mt 46.27 94.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 16' ' ' ASN . . . -101.32 15.8 57.32 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER 65.44 59.29 0.8 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -1.21 . . . . 0.0 110.119 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.54 145.73 4.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.119 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -98.62 159.75 14.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -1.164 . . . . 0.0 109.477 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.601 ' O ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -83.41 105.42 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 111.194 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.119 HD21 HD21 ' A' ' 18' ' ' LEU . 6.8 mt -117.97 3.64 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.958 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.72 HG21 ' O ' ' A' ' 56' ' ' ILE . 6.2 m -38.44 -30.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.679 0.752 . . . . 0.0 109.549 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.577 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -100.55 -31.49 5.78 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.87 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.32 -43.36 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.074 -1.251 . . . . 0.0 108.762 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.812 HD13 ' HG2' ' A' ' 67' ' ' MET . 1.8 pp -80.78 6.34 13.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 108.977 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE1' HD13 ' A' ' 52' ' ' LEU . 4.3 t80 -110.65 -18.08 13.24 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.544 -0.723 . . . . 0.0 111.034 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 158.3 67.02 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 C-N-CA 118.448 -1.834 . . . . 0.0 111.59 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.579 ' HB3' ' CG ' ' A' ' 35' ' ' LEU . 4.0 m120 41.28 111.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.943 . . . . 0.0 113.271 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -156.02 151.44 9.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.172 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLU . 12.6 m-20 -89.06 137.09 32.63 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.596 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 83.3 p -39.81 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.241 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -48.6 -21.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.6 29.5 5.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.33 131.5 54.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.122 -1.222 . . . . 0.0 110.085 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.765 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -101.86 139.16 37.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.934 HD12 ' N ' ' A' ' 36' ' ' GLN . 2.8 pp -124.57 -179.75 4.62 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.419 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.934 ' N ' HD12 ' A' ' 35' ' ' LEU . 7.5 mt-30 -135.02 144.95 47.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 110.143 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -50.71 -37.97 44.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.92 . . . . 0.0 110.733 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.82 145.21 35.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.597 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -134.07 140.28 46.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 110.047 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.11 33.09 5.33 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.42 79.63 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -1.137 . . . . 0.0 110.314 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.82 -23.34 69.78 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 52.94 2.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -1.155 . . . . 0.0 110.21 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.25 -33.83 0.75 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.39 -141.24 15.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 p -91.13 -173.75 3.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 110.185 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.89 135.88 5.22 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.659 ' CE1' HD12 ' A' ' 52' ' ' LEU . 21.6 p90 -88.6 16.58 6.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -1.157 . . . . 0.0 110.24 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 5.0 t70 -47.16 -53.09 13.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.9 . . . . 0.0 110.423 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.38 -4.96 24.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.414 -0.804 . . . . 0.0 110.463 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 18.3 tp10 -97.49 -25.46 15.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.014 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.659 HD12 ' CE1' ' A' ' 48' ' ' PHE . 5.9 mt -110.01 -44.94 3.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.626 -0.672 . . . . 0.0 110.055 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.79 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.02 -45.77 3.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.578 0.704 . . . . 0.0 109.984 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.27 -50.62 63.09 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.497 ' C ' HD12 ' A' ' 59' ' ' LEU . 64.0 m-20 -58.72 -38.77 79.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 109.174 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 53' ' ' ARG . 8.0 mt -50.91 -40.14 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.096 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -12.97 48.71 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.68 ' HB2' HD11 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -125.09 -0.24 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -1.12 . . . . 0.0 110.344 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.886 HD23 HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -80.52 51.86 1.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 24.3 t -134.06 50.24 2.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.887 . . . . 0.0 110.273 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 60' ' ' SER . 5.3 pttp 179.34 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.087 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.952 HD12 ' N ' ' A' ' 63' ' ' GLY . 1.1 pp -140.26 -29.54 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.054 -1.029 . . . . 0.0 111.146 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.952 ' N ' HD12 ' A' ' 62' ' ' LEU . . . 178.5 -48.99 0.09 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 62' ' ' LEU . 1.1 pp -82.95 -5.27 58.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.264 . . . . 0.0 110.812 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.7 t70 -44.47 -35.35 2.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.66 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -63.8 -47.04 82.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 0.0 109.619 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.812 ' HG2' HD13 ' A' ' 24' ' ' LEU . 7.1 ttp -65.02 -10.92 33.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.692 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.758 HD21 ' H ' ' A' ' 20' ' ' LEU . 4.9 tt -73.35 -61.27 1.88 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.78 0.86 11.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 109.939 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 25.4 tt0 -91.78 15.28 13.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 0.0 110.796 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.574 ' HB ' HD12 ' A' ' 20' ' ' LEU . 1.6 t -130.43 0.35 2.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.917 0.865 . . . . 0.0 109.016 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.975 HD11 HD12 ' A' ' 74' ' ' LEU . 1.3 tp -151.0 76.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 5.4 t0 -75.09 57.09 0.81 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.383 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.04 HD11 ' CB ' ' B' ' 101' ' ' ALA . 8.5 mt -89.83 30.28 1.07 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.469 -0.769 . . . . 0.0 110.572 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 77' ' ' ALA . 32.6 pttt -118.64 -157.39 0.68 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.505 -0.747 . . . . 0.0 110.419 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 75' ' ' LYS . 1.4 tp10 -50.92 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.818 . . . . 0.0 110.274 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.302 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.228 0.537 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.93 64.79 0.72 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.669 HG22 ' SG ' ' B' ' 164' ' ' CYS . 29.6 mt -99.5 -40.56 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -1.125 . . . . 0.0 110.044 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.506 HG23 ' C ' ' B' ' 63' ' ' ILE . 3.0 t 65.8 142.64 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 110.383 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.556 ' HG2' HG22 ' B' ' 223' ' ' ILE . 46.8 Cg_endo -75.96 137.88 20.17 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.098 1.578 . . . . 0.0 110.317 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.444 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 49.1 m -97.66 132.61 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.719 HD11 ' HG3' ' B' ' 220' ' ' ARG . 44.4 mt -69.72 120.61 15.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.961 . . . . 0.0 109.826 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 66' ' ' THR . 25.2 mm-40 -110.4 -14.04 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -162.56 144.52 10.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.987 . . . . 0.0 110.812 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.84 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 6.0 mm -126.35 150.75 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 109.333 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.74 126.29 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.011 -1.056 . . . . 0.0 110.549 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.83 170.75 15.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 110.05 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -141.2 145.26 35.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' B' ' 136' ' ' SER . 3.8 t -127.97 155.74 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 25.9 m -106.0 129.64 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.835 HD22 ' HB1' ' B' ' 150' ' ' ALA . 72.8 mt -84.29 -69.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.89 28.39 2.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' CYS . . . . . 0.949 ' SG ' ' HB3' ' B' ' 149' ' ' ALA . 39.8 t -164.02 152.1 12.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.457 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -73.23 139.81 46.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.707 HD11 ' CD1' ' B' ' 76' ' ' LEU . 28.9 mt -118.28 140.21 50.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 110.385 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 94.92 9.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.881 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.672 HD22 HG23 ' B' ' 102' ' ' VAL . 14.4 mt -44.05 -52.67 6.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.365 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -49.86 -43.46 49.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.028 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 28.0 m -76.27 -48.84 18.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 0.0 110.129 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.84 -47.81 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.56 65.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 tp -75.61 -42.22 52.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -88.26 -31.79 18.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' B' ' 92' ' ' ALA . . . -57.05 109.84 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.87 -22.35 66.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.052 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.491 ' ND2' ' HG3' ' B' ' 105' ' ' ARG . 2.4 t-20 -134.08 79.63 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.517 ' HB2' ' HB1' ' B' ' 89' ' ' ALA . . . -149.0 163.07 38.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -144.91 127.05 15.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.187 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -114.6 125.58 53.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.218 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.75 106.0 20.73 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.231 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.94 -21.78 20.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.033 1.544 . . . . 0.0 110.241 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -82.4 8.38 11.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.085 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.546 ' HB3' ' CD2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER -131.27 -70.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.594 ' HE2' ' HG ' ' A' ' 30' ' ' SER . 24.4 p90 -134.74 -173.62 3.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.046 . . . . 0.0 110.436 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 64.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.04 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -159.29 177.0 11.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.298 -0.876 . . . . 0.0 110.566 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.672 HG23 HD22 ' B' ' 82' ' ' LEU . 92.2 t -119.13 124.93 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.543 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 5.5 mt -89.66 107.36 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.663 ' SD ' HD13 ' B' ' 142' ' ' ILE . 37.8 ttm -108.31 151.14 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.491 ' HG3' ' ND2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -139.23 145.36 39.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.554 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 15.0 pt -111.66 175.35 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.136 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.6 mtt180 -116.73 26.73 9.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 110.408 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.5 tm-20 -175.88 87.13 0.29 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.752 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.0 Cg_endo -78.45 153.38 91.59 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.759 -2.184 . . . . 0.0 110.242 -0.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.6 OUTLIER -67.11 104.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 0.0 109.915 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.47 ' HA ' ' ND2' ' A' ' 27' ' ' ASN . 68.0 p -146.75 176.87 9.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.925 . . . . 0.0 110.566 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -115.76 144.18 44.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.604 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -135.21 129.58 33.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.959 -1.088 . . . . 0.0 110.885 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.647 ' HB2' HG12 ' B' ' 122' ' ' VAL . 3.5 mm? -89.59 120.49 30.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.044 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.56 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 1.6 mp -108.92 122.92 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' B' ' 120' ' ' LYS . 3.6 m-30 -96.49 149.04 22.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.71 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.51 -6.0 27.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.961 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.4 p -86.91 -16.77 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.427 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 119.31 -26.88 7.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 4.0 mttt -78.44 145.45 35.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -1.194 . . . . 0.0 110.157 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 7.3 ptt? -152.26 151.51 31.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 110.204 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' B' ' 114' ' ' LEU . 0.5 OUTLIER -110.47 162.38 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.902 . . . . 0.0 109.771 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.403 HG23 ' C ' ' B' ' 122' ' ' VAL . 12.7 t -145.2 119.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.52 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 10.2 t -113.56 151.33 31.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.91 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.563 ' N ' ' OD1' ' A' ' 27' ' ' ASN . . . 118.45 -31.48 5.58 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.407 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.84 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -39.92 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.0 110.305 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -104.4 -16.13 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.185 -0.947 . . . . 0.0 109.741 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 7.2 t -169.22 175.24 5.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.92 . . . . 0.0 110.043 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.07 -40.63 73.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.3 -47.12 65.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' B' ' 127' ' ' LYS . 15.8 t0 -58.17 -55.01 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 110.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.403 ' HB2' ' HB1' ' B' ' 126' ' ' ALA . 8.7 t -49.46 -47.43 48.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' B' ' 133' ' ' LYS . 1.3 tppt? -49.83 -40.48 42.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.41 -46.26 41.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.38 53.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.785 ' HB3' HG21 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -65.43 -53.35 44.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.812 . . . . 0.0 110.067 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.09 -38.7 5.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.116 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -62.93 -56.39 17.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 51.6 m-85 -56.03 -47.54 77.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.855 . . . . 0.0 109.976 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.94 -24.72 54.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.012 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 19.0 ttt180 -77.32 -51.84 10.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.663 HD13 ' SD ' ' B' ' 104' ' ' MET . 7.1 mt -45.75 -36.79 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.754 HG21 ' HB2' ' B' ' 150' ' ' ALA . 34.8 mm -76.48 -52.79 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.82 -32.0 73.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.62 -26.15 60.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' B' ' 142' ' ' ILE . 11.3 mt -77.71 -24.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.86 -21.16 6.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.578 ' HB2' HG22 ' B' ' 143' ' ' ILE . 17.8 m-85 -57.82 178.6 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.277 . . . . 0.0 110.944 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.949 ' HB3' ' SG ' ' B' ' 78' ' ' CYS . . . -113.89 45.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.528 -0.733 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.835 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -81.59 109.84 16.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 110.475 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.505 ' O ' HD23 ' B' ' 76' ' ' LEU . 6.2 tttp -85.34 -170.28 3.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.136 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.427 ' HD1' HG11 ' B' ' 74' ' ' VAL . 9.7 t80 -136.75 103.53 5.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.0 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -166.41 169.5 13.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.875 . . . . 0.0 110.308 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' B' ' 153' ' ' THR . 8.2 t0 69.58 10.99 7.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.818 . . . . 0.0 110.63 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.636 ' HD1' HG22 ' B' ' 74' ' ' VAL . 39.8 t80 -48.25 151.64 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 142.85 3.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.539 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.75 149.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 109.951 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -118.87 -60.18 1.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' B' ' 217' ' ' ALA . 51.9 m-80 -143.07 169.28 17.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 110.643 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.77 HD12 ' O ' ' B' ' 219' ' ' GLN . 45.4 mt -140.87 138.01 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 109.775 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.946 HG22 ' OG1' ' B' ' 215' ' ' THR . 26.1 t -110.47 129.42 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.06 174.82 18.22 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.38 146.21 3.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -1.209 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.669 ' SG ' HG22 ' B' ' 63' ' ' ILE . 0.5 OUTLIER -170.65 150.46 3.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.94 165.46 12.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.489 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -110.11 -83.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.489 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 179.65 -29.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.232 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 3.5 p90 -134.43 158.22 75.66 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.464 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.3 Cg_endo -71.88 159.91 49.2 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.998 1.525 . . . . 0.0 110.588 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.0 151.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.459 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' B' ' 171' ' ' ARG . 2.1 ptm180 -87.61 103.66 15.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.53 ' HB3' ' CE1' ' B' ' 185' ' ' TYR . 12.7 mt -53.54 -33.16 53.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.28 -43.35 95.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.66 -29.32 73.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.553 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -79.32 -32.03 43.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -1.096 . . . . 0.0 110.068 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.929 ' HB2' HD11 ' B' ' 193' ' ' LEU . . . -87.0 -25.53 24.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.91 -39.6 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 29.9 t -84.73 -38.84 19.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.511 ' CE1' HG13 ' B' ' 233' ' ' VAL . 69.4 m80 -107.27 15.4 25.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -44.61 -35.89 4.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.55 4.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -138.95 9.7 2.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 110.264 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.615 ' OG ' HD21 ' B' ' 193' ' ' LEU . 1.8 t -122.19 122.31 38.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.12 127.84 45.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.942 . . . . 0.0 110.234 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 0.573 ' CD1' HD12 ' B' ' 193' ' ' LEU . 23.0 t80 -126.13 120.5 30.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -137.68 102.33 8.64 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 110.054 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.32 0.1 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.13 1.594 . . . . 0.0 110.365 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -99.88 -4.78 29.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 58' ' ' SER . 0.5 OUTLIER -148.44 -38.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 110.472 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.572 ' HB2' HD23 ' B' ' 189' ' ' LEU . 6.7 t80 -124.39 113.78 27.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.382 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.04 -19.27 26.71 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.956 1.503 . . . . 0.0 110.079 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -97.72 179.92 33.14 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.929 HD11 ' HB2' ' B' ' 176' ' ' ALA . 0.9 OUTLIER -113.19 145.99 40.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -1.185 . . . . 0.0 110.533 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.505 ' CD1' HD22 ' A' ' 62' ' ' LEU . 5.8 mt -109.09 110.36 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -107.54 120.53 42.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.33 93.08 6.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.934 . . . . 0.0 110.046 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 52.9 tpp -49.64 136.04 17.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.426 ' O ' ' HE2' ' B' ' 201' ' ' LYS . 73.0 t -73.12 -50.71 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 7.9 tttp -142.3 115.91 6.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.451 ' HG3' ' HA ' ' B' ' 222' ' ' GLU . 48.8 Cg_endo -73.73 165.21 85.44 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.994 -2.086 . . . . 0.0 110.541 -0.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.445 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -74.75 98.86 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.992 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' B' ' 217' ' ' ALA . 31.7 mm -139.76 144.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.498 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.602 ' C ' HD12 ' B' ' 204' ' ' LEU . 90.4 t -93.45 118.61 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.738 ' N ' HD12 ' B' ' 204' ' ' LEU . 6.1 mp -115.58 123.77 49.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.568 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.502 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 5.7 mt -94.83 129.37 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.914 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.547 HG12 HD21 ' B' ' 234' ' ' LEU . 3.7 mp -118.8 129.47 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.549 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.492 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 96.6 m-85 -114.26 149.72 35.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 110.062 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 65.1 t -55.19 -24.8 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.0 p -64.36 -26.48 68.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.328 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.427 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 108.06 19.9 8.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -1.162 . . . . 0.0 110.274 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.72 132.99 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.384 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.586 ' C ' HD12 ' B' ' 214' ' ' LEU . 21.2 t -125.79 130.97 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.826 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.7 mp -118.42 126.28 51.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.403 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.946 ' OG1' HG22 ' B' ' 161' ' ' VAL . 1.1 t -147.3 136.03 22.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.968 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.468 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 120.45 7.55 8.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -86.87 134.36 33.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -1.213 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -78.36 -21.19 49.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.77 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.0 OUTLIER -139.1 -170.38 2.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ARG . . . . . 0.719 ' HG3' HD11 ' B' ' 67' ' ' LEU . 2.9 ttt180 -89.94 -36.54 14.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.133 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -52.79 -31.31 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.174 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' B' ' 200' ' ' PRO . 24.1 mt-10 -70.45 -56.99 5.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 110.109 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.556 HG22 ' HG2' ' B' ' 65' ' ' PRO . 31.0 mm -50.93 -38.73 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' B' ' 64' ' ' VAL . 1.1 m-30 -67.79 -50.97 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -27.47 67.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.044 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.43 -52.48 65.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.672 ' HA ' HG22 ' B' ' 230' ' ' ILE . 41.9 t80 -61.93 -42.33 98.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.946 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -18.17 52.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 110.306 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -96.7 -28.57 14.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.455 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' B' ' 227' ' ' PHE . 4.2 tp -98.29 -10.66 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.655 ' CD1' ' CZ ' ' B' ' 227' ' ' PHE . 14.9 t80 -59.18 -42.52 93.71 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 111.013 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 47.3 Cg_endo -76.23 -44.0 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.381 1.2 . . . . 0.0 110.353 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.553 HG12 HD21 ' B' ' 175' ' ' LEU . 7.7 t -55.27 -38.51 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.873 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.547 HD21 HG12 ' B' ' 206' ' ' ILE . 40.4 mt -67.27 -50.65 59.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -0.831 . . . . 0.0 110.201 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 1.6 m -58.4 -29.48 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.85 -35.42 76.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.99 39.44 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.8 176.71 1.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.115 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 -59.53 1.7 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.213 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.176 0.512 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.43 85.56 0.15 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.561 ' O ' HD13 ' A' ' 14' ' ' ILE . 69.4 m -139.99 43.95 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -1.125 . . . . 0.0 110.156 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 13' ' ' SER . 21.1 mm -135.51 64.8 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 110.245 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.53 172.98 15.54 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -83.09 -104.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.159 . . . . 0.0 110.239 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.48 142.31 12.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.066 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -112.66 175.25 5.51 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.374 -1.074 . . . . 0.0 109.288 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -93.7 97.4 10.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.063 -1.023 . . . . 0.0 111.004 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.066 HD21 HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -108.06 6.36 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.976 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.783 ' OG1' HD12 ' A' ' 68' ' ' LEU . 5.6 m -43.19 -26.77 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.483 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -98.55 -19.26 23.28 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.865 HG13 HD22 ' A' ' 20' ' ' LEU . 1.3 mm -57.07 -46.79 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.67 -1.488 . . . . 0.0 109.0 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.871 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.1 pp -83.53 -24.43 31.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.922 -1.111 . . . . 0.0 109.976 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -83.82 9.25 12.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 137.34 103.71 0.66 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.843 ' ND2' HD11 ' A' ' 35' ' ' LEU . 20.0 p-10 -18.56 129.77 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.717 0.77 . . . . 0.0 111.827 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 29' ' ' ASP . 1.5 pp -138.93 170.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.726 -0.609 . . . . 0.0 109.533 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.806 ' C ' HD12 ' A' ' 28' ' ' ILE . 77.5 m-20 -88.17 120.34 29.43 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.732 ' O ' HD11 ' A' ' 18' ' ' LEU . 4.6 p -35.33 -31.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.594 0.711 . . . . 0.0 109.662 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.9 tt0 -47.14 -23.35 0.49 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.23 21.78 5.1 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.38 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.98 134.27 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.315 . . . . 0.0 109.351 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.542 ' HA ' HG22 ' A' ' 28' ' ' ILE . 5.4 tt -87.82 162.06 17.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.895 -1.128 . . . . 0.0 111.157 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 36' ' ' GLN . 3.1 pp -139.05 -179.64 5.97 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.846 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.895 ' N ' HD12 ' A' ' 35' ' ' LEU . 22.2 mt-30 -125.89 145.4 50.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.467 -0.771 . . . . 0.0 109.842 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -98.73 -29.35 13.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.101 -0.999 . . . . 0.0 110.591 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 38' ' ' ASP . 58.2 p30 -156.37 -146.36 0.17 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 110.513 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -157.71 161.14 38.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -104.52 78.87 0.28 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -17.19 47.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -1.122 . . . . 0.0 110.281 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.78 -88.66 1.02 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -92.66 45.57 1.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -1.167 . . . . 0.0 109.988 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 40' ' ' GLY . . . -108.84 104.67 2.0 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.89 -102.45 1.06 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -85.05 137.24 33.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -1.164 . . . . 0.0 109.802 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.81 177.38 28.88 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' ASP . 26.0 p90 -99.73 36.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -1.097 . . . . 0.0 110.014 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' PHE . 2.0 m-20 -41.24 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.714 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.82 26.62 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -0.915 . . . . 0.0 110.668 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -100.24 -26.51 13.89 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.089 -1.007 . . . . 0.0 108.693 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 56' ' ' ILE . 2.8 mt -98.32 -39.01 9.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.402 0.62 . . . . 0.0 109.689 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -44.38 -46.71 9.56 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.29 -32.6 74.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 109.553 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.553 ' ND2' ' HB3' ' B' ' 190' ' ' PHE . 13.6 m120 -76.76 -39.07 52.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.409 -0.807 . . . . 0.0 109.676 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -53.46 -34.38 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.384 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.31 -27.12 72.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.975 ' O ' HD11 ' B' ' 189' ' ' LEU . 11.5 t -117.82 8.94 12.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.856 HD23 HD12 ' A' ' 62' ' ' LEU . 6.0 mt -96.16 13.8 26.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.44 41.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.23 -0.919 . . . . 0.0 110.306 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.586 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.57 19.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.856 HD12 HD23 ' A' ' 59' ' ' LEU . 6.0 mt -118.06 -58.64 1.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.361 -0.837 . . . . 0.0 109.232 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.4 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.871 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.5 mm? -52.13 -26.0 10.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -1.19 . . . . 0.0 110.57 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -45.95 -36.77 5.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.4 m -70.04 -59.5 2.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 110.048 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.558 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -64.77 -11.96 42.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.03 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.783 HD12 ' OG1' ' A' ' 21' ' ' THR . 6.1 tt -69.39 -62.17 1.49 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.391 -0.818 . . . . 0.0 109.292 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.8 pp -66.78 -6.3 15.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -84.58 16.37 3.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.619 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.919 HG12 HG11 ' B' ' 122' ' ' VAL . 2.9 t -141.37 4.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.932 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.779 ' HB ' HD11 ' A' ' 20' ' ' LEU . 1.4 tp -147.3 77.2 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.579 -0.701 . . . . 0.0 109.359 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.8 t70 -82.83 50.64 1.74 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 108.908 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.4 OUTLIER -75.89 43.47 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.74 -0.6 . . . . 0.0 111.657 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -170.91 2.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.825 -1.172 . . . . 0.0 110.193 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' OE2' ' O ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -64.16 129.49 40.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.331 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' B' ' 118' ' ' SER . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.216 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.233 0.539 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.04 64.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -62.03 103.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 110.349 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.77 134.75 83.61 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.55 135.66 26.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.937 1.493 . . . . 0.0 110.318 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.6 m -96.44 130.58 43.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.361 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' B' ' 161' ' ' VAL . 33.2 mt -74.76 123.35 24.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.867 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -113.95 -3.66 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -0.887 . . . . 0.0 110.705 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.532 ' CB ' ' HB ' ' B' ' 161' ' ' VAL . 0.2 OUTLIER -156.36 142.83 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.914 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.844 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 19.9 mm -132.13 150.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.829 . . . . 0.0 109.809 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' B' ' 124' ' ' THR . 22.0 t -141.44 134.65 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.64 165.27 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.252 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 68.1 p -110.15 145.65 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.72 131.21 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 41.4 m -111.84 128.59 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.855 HD22 ' HB1' ' B' ' 150' ' ' ALA . 49.0 mt -88.07 -17.33 31.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -2.31 84.26 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' B' ' 149' ' ' ALA . 3.6 t -137.33 151.14 48.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.339 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.828 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.9 OUTLIER -78.46 164.15 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.828 HD23 ' O ' ' B' ' 79' ' ' ARG . 23.8 mt -140.48 153.38 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 82' ' ' LEU . 34.8 t0 -92.77 100.59 13.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.519 ' HB3' HG23 ' B' ' 102' ' ' VAL . 18.0 mt -44.23 -34.95 2.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 1.9 tmtm? -66.14 -36.12 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 20.8 m -89.25 -40.13 13.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.29 -50.48 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 110.272 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.78 63.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.139 -0.976 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 27.6 tp -57.74 -28.48 63.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -98.94 -40.37 8.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.319 -0.863 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -47.38 124.3 6.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 20.9 mtt180 -67.28 -21.35 65.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.42 79.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -158.13 165.18 35.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.19 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -145.24 152.93 40.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.154 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -139.52 122.53 16.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.265 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.73 134.72 10.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.87 . . . . 0.0 110.228 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.85 -41.04 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.948 1.499 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -50.37 -23.2 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -98.32 -65.44 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 1.012 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.79 167.15 7.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.469 -0.77 . . . . 0.0 111.295 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.92 56.07 3.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.684 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.012 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -148.88 159.62 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.977 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' B' ' 82' ' ' LEU . 30.8 t -101.02 132.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.848 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.476 HG12 ' OG ' ' A' ' 30' ' ' SER . 6.5 mt -95.74 112.46 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 2.8 ttm -102.29 157.76 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 110.014 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -161.66 131.58 4.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.137 -0.977 . . . . 0.0 110.439 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 26.7 pt -115.64 172.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' B' ' 110' ' ' LYS . 7.7 mtp180 -115.45 29.53 7.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -174.63 86.16 0.33 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.503 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 51.0 Cg_endo -78.23 148.77 85.4 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.777 -2.176 . . . . 0.0 110.319 -0.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' B' ' 107' ' ' ARG . 12.0 mtmm -58.25 86.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.879 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.47 HG22 ' C ' ' B' ' 125' ' ' GLY . 11.3 p -130.45 168.64 16.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.519 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.696 HG22 HG23 ' B' ' 124' ' ' THR . 4.0 t -130.38 164.22 25.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.61 166.26 30.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.01 -1.057 . . . . 0.0 110.903 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.575 HD13 HD11 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -113.17 107.88 16.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.549 ' CD1' ' HG3' ' B' ' 121' ' ' MET . 13.8 mm -91.75 125.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 111.186 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 4.6 m-30 -103.57 166.06 10.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.479 -0.763 . . . . 0.0 109.64 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.05 -14.85 58.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.263 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' SER . . . . . 0.471 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 1.1 p -73.53 -30.27 62.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.305 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.75 -23.43 5.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -65.94 163.6 16.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.178 . . . . 0.0 110.049 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.549 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.8 OUTLIER -159.05 124.88 4.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 110.766 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.919 HG11 HG12 ' A' ' 71' ' ' VAL . 2.9 t -101.8 136.22 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 0.0 109.655 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.483 HG12 ' N ' ' B' ' 124' ' ' THR . 76.9 t -115.71 165.42 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.156 -0.965 . . . . 0.0 110.662 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.696 HG23 HG22 ' B' ' 112' ' ' THR . 5.9 t -169.52 155.89 6.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.439 -0.788 . . . . 0.0 110.014 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.544 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 113.8 -4.06 24.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.844 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -84.21 168.99 15.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.192 -1.181 . . . . 0.0 110.502 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.465 ' C ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -121.89 -19.21 6.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 110.292 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' B' ' 129' ' ' GLU . 1.0 OUTLIER -139.86 -178.92 5.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 129' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -68.74 -43.59 75.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -33.5 72.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.734 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 0.2 OUTLIER -70.24 -50.64 37.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.251 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' B' ' 136' ' ' SER . 5.2 t -61.21 -22.21 64.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.942 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.5 -49.53 18.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.843 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -45.47 74.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -50.68 -49.01 58.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.832 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 132' ' ' SER . 0.6 OUTLIER -66.85 -49.5 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.682 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -54.05 -29.68 44.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' B' ' 141' ' ' ARG . 27.4 mmtt -70.86 -55.84 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.702 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 47.0 m-85 -49.47 -48.49 47.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -57.01 -36.54 70.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.395 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 65.6 ttt180 -57.51 -38.36 74.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.425 -0.797 . . . . 0.0 109.949 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.407 ' O ' HG13 ' B' ' 146' ' ' ILE . 12.2 mt -66.76 -59.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.53 HD13 HD13 ' B' ' 80' ' ' LEU . 89.3 mt -56.6 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' B' ' 140' ' ' ALA . 20.5 mt-30 -67.55 -40.57 84.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 109.715 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -70.32 -21.29 62.94 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' B' ' 143' ' ' ILE . 6.5 mt -75.72 -29.46 20.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 125.07 -29.84 4.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' B' ' 147' ' ' GLY . 9.8 m-85 -43.89 156.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.014 -1.286 . . . . 0.0 110.637 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.513 ' HB3' ' SG ' ' B' ' 78' ' ' CYS . . . -91.62 48.58 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.129 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.855 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -84.42 171.49 12.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.403 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' B' ' 153' ' ' THR . 16.2 tttt -160.78 108.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.193 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.414 ' CD2' ' O ' ' B' ' 152' ' ' PHE . 47.7 t80 -49.7 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.265 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.9 OUTLIER -145.65 168.43 20.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.332 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t70 63.37 24.02 14.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' B' ' 73' ' ' THR . 43.5 t80 -67.72 132.98 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 110.023 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -166.24 134.69 2.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.413 HG21 HD13 ' B' ' 157' ' ' ILE . 18.0 mt -79.38 122.85 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -119.59 6.38 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.532 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 1.1 m120 -154.51 123.08 6.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.374 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' B' ' 215' ' ' THR . 30.8 mt -122.64 149.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.532 ' HB ' ' CB ' ' B' ' 69' ' ' ASN . 58.6 t -130.35 138.38 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.572 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.37 171.57 25.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.34 152.85 5.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.938 -1.33 . . . . 0.0 110.697 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.475 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 31.0 p -166.79 166.4 15.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.53 171.31 8.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.521 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -121.75 -83.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.521 ' H ' HG23 ' B' ' 166' ' ' VAL . 3.0 mmtt 178.1 -23.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.036 -1.04 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -125.48 153.67 72.5 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.979 -1.076 . . . . 0.0 109.703 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.34 147.29 46.87 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.943 1.496 . . . . 0.0 110.248 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.691 HG12 HD22 ' B' ' 234' ' ' LEU . 2.0 mp -108.23 156.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 110.599 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 14.2 mtt180 -91.29 101.97 14.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.775 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 25.2 mt -63.9 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.27 -34.29 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -64.97 -51.11 54.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.71 -41.83 91.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -1.074 . . . . 0.0 109.907 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 180' ' ' GLY . . . -58.46 -43.53 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 177' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.8 t80 -59.76 -30.11 68.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -59.56 2.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.42 ' O ' ' N ' ' B' ' 183' ' ' SER . 41.5 m170 -97.98 32.53 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.338 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 176' ' ' ALA . . . -47.93 -62.74 3.97 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' THR . . . . . 0.585 HG23 ' CD1' ' B' ' 182' ' ' PHE . 10.3 t -45.85 -24.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -1.195 . . . . 0.0 110.272 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.585 ' CD1' HG23 ' B' ' 181' ' ' THR . 20.7 m-85 -102.43 -14.19 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.469 ' O ' ' O ' ' B' ' 180' ' ' GLY . 0.3 OUTLIER -140.86 149.04 41.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.931 . . . . 0.0 110.089 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -121.01 137.58 54.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.588 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -134.71 109.43 8.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 0.0 109.79 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.03 121.63 33.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.19 -11.98 25.32 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.891 1.469 . . . . 0.0 110.279 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.73 -23.85 22.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.113 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.975 HD11 ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -89.84 -63.21 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.689 ' HZ ' HD11 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -169.68 161.07 7.18 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.43 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 191' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.9 Cg_endo -69.82 0.37 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.136 1.598 . . . . 0.0 111.842 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.584 ' HA3' ' CE2' ' B' ' 190' ' ' PHE . . . -89.25 149.41 20.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.897 ' O ' HD13 ' B' ' 205' ' ' LEU . 10.3 tt -110.33 130.83 55.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -1.171 . . . . 0.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 194' ' ' ILE . . . . . . . . . . . . . 3.3 mt -95.63 111.21 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.225 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -100.89 113.7 26.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.297 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -91.1 88.58 7.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 110.145 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 46.1 tpp -57.55 125.2 21.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.867 . . . . 0.0 110.377 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.41 HG23 ' H ' ' B' ' 198' ' ' VAL . 34.7 t -57.52 -49.62 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.57 124.73 5.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.997 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.405 ' O ' HG12 ' B' ' 202' ' ' ILE . 48.0 Cg_endo -74.8 148.68 92.39 Favored 'Cis proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.011 -2.079 . . . . 0.0 110.424 -0.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.414 ' O ' HD13 ' B' ' 202' ' ' ILE . 10.9 tptt -56.22 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.335 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.414 HD13 ' O ' ' B' ' 201' ' ' LYS . 36.6 mm -136.84 153.5 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.17 112.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.925 . . . . 0.0 110.297 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.859 HD21 ' HB1' ' B' ' 226' ' ' ALA . 1.7 mp -107.42 149.13 28.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.897 HD13 ' O ' ' B' ' 193' ' ' LEU . 0.2 OUTLIER -114.85 115.8 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.568 ' N ' HD12 ' B' ' 206' ' ' ILE . 4.6 mp -104.85 139.58 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -122.69 155.6 36.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 63.9 t -59.13 -31.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.3 t -57.04 -39.13 74.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.099 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.22 10.88 5.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.437 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -89.66 135.45 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.437 HD13 ' O ' ' B' ' 211' ' ' LYS . 25.5 mm -113.74 134.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.3 t -114.32 163.45 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 1.4 mp -145.92 129.8 17.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.915 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 15.1 t -158.83 149.05 19.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 110.333 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.505 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 101.95 5.17 50.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.94 33.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -1.191 . . . . 0.0 110.161 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -93.18 -6.12 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.123 -0.985 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -154.68 -179.99 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.143 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -79.05 -25.34 43.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 110.22 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.79 -23.89 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.13 -50.37 12.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 110.19 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.499 HG23 HD22 ' B' ' 214' ' ' LEU . 20.3 mm -58.8 -38.13 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -70.6 -38.53 74.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.311 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -30.3 59.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.551 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.859 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -64.72 -49.85 69.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -0.962 . . . . 0.0 110.417 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.513 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 16.1 t80 -69.07 -41.22 77.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.479 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -51.57 -38.19 53.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.82 -10.1 35.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.294 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.556 HG13 HD22 ' B' ' 204' ' ' LEU . 10.5 mm -96.22 -17.73 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.9 t80 -61.73 -42.1 81.41 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.5 Cg_endo -76.71 -49.26 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.346 1.182 . . . . 0.0 110.21 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 21.3 t -44.87 -40.48 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.764 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.691 HD22 HG12 ' B' ' 170' ' ' ILE . 74.0 mt -70.75 -63.36 1.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.779 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -46.9 -33.2 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.33 -34.19 77.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.403 -0.811 . . . . 0.0 110.014 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 57.3 m-85 -120.89 39.63 3.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.269 -0.894 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.49 ' NH2' ' O ' ' B' ' 239' ' ' LYS . 0.0 OUTLIER -71.57 -173.72 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.927 . . . . 0.0 110.175 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.49 ' O ' ' NH2' ' B' ' 238' ' ' ARG . 2.4 ttpt -125.68 -39.55 2.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.21 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.47 ' OE2' HD11 ' A' ' 14' ' ' ILE . 29.6 tt0 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.264 0.554 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.67 -88.59 1.21 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.05 89.63 2.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -1.12 . . . . 0.0 110.142 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.47 HD11 ' OE2' ' A' ' 11' ' ' GLU . 2.9 mp -52.52 97.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.312 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.06 69.98 0.32 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 14' ' ' ILE . 20.1 p-10 -124.04 145.87 48.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -1.172 . . . . 0.0 110.373 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.04 132.95 4.94 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.78 160.93 22.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.492 -1.005 . . . . 0.0 109.509 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.93 76.85 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.045 -1.034 . . . . 0.0 110.615 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.947 HD13 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -93.99 -0.32 55.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 111.253 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.719 ' N ' HD21 ' A' ' 68' ' ' LEU . 9.0 m -45.91 -24.25 0.38 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.889 -1.132 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.487 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -97.04 -31.93 6.7 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.947 HG21 HD13 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -47.94 -47.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.403 . . . . 0.0 109.132 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.833 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.8 pp -83.51 -26.74 29.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.969 -1.082 . . . . 0.0 110.549 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.689 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.3 OUTLIER -80.96 6.92 11.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.096 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 28' ' ' ILE . . . 138.33 106.58 0.74 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.858 ' ND2' HD11 ' A' ' 35' ' ' LEU . 5.9 p30 -16.94 133.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.915 0.864 . . . . 0.0 112.186 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 29' ' ' ASP . 2.0 pp -146.44 167.29 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.487 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.806 ' C ' HD12 ' A' ' 28' ' ' ILE . 10.8 m-20 -87.88 121.14 29.93 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.542 ' OG ' ' CD1' ' B' ' 103' ' ' ILE . 9.3 p -36.93 -28.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.145 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.6 tt0 -58.51 -11.95 3.47 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.181 -0.949 . . . . 0.0 110.446 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.64 23.94 6.34 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.4 tpp180 -107.34 120.45 42.19 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.045 -1.268 . . . . 0.0 109.644 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.805 ' C ' HD13 ' A' ' 34' ' ' LEU . 2.5 tm? -88.59 134.07 33.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.405 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 36' ' ' GLN . 1.1 pp -129.53 176.83 7.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.03 . . . . 0.0 109.993 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 1.033 ' N ' HD12 ' A' ' 35' ' ' LEU . 4.5 mt-30 -134.87 -76.73 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.967 . . . . 0.0 110.572 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 36' ' ' GLN . 9.3 p-10 178.4 -44.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.161 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.96 -173.75 3.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.344 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.83 71.48 1.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 110.125 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.33 143.09 16.17 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -175.79 153.89 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -1.086 . . . . 0.0 110.174 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.95 63.15 3.36 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -170.57 84.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -1.122 . . . . 0.0 110.038 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.62 -123.71 27.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.55 79.98 0.34 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.34 2.54 56.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -1.185 . . . . 0.0 110.278 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.73 148.76 5.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD2' HD12 ' A' ' 52' ' ' LEU . 6.9 p90 -50.76 176.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -1.079 . . . . 0.0 110.029 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -97.39 -137.66 0.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 110.037 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.96 33.4 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.965 . . . . 0.0 110.224 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.46 -17.67 17.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.901 . . . . 0.0 109.591 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 25' ' ' PHE . 4.0 mt -95.32 -47.06 6.47 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.513 -0.742 . . . . 0.0 109.977 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.922 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.58 -50.89 52.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -63.75 -25.82 68.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.795 . . . . 0.0 110.06 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -83.29 -33.88 25.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.922 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.3 mt -51.93 -46.03 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.292 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.28 -19.93 26.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.73 9.9 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -1.191 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.654 HD23 HD21 ' A' ' 62' ' ' LEU . 3.0 mt -84.76 15.85 3.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.141 -0.974 . . . . 0.0 110.419 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.0 p -105.94 39.78 1.71 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 110.221 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 29.31 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 63' ' ' GLY . 2.1 pp -147.5 -35.44 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.103 -0.998 . . . . 0.0 111.152 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.915 ' N ' HD12 ' A' ' 62' ' ' LEU . . . -170.14 -51.29 0.04 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.294 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.833 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.4 mm? -42.83 -24.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -1.232 . . . . 0.0 110.572 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 1.8 t70 -42.79 -38.97 2.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.854 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.43 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 58.5 m -66.84 -56.88 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.406 -0.809 . . . . 0.0 109.809 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.641 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -65.22 -10.54 32.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.486 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.719 HD21 ' N ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -67.92 -63.93 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.745 0.783 . . . . 0.0 109.298 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -68.57 -5.12 18.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.808 -0.557 . . . . 0.0 110.226 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -83.17 5.68 21.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 111.201 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.835 HG12 HG11 ' B' ' 122' ' ' VAL . 2.3 t -140.22 4.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.173 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.882 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.2 tp -145.48 73.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.779 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t70 -81.8 51.77 1.79 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.3 OUTLIER -78.01 45.1 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.528 -0.732 . . . . 0.0 111.46 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 76' ' ' GLU . 9.2 mtmt -100.23 153.45 19.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.056 -1.027 . . . . 0.0 110.069 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.52 ' OE1' ' CA ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER 64.24 28.17 13.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.271 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' OXT' ' HB1' ' B' ' 100' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.193 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.21 0.529 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 63' ' ' ILE . . . 167.51 41.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' B' ' 62' ' ' GLY . 2.1 mp -43.7 126.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -1.19 . . . . 0.0 110.089 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.536 HG13 ' HD2' ' B' ' 65' ' ' PRO . 70.2 t -89.82 142.2 28.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 110.505 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.536 ' HD2' HG13 ' B' ' 64' ' ' VAL . 47.2 Cg_endo -75.35 134.54 17.36 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.052 1.554 . . . . 0.0 110.417 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -90.71 127.17 36.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' B' ' 67' ' ' LEU . 17.6 mt -73.03 132.65 43.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.125 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -98.05 -41.08 8.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.101 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -170.03 179.07 3.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.561 HG12 HG23 ' B' ' 160' ' ' ILE . 9.5 mt -150.53 167.8 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.125 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.542 HG13 ' O ' ' B' ' 123' ' ' VAL . 52.8 t -137.4 140.64 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.131 -0.981 . . . . 0.0 110.426 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.55 50.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.426 -0.797 . . . . 0.0 110.068 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 133.85 55.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.451 HG21 ' OG ' ' B' ' 136' ' ' SER . 66.2 t -126.71 146.76 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 57.5 m -110.13 141.26 43.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.941 HD22 ' C ' ' B' ' 149' ' ' ALA . 7.4 mt -105.2 -72.93 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.485 -0.759 . . . . 0.0 109.898 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.33 -10.18 10.83 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 148' ' ' PHE . 68.5 m -109.31 119.92 40.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.034 -1.274 . . . . 0.0 109.354 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -44.02 147.94 0.45 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 110.032 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.701 ' CD2' ' HB2' ' B' ' 149' ' ' ALA . 27.0 mt -116.73 144.59 44.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 111.173 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' LYS . 0.2 OUTLIER -101.28 83.04 2.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.486 -0.758 . . . . 0.0 109.152 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' B' ' 81' ' ' ASP . 10.3 mt -37.09 -30.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.636 -0.665 . . . . 0.0 110.933 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' B' ' 81' ' ' ASP . 0.0 OUTLIER -70.28 -46.04 65.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 109.937 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 97.9 m -82.21 -31.41 30.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.382 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.5 -43.04 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.77 51.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 tp -85.24 -43.23 13.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.261 -0.9 . . . . 0.0 110.452 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.767 ' HB2' HD11 ' B' ' 146' ' ' ILE . 7.6 m170 -74.43 -44.84 50.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 110.591 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -54.88 128.48 33.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.438 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -66.55 -24.93 66.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 9.0 p30 -135.22 79.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.077 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -160.07 137.04 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -117.39 171.18 8.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' B' ' 102' ' ' VAL . 13.3 t80 -164.2 102.2 0.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 110.301 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' B' ' 98' ' ' ARG . 0.7 OUTLIER -119.1 136.95 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.272 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -21.01 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.996 1.524 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -76.65 -17.3 59.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.537 ' HD2' ' N ' ' B' ' 98' ' ' ARG . 3.2 mpt_? -96.45 -63.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 1.168 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.86 166.69 11.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.494 -0.754 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.501 ' HB1' ' OXT' ' A' ' 77' ' ' ALA . . . -81.97 53.43 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 111.909 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.168 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -153.19 154.25 34.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.143 . . . . 0.0 110.463 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.692 HG22 ' HB2' ' B' ' 94' ' ' TYR . 39.7 t -89.81 139.08 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.542 ' CD1' ' OG ' ' A' ' 30' ' ' SER . 8.4 mt -100.35 114.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 109.845 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.609 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 1.7 ttm -99.8 170.86 8.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 0.1 OUTLIER -169.99 132.42 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 0.0 110.046 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.558 HG23 ' CE1' ' B' ' 139' ' ' TYR . 22.8 pt -128.45 163.56 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.352 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -110.64 26.23 10.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.258 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER -172.76 86.28 0.41 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.267 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.731 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.3 Cg_endo -74.85 161.52 94.6 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.564 -0.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -72.28 82.9 1.03 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' B' ' 124' ' ' THR . 37.0 p -132.46 176.3 8.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 110.518 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.823 HG22 HG23 ' B' ' 124' ' ' THR . 5.8 t -135.68 174.07 11.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.6 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -170.25 176.45 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.967 -1.083 . . . . 0.0 111.091 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.832 HD13 HD13 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -143.17 122.89 13.35 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.423 ' CG2' ' CD1' ' B' ' 80' ' ' LEU . 20.4 mt -100.35 160.34 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.006 . . . . 0.0 111.479 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.72 ' CZ ' HD12 ' B' ' 114' ' ' LEU . 34.8 m-85 -119.42 156.17 30.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 110.246 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -64.8 -16.45 63.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 4.4 p -71.29 -36.73 71.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.629 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 129.41 4.24 4.96 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' LYS . . . . . 0.413 ' C ' ' HG3' ' B' ' 121' ' ' MET . 0.5 OUTLIER -100.4 138.89 36.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -1.175 . . . . 0.0 110.003 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.752 ' CG ' HD11 ' B' ' 76' ' ' LEU . 0.0 OUTLIER -128.03 129.45 46.72 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.04 . . . . 0.0 110.163 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.835 HG11 HG12 ' A' ' 71' ' ' VAL . 18.3 t -97.44 132.36 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 0.0 109.713 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.542 ' O ' HG13 ' B' ' 71' ' ' VAL . 29.7 t -114.95 149.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 110.574 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.823 HG23 HG22 ' B' ' 112' ' ' THR . 6.2 t -149.54 156.48 42.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.543 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 110.04 -32.81 6.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -45.35 125.13 5.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -1.115 . . . . 0.0 110.089 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -92.29 -17.92 24.09 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.23 -0.919 . . . . 0.0 109.802 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 42.0 t -142.44 151.87 42.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.387 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.16 -49.88 11.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -40.87 98.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.056 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -38.67 77.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -44.43 72.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.161 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -25.56 65.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.23 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.498 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 0.6 OUTLIER -85.25 -36.26 21.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.338 -0.851 . . . . 0.0 110.287 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.731 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -70.49 -36.11 73.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.047 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.451 ' OG ' HG21 ' B' ' 74' ' ' VAL . 28.8 t -71.64 -59.8 2.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.527 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.0 ptm180 -46.19 -37.36 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.527 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 8.8 mttt -64.72 -45.98 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.558 ' CE1' HG23 ' B' ' 106' ' ' ILE . 9.5 m-85 -57.47 -56.95 15.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' ALA . . . . . 0.53 ' HA ' HG12 ' B' ' 143' ' ' ILE . . . -49.04 -40.77 32.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.616 ' HA ' ' NE2' ' B' ' 144' ' ' GLN . 2.4 ttt-85 -53.4 -47.29 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.085 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.439 ' C ' HD13 ' B' ' 143' ' ' ILE . 83.2 mt -61.81 -25.44 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 110.349 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 1.152 ' CG2' ' HB3' ' B' ' 149' ' ' ALA . 0.5 OUTLIER -83.83 -51.2 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 109.397 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.878 ' HG2' ' HB1' ' B' ' 150' ' ' ALA . 4.2 mt-30 -46.96 -36.5 7.79 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -72.16 -31.65 66.14 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' B' ' 88' ' ' HIS . 0.1 OUTLIER -74.71 -45.02 45.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.41 -26.16 1.37 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.15 -1.5 . . . . 0.0 112.033 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.534 ' HB2' ' CD2' ' B' ' 80' ' ' LEU . 0.1 OUTLIER -142.31 -154.61 0.53 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.291 -1.711 . . . . 0.0 112.598 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 1.152 ' HB3' ' CG2' ' B' ' 143' ' ' ILE . . . 41.22 29.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.54 1.162 . . . . 0.0 107.889 -178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.878 ' HB1' ' HG2' ' B' ' 144' ' ' GLN . . . -89.74 -19.06 25.21 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.814 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.83 ' O ' HD23 ' B' ' 76' ' ' LEU . 1.9 mptt -71.03 133.21 46.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.568 -1.333 . . . . 0.0 110.33 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -115.19 75.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.858 . . . . 0.0 110.269 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -137.79 -174.05 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.229 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 1.9 t0 56.39 16.77 2.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -68.57 125.85 27.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.215 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -160.24 131.93 6.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 110.259 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.498 HD13 HG21 ' B' ' 70' ' ' ILE . 21.4 mt -79.43 132.01 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.857 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.419 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 38.3 mm-40 -130.7 1.16 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 110.652 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.471 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.5 OUTLIER -148.33 108.53 4.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.977 -1.077 . . . . 0.0 111.236 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.682 HD12 ' N ' ' B' ' 219' ' ' GLN . 69.8 mt -117.67 137.26 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.837 . . . . 0.0 109.209 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.547 HG22 ' OG1' ' B' ' 215' ' ' THR . 88.9 t -114.37 139.13 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 111.031 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -147.02 171.18 27.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.4 p -155.84 163.42 39.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.257 . . . . 0.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' B' ' 212' ' ' ILE . 17.6 p -165.65 169.84 14.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.843 . . . . 0.0 110.223 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 15.5 p-10 -120.55 144.01 48.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 109.988 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 1.129 HG21 HD11 ' B' ' 170' ' ' ILE . 25.3 m -94.02 2.7 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.988 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 28.2 tttp 71.86 10.16 6.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 110.917 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.602 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 9.3 p90 -166.23 154.58 9.79 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 110.416 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.65 158.02 51.35 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.996 1.524 . . . . 0.0 110.784 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 1.129 HD11 HG21 ' B' ' 166' ' ' VAL . 2.4 mp -131.07 147.86 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.229 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -76.93 92.05 3.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.924 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.514 HD11 ' N ' ' B' ' 208' ' ' VAL . 13.6 mt -50.57 -37.25 38.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.39 -43.49 60.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.245 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.39 80.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.727 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -71.36 -51.77 22.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -1.123 . . . . 0.0 110.12 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.498 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -57.84 -29.71 65.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.114 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -72.38 -36.54 68.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.13 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.59 -27.4 17.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.959 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -129.15 34.9 4.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 110.004 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.22 -18.29 64.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 181' ' ' THR . . . . . 0.864 HG23 ' CD2' ' B' ' 182' ' ' PHE . 8.9 t -69.31 -21.43 63.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -1.137 . . . . 0.0 110.31 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.864 ' CD2' HG23 ' B' ' 181' ' ' THR . 41.3 m-85 -129.57 3.14 5.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.662 ' HB2' HD21 ' B' ' 193' ' ' LEU . 0.9 OUTLIER -139.47 135.42 33.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 154.98 29.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.071 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 0.479 ' HB2' HD12 ' B' ' 193' ' ' LEU . 82.8 t80 -147.08 105.72 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.342 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 190' ' ' PHE . 7.4 mt-10 -108.75 105.27 56.71 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.0 Cg_endo -71.74 -2.07 10.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.981 1.516 . . . . 0.0 110.599 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -19.88 16.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.074 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.533 ' C ' HD23 ' B' ' 189' ' ' LEU . 4.7 tt -132.91 -29.73 1.44 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 110.551 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.627 ' CE2' HD21 ' A' ' 59' ' ' LEU . 1.9 t80 -131.8 111.29 14.7 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.32 -7.92 21.79 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.867 1.456 . . . . 0.0 110.231 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' B' ' 172' ' ' LEU . . . -107.97 179.98 21.89 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' B' ' 183' ' ' SER . 3.5 tt -113.74 125.95 54.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.398 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.678 HD13 HD13 ' A' ' 62' ' ' LEU . 44.2 mt -91.77 112.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.96 . . . . 0.0 109.953 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 2.2 t80 -108.49 124.61 50.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.381 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.458 ' HB2' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -105.82 79.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.057 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 32.1 ttm -49.11 134.72 17.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 40.5 t -73.01 -43.1 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.3 OUTLIER -143.2 116.43 6.05 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.113 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.1 Cg_endo -73.54 156.02 99.67 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.99 -2.087 . . . . 0.0 110.529 -0.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.926 ' O ' HD13 ' B' ' 202' ' ' ILE . 2.9 tptt -67.37 94.87 0.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.926 HD13 ' O ' ' B' ' 201' ' ' LYS . 11.2 mm -141.09 158.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.215 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.415 HG22 ' HG3' ' B' ' 196' ' ' ARG . 62.2 t -105.54 116.22 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.943 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.2 mp -108.12 108.67 19.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.497 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.689 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -95.08 118.88 32.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.614 HG23 ' CD1' ' B' ' 212' ' ' ILE . 3.2 mp -116.76 120.9 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.162 -0.962 . . . . 0.0 110.486 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' B' ' 207' ' ' PHE . 30.1 m-85 -93.33 172.22 8.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.514 ' N ' HD11 ' B' ' 172' ' ' LEU . 27.2 t -60.32 -39.83 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.327 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 50.6 m -53.16 -42.28 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.455 -0.778 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.655 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 125.81 4.34 6.75 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.31 136.45 44.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 110.089 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.614 ' CD1' HG23 ' B' ' 206' ' ' ILE . 14.6 mm -119.41 136.49 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.328 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 84.0 t -121.88 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.939 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.452 HD12 ' N ' ' B' ' 214' ' ' LEU . 2.2 mp -127.03 117.16 21.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.547 ' OG1' HG22 ' B' ' 161' ' ' VAL . 13.6 t -135.57 160.53 38.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.105 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.57 -5.88 64.91 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.62 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -73.54 136.18 44.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.16 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.425 ' N ' ' OE2' ' B' ' 222' ' ' GLU . 0.0 OUTLIER -84.57 -8.69 58.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.092 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.682 ' N ' HD12 ' B' ' 160' ' ' ILE . 1.0 OUTLIER -156.89 -174.02 4.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -82.15 -32.63 29.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 1.0 OUTLIER -52.44 -29.61 25.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.052 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.62 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 21.1 mt-10 -76.85 -48.0 19.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.3 -39.03 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -69.88 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -83.59 -46.77 12.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.265 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.442 ' O ' HG22 ' B' ' 230' ' ' ILE . . . -47.71 -40.65 20.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -74.37 -48.33 28.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.0 -17.38 62.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.007 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -86.4 -32.92 20.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 109.922 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.442 HG22 ' O ' ' B' ' 226' ' ' ALA . 1.0 OUTLIER -99.12 -17.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.846 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.616 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 51.9 t80 -47.71 -46.96 62.22 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.2 Cg_endo -71.43 -49.36 0.36 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.387 1.204 . . . . 0.0 110.18 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.727 HG12 HD21 ' B' ' 175' ' ' LEU . 9.3 t -47.71 -43.28 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.642 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.609 ' CD2' HG21 ' B' ' 170' ' ' ILE . 91.0 mt -63.12 -51.22 67.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 59.6 p -54.11 -27.76 35.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.65 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.82 -38.47 79.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.919 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.501 ' CD2' HD22 ' B' ' 175' ' ' LEU . 50.0 m-85 -110.15 37.77 2.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -63.21 163.21 10.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.202 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.61 -28.83 6.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.877 . . . . 0.0 110.218 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.256 0.55 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.49 80.02 1.28 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.1 p -157.23 67.59 0.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.175 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 mt -83.3 148.74 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.235 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.72 -91.25 0.64 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -78.26 172.45 13.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.324 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 168.5 20.24 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.925 HD22 ' CD2' ' B' ' 99' ' ' PHE . 0.1 OUTLIER -128.82 158.63 38.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.447 -1.031 . . . . 0.0 109.196 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.847 ' O ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -93.8 128.38 40.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.122 -0.987 . . . . 0.0 111.497 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.968 HD11 ' HB ' ' A' ' 72' ' ' ILE . 9.6 mt -124.64 24.98 7.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 110.47 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.59 ' OG1' HD23 ' A' ' 68' ' ' LEU . 8.4 m -49.01 -36.6 18.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.61 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -85.67 -24.66 41.54 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.497 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.831 HG21 HG11 ' A' ' 71' ' ' VAL . 9.5 mm -50.37 -54.22 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.883 -1.363 . . . . 0.0 109.011 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.961 HD13 ' SD ' ' A' ' 67' ' ' MET . 1.6 pp -79.33 8.89 5.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 110.023 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.742 ' HE2' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -111.75 -15.41 13.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.006 -1.059 . . . . 0.0 111.026 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 156.99 44.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.531 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB2' ' CG ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER 61.72 132.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.929 -1.336 . . . . 0.0 110.185 178.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.757 HG21 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -162.2 158.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.818 0.818 . . . . 0.0 109.524 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLU . 77.1 m-20 -88.49 118.36 28.08 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.623 ' HB2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -39.68 -26.82 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.992 -179.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 18.0 pt-20 -55.16 -16.33 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.043 -1.035 . . . . 0.0 109.991 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.98 14.29 10.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.536 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.69 115.88 28.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.074 -1.25 . . . . 0.0 109.939 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.61 HD12 ' HA3' ' A' ' 22' ' ' GLY . 1.2 tt -87.67 158.85 18.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.918 -1.114 . . . . 0.0 110.872 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 35' ' ' LEU . 4.0 pp -127.47 -179.57 4.98 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.711 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.757 ' N ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -146.98 103.32 3.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.502 -0.749 . . . . 0.0 110.35 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 9.9 p-10 -46.45 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -0.825 . . . . 0.0 110.264 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 39' ' ' ASP . 7.2 t0 63.23 -158.75 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 110.129 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 38' ' ' ASP . 15.3 m-20 59.84 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.6 -113.24 0.65 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -123.82 109.73 14.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -1.14 . . . . 0.0 110.253 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 46.28 10.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.52 -29.0 3.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -1.191 . . . . 0.0 110.273 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.81 0.1 10.91 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.04 150.67 46.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -136.79 146.11 45.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.137 . . . . 0.0 110.214 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 48' ' ' PHE . . . 135.68 171.26 12.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 49.7 p90 -43.47 122.07 2.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -1.139 . . . . 0.0 110.013 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.58 -127.75 0.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 110.379 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . . . -99.79 23.23 9.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.957 -1.09 . . . . 0.0 110.348 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 1.6 tp10 -88.67 -52.04 5.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.742 HD21 ' HE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -93.5 -11.6 31.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.025 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -56.7 -54.05 50.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -0.996 . . . . 0.0 108.784 178.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.63 -23.34 64.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 45.8 m-80 -80.06 -33.31 39.1 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.025 HD12 ' HA ' ' A' ' 53' ' ' ARG . 24.6 mt -50.01 -41.98 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.51 -14.61 28.74 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.99 -7.1 11.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.89 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.732 HD11 ' CE1' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -76.88 53.99 0.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.95 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m -126.81 32.59 5.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.786 . . . . 0.0 110.365 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.569 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.19 17.87 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.322 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 61' ' ' LYS . 6.9 mt -112.89 -63.09 1.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.561 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.5 -39.96 0.03 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.847 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.5 mm? -53.3 -19.4 3.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -1.117 . . . . 0.0 110.644 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 4.8 p-10 -46.07 -40.75 11.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 110.068 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -59.49 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.961 ' SD ' HD13 ' A' ' 24' ' ' LEU . 12.6 ttm -70.75 -3.49 19.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.766 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.69 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.5 tm? -69.43 -58.29 4.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pp -77.92 1.42 20.66 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.478 0.656 . . . . 0.0 109.613 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 3.9 tt0 -87.94 15.5 7.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.898 ' HB ' HD12 ' A' ' 20' ' ' LEU . 3.8 t -138.93 -0.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.729 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.072 HD11 HD12 ' A' ' 74' ' ' LEU . 2.9 tp -151.17 84.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.515 -0.741 . . . . 0.0 109.32 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 2.1 p-10 -87.4 49.19 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.964 -1.085 . . . . 0.0 108.486 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.072 HD12 HD11 ' A' ' 72' ' ' ILE . 9.9 mt -90.88 62.27 4.93 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.675 0.75 . . . . 0.0 110.872 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -168.32 110.86 0.58 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.618 -0.676 . . . . 0.0 110.211 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 1.2 mt-10 47.55 -112.7 0.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.149 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.853 -1.154 . . . . 0.0 110.318 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.177 0.513 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.87 39.72 62.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 6.3 mt -74.84 -40.54 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -1.124 . . . . 0.0 110.291 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 56.6 t 58.46 126.34 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.595 -0.691 . . . . 0.0 110.223 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.437 ' HA ' ' SG ' ' B' ' 164' ' ' CYS . 45.9 Cg_endo -73.49 151.53 47.68 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.858 1.451 . . . . 0.0 110.568 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.443 HG22 ' N ' ' B' ' 67' ' ' LEU . 98.1 m -101.47 164.79 11.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.443 ' N ' HG22 ' B' ' 66' ' ' THR . 19.4 mt -89.48 128.67 36.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.28 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.33 -32.62 10.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.507 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 7.6 m-20 -170.05 171.62 6.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.939 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 16.5 mm -131.77 155.52 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 110.149 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.53 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 37.6 t -138.29 113.7 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.864 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.51 ' HB2' ' CG1' ' B' ' 157' ' ' ILE . . . -128.42 156.46 43.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 110.587 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 26.1 p -105.69 114.16 28.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.55 HG22 ' CD1' ' B' ' 155' ' ' PHE . 21.6 t -107.93 120.64 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 52.5 m -97.08 160.68 14.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' B' ' 150' ' ' ALA . 22.0 mt -107.32 -59.89 1.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.237 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.86 -0.1 6.65 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 21.6 p -142.37 170.18 16.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -1.152 . . . . 0.0 110.187 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.533 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -83.34 154.32 24.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 1.025 HD11 ' CD1' ' B' ' 76' ' ' LEU . 70.8 mt -128.32 144.49 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.093 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.463 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 5.7 m-20 -89.86 94.6 9.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.631 HD22 HG23 ' B' ' 102' ' ' VAL . 12.3 mt -46.63 -45.17 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -54.78 -45.06 74.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 110.106 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 7.0 m -82.5 -38.68 23.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.465 HG12 HG11 ' B' ' 102' ' ' VAL . 19.7 t -61.44 -48.06 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.526 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -73.43 -24.24 60.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.277 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 19.7 tp -85.98 -23.8 26.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.498 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.4 OUTLIER -96.75 -42.91 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.181 -0.95 . . . . 0.0 110.378 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.701 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -45.92 123.49 4.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.129 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -24.05 64.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.25 -0.906 . . . . 0.0 110.293 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -137.14 79.59 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.737 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -164.96 161.24 19.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 0.0 109.856 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' B' ' 92' ' ' ALA . 58.6 mm-40 -152.78 138.38 17.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 110.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.535 ' HE1' HD13 ' B' ' 82' ' ' LEU . 19.8 t80 -93.17 148.24 22.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.725 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' B' ' 98' ' ' ARG . 0.1 OUTLIER -138.44 103.9 7.82 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 110.628 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.37 -17.71 16.44 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.045 1.55 . . . . 0.0 110.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.07 -4.23 58.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 0.0 110.269 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -116.55 -65.39 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 1.07 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -153.67 -168.07 2.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.356 -0.84 . . . . 0.0 111.294 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.18 53.7 0.68 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.07 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -145.33 164.21 32.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 0.0 110.93 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.631 HG23 HD22 ' B' ' 82' ' ' LEU . 86.2 t -102.27 127.0 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.818 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -94.61 108.78 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.737 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 3.4 ttm -93.63 170.75 9.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.01 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.6 119.66 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.465 HG23 ' CE1' ' B' ' 139' ' ' TYR . 8.7 pt -122.58 149.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.32 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 2.3 ptt180 -99.12 33.13 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.1 tt0 -171.93 84.2 0.46 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 47.7 Cg_endo -76.51 162.1 92.49 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.657 -2.226 . . . . 0.0 110.463 -0.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -70.36 79.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.008 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.51 HG22 ' HA3' ' B' ' 125' ' ' GLY . 67.7 p -131.12 -179.7 5.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.51 HG22 HG23 ' B' ' 124' ' ' THR . 13.4 t -138.58 158.48 44.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.77 154.96 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.934 -1.104 . . . . 0.0 111.162 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.477 ' N ' HD23 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -124.16 111.61 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.591 ' N ' HD12 ' B' ' 115' ' ' ILE . 5.2 mp -93.13 136.96 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 111.483 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 5.2 m-30 -96.84 169.33 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.77 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.06 -0.96 42.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 110.097 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.7 -7.31 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.08 -2.49 40.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' LYS . . . . . 0.541 ' HB3' ' CD2' ' B' ' 116' ' ' PHE . 0.1 OUTLIER -85.42 146.11 27.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.111 -1.229 . . . . 0.0 110.024 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 29.2 ttp -149.51 125.55 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.814 HG11 ' CG1' ' A' ' 71' ' ' VAL . 48.7 t -97.38 148.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.95 107.72 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 111.355 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.552 ' CG2' ' HA ' ' A' ' 27' ' ' ASN . 9.7 t -108.53 144.44 36.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.094 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.524 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 126.5 -27.2 5.03 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.939 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -52.92 149.01 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.03 -1.277 . . . . 0.0 109.719 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.0 OUTLIER -94.66 -19.97 19.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.027 -1.046 . . . . 0.0 109.862 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.436 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -161.99 -159.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -75.34 -36.83 60.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.07 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.48 -38.94 92.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.086 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.61 -52.8 22.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.299 -0.876 . . . . 0.0 110.231 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 30.3 t -45.91 -36.4 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.203 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -73.83 -31.93 63.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.686 HD23 ' HD3' ' B' ' 137' ' ' ARG . 50.5 mt -80.95 -46.63 14.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.47 -29.57 61.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.143 -0.973 . . . . 0.0 109.88 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.438 ' O ' ' C ' ' B' ' 137' ' ' ARG . 23.4 t -76.3 -64.43 1.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 110.243 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.686 ' HD3' HD23 ' B' ' 134' ' ' LEU . 14.6 ptm180 -41.79 -31.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.537 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 4.9 mmtm -67.83 -50.99 53.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.471 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.465 ' CE1' HG23 ' B' ' 106' ' ' ILE . 18.1 m-85 -60.03 -52.13 66.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.342 -0.849 . . . . 0.0 109.673 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.33 62.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.639 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -52.26 -40.44 61.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.646 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' B' ' 139' ' ' TYR . 84.2 mt -63.34 -43.0 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.835 . . . . 0.0 110.195 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.532 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 52.0 mt -75.5 -49.06 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.71 -37.43 84.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' B' ' 141' ' ' ARG . 32.5 tttp -71.82 -27.03 62.64 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.427 HG13 ' O ' ' B' ' 142' ' ' ILE . 6.2 mt -74.01 -10.64 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.67 -19.3 28.66 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.532 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 6.4 m-85 -55.18 157.98 3.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -1.222 . . . . 0.0 111.057 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.41 49.72 0.99 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.62 -0.675 . . . . 0.0 109.742 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -96.26 144.78 26.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 110.835 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.509 ' O ' HD23 ' B' ' 76' ' ' LEU . 9.2 ptpt -142.28 -157.6 0.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.45 -0.781 . . . . 0.0 109.551 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' B' ' 137' ' ' ARG . 33.8 m-85 -106.09 117.39 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.016 . . . . 0.0 110.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' B' ' 75' ' ' THR . 0.8 OUTLIER -151.27 163.28 39.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' B' ' 75' ' ' THR . 13.8 t0 42.65 26.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 110.438 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' B' ' 74' ' ' VAL . 1.4 t80 -76.63 124.05 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 110.023 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' LYS . . . . . 0.443 ' N ' ' CD1' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -163.75 131.57 3.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.366 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.51 ' CG1' ' HB2' ' B' ' 72' ' ' ALA . 31.5 mt -78.78 107.87 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -110.45 12.01 23.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.657 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.53 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 49.3 m-20 -153.46 115.44 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.548 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 215' ' ' THR . 31.2 mt -117.73 162.7 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.667 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.418 ' N ' HG22 ' B' ' 160' ' ' ILE . 21.5 t -137.34 128.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.033 . . . . 0.0 110.624 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' B' ' 66' ' ' THR . . . -133.53 175.18 20.36 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 3.3 m -167.49 154.11 8.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -1.223 . . . . 0.0 110.456 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -169.95 161.9 9.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.122 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.432 ' OD1' ' HA ' ' B' ' 211' ' ' LYS . 4.2 m-20 -106.65 157.54 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.0 OUTLIER -110.46 3.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 3.8 tmtm? 74.34 -4.06 2.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.504 -0.748 . . . . 0.0 111.166 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 38.5 p90 -149.57 144.91 18.31 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.009 -1.057 . . . . 0.0 110.278 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.468 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.7 Cg_endo -71.92 157.64 54.41 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.174 1.618 . . . . 0.0 110.714 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.18 154.35 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 110.284 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.34 90.4 8.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 109.994 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' B' ' 193' ' ' LEU . 24.3 mt -52.17 -34.25 44.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.518 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -62.86 -58.91 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -56.34 -42.24 88.66 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.527 HD12 ' CD2' ' B' ' 179' ' ' HIS . 14.5 tp -71.88 -38.37 70.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.185 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.662 ' HB2' HD12 ' B' ' 193' ' ' LEU . . . -71.13 -17.31 62.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -83.09 -40.86 19.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.123 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 15.3 t -81.61 -45.63 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.527 ' CD2' HD12 ' B' ' 175' ' ' LEU . 52.2 m-70 -95.4 14.93 20.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.33 -29.97 5.52 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 92.2 m -71.95 -25.44 61.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.3 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -106.1 -21.32 13.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.891 ' HB3' HD21 ' B' ' 193' ' ' LEU . 1.1 m -124.86 171.61 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.5 t -137.95 135.39 35.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.894 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 0.491 ' CD2' ' HD3' ' B' ' 187' ' ' PRO . 64.4 t80 -128.55 135.59 49.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.578 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' B' ' 190' ' ' PHE . 12.3 mm-40 -131.94 93.79 26.28 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.491 ' HD3' ' CD2' ' B' ' 185' ' ' TYR . 42.0 Cg_endo -68.99 -7.08 19.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.034 1.544 . . . . 0.0 110.365 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -100.41 -1.68 35.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -153.48 -48.33 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.134 -0.979 . . . . 0.0 110.565 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.816 ' HE2' HD11 ' B' ' 205' ' ' LEU . 3.0 t80 -108.76 117.56 53.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 110.514 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.53 -30.66 9.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.98 1.516 . . . . 0.0 110.178 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.75 -179.38 44.76 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.891 HD21 ' HB3' ' B' ' 183' ' ' SER . 3.6 tt -123.4 150.81 43.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -1.187 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' B' ' 183' ' ' SER . 4.5 mt -107.52 100.79 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.48 ' OH ' ' ND1' ' B' ' 179' ' ' HIS . 0.6 OUTLIER -89.62 103.88 16.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.262 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' B' ' 202' ' ' ILE . 22.2 mtm180 -92.36 79.51 4.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.523 ' CE ' HG12 ' B' ' 230' ' ' ILE . 34.3 ttm -43.53 146.28 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 110.589 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.14 -34.61 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 110.079 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -155.8 116.05 2.24 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.3 Cg_endo -73.54 147.42 89.56 Favored 'Cis proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.89 -2.129 . . . . 0.0 110.377 0.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' B' ' 197' ' ' MET . 0.0 OUTLIER -59.27 101.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' B' ' 217' ' ' ALA . 37.9 mm -138.85 153.55 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.343 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.71 100.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.925 HD22 HG13 ' B' ' 230' ' ' ILE . 6.2 mp -94.67 127.25 40.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.46 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.816 HD11 ' HE2' ' B' ' 190' ' ' PHE . 0.1 OUTLIER -92.54 111.12 22.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.45 HD12 HD21 ' B' ' 234' ' ' LEU . 10.9 mm -96.68 139.32 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' B' ' 205' ' ' LEU . 33.4 m-85 -128.81 136.41 50.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.141 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 54.8 t -49.19 -36.35 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.938 . . . . 0.0 110.215 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.6 m -53.3 -30.0 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.47 16.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.624 ' O ' HD13 ' B' ' 212' ' ' ILE . 8.8 mttt -92.26 133.97 35.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.13 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.624 HD13 ' O ' ' B' ' 211' ' ' LYS . 12.9 mm -117.54 135.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.371 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' B' ' 205' ' ' LEU . 69.3 t -123.06 113.68 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.812 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.533 HD12 ' H ' ' B' ' 214' ' ' LEU . 3.5 mp -103.74 117.37 34.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.462 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.9 t -147.8 165.64 29.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.183 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.447 ' HA3' ' HE1' ' A' ' 67' ' ' MET . . . 92.49 21.76 30.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.895 ' HB3' HD12 ' B' ' 223' ' ' ILE . . . -100.32 141.57 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -1.099 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -16.0 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 109.94 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -153.12 145.72 24.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 110.027 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' B' ' 67' ' ' LEU . 0.6 OUTLIER -53.03 -25.73 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.244 -0.91 . . . . 0.0 110.329 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -38.68 91.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.407 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 82.0 mt-10 -67.59 -52.09 42.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.292 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' B' ' 217' ' ' ALA . 0.0 OUTLIER -53.08 -56.64 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.685 ' N ' HG22 ' B' ' 223' ' ' ILE . 1.7 m-30 -47.56 -31.07 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.004 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' B' ' 228' ' ' GLU . 2.8 mt-30 -78.42 -41.97 31.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.801 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -45.88 -44.36 14.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.868 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -69.5 -45.18 69.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.812 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -53.28 -28.77 29.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.08 19.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 109.789 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.925 HG13 HD22 ' B' ' 204' ' ' LEU . 5.9 mm -97.58 -13.4 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 109.821 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 41.7 t80 -52.46 -44.95 95.48 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.924 . . . . 0.0 110.694 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -74.28 -26.73 12.15 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.39 1.205 . . . . 0.0 110.315 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.41 HG13 HD13 ' B' ' 175' ' ' LEU . 25.0 t -66.23 -39.48 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 109.785 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.45 HD21 HD12 ' B' ' 206' ' ' ILE . 67.6 mt -68.5 -45.62 71.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 110.018 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 94.9 p -64.94 -44.58 88.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.87 . . . . 0.0 110.04 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.62 -37.33 49.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.927 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -110.62 36.59 3.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.968 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.488 ' CD ' ' C ' ' B' ' 238' ' ' ARG . 0.2 OUTLIER -74.55 163.46 27.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -121.37 -30.68 4.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.106 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.261 0.553 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.63 130.77 4.78 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.87 55.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 110.447 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.989 ' O ' HD13 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -63.44 -27.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.101 -0.999 . . . . 0.0 110.156 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.9 138.35 5.54 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' GLY . 6.2 m120 -86.02 140.37 30.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -1.157 . . . . 0.0 110.343 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' ASN . . . 53.33 170.48 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.052 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.1 OUTLIER -60.29 159.57 9.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -1.144 . . . . 0.0 110.032 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 1.02 ' N ' HD12 ' A' ' 18' ' ' LEU . 37.0 t0 -68.28 67.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.753 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.985 HD21 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -84.28 -4.42 58.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 110.397 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.594 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 31.1 m -43.48 -36.45 2.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 110.289 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.507 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -92.41 -36.45 6.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.755 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -49.93 -45.46 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -1.213 . . . . 0.0 108.82 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.891 HD22 ' HB3' ' A' ' 67' ' ' MET . 3.8 pp -79.74 6.35 11.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 109.607 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.786 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.3 t80 -114.94 -13.89 11.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 111.232 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 164.73 46.9 0.02 OUTLIER Glycine 0 N--CA 1.496 2.649 0 C-N-CA 118.861 -1.638 . . . . 0.0 110.746 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.702 HD21 ' CD1' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 44.96 112.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.307 1.051 . . . . 0.0 111.784 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -145.0 158.24 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.777 ' HA ' HG21 ' B' ' 103' ' ' ILE . 44.8 m-20 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.052 ' HB2' HD13 ' A' ' 18' ' ' LEU . 13.7 p -38.66 -28.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.475 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.8 tt0 -54.02 -17.02 2.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 110.233 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.53 28.22 5.5 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -123.97 125.87 45.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.003 -1.293 . . . . 0.0 110.359 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.673 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.31 153.16 17.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 110.706 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.747 HD12 ' C ' ' A' ' 35' ' ' LEU . 4.3 pp -128.34 -178.88 4.74 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.784 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.708 ' N ' HD12 ' A' ' 35' ' ' LEU . 23.8 mt-30 -131.42 122.8 26.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.639 -0.663 . . . . 0.0 110.101 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' B' ' 110' ' ' LYS . 10.8 t0 -63.02 -11.84 22.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.359 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -58.39 163.94 2.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -118.18 8.96 12.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 110.383 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.57 116.55 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.87 -174.5 2.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -1.144 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.55 -64.15 2.32 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -59.84 117.47 5.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -1.12 . . . . 0.0 110.201 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.64 146.07 8.04 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.69 -157.3 32.61 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -124.2 120.13 31.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -1.168 . . . . 0.0 110.285 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.42 -163.69 26.36 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' A' ' 48' ' ' PHE . 25.1 p90 -78.47 149.33 33.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.166 . . . . 0.0 110.228 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -96.75 -114.87 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.73 34.94 2.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.141 . . . . 0.0 110.295 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' OE2' ' HB2' ' A' ' 48' ' ' PHE . 13.8 pt-20 -95.53 -23.73 16.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.668 HD21 ' HZ ' ' B' ' 207' ' ' PHE . 4.4 mt -96.81 -43.7 7.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.016 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.904 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -45.23 -45.16 11.64 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.967 -179.304 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.98 -30.26 70.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.564 ' HB3' ' CE1' ' B' ' 190' ' ' PHE . 13.7 m120 -80.69 -37.8 30.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.713 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.7 mt -49.28 -46.22 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.355 -0.841 . . . . 0.0 109.54 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.77 -17.12 26.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -119.46 7.75 11.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -1.143 . . . . 0.0 110.315 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 56' ' ' ILE . 1.8 mt -86.76 31.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.524 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -118.2 39.07 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.204 -0.935 . . . . 0.0 110.49 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' HD13 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -162.42 31.43 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.522 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -145.22 -26.65 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 111.256 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.999 ' N ' HD12 ' A' ' 62' ' ' LEU . . . 177.47 -44.52 0.1 OUTLIER Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.157 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.86 HD12 HD11 ' A' ' 24' ' ' LEU . 3.9 mm? -53.4 -17.7 2.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -1.188 . . . . 0.0 110.67 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 80.6 m-20 -46.42 -39.82 11.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.085 -1.009 . . . . 0.0 110.116 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -62.26 -57.05 12.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.877 . . . . 0.0 110.098 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.891 ' HB3' HD22 ' A' ' 24' ' ' LEU . 4.9 tpp -64.32 -11.01 27.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 21' ' ' THR . 1.3 tm? -68.0 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.974 0.892 . . . . 0.0 109.024 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.82 -2.46 17.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.307 0.575 . . . . 0.0 110.222 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 13.3 tt0 -85.8 0.53 52.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.229 -0.919 . . . . 0.0 111.53 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.778 HG12 HG11 ' B' ' 122' ' ' VAL . 2.2 t -137.92 3.24 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.265 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 74' ' ' LEU . 6.0 tp -149.85 70.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -75.83 57.33 1.02 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.933 HD12 HD11 ' A' ' 72' ' ' ILE . 6.1 mt -107.09 67.2 0.69 Allowed 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.681 0.753 . . . . 0.0 110.382 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 76' ' ' GLU . 0.9 OUTLIER -129.83 60.64 1.59 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.529 -0.732 . . . . 0.0 110.019 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.1 tt0 66.27 31.38 8.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -0.885 . . . . 0.0 110.183 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.25 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.306 0.574 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.13 69.45 0.05 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.79 136.99 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -1.15 . . . . 0.0 110.219 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.459 HG13 ' HD2' ' B' ' 65' ' ' PRO . 55.8 t -92.47 140.07 24.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.876 . . . . 0.0 110.248 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.467 ' HG3' ' HB2' ' B' ' 227' ' ' PHE . 44.5 Cg_endo -71.29 138.45 33.1 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.011 1.532 . . . . 0.0 110.476 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.479 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 17.0 m -106.67 141.35 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.826 HD22 HG22 ' B' ' 160' ' ' ILE . 40.6 mt -78.66 122.24 25.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 19.7 mm-40 -110.16 -15.71 13.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 110.383 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.544 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 71.9 m-20 -160.94 121.7 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.299 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.716 HD11 HD13 ' B' ' 67' ' ' LEU . 10.1 mt -122.54 171.33 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.902 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.579 ' N ' HG22 ' B' ' 70' ' ' ILE . 7.6 t -144.79 134.31 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.64 133.29 54.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 38.7 m -92.14 127.33 37.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.093 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.727 HG21 ' OG ' ' B' ' 136' ' ' SER . 40.6 t -131.12 133.04 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.385 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 4.4 m -101.27 139.98 36.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 110.056 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.831 HD22 ' HB1' ' B' ' 150' ' ' ALA . 29.2 mt -87.16 -67.25 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 143.32 -17.75 2.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 30.1 p -141.7 141.08 33.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.775 ' O ' HD23 ' B' ' 80' ' ' LEU . 1.5 ptt85 -57.9 163.56 2.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.775 HD23 ' O ' ' B' ' 79' ' ' ARG . 18.0 mt -139.86 155.98 46.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 110.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 3.7 m-20 -89.75 102.59 15.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' B' ' 102' ' ' VAL . 13.6 mt -48.39 -31.44 6.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.333 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -67.25 -38.59 85.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 110.255 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 31.7 p -81.9 -41.96 20.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.543 HG12 HG11 ' B' ' 102' ' ' VAL . 24.2 t -58.66 -42.46 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.404 ' CB ' ' HB2' ' B' ' 94' ' ' TYR . . . -81.03 -18.39 46.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.452 ' O ' HD12 ' B' ' 87' ' ' LEU . 13.4 tp -87.08 -31.38 20.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -95.59 -29.3 14.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.397 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -63.35 133.37 53.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -25.45 59.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 110.383 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 2.4 m120 -132.25 79.42 1.86 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.75 158.41 44.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' B' ' 102' ' ' VAL . 1.7 mm-40 -129.78 147.34 51.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.404 ' HB2' ' CB ' ' B' ' 86' ' ' ALA . 28.8 t80 -147.6 111.14 4.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.925 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -135.35 122.85 15.07 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 110.41 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.72 -17.3 26.11 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.916 1.482 . . . . 0.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -21.6 62.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 110.208 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.452 ' HG3' ' NH1' ' B' ' 98' ' ' ARG . 0.0 OUTLIER -101.9 -56.95 2.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.606 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.731 ' CG ' ' HB2' ' A' ' 18' ' ' LEU 0.257 62.6 t80 -170.18 -179.14 3.02 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.866 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.773 ' O ' HD13 ' A' ' 74' ' ' LEU . . . -99.41 70.72 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.869 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -155.43 149.67 25.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.558 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.543 HG11 HG12 ' B' ' 85' ' ' VAL . 44.7 t -102.03 117.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.777 HG21 ' HA ' ' A' ' 29' ' ' ASP . 1.3 mp -89.55 111.38 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.483 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.568 ' CB ' ' HB3' ' B' ' 113' ' ' ALA . 0.6 OUTLIER -89.93 153.01 20.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.774 179.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -149.53 118.05 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.047 -1.033 . . . . 0.0 110.728 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.584 HG23 ' CE1' ' B' ' 139' ' ' TYR . 34.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 109.706 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -104.03 35.59 2.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 110.39 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 5.9 tt0 -171.82 81.49 0.48 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.461 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.483 ' O ' HG13 ' B' ' 106' ' ' ILE . 50.3 Cg_endo -79.63 165.35 80.08 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.538 -0.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 8.4 tptt -70.24 94.17 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.518 HG22 ' HA3' ' B' ' 125' ' ' GLY . 18.4 p -139.59 177.66 7.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.713 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.58 ' HB ' HG23 ' B' ' 124' ' ' THR . 0.9 OUTLIER -119.7 173.43 7.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.451 -0.78 . . . . 0.0 109.383 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' B' ' 104' ' ' MET . . . -146.93 133.97 20.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.22 97.18 6.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.521 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 68.8 mt -97.34 150.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.101 -0.999 . . . . 0.0 111.274 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.3 m-85 -118.81 174.13 6.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 109.861 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -87.4 -3.29 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 109.907 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.88 -22.34 24.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.531 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 126.57 -38.98 2.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.63 153.46 2.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -1.157 . . . . 0.0 110.026 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.545 ' HE2' HD21 ' B' ' 76' ' ' LEU . 1.9 ttm -140.76 148.77 41.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.778 HG11 HG12 ' A' ' 71' ' ' VAL . 1.4 t -129.02 142.21 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.49 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.482 HG13 ' HE2' ' B' ' 139' ' ' TYR . 21.7 t -132.04 112.41 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.636 HG21 HD13 ' A' ' 23' ' ' ILE . 1.7 t -104.86 165.37 11.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.382 -0.824 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.518 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 107.87 -28.26 12.67 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -51.5 144.91 9.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -1.222 . . . . 0.0 110.241 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' B' ' 128' ' ' SER . 17.0 pttm -112.62 -23.54 10.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.442 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -137.25 -153.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.79 -39.27 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.319 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.9 -42.45 90.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.62 -47.21 79.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 110.204 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 35.7 t -52.27 -46.96 66.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.241 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -36.86 80.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 110.212 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.82 -50.39 36.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.73 -50.27 66.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.727 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -62.35 -54.34 41.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.009 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' B' ' 138' ' ' LYS . 0.0 OUTLIER -46.5 -39.37 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.961 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.469 ' HD3' ' HD3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -61.29 -53.73 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.945 . . . . 0.0 110.052 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.721 ' HA ' HD12 ' B' ' 142' ' ' ILE . 40.5 m-85 -54.21 -52.72 60.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.257 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.37 -31.93 16.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -35.98 81.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.721 HD12 ' HA ' ' B' ' 139' ' ' TYR . 13.8 mt -63.97 -48.62 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.526 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.84 HG21 ' HB2' ' B' ' 150' ' ' ALA . 20.4 mm -61.66 -49.32 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -68.95 -27.56 65.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.085 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -77.35 -20.6 54.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.237 -0.914 . . . . 0.0 108.75 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.8 mt -87.57 -19.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.697 -0.627 . . . . 0.0 109.34 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.45 -29.41 5.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.499 ' CB ' HG22 ' B' ' 143' ' ' ILE . 6.8 m-85 -47.88 159.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.032 -1.275 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.12 42.07 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.651 -0.655 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.84 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -71.33 154.87 41.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.601 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -144.42 120.52 10.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 109.768 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 63.3 t80 -60.89 111.46 1.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.452 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.466 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.1 OUTLIER -158.16 163.25 37.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 0.4 OUTLIER 63.43 13.95 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.649 ' HA ' HG22 ' B' ' 74' ' ' VAL . 19.8 t80 -61.41 126.41 27.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.972 -1.08 . . . . 0.0 109.838 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 156' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 155' ' ' PHE . 27.5 mtpt -160.77 133.35 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.548 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.479 HG23 ' CG2' ' B' ' 70' ' ' ILE . 2.9 mp -79.49 127.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.755 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -129.33 -25.69 2.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.209 -0.932 . . . . 0.0 110.88 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -113.54 96.88 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.793 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.826 HG22 HD22 ' B' ' 67' ' ' LEU . 44.5 mt -107.85 111.36 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.552 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.874 HG22 ' OG1' ' B' ' 215' ' ' THR . 25.2 t -94.8 107.66 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.789 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -111.5 167.52 12.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.8 t -169.16 159.72 9.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.923 -1.339 . . . . 0.0 110.63 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -169.85 170.11 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.845 . . . . 0.0 109.928 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.89 161.05 14.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.969 . . . . 0.0 110.281 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.548 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.1 OUTLIER -111.54 -83.8 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.489 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER -173.89 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 110.8 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.489 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 7.0 p90 -137.49 166.31 27.59 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.7 Cg_endo -71.18 149.42 57.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.782 1.412 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.39 160.57 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.301 -0.874 . . . . 0.0 110.376 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.07 91.42 6.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' B' ' 193' ' ' LEU . 83.0 mt -48.34 -26.37 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.38 -58.57 4.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -51.22 -31.82 27.68 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.571 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -72.97 -42.89 62.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -1.165 . . . . 0.0 110.229 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -68.09 -13.46 62.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.143 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 177' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.6 t80 -92.8 -37.52 12.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 178' ' ' SER . . . . . 0.491 ' HB2' ' CZ ' ' B' ' 237' ' ' PHE . 46.6 t -83.82 -50.27 8.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -105.4 19.4 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.887 . . . . 0.0 110.225 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 176' ' ' ALA . . . -54.36 -25.74 34.72 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.07 -24.31 62.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -1.145 . . . . 0.0 110.263 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.706 ' CE1' HG22 ' B' ' 198' ' ' VAL . 0.9 OUTLIER -134.66 12.04 3.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.466 ' HB3' HD21 ' B' ' 193' ' ' LEU . 48.6 m -120.15 159.47 24.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 0.0 110.373 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 16.9 m -134.84 126.81 29.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.174 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -136.55 120.03 17.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 110.41 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -132.25 105.17 13.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.818 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.96 -2.86 12.17 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.084 1.571 . . . . 0.0 110.346 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.0 5.86 45.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.875 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.446 HD13 ' HE3' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -157.82 -41.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 110.266 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 55' ' ' ASN . 3.0 t80 -126.35 114.15 23.42 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 191' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -17.82 28.02 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.838 1.441 . . . . 0.0 110.49 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -94.31 179.79 37.84 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.9 ' HB2' HD22 ' B' ' 172' ' ' LEU . 9.5 tt -120.41 126.99 51.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.334 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.782 HD13 HD13 ' A' ' 62' ' ' LEU . 6.5 mt -90.95 107.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.4 t80 -96.44 116.7 29.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 87.55 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.0 ttm -59.53 144.07 48.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.706 HG22 ' CE1' ' B' ' 182' ' ' PHE . 65.2 t -88.26 -40.37 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 110.436 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.2 OUTLIER -140.93 107.49 6.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.365 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.9 Cg_endo -75.96 166.31 83.26 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.049 -2.063 . . . . 0.0 110.55 -0.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.0 OUTLIER -76.31 95.73 3.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.784 HD11 ' OE1' ' B' ' 222' ' ' GLU . 33.4 mm -134.91 160.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.45 107.04 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' B' ' 195' ' ' TYR . 1.5 mp -100.07 134.63 42.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.786 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 2.8 mt -110.83 116.26 30.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.489 HG12 HD21 ' B' ' 234' ' ' LEU . 3.6 mp -100.48 136.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.273 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.668 ' HZ ' HD21 ' A' ' 52' ' ' LEU . 49.0 m-85 -119.92 131.23 55.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 0.0 110.069 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 22.0 t -42.79 -27.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 207' ' ' PHE . 98.3 p -64.51 -26.58 68.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.548 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 110.75 9.02 23.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.62 ' C ' HD12 ' B' ' 212' ' ' ILE . 0.1 OUTLIER -98.2 121.93 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -1.185 . . . . 0.0 110.153 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.62 HD12 ' C ' ' B' ' 211' ' ' LYS . 1.2 mp -109.97 146.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.248 -0.907 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.652 ' C ' HD12 ' B' ' 214' ' ' LEU . 27.6 t -127.81 146.65 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 110.08 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.765 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.4 mp -133.2 109.51 9.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.874 ' OG1' HG22 ' B' ' 161' ' ' VAL . 14.7 t -130.23 152.04 50.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.149 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.413 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 109.03 -11.92 34.31 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -68.77 144.57 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.165 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -90.04 -17.37 27.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.173 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.528 ' NE2' ' OE1' ' B' ' 221' ' ' GLU . 0.6 OUTLIER -147.95 168.94 20.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -14.54 62.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.138 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.528 ' OE1' ' NE2' ' B' ' 219' ' ' GLN . 8.5 mp0 -68.73 -42.19 77.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 110.081 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.784 ' OE1' HD11 ' B' ' 202' ' ' ILE . 13.9 mt-10 -63.78 -51.15 66.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.449 HG22 ' HG2' ' B' ' 65' ' ' PRO . 45.8 mm -56.0 -37.2 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.419 ' CZ ' HG11 ' B' ' 64' ' ' VAL . 0.9 OUTLIER -65.05 -42.87 93.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 226' ' ' ALA . 0.0 OUTLIER -75.9 -44.11 42.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.296 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.478 ' O ' HG22 ' B' ' 230' ' ' ILE . . . -45.3 -41.38 8.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.72 ' HA ' HG22 ' B' ' 230' ' ' ILE . 10.2 t80 -78.39 -50.26 12.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 109.88 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -18.62 33.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.982 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -97.86 -32.61 11.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.72 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.8 tp -92.98 -17.79 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.605 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.3 t80 -50.88 -44.99 87.24 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 111.107 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.7 Cg_endo -71.93 -32.65 10.95 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.205 1.108 . . . . 0.0 110.496 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.571 HG12 HD21 ' B' ' 175' ' ' LEU . 25.2 t -64.37 -30.41 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 109.893 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.489 HD21 HG12 ' B' ' 206' ' ' ILE . 89.7 mt -70.91 -56.49 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.993 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -25.3 17.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -48.88 62.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' B' ' 178' ' ' SER . 92.4 m-85 -106.87 37.51 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.38 -0.825 . . . . 0.0 109.87 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -163.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' B' ' 169' ' ' PRO . 1.7 ttmm -126.7 -81.12 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 1.8 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.314 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.274 0.559 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.11 -36.21 92.67 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 m -168.66 152.21 5.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -1.204 . . . . 0.0 110.403 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.7 tt -172.33 159.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.24 -0.913 . . . . 0.0 110.175 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.26 83.89 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.83 -68.25 0.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -1.181 . . . . 0.0 109.977 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' C ' ' CZ ' ' B' ' 99' ' ' PHE . . . 78.81 139.14 1.57 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.883 HD23 ' CG1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -65.02 173.88 2.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.325 -1.103 . . . . 0.0 109.647 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.493 ' N ' HD12 ' A' ' 18' ' ' LEU . 29.1 t0 -61.26 75.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 0.0 110.25 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -91.14 -7.53 51.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.86 ' OG1' HD21 ' A' ' 68' ' ' LEU . 91.9 m -43.38 -30.7 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.43 -31.48 6.44 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.762 HD12 HD11 ' B' ' 114' ' ' LEU . 0.3 OUTLIER -52.79 -41.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.316 . . . . 0.0 109.333 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.496 ' CD2' HD12 ' A' ' 68' ' ' LEU . 1.4 pp -84.51 -18.94 34.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.742 -1.223 . . . . 0.0 108.652 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.688 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -99.6 14.57 29.55 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 141.18 93.27 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.934 ' HB2' HG23 ' B' ' 124' ' ' THR . 4.9 p30 -28.42 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.69 0.757 . . . . 0.0 112.066 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.77 HG22 HD12 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.79 169.1 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.629 ' HB3' HG21 ' B' ' 103' ' ' ILE . 94.9 m-20 -86.41 123.92 32.17 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.628 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -36.56 -29.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.923 -177.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.5 tt0 -50.26 -21.16 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 109.87 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.82 25.45 4.23 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.672 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.57 135.19 52.94 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.808 -1.407 . . . . 0.0 110.988 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.77 HD12 HG22 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -103.43 154.01 19.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 111.235 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.9 HD21 ' OD1' ' A' ' 27' ' ' ASN . 3.0 pp -126.66 -178.88 4.54 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.156 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 11.5 mt-30 -145.4 13.11 1.38 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.494 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.423 ' OD2' ' HB3' ' B' ' 110' ' ' LYS . 1.2 m-20 50.34 50.61 18.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 0.0 110.216 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 61.63 -178.2 0.12 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 110.147 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -118.73 -169.15 1.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.934 . . . . 0.0 110.232 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.13 133.77 10.08 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -116.2 -169.59 1.64 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -1.146 . . . . 0.0 110.12 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.42 -88.5 1.3 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -21.76 66.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.324 -1.103 . . . . 0.0 110.245 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.98 171.28 40.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.21 -105.15 0.27 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.8 m 60.04 72.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -1.154 . . . . 0.0 110.19 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.92 -161.62 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.571 ' CD1' ' O ' ' A' ' 48' ' ' PHE . 23.2 p90 -45.92 126.19 7.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -1.132 . . . . 0.0 110.203 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -100.26 -84.14 0.43 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.071 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.23 33.84 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 110.144 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.5 tt0 -100.65 -24.29 14.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' ASN . 3.9 mt -99.61 -44.37 6.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.856 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.73 -44.38 4.32 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.395 -0.816 . . . . 0.0 109.931 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.26 -27.25 65.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 52' ' ' LEU . 29.2 m-80 -81.45 -36.03 29.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 53' ' ' ARG . 6.8 mt -55.54 -44.05 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 0.0 109.541 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.42 -17.09 31.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -129.75 18.83 5.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -1.089 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' A' ' 56' ' ' ILE . 3.0 mt -80.93 -5.1 57.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 97.9 p -90.08 37.88 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 0.0 109.691 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 58' ' ' SER . 13.7 mtpp -121.17 6.66 10.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 194' ' ' ILE . 0.1 OUTLIER -118.61 -85.02 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.48 28.9 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.307 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.621 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -100.69 -27.96 13.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.024 -1.28 . . . . 0.0 109.005 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.694 ' HA ' HD22 ' A' ' 68' ' ' LEU . 50.2 t0 -45.21 -38.28 5.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.846 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -53.9 -30.63 46.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.991 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.556 ' HB3' HD12 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -78.17 -25.63 47.29 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 109.803 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.86 HD21 ' OG1' ' A' ' 21' ' ' THR . 7.9 mp -61.93 -58.66 7.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.846 HD21 ' HA ' ' A' ' 66' ' ' SER . 2.1 pp -52.75 -19.1 2.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.555 -0.716 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 67' ' ' MET . 35.3 tt0 -75.33 -2.98 30.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 110.356 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.959 ' O ' HG21 ' B' ' 122' ' ' VAL . 1.4 t -132.77 1.46 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.118 -0.989 . . . . 0.0 109.875 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.883 ' CG1' HD23 ' A' ' 18' ' ' LEU . 7.5 tp -146.82 67.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.638 -0.664 . . . . 0.0 109.918 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 46.4 t0 -76.8 57.84 1.35 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.145 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 6.0 mt -105.12 66.94 0.77 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.577 0.703 . . . . 0.0 110.85 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 58.47 0.82 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.531 -0.731 . . . . 0.0 110.184 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 1.2 pt-20 178.47 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.141 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.878 -1.139 . . . . 0.0 110.162 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.332 0.587 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.02 67.28 0.34 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.605 HD13 ' O ' ' B' ' 165' ' ' ASP . 3.4 mt -81.07 -27.23 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -1.162 . . . . 0.0 110.116 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' B' ' 63' ' ' ILE . 38.8 t 58.55 137.79 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 0.0 110.514 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.5 ' HD3' ' CD2' ' B' ' 227' ' ' PHE . 44.6 Cg_endo -73.27 124.74 9.7 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.859 1.452 . . . . 0.0 110.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.5 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 2.3 m -89.97 156.4 18.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.96 137.97 31.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.213 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -126.91 -10.74 6.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.511 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.5 OUTLIER -168.02 131.0 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.474 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.744 HG12 HG23 ' B' ' 160' ' ' ILE . 4.1 mt -129.74 165.75 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.884 HG22 ' HB ' ' B' ' 124' ' ' THR . 42.5 t -139.89 144.76 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 110.568 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' B' ' 156' ' ' LYS . . . -139.97 162.31 35.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.055 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 42.1 p -110.76 141.64 43.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.067 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.92 146.6 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 110.173 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' B' ' 154' ' ' ASP . 2.3 m -118.84 129.1 55.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.592 HD22 ' HB1' ' B' ' 150' ' ' ALA . 64.2 mt -89.67 -40.72 12.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 110.102 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.04 22.18 20.98 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.86 146.55 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -1.191 . . . . 0.0 110.381 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.631 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -77.16 148.58 35.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.8 HD22 ' HD2' ' B' ' 148' ' ' PHE . 13.7 mt -129.37 149.31 51.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.407 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 0.7 OUTLIER -90.07 94.74 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.733 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.582 HD22 HG23 ' B' ' 102' ' ' VAL . 13.1 mt -40.24 -55.23 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 0.0 110.462 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -47.25 -39.72 14.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 99.3 m -76.35 -41.04 49.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.54 -56.76 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 110.448 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.81 55.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.324 -0.86 . . . . 0.0 110.734 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 0.9 OUTLIER -72.13 -51.26 22.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.543 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -72.77 -42.23 64.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 0.0 110.482 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -42.7 122.34 2.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.429 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -73.53 -26.07 60.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.094 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 1.8 m120 -130.05 78.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -170.28 170.23 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.429 -0.794 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.623 ' O ' HD12 ' B' ' 103' ' ' ILE . 9.6 pt-20 -160.2 137.2 9.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -108.54 116.47 32.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 110.088 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.23 107.12 55.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.314 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -23.13 18.95 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.895 1.471 . . . . 0.0 110.089 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -24.38 63.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.099 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.45 -69.32 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.031 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.655 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.36 166.23 26.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.4 44.85 1.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.145 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -122.83 146.83 47.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.582 HG23 HD22 ' B' ' 82' ' ' LEU . 30.9 t -89.97 122.15 41.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.325 -0.86 . . . . 0.0 109.05 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.629 HG21 ' HB3' ' A' ' 29' ' ' ASP . 4.1 mp -89.3 110.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.893 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.58 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 7.2 ttm -103.93 163.95 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' B' ' 111' ' ' THR . 0.4 OUTLIER -163.6 127.38 2.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 110.587 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.643 HG23 ' CE1' ' B' ' 139' ' ' TYR . 7.2 pt -112.08 170.94 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 109.895 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.519 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 12.1 ptt180 -114.09 18.06 17.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.1 -1.0 . . . . 0.0 110.536 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 9.6 tt0 -177.67 94.02 0.23 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.478 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 51.6 Cg_endo -77.8 139.54 57.63 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.957 -2.101 . . . . 0.0 110.484 -0.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.74 ' O ' HG23 ' B' ' 111' ' ' THR . 18.9 mttp -56.65 118.98 5.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.74 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -163.59 178.33 8.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 110.419 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -131.91 172.4 12.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.82 . . . . 0.0 109.149 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.505 ' N ' ' CG2' ' B' ' 112' ' ' THR . . . -166.1 137.24 3.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.824 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -97.91 102.52 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' B' ' 104' ' ' MET . 2.3 mp -89.65 126.15 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' A' ' 74' ' ' LEU . 2.6 m-85 -101.32 157.44 16.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 109.913 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.485 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -73.56 -23.02 59.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 1.5 t -58.18 -18.91 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.184 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.11 -17.79 16.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -96.71 147.25 24.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 110.142 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -138.5 169.24 18.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.959 HG21 ' O ' ' A' ' 71' ' ' VAL . 5.1 t -127.12 142.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 71' ' ' VAL . 11.2 t -119.63 149.67 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.794 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.934 HG23 ' HB2' ' A' ' 27' ' ' ASN . 3.0 t -162.36 160.21 26.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.877 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.686 ' C ' HG22 ' B' ' 111' ' ' THR . . . 104.25 -1.56 43.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' B' ' 69' ' ' ASN . . . -75.53 -179.0 4.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.249 . . . . 0.0 110.09 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -135.28 0.39 2.8 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.994 -1.066 . . . . 0.0 110.731 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -160.41 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.081 -1.012 . . . . 0.0 110.319 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -87.84 -34.12 18.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.67 -34.94 60.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -53.49 53.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 3.1 m -55.0 -42.8 72.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.992 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.43 78.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.926 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -71.49 -56.69 5.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.062 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.603 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -58.88 -31.44 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 21.0 t -65.77 -63.14 1.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.1 ptm180 -52.06 -31.15 28.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.499 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -62.99 -47.47 82.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.666 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.643 ' CE1' HG23 ' B' ' 106' ' ' ILE . 20.9 m-85 -63.73 -53.42 51.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.632 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.37 -22.94 13.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.33 -47.53 49.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.783 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 146' ' ' ILE . 1.8 mt -50.4 -43.3 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.643 HD12 ' N ' ' B' ' 143' ' ' ILE . 3.1 mp -73.08 -59.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.918 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 3.0 mm-40 -54.45 -34.82 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.617 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -73.22 -30.15 63.29 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 142' ' ' ILE . 3.4 mt -72.68 -16.16 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.1 -20.58 19.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.8 ' HD2' HD22 ' B' ' 80' ' ' LEU . 3.1 m-85 -49.8 171.13 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.961 -1.317 . . . . 0.0 110.548 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.7 43.55 1.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 110.097 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.592 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -85.68 151.97 23.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.579 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 6.6 mttp -120.98 -158.53 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 110.206 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.03 86.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -146.53 177.19 9.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.536 ' CB ' ' OG1' ' B' ' 75' ' ' THR . 2.8 t0 69.29 6.57 5.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.352 -0.842 . . . . 0.0 110.704 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -51.23 127.73 20.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.026 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -158.33 126.3 5.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.54 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 6.5 mt -82.67 117.16 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.752 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -117.98 2.5 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 110.602 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.466 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 0.4 OUTLIER -147.67 121.9 9.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.744 HG23 HG12 ' B' ' 70' ' ' ILE . 57.6 mt -130.93 126.14 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.716 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.9 HG22 ' OG1' ' B' ' 215' ' ' THR . 15.0 t -105.16 140.05 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -139.96 -179.81 18.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.9 OUTLIER -170.38 154.99 4.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.315 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.481 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 18.0 p -170.18 163.47 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.605 ' O ' HD13 ' B' ' 63' ' ' ILE . 4.3 t0 -106.24 133.73 50.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.974 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.775 HG21 HD11 ' B' ' 170' ' ' ILE . 12.8 m -83.48 7.43 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -0.931 . . . . 0.0 110.595 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 45.7 tttt 70.68 12.43 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 110.809 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 16.0 p90 -169.35 145.6 2.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.048 -1.032 . . . . 0.0 110.425 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.66 154.77 54.65 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.092 1.575 . . . . 0.0 110.648 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.775 HD11 HG21 ' B' ' 166' ' ' VAL . 2.7 mp -125.11 151.18 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 110.152 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' B' ' 171' ' ' ARG . 5.8 ptm180 -88.51 98.51 11.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.115 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.509 HD22 ' CB ' ' B' ' 193' ' ' LEU . 30.3 mt -54.81 -42.06 71.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.011 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 16.1 pt-20 -55.65 -44.51 77.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.999 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -66.77 -37.89 92.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.821 HD21 HG12 ' B' ' 233' ' ' VAL . 0.2 OUTLIER -67.19 -38.6 85.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.942 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.64 60.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.933 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.91 -29.35 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.903 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 3.1 t -97.18 -30.89 12.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.949 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 183' ' ' SER . 24.7 m170 -130.44 31.71 4.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -66.69 -10.88 56.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.9 m -64.71 -36.63 84.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.0 -14.77 11.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.83 . . . . 0.0 110.303 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.592 ' HB2' ' CD2' ' B' ' 195' ' ' TYR . 0.9 OUTLIER -104.38 149.0 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.404 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 2.3 p -128.95 133.91 48.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.078 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -133.3 124.17 26.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.286 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' B' ' 187' ' ' PRO . 2.3 mt-10 -122.81 104.78 35.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 110.074 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.3 Cg_endo -72.29 -2.52 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.97 1.511 . . . . 0.0 110.23 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.44 0.42 39.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.853 . . . . 0.0 110.398 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.476 HD23 ' N ' ' B' ' 190' ' ' PHE . 2.2 tt -161.13 -47.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' B' ' 194' ' ' ILE . 1.1 t80 -100.92 110.94 62.4 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.443 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.93 -25.64 16.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.994 1.523 . . . . 0.0 110.266 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.17 -179.68 34.07 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.719 HD23 ' C ' ' B' ' 193' ' ' LEU . 7.5 tt -115.91 127.25 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -1.226 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.893 HD13 HD13 ' A' ' 62' ' ' LEU . 4.2 mt -90.07 111.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' B' ' 183' ' ' SER . 10.2 t80 -108.92 113.32 26.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.347 -0.846 . . . . 0.0 110.144 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.1 91.63 5.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 28.0 ttm -60.3 131.34 50.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' B' ' 201' ' ' LYS . 38.5 t -70.71 -42.29 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 1.7 mttt -139.66 112.24 7.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.385 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.9 Cg_endo -73.23 169.94 71.42 Favored 'Cis proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.974 -2.094 . . . . 0.0 110.462 -0.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 8.6 mtmt -79.42 80.02 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' B' ' 217' ' ' ALA . 44.7 mm -121.97 150.82 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.527 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 79.6 t -101.81 104.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.904 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.3 mp -97.17 141.51 30.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.392 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.798 ' C ' HD13 ' B' ' 206' ' ' ILE . 2.5 mt -120.9 131.95 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.798 HD13 ' C ' ' B' ' 205' ' ' LEU . 5.0 mm -115.41 139.51 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -121.38 145.21 48.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.482 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 74.9 t -50.09 -33.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.119 -0.988 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.2 t -63.72 -35.22 79.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 110.082 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.426 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 119.03 30.02 1.69 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.98 129.31 46.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 110.312 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.546 HD12 HD12 ' B' ' 206' ' ' ILE . 19.2 mm -114.72 132.79 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.598 ' HB ' HD12 ' B' ' 205' ' ' LEU . 6.1 t -124.73 140.31 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.933 . . . . 0.0 110.213 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.566 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.1 mp -130.75 112.49 13.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.9 ' OG1' HG22 ' B' ' 161' ' ' VAL . 5.3 t -136.34 151.43 49.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.484 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 103.85 7.05 42.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -82.19 159.46 23.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -1.197 . . . . 0.0 110.165 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -99.57 -17.58 17.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 0.0 110.171 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.654 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.5 OUTLIER -147.44 -162.59 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -95.75 -21.08 18.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.23 -24.09 65.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.833 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.43 ' HB3' HD11 ' B' ' 202' ' ' ILE . 21.0 mt-10 -79.92 -52.68 7.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.906 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 22.5 mm -52.94 -39.35 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.865 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.24 -43.84 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.008 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.61 82.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.287 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.84 88.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.208 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.5 ' CD2' ' HD3' ' B' ' 65' ' ' PRO . 53.1 t80 -70.0 -49.0 55.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -24.5 67.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.63 -31.33 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.945 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' B' ' 232' ' ' PRO . 2.1 tp -96.96 -16.62 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.937 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.594 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.1 t80 -46.97 -46.34 53.15 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 110.827 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -72.67 -50.57 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.329 1.173 . . . . 0.0 110.427 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.821 HG12 HD21 ' B' ' 175' ' ' LEU . 25.5 t -44.26 -38.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.62 -42.46 64.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.888 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.53 34.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.491 ' CA ' ' HD3' ' B' ' 171' ' ' ARG . 86.6 m-85 -121.44 38.77 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.78 167.07 21.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -104.8 -36.92 7.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.263 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.308 0.575 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.62 31.28 3.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.23 100.41 5.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -1.209 . . . . 0.0 110.243 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.474 HG13 ' N ' ' A' ' 15' ' ' GLY . 22.8 pt -108.93 -36.05 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.474 ' N ' HG13 ' A' ' 14' ' ' ILE . . . 78.06 99.62 0.2 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.94 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -1.143 . . . . 0.0 110.145 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.512 ' C ' ' CE1' ' B' ' 99' ' ' PHE . . . -132.47 -145.54 5.49 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.967 HD12 ' N ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -69.43 161.0 30.34 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.354 -1.086 . . . . 0.0 109.705 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.967 ' N ' HD12 ' A' ' 18' ' ' LEU . 6.2 t70 -65.86 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.833 HD21 HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -84.4 -17.2 40.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.525 -0.734 . . . . 0.0 111.02 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.721 ' N ' HD21 ' A' ' 68' ' ' LEU . 8.8 m -44.65 -25.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.045 -1.034 . . . . 0.0 110.349 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -100.16 -34.57 4.78 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.808 HD12 HD11 ' B' ' 114' ' ' LEU . 0.3 OUTLIER -48.5 -40.35 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.216 -1.167 . . . . 0.0 109.688 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.4 pp -83.42 -18.24 39.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.943 -1.098 . . . . 0.0 108.724 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -98.68 6.32 47.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.631 -0.668 . . . . 0.0 109.381 179.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 151.26 89.96 0.08 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 1.001 ' ND2' HD11 ' A' ' 35' ' ' LEU . 12.5 p-10 -19.54 81.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.662 0.744 . . . . 0.0 112.896 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -89.44 164.54 2.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' HG12 ' A' ' 28' ' ' ILE . 70.3 m-20 -86.49 132.77 33.84 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.546 ' OG ' HD11 ' B' ' 103' ' ' ILE . 1.0 OUTLIER -42.29 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.178 -178.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.1 tm-20 -62.77 -7.48 5.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.44 5.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HD3' ' N ' ' A' ' 34' ' ' LEU . 1.1 tpp180 -127.12 128.95 47.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.096 -1.238 . . . . 0.0 110.376 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.639 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -98.75 150.94 21.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.937 -1.102 . . . . 0.0 110.33 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.001 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.5 pp -135.57 -178.08 4.96 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.262 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.53 ' N ' HD12 ' A' ' 35' ' ' LEU . 5.5 mt-30 -125.1 -69.1 0.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.815 . . . . 0.0 110.315 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.58 -63.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.09 58.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -108.84 97.27 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.917 . . . . 0.0 110.264 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.29 86.7 0.49 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 50.71 66.6 1.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.217 -1.167 . . . . 0.0 110.207 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 44' ' ' GLY . . . -139.27 106.23 0.5 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 44' ' ' GLY . 5.9 ttt-85 53.83 -88.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.191 -1.182 . . . . 0.0 110.072 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 42' ' ' GLY . . . -58.28 -163.53 0.07 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.94 -103.93 0.18 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.2 p -143.71 100.19 3.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -1.144 . . . . 0.0 110.31 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.73 -88.47 0.86 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.629 ' CD1' HD12 ' A' ' 52' ' ' LEU . 25.4 p90 -83.94 -0.95 53.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -1.152 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 48' ' ' PHE . 22.4 t70 -41.54 -62.64 0.84 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.67 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.75 -6.12 35.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.326 -0.859 . . . . 0.0 110.776 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.3 tt0 -100.37 -22.01 15.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.061 -1.025 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.629 HD12 ' CD1' ' A' ' 48' ' ' PHE . 5.1 mt -101.19 -51.39 3.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.947 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -47.4 -51.26 20.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.394 -0.817 . . . . 0.0 109.889 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -68.73 -15.29 63.47 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.729 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.592 ' HB3' ' CE2' ' B' ' 190' ' ' PHE . 1.9 m-80 -92.63 -35.0 13.77 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.947 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.5 mt -55.56 -42.44 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.416 -0.802 . . . . 0.0 109.309 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.4 -21.22 12.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.19 28.23 5.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -1.133 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' A' ' 56' ' ' ILE . 5.0 mt -92.12 10.44 29.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.59 34.82 1.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.845 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.953 ' HG3' HD23 ' A' ' 62' ' ' LEU . 11.6 ptpt -135.55 26.03 3.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.436 -0.79 . . . . 0.0 109.969 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.953 HD23 ' HG3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -142.96 -56.86 0.42 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.553 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . -164.0 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.4 mm? -42.07 -29.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.331 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -51.6 -33.65 33.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.739 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -68.9 -56.98 6.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.515 ' SD ' ' CA ' ' B' ' 216' ' ' GLY . 0.0 OUTLIER -67.3 -8.54 33.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.341 -0.849 . . . . 0.0 109.208 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.721 HD21 ' N ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -67.98 -63.84 0.98 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.805 0.812 . . . . 0.0 109.035 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD12 ' C ' ' A' ' 69' ' ' LEU . 3.4 pp -68.9 -5.95 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.215 0.531 . . . . 0.0 110.075 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 22.4 tt0 -80.92 3.37 23.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.981 HG12 HG11 ' B' ' 122' ' ' VAL . 2.1 t -143.27 4.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.816 -1.178 . . . . 0.0 110.656 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.867 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.9 tp -149.14 71.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.553 -0.717 . . . . 0.0 109.367 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t0 -76.52 57.34 1.21 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.157 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 5.6 mt -107.51 67.39 0.69 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.66 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -153.44 29.28 0.49 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 109.872 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -174.33 74.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.463 -0.773 . . . . 0.0 110.221 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.236 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 95.4 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.91 76.8 1.28 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.2 mp -90.86 -22.87 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -1.118 . . . . 0.0 110.342 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 57.0 t 59.62 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.466 -0.771 . . . . 0.0 110.385 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.5 Cg_endo -75.53 149.61 34.82 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.928 1.489 . . . . 0.0 110.631 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.457 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.1 m -113.93 143.08 45.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.909 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.484 HD22 ' CG2' ' B' ' 160' ' ' ILE . 67.6 mt -80.44 117.61 21.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -108.3 -10.69 15.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.278 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.569 HD22 HG21 ' B' ' 161' ' ' VAL . 6.3 t30 -165.76 160.13 16.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 110.299 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 10.2 mt -157.45 166.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.936 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.503 ' N ' HG22 ' B' ' 70' ' ' ILE . 16.6 t -135.41 132.85 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.488 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -121.2 136.51 54.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.9 m -97.11 134.06 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 0.0 110.125 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' B' ' 155' ' ' PHE . 8.4 t -133.63 169.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 56.2 m -144.11 133.66 23.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.387 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 1.103 HD12 HD11 ' B' ' 80' ' ' LEU . 82.9 mt -88.56 -14.39 37.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.67 -0.54 70.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 22.1 p -138.55 137.0 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -1.164 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 5.7 mtp85 -62.48 158.72 17.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 1.103 HD11 HD12 ' B' ' 76' ' ' LEU . 15.5 mt -130.36 150.45 51.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.271 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 1.0 OUTLIER -99.12 93.54 6.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.623 HD22 HG23 ' B' ' 102' ' ' VAL . 9.1 mt -39.16 -46.49 1.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.465 -0.772 . . . . 0.0 110.68 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.63 -43.56 76.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 84.8 m -83.58 -35.77 24.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.99 . . . . 0.0 110.22 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' B' ' 80' ' ' LEU . 30.4 t -65.96 -57.25 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.53 -36.59 80.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.493 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.03 -48.03 83.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.416 ' O ' ' C ' ' B' ' 89' ' ' ALA . 32.6 m170 -78.61 -42.95 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -0.951 . . . . 0.0 110.542 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -43.82 124.95 3.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 109.997 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.92 -18.01 62.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 3.3 m-20 -137.42 79.8 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.573 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -165.84 152.27 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.54 164.61 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 110.044 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.52 120.82 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 110.435 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.44 112.09 21.11 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.99 -18.8 30.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.932 1.491 . . . . 0.0 110.268 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -71.95 -17.13 62.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 11.1 mpt_? -105.54 -69.72 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.644 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -152.09 -178.93 7.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.494 -0.754 . . . . 0.0 109.953 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -99.48 49.89 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.915 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.157 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -130.95 149.84 52.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.946 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.623 HG23 HD22 ' B' ' 82' ' ' LEU . 99.4 t -92.27 124.07 44.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.71 ' H ' HD12 ' B' ' 103' ' ' ILE . 5.0 mp -88.76 107.35 17.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.573 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 0.9 OUTLIER -93.27 161.39 14.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.482 -0.761 . . . . 0.0 109.844 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -163.85 123.31 2.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 0.0 110.832 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 4.6 pt -122.59 155.56 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 109.696 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 5.3 mtt180 -103.49 30.86 4.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 4.3 tm-20 -177.9 87.8 0.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.5 Cg_endo -76.49 159.58 96.24 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.351 -0.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.835 ' O ' HG23 ' B' ' 111' ' ' THR . 0.1 OUTLIER -73.12 115.37 12.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.037 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.835 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.8 OUTLIER -165.99 175.26 8.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.319 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.593 HG22 HG23 ' B' ' 124' ' ' THR . 0.5 OUTLIER -134.53 157.87 45.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.128 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -147.34 158.81 44.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.808 HD11 HD12 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -115.3 107.37 15.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.486 -0.758 . . . . 0.0 109.375 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' B' ' 102' ' ' VAL . 3.0 mp -89.93 131.47 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.735 ' CD1' HD11 ' A' ' 74' ' ' LEU . 4.5 m-30 -106.95 149.9 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.795 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' B' ' 80' ' ' LEU . . . -61.36 -20.06 62.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 110.342 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' B' ' 79' ' ' ARG . 12.2 t -62.86 -33.76 75.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.343 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.475 ' HA2' ' HG ' ' B' ' 80' ' ' LEU . . . 126.19 -13.77 7.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -76.16 171.57 14.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.411 ' SD ' HG13 ' B' ' 115' ' ' ILE . 6.7 ttp -155.99 135.0 12.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.158 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.981 HG11 HG12 ' A' ' 71' ' ' VAL . 12.6 t -115.51 119.02 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.694 HG13 ' HE2' ' B' ' 139' ' ' TYR . 18.7 t -105.24 144.49 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.707 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -146.78 165.96 28.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.571 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 101.55 -24.27 32.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.61 156.51 0.66 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -1.219 . . . . 0.0 110.607 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -109.4 -14.5 14.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 4.3 m -163.71 -178.49 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.244 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' GLU . . . . . 0.405 ' HG2' HD11 ' B' ' 157' ' ' ILE . 93.3 mt-10 -58.18 -65.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.052 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.35 -30.44 2.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.079 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -71.33 -53.71 13.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.0 110.226 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -54.81 -37.85 66.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -48.86 79.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.051 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 39.5 mt -61.57 -49.56 76.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.847 . . . . 0.0 110.054 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -58.05 -35.65 71.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 13.5 t -70.57 -65.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 110.022 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -46.79 -34.42 5.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.017 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -63.86 -49.61 72.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.694 ' HE2' HG13 ' B' ' 123' ' ' VAL . 18.4 m-85 -66.6 -54.91 18.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.916 . . . . 0.0 109.959 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 140' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.98 -35.61 59.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 3.3 ttp180 -58.77 -41.71 87.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.99 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 139' ' ' TYR . 27.6 mt -59.0 -47.05 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.731 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.5 mp -60.46 -46.83 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.069 -1.02 . . . . 0.0 109.396 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 68.5 mt-30 -67.27 -31.89 72.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.452 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 3.1 mmtt -74.49 -28.71 61.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.94 -22.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.2 -22.85 7.0 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.479 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.484 ' HB2' HG23 ' B' ' 143' ' ' ILE . 15.5 m-85 -51.63 175.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.349 . . . . 0.0 110.756 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.16 36.03 3.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.478 -0.764 . . . . 0.0 110.542 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.909 ' CB ' HD22 ' B' ' 76' ' ' LEU . . . -62.47 131.09 48.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.569 ' O ' HG23 ' B' ' 153' ' ' THR . 2.0 ptpt -111.31 25.08 12.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.011 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.498 ' O ' HG23 ' B' ' 153' ' ' THR . 3.7 t80 31.55 95.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.124 0.488 . . . . 0.0 111.2 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.569 HG23 ' O ' ' B' ' 151' ' ' LYS . 1.9 p -153.23 174.41 14.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 153' ' ' THR . 1.6 t0 65.2 27.22 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.409 -0.807 . . . . 0.0 110.554 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.412 ' HA ' HG22 ' B' ' 74' ' ' VAL . 41.3 t80 -73.25 133.52 43.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.89 . . . . 0.0 109.903 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -166.7 135.52 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 110.48 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 44.8 mt -78.9 133.66 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.432 -0.792 . . . . 0.0 109.638 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' B' ' 218' ' ' LYS . 23.2 mt-30 -125.53 -40.0 2.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 110.939 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.452 ' HB2' ' HB ' ' B' ' 71' ' ' VAL . 0.3 OUTLIER -114.06 109.27 18.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.066 -1.021 . . . . 0.0 110.959 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.484 ' CG2' HD22 ' B' ' 67' ' ' LEU . 30.1 mt -105.94 123.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.7 HG22 ' OG1' ' B' ' 215' ' ' THR . 79.8 t -98.36 138.98 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 110.574 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -140.49 167.27 25.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 155.08 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.265 . . . . 0.0 110.708 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 5.5 p -169.4 171.63 7.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.426 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 7.9 m-20 -128.57 140.39 51.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.0 110.419 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' B' ' 63' ' ' ILE . 22.6 m -119.34 8.66 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.936 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt 52.03 29.9 6.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 110.179 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.458 ' H ' HG23 ' B' ' 166' ' ' VAL . 1.2 t80 -121.0 115.86 31.58 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.26 120.16 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.904 1.476 . . . . 0.0 110.223 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.805 HD13 ' CG2' ' B' ' 206' ' ' ILE . 3.3 mt -101.49 145.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.568 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.64 84.86 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.981 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.719 HD22 ' HB2' ' B' ' 193' ' ' LEU . 15.1 mt -48.04 -23.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.98 -53.13 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.25 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.82 -38.61 96.26 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.499 HD23 HD13 ' B' ' 193' ' ' LEU . 11.7 tp -74.81 -38.58 62.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 109.968 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' B' ' 172' ' ' LEU . . . -65.87 -38.66 89.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -0.924 . . . . 0.0 110.291 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -72.38 -24.41 61.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.178 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -89.24 -48.9 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' B' ' 183' ' ' SER . 4.6 m-70 -103.16 34.94 2.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.08 -33.63 51.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -19.09 44.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -1.095 . . . . 0.0 110.141 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' B' ' 198' ' ' VAL . 36.2 m-85 -136.37 6.02 3.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.447 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.664 ' OG ' HD21 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -133.64 135.57 44.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 0.0 110.67 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.98 122.17 37.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 109.792 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -124.49 129.42 50.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 110.597 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 190' ' ' PHE . 9.3 mt-10 -136.23 102.85 9.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.453 -0.779 . . . . 0.0 109.653 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -2.45 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.932 1.49 . . . . 0.0 110.825 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -100.43 -6.02 26.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 0.0 110.324 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -143.91 -50.37 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.327 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.675 ' HB2' HD23 ' B' ' 189' ' ' LEU . 2.7 t80 -111.26 121.49 40.28 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 191' ' ' PRO . . . . . 0.474 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.4 Cg_endo -73.54 -35.55 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.923 1.486 . . . . 0.0 110.631 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.39 175.83 42.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.719 ' HB2' HD22 ' B' ' 172' ' ' LEU . 8.7 tt -106.83 138.19 43.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -1.163 . . . . 0.0 110.251 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.615 ' N ' HD23 ' B' ' 193' ' ' LEU . 2.6 mt -98.35 96.74 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.523 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 7.6 t80 -93.89 120.37 34.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.856 ' HG2' HG22 ' B' ' 203' ' ' VAL . 17.0 mtp85 -108.2 97.82 7.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.328 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 45.3 tpp -52.88 148.34 7.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.051 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.618 HG21 ' CE1' ' B' ' 182' ' ' PHE . 86.2 t -91.48 -40.91 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.905 . . . . 0.0 110.394 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.1 OUTLIER -140.7 107.79 6.48 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.491 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -73.92 165.45 84.97 Favored 'Cis proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.952 -2.103 . . . . 0.0 110.395 -0.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 16.9 mtmt -75.05 97.31 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.795 HD11 ' HG2' ' B' ' 222' ' ' GLU . 23.9 mm -129.24 158.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.582 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.856 HG22 ' HG2' ' B' ' 196' ' ' ARG . 46.0 t -111.63 124.37 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 1.069 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.9 mp -123.9 135.85 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.171 -0.956 . . . . 0.0 110.623 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' B' ' 205' ' ' LEU . 3.8 mm? -101.33 125.23 47.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.83 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.805 ' CG2' HD13 ' B' ' 170' ' ' ILE . 2.8 mt -120.32 133.68 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' B' ' 207' ' ' PHE . 57.8 m-85 -119.46 154.22 34.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 52.7 t -60.44 -22.57 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.074 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.5 t -64.52 -36.17 83.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 121.29 11.04 6.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.851 ' O ' HD13 ' B' ' 212' ' ' ILE . 2.2 mptm? -92.51 141.65 28.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.105 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.851 HD13 ' O ' ' B' ' 211' ' ' LYS . 24.6 mm -131.78 132.7 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.4 t -123.08 140.08 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.226 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 5.6 mp -121.47 145.03 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.7 ' OG1' HG22 ' B' ' 161' ' ' VAL . 6.6 t -165.3 157.3 15.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.187 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.515 ' CA ' ' SD ' ' A' ' 67' ' ' MET . . . 98.02 -15.78 61.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' B' ' 222' ' ' GLU . . . -65.83 141.7 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' B' ' 158' ' ' GLN . 0.3 OUTLIER -92.56 -25.93 18.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.109 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.86 151.37 47.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -47.05 -33.23 4.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -38.47 70.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.795 ' HG2' HD11 ' B' ' 202' ' ' ILE . 0.2 OUTLIER -60.66 -49.68 76.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.419 HG23 HD22 ' B' ' 214' ' ' LEU . 47.2 mm -56.03 -38.65 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 110.342 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.34 -40.38 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 110.326 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.86 94.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 1.069 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -60.3 -56.45 21.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.134 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.453 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 2.9 t80 -58.64 -44.49 90.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.131 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.9 -36.19 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.14 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.48 -11.31 37.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.669 HG13 HD22 ' B' ' 204' ' ' LEU . 9.8 mm -97.77 -23.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.784 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -50.22 -48.45 79.93 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 110.758 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.72 -41.73 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.515 1.271 . . . . 0.0 110.376 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.443 ' CG1' HD13 ' B' ' 175' ' ' LEU . 57.1 t -50.53 -39.39 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.645 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.529 HD11 HG22 ' B' ' 230' ' ' ILE . 15.8 mt -68.65 -48.43 64.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.824 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 40.8 t -60.78 -31.99 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.845 . . . . 0.0 109.87 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -37.94 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.494 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 76.6 m-85 -116.23 38.04 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.95 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.44 ' HB3' ' CE2' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -60.85 145.89 48.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 110.086 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -93.71 -39.2 10.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.918 . . . . 0.0 110.167 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.218 179.926 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.214 0.53 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.24 -22.98 2.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.19 24.8 1.03 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -1.116 . . . . 0.0 110.043 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 mt 48.36 61.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.313 -0.867 . . . . 0.0 110.08 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.18 156.81 28.06 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.507 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 13.6 p-10 -175.41 64.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -1.144 . . . . 0.0 110.489 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.04 -176.83 54.55 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.981 ' CD2' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -132.33 166.09 22.73 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.058 -1.26 . . . . 0.0 110.247 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -63.43 81.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.981 HD22 ' CD2' ' A' ' 18' ' ' LEU . 4.1 tp -120.22 62.03 0.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.776 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.708 HG23 ' HB3' ' A' ' 64' ' ' LEU . 1.2 m -92.05 -3.6 55.56 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.544 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -101.62 -31.51 5.46 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.563 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.931 ' CG1' HD11 ' A' ' 20' ' ' LEU . 2.2 mm -46.15 -44.12 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.416 -1.638 . . . . 0.0 109.171 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.826 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.6 OUTLIER -83.94 -23.44 31.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.057 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.594 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -85.26 10.64 11.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.499 -0.75 . . . . 0.0 109.16 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 135.55 104.83 0.78 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.596 ' ND2' HD12 ' A' ' 35' ' ' LEU . 7.5 p-10 -21.74 118.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.944 0.878 . . . . 0.0 111.438 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -140.37 161.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.546 0.688 . . . . 0.0 109.461 -178.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 28' ' ' ILE . 1.2 m-20 -87.58 119.32 27.77 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.571 ' OG ' ' CE2' ' B' ' 99' ' ' PHE . 26.7 p -39.15 -25.8 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.3 tt0 -66.3 -3.49 6.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.948 -1.095 . . . . 0.0 111.306 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 29.11 5.83 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.023 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.556 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -121.03 117.18 26.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.916 -1.343 . . . . 0.0 109.534 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -87.27 162.82 17.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.229 . . . . 0.0 111.906 -178.303 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -88.75 108.33 19.43 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.558 0.694 . . . . 0.0 111.67 -178.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 38' ' ' ASP . 3.6 pt20 -89.69 -5.37 57.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 49.02 -88.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.717 -0.614 . . . . 0.0 110.861 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' GLN . 36.8 m-20 -79.51 -178.38 6.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.647 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -133.93 -35.67 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.398 -0.814 . . . . 0.0 110.102 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.11 -107.16 1.45 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 51.53 29.69 5.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -1.182 . . . . 0.0 109.943 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.02 -74.43 0.09 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -158.67 49.7 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -1.188 . . . . 0.0 110.379 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.41 51.09 60.76 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.87 -173.86 50.01 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.429 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 1.7 t -167.85 72.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -1.076 . . . . 0.0 110.206 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 36' ' ' GLN . . . 66.04 -151.43 52.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 49' ' ' ASP . 1.9 m-85 -60.94 144.5 53.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.361 -1.082 . . . . 0.0 110.246 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' PHE . 1.6 m-20 -50.57 -176.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.978 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.71 25.52 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -0.962 . . . . 0.0 109.935 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.6 pt-20 -97.47 -31.36 12.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.848 . . . . 0.0 110.29 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 3.1 mt -90.99 -41.29 11.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.002 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -48.81 -52.96 21.26 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.98 -26.53 67.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.368 -0.833 . . . . 0.0 109.524 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.537 ' HB3' HD23 ' A' ' 59' ' ' LEU . 1.9 m-80 -79.97 -42.9 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.459 -0.776 . . . . 0.0 110.05 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.002 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -48.43 -45.71 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.81 0.74 64.8 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.494 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.3 OUTLIER -120.71 -44.47 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -1.197 . . . . 0.0 110.884 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.057 HD22 ' CE2' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -85.59 34.84 0.59 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 110.698 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.69 34.38 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.894 -1.129 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.9 1.55 0.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 111.106 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 62' ' ' LEU . 5.7 mt -86.65 -67.62 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.661 -1.274 . . . . 0.0 109.93 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.63 -35.66 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.708 ' HB3' HG23 ' A' ' 21' ' ' THR . 3.9 mm? -54.24 -39.76 67.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.21 -1.17 . . . . 0.0 110.343 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 69' ' ' LEU . 16.4 t0 -43.91 -33.89 1.49 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 1.5 m -60.7 -62.88 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.826 ' HG2' HD13 ' A' ' 24' ' ' LEU . 1.1 ttp -72.01 -3.14 21.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.292 -0.88 . . . . 0.0 109.792 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -67.69 -54.98 15.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 108.933 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 65' ' ' ASP . 0.6 OUTLIER -69.92 0.28 6.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.72 -0.613 . . . . 0.0 109.953 179.249 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -91.83 -11.47 36.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -0.845 . . . . 0.0 110.577 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.921 HG11 HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.58 -17.59 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.084 -1.01 . . . . 0.0 108.797 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.065 HD11 HD12 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -146.57 78.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.845 -0.534 . . . . 0.0 110.148 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.46 53.24 1.51 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.885 -1.134 . . . . 0.0 109.049 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.126 HD11 ' CB ' ' B' ' 101' ' ' ALA . 8.0 mt -84.08 59.03 5.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.675 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 16' ' ' ASN . 1.8 tttm -121.38 81.31 1.78 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.667 -0.646 . . . . 0.0 110.085 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.624 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 1.9 mt-10 50.21 53.1 13.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.263 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.199 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.273 0.558 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.522 ' O ' HG23 ' B' ' 64' ' ' VAL . . . 137.28 60.42 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.579 ' C ' HG23 ' B' ' 64' ' ' VAL . 33.4 mt -65.35 -52.29 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.28 -1.129 . . . . 0.0 110.375 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.579 HG23 ' C ' ' B' ' 63' ' ' ILE . 2.7 t 67.2 125.19 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 46.5 Cg_endo -73.43 146.96 40.56 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.856 1.451 . . . . 0.0 110.617 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 3.3 m -105.4 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 110.07 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.448 HD22 HG23 ' B' ' 160' ' ' ILE . 27.3 mt -77.01 134.68 38.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -123.25 -18.39 6.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.405 ' OD1' ' HA2' ' B' ' 125' ' ' GLY . 5.4 t30 -169.88 154.24 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.399 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' B' ' 160' ' ' ILE . 5.0 mt -145.26 147.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 110.025 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.595 HG11 ' CG1' ' A' ' 71' ' ' VAL . 53.3 t -115.83 142.83 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.95 . . . . 0.0 110.582 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.31 162.04 33.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 0.0 110.172 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 0.3 OUTLIER -116.48 135.0 54.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.319 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.567 HG12 ' N ' ' B' ' 75' ' ' THR . 91.5 t -132.04 171.21 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.871 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.567 ' N ' HG12 ' B' ' 74' ' ' VAL . 46.1 m -148.03 151.63 36.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.95 HD22 ' HB1' ' B' ' 150' ' ' ALA . 33.7 mt -104.77 -57.5 2.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.837 . . . . 0.0 110.195 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.95 21.54 6.3 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.68 142.76 12.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -1.205 . . . . 0.0 110.282 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 146.86 53.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.045 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.741 HD11 ' CD1' ' B' ' 76' ' ' LEU . 15.5 mt -127.48 153.23 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.124 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.1 OUTLIER -90.37 88.12 7.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 110.017 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.659 HD22 HG23 ' B' ' 102' ' ' VAL . 10.7 mt -41.14 -44.04 2.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 110.277 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.4 OUTLIER -56.3 -42.28 77.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 110.092 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -83.96 -43.94 14.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.423 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 86.4 t -55.15 -48.2 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.244 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.625 ' HB2' HG13 ' B' ' 102' ' ' VAL . . . -72.96 -28.94 62.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 9.5 tp -77.21 -34.6 56.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.59 -25.71 22.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.96 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -65.52 143.09 57.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -72.06 -27.59 62.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.061 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' B' ' 104' ' ' MET . 71.7 m-20 -134.78 79.44 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 110.007 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -152.32 130.83 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.613 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -124.34 142.78 51.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -118.24 137.94 52.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 0.0 110.811 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' B' ' 95' ' ' ASN . 8.5 p30 -133.66 109.97 12.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.939 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 -26.9 12.79 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.99 1.521 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.28 -7.46 59.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' B' ' 95' ' ' ASN . 0.0 OUTLIER -102.45 -75.91 0.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.666 ' CE1' ' HB3' ' B' ' 101' ' ' ALA . 32.4 p90 -145.68 -178.86 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 110.075 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.612 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -99.2 56.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.051 -1.03 . . . . 0.0 112.099 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.126 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -152.53 166.32 32.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.867 -1.146 . . . . 0.0 110.524 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.659 HG23 HD22 ' B' ' 82' ' ' LEU . 21.3 t -97.39 157.74 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.47 HD13 ' OG ' ' A' ' 30' ' ' SER . 2.0 mt -118.25 100.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.99 . . . . 0.0 110.429 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.501 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 2.2 ttm -92.39 145.2 24.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.58 118.67 8.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.257 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 30.8 pt -116.81 164.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 110.063 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 1.1 ptm180 -120.04 42.44 2.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER 179.26 80.29 0.17 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 0.0 110.256 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.455 ' O ' HG13 ' B' ' 106' ' ' ILE . 49.4 Cg_endo -78.13 159.81 92.66 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.436 -0.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 2.1 tppt? -71.27 113.18 8.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.489 HG22 ' HA3' ' B' ' 125' ' ' GLY . 0.3 OUTLIER -154.47 164.8 38.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.687 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.616 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.9 m -114.84 146.45 41.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.502 -0.748 . . . . 0.0 109.325 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.717 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -149.53 140.82 23.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.102 . . . . 0.0 111.305 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.653 ' N ' HD23 ' B' ' 114' ' ' LEU . 0.2 OUTLIER -119.37 126.65 51.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.555 -0.716 . . . . 0.0 109.223 179.178 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 5.8 mt -108.36 136.65 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.935 . . . . 0.0 111.111 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 4.5 m-85 -93.81 161.43 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.58 -1.19 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.972 -1.08 . . . . 0.0 110.296 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 35.9 t -91.19 -7.67 50.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.348 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.1 -30.72 8.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -74.12 151.78 40.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -1.138 . . . . 0.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -153.64 169.45 23.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.201 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.89 HG11 HG12 ' A' ' 71' ' ' VAL . 24.8 t -133.38 147.98 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.478 HG12 ' N ' ' B' ' 124' ' ' THR . 23.3 t -126.67 170.04 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.588 HG23 ' CB ' ' A' ' 27' ' ' ASN . 10.1 t -170.04 154.18 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.881 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.583 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 111.43 8.3 23.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.472 ' CB ' ' HB2' ' B' ' 132' ' ' SER . . . -82.41 141.21 32.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.154 . . . . 0.0 110.046 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.64 -0.04 41.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.873 . . . . 0.0 110.283 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.79 -159.9 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.209 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.68 -49.09 9.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.55 -28.98 65.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.076 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -43.82 96.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.034 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.472 ' HB2' ' CB ' ' B' ' 126' ' ' ALA . 44.9 t -68.33 -36.64 79.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.79 -38.22 81.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.205 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.45 ' O ' ' HD2' ' B' ' 138' ' ' LYS . 6.1 mt -69.94 -45.41 67.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.31 -52.12 67.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 72.3 m -60.55 -50.85 71.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -39.66 69.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.998 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -59.41 -40.4 86.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.717 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 26.8 m-85 -65.62 -52.08 54.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.71 -36.16 56.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.955 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -59.94 -43.33 95.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 -35.26 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.853 HG21 ' HB2' ' B' ' 150' ' ' ALA . 39.8 mm -73.9 -57.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.65 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.14 -28.32 69.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 1.7 tttt -75.71 -19.27 59.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.97 -23.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.72 -0.613 . . . . 0.0 109.371 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.4 -29.37 4.8 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.534 ' CB ' HG22 ' B' ' 143' ' ' ILE . 12.2 m-85 -46.4 163.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -1.214 . . . . 0.0 110.937 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.2 38.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.559 -0.713 . . . . 0.0 109.942 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.95 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -73.55 136.41 44.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.627 ' O ' HD23 ' B' ' 76' ' ' LEU . 5.1 tttt -112.44 157.65 20.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 110.338 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -99.69 89.95 4.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.474 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -148.92 172.8 14.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.387 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.525 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t0 67.78 26.12 7.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 6.8 t80 -84.62 129.16 34.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.077 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -163.62 131.82 3.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.42 HG23 ' CG2' ' B' ' 70' ' ' ILE . 3.1 mt -79.88 123.74 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.666 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -119.69 -10.93 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.801 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 26.1 t30 -140.12 122.1 15.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' B' ' 215' ' ' THR . 3.9 mt -113.25 160.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.152 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.456 HG22 ' OG1' ' B' ' 215' ' ' THR . 54.7 t -138.67 126.35 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.714 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -130.95 176.2 19.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.1 p -158.33 154.54 27.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.447 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.9 p -170.2 174.21 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.818 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.484 ' O ' HD13 ' B' ' 63' ' ' ILE . 14.9 t0 -121.59 136.11 54.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.686 HG21 HD11 ' B' ' 170' ' ' ILE . 26.8 m -85.47 2.54 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.888 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.12 23.72 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.254 -0.904 . . . . 0.0 110.925 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.594 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 8.4 p90 -177.93 148.19 0.65 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.406 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.63 161.15 44.77 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.093 1.575 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.686 HD11 HG21 ' B' ' 166' ' ' VAL . 4.0 mt -131.08 150.84 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.37 90.62 7.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.533 HD21 HG22 ' B' ' 206' ' ' ILE . 22.2 mt -48.2 -29.13 3.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -64.14 -60.22 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.35 -34.15 25.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.573 ' HB3' HD13 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -63.99 -47.71 79.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 110.17 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.54 -30.03 67.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.886 . . . . 0.0 110.414 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -69.26 -27.35 65.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.279 -0.888 . . . . 0.0 110.583 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 11.3 p -99.14 -57.75 2.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.14 -0.975 . . . . 0.0 110.357 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' B' ' 183' ' ' SER . 26.6 m80 -100.54 38.26 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -62.85 -30.18 76.37 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' THR . . . . . 0.437 HG23 ' CG ' ' B' ' 182' ' ' PHE . 9.3 t -62.46 -33.47 74.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 110.362 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.437 ' CG ' HG23 ' B' ' 181' ' ' THR . 21.4 m-85 -113.16 -12.2 13.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.493 ' N ' ' O ' ' B' ' 179' ' ' HIS . 37.7 m -104.77 171.29 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.266 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.6 m -155.88 109.87 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.825 . . . . 0.0 110.053 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 1.019 ' HB2' HD12 ' B' ' 193' ' ' LEU . 17.8 t80 -113.49 114.51 26.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 110.23 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 3.2 mm-40 -125.55 102.52 29.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.44 -0.15 8.85 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.083 1.57 . . . . 0.0 110.325 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -98.42 -20.03 17.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.886 . . . . 0.0 110.035 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.602 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.6 tt -142.11 8.13 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.3 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 1.057 ' CE2' HD22 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -169.94 108.54 0.46 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.264 -0.897 . . . . 0.0 110.419 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -4.36 13.32 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.849 1.447 . . . . 0.0 110.516 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -117.47 162.96 12.76 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' B' ' 185' ' ' TYR . 2.4 tt -100.72 143.46 30.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 110.129 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.55 HD11 ' CE2' ' B' ' 190' ' ' PHE . 31.7 mt -104.78 106.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' B' ' 179' ' ' HIS . 0.3 OUTLIER -97.95 111.88 24.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -0.98 . . . . 0.0 109.87 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.77 80.99 5.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 110.41 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.9 ttm -50.83 141.68 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.23 -43.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 110.56 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 4.5 mttp -141.32 110.6 6.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.146 -0.971 . . . . 0.0 110.31 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.475 ' O ' HG12 ' B' ' 202' ' ' ILE . 47.5 Cg_endo -73.21 149.95 94.94 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.443 -0.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.8 OUTLIER -64.22 95.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.898 . . . . 0.0 109.967 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.519 HD12 ' HB2' ' B' ' 217' ' ' ALA . 11.4 mm -134.1 151.62 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 110.621 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -107.37 109.37 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 109.667 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.483 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.9 mp -100.98 134.93 43.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 110.913 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' B' ' 205' ' ' LEU . 0.2 OUTLIER -108.72 117.79 35.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 109.473 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.533 HG22 HD21 ' B' ' 172' ' ' LEU . 4.4 mp -107.87 137.31 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.488 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -118.29 135.25 54.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.048 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' B' ' 172' ' ' LEU . 69.0 t -45.21 -24.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -35.06 78.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.594 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 124.95 -12.45 7.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.28 154.76 37.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' B' ' 212' ' ' ILE . 12.2 mm -138.78 137.15 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 110.083 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.594 HG11 ' HE1' ' A' ' 25' ' ' PHE . 96.7 t -120.98 149.25 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 1.1 mt -133.35 102.14 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 14.2 t -131.53 153.65 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.388 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.25 15.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.519 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -100.03 131.23 46.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -1.199 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.422 ' N ' ' OE1' ' B' ' 222' ' ' GLU . 4.6 tttt -75.75 -13.98 60.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.434 ' C ' HD13 ' B' ' 160' ' ' ILE . 0.2 OUTLIER -152.91 173.46 15.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -32.23 70.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.117 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -55.98 -51.32 68.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.505 ' HB3' HD11 ' B' ' 202' ' ' ILE . 1.1 mt-10 -52.74 -42.28 64.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 109.943 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.444 HG12 ' CB ' ' B' ' 217' ' ' ALA . 18.4 mm -60.13 -45.83 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -68.63 -33.25 73.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -71.79 -46.25 58.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 109.966 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.483 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -54.48 -51.49 64.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.848 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.712 ' HA ' HG22 ' B' ' 230' ' ' ILE . 20.0 t80 -57.27 -37.34 72.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.78 . . . . 0.0 109.93 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.48 -18.2 63.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.037 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.97 -18.28 17.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.712 HG22 ' HA ' ' B' ' 227' ' ' PHE . 9.1 tp -100.03 -25.53 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 110.323 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 31.9 t80 -51.99 -44.18 91.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.02 -31.09 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.354 1.187 . . . . 0.0 110.555 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 30.7 t -70.06 -38.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.166 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 37.0 mt -67.87 -42.99 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.168 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.8 -39.22 88.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.91 -31.37 72.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -117.32 42.65 2.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.213 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -96.65 -176.03 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.59 -38.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.157 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.288 0.566 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.0 -147.97 5.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -123.68 -15.21 7.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.163 . . . . 0.0 110.44 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 mt 51.2 94.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.134 -0.979 . . . . 0.0 110.258 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.33 -119.79 1.03 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -54.05 173.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -1.152 . . . . 0.0 110.087 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' C ' ' CE1' ' B' ' 99' ' ' PHE . . . -96.55 -133.22 7.58 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.047 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.3 OUTLIER -65.64 176.33 1.55 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.107 -1.231 . . . . 0.0 109.731 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.993 ' N ' HD12 ' A' ' 18' ' ' LEU . 2.7 t70 -66.54 60.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.091 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.895 HD21 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -80.68 -17.23 51.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 110.691 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.551 ' N ' HD21 ' A' ' 68' ' ' LEU . 64.9 m -41.31 -28.96 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.94 -37.1 4.0 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.75 HD12 HD11 ' B' ' 114' ' ' LEU . 0.4 OUTLIER -48.59 -40.39 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.277 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.601 HD13 ' CE ' ' A' ' 67' ' ' MET . 3.5 pp -82.97 -27.81 30.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.978 -1.076 . . . . 0.0 108.92 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 52' ' ' LEU . 1.7 t80 -90.58 9.95 27.51 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 141.18 95.33 0.25 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.709 ' HB2' HG22 ' B' ' 112' ' ' THR . 6.8 p-10 -20.06 116.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.976 0.893 . . . . 0.0 112.315 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.689 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.33 163.79 27.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.774 ' HA ' HG21 ' B' ' 103' ' ' ILE . 75.7 m-20 -87.45 121.73 30.26 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.047 ' HB2' HD13 ' A' ' 18' ' ' LEU . 2.9 p -36.78 -28.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.471 0.653 . . . . 0.0 109.69 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.8 tt0 -51.64 -18.48 1.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 0.0 110.575 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.75 27.97 3.87 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.645 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -129.38 147.86 51.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.94 -1.33 . . . . 0.0 109.573 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.689 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.72 165.88 12.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 0.0 111.872 -178.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.651 HD12 ' ND2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -88.31 113.69 24.17 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.928 0.871 . . . . 0.0 111.552 -178.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.02 17.72 2.28 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.93 86.99 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.798 -0.564 . . . . 0.0 109.987 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -70.35 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.323 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.13 -77.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.359 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.52 -144.88 24.7 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 20.3 tt0 -92.38 19.67 6.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -1.195 . . . . 0.0 110.168 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.39 -59.86 0.51 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.24 158.78 15.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -1.109 . . . . 0.0 110.032 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.94 159.03 26.91 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.39 100.21 2.44 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.9 -36.11 0.84 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 0.0 110.098 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 48' ' ' PHE . . . -69.13 -146.86 0.2 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 47' ' ' GLY . 6.3 p90 -49.48 179.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -1.191 . . . . 0.0 110.267 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -91.9 -144.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.349 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -100.55 35.8 2.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.393 -0.817 . . . . 0.0 110.071 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 0.4 OUTLIER -89.31 -26.66 21.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 109.074 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.508 HD13 ' CE1' ' A' ' 25' ' ' PHE . 2.1 mt -88.81 -38.57 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.621 -0.674 . . . . 0.0 109.451 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.001 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -57.26 -57.49 12.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.362 -0.836 . . . . 0.0 109.913 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.12 -31.36 71.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 3.4 m-20 -73.21 -43.13 61.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.001 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.1 mt -46.26 -45.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.328 -0.857 . . . . 0.0 109.245 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.92 -26.48 18.77 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -136.51 44.19 2.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 110.232 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.156 HD21 ' CE1' ' B' ' 190' ' ' PHE . 6.7 mt -99.41 13.14 34.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.22 47.21 1.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.79 . . . . 0.0 109.864 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.523 ' C ' HD23 ' A' ' 62' ' ' LEU . 17.7 mtpp -135.99 1.93 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 110.102 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.908 HD11 HD22 ' A' ' 59' ' ' LEU . 1.5 mt -88.69 -38.96 14.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 109.743 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 3.35 4.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 62' ' ' LEU . 1.5 pp -87.0 0.59 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.092 -1.24 . . . . 0.0 110.064 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.9 t70 -44.05 -32.91 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.914 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -56.75 -49.73 74.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.017 -1.052 . . . . 0.0 109.478 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.601 ' CE ' HD13 ' A' ' 24' ' ' LEU . 12.7 ttp -65.96 -12.62 56.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.644 ' C ' HD13 ' A' ' 68' ' ' LEU . 1.3 tm? -70.09 -65.66 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.09 -6.33 22.34 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -79.45 -4.77 52.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 110.646 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.914 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.1 OUTLIER -129.65 -6.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 110.371 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.929 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.8 tp -140.74 72.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 110.166 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.8 t70 -79.79 56.19 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.016 HD13 ' HB2' ' B' ' 101' ' ' ALA . 6.4 mt -110.48 69.01 0.68 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.634 0.731 . . . . 0.0 110.746 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -133.96 -164.81 1.55 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.563 -0.711 . . . . 0.0 110.064 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.0 114.05 6.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.302 -0.874 . . . . 0.0 110.165 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.218 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.25 0.548 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.15 75.64 1.3 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.453 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt -96.84 -51.58 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -1.163 . . . . 0.0 110.237 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 4.8 t 62.1 132.09 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 109.961 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.523 ' HG2' HG22 ' B' ' 223' ' ' ILE . 49.3 Cg_endo -74.48 152.53 43.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.006 1.53 . . . . 0.0 110.778 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -118.92 129.86 55.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 109.865 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.787 HD22 HG22 ' B' ' 160' ' ' ILE . 29.2 mt -69.93 132.23 45.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 110.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.82 -16.36 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.421 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -152.49 111.6 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.577 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 20.0 mm -91.95 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' B' ' 159' ' ' ASN . 50.7 t -148.77 114.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.915 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.56 165.34 24.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.534 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' THR . . . . . 0.725 HG22 HG22 ' B' ' 122' ' ' VAL . 69.5 p -120.71 141.44 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.685 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' B' ' 121' ' ' MET . 3.3 t -140.23 156.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.042 . . . . 0.0 110.722 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.665 HG22 ' H ' ' B' ' 77' ' ' GLY . 24.2 m -106.18 144.44 32.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.965 HD12 HD11 ' B' ' 80' ' ' LEU . 93.5 mt -94.73 -6.29 43.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.447 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLY . . . . . 0.665 ' H ' HG22 ' B' ' 75' ' ' THR . . . 103.59 -38.8 3.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' CYS . . . . . 0.724 ' H ' ' HB1' ' B' ' 149' ' ' ALA . 0.0 OUTLIER -142.47 -174.5 4.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.113 -1.228 . . . . 0.0 110.836 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.688 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -78.7 178.86 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 110.222 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.965 HD11 HD12 ' B' ' 76' ' ' LEU . 10.4 mt -140.89 165.01 28.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.422 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.634 ' O ' HG23 ' B' ' 85' ' ' VAL . 1.1 m-20 -110.27 83.27 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' B' ' 81' ' ' ASP . 8.4 mt -38.11 -49.1 1.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.39 -51.62 58.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.697 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.544 ' HA ' ' CD2' ' B' ' 87' ' ' LEU . 43.3 p -76.87 -41.9 42.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 110.077 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.851 HG22 ' CE2' ' B' ' 148' ' ' PHE . 43.9 t -60.49 -37.02 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.121 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.27 78.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' B' ' 84' ' ' THR . 0.7 OUTLIER -90.74 -23.04 20.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.517 ' HB3' ' CD1' ' B' ' 146' ' ' ILE . 20.7 m170 -82.97 -35.38 25.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.684 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.527 ' HB2' ' HE1' ' B' ' 104' ' ' MET . . . -72.06 145.15 48.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.387 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -73.94 -27.13 60.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 1.7 m120 -133.69 79.29 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.938 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 89' ' ' ALA . . . -138.07 159.64 41.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.83 ' O ' HD12 ' B' ' 103' ' ' ILE . 73.9 mt-10 -147.83 120.34 8.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.244 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.475 ' HB2' HG22 ' B' ' 102' ' ' VAL . 24.8 t80 -113.52 113.4 25.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.121 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -119.8 111.72 35.72 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.15 -19.77 29.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.009 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -17.86 61.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -105.28 -76.46 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.444 -0.785 . . . . 0.0 110.027 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.658 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.25 173.15 11.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.891 . . . . 0.0 110.433 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.3 43.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.234 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.016 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -132.22 151.97 51.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 110.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' B' ' 94' ' ' TYR . 55.8 t -96.95 126.58 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 109.526 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.83 HD12 ' O ' ' B' ' 93' ' ' GLU . 3.3 mp -89.72 118.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 110.478 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.527 ' HE1' ' HB2' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -95.56 165.32 12.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.455 ' O ' ' ND2' ' B' ' 91' ' ' ASN . 10.3 mtp180 -163.8 116.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.783 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' B' ' 138' ' ' LYS . 37.7 pt -120.71 150.19 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.466 -0.771 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.5 OUTLIER -91.6 28.32 1.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.519 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 7.0 pt-20 -161.96 83.9 1.69 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.716 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' B' ' 111' ' ' THR . 51.1 Cg_endo -85.47 148.76 46.47 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.172 -0.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -51.54 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 109' ' ' PRO . 13.2 p -146.62 -179.46 6.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.899 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.81 HG22 HG23 ' B' ' 124' ' ' THR . 1.2 t -131.57 179.22 6.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 110.208 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -166.85 137.82 3.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 0.0 110.312 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.882 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -95.22 105.94 17.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.59 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.44 HD12 ' SD ' ' B' ' 104' ' ' MET . 33.8 mt -90.21 128.34 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.361 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.834 ' CD1' HD11 ' A' ' 74' ' ' LEU . 2.8 m-30 -99.84 162.31 13.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 79' ' ' ARG . . . -76.57 -11.09 59.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.699 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 m -83.05 -5.68 59.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.027 . . . . 0.0 110.211 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' B' ' 78' ' ' CYS . . . 107.14 -39.16 2.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.93 135.21 55.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.114 . . . . 0.0 109.987 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -133.01 168.34 18.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.356 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.914 HG21 ' O ' ' A' ' 71' ' ' VAL . 10.3 t -130.37 143.64 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.16 144.38 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.958 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.81 HG23 HG22 ' B' ' 112' ' ' THR . 1.2 t -153.08 165.58 35.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.568 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 108.72 -36.45 4.35 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -47.25 167.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -1.161 . . . . 0.0 110.416 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -118.77 -12.09 9.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.504 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m -154.43 173.65 15.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.062 -1.024 . . . . 0.0 110.406 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.2 mt-10 -57.96 -49.74 75.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.08 -35.3 73.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.69 -41.78 83.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 110.202 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -58.42 -54.61 45.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.164 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -50.17 -37.54 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' B' ' 138' ' ' LYS . 0.2 OUTLIER -70.09 -39.21 75.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 0.0 110.376 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -70.1 -35.37 74.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.14 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 50.7 m -72.28 -60.56 2.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 5.7 ptm180 -47.51 -30.11 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.294 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.569 ' HB3' HD13 ' B' ' 106' ' ' ILE . 57.7 mmtt -66.89 -48.16 69.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.014 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 28.6 m-85 -64.79 -52.79 54.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.79 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 140' ' ' ALA . . . . . 0.853 ' HB1' ' NE2' ' B' ' 144' ' ' GLN . . . -50.01 -37.09 31.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.864 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.85 85.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 mt -64.2 -25.44 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.771 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.456 HG23 ' HB2' ' B' ' 148' ' ' PHE . 0.3 OUTLIER -84.43 -25.12 7.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.385 -0.822 . . . . 0.0 109.029 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.853 ' NE2' ' HB1' ' B' ' 140' ' ' ALA . 24.2 mt-30 -89.17 -22.3 22.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.452 -0.78 . . . . 0.0 109.763 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -82.18 -27.81 32.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.975 HG21 ' CE2' ' B' ' 148' ' ' PHE . 25.7 mt -83.48 -37.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.655 -0.653 . . . . 0.0 109.806 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 117.74 20.2 4.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.975 ' CE2' HG21 ' B' ' 146' ' ' ILE . 13.8 m-85 -86.19 -160.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.088 -1.242 . . . . 0.0 110.335 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 149' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' B' ' 76' ' ' LEU . . . -34.66 -71.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.304 0.573 . . . . 0.0 110.501 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' B' ' 149' ' ' ALA . . . 64.88 72.72 0.43 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 112.002 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' B' ' 76' ' ' LEU . 0.4 OUTLIER -162.92 101.56 1.0 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.167 -0.958 . . . . 0.0 110.057 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.639 ' O ' HG23 ' B' ' 153' ' ' THR . 2.7 t80 -72.18 103.22 3.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.0 110.353 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.639 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.7 OUTLIER -159.22 158.27 32.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' B' ' 153' ' ' THR . 2.7 t70 70.45 18.5 6.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.885 . . . . 0.0 110.669 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.522 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 4.2 t80 -69.05 135.4 50.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.046 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.0 131.82 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -0.956 . . . . 0.0 110.704 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.402 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 51.5 mt -80.39 122.68 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 109.644 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -111.93 -3.6 14.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.119 -0.988 . . . . 0.0 110.972 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.479 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 11.2 m120 -155.8 140.42 16.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.855 -1.153 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.787 HG22 HD22 ' B' ' 67' ' ' LEU . 48.4 mt -133.88 123.97 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.388 -0.82 . . . . 0.0 109.655 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 8.0 t -101.6 131.1 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 110.627 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.73 172.15 18.97 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.99 152.24 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -1.197 . . . . 0.0 110.362 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.01 159.95 7.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' B' ' 166' ' ' VAL . 22.6 t0 -101.81 166.3 10.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.493 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.0 OUTLIER -114.32 -83.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.347 -0.846 . . . . 0.0 110.291 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -177.84 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.636 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.475 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 2.2 p90 -137.6 166.7 24.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.1 Cg_endo -70.97 171.63 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.82 1.431 . . . . 0.0 110.527 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.95 139.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 110.601 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 171' ' ' ARG . . . . . 0.428 ' CG ' ' H ' ' B' ' 174' ' ' GLY . 0.5 OUTLIER -75.13 88.07 2.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.607 HD22 ' CB ' ' B' ' 193' ' ' LEU . 71.9 mt -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.625 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -43.02 76.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.182 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' B' ' 171' ' ' ARG . . . -71.26 -31.03 66.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.459 ' O ' HD12 ' B' ' 175' ' ' LEU . 11.5 tp -75.45 -35.24 60.95 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -1.112 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.89 -27.36 64.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.3 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -75.44 -40.82 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.328 -0.857 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 2.1 t -78.3 -55.85 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.183 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -91.67 27.07 2.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.71 45.92 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -12.48 52.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.145 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -115.38 -23.99 8.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.04 171.28 10.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.7 m -132.33 147.77 52.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.241 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' B' ' 172' ' ' LEU . 33.6 t80 -149.64 104.54 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.913 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' B' ' 190' ' ' PHE . 6.5 mt-10 -113.67 103.94 55.3 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.81 -1.87 10.58 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.068 1.562 . . . . 0.0 110.113 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 188' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' B' ' 189' ' ' LEU . 1.7 pm0 -85.74 -18.21 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -148.7 -38.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 1.156 ' CE1' HD21 ' A' ' 59' ' ' LEU . 4.5 t80 -113.82 108.61 51.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.425 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.96 -20.52 19.42 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.031 1.543 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.55 178.43 44.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.607 ' CB ' HD22 ' B' ' 172' ' ' LEU . 9.7 tt -118.73 125.75 50.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -1.116 . . . . 0.0 110.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.767 HD13 HD22 ' A' ' 62' ' ' LEU . 4.7 mt -101.66 111.0 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.431 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 6.5 t80 -96.39 124.38 40.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.523 ' CB ' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -104.91 101.19 10.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 110.24 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.54 ' HE1' HG12 ' B' ' 230' ' ' ILE . 16.8 ttm -69.58 128.51 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.922 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.7 -51.38 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -138.06 119.05 10.36 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.103 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -74.69 150.28 95.25 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.91 -2.121 . . . . 0.0 110.427 -0.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' B' ' 197' ' ' MET . 3.2 tttt -63.04 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' B' ' 217' ' ' ALA . 47.1 mm -128.96 150.96 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.62 128.71 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.044 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.64 HD22 HG13 ' B' ' 230' ' ' ILE . 3.7 mp -120.36 135.05 55.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 110.548 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 1.9 mm? -102.97 126.66 50.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 109.795 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.556 HG12 HD21 ' B' ' 234' ' ' LEU . 3.7 mt -119.5 127.19 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 110.434 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.461 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 83.7 m-85 -118.23 143.67 46.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 110.241 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 25.4 t -48.06 -30.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.38 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.25 -45.74 68.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.493 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 128.24 3.25 5.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.438 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.5 OUTLIER -92.57 135.98 33.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -1.2 . . . . 0.0 110.301 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.438 HD13 ' O ' ' B' ' 211' ' ' LYS . 46.1 mm -121.09 125.3 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.348 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 24.7 t -107.07 154.78 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.961 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.1 mp -135.36 135.73 40.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 5.1 t -157.84 142.14 16.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.909 . . . . 0.0 110.204 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.406 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 111.39 21.78 6.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.742 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -108.82 126.92 53.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -1.136 . . . . 0.0 110.179 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -75.23 -25.69 58.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.415 ' HB3' ' HG2' ' B' ' 221' ' ' GLU . 1.2 tt0 -132.56 -178.57 4.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.12 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 28.4 ttp-105 -85.5 -37.42 19.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' B' ' 219' ' ' GLN . 13.2 pt-20 -52.49 -26.71 13.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -76.35 -44.56 36.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.828 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.523 HG22 ' HG2' ' B' ' 65' ' ' PRO . 28.2 mm -60.36 -38.23 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.64 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -64.99 -47.3 78.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -36.16 81.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.316 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.589 ' HB1' HD11 ' B' ' 204' ' ' LEU . . . -53.84 -52.86 59.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.524 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 25.5 t80 -71.57 -44.34 64.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.34 -32.36 2.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.51 -11.67 20.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.64 HG13 HD22 ' B' ' 204' ' ' LEU . 8.6 mm -100.03 -23.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.612 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 25.0 t80 -52.34 -48.22 90.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -70.31 -33.4 14.58 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.397 1.209 . . . . 0.0 110.391 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.84 -40.36 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.456 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.556 HD21 HG12 ' B' ' 206' ' ' ILE . 66.5 mt -68.11 -45.48 73.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.128 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -27.6 64.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.6 OUTLIER -66.49 -39.49 88.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.34 40.5 2.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.1 ptt85 -66.72 -170.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.466 ' HB2' ' HG2' ' B' ' 169' ' ' PRO . 1.3 mttp -123.33 -61.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.128 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.171 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.175 0.512 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.7 -82.33 0.21 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 m -72.83 142.26 48.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -1.101 . . . . 0.0 110.057 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 14' ' ' ILE . 11.8 pt -108.63 144.7 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.204 -0.935 . . . . 0.0 110.518 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 16' ' ' ASN . . . 49.44 -173.08 0.07 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER 174.03 -152.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -1.141 . . . . 0.0 110.133 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.31 -172.28 23.53 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.968 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -63.01 156.38 24.84 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.988 -1.301 . . . . 0.0 109.101 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.671 ' N ' HD12 ' A' ' 18' ' ' LEU . 14.4 t70 -81.22 98.68 8.2 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 111.123 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.968 HD21 HD21 ' A' ' 18' ' ' LEU . 4.9 mt -97.71 4.93 49.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.253 -0.904 . . . . 0.0 109.697 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.601 HG21 ' CB ' ' A' ' 59' ' ' LEU . 18.7 m -39.81 -28.61 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.104 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -100.19 -38.26 3.6 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.944 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -52.86 -46.87 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -1.073 . . . . 0.0 109.022 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.767 HD13 ' HG2' ' A' ' 67' ' ' MET . 3.4 pp -80.51 -3.92 51.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' O ' ' A' ' 21' ' ' THR . 1.4 t80 -112.75 -4.76 13.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.421 -0.799 . . . . 0.0 110.895 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 162.19 69.08 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.517 -1.801 . . . . 0.0 111.337 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.589 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 20.37 111.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.15 0.976 . . . . 0.0 113.301 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.738 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -149.0 156.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.876 ' HA ' HG21 ' B' ' 103' ' ' ILE . 5.4 m-20 -88.85 138.3 31.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.749 ' HB3' HD11 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -41.77 -26.55 0.08 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.407 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HA ' ' HG2' ' B' ' 98' ' ' ARG . 0.0 OUTLIER -55.47 -14.99 2.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 110.74 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.26 32.88 5.63 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.21 123.88 51.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.28 -1.13 . . . . 0.0 109.607 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -90.39 131.79 35.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.442 -0.786 . . . . 0.0 110.339 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.853 ' N ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -130.18 179.93 5.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.985 -1.072 . . . . 0.0 109.693 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.767 ' N ' HD12 ' A' ' 35' ' ' LEU . 5.3 mt-30 -125.77 -102.15 0.37 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 110.179 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' B' ' 110' ' ' LYS . 8.9 p30 176.62 43.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.584 -1.323 . . . . 0.0 110.084 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' N ' ' HD3' ' B' ' 110' ' ' LYS . 0.2 OUTLIER -85.83 84.73 7.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 0.0 110.481 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 20.3 p-10 -82.71 -147.76 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.898 . . . . 0.0 109.994 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.19 -46.56 85.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -121.97 106.34 11.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.154 . . . . 0.0 110.358 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.46 -71.47 0.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.75 44.33 23.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -1.118 . . . . 0.0 110.265 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.79 -150.97 0.02 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.97 -121.71 0.65 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -48.3 151.93 0.96 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -1.112 . . . . 0.0 110.358 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.41 138.3 2.47 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 48' ' ' PHE . 13.3 p90 -58.07 161.37 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -1.123 . . . . 0.0 110.463 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.12 -137.5 0.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.391 -0.818 . . . . 0.0 110.215 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . . . -100.92 36.04 2.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.815 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' CG ' ' HG3' ' B' ' 191' ' ' PRO . 2.8 tt0 -79.3 -31.8 43.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.84 HD22 ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -117.16 -9.17 11.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.483 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.84 ' N ' HD22 ' A' ' 52' ' ' LEU . 5.7 tpt180 -62.82 -54.25 41.84 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.559 ' OE2' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -57.64 -20.5 33.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.035 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.575 ' C ' HD12 ' A' ' 59' ' ' LEU . 9.3 m120 -88.43 -25.45 22.64 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 53' ' ' ARG . 40.7 mt -51.2 -38.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.34 -13.29 42.9 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 55' ' ' ASN . 18.0 m -138.15 11.59 2.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.241 -1.152 . . . . 0.0 110.808 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 56' ' ' ILE . 0.5 OUTLIER -83.54 19.83 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 0.0 110.669 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 p -104.21 31.41 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 110.301 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.662 ' H ' HD13 ' A' ' 62' ' ' LEU . 5.7 pttt -130.64 11.24 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.472 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -124.86 -2.2 7.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.016 -1.053 . . . . 0.0 110.979 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.762 ' N ' HD22 ' A' ' 62' ' ' LEU . . . 150.71 -47.27 0.6 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.581 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.1 mm? -41.83 -31.74 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -1.206 . . . . 0.0 110.718 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.517 ' CA ' ' HG ' ' A' ' 68' ' ' LEU . 36.0 t70 -41.02 -35.93 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.515 -0.741 . . . . 0.0 110.286 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.3 m -66.53 -43.64 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.832 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.767 ' HG2' HD13 ' A' ' 24' ' ' LEU . 5.2 tpp -70.32 -22.71 62.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.803 ' O ' HG22 ' A' ' 72' ' ' ILE . 4.7 mt -62.74 -61.25 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.973 -1.079 . . . . 0.0 108.904 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 69' ' ' LEU . 3.8 pp -62.48 -9.51 8.76 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.018 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.15 -17.23 37.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 111.274 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.68 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.1 OUTLIER -115.68 -20.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.688 -1.258 . . . . 0.0 109.319 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.913 HD11 HD12 ' A' ' 74' ' ' LEU . 3.9 tp -130.36 71.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.646 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.52 57.73 1.26 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.854 -1.154 . . . . 0.0 108.154 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.995 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 5.1 mt -102.23 65.65 0.97 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.534 0.683 . . . . 0.0 110.502 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -110.39 128.17 55.45 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.334 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 75' ' ' LYS . 16.1 mm-40 43.02 75.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.242 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.182 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.325 0.583 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -159.37 58.36 0.33 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' B' ' 166' ' ' VAL . 5.2 mt -61.81 138.68 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.133 . . . . 0.0 110.38 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.37 132.19 23.72 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.857 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.34 148.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.922 1.485 . . . . 0.0 110.627 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 17.9 m -108.07 127.01 53.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.855 . . . . 0.0 110.245 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.92 131.06 43.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -123.26 -7.86 8.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.594 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.477 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.9 OUTLIER -163.47 110.16 1.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.466 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.931 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 19.4 mm -100.96 146.69 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.778 HG22 ' CB ' ' B' ' 124' ' ' THR . 47.4 t -136.75 131.16 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.969 -1.082 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.95 156.78 44.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' THR . . . . . 0.406 ' O ' ' O ' ' B' ' 154' ' ' ASP . 24.3 m -109.98 137.86 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.657 HG21 ' OG ' ' B' ' 136' ' ' SER . 90.2 t -134.12 171.01 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.764 HG23 ' HG3' ' B' ' 120' ' ' LYS . 50.9 m -146.14 144.4 29.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.314 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.901 HD22 ' HB1' ' B' ' 150' ' ' ALA . 71.3 mt -97.27 -71.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.84 -5.91 5.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' CYS . . . . . 0.465 ' SG ' HD21 ' B' ' 80' ' ' LEU . 31.0 p -129.29 130.5 46.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -1.159 . . . . 0.0 110.165 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.655 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.7 OUTLIER -53.5 151.84 5.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 0.0 110.261 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.691 HD11 HD12 ' B' ' 76' ' ' LEU . 25.5 mt -131.13 159.59 37.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' B' ' 82' ' ' LEU . 31.9 t70 -105.58 92.03 4.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.846 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' B' ' 81' ' ' ASP . 16.3 mt -40.64 -34.39 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.1 OUTLIER -61.2 -49.04 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.052 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 41.3 m -80.24 -33.42 37.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.256 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.615 HG12 HG11 ' B' ' 102' ' ' VAL . 5.7 t -61.41 -50.1 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -76.45 -25.36 54.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 12.3 tp -68.39 -43.5 77.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 110.286 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -40.7 18.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -48.78 110.71 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -63.26 -11.35 20.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 0.8 OUTLIER -139.93 79.79 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.336 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.32 168.92 25.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.25 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.16 142.08 35.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.224 -0.923 . . . . 0.0 110.121 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -140.21 102.56 4.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.69 124.84 26.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.86 -20.98 21.79 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 110.74 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.34 59.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 6.0 mpt_? -93.18 -60.1 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.95 . . . . 0.0 110.723 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.713 ' CG ' ' HB2' ' A' ' 18' ' ' LEU . 64.3 t80 -170.32 179.97 3.25 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.523 -177.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.813 ' O ' HD13 ' A' ' 74' ' ' LEU . . . -100.9 69.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.005 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.995 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -154.24 142.84 20.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.567 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.615 HG11 HG12 ' B' ' 85' ' ' VAL . 12.5 t -96.69 117.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.876 HG21 ' HA ' ' A' ' 29' ' ' ASP . 3.4 mt -89.58 105.82 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 4.0 ttm -91.72 148.94 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.043 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.447 ' HD3' ' OD1' ' A' ' 29' ' ' ASP . 30.4 mtm180 -142.78 144.16 32.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 19.4 pt -131.27 179.16 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.882 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.45 34.99 4.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.129 -0.982 . . . . 0.0 110.514 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 179.25 81.05 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.0 Cg_endo -77.06 162.35 91.54 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.364 -0.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.573 ' C ' HG23 ' B' ' 111' ' ' THR . 3.5 tttp -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.898 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.622 HG22 ' C ' ' B' ' 125' ' ' GLY . 61.8 p -156.26 -179.63 8.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.295 -0.878 . . . . 0.0 110.485 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.844 HG22 HG23 ' B' ' 124' ' ' THR . 4.9 t -125.58 172.7 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.545 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -150.79 136.21 17.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.906 -1.121 . . . . 0.0 111.416 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.72 HD23 HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -92.54 95.81 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.43 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 73.9 mt -89.69 139.26 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.069 . . . . 0.0 111.116 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.643 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.0 m-85 -111.28 162.79 14.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.08 -15.59 57.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 8.2 m -76.85 -17.66 58.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.298 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 120.14 -26.22 7.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' LYS . . . . . 0.764 ' HG3' HG23 ' B' ' 75' ' ' THR . 3.4 mttt -77.75 163.02 26.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -1.114 . . . . 0.0 110.189 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 5.2 ptt? -160.99 170.27 20.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.68 HG21 ' O ' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -135.9 127.27 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.355 -0.84 . . . . 0.0 109.744 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 26.3 t -105.2 133.89 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.968 -1.083 . . . . 0.0 110.796 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.844 HG23 HG22 ' B' ' 112' ' ' THR . 2.4 t -140.64 159.03 43.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.616 -0.677 . . . . 0.0 109.23 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.622 ' C ' HG22 ' B' ' 111' ' ' THR . . . 112.58 -17.03 23.66 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -60.42 173.27 0.71 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -1.199 . . . . 0.0 110.191 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -120.47 -18.77 7.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.998 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.427 ' N ' HG13 ' B' ' 70' ' ' ILE . 14.5 t -146.7 -172.32 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -70.59 -59.23 2.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.214 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -52.53 -33.41 45.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.535 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 1.5 t0 -63.59 -46.4 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 4.0 t -63.27 -34.84 78.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.321 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' LYS . . . . . 0.472 ' HA ' ' CE1' ' B' ' 155' ' ' PHE . 6.4 ttpt -66.37 -43.51 85.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.141 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -70.36 -58.27 3.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.51 -26.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.121 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.657 ' OG ' HG21 ' B' ' 74' ' ' VAL . 47.7 t -77.52 -59.07 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' B' ' 134' ' ' LEU . 1.2 ptm180 -53.07 -26.01 14.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.003 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -70.65 -46.9 62.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.799 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.545 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 17.4 m-85 -60.76 -44.13 97.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.797 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.95 -27.79 67.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.766 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.502 ' HG3' ' NH1' ' B' ' 141' ' ' ARG . 0.2 OUTLIER -68.69 -37.4 79.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.8 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 11.2 mt -61.5 -48.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.991 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.789 HG21 ' HB2' ' B' ' 150' ' ' ALA . 3.2 mp -63.66 -44.09 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 109.666 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.768 ' HG3' ' HB3' ' B' ' 150' ' ' ALA . 35.4 mt-30 -70.97 -33.81 70.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -71.73 -22.25 61.65 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.7 -22.87 10.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.35 -34.65 2.75 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.468 ' CE1' ' HA ' ' B' ' 80' ' ' LEU . 11.8 m-85 -47.18 161.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.159 -1.201 . . . . 0.0 110.962 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.16 42.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 0.0 109.707 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.901 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -59.98 158.34 11.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 110.692 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 2.4 mttm -120.8 -156.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.539 -0.726 . . . . 0.0 109.688 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -153.0 71.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 110.211 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -142.85 -178.79 5.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 153' ' ' THR . 0.6 OUTLIER 69.04 11.75 8.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.606 ' HA ' HG22 ' B' ' 74' ' ' VAL . 40.4 t80 -68.67 132.25 46.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -169.83 131.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 1.9 mp -79.97 118.93 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.836 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.443 ' OE1' ' HG3' ' B' ' 218' ' ' LYS . 17.4 mm-40 -122.49 3.36 9.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.071 -1.018 . . . . 0.0 110.849 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.47 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 8.2 t-20 -149.83 95.91 2.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.894 -1.129 . . . . 0.0 110.768 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' B' ' 217' ' ' ALA . 88.1 mt -100.71 141.91 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.668 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 1.022 HG22 ' OG1' ' B' ' 215' ' ' THR . 26.5 t -122.31 132.8 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.775 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -134.98 -179.92 17.0 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.04 143.23 3.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -1.213 . . . . 0.0 110.369 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 26.9 p -170.23 175.41 4.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -119.35 173.82 6.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 209' ' ' SER . 0.0 OUTLIER -112.84 -85.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 110.098 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 166.97 -22.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.142 -0.974 . . . . 0.0 110.672 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.443 ' CE2' HG12 ' B' ' 170' ' ' ILE . 28.7 p90 -121.33 152.44 57.57 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.093 -1.005 . . . . 0.0 109.705 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.535 ' HA ' ' OG ' ' B' ' 209' ' ' SER . 50.9 Cg_endo -79.78 158.44 24.64 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.908 1.478 . . . . 0.0 110.619 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.991 HD12 ' CB ' ' B' ' 209' ' ' SER . 5.7 mt -133.95 164.92 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 0.0 110.293 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' ARG . . . . . 0.486 ' N ' HG22 ' B' ' 170' ' ' ILE . 0.0 OUTLIER -100.17 93.2 5.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.934 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.935 HD22 ' HB2' ' B' ' 193' ' ' LEU . 55.5 mt -47.45 -49.99 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 110.063 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 173' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 172' ' ' LEU . 1.5 mt-10 -44.61 -36.73 3.2 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.496 -0.752 . . . . 0.0 109.797 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.06 -38.57 63.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.66 HD11 ' HE2' ' B' ' 195' ' ' TYR . 0.1 OUTLIER -66.73 -38.06 85.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -1.125 . . . . 0.0 110.011 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.14 -13.74 59.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -89.18 -37.9 14.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -52.13 4.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.563 ' HB2' HD13 ' B' ' 175' ' ' LEU . 28.7 m80 -93.05 21.73 5.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 0.0 110.084 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' B' ' 179' ' ' HIS . . . -43.13 -65.29 1.48 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 9.3 t -48.71 -21.73 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -1.186 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.413 ' CZ ' ' CG2' ' B' ' 198' ' ' VAL . 1.1 m-30 -114.08 15.48 18.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' B' ' 179' ' ' HIS . 0.5 OUTLIER -151.52 153.45 34.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.77 141.23 51.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.875 . . . . 0.0 109.943 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -132.66 107.91 8.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.445 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 2.0 mm-40 -114.31 94.49 35.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.05 -8.94 24.67 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 110.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.37 -3.91 27.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.432 HD13 ' CE ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -140.42 -35.22 0.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.651 ' CZ ' HD22 ' B' ' 205' ' ' LEU . 2.5 t80 -126.48 128.97 24.25 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.146 -0.971 . . . . 0.0 110.4 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 191' ' ' PRO . . . . . 0.412 ' HG3' ' CG ' ' A' ' 51' ' ' GLU . 47.9 Cg_endo -75.88 -38.6 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.927 1.488 . . . . 0.0 110.65 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.71 -179.98 44.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.935 ' HB2' HD22 ' B' ' 172' ' ' LEU . 4.9 tt -106.53 131.92 53.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -1.157 . . . . 0.0 110.269 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.655 ' N ' HD23 ' B' ' 193' ' ' LEU . 23.8 mt -90.31 105.94 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.66 ' HE2' HD11 ' B' ' 175' ' ' LEU . 2.1 t80 -90.35 116.26 28.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 79.87 1.77 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -67.5 161.02 26.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.413 ' CG2' ' CZ ' ' B' ' 182' ' ' PHE . 53.0 t -111.8 -31.08 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -130.83 94.16 29.37 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.5 Cg_endo -73.36 165.66 83.9 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.787 -2.172 . . . . 0.0 110.471 0.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' B' ' 197' ' ' MET . 35.2 tttm -88.72 93.11 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.485 ' CD1' ' HB2' ' B' ' 217' ' ' ALA . 13.7 mt -144.39 148.5 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.521 ' C ' HD12 ' B' ' 204' ' ' LEU . 14.4 t -94.86 142.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.566 ' N ' HD12 ' B' ' 204' ' ' LEU . 5.2 mp -135.27 148.9 49.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.651 HD22 ' CZ ' ' B' ' 190' ' ' PHE . 69.7 mt -105.76 110.64 23.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.901 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' B' ' 208' ' ' VAL . 18.5 mm -94.79 96.15 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.477 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.633 ' C ' HG23 ' B' ' 208' ' ' VAL . 12.8 m-85 -70.31 58.93 0.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.633 HG23 ' C ' ' B' ' 207' ' ' PHE . 5.8 t 80.37 -37.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.937 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.991 ' CB ' HD12 ' B' ' 170' ' ' ILE . 2.9 p 156.74 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.937 0.875 . . . . 0.0 110.163 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.76 -67.66 1.89 Allowed Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.698 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 212' ' ' ILE . 4.8 mttp -100.74 139.92 35.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -1.15 . . . . 0.0 111.142 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.648 HD13 ' O ' ' B' ' 211' ' ' LYS . 27.1 mm -123.15 140.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.308 -0.87 . . . . 0.0 110.032 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.564 ' C ' HD12 ' B' ' 214' ' ' LEU . 12.0 t -123.63 152.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.185 -0.947 . . . . 0.0 110.492 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.643 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.4 mp -144.08 123.65 13.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.322 -0.862 . . . . 0.0 110.545 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 215' ' ' THR . . . . . 1.022 ' OG1' HG22 ' B' ' 161' ' ' VAL . 2.9 t -147.21 144.42 28.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.088 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 116.88 1.16 19.49 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -75.59 152.41 37.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -1.124 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.443 ' HG3' ' OE1' ' B' ' 158' ' ' GLN . 8.6 tttt -100.49 -2.53 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.3 164.93 19.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.086 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.28 -24.77 65.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.466 ' OE1' ' CA ' ' B' ' 221' ' ' GLU . 0.1 OUTLIER -69.1 -37.98 78.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.912 . . . . 0.0 109.964 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 2.9 mt-10 -63.66 -46.92 83.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.07 -1.019 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.489 HG12 ' CB ' ' B' ' 217' ' ' ALA . 10.7 mm -58.46 -48.37 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.922 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -55.68 -26.8 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.078 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -48.72 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.26 -35.95 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.45 -47.43 12.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.345 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -25.97 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.509 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -83.37 -36.57 24.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.584 HD13 ' O ' ' B' ' 230' ' ' ILE . 0.3 OUTLIER -88.19 -29.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 109.906 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.606 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 6.7 t80 -44.21 -49.55 23.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.409 -0.807 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 41.1 Cg_endo -68.17 -45.11 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.35 1.184 . . . . 0.0 110.355 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.571 ' HB ' HD13 ' B' ' 230' ' ' ILE . 4.3 t -47.18 -37.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 108.981 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.814 HD22 HD13 ' B' ' 170' ' ' ILE . 57.3 mt -65.41 -53.0 49.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.84 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.91 -38.17 15.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.981 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -60.08 -45.43 92.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -97.63 34.38 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.931 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -52.01 146.71 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 110.276 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -29.94 9.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.37 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.327 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.293 0.568 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.29 -144.44 17.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.4 p -147.78 68.86 1.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -1.141 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.86 -158.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.15 -41.15 1.74 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.76 99.39 3.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -1.098 . . . . 0.0 109.82 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.15 136.98 5.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.073 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -96.4 157.58 15.83 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.136 -1.214 . . . . 0.0 109.235 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.65 95.32 5.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.038 -1.039 . . . . 0.0 111.552 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.073 HD21 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -107.94 9.43 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.978 . . . . 0.0 110.81 179.417 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.662 ' OG1' HD23 ' A' ' 68' ' ' LEU . 24.0 m -48.85 -23.79 1.21 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.857 -1.152 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.2 -29.0 6.95 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.8 ' CG2' HG11 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -44.99 -44.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.294 . . . . 0.0 108.848 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.864 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.6 pp -84.41 -22.32 30.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.924 -1.11 . . . . 0.0 109.294 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.743 ' HZ ' HD11 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -86.12 2.82 45.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.35 178.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 149.98 101.03 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.744 ' ND2' HD11 ' A' ' 35' ' ' LEU . 13.6 p-10 -22.08 84.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.813 0.816 . . . . 0.0 111.878 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.2 pp -88.49 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.907 ' O ' HD12 ' A' ' 28' ' ' ILE . 66.0 m-20 -88.22 126.52 35.19 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.549 ' HB3' ' CD1' ' B' ' 103' ' ' ILE . 1.1 p -39.71 -25.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.758 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' ASP . 16.2 tt0 -59.77 -10.62 3.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.09 -1.006 . . . . 0.0 110.202 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.59 29.84 5.78 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -117.36 119.65 35.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.306 -1.114 . . . . 0.0 110.519 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.96 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -90.81 143.55 26.61 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.051 -1.03 . . . . 0.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.96 ' N ' HD22 ' A' ' 34' ' ' LEU . 4.5 pp -132.48 -178.77 5.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.786 -1.196 . . . . 0.0 110.959 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 35' ' ' LEU . 1.9 mt-30 -128.49 139.36 52.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 110.152 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 23.9 p-10 -78.28 67.21 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.877 . . . . 0.0 110.179 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -160.13 146.05 15.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.888 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -150.19 92.26 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.24 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.62 102.41 1.01 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -65.13 94.44 0.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -1.159 . . . . 0.0 110.19 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.83 -80.38 1.39 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.96 162.87 39.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 110.314 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.21 -157.03 40.33 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.54 101.3 0.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.22 128.32 33.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 110.206 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.77 130.88 1.86 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.577 ' CG ' HD12 ' A' ' 52' ' ' LEU . 28.1 p90 -46.54 137.58 6.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -1.138 . . . . 0.0 110.3 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.73 -138.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 110.106 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -93.31 30.37 1.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 110.163 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.39 -19.51 16.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.518 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.577 HD12 ' CG ' ' A' ' 48' ' ' PHE . 4.0 mt -100.28 -45.79 5.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.775 . . . . 0.0 110.331 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.898 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -53.2 -57.56 10.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.274 -0.891 . . . . 0.0 109.738 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 3.0 pp20? -62.77 -19.99 64.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.78 . . . . 0.0 109.416 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 7.7 m-20 -84.15 -35.79 23.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.5 -0.75 . . . . 0.0 109.211 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.898 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.5 mt -53.09 -41.51 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.394 -0.817 . . . . 0.0 109.141 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.54 -23.88 44.69 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p -118.52 12.8 13.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -1.182 . . . . 0.0 110.567 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.044 HD23 HD11 ' A' ' 62' ' ' LEU . 4.0 mt -87.81 26.46 1.32 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.098 -1.001 . . . . 0.0 110.369 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 52.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.527 ' HG3' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -173.35 26.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 110.364 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.044 HD11 HD23 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -148.09 12.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.186 -0.947 . . . . 0.0 110.393 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.94 -58.49 0.51 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 4.1 mm? -50.34 -20.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -1.116 . . . . 0.0 110.928 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 t70 -45.43 -43.03 11.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -66.78 -50.45 62.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.391 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.864 ' HG2' HD22 ' A' ' 24' ' ' LEU . 2.0 tpp -68.27 -7.67 32.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.296 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.662 HD23 ' OG1' ' A' ' 21' ' ' THR . 2.3 tm? -70.05 -59.63 2.79 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 122.061 0.934 . . . . 0.0 108.631 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.3 pp -75.74 0.56 17.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 4.1 tt0 -92.49 13.93 18.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 112.222 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.893 HG12 HG11 ' B' ' 122' ' ' VAL . 2.0 t -140.58 3.7 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.743 -1.223 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.838 ' CG1' HD23 ' A' ' 18' ' ' LEU . 1.5 tp -148.99 76.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.6 t70 -77.73 55.43 1.36 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.12 -0.988 . . . . 0.0 108.455 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.577 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER -85.54 34.57 0.59 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.531 0.681 . . . . 0.0 110.629 -178.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.77 162.78 14.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 0.0 110.354 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 58.84 40.15 23.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.4 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.143 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.199 0.524 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.55 65.37 0.97 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.597 HD13 ' O ' ' B' ' 165' ' ' ASP . 89.8 mt -93.51 115.28 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -1.161 . . . . 0.0 110.196 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.474 ' CG1' ' OH ' ' B' ' 224' ' ' TYR . 6.6 t -70.96 140.14 85.83 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.321 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.9 Cg_endo -73.85 130.0 14.06 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.011 1.532 . . . . 0.0 110.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.406 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 2.3 m -91.17 135.57 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' B' ' 67' ' ' LEU . 49.9 mt -80.06 124.29 28.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.02 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -106.49 -18.76 13.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.487 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.9 163.94 11.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.178 -0.951 . . . . 0.0 110.447 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.591 HG12 HG23 ' B' ' 160' ' ' ILE . 5.6 mt -151.27 165.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.381 -0.824 . . . . 0.0 109.959 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.772 HG22 ' HB ' ' B' ' 124' ' ' THR . 3.4 t -148.17 142.09 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.48 152.28 48.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.986 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.29 132.2 45.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 110.342 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.658 HG21 ' OG ' ' B' ' 136' ' ' SER . 94.1 t -123.88 158.34 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.922 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.496 ' CB ' ' HB2' ' B' ' 154' ' ' ASP . 7.7 m -133.39 144.27 49.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' B' ' 150' ' ' ALA . 96.1 mt -101.4 -32.44 10.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.852 . . . . 0.0 110.032 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.93 18.36 59.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.73 144.91 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -1.212 . . . . 0.0 110.313 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.571 ' O ' HD23 ' B' ' 80' ' ' LEU . 4.2 ttp85 -75.23 152.18 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 110.005 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.571 HD23 ' O ' ' B' ' 79' ' ' ARG . 39.7 mt -132.93 163.09 29.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.406 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.454 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 97.7 m-20 -98.21 113.7 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.25 -53.93 51.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -0.966 . . . . 0.0 110.174 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 8.6 tppt? -51.42 -47.2 63.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.997 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 84.8 m -72.93 -45.71 56.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.08 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.638 HG12 HG11 ' B' ' 102' ' ' VAL . 25.2 t -58.04 -47.95 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.963 . . . . 0.0 109.999 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.578 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -75.01 -10.24 59.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 7.7 tp -98.12 -24.78 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.451 ' O ' ' NH2' ' B' ' 90' ' ' ARG . 2.1 m-70 -98.67 -30.42 12.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.448 ' HB1' ' HE2' ' B' ' 104' ' ' MET . . . -62.28 146.36 51.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.139 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' B' ' 88' ' ' HIS . 5.2 mmt-85 -76.07 -33.57 59.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -134.37 79.3 1.8 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.319 -0.863 . . . . 0.0 109.989 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.431 ' C ' ' HG2' ' B' ' 93' ' ' GLU . . . -127.13 156.71 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.406 -0.808 . . . . 0.0 110.174 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' B' ' 103' ' ' ILE . 1.5 mm-40 -134.1 126.05 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.594 ' HB2' HG22 ' B' ' 102' ' ' VAL . 9.6 t80 -134.93 111.89 10.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.441 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -128.59 126.19 23.34 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.58 -25.55 14.87 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 0.0 110.8 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -68.4 -17.04 64.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 0.0 110.299 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.6 -50.37 3.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 1.181 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -173.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.436 -0.79 . . . . 0.0 111.582 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.24 56.46 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.837 . . . . 0.0 110.947 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.181 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -145.07 152.82 40.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.523 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.638 HG11 HG12 ' B' ' 85' ' ' VAL . 23.8 t -98.46 135.74 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.57 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 25.4 mm -109.62 120.66 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.043 . . . . 0.0 110.887 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.572 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.9 OUTLIER -90.76 162.93 14.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.667 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.438 ' NH2' ' HG2' ' B' ' 105' ' ' ARG . 0.0 OUTLIER -155.96 126.76 6.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.076 -1.015 . . . . 0.0 110.44 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.577 HG23 ' CE1' ' B' ' 139' ' ' TYR . 43.9 pt -128.47 149.45 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -99.74 26.94 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 2.0 tt0 -162.62 83.0 1.59 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 51.3 Cg_endo -80.88 163.76 79.58 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.977 -2.093 . . . . 0.0 110.635 -0.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -68.78 103.93 1.89 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.661 HG22 ' HA3' ' B' ' 125' ' ' GLY . 13.9 p -148.97 169.61 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 111.149 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.7 m -117.73 153.99 32.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.579 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -143.6 132.89 23.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.057 -1.027 . . . . 0.0 110.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.55 HD23 HD12 ' B' ' 103' ' ' ILE . 7.2 mt -96.35 137.05 36.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' B' ' 102' ' ' VAL . 46.5 mt -125.83 118.52 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 0.8 OUTLIER -99.89 141.24 32.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -51.83 -20.52 2.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.207 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -21.44 64.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.7 -23.34 13.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' LYS . . . . . 0.481 ' HG3' HG23 ' B' ' 75' ' ' THR . 3.9 ttmt -72.66 177.22 4.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -1.162 . . . . 0.0 110.383 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.526 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 6.0 ptm -168.83 140.96 2.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.893 HG11 HG12 ' A' ' 71' ' ' VAL . 4.2 t -115.1 132.98 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.92 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.31 167.88 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 110.091 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.772 ' HB ' HG22 ' B' ' 71' ' ' VAL . 4.7 t -169.16 160.25 9.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.954 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 113.2 -4.75 25.28 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -76.8 146.64 37.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -1.188 . . . . 0.0 110.309 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.69 -21.45 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.252 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' B' ' 129' ' ' GLU . 0.3 OUTLIER -127.23 32.34 5.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 129' ' ' GLU . . . . . 0.524 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.1 tt0 66.6 -68.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 128' ' ' SER . 7.3 t70 -44.07 -31.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -0.84 . . . . 0.0 110.363 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.487 ' HB3' ' HA ' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -63.02 -58.99 5.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' B' ' 126' ' ' ALA . 0.1 OUTLIER -52.48 -31.53 35.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -46.41 75.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.958 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.35 -45.9 71.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.257 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.484 ' HA ' HD11 ' B' ' 106' ' ' ILE . . . -53.01 -48.69 67.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.942 . . . . 0.0 110.083 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.658 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -57.29 -53.63 55.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -51.83 -36.86 49.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.959 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -48.28 65.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 21.8 m-85 -61.78 -55.71 27.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.093 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.28 -21.65 9.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.877 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -78.99 -29.34 43.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 110.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.435 ' O ' HG13 ' B' ' 146' ' ' ILE . 49.0 mt -68.62 -43.69 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' B' ' 150' ' ' ALA . 52.1 mt -70.66 -50.5 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.098 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 90.0 mt-30 -60.15 -37.2 79.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 109.693 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -32.64 68.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.435 HG13 ' O ' ' B' ' 142' ' ' ILE . 5.2 mt -66.6 -17.93 23.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.6 -23.45 12.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.42 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 13.1 m-85 -52.34 169.01 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.007 -1.29 . . . . 0.0 110.745 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.53 50.42 0.81 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 110.308 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -80.32 144.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.419 ' O ' ' OG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -126.01 106.37 9.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 0.0 110.331 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -55.78 101.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -162.08 -178.91 6.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.496 ' HB2' ' CB ' ' B' ' 75' ' ' THR . 3.4 m-20 57.8 26.47 13.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 110.445 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.529 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 5.7 t80 -78.99 133.14 36.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.073 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -161.91 130.52 4.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.609 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.524 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 30.0 mt -79.86 126.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 109.826 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' B' ' 218' ' ' LYS . 6.5 mt-30 -134.36 4.68 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 0.0 110.455 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.511 ' HB2' ' HB ' ' B' ' 71' ' ' VAL . 77.3 m-20 -147.5 90.8 1.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.816 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.591 HG23 HG12 ' B' ' 70' ' ' ILE . 96.7 mt -99.72 141.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.903 . . . . 0.0 109.863 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 11.4 t -109.36 135.44 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.526 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.436 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.19 172.79 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 5.1 m -164.13 150.13 10.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -1.164 . . . . 0.0 110.159 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.493 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 21.0 p -170.62 157.78 5.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.597 ' O ' HD13 ' B' ' 63' ' ' ILE . 2.7 p30 -113.6 175.22 5.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 109.796 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.575 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.1 OUTLIER -119.44 -84.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.486 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.3 OUTLIER 178.39 -27.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.435 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 30.7 p90 -129.69 164.67 38.51 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.768 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 48.0 Cg_endo -76.86 156.55 34.86 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.023 1.539 . . . . 0.0 110.488 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.79 147.84 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -82.62 101.2 10.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.408 ' CD1' ' HA2' ' B' ' 192' ' ' GLY . 20.8 mt -58.65 -52.03 67.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 173' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' B' ' 177' ' ' PHE . 1.1 mt-10 -50.44 -45.71 56.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.93 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.12 70.59 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.488 ' HB3' HD13 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -76.33 -51.95 10.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.46 -1.023 . . . . 0.0 109.83 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.454 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -63.78 -11.69 28.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.76 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 177' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' B' ' 173' ' ' GLU . 3.4 t80 -88.89 -49.36 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 110.125 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 178' ' ' SER . . . . . 0.466 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 36.4 t -88.38 -35.56 17.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -112.36 18.73 18.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' B' ' 176' ' ' ALA . . . -59.38 -18.77 44.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 5.6 t -64.95 -20.61 66.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -1.17 . . . . 0.0 110.21 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -131.85 5.53 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.897 . . . . 0.0 110.228 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.75 ' HB2' HD21 ' B' ' 193' ' ' LEU . 37.2 p -124.35 153.54 41.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -125.91 137.42 53.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -129.69 101.09 5.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.77 111.85 27.37 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.917 . . . . 0.0 109.908 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 -2.03 10.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.881 1.464 . . . . 0.0 110.377 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.73 -22.51 50.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.305 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.517 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 2.6 pp -159.37 24.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.727 ' CZ ' HD22 ' B' ' 205' ' ' LEU . 0.6 OUTLIER -170.07 106.9 0.44 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.475 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.66 -31.42 6.82 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.97 1.51 . . . . 0.0 109.986 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.78 171.33 37.58 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' B' ' 183' ' ' SER . 5.1 tt -101.01 140.06 35.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.237 -1.155 . . . . 0.0 110.463 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' B' ' 183' ' ' SER . 65.0 mt -96.04 123.22 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.854 . . . . 0.0 110.109 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.51 ' O ' HD12 ' B' ' 204' ' ' LEU . 7.4 t80 -107.94 124.15 49.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.367 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -99.66 90.95 4.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.539 ' HE1' ' HB ' ' B' ' 230' ' ' ILE . 29.7 tpp -47.11 134.51 10.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.349 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 56.5 t -65.62 -58.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.403 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -138.72 118.55 9.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -75.66 163.22 90.82 Favored 'Cis proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.962 -2.099 . . . . 0.0 110.377 -0.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' B' ' 197' ' ' MET . 6.3 mmtt -69.1 94.27 0.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.431 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 36.4 mm -126.43 146.29 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.95 . . . . 0.0 110.497 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 71.5 t -98.28 134.63 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.848 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.866 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.5 mp -136.34 136.83 40.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 110.542 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.743 HD11 ' HZ ' ' A' ' 25' ' ' PHE . 67.4 mt -99.12 145.2 27.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 110.08 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.507 HG12 HD21 ' B' ' 234' ' ' LEU . 6.6 mt -125.39 103.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -87.17 135.43 33.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 110.307 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 42.5 t -48.15 -24.45 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.2 p -66.38 -44.15 83.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.575 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 135.26 -3.43 4.02 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 137.16 34.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -1.226 . . . . 0.0 110.492 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 13.5 mm -121.66 152.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.28 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.496 ' C ' HD12 ' B' ' 214' ' ' LEU . 33.4 t -124.77 162.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.056 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.496 HD12 ' C ' ' B' ' 213' ' ' VAL . 3.2 mp -148.29 135.41 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.404 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 4.8 t -166.6 141.17 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 110.082 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 112.9 14.59 9.99 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -90.23 160.35 16.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -1.195 . . . . 0.0 110.361 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' B' ' 158' ' ' GLN . 3.7 mmmm -106.12 -5.34 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -168.59 159.46 10.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.353 -0.842 . . . . 0.0 110.109 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -56.62 -17.79 9.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.337 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -25.63 59.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 109.776 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.667 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 3.6 mt-10 -80.02 -44.76 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.34 -40.43 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.474 ' OH ' ' CG1' ' B' ' 64' ' ' VAL . 2.4 m-85 -66.77 -37.26 84.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.887 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -72.54 -38.97 67.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.866 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.91 -33.98 71.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.631 ' HA ' HG22 ' B' ' 230' ' ' ILE . 33.0 t80 -77.84 -54.23 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -17.73 5.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.09 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.404 ' C ' ' HD2' ' B' ' 232' ' ' PRO . . . -93.39 -37.63 11.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.312 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.9 tp -84.47 -24.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.55 -49.24 56.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.887 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.1 Cg_endo -71.4 -36.47 6.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.547 1.288 . . . . 0.0 110.339 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.67 -35.83 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.653 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.507 HD21 HG12 ' B' ' 206' ' ' ILE . 8.2 mt -71.27 -48.51 50.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.039 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -22.66 53.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.177 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.2 -35.39 41.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 110.269 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.466 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 64.3 m-85 -113.75 40.77 2.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.343 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.497 ' HG2' ' NH2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -63.67 172.58 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -117.88 -55.62 2.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.159 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 32.3 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.22 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 12' ' ' GLY . 52.0 tt0 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.302 0.572 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' N ' ' HG2' ' A' ' 11' ' ' GLU . . . -171.11 53.22 0.19 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 t -111.51 53.27 0.72 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.29 -1.124 . . . . 0.0 110.132 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 mm -130.11 -33.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.288 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' HA2' ' OD2' ' A' ' 65' ' ' ASP . . . 114.82 110.12 2.8 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 17' ' ' GLY . 57.3 m-20 -127.0 -158.69 0.88 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -1.166 . . . . 0.0 110.353 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 16' ' ' ASN . . . 62.07 125.72 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.808 HD11 ' CA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -60.0 -172.9 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.196 -1.179 . . . . 0.0 109.19 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.543 ' H ' HD12 ' A' ' 18' ' ' LEU . 2.0 t70 -57.62 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.856 -1.153 . . . . 0.0 110.049 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.812 HD13 ' CB ' ' A' ' 23' ' ' ILE . 1.4 mm? -107.21 -20.55 13.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 111.025 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.817 HG21 ' HB2' ' A' ' 59' ' ' LEU . 13.5 m -43.31 -26.83 0.2 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.782 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -95.59 -27.11 10.87 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.989 HG23 HG21 ' B' ' 124' ' ' THR . 4.6 mm -59.43 -50.99 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -1.104 . . . . 0.0 108.942 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.87 HD11 ' CD1' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -77.56 1.76 18.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -104.78 -21.49 13.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 110.74 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.536 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 159.86 48.32 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.999 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.886 ' OD1' HD21 ' A' ' 35' ' ' LEU . 1.4 t-20 56.33 151.67 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -1.112 . . . . 0.0 111.039 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.944 HD12 HG12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -171.06 156.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 31' ' ' GLU . 96.7 m-20 -86.18 116.1 24.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.808 ' CA ' HD11 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -35.34 -28.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.306 0.574 . . . . 0.0 110.318 -177.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 29' ' ' ASP . 21.3 tt0 -51.77 -18.5 1.27 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.325 -0.86 . . . . 0.0 110.061 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.74 26.59 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.082 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' HD3' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -121.44 132.13 54.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.089 -1.242 . . . . 0.0 110.438 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 56' ' ' ILE . 1.6 tt -102.9 152.65 21.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.848 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.886 HD21 ' OD1' ' A' ' 27' ' ' ASN . 3.0 pp -127.88 -179.62 5.05 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.688 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.868 ' N ' HD12 ' A' ' 35' ' ' LEU . 7.2 mt-30 -132.24 110.78 10.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 110.231 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' GLN . 12.5 t0 -43.17 -34.88 1.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.275 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -94.82 70.2 3.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.384 -0.823 . . . . 0.0 110.33 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 20.4 p-10 -92.54 45.47 1.2 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.44 68.85 1.17 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' GLY . 3.2 mt-10 53.29 28.34 7.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -1.197 . . . . 0.0 110.251 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 43' ' ' ARG . . . 44.88 -101.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER 43.45 92.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -1.131 . . . . 0.0 110.258 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.45 -118.76 4.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.27 -142.0 46.79 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.2 m -145.91 146.58 31.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.129 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.06 -166.6 39.83 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.66 127.26 34.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -1.133 . . . . 0.0 110.117 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -171.81 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.143 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.54 22.62 5.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.923 . . . . 0.0 110.153 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.73 -19.01 16.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 52' ' ' LEU . 4.4 mt -94.59 -47.65 6.43 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.774 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.3 -48.87 18.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.434 -0.791 . . . . 0.0 109.593 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.35 -26.28 66.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 6.7 m-20 -79.85 -40.46 28.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.965 HD13 HD13 ' A' ' 34' ' ' LEU . 5.9 mt -50.97 -39.97 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 0.0 109.141 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -22.75 48.91 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 p -129.67 18.85 5.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -1.224 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.02 HD21 ' CE2' ' B' ' 190' ' ' PHE . 4.3 mt -84.14 5.21 27.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.4 m -89.53 45.36 1.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.118 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 11.3 ttpt -147.52 12.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.147 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.985 HD13 HD13 ' B' ' 194' ' ' ILE . 0.8 OUTLIER -131.06 -27.17 2.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.622 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.31 -42.77 0.14 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.87 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.9 mm? -44.85 -36.99 3.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -1.202 . . . . 0.0 110.54 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.561 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 15.3 t0 -42.39 -35.38 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 14.8 m -65.17 -46.8 79.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.335 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.613 ' HG2' HD13 ' A' ' 24' ' ' LEU . 6.4 tpp -66.76 -16.63 64.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 72' ' ' ILE . 6.5 mt -70.48 -61.42 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.953 -1.092 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.1 pp -66.45 -2.66 4.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.58 -0.7 . . . . 0.0 110.808 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -91.51 -13.55 31.95 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.151 -0.968 . . . . 0.0 111.241 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.0 OUTLIER -119.05 -26.72 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.938 -1.101 . . . . 0.0 110.045 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 HD12 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -128.23 67.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 73' ' ' ASP . 16.5 t70 -70.09 59.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.092 HD22 ' HB3' ' B' ' 100' ' ' ALA . 3.0 mt -91.84 62.05 4.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.612 0.72 . . . . 0.0 110.97 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.26 132.11 56.76 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.12 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 57.98 18.72 5.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.228 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.2 0.524 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -146.87 18.17 1.6 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 87.5 mt -137.61 117.81 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.237 -1.155 . . . . 0.0 110.287 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' B' ' 65' ' ' PRO . 39.5 t -97.93 139.45 21.3 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.329 -0.857 . . . . 0.0 109.916 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.49 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 45.5 Cg_endo -71.58 130.12 16.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.94 1.495 . . . . 0.0 110.62 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.471 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 94.1 m -93.45 132.08 38.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.123 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 mt -70.17 128.61 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.532 ' NE2' ' HB2' ' B' ' 163' ' ' SER . 2.0 mt-30 -106.86 -18.33 13.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 110.219 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.536 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -170.17 153.59 4.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.909 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 37.7 mm -129.28 153.74 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.972 HG22 ' HB ' ' B' ' 124' ' ' THR . 22.4 t -141.76 129.9 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.341 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.535 ' HB2' HG13 ' B' ' 157' ' ' ILE . . . -137.9 157.19 46.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 41.6 p -104.04 146.19 29.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.251 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.462 HG21 ' OG ' ' B' ' 136' ' ' SER . 54.7 t -137.8 132.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 110.163 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.449 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 5.9 m -114.62 128.24 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.925 HD22 ' HB1' ' B' ' 150' ' ' ALA . 70.3 mt -83.25 -71.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.79 -11.11 3.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' CYS . . . . . 0.523 ' SG ' HD21 ' B' ' 80' ' ' LEU . 31.6 p -129.68 134.16 47.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -1.219 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.666 ' O ' HD23 ' B' ' 80' ' ' LEU . 5.8 ttt180 -58.16 155.26 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.666 HD23 ' O ' ' B' ' 79' ' ' ARG . 14.6 mt -137.38 153.19 50.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 40.7 t0 -93.9 101.11 13.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.808 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.766 HD22 HG23 ' B' ' 102' ' ' VAL . 17.8 mt -41.36 -49.33 3.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.185 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -54.23 -34.57 61.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.002 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 85.9 m -80.24 -40.35 27.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.913 HG22 ' CE2' ' B' ' 148' ' ' PHE . 24.8 t -71.9 -37.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.065 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.99 -19.02 48.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 110.192 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 13.1 tp -91.54 -30.63 16.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.6 m80 -92.51 -17.77 24.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.339 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -74.7 133.4 42.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -70.32 -21.43 62.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.885 . . . . 0.0 110.351 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -139.44 79.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.083 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.784 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -160.2 154.29 23.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.48 ' HG2' ' HB ' ' B' ' 103' ' ' ILE . 8.2 pt-20 -141.27 171.59 13.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.447 ' CE1' HD13 ' B' ' 82' ' ' LEU . 21.5 t80 -140.46 124.89 17.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 110.568 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.467 ' ND2' ' HB2' ' A' ' 31' ' ' GLU . 7.5 m-20 -114.27 98.83 49.68 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' B' ' 95' ' ' ASN . 47.5 Cg_endo -71.88 -24.01 21.56 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.076 1.566 . . . . 0.0 110.357 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -74.15 -20.78 60.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.384 -0.822 . . . . 0.0 110.298 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.24 -74.03 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 110.363 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -133.25 178.19 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 1.092 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -104.39 40.13 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.047 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -117.96 149.18 41.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -0.949 . . . . 0.0 110.766 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.766 HG23 HD22 ' B' ' 82' ' ' LEU . 40.6 t -89.99 124.51 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.044 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 30' ' ' SER . 3.8 mm -89.28 111.77 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.04 . . . . 0.0 110.224 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 2.1 ttm -107.72 155.77 19.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.701 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.42 ' CG ' ' C ' ' B' ' 104' ' ' MET . 56.5 mtm180 -146.33 148.01 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 110.567 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.696 HD11 ' OG1' ' B' ' 111' ' ' THR . 9.8 pt -131.44 157.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.465 -0.772 . . . . 0.0 109.656 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.07 -28.19 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 108' ' ' GLU . 0.5 OUTLIER -156.69 118.69 2.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.168 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.915 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.1 Cg_endo -73.63 122.36 7.71 Favored 'Cis proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.881 -2.133 . . . . 0.0 110.36 -0.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.667 ' O ' HG23 ' B' ' 111' ' ' THR . 24.2 tttp -43.25 108.16 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.696 ' OG1' HD11 ' B' ' 106' ' ' ILE . 18.8 p -158.67 -178.92 7.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.703 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' B' ' 104' ' ' MET . 1.2 m -135.23 154.79 51.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.775 . . . . 0.0 109.096 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -136.48 123.92 22.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.836 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.788 HD12 ' HB ' ' B' ' 122' ' ' VAL . 0.1 OUTLIER -95.71 97.62 9.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.412 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 9.3 mt -89.51 140.54 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.09 -1.006 . . . . 0.0 110.912 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 1.9 m-30 -106.51 150.89 25.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 109.878 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.571 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -65.25 -17.86 64.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 0.0 110.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.6 m -67.52 -18.93 65.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.282 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.56 -13.49 15.39 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -87.95 164.61 15.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -1.196 . . . . 0.0 110.224 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.44 ' HG3' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -163.18 161.74 25.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 0.0 110.251 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.788 ' HB ' HD12 ' B' ' 114' ' ' LEU . 24.8 t -129.98 154.39 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.41 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 14.3 t -133.11 104.11 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.989 HG21 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -112.04 172.62 6.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.36 -0.837 . . . . 0.0 110.167 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.592 ' C ' HG22 ' B' ' 111' ' ' THR . . . 97.31 -15.95 61.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.909 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -60.21 166.11 3.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -1.226 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -26.46 10.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.764 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.526 ' N ' HG13 ' B' ' 70' ' ' ILE . 40.0 m -153.68 166.44 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.429 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 129' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 128' ' ' SER . 3.8 mt-10 -43.64 -48.41 7.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.15 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.62 -50.63 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.46 -45.34 69.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -36.66 78.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -33.64 72.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.139 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -42.91 64.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.915 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -66.9 -39.81 87.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.194 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.462 ' OG ' HG21 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -60.24 -57.4 12.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.964 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -44.75 -52.2 8.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -53.74 -47.75 70.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.913 ' HA ' HD12 ' B' ' 142' ' ' ILE . 15.4 m-85 -61.68 -57.74 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 140' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' B' ' 152' ' ' PHE . . . -48.77 -26.91 2.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.453 ' HG2' ' HG3' ' B' ' 145' ' ' LYS . 9.0 ttm180 -73.84 -49.29 25.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.836 . . . . 0.0 110.092 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.913 HD12 ' HA ' ' B' ' 139' ' ' TYR . 42.2 mt -47.12 -39.2 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.938 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.758 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.8 mp -72.21 -53.04 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.92 -28.28 68.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.65 -24.85 60.05 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 0.0 108.436 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 7.1 mt -82.33 -24.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 130.35 -23.11 4.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.913 ' CE2' HG22 ' B' ' 85' ' ' VAL . 7.3 m-85 -49.32 165.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.293 . . . . 0.0 110.746 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.62 36.82 2.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.452 -0.78 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.925 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -62.83 152.69 35.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 13.6 ptpt -136.99 24.07 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.124 -0.985 . . . . 0.0 110.462 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' B' ' 151' ' ' LYS . 2.7 t80 27.25 98.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.211 0.529 . . . . 0.0 111.795 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -151.86 169.5 22.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 110.369 179.65 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.449 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 7.3 t0 65.45 30.12 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 7.1 t80 -71.85 122.87 21.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.924 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.36 131.19 8.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' B' ' 72' ' ' ALA . 3.3 mp -79.53 123.91 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -110.91 -14.99 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.4 t30 -142.49 135.96 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.711 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.722 HG23 ' CD1' ' B' ' 70' ' ' ILE . 29.8 mt -131.26 129.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 24' ' ' LEU . 10.2 t -96.8 134.72 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -141.97 168.74 25.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.532 ' HB2' ' NE2' ' B' ' 68' ' ' GLN . 0.3 OUTLIER -161.76 153.05 18.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.285 . . . . 0.0 110.711 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.438 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 7.5 p -165.95 155.65 12.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.13 153.08 21.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.348 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.621 HG21 HD11 ' B' ' 170' ' ' ILE . 13.2 m -105.91 3.46 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.56 -2.8 2.52 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.361 -0.837 . . . . 0.0 111.262 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.588 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 15.3 p90 -150.24 149.84 27.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.797 -1.189 . . . . 0.0 110.38 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.479 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 47.4 Cg_endo -73.64 160.62 43.67 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.135 1.597 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.621 HD11 HG21 ' B' ' 166' ' ' VAL . 3.1 mt -131.34 150.83 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.872 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.66 103.03 9.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.875 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.454 ' O ' HD12 ' B' ' 193' ' ' LEU . 15.5 mt -63.37 -34.68 78.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.662 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 173' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 9.4 pt-20 -78.3 -32.44 49.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.385 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' GLY . . . . . 0.533 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -64.16 -48.02 79.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -60.63 -42.2 96.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -1.106 . . . . 0.0 110.296 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.76 64.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.451 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -83.23 -27.78 29.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 67.0 m -95.13 -44.72 7.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -123.72 49.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.09 -20.59 79.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 32.6 m -60.32 -23.58 64.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -1.146 . . . . 0.0 110.208 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' B' ' 196' ' ' ARG . 17.7 m-85 -123.5 -5.37 8.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.31 152.93 40.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 8.5 p -131.8 139.33 48.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -127.16 113.46 16.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' B' ' 190' ' ' PHE . 8.6 mt-10 -117.72 92.15 40.55 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.127 -0.983 . . . . 0.0 109.921 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.64 -3.78 13.29 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.001 1.527 . . . . 0.0 110.167 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.57 -13.58 18.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.89 . . . . 0.0 110.014 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.491 HD23 ' HB2' ' B' ' 190' ' ' PHE . 4.3 tt -138.54 -35.11 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.462 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 1.02 ' CE2' HD21 ' A' ' 59' ' ' LEU . 2.7 t80 -125.49 114.04 25.4 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.39 -10.32 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.897 1.472 . . . . 0.0 110.457 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.99 172.81 18.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.454 HD12 ' O ' ' B' ' 172' ' ' LEU . 6.1 tt -105.15 121.53 44.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.985 HD13 HD13 ' A' ' 62' ' ' LEU . 6.4 mt -90.3 106.27 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.214 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' B' ' 204' ' ' LEU . 5.7 t80 -101.58 122.32 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -111.67 80.06 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.405 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.5 OUTLIER -68.34 166.09 17.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.883 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' B' ' 201' ' ' LYS . 63.1 t -111.02 -31.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.97 . . . . 0.0 110.704 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 7.0 tttt -134.78 97.14 14.22 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.585 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -72.37 150.18 94.55 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.8 -2.167 . . . . 0.0 110.401 -0.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.54 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -77.39 92.69 3.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.969 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' B' ' 217' ' ' ALA . 27.6 mm -140.33 153.53 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.07 103.8 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 109.844 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.442 HD12 ' H ' ' B' ' 204' ' ' LEU . 3.3 mp -95.01 142.45 27.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.881 HD12 ' HB ' ' B' ' 213' ' ' VAL . 4.4 mt -118.87 116.01 25.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.663 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.462 HG13 HG13 ' B' ' 212' ' ' ILE . 2.6 mt -108.71 119.87 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' B' ' 208' ' ' VAL . 10.0 m-85 -99.29 147.83 24.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.443 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 67.7 t -44.42 -25.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.021 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.406 ' N ' ' O ' ' B' ' 207' ' ' PHE . 3.8 p -66.11 -39.73 90.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.055 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.582 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 120.75 17.27 4.28 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.7 ' O ' HD12 ' B' ' 212' ' ' ILE . 0.1 OUTLIER -91.36 130.77 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.123 . . . . 0.0 110.135 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.855 HG22 HD11 ' B' ' 214' ' ' LEU . 1.2 mp -116.35 121.68 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 110.028 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.881 ' HB ' HD12 ' B' ' 205' ' ' LEU . 27.0 t -107.69 113.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 110.139 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.855 HD11 HG22 ' B' ' 212' ' ' ILE . 3.7 mp -101.23 103.5 14.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 5.0 t -130.31 142.95 50.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.971 . . . . 0.0 110.105 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 114.14 14.05 9.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.707 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -90.96 145.55 24.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.157 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -85.33 -13.76 48.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.348 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.509 ' CA ' ' CD1' ' B' ' 160' ' ' ILE . 1.3 tt0 -151.51 -173.44 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.066 -1.021 . . . . 0.0 110.539 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -79.77 -52.97 7.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.408 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.449 ' OE2' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -45.7 -25.72 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 110.538 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.543 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 56.3 mm-40 -69.83 -54.34 14.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.6 -39.81 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.49 ' CE1' ' HG2' ' B' ' 65' ' ' PRO . 5.5 m-85 -67.35 -33.15 74.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.491 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.438 ' HB3' ' HG3' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -78.24 -37.09 46.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.956 . . . . 0.0 110.145 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.3 80.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.515 ' HA ' HG22 ' B' ' 230' ' ' ILE . 2.3 t80 -67.85 -50.12 58.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.92 -15.19 7.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -95.88 -34.57 11.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.484 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.6 tp -95.48 -16.21 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.601 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 18.8 t80 -50.09 -45.3 81.77 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.3 Cg_endo -73.13 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.327 1.172 . . . . 0.0 110.497 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' B' ' 232' ' ' PRO . 14.1 t -44.36 -37.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.761 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.4 -47.64 32.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 13.2 m -55.74 -33.21 64.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.03 -29.34 61.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.317 -0.864 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' B' ' 175' ' ' LEU . 52.5 m-85 -118.78 40.56 3.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.093 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -78.29 -170.74 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -46.31 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' MET . . . . . 0.422 ' OXT' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.279 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.248 0.547 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.6 77.37 1.76 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -104.29 74.71 1.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 110.483 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.0 mt -97.55 143.02 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.17 29.13 2.07 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.092 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.13 109.92 16.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.084 -1.245 . . . . 0.0 109.924 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.463 ' C ' ' CE1' ' B' ' 99' ' ' PHE . . . 63.65 165.26 0.73 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.117 HD21 HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -70.53 0.64 6.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.903 -1.351 . . . . 0.0 111.29 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 4.5 m-20 79.84 76.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.482 0.658 . . . . 0.0 110.749 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.117 HD21 HD21 ' A' ' 18' ' ' LEU . 1.1 mt -97.87 25.92 5.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.411 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.579 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 24.3 m -54.59 -19.55 6.19 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 109.533 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.664 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.37 -36.68 4.02 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.769 HG13 HD22 ' A' ' 20' ' ' LEU . 7.8 mm -43.93 -45.13 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.981 -1.305 . . . . 0.0 108.857 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.013 HD13 ' SD ' ' A' ' 67' ' ' MET . 1.2 pp -80.81 -21.92 40.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.73 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -101.14 13.84 33.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.545 -0.722 . . . . 0.0 109.757 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 139.24 83.61 0.1 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.86 ' OD1' HD11 ' A' ' 35' ' ' LEU . 20.6 p-10 -15.18 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.698 0.761 . . . . 0.0 112.755 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.2 pp -88.55 171.65 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.803 ' O ' HD12 ' A' ' 28' ' ' ILE . 71.2 m-20 -86.81 119.38 26.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.564 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.2 -27.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.024 -177.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.2 tt0 -57.36 -13.29 3.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 110.21 27.32 4.55 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.25 116.77 28.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.085 -1.244 . . . . 0.0 110.778 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.988 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -88.94 143.58 26.77 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.822 -1.174 . . . . 0.0 109.83 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.988 ' N ' HD22 ' A' ' 34' ' ' LEU . 4.5 pp -130.91 -178.97 5.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.614 -1.304 . . . . 0.0 111.312 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' N ' HD12 ' A' ' 35' ' ' LEU . 2.1 mt-30 -130.56 133.01 45.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.578 -0.701 . . . . 0.0 109.726 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.69 75.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.206 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 36' ' ' GLN . 0.5 OUTLIER 58.22 -166.87 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.365 -0.835 . . . . 0.0 110.345 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.64 80.58 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.163 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.31 105.09 0.2 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -132.94 72.48 1.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 110.161 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.66 -119.32 8.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -104.4 104.1 13.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 0.0 110.069 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.88 -125.49 1.8 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.16 114.59 2.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.8 -85.59 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -1.117 . . . . 0.0 110.282 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.42 157.33 33.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.541 ' HE1' HG21 ' B' ' 213' ' ' VAL . 27.5 m-85 -78.51 137.88 38.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -1.159 . . . . 0.0 110.262 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -77.22 -169.59 1.43 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 109.935 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -88.56 25.11 1.78 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.112 -0.992 . . . . 0.0 110.356 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' CD ' ' HG3' ' B' ' 191' ' ' PRO . 2.5 tp10 -101.03 -20.41 15.4 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.138 -0.977 . . . . 0.0 109.319 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.687 HD21 ' CD1' ' B' ' 205' ' ' LEU . 3.0 mt -95.5 -44.59 7.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 110.149 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.816 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -53.88 -59.05 5.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.243 -0.911 . . . . 0.0 109.595 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.52 -13.38 30.0 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.497 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 2.8 m-20 -91.02 -39.15 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -0.797 . . . . 0.0 109.278 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.816 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.5 mt -51.97 -39.38 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.531 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 -16.19 41.83 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.531 ' HB3' HD11 ' B' ' 189' ' ' LEU . 0.1 OUTLIER -133.15 9.87 4.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.243 -1.151 . . . . 0.0 110.781 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.563 HD21 ' CE2' ' B' ' 190' ' ' PHE . 1.2 mt -79.31 7.05 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.507 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -94.09 43.27 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.311 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 58' ' ' SER . 3.3 ptmm? -143.67 15.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.64 HD22 HD12 ' B' ' 194' ' ' ILE . 0.0 OUTLIER -131.42 -60.43 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 65' ' ' ASP . . . -146.84 -44.93 0.03 OUTLIER Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.709 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.4 mm? -42.06 -26.14 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -1.17 . . . . 0.0 110.394 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.472 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.1 t70 -44.5 -37.7 3.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -71.11 -54.19 11.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.699 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' MET . . . . . 1.013 ' SD ' HD13 ' A' ' 24' ' ' LEU . 10.6 ttm -72.65 -3.7 26.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.553 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.653 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.9 tm? -75.81 -59.04 2.93 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.87 0.843 . . . . 0.0 108.975 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 65' ' ' ASP . 1.3 pp -78.48 1.01 23.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.246 0.546 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.53 9.32 27.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 111.446 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.021 HG12 HG11 ' B' ' 122' ' ' VAL . 1.6 t -135.73 2.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.866 -1.146 . . . . 0.0 109.809 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.103 HD11 HD12 ' A' ' 74' ' ' LEU . 3.5 tp -149.86 75.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.4 t70 -77.84 57.47 1.71 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 108.26 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.114 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 8.0 mt -105.44 67.97 0.79 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.716 0.769 . . . . 0.0 110.727 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -169.05 131.57 1.26 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.775 -0.578 . . . . 0.0 110.124 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 52.9 43.98 30.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.254 179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.318 0.58 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 64' ' ' VAL . . . -146.14 -67.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' B' ' 62' ' ' GLY . 4.0 mt 60.61 -72.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.553 -0.969 . . . . 0.0 110.483 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 62' ' ' GLY . 14.0 t 61.07 128.91 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.4 ' CG ' HG22 ' B' ' 223' ' ' ILE . 44.5 Cg_endo -71.76 120.42 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.894 1.47 . . . . 0.0 110.193 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.48 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 90.5 m -89.68 135.11 33.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.59 HD22 ' CG2' ' B' ' 160' ' ' ILE . 32.4 mt -69.91 123.85 22.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 110.064 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.485 ' HA ' ' HD3' ' B' ' 127' ' ' LYS . 1.4 mm-40 -109.31 -7.1 15.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.479 ' ND2' ' HA2' ' A' ' 26' ' ' GLY . 4.1 t-20 -164.43 156.72 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 23.5 mm -137.47 147.2 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 14.6 t -137.02 138.44 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.05 159.3 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.459 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.09 138.85 44.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.842 . . . . 0.0 109.875 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 92.9 t -135.64 154.65 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.112 -0.992 . . . . 0.0 110.649 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.518 ' HG1' ' CG ' ' B' ' 154' ' ' ASP . 33.6 m -129.7 131.91 46.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 109.932 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.796 HD22 ' HB1' ' B' ' 150' ' ' ALA . 57.4 mt -89.43 -27.65 20.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.38 80.38 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' CYS . . . . . 0.429 ' SG ' ' HA ' ' B' ' 150' ' ' ALA . 24.8 p -137.12 139.16 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -1.228 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -69.26 152.27 45.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.682 HD11 ' CD1' ' B' ' 76' ' ' LEU . 16.6 mt -131.17 150.92 51.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.352 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' B' ' 82' ' ' LEU . 1.1 t0 -91.12 97.71 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' B' ' 100' ' ' ALA . 13.0 mt -41.16 -36.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.604 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.552 ' O ' HD23 ' B' ' 87' ' ' LEU . 0.0 OUTLIER -62.01 -40.7 96.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 110.475 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 26.7 p -85.83 -39.34 17.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.963 . . . . 0.0 110.425 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.596 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 56.7 t -62.55 -30.17 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 110.083 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.518 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -89.54 -23.93 21.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -0.859 . . . . 0.0 110.12 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.552 HD23 ' O ' ' B' ' 83' ' ' LYS . 1.0 OUTLIER -76.98 -47.98 19.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.32 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -77.28 -39.16 49.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.375 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -50.23 113.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.357 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -26.32 62.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.499 ' ND2' HG22 ' B' ' 106' ' ' ILE . 31.7 p30 -130.11 79.12 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.764 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -161.03 145.81 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.709 ' O ' HD12 ' B' ' 103' ' ' ILE . 12.5 mt-10 -134.85 136.65 42.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.285 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -114.58 110.75 20.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -106.51 112.69 63.65 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.98 -16.56 29.02 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.022 1.538 . . . . 0.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.61 -22.07 24.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 5.3 mpt_? -91.8 -73.28 0.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.675 ' CG ' ' CB ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -153.6 164.14 38.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.43 -0.794 . . . . 0.0 110.253 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -81.7 47.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.889 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.114 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -129.61 146.49 51.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 111.087 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' B' ' 86' ' ' ALA . 20.1 t -93.28 122.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.447 -0.783 . . . . 0.0 108.997 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.709 HD12 ' O ' ' B' ' 93' ' ' GLU . 3.1 mp -89.18 115.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 110.52 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.555 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.4 OUTLIER -97.37 147.97 23.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.966 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.73 95.01 2.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.499 HG22 ' ND2' ' B' ' 91' ' ' ASN . 16.5 pt -94.81 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -129.3 43.89 3.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.456 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.2 tt0 176.47 78.58 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.391 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.474 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.7 Cg_endo -79.66 157.03 89.34 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.455 -0.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 45.8 tttp -65.65 109.41 2.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.888 . . . . 0.0 109.945 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.462 HG22 ' C ' ' B' ' 125' ' ' GLY . 1.3 p -148.29 177.77 9.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.64 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.668 HG22 ' CG2' ' B' ' 124' ' ' THR . 0.4 OUTLIER -130.04 171.5 12.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.434 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -164.19 140.17 6.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.795 -1.191 . . . . 0.0 110.876 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.574 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.4 OUTLIER -105.54 100.02 9.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.422 -0.799 . . . . 0.0 108.849 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.445 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt -89.21 137.31 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.091 -1.006 . . . . 0.0 110.569 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.726 ' CD1' HD11 ' A' ' 74' ' ' LEU . 1.9 m-30 -108.45 166.15 10.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.25 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -53.72 -20.02 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.06 -18.32 16.36 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.25 162.99 18.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -1.166 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.422 ' HB2' HG12 ' B' ' 115' ' ' ILE . 4.0 ptt? -159.97 149.4 17.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.081 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 1.021 HG11 HG12 ' A' ' 71' ' ' VAL . 21.0 t -112.74 135.1 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.39 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.577 HG13 ' HE2' ' B' ' 139' ' ' TYR . 16.8 t -110.22 148.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 109.882 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.854 HG23 ' CB ' ' A' ' 27' ' ' ASN . 3.5 t -156.11 162.51 40.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.788 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.556 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 112.65 -37.1 3.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.72 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -46.1 160.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -1.142 . . . . 0.0 110.256 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' B' ' 68' ' ' GLN . 1.3 mmmt -115.92 -2.31 12.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.193 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.473 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.5 OUTLIER -158.78 162.85 37.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.24 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.91 -31.79 67.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.34 -50.95 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.11 -44.13 97.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.904 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.539 ' HB2' HG21 ' B' ' 70' ' ' ILE . 46.6 t -53.7 -47.45 70.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.964 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -54.85 -46.74 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.39 -52.76 29.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.304 -0.872 . . . . 0.0 110.033 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.405 ' O ' ' C ' ' B' ' 137' ' ' ARG . 1.6 p -71.65 -60.08 2.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.592 ' HD2' ' CE2' ' B' ' 152' ' ' PHE . 4.7 mtp180 -43.54 -46.22 6.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -51.38 65.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.098 -1.001 . . . . 0.0 109.966 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.577 ' HE2' HG13 ' B' ' 123' ' ' VAL . 15.4 m-85 -50.33 -48.8 55.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 109.863 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.24 -24.86 67.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.821 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -71.0 -31.44 67.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 110.064 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 146' ' ' ILE . 23.1 mt -69.64 -47.02 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.647 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.7 mp -65.3 -49.52 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 1.5 mt-30 -64.39 -39.34 93.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.025 -1.047 . . . . 0.0 110.017 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -68.23 -21.68 64.82 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' B' ' 143' ' ' ILE . 9.2 mt -81.15 -24.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.52 -35.34 2.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.546 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 13.5 m-85 -51.03 165.86 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.138 -1.213 . . . . 0.0 110.89 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.99 48.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.674 -0.641 . . . . 0.0 109.975 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.796 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -71.55 134.88 46.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.27 -153.9 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.592 ' CE2' ' HD2' ' B' ' 137' ' ' ARG . 22.3 t80 -149.46 78.3 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.267 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' B' ' 154' ' ' ASP . 1.1 p -141.66 179.55 6.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.518 ' CG ' ' HG1' ' B' ' 75' ' ' THR . 8.7 t0 66.31 13.93 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.952 . . . . 0.0 110.351 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -66.76 136.72 55.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.887 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -168.57 124.12 0.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.584 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.7 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.475 ' HA ' ' HG3' ' B' ' 218' ' ' LYS . 1.6 mt-30 -122.98 -11.86 8.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.036 . . . . 0.0 111.042 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.494 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.2 t30 -136.69 130.4 32.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.082 . . . . 0.0 111.061 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.59 ' CG2' HD22 ' B' ' 67' ' ' LEU . 7.9 mt -129.56 122.53 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 58.1 t -94.27 125.58 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -131.51 162.99 23.75 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 93.4 p -164.4 151.08 11.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.099 -1.236 . . . . 0.0 110.403 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.425 ' HB2' HG22 ' B' ' 63' ' ' ILE . 26.5 p -167.59 146.75 4.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.236 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 11.4 p-10 -91.26 163.36 14.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -102.43 -71.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 165.43 -23.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.72 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' B' ' 168' ' ' PHE . 16.2 p90 -136.32 163.18 51.88 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.6 Cg_endo -72.04 142.09 37.73 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.8 1.421 . . . . 0.0 110.555 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.702 HD12 ' HA2' ' B' ' 210' ' ' GLY . 3.8 mt -101.83 149.82 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.32 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.58 98.5 10.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.775 HD11 HG23 ' B' ' 208' ' ' VAL . 91.4 mt -56.9 -30.01 63.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 110.391 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -49.1 33.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.882 . . . . 0.0 110.419 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.79 -28.78 68.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' B' ' 175' ' ' LEU . 0.1 OUTLIER -71.19 -44.94 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 0.0 110.195 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.63 -13.77 59.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.024 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.22 -34.71 37.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.778 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' SER . . . . . 0.404 ' HB2' ' CZ ' ' B' ' 237' ' ' PHE . 0.3 OUTLIER -100.03 -35.08 9.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.785 . . . . 0.0 109.888 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' B' ' 183' ' ' SER . 34.0 m170 -115.63 37.51 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.351 -0.843 . . . . 0.0 110.135 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.56 -9.96 82.4 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 7.0 t -76.11 -24.79 54.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -1.197 . . . . 0.0 110.061 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.435 ' CE2' HG22 ' B' ' 198' ' ' VAL . 0.2 OUTLIER -127.81 -2.44 5.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 183' ' ' SER . . . . . 1.017 ' OG ' HD21 ' B' ' 193' ' ' LEU . 0.9 OUTLIER -114.97 140.99 48.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.107 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 3.8 t -111.56 136.75 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -145.32 91.28 2.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -108.44 110.21 61.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.89 1.08 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.959 1.505 . . . . 0.0 110.462 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.9 -13.92 28.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.644 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.1 tt -155.71 16.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.278 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.563 ' CE2' HD21 ' A' ' 59' ' ' LEU . 1.7 t80 -170.18 106.16 0.44 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.762 -1.211 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 191' ' ' PRO . . . . . 0.466 ' HG3' ' CD ' ' A' ' 51' ' ' GLU . 45.5 Cg_endo -73.85 -23.41 16.5 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.987 1.519 . . . . 0.0 110.238 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.93 -179.88 42.96 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 1.017 HD21 ' OG ' ' B' ' 183' ' ' SER . 1.9 tt -115.11 146.69 41.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.787 HG12 HD21 ' B' ' 205' ' ' LEU . 77.0 mt -113.45 103.82 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 109.943 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.5 t80 -102.14 118.21 36.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.892 . . . . 0.0 110.351 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.876 ' HD3' HG22 ' B' ' 203' ' ' VAL . 3.3 tpp85 -92.41 92.72 8.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 56.4 tpp -50.8 125.65 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.354 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.435 HG22 ' CE2' ' B' ' 182' ' ' PHE . 30.8 t -64.23 -43.31 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.292 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 21.6 tttm -149.43 117.16 3.72 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.7 Cg_endo -72.89 166.96 79.81 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.916 -2.118 . . . . 0.0 110.304 -0.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.455 ' O ' ' CG1' ' B' ' 202' ' ' ILE . 4.9 mttm -75.35 108.38 8.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.755 ' CD1' ' HB2' ' B' ' 217' ' ' ALA . 13.3 mt -154.67 151.76 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.876 HG22 ' HD3' ' B' ' 196' ' ' ARG . 20.0 t -96.98 127.71 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 109.991 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 2.3 mp -112.53 125.7 54.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.787 HD21 HG12 ' B' ' 194' ' ' ILE . 13.1 mt -102.58 120.19 40.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.667 HG23 HD13 ' B' ' 170' ' ' ILE . 12.3 mt -114.84 115.17 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.07 154.84 16.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 110.245 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.775 HG23 HD11 ' B' ' 172' ' ' LEU . 52.9 t -49.98 -35.42 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.52 90.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 110.498 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.702 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 130.93 32.4 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.609 ' C ' HD12 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -95.97 117.08 29.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -1.183 . . . . 0.0 109.828 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.746 HG22 HD11 ' B' ' 214' ' ' LEU . 1.2 mp -107.08 111.14 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.73 HG11 ' HE1' ' A' ' 25' ' ' PHE . 75.9 t -104.91 150.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.928 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.746 HD11 HG22 ' B' ' 212' ' ' ILE . 4.1 mp -142.33 107.96 5.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.549 ' O ' HG23 ' B' ' 202' ' ' ILE . 10.1 t -129.61 157.58 41.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.455 ' HA2' ' OD1' ' B' ' 159' ' ' ASN . . . 102.85 11.75 33.99 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.755 ' HB2' ' CD1' ' B' ' 202' ' ' ILE . . . -91.77 155.1 18.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.31 -1.112 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' B' ' 218' ' ' LYS . 22.4 tttt -104.79 0.71 28.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.375 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.2 137.78 5.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.028 . . . . 0.0 110.432 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 220' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 220' ' ' ARG . 10.4 ttm180 -45.18 -26.62 0.5 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -34.03 77.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.989 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.604 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 1.4 mm-40 -67.82 -55.13 14.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' B' ' 217' ' ' ALA . 14.3 mm -51.08 -47.53 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.786 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.05 -27.58 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.778 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.16 -43.4 24.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 110.107 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' B' ' 204' ' ' LEU . . . -60.12 -40.16 88.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.15 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.533 ' HA ' HG22 ' B' ' 230' ' ' ILE . 46.8 t80 -70.28 -42.58 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -20.09 66.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.84 -22.99 18.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 110.318 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' B' ' 227' ' ' PHE . 7.5 tp -100.36 -28.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 30.6 t80 -44.08 -49.52 22.24 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.4 Cg_endo -69.45 -40.49 5.73 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.36 1.189 . . . . 0.0 110.606 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.7 -39.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.881 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.42 HD21 HD13 ' B' ' 206' ' ' ILE . 95.1 mt -64.87 -55.16 21.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.115 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -50.69 -28.81 9.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.95 -32.92 65.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 110.446 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' B' ' 178' ' ' SER . 49.6 m-85 -113.66 41.4 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.393 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -160.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -144.47 -54.73 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.187 -0.946 . . . . 0.0 110.236 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.259 0.552 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.89 43.57 97.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.8 -51.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.149 . . . . 0.0 110.2 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.9 tt -125.97 16.6 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.152 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.8 83.97 0.33 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -118.72 99.25 6.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -1.158 . . . . 0.0 109.965 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.57 115.94 1.7 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.009 HD23 ' CG1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -80.64 2.29 26.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -1.206 . . . . 0.0 110.664 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.729 ' HA ' HD11 ' A' ' 68' ' ' LEU . 5.9 t0 75.5 90.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 111.529 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 18' ' ' LEU . 2.3 mt -107.27 35.45 3.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.787 . . . . 0.0 110.034 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.708 ' OG1' HD23 ' A' ' 68' ' ' LEU . 20.2 m -56.6 -25.45 52.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.595 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -98.24 -27.49 8.69 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.239 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.781 HG13 HD13 ' A' ' 20' ' ' LEU . 14.8 mm -46.46 -46.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.801 -1.411 . . . . 0.0 108.849 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.874 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.1 pp -82.66 -25.65 32.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 109.137 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.013 ' CZ ' HD13 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -90.6 14.65 12.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 135.88 98.32 0.54 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 1.033 ' HB2' HG23 ' B' ' 124' ' ' THR . 25.8 p-10 -33.9 93.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.519 -0.989 . . . . 0.0 111.737 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.779 ' O ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -90.63 175.57 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 31' ' ' GLU . 21.4 m-20 -87.86 126.19 34.89 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.49 ' HB3' HG12 ' B' ' 103' ' ' ILE . 0.0 OUTLIER -40.13 -25.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -178.442 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -64.12 -6.81 7.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.986 -1.071 . . . . 0.0 110.408 178.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 102.35 29.43 6.01 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.685 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.511 ' CD ' ' C ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -119.44 111.33 17.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.9 -1.353 . . . . 0.0 110.6 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.921 HD13 HD13 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -89.47 149.14 23.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.945 HD11 ' OD1' ' A' ' 27' ' ' ASN . 3.4 pp -127.47 -179.01 4.68 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.594 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.61 -41.88 1.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 109.958 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.33 -75.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.473 -0.767 . . . . 0.0 109.979 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 38' ' ' ASP . 6.9 p30 -132.48 164.15 27.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 110.025 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -139.08 168.42 19.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.989 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.69 -150.79 20.01 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 158.68 18.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.9 -100.06 0.27 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -122.41 -48.12 2.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 0.0 110.169 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.32 158.33 16.5 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.57 167.54 5.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -135.76 28.76 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 110.139 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.66 -162.2 10.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -51.8 153.31 2.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 110.247 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 20.4 p30 -86.07 -128.84 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.506 ' N ' ' OD1' ' A' ' 49' ' ' ASP . . . -99.89 36.54 1.8 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.955 -1.091 . . . . 0.0 110.146 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -97.13 -20.97 17.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.291 -0.881 . . . . 0.0 109.08 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.614 HD21 ' HZ ' ' B' ' 207' ' ' PHE . 3.5 mt -98.95 -42.66 7.03 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.683 . . . . 0.0 110.094 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.758 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.71 -55.69 18.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.43 -0.794 . . . . 0.0 109.534 -179.522 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -61.79 -14.04 29.18 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.499 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 58' ' ' SER . 3.6 m-20 -92.75 -39.86 11.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.293 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.921 HD13 HD13 ' A' ' 34' ' ' LEU . 2.9 mt -47.7 -41.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 0.0 108.922 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.93 -20.05 12.65 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.422 ' HB3' HD11 ' B' ' 189' ' ' LEU . 50.2 m -113.44 0.64 14.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -1.123 . . . . 0.0 110.371 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 56' ' ' ILE . 29.8 mt -88.91 33.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -115.88 23.15 12.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.391 -0.818 . . . . 0.0 110.501 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.87 50.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -152.19 -29.11 0.16 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.354 -0.841 . . . . 0.0 111.0 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.859 ' H ' HD12 ' A' ' 62' ' ' LEU . . . -175.8 -42.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.869 HD12 HD11 ' A' ' 24' ' ' LEU . 2.8 mm? -69.46 -3.53 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -46.14 -41.8 13.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 110.129 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 p -65.99 -48.83 69.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 0.0 109.907 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.874 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.87 -3.36 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.729 HD11 ' HA ' ' A' ' 19' ' ' ASP . 2.4 tm? -80.6 -60.49 2.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.284 -0.885 . . . . 0.0 109.343 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.448 HD12 ' C ' ' A' ' 69' ' ' LEU . 3.5 pp -78.74 0.3 27.36 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.444 0.64 . . . . 0.0 109.794 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 22.9 tt0 -93.01 10.47 31.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.384 -0.822 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.804 ' HB ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -133.2 -4.26 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 120.954 -1.091 . . . . 0.0 110.072 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.009 ' CG1' HD23 ' A' ' 18' ' ' LEU . 2.6 tp -138.69 74.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.0 t0 -83.34 52.41 2.21 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.034 -1.041 . . . . 0.0 108.615 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.612 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -77.36 40.46 0.28 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.528 -0.733 . . . . 0.0 111.766 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -70.31 159.81 33.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.904 -1.123 . . . . 0.0 110.035 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 2.3 tt0 -51.35 -31.51 22.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 110.267 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' B' ' 118' ' ' SER . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.181 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.329 0.585 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.59 -44.92 0.33 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 5.1 mt -79.56 -23.47 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -1.13 . . . . 0.0 110.254 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 45.4 t 58.77 119.63 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 0.0 110.363 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 44.6 Cg_endo -72.02 137.88 30.0 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.781 1.411 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.479 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 15.8 m -93.31 153.43 18.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 110.437 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 88.2 mt -86.52 133.06 33.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.432 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 2.9 mm-40 -116.06 -19.45 10.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.529 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 14.5 m-80 -167.63 167.76 13.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.362 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 9.2 mt -158.11 158.17 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' B' ' 123' ' ' VAL . 61.5 t -134.22 144.42 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 110.351 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.04 155.44 48.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.87 141.56 42.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.725 HG21 ' OG ' ' B' ' 136' ' ' SER . 86.2 t -133.07 135.88 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 0.0 110.211 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -105.71 123.01 47.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.223 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.867 HD22 ' HB1' ' B' ' 150' ' ' ALA . 71.4 mt -78.45 -43.5 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.83 9.71 42.27 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.53 150.24 21.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -1.189 . . . . 0.0 110.359 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.922 ' O ' HD23 ' B' ' 80' ' ' LEU . 9.6 mtp180 -70.65 164.94 23.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.163 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.922 HD23 ' O ' ' B' ' 79' ' ' ARG . 20.6 mt -140.39 160.22 40.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.331 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.3 OUTLIER -96.27 92.46 6.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 1.041 HD22 HG23 ' B' ' 102' ' ' VAL . 13.8 mt -42.35 -46.72 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.26 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 3.8 tptm -52.62 -46.57 67.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.444 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 18.6 p -86.89 -38.96 16.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.441 HG12 HG11 ' B' ' 102' ' ' VAL . 53.6 t -54.26 -37.51 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.798 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.65 -31.84 23.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 14.1 tp -76.8 -27.87 55.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.772 . . . . 0.0 109.97 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -47.62 9.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 110.098 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -48.49 135.86 13.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -71.69 -24.59 61.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 10.1 p30 -136.14 79.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.111 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -151.6 153.56 34.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.389 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.418 ' OE1' ' HA ' ' B' ' 93' ' ' GLU . 52.7 mm-40 -134.49 141.54 46.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 110.108 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -134.41 117.79 16.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.5 125.3 26.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.55 -34.13 7.7 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.845 1.445 . . . . 0.0 110.098 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.021 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.513 ' HD2' ' N ' ' B' ' 98' ' ' ARG . 5.6 mpt_? -98.15 -59.76 1.69 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.375 -0.828 . . . . 0.0 110.202 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 1.201 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.57 175.0 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.629 -0.67 . . . . 0.0 111.375 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.41 55.89 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 111.298 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.201 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -147.87 160.23 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 1.041 HG23 HD22 ' B' ' 82' ' ' LEU . 84.6 t -92.61 162.27 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.543 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 30' ' ' SER . 9.9 mt -131.57 125.32 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 109.711 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.85 162.85 12.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -160.01 130.07 5.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 5.6 pt -139.72 167.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.44 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -125.28 37.14 4.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 110.224 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.4 OUTLIER -177.88 80.05 0.23 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.461 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.8 Cg_endo -75.93 165.82 84.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.483 -2.299 . . . . 0.0 110.3 -0.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -78.58 109.47 12.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 110.334 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.563 HG22 ' O ' ' B' ' 124' ' ' THR . 0.2 OUTLIER -157.27 171.33 20.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.908 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.546 HG22 HG23 ' B' ' 124' ' ' THR . 6.5 t -137.12 155.35 49.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -150.8 167.22 28.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.745 HD13 HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -140.86 113.56 8.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 0.0 109.507 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.723 HG23 ' O ' ' B' ' 120' ' ' LYS . 2.9 mp -98.22 149.85 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.432 -0.792 . . . . 0.0 111.02 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.623 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.1 m-85 -95.68 -177.65 4.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.491 -0.756 . . . . 0.0 109.511 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -84.96 -15.65 43.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.728 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 77' ' ' ALA . 66.7 p -73.09 -18.53 61.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.17 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 6.72 22.28 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' LYS . . . . . 0.723 ' O ' HG23 ' B' ' 115' ' ' ILE . 2.4 mttt -87.85 157.82 18.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -1.168 . . . . 0.0 110.015 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.551 ' CG ' HG13 ' B' ' 115' ' ' ILE . 7.2 tmm? -147.35 133.95 19.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.816 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.786 HG11 HG12 ' A' ' 71' ' ' VAL . 7.0 t -113.68 132.93 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.837 . . . . 0.0 109.759 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.561 HG13 ' HE2' ' B' ' 139' ' ' TYR . 12.7 t -112.96 138.12 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 124' ' ' THR . . . . . 1.033 HG23 ' HB2' ' A' ' 27' ' ' ASN . 9.0 t -147.02 146.58 30.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.824 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.617 ' N ' ' HB3' ' A' ' 27' ' ' ASN . . . 119.42 -9.51 11.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -75.75 151.45 37.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.218 . . . . 0.0 110.167 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -117.88 -23.32 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.881 . . . . 0.0 110.145 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.1 OUTLIER -123.02 -173.66 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -82.62 -48.68 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.294 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -65.77 -16.58 63.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.63 -46.54 14.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 136' ' ' SER . 2.0 t -65.75 -30.36 71.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.13 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -71.18 -51.27 25.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.3 -50.05 74.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.32 -0.862 . . . . 0.0 110.182 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.611 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -54.99 -46.06 75.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.725 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -60.87 -58.61 7.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 110.05 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.55 -36.94 25.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.761 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -49.66 77.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.561 ' HE2' HG13 ' B' ' 123' ' ' VAL . 25.2 m-85 -58.8 -50.07 75.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 109.97 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.65 71.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.064 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 1.3 mmt85 -60.38 -40.88 92.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 110.039 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' B' ' 139' ' ' TYR . 38.6 mt -54.71 -48.14 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.514 HD13 HD13 ' B' ' 80' ' ' LEU . 57.5 mt -66.56 -49.77 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -61.24 -36.9 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.0 OUTLIER -71.84 -27.58 62.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.1 mt -72.8 -18.54 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.44 -27.07 7.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' B' ' 143' ' ' ILE . 12.1 m-85 -46.79 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.25 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.78 29.97 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.532 -0.73 . . . . 0.0 109.815 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.867 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -66.38 151.59 46.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.513 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.97 107.53 6.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.95 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -53.3 102.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.902 . . . . 0.0 110.308 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.8 p -148.39 172.21 14.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 t0 60.85 15.88 6.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -60.62 134.53 57.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.966 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -170.08 134.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.352 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.96 126.81 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.365 -0.835 . . . . 0.0 109.665 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -115.67 -12.48 11.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.851 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.3 112.05 5.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.054 -1.029 . . . . 0.0 111.047 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' ' 215' ' ' THR . 11.0 mt -105.52 148.48 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 0.0 109.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' B' ' 69' ' ' ASN . 6.4 t -117.09 142.4 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.037 . . . . 0.0 111.079 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -159.9 164.81 34.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.0 OUTLIER -168.49 164.17 12.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.845 -1.385 . . . . 0.0 111.029 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.432 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -170.01 175.81 4.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.846 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -108.03 149.02 28.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.743 HG21 HD11 ' B' ' 170' ' ' ILE . 16.1 m -97.22 4.34 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 110.224 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.69 12.92 6.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.259 -0.901 . . . . 0.0 110.722 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.569 ' CE1' HG13 ' B' ' 170' ' ' ILE . 10.3 p90 -171.43 139.82 1.19 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.133 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.0 Cg_endo -71.31 153.62 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.104 1.581 . . . . 0.0 111.007 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 1.022 HD13 HD22 ' B' ' 234' ' ' LEU . 3.2 mt -125.42 150.65 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -80.25 92.79 5.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.633 HD11 ' HA ' ' B' ' 207' ' ' PHE . 97.9 mt -52.73 -32.38 42.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.406 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.69 -59.82 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.946 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.61 -37.18 33.15 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.566 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.2 OUTLIER -64.89 -53.69 42.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -1.101 . . . . 0.0 109.98 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.46 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -58.1 -20.98 44.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 0.0 110.075 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.66 -56.31 4.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 0.0 109.878 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.7 t -69.9 -46.03 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 0.0 110.043 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -105.89 41.57 1.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.018 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.36 -16.89 63.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 68.0 p -85.82 -31.74 22.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -1.209 . . . . 0.0 110.378 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -104.63 -10.36 17.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.792 ' HB2' HD21 ' B' ' 193' ' ' LEU . 1.2 p -140.88 123.41 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.57 165.89 11.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.866 . . . . 0.0 110.083 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -160.66 126.89 4.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 110.28 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' B' ' 187' ' ' PRO . 81.3 mt-10 -130.97 107.9 15.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.273 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.9 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.996 1.524 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -95.75 4.42 52.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.686 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -159.78 -51.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.686 ' HB2' HD23 ' B' ' 189' ' ' LEU . 26.6 t80 -113.19 109.95 51.41 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 0.0 110.374 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.69 -20.8 22.59 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.975 1.513 . . . . 0.0 110.152 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' B' ' 190' ' ' PHE . . . -90.74 -179.94 43.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' B' ' 183' ' ' SER . 6.0 tt -123.79 131.8 53.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -1.18 . . . . 0.0 110.321 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.837 HD13 HD13 ' A' ' 62' ' ' LEU . 4.6 mt -96.32 111.26 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 20.5 t80 -95.31 111.57 23.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.259 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -94.98 86.85 4.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.562 ' HE1' HG12 ' B' ' 230' ' ' ILE . 20.6 ttm -65.27 135.1 54.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 110.169 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 74.2 t -86.11 -28.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.878 . . . . 0.0 110.307 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' B' ' 199' ' ' LYS . 0.0 OUTLIER -149.4 110.15 3.41 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.432 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.446 ' HB2' ' OE2' ' B' ' 222' ' ' GLU . 48.5 Cg_endo -73.72 171.28 67.23 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.035 -2.069 . . . . 0.0 110.485 -0.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.404 ' C ' HG12 ' B' ' 202' ' ' ILE . 11.8 tptt -74.46 92.57 2.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.87 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' B' ' 217' ' ' ALA . 24.6 mm -140.16 153.63 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.741 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' B' ' 195' ' ' TYR . 48.4 t -114.34 116.69 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.714 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.755 HD22 HG13 ' B' ' 230' ' ' ILE . 3.4 mp -110.71 131.21 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 1.013 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -110.59 122.65 48.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.19 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.51 HG12 HD21 ' B' ' 234' ' ' LEU . 2.8 mp -113.68 145.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.108 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.633 ' HA ' HD11 ' B' ' 172' ' ' LEU . 84.2 m-85 -121.15 156.32 32.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.462 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 12.8 t -47.97 -27.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.421 -0.8 . . . . 0.0 110.137 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 4.7 m -71.54 -31.92 67.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.927 . . . . 0.0 110.303 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.39 5.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.2 OUTLIER -87.77 133.65 33.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' B' ' 163' ' ' SER . 36.5 mm -117.49 132.93 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 25' ' ' PHE . 76.0 t -125.85 114.52 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 110.393 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.69 104.19 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 110.172 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.8 t -132.56 142.29 49.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.953 . . . . 0.0 110.235 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.428 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 108.0 19.21 9.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.827 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -99.99 164.43 12.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.288 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.15 -29.97 8.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.77 154.0 44.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.865 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -53.8 -18.69 3.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -59.44 -45.51 91.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -0.92 . . . . 0.0 110.461 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' B' ' 200' ' ' PRO . 30.6 mt-10 -72.43 -46.4 55.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 13.6 mm -51.57 -44.71 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 110.025 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.462 ' CZ ' HG13 ' B' ' 64' ' ' VAL . 2.2 m-30 -71.38 -48.98 46.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.49 -33.91 73.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 110.446 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.585 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -61.44 -59.77 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.867 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 35.8 t80 -56.27 -26.83 53.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.836 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -32.26 73.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.871 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -94.75 -13.17 25.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.755 HG13 HD22 ' B' ' 204' ' ' LEU . 6.0 mm -96.77 -23.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.36 -0.837 . . . . 0.0 109.83 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.591 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 10.3 t80 -58.43 -42.3 93.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 0.0 110.966 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.2 Cg_endo -76.33 -31.17 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.416 1.219 . . . . 0.0 110.755 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.566 ' CG1' HD11 ' B' ' 175' ' ' LEU . 39.5 t -67.27 -35.89 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 1.022 HD22 HD13 ' B' ' 170' ' ' ILE . 18.3 mt -71.88 -39.72 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.057 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.51 80.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.87 -39.92 91.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.006 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.458 ' HB2' ' CD2' ' B' ' 175' ' ' LEU . 84.4 m-85 -110.04 37.78 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 177.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -121.54 -51.42 2.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 110.094 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.225 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.18 0.514 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.71 -56.49 0.03 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.97 59.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -1.163 . . . . 0.0 110.276 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -89.88 56.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.149 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . 162.86 -37.14 0.34 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 53.7 t-20 60.78 127.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -1.102 . . . . 0.0 110.339 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.518 ' CA ' ' CZ ' ' B' ' 99' ' ' PHE . . . -72.57 -148.97 0.91 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.731 HD21 ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -77.49 161.61 27.8 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.186 -1.185 . . . . 0.0 109.701 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 2.6 m-20 -63.7 71.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.052 -1.03 . . . . 0.0 110.207 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.731 ' CD2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -86.65 8.98 20.09 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.35 -0.844 . . . . 0.0 111.322 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.871 HG22 HG23 ' A' ' 56' ' ' ILE . 10.4 m -54.96 -18.87 5.59 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.467 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.645 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.43 -36.2 4.16 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.573 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 28' ' ' ILE . 1.1 mm -46.68 -47.42 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.802 -1.411 . . . . 0.0 108.985 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.072 HD11 ' CD1' ' A' ' 64' ' ' LEU . 2.0 pp -82.91 -28.06 30.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CE1' ' CD1' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -86.97 8.71 22.07 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.653 ' O ' HG23 ' A' ' 28' ' ' ILE . . . 141.57 98.54 0.33 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.72 ' HB3' HG23 ' B' ' 124' ' ' THR . 0.2 OUTLIER -16.75 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.91 0.862 . . . . 0.0 111.436 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.897 HG22 HD22 ' A' ' 34' ' ' LEU . 2.3 pp -138.07 166.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 121.464 -0.773 . . . . 0.0 109.443 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.743 ' C ' HD12 ' A' ' 28' ' ' ILE . 80.6 m-20 -87.11 116.71 25.35 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.529 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -36.28 -28.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.484 0.659 . . . . 0.0 110.157 -177.365 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.9 tt0 -57.04 -13.03 2.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 110.544 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.28 24.37 5.7 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.052 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.565 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -109.83 124.23 50.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -1.155 . . . . 0.0 109.235 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.03 HD13 ' N ' ' A' ' 35' ' ' LEU . 3.2 tm? -87.55 150.57 23.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 111.066 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.03 ' N ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -86.72 106.46 17.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 111.23 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -90.05 8.38 32.93 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 t70 50.92 -165.86 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.729 -0.607 . . . . 0.0 110.483 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.14 52.14 1.91 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -0.974 . . . . 0.0 110.34 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.79 41.67 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.22 58.8 0.62 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -96.43 75.5 2.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -1.132 . . . . 0.0 110.206 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.44 22.97 4.6 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 47.18 -168.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -1.171 . . . . 0.0 110.202 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.45 5.67 8.44 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.17 70.12 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.0 p -59.8 159.97 8.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -1.155 . . . . 0.0 110.125 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.53 -99.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.495 ' CD1' HD12 ' A' ' 52' ' ' LEU . 9.5 m-85 -85.79 101.66 12.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -1.121 . . . . 0.0 109.944 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 51' ' ' GLU . 19.7 p-10 -68.47 -158.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.74 23.25 2.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.158 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.7 tt0 -93.42 -33.7 13.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.533 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 1.8 mt -90.97 -41.2 11.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.361 -0.837 . . . . 0.0 110.064 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.974 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.51 -50.26 17.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.54 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.29 -29.48 68.27 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.702 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.53 ' C ' HD23 ' A' ' 59' ' ' LEU . 8.4 m-80 -77.82 -40.58 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.974 HD12 ' HA ' ' A' ' 53' ' ' ARG . 23.0 mt -49.97 -47.38 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.32 0.07 69.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.33 -46.57 3.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -1.143 . . . . 0.0 110.437 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.785 HD22 ' CE2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -85.98 44.54 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 0.0 110.421 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -84.86 22.36 1.39 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.739 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' C ' HD23 ' A' ' 62' ' ' LEU . 1.8 pttt -152.68 8.04 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 111.195 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 62' ' ' LEU . 3.0 mt -86.37 -34.68 20.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.621 -1.299 . . . . 0.0 109.852 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.48 -35.25 0.04 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.072 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.8 mm? -56.92 -28.25 61.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -1.171 . . . . 0.0 110.709 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' LEU . 11.5 t0 -43.67 -38.67 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.471 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.0 m -70.73 -51.01 30.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.374 -0.828 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.827 ' HG2' HD13 ' A' ' 24' ' ' LEU . 3.5 tpp -65.38 -12.73 55.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -72.69 -64.03 1.04 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 109.719 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -60.85 -12.15 10.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.583 -0.698 . . . . 0.0 110.022 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.62 2.69 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.065 HG12 HG11 ' B' ' 122' ' ' VAL . 1.5 t -140.04 3.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.046 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 72' ' ' ILE . 2.6 tp -148.64 67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.396 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 11.1 t0 -77.1 53.54 0.98 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.975 -1.078 . . . . 0.0 109.359 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.959 HD11 ' CE1' ' B' ' 116' ' ' PHE . 1.5 mt -97.72 53.6 1.13 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -78.96 165.8 23.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.0 110.257 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -72.16 74.64 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.938 . . . . 0.0 110.272 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.205 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.295 0.569 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.55 25.8 0.25 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' B' ' 64' ' ' VAL . 2.9 mp -121.77 -65.63 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -1.156 . . . . 0.0 110.29 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' B' ' 63' ' ' ILE . 91.5 t 58.03 119.62 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 110.25 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.604 ' HG2' HG22 ' B' ' 223' ' ' ILE . 43.4 Cg_endo -71.13 134.46 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.793 1.417 . . . . 0.0 110.407 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.6 m -96.82 137.5 35.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.379 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' B' ' 161' ' ' VAL . 33.2 mt -70.67 139.36 51.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -126.48 -5.64 6.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.655 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.609 ' ND2' HG21 ' B' ' 161' ' ' VAL . 1.8 t30 -168.41 124.53 1.0 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.0 -1.063 . . . . 0.0 110.755 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' B' ' 124' ' ' THR . 11.5 mm -108.89 147.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 109.311 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 25.5 t -134.61 135.7 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.956 -1.09 . . . . 0.0 110.456 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -141.52 155.43 45.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.316 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 60.6 m -104.47 126.93 52.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.227 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 t -126.67 138.54 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.926 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 9.5 m -109.65 145.86 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.553 ' CD1' HD11 ' B' ' 80' ' ' LEU . 59.3 mt -96.53 -30.13 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 109.751 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' B' ' 78' ' ' CYS . . . 80.52 32.48 34.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' B' ' 77' ' ' GLY . 1.2 m -166.29 164.88 17.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 110.273 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.811 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -91.82 152.71 20.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.113 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.811 HD23 ' O ' ' B' ' 79' ' ' ARG . 22.5 mt -138.95 163.88 31.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.422 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 2.8 t70 -108.74 97.92 7.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.526 -0.734 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.46 HD22 HG23 ' B' ' 102' ' ' VAL . 14.3 mt -40.94 -35.78 0.57 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -48.2 73.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 60.8 m -66.18 -37.78 86.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.622 HG12 HG11 ' B' ' 102' ' ' VAL . 22.7 t -72.88 -46.12 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.978 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.71 -13.01 61.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tp -99.27 -29.64 12.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.857 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.2 OUTLIER -99.81 -20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.285 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -61.74 151.65 33.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.144 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -85.65 -37.8 19.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.219 -0.926 . . . . 0.0 110.195 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -131.38 78.76 1.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.593 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -146.92 160.51 42.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.865 . . . . 0.0 110.725 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.533 ' O ' HD12 ' B' ' 103' ' ' ILE . 3.0 mt-10 -137.35 157.62 46.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 109.939 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -147.44 101.48 3.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.222 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.539 ' O ' ' HG3' ' B' ' 98' ' ' ARG . 1.5 m-20 -109.86 121.16 42.8 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.63 -10.83 20.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.704 1.37 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -87.21 10.74 16.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 111.155 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 95' ' ' ASN . 1.0 OUTLIER -139.68 -43.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.826 -1.172 . . . . 0.0 110.799 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.698 ' CD2' ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -170.35 168.89 7.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.25 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.39 55.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.83 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -136.24 158.51 44.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 111.155 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.622 HG11 HG12 ' B' ' 85' ' ' VAL . 49.0 t -102.58 122.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.473 -0.767 . . . . 0.0 109.184 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.695 ' H ' HD12 ' B' ' 103' ' ' ILE . 3.6 mp -89.36 109.18 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.471 ' SD ' HD11 ' B' ' 115' ' ' ILE . 3.2 ttm -91.57 160.89 15.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.2 112.0 3.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.989 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.676 HD11 ' OG1' ' B' ' 111' ' ' THR . 44.5 pt -101.91 167.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -125.64 33.08 5.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 3.3 tt0 -178.89 83.35 0.22 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.5 Cg_endo -78.79 151.44 88.32 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.786 -2.173 . . . . 0.0 110.33 -0.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.455 ' C ' HG23 ' B' ' 111' ' ' THR . 7.1 mttt -61.53 110.15 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.8 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.676 ' OG1' HD11 ' B' ' 106' ' ' ILE . 74.0 p -148.57 175.17 11.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.582 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.0 OUTLIER -126.67 162.81 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.755 . . . . 0.0 109.416 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -156.35 133.4 10.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.805 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.2 OUTLIER -97.92 105.8 18.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.471 HD11 ' SD ' ' B' ' 104' ' ' MET . 9.7 mt -90.78 140.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.957 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.959 ' CE1' HD11 ' A' ' 74' ' ' LEU . 1.4 m-85 -111.31 159.42 17.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.585 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -77.94 -4.59 47.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 45.7 p -83.47 -15.2 50.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.45 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 114.02 -18.66 18.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -84.11 154.32 23.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 110.009 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 50.9 ttp -149.42 149.2 30.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.958 . . . . 0.0 110.333 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 1.065 HG11 HG12 ' A' ' 71' ' ' VAL . 7.3 t -116.21 141.18 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 109.723 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 22.9 t -114.12 157.18 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 110.789 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 27' ' ' ASN . 14.6 t -167.73 147.76 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.652 -0.655 . . . . 0.0 109.433 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.546 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 123.09 -25.97 6.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -66.18 160.59 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -1.207 . . . . 0.0 110.336 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -120.15 4.38 10.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 131' ' ' ASP . 0.5 OUTLIER -158.1 162.55 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.361 -0.837 . . . . 0.0 110.034 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -56.12 -48.65 75.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 110.178 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.57 -29.27 70.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.375 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' B' ' 128' ' ' SER . 88.7 m-20 -65.81 -60.75 2.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.42 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 60.3 p -61.68 -33.31 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -44.64 75.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 110.23 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.78 -54.16 6.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.408 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.96 -39.64 9.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.978 . . . . 0.0 109.829 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.8 m -63.1 -56.3 18.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -54.06 -32.94 56.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.841 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' B' ' 138' ' ' LYS . 9.3 mptt -69.14 -42.09 76.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.952 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.834 ' HA ' HD12 ' B' ' 142' ' ' ILE . 22.3 m-85 -61.98 -47.66 83.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.15 75.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.933 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.65 -40.92 88.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' B' ' 139' ' ' TYR . 59.0 mt -54.02 -45.79 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.593 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' B' ' 150' ' ' ALA . 21.0 mm -65.37 -46.83 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' B' ' 150' ' ' ALA . 29.4 mt-30 -66.63 -28.79 68.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.845 . . . . 0.0 109.525 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -23.37 55.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 1.5 mt -81.47 -25.02 10.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.13 -32.66 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' B' ' 80' ' ' LEU . 12.5 m-85 -46.62 162.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.247 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.93 44.48 1.03 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.608 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -81.44 154.56 26.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 -166.55 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.845 ' O ' HG23 ' B' ' 153' ' ' THR . 73.3 t80 -129.87 118.38 21.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -0.975 . . . . 0.0 110.141 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.6 OUTLIER -167.8 174.0 7.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.529 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.463 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 4.0 m-20 52.15 42.48 30.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.614 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 155' ' ' PHE . 8.4 t80 -90.13 132.71 35.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.9 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.33 134.84 1.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 110.39 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 4.4 mt -78.9 124.24 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.72 -4.11 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.506 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 28.6 t-20 -152.8 131.46 12.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.86 -1.15 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.572 HG22 ' N ' ' B' ' 161' ' ' VAL . 7.0 mt -124.37 171.55 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.508 -0.745 . . . . 0.0 109.672 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.644 HG22 ' OG1' ' B' ' 215' ' ' THR . 72.8 t -144.11 128.89 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.053 . . . . 0.0 110.884 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -134.02 165.18 24.37 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.8 t -165.45 149.85 8.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.028 -1.277 . . . . 0.0 110.37 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.0 OUTLIER -170.2 173.99 5.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.281 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -113.92 168.83 9.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.598 HG12 ' HE1' ' B' ' 231' ' ' TYR . 0.0 OUTLIER -112.74 -80.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.279 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.456 ' H ' HG23 ' B' ' 166' ' ' VAL . 4.7 tmtt? 177.96 -27.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.019 -1.051 . . . . 0.0 110.682 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.477 ' HB2' ' OXT' ' B' ' 240' ' ' MET . 13.7 p90 -131.29 158.09 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.981 . . . . 0.0 109.705 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.8 Cg_endo -72.74 152.71 53.33 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.85 1.447 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.472 HD13 HD22 ' B' ' 234' ' ' LEU . 4.0 mt -119.84 158.08 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.503 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' ARG . . . . . 0.467 ' NE ' ' HG3' ' B' ' 239' ' ' LYS . 6.5 mtt-85 -95.82 99.27 11.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 45.9 mt -50.08 -33.03 17.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 173' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 174' ' ' GLY . 4.3 mt-10 -68.08 -56.38 9.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.165 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 174' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' B' ' 173' ' ' GLU . . . -44.35 -30.25 1.95 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.856 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.2 OUTLIER -80.86 -59.04 2.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 110.254 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' B' ' 185' ' ' TYR . . . -54.14 -24.39 17.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.47 -46.82 18.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.046 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 5.0 t -79.63 -58.43 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -92.63 36.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.48 -13.54 37.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.97 -14.64 38.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -1.2 . . . . 0.0 110.306 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 -6.37 8.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.276 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.674 ' HB2' HD21 ' B' ' 193' ' ' LEU . 82.6 p -133.66 164.19 27.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 184' ' ' SER . . . . . 0.471 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 14.7 m -135.13 147.43 49.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.98 . . . . 0.0 110.07 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' B' ' 176' ' ' ALA . 16.1 t80 -133.77 115.98 15.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.163 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 190' ' ' PHE . 9.3 mm-40 -115.87 92.75 35.59 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.89 -9.91 26.62 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.993 1.522 . . . . 0.0 110.356 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -9.57 21.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 110.053 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.632 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.7 tt -153.08 19.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.785 ' CE2' HD22 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -170.07 113.54 0.48 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.992 . . . . 0.0 110.317 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 191' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -37.28 4.96 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.048 1.552 . . . . 0.0 110.552 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -91.32 179.32 42.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' B' ' 183' ' ' SER . 3.1 tt -116.32 138.64 51.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.121 . . . . 0.0 110.225 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.469 HD11 ' CE2' ' B' ' 190' ' ' PHE . 25.1 mt -93.51 111.06 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -101.35 117.21 34.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.12 89.24 7.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.378 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.403 ' HB2' HD13 ' B' ' 204' ' ' LEU . 52.0 tpp -53.22 128.44 27.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.6 -47.28 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.29 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.5 OUTLIER -146.28 123.83 6.09 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.941 . . . . 0.0 110.246 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.8 Cg_endo -73.44 155.2 99.8 Favored 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.891 -2.129 . . . . 0.0 110.321 -0.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.482 ' O ' HG13 ' B' ' 202' ' ' ILE . 16.2 tttt -56.64 112.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.482 HG13 ' O ' ' B' ' 201' ' ' LYS . 4.7 mt -158.58 154.72 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 0.0 110.471 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.6 114.99 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.479 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.538 ' N ' HD12 ' B' ' 204' ' ' LEU . 6.2 mp -101.53 135.09 43.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 110.95 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' B' ' 205' ' ' LEU . 0.9 OUTLIER -103.24 119.14 38.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 109.535 179.363 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 13.7 mm -105.16 147.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 0.0 110.566 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.521 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 21.0 m-85 -132.53 141.14 48.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.063 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.607 HG23 ' H ' ' B' ' 209' ' ' SER . 0.8 OUTLIER -46.48 -54.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 110.105 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.607 ' H ' HG23 ' B' ' 208' ' ' VAL . 68.2 m -39.2 -36.9 0.36 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.317 0.579 . . . . 0.0 110.187 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 118.01 24.23 3.36 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.528 ' O ' HD13 ' B' ' 212' ' ' ILE . 1.9 mttm -97.53 134.61 40.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -1.223 . . . . 0.0 110.099 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 211' ' ' LYS . 15.8 mm -119.82 138.45 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 59.6 t -128.41 132.32 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.233 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.48 ' HB2' HD12 ' B' ' 223' ' ' ILE . 2.6 mp -118.77 119.14 33.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 110.16 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.644 ' OG1' HG22 ' B' ' 161' ' ' VAL . 12.6 t -139.0 157.67 45.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 110.241 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.71 14.38 55.34 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.659 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -83.92 144.42 29.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -1.09 . . . . 0.0 110.276 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -81.44 -7.28 59.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.567 ' C ' HD12 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -169.37 -176.69 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -73.98 -45.42 50.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.449 ' HG3' ' OE1' ' B' ' 222' ' ' GLU . 24.0 pt-20 -49.74 -32.76 14.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.659 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 8.7 mm-40 -61.17 -49.14 78.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.942 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.604 HG22 ' HG2' ' B' ' 65' ' ' PRO . 47.8 mm -59.43 -36.14 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -65.28 -35.54 81.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.47 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -82.08 -41.46 20.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.418 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.84 -34.4 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 110.247 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.685 ' HA ' HG22 ' B' ' 230' ' ' ILE . 18.1 t80 -76.18 -49.45 17.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.366 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -23.04 40.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.479 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.18 -24.78 19.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.992 . . . . 0.0 110.255 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' B' ' 227' ' ' PHE . 6.6 tp -100.28 -17.98 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.341 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.632 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.6 t80 -55.1 -43.63 99.17 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 111.144 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -72.87 -42.68 1.01 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.312 1.164 . . . . 0.0 110.343 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.856 ' CG1' HD11 ' B' ' 175' ' ' LEU . 40.6 t -53.97 -42.69 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.972 . . . . 0.0 109.682 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.472 HD22 HD13 ' B' ' 170' ' ' ILE . 81.9 mt -65.01 -58.16 6.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 109.966 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 235' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -52.9 -30.94 37.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.035 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.71 -36.85 84.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.441 ' CD2' HD22 ' B' ' 175' ' ' LEU . 94.8 m-85 -113.04 41.47 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' B' ' 235' ' ' SER . 1.5 ptt180 -74.56 -176.14 2.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.499 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 6.2 ttmt -125.33 -29.46 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 109.979 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 240' ' ' MET . . . . . 0.477 ' OXT' ' HB2' ' B' ' 168' ' ' PHE . 10.8 mtp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.139 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.306 0.574 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.62 -109.76 0.46 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 0.6 OUTLIER -166.89 -49.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -1.111 . . . . 0.0 110.03 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 13' ' ' SER . 30.8 mm 57.68 84.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 16' ' ' ASN . . . 128.97 31.76 0.62 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 27.9 m-20 -167.44 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -1.217 . . . . 0.0 110.216 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.677 ' HA3' HG23 ' A' ' 72' ' ' ILE . . . -145.52 158.8 27.77 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.97 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -67.8 -176.12 0.62 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.132 -1.216 . . . . 0.0 109.974 -179.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 4.8 t70 -76.1 96.27 3.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.049 -1.032 . . . . 0.0 111.1 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.043 HD13 HG21 ' A' ' 23' ' ' ILE . 2.0 mt -99.06 12.2 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.078 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.718 HG23 HG23 ' A' ' 56' ' ' ILE . 1.3 t -40.93 -33.63 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.635 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.51 -31.55 6.38 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.043 HG21 HD13 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -47.39 -44.38 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.685 -1.479 . . . . 0.0 109.084 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.68 HD21 ' CD2' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -82.84 -22.56 34.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.022 -1.049 . . . . 0.0 109.0 178.258 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.594 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -92.77 11.09 28.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 143.64 98.67 0.28 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.995 ' OD1' HD11 ' A' ' 35' ' ' LEU . 12.7 p-10 -30.73 90.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.05 0.928 . . . . 0.0 111.832 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.631 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -92.6 164.16 2.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 28' ' ' ILE . 26.0 m-20 -85.59 123.85 31.47 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.698 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -37.03 -29.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.363 0.601 . . . . 0.0 109.825 -178.143 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.9 tt0 -54.85 -16.13 2.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.09 27.97 4.61 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.589 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -123.27 126.41 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.998 -1.295 . . . . 0.0 110.557 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.86 HD13 HD13 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -98.95 155.34 17.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.688 -1.257 . . . . 0.0 110.645 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.995 HD11 ' OD1' ' A' ' 27' ' ' ASN . 3.3 pp -124.66 -179.29 4.44 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.117 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.453 ' OE1' ' HB2' ' A' ' 49' ' ' ASP . 5.8 mt-30 -118.06 135.48 54.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.679 -0.638 . . . . 0.0 109.778 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' OD2' ' HA2' ' B' ' 125' ' ' GLY . 47.0 m-20 -108.02 -16.25 14.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.581 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -97.79 172.05 7.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 110.316 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -69.11 173.93 5.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.955 . . . . 0.0 109.885 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.95 105.47 3.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.461 ' O ' ' CG ' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -144.8 23.86 1.54 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -1.132 . . . . 0.0 110.105 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.72 -121.57 0.18 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -128.9 65.45 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -1.203 . . . . 0.0 110.295 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.94 -129.08 20.86 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.19 -99.15 0.69 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.29 101.86 13.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -1.189 . . . . 0.0 110.272 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.95 127.42 1.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 16.4 p90 -82.89 2.92 32.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -1.14 . . . . 0.0 110.217 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 13.0 p-10 -48.17 -42.37 29.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.194 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 49' ' ' ASP . . . -96.57 10.37 38.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.423 -0.798 . . . . 0.0 110.073 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 41.8 tt0 -100.59 -29.86 12.1 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.633 HD21 ' CD1' ' B' ' 205' ' ' LEU . 3.4 mt -98.58 -45.31 6.13 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 110.009 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -45.04 -49.05 11.7 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.763 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -64.14 -20.7 66.17 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.719 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 76.5 m-20 -91.34 -38.12 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.653 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.86 HD13 HD13 ' A' ' 34' ' ' LEU . 3.2 mt -47.71 -43.49 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.95 -17.18 28.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.7 OUTLIER -138.39 35.54 2.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -1.195 . . . . 0.0 110.468 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.065 ' CD2' HD11 ' A' ' 62' ' ' LEU . 12.2 mt -102.58 21.18 15.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.159 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.11 45.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.548 ' C ' HD23 ' A' ' 62' ' ' LEU . 21.7 ttpt -150.28 15.84 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.065 HD11 ' CD2' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -93.75 -31.83 14.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.28 -0.888 . . . . 0.0 109.768 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.53 1.77 7.64 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.949 HD12 HD21 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -95.28 0.19 53.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.2 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.539 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 22.6 m-20 -46.2 -41.93 13.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.662 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.666 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -60.61 -35.36 75.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.894 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.526 ' HE3' ' HB2' ' A' ' 64' ' ' LEU . 4.9 ttp -69.0 -18.98 64.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.949 HD21 HD12 ' A' ' 64' ' ' LEU . 7.4 mt -71.96 -60.18 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.526 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 66' ' ' SER . 2.7 pp -62.61 -9.02 7.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -85.58 5.74 30.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.124 -0.985 . . . . 0.0 110.619 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.866 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.7 OUTLIER -132.49 0.93 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.756 179.552 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.956 ' HB ' HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -150.94 66.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.3 p-10 -76.72 54.67 0.99 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.622 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.932 ' CD2' ' HB2' ' B' ' 101' ' ' ALA . 0.6 OUTLIER -89.75 54.77 2.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.751 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -96.59 121.24 38.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.078 -1.014 . . . . 0.0 110.16 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 1.7 mt-10 59.61 -157.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.928 . . . . 0.0 110.124 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.309 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.245 0.545 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -169.87 -41.0 0.03 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.552 HG22 ' N ' ' B' ' 64' ' ' VAL . 92.4 mt -90.15 169.79 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -1.141 . . . . 0.0 110.147 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.552 ' N ' HG22 ' B' ' 63' ' ' ILE . 91.4 t -143.2 139.55 16.79 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.41 ' HD2' HG13 ' B' ' 64' ' ' VAL . 46.2 Cg_endo -73.12 122.57 8.16 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 67.7 m -91.07 132.38 36.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.507 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.848 HD11 ' HD2' ' B' ' 220' ' ' ARG . 34.2 mt -70.27 133.82 47.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 109.89 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -121.18 -15.99 8.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.662 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.448 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -161.38 119.53 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.595 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.951 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 13.8 mm -104.25 157.07 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 30.8 t -135.9 136.85 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.8 166.29 28.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.208 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' THR . . . . . 0.701 HG23 HG22 ' B' ' 122' ' ' VAL . 0.0 OUTLIER -119.01 151.93 37.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.51 151.3 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.292 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -118.34 142.35 47.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.022 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.789 HD13 ' HB1' ' B' ' 150' ' ' ALA . 49.4 mt -89.84 -61.1 1.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.77 4.75 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 1.3 m -162.3 151.28 15.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -1.172 . . . . 0.0 110.167 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.761 ' O ' HD23 ' B' ' 80' ' ' LEU . 18.1 ttp85 -71.46 155.55 40.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' B' ' 76' ' ' LEU . 44.6 mt -138.07 148.91 45.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 29.9 t70 -89.81 95.59 10.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.013 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.453 HD22 HG23 ' B' ' 102' ' ' VAL . 14.5 mt -42.68 -48.61 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.181 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -46.13 61.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.864 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 9.0 m -76.46 -48.37 19.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.445 HG22 ' CE2' ' B' ' 148' ' ' PHE . 95.8 t -54.62 -50.42 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.236 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.08 -20.54 64.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 110.005 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.27 -37.62 15.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.246 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.71 -26.78 29.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.485 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -65.31 140.27 58.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 110.375 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -76.07 -27.05 57.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.402 -0.811 . . . . 0.0 109.983 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 0.7 OUTLIER -132.54 79.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.946 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.818 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -163.89 167.75 20.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.407 ' O ' HD12 ' B' ' 103' ' ' ILE . 17.3 pt-20 -161.27 141.04 10.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 110.135 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.405 ' HB2' HG22 ' B' ' 102' ' ' VAL . 30.3 t80 -114.06 105.4 13.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.274 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -102.67 105.35 43.98 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.73 -16.58 33.48 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.986 1.519 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -73.07 -27.54 61.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.811 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.71 -72.09 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.986 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.656 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -138.55 -177.28 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.31 44.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.116 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . . . -131.18 165.02 24.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 110.563 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.453 HG23 HD22 ' B' ' 82' ' ' LEU . 57.9 t -102.97 123.64 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.354 -0.841 . . . . 0.0 109.586 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.5 mp -89.29 122.47 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.865 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.818 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 9.8 ttm -115.81 166.09 12.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 110.514 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' B' ' 111' ' ' THR . 3.9 ttt85 -164.71 118.98 1.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 12.9 pt -112.71 170.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 110.376 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.89 38.16 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.808 . . . . 0.0 109.799 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.2 tt0 -174.17 79.33 0.36 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.507 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 53.0 Cg_endo -83.65 162.47 70.67 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.795 -2.169 . . . . 0.0 110.444 -0.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.569 ' O ' HG23 ' B' ' 111' ' ' THR . 21.5 mttt -61.81 106.7 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.933 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.569 HG23 ' O ' ' B' ' 110' ' ' LYS . 20.7 p -156.45 173.33 17.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.607 HG22 HG23 ' B' ' 124' ' ' THR . 0.4 OUTLIER -121.97 -179.51 4.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.357 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.674 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -167.19 122.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 0.0 111.218 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.638 HD22 HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -89.87 103.29 15.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 178.817 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.442 ' HA ' ' HB3' ' B' ' 121' ' ' MET . 15.8 mt -91.05 141.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 111.468 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.898 ' CE1' HD11 ' A' ' 74' ' ' LEU . 1.8 m-85 -110.6 151.46 27.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.46 66.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.295 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 p -71.04 -3.94 22.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.38 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.18 -28.36 16.27 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -73.2 163.99 27.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -1.068 . . . . 0.0 110.099 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.442 ' HB3' ' HA ' ' B' ' 115' ' ' ILE . 0.0 OUTLIER -167.44 176.02 6.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.274 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.866 HG21 ' O ' ' A' ' 71' ' ' VAL . 9.3 t -132.15 160.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.623 HG13 ' HE2' ' B' ' 139' ' ' TYR . 81.8 t -140.46 131.79 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.386 -0.821 . . . . 0.0 110.049 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.76 HG23 ' CB ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -142.15 173.28 11.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.559 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 100.33 -18.82 54.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.951 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -54.81 162.77 1.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -1.158 . . . . 0.0 110.456 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.46 13.33 16.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.192 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.66 -164.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.452 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.76 -43.91 16.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.17 -28.94 69.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.42 -53.41 12.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 110.187 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 88.8 p -49.97 -37.37 32.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.356 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -66.71 -40.41 88.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.298 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' B' ' 138' ' ' LYS . 0.3 OUTLIER -70.85 -50.65 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.342 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' B' ' 109' ' ' PRO . . . -53.21 -34.46 57.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.4 m -68.71 -56.52 7.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -48.08 -37.0 14.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.97 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.475 ' O ' HG12 ' B' ' 142' ' ' ILE . 9.8 mmtp -59.6 -51.62 69.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 26.2 m-85 -58.3 -54.72 43.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 140' ' ' ALA . . . . . 0.425 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.54 -24.42 8.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 109.83 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.509 ' HG2' ' HE3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -79.23 -39.66 32.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.976 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.475 HG12 ' O ' ' B' ' 138' ' ' LYS . 25.1 mm -54.03 -47.34 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.881 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.754 HD13 HD13 ' B' ' 80' ' ' LEU . 51.0 mt -71.59 -41.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.452 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 27.5 mt-30 -68.25 -38.92 82.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.852 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.509 ' HE3' ' HG2' ' B' ' 141' ' ' ARG . 0.5 OUTLIER -70.44 -20.74 62.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.9 mt -81.99 -16.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 111.75 -23.03 18.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.702 ' CB ' HG22 ' B' ' 143' ' ' ILE . 8.6 m-85 -50.13 176.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 110.859 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.67 42.64 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.735 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.789 ' HB1' HD13 ' B' ' 76' ' ' LEU . . . -88.23 125.94 34.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.596 ' O ' HD23 ' B' ' 76' ' ' LEU . 0.0 OUTLIER -100.73 -152.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.887 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.546 ' O ' HG23 ' B' ' 153' ' ' THR . 18.9 t80 -151.33 110.91 4.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.546 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.0 OUTLIER -165.26 -173.4 2.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 110.319 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.04 27.81 7.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.399 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' B' ' 73' ' ' THR . 10.6 t80 -74.06 136.63 43.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 109.92 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.06 133.98 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.978 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 31.9 mt -79.84 135.29 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.401 ' HA ' ' HG2' ' B' ' 218' ' ' LYS . 31.9 mm-40 -121.77 -18.87 6.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 110.516 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.543 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 2.7 t-20 -142.69 130.53 21.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.138 -0.976 . . . . 0.0 110.622 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' B' ' 217' ' ' ALA . 32.5 mt -120.47 142.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.637 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.791 HG22 ' OG1' ' B' ' 215' ' ' THR . 94.7 t -116.5 125.72 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.38 171.01 18.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.2 OUTLIER -162.35 146.33 11.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -1.223 . . . . 0.0 110.427 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 7.7 p -168.94 159.9 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' B' ' 211' ' ' LYS . 5.6 t70 -103.55 154.78 19.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 1.061 HG21 HD11 ' B' ' 170' ' ' ILE . 22.5 m -97.48 11.88 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.42 -2.06 2.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.408 -0.808 . . . . 0.0 111.214 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 11.6 p90 -155.22 157.3 31.74 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.869 -1.144 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.0 Cg_endo -72.05 160.03 48.55 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.147 1.604 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 1.061 HD11 HG21 ' B' ' 166' ' ' VAL . 1.5 mp -131.85 153.92 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 110.314 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -87.51 110.18 20.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.931 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.39 -64.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.331 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -25.95 64.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.08 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -72.56 -48.21 24.14 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.501 ' HA ' ' OG ' ' B' ' 178' ' ' SER . 9.6 tp -74.77 -33.76 62.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.343 -1.093 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.73 71.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.947 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -80.44 -28.31 37.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.992 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 178' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' B' ' 175' ' ' LEU . 1.2 p -83.58 -58.6 2.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -0.802 . . . . 0.0 110.097 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -96.28 32.65 1.92 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.021 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 181' ' ' THR . . . -52.75 -26.49 25.35 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 181' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 180' ' ' GLY . 22.6 p -42.37 -55.27 3.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -1.174 . . . . 0.0 110.133 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.621 ' CZ ' ' CG2' ' B' ' 198' ' ' VAL . 3.2 m-85 -115.49 -3.24 12.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.611 ' OG ' HD21 ' B' ' 193' ' ' LEU . 9.4 t -92.11 140.78 29.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.99 130.46 41.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 0.414 ' HB2' ' HG ' ' B' ' 193' ' ' LEU . 5.6 t80 -146.52 101.42 3.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 110.272 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.16 116.99 46.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.152 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.73 -0.24 9.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.945 1.497 . . . . 0.0 110.525 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.87 -6.67 28.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.824 HD23 ' N ' ' B' ' 190' ' ' PHE . 3.8 tt -143.13 -57.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 110.425 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.824 ' N ' HD23 ' B' ' 189' ' ' LEU . 7.4 t80 -105.74 124.92 34.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 191' ' ' PRO . . . . . 0.497 ' HD2' ' CD1' ' B' ' 190' ' ' PHE . 46.3 Cg_endo -73.84 -35.77 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.905 1.477 . . . . 0.0 110.351 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.544 ' HA3' ' CD1' ' B' ' 207' ' ' PHE . . . -90.3 174.85 40.57 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.977 HD23 ' N ' ' B' ' 194' ' ' ILE . 9.1 tt -94.11 159.75 15.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -1.137 . . . . 0.0 110.272 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.977 ' N ' HD23 ' B' ' 193' ' ' LEU . 75.9 mt -130.82 107.58 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 12.5 t80 -98.56 119.65 37.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.002 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.51 ' NH2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -91.96 117.73 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 110.457 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.428 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 30.1 ttm -93.45 144.26 25.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.937 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.621 ' CG2' ' CZ ' ' B' ' 182' ' ' PHE . 84.7 t -92.34 -50.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.965 . . . . 0.0 110.274 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -129.44 106.41 17.43 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.861 . . . . 0.0 110.314 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.1 Cg_endo -73.54 171.14 67.74 Favored 'Cis proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.359 -0.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' B' ' 197' ' ' MET . 4.2 tptt -85.14 98.58 10.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' B' ' 217' ' ' ALA . 29.2 mt -145.82 149.68 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.682 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' B' ' 196' ' ' ARG . 75.0 t -103.7 117.68 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.477 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.826 ' N ' HD12 ' B' ' 204' ' ' LEU . 4.8 mp -104.54 152.06 22.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.724 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.633 ' CD1' HD21 ' A' ' 52' ' ' LEU . 18.5 mt -117.13 143.51 45.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.371 -0.83 . . . . 0.0 110.013 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.601 HG12 HD21 ' B' ' 234' ' ' LEU . 6.5 mt -132.49 103.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.544 ' CD1' ' HA3' ' B' ' 192' ' ' GLY . 14.2 m-30 -94.48 145.74 24.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.111 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 37.6 t -45.46 -28.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.892 . . . . 0.0 110.467 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -16.19 56.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.447 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.442 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 97.67 -4.36 61.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.44 ' HG2' ' OD1' ' B' ' 165' ' ' ASP . 8.7 mttm -73.22 131.96 42.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 110.166 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' B' ' 163' ' ' SER . 17.0 mm -119.73 143.98 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.594 HG11 ' HE1' ' A' ' 25' ' ' PHE . 12.0 t -124.76 157.38 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.526 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.8 mp -144.46 107.38 4.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.791 ' OG1' HG22 ' B' ' 161' ' ' VAL . 1.6 t -128.95 137.19 51.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 0.0 110.144 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.461 ' C ' HG12 ' B' ' 202' ' ' ILE . . . 119.8 9.74 8.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.631 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -88.19 154.89 20.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.308 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' B' ' 158' ' ' GLN . 0.8 OUTLIER -106.56 -12.26 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.512 ' CG ' ' HG2' ' B' ' 221' ' ' GLU . 9.4 tp60 -150.32 150.1 31.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.059 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 220' ' ' ARG . . . . . 0.848 ' HD2' HD11 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -49.18 -38.72 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 110.368 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 16.0 pt-20 -54.45 -34.51 61.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 16.8 mt-10 -65.16 -58.73 5.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.11 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.403 HG23 HD12 ' B' ' 223' ' ' ILE . 29.5 mm -50.67 -45.2 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.992 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -65.7 -33.14 75.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.67 -46.05 23.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.018 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.496 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -55.66 -27.61 50.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.89 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.572 ' HA ' HG22 ' B' ' 230' ' ' ILE . 16.9 t80 -78.78 -46.65 18.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -59.5 -22.61 61.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.087 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -88.25 -30.54 19.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.8 tp -99.82 -9.65 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.069 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.7 t80 -63.14 -46.73 86.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -71.51 -25.95 20.62 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.229 1.12 . . . . 0.0 110.065 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.63 -36.69 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.768 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.958 HD13 HG11 ' B' ' 166' ' ' VAL . 54.7 mt -71.4 -40.93 70.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 109.972 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -19.94 66.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.314 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -82.7 -41.8 18.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -109.04 38.54 2.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.385 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -75.22 176.01 7.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.277 -0.89 . . . . 0.0 110.078 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -128.93 -36.86 1.76 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.953 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.216 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.316 0.579 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.09 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -175.14 89.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -1.127 . . . . 0.0 110.139 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 14' ' ' ILE . 2.9 mp -94.42 19.96 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.935 . . . . 0.0 110.222 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.92 66.31 2.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.5 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 1.6 p-10 -121.8 89.65 3.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -1.094 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.05 121.15 2.33 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.084 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -99.75 161.25 13.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -1.159 . . . . 0.0 109.166 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.845 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -88.38 78.26 7.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 111.565 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.084 HD21 HD21 ' A' ' 18' ' ' LEU . 4.2 mt -86.3 30.11 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.836 HG22 HG23 ' A' ' 56' ' ' ILE . 1.8 m -77.76 -6.01 52.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.24 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.776 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -99.97 -41.73 2.79 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.002 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.679 HG22 HG21 ' B' ' 124' ' ' THR . 17.2 pt -51.93 -46.17 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.651 -1.5 . . . . 0.0 109.601 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.809 ' CD1' HD12 ' A' ' 64' ' ' LEU . 1.3 pp -75.27 0.33 16.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 0.0 109.272 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -120.27 -13.99 8.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.327 -0.858 . . . . 0.0 110.721 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 157.31 45.47 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB3' HG22 ' B' ' 112' ' ' THR . 0.0 OUTLIER 52.87 147.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.368 -1.078 . . . . 0.0 111.43 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.776 ' O ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -170.49 161.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.461 -0.775 . . . . 0.0 109.284 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 31' ' ' GLU . 81.1 m-20 -88.57 135.02 33.7 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.502 ' C ' ' O ' ' A' ' 29' ' ' ASP . 1.1 p -36.27 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.904 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -49.2 -21.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 110.007 179.121 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.87 21.1 7.99 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.85 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -114.48 130.84 56.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.805 -1.409 . . . . 0.0 109.586 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.875 HD22 ' C ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -102.77 151.02 22.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 111.703 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.664 HD11 ' OD1' ' A' ' 27' ' ' ASN . 4.0 pp -112.87 -178.86 3.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 110.367 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.651 ' N ' HD12 ' A' ' 35' ' ' LEU . 13.1 mt-30 -146.11 75.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.596 -0.69 . . . . 0.0 109.999 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 46.23 44.81 12.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.55 -177.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 110.091 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.39 141.35 57.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.166 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.59 -136.13 2.65 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -172.04 145.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -1.11 . . . . 0.0 110.15 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.8 -104.69 0.81 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -152.96 -66.95 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 109.924 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.49 22.06 42.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.48 -168.69 36.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.28 67.66 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.14 . . . . 0.0 110.273 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' PHE . . . 98.72 -174.08 27.63 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 47' ' ' GLY . 5.1 m-30 -43.72 147.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -1.162 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -72.86 -172.1 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.862 . . . . 0.0 110.28 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.45 27.28 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.087 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -100.22 -25.53 14.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.521 HD21 ' CZ ' ' B' ' 190' ' ' PHE . 3.5 mt -96.43 -40.83 8.9 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.399 -0.813 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.958 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -47.98 -52.29 20.37 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.231 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.38 -40.51 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.393 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' LEU . 3.9 m-80 -63.75 -45.36 90.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.664 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 53' ' ' ARG . 39.2 mt -46.75 -44.61 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -0.847 . . . . 0.0 109.777 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.96 -22.65 60.5 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.7 OUTLIER -142.17 39.04 1.59 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.31 . . . . 0.0 109.34 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.774 ' CD1' HD21 ' A' ' 62' ' ' LEU . 1.8 tp -104.05 -9.74 18.56 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.413 -0.805 . . . . 0.0 109.718 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 p -75.83 48.15 0.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 109.835 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -134.49 -19.4 1.89 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 110.325 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.89 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.25 22.73 4.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.673 -1.267 . . . . 0.0 111.19 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.91 -69.77 0.13 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.397 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.809 HD12 ' CD1' ' A' ' 24' ' ' LEU . 4.0 mm? -69.97 -2.09 11.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.239 . . . . 0.0 111.274 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -52.66 -49.62 64.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 109.837 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 54.3 p -67.56 -45.42 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.943 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.5 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.66 -4.41 19.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.777 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.881 HD11 ' O ' ' A' ' 18' ' ' LEU . 2.7 tm? -82.0 -60.49 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.891 . . . . 0.0 109.735 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.54 2.02 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.906 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 3.3 tt0 -97.32 16.94 18.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 111.109 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' A' ' 20' ' ' LEU . 4.2 t -136.62 -1.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.243 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.928 HD11 ' CD1' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -151.73 76.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 1.9 p-10 -75.04 57.6 0.83 Allowed 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.739 -1.226 . . . . 0.0 108.563 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.928 ' CD1' HD11 ' A' ' 72' ' ' ILE . 8.7 mt -93.12 64.34 3.82 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.622 0.725 . . . . 0.0 110.815 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -135.07 -177.28 4.57 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.652 -0.655 . . . . 0.0 110.214 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -55.1 96.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 110.183 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.213 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.29 0.567 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.86 76.74 1.2 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.462 ' C ' HG23 ' B' ' 64' ' ' VAL . 1.9 mp -76.52 -48.58 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -1.141 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.628 ' CG1' ' CZ ' ' B' ' 224' ' ' TYR . 3.4 t 64.05 123.14 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 46.1 Cg_endo -72.72 145.93 42.19 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.938 1.494 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.5 m -96.72 136.72 36.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.512 HD22 ' CG2' ' B' ' 160' ' ' ILE . 39.7 mt -70.0 121.36 17.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.897 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -95.34 -29.52 14.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.481 HD21 HG21 ' B' ' 161' ' ' VAL . 1.5 p-10 -170.37 -179.49 3.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.557 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.599 HG12 HG23 ' B' ' 160' ' ' ILE . 21.0 mt -153.93 164.45 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.971 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.708 HG21 ' HA ' ' A' ' 24' ' ' LEU . 25.8 t -130.6 133.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.24 169.74 15.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.289 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 28.1 p -122.48 144.19 49.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.303 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' B' ' 136' ' ' SER . 47.8 t -136.08 142.4 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.365 -0.835 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' B' ' 120' ' ' LYS . 1.3 m -123.99 132.75 53.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.729 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.997 HD22 ' HB1' ' B' ' 150' ' ' ALA . 11.7 mt -100.42 -26.09 13.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 109.963 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 51.78 39.36 47.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 79' ' ' ARG . 89.0 m -134.67 -0.22 2.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.938 ' O ' HD23 ' B' ' 80' ' ' LEU . 4.9 mmm180 59.77 139.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.026 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.938 HD23 ' O ' ' B' ' 79' ' ' ARG . 24.1 mt -139.54 151.01 45.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.961 -1.087 . . . . 0.0 110.6 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' B' ' 81' ' ' ASP . 2.0 m-20 -89.83 89.25 7.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.84 HD22 HG23 ' B' ' 102' ' ' VAL . 32.3 mt -40.84 -43.07 1.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 110.689 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -54.59 -47.21 73.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.638 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.401 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 12.0 p -80.44 -40.87 25.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.713 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.405 HG12 HG11 ' B' ' 102' ' ' VAL . 55.9 t -52.56 -42.87 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.124 -0.985 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.28 -23.53 40.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.067 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.91 -27.26 43.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.368 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -100.43 -38.92 8.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.479 ' HB1' ' SD ' ' B' ' 104' ' ' MET . . . -53.21 134.27 39.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.204 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -73.96 -22.9 59.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.444 ' O ' ' SD ' ' B' ' 104' ' ' MET . 1.4 m120 -134.79 79.52 1.8 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.829 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 1.006 ' HB2' ' SD ' ' B' ' 104' ' ' MET . . . -150.43 162.42 40.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -143.07 171.87 13.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.004 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.28 104.68 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.11 112.84 59.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.56 -17.48 23.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.911 1.479 . . . . 0.0 110.619 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -82.22 -17.7 45.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.158 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -55.55 2.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 1.124 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -160.41 -164.65 1.29 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 111.397 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.38 54.39 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.935 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.124 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -143.9 167.45 22.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 110.382 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.84 HG23 HD22 ' B' ' 82' ' ' LEU . 49.7 t -100.58 139.91 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 110.159 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.527 ' N ' HD12 ' B' ' 103' ' ' ILE . 4.8 mp -106.52 113.43 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' MET . . . . . 1.006 ' SD ' ' HB2' ' B' ' 92' ' ' ALA . 21.0 tpp -104.65 162.07 13.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 110.224 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.42 131.65 11.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.566 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 7.4 pt -125.8 169.68 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' B' ' 108' ' ' GLU . 1.1 mtt180 -115.16 22.61 13.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' B' ' 107' ' ' ARG . 3.1 mt-10 -166.1 93.14 0.81 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.455 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.697 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.5 Cg_endo -75.22 159.57 97.59 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.818 -2.159 . . . . 0.0 110.423 -0.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.49 ' C ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -65.84 98.21 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.917 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.49 HG23 ' C ' ' B' ' 110' ' ' LYS . 38.3 p -153.17 -179.29 7.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.853 . . . . 0.0 110.113 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.704 HG22 ' HB3' ' A' ' 27' ' ' ASN . 15.1 t -134.38 162.47 32.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.102 -0.999 . . . . 0.0 110.062 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -161.51 156.76 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.913 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.742 HD12 ' HE1' ' B' ' 116' ' ' PHE . 0.3 OUTLIER -132.05 115.12 15.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.522 -0.736 . . . . 0.0 109.422 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' B' ' 102' ' ' VAL . 50.6 mt -90.77 137.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.867 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.742 ' HE1' HD12 ' B' ' 114' ' ' LEU . 2.6 m-30 -90.53 -171.04 2.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.347 -0.846 . . . . 0.0 109.515 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.485 ' O ' ' HD2' ' B' ' 79' ' ' ARG . . . -93.01 -10.25 36.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.52 -28.55 18.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.466 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 135.19 -38.65 1.78 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 120' ' ' LYS . . . . . 0.517 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 5.0 tttt -61.24 139.83 58.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 110.139 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.442 ' HG3' ' HB ' ' B' ' 74' ' ' VAL . 3.7 ptt? -144.69 157.13 44.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 71' ' ' VAL . 31.3 t -104.37 154.01 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.438 HG23 ' C ' ' B' ' 122' ' ' VAL . 7.5 t -147.27 101.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 110.711 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.679 HG21 HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -104.92 179.88 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 0.0 109.001 178.599 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.592 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 98.46 -29.74 10.91 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.53 ' CB ' ' OG ' ' B' ' 132' ' ' SER . . . -48.19 131.62 16.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 109.991 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' B' ' 128' ' ' SER . 0.2 OUTLIER -101.09 13.67 34.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.382 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' B' ' 127' ' ' LYS . 0.3 OUTLIER 178.93 -169.67 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -74.21 -45.92 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.57 -27.03 64.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.68 -45.82 85.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.269 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 39.2 m -65.2 -48.52 73.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 133' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 10.8 ttpp -53.37 -41.28 65.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 110.47 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' B' ' 138' ' ' LYS . 0.7 OUTLIER -77.63 -43.76 30.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 110.444 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.697 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -64.38 -36.75 85.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.277 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.458 ' HB2' HG21 ' B' ' 74' ' ' VAL . 11.8 p -68.78 -59.93 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.121 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' B' ' 137' ' ' ARG . 8.5 ptm85 -51.82 -26.41 9.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.896 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -67.1 -48.55 67.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.657 ' HA ' HD12 ' B' ' 142' ' ' ILE . 35.7 m-85 -62.56 -47.3 84.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 140' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -55.6 -28.36 54.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.91 . . . . 0.0 109.69 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -70.95 -51.57 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 110.003 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' B' ' 139' ' ' TYR . 6.4 mt -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.045 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.705 HG22 ' HB2' ' B' ' 148' ' ' PHE . 49.3 mm -73.64 -53.77 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.82 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 28.0 mt-30 -64.72 -29.95 70.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 109.989 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -74.09 -22.61 59.44 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 142' ' ' ILE . 4.2 mt -81.04 -22.16 10.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.94 4.85 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.705 ' HB2' HG22 ' B' ' 143' ' ' ILE . 24.2 m-85 -63.99 175.02 1.3 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.007 -1.29 . . . . 0.0 111.416 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.15 24.32 11.77 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.458 0.647 . . . . 0.0 109.679 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.997 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -46.24 150.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 110.598 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -124.44 101.53 7.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 110.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.434 ' O ' HG23 ' B' ' 153' ' ' THR . 23.6 t80 -57.95 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.304 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.9 OUTLIER -151.74 173.09 15.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 110.395 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' B' ' 153' ' ' THR . 0.1 OUTLIER 65.39 21.46 11.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.341 -0.849 . . . . 0.0 110.436 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -65.67 135.13 54.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.989 . . . . 0.0 110.09 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -166.04 136.71 3.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 110.35 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 7.3 mt -79.04 154.23 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.897 . . . . 0.0 109.653 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -137.06 -23.8 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.005 -1.059 . . . . 0.0 111.63 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' B' ' 217' ' ' ALA . 13.7 t-20 -149.51 122.19 8.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.712 -1.243 . . . . 0.0 111.523 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.599 HG23 HG12 ' B' ' 70' ' ' ILE . 84.8 mt -106.92 144.89 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 108.903 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.481 HG21 HD21 ' B' ' 69' ' ' ASN . 48.6 t -118.06 142.5 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.827 -1.17 . . . . 0.0 111.435 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -139.72 162.03 26.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 54.5 p -161.2 143.93 12.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.314 . . . . 0.0 110.676 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.5 OUTLIER -170.36 171.72 6.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.374 -0.829 . . . . 0.0 110.144 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.455 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 0.8 OUTLIER -114.83 131.53 56.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.042 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.709 HG23 ' H ' ' B' ' 167' ' ' LYS . 5.1 m -67.62 -61.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.121 -0.987 . . . . 0.0 110.957 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.709 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 169.59 -31.42 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.033 . . . . 0.0 110.441 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 17.0 p90 -134.34 165.78 34.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.2 Cg_endo -71.81 147.39 50.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.975 1.513 . . . . 0.0 110.26 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.641 HD12 ' HA2' ' B' ' 210' ' ' GLY . 4.1 mt -110.49 152.91 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -93.8 105.18 17.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.695 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.446 ' N ' HD23 ' B' ' 172' ' ' LEU . 8.5 mt -63.37 -43.95 96.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 110.615 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.4 -49.62 75.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 110.424 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -62.0 -38.07 95.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -74.37 -36.73 63.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -1.168 . . . . 0.0 110.451 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.64 67.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.271 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -92.39 -42.3 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.052 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 178' ' ' SER . . . . . 0.414 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -63.36 -52.78 60.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -115.38 40.2 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.098 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.6 -19.8 49.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.0 m -58.03 -35.85 71.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -1.162 . . . . 0.0 110.257 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.858 ' CE1' HG22 ' B' ' 198' ' ' VAL . 44.1 m-85 -125.19 12.15 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.51 ' HB3' HD21 ' B' ' 193' ' ' LEU . 50.6 m -114.72 143.91 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 0.0 110.226 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.09 114.2 16.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 110.25 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -125.7 91.42 3.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.93 113.98 60.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.25 5.04 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.908 1.478 . . . . 0.0 110.937 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.87 -9.19 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.025 . . . . 0.0 110.248 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.579 ' C ' HD23 ' B' ' 189' ' ' LEU . 3.8 tt -152.51 -40.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.682 ' CE2' HD13 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -117.76 107.81 43.81 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.405 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.61 -23.69 19.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.029 1.542 . . . . 0.0 110.279 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.23 177.87 39.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' B' ' 183' ' ' SER . 7.4 tt -108.05 128.42 54.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.166 . . . . 0.0 110.402 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.543 ' HA ' HD23 ' B' ' 205' ' ' LEU . 22.2 mt -101.72 108.04 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.49 ' CD2' HD13 ' B' ' 230' ' ' ILE . 17.0 t80 -95.77 113.1 24.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.236 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.417 ' CB ' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -90.6 88.29 7.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.445 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 22.9 ttm -59.28 139.11 57.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 110.161 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.858 HG22 ' CE1' ' B' ' 182' ' ' PHE . 3.0 t -77.3 -46.09 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 109.949 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' B' ' 199' ' ' LYS . 34.2 pttt -142.21 118.56 7.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 0.0 109.863 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.4 Cg_endo -73.32 145.99 85.68 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.971 -2.096 . . . . 0.0 110.513 0.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.496 ' O ' HD13 ' B' ' 202' ' ' ILE . 1.4 tptm -57.34 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.115 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' B' ' 217' ' ' ALA . 42.5 mm -138.34 165.16 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.581 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.461 ' N ' HG22 ' B' ' 202' ' ' ILE . 45.1 t -121.91 125.24 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 1.101 HD21 ' HB1' ' B' ' 226' ' ' ALA . 1.6 mp -121.94 140.5 52.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.508 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' B' ' 194' ' ' ILE . 12.5 mt -103.96 156.0 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.854 . . . . 0.0 109.952 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.704 HG12 HD21 ' B' ' 234' ' ' LEU . 2.8 mt -140.05 105.69 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -97.62 152.05 19.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 62.0 t -49.23 -34.11 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 97.5 p -55.66 -31.85 62.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 110.1 12.86 16.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.455 ' HG3' ' OD1' ' B' ' 165' ' ' ASP . 29.1 tttt -89.7 131.86 35.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.029 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' B' ' 206' ' ' ILE . 34.1 mm -118.12 122.14 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.749 HG11 ' HE1' ' A' ' 25' ' ' PHE . 16.1 t -92.39 154.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.435 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.2 mp -143.17 100.95 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.979 . . . . 0.0 110.716 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 0.9 OUTLIER -136.84 170.72 15.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.204 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 216' ' ' GLY . . . . . 0.515 ' HA2' ' ND2' ' B' ' 159' ' ' ASN . . . 92.28 13.33 57.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -98.48 157.15 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -1.131 . . . . 0.0 110.297 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -36.58 13.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.28 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.51 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.1 OUTLIER -128.86 -158.8 0.91 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 110.165 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -97.08 -22.52 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.48 -38.04 82.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.52 -48.82 65.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 23.9 mm -52.79 -41.64 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.628 ' CZ ' ' CG1' ' B' ' 64' ' ' VAL . 3.8 m-85 -70.51 -28.15 64.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -45.53 21.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 1.101 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -56.21 -35.16 67.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.354 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.532 ' HA ' HG22 ' B' ' 230' ' ' ILE . 21.5 t80 -72.47 -49.69 31.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -18.63 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.29 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.16 -28.41 17.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 110.079 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' B' ' 227' ' ' PHE . 7.4 tp -99.59 -16.32 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 110.161 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.621 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 3.9 t80 -55.92 -43.25 99.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.9 Cg_endo -74.21 -31.24 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.449 1.237 . . . . 0.0 110.255 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' B' ' 175' ' ' LEU . 8.8 t -67.36 -43.84 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.707 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.704 HD21 HG12 ' B' ' 206' ' ' ILE . 71.2 mt -58.46 -44.24 89.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.967 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -28.02 67.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.151 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -74.31 -24.41 59.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.113 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.582 ' HB2' HD23 ' B' ' 175' ' ' LEU . 86.8 m-85 -125.12 45.57 2.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -63.26 -162.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -42.45 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 110.145 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.216 179.871 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.18 0.514 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.97 -171.69 12.99 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.4 p -133.95 23.1 3.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.101 . . . . 0.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 14' ' ' ILE . 29.0 mm -108.87 49.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 110.272 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.95 -158.13 17.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.53 -71.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -1.174 . . . . 0.0 110.374 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA3' HD11 ' A' ' 74' ' ' LEU . . . -137.44 -52.49 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.08 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -114.58 160.95 18.69 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.362 -1.081 . . . . 0.0 109.281 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.716 ' N ' HD12 ' A' ' 18' ' ' LEU . 55.6 t0 -90.01 89.26 7.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 111.018 -178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.08 HD21 HD21 ' A' ' 18' ' ' LEU . 2.4 mt -87.93 -5.4 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.042 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.663 ' N ' HD23 ' A' ' 68' ' ' LEU . 96.0 m -39.38 -38.85 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.292 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -91.59 -32.34 8.74 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.734 HG12 HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -51.25 -44.28 30.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.198 -1.178 . . . . 0.0 109.46 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.94 ' HA ' HG21 ' B' ' 71' ' ' VAL . 1.6 pp -83.02 -25.98 31.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.892 -1.13 . . . . 0.0 109.417 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.799 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.9 t80 -87.22 0.4 55.42 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.723 0.773 . . . . 0.0 109.101 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 150.1 98.68 0.19 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.84 ' HB2' HG22 ' B' ' 112' ' ' THR . 8.3 p-10 -21.99 119.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.095 0.95 . . . . 0.0 112.849 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.734 HG23 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -130.21 165.47 30.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.535 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 28' ' ' ILE . 77.2 m-20 -86.18 125.95 33.89 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.959 ' HB2' HD13 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -39.47 -24.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 -178.484 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.648 ' HG3' HD13 ' B' ' 103' ' ' ILE . 65.0 mt-10 -64.61 -4.91 4.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.018 . . . . 0.0 111.142 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.55 38.07 4.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.525 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.8 tpp180 -126.54 130.08 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -1.142 . . . . 0.0 109.511 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.716 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -89.01 158.69 17.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.589 -1.32 . . . . 0.0 111.429 -179.046 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.52 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -87.37 108.55 19.04 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.611 0.72 . . . . 0.0 111.504 -178.583 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 38' ' ' ASP . 14.0 mt-30 -91.0 -12.98 34.2 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 36' ' ' GLN . 2.8 m-20 65.65 -60.1 0.28 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.759 -0.588 . . . . 0.0 110.155 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 36' ' ' GLN . 33.8 p-10 -147.45 143.92 28.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 109.89 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -72.1 142.88 49.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -0.945 . . . . 0.0 110.406 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -103.98 121.88 7.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 -36.47 11.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -1.168 . . . . 0.0 110.501 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.27 60.41 0.42 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 54.08 98.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -1.124 . . . . 0.0 110.148 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.58 -114.05 0.25 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 155.27 -37.07 0.64 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.1 p -82.14 68.41 8.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -1.087 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.93 117.29 0.59 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -47.2 156.78 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.182 . . . . 0.0 110.239 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -90.73 -154.1 0.33 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 28.91 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -95.45 -32.93 12.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 0.0 108.631 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.53 HD13 ' CE1' ' A' ' 25' ' ' PHE . 1.7 mt -88.87 -34.62 16.93 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.08 -49.51 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.38 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.0 -29.53 68.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.593 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.501 ' OD1' ' HD2' ' B' ' 191' ' ' PRO . 20.8 m-80 -76.28 -41.06 50.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.613 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 53' ' ' ARG . 45.7 mt -49.96 -47.08 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.58 0.52 60.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.51 -41.73 3.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -86.57 36.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.13 -0.981 . . . . 0.0 110.458 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -80.21 17.12 1.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.112 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.556 ' HE2' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -152.99 11.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 -179.697 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.851 HD11 ' CD2' ' B' ' 189' ' ' LEU . 3.5 mt -90.32 -26.07 20.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.744 -1.223 . . . . 0.0 109.47 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.54 -38.71 0.04 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.724 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.7 mm? -62.93 -12.14 23.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 110.537 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -48.03 -41.1 24.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.981 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -42.75 76.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.568 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -81.86 -1.92 49.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.995 179.739 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.763 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.8 tm? -82.29 -47.2 12.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.413 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -90.26 0.28 57.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 110.176 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' C ' HG23 ' A' ' 71' ' ' VAL . 3.1 tt0 -90.9 15.85 10.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.322 -0.861 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.643 ' HB ' HD12 ' A' ' 20' ' ' LEU . 45.0 t -145.67 5.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.328 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.951 ' CD1' HD23 ' A' ' 18' ' ' LEU . 4.0 tp -150.52 77.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.881 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.6 t70 -84.29 49.3 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.016 -1.053 . . . . 0.0 108.523 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.912 HD13 ' CG1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -74.91 47.29 0.33 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.319 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -148.17 41.13 0.98 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.989 -1.07 . . . . 0.0 110.129 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.96 24.63 2.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.397 -0.815 . . . . 0.0 109.956 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.115 -179.99 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.187 0.518 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.16 -53.85 0.07 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.44 88.9 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -1.129 . . . . 0.0 110.407 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.531 ' CG1' ' HD2' ' B' ' 65' ' ' PRO . 15.5 t -57.9 145.51 71.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.006 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.617 ' CG ' HG22 ' B' ' 223' ' ' ILE . 44.1 Cg_endo -71.69 138.43 31.94 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.806 1.424 . . . . 0.0 110.377 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.472 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 72.8 m -105.17 135.19 46.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -75.03 122.04 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.91 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -113.38 -3.66 13.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.649 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.4 142.47 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 110.574 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.541 ' CD1' HG23 ' B' ' 160' ' ' ILE . 13.3 mm -126.99 161.16 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.355 -0.841 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.94 HG21 ' HA ' ' A' ' 24' ' ' LEU . 47.8 t -141.74 121.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.126 -0.984 . . . . 0.0 110.233 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 157' ' ' ILE . . . -134.9 168.5 18.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 73' ' ' THR . . . . . 0.774 HG23 HG22 ' B' ' 122' ' ' VAL . 0.2 OUTLIER -124.71 153.5 42.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 53.2 t -143.91 155.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 110.303 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 9.1 m -124.72 133.13 53.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.842 HD22 ' HB1' ' B' ' 150' ' ' ALA . 67.6 mt -87.56 -65.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.88 -20.83 2.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 40.6 m -135.18 143.78 46.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.247 . . . . 0.0 110.471 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.504 ' O ' HD23 ' B' ' 80' ' ' LEU . 7.3 ptm85 -59.54 163.37 4.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.913 . . . . 0.0 109.816 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.681 HD11 HD12 ' B' ' 76' ' ' LEU . 25.6 mt -131.43 153.6 49.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 42.3 t0 -89.64 89.02 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.495 HD11 ' O ' ' B' ' 100' ' ' ALA . 15.1 mt -38.52 -36.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 110.666 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -66.18 -42.51 88.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.44 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 16.0 m -79.34 -25.73 42.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.159 -0.963 . . . . 0.0 110.543 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.478 HG12 HG11 ' B' ' 102' ' ' VAL . 22.9 t -75.26 -40.39 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.13 -21.19 43.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.1 tp -88.9 -18.49 27.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -100.03 -41.13 7.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 110.362 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.48 140.42 58.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.855 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -77.55 -14.43 59.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.096 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.427 ' HB3' ' HG2' ' B' ' 105' ' ' ARG . 8.6 m-20 -137.7 79.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -162.02 154.0 19.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.286 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -143.34 155.63 44.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -119.3 135.74 54.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -148.83 101.57 3.43 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.178 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.87 -16.19 26.2 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.044 1.549 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -72.66 -6.58 45.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -123.95 -65.72 1.04 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 110.377 -179.814 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -146.86 133.18 19.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.365 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.495 ' O ' HD11 ' B' ' 82' ' ' LEU . . . -60.62 57.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.989 -177.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.905 ' HB1' ' O ' ' B' ' 115' ' ' ILE . . . -152.48 169.02 23.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.872 -1.142 . . . . 0.0 111.159 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' B' ' 82' ' ' LEU . 17.2 t -102.23 130.39 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.609 -0.682 . . . . 0.0 109.303 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.648 HD13 ' HG3' ' A' ' 31' ' ' GLU . 2.4 mp -89.3 118.29 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 110.2 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 27.2 ttm -104.16 164.62 11.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 110.236 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.508 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 9.0 ptm180 -156.03 122.41 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.818 HG23 ' CE1' ' B' ' 139' ' ' TYR . 10.4 pt -108.68 151.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.509 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 23.77 8.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 109.931 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.0 OUTLIER -175.9 94.92 0.26 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.88 . . . . 0.0 110.114 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 46.4 Cg_endo -72.8 162.22 91.72 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.546 0.146 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.412 ' C ' HG23 ' B' ' 111' ' ' THR . 6.6 tppt? -71.5 89.83 0.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 109.918 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' B' ' 124' ' ' THR . 21.9 p -145.32 -179.83 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.293 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.84 HG22 ' HB2' ' A' ' 27' ' ' ASN . 6.1 t -133.69 176.06 8.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -170.5 177.58 3.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.04 . . . . 0.0 111.049 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.68 HD12 ' CE1' ' B' ' 116' ' ' PHE . 0.3 OUTLIER -145.7 123.44 11.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.432 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.905 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 18.0 mt -94.04 134.55 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.935 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.773 ' CZ ' HD12 ' A' ' 72' ' ' ILE . 8.3 m-85 -87.41 134.21 33.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.611 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' B' ' 82' ' ' LEU . . . -52.24 -19.69 2.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 55.0 m -79.41 -29.6 42.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.256 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.09 -31.28 2.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.42 163.3 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.225 -1.162 . . . . 0.0 110.135 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.417 ' SD ' ' CG2' ' B' ' 123' ' ' VAL . 8.1 tmm? -160.89 128.18 4.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.774 HG22 HG23 ' B' ' 73' ' ' THR . 22.6 t -107.94 154.64 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.442 HG23 ' C ' ' B' ' 122' ' ' VAL . 25.7 t -146.37 131.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.469 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.617 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -139.04 167.01 23.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.337 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.578 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 117.36 -37.48 3.31 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -53.52 173.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -1.086 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.507 ' HA ' HG12 ' B' ' 70' ' ' ILE . 8.5 mtmm -135.34 5.8 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -147.23 163.18 37.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 129' ' ' GLU . . . . . 0.536 ' HG2' ' CD1' ' B' ' 157' ' ' ILE . 3.8 mt-10 -57.73 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.173 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' B' ' 133' ' ' LYS . 0.4 OUTLIER -47.92 -36.17 11.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.847 . . . . 0.0 110.345 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' B' ' 128' ' ' SER . 9.3 t0 -53.89 -49.57 68.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.128 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 57.0 m -56.23 -42.04 76.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 133' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' B' ' 137' ' ' ARG . 3.7 mttt -53.86 -38.43 64.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 1.4 mt -66.25 -41.1 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.133 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.59 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -51.53 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' B' ' 133' ' ' LYS . 0.2 OUTLIER -53.41 -37.43 62.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.924 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' B' ' 134' ' ' LEU . 4.8 mmtt -68.15 -50.78 52.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.898 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.818 ' CE1' HG23 ' B' ' 106' ' ' ILE . 28.2 m-85 -52.75 -54.18 37.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.941 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.63 58.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.49 -46.25 55.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 57.0 mt -51.69 -41.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' B' ' 148' ' ' PHE . 23.5 mm -64.37 -49.95 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.531 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.75 -31.45 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.376 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 2.7 tmtt? -74.23 -21.17 59.91 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 5.4 mt -84.58 -17.13 10.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.97 -21.88 9.33 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.672 ' HB2' HG22 ' B' ' 143' ' ' ILE . 15.3 m-85 -53.94 174.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 110.958 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.65 36.56 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.515 -0.74 . . . . 0.0 110.193 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.842 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -71.06 144.47 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.451 ' O ' ' OG1' ' B' ' 153' ' ' THR . 4.2 tttp -128.74 104.52 7.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.459 ' O ' HG23 ' B' ' 153' ' ' THR . 54.9 t80 -53.41 102.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 110.319 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.459 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.6 OUTLIER -154.09 172.09 18.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.164 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.0 33.61 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -72.35 138.22 47.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -161.74 136.14 6.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.536 ' CD1' ' HG2' ' B' ' 129' ' ' GLU . 37.2 mt -80.23 140.77 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.853 . . . . 0.0 110.139 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -92.77 -61.76 1.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.425 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -145.75 168.77 19.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.568 HD12 ' O ' ' B' ' 219' ' ' GLN . 67.1 mt -119.54 144.4 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 12.4 t -112.0 121.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -132.64 172.28 21.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 28.3 t -166.1 161.16 16.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.173 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.452 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 29.5 p -167.88 139.5 2.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -92.69 161.69 14.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.1 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.489 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.0 OUTLIER -110.94 -81.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.182 -0.948 . . . . 0.0 110.198 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 6.1 mtpt 170.01 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 0.0 110.407 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' B' ' 168' ' ' PHE . 10.5 p90 -129.56 155.99 79.37 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.201 -0.937 . . . . 0.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 44.6 Cg_endo -71.45 161.27 46.07 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.859 1.452 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 1.7 mp -126.93 149.67 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.154 -0.967 . . . . 0.0 110.663 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.46 110.59 19.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.848 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' B' ' 193' ' ' LEU . 11.9 mt -65.61 -32.21 73.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 110.612 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.13 -28.96 67.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 110.175 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.79 65.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' B' ' 175' ' ' LEU . 0.2 OUTLIER -71.41 -45.46 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 110.227 179.898 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.53 -13.63 62.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -90.31 -32.45 16.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 178' ' ' SER . . . . . 0.508 ' OG ' ' ND1' ' B' ' 179' ' ' HIS . 37.6 p -98.27 -30.53 12.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.907 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.508 ' ND1' ' OG ' ' B' ' 178' ' ' SER . 76.1 m80 -123.94 44.38 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -65.34 -27.68 72.72 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 2.2 t -54.16 -26.22 26.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.151 . . . . 0.0 110.221 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.565 ' CE2' ' CG2' ' B' ' 198' ' ' VAL . 31.4 m-85 -136.17 8.77 3.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.895 . . . . 0.0 110.196 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.718 ' OG ' HD21 ' B' ' 193' ' ' LEU . 22.9 t -110.96 120.72 43.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.969 . . . . 0.0 110.632 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 40.2 t -111.55 103.98 12.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.53 105.9 15.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' B' ' 190' ' ' PHE . 1.6 mm-40 -113.62 99.19 49.23 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.946 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.19 -4.66 15.35 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.052 1.554 . . . . 0.0 110.49 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.13 -13.02 19.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.952 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.851 ' CD2' HD11 ' A' ' 62' ' ' LEU . 2.4 tt -146.43 11.2 1.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 110.263 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.617 ' CE2' ' CG1' ' B' ' 194' ' ' ILE . 2.2 t80 -166.2 112.6 0.74 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 191' ' ' PRO . . . . . 0.501 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.7 Cg_endo -74.43 -26.89 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.898 1.472 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.99 178.28 37.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.718 HD21 ' OG ' ' B' ' 183' ' ' SER . 8.3 tt -110.6 132.82 53.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -1.103 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.617 ' CG1' ' CE2' ' B' ' 190' ' ' PHE . 93.8 mt -100.46 118.39 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -120.85 128.95 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' B' ' 203' ' ' VAL . 7.6 mtp-105 -108.42 89.38 2.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.483 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 32.9 ttm -50.74 141.13 13.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.075 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.565 ' CG2' ' CE2' ' B' ' 182' ' ' PHE . 31.3 t -71.35 -59.27 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 20.5 tttp -127.13 117.18 21.84 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.952 . . . . 0.0 110.304 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.6 Cg_endo -74.08 156.46 99.72 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.92 -2.117 . . . . 0.0 110.277 -0.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 85.43 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.978 . . . . 0.0 110.106 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' B' ' 217' ' ' ALA . 25.3 mm -130.27 163.07 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' B' ' 196' ' ' ARG . 12.6 t -109.57 120.38 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.863 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.5 mp -114.76 124.49 51.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.161 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.799 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 1.8 mt -102.63 148.67 25.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.57 HG23 ' CD1' ' B' ' 212' ' ' ILE . 4.1 mp -139.56 127.16 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.327 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.509 ' HZ ' HD21 ' A' ' 52' ' ' LEU . 26.0 m-85 -105.13 155.61 18.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 72.6 t -51.33 -24.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 0.0 110.306 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -24.32 62.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 110.421 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 107.54 24.92 6.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.0 OUTLIER -91.15 126.18 36.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -1.114 . . . . 0.0 110.204 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.57 ' CD1' HG23 ' B' ' 206' ' ' ILE . 23.8 mm -114.37 116.17 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.507 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 29.0 t -107.61 143.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.063 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.594 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.1 mp -135.58 112.36 10.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 13.2 t -135.95 153.68 51.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.15 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.05 -5.59 34.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.621 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -81.99 127.47 33.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -1.194 . . . . 0.0 110.051 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -71.19 -38.61 72.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 110.432 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.568 ' O ' HD12 ' B' ' 160' ' ' ILE . 3.7 mt-30 -117.69 -173.01 2.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.274 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 220' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 35.5 ttp180 -88.48 -24.66 22.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.277 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.503 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 3.4 pt-20 -63.96 -22.47 66.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.21 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.621 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 33.2 mt-10 -76.39 -53.75 7.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 110.07 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.617 HG22 ' CG ' ' B' ' 65' ' ' PRO . 27.8 mm -56.59 -37.7 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 110.035 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.571 ' CE1' ' HG2' ' B' ' 220' ' ' ARG . 5.5 m-85 -66.11 -40.54 90.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 110.134 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -80.02 -22.48 42.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.872 . . . . 0.0 110.087 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.863 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -67.68 -47.49 69.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.747 ' HA ' HG22 ' B' ' 230' ' ' ILE . 19.6 t80 -76.92 -34.21 57.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 228' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' B' ' 224' ' ' TYR . 35.9 mm-40 -65.68 -18.48 65.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.213 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.443 ' HB3' ' SD ' ' B' ' 197' ' ' MET . . . -97.04 -25.91 15.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.065 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' B' ' 227' ' ' PHE . 2.9 tp -96.21 -11.3 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.05 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 2.4 t80 -53.89 -44.03 97.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.72 -43.74 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.468 1.246 . . . . 0.0 110.68 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.413 HG12 HD21 ' B' ' 175' ' ' LEU . 30.5 t -56.92 -36.51 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.455 HD21 HG12 ' B' ' 206' ' ' ILE . 20.2 mt -63.44 -62.13 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 43.1 m -53.79 -20.31 5.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.512 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 236' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 233' ' ' VAL . 2.0 tt0 -67.69 -40.25 84.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.452 -0.78 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -116.14 41.68 2.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 110.516 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -168.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.145 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -141.35 -41.38 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 30.2 mtp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.18 179.852 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.255 0.55 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.04 -133.38 10.6 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 p -138.04 -179.51 5.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -1.113 . . . . 0.0 110.273 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.0 tt -117.23 28.32 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 110.032 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.42 47.3 1.03 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.525 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 2.2 t-20 -138.34 166.77 23.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -1.16 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 74' ' ' LEU . . . 95.33 159.11 32.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.035 HD23 HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -80.18 165.27 22.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -1.108 . . . . 0.0 109.534 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.522 ' HA ' HD11 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -100.55 128.07 46.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.764 -179.481 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.839 HD11 ' HB ' ' A' ' 72' ' ' ILE . 43.4 mt -123.92 22.69 8.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.54 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.642 ' OG1' HD23 ' A' ' 68' ' ' LEU . 6.4 m -43.7 -37.41 2.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.49 -32.02 5.89 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.674 HG12 HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -46.62 -41.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.392 -1.064 . . . . 0.0 108.644 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.869 HD22 ' HG2' ' A' ' 67' ' ' MET . 3.1 pp -84.29 -26.22 28.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.033 -1.042 . . . . 0.0 108.539 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.704 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.7 t80 -85.85 7.03 25.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 142.23 99.66 0.35 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.218 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.723 ' ND2' HD12 ' A' ' 35' ' ' LEU . 6.4 p-10 -20.84 115.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.912 0.863 . . . . 0.0 112.357 -178.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.676 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -136.42 158.81 38.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.568 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 31' ' ' GLU . 4.4 m-20 -88.12 123.57 32.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.605 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . 17.3 p -39.41 -26.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.588 -0.695 . . . . 0.0 110.145 -178.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.0 mt-10 -55.9 -14.32 2.38 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.65 26.56 6.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 28' ' ' ILE . 11.7 mmt-85 -116.55 123.88 48.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -1.149 . . . . 0.0 109.501 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.676 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.39 160.95 16.56 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 111.163 -178.954 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.723 HD12 ' ND2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -88.15 116.14 26.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 0.0 111.272 -178.78 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -88.94 6.42 39.52 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 38' ' ' ASP . 8.9 t70 50.16 20.25 0.6 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.759 -0.588 . . . . 0.0 110.485 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' ASP . 0.7 OUTLIER 42.78 39.26 1.62 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -105.89 176.06 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.324 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.86 98.54 1.74 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 143.26 36.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -1.148 . . . . 0.0 110.263 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.53 -112.97 5.44 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -94.77 -164.41 1.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 110.269 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.49 -172.79 41.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.71 -45.25 0.26 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -79.44 101.49 8.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -1.113 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.14 -74.5 0.29 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -63.24 148.79 47.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -1.138 . . . . 0.0 110.372 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -175.14 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 110.315 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.63 21.02 7.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.294 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.65 -20.31 15.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.107 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 52' ' ' LEU . 3.5 mt -96.31 -43.78 7.53 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.702 . . . . 0.0 110.303 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.029 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.6 -52.96 34.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.577 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.13 -27.24 67.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.429 -0.794 . . . . 0.0 109.559 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.568 ' OD1' ' CD1' ' B' ' 190' ' ' PHE . 1.6 m-80 -77.8 -31.62 51.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.195 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.029 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -56.81 -47.41 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.386 -0.821 . . . . 0.0 109.195 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.54 -25.95 14.75 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB2' HD11 ' B' ' 189' ' ' LEU . 0.8 OUTLIER -124.03 25.63 7.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -1.114 . . . . 0.0 110.136 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 56' ' ' ILE . 2.6 mt -82.08 -21.2 36.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.891 . . . . 0.0 110.069 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.47 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.41 40.36 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 110.548 -179.817 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' HD13 ' A' ' 62' ' ' LEU . 3.4 ttpp -132.81 -4.61 3.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.957 . . . . 0.0 110.521 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -129.39 -2.96 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 111.331 -179.752 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.783 ' N ' HD22 ' A' ' 62' ' ' LEU . . . 168.8 -55.43 0.21 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 4.0 mm? -42.92 -24.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -1.205 . . . . 0.0 110.933 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t70 -44.05 -41.96 5.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 109.716 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.9 m -67.23 -51.19 56.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.435 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.869 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -71.12 -4.47 25.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 178.86 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.663 ' C ' HD13 ' A' ' 68' ' ' LEU . 1.8 tm? -72.32 -62.09 1.56 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.858 0.837 . . . . 0.0 109.032 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.7 0.69 12.18 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.24 0.543 . . . . 0.0 110.298 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 37.3 tt0 -84.36 8.12 17.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 111.196 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.951 HG12 HG11 ' B' ' 122' ' ' VAL . 6.0 t -140.69 2.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.121 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.035 HD13 HD23 ' A' ' 18' ' ' LEU . 3.1 tp -151.01 81.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.78 . . . . 0.0 109.232 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 8.6 t0 -83.98 49.78 1.7 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.095 -1.003 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.974 HD11 ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt -101.82 62.32 0.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.343 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' A' ' 16' ' ' ASN . 11.5 mtmt -112.94 -173.01 2.16 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 110.321 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 5.8 mt-10 58.61 -79.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.435 -0.79 . . . . 0.0 110.458 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.32 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.201 0.524 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -164.1 25.18 0.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.569 HD13 ' CE2' ' B' ' 231' ' ' TYR . 1.3 mp -130.13 -48.78 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -1.183 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 90.3 t 58.61 125.13 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 110.583 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.7 Cg_endo -74.43 144.05 31.93 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.825 1.434 . . . . 0.0 110.589 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -107.19 129.76 54.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.532 HD22 ' CG2' ' B' ' 160' ' ' ILE . 73.4 mt -69.66 127.1 31.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' B' ' 68' ' ' GLN . 5.6 mm-40 -106.25 -20.28 13.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.441 ' HB2' ' HB ' ' B' ' 161' ' ' VAL . 43.3 m-20 -161.42 137.02 7.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.074 -1.016 . . . . 0.0 110.567 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 13.1 mm -115.73 148.39 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.917 HG22 ' CB ' ' B' ' 124' ' ' THR . 27.6 t -137.89 129.18 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.505 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.58 155.55 46.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 65.0 p -111.34 139.26 46.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.182 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.476 ' HB ' ' CG ' ' B' ' 121' ' ' MET . 22.6 t -123.9 148.78 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.837 . . . . 0.0 110.13 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' B' ' 154' ' ' ASP . 4.7 m -119.06 127.52 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.977 HD22 ' HB1' ' B' ' 150' ' ' ALA . 70.2 mt -92.02 -42.94 9.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.004 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.72 68.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 52.9 m -132.84 151.14 52.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -1.198 . . . . 0.0 110.365 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.523 ' O ' HD23 ' B' ' 80' ' ' LEU . 39.2 mtp-105 -79.32 155.2 28.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 110.075 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.523 HD23 ' O ' ' B' ' 79' ' ' ARG . 18.7 mt -127.74 161.0 29.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 8.6 m-20 -94.63 82.11 3.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.81 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.727 ' CD1' ' HB2' ' B' ' 117' ' ' ALA . 92.6 mt -42.01 -27.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.241 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' B' ' 81' ' ' ASP . 18.9 mmmt -67.01 -44.99 78.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 10.9 p -85.41 -38.5 18.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.871 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 43.3 t -52.36 -44.61 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' B' ' 102' ' ' VAL . . . -77.81 -30.36 51.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' B' ' 87' ' ' LEU . 14.1 tp -80.53 -18.9 47.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' B' ' 84' ' ' THR . 1.2 m-70 -99.91 -32.87 10.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.338 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 150.48 45.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -87.15 -26.13 23.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' B' ' 104' ' ' MET . 90.6 m-20 -127.74 78.82 1.85 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.541 ' HB1' ' CG1' ' B' ' 102' ' ' VAL . . . -145.49 158.35 43.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 110.136 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.07 141.12 44.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.67 109.31 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 110.095 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.413 ' OD1' ' NH1' ' B' ' 98' ' ' ARG . 2.6 t-20 -129.35 128.31 23.19 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.83 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -16.16 31.79 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.842 1.443 . . . . 0.0 110.186 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.493 ' HE2' ' NH2' ' B' ' 98' ' ' ARG . 7.3 tttt -86.32 -16.92 35.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.86 . . . . 0.0 110.066 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.493 ' NH2' ' HE2' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -92.21 -67.0 0.88 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.486 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 1.18 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.08 161.67 8.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.288 -0.883 . . . . 0.0 111.225 -179.389 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.83 54.06 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.532 -0.73 . . . . 0.0 111.677 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.18 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -161.85 173.27 14.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.941 -1.099 . . . . 0.0 110.258 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.541 ' CG1' ' HB1' ' B' ' 92' ' ' ALA . 38.0 t -108.06 155.82 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.477 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.519 HD11 ' OG ' ' A' ' 30' ' ' SER . 16.1 mt -113.51 110.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' B' ' 91' ' ' ASN . 12.0 ttm -94.19 151.07 19.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.624 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -149.56 120.88 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.677 HG23 ' CE1' ' B' ' 139' ' ' TYR . 25.1 pt -107.57 156.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.116 -0.99 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -106.88 37.81 2.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.847 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER -175.63 82.19 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.592 -179.78 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.474 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.0 Cg_endo -80.64 161.49 83.41 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.801 -2.166 . . . . 0.0 110.472 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -64.24 104.74 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 109.995 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.435 HG23 ' C ' ' B' ' 110' ' ' LYS . 30.5 p -146.63 166.1 27.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.66 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' B' ' 113' ' ' ALA . 1.8 m -112.52 164.8 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -167.2 146.07 5.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.524 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.886 HD12 ' CE1' ' B' ' 116' ' ' PHE . 0.2 OUTLIER -124.28 119.4 29.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.726 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.566 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 78.6 mt -95.41 131.46 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.974 ' CD1' HD11 ' A' ' 74' ' ' LEU . 8.5 m-30 -90.13 155.19 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.727 ' HB2' ' CD1' ' B' ' 82' ' ' LEU . . . -69.99 -11.61 61.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 110.152 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 118' ' ' SER . . . . . 0.413 ' HA ' ' HG2' ' B' ' 79' ' ' ARG . 3.9 m -85.7 -40.48 16.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.27 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.633 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 148.06 -34.79 1.2 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -67.8 150.19 48.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -1.218 . . . . 0.0 110.508 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.476 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -150.14 159.3 44.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.951 HG11 HG12 ' A' ' 71' ' ' VAL . 99.0 t -124.51 137.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 88.6 t -121.89 140.95 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.868 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.917 ' CB ' HG22 ' B' ' 71' ' ' VAL . 3.9 t -145.55 160.83 41.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.444 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.577 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 114.32 -35.26 4.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.42 147.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -1.191 . . . . 0.0 110.083 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.467 ' HB2' ' OD2' ' B' ' 131' ' ' ASP . 13.1 mmtt -96.11 0.74 51.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.63 -165.19 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.39 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.13 -40.38 74.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.04 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -44.64 92.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.482 ' CB ' ' HB1' ' B' ' 126' ' ' ALA . 8.8 m-20 -56.31 -53.51 56.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 0.0 109.964 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 1.5 p -57.81 -32.5 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.848 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 133' ' ' LYS . . . . . 0.438 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -67.69 -44.69 77.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 109.999 179.691 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -59.73 2.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.043 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.13 3.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.025 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' B' ' 152' ' ' PHE . 18.4 m -65.98 -58.69 4.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.138 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -46.2 -44.03 15.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.004 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -53.29 -47.12 69.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.677 ' CE1' HG23 ' B' ' 106' ' ' ILE . 31.7 m-85 -65.62 -55.05 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 0.0 109.912 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -17.66 8.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -47.02 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 42.0 mt -52.74 -38.06 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' B' ' 150' ' ' ALA . 34.0 mm -71.7 -55.63 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.098 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.26 -27.3 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.942 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -75.54 -21.71 57.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.94 . . . . 0.0 108.613 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 5.7 mt -86.17 -21.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.27 -18.86 6.86 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.569 ' HB2' HG22 ' B' ' 143' ' ' ILE . 11.0 m-85 -53.84 165.98 0.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.286 . . . . 0.0 110.882 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.56 23.8 13.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.552 -0.717 . . . . 0.0 109.823 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.977 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -54.94 148.3 13.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.83 . . . . 0.0 110.552 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -123.35 114.77 20.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 110.04 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' B' ' 136' ' ' SER . 36.2 t80 -69.89 90.9 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 1.4 p -145.6 171.89 14.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' B' ' 75' ' ' THR . 1.1 t0 63.21 29.79 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.438 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.9 t80 -77.36 136.73 38.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.88 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 134.17 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.404 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.68 121.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.862 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -119.68 -4.33 10.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.459 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 3.3 m120 -138.29 115.3 10.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.0 . . . . 0.0 110.616 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.532 ' CG2' HD22 ' B' ' 67' ' ' LEU . 68.9 mt -122.65 125.58 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' B' ' 69' ' ' ASN . 26.0 t -100.26 130.75 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.524 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.05 169.86 24.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 2.3 m -162.89 164.53 25.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -1.147 . . . . 0.0 110.119 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.486 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.6 p -170.34 166.93 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 0.0 110.607 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.67 137.45 50.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 109.74 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.74 HG21 HD11 ' B' ' 170' ' ' ILE . 20.9 m -89.71 12.07 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.423 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.1 OUTLIER 70.82 3.63 4.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.281 -0.887 . . . . 0.0 110.711 179.662 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.61 ' O ' HG23 ' B' ' 166' ' ' VAL . 8.1 p90 -162.58 150.98 12.13 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.386 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 45.1 Cg_endo -71.84 165.66 31.87 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.998 1.525 . . . . 0.0 110.512 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.74 HD11 HG21 ' B' ' 166' ' ' VAL . 3.7 mt -133.25 158.09 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.934 . . . . 0.0 110.79 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 171' ' ' ARG . . . . . 0.493 ' HD3' ' HG3' ' B' ' 173' ' ' GLU . 3.4 ttm180 -89.3 98.81 11.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.685 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' B' ' 193' ' ' LEU . 92.6 mt -53.66 -55.24 27.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.19 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 173' ' ' GLU . . . . . 0.493 ' HG3' ' HD3' ' B' ' 171' ' ' ARG . 15.4 pt-20 -54.02 -26.54 26.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.725 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 174' ' ' GLY . . . . . 0.413 ' HA3' ' HD2' ' B' ' 171' ' ' ARG . . . -73.55 -37.14 53.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.494 ' HA ' HD13 ' B' ' 175' ' ' LEU . 0.1 OUTLIER -71.54 -44.58 64.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -1.166 . . . . 0.0 110.056 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -59.38 -38.3 80.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -65.5 -32.69 74.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -58.66 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' B' ' 183' ' ' SER . 37.3 m80 -101.74 30.38 4.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.343 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -60.1 -14.71 33.42 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -30.38 64.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -1.19 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' B' ' 198' ' ' VAL . 60.4 m-85 -119.77 0.68 10.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' B' ' 194' ' ' ILE . 0.1 OUTLIER -120.59 174.07 6.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.074 179.873 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.29 152.98 35.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.265 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 0.76 ' HB2' HD12 ' B' ' 193' ' ' LEU . 75.0 t80 -148.75 100.94 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' B' ' 190' ' ' PHE . 23.5 mt-10 -101.31 103.5 27.0 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.936 . . . . 0.0 110.02 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.68 -6.32 18.89 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.938 1.493 . . . . 0.0 110.146 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -99.95 -2.92 33.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 58' ' ' SER . 0.8 OUTLIER -154.71 -41.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 0.0 110.626 -179.846 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.645 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -111.24 110.8 55.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 110.675 -179.524 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.46 -25.35 15.34 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.115 1.587 . . . . 0.0 110.07 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -95.64 -179.91 36.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.76 HD12 ' HB2' ' B' ' 185' ' ' TYR . 0.7 OUTLIER -113.22 140.62 47.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -1.163 . . . . 0.0 110.359 -179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.529 HG12 ' CD2' ' B' ' 205' ' ' LEU . 67.9 mt -104.87 104.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' B' ' 203' ' ' VAL . 17.9 t80 -96.78 137.21 36.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.546 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -115.66 83.6 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 30.4 ttm -51.87 139.84 21.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' B' ' 182' ' ' PHE . 25.6 t -82.4 -42.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.216 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 9.7 tttp -140.41 114.51 7.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.893 . . . . 0.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.9 Cg_endo -73.49 168.68 75.51 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.968 -2.097 . . . . 0.0 110.607 0.157 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.407 ' C ' HG12 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -72.69 87.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 0.0 110.005 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 19.1 mm -137.76 153.29 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 110.51 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 195' ' ' TYR . 43.0 t -105.73 126.85 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.573 HD21 ' HB1' ' B' ' 226' ' ' ALA . 5.0 mp -116.55 136.82 52.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 110.277 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.704 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 1.2 mt -119.32 132.69 55.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.329 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.654 HG13 HD12 ' B' ' 212' ' ' ILE . 3.5 mp -112.58 159.98 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.508 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 2.9 m-85 -135.75 147.74 48.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 37.9 t -45.87 -24.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -76.12 -22.65 55.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.438 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.689 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 107.24 4.31 35.4 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.592 ' O ' HD13 ' B' ' 212' ' ' ILE . 22.1 tttt -77.84 141.43 39.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.654 HD12 HG13 ' B' ' 206' ' ' ILE . 15.2 mm -124.53 142.14 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.102 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 11.1 t -124.24 151.9 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.199 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' B' ' 213' ' ' VAL . 3.1 mp -141.35 119.24 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 12.8 t -135.52 166.17 23.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 110.314 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.38 79.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -79.39 132.64 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -1.171 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' B' ' 218' ' ' LYS . 2.1 ttmt -79.24 -26.31 42.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.516 ' HB3' ' HG3' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -144.87 162.23 37.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.375 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -59.44 -26.56 65.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.806 . . . . 0.0 110.552 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -63.85 -27.55 69.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 -179.824 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.43 ' OE1' HD11 ' B' ' 202' ' ' ILE . 4.5 mt-10 -74.57 -42.27 59.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 109.879 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' B' ' 214' ' ' LEU . 32.0 mm -63.75 -40.35 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.37 -39.88 94.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.08 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -74.62 -31.45 62.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -63.92 -38.3 90.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.856 . . . . 0.0 110.156 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.689 ' HA ' HG22 ' B' ' 230' ' ' ILE . 27.5 t80 -79.55 -42.32 25.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 110.221 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 228' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' B' ' 228' ' ' GLU . 0.3 OUTLIER -61.83 -17.04 54.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.972 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -96.06 -32.96 12.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.3 tp -89.59 -16.34 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.995 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.594 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.4 t80 -53.86 -43.39 96.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.379 -0.825 . . . . 0.0 111.083 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 46.1 Cg_endo -74.58 -36.87 2.64 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.356 1.188 . . . . 0.0 110.613 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.42 HG12 HD21 ' B' ' 175' ' ' LEU . 40.9 t -63.11 -40.72 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.869 179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.547 HD13 HG11 ' B' ' 166' ' ' VAL . 26.3 mt -62.66 -48.81 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 110.233 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -42.54 84.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.988 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 236' ' ' GLU . . . . . 0.441 ' OE1' ' CA ' ' B' ' 236' ' ' GLU . 0.0 OUTLIER -61.73 -30.0 70.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 110.156 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -119.58 39.58 3.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' B' ' 239' ' ' LYS . 7.1 tmm_? -69.75 148.49 49.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.235 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.433 ' N ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -91.7 -56.19 3.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.343 -179.895 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 36.5 ttm . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.253 -179.998 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.222 0.534 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' SER . . . 63.3 -117.83 12.21 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 12' ' ' GLY . 5.5 t 56.86 112.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -1.101 . . . . 0.0 110.191 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.6 pt -105.88 48.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 110.153 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.13 -72.31 1.19 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -67.78 -162.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.17 -1.194 . . . . 0.0 110.11 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 64.63 147.6 0.04 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.011 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -111.18 166.88 10.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -1.196 . . . . 0.0 109.952 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.885 ' N ' HD12 ' A' ' 18' ' ' LEU . 5.6 p-10 -86.68 93.12 9.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 111.024 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.011 HD21 HD21 ' A' ' 18' ' ' LEU . 2.9 mt -99.21 2.62 45.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.317 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 59' ' ' LEU . 42.3 m -42.33 -39.29 2.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -89.41 -35.25 8.08 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.689 HG12 HG23 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -51.19 -45.44 31.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.459 -1.024 . . . . 0.0 109.076 -179.49 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.769 HD22 ' HG2' ' A' ' 67' ' ' MET . 3.8 pp -82.88 -19.62 37.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 109.827 178.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -100.22 11.62 38.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.246 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 146.58 89.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.986 ' ND2' HD11 ' A' ' 35' ' ' LEU . 4.3 p30 -16.06 124.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.075 0.941 . . . . 0.0 112.506 -179.264 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.689 HG23 HG12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -145.67 161.13 12.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.854 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 28' ' ' ILE . 68.9 m-20 -86.8 134.33 33.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 1.01 ' HB2' HD13 ' A' ' 18' ' ' LEU . 9.7 p -39.35 -27.36 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.598 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 10.3 tt0 -55.57 -15.41 2.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 178.275 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 31.26 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.72 129.32 49.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.957 -1.32 . . . . 0.0 110.571 179.83 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.35 150.58 20.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.299 -0.876 . . . . 0.0 110.698 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.986 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp -123.35 -178.79 4.1 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.522 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.605 ' N ' HD12 ' A' ' 35' ' ' LEU . 27.1 mt-30 -122.48 136.79 54.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.425 -0.797 . . . . 0.0 110.357 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.517 ' OD1' ' ND2' ' A' ' 27' ' ' ASN . 10.3 m-20 -64.79 -40.28 94.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 110.227 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.8 152.02 16.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 110.076 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 19.6 t0 -117.0 -23.18 8.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 110.263 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.63 -158.25 2.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.55 21.13 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -1.118 . . . . 0.0 110.189 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.74 87.11 0.14 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.1 8.55 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -1.184 . . . . 0.0 110.357 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.93 8.08 14.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.97 48.81 7.43 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m -68.66 170.31 9.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 110.301 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' PHE . . . 106.99 124.61 5.27 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.71 ' CD2' HD12 ' A' ' 52' ' ' LEU . 4.9 m-85 -43.8 151.69 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -1.108 . . . . 0.0 110.28 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -79.92 -159.39 0.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 110.255 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -98.48 31.77 2.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.403 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -22.8 14.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.192 -0.943 . . . . 0.0 108.833 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.71 HD12 ' CD2' ' A' ' 48' ' ' PHE . 4.0 mt -103.51 -40.06 6.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.591 -0.693 . . . . 0.0 110.435 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.924 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.75 -56.01 16.34 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.721 -179.16 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -64.88 -24.53 67.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.643 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 2.2 m-20 -80.04 -37.03 34.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.466 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.924 HD12 ' HA ' ' A' ' 53' ' ' ARG . 8.0 mt -53.71 -43.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.65 -22.46 46.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.6 p -127.21 17.83 7.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -1.117 . . . . 0.0 110.31 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.857 HD23 HD21 ' A' ' 62' ' ' LEU . 4.8 mt -79.02 -11.47 60.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.53 38.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.537 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 24.8 ttpt -137.16 12.99 3.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.996 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.857 HD21 HD23 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -136.96 -29.77 0.9 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 110.948 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.9 -44.35 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.112 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.8 mm? -44.83 -23.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -1.231 . . . . 0.0 110.793 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 64' ' ' LEU . 7.8 t0 -43.93 -41.65 5.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.022 . . . . 0.0 109.744 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.7 -45.82 74.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.428 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.769 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -72.22 -8.73 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.388 179.17 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.654 ' C ' HD13 ' A' ' 68' ' ' LEU . 2.2 tm? -71.17 -60.89 1.99 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.948 0.88 . . . . 0.0 108.88 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -72.57 0.4 10.59 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.328 0.585 . . . . 0.0 110.14 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 44.8 tt0 -84.3 1.18 46.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -0.918 . . . . 0.0 111.171 -179.179 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.759 HG12 HG11 ' B' ' 122' ' ' VAL . 3.4 t -138.36 -2.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.128 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.98 HD11 HD12 ' A' ' 74' ' ' LEU . 4.4 tp -150.85 77.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.444 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.7 p-10 -78.57 55.35 1.62 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.962 -1.086 . . . . 0.0 108.851 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.042 HD11 ' HB2' ' B' ' 101' ' ' ALA . 8.7 mt -99.78 65.44 1.33 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.672 0.748 . . . . 0.0 110.668 -179.109 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -156.25 155.06 31.69 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.696 -0.628 . . . . 0.0 110.006 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 52.84 44.13 30.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 110.064 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.343 -179.977 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.476 ' HA ' ' OH ' ' B' ' 231' ' ' TYR . 3.7 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.305 0.574 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.29 37.96 0.09 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' B' ' 64' ' ' VAL . 1.5 mp -84.81 -25.23 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -1.188 . . . . 0.0 109.971 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' B' ' 63' ' ' ILE . 4.3 t 61.04 130.65 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 0.0 110.318 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 45.6 Cg_endo -74.03 137.44 24.1 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.973 1.512 . . . . 0.0 110.388 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -99.06 128.51 45.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.537 HD22 HG22 ' B' ' 160' ' ' ILE . 69.9 mt -70.42 114.6 8.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 110.121 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 30.9 mm100 -102.82 -9.62 19.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.291 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.498 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 1.1 m-80 -168.27 157.86 9.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 126' ' ' ALA . 8.1 mt -156.9 159.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.965 . . . . 0.0 109.853 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.631 HG22 ' HB ' ' B' ' 124' ' ' THR . 50.7 t -139.47 143.02 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' B' ' 157' ' ' ILE . . . -132.82 151.55 51.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 14.8 p -108.58 120.77 43.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 65.4 t -116.76 151.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.165 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 27.5 m -122.8 152.24 40.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 1.006 HD22 ' HB1' ' B' ' 150' ' ' ALA . 14.0 mt -105.14 -44.52 4.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.95 -11.22 34.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 176.35 8.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -1.124 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.738 ' O ' HD23 ' B' ' 80' ' ' LEU . 9.6 ttt180 -93.73 160.95 14.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.999 HD11 ' CD1' ' B' ' 76' ' ' LEU . 13.5 mt -134.84 149.41 50.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.979 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 2.7 m-20 -95.45 100.44 12.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 21.2 mt -50.66 -39.4 50.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.042 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -42.28 84.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 4.2 m -87.64 -44.24 11.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.025 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -53.72 -37.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.551 ' HB2' ' CG2' ' B' ' 102' ' ' VAL . . . -83.67 -28.95 27.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' B' ' 87' ' ' LEU . 1.9 tp -84.14 -23.63 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' B' ' 84' ' ' THR . 8.2 m80 -94.03 -32.49 13.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -64.02 139.41 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.044 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -73.47 -27.74 61.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.955 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 10.6 t-20 -134.69 79.48 1.8 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -149.38 154.72 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 93' ' ' GLU . . . . . 0.537 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 16.2 pt-20 -136.24 165.49 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -139.86 113.76 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.099 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -115.67 96.23 45.79 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.363 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -16.27 25.82 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.974 1.512 . . . . 0.0 110.412 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -3.94 44.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.406 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -126.54 -34.45 2.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.141 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.957 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.49 -171.59 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.402 -0.811 . . . . 0.0 110.842 -179.301 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.96 57.03 0.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 111.542 -178.636 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -147.84 155.82 42.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.959 -1.088 . . . . 0.0 110.775 179.22 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' B' ' 86' ' ' ALA . 73.0 t -97.79 126.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.919 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 20.0 mm -90.29 129.51 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.358 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 1.3 ttt -102.4 162.54 12.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.449 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 0.6 OUTLIER -154.36 124.3 6.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 110.601 -179.773 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.529 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 8.7 pt -129.06 155.62 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.631 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.457 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 0.4 OUTLIER -102.41 34.28 2.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.435 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.0 OUTLIER -177.06 87.45 0.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.8 Cg_endo -79.08 149.31 83.84 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.21 -0.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 3.9 tttt -62.05 97.69 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.153 -0.967 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' B' ' 124' ' ' THR . 23.8 p -149.67 170.95 17.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 110.749 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -110.79 156.55 20.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.557 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -136.82 143.64 43.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 110.938 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.53 ' HB3' ' CZ ' ' B' ' 116' ' ' PHE . 2.8 mm? -104.87 125.39 50.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.4 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.582 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 31.4 mm -110.13 121.56 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 0.0 110.868 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.53 ' CZ ' ' HB3' ' B' ' 114' ' ' LEU . 6.8 m-85 -106.24 128.43 53.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.301 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.25 -24.3 4.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.219 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.472 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 131.83 -26.47 3.81 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -71.61 149.96 45.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.481 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.9 OUTLIER -139.86 140.91 36.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -115.29 157.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.949 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 71' ' ' VAL . 33.6 t -142.46 153.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.672 HG21 HD13 ' A' ' 23' ' ' ILE . 1.8 t -149.71 163.12 38.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.562 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 112.0 -30.42 7.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -56.0 147.62 19.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -1.07 . . . . 0.0 110.253 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 127' ' ' LYS . . . . . 0.401 ' HG2' ' OD2' ' B' ' 131' ' ' ASP . 10.9 ptmt -119.41 -22.08 7.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m -121.88 -141.32 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.814 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.91 -41.92 5.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 131' ' ' ASP . 6.4 p30 -72.07 -21.87 61.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.204 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 73.9 m-20 -70.95 -35.16 72.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 110.434 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.481 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 12.1 m -79.27 -32.59 43.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.278 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -74.82 -42.95 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 110.151 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' B' ' 130' ' ' ASP . 0.2 OUTLIER -64.12 -37.59 88.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.76 -60.79 2.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.518 ' OG ' HG21 ' B' ' 123' ' ' VAL . 2.8 m -51.08 -46.63 61.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -45.08 88.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.8 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.473 ' CD ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -58.93 -41.4 87.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.903 179.746 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.723 ' HA ' HD12 ' B' ' 142' ' ' ILE . 37.5 m-85 -66.79 -55.45 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.985 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 140' ' ' ALA . . . . . 0.521 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -48.57 -33.77 10.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 8.3 mmt180 -64.73 -41.32 96.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' B' ' 139' ' ' TYR . 28.1 mt -54.63 -49.75 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.624 HD13 HD13 ' B' ' 80' ' ' LEU . 9.0 mt -69.25 -54.23 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.579 HE21 ' HB3' ' B' ' 150' ' ' ALA . 0.9 OUTLIER -59.56 -32.89 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.94 . . . . 0.0 109.925 179.719 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 0.6 OUTLIER -72.92 -27.24 61.75 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.069 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.6 mt -76.28 -15.71 15.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 117.17 -27.34 7.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.481 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 9.6 m-85 -41.99 154.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.258 . . . . 0.0 110.765 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.52 24.63 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 1.006 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -72.42 165.59 24.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.11 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.533 ' O ' HD23 ' B' ' 76' ' ' LEU . 19.0 tttt -142.78 169.48 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.374 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 152' ' ' PHE . . . . . 0.503 ' O ' HG23 ' B' ' 153' ' ' THR . 60.6 t80 -101.1 91.47 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.161 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.503 HG23 ' O ' ' B' ' 152' ' ' PHE . 1.5 p -153.52 176.6 11.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.259 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.506 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 20.5 t0 60.84 24.11 14.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.092 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 3.3 t80 -80.54 133.12 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -163.74 132.17 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 110.151 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' B' ' 72' ' ' ALA . 1.9 mp -79.96 109.4 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 109.917 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -103.47 -3.04 25.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 110.838 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.91 108.5 4.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.036 -1.04 . . . . 0.0 110.904 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.537 HG22 HD22 ' B' ' 67' ' ' LEU . 95.6 mt -113.21 120.03 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.177 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.589 HG22 ' OG1' ' B' ' 215' ' ' THR . 3.5 t -95.37 140.37 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.637 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.75 177.04 20.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 163' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 73.7 m -166.05 140.6 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -1.178 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.505 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 8.9 p -170.23 136.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.95 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 59.2 p30 -103.41 179.81 4.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.024 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.553 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.2 OUTLIER -124.44 -86.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.213 -0.929 . . . . 0.0 110.3 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.553 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 173.97 33.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.53 ' CD1' ' HG2' ' B' ' 238' ' ' ARG . 11.8 p90 -166.32 149.32 6.41 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.64 145.49 46.83 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.098 1.578 . . . . 0.0 110.484 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.43 HD13 ' CG2' ' B' ' 206' ' ' ILE . 6.0 mt -112.2 142.62 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 0.0 110.514 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 171' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -82.1 92.83 6.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -0.834 . . . . 0.0 109.793 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' B' ' 193' ' ' LEU . 11.5 mt -51.23 -47.48 62.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.72 -50.12 74.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.937 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -49.79 -34.09 21.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.4 OUTLIER -71.32 -59.44 2.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 109.92 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' B' ' 180' ' ' GLY . . . -58.63 -19.49 39.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.07 -51.09 23.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.33 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 -32.72 11.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.463 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' B' ' 183' ' ' SER . 54.5 m80 -108.75 19.98 19.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' B' ' 176' ' ' ALA . . . -45.3 -51.6 9.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 55.5 m -62.09 -18.58 61.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -1.135 . . . . 0.0 109.931 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 182' ' ' PHE . . . . . 0.446 ' N ' ' O ' ' B' ' 179' ' ' HIS . 1.4 m-85 -105.4 -10.5 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.058 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.478 ' N ' ' O ' ' B' ' 179' ' ' HIS . 13.9 p -154.07 154.96 34.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 184' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 0.5 OUTLIER -126.7 164.74 20.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 110.06 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 0.578 ' HB2' HD12 ' B' ' 193' ' ' LEU . 1.7 t80 -164.1 86.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -92.11 110.04 41.57 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 110.135 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -7.18 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.9 1.474 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.34 -6.43 56.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 189' ' ' LEU . 1.9 tt -146.97 -35.61 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.569 ' CD2' HD11 ' B' ' 194' ' ' ILE . 0.8 OUTLIER -118.47 130.38 24.81 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.992 . . . . 0.0 110.609 -179.888 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.45 -42.09 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.949 1.499 . . . . 0.0 110.376 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.69 -179.55 44.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' B' ' 185' ' ' TYR . 0.9 OUTLIER -96.46 147.49 23.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -1.156 . . . . 0.0 110.297 -179.92 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.691 HG21 HD13 ' A' ' 62' ' ' LEU . 63.4 mt -109.82 104.93 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -97.58 128.66 44.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.474 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' B' ' 203' ' ' VAL . 12.2 ttt-85 -110.92 80.74 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.456 ' N ' ' O ' ' B' ' 202' ' ' ILE . 37.1 tpp -45.81 134.59 7.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 75.3 t -88.17 -34.72 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.359 -0.838 . . . . 0.0 109.975 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.1 OUTLIER -143.58 108.34 5.17 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 110.049 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.2 Cg_endo -71.44 169.46 69.37 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.94 -2.109 . . . . 0.0 110.786 0.046 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.553 ' O ' HD13 ' B' ' 202' ' ' ILE . 5.6 mtmp? -75.22 81.56 2.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.34 -0.85 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.553 HD13 ' O ' ' B' ' 201' ' ' LYS . 10.4 mm -130.41 148.22 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.708 ' C ' HD12 ' B' ' 204' ' ' LEU . 10.5 t -108.42 137.46 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.019 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.83 ' N ' HD12 ' B' ' 204' ' ' LEU . 3.6 mp -131.51 151.82 51.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.925 . . . . 0.0 110.571 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.698 ' O ' HD13 ' B' ' 206' ' ' ILE . 25.1 mt -110.13 144.9 38.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.473 179.26 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.698 HD13 ' O ' ' B' ' 205' ' ' LEU . 11.8 mm -127.81 104.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.989 -1.07 . . . . 0.0 110.302 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' B' ' 209' ' ' SER . 66.8 m-85 -91.05 133.99 34.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 36.1 t -42.24 -26.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 110.416 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.439 ' N ' ' O ' ' B' ' 207' ' ' PHE . 0.0 OUTLIER -59.34 -38.63 80.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' B' ' 165' ' ' ASP . . . 121.35 15.86 4.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 124.98 41.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.031 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.577 HD12 HD12 ' B' ' 206' ' ' ILE . 21.1 mm -108.89 125.6 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.538 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.522 ' C ' HD12 ' B' ' 214' ' ' LEU . 17.1 t -105.77 159.4 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.395 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.1 mp -143.05 146.17 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.589 ' OG1' HG22 ' B' ' 161' ' ' VAL . 5.5 t -169.8 145.09 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 110.18 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.62 10.74 26.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -91.3 158.74 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -1.198 . . . . 0.0 110.227 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -103.39 -23.75 13.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.479 ' N ' ' HG2' ' B' ' 218' ' ' LYS . 0.0 OUTLIER -137.65 179.35 6.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 220' ' ' ARG . . . . . 0.454 ' HG3' ' CE1' ' B' ' 224' ' ' TYR . 1.6 ttt180 -75.88 -27.75 57.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.363 -0.836 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 221' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -61.05 -41.17 96.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.496 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -61.43 -52.16 65.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 0.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.468 HD11 ' O ' ' B' ' 160' ' ' ILE . 22.6 mm -58.05 -43.8 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' B' ' 220' ' ' ARG . 10.5 m-85 -70.98 -34.16 71.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.204 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 3.4 tp60 -80.48 -44.16 19.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 110.047 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.14 -38.42 68.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.627 ' O ' HG22 ' B' ' 230' ' ' ILE . 15.7 t80 -68.92 -52.72 26.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.995 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -54.29 -24.21 18.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.783 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.81 -30.82 45.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 110.039 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.627 HG22 ' O ' ' B' ' 227' ' ' PHE . 6.0 tp -93.38 -17.37 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.891 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.72 -47.88 60.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 111.015 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.77 -40.44 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.593 1.312 . . . . 0.0 110.612 -179.404 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.494 ' CG1' HD11 ' B' ' 175' ' ' LEU . 40.8 t -58.52 -42.32 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.907 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 77.5 mt -66.67 -40.22 88.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.34 -25.4 63.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.36 -27.15 59.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 59.9 m-85 -117.16 42.74 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.53 ' HG2' ' CD1' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -68.16 -172.01 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -35.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.142 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 240' ' ' MET . . . . . 0.462 ' HG3' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.141 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.177 0.513 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.77 62.78 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.721 ' OG ' HD12 ' A' ' 14' ' ' ILE . 96.7 p -172.13 -70.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 110.243 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.721 HD12 ' OG ' ' A' ' 13' ' ' SER . 2.6 mp -90.52 164.86 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' N ' HG22 ' A' ' 14' ' ' ILE . . . -89.25 168.02 34.78 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -60.55 163.51 5.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 110.146 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.76 154.86 30.08 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.06 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -113.2 172.18 7.11 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.33 -1.1 . . . . 0.0 108.747 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.799 ' HA ' HD11 ' A' ' 68' ' ' LEU . 12.0 t0 -101.04 118.38 36.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.919 -1.113 . . . . 0.0 111.117 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.06 HD21 HD21 ' A' ' 18' ' ' LEU . 6.6 mt -113.78 12.79 18.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 110.641 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.687 ' OG1' HD23 ' A' ' 68' ' ' LEU . 3.1 m -42.43 -27.74 0.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 110.187 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.567 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -91.36 -30.2 11.2 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 20' ' ' LEU . 16.3 mm -50.65 -53.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.295 . . . . 0.0 108.771 -179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.1 pp -78.97 5.7 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.468 -0.77 . . . . 0.0 110.004 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CD1' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -107.99 -17.61 14.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.177 -0.952 . . . . 0.0 111.14 -179.516 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 151.79 48.74 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.252 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.988 ' OD1' HD21 ' A' ' 35' ' ' LEU . 0.9 OUTLIER 63.86 139.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.012 -1.287 . . . . 0.0 111.275 178.524 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.763 HG23 HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.35 157.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 68.1 m-20 -90.08 122.52 33.13 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 177.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.479 ' OG ' HG13 ' B' ' 103' ' ' ILE . 1.5 p -39.8 -26.67 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.727 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.1 tt0 -57.48 -13.53 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.447 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.92 26.3 5.58 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.98 117.43 26.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.076 -1.249 . . . . 0.0 109.814 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 35' ' ' LEU . 2.8 tt -88.36 156.9 18.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.778 -1.201 . . . . 0.0 110.244 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.988 HD21 ' OD1' ' A' ' 27' ' ' ASN . 4.2 pp -136.68 -178.77 5.33 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.043 -179.055 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.742 ' N ' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -163.94 23.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.611 -0.68 . . . . 0.0 110.23 -179.324 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 36' ' ' GLN . 20.5 t0 61.5 97.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.143 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.77 134.3 39.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 110.311 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.54 -158.47 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.77 -120.59 3.4 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.14 97.06 2.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -1.167 . . . . 0.0 110.334 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.86 -63.01 0.07 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -74.88 -7.4 53.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -1.175 . . . . 0.0 110.139 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.52 12.19 15.57 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.08 144.32 4.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.3 m -152.72 139.81 19.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -1.214 . . . . 0.0 110.288 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.08 -170.99 29.4 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 49' ' ' ASP . 28.0 m-85 -90.0 121.02 31.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -1.08 . . . . 0.0 110.235 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 48' ' ' PHE . 23.3 p30 -56.79 -166.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.731 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.07 28.64 4.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.028 . . . . 0.0 110.321 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.01 -25.5 14.04 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.973 ' O ' HD12 ' A' ' 56' ' ' ILE . 2.7 mt -92.54 -42.28 9.78 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.552 -0.718 . . . . 0.0 110.139 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.66 -51.22 16.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 0.0 109.609 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -66.53 -13.83 61.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.825 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' A' ' 59' ' ' LEU . 9.7 m-80 -96.23 -40.19 9.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.825 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.973 HD12 ' O ' ' A' ' 52' ' ' LEU . 1.2 mp -51.42 -40.65 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.399 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.39 -14.54 49.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 p -134.53 18.11 3.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 110.39 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 6.7 mt -98.04 16.27 21.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.2 m -90.95 42.97 1.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 110.433 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HG3' ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -151.78 -30.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -0.971 . . . . 0.0 110.954 179.854 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -74.37 6.15 3.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.977 -1.077 . . . . 0.0 111.271 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.586 ' N ' HD13 ' A' ' 62' ' ' LEU . . . 144.03 -46.92 0.8 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.751 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.6 mm? -52.0 -18.15 1.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 110.678 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 66' ' ' SER . 2.7 p30 -43.0 -39.65 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 10.9 m -67.67 -55.92 11.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.387 -0.821 . . . . 0.0 109.976 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.461 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.52 -6.6 26.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.602 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.799 HD11 ' HA ' ' A' ' 19' ' ' ASP . 1.2 tm? -71.02 -62.89 1.23 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.179 0.99 . . . . 0.0 108.848 179.301 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.48 1.69 13.46 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.164 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 66' ' ' SER . 15.4 tt0 -91.24 11.36 23.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 111.696 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 20' ' ' LEU . 3.2 t -138.4 0.42 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.042 HD11 ' CD1' ' A' ' 74' ' ' LEU . 2.0 tp -152.0 74.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 110.233 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 56.9 t0 -79.74 56.65 2.32 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.923 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.042 ' CD1' HD11 ' A' ' 72' ' ' ILE . 5.8 mt -82.11 59.56 4.48 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.719 0.771 . . . . 0.0 110.716 -179.193 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -126.45 37.63 4.28 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.758 -0.588 . . . . 0.0 110.134 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.88 88.0 1.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 110.197 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.167 -179.899 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.306 0.574 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' B' ' 231' ' ' TYR . . . -148.94 -68.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.0 mp -115.01 -6.51 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -1.188 . . . . 0.0 110.148 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 14.5 t 60.54 126.93 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.301 -0.874 . . . . 0.0 110.057 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.475 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 44.2 Cg_endo -70.95 150.31 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.85 1.447 . . . . 0.0 110.484 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' B' ' 68' ' ' GLN . 18.1 m -122.04 128.02 50.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.486 HD21 HG21 ' B' ' 223' ' ' ILE . 21.7 mt -70.29 117.53 11.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 110.211 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.609 ' O ' ' ND2' ' B' ' 69' ' ' ASN . 19.8 mm-40 -112.35 -13.63 13.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.351 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' B' ' 68' ' ' GLN . 4.6 m-80 -153.53 158.03 40.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.562 HG22 ' N ' ' B' ' 71' ' ' VAL . 8.4 mt -154.96 169.2 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.987 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' B' ' 124' ' ' THR . 27.0 t -139.23 130.48 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.94 143.96 50.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 94.7 m -93.62 128.93 40.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.89 . . . . 0.0 110.355 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.63 146.07 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.2 m -125.49 145.68 49.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 1.133 HD22 ' HB1' ' B' ' 150' ' ' ALA . 91.8 mt -97.08 -41.85 8.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.11 54.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 7.3 t -148.43 153.87 39.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -1.181 . . . . 0.0 110.335 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -77.52 149.21 34.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.097 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.938 HD11 ' CD1' ' B' ' 76' ' ' LEU . 68.9 mt -124.69 155.66 38.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -0.97 . . . . 0.0 110.505 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' B' ' 82' ' ' LEU . 4.9 m-20 -92.69 83.64 4.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 109.455 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.786 HD22 HG23 ' B' ' 102' ' ' VAL . 94.6 mt -40.1 -35.6 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.723 . . . . 0.0 110.536 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -50.12 73.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 110.008 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -77.47 -43.28 32.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.495 HG22 ' CE2' ' B' ' 148' ' ' PHE . 85.2 t -50.38 -43.96 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.142 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.96 -21.72 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 tp -86.2 -37.22 18.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -87.74 -24.95 23.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.478 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -70.63 136.34 49.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.145 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -24.08 58.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 9.6 t-20 -135.63 79.45 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.096 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.85 149.97 46.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -0.859 . . . . 0.0 109.955 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -125.78 119.36 27.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.341 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.525 ' CE1' ' HB3' ' B' ' 82' ' ' LEU . 8.1 t80 -114.37 118.96 35.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 109.929 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -129.05 110.22 18.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.277 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.47 -22.1 18.85 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.969 1.51 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -17.94 56.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -102.02 -45.34 5.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.752 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.54 -162.42 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.913 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.414 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -122.12 54.86 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 111.043 -179.357 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.997 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -143.14 172.16 13.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 110.095 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.786 HG23 HD22 ' B' ' 82' ' ' LEU . 42.1 t -114.56 123.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.36 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.81 ' CD1' HD13 ' B' ' 114' ' ' LEU . 15.2 mm -93.67 108.6 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.979 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.562 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 1.4 ttm -89.81 146.54 24.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.428 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 3.8 ttt85 -135.63 118.66 16.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.439 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.757 HG23 ' CE1' ' B' ' 139' ' ' TYR . 18.2 pt -114.71 165.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.934 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.7 ptm180 -110.59 22.9 14.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.389 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 2.4 tt0 -176.9 94.74 0.24 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.267 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.1 Cg_endo -76.73 143.93 77.33 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.477 -0.243 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.721 ' O ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -57.12 108.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.0 109.926 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.721 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -161.76 -179.14 6.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.753 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -126.54 158.74 35.4 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.7 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -132.82 124.98 29.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 111.103 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.81 HD13 ' CD1' ' B' ' 103' ' ' ILE . 3.9 mm? -92.24 89.83 7.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.711 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 41.1 mt -90.28 128.61 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.168 -178.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.787 ' CZ ' HD12 ' A' ' 72' ' ' ILE . 4.0 m-30 -110.19 144.75 38.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 109.593 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -54.36 -19.88 6.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 110.408 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -7.18 37.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 119' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 101.55 -25.93 26.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -56.23 173.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -1.206 . . . . 0.0 110.082 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.51 ' CG ' HG12 ' B' ' 115' ' ' ILE . 3.2 tmm? -169.05 119.89 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 71' ' ' VAL . 3.8 t -109.4 138.98 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.378 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.42 124.01 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 110.766 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.694 HG23 ' ND2' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -117.44 170.63 8.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 109.801 179.656 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 102.81 -35.67 4.83 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -50.04 157.09 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -1.187 . . . . 0.0 110.387 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -121.76 -25.39 5.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 164.82 27.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.88 -63.01 1.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.189 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -45.44 -37.48 5.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -70.4 -42.02 72.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.159 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -55.48 -40.64 71.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 133' ' ' LYS . . . . . 0.474 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -69.1 -49.05 60.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.328 -179.918 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.455 ' HB3' ' HG3' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -55.0 -51.66 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 110.168 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.3 -47.55 65.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.218 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -69.31 -47.24 65.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.07 -42.36 65.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.391 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.478 ' NZ ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -63.73 -36.73 84.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.757 ' CE1' HG23 ' B' ' 106' ' ' ILE . 13.4 m-85 -72.01 -56.95 4.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.61 -22.95 0.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.766 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 141' ' ' ARG . . . . . 0.451 ' HD3' ' HD3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -73.58 -50.53 20.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 110.073 179.803 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' B' ' 139' ' ' TYR . 46.4 mt -50.75 -38.83 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.69 HG22 ' HB2' ' B' ' 148' ' ' PHE . 38.8 mm -72.54 -58.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 110.039 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 33.3 mt-30 -61.39 -27.63 68.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 109.961 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.451 ' HD3' ' HD3' ' B' ' 141' ' ' ARG . 27.5 ttpt -75.39 -23.45 57.08 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.179 -0.95 . . . . 0.0 108.504 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.6 mt -83.79 -21.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.87 -16.23 7.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.438 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.69 ' HB2' HG22 ' B' ' 143' ' ' ILE . 14.9 m-85 -54.4 172.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.077 -1.249 . . . . 0.0 110.865 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.27 32.06 5.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.631 -0.668 . . . . 0.0 109.747 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 1.133 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -77.16 144.24 38.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 110.504 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.18 51.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -71.94 97.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.172 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 176.24 9.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.56 33.98 23.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.659 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 155' ' ' PHE . . . . . 0.474 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.0 t80 -76.16 127.91 33.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 109.927 179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -161.43 129.64 4.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.123 -0.985 . . . . 0.0 110.709 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 20.3 mt -87.65 131.0 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.73 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 158' ' ' GLN . . . . . 0.447 ' HA ' ' HG2' ' B' ' 218' ' ' LYS . 4.5 mt-30 -135.31 0.56 2.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.046 -1.034 . . . . 0.0 110.95 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.525 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.2 OUTLIER -142.53 96.85 3.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.01 -1.056 . . . . 0.0 110.932 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' B' ' 215' ' ' THR . 75.4 mt -98.71 153.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 15.8 t -134.15 131.12 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.031 . . . . 0.0 110.571 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.43 175.7 18.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.14 148.63 8.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -1.21 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.475 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.3 p -169.45 170.71 8.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 165' ' ' ASP . . . . . 0.417 ' O ' HD13 ' B' ' 63' ' ' ILE . 6.2 m-20 -116.29 155.77 27.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.294 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.56 ' O ' ' CD2' ' B' ' 168' ' ' PHE . 10.2 m -103.87 11.5 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 167' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.9 OUTLIER 71.89 3.46 4.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.368 -0.832 . . . . 0.0 110.789 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 8.3 p90 -162.02 156.04 18.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 110.495 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.494 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 45.3 Cg_endo -74.24 161.87 39.74 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.103 1.581 . . . . 0.0 110.357 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.485 HD11 HG21 ' B' ' 166' ' ' VAL . 3.0 mt -127.07 148.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.38 104.6 16.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.825 HD22 ' CB ' ' B' ' 193' ' ' LEU . 26.9 mt -61.7 -48.51 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.44 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.69 -51.45 69.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.599 -179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.8 -51.08 55.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' B' ' 237' ' ' PHE . 8.0 tp -68.4 -36.25 78.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -1.141 . . . . 0.0 110.676 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -61.11 -30.65 70.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 177' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 7.0 t80 -76.93 -44.59 30.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.6 t -68.73 -48.94 62.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.273 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -110.87 37.44 2.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 180' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -54.14 -34.32 52.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -15.92 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.191 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -111.32 -0.75 16.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.888 . . . . 0.0 110.283 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.563 ' HB2' HD21 ' B' ' 193' ' ' LEU . 1.1 p -140.86 168.92 18.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 110.429 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 69.1 m -139.95 130.64 25.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.032 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -132.75 120.31 21.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.128 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 190' ' ' PHE . 99.2 mt-10 -121.19 100.71 45.13 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.46 -0.71 9.15 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.932 1.49 . . . . 0.0 110.4 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.82 -18.62 17.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.151 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.646 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.6 tt -147.34 9.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.604 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.489 ' HB2' HD23 ' B' ' 189' ' ' LEU . 19.0 t80 -167.97 107.63 0.57 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.874 -1.141 . . . . 0.0 110.421 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.79 -15.77 23.82 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.916 1.482 . . . . 0.0 110.165 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.61 44.13 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.825 ' CB ' HD22 ' B' ' 172' ' ' LEU . 7.3 tt -124.53 134.29 53.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -1.169 . . . . 0.0 110.433 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.765 HD13 HD23 ' A' ' 62' ' ' LEU . 3.3 mt -104.74 113.85 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 109.886 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.633 ' CD2' HD11 ' B' ' 230' ' ' ILE . 4.5 t80 -93.32 127.06 38.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.442 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.442 ' NH2' ' HA3' ' A' ' 63' ' ' GLY . 65.0 mtt180 -99.12 103.15 15.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.108 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 47.4 tpp -75.97 131.1 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.096 -1.003 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 198' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' B' ' 199' ' ' LYS . 39.4 t -80.51 -32.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.587 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 10.2 mttt -147.39 108.26 3.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.47 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -73.9 172.32 62.09 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.96 -2.1 . . . . 0.0 110.328 -0.223 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 201' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.5 OUTLIER -78.2 81.47 4.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.004 179.835 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' B' ' 217' ' ' ALA . 35.3 mm -126.04 154.01 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.29 111.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 110.295 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.713 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.9 mp -99.71 133.13 44.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.927 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 0.5 OUTLIER -93.69 147.31 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 179.984 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.451 HG22 HD21 ' B' ' 172' ' ' LEU . 5.1 mt -137.86 120.14 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -110.72 150.11 29.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 93.2 t -52.16 -27.14 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.382 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -37.44 84.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 110.253 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 119.81 1.92 13.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.413 ' HA ' ' OD1' ' B' ' 165' ' ' ASP . 11.2 tttm -81.21 140.48 34.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 110.049 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.408 HD13 ' O ' ' B' ' 211' ' ' LYS . 22.0 mm -123.13 132.38 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.405 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 2.3 t -120.04 148.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.24 -0.912 . . . . 0.0 109.694 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.0 mp -135.17 127.76 30.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.077 -1.014 . . . . 0.0 110.654 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 3.4 t -150.42 174.46 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.557 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.58 -0.42 77.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.813 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -94.24 142.54 27.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 110.183 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' B' ' 158' ' ' GLN . 3.2 mttm -87.27 -25.34 24.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.426 ' C ' HD12 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -127.41 168.45 14.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -73.93 -27.53 61.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.331 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -57.37 -42.53 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.446 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 31.3 mt-10 -59.45 -46.81 87.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 109.871 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.682 HG22 ' N ' ' B' ' 224' ' ' TYR . 0.9 OUTLIER -56.49 -56.96 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -0.821 . . . . 0.0 109.42 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 224' ' ' TYR . . . . . 0.682 ' N ' HG22 ' B' ' 223' ' ' ILE . 1.1 m-85 -53.09 -33.61 52.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 110.273 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -79.03 -40.69 30.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.005 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.713 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.77 -42.59 89.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.662 ' HA ' HG22 ' B' ' 230' ' ' ILE . 79.4 t80 -68.51 -55.98 9.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.05 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 228' ' ' GLU . . . . . 0.429 ' O ' ' HD3' ' B' ' 232' ' ' PRO . 0.4 OUTLIER -50.21 -29.87 10.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.886 . . . . 0.0 110.064 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.452 ' O ' ' HD2' ' B' ' 232' ' ' PRO . . . -81.49 -36.0 29.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 110.165 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.6 tp -88.14 -13.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 110.025 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.603 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 64.3 t80 -59.63 -43.21 95.12 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.852 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -75.9 -23.37 12.43 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.396 1.209 . . . . 0.0 110.24 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 37.7 t -72.59 -40.89 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.461 ' HB3' HG12 ' B' ' 170' ' ' ILE . 35.8 mt -67.0 -50.25 62.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -33.13 65.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 110.357 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.24 -40.89 90.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 237' ' ' PHE . . . . . 0.462 ' CD2' HD13 ' B' ' 175' ' ' LEU . 51.7 m-85 -113.72 38.81 2.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.17 -0.956 . . . . 0.0 110.194 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -179.99 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.494 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 4.3 tptt -116.87 -35.45 4.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.223 179.897 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.302 0.573 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.97 -108.77 0.41 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.95 98.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -1.168 . . . . 0.0 110.272 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.49 148.93 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.108 179.859 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.35 172.29 45.27 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -106.22 108.41 19.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -1.085 . . . . 0.0 110.118 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.39 159.97 10.05 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.825 ' CD2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -116.35 174.75 5.89 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.088 -1.242 . . . . 0.0 109.031 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.543 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -82.56 63.18 6.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 0.0 111.917 -178.628 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.822 HD21 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -83.9 -3.16 57.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.964 -1.085 . . . . 0.0 109.604 178.627 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.632 ' OG1' HD23 ' A' ' 68' ' ' LEU . 3.4 m -52.95 -21.55 4.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.281 -0.887 . . . . 0.0 109.638 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -97.23 -37.9 4.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.629 HD11 HD21 ' B' ' 114' ' ' LEU . 0.6 OUTLIER -46.09 -46.33 5.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.22 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.914 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.9 OUTLIER -79.5 -19.48 49.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.144 -0.972 . . . . 0.0 108.944 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.5 OUTLIER -85.94 -17.44 35.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.395 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 158.34 93.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.066 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.688 ' ND2' HG23 ' B' ' 124' ' ' THR . 4.5 t-20 2.53 112.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.001 0.905 . . . . 0.0 113.043 178.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.703 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -138.41 159.66 31.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.799 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 31' ' ' GLU . 39.5 m-20 -86.76 125.99 34.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.565 ' CA ' HD11 ' A' ' 18' ' ' LEU . 3.0 p -37.99 -28.03 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.433 0.635 . . . . 0.0 109.895 -178.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 29' ' ' ASP . 8.7 tt0 -57.04 -13.43 2.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.449 178.535 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.56 34.5 3.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.08 129.65 53.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -1.131 . . . . 0.0 110.069 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.838 HD23 ' N ' ' A' ' 35' ' ' LEU . 5.6 tt -89.02 155.37 19.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 111.067 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.838 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -86.98 107.34 18.36 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 122.073 0.939 . . . . 0.0 111.304 -179.112 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 38' ' ' ASP . 10.6 pt20 -120.59 10.34 11.05 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' OD1' ' HD2' ' B' ' 110' ' ' LYS . 0.7 OUTLIER 53.81 -84.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.721 -0.612 . . . . 0.0 110.371 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' GLN . 0.3 OUTLIER -95.05 148.89 21.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.953 . . . . 0.0 110.405 -179.723 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.36 108.27 7.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.68 69.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -89.97 57.94 4.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -1.096 . . . . 0.0 110.291 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.75 -48.28 0.04 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 16.8 ttt180 -115.01 10.35 16.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 110.118 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.42 -51.62 5.17 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.4 -117.5 2.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.03 170.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.69 150.37 25.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.581 ' CG ' HD12 ' A' ' 52' ' ' LEU . 11.2 m-85 -76.69 145.57 38.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -1.171 . . . . 0.0 110.245 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.0 -141.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 109.892 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -89.57 25.83 1.89 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.132 -0.98 . . . . 0.0 110.097 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -101.19 -26.34 13.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.079 -1.013 . . . . 0.0 110.141 -179.969 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.581 HD12 ' CG ' ' A' ' 48' ' ' PHE . 5.2 mt -105.31 -44.99 4.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 110.898 -179.352 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.91 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -51.76 -55.53 19.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.1 pp20? -65.82 -15.45 62.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.635 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 3.9 m-20 -87.61 -39.57 14.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.508 -0.745 . . . . 0.0 109.28 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.91 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.0 mt -52.26 -43.65 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.481 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.76 13.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -126.52 7.84 6.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -1.153 . . . . 0.0 110.669 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 56' ' ' ILE . 7.4 mt -72.02 -8.45 54.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 110.332 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -80.65 50.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.318 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -148.77 -39.62 0.16 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.812 HD22 HD12 ' B' ' 194' ' ' ILE . 0.1 OUTLIER -71.24 -70.12 0.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.341 -0.849 . . . . 0.0 110.519 -179.904 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.38 -35.07 0.08 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' A' ' 64' ' ' LEU . 3.9 mm? -51.22 -20.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -1.179 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.1 t0 -44.33 -40.62 5.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.95 . . . . 0.0 109.955 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.8 OUTLIER -65.36 -48.41 73.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.914 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.89 -4.26 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.732 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.725 ' C ' HD13 ' A' ' 68' ' ' LEU . 3.4 tm? -78.23 -54.91 5.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.73 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -83.64 1.34 42.81 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.46 0.648 . . . . 0.0 109.695 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 1.5 tt0 -88.31 -1.71 58.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 111.643 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 20' ' ' LEU . 2.2 t -131.74 -1.04 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 118.527 -1.269 . . . . 0.0 109.688 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.036 HD11 HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -151.23 67.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.504 -0.747 . . . . 0.0 110.042 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.6 58.65 0.43 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.993 -1.067 . . . . 0.0 108.622 179.473 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.036 HD12 HD11 ' A' ' 72' ' ' ILE . 27.9 mt -91.59 61.46 4.28 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.571 0.701 . . . . 0.0 110.907 -178.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -100.43 58.59 0.96 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.488 -0.758 . . . . 0.0 110.146 179.763 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 75' ' ' LYS . 18.6 pt-20 37.05 51.66 1.02 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.724 -0.61 . . . . 0.0 110.797 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.361 -179.88 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 61' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' B' ' 62' ' ' GLY . 2.5 t . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.239 0.542 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 62' ' ' GLY . . . . . 0.401 ' N ' ' OG ' ' B' ' 61' ' ' SER . . . -112.77 -42.99 0.9 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.5 mt -115.14 -27.21 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -1.206 . . . . 0.0 110.202 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 8.2 t 61.06 128.2 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.934 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 44.1 Cg_endo -70.14 161.55 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.8 1.421 . . . . 0.0 110.556 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 66' ' ' THR . . . . . 0.483 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.4 m -121.39 133.28 55.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.888 . . . . 0.0 110.161 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.746 HD22 ' CG2' ' B' ' 160' ' ' ILE . 80.9 mt -74.6 108.38 7.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 41.6 mm-40 -89.98 -15.04 32.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.425 ' O ' HG13 ' B' ' 70' ' ' ILE . 2.1 m120 -167.84 164.51 14.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.528 HG12 HG23 ' B' ' 160' ' ' ILE . 7.4 mt -154.82 164.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.556 HG22 ' HB ' ' B' ' 124' ' ' THR . 71.5 t -141.49 132.97 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.265 -0.897 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.02 154.44 39.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.77 121.76 41.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' B' ' 121' ' ' MET . 66.2 t -121.63 134.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -122.79 131.25 53.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 110.16 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' B' ' 150' ' ' ALA . 15.0 mt -83.14 -51.27 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.88 27.4 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.0 134.73 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.266 . . . . 0.0 110.446 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.483 ' O ' HD23 ' B' ' 80' ' ' LEU . 71.6 ttt-85 -56.62 152.24 12.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.612 HD11 HD12 ' B' ' 76' ' ' LEU . 18.3 mt -133.65 158.63 42.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.416 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -102.05 94.01 5.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.029 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.714 HD22 HG23 ' B' ' 102' ' ' VAL . 16.0 mt -43.57 -37.53 2.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 110.341 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 83' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.5 OUTLIER -58.3 -38.88 77.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.183 -179.882 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 27.2 p -89.1 -43.08 11.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.202 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 63.2 t -56.37 -39.89 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -83.89 -26.37 29.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.399 -0.813 . . . . 0.0 109.934 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 25.9 tp -80.13 -43.83 20.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 88' ' ' HIS . . . . . 0.421 ' HB3' HG12 ' B' ' 146' ' ' ILE . 65.2 m80 -77.55 -28.81 51.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 89' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -69.8 139.88 53.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.067 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -23.46 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 110.334 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' B' ' 105' ' ' ARG . 3.2 t-20 -134.88 79.67 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 86' ' ' ALA . . . -141.8 152.58 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.12 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -130.75 131.54 44.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.79 103.59 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 0.5 OUTLIER -115.95 104.8 52.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 96' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' B' ' 95' ' ' ASN . 44.3 Cg_endo -70.67 -23.76 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.107 1.582 . . . . 0.0 110.26 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.33 60.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.545 ' HB3' ' CD1' ' B' ' 99' ' ' PHE . 4.2 tpm_? -112.66 -66.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 109.864 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 99' ' ' PHE . . . . . 0.696 ' CD1' HD13 ' A' ' 18' ' ' LEU . 30.5 p90 -141.55 -170.77 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 110.12 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.46 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -117.49 62.34 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -0.966 . . . . 0.0 110.652 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.883 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -152.02 170.4 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.083 -1.01 . . . . 0.0 110.649 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 102' ' ' VAL . . . . . 0.714 HG23 HD22 ' B' ' 82' ' ' LEU . 24.5 t -106.98 132.63 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.561 179.506 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.648 HD12 HD13 ' B' ' 114' ' ' LEU . 12.8 mm -99.85 97.47 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.135 -0.978 . . . . 0.0 110.507 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 104' ' ' MET . . . . . 0.46 ' HB2' ' HE3' ' B' ' 104' ' ' MET . 23.4 ttm -90.01 158.68 17.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.953 . . . . 0.0 109.824 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' OH ' ' B' ' 139' ' ' TYR . 0.1 OUTLIER -157.3 155.84 31.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.753 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 3.9 pt -136.09 162.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 107' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -102.0 25.11 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 110.083 179.973 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 3.6 tt0 -177.97 90.01 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.95 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 109' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 50.8 Cg_endo -83.11 155.5 73.97 Favored 'Cis proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.181 -2.008 . . . . 0.0 110.345 -0.097 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 5.3 ttmt -61.34 104.01 0.36 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.057 -1.027 . . . . 0.0 109.619 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 111' ' ' THR . . . . . 0.423 HG22 ' C ' ' B' ' 125' ' ' GLY . 29.3 p -144.89 179.49 7.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.754 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -138.64 128.97 25.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.556 -0.715 . . . . 0.0 109.228 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 113' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -106.0 123.69 48.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 111.063 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 114' ' ' LEU . . . . . 0.648 HD13 HD12 ' B' ' 103' ' ' ILE . 4.2 mm? -89.58 92.55 9.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 115' ' ' ILE . . . . . 0.613 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 10.5 mt -92.66 127.11 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.162 -0.961 . . . . 0.0 111.33 -178.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 116' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 2.8 m-85 -100.77 160.26 14.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 109.649 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -79.4 2.52 21.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.996 -1.065 . . . . 0.0 110.111 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.3 t -90.58 -21.71 21.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.97 -33.9 3.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -63.48 172.14 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 109.901 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 121' ' ' MET . . . . . 0.453 ' N ' ' O ' ' B' ' 74' ' ' VAL . 2.5 ttm -164.63 149.65 9.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.587 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.719 HG21 HG12 ' A' ' 71' ' ' VAL . 1.2 t -125.4 145.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.183 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.2 t -129.81 100.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.038 . . . . 0.0 111.029 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 124' ' ' THR . . . . . 0.688 HG23 ' ND2' ' A' ' 27' ' ' ASN . 1.2 t -99.62 165.28 11.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 108.908 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 125' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 27' ' ' ASN . . . 101.92 -3.51 52.35 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.552 ' HB1' ' OG ' ' B' ' 132' ' ' SER . . . -73.22 133.79 44.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.262 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.42 -6.65 27.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 110.438 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 128' ' ' SER . . . . . 0.432 ' HB2' ' CG ' ' B' ' 131' ' ' ASP . 0.4 OUTLIER -160.25 -168.2 2.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 0.0 110.367 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.5 -56.03 4.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.187 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 130' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 7.9 m-20 -63.82 -22.45 66.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.878 . . . . 0.0 110.389 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' B' ' 128' ' ' SER . 5.0 m-20 -68.18 -48.8 64.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.99 . . . . 0.0 110.313 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 132' ' ' SER . . . . . 0.552 ' OG ' ' HB1' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -66.2 -36.59 83.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.217 -179.884 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -58.7 -42.16 87.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.56 -50.78 11.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.44 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -54.13 -50.49 66.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 136' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' B' ' 137' ' ' ARG . 20.6 p -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.771 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 137' ' ' ARG . . . . . 0.424 ' N ' ' OG ' ' B' ' 136' ' ' SER . 5.4 mtp180 -48.25 -43.23 32.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.363 -0.836 . . . . 0.0 109.95 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -57.25 -45.69 83.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.842 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 139' ' ' TYR . . . . . 0.838 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 11.8 m-85 -57.03 -53.23 60.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.77 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.55 -20.14 64.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.85 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -31.96 58.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' B' ' 139' ' ' TYR . 6.3 mt -70.29 -41.36 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 143' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 33.7 mt -68.31 -42.27 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -68.4 -33.98 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -71.47 -22.37 61.82 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' B' ' 88' ' ' HIS . 1.3 mt -81.21 -20.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 122.51 -32.15 4.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 148' ' ' PHE . . . . . 0.581 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 7.7 m-85 -40.85 150.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.132 . . . . 0.0 110.964 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.39 28.68 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.525 -0.734 . . . . 0.0 109.859 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -67.14 148.69 51.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.512 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.0 OUTLIER -136.73 117.86 14.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -56.02 100.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.179 -0.951 . . . . 0.0 110.087 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.2 OUTLIER -144.19 166.17 25.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.845 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.63 35.33 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 110.435 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -78.36 130.86 36.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -165.75 129.19 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 110.607 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 40.5 mt -79.51 129.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.598 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -125.56 -13.17 6.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.056 -1.028 . . . . 0.0 110.933 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 159' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' A' ' 24' ' ' LEU . 2.2 t30 -139.27 98.02 3.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.878 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 160' ' ' ILE . . . . . 0.746 ' CG2' HD22 ' B' ' 67' ' ' LEU . 53.1 mt -97.47 134.08 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.518 179.192 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 24' ' ' LEU . 5.9 t -101.71 133.96 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.665 -179.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 162' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -148.47 163.21 28.97 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 43.2 p -167.56 159.79 12.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 164' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 11.0 p -168.51 158.44 9.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.7 130.97 54.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.578 HG22 ' O ' ' B' ' 210' ' ' GLY . 35.1 m -105.25 12.21 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.181 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 48.79 41.59 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.969 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 168' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' B' ' 238' ' ' ARG . 0.1 OUTLIER -136.55 115.6 10.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 110.206 -179.953 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 169' ' ' PRO . . . . . 0.464 ' HB2' ' CB ' ' B' ' 239' ' ' LYS . 46.4 Cg_endo -72.28 140.21 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.904 1.476 . . . . 0.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.51 ' CD1' ' HA2' ' B' ' 210' ' ' GLY . 2.8 mp -130.17 151.43 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.616 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.5 88.32 7.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.803 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.579 ' CD1' HG23 ' B' ' 208' ' ' VAL . 68.9 mt -51.01 -23.69 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -55.37 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.202 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.63 -46.56 74.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.451 ' O ' HD12 ' B' ' 175' ' ' LEU . 10.3 tp -62.92 -36.95 85.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -1.155 . . . . 0.0 110.446 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 176' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' B' ' 185' ' ' TYR . . . -66.51 -19.87 65.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.277 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -93.84 -35.27 12.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 p -81.36 -26.71 35.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.046 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 179' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' B' ' 183' ' ' SER . 26.4 m-70 -122.83 12.82 9.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -0.853 . . . . 0.0 110.041 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.09 -36.59 5.3 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -26.1 65.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -1.144 . . . . 0.0 110.499 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -122.48 -18.89 6.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 110.344 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' B' ' 195' ' ' TYR . 57.8 m -115.83 165.61 12.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.432 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 2.5 p -141.46 143.2 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.403 -0.811 . . . . 0.0 109.987 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 185' ' ' TYR . . . . . 0.557 ' CD1' ' HB3' ' B' ' 172' ' ' LEU . 78.4 t80 -133.15 94.54 3.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 186' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' B' ' 190' ' ' PHE . 27.4 mt-10 -100.59 102.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.763 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' B' ' 185' ' ' TYR . 45.4 Cg_endo -71.5 -6.94 20.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.687 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.75 -13.99 18.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 189' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' B' ' 189' ' ' LEU . 2.4 tt -137.03 3.64 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.478 ' HB2' HD23 ' B' ' 189' ' ' LEU . 1.4 t80 -169.73 113.4 0.49 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.211 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -19.66 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.923 1.486 . . . . 0.0 110.176 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 192' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' B' ' 172' ' ' LEU . . . -99.64 176.6 28.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 193' ' ' LEU . . . . . 0.457 ' CB ' HD22 ' B' ' 172' ' ' LEU . 5.7 tt -110.69 132.97 53.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 194' ' ' ILE . . . . . 0.812 HD12 HD22 ' A' ' 62' ' ' LEU . 6.8 mt -93.69 106.6 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.302 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 195' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' B' ' 183' ' ' SER . 3.9 t80 -101.33 107.48 18.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 196' ' ' ARG . . . . . 0.51 ' CG ' HG22 ' B' ' 203' ' ' VAL . 1.0 OUTLIER -92.12 99.72 12.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 110.103 -179.974 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 197' ' ' MET . . . . . 0.542 ' HE1' ' HB3' ' B' ' 229' ' ' ALA . 41.5 ttm -70.31 145.05 51.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.266 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.66 -39.14 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 199' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 1.0 OUTLIER -139.7 114.72 8.0 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.91 179.976 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 200' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -72.2 167.32 77.39 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.946 -2.106 . . . . 0.0 110.639 0.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -76.27 93.58 3.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 202' ' ' ILE . . . . . 0.833 HD11 ' CB ' ' B' ' 217' ' ' ALA . 4.5 mt -146.21 165.91 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.914 . . . . 0.0 110.342 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.51 HG22 ' CG ' ' B' ' 196' ' ' ARG . 26.0 t -111.09 119.32 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.43 -0.793 . . . . 0.0 109.661 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 204' ' ' LEU . . . . . 0.573 HD21 ' HB1' ' B' ' 226' ' ' ALA . 5.0 mp -106.37 117.95 35.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.662 HD12 ' HB ' ' B' ' 213' ' ' VAL . 3.4 mt -97.18 119.9 36.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 206' ' ' ILE . . . . . 0.597 HG23 HD21 ' B' ' 234' ' ' LEU . 17.9 mm -98.5 141.22 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.381 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.43 144.98 47.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.035 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.579 HG23 ' CD1' ' B' ' 172' ' ' LEU . 75.5 t -51.66 -24.72 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.291 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.9 t -78.16 -19.37 54.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.096 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.578 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 108.68 5.82 31.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 211' ' ' LYS . . . . . 0.788 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.5 OUTLIER -73.24 137.71 45.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 109.951 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 212' ' ' ILE . . . . . 0.788 HD13 ' O ' ' B' ' 211' ' ' LYS . 17.2 mm -125.37 131.55 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.557 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.662 ' HB ' HD12 ' B' ' 205' ' ' LEU . 21.8 t -114.3 150.28 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.821 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.523 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.2 mp -141.81 111.69 6.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 110.381 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 215' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 15.2 t -134.12 151.61 51.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.125 -0.984 . . . . 0.0 110.155 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.54 -5.4 48.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 217' ' ' ALA . . . . . 0.833 ' CB ' HD11 ' B' ' 202' ' ' ILE . . . -64.71 172.94 2.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -1.143 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -116.57 -16.44 10.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -167.42 163.14 14.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -51.85 -21.9 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.303 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -68.75 -35.93 77.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.54 -53.63 11.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 110.322 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.416 HG22 ' CG ' ' B' ' 65' ' ' PRO . 32.8 mm -50.53 -44.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.63 -34.71 77.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -36.31 59.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 226' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -57.88 -35.7 71.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.298 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 227' ' ' PHE . . . . . 0.643 ' HA ' HG22 ' B' ' 230' ' ' ILE . 20.7 t80 -80.85 -46.3 15.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -58.71 -27.61 65.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' B' ' 197' ' ' MET . . . -83.05 -36.78 24.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.643 HG22 ' HA ' ' B' ' 227' ' ' PHE . 0.8 OUTLIER -89.65 -11.94 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.916 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 231' ' ' TYR . . . . . 0.566 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -43.14 -50.53 14.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.799 . . . . 0.0 110.783 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 232' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.8 Cg_endo -73.27 -44.35 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.599 1.316 . . . . 0.0 110.624 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.65 -30.62 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 109.986 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 234' ' ' LEU . . . . . 0.597 HD21 HG23 ' B' ' 206' ' ' ILE . 9.8 mt -77.09 -47.67 19.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.187 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -21.15 63.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 236' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.2 OUTLIER -70.61 -54.3 12.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.83 . . . . 0.0 110.011 179.838 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.99 34.42 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -64.43 -178.23 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.516 -0.74 . . . . 0.0 110.571 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 239' ' ' LYS . . . . . 0.464 ' CB ' ' HB2' ' B' ' 169' ' ' PRO . 1.2 tttp -114.92 -33.74 5.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.139 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 15.7 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.262 -179.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.952 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.55 ' HA ' HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -88.61 93.08 9.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 111.233 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.952 HD21 HD21 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -99.79 23.14 10.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 1.025 HG22 HG23 ' A' ' 56' ' ' ILE . 3.4 m -52.22 -31.47 32.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.919 -1.113 . . . . 0.0 109.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.74 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -91.9 -26.4 19.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.824 HG13 HD22 ' A' ' 20' ' ' LEU . 1.8 mm -50.74 -48.8 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.332 . . . . 0.0 108.944 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.7 OUTLIER -78.69 -10.68 59.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 0.0 110.193 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.482 ' HB2' ' HA2' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -87.99 -15.22 37.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 110.859 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 148.78 81.78 0.04 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.116 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.635 ' HB2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 33.04 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.067 0.937 . . . . 0.0 112.719 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.0 OUTLIER -139.78 165.02 22.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.767 -1.208 . . . . 0.0 109.765 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.877 ' O ' HD12 ' A' ' 28' ' ' ILE . 69.8 m-20 -88.71 126.63 35.41 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 60.0 p -37.74 -28.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.113 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' ASP . 31.0 mt-10 -57.59 -12.7 2.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 110.447 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 13.88 17.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -96.33 115.5 27.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -1.149 . . . . 0.0 109.515 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.109 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -89.05 138.72 31.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 109.431 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.109 ' N ' HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.897 -1.127 . . . . 0.0 111.506 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.132 0.491 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 26.8 pt-20 -100.85 -21.12 15.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.828 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 52' ' ' LEU . 5.1 mt -102.1 -45.04 5.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 110.694 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.843 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.29 -54.36 21.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.381 -0.824 . . . . 0.0 110.056 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -68.52 -19.86 64.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 44.6 m-20 -86.62 -37.88 17.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 21' ' ' THR . 11.3 mt -52.56 -48.32 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.423 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.11 -22.02 4.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -124.53 8.97 8.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 56' ' ' ILE . 12.3 mt -75.17 -2.23 26.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.047 . . . . 0.0 110.272 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.72 42.42 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -143.89 13.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.779 ' CD1' HG21 ' B' ' 194' ' ' ILE . 3.7 pp -133.32 -31.9 1.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 110.655 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.527 ' N ' HD12 ' A' ' 62' ' ' LEU . . . -175.37 -40.11 0.05 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.637 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.7 mm? -49.84 -20.53 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -1.226 . . . . 0.0 110.531 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -46.89 -39.9 13.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 109.916 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.9 -51.0 60.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.81 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -72.37 -1.98 17.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.623 HD23 ' OG1' ' A' ' 21' ' ' THR . 1.5 tm? -76.46 -60.56 2.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.967 0.889 . . . . 0.0 108.944 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -78.87 0.53 26.87 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.251 0.548 . . . . 0.0 109.993 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 66' ' ' SER . 5.2 tt0 -88.16 8.55 26.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 111.364 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.013 HG12 HG11 ' B' ' 122' ' ' VAL . 2.1 t -138.19 1.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.941 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.019 HD11 ' CD1' ' A' ' 74' ' ' LEU . 4.1 tp -149.08 73.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 6.8 p-10 -75.96 55.77 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.173 -0.954 . . . . 0.0 108.843 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.019 ' CD1' HD11 ' A' ' 72' ' ' ILE . 6.0 mt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.583 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 35.6 mm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.191 0.52 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 5.3 t 62.11 129.28 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.58 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 49.8 Cg_endo -77.57 135.46 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 124.026 1.54 . . . . 0.0 110.253 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -97.59 137.77 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' B' ' 67' ' ' LEU . 20.2 mt -72.68 135.22 45.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -114.64 -29.96 6.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 1.8 m120 -170.0 171.78 6.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 110.119 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.834 HG22 ' HB3' ' B' ' 126' ' ' ALA . 0.5 OUTLIER -144.6 160.6 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.081 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.575 HG22 ' OG1' ' B' ' 124' ' ' THR . 20.5 t -134.96 132.37 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.851 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.29 156.21 48.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.33 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 13.5 m -108.7 144.25 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' B' ' 121' ' ' MET . 8.1 t -132.18 156.89 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 109.961 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -130.15 130.56 44.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.981 HD22 ' HB1' ' B' ' 150' ' ' ALA . 53.3 mt -82.31 -19.65 38.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . 0.418 ' C ' ' SG ' ' B' ' 78' ' ' CYS . . . 79.75 4.53 89.44 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . 0.418 ' SG ' ' C ' ' B' ' 77' ' ' GLY . 23.1 m -143.66 146.72 33.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -1.181 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.682 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -78.95 153.02 30.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' B' ' 76' ' ' LEU . 14.4 mt -132.42 167.62 19.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 2.8 t70 -99.88 94.77 6.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.628 HD22 HG23 ' B' ' 102' ' ' VAL . 26.2 mt -40.94 -46.15 2.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -0.837 . . . . 0.0 110.827 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -54.51 -48.84 71.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.549 HG23 ' CE1' ' B' ' 88' ' ' HIS . 20.1 m -77.57 -38.54 48.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 110.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 55.3 t -54.73 -47.9 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.062 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.37 -29.56 63.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.023 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 28.5 tp -78.21 -30.16 48.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 109.987 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.549 ' CE1' HG23 ' B' ' 84' ' ' THR . 0.7 OUTLIER -91.5 -25.76 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.945 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.01 131.82 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 110.071 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 -69.53 -29.74 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -133.5 79.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -143.31 152.79 42.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -130.3 136.97 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.149 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -125.89 101.54 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 110.386 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.21 110.33 63.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.861 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.82 -15.38 26.67 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.057 1.556 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.45 -15.29 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.651 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -102.65 -43.09 5.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.081 -1.012 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.762 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -165.19 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 111.314 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.29 54.0 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.143 -0.973 . . . . 0.0 111.128 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.935 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -149.42 166.14 29.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.628 HG23 HD22 ' B' ' 82' ' ' LEU . 66.8 t -99.43 166.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.93 . . . . 0.0 109.985 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.55 ' CD1' ' HB3' ' B' ' 114' ' ' LEU . 23.1 mm -129.84 107.45 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.38 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.54 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.0 OUTLIER -89.67 164.72 14.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.009 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.71 135.24 6.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 19.0 pt -133.58 159.48 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.795 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' B' ' 108' ' ' GLU . 1.4 ptt180 -102.62 17.65 23.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.523 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.5 OUTLIER -161.05 88.94 1.63 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 110.446 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.3 Cg_endo -75.88 162.37 92.4 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.35 -0.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -74.36 83.54 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.055 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' B' ' 124' ' ' THR . 14.6 p -134.05 178.4 6.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 110.272 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.513 HG22 HG23 ' B' ' 124' ' ' THR . 5.2 t -131.82 159.24 39.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -152.8 155.44 37.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.966 -1.084 . . . . 0.0 110.868 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.55 ' HB3' ' CD1' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -131.66 115.1 15.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.739 . . . . 0.0 109.611 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' B' ' 121' ' ' MET . 10.8 mt -96.37 146.08 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.946 . . . . 0.0 110.753 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 3.5 m-30 -104.51 157.81 16.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.374 -0.829 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.91 -15.43 30.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.353 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 60.2 p -84.8 4.5 32.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.09 -28.59 7.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 3.6 ttmt -67.88 127.91 34.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -1.169 . . . . 0.0 110.116 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.425 ' HB3' HG12 ' B' ' 115' ' ' ILE . 0.2 OUTLIER -136.03 157.72 46.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 1.013 HG11 HG12 ' A' ' 71' ' ' VAL . 11.4 t -123.06 129.86 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.366 -0.834 . . . . 0.0 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' B' ' 139' ' ' TYR . 60.2 t -113.85 139.55 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.476 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.575 ' OG1' HG22 ' B' ' 71' ' ' VAL . 10.2 t -142.6 156.83 45.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.524 ' CA ' ' HB3' ' A' ' 27' ' ' ASN . . . 123.83 -13.89 8.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.834 ' HB3' HG22 ' B' ' 70' ' ' ILE . . . -76.87 158.71 30.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.117 . . . . 0.0 110.029 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.414 ' C ' ' OG ' ' B' ' 128' ' ' SER . 25.2 mtmt -109.47 -1.15 18.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.278 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -163.89 -170.12 2.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.0 OUTLIER -68.44 -60.58 2.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -55.86 -31.95 63.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.409 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 9.9 m-20 -65.04 -42.1 94.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.72 -38.69 32.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . 0.423 ' CG ' ' CE2' ' B' ' 155' ' ' PHE . 10.8 mttm -53.1 -39.5 63.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.118 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.4 -47.04 29.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.97 -43.59 70.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.01 -55.71 26.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -46.21 -44.8 16.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 110.082 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -57.79 -51.35 69.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' B' ' 104' ' ' MET . 22.7 m-85 -58.2 -57.63 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . 0.463 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -50.28 -31.68 14.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.11 62.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.312 -0.868 . . . . 0.0 109.855 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.423 HG21 ' SD ' ' B' ' 104' ' ' MET . 50.5 mt -45.03 -38.86 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.985 HG21 ' HB2' ' B' ' 150' ' ' ALA . 41.0 mm -69.37 -52.73 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.676 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.463 ' NE2' ' O ' ' B' ' 140' ' ' ALA . 16.1 mt-30 -64.97 -28.48 69.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -75.1 -21.2 59.06 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.29 -21.24 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.74 -22.26 5.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' B' ' 143' ' ' ILE . 23.2 m-85 -64.41 179.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.312 . . . . 0.0 111.199 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -113.76 36.35 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.592 -0.692 . . . . 0.0 110.304 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.985 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -60.46 148.33 37.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.97 . . . . 0.0 110.201 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -113.47 -157.97 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.227 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' B' ' 152' ' ' PHE . 1.0 OUTLIER -147.09 77.93 1.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 110.077 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -144.75 178.95 7.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' B' ' 153' ' ' THR . 15.1 t0 66.97 22.3 10.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 110.298 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' B' ' 73' ' ' THR . 8.4 t80 -77.38 132.74 38.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -164.97 133.48 3.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.149 -0.969 . . . . 0.0 110.731 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.461 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 33.9 mt -81.2 108.37 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.721 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.09 -2.04 32.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.746 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 8.9 t-20 -152.24 120.36 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.936 -1.103 . . . . 0.0 110.983 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.38 137.76 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 109.428 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -106.99 135.28 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 110.798 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.78 177.08 20.77 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.1 OUTLIER -169.65 153.33 4.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.246 . . . . 0.0 110.722 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 24.6 p -169.11 165.46 11.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 109.824 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 22.4 p-10 -115.94 134.05 55.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.328 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.846 HG21 HD11 ' B' ' 170' ' ' ILE . 33.6 m -80.06 4.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 110.089 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.59 -4.51 2.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.49 -0.756 . . . . 0.0 111.138 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.732 ' H ' HG23 ' B' ' 166' ' ' VAL . 22.4 p90 -145.91 153.11 49.47 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.9 -1.125 . . . . 0.0 110.532 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.51 159.72 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.072 1.564 . . . . 0.0 110.329 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.846 HD11 HG21 ' B' ' 166' ' ' VAL . 2.1 mp -128.38 152.93 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.514 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -82.11 101.45 10.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.81 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.521 HD22 ' HB2' ' B' ' 193' ' ' LEU . 18.8 mt -55.0 -42.03 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 110.512 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.92 -21.61 59.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.14 -45.52 31.27 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 1.015 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -67.84 -36.67 80.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.88 61.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.303 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -91.12 -16.37 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . 0.534 ' OG ' ' CZ ' ' B' ' 237' ' ' PHE . 0.3 OUTLIER -99.59 -33.37 10.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -120.89 37.06 4.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.42 -21.2 6.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . 0.461 ' O ' ' CG ' ' B' ' 182' ' ' PHE . 16.2 p -87.53 23.47 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.506 ' CZ ' HG22 ' B' ' 198' ' ' VAL . 0.9 OUTLIER -169.82 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.282 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 13.5 p -89.98 151.07 21.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.276 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.9 m -128.69 148.73 50.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -158.1 112.6 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.55 104.02 53.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.94 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.35 -3.17 12.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.467 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.8 -7.32 30.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' B' ' 190' ' ' PHE . 2.5 tt -148.66 -44.02 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 110.551 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.699 ' HB2' HD23 ' B' ' 189' ' ' LEU . 12.6 t80 -117.12 110.17 41.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . 0.513 ' O ' HD13 ' B' ' 172' ' ' LEU . 45.6 Cg_endo -74.79 -12.81 22.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.924 1.486 . . . . 0.0 110.21 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.514 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -92.9 179.52 39.77 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.863 HD23 ' N ' ' B' ' 194' ' ' ILE . 3.7 tt -115.18 148.34 39.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 110.102 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.863 ' N ' HD23 ' B' ' 193' ' ' LEU . 4.3 mt -123.3 103.37 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.279 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.503 ' CD1' HD13 ' B' ' 230' ' ' ILE . 27.0 t80 -95.03 120.47 35.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 197' ' ' MET . 1.8 ttp180 -90.03 82.62 6.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.427 ' C ' ' O ' ' B' ' 196' ' ' ARG . 31.2 tpp -42.63 130.16 4.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.506 HG22 ' CZ ' ' B' ' 182' ' ' PHE . 14.9 t -70.51 -52.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 8.5 ttpp -143.68 117.11 5.92 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.1 Cg_endo -71.98 171.89 59.82 Favored 'Cis proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.025 -2.073 . . . . 0.0 110.601 -0.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -82.31 108.69 15.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.138 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' B' ' 217' ' ' ALA . 9.2 mt -150.8 155.95 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.496 HG13 HG23 ' B' ' 194' ' ' ILE . 70.0 t -105.39 131.21 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 109.671 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.506 HD22 HG21 ' B' ' 230' ' ' ILE . 5.3 mp -119.19 123.04 43.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.508 HD22 ' N ' ' B' ' 205' ' ' LEU . 4.4 mm? -94.12 124.04 37.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.517 HG12 HD12 ' B' ' 212' ' ' ILE . 2.5 mp -124.55 122.44 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.514 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 95.6 m-85 -110.36 149.84 29.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 40.8 t -45.73 -24.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -29.23 70.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.363 -0.836 . . . . 0.0 110.331 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 109.85 2.91 30.31 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 123.61 27.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -1.156 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.517 HD12 HG12 ' B' ' 206' ' ' ILE . 19.4 mm -116.56 125.43 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.64 ' C ' HD12 ' B' ' 214' ' ' LEU . 4.0 t -110.62 154.82 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.052 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.64 HD12 ' C ' ' B' ' 213' ' ' VAL . 5.2 mp -141.87 103.35 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -0.884 . . . . 0.0 110.481 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.476 ' O ' HG23 ' B' ' 202' ' ' ILE . 13.3 t -126.66 152.57 46.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.984 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.473 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 106.64 -4.41 36.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' B' ' 202' ' ' ILE . . . -68.87 162.67 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -1.193 . . . . 0.0 110.013 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -114.68 -6.9 12.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.15 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' B' ' 222' ' ' GLU . 1.9 tt0 -159.66 147.44 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' B' ' 219' ' ' GLN . 20.7 ttm180 -43.85 -37.25 2.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -61.43 -34.07 74.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 110.156 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.593 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 6.2 mt-10 -63.73 -53.31 53.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 110.254 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.518 HG12 ' CB ' ' B' ' 217' ' ' ALA . 18.7 mm -57.71 -42.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.46 ' CE2' HG13 ' B' ' 64' ' ' VAL . 2.7 m-85 -66.56 -28.84 68.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.107 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 2.6 tt0 -82.4 -50.06 9.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.153 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' B' ' 225' ' ' GLN . . . -45.51 -43.59 11.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.728 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 26.2 t80 -69.69 -41.46 75.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -15.38 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.174 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -92.53 -42.0 9.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 110.027 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.506 HG21 HD22 ' B' ' 204' ' ' LEU . 1.5 tp -90.55 -14.74 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.5 t80 -49.28 -49.72 68.72 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.3 Cg_endo -70.39 -45.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.47 1.247 . . . . 0.0 110.272 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 1.015 HG12 HD21 ' B' ' 175' ' ' LEU . 22.4 t -49.96 -39.24 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.705 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.403 HD22 HG21 ' B' ' 170' ' ' ILE . 96.5 mt -73.33 -50.75 20.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.744 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 14.0 t -55.93 -33.16 64.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.17 -32.38 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.77 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.546 ' HD2' HD22 ' B' ' 175' ' ' LEU . 22.5 m-85 -117.36 37.72 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 110.092 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -61.31 171.95 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.127 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -102.49 -47.14 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 110.111 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.023 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.235 0.541 . . . . 0.0 109.825 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.896 ' N ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -66.91 82.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.174 -0.954 . . . . 0.0 110.762 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.92 HD21 HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -98.59 -0.16 43.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.08 -1.013 . . . . 0.0 110.706 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 59' ' ' LEU . 8.2 m -45.98 -29.34 1.41 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.57 -32.26 5.78 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.875 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -55.81 -43.07 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 108.738 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.009 HD13 ' SD ' ' A' ' 67' ' ' MET . 3.4 pp -82.4 -28.71 31.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.545 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.2 OUTLIER -93.36 13.12 22.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.397 -0.814 . . . . 0.0 108.871 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.587 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 142.85 94.46 0.2 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 1.008 ' ND2' HD11 ' A' ' 35' ' ' LEU . 7.0 p30 -20.27 132.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.031 0.919 . . . . 0.0 112.39 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.714 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -147.11 163.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 31' ' ' GLU . 80.3 m-20 -87.3 124.2 33.1 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.023 ' HB2' HD13 ' A' ' 18' ' ' LEU . 5.3 p -37.96 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.793 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.4 mm-40 -55.1 -15.99 2.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 110.164 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.86 27.49 5.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.492 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -123.33 121.22 35.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.098 -1.236 . . . . 0.0 110.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -94.24 157.8 15.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.759 -1.213 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.008 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.997 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.274 0.559 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -100.87 -17.73 16.71 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 52' ' ' LEU . 4.0 mt -99.26 -44.24 6.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.436 -0.79 . . . . 0.0 110.384 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.008 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.21 -54.25 42.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 110.085 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -67.41 -22.47 65.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.475 -0.765 . . . . 0.0 110.211 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.58 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 7.0 m-80 -87.4 -28.65 22.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.31 -0.869 . . . . 0.0 109.186 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' A' ' 53' ' ' ARG . 12.6 mt -56.93 -48.3 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.462 -0.773 . . . . 0.0 108.981 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.49 -22.09 5.11 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.413 ' HB3' HD11 ' B' ' 189' ' ' LEU . 0.5 OUTLIER -130.07 25.76 5.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.847 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.789 HD21 ' CE2' ' B' ' 190' ' ' PHE . 6.2 mt -92.79 22.63 4.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.01 . . . . 0.0 109.88 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.38 52.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.687 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -169.82 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.697 ' CD1' HD23 ' A' ' 59' ' ' LEU . 3.4 mt -112.79 -50.03 2.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 109.805 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.85 -31.11 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -75.2 0.92 14.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.787 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' LEU . 10.5 t70 -43.71 -41.34 4.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.777 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -46.23 78.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.414 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 1.009 ' SD ' HD13 ' A' ' 24' ' ' LEU . 15.9 ttm -65.99 -9.61 31.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 109.417 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.0 tm? -71.41 -61.73 1.67 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.987 0.899 . . . . 0.0 108.687 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.61 -1.74 26.0 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.528 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 11.9 tt0 -85.9 11.59 11.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.272 -0.893 . . . . 0.0 111.347 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.953 ' O ' HG21 ' B' ' 122' ' ' VAL . 2.2 t -144.88 3.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.963 -1.085 . . . . 0.0 110.565 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.002 ' CD1' HD23 ' A' ' 18' ' ' LEU . 4.1 tp -147.33 74.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.7 54.38 1.8 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.144 -0.972 . . . . 0.0 108.553 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.133 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 7.5 mt . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 121.564 0.697 . . . . 0.0 110.397 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.641 HG22 ' SG ' ' B' ' 164' ' ' CYS . 2.3 mp . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 120.927 0.394 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 5.9 t 63.76 139.4 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 109.987 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.744 ' HG2' HG22 ' B' ' 223' ' ' ILE . 45.1 Cg_endo -72.32 135.67 25.06 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.115 1.587 . . . . 0.0 110.856 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 51.6 m -100.18 136.84 39.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.663 HD22 ' CG2' ' B' ' 160' ' ' ILE . 84.6 mt -70.4 133.79 47.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -130.82 -3.29 4.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 110.348 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.4 OUTLIER -162.51 126.41 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.332 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.971 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 14.1 mm -115.21 157.17 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.504 HG22 ' HB ' ' B' ' 124' ' ' THR . 7.7 t -141.82 121.53 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 109.692 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.5 162.88 26.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 110.549 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . 0.587 HG22 HG22 ' B' ' 122' ' ' VAL . 18.1 p -121.85 135.4 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.538 HG11 ' CD1' ' B' ' 152' ' ' PHE . 13.0 t -125.23 148.45 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 17.5 m -118.08 142.19 47.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.888 HD22 ' HB1' ' B' ' 150' ' ' ALA . 40.6 mt -101.29 -50.86 3.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.075 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.56 -12.5 23.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.46 172.46 9.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.623 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.5 OUTLIER -101.71 150.53 23.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.184 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.623 HD23 ' O ' ' B' ' 79' ' ' ARG . 17.4 mt -126.23 175.78 7.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -0.908 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.59 96.85 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.049 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.612 HD22 HG23 ' B' ' 102' ' ' VAL . 17.7 mt -43.87 -41.13 4.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.875 . . . . 0.0 110.329 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' B' ' 94' ' ' TYR . 12.8 mmtp -55.55 -47.45 76.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 110.343 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -79.91 -41.24 26.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 54.4 t -54.8 -54.59 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.933 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.71 69.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.927 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 34.9 tp -81.84 -25.1 35.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -98.34 -42.27 7.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.127 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -47.6 133.2 13.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.066 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . 0.506 ' HG3' ' N ' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -70.63 -25.28 62.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.506 ' N ' ' HG3' ' B' ' 90' ' ' ARG . 1.2 m-20 -138.7 79.18 1.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.345 -0.847 . . . . 0.0 109.794 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.814 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -159.13 171.9 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.531 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.529 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -157.23 172.01 19.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 110.051 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.435 ' CD2' ' HE3' ' B' ' 83' ' ' LYS . 18.6 t80 -135.7 129.21 32.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' B' ' 95' ' ' ASN . 6.7 p30 -123.17 102.34 37.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.095 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.32 -26.06 17.83 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.015 1.534 . . . . 0.0 110.479 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -75.43 -20.94 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -100.07 -71.64 0.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -149.3 163.5 37.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 110.402 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.411 ' O ' HD11 ' B' ' 82' ' ' LEU . . . -82.51 47.96 1.24 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 109.305 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.133 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -126.35 144.5 50.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.904 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.612 HG23 HD22 ' B' ' 82' ' ' LEU . 6.8 t -90.02 124.95 42.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.529 ' HB ' ' CG ' ' B' ' 93' ' ' GLU . 8.8 mm -88.27 110.35 20.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.857 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.814 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 3.1 ttm -106.49 161.08 14.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 110.387 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' B' ' 111' ' ' THR . 0.5 OUTLIER -162.29 126.6 3.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.893 . . . . 0.0 110.293 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.64 HG23 ' CE1' ' B' ' 139' ' ' TYR . 37.4 pt -107.85 176.37 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.981 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.475 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -120.04 42.05 3.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER 170.7 85.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 48.8 Cg_endo -78.3 160.23 91.81 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.723 -2.199 . . . . 0.0 110.467 -0.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.476 ' O ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -67.56 105.25 1.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.95 . . . . 0.0 109.777 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.666 HG22 ' HA3' ' B' ' 125' ' ' GLY . 11.2 p -152.85 176.67 11.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.615 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.85 HG22 HG23 ' B' ' 124' ' ' THR . 5.3 t -131.37 171.42 13.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -156.74 141.61 17.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.991 -1.068 . . . . 0.0 110.642 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.818 HD22 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -98.53 103.78 15.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.449 -0.782 . . . . 0.0 109.048 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' B' ' 104' ' ' MET . 4.4 mt -89.76 135.74 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.119 -0.988 . . . . 0.0 110.61 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.905 ' CD1' HD11 ' A' ' 74' ' ' LEU . 3.0 m-30 -110.35 150.72 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.102 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.514 ' O ' ' CG ' ' B' ' 79' ' ' ARG . . . -70.05 -10.9 60.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.274 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -7.37 53.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.508 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 105.77 -18.61 40.23 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -88.32 160.07 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -1.183 . . . . 0.0 110.246 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 3.3 ptm -156.69 164.44 38.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.252 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.953 HG21 ' O ' ' A' ' 71' ' ' VAL . 35.7 t -128.57 161.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 110.485 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.418 ' N ' HG12 ' B' ' 122' ' ' VAL . 53.3 t -138.76 151.23 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.015 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.85 HG23 HG22 ' B' ' 112' ' ' THR . 1.2 t -157.23 164.26 37.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 110.344 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.666 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 110.79 -39.2 2.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.971 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.48 158.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -1.106 . . . . 0.0 110.317 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -124.05 -6.02 7.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.6 175.44 9.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.146 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.59 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.22 -16.71 5.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.264 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.678 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 0.3 OUTLIER -72.3 -49.66 32.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -25.06 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 110.422 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -78.91 -26.09 43.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.521 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.473 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 7.4 mt -79.12 -49.82 12.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -65.79 -30.83 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 51.0 p -67.97 -60.57 2.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.198 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' B' ' 134' ' ' LEU . 1.4 ptm180 -54.68 -33.19 60.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.006 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.422 ' O ' HG13 ' B' ' 142' ' ' ILE . 0.1 OUTLIER -65.91 -40.78 91.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 0.0 110.074 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.64 ' CE1' HG23 ' B' ' 106' ' ' ILE . 11.7 m-85 -65.98 -49.25 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' B' ' 152' ' ' PHE . . . -55.62 -30.58 61.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -71.94 -31.68 66.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 138' ' ' LYS . 34.5 mt -61.79 -42.7 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.626 ' N ' HD12 ' B' ' 143' ' ' ILE . 1.8 mp -67.51 -44.5 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -72.94 -30.05 63.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.655 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -20.11 61.52 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.412 HD13 HG21 ' B' ' 146' ' ' ILE . 3.6 mt -86.14 -24.07 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.72 -26.27 3.65 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.535 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.497 ' CD1' HD22 ' B' ' 80' ' ' LEU . 12.3 m-85 -52.27 158.16 1.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.943 -1.328 . . . . 0.0 110.988 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.65 34.72 2.16 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.888 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -68.57 169.6 10.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.352 -0.842 . . . . 0.0 110.421 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.9 OUTLIER -148.91 112.74 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 110.264 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.573 ' O ' HG23 ' B' ' 153' ' ' THR . 83.5 t80 -58.97 108.34 0.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 152' ' ' PHE . 1.4 p -156.18 169.37 24.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' B' ' 153' ' ' THR . 4.2 t70 62.41 28.84 17.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.217 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -70.91 134.02 46.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.953 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.91 131.41 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.496 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.435 ' C ' ' HG2' ' B' ' 158' ' ' GLN . 14.7 mt -82.91 131.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.435 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 3.6 mt-30 -128.76 0.32 5.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.781 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.462 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 2.1 t-20 -147.79 110.11 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.921 -1.112 . . . . 0.0 110.709 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.663 ' CG2' HD22 ' B' ' 67' ' ' LEU . 66.4 mt -113.26 141.35 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.589 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.575 HG22 ' OG1' ' B' ' 215' ' ' THR . 72.8 t -115.93 130.05 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.13 -0.981 . . . . 0.0 110.645 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.97 168.3 19.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 1.0 OUTLIER -166.57 149.44 6.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.262 . . . . 0.0 110.545 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.641 ' SG ' HG22 ' B' ' 63' ' ' ILE . 0.8 OUTLIER -170.07 170.18 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.021 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 164.08 12.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.032 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.797 HG21 HD11 ' B' ' 170' ' ' ILE . 32.6 m -113.2 11.97 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.279 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.53 -2.25 2.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.585 ' O ' HG23 ' B' ' 166' ' ' VAL . 26.1 p90 -161.37 150.09 13.09 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.987 -1.071 . . . . 0.0 110.568 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.508 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 47.8 Cg_endo -73.88 170.24 20.53 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.133 1.596 . . . . 0.0 110.732 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.797 HD11 HG21 ' B' ' 166' ' ' VAL . 4.4 mp -140.36 151.28 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 110.378 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.76 80.27 7.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 109.946 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.792 HD21 HG22 ' B' ' 206' ' ' ILE . 18.9 mt -47.07 -37.97 10.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 110.42 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.17 -55.27 22.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.24 92.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 18.3 tp -70.12 -39.67 75.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -1.169 . . . . 0.0 110.373 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.64 -26.69 67.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.955 . . . . 0.0 110.18 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -77.01 -30.05 55.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 1.3 p -87.42 -44.64 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -105.72 26.51 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 110.259 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.55 54.85 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.7 m -53.8 -39.03 65.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -1.188 . . . . 0.0 110.433 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' B' ' 198' ' ' VAL . 19.9 m-85 -108.26 -26.97 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.401 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.797 ' HB2' HD21 ' B' ' 193' ' ' LEU . 47.9 p -96.05 158.05 15.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.624 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.2 m -132.43 119.75 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.677 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -125.42 112.13 15.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 110.565 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -118.94 102.55 49.11 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 109.666 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.61 -1.18 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.93 1.489 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -98.95 -3.64 34.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.036 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.509 HD13 ' HE3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -150.93 -37.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.789 ' CE2' HD21 ' A' ' 59' ' ' LEU . 7.8 t80 -127.95 110.98 20.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.86 -17.64 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.888 1.467 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.87 -179.94 44.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' B' ' 183' ' ' SER . 7.6 tt -118.38 130.07 55.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -1.143 . . . . 0.0 110.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.482 HD13 ' CD1' ' A' ' 62' ' ' LEU . 5.7 mt -102.96 100.94 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 109.914 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -91.79 120.26 32.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.471 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' B' ' 203' ' ' VAL . 1.1 mtp180 -92.54 83.45 4.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.475 ' HB2' ' CD1' ' B' ' 204' ' ' LEU . 33.7 tpp -42.11 126.81 3.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.935 . . . . 0.0 110.189 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.507 HG22 ' CE1' ' B' ' 182' ' ' PHE . 61.9 t -63.17 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 8.8 mtmt -137.4 118.13 10.65 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.6 Cg_endo -74.16 169.54 73.53 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.986 -2.089 . . . . 0.0 110.369 -0.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' B' ' 197' ' ' MET . 37.2 mttt -76.85 95.35 4.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.044 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' B' ' 217' ' ' ALA . 31.8 mm -130.96 149.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' B' ' 196' ' ' ARG . 71.4 t -101.83 105.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.032 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.749 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.5 mp -95.82 118.5 32.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.45 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' B' ' 205' ' ' LEU . 0.5 OUTLIER -89.65 117.41 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 109.935 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.792 HG22 HD21 ' B' ' 172' ' ' LEU . 3.2 mt -113.0 136.0 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.351 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.544 ' HA ' HD11 ' B' ' 172' ' ' LEU . 44.7 m-85 -119.62 145.2 46.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 64.3 t -49.19 -24.36 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -62.67 -38.65 91.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 110.133 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.483 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 123.36 8.77 6.29 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -90.06 145.22 25.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.241 . . . . 0.0 110.232 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' B' ' 163' ' ' SER . 30.3 mm -130.05 121.69 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.335 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.516 HG11 ' HE1' ' A' ' 25' ' ' PHE . 57.4 t -113.86 155.74 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.051 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.487 HD12 ' N ' ' B' ' 214' ' ' LEU . 2.6 mp -140.12 121.94 15.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 110.629 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.575 ' OG1' HG22 ' B' ' 161' ' ' VAL . 6.2 t -137.02 146.48 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.886 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 111.18 3.9 27.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -82.99 138.45 33.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -29.27 32.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.582 ' O ' HD12 ' B' ' 160' ' ' ILE . 3.2 tt0 -136.17 -152.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 110.029 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -100.11 -36.89 9.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.432 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 16.0 pt-20 -54.69 -27.38 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.119 -0.988 . . . . 0.0 110.518 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 0.8 OUTLIER -71.61 -47.43 54.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.242 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.744 HG22 ' HG2' ' B' ' 65' ' ' PRO . 40.8 mm -62.63 -37.61 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.29 -29.19 67.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.923 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -37.63 41.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.321 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.749 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -61.32 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.365 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' B' ' 230' ' ' ILE . 27.9 t80 -64.81 -46.54 81.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.394 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.42 -32.68 71.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -85.14 -25.94 27.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.426 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' B' ' 227' ' ' PHE . 8.7 tp -97.2 -17.94 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.595 ' N ' ' CD ' ' B' ' 232' ' ' PRO . 14.3 t80 -59.63 -41.34 85.76 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.943 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -77.93 -47.22 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.36 1.189 . . . . 0.0 110.384 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.49 -50.8 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.724 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.522 ' CD1' HG13 ' B' ' 230' ' ' ILE . 95.7 mt -59.14 -38.13 78.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.833 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 3.4 t -65.53 -39.39 91.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.392 -0.818 . . . . 0.0 109.816 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . 0.519 ' HG2' ' CE1' ' B' ' 237' ' ' PHE . 0.8 OUTLIER -60.14 -33.85 72.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.677 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.519 ' CE1' ' HG2' ' B' ' 236' ' ' GLU . 65.2 m-85 -115.39 37.41 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.827 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -62.52 168.64 3.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 0.0 110.257 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.429 ' HB2' ' C ' ' B' ' 169' ' ' PRO . 0.0 OUTLIER -111.84 -33.32 6.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 110.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.196 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.095 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 19' ' ' ASP . 1.9 p30 -86.19 109.12 18.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.095 HD21 HD21 ' A' ' 18' ' ' LEU . 3.4 mt -101.17 18.45 19.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.89 HG22 HG23 ' A' ' 56' ' ' ILE . 1.3 m -45.19 -29.86 1.05 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.057 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -98.44 -27.8 8.4 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.495 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.934 HG13 HD22 ' A' ' 20' ' ' LEU . 1.1 mm -52.36 -45.87 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.912 -1.346 . . . . 0.0 109.359 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 67' ' ' MET . 2.0 pp -85.86 -26.51 25.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.608 -1.308 . . . . 0.0 109.665 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CD1' HG21 ' B' ' 215' ' ' THR . 0.5 OUTLIER -83.88 7.41 18.22 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 142.61 106.04 0.57 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 6.4 p-10 -24.49 135.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.784 0.802 . . . . 0.0 111.396 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.749 HG23 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -150.42 161.77 3.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.546 ' N ' HG12 ' A' ' 28' ' ' ILE . 5.3 m-20 -87.48 119.2 27.52 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.572 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 1.3 p -39.53 -26.69 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.898 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.1 tt0 -57.55 -13.37 3.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.117 -0.989 . . . . 0.0 110.43 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.23 27.71 4.67 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.416 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.555 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.5 mmt-85 -120.77 122.19 39.83 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.085 -1.244 . . . . 0.0 109.861 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 35' ' ' LEU . 3.1 tt -87.67 162.07 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.933 -1.105 . . . . 0.0 111.738 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.691 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 O-C-N 121.472 -0.767 . . . . 0.0 111.355 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.14 0.495 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.503 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -100.28 -22.13 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.349 -0.844 . . . . 0.0 109.469 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.493 HD13 ' CE2' ' A' ' 25' ' ' PHE . 3.7 mt -95.39 -45.21 7.22 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.546 -0.721 . . . . 0.0 110.157 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.999 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -49.5 -52.47 29.21 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.152 -0.968 . . . . 0.0 109.6 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.79 -23.21 66.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 12.5 m-20 -85.83 -33.99 21.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.999 HD12 ' HA ' ' A' ' 53' ' ' ARG . 15.6 mt -54.22 -42.14 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 109.372 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.35 -14.89 35.96 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.976 ' HB3' HD11 ' B' ' 189' ' ' LEU . 49.7 m -122.07 0.05 9.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.12 -1.223 . . . . 0.0 110.297 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.897 HD23 HD12 ' A' ' 62' ' ' LEU . 1.2 mt -81.38 8.32 9.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -91.18 43.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.697 ' C ' HD23 ' A' ' 62' ' ' LEU . 5.9 pttt -172.88 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.897 HD12 HD23 ' A' ' 59' ' ' LEU . 3.7 mt -105.15 -43.82 4.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.03 -28.3 0.09 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.719 HD12 HD21 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -84.53 0.19 50.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -1.212 . . . . 0.0 110.108 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.546 ' HA ' ' HG ' ' A' ' 68' ' ' LEU . 4.7 t70 -50.36 -39.69 47.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 109.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.76 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -58.7 -32.2 68.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.895 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.704 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -70.45 -26.79 63.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.885 . . . . 0.0 109.74 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.719 HD21 HD12 ' A' ' 64' ' ' LEU . 7.4 mt -64.43 -61.7 2.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.725 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.76 HD21 ' HA ' ' A' ' 66' ' ' SER . 3.3 pp -58.04 -12.63 3.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.676 -0.64 . . . . 0.0 110.341 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -87.05 2.75 48.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 110.592 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.018 HG12 HG11 ' B' ' 122' ' ' VAL . 2.8 t -127.74 -0.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.393 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.054 HD11 HD12 ' A' ' 74' ' ' LEU . 2.8 tp -150.51 68.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -73.43 56.95 0.52 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.849 -1.157 . . . . 0.0 108.975 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.095 HD11 ' CB ' ' B' ' 101' ' ' ALA . 5.6 mt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.693 0.759 . . . . 0.0 110.472 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.495 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 4.2 mt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.156 0.503 . . . . 0.0 110.381 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' B' ' 65' ' ' PRO . 91.8 t 59.34 142.22 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.436 -0.79 . . . . 0.0 110.301 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' B' ' 64' ' ' VAL . 47.3 Cg_endo -72.97 123.96 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.844 1.444 . . . . 0.0 110.745 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.447 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 9.3 m -92.06 135.0 34.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.484 ' HG ' ' NH2' ' B' ' 220' ' ' ARG . 19.0 mt -69.95 125.41 26.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 110.323 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -101.4 -27.29 13.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.147 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' HB ' ' B' ' 161' ' ' VAL . 5.6 m120 -156.14 162.73 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.861 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 17.0 mm -136.48 150.64 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.794 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' B' ' 124' ' ' THR . 24.1 t -136.76 140.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.99 149.4 36.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.909 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.38 128.32 45.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -0.954 . . . . 0.0 110.539 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' B' ' 121' ' ' MET . 59.0 t -119.67 151.2 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 109.955 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 23.5 m -129.49 142.91 50.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' B' ' 150' ' ' ALA . 49.4 mt -100.05 -46.2 5.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.18 55.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.5 158.65 43.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -1.178 . . . . 0.0 110.212 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -80.13 142.96 34.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 1.028 HD11 ' CD1' ' B' ' 76' ' ' LEU . 25.7 mt -116.65 153.68 31.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.423 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' B' ' 82' ' ' LEU . 8.2 t0 -96.93 86.9 4.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.468 ' HA ' HG21 ' B' ' 102' ' ' VAL . 8.6 mt -40.66 -43.62 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.845 . . . . 0.0 110.362 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -54.13 -45.45 71.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.94 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 14.7 m -81.02 -44.5 17.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.96 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 40.8 t -54.94 -43.08 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 110.159 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.86 -25.59 48.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.69 -33.49 20.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.213 -0.929 . . . . 0.0 110.124 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.0 m80 -83.22 -44.83 14.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.31 141.84 22.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.089 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . 0.41 ' O ' ' OD1' ' B' ' 91' ' ' ASN . 21.7 mtt85 -81.05 -15.44 56.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.483 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' B' ' 104' ' ' MET . 16.0 m-20 -139.54 79.94 1.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' B' ' 93' ' ' GLU . . . -152.95 161.91 41.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' B' ' 92' ' ' ALA . 37.7 mt-10 -142.46 161.61 37.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 110.132 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -152.04 130.56 12.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.928 . . . . 0.0 110.324 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.41 122.99 6.28 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.11 -16.71 28.56 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.908 1.478 . . . . 0.0 110.343 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -77.78 -9.73 59.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -109.3 -59.94 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.261 -0.899 . . . . 0.0 110.137 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.666 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -163.07 -159.23 0.53 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.496 -0.753 . . . . 0.0 110.704 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.47 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -121.38 49.8 1.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 111.602 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.095 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -143.57 163.77 32.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' B' ' 82' ' ' LEU . 90.0 t -101.41 136.93 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 29' ' ' ASP . 3.1 mp -106.03 111.34 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.369 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.501 ' HB2' ' HE3' ' B' ' 104' ' ' MET . 14.6 ttm -94.53 170.52 9.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.323 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -157.56 113.15 2.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.841 HG23 ' CE1' ' B' ' 139' ' ' TYR . 48.3 pt -101.29 170.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' B' ' 108' ' ' GLU . 5.3 mmt85 -124.93 46.32 2.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 0.0 110.291 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 175.27 79.21 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 0.0 110.338 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 52.5 Cg_endo -81.63 161.56 79.77 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.756 -2.185 . . . . 0.0 110.473 -0.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.15 106.38 1.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.556 HG22 ' HA3' ' B' ' 125' ' ' GLY . 1.7 p -147.27 177.5 9.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.645 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.7 m -124.57 159.14 31.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -147.48 138.35 23.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 110.41 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 121' ' ' MET . 8.0 mt -98.46 120.51 39.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 109.723 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.421 HG13 ' HG2' ' B' ' 121' ' ' MET . 3.6 mt -111.97 115.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.985 . . . . 0.0 110.375 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 3.6 m-30 -94.93 168.32 10.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -78.41 -13.52 59.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.4 t -81.05 -7.81 59.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.79 -26.27 20.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -56.2 149.74 15.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -1.135 . . . . 0.0 110.096 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 1.7 tmm? -148.66 128.82 13.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 1.018 HG11 HG12 ' A' ' 71' ' ' VAL . 73.4 t -114.91 128.1 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.2 t -112.86 151.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.349 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.559 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.8 t -155.09 164.42 38.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 109.983 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.569 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 110.83 -34.84 5.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.861 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.24 149.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -1.148 . . . . 0.0 110.442 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -3.19 30.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.492 ' N ' HG13 ' B' ' 70' ' ' ILE . 3.0 m -167.17 -163.23 0.51 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . 0.451 ' HA ' HD11 ' B' ' 157' ' ' ILE . 3.1 mt-10 -78.24 -44.65 24.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.316 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.11 -26.1 66.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 110.387 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.93 -58.29 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.885 . . . . 0.0 110.286 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . 0.652 ' OG ' HG21 ' B' ' 70' ' ' ILE . 2.2 m -47.57 -40.01 18.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 12.2 mttt -60.24 -51.06 71.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' B' ' 137' ' ' ARG . 39.6 mt -62.88 -32.81 74.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -74.3 -41.1 61.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.271 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 3.6 p -65.7 -52.09 54.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.509 ' HB2' ' CZ ' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -55.15 -34.1 63.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.493 ' HD3' ' HD2' ' B' ' 137' ' ' ARG . 7.0 mptt -65.42 -36.67 84.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 110.032 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.877 ' HA ' HD12 ' B' ' 142' ' ' ILE . 31.4 m-85 -71.41 -52.3 19.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.875 . . . . 0.0 110.04 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.74 64.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.087 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -40.71 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' B' ' 139' ' ' TYR . 24.6 mt -59.37 -54.93 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.723 HG21 ' HB2' ' B' ' 150' ' ' ALA . 10.0 mt -55.73 -46.61 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 35.0 mt-30 -66.26 -35.24 79.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' B' ' 145' ' ' LYS . 10.1 tttm -71.55 -21.05 61.94 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mt -83.31 -18.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.88 -21.37 12.43 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.533 ' HB2' HG22 ' B' ' 143' ' ' ILE . 12.3 m-85 -57.55 172.6 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.278 . . . . 0.0 111.016 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.54 54.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.75 . . . . 0.0 110.328 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -90.74 130.57 36.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 110.423 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -121.85 119.28 31.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 17.0 t80 -60.79 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -140.6 171.35 14.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 110.227 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.474 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 56.5 m-20 58.37 19.32 6.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.367 -0.833 . . . . 0.0 110.559 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' B' ' 152' ' ' PHE . 15.1 t80 -68.69 136.79 53.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.92 136.5 1.93 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.451 HD11 ' HA ' ' B' ' 129' ' ' GLU . 70.7 mt -79.29 124.51 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -118.5 -8.81 10.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.114 -0.991 . . . . 0.0 110.992 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 30.4 t30 -148.98 134.42 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.783 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.414 ' CG2' HD22 ' B' ' 67' ' ' LEU . 60.0 mt -129.4 142.85 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.747 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 41.6 t -113.1 135.75 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.985 . . . . 0.0 110.55 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -136.94 173.11 22.32 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.3 t -164.82 151.18 10.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -1.184 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.478 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.0 p -170.21 146.57 2.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.406 ' O ' HD13 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -98.03 169.53 9.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.962 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.0 OUTLIER -113.31 -83.33 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -176.01 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' B' ' 238' ' ' ARG . 14.8 p90 -131.8 159.45 71.92 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.363 -0.836 . . . . 0.0 109.576 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -71.34 152.19 60.74 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.873 1.46 . . . . 0.0 110.146 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.26 148.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.561 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -86.88 106.45 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.934 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.51 HD22 ' CB ' ' B' ' 193' ' ' LEU . 21.9 mt -63.23 -59.91 4.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.342 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 23.5 pt-20 -50.19 -33.85 20.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -72.96 -41.57 48.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.457 ' O ' HD12 ' B' ' 175' ' ' LEU . 9.7 tp -80.23 -32.28 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -1.119 . . . . 0.0 110.23 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.808 ' HB2' ' CD1' ' B' ' 193' ' ' LEU . . . -73.95 -24.3 59.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 110.178 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -79.14 -42.61 25.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 t -78.74 -52.19 8.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.14 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -93.41 13.48 21.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.072 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -46.42 -32.97 5.63 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . 0.552 HG23 ' HD2' ' B' ' 182' ' ' PHE . 1.8 t -54.08 -24.15 16.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -1.221 . . . . 0.0 110.378 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.829 ' CE1' HG22 ' B' ' 198' ' ' VAL . 26.4 m-85 -133.05 13.63 4.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.497 ' HB3' HD21 ' B' ' 193' ' ' LEU . 58.8 m -129.65 150.38 51.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.281 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.92 133.94 53.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 0.495 ' O ' ' CD2' ' B' ' 185' ' ' TYR . 26.4 t80 -150.45 102.61 3.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.101 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' B' ' 190' ' ' PHE . 1.3 mt-10 -113.31 115.26 47.56 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 110.091 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.82 -1.49 10.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.403 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -100.27 6.82 44.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.976 HD11 ' HB3' ' A' ' 58' ' ' SER . 0.4 OUTLIER -166.36 -38.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 110.386 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.544 ' CZ ' HD11 ' B' ' 205' ' ' LEU . 1.8 t80 -118.65 114.05 36.08 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.4 -31.12 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.863 1.454 . . . . 0.0 110.568 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.96 -179.72 44.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.808 ' CD1' ' HB2' ' B' ' 176' ' ' ALA . 8.5 tt -113.42 133.78 55.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -1.125 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.666 ' CD1' HD13 ' A' ' 62' ' ' LEU . 53.0 mt -100.68 109.11 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.737 ' CD2' HD13 ' B' ' 230' ' ' ILE . 15.4 t80 -99.69 114.15 27.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -90.63 98.47 11.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.104 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.416 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 0.5 OUTLIER -56.73 131.09 48.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.419 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.829 HG22 ' CE1' ' B' ' 182' ' ' PHE . 13.2 t -70.82 -48.75 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.061 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 6.9 tttm -144.29 117.03 5.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.7 Cg_endo -72.79 163.18 89.58 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.931 -2.112 . . . . 0.0 110.63 0.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.788 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -70.94 99.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.788 HD13 ' O ' ' B' ' 201' ' ' LYS . 37.6 mm -143.65 145.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.06 141.47 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.704 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 133.99 50.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.042 -1.036 . . . . 0.0 110.716 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.544 HD11 ' CZ ' ' B' ' 190' ' ' PHE . 2.6 mm? -103.32 116.6 32.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.714 HG13 HD12 ' B' ' 212' ' ' ILE . 3.5 mp -114.3 120.73 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.09 -1.006 . . . . 0.0 110.406 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.407 ' CD1' ' HA3' ' B' ' 192' ' ' GLY . 66.9 m-85 -110.88 143.76 40.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 110.208 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 17.2 t -44.11 -25.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 207' ' ' PHE . 25.2 m -59.94 -38.33 82.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.31 -0.869 . . . . 0.0 110.36 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.438 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 115.83 13.91 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.475 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -99.61 133.39 44.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.023 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.714 HD12 HG13 ' B' ' 206' ' ' ILE . 29.0 mm -118.52 136.68 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.941 . . . . 0.0 110.429 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 4.6 t -119.93 155.51 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 109.921 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.455 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.9 mp -134.34 123.2 23.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.975 . . . . 0.0 110.376 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 25' ' ' PHE . 8.3 t -141.27 147.57 38.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.07 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.42 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 103.92 5.82 43.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -89.08 134.6 33.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -1.124 . . . . 0.0 110.119 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -27.34 48.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.363 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.22 163.0 33.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.267 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . 0.505 ' CG ' ' CE1' ' B' ' 224' ' ' TYR . 4.9 ttm180 -65.54 -20.58 66.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 110.119 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -54.67 -44.32 73.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 226' ' ' ALA . 30.1 mt-10 -72.71 -39.98 66.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.911 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.411 HD12 HG23 ' B' ' 223' ' ' ILE . 34.0 mm -57.91 -41.51 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.891 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' B' ' 220' ' ' ARG . 10.1 m-85 -79.04 -47.22 16.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.103 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -65.54 -42.72 91.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' B' ' 222' ' ' GLU . . . -57.47 -44.54 84.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.606 ' CZ ' ' CE2' ' B' ' 231' ' ' TYR . 32.6 t80 -67.6 -28.66 67.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.145 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.27 -19.18 61.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.108 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.77 -31.86 15.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.737 HD13 ' CD2' ' B' ' 195' ' ' TYR . 9.2 tp -85.51 -22.61 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.606 ' CE2' ' CZ ' ' B' ' 227' ' ' PHE . 0.3 OUTLIER -40.89 -50.95 7.45 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.963 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.1 Cg_endo -69.22 -42.2 4.19 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.428 1.225 . . . . 0.0 110.633 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.66 -40.36 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.551 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 74.0 mt -61.25 -45.02 96.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 22.9 t -64.64 -46.71 81.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -35.91 49.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -108.58 38.56 2.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.494 ' HB3' ' CE1' ' B' ' 168' ' ' PHE . 1.0 OUTLIER -89.05 149.31 23.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -94.21 -60.16 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.5 mmm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.225 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.119 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.601 ' O ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -83.41 105.42 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 111.194 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.119 HD21 HD21 ' A' ' 18' ' ' LEU . 6.8 mt -117.97 3.64 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.958 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.72 HG21 ' O ' ' A' ' 56' ' ' ILE . 6.2 m -38.44 -30.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.679 0.752 . . . . 0.0 109.549 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.577 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -100.55 -31.49 5.78 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.87 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.32 -43.36 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.074 -1.251 . . . . 0.0 108.762 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.812 HD13 ' HG2' ' A' ' 67' ' ' MET . 1.8 pp -80.78 6.34 13.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 108.977 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE1' HD13 ' A' ' 52' ' ' LEU . 4.3 t80 -110.65 -18.08 13.24 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.544 -0.723 . . . . 0.0 111.034 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 158.3 67.02 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 C-N-CA 118.448 -1.834 . . . . 0.0 111.59 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.579 ' HB3' ' CG ' ' A' ' 35' ' ' LEU . 4.0 m120 41.28 111.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.943 . . . . 0.0 113.271 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -156.02 151.44 9.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLU . 12.6 m-20 -89.06 137.09 32.63 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.596 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 83.3 p -39.81 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.241 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -48.6 -21.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.6 29.5 5.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.33 131.5 54.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.122 -1.222 . . . . 0.0 110.085 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.765 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -101.86 139.16 37.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 35' ' ' LEU . 2.8 pp . . . . . 0 N--CA 1.491 1.593 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.419 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.184 0.516 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 18.3 tp10 -97.49 -25.46 15.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.014 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.643 HD13 ' CE1' ' A' ' 25' ' ' PHE . 5.9 mt -110.01 -44.94 3.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.626 -0.672 . . . . 0.0 110.055 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.79 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.02 -45.77 3.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.578 0.704 . . . . 0.0 109.984 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.27 -50.62 63.09 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.497 ' C ' HD12 ' A' ' 59' ' ' LEU . 64.0 m-20 -58.72 -38.77 79.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 109.174 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 53' ' ' ARG . 8.0 mt -50.91 -40.14 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.096 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -12.97 48.71 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.68 ' HB2' HD11 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -125.09 -0.24 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -1.12 . . . . 0.0 110.344 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.886 HD23 HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -80.52 51.86 1.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 24.3 t -134.06 50.24 2.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.887 . . . . 0.0 110.273 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 60' ' ' SER . 5.3 pttp 179.34 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.087 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.952 HD12 ' N ' ' A' ' 63' ' ' GLY . 1.1 pp -140.26 -29.54 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.054 -1.029 . . . . 0.0 111.146 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.952 ' N ' HD12 ' A' ' 62' ' ' LEU . . . 178.5 -48.99 0.09 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 62' ' ' LEU . 1.1 pp -82.95 -5.27 58.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.264 . . . . 0.0 110.812 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.7 t70 -44.47 -35.35 2.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.66 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -63.8 -47.04 82.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 0.0 109.619 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.812 ' HG2' HD13 ' A' ' 24' ' ' LEU . 7.1 ttp -65.02 -10.92 33.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.692 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.758 HD21 ' H ' ' A' ' 20' ' ' LEU . 4.9 tt -73.35 -61.27 1.88 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.78 0.86 11.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 109.939 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 25.4 tt0 -91.78 15.28 13.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 0.0 110.796 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.574 ' HB ' HD12 ' A' ' 20' ' ' LEU . 1.6 t -130.43 0.35 2.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.917 0.865 . . . . 0.0 109.016 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.975 HD11 HD12 ' A' ' 74' ' ' LEU . 1.3 tp -151.0 76.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 5.4 t0 -75.09 57.09 0.81 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.383 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.04 HD11 ' CB ' ' B' ' 101' ' ' ALA . 8.5 mt . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.469 -0.769 . . . . 0.0 110.572 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.669 HG22 ' SG ' ' B' ' 164' ' ' CYS . 29.6 mt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.262 0.553 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.506 HG23 ' C ' ' B' ' 63' ' ' ILE . 3.0 t 65.8 142.64 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 110.383 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.556 ' HG2' HG22 ' B' ' 223' ' ' ILE . 46.8 Cg_endo -75.96 137.88 20.17 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.098 1.578 . . . . 0.0 110.317 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.444 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 49.1 m -97.66 132.61 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.719 HD11 ' HG3' ' B' ' 220' ' ' ARG . 44.4 mt -69.72 120.61 15.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.961 . . . . 0.0 109.826 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 66' ' ' THR . 25.2 mm-40 -110.4 -14.04 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.443 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 1.7 t30 -162.56 144.52 10.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.987 . . . . 0.0 110.812 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.84 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 6.0 mm -126.35 150.75 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 109.333 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.74 126.29 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.011 -1.056 . . . . 0.0 110.549 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.83 170.75 15.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 110.05 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -141.2 145.26 35.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' B' ' 136' ' ' SER . 3.8 t -127.97 155.74 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 25.9 m -106.0 129.64 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.835 HD22 ' HB1' ' B' ' 150' ' ' ALA . 72.8 mt -84.29 -69.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.89 28.39 2.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . 0.949 ' SG ' ' HB3' ' B' ' 149' ' ' ALA . 39.8 t -164.02 152.1 12.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.457 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -73.23 139.81 46.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.707 HD11 ' CD1' ' B' ' 76' ' ' LEU . 28.9 mt -118.28 140.21 50.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 110.385 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 94.92 9.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.881 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.672 HD22 HG23 ' B' ' 102' ' ' VAL . 14.4 mt -44.05 -52.67 6.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.365 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -49.86 -43.46 49.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.028 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 28.0 m -76.27 -48.84 18.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 0.0 110.129 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.84 -47.81 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.56 65.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 tp -75.61 -42.22 52.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -88.26 -31.79 18.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' B' ' 92' ' ' ALA . . . -57.05 109.84 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.87 -22.35 66.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.052 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.491 ' ND2' ' HG3' ' B' ' 105' ' ' ARG . 2.4 t-20 -134.08 79.63 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.517 ' HB2' ' HB1' ' B' ' 89' ' ' ALA . . . -149.0 163.07 38.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -144.91 127.05 15.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.187 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -114.6 125.58 53.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.218 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.75 106.0 20.73 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.231 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.94 -21.78 20.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.033 1.544 . . . . 0.0 110.241 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -82.4 8.38 11.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.085 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.546 ' HB3' ' CD2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER -131.27 -70.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.594 ' HE2' ' HG ' ' A' ' 30' ' ' SER . 24.4 p90 -134.74 -173.62 3.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.046 . . . . 0.0 110.436 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 64.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.04 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -159.29 177.0 11.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.298 -0.876 . . . . 0.0 110.566 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.672 HG23 HD22 ' B' ' 82' ' ' LEU . 92.2 t -119.13 124.93 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.543 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 5.5 mt -89.66 107.36 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.663 ' SD ' HD13 ' B' ' 142' ' ' ILE . 37.8 ttm -108.31 151.14 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.491 ' HG3' ' ND2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -139.23 145.36 39.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.554 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 15.0 pt -111.66 175.35 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.136 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.6 mtt180 -116.73 26.73 9.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 110.408 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.5 tm-20 -175.88 87.13 0.29 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.752 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.0 Cg_endo -78.45 153.38 91.59 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.759 -2.184 . . . . 0.0 110.242 -0.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.6 OUTLIER -67.11 104.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 0.0 109.915 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.47 ' HA ' ' ND2' ' A' ' 27' ' ' ASN . 68.0 p -146.75 176.87 9.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.925 . . . . 0.0 110.566 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -115.76 144.18 44.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.604 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -135.21 129.58 33.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.959 -1.088 . . . . 0.0 110.885 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.647 ' HB2' HG12 ' B' ' 122' ' ' VAL . 3.5 mm? -89.59 120.49 30.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.044 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.56 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 1.6 mp -108.92 122.92 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' B' ' 120' ' ' LYS . 3.6 m-30 -96.49 149.04 22.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.71 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.51 -6.0 27.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.961 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.4 p -86.91 -16.77 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.427 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 119.31 -26.88 7.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 4.0 mttt -78.44 145.45 35.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -1.194 . . . . 0.0 110.157 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 7.3 ptt? -152.26 151.51 31.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 110.204 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' B' ' 114' ' ' LEU . 0.5 OUTLIER -110.47 162.38 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.902 . . . . 0.0 109.771 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.403 HG23 ' C ' ' B' ' 122' ' ' VAL . 12.7 t -145.2 119.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.52 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 10.2 t -113.56 151.33 31.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.91 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.563 ' N ' ' OD1' ' A' ' 27' ' ' ASN . . . 118.45 -31.48 5.58 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.407 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.84 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -39.92 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.0 110.305 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -104.4 -16.13 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.185 -0.947 . . . . 0.0 109.741 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 7.2 t -169.22 175.24 5.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.92 . . . . 0.0 110.043 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.07 -40.63 73.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.3 -47.12 65.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' B' ' 127' ' ' LYS . 15.8 t0 -58.17 -55.01 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 110.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . 0.403 ' HB2' ' HB1' ' B' ' 126' ' ' ALA . 8.7 t -49.46 -47.43 48.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' B' ' 133' ' ' LYS . 1.3 tppt? -49.83 -40.48 42.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.41 -46.26 41.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.38 53.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.785 ' HB3' HG21 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -65.43 -53.35 44.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.812 . . . . 0.0 110.067 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.09 -38.7 5.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.116 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -62.93 -56.39 17.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 51.6 m-85 -56.03 -47.54 77.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.855 . . . . 0.0 109.976 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.94 -24.72 54.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.012 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 19.0 ttt180 -77.32 -51.84 10.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.663 HD13 ' SD ' ' B' ' 104' ' ' MET . 7.1 mt -45.75 -36.79 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.754 HG21 ' HB2' ' B' ' 150' ' ' ALA . 34.8 mm -76.48 -52.79 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.82 -32.0 73.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.62 -26.15 60.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' B' ' 142' ' ' ILE . 11.3 mt -77.71 -24.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.86 -21.16 6.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.578 ' HB2' HG22 ' B' ' 143' ' ' ILE . 17.8 m-85 -57.82 178.6 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.277 . . . . 0.0 110.944 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.949 ' HB3' ' SG ' ' B' ' 78' ' ' CYS . . . -113.89 45.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.528 -0.733 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.835 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -81.59 109.84 16.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 110.475 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.505 ' O ' HD23 ' B' ' 76' ' ' LEU . 6.2 tttp -85.34 -170.28 3.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.136 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.427 ' HD1' HG11 ' B' ' 74' ' ' VAL . 9.7 t80 -136.75 103.53 5.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.0 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -166.41 169.5 13.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.875 . . . . 0.0 110.308 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' B' ' 153' ' ' THR . 8.2 t0 69.58 10.99 7.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.818 . . . . 0.0 110.63 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.636 ' HD1' HG22 ' B' ' 74' ' ' VAL . 39.8 t80 -48.25 151.64 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 142.85 3.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.539 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.75 149.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 109.951 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -118.87 -60.18 1.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' B' ' 217' ' ' ALA . 24.3 m120 -143.07 169.28 17.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 110.643 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.77 HD12 ' O ' ' B' ' 219' ' ' GLN . 45.4 mt -140.87 138.01 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 109.775 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.946 HG22 ' OG1' ' B' ' 215' ' ' THR . 26.1 t -110.47 129.42 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.06 174.82 18.22 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.38 146.21 3.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -1.209 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.669 ' SG ' HG22 ' B' ' 63' ' ' ILE . 0.5 OUTLIER -170.65 150.46 3.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.94 165.46 12.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.489 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -110.11 -83.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.489 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 179.65 -29.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.232 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 3.5 p90 -134.43 158.22 75.66 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.464 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.3 Cg_endo -71.88 159.91 49.2 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.998 1.525 . . . . 0.0 110.588 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.0 151.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.459 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 2.1 ptm180 -87.61 103.66 15.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.53 ' HB3' ' CE1' ' B' ' 185' ' ' TYR . 12.7 mt -53.54 -33.16 53.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.28 -43.35 95.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.66 -29.32 73.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.553 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -79.32 -32.03 43.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -1.096 . . . . 0.0 110.068 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.929 ' HB2' HD11 ' B' ' 193' ' ' LEU . . . -87.0 -25.53 24.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.91 -39.6 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 29.9 t -84.73 -38.84 19.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.511 ' CE1' HG13 ' B' ' 233' ' ' VAL . 69.4 m80 -107.27 15.4 25.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -44.61 -35.89 4.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.55 4.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -138.95 9.7 2.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 110.264 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.615 ' OG ' HD21 ' B' ' 193' ' ' LEU . 1.8 t -122.19 122.31 38.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.12 127.84 45.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.942 . . . . 0.0 110.234 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 0.573 ' CD1' HD12 ' B' ' 193' ' ' LEU . 23.0 t80 -126.13 120.5 30.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -137.68 102.33 8.64 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 110.054 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.32 0.1 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.13 1.594 . . . . 0.0 110.365 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -99.88 -4.78 29.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 58' ' ' SER . 0.5 OUTLIER -148.44 -38.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 110.472 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.572 ' HB2' HD23 ' B' ' 189' ' ' LEU . 6.7 t80 -124.39 113.78 27.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.382 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.04 -19.27 26.71 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.956 1.503 . . . . 0.0 110.079 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -97.72 179.92 33.14 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.929 HD11 ' HB2' ' B' ' 176' ' ' ALA . 0.9 OUTLIER -113.19 145.99 40.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -1.185 . . . . 0.0 110.533 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.505 ' CD1' HD22 ' A' ' 62' ' ' LEU . 5.8 mt -109.09 110.36 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -107.54 120.53 42.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.33 93.08 6.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.934 . . . . 0.0 110.046 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 52.9 tpp -49.64 136.04 17.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.426 ' O ' ' HE2' ' B' ' 201' ' ' LYS . 73.0 t -73.12 -50.71 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 7.9 tttp -142.3 115.91 6.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.451 ' HG3' ' HA ' ' B' ' 222' ' ' GLU . 48.8 Cg_endo -73.73 165.21 85.44 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.994 -2.086 . . . . 0.0 110.541 -0.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.445 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -74.75 98.86 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.992 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' B' ' 217' ' ' ALA . 31.7 mm -139.76 144.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.498 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.602 ' C ' HD12 ' B' ' 204' ' ' LEU . 90.4 t -93.45 118.61 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.738 ' N ' HD12 ' B' ' 204' ' ' LEU . 6.1 mp -115.58 123.77 49.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.568 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.502 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 5.7 mt -94.83 129.37 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.914 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.547 HG12 HD21 ' B' ' 234' ' ' LEU . 3.7 mp -118.8 129.47 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.549 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.492 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 96.6 m-85 -114.26 149.72 35.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 110.062 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 65.1 t -55.19 -24.8 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.0 p -64.36 -26.48 68.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.328 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.427 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 108.06 19.9 8.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -1.162 . . . . 0.0 110.274 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.72 132.99 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.384 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.586 ' C ' HD12 ' B' ' 214' ' ' LEU . 21.2 t -125.79 130.97 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.826 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.7 mp -118.42 126.28 51.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.403 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.946 ' OG1' HG22 ' B' ' 161' ' ' VAL . 1.1 t -147.3 136.03 22.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.968 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.468 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 120.45 7.55 8.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -86.87 134.36 33.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -1.213 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -78.36 -21.19 49.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.77 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.0 OUTLIER -139.1 -170.38 2.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . 0.719 ' HG3' HD11 ' B' ' 67' ' ' LEU . 2.9 ttt180 -89.94 -36.54 14.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.133 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -52.79 -31.31 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.174 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' B' ' 200' ' ' PRO . 24.1 mt-10 -70.45 -56.99 5.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 110.109 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.556 HG22 ' HG2' ' B' ' 65' ' ' PRO . 31.0 mm -50.93 -38.73 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' B' ' 64' ' ' VAL . 1.1 m-30 -67.79 -50.97 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -27.47 67.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.044 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.43 -52.48 65.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.672 ' HA ' HG22 ' B' ' 230' ' ' ILE . 41.9 t80 -61.93 -42.33 98.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.946 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -18.17 52.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 110.306 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -96.7 -28.57 14.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.455 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' B' ' 227' ' ' PHE . 4.2 tp -98.29 -10.66 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.655 ' CD1' ' CZ ' ' B' ' 227' ' ' PHE . 14.9 t80 -59.18 -42.52 93.71 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 111.013 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 47.3 Cg_endo -76.23 -44.0 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.381 1.2 . . . . 0.0 110.353 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.553 HG12 HD21 ' B' ' 175' ' ' LEU . 7.7 t -55.27 -38.51 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.873 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.547 HD21 HG12 ' B' ' 206' ' ' ILE . 40.4 mt -67.27 -50.65 59.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -0.831 . . . . 0.0 110.201 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 1.6 m -58.4 -29.48 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.85 -35.42 76.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.99 39.44 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.8 176.71 1.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.115 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 -59.53 1.7 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.213 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.066 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -93.7 97.4 10.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.063 -1.023 . . . . 0.0 111.004 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.066 HD21 HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -108.06 6.36 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.976 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.783 ' OG1' HD12 ' A' ' 68' ' ' LEU . 5.6 m -43.19 -26.77 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.483 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.523 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -98.55 -19.26 23.28 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.865 HG13 HD22 ' A' ' 20' ' ' LEU . 1.3 mm -57.07 -46.79 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.67 -1.488 . . . . 0.0 109.0 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.871 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.1 pp -83.53 -24.43 31.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.922 -1.111 . . . . 0.0 109.976 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -83.82 9.25 12.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 137.34 103.71 0.66 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.843 ' ND2' HD11 ' A' ' 35' ' ' LEU . 20.0 p-10 -18.56 129.77 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.717 0.77 . . . . 0.0 111.827 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 29' ' ' ASP . 1.5 pp -138.93 170.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.726 -0.609 . . . . 0.0 109.533 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.806 ' C ' HD12 ' A' ' 28' ' ' ILE . 77.5 m-20 -88.17 120.34 29.43 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.732 ' O ' HD11 ' A' ' 18' ' ' LEU . 4.6 p -35.33 -31.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.594 0.711 . . . . 0.0 109.662 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.9 tt0 -47.14 -23.35 0.49 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.23 21.78 5.1 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.38 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.98 134.27 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.315 . . . . 0.0 109.351 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.542 ' HA ' HG22 ' A' ' 28' ' ' ILE . 5.4 tt -87.82 162.06 17.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.895 -1.128 . . . . 0.0 111.157 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.843 HD11 ' ND2' ' A' ' 27' ' ' ASN . 3.1 pp . . . . . 0 N--CA 1.49 1.529 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.846 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.086 0.469 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.4 tp10 -100.24 -26.51 13.89 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.089 -1.007 . . . . 0.0 108.693 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 56' ' ' ILE . 2.8 mt -98.32 -39.01 9.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.402 0.62 . . . . 0.0 109.689 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -44.38 -46.71 9.56 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.29 -32.6 74.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 109.553 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.531 ' HB3' ' CD1' ' A' ' 59' ' ' LEU . 92.4 m-20 -76.76 -39.07 52.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.409 -0.807 . . . . 0.0 109.676 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -53.46 -34.38 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.384 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.31 -27.12 72.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.975 ' O ' HD11 ' B' ' 189' ' ' LEU . 11.5 t -117.82 8.94 12.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.856 HD23 HD12 ' A' ' 62' ' ' LEU . 6.0 mt -96.16 13.8 26.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.44 41.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.23 -0.919 . . . . 0.0 110.306 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.586 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.57 19.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.856 HD12 HD23 ' A' ' 59' ' ' LEU . 6.0 mt -118.06 -58.64 1.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.361 -0.837 . . . . 0.0 109.232 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.4 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.871 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.5 mm? -52.13 -26.0 10.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -1.19 . . . . 0.0 110.57 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -45.95 -36.77 5.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.4 m -70.04 -59.5 2.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 110.048 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.558 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -64.77 -11.96 42.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.03 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.783 HD12 ' OG1' ' A' ' 21' ' ' THR . 6.1 tt -69.39 -62.17 1.49 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.391 -0.818 . . . . 0.0 109.292 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.8 pp -66.78 -6.3 15.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -84.58 16.37 3.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.619 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.919 HG12 HG11 ' B' ' 122' ' ' VAL . 2.9 t -141.37 4.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.932 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.779 ' HB ' HD11 ' A' ' 20' ' ' LEU . 1.4 tp -147.3 77.2 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.579 -0.701 . . . . 0.0 109.359 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.8 t70 -82.83 50.64 1.74 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 108.908 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.74 -0.6 . . . . 0.0 111.657 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.77 134.75 83.61 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.55 135.66 26.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.937 1.493 . . . . 0.0 110.318 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.6 m -96.44 130.58 43.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.361 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' B' ' 161' ' ' VAL . 33.2 mt -74.76 123.35 24.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.867 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -113.95 -3.66 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -0.887 . . . . 0.0 110.705 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.532 ' CB ' ' HB ' ' B' ' 161' ' ' VAL . 0.2 OUTLIER -156.36 142.83 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.914 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.844 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 19.9 mm -132.13 150.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.829 . . . . 0.0 109.809 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' B' ' 124' ' ' THR . 22.0 t -141.44 134.65 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.64 165.27 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.252 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 68.1 p -110.15 145.65 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.72 131.21 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 41.4 m -111.84 128.59 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.855 HD22 ' HB1' ' B' ' 150' ' ' ALA . 49.0 mt -88.07 -17.33 31.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -2.31 84.26 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' B' ' 149' ' ' ALA . 3.6 t -137.33 151.14 48.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.339 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.828 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.9 OUTLIER -78.46 164.15 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.828 HD23 ' O ' ' B' ' 79' ' ' ARG . 23.8 mt -140.48 153.38 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 82' ' ' LEU . 34.8 t0 -92.77 100.59 13.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.519 ' HB3' HG23 ' B' ' 102' ' ' VAL . 18.0 mt -44.23 -34.95 2.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 1.9 tmtm? -66.14 -36.12 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 20.8 m -89.25 -40.13 13.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.29 -50.48 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 110.272 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.78 63.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.139 -0.976 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 27.6 tp -57.74 -28.48 63.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -98.94 -40.37 8.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.319 -0.863 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -47.38 124.3 6.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 20.9 mtt180 -67.28 -21.35 65.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.42 79.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -158.13 165.18 35.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.19 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -145.24 152.93 40.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.154 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -139.52 122.53 16.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.265 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.73 134.72 10.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.87 . . . . 0.0 110.228 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.85 -41.04 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.948 1.499 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -50.37 -23.2 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -98.32 -65.44 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 1.012 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.79 167.15 7.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.469 -0.77 . . . . 0.0 111.295 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.92 56.07 3.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.684 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.012 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -148.88 159.62 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.977 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' B' ' 82' ' ' LEU . 30.8 t -101.02 132.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.848 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.476 HG12 ' OG ' ' A' ' 30' ' ' SER . 6.5 mt -95.74 112.46 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 2.8 ttm -102.29 157.76 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 110.014 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -161.66 131.58 4.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.137 -0.977 . . . . 0.0 110.439 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 26.7 pt -115.64 172.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' B' ' 110' ' ' LYS . 7.7 mtp180 -115.45 29.53 7.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -174.63 86.16 0.33 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.503 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 51.0 Cg_endo -78.23 148.77 85.4 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.777 -2.176 . . . . 0.0 110.319 -0.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' B' ' 107' ' ' ARG . 12.0 mtmm -58.25 86.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.879 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.47 HG22 ' C ' ' B' ' 125' ' ' GLY . 11.3 p -130.45 168.64 16.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.519 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.696 HG22 HG23 ' B' ' 124' ' ' THR . 4.0 t -130.38 164.22 25.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.61 166.26 30.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.01 -1.057 . . . . 0.0 110.903 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.575 HD13 HD11 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -113.17 107.88 16.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.549 ' CD1' ' HG3' ' B' ' 121' ' ' MET . 13.8 mm -91.75 125.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 111.186 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 4.6 m-30 -103.57 166.06 10.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.479 -0.763 . . . . 0.0 109.64 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.05 -14.85 58.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.263 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 1.1 p -73.53 -30.27 62.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.305 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.75 -23.43 5.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -65.94 163.6 16.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.178 . . . . 0.0 110.049 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.549 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.8 OUTLIER -159.05 124.88 4.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 110.766 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.919 HG11 HG12 ' A' ' 71' ' ' VAL . 2.9 t -101.8 136.22 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 0.0 109.655 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.483 HG12 ' N ' ' B' ' 124' ' ' THR . 76.9 t -115.71 165.42 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.156 -0.965 . . . . 0.0 110.662 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.696 HG23 HG22 ' B' ' 112' ' ' THR . 5.9 t -169.52 155.89 6.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.439 -0.788 . . . . 0.0 110.014 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.544 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 113.8 -4.06 24.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.844 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -84.21 168.99 15.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.192 -1.181 . . . . 0.0 110.502 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.465 ' C ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -121.89 -19.21 6.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 110.292 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' B' ' 129' ' ' GLU . 1.0 OUTLIER -139.86 -178.92 5.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -68.74 -43.59 75.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -33.5 72.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.734 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 0.2 OUTLIER -70.24 -50.64 37.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.251 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' B' ' 136' ' ' SER . 5.2 t -61.21 -22.21 64.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.942 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.5 -49.53 18.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.843 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -45.47 74.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -50.68 -49.01 58.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.832 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 132' ' ' SER . 0.6 OUTLIER -66.85 -49.5 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.682 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -54.05 -29.68 44.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' B' ' 141' ' ' ARG . 27.4 mmtt -70.86 -55.84 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.702 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 47.0 m-85 -49.47 -48.49 47.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -57.01 -36.54 70.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.395 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 65.6 ttt180 -57.51 -38.36 74.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.425 -0.797 . . . . 0.0 109.949 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.407 ' O ' HG13 ' B' ' 146' ' ' ILE . 12.2 mt -66.76 -59.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.53 HD13 HD13 ' B' ' 80' ' ' LEU . 89.3 mt -56.6 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' B' ' 140' ' ' ALA . 20.5 mt-30 -67.55 -40.57 84.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 109.715 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -70.32 -21.29 62.94 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' B' ' 143' ' ' ILE . 6.5 mt -75.72 -29.46 20.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 125.07 -29.84 4.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' B' ' 147' ' ' GLY . 9.8 m-85 -43.89 156.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.014 -1.286 . . . . 0.0 110.637 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.513 ' HB3' ' SG ' ' B' ' 78' ' ' CYS . . . -91.62 48.58 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.129 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.855 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -84.42 171.49 12.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.403 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' B' ' 153' ' ' THR . 16.2 tttt -160.78 108.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.193 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.414 ' O ' ' CD2' ' B' ' 152' ' ' PHE . 47.7 t80 -49.7 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.265 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.9 OUTLIER -145.65 168.43 20.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.332 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t70 63.37 24.02 14.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' B' ' 73' ' ' THR . 43.5 t80 -67.72 132.98 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 110.023 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -166.24 134.69 2.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.413 HG21 HD13 ' B' ' 157' ' ' ILE . 18.0 mt -79.38 122.85 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.59 6.38 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.532 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 1.1 m120 -154.51 123.08 6.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.374 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' B' ' 215' ' ' THR . 30.8 mt -122.64 149.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.532 ' HB ' ' CB ' ' B' ' 69' ' ' ASN . 58.6 t -130.35 138.38 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.572 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.37 171.57 25.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.34 152.85 5.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.938 -1.33 . . . . 0.0 110.697 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.475 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 31.0 p -166.79 166.4 15.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.53 171.31 8.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.521 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -121.75 -83.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.521 ' H ' HG23 ' B' ' 166' ' ' VAL . 3.0 mmtt 178.1 -23.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.036 -1.04 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -125.48 153.67 72.5 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.979 -1.076 . . . . 0.0 109.703 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.34 147.29 46.87 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.943 1.496 . . . . 0.0 110.248 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.691 HG12 HD22 ' B' ' 234' ' ' LEU . 2.0 mp -108.23 156.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 110.599 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 14.2 mtt180 -91.29 101.97 14.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.775 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 25.2 mt -63.9 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.27 -34.29 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -64.97 -51.11 54.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.71 -41.83 91.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -1.074 . . . . 0.0 109.907 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 180' ' ' GLY . . . -58.46 -43.53 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.8 t80 -59.76 -30.11 68.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -59.56 2.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.42 ' O ' ' N ' ' B' ' 183' ' ' SER . 41.5 m170 -97.98 32.53 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.338 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 176' ' ' ALA . . . -47.93 -62.74 3.97 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . 0.585 HG23 ' CD1' ' B' ' 182' ' ' PHE . 10.3 t -45.85 -24.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -1.195 . . . . 0.0 110.272 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.585 ' CD1' HG23 ' B' ' 181' ' ' THR . 20.7 m-85 -102.43 -14.19 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.469 ' O ' ' O ' ' B' ' 180' ' ' GLY . 0.3 OUTLIER -140.86 149.04 41.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.931 . . . . 0.0 110.089 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -121.01 137.58 54.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.588 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -134.71 109.43 8.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 0.0 109.79 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.03 121.63 33.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.19 -11.98 25.32 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.891 1.469 . . . . 0.0 110.279 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.73 -23.85 22.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.113 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.975 HD11 ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -89.84 -63.21 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.689 ' HZ ' HD11 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -169.68 161.07 7.18 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.43 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.9 Cg_endo -69.82 0.37 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.136 1.598 . . . . 0.0 111.842 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.584 ' HA3' ' CE2' ' B' ' 190' ' ' PHE . . . -89.25 149.41 20.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.897 ' O ' HD13 ' B' ' 205' ' ' LEU . 10.3 tt -110.33 130.83 55.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -1.171 . . . . 0.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . . . . . . . . . 3.3 mt -95.63 111.21 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.225 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -100.89 113.7 26.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.297 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -91.1 88.58 7.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 110.145 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 46.1 tpp -57.55 125.2 21.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.867 . . . . 0.0 110.377 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.41 HG23 ' H ' ' B' ' 198' ' ' VAL . 34.7 t -57.52 -49.62 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.57 124.73 5.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.997 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.405 ' O ' HG12 ' B' ' 202' ' ' ILE . 48.0 Cg_endo -74.8 148.68 92.39 Favored 'Cis proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.011 -2.079 . . . . 0.0 110.424 -0.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.414 ' O ' HD13 ' B' ' 202' ' ' ILE . 10.9 tptt -56.22 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.335 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.414 HD13 ' O ' ' B' ' 201' ' ' LYS . 36.6 mm -136.84 153.5 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.17 112.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.925 . . . . 0.0 110.297 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.859 HD21 ' HB1' ' B' ' 226' ' ' ALA . 1.7 mp -107.42 149.13 28.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.897 HD13 ' O ' ' B' ' 193' ' ' LEU . 0.2 OUTLIER -114.85 115.8 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.568 HD12 ' N ' ' B' ' 206' ' ' ILE . 4.6 mp -104.85 139.58 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -122.69 155.6 36.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 63.9 t -59.13 -31.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.3 t -57.04 -39.13 74.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.099 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.22 10.88 5.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.437 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -89.66 135.45 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.437 HD13 ' O ' ' B' ' 211' ' ' LYS . 25.5 mm -113.74 134.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.3 t -114.32 163.45 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 1.4 mp -145.92 129.8 17.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.915 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 15.1 t -158.83 149.05 19.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 110.333 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.505 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 101.95 5.17 50.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.94 33.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -1.191 . . . . 0.0 110.161 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -93.18 -6.12 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.123 -0.985 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -154.68 -179.99 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.143 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -79.05 -25.34 43.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 110.22 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.79 -23.89 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.13 -50.37 12.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 110.19 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.499 HG23 HD22 ' B' ' 214' ' ' LEU . 20.3 mm -58.8 -38.13 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -70.6 -38.53 74.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.311 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -30.3 59.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.551 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.859 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -64.72 -49.85 69.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -0.962 . . . . 0.0 110.417 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.513 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 16.1 t80 -69.07 -41.22 77.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.479 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -51.57 -38.19 53.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.82 -10.1 35.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.294 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.556 HG13 HD22 ' B' ' 204' ' ' LEU . 10.5 mm -96.22 -17.73 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.9 t80 -61.73 -42.1 81.41 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.5 Cg_endo -76.71 -49.26 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.346 1.182 . . . . 0.0 110.21 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 21.3 t -44.87 -40.48 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.764 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.691 HD22 HG12 ' B' ' 170' ' ' ILE . 74.0 mt -70.75 -63.36 1.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.779 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -46.9 -33.2 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.33 -34.19 77.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.403 -0.811 . . . . 0.0 110.014 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 57.3 m-85 -120.89 39.63 3.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.269 -0.894 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.49 ' NH2' ' O ' ' B' ' 239' ' ' LYS . 0.0 OUTLIER -71.57 -173.72 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.927 . . . . 0.0 110.175 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.49 ' O ' ' NH2' ' B' ' 238' ' ' ARG . 2.4 ttpt -125.68 -39.55 2.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.21 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.93 76.85 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.045 -1.034 . . . . 0.0 110.615 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.947 HD13 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -93.99 -0.32 55.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 111.253 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.719 ' N ' HD21 ' A' ' 68' ' ' LEU . 9.0 m -45.91 -24.25 0.38 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.889 -1.132 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.487 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -97.04 -31.93 6.7 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.947 HG21 HD13 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -47.94 -47.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.403 . . . . 0.0 109.132 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.833 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.8 pp -83.51 -26.74 29.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.969 -1.082 . . . . 0.0 110.549 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.689 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.3 OUTLIER -80.96 6.92 11.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.096 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 28' ' ' ILE . . . 138.33 106.58 0.74 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.858 ' ND2' HD11 ' A' ' 35' ' ' LEU . 5.9 p30 -16.94 133.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.915 0.864 . . . . 0.0 112.186 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 29' ' ' ASP . 2.0 pp -146.44 167.29 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.487 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.806 ' C ' HD12 ' A' ' 28' ' ' ILE . 10.8 m-20 -87.88 121.14 29.93 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.542 ' OG ' ' CD1' ' B' ' 103' ' ' ILE . 9.3 p -36.93 -28.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.145 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.6 tt0 -58.51 -11.95 3.47 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.181 -0.949 . . . . 0.0 110.446 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.64 23.94 6.34 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.4 tpp180 -107.34 120.45 42.19 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.045 -1.268 . . . . 0.0 109.644 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.805 ' C ' HD13 ' A' ' 34' ' ' LEU . 2.5 tm? -88.59 134.07 33.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.405 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.858 HD11 ' ND2' ' A' ' 27' ' ' ASN . 1.1 pp . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.03 . . . . 0.0 109.993 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.23 0.538 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -100.46 -17.67 17.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.901 . . . . 0.0 109.591 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 25' ' ' PHE . 4.0 mt -95.32 -47.06 6.47 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.513 -0.742 . . . . 0.0 109.977 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.922 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.58 -50.89 52.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -63.75 -25.82 68.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.795 . . . . 0.0 110.06 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 3.5 m-80 -83.29 -33.88 25.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.922 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.3 mt -51.93 -46.03 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.292 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.28 -19.93 26.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.73 9.9 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -1.191 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.654 HD23 HD21 ' A' ' 62' ' ' LEU . 3.0 mt -84.76 15.85 3.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.141 -0.974 . . . . 0.0 110.419 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.0 p -105.94 39.78 1.71 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 110.221 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 29.31 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 63' ' ' GLY . 2.1 pp -147.5 -35.44 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.103 -0.998 . . . . 0.0 111.152 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.915 ' N ' HD12 ' A' ' 62' ' ' LEU . . . -170.14 -51.29 0.04 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.294 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.833 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.4 mm? -42.83 -24.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -1.232 . . . . 0.0 110.572 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 1.8 t70 -42.79 -38.97 2.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.854 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.43 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 58.5 m -66.84 -56.88 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.406 -0.809 . . . . 0.0 109.809 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.641 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -65.22 -10.54 32.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.486 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.719 HD21 ' N ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -67.92 -63.93 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.745 0.783 . . . . 0.0 109.298 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -68.57 -5.12 18.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.808 -0.557 . . . . 0.0 110.226 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -83.17 5.68 21.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 111.201 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.835 HG12 HG11 ' B' ' 122' ' ' VAL . 2.3 t -140.22 4.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.173 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.882 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.2 tp -145.48 73.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.779 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t70 -81.8 51.77 1.79 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.528 -0.732 . . . . 0.0 111.46 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.243 0.544 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.536 HG13 ' HD2' ' B' ' 65' ' ' PRO . 70.2 t -89.82 142.2 28.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 110.505 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.536 ' HD2' HG13 ' B' ' 64' ' ' VAL . 47.2 Cg_endo -75.35 134.54 17.36 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.052 1.554 . . . . 0.0 110.417 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -90.71 127.17 36.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' B' ' 67' ' ' LEU . 17.6 mt -73.03 132.65 43.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.125 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -98.05 -41.08 8.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.101 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -170.03 179.07 3.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.561 HG12 HG23 ' B' ' 160' ' ' ILE . 9.5 mt -150.53 167.8 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.125 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.542 HG13 ' O ' ' B' ' 123' ' ' VAL . 52.8 t -137.4 140.64 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.131 -0.981 . . . . 0.0 110.426 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.55 50.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.426 -0.797 . . . . 0.0 110.068 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 133.85 55.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.451 HG21 ' OG ' ' B' ' 136' ' ' SER . 66.2 t -126.71 146.76 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 57.5 m -110.13 141.26 43.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.941 HD22 ' C ' ' B' ' 149' ' ' ALA . 7.4 mt -105.2 -72.93 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.485 -0.759 . . . . 0.0 109.898 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.33 -10.18 10.83 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 148' ' ' PHE . 68.5 m -109.31 119.92 40.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.034 -1.274 . . . . 0.0 109.354 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -44.02 147.94 0.45 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 110.032 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.701 ' CD2' ' HB2' ' B' ' 149' ' ' ALA . 27.0 mt -116.73 144.59 44.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 111.173 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' LYS . 0.2 OUTLIER -101.28 83.04 2.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.486 -0.758 . . . . 0.0 109.152 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' B' ' 81' ' ' ASP . 10.3 mt -37.09 -30.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.636 -0.665 . . . . 0.0 110.933 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' B' ' 81' ' ' ASP . 0.0 OUTLIER -70.28 -46.04 65.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 109.937 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 97.9 m -82.21 -31.41 30.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.382 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.5 -43.04 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.77 51.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 tp -85.24 -43.23 13.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.261 -0.9 . . . . 0.0 110.452 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.767 ' HB2' HD11 ' B' ' 146' ' ' ILE . 0.3 OUTLIER -74.43 -44.84 50.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 110.591 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -54.88 128.48 33.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.438 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -66.55 -24.93 66.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 9.0 p30 -135.22 79.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.077 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -160.07 137.04 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -117.39 171.18 8.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' B' ' 102' ' ' VAL . 13.3 t80 -164.2 102.2 0.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 110.301 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' B' ' 98' ' ' ARG . 0.7 OUTLIER -119.1 136.95 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.272 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -21.01 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.996 1.524 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -76.65 -17.3 59.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.537 ' N ' ' HD2' ' B' ' 98' ' ' ARG . 3.2 mpt_? -96.45 -63.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 1.168 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.86 166.69 11.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.494 -0.754 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.97 53.43 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 111.909 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.168 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -153.19 154.25 34.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.143 . . . . 0.0 110.463 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.692 HG22 ' HB2' ' B' ' 94' ' ' TYR . 39.7 t -89.81 139.08 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.542 ' CD1' ' OG ' ' A' ' 30' ' ' SER . 8.4 mt -100.35 114.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 109.845 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.609 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 1.7 ttm -99.8 170.86 8.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 0.1 OUTLIER -169.99 132.42 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 0.0 110.046 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.558 HG23 ' CE1' ' B' ' 139' ' ' TYR . 22.8 pt -128.45 163.56 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.352 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -110.64 26.23 10.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.258 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER -172.76 86.28 0.41 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.267 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.731 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.3 Cg_endo -74.85 161.52 94.6 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.564 -0.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -72.28 82.9 1.03 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' B' ' 124' ' ' THR . 37.0 p -132.46 176.3 8.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 110.518 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.823 HG22 HG23 ' B' ' 124' ' ' THR . 5.8 t -135.68 174.07 11.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.6 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -170.25 176.45 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.967 -1.083 . . . . 0.0 111.091 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.832 HD13 HD13 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -143.17 122.89 13.35 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.423 ' CG2' ' CD1' ' B' ' 80' ' ' LEU . 20.4 mt -100.35 160.34 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.006 . . . . 0.0 111.479 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.72 ' CZ ' HD12 ' B' ' 114' ' ' LEU . 34.8 m-85 -119.42 156.17 30.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 110.246 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -64.8 -16.45 63.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 4.4 p -71.29 -36.73 71.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.629 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 129.41 4.24 4.96 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . 0.413 ' C ' ' HG3' ' B' ' 121' ' ' MET . 0.5 OUTLIER -100.4 138.89 36.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -1.175 . . . . 0.0 110.003 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.752 ' CG ' HD11 ' B' ' 76' ' ' LEU . 0.0 OUTLIER -128.03 129.45 46.72 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.04 . . . . 0.0 110.163 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.835 HG11 HG12 ' A' ' 71' ' ' VAL . 18.3 t -97.44 132.36 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 0.0 109.713 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.542 ' O ' HG13 ' B' ' 71' ' ' VAL . 29.7 t -114.95 149.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 110.574 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.823 HG23 HG22 ' B' ' 112' ' ' THR . 6.2 t -149.54 156.48 42.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.543 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 110.04 -32.81 6.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -45.35 125.13 5.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -1.115 . . . . 0.0 110.089 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -92.29 -17.92 24.09 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.23 -0.919 . . . . 0.0 109.802 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 42.0 t -142.44 151.87 42.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.387 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.16 -49.88 11.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -40.87 98.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.056 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -38.67 77.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -44.43 72.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.161 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -25.56 65.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.23 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.498 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 0.6 OUTLIER -85.25 -36.26 21.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.338 -0.851 . . . . 0.0 110.287 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.731 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -70.49 -36.11 73.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.047 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.451 ' OG ' HG21 ' B' ' 74' ' ' VAL . 28.8 t -71.64 -59.8 2.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.527 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.0 ptm180 -46.19 -37.36 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.527 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 8.8 mttt -64.72 -45.98 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.558 ' CE1' HG23 ' B' ' 106' ' ' ILE . 9.5 m-85 -57.47 -56.95 15.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . 0.53 ' HA ' HG12 ' B' ' 143' ' ' ILE . . . -49.04 -40.77 32.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.474 ' HA ' ' OE1' ' B' ' 144' ' ' GLN . 2.4 ttt-85 -53.4 -47.29 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.085 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.439 ' C ' HD13 ' B' ' 143' ' ' ILE . 83.2 mt -61.81 -25.44 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 110.349 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 1.152 ' CG2' ' HB3' ' B' ' 149' ' ' ALA . 0.5 OUTLIER -83.83 -51.2 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 109.397 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.878 ' HG2' ' HB1' ' B' ' 150' ' ' ALA . 19.9 mt-30 -46.96 -36.5 7.79 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -72.16 -31.65 66.14 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' B' ' 88' ' ' HIS . 0.1 OUTLIER -74.71 -45.02 45.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.41 -26.16 1.37 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.15 -1.5 . . . . 0.0 112.033 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.534 ' HB2' ' CD2' ' B' ' 80' ' ' LEU . 0.1 OUTLIER -142.31 -154.61 0.53 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.291 -1.711 . . . . 0.0 112.598 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 1.152 ' HB3' ' CG2' ' B' ' 143' ' ' ILE . . . 41.22 29.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.54 1.162 . . . . 0.0 107.889 -178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.878 ' HB1' ' HG2' ' B' ' 144' ' ' GLN . . . -89.74 -19.06 25.21 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.814 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.83 ' O ' HD23 ' B' ' 76' ' ' LEU . 1.9 mptt -71.03 133.21 46.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.568 -1.333 . . . . 0.0 110.33 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -115.19 75.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.858 . . . . 0.0 110.269 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -137.79 -174.05 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.229 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 1.9 t0 56.39 16.77 2.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -68.57 125.85 27.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.215 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -160.24 131.93 6.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 110.259 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.498 HD13 HG21 ' B' ' 70' ' ' ILE . 21.4 mt -79.43 132.01 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.857 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.419 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 38.3 mm-40 -130.7 1.16 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 110.652 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -148.33 108.53 4.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.977 -1.077 . . . . 0.0 111.236 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.682 HD12 ' N ' ' B' ' 219' ' ' GLN . 69.8 mt -117.67 137.26 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.837 . . . . 0.0 109.209 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.547 HG22 ' OG1' ' B' ' 215' ' ' THR . 88.9 t -114.37 139.13 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 111.031 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -147.02 171.18 27.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.4 p -155.84 163.42 39.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.257 . . . . 0.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' B' ' 212' ' ' ILE . 17.6 p -165.65 169.84 14.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.843 . . . . 0.0 110.223 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 15.5 p-10 -120.55 144.01 48.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 109.988 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 1.129 HG21 HD11 ' B' ' 170' ' ' ILE . 25.3 m -94.02 2.7 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.988 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 28.2 tttp 71.86 10.16 6.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 110.917 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.602 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 9.3 p90 -166.23 154.58 9.79 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 110.416 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.65 158.02 51.35 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.996 1.524 . . . . 0.0 110.784 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 1.129 HD11 HG21 ' B' ' 166' ' ' VAL . 2.4 mp -131.07 147.86 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.229 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -76.93 92.05 3.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.924 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.514 HD11 ' N ' ' B' ' 208' ' ' VAL . 13.6 mt -50.57 -37.25 38.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.39 -43.49 60.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.245 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.39 80.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.727 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -71.36 -51.77 22.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -1.123 . . . . 0.0 110.12 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.498 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -57.84 -29.71 65.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.114 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -72.38 -36.54 68.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.13 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.59 -27.4 17.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.959 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -129.15 34.9 4.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 110.004 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.22 -18.29 64.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . 0.864 HG23 ' CD2' ' B' ' 182' ' ' PHE . 8.9 t -69.31 -21.43 63.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -1.137 . . . . 0.0 110.31 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.864 ' CD2' HG23 ' B' ' 181' ' ' THR . 41.3 m-85 -129.57 3.14 5.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.662 ' HB2' HD21 ' B' ' 193' ' ' LEU . 0.9 OUTLIER -139.47 135.42 33.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 154.98 29.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.071 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 0.479 ' HB2' HD12 ' B' ' 193' ' ' LEU . 82.8 t80 -147.08 105.72 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.342 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 190' ' ' PHE . 7.4 mt-10 -108.75 105.27 56.71 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.0 Cg_endo -71.74 -2.07 10.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.981 1.516 . . . . 0.0 110.599 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -19.88 16.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.074 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.533 ' C ' HD23 ' B' ' 189' ' ' LEU . 4.7 tt -132.91 -29.73 1.44 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 110.551 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.627 ' CE2' HD21 ' A' ' 59' ' ' LEU . 1.9 t80 -131.8 111.29 14.7 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.32 -7.92 21.79 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.867 1.456 . . . . 0.0 110.231 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' B' ' 172' ' ' LEU . . . -107.97 179.98 21.89 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' B' ' 183' ' ' SER . 3.5 tt -113.74 125.95 54.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.398 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.678 HD13 HD13 ' A' ' 62' ' ' LEU . 44.2 mt -91.77 112.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.96 . . . . 0.0 109.953 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 2.2 t80 -108.49 124.61 50.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.381 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.458 ' HB2' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -105.82 79.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.057 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 32.1 ttm -49.11 134.72 17.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 40.5 t -73.01 -43.1 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.3 OUTLIER -143.2 116.43 6.05 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.113 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.1 Cg_endo -73.54 156.02 99.67 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.99 -2.087 . . . . 0.0 110.529 -0.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.926 ' O ' HD13 ' B' ' 202' ' ' ILE . 2.9 tptt -67.37 94.87 0.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.926 HD13 ' O ' ' B' ' 201' ' ' LYS . 11.2 mm -141.09 158.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.215 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.415 HG22 ' HG3' ' B' ' 196' ' ' ARG . 62.2 t -105.54 116.22 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.943 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.2 mp -108.12 108.67 19.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.497 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.689 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -95.08 118.88 32.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.614 HG23 ' CD1' ' B' ' 212' ' ' ILE . 3.2 mp -116.76 120.9 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.162 -0.962 . . . . 0.0 110.486 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' B' ' 207' ' ' PHE . 30.1 m-85 -93.33 172.22 8.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.514 ' N ' HD11 ' B' ' 172' ' ' LEU . 27.2 t -60.32 -39.83 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.327 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 50.6 m -53.16 -42.28 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.455 -0.778 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.655 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 125.81 4.34 6.75 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.31 136.45 44.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 110.089 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.614 ' CD1' HG23 ' B' ' 206' ' ' ILE . 14.6 mm -119.41 136.49 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.328 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 84.0 t -121.88 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.939 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.452 HD12 ' N ' ' B' ' 214' ' ' LEU . 2.2 mp -127.03 117.16 21.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.547 ' OG1' HG22 ' B' ' 161' ' ' VAL . 13.6 t -135.57 160.53 38.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.105 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.57 -5.88 64.91 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.62 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -73.54 136.18 44.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.16 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.425 ' N ' ' OE2' ' B' ' 222' ' ' GLU . 0.0 OUTLIER -84.57 -8.69 58.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.092 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.682 ' N ' HD12 ' B' ' 160' ' ' ILE . 1.0 OUTLIER -156.89 -174.02 4.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -82.15 -32.63 29.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 1.0 OUTLIER -52.44 -29.61 25.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.052 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.62 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 21.1 mt-10 -76.85 -48.0 19.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.3 -39.03 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -69.88 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -83.59 -46.77 12.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.265 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.442 ' O ' HG22 ' B' ' 230' ' ' ILE . . . -47.71 -40.65 20.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -74.37 -48.33 28.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.0 -17.38 62.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.007 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -86.4 -32.92 20.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 109.922 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.442 HG22 ' O ' ' B' ' 226' ' ' ALA . 1.0 OUTLIER -99.12 -17.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.846 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.616 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 51.9 t80 -47.71 -46.96 62.22 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.2 Cg_endo -71.43 -49.36 0.36 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.387 1.204 . . . . 0.0 110.18 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.727 HG12 HD21 ' B' ' 175' ' ' LEU . 9.3 t -47.71 -43.28 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.642 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.609 ' CD2' HG21 ' B' ' 170' ' ' ILE . 91.0 mt -63.12 -51.22 67.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 59.6 p -54.11 -27.76 35.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.65 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.82 -38.47 79.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.919 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.501 ' CD2' HD22 ' B' ' 175' ' ' LEU . 50.0 m-85 -110.15 37.77 2.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -63.21 163.21 10.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.202 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.61 -28.83 6.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.877 . . . . 0.0 110.218 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.925 HD22 ' CD2' ' B' ' 99' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.847 ' O ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -93.8 128.38 40.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.122 -0.987 . . . . 0.0 111.497 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.968 HD11 ' HB ' ' A' ' 72' ' ' ILE . 9.6 mt -124.64 24.98 7.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 110.47 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.59 ' OG1' HD23 ' A' ' 68' ' ' LEU . 8.4 m -49.01 -36.6 18.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.61 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -85.67 -24.66 41.54 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.497 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.831 HG21 HG11 ' A' ' 71' ' ' VAL . 9.5 mm -50.37 -54.22 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.883 -1.363 . . . . 0.0 109.011 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.961 HD13 ' SD ' ' A' ' 67' ' ' MET . 1.6 pp -79.33 8.89 5.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 110.023 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.742 ' HE2' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -111.75 -15.41 13.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.006 -1.059 . . . . 0.0 111.026 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 156.99 44.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.531 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB2' ' CG ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER 61.72 132.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.929 -1.336 . . . . 0.0 110.185 178.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.757 HG21 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -162.2 158.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.818 0.818 . . . . 0.0 109.524 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLU . 77.1 m-20 -88.49 118.36 28.08 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.623 ' HB2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -39.68 -26.82 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.992 -179.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 18.0 pt-20 -55.16 -16.33 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.043 -1.035 . . . . 0.0 109.991 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.98 14.29 10.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.536 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.69 115.88 28.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.074 -1.25 . . . . 0.0 109.939 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.61 HD12 ' HA3' ' A' ' 22' ' ' GLY . 1.2 tt -87.67 158.85 18.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.918 -1.114 . . . . 0.0 110.872 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 35' ' ' LEU . 4.0 pp . . . . . 0 N--CA 1.492 1.631 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.711 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.211 0.529 . . . . 0.0 110.348 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 1.6 tp10 -88.67 -52.04 5.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.742 HD21 ' HE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -93.5 -11.6 31.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.025 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -56.7 -54.05 50.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -0.996 . . . . 0.0 108.784 178.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.63 -23.34 64.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 45.8 m-80 -80.06 -33.31 39.1 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.025 HD12 ' HA ' ' A' ' 53' ' ' ARG . 24.6 mt -50.01 -41.98 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.51 -14.61 28.74 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.99 -7.1 11.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.89 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.732 HD11 ' CE1' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -76.88 53.99 0.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.95 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m -126.81 32.59 5.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.786 . . . . 0.0 110.365 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.569 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.19 17.87 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.322 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 61' ' ' LYS . 6.9 mt -112.89 -63.09 1.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.561 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.5 -39.96 0.03 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.847 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.5 mm? -53.3 -19.4 3.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -1.117 . . . . 0.0 110.644 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 4.8 p-10 -46.07 -40.75 11.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 110.068 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -59.49 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.961 ' SD ' HD13 ' A' ' 24' ' ' LEU . 12.6 ttm -70.75 -3.49 19.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.766 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.69 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.5 tm? -69.43 -58.29 4.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pp -77.92 1.42 20.66 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.478 0.656 . . . . 0.0 109.613 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.493 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 3.9 tt0 -87.94 15.5 7.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.898 ' HB ' HD12 ' A' ' 20' ' ' LEU . 3.8 t -138.93 -0.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.729 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.072 HD11 HD12 ' A' ' 74' ' ' LEU . 2.9 tp -151.17 84.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.515 -0.741 . . . . 0.0 109.32 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 2.1 p-10 -87.4 49.19 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.964 -1.085 . . . . 0.0 108.486 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.072 HD12 HD11 ' A' ' 72' ' ' ILE . 9.9 mt . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.675 0.75 . . . . 0.0 110.872 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 6.3 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.07 0.462 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 56.6 t 58.46 126.34 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.595 -0.691 . . . . 0.0 110.223 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.437 ' HA ' ' SG ' ' B' ' 164' ' ' CYS . 45.9 Cg_endo -73.49 151.53 47.68 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.858 1.451 . . . . 0.0 110.568 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.443 HG22 ' N ' ' B' ' 67' ' ' LEU . 98.1 m -101.47 164.79 11.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.443 ' N ' HG22 ' B' ' 66' ' ' THR . 19.4 mt -89.48 128.67 36.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.28 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.33 -32.62 10.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.507 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 7.6 m-20 -170.05 171.62 6.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.939 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 16.5 mm -131.77 155.52 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 110.149 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.53 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 37.6 t -138.29 113.7 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.864 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.51 ' HB2' ' CG1' ' B' ' 157' ' ' ILE . . . -128.42 156.46 43.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 110.587 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 26.1 p -105.69 114.16 28.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.55 HG22 ' CD1' ' B' ' 155' ' ' PHE . 21.6 t -107.93 120.64 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 52.5 m -97.08 160.68 14.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' B' ' 150' ' ' ALA . 22.0 mt -107.32 -59.89 1.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.237 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.86 -0.1 6.65 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 21.6 p -142.37 170.18 16.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -1.152 . . . . 0.0 110.187 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.533 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -83.34 154.32 24.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 1.025 HD11 ' CD1' ' B' ' 76' ' ' LEU . 70.8 mt -128.32 144.49 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.093 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.463 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 5.7 m-20 -89.86 94.6 9.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.631 HD22 HG23 ' B' ' 102' ' ' VAL . 12.3 mt -46.63 -45.17 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -54.78 -45.06 74.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 110.106 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 7.0 m -82.5 -38.68 23.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.465 HG12 HG11 ' B' ' 102' ' ' VAL . 19.7 t -61.44 -48.06 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.526 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -73.43 -24.24 60.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.277 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 19.7 tp -85.98 -23.8 26.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.498 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.4 OUTLIER -96.75 -42.91 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.181 -0.95 . . . . 0.0 110.378 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.701 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -45.92 123.49 4.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.129 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -24.05 64.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.25 -0.906 . . . . 0.0 110.293 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -137.14 79.59 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.737 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -164.96 161.24 19.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 0.0 109.856 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' B' ' 92' ' ' ALA . 58.6 mm-40 -152.78 138.38 17.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 110.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.535 ' HE1' HD13 ' B' ' 82' ' ' LEU . 19.8 t80 -93.17 148.24 22.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.725 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' B' ' 98' ' ' ARG . 0.1 OUTLIER -138.44 103.9 7.82 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 110.628 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.37 -17.71 16.44 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.045 1.55 . . . . 0.0 110.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.07 -4.23 58.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 0.0 110.269 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -116.55 -65.39 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 1.07 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -153.67 -168.07 2.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.356 -0.84 . . . . 0.0 111.294 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.18 53.7 0.68 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.07 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -145.33 164.21 32.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 0.0 110.93 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.631 HG23 HD22 ' B' ' 82' ' ' LEU . 86.2 t -102.27 127.0 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.818 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -94.61 108.78 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.737 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 3.4 ttm -93.63 170.75 9.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.01 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.6 119.66 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.465 HG23 ' CE1' ' B' ' 139' ' ' TYR . 8.7 pt -122.58 149.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.32 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 2.3 ptt180 -99.12 33.13 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.1 tt0 -171.93 84.2 0.46 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 47.7 Cg_endo -76.51 162.1 92.49 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.657 -2.226 . . . . 0.0 110.463 -0.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -70.36 79.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.008 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.51 HG22 ' HA3' ' B' ' 125' ' ' GLY . 67.7 p -131.12 -179.7 5.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.51 HG22 HG23 ' B' ' 124' ' ' THR . 13.4 t -138.58 158.48 44.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.77 154.96 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.934 -1.104 . . . . 0.0 111.162 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.477 ' N ' HD23 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -124.16 111.61 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.591 HD12 ' N ' ' B' ' 115' ' ' ILE . 5.2 mp -93.13 136.96 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 111.483 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 5.2 m-30 -96.84 169.33 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.77 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.06 -0.96 42.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 110.097 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.7 -7.31 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.08 -2.49 40.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . 0.541 ' HB3' ' CD2' ' B' ' 116' ' ' PHE . 0.1 OUTLIER -85.42 146.11 27.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.111 -1.229 . . . . 0.0 110.024 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 29.2 ttp -149.51 125.55 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.814 HG11 ' CG1' ' A' ' 71' ' ' VAL . 48.7 t -97.38 148.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.95 107.72 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 111.355 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.552 ' CG2' ' HA ' ' A' ' 27' ' ' ASN . 9.7 t -108.53 144.44 36.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.094 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.524 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 126.5 -27.2 5.03 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.939 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -52.92 149.01 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.03 -1.277 . . . . 0.0 109.719 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.0 OUTLIER -94.66 -19.97 19.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.027 -1.046 . . . . 0.0 109.862 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.436 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -161.99 -159.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -75.34 -36.83 60.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.07 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.48 -38.94 92.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.086 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.61 -52.8 22.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.299 -0.876 . . . . 0.0 110.231 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 30.3 t -45.91 -36.4 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.203 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -73.83 -31.93 63.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.686 HD23 ' HD3' ' B' ' 137' ' ' ARG . 50.5 mt -80.95 -46.63 14.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.47 -29.57 61.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.143 -0.973 . . . . 0.0 109.88 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.438 ' O ' ' C ' ' B' ' 137' ' ' ARG . 23.4 t -76.3 -64.43 1.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 110.243 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.686 ' HD3' HD23 ' B' ' 134' ' ' LEU . 14.6 ptm180 -41.79 -31.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.537 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 4.9 mmtm -67.83 -50.99 53.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.471 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.465 ' CE1' HG23 ' B' ' 106' ' ' ILE . 18.1 m-85 -60.03 -52.13 66.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.342 -0.849 . . . . 0.0 109.673 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.33 62.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.639 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -52.26 -40.44 61.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.646 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' B' ' 139' ' ' TYR . 84.2 mt -63.34 -43.0 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.835 . . . . 0.0 110.195 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.532 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 52.0 mt -75.5 -49.06 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.71 -37.43 84.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' B' ' 141' ' ' ARG . 32.5 tttp -71.82 -27.03 62.64 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.427 HG13 ' O ' ' B' ' 142' ' ' ILE . 6.2 mt -74.01 -10.64 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.67 -19.3 28.66 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.532 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 6.4 m-85 -55.18 157.98 3.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -1.222 . . . . 0.0 111.057 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.41 49.72 0.99 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.62 -0.675 . . . . 0.0 109.742 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -96.26 144.78 26.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 110.835 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.509 ' O ' HD23 ' B' ' 76' ' ' LEU . 9.2 ptpt -142.28 -157.6 0.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.45 -0.781 . . . . 0.0 109.551 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' B' ' 137' ' ' ARG . 33.8 m-85 -106.09 117.39 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.016 . . . . 0.0 110.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' B' ' 75' ' ' THR . 0.8 OUTLIER -151.27 163.28 39.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' B' ' 75' ' ' THR . 13.8 t0 42.65 26.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 110.438 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' B' ' 74' ' ' VAL . 1.4 t80 -76.63 124.05 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 110.023 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . 0.443 ' N ' ' CD1' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -163.75 131.57 3.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.366 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.51 ' CG1' ' HB2' ' B' ' 72' ' ' ALA . 31.5 mt -78.78 107.87 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -110.45 12.01 23.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.657 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.53 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 6.2 m120 -153.46 115.44 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.548 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 215' ' ' THR . 31.2 mt -117.73 162.7 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.667 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.418 ' N ' HG22 ' B' ' 160' ' ' ILE . 21.5 t -137.34 128.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.033 . . . . 0.0 110.624 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' B' ' 66' ' ' THR . . . -133.53 175.18 20.36 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 3.3 m -167.49 154.11 8.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -1.223 . . . . 0.0 110.456 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -169.95 161.9 9.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.122 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.432 ' OD1' ' HA ' ' B' ' 211' ' ' LYS . 4.2 m-20 -106.65 157.54 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.0 OUTLIER -110.46 3.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 3.8 tmtm? 74.34 -4.06 2.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.504 -0.748 . . . . 0.0 111.166 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 38.5 p90 -149.57 144.91 18.31 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.009 -1.057 . . . . 0.0 110.278 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.468 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.7 Cg_endo -71.92 157.64 54.41 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.174 1.618 . . . . 0.0 110.714 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.18 154.35 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 110.284 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.34 90.4 8.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 109.994 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' B' ' 193' ' ' LEU . 24.3 mt -52.17 -34.25 44.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.518 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -62.86 -58.91 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -56.34 -42.24 88.66 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.527 HD12 ' CD2' ' B' ' 179' ' ' HIS . 14.5 tp -71.88 -38.37 70.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.185 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.662 ' HB2' HD12 ' B' ' 193' ' ' LEU . . . -71.13 -17.31 62.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -83.09 -40.86 19.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.123 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 15.3 t -81.61 -45.63 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.527 ' CD2' HD12 ' B' ' 175' ' ' LEU . 52.2 m-70 -95.4 14.93 20.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.33 -29.97 5.52 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 92.2 m -71.95 -25.44 61.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.3 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -106.1 -21.32 13.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.891 ' HB3' HD21 ' B' ' 193' ' ' LEU . 1.1 m -124.86 171.61 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.5 t -137.95 135.39 35.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.894 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 0.491 ' CD2' ' HD3' ' B' ' 187' ' ' PRO . 64.4 t80 -128.55 135.59 49.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.578 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' B' ' 190' ' ' PHE . 12.3 mm-40 -131.94 93.79 26.28 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . 0.491 ' HD3' ' CD2' ' B' ' 185' ' ' TYR . 42.0 Cg_endo -68.99 -7.08 19.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.034 1.544 . . . . 0.0 110.365 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -100.41 -1.68 35.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -153.48 -48.33 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.134 -0.979 . . . . 0.0 110.565 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.816 ' HE2' HD11 ' B' ' 205' ' ' LEU . 3.0 t80 -108.76 117.56 53.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 110.514 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.53 -30.66 9.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.98 1.516 . . . . 0.0 110.178 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.75 -179.38 44.76 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.891 HD21 ' HB3' ' B' ' 183' ' ' SER . 3.6 tt -123.4 150.81 43.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -1.187 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' B' ' 183' ' ' SER . 4.5 mt -107.52 100.79 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.48 ' OH ' ' ND1' ' B' ' 179' ' ' HIS . 0.6 OUTLIER -89.62 103.88 16.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.262 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' B' ' 202' ' ' ILE . 22.2 mtm180 -92.36 79.51 4.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.523 ' CE ' HG12 ' B' ' 230' ' ' ILE . 34.3 ttm -43.53 146.28 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 110.589 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.14 -34.61 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 110.079 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -155.8 116.05 2.24 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.3 Cg_endo -73.54 147.42 89.56 Favored 'Cis proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.89 -2.129 . . . . 0.0 110.377 0.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' B' ' 197' ' ' MET . 0.0 OUTLIER -59.27 101.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' B' ' 217' ' ' ALA . 37.9 mm -138.85 153.55 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.343 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.71 100.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.925 HD22 HG13 ' B' ' 230' ' ' ILE . 6.2 mp -94.67 127.25 40.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.46 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.816 HD11 ' HE2' ' B' ' 190' ' ' PHE . 0.1 OUTLIER -92.54 111.12 22.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.45 HD12 HD21 ' B' ' 234' ' ' LEU . 10.9 mm -96.68 139.32 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' B' ' 205' ' ' LEU . 33.4 m-85 -128.81 136.41 50.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.141 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 54.8 t -49.19 -36.35 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.938 . . . . 0.0 110.215 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.6 m -53.3 -30.0 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.47 16.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.624 ' O ' HD13 ' B' ' 212' ' ' ILE . 8.8 mttt -92.26 133.97 35.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.13 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.624 HD13 ' O ' ' B' ' 211' ' ' LYS . 12.9 mm -117.54 135.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.371 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' B' ' 205' ' ' LEU . 69.3 t -123.06 113.68 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.812 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.533 ' H ' HD12 ' B' ' 214' ' ' LEU . 3.5 mp -103.74 117.37 34.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.462 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.9 t -147.8 165.64 29.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.183 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.447 ' HA3' ' HE1' ' A' ' 67' ' ' MET . . . 92.49 21.76 30.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.895 ' HB3' HD12 ' B' ' 223' ' ' ILE . . . -100.32 141.57 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -1.099 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -16.0 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 109.94 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.12 145.72 24.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 110.027 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' B' ' 67' ' ' LEU . 0.6 OUTLIER -53.03 -25.73 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.244 -0.91 . . . . 0.0 110.329 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -38.68 91.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.407 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 82.0 mt-10 -67.59 -52.09 42.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.292 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' B' ' 217' ' ' ALA . 0.0 OUTLIER -53.08 -56.64 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.685 ' N ' HG22 ' B' ' 223' ' ' ILE . 1.7 m-30 -47.56 -31.07 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.004 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' B' ' 228' ' ' GLU . 2.8 mt-30 -78.42 -41.97 31.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.801 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -45.88 -44.36 14.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.868 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -69.5 -45.18 69.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.812 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -53.28 -28.77 29.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.08 19.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 109.789 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.925 HG13 HD22 ' B' ' 204' ' ' LEU . 5.9 mm -97.58 -13.4 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 109.821 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 41.7 t80 -52.46 -44.95 95.48 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.924 . . . . 0.0 110.694 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -74.28 -26.73 12.15 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.39 1.205 . . . . 0.0 110.315 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.41 HG13 HD13 ' B' ' 175' ' ' LEU . 25.0 t -66.23 -39.48 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 109.785 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.45 HD21 HD12 ' B' ' 206' ' ' ILE . 67.6 mt -68.5 -45.62 71.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 110.018 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 94.9 p -64.94 -44.58 88.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.87 . . . . 0.0 110.04 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.62 -37.33 49.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.927 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -110.62 36.59 3.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.968 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' B' ' 238' ' ' ARG . 0.2 OUTLIER -74.55 163.46 27.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -121.37 -30.68 4.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.106 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.052 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.379 0.609 . . . . 0.0 110.032 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 1.02 ' N ' HD12 ' A' ' 18' ' ' LEU . 37.0 t0 -68.28 67.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.753 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.985 HD21 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -84.28 -4.42 58.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 110.397 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.594 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 31.1 m -43.48 -36.45 2.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 110.289 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.507 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -92.41 -36.45 6.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.755 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -49.93 -45.46 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -1.213 . . . . 0.0 108.82 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.891 HD22 ' HB3' ' A' ' 67' ' ' MET . 3.8 pp -79.74 6.35 11.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 109.607 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.786 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.3 t80 -114.94 -13.89 11.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 111.232 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 164.73 46.9 0.02 OUTLIER Glycine 0 N--CA 1.496 2.649 0 C-N-CA 118.861 -1.638 . . . . 0.0 110.746 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.552 ' HB2' ' CG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 44.96 112.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.307 1.051 . . . . 0.0 111.784 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -145.0 158.24 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.777 ' HA ' HG21 ' B' ' 103' ' ' ILE . 44.8 m-20 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.052 ' HB2' HD13 ' A' ' 18' ' ' LEU . 13.7 p -38.66 -28.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.475 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.8 tt0 -54.02 -17.02 2.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 110.233 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.53 28.22 5.5 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -123.97 125.87 45.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.003 -1.293 . . . . 0.0 110.359 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.673 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.31 153.16 17.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 110.706 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.747 HD12 ' C ' ' A' ' 35' ' ' LEU . 4.3 pp . . . . . 0 N--CA 1.494 1.753 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.784 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.187 0.518 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 13.8 pt-20 -95.53 -23.73 16.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.668 HD21 ' HZ ' ' B' ' 207' ' ' PHE . 4.4 mt -96.81 -43.7 7.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.016 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.904 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -45.23 -45.16 11.64 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.967 -179.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.98 -30.26 70.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.564 ' HB3' ' CE1' ' B' ' 190' ' ' PHE . 91.2 m-20 -80.69 -37.8 30.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.713 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.7 mt -49.28 -46.22 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.355 -0.841 . . . . 0.0 109.54 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.77 -17.12 26.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -119.46 7.75 11.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -1.143 . . . . 0.0 110.315 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 56' ' ' ILE . 1.8 mt -86.76 31.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.524 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -118.2 39.07 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.204 -0.935 . . . . 0.0 110.49 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' HD13 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -162.42 31.43 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.522 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -145.22 -26.65 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 111.256 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.999 ' N ' HD12 ' A' ' 62' ' ' LEU . . . 177.47 -44.52 0.1 OUTLIER Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.157 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.86 HD12 HD11 ' A' ' 24' ' ' LEU . 3.9 mm? -53.4 -17.7 2.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -1.188 . . . . 0.0 110.67 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 80.6 m-20 -46.42 -39.82 11.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.085 -1.009 . . . . 0.0 110.116 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -62.26 -57.05 12.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.877 . . . . 0.0 110.098 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.891 ' HB3' HD22 ' A' ' 24' ' ' LEU . 4.9 tpp -64.32 -11.01 27.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 21' ' ' THR . 1.3 tm? -68.0 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.974 0.892 . . . . 0.0 109.024 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.82 -2.46 17.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.307 0.575 . . . . 0.0 110.222 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 13.3 tt0 -85.8 0.53 52.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.229 -0.919 . . . . 0.0 111.53 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.778 HG12 HG11 ' B' ' 122' ' ' VAL . 2.2 t -137.92 3.24 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.265 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 74' ' ' LEU . 6.0 tp -149.85 70.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -75.83 57.33 1.02 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.933 HD12 HD11 ' A' ' 72' ' ' ILE . 6.1 mt . . . . . 0 C--N 1.303 -1.444 0 CA-C-O 121.681 0.753 . . . . 0.0 110.382 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.29 0.567 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.459 HG13 ' HD2' ' B' ' 65' ' ' PRO . 55.8 t -92.47 140.07 24.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.876 . . . . 0.0 110.248 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.467 ' HG3' ' HB2' ' B' ' 227' ' ' PHE . 44.5 Cg_endo -71.29 138.45 33.1 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.011 1.532 . . . . 0.0 110.476 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.479 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 17.0 m -106.67 141.35 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.826 HD22 HG22 ' B' ' 160' ' ' ILE . 40.6 mt -78.66 122.24 25.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.521 ' O ' ' ND2' ' B' ' 69' ' ' ASN . 19.7 mm-40 -110.16 -15.71 13.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 110.383 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.544 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 10.4 m120 -160.94 121.7 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.299 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.716 HD11 HD13 ' B' ' 67' ' ' LEU . 10.1 mt -122.54 171.33 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.902 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.579 ' N ' HG22 ' B' ' 70' ' ' ILE . 7.6 t -144.79 134.31 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.64 133.29 54.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 38.7 m -92.14 127.33 37.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.093 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.727 HG21 ' OG ' ' B' ' 136' ' ' SER . 40.6 t -131.12 133.04 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.385 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 4.4 m -101.27 139.98 36.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 110.056 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.831 HD22 ' HB1' ' B' ' 150' ' ' ALA . 29.2 mt -87.16 -67.25 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 143.32 -17.75 2.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 30.1 p -141.7 141.08 33.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.775 ' O ' HD23 ' B' ' 80' ' ' LEU . 1.5 ptt85 -57.9 163.56 2.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.775 HD23 ' O ' ' B' ' 79' ' ' ARG . 18.0 mt -139.86 155.98 46.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 110.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 3.7 m-20 -89.75 102.59 15.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' B' ' 102' ' ' VAL . 13.6 mt -48.39 -31.44 6.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.333 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -67.25 -38.59 85.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 110.255 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 31.7 p -81.9 -41.96 20.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.543 HG12 HG11 ' B' ' 102' ' ' VAL . 24.2 t -58.66 -42.46 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.404 ' CB ' ' HB2' ' B' ' 94' ' ' TYR . . . -81.03 -18.39 46.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.452 ' O ' HD12 ' B' ' 87' ' ' LEU . 13.4 tp -87.08 -31.38 20.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -95.59 -29.3 14.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.397 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -63.35 133.37 53.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -25.45 59.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 110.383 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 2.4 m120 -132.25 79.42 1.86 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.75 158.41 44.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' B' ' 102' ' ' VAL . 1.7 mm-40 -129.78 147.34 51.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.404 ' HB2' ' CB ' ' B' ' 86' ' ' ALA . 28.8 t80 -147.6 111.14 4.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.925 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -135.35 122.85 15.07 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 110.41 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.72 -17.3 26.11 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.916 1.482 . . . . 0.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -21.6 62.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 110.208 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.452 ' HG3' ' NH1' ' B' ' 98' ' ' ARG . 0.0 OUTLIER -101.9 -56.95 2.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.606 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.731 ' CG ' ' HB2' ' A' ' 18' ' ' LEU 0.257 62.6 t80 -170.18 -179.14 3.02 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.866 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.773 ' O ' HD13 ' A' ' 74' ' ' LEU . . . -99.41 70.72 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.869 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -155.43 149.67 25.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.558 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.543 HG11 HG12 ' B' ' 85' ' ' VAL . 44.7 t -102.03 117.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.777 HG21 ' HA ' ' A' ' 29' ' ' ASP . 1.3 mp -89.55 111.38 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.483 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.568 ' CB ' ' HB3' ' B' ' 113' ' ' ALA . 0.6 OUTLIER -89.93 153.01 20.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.774 179.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -149.53 118.05 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.047 -1.033 . . . . 0.0 110.728 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.584 HG23 ' CE1' ' B' ' 139' ' ' TYR . 34.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 109.706 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -104.03 35.59 2.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 110.39 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 5.9 tt0 -171.82 81.49 0.48 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.461 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.483 ' O ' HG13 ' B' ' 106' ' ' ILE . 50.3 Cg_endo -79.63 165.35 80.08 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.538 -0.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 8.4 tptt -70.24 94.17 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.518 HG22 ' HA3' ' B' ' 125' ' ' GLY . 18.4 p -139.59 177.66 7.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.713 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.58 ' HB ' HG23 ' B' ' 124' ' ' THR . 0.9 OUTLIER -119.7 173.43 7.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.451 -0.78 . . . . 0.0 109.383 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' B' ' 104' ' ' MET . . . -146.93 133.97 20.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.22 97.18 6.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.521 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 68.8 mt -97.34 150.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.101 -0.999 . . . . 0.0 111.274 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.3 m-85 -118.81 174.13 6.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 109.861 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -87.4 -3.29 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 109.907 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.88 -22.34 24.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.531 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 126.57 -38.98 2.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.63 153.46 2.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -1.157 . . . . 0.0 110.026 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.545 ' HE2' HD21 ' B' ' 76' ' ' LEU . 1.9 ttm -140.76 148.77 41.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.778 HG11 HG12 ' A' ' 71' ' ' VAL . 1.4 t -129.02 142.21 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.49 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.482 HG13 ' HE2' ' B' ' 139' ' ' TYR . 21.7 t -132.04 112.41 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.636 HG21 HD13 ' A' ' 23' ' ' ILE . 1.7 t -104.86 165.37 11.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.382 -0.824 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.518 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 107.87 -28.26 12.67 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -51.5 144.91 9.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -1.222 . . . . 0.0 110.241 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' B' ' 128' ' ' SER . 17.0 pttm -112.62 -23.54 10.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.442 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -137.25 -153.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.79 -39.27 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.319 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.9 -42.45 90.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.62 -47.21 79.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 110.204 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 35.7 t -52.27 -46.96 66.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.241 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -36.86 80.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 110.212 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.82 -50.39 36.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.73 -50.27 66.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.727 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -62.35 -54.34 41.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.009 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' B' ' 138' ' ' LYS . 0.0 OUTLIER -46.5 -39.37 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.961 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.469 ' HD3' ' HD3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -61.29 -53.73 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.945 . . . . 0.0 110.052 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.721 ' HA ' HD12 ' B' ' 142' ' ' ILE . 40.5 m-85 -54.21 -52.72 60.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.257 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.37 -31.93 16.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -35.98 81.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.721 HD12 ' HA ' ' B' ' 139' ' ' TYR . 13.8 mt -63.97 -48.62 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.526 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.84 HG21 ' HB2' ' B' ' 150' ' ' ALA . 20.4 mm -61.66 -49.32 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -68.95 -27.56 65.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.085 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -77.35 -20.6 54.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.237 -0.914 . . . . 0.0 108.75 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.8 mt -87.57 -19.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.697 -0.627 . . . . 0.0 109.34 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.45 -29.41 5.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.499 ' CB ' HG22 ' B' ' 143' ' ' ILE . 6.8 m-85 -47.88 159.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.032 -1.275 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.12 42.07 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.651 -0.655 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.84 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -71.33 154.87 41.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.601 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -144.42 120.52 10.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 109.768 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 63.3 t80 -60.89 111.46 1.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.452 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.466 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.1 OUTLIER -158.16 163.25 37.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 0.4 OUTLIER 63.43 13.95 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.649 ' HA ' HG22 ' B' ' 74' ' ' VAL . 19.8 t80 -61.41 126.41 27.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.972 -1.08 . . . . 0.0 109.838 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 155' ' ' PHE . 27.5 mtpt -160.77 133.35 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.548 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.479 HG23 ' CG2' ' B' ' 70' ' ' ILE . 2.9 mp -79.49 127.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.755 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -129.33 -25.69 2.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.209 -0.932 . . . . 0.0 110.88 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -113.54 96.88 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.793 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.826 HG22 HD22 ' B' ' 67' ' ' LEU . 44.5 mt -107.85 111.36 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.552 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.874 HG22 ' OG1' ' B' ' 215' ' ' THR . 25.2 t -94.8 107.66 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.789 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -111.5 167.52 12.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.8 t -169.16 159.72 9.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.923 -1.339 . . . . 0.0 110.63 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -169.85 170.11 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.845 . . . . 0.0 109.928 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.89 161.05 14.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.969 . . . . 0.0 110.281 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.548 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.1 OUTLIER -111.54 -83.8 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.489 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER -173.89 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 110.8 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.489 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 7.0 p90 -137.49 166.31 27.59 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.7 Cg_endo -71.18 149.42 57.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.782 1.412 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.39 160.57 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.301 -0.874 . . . . 0.0 110.376 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.07 91.42 6.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' B' ' 193' ' ' LEU . 83.0 mt -48.34 -26.37 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.38 -58.57 4.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -51.22 -31.82 27.68 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.571 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -72.97 -42.89 62.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -1.165 . . . . 0.0 110.229 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -68.09 -13.46 62.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.143 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.6 t80 -92.8 -37.52 12.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . 0.491 ' HB2' ' CZ ' ' B' ' 237' ' ' PHE . 46.6 t -83.82 -50.27 8.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -105.4 19.4 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.887 . . . . 0.0 110.225 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 176' ' ' ALA . . . -54.36 -25.74 34.72 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.07 -24.31 62.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -1.145 . . . . 0.0 110.263 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.706 ' CE1' HG22 ' B' ' 198' ' ' VAL . 0.9 OUTLIER -134.66 12.04 3.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.466 ' HB3' HD21 ' B' ' 193' ' ' LEU . 48.6 m -120.15 159.47 24.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 0.0 110.373 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 16.9 m -134.84 126.81 29.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.174 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -136.55 120.03 17.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 110.41 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -132.25 105.17 13.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.818 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.96 -2.86 12.17 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.084 1.571 . . . . 0.0 110.346 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.0 5.86 45.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.875 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.446 HD13 ' HE3' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -157.82 -41.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 110.266 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 55' ' ' ASN . 3.0 t80 -126.35 114.15 23.42 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -17.82 28.02 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.838 1.441 . . . . 0.0 110.49 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -94.31 179.79 37.84 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.9 ' HB2' HD22 ' B' ' 172' ' ' LEU . 9.5 tt -120.41 126.99 51.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.334 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.782 HD13 HD13 ' A' ' 62' ' ' LEU . 6.5 mt -90.95 107.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.4 t80 -96.44 116.7 29.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 87.55 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.0 ttm -59.53 144.07 48.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.706 HG22 ' CE1' ' B' ' 182' ' ' PHE . 65.2 t -88.26 -40.37 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 110.436 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.2 OUTLIER -140.93 107.49 6.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.365 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.9 Cg_endo -75.96 166.31 83.26 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.049 -2.063 . . . . 0.0 110.55 -0.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.0 OUTLIER -76.31 95.73 3.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.784 HD11 ' OE1' ' B' ' 222' ' ' GLU . 33.4 mm -134.91 160.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.45 107.04 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' B' ' 195' ' ' TYR . 1.5 mp -100.07 134.63 42.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.786 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 2.8 mt -110.83 116.26 30.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.489 HG12 HD21 ' B' ' 234' ' ' LEU . 3.6 mp -100.48 136.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.273 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.668 ' HZ ' HD21 ' A' ' 52' ' ' LEU . 49.0 m-85 -119.92 131.23 55.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 0.0 110.069 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 22.0 t -42.79 -27.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 207' ' ' PHE . 98.3 p -64.51 -26.58 68.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.548 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 110.75 9.02 23.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.62 ' C ' HD12 ' B' ' 212' ' ' ILE . 0.1 OUTLIER -98.2 121.93 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -1.185 . . . . 0.0 110.153 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.62 HD12 ' C ' ' B' ' 211' ' ' LYS . 1.2 mp -109.97 146.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.248 -0.907 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.652 ' C ' HD12 ' B' ' 214' ' ' LEU . 27.6 t -127.81 146.65 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 110.08 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.765 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.4 mp -133.2 109.51 9.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.874 ' OG1' HG22 ' B' ' 161' ' ' VAL . 14.7 t -130.23 152.04 50.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.149 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.413 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 109.03 -11.92 34.31 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -68.77 144.57 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.165 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -90.04 -17.37 27.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.173 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.408 ' N ' ' CD1' ' B' ' 160' ' ' ILE . 1.7 mt-30 -147.95 168.94 20.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -14.54 62.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.138 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' B' ' 221' ' ' GLU . 8.5 mp0 -68.73 -42.19 77.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 110.081 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.784 ' OE1' HD11 ' B' ' 202' ' ' ILE . 13.9 mt-10 -63.78 -51.15 66.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.449 HG22 ' HG2' ' B' ' 65' ' ' PRO . 45.8 mm -56.0 -37.2 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.419 ' CZ ' HG11 ' B' ' 64' ' ' VAL . 0.9 OUTLIER -65.05 -42.87 93.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 226' ' ' ALA . 0.0 OUTLIER -75.9 -44.11 42.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.296 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.478 ' O ' HG22 ' B' ' 230' ' ' ILE . . . -45.3 -41.38 8.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.72 ' HA ' HG22 ' B' ' 230' ' ' ILE . 10.2 t80 -78.39 -50.26 12.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 109.88 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -18.62 33.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.982 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -97.86 -32.61 11.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.72 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.8 tp -92.98 -17.79 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.605 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.3 t80 -50.88 -44.99 87.24 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 111.107 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.7 Cg_endo -71.93 -32.65 10.95 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.205 1.108 . . . . 0.0 110.496 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.571 HG12 HD21 ' B' ' 175' ' ' LEU . 25.2 t -64.37 -30.41 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 109.893 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.489 HD21 HG12 ' B' ' 206' ' ' ILE . 89.7 mt -70.91 -56.49 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.993 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -25.3 17.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -48.88 62.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' B' ' 178' ' ' SER . 92.4 m-85 -106.87 37.51 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.38 -0.825 . . . . 0.0 109.87 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -163.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' B' ' 169' ' ' PRO . 1.7 ttmm -126.7 -81.12 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 1.8 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.314 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.883 HD23 ' CG1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.493 ' N ' HD12 ' A' ' 18' ' ' LEU . 29.1 t0 -61.26 75.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 0.0 110.25 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -91.14 -7.53 51.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.86 ' OG1' HD21 ' A' ' 68' ' ' LEU . 91.9 m -43.38 -30.7 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.43 -31.48 6.44 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.762 HD12 HD11 ' B' ' 114' ' ' LEU . 0.3 OUTLIER -52.79 -41.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.316 . . . . 0.0 109.333 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.496 ' CD2' HD12 ' A' ' 68' ' ' LEU . 1.4 pp -84.51 -18.94 34.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.742 -1.223 . . . . 0.0 108.652 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.688 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -99.6 14.57 29.55 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 141.18 93.27 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.934 ' HB2' HG23 ' B' ' 124' ' ' THR . 4.9 p30 -28.42 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.69 0.757 . . . . 0.0 112.066 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.77 HG22 HD12 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.79 169.1 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.629 ' HB3' HG21 ' B' ' 103' ' ' ILE . 94.9 m-20 -86.41 123.92 32.17 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.628 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -36.56 -29.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.923 -177.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.5 tt0 -50.26 -21.16 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 109.87 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.82 25.45 4.23 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.672 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.57 135.19 52.94 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.808 -1.407 . . . . 0.0 110.988 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.77 HD12 HG22 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -103.43 154.01 19.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 111.235 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.9 HD21 ' OD1' ' A' ' 27' ' ' ASN . 3.0 pp . . . . . 0 N--CA 1.492 1.645 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.156 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.231 0.539 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.5 tt0 -100.65 -24.29 14.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' ASN . 3.9 mt -99.61 -44.37 6.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.856 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.73 -44.38 4.32 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.395 -0.816 . . . . 0.0 109.931 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.26 -27.25 65.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 52' ' ' LEU . 29.2 m-80 -81.45 -36.03 29.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 53' ' ' ARG . 6.8 mt -55.54 -44.05 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 0.0 109.541 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.42 -17.09 31.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -129.75 18.83 5.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -1.089 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' A' ' 56' ' ' ILE . 3.0 mt -80.93 -5.1 57.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 97.9 p -90.08 37.88 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 0.0 109.691 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 58' ' ' SER . 13.7 mtpp -121.17 6.66 10.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 194' ' ' ILE . 0.1 OUTLIER -118.61 -85.02 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.48 28.9 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.307 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -100.69 -27.96 13.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.024 -1.28 . . . . 0.0 109.005 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.694 ' HA ' HD22 ' A' ' 68' ' ' LEU . 50.2 t0 -45.21 -38.28 5.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.846 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -53.9 -30.63 46.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.991 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.556 ' HB3' HD12 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -78.17 -25.63 47.29 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 109.803 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.86 HD21 ' OG1' ' A' ' 21' ' ' THR . 7.9 mp -61.93 -58.66 7.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.846 HD21 ' HA ' ' A' ' 66' ' ' SER . 2.1 pp -52.75 -19.1 2.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.555 -0.716 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 67' ' ' MET . 35.3 tt0 -75.33 -2.98 30.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 110.356 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.959 ' O ' HG21 ' B' ' 122' ' ' VAL . 1.4 t -132.77 1.46 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.118 -0.989 . . . . 0.0 109.875 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.883 ' CG1' HD23 ' A' ' 18' ' ' LEU . 7.5 tp -146.82 67.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.638 -0.664 . . . . 0.0 109.918 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 46.4 t0 -76.8 57.84 1.35 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.145 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 6.0 mt . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 121.577 0.703 . . . . 0.0 110.85 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.605 HD13 ' O ' ' B' ' 165' ' ' ASP . 3.4 mt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.124 0.488 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' B' ' 63' ' ' ILE . 38.8 t 58.55 137.79 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 0.0 110.514 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.5 ' HD3' ' CD2' ' B' ' 227' ' ' PHE . 44.6 Cg_endo -73.27 124.74 9.7 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.859 1.452 . . . . 0.0 110.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.5 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 2.3 m -89.97 156.4 18.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.96 137.97 31.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.213 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -126.91 -10.74 6.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.511 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.5 OUTLIER -168.02 131.0 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.474 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.744 HG12 HG23 ' B' ' 160' ' ' ILE . 4.1 mt -129.74 165.75 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.884 HG22 ' HB ' ' B' ' 124' ' ' THR . 42.5 t -139.89 144.76 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 110.568 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' B' ' 156' ' ' LYS . . . -139.97 162.31 35.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.055 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 42.1 p -110.76 141.64 43.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.067 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.92 146.6 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 110.173 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' B' ' 154' ' ' ASP . 2.3 m -118.84 129.1 55.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.592 HD22 ' HB1' ' B' ' 150' ' ' ALA . 64.2 mt -89.67 -40.72 12.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 110.102 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.04 22.18 20.98 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.86 146.55 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -1.191 . . . . 0.0 110.381 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.631 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -77.16 148.58 35.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.8 HD22 ' HD2' ' B' ' 148' ' ' PHE . 13.7 mt -129.37 149.31 51.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.407 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 0.7 OUTLIER -90.07 94.74 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.733 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.582 HD22 HG23 ' B' ' 102' ' ' VAL . 13.1 mt -40.24 -55.23 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 0.0 110.462 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -47.25 -39.72 14.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 99.3 m -76.35 -41.04 49.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.54 -56.76 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 110.448 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.81 55.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.324 -0.86 . . . . 0.0 110.734 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 0.9 OUTLIER -72.13 -51.26 22.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.543 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -72.77 -42.23 64.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 0.0 110.482 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -42.7 122.34 2.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.429 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -73.53 -26.07 60.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.094 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 1.8 m120 -130.05 78.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -170.28 170.23 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.429 -0.794 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.623 ' O ' HD12 ' B' ' 103' ' ' ILE . 9.6 pt-20 -160.2 137.2 9.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -108.54 116.47 32.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 110.088 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.23 107.12 55.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.314 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -23.13 18.95 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.895 1.471 . . . . 0.0 110.089 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -24.38 63.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.099 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.45 -69.32 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.031 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.655 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.36 166.23 26.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.4 44.85 1.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.145 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -122.83 146.83 47.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.582 HG23 HD22 ' B' ' 82' ' ' LEU . 30.9 t -89.97 122.15 41.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.325 -0.86 . . . . 0.0 109.05 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.629 HG21 ' HB3' ' A' ' 29' ' ' ASP . 4.1 mp -89.3 110.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.893 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.58 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 7.2 ttm -103.93 163.95 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' B' ' 111' ' ' THR . 0.4 OUTLIER -163.6 127.38 2.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 110.587 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.643 HG23 ' CE1' ' B' ' 139' ' ' TYR . 7.2 pt -112.08 170.94 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 109.895 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.519 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 12.1 ptt180 -114.09 18.06 17.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.1 -1.0 . . . . 0.0 110.536 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 9.6 tt0 -177.67 94.02 0.23 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.478 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 51.6 Cg_endo -77.8 139.54 57.63 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.957 -2.101 . . . . 0.0 110.484 -0.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.74 ' O ' HG23 ' B' ' 111' ' ' THR . 18.9 mttp -56.65 118.98 5.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.74 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -163.59 178.33 8.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 110.419 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -131.91 172.4 12.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.82 . . . . 0.0 109.149 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.505 ' N ' ' CG2' ' B' ' 112' ' ' THR . . . -166.1 137.24 3.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.824 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -97.91 102.52 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' B' ' 104' ' ' MET . 2.3 mp -89.65 126.15 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' A' ' 74' ' ' LEU . 2.6 m-85 -101.32 157.44 16.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 109.913 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.485 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -73.56 -23.02 59.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 1.5 t -58.18 -18.91 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.184 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.11 -17.79 16.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -96.71 147.25 24.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 110.142 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -138.5 169.24 18.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.959 HG21 ' O ' ' A' ' 71' ' ' VAL . 5.1 t -127.12 142.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 71' ' ' VAL . 11.2 t -119.63 149.67 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.794 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.934 HG23 ' HB2' ' A' ' 27' ' ' ASN . 3.0 t -162.36 160.21 26.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.877 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.686 ' C ' HG22 ' B' ' 111' ' ' THR . . . 104.25 -1.56 43.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' B' ' 69' ' ' ASN . . . -75.53 -179.0 4.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.249 . . . . 0.0 110.09 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -135.28 0.39 2.8 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.994 -1.066 . . . . 0.0 110.731 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -160.41 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.081 -1.012 . . . . 0.0 110.319 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -87.84 -34.12 18.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.67 -34.94 60.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -53.49 53.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 3.1 m -55.0 -42.8 72.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.992 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.43 78.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.926 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -71.49 -56.69 5.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.062 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.603 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -58.88 -31.44 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 21.0 t -65.77 -63.14 1.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.1 ptm180 -52.06 -31.15 28.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.499 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -62.99 -47.47 82.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.666 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.643 ' CE1' HG23 ' B' ' 106' ' ' ILE . 20.9 m-85 -63.73 -53.42 51.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.632 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.37 -22.94 13.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.33 -47.53 49.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.783 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 146' ' ' ILE . 1.8 mt -50.4 -43.3 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.643 ' N ' HD12 ' B' ' 143' ' ' ILE . 3.1 mp -73.08 -59.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.918 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 3.0 mm-40 -54.45 -34.82 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.617 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -73.22 -30.15 63.29 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 142' ' ' ILE . 3.4 mt -72.68 -16.16 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.1 -20.58 19.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.8 ' HD2' HD22 ' B' ' 80' ' ' LEU . 3.1 m-85 -49.8 171.13 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.961 -1.317 . . . . 0.0 110.548 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.7 43.55 1.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 110.097 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.592 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -85.68 151.97 23.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.579 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 6.6 mttp -120.98 -158.53 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 110.206 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.03 86.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -146.53 177.19 9.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.536 ' CB ' ' OG1' ' B' ' 75' ' ' THR . 2.8 t0 69.29 6.57 5.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.352 -0.842 . . . . 0.0 110.704 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -51.23 127.73 20.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.026 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -158.33 126.3 5.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.54 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 6.5 mt -82.67 117.16 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.752 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -117.98 2.5 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 110.602 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.466 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 0.4 OUTLIER -147.67 121.9 9.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.744 HG23 HG12 ' B' ' 70' ' ' ILE . 57.6 mt -130.93 126.14 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.716 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.9 HG22 ' OG1' ' B' ' 215' ' ' THR . 15.0 t -105.16 140.05 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -139.96 -179.81 18.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.9 OUTLIER -170.38 154.99 4.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.315 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.481 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 18.0 p -170.18 163.47 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.605 ' O ' HD13 ' B' ' 63' ' ' ILE . 4.3 t0 -106.24 133.73 50.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.974 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.775 HG21 HD11 ' B' ' 170' ' ' ILE . 12.8 m -83.48 7.43 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -0.931 . . . . 0.0 110.595 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 45.7 tttt 70.68 12.43 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 110.809 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 16.0 p90 -169.35 145.6 2.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.048 -1.032 . . . . 0.0 110.425 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.66 154.77 54.65 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.092 1.575 . . . . 0.0 110.648 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.775 HD11 HG21 ' B' ' 166' ' ' VAL . 2.7 mp -125.11 151.18 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 110.152 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 5.8 ptm180 -88.51 98.51 11.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.115 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.509 HD22 ' CB ' ' B' ' 193' ' ' LEU . 30.3 mt -54.81 -42.06 71.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.011 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 16.1 pt-20 -55.65 -44.51 77.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.999 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -66.77 -37.89 92.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.821 HD21 HG12 ' B' ' 233' ' ' VAL . 0.2 OUTLIER -67.19 -38.6 85.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.942 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.64 60.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.933 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.91 -29.35 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.903 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 3.1 t -97.18 -30.89 12.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.949 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 183' ' ' SER . 24.7 m170 -130.44 31.71 4.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -66.69 -10.88 56.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.9 m -64.71 -36.63 84.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.0 -14.77 11.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.83 . . . . 0.0 110.303 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.592 ' HB2' ' CD2' ' B' ' 195' ' ' TYR . 0.9 OUTLIER -104.38 149.0 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.404 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 2.3 p -128.95 133.91 48.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.078 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -133.3 124.17 26.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.286 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' B' ' 187' ' ' PRO . 2.3 mt-10 -122.81 104.78 35.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 110.074 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.3 Cg_endo -72.29 -2.52 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.97 1.511 . . . . 0.0 110.23 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.44 0.42 39.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.853 . . . . 0.0 110.398 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.476 HD23 ' N ' ' B' ' 190' ' ' PHE . 2.2 tt -161.13 -47.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' B' ' 194' ' ' ILE . 1.1 t80 -100.92 110.94 62.4 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.443 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.93 -25.64 16.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.994 1.523 . . . . 0.0 110.266 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.17 -179.68 34.07 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.719 HD23 ' C ' ' B' ' 193' ' ' LEU . 7.5 tt -115.91 127.25 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -1.226 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.893 HD13 HD13 ' A' ' 62' ' ' LEU . 4.2 mt -90.07 111.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' B' ' 183' ' ' SER . 10.2 t80 -108.92 113.32 26.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.347 -0.846 . . . . 0.0 110.144 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.1 91.63 5.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 28.0 ttm -60.3 131.34 50.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' B' ' 201' ' ' LYS . 38.5 t -70.71 -42.29 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 1.7 mttt -139.66 112.24 7.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.385 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.9 Cg_endo -73.23 169.94 71.42 Favored 'Cis proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.974 -2.094 . . . . 0.0 110.462 -0.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 8.6 mtmt -79.42 80.02 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' B' ' 217' ' ' ALA . 44.7 mm -121.97 150.82 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.527 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 79.6 t -101.81 104.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.904 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.3 mp -97.17 141.51 30.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.392 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.798 ' C ' HD13 ' B' ' 206' ' ' ILE . 2.5 mt -120.9 131.95 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.798 HD13 ' C ' ' B' ' 205' ' ' LEU . 5.0 mm -115.41 139.51 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -121.38 145.21 48.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.482 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 74.9 t -50.09 -33.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.119 -0.988 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.2 t -63.72 -35.22 79.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 110.082 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.426 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 119.03 30.02 1.69 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.98 129.31 46.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 110.312 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.546 HD12 HD12 ' B' ' 206' ' ' ILE . 19.2 mm -114.72 132.79 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.598 ' HB ' HD12 ' B' ' 205' ' ' LEU . 6.1 t -124.73 140.31 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.933 . . . . 0.0 110.213 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.566 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.1 mp -130.75 112.49 13.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.9 ' OG1' HG22 ' B' ' 161' ' ' VAL . 5.3 t -136.34 151.43 49.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.484 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 103.85 7.05 42.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -82.19 159.46 23.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -1.197 . . . . 0.0 110.165 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -99.57 -17.58 17.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 0.0 110.171 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.654 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.5 OUTLIER -147.44 -162.59 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -95.75 -21.08 18.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.23 -24.09 65.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.833 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.43 ' HB3' HD11 ' B' ' 202' ' ' ILE . 21.0 mt-10 -79.92 -52.68 7.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.906 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 22.5 mm -52.94 -39.35 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.865 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.24 -43.84 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.008 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.61 82.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.287 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.84 88.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.208 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.5 ' CD2' ' HD3' ' B' ' 65' ' ' PRO . 53.1 t80 -70.0 -49.0 55.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -24.5 67.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.63 -31.33 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.945 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' B' ' 232' ' ' PRO . 2.1 tp -96.96 -16.62 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.937 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.594 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.1 t80 -46.97 -46.34 53.15 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 110.827 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -72.67 -50.57 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.329 1.173 . . . . 0.0 110.427 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.821 HG12 HD21 ' B' ' 175' ' ' LEU . 25.5 t -44.26 -38.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.62 -42.46 64.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.888 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.53 34.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.491 ' CA ' ' HD3' ' B' ' 171' ' ' ARG . 86.6 m-85 -121.44 38.77 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.78 167.07 21.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -104.8 -36.92 7.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.263 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.967 HD12 ' N ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.967 ' N ' HD12 ' A' ' 18' ' ' LEU . 6.2 t70 -65.86 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.833 HD21 HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -84.4 -17.2 40.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.525 -0.734 . . . . 0.0 111.02 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.721 ' N ' HD21 ' A' ' 68' ' ' LEU . 8.8 m -44.65 -25.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.045 -1.034 . . . . 0.0 110.349 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -100.16 -34.57 4.78 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.808 HD12 HD11 ' B' ' 114' ' ' LEU . 0.3 OUTLIER -48.5 -40.35 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.216 -1.167 . . . . 0.0 109.688 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.4 pp -83.42 -18.24 39.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.943 -1.098 . . . . 0.0 108.724 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -98.68 6.32 47.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.631 -0.668 . . . . 0.0 109.381 179.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 151.26 89.96 0.08 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 1.001 ' ND2' HD11 ' A' ' 35' ' ' LEU . 12.5 p-10 -19.54 81.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.662 0.744 . . . . 0.0 112.896 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -89.44 164.54 2.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' HG12 ' A' ' 28' ' ' ILE . 70.3 m-20 -86.49 132.77 33.84 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.546 ' OG ' HD11 ' B' ' 103' ' ' ILE . 1.0 OUTLIER -42.29 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.178 -178.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.1 tm-20 -62.77 -7.48 5.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.44 5.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HD3' ' N ' ' A' ' 34' ' ' LEU . 1.1 tpp180 -127.12 128.95 47.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.096 -1.238 . . . . 0.0 110.376 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.639 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -98.75 150.94 21.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.937 -1.102 . . . . 0.0 110.33 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.001 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.5 pp . . . . . 0 N--CA 1.49 1.562 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.262 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.095 0.474 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.3 tt0 -100.37 -22.01 15.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.061 -1.025 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 52' ' ' LEU . 5.1 mt -101.19 -51.39 3.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.947 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -47.4 -51.26 20.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.394 -0.817 . . . . 0.0 109.889 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -68.73 -15.29 63.47 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.729 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.592 ' HB3' ' CE2' ' B' ' 190' ' ' PHE . 1.9 m-80 -92.63 -35.0 13.77 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.947 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.5 mt -55.56 -42.44 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.416 -0.802 . . . . 0.0 109.309 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.4 -21.22 12.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.19 28.23 5.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -1.133 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' A' ' 56' ' ' ILE . 5.0 mt -92.12 10.44 29.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.59 34.82 1.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.845 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.953 ' HG3' HD23 ' A' ' 62' ' ' LEU . 11.6 ptpt -135.55 26.03 3.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.436 -0.79 . . . . 0.0 109.969 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.953 HD23 ' HG3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -142.96 -56.86 0.42 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.553 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . -164.0 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.4 mm? -42.07 -29.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.331 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -51.6 -33.65 33.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.739 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -68.9 -56.98 6.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.515 ' SD ' ' CA ' ' B' ' 216' ' ' GLY . 0.0 OUTLIER -67.3 -8.54 33.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.341 -0.849 . . . . 0.0 109.208 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.721 HD21 ' N ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -67.98 -63.84 0.98 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.805 0.812 . . . . 0.0 109.035 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.4 HD12 ' C ' ' A' ' 69' ' ' LEU . 3.4 pp -68.9 -5.95 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.215 0.531 . . . . 0.0 110.075 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 22.4 tt0 -80.92 3.37 23.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.981 HG12 HG11 ' B' ' 122' ' ' VAL . 2.1 t -143.27 4.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.816 -1.178 . . . . 0.0 110.656 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.867 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.9 tp -149.14 71.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.553 -0.717 . . . . 0.0 109.367 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t0 -76.52 57.34 1.21 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.157 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 5.6 mt . . . . . 0 C--N 1.304 -1.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.66 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.2 mp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.209 0.528 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 57.0 t 59.62 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.466 -0.771 . . . . 0.0 110.385 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.5 Cg_endo -75.53 149.61 34.82 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.928 1.489 . . . . 0.0 110.631 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.457 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.1 m -113.93 143.08 45.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.909 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.484 HD22 ' CG2' ' B' ' 160' ' ' ILE . 67.6 mt -80.44 117.61 21.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -108.3 -10.69 15.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.278 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.569 HD22 HG21 ' B' ' 161' ' ' VAL . 6.3 t30 -165.76 160.13 16.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 110.299 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 10.2 mt -157.45 166.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.936 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.503 ' N ' HG22 ' B' ' 70' ' ' ILE . 16.6 t -135.41 132.85 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.488 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -121.2 136.51 54.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.9 m -97.11 134.06 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 0.0 110.125 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' B' ' 155' ' ' PHE . 8.4 t -133.63 169.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 56.2 m -144.11 133.66 23.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.387 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 1.103 HD12 HD11 ' B' ' 80' ' ' LEU . 82.9 mt -88.56 -14.39 37.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.67 -0.54 70.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 22.1 p -138.55 137.0 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -1.164 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 5.7 mtp85 -62.48 158.72 17.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 1.103 HD11 HD12 ' B' ' 76' ' ' LEU . 15.5 mt -130.36 150.45 51.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.271 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 1.0 OUTLIER -99.12 93.54 6.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.623 HD22 HG23 ' B' ' 102' ' ' VAL . 9.1 mt -39.16 -46.49 1.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.465 -0.772 . . . . 0.0 110.68 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.63 -43.56 76.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 84.8 m -83.58 -35.77 24.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.99 . . . . 0.0 110.22 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' B' ' 80' ' ' LEU . 30.4 t -65.96 -57.25 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.53 -36.59 80.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.493 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.03 -48.03 83.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.416 ' O ' ' C ' ' B' ' 89' ' ' ALA . 45.2 m-70 -78.61 -42.95 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -0.951 . . . . 0.0 110.542 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -43.82 124.95 3.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 109.997 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.92 -18.01 62.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 3.3 m-20 -137.42 79.8 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.573 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -165.84 152.27 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.54 164.61 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 110.044 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.52 120.82 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 110.435 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.44 112.09 21.11 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.99 -18.8 30.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.932 1.491 . . . . 0.0 110.268 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -71.95 -17.13 62.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 11.1 mpt_? -105.54 -69.72 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.644 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -152.09 -178.93 7.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.494 -0.754 . . . . 0.0 109.953 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -99.48 49.89 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.915 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.157 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -130.95 149.84 52.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.946 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.623 HG23 HD22 ' B' ' 82' ' ' LEU . 99.4 t -92.27 124.07 44.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.71 HD12 ' H ' ' B' ' 103' ' ' ILE . 5.0 mp -88.76 107.35 17.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.573 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 0.9 OUTLIER -93.27 161.39 14.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.482 -0.761 . . . . 0.0 109.844 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -163.85 123.31 2.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 0.0 110.832 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 4.6 pt -122.59 155.56 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 109.696 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 5.3 mtt180 -103.49 30.86 4.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 4.3 tm-20 -177.9 87.8 0.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.5 Cg_endo -76.49 159.58 96.24 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.351 -0.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.835 ' O ' HG23 ' B' ' 111' ' ' THR . 0.1 OUTLIER -73.12 115.37 12.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.037 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.835 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.8 OUTLIER -165.99 175.26 8.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.319 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.593 HG22 HG23 ' B' ' 124' ' ' THR . 0.5 OUTLIER -134.53 157.87 45.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.128 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -147.34 158.81 44.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.808 HD11 HD12 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -115.3 107.37 15.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.486 -0.758 . . . . 0.0 109.375 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' B' ' 102' ' ' VAL . 3.0 mp -89.93 131.47 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.735 ' CD1' HD11 ' A' ' 74' ' ' LEU . 4.5 m-30 -106.95 149.9 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.795 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' B' ' 80' ' ' LEU . . . -61.36 -20.06 62.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 110.342 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' B' ' 79' ' ' ARG . 12.2 t -62.86 -33.76 75.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.343 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.475 ' HA2' ' HG ' ' B' ' 80' ' ' LEU . . . 126.19 -13.77 7.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -76.16 171.57 14.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.411 ' SD ' HG13 ' B' ' 115' ' ' ILE . 6.7 ttp -155.99 135.0 12.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.158 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.981 HG11 HG12 ' A' ' 71' ' ' VAL . 12.6 t -115.51 119.02 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.694 HG13 ' HE2' ' B' ' 139' ' ' TYR . 18.7 t -105.24 144.49 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.707 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -146.78 165.96 28.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.571 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 101.55 -24.27 32.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.61 156.51 0.66 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -1.219 . . . . 0.0 110.607 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -109.4 -14.5 14.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 4.3 m -163.71 -178.49 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.244 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . 0.405 ' HG2' HD11 ' B' ' 157' ' ' ILE . 93.3 mt-10 -58.18 -65.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.052 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.35 -30.44 2.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.079 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -71.33 -53.71 13.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.0 110.226 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -54.81 -37.85 66.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -48.86 79.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.051 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 39.5 mt -61.57 -49.56 76.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.847 . . . . 0.0 110.054 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -58.05 -35.65 71.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 13.5 t -70.57 -65.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 110.022 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -46.79 -34.42 5.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.017 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -63.86 -49.61 72.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.694 ' HE2' HG13 ' B' ' 123' ' ' VAL . 18.4 m-85 -66.6 -54.91 18.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.916 . . . . 0.0 109.959 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.98 -35.61 59.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 3.3 ttp180 -58.77 -41.71 87.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.99 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 139' ' ' TYR . 27.6 mt -59.0 -47.05 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.731 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.5 mp -60.46 -46.83 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.069 -1.02 . . . . 0.0 109.396 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 68.5 mt-30 -67.27 -31.89 72.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.452 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 3.1 mmtt -74.49 -28.71 61.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.94 -22.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.2 -22.85 7.0 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.479 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.484 ' HB2' HG23 ' B' ' 143' ' ' ILE . 15.5 m-85 -51.63 175.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.349 . . . . 0.0 110.756 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.16 36.03 3.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.478 -0.764 . . . . 0.0 110.542 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.909 ' CB ' HD22 ' B' ' 76' ' ' LEU . . . -62.47 131.09 48.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.569 ' O ' HG23 ' B' ' 153' ' ' THR . 2.0 ptpt -111.31 25.08 12.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.011 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.498 ' O ' HG23 ' B' ' 153' ' ' THR . 3.7 t80 31.55 95.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.124 0.488 . . . . 0.0 111.2 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.569 HG23 ' O ' ' B' ' 151' ' ' LYS . 1.9 p -153.23 174.41 14.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 153' ' ' THR . 1.6 t0 65.2 27.22 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.409 -0.807 . . . . 0.0 110.554 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.412 ' HA ' HG22 ' B' ' 74' ' ' VAL . 41.3 t80 -73.25 133.52 43.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.89 . . . . 0.0 109.903 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -166.7 135.52 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 110.48 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 44.8 mt -78.9 133.66 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.432 -0.792 . . . . 0.0 109.638 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' B' ' 218' ' ' LYS . 23.2 mt-30 -125.53 -40.0 2.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 110.939 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.461 ' ND2' ' HA2' ' B' ' 216' ' ' GLY . 0.7 OUTLIER -114.06 109.27 18.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.066 -1.021 . . . . 0.0 110.959 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.484 ' CG2' HD22 ' B' ' 67' ' ' LEU . 30.1 mt -105.94 123.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.7 HG22 ' OG1' ' B' ' 215' ' ' THR . 79.8 t -98.36 138.98 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 110.574 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -140.49 167.27 25.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 155.08 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.265 . . . . 0.0 110.708 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 5.5 p -169.4 171.63 7.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.426 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 7.9 m-20 -128.57 140.39 51.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.0 110.419 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' B' ' 63' ' ' ILE . 22.6 m -119.34 8.66 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.936 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt 52.03 29.9 6.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 110.179 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.458 ' H ' HG23 ' B' ' 166' ' ' VAL . 1.2 t80 -121.0 115.86 31.58 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.26 120.16 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.904 1.476 . . . . 0.0 110.223 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.805 HD13 ' CG2' ' B' ' 206' ' ' ILE . 3.3 mt -101.49 145.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.568 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.64 84.86 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.981 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.719 HD22 ' HB2' ' B' ' 193' ' ' LEU . 15.1 mt -48.04 -23.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.98 -53.13 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.25 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.82 -38.61 96.26 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.499 HD23 HD13 ' B' ' 193' ' ' LEU . 11.7 tp -74.81 -38.58 62.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 109.968 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' B' ' 172' ' ' LEU . . . -65.87 -38.66 89.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -0.924 . . . . 0.0 110.291 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -72.38 -24.41 61.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.178 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -89.24 -48.9 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' B' ' 183' ' ' SER . 53.1 m170 -103.16 34.94 2.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.08 -33.63 51.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -19.09 44.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -1.095 . . . . 0.0 110.141 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' B' ' 198' ' ' VAL . 36.2 m-85 -136.37 6.02 3.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.447 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.664 ' OG ' HD21 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -133.64 135.57 44.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 0.0 110.67 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.98 122.17 37.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 109.792 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -124.49 129.42 50.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 110.597 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 190' ' ' PHE . 9.3 mt-10 -136.23 102.85 9.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.453 -0.779 . . . . 0.0 109.653 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -2.45 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.932 1.49 . . . . 0.0 110.825 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -100.43 -6.02 26.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 0.0 110.324 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -143.91 -50.37 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.327 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.675 ' HB2' HD23 ' B' ' 189' ' ' LEU . 2.7 t80 -111.26 121.49 40.28 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . 0.474 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.4 Cg_endo -73.54 -35.55 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.923 1.486 . . . . 0.0 110.631 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.39 175.83 42.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.719 ' HB2' HD22 ' B' ' 172' ' ' LEU . 8.7 tt -106.83 138.19 43.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -1.163 . . . . 0.0 110.251 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.615 ' N ' HD23 ' B' ' 193' ' ' LEU . 2.6 mt -98.35 96.74 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.523 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 7.6 t80 -93.89 120.37 34.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.856 ' HG2' HG22 ' B' ' 203' ' ' VAL . 17.0 mtp85 -108.2 97.82 7.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.328 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 45.3 tpp -52.88 148.34 7.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.051 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.618 HG21 ' CE1' ' B' ' 182' ' ' PHE . 86.2 t -91.48 -40.91 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.905 . . . . 0.0 110.394 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.1 OUTLIER -140.7 107.79 6.48 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.491 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -73.92 165.45 84.97 Favored 'Cis proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.952 -2.103 . . . . 0.0 110.395 -0.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 16.9 mtmt -75.05 97.31 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.795 HD11 ' HG2' ' B' ' 222' ' ' GLU . 23.9 mm -129.24 158.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.582 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.856 HG22 ' HG2' ' B' ' 196' ' ' ARG . 46.0 t -111.63 124.37 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 1.069 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.9 mp -123.9 135.85 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.171 -0.956 . . . . 0.0 110.623 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' B' ' 205' ' ' LEU . 3.8 mm? -101.33 125.23 47.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.83 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.805 ' CG2' HD13 ' B' ' 170' ' ' ILE . 2.8 mt -120.32 133.68 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' B' ' 207' ' ' PHE . 57.8 m-85 -119.46 154.22 34.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 52.7 t -60.44 -22.57 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.074 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.5 t -64.52 -36.17 83.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 121.29 11.04 6.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.851 ' O ' HD13 ' B' ' 212' ' ' ILE . 2.2 mptm? -92.51 141.65 28.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.105 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.851 HD13 ' O ' ' B' ' 211' ' ' LYS . 24.6 mm -131.78 132.7 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.4 t -123.08 140.08 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.226 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 5.6 mp -121.47 145.03 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.7 ' OG1' HG22 ' B' ' 161' ' ' VAL . 6.6 t -165.3 157.3 15.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.187 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.515 ' CA ' ' SD ' ' A' ' 67' ' ' MET . . . 98.02 -15.78 61.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' B' ' 222' ' ' GLU . . . -65.83 141.7 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' B' ' 158' ' ' GLN . 0.3 OUTLIER -92.56 -25.93 18.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.109 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.86 151.37 47.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -47.05 -33.23 4.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -38.47 70.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.795 ' HG2' HD11 ' B' ' 202' ' ' ILE . 0.2 OUTLIER -60.66 -49.68 76.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.419 HG23 HD22 ' B' ' 214' ' ' LEU . 47.2 mm -56.03 -38.65 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 110.342 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.34 -40.38 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 110.326 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.86 94.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 1.069 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -60.3 -56.45 21.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.134 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.453 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 2.9 t80 -58.64 -44.49 90.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.131 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.9 -36.19 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.14 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.48 -11.31 37.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.669 HG13 HD22 ' B' ' 204' ' ' LEU . 9.8 mm -97.77 -23.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.784 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -50.22 -48.45 79.93 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 110.758 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.72 -41.73 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.515 1.271 . . . . 0.0 110.376 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.443 ' CG1' HD13 ' B' ' 175' ' ' LEU . 57.1 t -50.53 -39.39 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.645 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.529 HD11 HG22 ' B' ' 230' ' ' ILE . 15.8 mt -68.65 -48.43 64.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.824 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 40.8 t -60.78 -31.99 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.845 . . . . 0.0 109.87 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -37.94 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.494 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 76.6 m-85 -116.23 38.04 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.95 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.44 ' HB3' ' CE2' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -60.85 145.89 48.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 110.086 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -93.71 -39.2 10.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.918 . . . . 0.0 110.167 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.218 179.926 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.981 ' CD2' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.22 0.534 . . . . 0.0 110.247 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -63.43 81.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.981 HD22 ' CD2' ' A' ' 18' ' ' LEU . 4.1 tp -120.22 62.03 0.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.776 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.708 HG23 ' HB3' ' A' ' 64' ' ' LEU . 1.2 m -92.05 -3.6 55.56 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.544 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -101.62 -31.51 5.46 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.563 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.931 ' CG1' HD11 ' A' ' 20' ' ' LEU . 2.2 mm -46.15 -44.12 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.416 -1.638 . . . . 0.0 109.171 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.826 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.6 OUTLIER -83.94 -23.44 31.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.057 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.594 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -85.26 10.64 11.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.499 -0.75 . . . . 0.0 109.16 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 135.55 104.83 0.78 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.596 ' ND2' HD12 ' A' ' 35' ' ' LEU . 7.5 p-10 -21.74 118.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.944 0.878 . . . . 0.0 111.438 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -140.37 161.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.546 0.688 . . . . 0.0 109.461 -178.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 28' ' ' ILE . 1.2 m-20 -87.58 119.32 27.77 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.571 ' OG ' ' CE2' ' B' ' 99' ' ' PHE . 26.7 p -39.15 -25.8 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.3 tt0 -66.3 -3.49 6.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.948 -1.095 . . . . 0.0 111.306 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 29.11 5.83 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.023 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.556 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -121.03 117.18 26.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.916 -1.343 . . . . 0.0 109.534 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -87.27 162.82 17.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.229 . . . . 0.0 111.906 -178.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.558 0.694 . . . . 0.0 111.67 -178.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.291 0.567 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.6 pt-20 -97.47 -31.36 12.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.848 . . . . 0.0 110.29 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 3.1 mt -90.99 -41.29 11.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.002 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -48.81 -52.96 21.26 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.98 -26.53 67.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.368 -0.833 . . . . 0.0 109.524 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.537 ' HB3' HD23 ' A' ' 59' ' ' LEU . 1.9 m-80 -79.97 -42.9 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.459 -0.776 . . . . 0.0 110.05 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.002 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -48.43 -45.71 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.81 0.74 64.8 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.494 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.3 OUTLIER -120.71 -44.47 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -1.197 . . . . 0.0 110.884 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.057 HD22 ' CE2' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -85.59 34.84 0.59 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 110.698 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.69 34.38 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.894 -1.129 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.9 1.55 0.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 111.106 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 62' ' ' LEU . 5.7 mt -86.65 -67.62 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.661 -1.274 . . . . 0.0 109.93 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.63 -35.66 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.708 ' HB3' HG23 ' A' ' 21' ' ' THR . 3.9 mm? -54.24 -39.76 67.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.21 -1.17 . . . . 0.0 110.343 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 69' ' ' LEU . 16.4 t0 -43.91 -33.89 1.49 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 1.5 m -60.7 -62.88 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.826 ' HG2' HD13 ' A' ' 24' ' ' LEU . 1.1 ttp -72.01 -3.14 21.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.292 -0.88 . . . . 0.0 109.792 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.553 HD23 ' C ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -67.69 -54.98 15.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 108.933 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 65' ' ' ASP . 0.6 OUTLIER -69.92 0.28 6.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.72 -0.613 . . . . 0.0 109.953 179.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -91.83 -11.47 36.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -0.845 . . . . 0.0 110.577 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.921 HG11 HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.58 -17.59 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.084 -1.01 . . . . 0.0 108.797 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.065 HD11 HD12 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -146.57 78.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.845 -0.534 . . . . 0.0 110.148 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.46 53.24 1.51 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.885 -1.134 . . . . 0.0 109.049 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.126 HD11 ' CB ' ' B' ' 101' ' ' ALA . 8.0 mt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.675 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.579 ' C ' HG23 ' B' ' 64' ' ' VAL . 33.4 mt . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.216 0.531 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.579 HG23 ' C ' ' B' ' 63' ' ' ILE . 2.7 t 67.2 125.19 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 46.5 Cg_endo -73.43 146.96 40.56 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.856 1.451 . . . . 0.0 110.617 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 3.3 m -105.4 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 110.07 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.448 HD22 HG23 ' B' ' 160' ' ' ILE . 27.3 mt -77.01 134.68 38.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -123.25 -18.39 6.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.405 ' OD1' ' HA2' ' B' ' 125' ' ' GLY . 5.4 t30 -169.88 154.24 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.399 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' B' ' 160' ' ' ILE . 5.0 mt -145.26 147.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 110.025 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.595 HG11 ' CG1' ' A' ' 71' ' ' VAL . 53.3 t -115.83 142.83 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.95 . . . . 0.0 110.582 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.31 162.04 33.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 0.0 110.172 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 0.3 OUTLIER -116.48 135.0 54.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.319 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.567 HG12 ' N ' ' B' ' 75' ' ' THR . 91.5 t -132.04 171.21 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.871 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.567 ' N ' HG12 ' B' ' 74' ' ' VAL . 46.1 m -148.03 151.63 36.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.95 HD22 ' HB1' ' B' ' 150' ' ' ALA . 33.7 mt -104.77 -57.5 2.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.837 . . . . 0.0 110.195 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.95 21.54 6.3 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.68 142.76 12.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -1.205 . . . . 0.0 110.282 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 146.86 53.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.045 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.741 HD11 ' CD1' ' B' ' 76' ' ' LEU . 15.5 mt -127.48 153.23 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.124 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.1 OUTLIER -90.37 88.12 7.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 110.017 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.659 HD22 HG23 ' B' ' 102' ' ' VAL . 10.7 mt -41.14 -44.04 2.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 110.277 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.4 OUTLIER -56.3 -42.28 77.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 110.092 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -83.96 -43.94 14.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.423 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 86.4 t -55.15 -48.2 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.244 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.625 ' HB2' HG13 ' B' ' 102' ' ' VAL . . . -72.96 -28.94 62.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 9.5 tp -77.21 -34.6 56.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.59 -25.71 22.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.96 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -65.52 143.09 57.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -72.06 -27.59 62.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.061 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' B' ' 104' ' ' MET . 71.7 m-20 -134.78 79.44 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 110.007 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -152.32 130.83 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.613 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -124.34 142.78 51.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -118.24 137.94 52.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 0.0 110.811 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' B' ' 95' ' ' ASN . 8.5 p30 -133.66 109.97 12.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.939 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 -26.9 12.79 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.99 1.521 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.28 -7.46 59.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' B' ' 95' ' ' ASN . 0.0 OUTLIER -102.45 -75.91 0.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.666 ' CE1' ' HB3' ' B' ' 101' ' ' ALA . 32.4 p90 -145.68 -178.86 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 110.075 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.612 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -99.2 56.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.051 -1.03 . . . . 0.0 112.099 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.126 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -152.53 166.32 32.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.867 -1.146 . . . . 0.0 110.524 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.659 HG23 HD22 ' B' ' 82' ' ' LEU . 21.3 t -97.39 157.74 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.47 HD13 ' OG ' ' A' ' 30' ' ' SER . 2.0 mt -118.25 100.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.99 . . . . 0.0 110.429 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.501 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 2.2 ttm -92.39 145.2 24.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.58 118.67 8.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.257 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 30.8 pt -116.81 164.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 110.063 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 1.1 ptm180 -120.04 42.44 2.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER 179.26 80.29 0.17 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 0.0 110.256 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.455 ' O ' HG13 ' B' ' 106' ' ' ILE . 49.4 Cg_endo -78.13 159.81 92.66 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.436 -0.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 2.1 tppt? -71.27 113.18 8.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.489 HG22 ' HA3' ' B' ' 125' ' ' GLY . 0.3 OUTLIER -154.47 164.8 38.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.687 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.616 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.9 m -114.84 146.45 41.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.502 -0.748 . . . . 0.0 109.325 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.717 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -149.53 140.82 23.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.102 . . . . 0.0 111.305 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.653 ' N ' HD23 ' B' ' 114' ' ' LEU . 0.2 OUTLIER -119.37 126.65 51.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.555 -0.716 . . . . 0.0 109.223 179.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 5.8 mt -108.36 136.65 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.935 . . . . 0.0 111.111 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 4.5 m-85 -93.81 161.43 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.58 -1.19 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.972 -1.08 . . . . 0.0 110.296 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 35.9 t -91.19 -7.67 50.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.348 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.1 -30.72 8.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -74.12 151.78 40.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -1.138 . . . . 0.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -153.64 169.45 23.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.201 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.89 HG11 HG12 ' A' ' 71' ' ' VAL . 24.8 t -133.38 147.98 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.478 HG12 ' N ' ' B' ' 124' ' ' THR . 23.3 t -126.67 170.04 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.588 HG23 ' CB ' ' A' ' 27' ' ' ASN . 10.1 t -170.04 154.18 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.881 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.583 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 111.43 8.3 23.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.472 ' CB ' ' HB2' ' B' ' 132' ' ' SER . . . -82.41 141.21 32.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.154 . . . . 0.0 110.046 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.64 -0.04 41.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.873 . . . . 0.0 110.283 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.79 -159.9 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.209 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.68 -49.09 9.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.55 -28.98 65.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.076 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -43.82 96.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.034 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . 0.472 ' HB2' ' CB ' ' B' ' 126' ' ' ALA . 44.9 t -68.33 -36.64 79.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.79 -38.22 81.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.205 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.45 ' O ' ' HD2' ' B' ' 138' ' ' LYS . 6.1 mt -69.94 -45.41 67.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.31 -52.12 67.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 72.3 m -60.55 -50.85 71.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -39.66 69.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.998 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -59.41 -40.4 86.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.717 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 26.8 m-85 -65.62 -52.08 54.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.71 -36.16 56.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.955 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -59.94 -43.33 95.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 -35.26 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.853 HG21 ' HB2' ' B' ' 150' ' ' ALA . 39.8 mm -73.9 -57.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.65 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.14 -28.32 69.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 1.7 tttt -75.71 -19.27 59.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.97 -23.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.72 -0.613 . . . . 0.0 109.371 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.4 -29.37 4.8 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.534 ' CB ' HG22 ' B' ' 143' ' ' ILE . 12.2 m-85 -46.4 163.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -1.214 . . . . 0.0 110.937 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.2 38.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.559 -0.713 . . . . 0.0 109.942 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.95 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -73.55 136.41 44.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.627 ' O ' HD23 ' B' ' 76' ' ' LEU . 5.1 tttt -112.44 157.65 20.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 110.338 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -99.69 89.95 4.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.474 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -148.92 172.8 14.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.387 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.525 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t0 67.78 26.12 7.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 6.8 t80 -84.62 129.16 34.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.077 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -163.62 131.82 3.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.42 HG23 ' CG2' ' B' ' 70' ' ' ILE . 3.1 mt -79.88 123.74 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.666 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -119.69 -10.93 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.801 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 26.1 t30 -140.12 122.1 15.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' B' ' 215' ' ' THR . 3.9 mt -113.25 160.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.152 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.456 HG22 ' OG1' ' B' ' 215' ' ' THR . 54.7 t -138.67 126.35 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.714 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -130.95 176.2 19.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.1 p -158.33 154.54 27.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.447 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.9 p -170.2 174.21 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.818 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.484 ' O ' HD13 ' B' ' 63' ' ' ILE . 14.9 t0 -121.59 136.11 54.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.686 HG21 HD11 ' B' ' 170' ' ' ILE . 26.8 m -85.47 2.54 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.888 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.12 23.72 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.254 -0.904 . . . . 0.0 110.925 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.594 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 8.4 p90 -177.93 148.19 0.65 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.406 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.63 161.15 44.77 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.093 1.575 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.686 HD11 HG21 ' B' ' 166' ' ' VAL . 4.0 mt -131.08 150.84 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.37 90.62 7.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.533 HD21 HG22 ' B' ' 206' ' ' ILE . 22.2 mt -48.2 -29.13 3.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -64.14 -60.22 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.35 -34.15 25.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.573 ' HB3' HD13 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -63.99 -47.71 79.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 110.17 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.54 -30.03 67.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.886 . . . . 0.0 110.414 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -69.26 -27.35 65.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.279 -0.888 . . . . 0.0 110.583 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 11.3 p -99.14 -57.75 2.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.14 -0.975 . . . . 0.0 110.357 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' B' ' 183' ' ' SER . 26.6 m80 -100.54 38.26 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -62.85 -30.18 76.37 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . 0.437 HG23 ' CG ' ' B' ' 182' ' ' PHE . 9.3 t -62.46 -33.47 74.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 110.362 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.437 ' CG ' HG23 ' B' ' 181' ' ' THR . 21.4 m-85 -113.16 -12.2 13.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.493 ' N ' ' O ' ' B' ' 179' ' ' HIS . 37.7 m -104.77 171.29 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.266 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.6 m -155.88 109.87 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.825 . . . . 0.0 110.053 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 1.019 ' HB2' HD12 ' B' ' 193' ' ' LEU . 17.8 t80 -113.49 114.51 26.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 110.23 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 3.2 mm-40 -125.55 102.52 29.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.44 -0.15 8.85 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.083 1.57 . . . . 0.0 110.325 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -98.42 -20.03 17.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.886 . . . . 0.0 110.035 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.602 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.6 tt -142.11 8.13 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.3 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 1.057 ' CE2' HD22 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -169.94 108.54 0.46 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.264 -0.897 . . . . 0.0 110.419 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -4.36 13.32 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.849 1.447 . . . . 0.0 110.516 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -117.47 162.96 12.76 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' B' ' 185' ' ' TYR . 2.4 tt -100.72 143.46 30.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 110.129 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.55 HD11 ' CE2' ' B' ' 190' ' ' PHE . 31.7 mt -104.78 106.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' B' ' 179' ' ' HIS . 0.3 OUTLIER -97.95 111.88 24.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -0.98 . . . . 0.0 109.87 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.77 80.99 5.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 110.41 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.9 ttm -50.83 141.68 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.23 -43.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 110.56 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 4.5 mttp -141.32 110.6 6.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.146 -0.971 . . . . 0.0 110.31 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.475 ' O ' HG12 ' B' ' 202' ' ' ILE . 47.5 Cg_endo -73.21 149.95 94.94 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.443 -0.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.8 OUTLIER -64.22 95.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.898 . . . . 0.0 109.967 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.519 HD12 ' HB2' ' B' ' 217' ' ' ALA . 11.4 mm -134.1 151.62 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 110.621 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -107.37 109.37 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 109.667 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.483 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.9 mp -100.98 134.93 43.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 110.913 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' B' ' 205' ' ' LEU . 0.2 OUTLIER -108.72 117.79 35.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 109.473 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.533 HG22 HD21 ' B' ' 172' ' ' LEU . 4.4 mp -107.87 137.31 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.488 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -118.29 135.25 54.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.048 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' B' ' 172' ' ' LEU . 69.0 t -45.21 -24.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -35.06 78.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.594 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 124.95 -12.45 7.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.28 154.76 37.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' B' ' 212' ' ' ILE . 12.2 mm -138.78 137.15 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 110.083 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.594 HG11 ' HE1' ' A' ' 25' ' ' PHE . 96.7 t -120.98 149.25 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 1.1 mt -133.35 102.14 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 14.2 t -131.53 153.65 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.388 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.25 15.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.519 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -100.03 131.23 46.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -1.199 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.422 ' N ' ' OE1' ' B' ' 222' ' ' GLU . 4.6 tttt -75.75 -13.98 60.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.434 ' C ' HD13 ' B' ' 160' ' ' ILE . 0.2 OUTLIER -152.91 173.46 15.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -32.23 70.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.117 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -55.98 -51.32 68.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.505 ' HB3' HD11 ' B' ' 202' ' ' ILE . 1.1 mt-10 -52.74 -42.28 64.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 109.943 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.444 HG12 ' CB ' ' B' ' 217' ' ' ALA . 18.4 mm -60.13 -45.83 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -68.63 -33.25 73.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -71.79 -46.25 58.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 109.966 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.483 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -54.48 -51.49 64.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.848 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.712 ' HA ' HG22 ' B' ' 230' ' ' ILE . 20.0 t80 -57.27 -37.34 72.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.78 . . . . 0.0 109.93 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.48 -18.2 63.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.037 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.97 -18.28 17.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.712 HG22 ' HA ' ' B' ' 227' ' ' PHE . 9.1 tp -100.03 -25.53 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 110.323 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 31.9 t80 -51.99 -44.18 91.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.02 -31.09 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.354 1.187 . . . . 0.0 110.555 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 30.7 t -70.06 -38.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.166 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 37.0 mt -67.87 -42.99 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.168 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.8 -39.22 88.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.91 -31.37 72.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -117.32 42.65 2.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.213 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -96.65 -176.03 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.59 -38.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.157 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.047 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.993 ' N ' HD12 ' A' ' 18' ' ' LEU . 2.7 t70 -66.54 60.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.091 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.895 HD21 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -80.68 -17.23 51.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 110.691 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.551 ' N ' HD21 ' A' ' 68' ' ' LEU . 64.9 m -41.31 -28.96 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.94 -37.1 4.0 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.75 HD12 HD11 ' B' ' 114' ' ' LEU . 0.4 OUTLIER -48.59 -40.39 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.277 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.601 HD13 ' CE ' ' A' ' 67' ' ' MET . 3.5 pp -82.97 -27.81 30.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.978 -1.076 . . . . 0.0 108.92 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 52' ' ' LEU . 1.7 t80 -90.58 9.95 27.51 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 141.18 95.33 0.25 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.709 ' HB2' HG22 ' B' ' 112' ' ' THR . 6.8 p-10 -20.06 116.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.976 0.893 . . . . 0.0 112.315 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.689 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.33 163.79 27.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.774 ' HA ' HG21 ' B' ' 103' ' ' ILE . 75.7 m-20 -87.45 121.73 30.26 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.047 ' HB2' HD13 ' A' ' 18' ' ' LEU . 2.9 p -36.78 -28.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.471 0.653 . . . . 0.0 109.69 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.8 tt0 -51.64 -18.48 1.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 0.0 110.575 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.75 27.97 3.87 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.645 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -129.38 147.86 51.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.94 -1.33 . . . . 0.0 109.573 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.689 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.72 165.88 12.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 0.0 111.872 -178.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.651 HD12 ' ND2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.928 0.871 . . . . 0.0 111.552 -178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.24 0.543 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 0.4 OUTLIER -89.31 -26.66 21.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 109.074 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.508 HD13 ' CE1' ' A' ' 25' ' ' PHE . 2.1 mt -88.81 -38.57 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.621 -0.674 . . . . 0.0 109.451 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.001 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -57.26 -57.49 12.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.362 -0.836 . . . . 0.0 109.913 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.12 -31.36 71.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 3.4 m-20 -73.21 -43.13 61.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.001 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.1 mt -46.26 -45.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.328 -0.857 . . . . 0.0 109.245 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.92 -26.48 18.77 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -136.51 44.19 2.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 110.232 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.156 HD21 ' CE1' ' B' ' 190' ' ' PHE . 6.7 mt -99.41 13.14 34.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.22 47.21 1.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.79 . . . . 0.0 109.864 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.523 ' C ' HD23 ' A' ' 62' ' ' LEU . 17.7 mtpp -135.99 1.93 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 110.102 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.908 HD11 HD22 ' A' ' 59' ' ' LEU . 1.5 mt -88.69 -38.96 14.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 109.743 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 3.35 4.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 62' ' ' LEU . 1.5 pp -87.0 0.59 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.092 -1.24 . . . . 0.0 110.064 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.9 t70 -44.05 -32.91 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.914 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -56.75 -49.73 74.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.017 -1.052 . . . . 0.0 109.478 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.601 ' CE ' HD13 ' A' ' 24' ' ' LEU . 12.7 ttp -65.96 -12.62 56.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.644 HD13 ' C ' ' A' ' 68' ' ' LEU . 1.3 tm? -70.09 -65.66 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.09 -6.33 22.34 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -79.45 -4.77 52.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 110.646 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.914 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.1 OUTLIER -129.65 -6.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 110.371 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.929 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.8 tp -140.74 72.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 110.166 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.8 t70 -79.79 56.19 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.016 HD13 ' HB2' ' B' ' 101' ' ' ALA . 6.4 mt . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.634 0.731 . . . . 0.0 110.746 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.453 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.21 0.528 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 4.8 t 62.1 132.09 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 109.961 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.523 ' HG2' HG22 ' B' ' 223' ' ' ILE . 49.3 Cg_endo -74.48 152.53 43.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.006 1.53 . . . . 0.0 110.778 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -118.92 129.86 55.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 109.865 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.787 HD22 HG22 ' B' ' 160' ' ' ILE . 29.2 mt -69.93 132.23 45.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 110.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.82 -16.36 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.421 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -152.49 111.6 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.577 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 20.0 mm -91.95 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' B' ' 159' ' ' ASN . 50.7 t -148.77 114.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.915 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.56 165.34 24.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.534 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . 0.725 HG22 HG22 ' B' ' 122' ' ' VAL . 69.5 p -120.71 141.44 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.685 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' B' ' 121' ' ' MET . 3.3 t -140.23 156.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.042 . . . . 0.0 110.722 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.665 HG22 ' H ' ' B' ' 77' ' ' GLY . 24.2 m -106.18 144.44 32.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.965 HD12 HD11 ' B' ' 80' ' ' LEU . 93.5 mt -94.73 -6.29 43.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.447 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . 0.665 ' H ' HG22 ' B' ' 75' ' ' THR . . . 103.59 -38.8 3.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . 0.724 ' H ' ' HB1' ' B' ' 149' ' ' ALA . 0.0 OUTLIER -142.47 -174.5 4.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.113 -1.228 . . . . 0.0 110.836 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.688 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -78.7 178.86 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 110.222 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.965 HD11 HD12 ' B' ' 76' ' ' LEU . 10.4 mt -140.89 165.01 28.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.422 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.634 ' O ' HG23 ' B' ' 85' ' ' VAL . 1.1 m-20 -110.27 83.27 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' B' ' 81' ' ' ASP . 8.4 mt -38.11 -49.1 1.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.39 -51.62 58.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.697 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.544 ' HA ' ' CD2' ' B' ' 87' ' ' LEU . 43.3 p -76.87 -41.9 42.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 110.077 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.851 HG22 ' CE2' ' B' ' 148' ' ' PHE . 43.9 t -60.49 -37.02 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.121 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.27 78.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' B' ' 84' ' ' THR . 0.7 OUTLIER -90.74 -23.04 20.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.517 ' HB3' ' CD1' ' B' ' 146' ' ' ILE . 6.7 m-70 -82.97 -35.38 25.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.684 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.527 ' HB2' ' HE1' ' B' ' 104' ' ' MET . . . -72.06 145.15 48.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.387 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -73.94 -27.13 60.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 1.7 m120 -133.69 79.29 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.938 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 89' ' ' ALA . . . -138.07 159.64 41.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.83 ' O ' HD12 ' B' ' 103' ' ' ILE . 73.9 mt-10 -147.83 120.34 8.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.244 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.475 ' HB2' HG22 ' B' ' 102' ' ' VAL . 24.8 t80 -113.52 113.4 25.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.121 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -119.8 111.72 35.72 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.15 -19.77 29.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.009 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -17.86 61.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -105.28 -76.46 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.444 -0.785 . . . . 0.0 110.027 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.658 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.25 173.15 11.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.891 . . . . 0.0 110.433 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.3 43.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.234 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.016 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -132.22 151.97 51.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 110.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' B' ' 94' ' ' TYR . 55.8 t -96.95 126.58 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 109.526 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.83 HD12 ' O ' ' B' ' 93' ' ' GLU . 3.3 mp -89.72 118.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 110.478 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.527 ' HE1' ' HB2' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -95.56 165.32 12.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.455 ' O ' ' ND2' ' B' ' 91' ' ' ASN . 10.3 mtp180 -163.8 116.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.783 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' B' ' 138' ' ' LYS . 37.7 pt -120.71 150.19 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.466 -0.771 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.5 OUTLIER -91.6 28.32 1.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.519 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 7.0 pt-20 -161.96 83.9 1.69 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.716 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' B' ' 111' ' ' THR . 51.1 Cg_endo -85.47 148.76 46.47 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.172 -0.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -51.54 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 109' ' ' PRO . 13.2 p -146.62 -179.46 6.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.899 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.81 HG22 HG23 ' B' ' 124' ' ' THR . 1.2 t -131.57 179.22 6.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 110.208 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -166.85 137.82 3.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 0.0 110.312 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.882 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -95.22 105.94 17.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.59 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.44 HD12 ' SD ' ' B' ' 104' ' ' MET . 33.8 mt -90.21 128.34 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.361 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.834 ' CD1' HD11 ' A' ' 74' ' ' LEU . 2.8 m-30 -99.84 162.31 13.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 79' ' ' ARG . . . -76.57 -11.09 59.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.699 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 m -83.05 -5.68 59.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.027 . . . . 0.0 110.211 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' B' ' 78' ' ' CYS . . . 107.14 -39.16 2.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.93 135.21 55.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.114 . . . . 0.0 109.987 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -133.01 168.34 18.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.356 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.914 HG21 ' O ' ' A' ' 71' ' ' VAL . 10.3 t -130.37 143.64 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.16 144.38 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.958 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.81 HG23 HG22 ' B' ' 112' ' ' THR . 1.2 t -153.08 165.58 35.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.568 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 108.72 -36.45 4.35 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -47.25 167.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -1.161 . . . . 0.0 110.416 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -118.77 -12.09 9.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.504 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m -154.43 173.65 15.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.062 -1.024 . . . . 0.0 110.406 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.2 mt-10 -57.96 -49.74 75.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.08 -35.3 73.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.69 -41.78 83.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 110.202 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -58.42 -54.61 45.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.164 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -50.17 -37.54 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' B' ' 138' ' ' LYS . 0.2 OUTLIER -70.09 -39.21 75.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 0.0 110.376 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -70.1 -35.37 74.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.14 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 50.7 m -72.28 -60.56 2.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 5.7 ptm180 -47.51 -30.11 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.294 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.569 ' HB3' HD13 ' B' ' 106' ' ' ILE . 57.7 mmtt -66.89 -48.16 69.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.014 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 28.6 m-85 -64.79 -52.79 54.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.79 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . 0.853 ' HB1' ' NE2' ' B' ' 144' ' ' GLN . . . -50.01 -37.09 31.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.864 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.85 85.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 mt -64.2 -25.44 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.771 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.456 HG23 ' HB2' ' B' ' 148' ' ' PHE . 0.3 OUTLIER -84.43 -25.12 7.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.385 -0.822 . . . . 0.0 109.029 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.853 ' NE2' ' HB1' ' B' ' 140' ' ' ALA . 24.2 mt-30 -89.17 -22.3 22.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.452 -0.78 . . . . 0.0 109.763 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -82.18 -27.81 32.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.975 HG21 ' CE2' ' B' ' 148' ' ' PHE . 25.7 mt -83.48 -37.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.655 -0.653 . . . . 0.0 109.806 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 117.74 20.2 4.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.975 ' CE2' HG21 ' B' ' 146' ' ' ILE . 13.8 m-85 -86.19 -160.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.088 -1.242 . . . . 0.0 110.335 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' B' ' 76' ' ' LEU . . . -34.66 -71.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.304 0.573 . . . . 0.0 110.501 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' B' ' 149' ' ' ALA . . . 64.88 72.72 0.43 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 112.002 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' B' ' 76' ' ' LEU . 0.4 OUTLIER -162.92 101.56 1.0 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.167 -0.958 . . . . 0.0 110.057 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.639 ' O ' HG23 ' B' ' 153' ' ' THR . 2.7 t80 -72.18 103.22 3.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.0 110.353 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.639 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.7 OUTLIER -159.22 158.27 32.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' B' ' 153' ' ' THR . 2.7 t70 70.45 18.5 6.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.885 . . . . 0.0 110.669 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.522 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 4.2 t80 -69.05 135.4 50.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.046 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.0 131.82 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -0.956 . . . . 0.0 110.704 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.402 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 51.5 mt -80.39 122.68 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 109.644 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -111.93 -3.6 14.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.119 -0.988 . . . . 0.0 110.972 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.479 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 11.2 m120 -155.8 140.42 16.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.855 -1.153 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.787 HG22 HD22 ' B' ' 67' ' ' LEU . 48.4 mt -133.88 123.97 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.388 -0.82 . . . . 0.0 109.655 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 8.0 t -101.6 131.1 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 110.627 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.73 172.15 18.97 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.99 152.24 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -1.197 . . . . 0.0 110.362 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.01 159.95 7.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' B' ' 166' ' ' VAL . 22.6 t0 -101.81 166.3 10.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.493 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.0 OUTLIER -114.32 -83.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.347 -0.846 . . . . 0.0 110.291 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -177.84 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.636 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.475 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 2.2 p90 -137.6 166.7 24.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.1 Cg_endo -70.97 171.63 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.82 1.431 . . . . 0.0 110.527 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.95 139.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 110.601 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . 0.428 ' CG ' ' H ' ' B' ' 174' ' ' GLY . 0.5 OUTLIER -75.13 88.07 2.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.607 HD22 ' CB ' ' B' ' 193' ' ' LEU . 71.9 mt -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.625 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -43.02 76.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.182 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' B' ' 171' ' ' ARG . . . -71.26 -31.03 66.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.459 ' O ' HD12 ' B' ' 175' ' ' LEU . 11.5 tp -75.45 -35.24 60.95 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -1.112 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.89 -27.36 64.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.3 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -75.44 -40.82 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.328 -0.857 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 2.1 t -78.3 -55.85 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.183 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -91.67 27.07 2.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.71 45.92 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -12.48 52.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.145 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -115.38 -23.99 8.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.04 171.28 10.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.7 m -132.33 147.77 52.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.241 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' B' ' 172' ' ' LEU . 33.6 t80 -149.64 104.54 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.913 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' B' ' 190' ' ' PHE . 6.5 mt-10 -113.67 103.94 55.3 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.81 -1.87 10.58 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.068 1.562 . . . . 0.0 110.113 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' B' ' 189' ' ' LEU . 1.7 pm0 -85.74 -18.21 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -148.7 -38.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 1.156 ' CE1' HD21 ' A' ' 59' ' ' LEU . 4.5 t80 -113.82 108.61 51.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.425 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.96 -20.52 19.42 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.031 1.543 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.55 178.43 44.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.607 ' CB ' HD22 ' B' ' 172' ' ' LEU . 9.7 tt -118.73 125.75 50.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -1.116 . . . . 0.0 110.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.767 HD13 HD22 ' A' ' 62' ' ' LEU . 4.7 mt -101.66 111.0 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.431 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 6.5 t80 -96.39 124.38 40.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.523 ' CZ ' ' CB ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -104.91 101.19 10.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 110.24 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.54 ' HE1' HG12 ' B' ' 230' ' ' ILE . 16.8 ttm -69.58 128.51 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.922 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.7 -51.38 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -138.06 119.05 10.36 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.103 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -74.69 150.28 95.25 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.91 -2.121 . . . . 0.0 110.427 -0.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' B' ' 197' ' ' MET . 3.2 tttt -63.04 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' B' ' 217' ' ' ALA . 47.1 mm -128.96 150.96 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.62 128.71 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.044 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.64 HD22 HG13 ' B' ' 230' ' ' ILE . 3.7 mp -120.36 135.05 55.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 110.548 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 1.9 mm? -102.97 126.66 50.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 109.795 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.556 HG12 HD21 ' B' ' 234' ' ' LEU . 3.7 mt -119.5 127.19 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 110.434 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.461 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 83.7 m-85 -118.23 143.67 46.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 110.241 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 25.4 t -48.06 -30.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.38 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.25 -45.74 68.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.493 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 128.24 3.25 5.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.438 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.5 OUTLIER -92.57 135.98 33.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -1.2 . . . . 0.0 110.301 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.438 HD13 ' O ' ' B' ' 211' ' ' LYS . 46.1 mm -121.09 125.3 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.348 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 24.7 t -107.07 154.78 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.961 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.1 mp -135.36 135.73 40.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 5.1 t -157.84 142.14 16.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.909 . . . . 0.0 110.204 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.406 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 111.39 21.78 6.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.742 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -108.82 126.92 53.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -1.136 . . . . 0.0 110.179 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -75.23 -25.69 58.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.415 ' HB3' ' HG2' ' B' ' 221' ' ' GLU . 1.2 tt0 -132.56 -178.57 4.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.12 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 28.4 ttp-105 -85.5 -37.42 19.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' B' ' 219' ' ' GLN . 13.2 pt-20 -52.49 -26.71 13.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -76.35 -44.56 36.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.828 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.523 HG22 ' HG2' ' B' ' 65' ' ' PRO . 28.2 mm -60.36 -38.23 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.64 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -64.99 -47.3 78.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -36.16 81.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.316 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.589 ' HB1' HD11 ' B' ' 204' ' ' LEU . . . -53.84 -52.86 59.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.524 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 25.5 t80 -71.57 -44.34 64.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.34 -32.36 2.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.51 -11.67 20.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.64 HG13 HD22 ' B' ' 204' ' ' LEU . 8.6 mm -100.03 -23.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.612 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 25.0 t80 -52.34 -48.22 90.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -70.31 -33.4 14.58 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.397 1.209 . . . . 0.0 110.391 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.84 -40.36 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.456 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.556 HD21 HG12 ' B' ' 206' ' ' ILE . 66.5 mt -68.11 -45.48 73.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.128 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -27.6 64.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.6 OUTLIER -66.49 -39.49 88.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.34 40.5 2.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.1 ptt85 -66.72 -170.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.466 ' HB2' ' HG2' ' B' ' 169' ' ' PRO . 1.3 mttp -123.33 -61.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.128 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.171 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.968 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.671 ' N ' HD12 ' A' ' 18' ' ' LEU . 14.4 t70 -81.22 98.68 8.2 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 111.123 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.968 HD21 HD21 ' A' ' 18' ' ' LEU . 4.9 mt -97.71 4.93 49.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.253 -0.904 . . . . 0.0 109.697 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.601 HG21 ' CB ' ' A' ' 59' ' ' LEU . 18.7 m -39.81 -28.61 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.104 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -100.19 -38.26 3.6 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.944 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -52.86 -46.87 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -1.073 . . . . 0.0 109.022 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.767 HD13 ' HG2' ' A' ' 67' ' ' MET . 3.4 pp -80.51 -3.92 51.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' O ' ' A' ' 21' ' ' THR . 1.4 t80 -112.75 -4.76 13.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.421 -0.799 . . . . 0.0 110.895 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 162.19 69.08 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.517 -1.801 . . . . 0.0 111.337 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.589 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 20.37 111.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.15 0.976 . . . . 0.0 113.301 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.738 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -149.0 156.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.876 ' HA ' HG21 ' B' ' 103' ' ' ILE . 5.4 m-20 -88.85 138.3 31.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.749 ' HB3' HD11 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -41.77 -26.55 0.08 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.407 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HA ' ' HG2' ' B' ' 98' ' ' ARG . 0.0 OUTLIER -55.47 -14.99 2.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 110.74 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.26 32.88 5.63 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.21 123.88 51.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.28 -1.13 . . . . 0.0 109.607 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -90.39 131.79 35.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.442 -0.786 . . . . 0.0 110.339 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.853 ' N ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 120.985 -1.072 . . . . 0.0 109.693 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.324 0.583 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.429 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.8 tt0 -79.3 -31.8 43.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.84 HD22 ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -117.16 -9.17 11.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.483 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.84 ' N ' HD22 ' A' ' 52' ' ' LEU . 5.7 tpt180 -62.82 -54.25 41.84 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.64 -20.5 33.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.575 ' C ' HD12 ' A' ' 59' ' ' LEU . 85.7 m-20 -88.43 -25.45 22.64 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 53' ' ' ARG . 40.7 mt -51.2 -38.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.34 -13.29 42.9 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 55' ' ' ASN . 18.0 m -138.15 11.59 2.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.241 -1.152 . . . . 0.0 110.808 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 56' ' ' ILE . 0.5 OUTLIER -83.54 19.83 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 0.0 110.669 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 p -104.21 31.41 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 110.301 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.662 ' H ' HD13 ' A' ' 62' ' ' LEU . 5.7 pttt -130.64 11.24 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.472 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -124.86 -2.2 7.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.016 -1.053 . . . . 0.0 110.979 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.762 ' N ' HD22 ' A' ' 62' ' ' LEU . . . 150.71 -47.27 0.6 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.581 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.1 mm? -41.83 -31.74 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -1.206 . . . . 0.0 110.718 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.517 ' CA ' ' HG ' ' A' ' 68' ' ' LEU . 36.0 t70 -41.02 -35.93 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.515 -0.741 . . . . 0.0 110.286 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.3 m -66.53 -43.64 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.832 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.767 ' HG2' HD13 ' A' ' 24' ' ' LEU . 5.2 tpp -70.32 -22.71 62.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.803 ' O ' HG22 ' A' ' 72' ' ' ILE . 4.7 mt -62.74 -61.25 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.973 -1.079 . . . . 0.0 108.904 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.496 ' C ' HD12 ' A' ' 69' ' ' LEU . 3.8 pp -62.48 -9.51 8.76 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.018 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.15 -17.23 37.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 111.274 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.68 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.1 OUTLIER -115.68 -20.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.688 -1.258 . . . . 0.0 109.319 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.913 HD11 HD12 ' A' ' 74' ' ' LEU . 3.9 tp -130.36 71.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.646 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.52 57.73 1.26 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.854 -1.154 . . . . 0.0 108.154 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.995 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 5.1 mt . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 121.534 0.683 . . . . 0.0 110.502 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' B' ' 166' ' ' VAL . 5.2 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.346 0.593 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.37 132.19 23.72 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.857 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.34 148.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.922 1.485 . . . . 0.0 110.627 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 17.9 m -108.07 127.01 53.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.855 . . . . 0.0 110.245 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.92 131.06 43.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -123.26 -7.86 8.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.594 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.477 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.9 OUTLIER -163.47 110.16 1.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.466 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.931 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 19.4 mm -100.96 146.69 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.778 HG22 ' CB ' ' B' ' 124' ' ' THR . 47.4 t -136.75 131.16 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.969 -1.082 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.95 156.78 44.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . 0.406 ' O ' ' O ' ' B' ' 154' ' ' ASP . 24.3 m -109.98 137.86 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.657 HG21 ' OG ' ' B' ' 136' ' ' SER . 90.2 t -134.12 171.01 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.764 HG23 ' HG3' ' B' ' 120' ' ' LYS . 50.9 m -146.14 144.4 29.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.314 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.901 HD22 ' HB1' ' B' ' 150' ' ' ALA . 71.3 mt -97.27 -71.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.84 -5.91 5.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . 0.465 ' SG ' HD21 ' B' ' 80' ' ' LEU . 31.0 p -129.29 130.5 46.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -1.159 . . . . 0.0 110.165 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.655 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.7 OUTLIER -53.5 151.84 5.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 0.0 110.261 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.691 HD11 HD12 ' B' ' 76' ' ' LEU . 25.5 mt -131.13 159.59 37.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' B' ' 82' ' ' LEU . 31.9 t70 -105.58 92.03 4.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.846 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' B' ' 81' ' ' ASP . 16.3 mt -40.64 -34.39 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.1 OUTLIER -61.2 -49.04 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.052 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 41.3 m -80.24 -33.42 37.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.256 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.615 HG12 HG11 ' B' ' 102' ' ' VAL . 5.7 t -61.41 -50.1 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -76.45 -25.36 54.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 12.3 tp -68.39 -43.5 77.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 110.286 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -40.7 18.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -48.78 110.71 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -63.26 -11.35 20.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 0.8 OUTLIER -139.93 79.79 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.336 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.32 168.92 25.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.25 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.16 142.08 35.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.224 -0.923 . . . . 0.0 110.121 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -140.21 102.56 4.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.69 124.84 26.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.86 -20.98 21.79 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 110.74 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.34 59.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 6.0 mpt_? -93.18 -60.1 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.95 . . . . 0.0 110.723 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.713 ' CG ' ' HB2' ' A' ' 18' ' ' LEU . 64.3 t80 -170.32 179.97 3.25 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.523 -177.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.813 ' O ' HD13 ' A' ' 74' ' ' LEU . . . -100.9 69.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.005 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.995 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -154.24 142.84 20.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.567 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.615 HG11 HG12 ' B' ' 85' ' ' VAL . 12.5 t -96.69 117.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.876 HG21 ' HA ' ' A' ' 29' ' ' ASP . 3.4 mt -89.58 105.82 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 4.0 ttm -91.72 148.94 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.043 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.447 ' HD3' ' OD1' ' A' ' 29' ' ' ASP . 30.4 mtm180 -142.78 144.16 32.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 19.4 pt -131.27 179.16 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.882 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.45 34.99 4.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.129 -0.982 . . . . 0.0 110.514 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 179.25 81.05 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.0 Cg_endo -77.06 162.35 91.54 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.364 -0.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.573 ' C ' HG23 ' B' ' 111' ' ' THR . 3.5 tttp -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.898 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.622 HG22 ' C ' ' B' ' 125' ' ' GLY . 61.8 p -156.26 -179.63 8.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.295 -0.878 . . . . 0.0 110.485 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.844 HG22 HG23 ' B' ' 124' ' ' THR . 4.9 t -125.58 172.7 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.545 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -150.79 136.21 17.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.906 -1.121 . . . . 0.0 111.416 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.72 HD23 HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -92.54 95.81 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.43 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 73.9 mt -89.69 139.26 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.069 . . . . 0.0 111.116 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.643 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.0 m-85 -111.28 162.79 14.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.08 -15.59 57.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 8.2 m -76.85 -17.66 58.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.298 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 120.14 -26.22 7.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . 0.764 ' HG3' HG23 ' B' ' 75' ' ' THR . 3.4 mttt -77.75 163.02 26.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -1.114 . . . . 0.0 110.189 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 5.2 ptt? -160.99 170.27 20.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.68 HG21 ' O ' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -135.9 127.27 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.355 -0.84 . . . . 0.0 109.744 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 26.3 t -105.2 133.89 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.968 -1.083 . . . . 0.0 110.796 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.844 HG23 HG22 ' B' ' 112' ' ' THR . 2.4 t -140.64 159.03 43.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.616 -0.677 . . . . 0.0 109.23 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.622 ' C ' HG22 ' B' ' 111' ' ' THR . . . 112.58 -17.03 23.66 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -60.42 173.27 0.71 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -1.199 . . . . 0.0 110.191 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -120.47 -18.77 7.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.998 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.427 ' N ' HG13 ' B' ' 70' ' ' ILE . 14.5 t -146.7 -172.32 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -70.59 -59.23 2.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.214 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -52.53 -33.41 45.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.535 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 1.5 t0 -63.59 -46.4 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 4.0 t -63.27 -34.84 78.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.321 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . 0.472 ' HA ' ' CE1' ' B' ' 155' ' ' PHE . 6.4 ttpt -66.37 -43.51 85.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.141 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -70.36 -58.27 3.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.51 -26.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.121 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.657 ' OG ' HG21 ' B' ' 74' ' ' VAL . 47.7 t -77.52 -59.07 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' B' ' 134' ' ' LEU . 1.2 ptm180 -53.07 -26.01 14.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.003 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -70.65 -46.9 62.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.799 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.545 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 17.4 m-85 -60.76 -44.13 97.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.797 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.95 -27.79 67.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.766 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.502 ' HG3' ' NH1' ' B' ' 141' ' ' ARG . 0.2 OUTLIER -68.69 -37.4 79.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.8 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 11.2 mt -61.5 -48.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.991 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.789 HG21 ' HB2' ' B' ' 150' ' ' ALA . 3.2 mp -63.66 -44.09 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 109.666 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.768 ' HG3' ' HB3' ' B' ' 150' ' ' ALA . 76.5 mt-30 -70.97 -33.81 70.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -71.73 -22.25 61.65 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.7 -22.87 10.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.35 -34.65 2.75 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.468 ' CE1' ' HA ' ' B' ' 80' ' ' LEU . 11.8 m-85 -47.18 161.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.159 -1.201 . . . . 0.0 110.962 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.16 42.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 0.0 109.707 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.901 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -59.98 158.34 11.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 110.692 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 2.4 mttm -120.8 -156.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.539 -0.726 . . . . 0.0 109.688 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -153.0 71.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 110.211 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -142.85 -178.79 5.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 153' ' ' THR . 0.6 OUTLIER 69.04 11.75 8.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.606 ' HA ' HG22 ' B' ' 74' ' ' VAL . 40.4 t80 -68.67 132.25 46.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -169.83 131.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 1.9 mp -79.97 118.93 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.836 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.443 ' OE1' ' HG3' ' B' ' 218' ' ' LYS . 17.4 mm-40 -122.49 3.36 9.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.071 -1.018 . . . . 0.0 110.849 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.47 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 8.2 t-20 -149.83 95.91 2.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.894 -1.129 . . . . 0.0 110.768 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' B' ' 217' ' ' ALA . 88.1 mt -100.71 141.91 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.668 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 1.022 HG22 ' OG1' ' B' ' 215' ' ' THR . 26.5 t -122.31 132.8 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.775 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -134.98 -179.92 17.0 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.04 143.23 3.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -1.213 . . . . 0.0 110.369 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 26.9 p -170.23 175.41 4.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -119.35 173.82 6.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 209' ' ' SER . 0.0 OUTLIER -112.84 -85.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 110.098 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 166.97 -22.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.142 -0.974 . . . . 0.0 110.672 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.443 ' CE2' HG12 ' B' ' 170' ' ' ILE . 28.7 p90 -121.33 152.44 57.57 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.093 -1.005 . . . . 0.0 109.705 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.535 ' HA ' ' OG ' ' B' ' 209' ' ' SER . 50.9 Cg_endo -79.78 158.44 24.64 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.908 1.478 . . . . 0.0 110.619 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.991 HD12 ' CB ' ' B' ' 209' ' ' SER . 5.7 mt -133.95 164.92 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 0.0 110.293 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . 0.486 ' N ' HG22 ' B' ' 170' ' ' ILE . 0.0 OUTLIER -100.17 93.2 5.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.934 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.935 HD22 ' HB2' ' B' ' 193' ' ' LEU . 55.5 mt -47.45 -49.99 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 110.063 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 172' ' ' LEU . 1.5 mt-10 -44.61 -36.73 3.2 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.496 -0.752 . . . . 0.0 109.797 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.06 -38.57 63.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.66 HD11 ' HE2' ' B' ' 195' ' ' TYR . 0.1 OUTLIER -66.73 -38.06 85.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -1.125 . . . . 0.0 110.011 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.14 -13.74 59.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -89.18 -37.9 14.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -52.13 4.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.563 ' HB2' HD13 ' B' ' 175' ' ' LEU . 28.7 m80 -93.05 21.73 5.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 0.0 110.084 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' B' ' 179' ' ' HIS . . . -43.13 -65.29 1.48 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 9.3 t -48.71 -21.73 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -1.186 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.413 ' CZ ' ' CG2' ' B' ' 198' ' ' VAL . 1.1 m-30 -114.08 15.48 18.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' B' ' 179' ' ' HIS . 0.5 OUTLIER -151.52 153.45 34.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.77 141.23 51.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.875 . . . . 0.0 109.943 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -132.66 107.91 8.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.445 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 2.0 mm-40 -114.31 94.49 35.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.05 -8.94 24.67 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 110.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.37 -3.91 27.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.432 HD13 ' CE ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -140.42 -35.22 0.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.651 ' CZ ' HD22 ' B' ' 205' ' ' LEU . 2.5 t80 -126.48 128.97 24.25 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.146 -0.971 . . . . 0.0 110.4 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . 0.412 ' HG3' ' CG ' ' A' ' 51' ' ' GLU . 47.9 Cg_endo -75.88 -38.6 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.927 1.488 . . . . 0.0 110.65 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.71 -179.98 44.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.935 ' HB2' HD22 ' B' ' 172' ' ' LEU . 4.9 tt -106.53 131.92 53.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -1.157 . . . . 0.0 110.269 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.655 ' N ' HD23 ' B' ' 193' ' ' LEU . 23.8 mt -90.31 105.94 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.66 ' HE2' HD11 ' B' ' 175' ' ' LEU . 2.1 t80 -90.35 116.26 28.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 79.87 1.77 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -67.5 161.02 26.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.413 ' CG2' ' CZ ' ' B' ' 182' ' ' PHE . 53.0 t -111.8 -31.08 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -130.83 94.16 29.37 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.5 Cg_endo -73.36 165.66 83.9 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.787 -2.172 . . . . 0.0 110.471 0.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' B' ' 197' ' ' MET . 35.2 tttm -88.72 93.11 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.485 ' CD1' ' HB2' ' B' ' 217' ' ' ALA . 13.7 mt -144.39 148.5 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.521 ' C ' HD12 ' B' ' 204' ' ' LEU . 14.4 t -94.86 142.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.566 ' N ' HD12 ' B' ' 204' ' ' LEU . 5.2 mp -135.27 148.9 49.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.651 HD22 ' CZ ' ' B' ' 190' ' ' PHE . 69.7 mt -105.76 110.64 23.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.901 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' B' ' 208' ' ' VAL . 18.5 mm -94.79 96.15 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.477 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.633 ' C ' HG23 ' B' ' 208' ' ' VAL . 12.8 m-85 -70.31 58.93 0.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.633 HG23 ' C ' ' B' ' 207' ' ' PHE . 5.8 t 80.37 -37.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.937 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.991 ' CB ' HD12 ' B' ' 170' ' ' ILE . 2.9 p 156.74 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.937 0.875 . . . . 0.0 110.163 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.76 -67.66 1.89 Allowed Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.698 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 212' ' ' ILE . 4.8 mttp -100.74 139.92 35.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -1.15 . . . . 0.0 111.142 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.648 HD13 ' O ' ' B' ' 211' ' ' LYS . 27.1 mm -123.15 140.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.308 -0.87 . . . . 0.0 110.032 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.564 ' C ' HD12 ' B' ' 214' ' ' LEU . 12.0 t -123.63 152.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.185 -0.947 . . . . 0.0 110.492 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.643 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.4 mp -144.08 123.65 13.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.322 -0.862 . . . . 0.0 110.545 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 1.022 ' OG1' HG22 ' B' ' 161' ' ' VAL . 2.9 t -147.21 144.42 28.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.088 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 116.88 1.16 19.49 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -75.59 152.41 37.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -1.124 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.443 ' HG3' ' OE1' ' B' ' 158' ' ' GLN . 8.6 tttt -100.49 -2.53 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.3 164.93 19.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.086 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.28 -24.77 65.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.466 ' CA ' ' OE1' ' B' ' 221' ' ' GLU . 0.1 OUTLIER -69.1 -37.98 78.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.912 . . . . 0.0 109.964 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 2.9 mt-10 -63.66 -46.92 83.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.07 -1.019 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.489 HG12 ' CB ' ' B' ' 217' ' ' ALA . 10.7 mm -58.46 -48.37 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.922 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -55.68 -26.8 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.078 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -48.72 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.26 -35.95 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.45 -47.43 12.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.345 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -25.97 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.509 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -83.37 -36.57 24.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.584 HD13 ' O ' ' B' ' 230' ' ' ILE . 0.3 OUTLIER -88.19 -29.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 109.906 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.606 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 6.7 t80 -44.21 -49.55 23.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.409 -0.807 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 41.1 Cg_endo -68.17 -45.11 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.35 1.184 . . . . 0.0 110.355 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.571 ' HB ' HD13 ' B' ' 230' ' ' ILE . 4.3 t -47.18 -37.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 108.981 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.814 HD22 HD13 ' B' ' 170' ' ' ILE . 57.3 mt -65.41 -53.0 49.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.84 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.91 -38.17 15.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.981 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -60.08 -45.43 92.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -97.63 34.38 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.931 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -52.01 146.71 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 110.276 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -29.94 9.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.37 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.327 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.073 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.65 95.32 5.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.038 -1.039 . . . . 0.0 111.552 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.073 HD21 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -107.94 9.43 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.978 . . . . 0.0 110.81 179.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.662 ' OG1' HD23 ' A' ' 68' ' ' LEU . 24.0 m -48.85 -23.79 1.21 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.857 -1.152 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.2 -29.0 6.95 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.8 ' CG2' HG11 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -44.99 -44.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.294 . . . . 0.0 108.848 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.864 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.6 pp -84.41 -22.32 30.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.924 -1.11 . . . . 0.0 109.294 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.743 ' HZ ' HD11 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -86.12 2.82 45.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.35 178.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 149.98 101.03 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.744 ' ND2' HD11 ' A' ' 35' ' ' LEU . 13.6 p-10 -22.08 84.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.813 0.816 . . . . 0.0 111.878 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.2 pp -88.49 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.907 ' O ' HD12 ' A' ' 28' ' ' ILE . 66.0 m-20 -88.22 126.52 35.19 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.549 ' HB3' ' CD1' ' B' ' 103' ' ' ILE . 1.1 p -39.71 -25.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.758 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' ASP . 16.2 tt0 -59.77 -10.62 3.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.09 -1.006 . . . . 0.0 110.202 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.59 29.84 5.78 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -117.36 119.65 35.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.306 -1.114 . . . . 0.0 110.519 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.96 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -90.81 143.55 26.61 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.051 -1.03 . . . . 0.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.96 ' N ' HD22 ' A' ' 34' ' ' LEU . 4.5 pp . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.786 -1.196 . . . . 0.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.345 0.593 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.39 -19.51 16.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.518 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD21 HD13 ' B' ' 205' ' ' LEU . 4.0 mt -100.28 -45.79 5.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.775 . . . . 0.0 110.331 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.898 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -53.2 -57.56 10.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.274 -0.891 . . . . 0.0 109.738 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 3.0 pp20? -62.77 -19.99 64.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.78 . . . . 0.0 109.416 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 7.7 m-20 -84.15 -35.79 23.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.5 -0.75 . . . . 0.0 109.211 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.898 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.5 mt -53.09 -41.51 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.394 -0.817 . . . . 0.0 109.141 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.54 -23.88 44.69 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p -118.52 12.8 13.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -1.182 . . . . 0.0 110.567 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.044 HD23 HD11 ' A' ' 62' ' ' LEU . 4.0 mt -87.81 26.46 1.32 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.098 -1.001 . . . . 0.0 110.369 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 52.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.527 ' HG3' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -173.35 26.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 110.364 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.044 HD11 HD23 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -148.09 12.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.186 -0.947 . . . . 0.0 110.393 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.94 -58.49 0.51 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 4.1 mm? -50.34 -20.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -1.116 . . . . 0.0 110.928 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 t70 -45.43 -43.03 11.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -66.78 -50.45 62.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.391 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.864 ' HG2' HD22 ' A' ' 24' ' ' LEU . 2.0 tpp -68.27 -7.67 32.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.296 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.662 HD23 ' OG1' ' A' ' 21' ' ' THR . 2.3 tm? -70.05 -59.63 2.79 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 122.061 0.934 . . . . 0.0 108.631 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.3 pp -75.74 0.56 17.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 4.1 tt0 -92.49 13.93 18.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 112.222 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.893 HG12 HG11 ' B' ' 122' ' ' VAL . 2.0 t -140.58 3.7 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.743 -1.223 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.838 ' CG1' HD23 ' A' ' 18' ' ' LEU . 1.5 tp -148.99 76.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.6 t70 -77.73 55.43 1.36 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.12 -0.988 . . . . 0.0 108.455 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.577 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.531 0.681 . . . . 0.0 110.629 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.597 HD13 ' O ' ' B' ' 165' ' ' ASP . 89.8 mt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.179 0.514 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.474 ' CG1' ' OH ' ' B' ' 224' ' ' TYR . 6.6 t -70.96 140.14 85.83 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.321 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.9 Cg_endo -73.85 130.0 14.06 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.011 1.532 . . . . 0.0 110.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.406 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 2.3 m -91.17 135.57 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' B' ' 67' ' ' LEU . 49.9 mt -80.06 124.29 28.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.02 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -106.49 -18.76 13.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.487 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.9 163.94 11.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.178 -0.951 . . . . 0.0 110.447 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.591 HG12 HG23 ' B' ' 160' ' ' ILE . 5.6 mt -151.27 165.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.381 -0.824 . . . . 0.0 109.959 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.772 HG22 ' HB ' ' B' ' 124' ' ' THR . 3.4 t -148.17 142.09 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.48 152.28 48.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.986 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.29 132.2 45.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 110.342 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.658 HG21 ' OG ' ' B' ' 136' ' ' SER . 94.1 t -123.88 158.34 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.922 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.496 ' CB ' ' HB2' ' B' ' 154' ' ' ASP . 7.7 m -133.39 144.27 49.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' B' ' 150' ' ' ALA . 96.1 mt -101.4 -32.44 10.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.852 . . . . 0.0 110.032 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.93 18.36 59.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.73 144.91 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -1.212 . . . . 0.0 110.313 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.571 ' O ' HD23 ' B' ' 80' ' ' LEU . 4.2 ttp85 -75.23 152.18 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 110.005 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.571 HD23 ' O ' ' B' ' 79' ' ' ARG . 39.7 mt -132.93 163.09 29.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.406 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.454 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 97.7 m-20 -98.21 113.7 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.25 -53.93 51.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -0.966 . . . . 0.0 110.174 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 8.6 tppt? -51.42 -47.2 63.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.997 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 84.8 m -72.93 -45.71 56.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.08 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.638 HG12 HG11 ' B' ' 102' ' ' VAL . 25.2 t -58.04 -47.95 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.963 . . . . 0.0 109.999 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.578 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -75.01 -10.24 59.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 7.7 tp -98.12 -24.78 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.451 ' O ' ' NH2' ' B' ' 90' ' ' ARG . 2.1 m-70 -98.67 -30.42 12.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.448 ' HB1' ' HE2' ' B' ' 104' ' ' MET . . . -62.28 146.36 51.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.139 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' B' ' 88' ' ' HIS . 5.2 mmt-85 -76.07 -33.57 59.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -134.37 79.3 1.8 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.319 -0.863 . . . . 0.0 109.989 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.431 ' C ' ' HG2' ' B' ' 93' ' ' GLU . . . -127.13 156.71 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.406 -0.808 . . . . 0.0 110.174 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' B' ' 103' ' ' ILE . 1.5 mm-40 -134.1 126.05 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.594 ' HB2' HG22 ' B' ' 102' ' ' VAL . 9.6 t80 -134.93 111.89 10.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.441 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -128.59 126.19 23.34 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.58 -25.55 14.87 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 0.0 110.8 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -68.4 -17.04 64.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 0.0 110.299 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.6 -50.37 3.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 1.181 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -173.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.436 -0.79 . . . . 0.0 111.582 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.24 56.46 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.837 . . . . 0.0 110.947 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.181 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -145.07 152.82 40.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.523 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.638 HG11 HG12 ' B' ' 85' ' ' VAL . 23.8 t -98.46 135.74 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.57 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 25.4 mm -109.62 120.66 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.043 . . . . 0.0 110.887 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.572 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.9 OUTLIER -90.76 162.93 14.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.667 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.438 ' NH2' ' HG2' ' B' ' 105' ' ' ARG . 0.0 OUTLIER -155.96 126.76 6.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.076 -1.015 . . . . 0.0 110.44 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.577 HG23 ' CE1' ' B' ' 139' ' ' TYR . 43.9 pt -128.47 149.45 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -99.74 26.94 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 2.0 tt0 -162.62 83.0 1.59 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 51.3 Cg_endo -80.88 163.76 79.58 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.977 -2.093 . . . . 0.0 110.635 -0.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -68.78 103.93 1.89 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.661 HG22 ' HA3' ' B' ' 125' ' ' GLY . 13.9 p -148.97 169.61 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 111.149 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.7 m -117.73 153.99 32.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.579 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -143.6 132.89 23.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.057 -1.027 . . . . 0.0 110.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.55 HD23 HD12 ' B' ' 103' ' ' ILE . 7.2 mt -96.35 137.05 36.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' B' ' 102' ' ' VAL . 46.5 mt -125.83 118.52 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 0.8 OUTLIER -99.89 141.24 32.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -51.83 -20.52 2.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.207 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -21.44 64.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.7 -23.34 13.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . 0.481 ' HG3' HG23 ' B' ' 75' ' ' THR . 3.9 ttmt -72.66 177.22 4.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -1.162 . . . . 0.0 110.383 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.526 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 6.0 ptm -168.83 140.96 2.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.893 HG11 HG12 ' A' ' 71' ' ' VAL . 4.2 t -115.1 132.98 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.92 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.31 167.88 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 110.091 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.772 ' HB ' HG22 ' B' ' 71' ' ' VAL . 4.7 t -169.16 160.25 9.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.954 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 113.2 -4.75 25.28 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -76.8 146.64 37.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -1.188 . . . . 0.0 110.309 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.69 -21.45 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.252 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' B' ' 129' ' ' GLU . 0.3 OUTLIER -127.23 32.34 5.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . 0.524 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.1 tt0 66.6 -68.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 128' ' ' SER . 7.3 t70 -44.07 -31.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -0.84 . . . . 0.0 110.363 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.487 ' HB3' ' HA ' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -63.02 -58.99 5.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' B' ' 126' ' ' ALA . 0.1 OUTLIER -52.48 -31.53 35.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -46.41 75.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.958 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.35 -45.9 71.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.257 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.484 ' HA ' HD11 ' B' ' 106' ' ' ILE . . . -53.01 -48.69 67.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.942 . . . . 0.0 110.083 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.658 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -57.29 -53.63 55.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -51.83 -36.86 49.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.959 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -48.28 65.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 21.8 m-85 -61.78 -55.71 27.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.093 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.28 -21.65 9.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.877 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -78.99 -29.34 43.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 110.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.435 ' O ' HG13 ' B' ' 146' ' ' ILE . 49.0 mt -68.62 -43.69 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' B' ' 150' ' ' ALA . 52.1 mt -70.66 -50.5 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.098 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 90.0 mt-30 -60.15 -37.2 79.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 109.693 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -32.64 68.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.435 HG13 ' O ' ' B' ' 142' ' ' ILE . 5.2 mt -66.6 -17.93 23.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.6 -23.45 12.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.42 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 13.1 m-85 -52.34 169.01 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.007 -1.29 . . . . 0.0 110.745 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.53 50.42 0.81 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 110.308 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -80.32 144.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.419 ' O ' ' OG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -126.01 106.37 9.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 0.0 110.331 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -55.78 101.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -162.08 -178.91 6.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.496 ' HB2' ' CB ' ' B' ' 75' ' ' THR . 3.4 m-20 57.8 26.47 13.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 110.445 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.529 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 5.7 t80 -78.99 133.14 36.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.073 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -161.91 130.52 4.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.609 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.524 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 30.0 mt -79.86 126.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 109.826 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' B' ' 218' ' ' LYS . 6.5 mt-30 -134.36 4.68 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 0.0 110.455 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.511 ' HB2' ' HB ' ' B' ' 71' ' ' VAL . 16.1 m120 -147.5 90.8 1.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.816 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.591 HG23 HG12 ' B' ' 70' ' ' ILE . 96.7 mt -99.72 141.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.903 . . . . 0.0 109.863 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 11.4 t -109.36 135.44 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.526 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.436 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.19 172.79 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 5.1 m -164.13 150.13 10.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -1.164 . . . . 0.0 110.159 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.493 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 21.0 p -170.62 157.78 5.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.597 ' O ' HD13 ' B' ' 63' ' ' ILE . 2.7 p30 -113.6 175.22 5.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 109.796 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.575 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.1 OUTLIER -119.44 -84.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.486 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.3 OUTLIER 178.39 -27.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.435 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 30.7 p90 -129.69 164.67 38.51 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.768 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 48.0 Cg_endo -76.86 156.55 34.86 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.023 1.539 . . . . 0.0 110.488 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.79 147.84 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -82.62 101.2 10.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.408 ' CD1' ' HA2' ' B' ' 192' ' ' GLY . 20.8 mt -58.65 -52.03 67.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' B' ' 177' ' ' PHE . 1.1 mt-10 -50.44 -45.71 56.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.93 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.12 70.59 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.488 ' HB3' HD13 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -76.33 -51.95 10.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.46 -1.023 . . . . 0.0 109.83 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.454 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -63.78 -11.69 28.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.76 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' B' ' 173' ' ' GLU . 3.4 t80 -88.89 -49.36 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 110.125 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . 0.466 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 36.4 t -88.38 -35.56 17.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -112.36 18.73 18.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' B' ' 176' ' ' ALA . . . -59.38 -18.77 44.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 5.6 t -64.95 -20.61 66.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -1.17 . . . . 0.0 110.21 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -131.85 5.53 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.897 . . . . 0.0 110.228 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.75 ' HB2' HD21 ' B' ' 193' ' ' LEU . 37.2 p -124.35 153.54 41.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -125.91 137.42 53.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -129.69 101.09 5.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.77 111.85 27.37 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.917 . . . . 0.0 109.908 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 -2.03 10.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.881 1.464 . . . . 0.0 110.377 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.73 -22.51 50.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.305 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.517 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 2.6 pp -159.37 24.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.727 ' CZ ' HD22 ' B' ' 205' ' ' LEU . 0.6 OUTLIER -170.07 106.9 0.44 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.475 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.66 -31.42 6.82 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.97 1.51 . . . . 0.0 109.986 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.78 171.33 37.58 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' B' ' 183' ' ' SER . 5.1 tt -101.01 140.06 35.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.237 -1.155 . . . . 0.0 110.463 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' B' ' 183' ' ' SER . 65.0 mt -96.04 123.22 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.854 . . . . 0.0 110.109 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.51 ' O ' HD12 ' B' ' 204' ' ' LEU . 7.4 t80 -107.94 124.15 49.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.367 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -99.66 90.95 4.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.539 ' HE1' ' HB ' ' B' ' 230' ' ' ILE . 29.7 tpp -47.11 134.51 10.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.349 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 56.5 t -65.62 -58.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.403 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -138.72 118.55 9.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -75.66 163.22 90.82 Favored 'Cis proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.962 -2.099 . . . . 0.0 110.377 -0.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' B' ' 197' ' ' MET . 6.3 mmtt -69.1 94.27 0.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.431 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 36.4 mm -126.43 146.29 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.95 . . . . 0.0 110.497 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 71.5 t -98.28 134.63 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.848 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.866 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.5 mp -136.34 136.83 40.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 110.542 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.743 HD11 ' HZ ' ' A' ' 25' ' ' PHE . 67.4 mt -99.12 145.2 27.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 110.08 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.507 HG12 HD21 ' B' ' 234' ' ' LEU . 6.6 mt -125.39 103.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -87.17 135.43 33.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 110.307 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 42.5 t -48.15 -24.45 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.2 p -66.38 -44.15 83.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.575 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 135.26 -3.43 4.02 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 137.16 34.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -1.226 . . . . 0.0 110.492 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 13.5 mm -121.66 152.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.28 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.496 ' C ' HD12 ' B' ' 214' ' ' LEU . 33.4 t -124.77 162.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.056 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.496 HD12 ' C ' ' B' ' 213' ' ' VAL . 3.2 mp -148.29 135.41 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.404 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 4.8 t -166.6 141.17 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 110.082 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 112.9 14.59 9.99 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -90.23 160.35 16.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -1.195 . . . . 0.0 110.361 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' B' ' 158' ' ' GLN . 3.7 mmmm -106.12 -5.34 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -168.59 159.46 10.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.353 -0.842 . . . . 0.0 110.109 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -56.62 -17.79 9.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.337 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -25.63 59.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 109.776 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.667 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 3.6 mt-10 -80.02 -44.76 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.34 -40.43 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.474 ' OH ' ' CG1' ' B' ' 64' ' ' VAL . 2.4 m-85 -66.77 -37.26 84.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.887 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -72.54 -38.97 67.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.866 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.91 -33.98 71.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.631 ' HA ' HG22 ' B' ' 230' ' ' ILE . 33.0 t80 -77.84 -54.23 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -17.73 5.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.09 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.404 ' C ' ' HD2' ' B' ' 232' ' ' PRO . . . -93.39 -37.63 11.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.312 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.9 tp -84.47 -24.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.55 -49.24 56.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.887 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.1 Cg_endo -71.4 -36.47 6.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.547 1.288 . . . . 0.0 110.339 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.67 -35.83 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.653 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.507 HD21 HG12 ' B' ' 206' ' ' ILE . 8.2 mt -71.27 -48.51 50.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.039 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -22.66 53.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.177 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.2 -35.39 41.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 110.269 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.466 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 64.3 m-85 -113.75 40.77 2.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.343 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.497 ' NH2' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -63.67 172.58 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -117.88 -55.62 2.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.159 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 32.3 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.22 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.808 HD11 ' CA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.543 ' H ' HD12 ' A' ' 18' ' ' LEU . 2.0 t70 -57.62 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.856 -1.153 . . . . 0.0 110.049 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.812 HD13 ' CB ' ' A' ' 23' ' ' ILE . 1.4 mm? -107.21 -20.55 13.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 111.025 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.817 HG21 ' HB2' ' A' ' 59' ' ' LEU . 13.5 m -43.31 -26.83 0.2 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.782 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -95.59 -27.11 10.87 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.989 HG23 HG21 ' B' ' 124' ' ' THR . 4.6 mm -59.43 -50.99 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -1.104 . . . . 0.0 108.942 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.87 HD11 ' CD1' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -77.56 1.76 18.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -104.78 -21.49 13.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 110.74 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.536 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 159.86 48.32 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.999 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.886 ' OD1' HD21 ' A' ' 35' ' ' LEU . 1.4 t-20 56.33 151.67 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -1.112 . . . . 0.0 111.039 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.944 HD12 HG12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -171.06 156.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 31' ' ' GLU . 96.7 m-20 -86.18 116.1 24.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.808 ' CA ' HD11 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -35.34 -28.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.306 0.574 . . . . 0.0 110.318 -177.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 29' ' ' ASP . 21.3 tt0 -51.77 -18.5 1.27 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.325 -0.86 . . . . 0.0 110.061 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.74 26.59 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.082 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' HD3' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -121.44 132.13 54.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.089 -1.242 . . . . 0.0 110.438 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 56' ' ' ILE . 1.6 tt -102.9 152.65 21.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.848 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.886 HD21 ' OD1' ' A' ' 27' ' ' ASN . 3.0 pp . . . . . 0 N--CA 1.493 1.707 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.688 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.333 0.587 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.73 -19.01 16.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 52' ' ' LEU . 4.4 mt -94.59 -47.65 6.43 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.774 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.3 -48.87 18.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.434 -0.791 . . . . 0.0 109.593 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.35 -26.28 66.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 6.7 m-20 -79.85 -40.46 28.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.965 HD13 HD13 ' A' ' 34' ' ' LEU . 5.9 mt -50.97 -39.97 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 0.0 109.141 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -22.75 48.91 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 p -129.67 18.85 5.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -1.224 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.02 HD21 ' CE2' ' B' ' 190' ' ' PHE . 4.3 mt -84.14 5.21 27.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.4 m -89.53 45.36 1.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.118 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 11.3 ttpt -147.52 12.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.147 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.985 HD13 HD13 ' B' ' 194' ' ' ILE . 0.8 OUTLIER -131.06 -27.17 2.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.622 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.31 -42.77 0.14 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.87 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.9 mm? -44.85 -36.99 3.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -1.202 . . . . 0.0 110.54 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.561 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 15.3 t0 -42.39 -35.38 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 14.8 m -65.17 -46.8 79.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.335 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.613 ' HG2' HD13 ' A' ' 24' ' ' LEU . 6.4 tpp -66.76 -16.63 64.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 72' ' ' ILE . 6.5 mt -70.48 -61.42 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.953 -1.092 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.1 pp -66.45 -2.66 4.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.58 -0.7 . . . . 0.0 110.808 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -91.51 -13.55 31.95 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.151 -0.968 . . . . 0.0 111.241 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.0 OUTLIER -119.05 -26.72 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.938 -1.101 . . . . 0.0 110.045 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 HD12 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -128.23 67.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 73' ' ' ASP . 16.5 t70 -70.09 59.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.092 HD22 ' HB3' ' B' ' 100' ' ' ALA . 3.0 mt . . . . . 0 C--N 1.299 -1.615 0 CA-C-O 121.612 0.72 . . . . 0.0 110.97 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.197 0.522 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' B' ' 65' ' ' PRO . 39.5 t -97.93 139.45 21.3 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.329 -0.857 . . . . 0.0 109.916 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.49 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 45.5 Cg_endo -71.58 130.12 16.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.94 1.495 . . . . 0.0 110.62 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.471 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 94.1 m -93.45 132.08 38.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.123 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 mt -70.17 128.61 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.532 ' NE2' ' HB2' ' B' ' 163' ' ' SER . 2.0 mt-30 -106.86 -18.33 13.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 110.219 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.536 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -170.17 153.59 4.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.909 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 37.7 mm -129.28 153.74 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.972 HG22 ' HB ' ' B' ' 124' ' ' THR . 22.4 t -141.76 129.9 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.341 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.535 ' HB2' HG13 ' B' ' 157' ' ' ILE . . . -137.9 157.19 46.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 41.6 p -104.04 146.19 29.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.251 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.462 HG21 ' OG ' ' B' ' 136' ' ' SER . 54.7 t -137.8 132.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 110.163 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.449 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 5.9 m -114.62 128.24 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.925 HD22 ' HB1' ' B' ' 150' ' ' ALA . 70.3 mt -83.25 -71.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.79 -11.11 3.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . 0.523 ' SG ' HD21 ' B' ' 80' ' ' LEU . 31.6 p -129.68 134.16 47.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -1.219 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.666 ' O ' HD23 ' B' ' 80' ' ' LEU . 5.8 ttt180 -58.16 155.26 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.666 HD23 ' O ' ' B' ' 79' ' ' ARG . 14.6 mt -137.38 153.19 50.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 40.7 t0 -93.9 101.11 13.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.808 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.766 HD22 HG23 ' B' ' 102' ' ' VAL . 17.8 mt -41.36 -49.33 3.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.185 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -54.23 -34.57 61.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.002 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 85.9 m -80.24 -40.35 27.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.913 HG22 ' CE2' ' B' ' 148' ' ' PHE . 24.8 t -71.9 -37.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.065 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.99 -19.02 48.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 110.192 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 13.1 tp -91.54 -30.63 16.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.6 m80 -92.51 -17.77 24.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.339 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -74.7 133.4 42.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -70.32 -21.43 62.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.885 . . . . 0.0 110.351 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -139.44 79.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.083 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.784 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -160.2 154.29 23.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.48 ' HG2' ' HB ' ' B' ' 103' ' ' ILE . 8.2 pt-20 -141.27 171.59 13.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.447 ' CE1' HD13 ' B' ' 82' ' ' LEU . 21.5 t80 -140.46 124.89 17.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 110.568 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.467 ' ND2' ' HB2' ' A' ' 31' ' ' GLU . 7.5 m-20 -114.27 98.83 49.68 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' B' ' 95' ' ' ASN . 47.5 Cg_endo -71.88 -24.01 21.56 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.076 1.566 . . . . 0.0 110.357 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -74.15 -20.78 60.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.384 -0.822 . . . . 0.0 110.298 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.24 -74.03 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 110.363 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -133.25 178.19 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 1.092 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -104.39 40.13 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.047 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -117.96 149.18 41.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -0.949 . . . . 0.0 110.766 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.766 HG23 HD22 ' B' ' 82' ' ' LEU . 40.6 t -89.99 124.51 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.044 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 30' ' ' SER . 3.8 mm -89.28 111.77 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.04 . . . . 0.0 110.224 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 2.1 ttm -107.72 155.77 19.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.701 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.42 ' CG ' ' C ' ' B' ' 104' ' ' MET . 56.5 mtm180 -146.33 148.01 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 110.567 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.696 HD11 ' OG1' ' B' ' 111' ' ' THR . 9.8 pt -131.44 157.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.465 -0.772 . . . . 0.0 109.656 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.07 -28.19 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 108' ' ' GLU . 0.5 OUTLIER -156.69 118.69 2.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.168 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.915 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.1 Cg_endo -73.63 122.36 7.71 Favored 'Cis proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.881 -2.133 . . . . 0.0 110.36 -0.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.667 ' O ' HG23 ' B' ' 111' ' ' THR . 24.2 tttp -43.25 108.16 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.696 ' OG1' HD11 ' B' ' 106' ' ' ILE . 18.8 p -158.67 -178.92 7.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.703 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' B' ' 104' ' ' MET . 1.2 m -135.23 154.79 51.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.775 . . . . 0.0 109.096 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -136.48 123.92 22.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.836 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.788 HD12 ' HB ' ' B' ' 122' ' ' VAL . 0.1 OUTLIER -95.71 97.62 9.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.412 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 9.3 mt -89.51 140.54 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.09 -1.006 . . . . 0.0 110.912 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 1.9 m-30 -106.51 150.89 25.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 109.878 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.571 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -65.25 -17.86 64.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 0.0 110.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.6 m -67.52 -18.93 65.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.282 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.56 -13.49 15.39 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -87.95 164.61 15.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -1.196 . . . . 0.0 110.224 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.44 ' HG3' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -163.18 161.74 25.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 0.0 110.251 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.788 ' HB ' HD12 ' B' ' 114' ' ' LEU . 24.8 t -129.98 154.39 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.41 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 14.3 t -133.11 104.11 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.989 HG21 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -112.04 172.62 6.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.36 -0.837 . . . . 0.0 110.167 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.592 ' C ' HG22 ' B' ' 111' ' ' THR . . . 97.31 -15.95 61.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.909 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -60.21 166.11 3.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -1.226 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -26.46 10.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.764 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.526 ' N ' HG13 ' B' ' 70' ' ' ILE . 40.0 m -153.68 166.44 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.429 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 128' ' ' SER . 3.8 mt-10 -43.64 -48.41 7.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.15 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.62 -50.63 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.46 -45.34 69.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -36.66 78.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -33.64 72.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.139 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -42.91 64.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.915 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -66.9 -39.81 87.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.194 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.462 ' OG ' HG21 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -60.24 -57.4 12.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.964 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -44.75 -52.2 8.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -53.74 -47.75 70.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.913 ' HA ' HD12 ' B' ' 142' ' ' ILE . 15.4 m-85 -61.68 -57.74 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' B' ' 152' ' ' PHE . . . -48.77 -26.91 2.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.453 ' HG2' ' HG3' ' B' ' 145' ' ' LYS . 9.0 ttm180 -73.84 -49.29 25.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.836 . . . . 0.0 110.092 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.913 HD12 ' HA ' ' B' ' 139' ' ' TYR . 42.2 mt -47.12 -39.2 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.938 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.758 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.8 mp -72.21 -53.04 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 3.5 mt-30 -66.92 -28.28 68.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.65 -24.85 60.05 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 0.0 108.436 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 7.1 mt -82.33 -24.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 130.35 -23.11 4.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.913 ' CE2' HG22 ' B' ' 85' ' ' VAL . 7.3 m-85 -49.32 165.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.293 . . . . 0.0 110.746 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.62 36.82 2.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.452 -0.78 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.925 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -62.83 152.69 35.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 13.6 ptpt -136.99 24.07 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.124 -0.985 . . . . 0.0 110.462 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' B' ' 151' ' ' LYS . 2.7 t80 27.25 98.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.211 0.529 . . . . 0.0 111.795 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -151.86 169.5 22.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 110.369 179.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.449 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 7.3 t0 65.45 30.12 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 7.1 t80 -71.85 122.87 21.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.924 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.36 131.19 8.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' B' ' 72' ' ' ALA . 3.3 mp -79.53 123.91 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -110.91 -14.99 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.4 t30 -142.49 135.96 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.711 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.722 HG23 ' CD1' ' B' ' 70' ' ' ILE . 29.8 mt -131.26 129.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 24' ' ' LEU . 10.2 t -96.8 134.72 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -141.97 168.74 25.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.532 ' HB2' ' NE2' ' B' ' 68' ' ' GLN . 0.3 OUTLIER -161.76 153.05 18.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.285 . . . . 0.0 110.711 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.438 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 7.5 p -165.95 155.65 12.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.13 153.08 21.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.348 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.621 HG21 HD11 ' B' ' 170' ' ' ILE . 13.2 m -105.91 3.46 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.56 -2.8 2.52 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.361 -0.837 . . . . 0.0 111.262 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.588 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 15.3 p90 -150.24 149.84 27.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.797 -1.189 . . . . 0.0 110.38 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.479 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 47.4 Cg_endo -73.64 160.62 43.67 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.135 1.597 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.621 HD11 HG21 ' B' ' 166' ' ' VAL . 3.1 mt -131.34 150.83 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.872 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.66 103.03 9.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.875 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.454 ' O ' HD12 ' B' ' 193' ' ' LEU . 15.5 mt -63.37 -34.68 78.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.662 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 9.4 pt-20 -78.3 -32.44 49.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.385 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . 0.533 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -64.16 -48.02 79.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -60.63 -42.2 96.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -1.106 . . . . 0.0 110.296 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.76 64.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.451 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -83.23 -27.78 29.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 67.0 m -95.13 -44.72 7.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -123.72 49.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.09 -20.59 79.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 32.6 m -60.32 -23.58 64.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -1.146 . . . . 0.0 110.208 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' B' ' 196' ' ' ARG . 17.7 m-85 -123.5 -5.37 8.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.31 152.93 40.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 8.5 p -131.8 139.33 48.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -127.16 113.46 16.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' B' ' 190' ' ' PHE . 8.6 mt-10 -117.72 92.15 40.55 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.127 -0.983 . . . . 0.0 109.921 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.64 -3.78 13.29 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.001 1.527 . . . . 0.0 110.167 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.57 -13.58 18.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.89 . . . . 0.0 110.014 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.491 HD23 ' HB2' ' B' ' 190' ' ' PHE . 4.3 tt -138.54 -35.11 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.462 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 1.02 ' CE2' HD21 ' A' ' 59' ' ' LEU . 2.7 t80 -125.49 114.04 25.4 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.39 -10.32 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.897 1.472 . . . . 0.0 110.457 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.99 172.81 18.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.454 HD12 ' O ' ' B' ' 172' ' ' LEU . 6.1 tt -105.15 121.53 44.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.985 HD13 HD13 ' A' ' 62' ' ' LEU . 6.4 mt -90.3 106.27 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.214 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' B' ' 204' ' ' LEU . 5.7 t80 -101.58 122.32 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -111.67 80.06 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.405 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.5 OUTLIER -68.34 166.09 17.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.883 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' B' ' 201' ' ' LYS . 63.1 t -111.02 -31.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.97 . . . . 0.0 110.704 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 7.0 tttt -134.78 97.14 14.22 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.585 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -72.37 150.18 94.55 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.8 -2.167 . . . . 0.0 110.401 -0.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.54 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -77.39 92.69 3.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.969 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' B' ' 217' ' ' ALA . 27.6 mm -140.33 153.53 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.07 103.8 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 109.844 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.442 HD12 ' H ' ' B' ' 204' ' ' LEU . 3.3 mp -95.01 142.45 27.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.881 HD12 ' HB ' ' B' ' 213' ' ' VAL . 4.4 mt -118.87 116.01 25.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.663 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.462 HG13 HG13 ' B' ' 212' ' ' ILE . 2.6 mt -108.71 119.87 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' B' ' 208' ' ' VAL . 10.0 m-85 -99.29 147.83 24.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.443 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 67.7 t -44.42 -25.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.021 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.406 ' N ' ' O ' ' B' ' 207' ' ' PHE . 3.8 p -66.11 -39.73 90.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.055 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.582 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 120.75 17.27 4.28 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.7 ' O ' HD12 ' B' ' 212' ' ' ILE . 0.1 OUTLIER -91.36 130.77 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.123 . . . . 0.0 110.135 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.855 HG22 HD11 ' B' ' 214' ' ' LEU . 1.2 mp -116.35 121.68 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 110.028 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.881 ' HB ' HD12 ' B' ' 205' ' ' LEU . 27.0 t -107.69 113.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 110.139 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.855 HD11 HG22 ' B' ' 212' ' ' ILE . 3.7 mp -101.23 103.5 14.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 5.0 t -130.31 142.95 50.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.971 . . . . 0.0 110.105 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 114.14 14.05 9.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.707 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -90.96 145.55 24.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.157 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -85.33 -13.76 48.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.348 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.509 ' CA ' ' CD1' ' B' ' 160' ' ' ILE . 1.3 tt0 -151.51 -173.44 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.066 -1.021 . . . . 0.0 110.539 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -79.77 -52.97 7.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.408 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.449 ' OE2' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -45.7 -25.72 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 110.538 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.543 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 56.3 mm-40 -69.83 -54.34 14.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.6 -39.81 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.49 ' CE1' ' HG2' ' B' ' 65' ' ' PRO . 5.5 m-85 -67.35 -33.15 74.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.491 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.438 ' HB3' ' HG3' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -78.24 -37.09 46.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.956 . . . . 0.0 110.145 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.3 80.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.515 ' HA ' HG22 ' B' ' 230' ' ' ILE . 2.3 t80 -67.85 -50.12 58.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.92 -15.19 7.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -95.88 -34.57 11.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.484 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.6 tp -95.48 -16.21 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.601 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 18.8 t80 -50.09 -45.3 81.77 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.3 Cg_endo -73.13 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.327 1.172 . . . . 0.0 110.497 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' B' ' 232' ' ' PRO . 14.1 t -44.36 -37.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.761 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.4 -47.64 32.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 13.2 m -55.74 -33.21 64.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.03 -29.34 61.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.317 -0.864 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' B' ' 175' ' ' LEU . 52.5 m-85 -118.78 40.56 3.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.093 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -78.29 -170.74 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -46.31 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . 0.422 ' OXT' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.279 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.117 HD21 HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.42 0.628 . . . . 0.0 111.29 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 4.5 m-20 79.84 76.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.482 0.658 . . . . 0.0 110.749 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.117 HD21 HD21 ' A' ' 18' ' ' LEU . 1.1 mt -97.87 25.92 5.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.411 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.579 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 24.3 m -54.59 -19.55 6.19 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 109.533 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.664 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.37 -36.68 4.02 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.769 HG13 HD22 ' A' ' 20' ' ' LEU . 7.8 mm -43.93 -45.13 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.981 -1.305 . . . . 0.0 108.857 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.013 HD13 ' SD ' ' A' ' 67' ' ' MET . 1.2 pp -80.81 -21.92 40.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.73 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -101.14 13.84 33.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.545 -0.722 . . . . 0.0 109.757 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 139.24 83.61 0.1 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.86 ' OD1' HD11 ' A' ' 35' ' ' LEU . 20.6 p-10 -15.18 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.698 0.761 . . . . 0.0 112.755 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.2 pp -88.55 171.65 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.803 ' O ' HD12 ' A' ' 28' ' ' ILE . 71.2 m-20 -86.81 119.38 26.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.564 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.2 -27.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.024 -177.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.2 tt0 -57.36 -13.29 3.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 110.21 27.32 4.55 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.25 116.77 28.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.085 -1.244 . . . . 0.0 110.778 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.988 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -88.94 143.58 26.77 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.822 -1.174 . . . . 0.0 109.83 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.988 ' N ' HD22 ' A' ' 34' ' ' LEU . 4.5 pp . . . . . 0 N--CA 1.494 1.75 0 O-C-N 120.614 -1.304 . . . . 0.0 111.312 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.188 0.518 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' CD ' ' HG3' ' B' ' 191' ' ' PRO . 2.5 tp10 -101.03 -20.41 15.4 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.138 -0.977 . . . . 0.0 109.319 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.687 HD21 ' CD1' ' B' ' 205' ' ' LEU . 3.0 mt -95.5 -44.59 7.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 110.149 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.816 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -53.88 -59.05 5.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.243 -0.911 . . . . 0.0 109.595 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.52 -13.38 30.0 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.497 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 2.8 m-20 -91.02 -39.15 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -0.797 . . . . 0.0 109.278 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.816 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.5 mt -51.97 -39.38 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.531 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 -16.19 41.83 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.531 ' HB3' HD11 ' B' ' 189' ' ' LEU . 0.1 OUTLIER -133.15 9.87 4.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.243 -1.151 . . . . 0.0 110.781 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.563 HD21 ' CE2' ' B' ' 190' ' ' PHE . 1.2 mt -79.31 7.05 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.507 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -94.09 43.27 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.311 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 58' ' ' SER . 3.3 ptmm? -143.67 15.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.64 HD22 HD12 ' B' ' 194' ' ' ILE . 0.0 OUTLIER -131.42 -60.43 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 65' ' ' ASP . . . -146.84 -44.93 0.03 OUTLIER Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.709 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.4 mm? -42.06 -26.14 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -1.17 . . . . 0.0 110.394 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.472 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.1 t70 -44.5 -37.7 3.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -71.11 -54.19 11.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.699 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 1.013 ' SD ' HD13 ' A' ' 24' ' ' LEU . 10.6 ttm -72.65 -3.7 26.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.553 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.653 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.9 tm? -75.81 -59.04 2.93 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.87 0.843 . . . . 0.0 108.975 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 65' ' ' ASP . 1.3 pp -78.48 1.01 23.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.246 0.546 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.53 9.32 27.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 111.446 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.021 HG12 HG11 ' B' ' 122' ' ' VAL . 1.6 t -135.73 2.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.866 -1.146 . . . . 0.0 109.809 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.103 HD11 HD12 ' A' ' 74' ' ' LEU . 3.5 tp -149.86 75.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.4 t70 -77.84 57.47 1.71 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 108.26 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.114 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 8.0 mt . . . . . 0 C--N 1.305 -1.348 0 CA-C-O 121.716 0.769 . . . . 0.0 110.727 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 4.0 mt . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.1 0.476 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 14.0 t 61.07 128.91 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.4 ' CG ' HG22 ' B' ' 223' ' ' ILE . 44.5 Cg_endo -71.76 120.42 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.894 1.47 . . . . 0.0 110.193 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.48 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 90.5 m -89.68 135.11 33.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.59 HD22 ' CG2' ' B' ' 160' ' ' ILE . 32.4 mt -69.91 123.85 22.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 110.064 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.485 ' HA ' ' HD3' ' B' ' 127' ' ' LYS . 1.4 mm-40 -109.31 -7.1 15.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.479 ' ND2' ' HA2' ' A' ' 26' ' ' GLY . 4.1 t-20 -164.43 156.72 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 23.5 mm -137.47 147.2 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 14.6 t -137.02 138.44 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.05 159.3 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.459 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.09 138.85 44.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.842 . . . . 0.0 109.875 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 92.9 t -135.64 154.65 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.112 -0.992 . . . . 0.0 110.649 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.518 ' HG1' ' CG ' ' B' ' 154' ' ' ASP . 33.6 m -129.7 131.91 46.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 109.932 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.796 HD22 ' HB1' ' B' ' 150' ' ' ALA . 57.4 mt -89.43 -27.65 20.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.38 80.38 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . 0.429 ' SG ' ' HA ' ' B' ' 150' ' ' ALA . 24.8 p -137.12 139.16 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -1.228 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -69.26 152.27 45.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.682 HD11 ' CD1' ' B' ' 76' ' ' LEU . 16.6 mt -131.17 150.92 51.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.352 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' B' ' 82' ' ' LEU . 1.1 t0 -91.12 97.71 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' B' ' 100' ' ' ALA . 13.0 mt -41.16 -36.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.604 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.552 ' O ' HD23 ' B' ' 87' ' ' LEU . 0.0 OUTLIER -62.01 -40.7 96.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 110.475 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 26.7 p -85.83 -39.34 17.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.963 . . . . 0.0 110.425 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.596 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 56.7 t -62.55 -30.17 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 110.083 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.518 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -89.54 -23.93 21.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -0.859 . . . . 0.0 110.12 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.552 HD23 ' O ' ' B' ' 83' ' ' LYS . 1.0 OUTLIER -76.98 -47.98 19.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.32 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -77.28 -39.16 49.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.375 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -50.23 113.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.357 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -26.32 62.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.499 ' ND2' HG22 ' B' ' 106' ' ' ILE . 31.7 p30 -130.11 79.12 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.764 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -161.03 145.81 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.709 ' O ' HD12 ' B' ' 103' ' ' ILE . 12.5 mt-10 -134.85 136.65 42.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.285 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -114.58 110.75 20.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -106.51 112.69 63.65 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.98 -16.56 29.02 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.022 1.538 . . . . 0.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.61 -22.07 24.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 5.3 mpt_? -91.8 -73.28 0.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.675 ' CG ' ' CB ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -153.6 164.14 38.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.43 -0.794 . . . . 0.0 110.253 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -81.7 47.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.889 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.114 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -129.61 146.49 51.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 111.087 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' B' ' 86' ' ' ALA . 20.1 t -93.28 122.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.447 -0.783 . . . . 0.0 108.997 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.709 HD12 ' O ' ' B' ' 93' ' ' GLU . 3.1 mp -89.18 115.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 110.52 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.555 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.4 OUTLIER -97.37 147.97 23.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.966 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.73 95.01 2.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.499 HG22 ' ND2' ' B' ' 91' ' ' ASN . 16.5 pt -94.81 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -129.3 43.89 3.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.456 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.2 tt0 176.47 78.58 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.391 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.474 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.7 Cg_endo -79.66 157.03 89.34 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.455 -0.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 45.8 tttp -65.65 109.41 2.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.888 . . . . 0.0 109.945 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.462 HG22 ' C ' ' B' ' 125' ' ' GLY . 1.3 p -148.29 177.77 9.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.64 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.668 HG22 ' CG2' ' B' ' 124' ' ' THR . 0.4 OUTLIER -130.04 171.5 12.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.434 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -164.19 140.17 6.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.795 -1.191 . . . . 0.0 110.876 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.574 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.4 OUTLIER -105.54 100.02 9.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.422 -0.799 . . . . 0.0 108.849 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.445 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt -89.21 137.31 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.091 -1.006 . . . . 0.0 110.569 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.726 ' CD1' HD11 ' A' ' 74' ' ' LEU . 1.9 m-30 -108.45 166.15 10.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.25 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -53.72 -20.02 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.06 -18.32 16.36 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.25 162.99 18.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -1.166 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.422 ' HB2' HG12 ' B' ' 115' ' ' ILE . 4.0 ptt? -159.97 149.4 17.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.081 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 1.021 HG11 HG12 ' A' ' 71' ' ' VAL . 21.0 t -112.74 135.1 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.39 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.577 HG13 ' HE2' ' B' ' 139' ' ' TYR . 16.8 t -110.22 148.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 109.882 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.854 HG23 ' CB ' ' A' ' 27' ' ' ASN . 3.5 t -156.11 162.51 40.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.788 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.556 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 112.65 -37.1 3.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.72 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -46.1 160.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -1.142 . . . . 0.0 110.256 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' B' ' 68' ' ' GLN . 1.3 mmmt -115.92 -2.31 12.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.193 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.473 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.5 OUTLIER -158.78 162.85 37.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.24 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.91 -31.79 67.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.34 -50.95 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.11 -44.13 97.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.904 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . 0.539 ' HB2' HG21 ' B' ' 70' ' ' ILE . 46.6 t -53.7 -47.45 70.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.964 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -54.85 -46.74 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.39 -52.76 29.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.304 -0.872 . . . . 0.0 110.033 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.405 ' O ' ' C ' ' B' ' 137' ' ' ARG . 1.6 p -71.65 -60.08 2.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.592 ' HD2' ' CE2' ' B' ' 152' ' ' PHE . 4.7 mtp180 -43.54 -46.22 6.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -51.38 65.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.098 -1.001 . . . . 0.0 109.966 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.577 ' HE2' HG13 ' B' ' 123' ' ' VAL . 15.4 m-85 -50.33 -48.8 55.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 109.863 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.24 -24.86 67.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.821 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -71.0 -31.44 67.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 110.064 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 146' ' ' ILE . 23.1 mt -69.64 -47.02 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.647 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.7 mp -65.3 -49.52 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 1.5 mt-30 -64.39 -39.34 93.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.025 -1.047 . . . . 0.0 110.017 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -68.23 -21.68 64.82 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' B' ' 143' ' ' ILE . 9.2 mt -81.15 -24.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.52 -35.34 2.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.546 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 13.5 m-85 -51.03 165.86 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.138 -1.213 . . . . 0.0 110.89 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.99 48.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.674 -0.641 . . . . 0.0 109.975 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.796 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -71.55 134.88 46.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.27 -153.9 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.592 ' CE2' ' HD2' ' B' ' 137' ' ' ARG . 22.3 t80 -149.46 78.3 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.267 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' B' ' 154' ' ' ASP . 1.1 p -141.66 179.55 6.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.518 ' CG ' ' HG1' ' B' ' 75' ' ' THR . 8.7 t0 66.31 13.93 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.952 . . . . 0.0 110.351 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -66.76 136.72 55.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.887 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -168.57 124.12 0.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.584 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.7 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.475 ' HA ' ' HG3' ' B' ' 218' ' ' LYS . 1.6 mt-30 -122.98 -11.86 8.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.036 . . . . 0.0 111.042 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.494 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.2 t30 -136.69 130.4 32.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.082 . . . . 0.0 111.061 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.59 ' CG2' HD22 ' B' ' 67' ' ' LEU . 7.9 mt -129.56 122.53 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 58.1 t -94.27 125.58 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -131.51 162.99 23.75 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 93.4 p -164.4 151.08 11.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.099 -1.236 . . . . 0.0 110.403 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.425 ' HB2' HG22 ' B' ' 63' ' ' ILE . 26.5 p -167.59 146.75 4.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.236 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 11.4 p-10 -91.26 163.36 14.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -102.43 -71.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 165.43 -23.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.72 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' B' ' 168' ' ' PHE . 16.2 p90 -136.32 163.18 51.88 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.6 Cg_endo -72.04 142.09 37.73 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.8 1.421 . . . . 0.0 110.555 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.702 HD12 ' HA2' ' B' ' 210' ' ' GLY . 3.8 mt -101.83 149.82 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.32 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.58 98.5 10.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.775 HD11 HG23 ' B' ' 208' ' ' VAL . 91.4 mt -56.9 -30.01 63.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 110.391 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -49.1 33.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.882 . . . . 0.0 110.419 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.79 -28.78 68.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' B' ' 175' ' ' LEU . 0.1 OUTLIER -71.19 -44.94 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 0.0 110.195 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.63 -13.77 59.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.024 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.22 -34.71 37.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.778 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . 0.404 ' HB2' ' CZ ' ' B' ' 237' ' ' PHE . 0.3 OUTLIER -100.03 -35.08 9.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.785 . . . . 0.0 109.888 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' B' ' 183' ' ' SER . 34.0 m170 -115.63 37.51 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.351 -0.843 . . . . 0.0 110.135 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.56 -9.96 82.4 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 7.0 t -76.11 -24.79 54.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -1.197 . . . . 0.0 110.061 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.435 ' CE2' HG22 ' B' ' 198' ' ' VAL . 0.2 OUTLIER -127.81 -2.44 5.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 1.017 ' OG ' HD21 ' B' ' 193' ' ' LEU . 0.9 OUTLIER -114.97 140.99 48.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.107 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 3.8 t -111.56 136.75 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -145.32 91.28 2.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -108.44 110.21 61.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.89 1.08 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.959 1.505 . . . . 0.0 110.462 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.9 -13.92 28.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.644 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.1 tt -155.71 16.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.278 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.563 ' CE2' HD21 ' A' ' 59' ' ' LEU . 1.7 t80 -170.18 106.16 0.44 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.762 -1.211 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . 0.466 ' HG3' ' CD ' ' A' ' 51' ' ' GLU . 45.5 Cg_endo -73.85 -23.41 16.5 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.987 1.519 . . . . 0.0 110.238 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.93 -179.88 42.96 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 1.017 HD21 ' OG ' ' B' ' 183' ' ' SER . 1.9 tt -115.11 146.69 41.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.787 HG12 HD21 ' B' ' 205' ' ' LEU . 77.0 mt -113.45 103.82 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 109.943 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.5 t80 -102.14 118.21 36.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.892 . . . . 0.0 110.351 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.876 ' HD3' HG22 ' B' ' 203' ' ' VAL . 3.3 tpp85 -92.41 92.72 8.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 56.4 tpp -50.8 125.65 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.354 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.435 HG22 ' CE2' ' B' ' 182' ' ' PHE . 30.8 t -64.23 -43.31 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.292 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 21.6 tttm -149.43 117.16 3.72 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.7 Cg_endo -72.89 166.96 79.81 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.916 -2.118 . . . . 0.0 110.304 -0.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.455 ' O ' ' CG1' ' B' ' 202' ' ' ILE . 4.9 mttm -75.35 108.38 8.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.755 ' CD1' ' HB2' ' B' ' 217' ' ' ALA . 13.3 mt -154.67 151.76 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.876 HG22 ' HD3' ' B' ' 196' ' ' ARG . 20.0 t -96.98 127.71 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 109.991 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 2.3 mp -112.53 125.7 54.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.787 HD21 HG12 ' B' ' 194' ' ' ILE . 13.1 mt -102.58 120.19 40.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.667 HG23 HD13 ' B' ' 170' ' ' ILE . 12.3 mt -114.84 115.17 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.07 154.84 16.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 110.245 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.775 HG23 HD11 ' B' ' 172' ' ' LEU . 52.9 t -49.98 -35.42 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.52 90.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 110.498 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.702 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 130.93 32.4 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.609 ' C ' HD12 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -95.97 117.08 29.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -1.183 . . . . 0.0 109.828 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.746 HG22 HD11 ' B' ' 214' ' ' LEU . 1.2 mp -107.08 111.14 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.73 HG11 ' HE1' ' A' ' 25' ' ' PHE . 75.9 t -104.91 150.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.928 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.746 HD11 HG22 ' B' ' 212' ' ' ILE . 4.1 mp -142.33 107.96 5.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.549 ' O ' HG23 ' B' ' 202' ' ' ILE . 10.1 t -129.61 157.58 41.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.455 ' HA2' ' OD1' ' B' ' 159' ' ' ASN . . . 102.85 11.75 33.99 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.755 ' HB2' ' CD1' ' B' ' 202' ' ' ILE . . . -91.77 155.1 18.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.31 -1.112 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' B' ' 218' ' ' LYS . 22.4 tttt -104.79 0.71 28.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.375 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.2 137.78 5.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.028 . . . . 0.0 110.432 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 220' ' ' ARG . 10.4 ttm180 -45.18 -26.62 0.5 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -34.03 77.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.989 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.604 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 1.4 mm-40 -67.82 -55.13 14.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' B' ' 217' ' ' ALA . 14.3 mm -51.08 -47.53 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.786 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.05 -27.58 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.778 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.16 -43.4 24.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 110.107 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' B' ' 204' ' ' LEU . . . -60.12 -40.16 88.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.15 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.533 ' HA ' HG22 ' B' ' 230' ' ' ILE . 46.8 t80 -70.28 -42.58 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -20.09 66.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.84 -22.99 18.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 110.318 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' B' ' 227' ' ' PHE . 7.5 tp -100.36 -28.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 30.6 t80 -44.08 -49.52 22.24 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.4 Cg_endo -69.45 -40.49 5.73 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.36 1.189 . . . . 0.0 110.606 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.7 -39.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.881 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.42 HD21 HD13 ' B' ' 206' ' ' ILE . 95.1 mt -64.87 -55.16 21.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.115 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -50.69 -28.81 9.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.95 -32.92 65.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 110.446 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' B' ' 178' ' ' SER . 49.6 m-85 -113.66 41.4 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.393 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -160.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -144.47 -54.73 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.187 -0.946 . . . . 0.0 110.236 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.009 HD23 ' CG1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.806 0.812 . . . . 0.0 110.664 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.729 ' HA ' HD11 ' A' ' 68' ' ' LEU . 5.9 t0 75.5 90.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 111.529 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 18' ' ' LEU . 2.3 mt -107.27 35.45 3.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.787 . . . . 0.0 110.034 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.708 ' OG1' HD23 ' A' ' 68' ' ' LEU . 20.2 m -56.6 -25.45 52.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.595 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -98.24 -27.49 8.69 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.239 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.781 HG13 HD13 ' A' ' 20' ' ' LEU . 14.8 mm -46.46 -46.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.801 -1.411 . . . . 0.0 108.849 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.874 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.1 pp -82.66 -25.65 32.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 109.137 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.013 ' CZ ' HD13 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -90.6 14.65 12.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 135.88 98.32 0.54 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 1.033 ' HB2' HG23 ' B' ' 124' ' ' THR . 25.8 p-10 -33.9 93.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.519 -0.989 . . . . 0.0 111.737 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -90.63 175.57 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 31' ' ' GLU . 21.4 m-20 -87.86 126.19 34.89 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.49 ' HB3' HG12 ' B' ' 103' ' ' ILE . 0.0 OUTLIER -40.13 -25.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -178.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -64.12 -6.81 7.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.986 -1.071 . . . . 0.0 110.408 178.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 102.35 29.43 6.01 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.685 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.511 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -119.44 111.33 17.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.9 -1.353 . . . . 0.0 110.6 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.921 HD13 HD13 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -89.47 149.14 23.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.945 HD11 ' OD1' ' A' ' 27' ' ' ASN . 3.4 pp . . . . . 0 N--CA 1.492 1.643 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.594 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.263 0.554 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -97.13 -20.97 17.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.291 -0.881 . . . . 0.0 109.08 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.614 HD21 ' HZ ' ' B' ' 207' ' ' PHE . 3.5 mt -98.95 -42.66 7.03 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.683 . . . . 0.0 110.094 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.758 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.71 -55.69 18.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.43 -0.794 . . . . 0.0 109.534 -179.522 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -61.79 -14.04 29.18 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.499 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 58' ' ' SER . 3.6 m-20 -92.75 -39.86 11.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.293 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.921 HD13 HD13 ' A' ' 34' ' ' LEU . 2.9 mt -47.7 -41.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 0.0 108.922 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.93 -20.05 12.65 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.422 ' HB3' HD11 ' B' ' 189' ' ' LEU . 50.2 m -113.44 0.64 14.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -1.123 . . . . 0.0 110.371 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 56' ' ' ILE . 29.8 mt -88.91 33.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -115.88 23.15 12.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.391 -0.818 . . . . 0.0 110.501 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.87 50.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -152.19 -29.11 0.16 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.354 -0.841 . . . . 0.0 111.0 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.859 ' H ' HD12 ' A' ' 62' ' ' LEU . . . -175.8 -42.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.869 HD12 HD11 ' A' ' 24' ' ' LEU . 2.8 mm? -69.46 -3.53 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -46.14 -41.8 13.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 110.129 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 p -65.99 -48.83 69.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 0.0 109.907 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.874 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.87 -3.36 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.729 HD11 ' HA ' ' A' ' 19' ' ' ASP . 2.4 tm? -80.6 -60.49 2.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.284 -0.885 . . . . 0.0 109.343 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' C ' HD12 ' A' ' 69' ' ' LEU . 3.5 pp -78.74 0.3 27.36 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.444 0.64 . . . . 0.0 109.794 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.476 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 22.9 tt0 -93.01 10.47 31.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.384 -0.822 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.804 ' HB ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -133.2 -4.26 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 120.954 -1.091 . . . . 0.0 110.072 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.009 ' CG1' HD23 ' A' ' 18' ' ' LEU . 2.6 tp -138.69 74.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.0 t0 -83.34 52.41 2.21 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.034 -1.041 . . . . 0.0 108.615 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.612 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.528 -0.733 . . . . 0.0 111.766 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 5.1 mt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.202 0.525 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 45.4 t 58.77 119.63 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 0.0 110.363 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 44.6 Cg_endo -72.02 137.88 30.0 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.781 1.411 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.479 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 15.8 m -93.31 153.43 18.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 110.437 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 88.2 mt -86.52 133.06 33.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.432 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 2.9 mm-40 -116.06 -19.45 10.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.529 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 4.4 m120 -167.63 167.76 13.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.362 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 9.2 mt -158.11 158.17 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' B' ' 123' ' ' VAL . 61.5 t -134.22 144.42 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 110.351 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.04 155.44 48.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.87 141.56 42.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.725 HG21 ' OG ' ' B' ' 136' ' ' SER . 86.2 t -133.07 135.88 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 0.0 110.211 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -105.71 123.01 47.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.223 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.867 HD22 ' HB1' ' B' ' 150' ' ' ALA . 71.4 mt -78.45 -43.5 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.83 9.71 42.27 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.53 150.24 21.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -1.189 . . . . 0.0 110.359 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.922 ' O ' HD23 ' B' ' 80' ' ' LEU . 9.6 mtp180 -70.65 164.94 23.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.163 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.922 HD23 ' O ' ' B' ' 79' ' ' ARG . 20.6 mt -140.39 160.22 40.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.331 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.3 OUTLIER -96.27 92.46 6.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 1.041 HD22 HG23 ' B' ' 102' ' ' VAL . 13.8 mt -42.35 -46.72 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.26 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 3.8 tptm -52.62 -46.57 67.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.444 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 18.6 p -86.89 -38.96 16.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.441 HG12 HG11 ' B' ' 102' ' ' VAL . 53.6 t -54.26 -37.51 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.798 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.65 -31.84 23.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 14.1 tp -76.8 -27.87 55.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.772 . . . . 0.0 109.97 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -47.62 9.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 110.098 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -48.49 135.86 13.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -71.69 -24.59 61.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 10.1 p30 -136.14 79.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.111 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -151.6 153.56 34.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.389 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' B' ' 93' ' ' GLU . 52.7 mm-40 -134.49 141.54 46.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 110.108 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -134.41 117.79 16.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.5 125.3 26.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.55 -34.13 7.7 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.845 1.445 . . . . 0.0 110.098 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.021 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' B' ' 98' ' ' ARG . 5.6 mpt_? -98.15 -59.76 1.69 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.375 -0.828 . . . . 0.0 110.202 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 1.201 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.57 175.0 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.629 -0.67 . . . . 0.0 111.375 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.41 55.89 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 111.298 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.201 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -147.87 160.23 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 1.041 HG23 HD22 ' B' ' 82' ' ' LEU . 84.6 t -92.61 162.27 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.543 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 30' ' ' SER . 9.9 mt -131.57 125.32 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 109.711 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.85 162.85 12.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -160.01 130.07 5.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 5.6 pt -139.72 167.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.44 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -125.28 37.14 4.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 110.224 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.4 OUTLIER -177.88 80.05 0.23 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.461 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.8 Cg_endo -75.93 165.82 84.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.483 -2.299 . . . . 0.0 110.3 -0.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -78.58 109.47 12.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 110.334 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.563 HG22 ' O ' ' B' ' 124' ' ' THR . 0.2 OUTLIER -157.27 171.33 20.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.908 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.546 HG22 HG23 ' B' ' 124' ' ' THR . 6.5 t -137.12 155.35 49.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -150.8 167.22 28.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.745 HD13 HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -140.86 113.56 8.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 0.0 109.507 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.723 HG23 ' O ' ' B' ' 120' ' ' LYS . 2.9 mp -98.22 149.85 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.432 -0.792 . . . . 0.0 111.02 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.623 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.1 m-85 -95.68 -177.65 4.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.491 -0.756 . . . . 0.0 109.511 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -84.96 -15.65 43.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.728 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . 0.493 ' HA ' ' HG2' ' B' ' 79' ' ' ARG . 66.7 p -73.09 -18.53 61.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.17 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 6.72 22.28 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . 0.723 ' O ' HG23 ' B' ' 115' ' ' ILE . 2.4 mttt -87.85 157.82 18.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -1.168 . . . . 0.0 110.015 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.551 ' CG ' HG13 ' B' ' 115' ' ' ILE . 7.2 tmm? -147.35 133.95 19.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.816 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.786 HG11 HG12 ' A' ' 71' ' ' VAL . 7.0 t -113.68 132.93 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.837 . . . . 0.0 109.759 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.561 HG13 ' HE2' ' B' ' 139' ' ' TYR . 12.7 t -112.96 138.12 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 1.033 HG23 ' HB2' ' A' ' 27' ' ' ASN . 9.0 t -147.02 146.58 30.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.824 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.617 ' N ' ' HB3' ' A' ' 27' ' ' ASN . . . 119.42 -9.51 11.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -75.75 151.45 37.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.218 . . . . 0.0 110.167 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -117.88 -23.32 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.881 . . . . 0.0 110.145 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.1 OUTLIER -123.02 -173.66 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -82.62 -48.68 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.294 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -65.77 -16.58 63.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.63 -46.54 14.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 136' ' ' SER . 2.0 t -65.75 -30.36 71.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.13 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -71.18 -51.27 25.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.3 -50.05 74.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.32 -0.862 . . . . 0.0 110.182 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.611 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -54.99 -46.06 75.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.725 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -60.87 -58.61 7.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 110.05 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.55 -36.94 25.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.761 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -49.66 77.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.561 ' HE2' HG13 ' B' ' 123' ' ' VAL . 25.2 m-85 -58.8 -50.07 75.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 109.97 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.65 71.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.064 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 1.3 mmt85 -60.38 -40.88 92.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 110.039 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' B' ' 139' ' ' TYR . 38.6 mt -54.71 -48.14 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.514 HD13 HD13 ' B' ' 80' ' ' LEU . 57.5 mt -66.56 -49.77 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -61.24 -36.9 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.0 OUTLIER -71.84 -27.58 62.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.1 mt -72.8 -18.54 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.44 -27.07 7.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' B' ' 143' ' ' ILE . 12.1 m-85 -46.79 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.25 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.78 29.97 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.532 -0.73 . . . . 0.0 109.815 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.867 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -66.38 151.59 46.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.513 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.97 107.53 6.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.95 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -53.3 102.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.902 . . . . 0.0 110.308 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.8 p -148.39 172.21 14.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 t0 60.85 15.88 6.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -60.62 134.53 57.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.966 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -170.08 134.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.352 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.96 126.81 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.365 -0.835 . . . . 0.0 109.665 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -115.67 -12.48 11.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.851 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.3 112.05 5.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.054 -1.029 . . . . 0.0 111.047 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' ' 215' ' ' THR . 11.0 mt -105.52 148.48 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 0.0 109.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' B' ' 69' ' ' ASN . 6.4 t -117.09 142.4 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.037 . . . . 0.0 111.079 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -159.9 164.81 34.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.0 OUTLIER -168.49 164.17 12.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.845 -1.385 . . . . 0.0 111.029 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.432 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -170.01 175.81 4.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.846 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -108.03 149.02 28.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.743 HG21 HD11 ' B' ' 170' ' ' ILE . 16.1 m -97.22 4.34 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 110.224 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.69 12.92 6.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.259 -0.901 . . . . 0.0 110.722 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.569 ' CE1' HG13 ' B' ' 170' ' ' ILE . 10.3 p90 -171.43 139.82 1.19 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.133 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.0 Cg_endo -71.31 153.62 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.104 1.581 . . . . 0.0 111.007 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 1.022 HD13 HD22 ' B' ' 234' ' ' LEU . 3.2 mt -125.42 150.65 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -80.25 92.79 5.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.633 HD11 ' HA ' ' B' ' 207' ' ' PHE . 97.9 mt -52.73 -32.38 42.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.406 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.69 -59.82 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.946 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.61 -37.18 33.15 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.566 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.2 OUTLIER -64.89 -53.69 42.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -1.101 . . . . 0.0 109.98 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.46 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -58.1 -20.98 44.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 0.0 110.075 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.66 -56.31 4.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 0.0 109.878 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.7 t -69.9 -46.03 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 0.0 110.043 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -105.89 41.57 1.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.018 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.36 -16.89 63.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 68.0 p -85.82 -31.74 22.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -1.209 . . . . 0.0 110.378 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -104.63 -10.36 17.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.792 ' HB2' HD21 ' B' ' 193' ' ' LEU . 1.2 p -140.88 123.41 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.57 165.89 11.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.866 . . . . 0.0 110.083 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -160.66 126.89 4.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 110.28 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' B' ' 187' ' ' PRO . 81.3 mt-10 -130.97 107.9 15.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.273 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.9 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.996 1.524 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -95.75 4.42 52.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.686 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -159.78 -51.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.686 ' HB2' HD23 ' B' ' 189' ' ' LEU . 26.6 t80 -113.19 109.95 51.41 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 0.0 110.374 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.69 -20.8 22.59 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.975 1.513 . . . . 0.0 110.152 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' B' ' 190' ' ' PHE . . . -90.74 -179.94 43.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' B' ' 183' ' ' SER . 6.0 tt -123.79 131.8 53.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -1.18 . . . . 0.0 110.321 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.837 HD13 HD13 ' A' ' 62' ' ' LEU . 4.6 mt -96.32 111.26 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 20.5 t80 -95.31 111.57 23.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.259 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -94.98 86.85 4.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.562 ' HE1' HG12 ' B' ' 230' ' ' ILE . 20.6 ttm -65.27 135.1 54.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 110.169 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 74.2 t -86.11 -28.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.878 . . . . 0.0 110.307 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' B' ' 199' ' ' LYS . 0.0 OUTLIER -149.4 110.15 3.41 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.432 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.446 ' HB2' ' OE2' ' B' ' 222' ' ' GLU . 48.5 Cg_endo -73.72 171.28 67.23 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.035 -2.069 . . . . 0.0 110.485 -0.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.404 ' C ' HG12 ' B' ' 202' ' ' ILE . 11.8 tptt -74.46 92.57 2.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.87 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' B' ' 217' ' ' ALA . 24.6 mm -140.16 153.63 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.741 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' B' ' 195' ' ' TYR . 48.4 t -114.34 116.69 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.714 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.755 HD22 HG13 ' B' ' 230' ' ' ILE . 3.4 mp -110.71 131.21 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 1.013 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -110.59 122.65 48.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.19 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.51 HG12 HD21 ' B' ' 234' ' ' LEU . 2.8 mp -113.68 145.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.108 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.633 ' HA ' HD11 ' B' ' 172' ' ' LEU . 84.2 m-85 -121.15 156.32 32.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.462 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 12.8 t -47.97 -27.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.421 -0.8 . . . . 0.0 110.137 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 4.7 m -71.54 -31.92 67.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.927 . . . . 0.0 110.303 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.39 5.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.2 OUTLIER -87.77 133.65 33.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' B' ' 163' ' ' SER . 36.5 mm -117.49 132.93 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 25' ' ' PHE . 76.0 t -125.85 114.52 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 110.393 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.69 104.19 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 110.172 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.8 t -132.56 142.29 49.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.953 . . . . 0.0 110.235 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.428 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 108.0 19.21 9.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.827 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -99.99 164.43 12.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.288 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.15 -29.97 8.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.77 154.0 44.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.865 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -53.8 -18.69 3.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -59.44 -45.51 91.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -0.92 . . . . 0.0 110.461 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' B' ' 200' ' ' PRO . 30.6 mt-10 -72.43 -46.4 55.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 13.6 mm -51.57 -44.71 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 110.025 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.462 ' CZ ' HG13 ' B' ' 64' ' ' VAL . 2.2 m-30 -71.38 -48.98 46.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.49 -33.91 73.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 110.446 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.585 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -61.44 -59.77 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.867 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 35.8 t80 -56.27 -26.83 53.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.836 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -32.26 73.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.871 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -94.75 -13.17 25.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.755 HG13 HD22 ' B' ' 204' ' ' LEU . 6.0 mm -96.77 -23.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.36 -0.837 . . . . 0.0 109.83 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.591 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 10.3 t80 -58.43 -42.3 93.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 0.0 110.966 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.2 Cg_endo -76.33 -31.17 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.416 1.219 . . . . 0.0 110.755 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.566 ' CG1' HD11 ' B' ' 175' ' ' LEU . 39.5 t -67.27 -35.89 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 1.022 HD22 HD13 ' B' ' 170' ' ' ILE . 18.3 mt -71.88 -39.72 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.057 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.51 80.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.87 -39.92 91.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.006 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.458 ' HB2' ' CD2' ' B' ' 175' ' ' LEU . 84.4 m-85 -110.04 37.78 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 177.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -121.54 -51.42 2.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 110.094 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.225 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.731 HD21 ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 2.6 m-20 -63.7 71.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.052 -1.03 . . . . 0.0 110.207 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.731 ' CD2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -86.65 8.98 20.09 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.35 -0.844 . . . . 0.0 111.322 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.871 HG22 HG23 ' A' ' 56' ' ' ILE . 10.4 m -54.96 -18.87 5.59 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.467 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.645 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.43 -36.2 4.16 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.573 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 28' ' ' ILE . 1.1 mm -46.68 -47.42 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.802 -1.411 . . . . 0.0 108.985 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.072 HD11 ' CD1' ' A' ' 64' ' ' LEU . 2.0 pp -82.91 -28.06 30.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CE1' ' CD1' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -86.97 8.71 22.07 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.653 ' O ' HG23 ' A' ' 28' ' ' ILE . . . 141.57 98.54 0.33 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.72 ' HB3' HG23 ' B' ' 124' ' ' THR . 0.2 OUTLIER -16.75 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.91 0.862 . . . . 0.0 111.436 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.897 HG22 HD22 ' A' ' 34' ' ' LEU . 2.3 pp -138.07 166.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 121.464 -0.773 . . . . 0.0 109.443 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.743 ' C ' HD12 ' A' ' 28' ' ' ILE . 80.6 m-20 -87.11 116.71 25.35 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.529 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -36.28 -28.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.484 0.659 . . . . 0.0 110.157 -177.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.9 tt0 -57.04 -13.03 2.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 110.544 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.28 24.37 5.7 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.052 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.565 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -109.83 124.23 50.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -1.155 . . . . 0.0 109.235 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.03 HD13 ' N ' ' A' ' 35' ' ' LEU . 3.2 tm? -87.55 150.57 23.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 111.066 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 1.03 ' N ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 111.23 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.211 0.529 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.7 tt0 -93.42 -33.7 13.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.533 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 1.8 mt -90.97 -41.2 11.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.361 -0.837 . . . . 0.0 110.064 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.974 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.51 -50.26 17.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.54 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.29 -29.48 68.27 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.702 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.53 ' C ' HD23 ' A' ' 59' ' ' LEU . 8.4 m-80 -77.82 -40.58 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.974 HD12 ' HA ' ' A' ' 53' ' ' ARG . 23.0 mt -49.97 -47.38 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.32 0.07 69.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.33 -46.57 3.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -1.143 . . . . 0.0 110.437 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.785 HD22 ' CE2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -85.98 44.54 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 0.0 110.421 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -84.86 22.36 1.39 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.739 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.447 ' C ' HD23 ' A' ' 62' ' ' LEU . 1.8 pttt -152.68 8.04 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 111.195 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 62' ' ' LEU . 3.0 mt -86.37 -34.68 20.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.621 -1.299 . . . . 0.0 109.852 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.48 -35.25 0.04 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.072 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.8 mm? -56.92 -28.25 61.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -1.171 . . . . 0.0 110.709 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' LEU . 11.5 t0 -43.67 -38.67 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.471 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.0 m -70.73 -51.01 30.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.374 -0.828 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.827 ' HG2' HD13 ' A' ' 24' ' ' LEU . 3.5 tpp -65.38 -12.73 55.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -72.69 -64.03 1.04 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 109.719 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -60.85 -12.15 10.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.583 -0.698 . . . . 0.0 110.022 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.62 2.69 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.065 HG12 HG11 ' B' ' 122' ' ' VAL . 1.5 t -140.04 3.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.046 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 72' ' ' ILE . 2.6 tp -148.64 67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.396 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 11.1 t0 -77.1 53.54 0.98 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.975 -1.078 . . . . 0.0 109.359 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.959 HD11 ' CE1' ' B' ' 116' ' ' PHE . 1.5 mt . . . . . 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' B' ' 64' ' ' VAL . 2.9 mp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.155 0.502 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' B' ' 63' ' ' ILE . 91.5 t 58.03 119.62 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 110.25 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.604 ' HG2' HG22 ' B' ' 223' ' ' ILE . 43.4 Cg_endo -71.13 134.46 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.793 1.417 . . . . 0.0 110.407 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.6 m -96.82 137.5 35.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.379 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' B' ' 161' ' ' VAL . 33.2 mt -70.67 139.36 51.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -126.48 -5.64 6.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.655 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.478 ' ND2' ' C ' ' B' ' 69' ' ' ASN . 0.4 OUTLIER -168.41 124.53 1.0 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.0 -1.063 . . . . 0.0 110.755 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' B' ' 124' ' ' THR . 11.5 mm -108.89 147.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 109.311 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 25.5 t -134.61 135.7 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.956 -1.09 . . . . 0.0 110.456 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -141.52 155.43 45.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.316 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 60.6 m -104.47 126.93 52.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.227 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 t -126.67 138.54 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.926 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 9.5 m -109.65 145.86 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.553 ' CD1' HD11 ' B' ' 80' ' ' LEU . 59.3 mt -96.53 -30.13 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 109.751 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' B' ' 78' ' ' CYS . . . 80.52 32.48 34.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' B' ' 77' ' ' GLY . 1.2 m -166.29 164.88 17.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 110.273 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.811 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -91.82 152.71 20.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.113 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.811 HD23 ' O ' ' B' ' 79' ' ' ARG . 22.5 mt -138.95 163.88 31.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.422 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 2.8 t70 -108.74 97.92 7.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.526 -0.734 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.46 HD22 HG23 ' B' ' 102' ' ' VAL . 14.3 mt -40.94 -35.78 0.57 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -48.2 73.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 60.8 m -66.18 -37.78 86.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.622 HG12 HG11 ' B' ' 102' ' ' VAL . 22.7 t -72.88 -46.12 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.978 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.71 -13.01 61.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tp -99.27 -29.64 12.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.857 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.2 OUTLIER -99.81 -20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.285 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -61.74 151.65 33.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.144 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -85.65 -37.8 19.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.219 -0.926 . . . . 0.0 110.195 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -131.38 78.76 1.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.593 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -146.92 160.51 42.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.865 . . . . 0.0 110.725 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.533 ' O ' HD12 ' B' ' 103' ' ' ILE . 3.0 mt-10 -137.35 157.62 46.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 109.939 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -147.44 101.48 3.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.222 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.539 ' O ' ' HG3' ' B' ' 98' ' ' ARG . 1.5 m-20 -109.86 121.16 42.8 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.63 -10.83 20.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.704 1.37 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -87.21 10.74 16.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 111.155 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 95' ' ' ASN . 1.0 OUTLIER -139.68 -43.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.826 -1.172 . . . . 0.0 110.799 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.698 ' CD2' ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -170.35 168.89 7.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.25 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.39 55.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.83 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -136.24 158.51 44.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 111.155 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.622 HG11 HG12 ' B' ' 85' ' ' VAL . 49.0 t -102.58 122.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.473 -0.767 . . . . 0.0 109.184 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.695 HD12 ' H ' ' B' ' 103' ' ' ILE . 3.6 mp -89.36 109.18 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.471 ' SD ' HD11 ' B' ' 115' ' ' ILE . 3.2 ttm -91.57 160.89 15.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.2 112.0 3.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.989 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.676 HD11 ' OG1' ' B' ' 111' ' ' THR . 44.5 pt -101.91 167.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -125.64 33.08 5.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 3.3 tt0 -178.89 83.35 0.22 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.5 Cg_endo -78.79 151.44 88.32 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.786 -2.173 . . . . 0.0 110.33 -0.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.455 ' C ' HG23 ' B' ' 111' ' ' THR . 7.1 mttt -61.53 110.15 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.8 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.676 ' OG1' HD11 ' B' ' 106' ' ' ILE . 74.0 p -148.57 175.17 11.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.582 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.0 OUTLIER -126.67 162.81 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.755 . . . . 0.0 109.416 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -156.35 133.4 10.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.805 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.2 OUTLIER -97.92 105.8 18.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.471 HD11 ' SD ' ' B' ' 104' ' ' MET . 9.7 mt -90.78 140.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.957 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.959 ' CE1' HD11 ' A' ' 74' ' ' LEU . 1.4 m-85 -111.31 159.42 17.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.585 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -77.94 -4.59 47.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 45.7 p -83.47 -15.2 50.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.45 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 114.02 -18.66 18.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -84.11 154.32 23.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 110.009 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 50.9 ttp -149.42 149.2 30.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.958 . . . . 0.0 110.333 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 1.065 HG11 HG12 ' A' ' 71' ' ' VAL . 7.3 t -116.21 141.18 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 109.723 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 22.9 t -114.12 157.18 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 110.789 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 27' ' ' ASN . 14.6 t -167.73 147.76 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.652 -0.655 . . . . 0.0 109.433 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.546 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 123.09 -25.97 6.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -66.18 160.59 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -1.207 . . . . 0.0 110.336 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -120.15 4.38 10.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 131' ' ' ASP . 0.5 OUTLIER -158.1 162.55 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.361 -0.837 . . . . 0.0 110.034 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -56.12 -48.65 75.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 110.178 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.57 -29.27 70.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.375 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' B' ' 128' ' ' SER . 88.7 m-20 -65.81 -60.75 2.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.42 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 60.3 p -61.68 -33.31 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -44.64 75.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 110.23 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.78 -54.16 6.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.408 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.96 -39.64 9.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.978 . . . . 0.0 109.829 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.8 m -63.1 -56.3 18.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -54.06 -32.94 56.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.841 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' B' ' 138' ' ' LYS . 9.3 mptt -69.14 -42.09 76.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.952 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.834 ' HA ' HD12 ' B' ' 142' ' ' ILE . 22.3 m-85 -61.98 -47.66 83.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.15 75.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.933 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.65 -40.92 88.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' B' ' 139' ' ' TYR . 59.0 mt -54.02 -45.79 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.593 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' B' ' 150' ' ' ALA . 21.0 mm -65.37 -46.83 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' B' ' 150' ' ' ALA . 29.4 mt-30 -66.63 -28.79 68.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.845 . . . . 0.0 109.525 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -23.37 55.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 1.5 mt -81.47 -25.02 10.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.13 -32.66 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' B' ' 80' ' ' LEU . 12.5 m-85 -46.62 162.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.247 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.93 44.48 1.03 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.608 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -81.44 154.56 26.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 -166.55 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.845 ' O ' HG23 ' B' ' 153' ' ' THR . 73.3 t80 -129.87 118.38 21.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -0.975 . . . . 0.0 110.141 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.6 OUTLIER -167.8 174.0 7.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.529 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.463 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 4.0 m-20 52.15 42.48 30.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.614 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 155' ' ' PHE . 8.4 t80 -90.13 132.71 35.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.9 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.33 134.84 1.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 110.39 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 4.4 mt -78.9 124.24 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.72 -4.11 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.506 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 28.6 t-20 -152.8 131.46 12.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.86 -1.15 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.572 HG22 ' N ' ' B' ' 161' ' ' VAL . 7.0 mt -124.37 171.55 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.508 -0.745 . . . . 0.0 109.672 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.644 HG22 ' OG1' ' B' ' 215' ' ' THR . 72.8 t -144.11 128.89 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.053 . . . . 0.0 110.884 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -134.02 165.18 24.37 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.8 t -165.45 149.85 8.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.028 -1.277 . . . . 0.0 110.37 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.0 OUTLIER -170.2 173.99 5.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.281 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -113.92 168.83 9.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.598 HG12 ' HE1' ' B' ' 231' ' ' TYR . 0.0 OUTLIER -112.74 -80.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.279 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.456 ' H ' HG23 ' B' ' 166' ' ' VAL . 4.7 tmtt? 177.96 -27.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.019 -1.051 . . . . 0.0 110.682 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.477 ' HB2' ' OXT' ' B' ' 240' ' ' MET . 13.7 p90 -131.29 158.09 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.981 . . . . 0.0 109.705 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.8 Cg_endo -72.74 152.71 53.33 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.85 1.447 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.472 HD13 HD22 ' B' ' 234' ' ' LEU . 4.0 mt -119.84 158.08 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.503 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . 0.467 ' NE ' ' HG3' ' B' ' 239' ' ' LYS . 6.5 mtt-85 -95.82 99.27 11.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 45.9 mt -50.08 -33.03 17.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 174' ' ' GLY . 4.3 mt-10 -68.08 -56.38 9.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.165 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' B' ' 173' ' ' GLU . . . -44.35 -30.25 1.95 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.856 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.2 OUTLIER -80.86 -59.04 2.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 110.254 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' B' ' 185' ' ' TYR . . . -54.14 -24.39 17.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.47 -46.82 18.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.046 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 5.0 t -79.63 -58.43 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.571 ' HE1' HG22 ' B' ' 233' ' ' VAL . 16.5 m170 -92.63 36.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.48 -13.54 37.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.97 -14.64 38.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -1.2 . . . . 0.0 110.306 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 -6.37 8.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.276 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.674 ' HB2' HD21 ' B' ' 193' ' ' LEU . 82.6 p -133.66 164.19 27.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . 0.471 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 14.7 m -135.13 147.43 49.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.98 . . . . 0.0 110.07 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' B' ' 176' ' ' ALA . 16.1 t80 -133.77 115.98 15.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.163 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 190' ' ' PHE . 9.3 mm-40 -115.87 92.75 35.59 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.89 -9.91 26.62 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.993 1.522 . . . . 0.0 110.356 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -9.57 21.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 110.053 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.632 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.7 tt -153.08 19.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.785 ' CE2' HD22 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -170.07 113.54 0.48 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.992 . . . . 0.0 110.317 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -37.28 4.96 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.048 1.552 . . . . 0.0 110.552 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -91.32 179.32 42.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' B' ' 183' ' ' SER . 3.1 tt -116.32 138.64 51.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.121 . . . . 0.0 110.225 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.469 HD11 ' CE2' ' B' ' 190' ' ' PHE . 25.1 mt -93.51 111.06 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -101.35 117.21 34.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.12 89.24 7.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.378 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.403 ' HB2' HD13 ' B' ' 204' ' ' LEU . 52.0 tpp -53.22 128.44 27.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.6 -47.28 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.29 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.5 OUTLIER -146.28 123.83 6.09 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.941 . . . . 0.0 110.246 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.8 Cg_endo -73.44 155.2 99.8 Favored 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.891 -2.129 . . . . 0.0 110.321 -0.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.482 ' O ' HG13 ' B' ' 202' ' ' ILE . 16.2 tttt -56.64 112.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.482 HG13 ' O ' ' B' ' 201' ' ' LYS . 4.7 mt -158.58 154.72 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 0.0 110.471 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.6 114.99 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.479 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.538 ' N ' HD12 ' B' ' 204' ' ' LEU . 6.2 mp -101.53 135.09 43.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 110.95 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' B' ' 205' ' ' LEU . 0.9 OUTLIER -103.24 119.14 38.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 109.535 179.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 13.7 mm -105.16 147.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 0.0 110.566 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.521 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 21.0 m-85 -132.53 141.14 48.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.063 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.607 HG23 ' H ' ' B' ' 209' ' ' SER . 0.8 OUTLIER -46.48 -54.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 110.105 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.607 ' H ' HG23 ' B' ' 208' ' ' VAL . 68.2 m -39.2 -36.9 0.36 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.317 0.579 . . . . 0.0 110.187 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 118.01 24.23 3.36 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.528 ' O ' HD13 ' B' ' 212' ' ' ILE . 1.9 mttm -97.53 134.61 40.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -1.223 . . . . 0.0 110.099 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 211' ' ' LYS . 15.8 mm -119.82 138.45 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 59.6 t -128.41 132.32 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.233 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.48 ' HB2' HD12 ' B' ' 223' ' ' ILE . 2.6 mp -118.77 119.14 33.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 110.16 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.644 ' OG1' HG22 ' B' ' 161' ' ' VAL . 12.6 t -139.0 157.67 45.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 110.241 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.71 14.38 55.34 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.659 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -83.92 144.42 29.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -1.09 . . . . 0.0 110.276 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -81.44 -7.28 59.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.567 ' C ' HD12 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -169.37 -176.69 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -73.98 -45.42 50.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.449 ' HG3' ' OE1' ' B' ' 222' ' ' GLU . 24.0 pt-20 -49.74 -32.76 14.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.659 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 8.7 mm-40 -61.17 -49.14 78.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.942 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.604 HG22 ' HG2' ' B' ' 65' ' ' PRO . 47.8 mm -59.43 -36.14 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -65.28 -35.54 81.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.47 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -82.08 -41.46 20.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.418 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.84 -34.4 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 110.247 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.685 ' HA ' HG22 ' B' ' 230' ' ' ILE . 18.1 t80 -76.18 -49.45 17.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.366 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -23.04 40.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.479 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.18 -24.78 19.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.992 . . . . 0.0 110.255 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' B' ' 227' ' ' PHE . 6.6 tp -100.28 -17.98 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.341 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.632 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.6 t80 -55.1 -43.63 99.17 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 111.144 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -72.87 -42.68 1.01 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.312 1.164 . . . . 0.0 110.343 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.856 ' CG1' HD11 ' B' ' 175' ' ' LEU . 40.6 t -53.97 -42.69 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.972 . . . . 0.0 109.682 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.472 HD22 HD13 ' B' ' 170' ' ' ILE . 81.9 mt -65.01 -58.16 6.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 109.966 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -52.9 -30.94 37.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.035 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.71 -36.85 84.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.441 ' CD2' HD22 ' B' ' 175' ' ' LEU . 94.8 m-85 -113.04 41.47 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' B' ' 235' ' ' SER . 1.5 ptt180 -74.56 -176.14 2.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.499 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 6.2 ttmt -125.33 -29.46 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 109.979 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . 0.477 ' OXT' ' HB2' ' B' ' 168' ' ' PHE . 10.8 mtp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.139 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.97 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 121.033 0.444 . . . . 0.0 109.974 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.442 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 4.8 t70 -76.1 96.27 3.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.049 -1.032 . . . . 0.0 111.1 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.043 HD13 HG21 ' A' ' 23' ' ' ILE . 2.0 mt -99.06 12.2 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.078 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.718 HG23 HG23 ' A' ' 56' ' ' ILE . 1.3 t -40.93 -33.63 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.635 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.51 -31.55 6.38 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.043 HG21 HD13 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -47.39 -44.38 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.685 -1.479 . . . . 0.0 109.084 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.68 HD21 ' CD2' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -82.84 -22.56 34.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.022 -1.049 . . . . 0.0 109.0 178.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.594 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -92.77 11.09 28.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 143.64 98.67 0.28 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.995 ' OD1' HD11 ' A' ' 35' ' ' LEU . 12.7 p-10 -30.73 90.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.05 0.928 . . . . 0.0 111.832 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.631 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -92.6 164.16 2.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 28' ' ' ILE . 26.0 m-20 -85.59 123.85 31.47 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.698 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -37.03 -29.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.363 0.601 . . . . 0.0 109.825 -178.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.9 tt0 -54.85 -16.13 2.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.09 27.97 4.61 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.589 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -123.27 126.41 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.998 -1.295 . . . . 0.0 110.557 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.86 HD13 HD13 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -98.95 155.34 17.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.688 -1.257 . . . . 0.0 110.645 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.995 HD11 ' OD1' ' A' ' 27' ' ' ASN . 3.3 pp . . . . . 0 N--CA 1.493 1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.117 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.286 0.565 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 41.8 tt0 -100.59 -29.86 12.1 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.633 HD21 ' CD1' ' B' ' 205' ' ' LEU . 3.4 mt -98.58 -45.31 6.13 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 110.009 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -45.04 -49.05 11.7 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.763 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -64.14 -20.7 66.17 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.719 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 76.5 m-20 -91.34 -38.12 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.653 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.86 HD13 HD13 ' A' ' 34' ' ' LEU . 3.2 mt -47.71 -43.49 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.95 -17.18 28.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.7 OUTLIER -138.39 35.54 2.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -1.195 . . . . 0.0 110.468 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.065 ' CD2' HD11 ' A' ' 62' ' ' LEU . 12.2 mt -102.58 21.18 15.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.159 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.11 45.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.548 ' C ' HD23 ' A' ' 62' ' ' LEU . 21.7 ttpt -150.28 15.84 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.065 HD11 ' CD2' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -93.75 -31.83 14.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.28 -0.888 . . . . 0.0 109.768 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.53 1.77 7.64 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.949 HD12 HD21 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -95.28 0.19 53.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.2 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.539 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 22.6 m-20 -46.2 -41.93 13.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.662 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.666 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -60.61 -35.36 75.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.894 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.526 ' HE3' ' HB2' ' A' ' 64' ' ' LEU . 4.9 ttp -69.0 -18.98 64.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.949 HD21 HD12 ' A' ' 64' ' ' LEU . 7.4 mt -71.96 -60.18 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.526 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 66' ' ' SER . 2.7 pp -62.61 -9.02 7.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -85.58 5.74 30.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.124 -0.985 . . . . 0.0 110.619 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.866 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.7 OUTLIER -132.49 0.93 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.756 179.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.956 ' HB ' HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -150.94 66.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.3 p-10 -76.72 54.67 0.99 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.622 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.932 ' CD2' ' HB2' ' B' ' 101' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.751 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.552 HG22 ' N ' ' B' ' 64' ' ' VAL . 92.4 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.212 0.53 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.552 ' N ' HG22 ' B' ' 63' ' ' ILE . 91.4 t -143.2 139.55 16.79 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.41 ' HD2' HG13 ' B' ' 64' ' ' VAL . 46.2 Cg_endo -73.12 122.57 8.16 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 67.7 m -91.07 132.38 36.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.507 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.848 HD11 ' HD2' ' B' ' 220' ' ' ARG . 34.2 mt -70.27 133.82 47.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 109.89 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -121.18 -15.99 8.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.662 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.448 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -161.38 119.53 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.595 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.951 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 13.8 mm -104.25 157.07 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 30.8 t -135.9 136.85 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.8 166.29 28.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.208 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . 0.701 HG23 HG22 ' B' ' 122' ' ' VAL . 0.0 OUTLIER -119.01 151.93 37.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.51 151.3 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.292 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -118.34 142.35 47.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.022 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.789 HD13 ' HB1' ' B' ' 150' ' ' ALA . 49.4 mt -89.84 -61.1 1.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.77 4.75 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 1.3 m -162.3 151.28 15.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -1.172 . . . . 0.0 110.167 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.761 ' O ' HD23 ' B' ' 80' ' ' LEU . 18.1 ttp85 -71.46 155.55 40.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' B' ' 76' ' ' LEU . 44.6 mt -138.07 148.91 45.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 29.9 t70 -89.81 95.59 10.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.013 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.453 HD22 HG23 ' B' ' 102' ' ' VAL . 14.5 mt -42.68 -48.61 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.181 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -46.13 61.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.864 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 9.0 m -76.46 -48.37 19.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.445 HG22 ' CE2' ' B' ' 148' ' ' PHE . 95.8 t -54.62 -50.42 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.236 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.08 -20.54 64.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 110.005 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.27 -37.62 15.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.246 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.71 -26.78 29.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.485 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -65.31 140.27 58.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 110.375 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -76.07 -27.05 57.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.402 -0.811 . . . . 0.0 109.983 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 0.7 OUTLIER -132.54 79.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.946 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.818 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -163.89 167.75 20.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.407 ' O ' HD12 ' B' ' 103' ' ' ILE . 17.3 pt-20 -161.27 141.04 10.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 110.135 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.405 ' HB2' HG22 ' B' ' 102' ' ' VAL . 30.3 t80 -114.06 105.4 13.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.274 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -102.67 105.35 43.98 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.73 -16.58 33.48 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.986 1.519 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -73.07 -27.54 61.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.811 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.71 -72.09 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.986 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.656 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -138.55 -177.28 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.31 44.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.116 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . . . -131.18 165.02 24.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 110.563 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.453 HG23 HD22 ' B' ' 82' ' ' LEU . 57.9 t -102.97 123.64 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.354 -0.841 . . . . 0.0 109.586 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.5 mp -89.29 122.47 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.865 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.818 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 9.8 ttm -115.81 166.09 12.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 110.514 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' B' ' 111' ' ' THR . 3.9 ttt85 -164.71 118.98 1.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 12.9 pt -112.71 170.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 110.376 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.89 38.16 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.808 . . . . 0.0 109.799 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.2 tt0 -174.17 79.33 0.36 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.507 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 53.0 Cg_endo -83.65 162.47 70.67 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.795 -2.169 . . . . 0.0 110.444 -0.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.569 ' O ' HG23 ' B' ' 111' ' ' THR . 21.5 mttt -61.81 106.7 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.933 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.569 HG23 ' O ' ' B' ' 110' ' ' LYS . 20.7 p -156.45 173.33 17.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.607 HG22 HG23 ' B' ' 124' ' ' THR . 0.4 OUTLIER -121.97 -179.51 4.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.357 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.674 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -167.19 122.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 0.0 111.218 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.638 HD22 HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -89.87 103.29 15.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 178.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.442 ' HA ' ' HB3' ' B' ' 121' ' ' MET . 15.8 mt -91.05 141.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 111.468 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.898 ' CE1' HD11 ' A' ' 74' ' ' LEU . 1.8 m-85 -110.6 151.46 27.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.46 66.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.295 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 p -71.04 -3.94 22.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.38 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.18 -28.36 16.27 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -73.2 163.99 27.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -1.068 . . . . 0.0 110.099 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.442 ' HB3' ' HA ' ' B' ' 115' ' ' ILE . 0.0 OUTLIER -167.44 176.02 6.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.274 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.866 HG21 ' O ' ' A' ' 71' ' ' VAL . 9.3 t -132.15 160.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.623 HG13 ' HE2' ' B' ' 139' ' ' TYR . 81.8 t -140.46 131.79 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.386 -0.821 . . . . 0.0 110.049 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.76 HG23 ' CB ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -142.15 173.28 11.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.559 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 100.33 -18.82 54.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.951 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -54.81 162.77 1.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -1.158 . . . . 0.0 110.456 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.46 13.33 16.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.192 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.66 -164.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.452 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.76 -43.91 16.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.17 -28.94 69.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.42 -53.41 12.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 110.187 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 88.8 p -49.97 -37.37 32.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.356 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -66.71 -40.41 88.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.298 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' B' ' 138' ' ' LYS . 0.3 OUTLIER -70.85 -50.65 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.342 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' B' ' 109' ' ' PRO . . . -53.21 -34.46 57.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.4 m -68.71 -56.52 7.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -48.08 -37.0 14.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.97 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.475 ' O ' HG12 ' B' ' 142' ' ' ILE . 9.8 mmtp -59.6 -51.62 69.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 26.2 m-85 -58.3 -54.72 43.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . 0.425 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.54 -24.42 8.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 109.83 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.509 ' HG2' ' HE3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -79.23 -39.66 32.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.976 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.475 HG12 ' O ' ' B' ' 138' ' ' LYS . 25.1 mm -54.03 -47.34 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.881 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.754 HD13 HD13 ' B' ' 80' ' ' LEU . 51.0 mt -71.59 -41.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.452 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 27.5 mt-30 -68.25 -38.92 82.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.852 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.509 ' HE3' ' HG2' ' B' ' 141' ' ' ARG . 0.5 OUTLIER -70.44 -20.74 62.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.9 mt -81.99 -16.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 111.75 -23.03 18.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.702 ' CB ' HG22 ' B' ' 143' ' ' ILE . 8.6 m-85 -50.13 176.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 110.859 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.67 42.64 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.735 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.789 ' HB1' HD13 ' B' ' 76' ' ' LEU . . . -88.23 125.94 34.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.596 ' O ' HD23 ' B' ' 76' ' ' LEU . 0.0 OUTLIER -100.73 -152.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.887 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.546 ' O ' HG23 ' B' ' 153' ' ' THR . 18.9 t80 -151.33 110.91 4.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.546 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.0 OUTLIER -165.26 -173.4 2.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 110.319 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.04 27.81 7.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.399 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' B' ' 73' ' ' THR . 10.6 t80 -74.06 136.63 43.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 109.92 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.06 133.98 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.978 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 31.9 mt -79.84 135.29 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.401 ' HA ' ' HG2' ' B' ' 218' ' ' LYS . 31.9 mm-40 -121.77 -18.87 6.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 110.516 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.543 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 2.7 t-20 -142.69 130.53 21.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.138 -0.976 . . . . 0.0 110.622 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' B' ' 217' ' ' ALA . 32.5 mt -120.47 142.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.637 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.791 HG22 ' OG1' ' B' ' 215' ' ' THR . 94.7 t -116.5 125.72 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.38 171.01 18.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.2 OUTLIER -162.35 146.33 11.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -1.223 . . . . 0.0 110.427 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 7.7 p -168.94 159.9 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' B' ' 211' ' ' LYS . 5.6 t70 -103.55 154.78 19.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 1.061 HG21 HD11 ' B' ' 170' ' ' ILE . 22.5 m -97.48 11.88 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.42 -2.06 2.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.408 -0.808 . . . . 0.0 111.214 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 11.6 p90 -155.22 157.3 31.74 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.869 -1.144 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.0 Cg_endo -72.05 160.03 48.55 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.147 1.604 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 1.061 HD11 HG21 ' B' ' 166' ' ' VAL . 1.5 mp -131.85 153.92 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 110.314 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -87.51 110.18 20.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.931 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.39 -64.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.331 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -25.95 64.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.08 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -72.56 -48.21 24.14 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.501 ' HA ' ' OG ' ' B' ' 178' ' ' SER . 9.6 tp -74.77 -33.76 62.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.343 -1.093 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.73 71.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.947 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -80.44 -28.31 37.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.992 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' B' ' 175' ' ' LEU . 1.2 p -83.58 -58.6 2.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -0.802 . . . . 0.0 110.097 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -96.28 32.65 1.92 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.021 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 181' ' ' THR . . . -52.75 -26.49 25.35 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 180' ' ' GLY . 22.6 p -42.37 -55.27 3.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -1.174 . . . . 0.0 110.133 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.621 ' CZ ' ' CG2' ' B' ' 198' ' ' VAL . 3.2 m-85 -115.49 -3.24 12.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.611 ' OG ' HD21 ' B' ' 193' ' ' LEU . 9.4 t -92.11 140.78 29.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.99 130.46 41.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 0.414 ' HB2' ' HG ' ' B' ' 193' ' ' LEU . 5.6 t80 -146.52 101.42 3.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 110.272 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.16 116.99 46.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.152 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.73 -0.24 9.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.945 1.497 . . . . 0.0 110.525 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.87 -6.67 28.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.824 HD23 ' N ' ' B' ' 190' ' ' PHE . 3.8 tt -143.13 -57.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 110.425 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.824 ' N ' HD23 ' B' ' 189' ' ' LEU . 7.4 t80 -105.74 124.92 34.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . 0.497 ' HD2' ' CD1' ' B' ' 190' ' ' PHE . 46.3 Cg_endo -73.84 -35.77 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.905 1.477 . . . . 0.0 110.351 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.544 ' HA3' ' CD1' ' B' ' 207' ' ' PHE . . . -90.3 174.85 40.57 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.977 HD23 ' N ' ' B' ' 194' ' ' ILE . 9.1 tt -94.11 159.75 15.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -1.137 . . . . 0.0 110.272 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.977 ' N ' HD23 ' B' ' 193' ' ' LEU . 75.9 mt -130.82 107.58 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 12.5 t80 -98.56 119.65 37.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.002 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.51 ' NH2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -91.96 117.73 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 110.457 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.428 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 30.1 ttm -93.45 144.26 25.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.937 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.621 ' CG2' ' CZ ' ' B' ' 182' ' ' PHE . 84.7 t -92.34 -50.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.965 . . . . 0.0 110.274 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -129.44 106.41 17.43 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.861 . . . . 0.0 110.314 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.1 Cg_endo -73.54 171.14 67.74 Favored 'Cis proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.359 -0.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' B' ' 197' ' ' MET . 4.2 tptt -85.14 98.58 10.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' B' ' 217' ' ' ALA . 29.2 mt -145.82 149.68 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.682 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' B' ' 196' ' ' ARG . 75.0 t -103.7 117.68 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.477 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.826 ' N ' HD12 ' B' ' 204' ' ' LEU . 4.8 mp -104.54 152.06 22.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.724 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.633 ' CD1' HD21 ' A' ' 52' ' ' LEU . 18.5 mt -117.13 143.51 45.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.371 -0.83 . . . . 0.0 110.013 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.601 HG12 HD21 ' B' ' 234' ' ' LEU . 6.5 mt -132.49 103.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.544 ' CD1' ' HA3' ' B' ' 192' ' ' GLY . 14.2 m-30 -94.48 145.74 24.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.111 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 37.6 t -45.46 -28.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.892 . . . . 0.0 110.467 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -16.19 56.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.447 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.442 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 97.67 -4.36 61.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.44 ' HG2' ' OD1' ' B' ' 165' ' ' ASP . 8.7 mttm -73.22 131.96 42.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 110.166 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' B' ' 163' ' ' SER . 17.0 mm -119.73 143.98 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.594 HG11 ' HE1' ' A' ' 25' ' ' PHE . 12.0 t -124.76 157.38 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.526 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.8 mp -144.46 107.38 4.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.791 ' OG1' HG22 ' B' ' 161' ' ' VAL . 1.6 t -128.95 137.19 51.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 0.0 110.144 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.461 ' C ' HG12 ' B' ' 202' ' ' ILE . . . 119.8 9.74 8.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.631 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -88.19 154.89 20.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.308 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' B' ' 158' ' ' GLN . 0.8 OUTLIER -106.56 -12.26 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.512 ' CG ' ' HG2' ' B' ' 221' ' ' GLU . 9.4 tp60 -150.32 150.1 31.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.059 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . 0.848 ' HD2' HD11 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -49.18 -38.72 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 110.368 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 16.0 pt-20 -54.45 -34.51 61.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 16.8 mt-10 -65.16 -58.73 5.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.11 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.403 HG23 HD12 ' B' ' 223' ' ' ILE . 29.5 mm -50.67 -45.2 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.992 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -65.7 -33.14 75.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.67 -46.05 23.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.018 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.496 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -55.66 -27.61 50.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.89 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.572 ' HA ' HG22 ' B' ' 230' ' ' ILE . 16.9 t80 -78.78 -46.65 18.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -59.5 -22.61 61.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.087 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -88.25 -30.54 19.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.8 tp -99.82 -9.65 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.069 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.7 t80 -63.14 -46.73 86.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -71.51 -25.95 20.62 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.229 1.12 . . . . 0.0 110.065 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.63 -36.69 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.768 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.958 HD13 HG11 ' B' ' 166' ' ' VAL . 54.7 mt -71.4 -40.93 70.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 109.972 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -19.94 66.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.314 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -82.7 -41.8 18.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -109.04 38.54 2.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.385 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -75.22 176.01 7.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.277 -0.89 . . . . 0.0 110.078 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -128.93 -36.86 1.76 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.953 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.216 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.084 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.845 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -88.38 78.26 7.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 111.565 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.084 HD21 HD21 ' A' ' 18' ' ' LEU . 4.2 mt -86.3 30.11 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.836 HG22 HG23 ' A' ' 56' ' ' ILE . 1.8 m -77.76 -6.01 52.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.24 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.776 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -99.97 -41.73 2.79 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.002 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.679 HG22 HG21 ' B' ' 124' ' ' THR . 17.2 pt -51.93 -46.17 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.651 -1.5 . . . . 0.0 109.601 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.809 ' CD1' HD12 ' A' ' 64' ' ' LEU . 1.3 pp -75.27 0.33 16.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 0.0 109.272 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -120.27 -13.99 8.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.327 -0.858 . . . . 0.0 110.721 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 157.31 45.47 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB3' HG22 ' B' ' 112' ' ' THR . 0.0 OUTLIER 52.87 147.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.368 -1.078 . . . . 0.0 111.43 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -170.49 161.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.461 -0.775 . . . . 0.0 109.284 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 31' ' ' GLU . 81.1 m-20 -88.57 135.02 33.7 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.502 ' C ' ' O ' ' A' ' 29' ' ' ASP . 1.1 p -36.27 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.904 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -49.2 -21.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 110.007 179.121 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.87 21.1 7.99 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.85 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -114.48 130.84 56.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.805 -1.409 . . . . 0.0 109.586 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.875 HD22 ' C ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -102.77 151.02 22.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 111.703 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.664 HD11 ' OD1' ' A' ' 27' ' ' ASN . 4.0 pp . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 110.367 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.193 0.52 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -100.22 -25.53 14.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.521 HD21 ' CZ ' ' B' ' 190' ' ' PHE . 3.5 mt -96.43 -40.83 8.9 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.399 -0.813 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.958 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -47.98 -52.29 20.37 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.231 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.38 -40.51 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.393 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' LEU . 3.9 m-80 -63.75 -45.36 90.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.664 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 53' ' ' ARG . 39.2 mt -46.75 -44.61 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -0.847 . . . . 0.0 109.777 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.96 -22.65 60.5 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.7 OUTLIER -142.17 39.04 1.59 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.31 . . . . 0.0 109.34 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.774 ' CD1' HD21 ' A' ' 62' ' ' LEU . 1.8 tp -104.05 -9.74 18.56 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.413 -0.805 . . . . 0.0 109.718 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 p -75.83 48.15 0.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 109.835 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -134.49 -19.4 1.89 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 110.325 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.89 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.25 22.73 4.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.673 -1.267 . . . . 0.0 111.19 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.91 -69.77 0.13 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.397 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.809 HD12 ' CD1' ' A' ' 24' ' ' LEU . 4.0 mm? -69.97 -2.09 11.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.239 . . . . 0.0 111.274 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -52.66 -49.62 64.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 109.837 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 54.3 p -67.56 -45.42 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.943 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.5 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.66 -4.41 19.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.777 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.881 HD11 ' O ' ' A' ' 18' ' ' LEU . 2.7 tm? -82.0 -60.49 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.891 . . . . 0.0 109.735 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.54 2.02 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.906 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 3.3 tt0 -97.32 16.94 18.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 111.109 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' A' ' 20' ' ' LEU . 4.2 t -136.62 -1.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.243 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.928 HD11 ' CD1' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -151.73 76.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 1.9 p-10 -75.04 57.6 0.83 Allowed 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.739 -1.226 . . . . 0.0 108.563 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.928 ' CD1' HD11 ' A' ' 72' ' ' ILE . 8.7 mt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.622 0.725 . . . . 0.0 110.815 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.462 ' C ' HG23 ' B' ' 64' ' ' VAL . 1.9 mp . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.289 0.566 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.628 ' CG1' ' CZ ' ' B' ' 224' ' ' TYR . 3.4 t 64.05 123.14 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 46.1 Cg_endo -72.72 145.93 42.19 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.938 1.494 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.5 m -96.72 136.72 36.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.512 HD22 ' CG2' ' B' ' 160' ' ' ILE . 39.7 mt -70.0 121.36 17.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.897 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -95.34 -29.52 14.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.481 HD21 HG21 ' B' ' 161' ' ' VAL . 1.5 p-10 -170.37 -179.49 3.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.557 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.599 HG12 HG23 ' B' ' 160' ' ' ILE . 21.0 mt -153.93 164.45 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.971 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.708 HG21 ' HA ' ' A' ' 24' ' ' LEU . 25.8 t -130.6 133.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.24 169.74 15.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.289 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 28.1 p -122.48 144.19 49.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.303 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' B' ' 136' ' ' SER . 47.8 t -136.08 142.4 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.365 -0.835 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' B' ' 120' ' ' LYS . 1.3 m -123.99 132.75 53.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.729 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.997 HD22 ' HB1' ' B' ' 150' ' ' ALA . 11.7 mt -100.42 -26.09 13.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 109.963 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 51.78 39.36 47.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 79' ' ' ARG . 89.0 m -134.67 -0.22 2.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.938 ' O ' HD23 ' B' ' 80' ' ' LEU . 4.9 mmm180 59.77 139.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.026 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.938 HD23 ' O ' ' B' ' 79' ' ' ARG . 24.1 mt -139.54 151.01 45.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.961 -1.087 . . . . 0.0 110.6 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' B' ' 81' ' ' ASP . 2.0 m-20 -89.83 89.25 7.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.84 HD22 HG23 ' B' ' 102' ' ' VAL . 32.3 mt -40.84 -43.07 1.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 110.689 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -54.59 -47.21 73.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.638 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.401 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 12.0 p -80.44 -40.87 25.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.713 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.405 HG12 HG11 ' B' ' 102' ' ' VAL . 55.9 t -52.56 -42.87 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.124 -0.985 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.28 -23.53 40.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.067 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.91 -27.26 43.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.368 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -100.43 -38.92 8.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.479 ' HB1' ' SD ' ' B' ' 104' ' ' MET . . . -53.21 134.27 39.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.204 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -73.96 -22.9 59.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.444 ' O ' ' SD ' ' B' ' 104' ' ' MET . 1.4 m120 -134.79 79.52 1.8 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.829 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 1.006 ' HB2' ' SD ' ' B' ' 104' ' ' MET . . . -150.43 162.42 40.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -143.07 171.87 13.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.004 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.28 104.68 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.11 112.84 59.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.56 -17.48 23.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.911 1.479 . . . . 0.0 110.619 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -82.22 -17.7 45.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.158 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -55.55 2.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 1.124 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -160.41 -164.65 1.29 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 111.397 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.38 54.39 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.935 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.124 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -143.9 167.45 22.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 110.382 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.84 HG23 HD22 ' B' ' 82' ' ' LEU . 49.7 t -100.58 139.91 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 110.159 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.527 HD12 ' N ' ' B' ' 103' ' ' ILE . 4.8 mp -106.52 113.43 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 1.006 ' SD ' ' HB2' ' B' ' 92' ' ' ALA . 21.0 tpp -104.65 162.07 13.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 110.224 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.42 131.65 11.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.566 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 7.4 pt -125.8 169.68 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' B' ' 108' ' ' GLU . 1.1 mtt180 -115.16 22.61 13.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' B' ' 107' ' ' ARG . 3.1 mt-10 -166.1 93.14 0.81 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.455 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.697 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.5 Cg_endo -75.22 159.57 97.59 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.818 -2.159 . . . . 0.0 110.423 -0.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.49 ' C ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -65.84 98.21 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.917 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.49 HG23 ' C ' ' B' ' 110' ' ' LYS . 38.3 p -153.17 -179.29 7.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.853 . . . . 0.0 110.113 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.704 HG22 ' HB3' ' A' ' 27' ' ' ASN . 15.1 t -134.38 162.47 32.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.102 -0.999 . . . . 0.0 110.062 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -161.51 156.76 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.913 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.742 HD12 ' HE1' ' B' ' 116' ' ' PHE . 0.3 OUTLIER -132.05 115.12 15.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.522 -0.736 . . . . 0.0 109.422 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' B' ' 102' ' ' VAL . 50.6 mt -90.77 137.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.867 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.742 ' HE1' HD12 ' B' ' 114' ' ' LEU . 2.6 m-30 -90.53 -171.04 2.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.347 -0.846 . . . . 0.0 109.515 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.485 ' O ' ' HD2' ' B' ' 79' ' ' ARG . . . -93.01 -10.25 36.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.52 -28.55 18.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.466 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 135.19 -38.65 1.78 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . 0.517 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 5.0 tttt -61.24 139.83 58.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 110.139 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.442 ' HG3' ' HB ' ' B' ' 74' ' ' VAL . 3.7 ptt? -144.69 157.13 44.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 71' ' ' VAL . 31.3 t -104.37 154.01 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.438 HG23 ' C ' ' B' ' 122' ' ' VAL . 7.5 t -147.27 101.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 110.711 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.679 HG21 HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -104.92 179.88 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 0.0 109.001 178.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.592 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 98.46 -29.74 10.91 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.53 ' CB ' ' OG ' ' B' ' 132' ' ' SER . . . -48.19 131.62 16.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 109.991 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' B' ' 128' ' ' SER . 0.2 OUTLIER -101.09 13.67 34.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.382 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' B' ' 127' ' ' LYS . 0.3 OUTLIER 178.93 -169.67 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -74.21 -45.92 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.57 -27.03 64.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.68 -45.82 85.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.269 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 39.2 m -65.2 -48.52 73.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 10.8 ttpp -53.37 -41.28 65.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 110.47 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' B' ' 138' ' ' LYS . 0.7 OUTLIER -77.63 -43.76 30.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 110.444 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.697 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -64.38 -36.75 85.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.277 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.458 ' HB2' HG21 ' B' ' 74' ' ' VAL . 11.8 p -68.78 -59.93 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.121 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' B' ' 137' ' ' ARG . 8.5 ptm85 -51.82 -26.41 9.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.896 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -67.1 -48.55 67.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.657 ' HA ' HD12 ' B' ' 142' ' ' ILE . 35.7 m-85 -62.56 -47.3 84.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -55.6 -28.36 54.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.91 . . . . 0.0 109.69 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -70.95 -51.57 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 110.003 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' B' ' 139' ' ' TYR . 6.4 mt -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.045 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.705 HG22 ' HB2' ' B' ' 148' ' ' PHE . 49.3 mm -73.64 -53.77 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.82 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 28.0 mt-30 -64.72 -29.95 70.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 109.989 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -74.09 -22.61 59.44 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 142' ' ' ILE . 4.2 mt -81.04 -22.16 10.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.94 4.85 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.705 ' HB2' HG22 ' B' ' 143' ' ' ILE . 24.2 m-85 -63.99 175.02 1.3 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.007 -1.29 . . . . 0.0 111.416 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.15 24.32 11.77 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.458 0.647 . . . . 0.0 109.679 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.997 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -46.24 150.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 110.598 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -124.44 101.53 7.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 110.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.434 ' O ' HG23 ' B' ' 153' ' ' THR . 23.6 t80 -57.95 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.304 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.9 OUTLIER -151.74 173.09 15.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 110.395 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' B' ' 153' ' ' THR . 0.1 OUTLIER 65.39 21.46 11.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.341 -0.849 . . . . 0.0 110.436 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -65.67 135.13 54.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.989 . . . . 0.0 110.09 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -166.04 136.71 3.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 110.35 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 7.3 mt -79.04 154.23 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.897 . . . . 0.0 109.653 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -137.06 -23.8 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.005 -1.059 . . . . 0.0 111.63 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' B' ' 217' ' ' ALA . 13.7 t-20 -149.51 122.19 8.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.712 -1.243 . . . . 0.0 111.523 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.599 HG23 HG12 ' B' ' 70' ' ' ILE . 84.8 mt -106.92 144.89 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 108.903 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.481 HG21 HD21 ' B' ' 69' ' ' ASN . 48.6 t -118.06 142.5 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.827 -1.17 . . . . 0.0 111.435 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -139.72 162.03 26.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 54.5 p -161.2 143.93 12.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.314 . . . . 0.0 110.676 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.5 OUTLIER -170.36 171.72 6.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.374 -0.829 . . . . 0.0 110.144 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.455 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 0.8 OUTLIER -114.83 131.53 56.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.042 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.709 HG23 ' H ' ' B' ' 167' ' ' LYS . 5.1 m -67.62 -61.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.121 -0.987 . . . . 0.0 110.957 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.709 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 169.59 -31.42 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.033 . . . . 0.0 110.441 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 17.0 p90 -134.34 165.78 34.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.2 Cg_endo -71.81 147.39 50.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.975 1.513 . . . . 0.0 110.26 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.641 HD12 ' HA2' ' B' ' 210' ' ' GLY . 4.1 mt -110.49 152.91 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -93.8 105.18 17.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.695 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.446 ' N ' HD23 ' B' ' 172' ' ' LEU . 8.5 mt -63.37 -43.95 96.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 110.615 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.4 -49.62 75.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 110.424 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -62.0 -38.07 95.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -74.37 -36.73 63.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -1.168 . . . . 0.0 110.451 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.64 67.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.271 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -92.39 -42.3 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.052 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . 0.414 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -63.36 -52.78 60.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -115.38 40.2 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.098 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.6 -19.8 49.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.0 m -58.03 -35.85 71.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -1.162 . . . . 0.0 110.257 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.858 ' CE1' HG22 ' B' ' 198' ' ' VAL . 44.1 m-85 -125.19 12.15 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.51 ' HB3' HD21 ' B' ' 193' ' ' LEU . 50.6 m -114.72 143.91 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 0.0 110.226 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.09 114.2 16.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 110.25 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -125.7 91.42 3.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.93 113.98 60.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.25 5.04 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.908 1.478 . . . . 0.0 110.937 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.87 -9.19 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.025 . . . . 0.0 110.248 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.579 ' C ' HD23 ' B' ' 189' ' ' LEU . 3.8 tt -152.51 -40.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.682 ' CE2' HD13 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -117.76 107.81 43.81 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.405 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.61 -23.69 19.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.029 1.542 . . . . 0.0 110.279 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.23 177.87 39.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' B' ' 183' ' ' SER . 7.4 tt -108.05 128.42 54.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.166 . . . . 0.0 110.402 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.543 ' HA ' HD23 ' B' ' 205' ' ' LEU . 22.2 mt -101.72 108.04 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.49 ' CD2' HD13 ' B' ' 230' ' ' ILE . 17.0 t80 -95.77 113.1 24.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.236 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.417 ' CB ' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -90.6 88.29 7.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.445 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 22.9 ttm -59.28 139.11 57.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 110.161 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.858 HG22 ' CE1' ' B' ' 182' ' ' PHE . 3.0 t -77.3 -46.09 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 109.949 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' B' ' 199' ' ' LYS . 34.2 pttt -142.21 118.56 7.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 0.0 109.863 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.4 Cg_endo -73.32 145.99 85.68 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.971 -2.096 . . . . 0.0 110.513 0.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.496 ' O ' HD13 ' B' ' 202' ' ' ILE . 1.4 tptm -57.34 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.115 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' B' ' 217' ' ' ALA . 42.5 mm -138.34 165.16 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.581 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.461 ' N ' HG22 ' B' ' 202' ' ' ILE . 45.1 t -121.91 125.24 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 1.101 HD21 ' HB1' ' B' ' 226' ' ' ALA . 1.6 mp -121.94 140.5 52.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.508 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' B' ' 194' ' ' ILE . 12.5 mt -103.96 156.0 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.854 . . . . 0.0 109.952 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.704 HG12 HD21 ' B' ' 234' ' ' LEU . 2.8 mt -140.05 105.69 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -97.62 152.05 19.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 62.0 t -49.23 -34.11 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 97.5 p -55.66 -31.85 62.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 110.1 12.86 16.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.455 ' HG3' ' OD1' ' B' ' 165' ' ' ASP . 29.1 tttt -89.7 131.86 35.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.029 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' B' ' 206' ' ' ILE . 34.1 mm -118.12 122.14 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.749 HG11 ' HE1' ' A' ' 25' ' ' PHE . 16.1 t -92.39 154.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.435 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.2 mp -143.17 100.95 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.979 . . . . 0.0 110.716 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 0.9 OUTLIER -136.84 170.72 15.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.204 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . 0.515 ' HA2' ' ND2' ' B' ' 159' ' ' ASN . . . 92.28 13.33 57.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -98.48 157.15 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -1.131 . . . . 0.0 110.297 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -36.58 13.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.28 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.51 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.1 OUTLIER -128.86 -158.8 0.91 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 110.165 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -97.08 -22.52 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.48 -38.04 82.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.52 -48.82 65.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 23.9 mm -52.79 -41.64 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.628 ' CZ ' ' CG1' ' B' ' 64' ' ' VAL . 3.8 m-85 -70.51 -28.15 64.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -45.53 21.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 1.101 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -56.21 -35.16 67.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.354 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.532 ' HA ' HG22 ' B' ' 230' ' ' ILE . 21.5 t80 -72.47 -49.69 31.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -18.63 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.29 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.16 -28.41 17.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 110.079 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' B' ' 227' ' ' PHE . 7.4 tp -99.59 -16.32 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 110.161 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.621 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 3.9 t80 -55.92 -43.25 99.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.9 Cg_endo -74.21 -31.24 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.449 1.237 . . . . 0.0 110.255 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' B' ' 175' ' ' LEU . 8.8 t -67.36 -43.84 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.707 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.704 HD21 HG12 ' B' ' 206' ' ' ILE . 71.2 mt -58.46 -44.24 89.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.967 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -28.02 67.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.151 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -74.31 -24.41 59.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.113 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.582 ' HB2' HD23 ' B' ' 175' ' ' LEU . 86.8 m-85 -125.12 45.57 2.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -63.26 -162.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -42.45 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 110.145 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.216 179.871 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.08 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.716 ' N ' HD12 ' A' ' 18' ' ' LEU . 55.6 t0 -90.01 89.26 7.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 111.018 -178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.08 HD21 HD21 ' A' ' 18' ' ' LEU . 2.4 mt -87.93 -5.4 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.042 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.663 ' N ' HD23 ' A' ' 68' ' ' LEU . 96.0 m -39.38 -38.85 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.292 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -91.59 -32.34 8.74 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.734 HG12 HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -51.25 -44.28 30.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.198 -1.178 . . . . 0.0 109.46 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.94 ' HA ' HG21 ' B' ' 71' ' ' VAL . 1.6 pp -83.02 -25.98 31.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.892 -1.13 . . . . 0.0 109.417 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.799 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.9 t80 -87.22 0.4 55.42 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.723 0.773 . . . . 0.0 109.101 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 150.1 98.68 0.19 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.84 ' HB2' HG22 ' B' ' 112' ' ' THR . 8.3 p-10 -21.99 119.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.095 0.95 . . . . 0.0 112.849 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.734 HG23 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -130.21 165.47 30.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.535 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 28' ' ' ILE . 77.2 m-20 -86.18 125.95 33.89 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.959 ' HB2' HD13 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -39.47 -24.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 -178.484 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.648 ' HG3' HD13 ' B' ' 103' ' ' ILE . 65.0 mt-10 -64.61 -4.91 4.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.018 . . . . 0.0 111.142 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.55 38.07 4.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.525 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.8 tpp180 -126.54 130.08 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -1.142 . . . . 0.0 109.511 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.716 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -89.01 158.69 17.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.589 -1.32 . . . . 0.0 111.429 -179.046 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.52 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.611 0.72 . . . . 0.0 111.504 -178.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.189 0.519 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -95.45 -32.93 12.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 0.0 108.631 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.53 HD13 ' CE1' ' A' ' 25' ' ' PHE . 1.7 mt -88.87 -34.62 16.93 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.08 -49.51 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.38 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.0 -29.53 68.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.593 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.501 ' OD1' ' HD2' ' B' ' 191' ' ' PRO . 20.8 m-80 -76.28 -41.06 50.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.613 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 53' ' ' ARG . 45.7 mt -49.96 -47.08 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.58 0.52 60.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.51 -41.73 3.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -86.57 36.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.13 -0.981 . . . . 0.0 110.458 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -80.21 17.12 1.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.112 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.556 ' HE2' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -152.99 11.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 -179.697 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.851 HD11 ' CD2' ' B' ' 189' ' ' LEU . 3.5 mt -90.32 -26.07 20.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.744 -1.223 . . . . 0.0 109.47 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.54 -38.71 0.04 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.724 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.7 mm? -62.93 -12.14 23.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 110.537 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -48.03 -41.1 24.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.981 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -42.75 76.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.568 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -81.86 -1.92 49.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.995 179.739 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.763 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.8 tm? -82.29 -47.2 12.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.413 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -90.26 0.28 57.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 110.176 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.505 ' C ' HG23 ' A' ' 71' ' ' VAL . 3.1 tt0 -90.9 15.85 10.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.322 -0.861 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.643 ' HB ' HD12 ' A' ' 20' ' ' LEU . 45.0 t -145.67 5.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.328 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.951 ' CD1' HD23 ' A' ' 18' ' ' LEU . 4.0 tp -150.52 77.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.881 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.6 t70 -84.29 49.3 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.016 -1.053 . . . . 0.0 108.523 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.912 HD13 ' CG1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.215 0.531 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.531 ' CG1' ' HD2' ' B' ' 65' ' ' PRO . 15.5 t -57.9 145.51 71.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.006 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.617 ' CG ' HG22 ' B' ' 223' ' ' ILE . 44.1 Cg_endo -71.69 138.43 31.94 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.806 1.424 . . . . 0.0 110.377 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.472 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 72.8 m -105.17 135.19 46.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -75.03 122.04 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.91 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -113.38 -3.66 13.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.649 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.4 142.47 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 110.574 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.541 ' CD1' HG23 ' B' ' 160' ' ' ILE . 13.3 mm -126.99 161.16 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.355 -0.841 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.94 HG21 ' HA ' ' A' ' 24' ' ' LEU . 47.8 t -141.74 121.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.126 -0.984 . . . . 0.0 110.233 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 157' ' ' ILE . . . -134.9 168.5 18.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . 0.774 HG23 HG22 ' B' ' 122' ' ' VAL . 0.2 OUTLIER -124.71 153.5 42.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 53.2 t -143.91 155.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 110.303 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 9.1 m -124.72 133.13 53.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.842 HD22 ' HB1' ' B' ' 150' ' ' ALA . 67.6 mt -87.56 -65.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.88 -20.83 2.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 40.6 m -135.18 143.78 46.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.247 . . . . 0.0 110.471 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.504 ' O ' HD23 ' B' ' 80' ' ' LEU . 7.3 ptm85 -59.54 163.37 4.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.913 . . . . 0.0 109.816 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.681 HD11 HD12 ' B' ' 76' ' ' LEU . 25.6 mt -131.43 153.6 49.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 42.3 t0 -89.64 89.02 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.495 HD11 ' O ' ' B' ' 100' ' ' ALA . 15.1 mt -38.52 -36.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 110.666 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -66.18 -42.51 88.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.44 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 16.0 m -79.34 -25.73 42.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.159 -0.963 . . . . 0.0 110.543 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.478 HG12 HG11 ' B' ' 102' ' ' VAL . 22.9 t -75.26 -40.39 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.13 -21.19 43.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.1 tp -88.9 -18.49 27.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -100.03 -41.13 7.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 110.362 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.48 140.42 58.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.855 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -77.55 -14.43 59.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.096 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.427 ' HB3' ' HG2' ' B' ' 105' ' ' ARG . 8.6 m-20 -137.7 79.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -162.02 154.0 19.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.286 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -143.34 155.63 44.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -119.3 135.74 54.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.83 101.57 3.43 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.178 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.87 -16.19 26.2 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.044 1.549 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -72.66 -6.58 45.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -123.95 -65.72 1.04 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 110.377 -179.814 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -146.86 133.18 19.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.365 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.495 ' O ' HD11 ' B' ' 82' ' ' LEU . . . -60.62 57.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.989 -177.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.905 ' HB1' ' O ' ' B' ' 115' ' ' ILE . . . -152.48 169.02 23.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.872 -1.142 . . . . 0.0 111.159 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' B' ' 82' ' ' LEU . 17.2 t -102.23 130.39 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.609 -0.682 . . . . 0.0 109.303 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.648 HD13 ' HG3' ' A' ' 31' ' ' GLU . 2.4 mp -89.3 118.29 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 110.2 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 27.2 ttm -104.16 164.62 11.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 110.236 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.508 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 9.0 ptm180 -156.03 122.41 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.818 HG23 ' CE1' ' B' ' 139' ' ' TYR . 10.4 pt -108.68 151.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.509 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 23.77 8.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 109.931 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.0 OUTLIER -175.9 94.92 0.26 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.88 . . . . 0.0 110.114 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 46.4 Cg_endo -72.8 162.22 91.72 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.546 0.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.412 ' C ' HG23 ' B' ' 111' ' ' THR . 6.6 tppt? -71.5 89.83 0.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 109.918 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' B' ' 124' ' ' THR . 21.9 p -145.32 -179.83 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.293 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.84 HG22 ' HB2' ' A' ' 27' ' ' ASN . 6.1 t -133.69 176.06 8.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -170.5 177.58 3.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.04 . . . . 0.0 111.049 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.68 HD12 ' CE1' ' B' ' 116' ' ' PHE . 0.3 OUTLIER -145.7 123.44 11.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.432 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.905 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 18.0 mt -94.04 134.55 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.935 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.773 ' CZ ' HD12 ' A' ' 72' ' ' ILE . 8.3 m-85 -87.41 134.21 33.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.611 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' B' ' 82' ' ' LEU . . . -52.24 -19.69 2.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 55.0 m -79.41 -29.6 42.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.256 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.09 -31.28 2.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.42 163.3 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.225 -1.162 . . . . 0.0 110.135 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.417 ' SD ' ' CG2' ' B' ' 123' ' ' VAL . 8.1 tmm? -160.89 128.18 4.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.774 HG22 HG23 ' B' ' 73' ' ' THR . 22.6 t -107.94 154.64 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.442 HG23 ' C ' ' B' ' 122' ' ' VAL . 25.7 t -146.37 131.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.469 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.617 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -139.04 167.01 23.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.337 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.578 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 117.36 -37.48 3.31 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -53.52 173.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -1.086 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.507 ' HA ' HG12 ' B' ' 70' ' ' ILE . 8.5 mtmm -135.34 5.8 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -147.23 163.18 37.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . 0.536 ' HG2' ' CD1' ' B' ' 157' ' ' ILE . 3.8 mt-10 -57.73 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.173 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' B' ' 133' ' ' LYS . 0.4 OUTLIER -47.92 -36.17 11.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.847 . . . . 0.0 110.345 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' B' ' 128' ' ' SER . 9.3 t0 -53.89 -49.57 68.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.128 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 57.0 m -56.23 -42.04 76.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' B' ' 137' ' ' ARG . 3.7 mttt -53.86 -38.43 64.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 1.4 mt -66.25 -41.1 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.133 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.59 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -51.53 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' B' ' 133' ' ' LYS . 0.2 OUTLIER -53.41 -37.43 62.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.924 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' B' ' 134' ' ' LEU . 4.8 mmtt -68.15 -50.78 52.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.898 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.818 ' CE1' HG23 ' B' ' 106' ' ' ILE . 28.2 m-85 -52.75 -54.18 37.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.941 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.63 58.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.49 -46.25 55.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 57.0 mt -51.69 -41.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' B' ' 148' ' ' PHE . 23.5 mm -64.37 -49.95 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.531 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.75 -31.45 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.376 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 2.7 tmtt? -74.23 -21.17 59.91 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 5.4 mt -84.58 -17.13 10.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.97 -21.88 9.33 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.672 ' HB2' HG22 ' B' ' 143' ' ' ILE . 15.3 m-85 -53.94 174.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 110.958 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.65 36.56 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.515 -0.74 . . . . 0.0 110.193 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.842 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -71.06 144.47 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.451 ' O ' ' OG1' ' B' ' 153' ' ' THR . 4.2 tttp -128.74 104.52 7.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.459 ' O ' HG23 ' B' ' 153' ' ' THR . 54.9 t80 -53.41 102.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 110.319 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.459 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.6 OUTLIER -154.09 172.09 18.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.164 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.0 33.61 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -72.35 138.22 47.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -161.74 136.14 6.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.536 ' CD1' ' HG2' ' B' ' 129' ' ' GLU . 37.2 mt -80.23 140.77 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.853 . . . . 0.0 110.139 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -92.77 -61.76 1.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.425 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -145.75 168.77 19.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.568 HD12 ' O ' ' B' ' 219' ' ' GLN . 67.1 mt -119.54 144.4 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 12.4 t -112.0 121.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -132.64 172.28 21.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 28.3 t -166.1 161.16 16.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.173 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.452 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 29.5 p -167.88 139.5 2.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -92.69 161.69 14.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.1 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.489 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.0 OUTLIER -110.94 -81.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.182 -0.948 . . . . 0.0 110.198 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 6.1 mtpt 170.01 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 0.0 110.407 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' B' ' 168' ' ' PHE . 10.5 p90 -129.56 155.99 79.37 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.201 -0.937 . . . . 0.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 44.6 Cg_endo -71.45 161.27 46.07 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.859 1.452 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 1.7 mp -126.93 149.67 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.154 -0.967 . . . . 0.0 110.663 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.46 110.59 19.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.848 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' B' ' 193' ' ' LEU . 11.9 mt -65.61 -32.21 73.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 110.612 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.13 -28.96 67.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 110.175 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.79 65.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' B' ' 175' ' ' LEU . 0.2 OUTLIER -71.41 -45.46 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 110.227 179.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.53 -13.63 62.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -90.31 -32.45 16.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . 0.508 ' OG ' ' ND1' ' B' ' 179' ' ' HIS . 37.6 p -98.27 -30.53 12.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.907 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.508 ' ND1' ' OG ' ' B' ' 178' ' ' SER . 76.1 m80 -123.94 44.38 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -65.34 -27.68 72.72 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 2.2 t -54.16 -26.22 26.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.151 . . . . 0.0 110.221 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.565 ' CE2' ' CG2' ' B' ' 198' ' ' VAL . 31.4 m-85 -136.17 8.77 3.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.895 . . . . 0.0 110.196 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.718 ' OG ' HD21 ' B' ' 193' ' ' LEU . 22.9 t -110.96 120.72 43.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.969 . . . . 0.0 110.632 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 40.2 t -111.55 103.98 12.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.53 105.9 15.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' B' ' 190' ' ' PHE . 1.6 mm-40 -113.62 99.19 49.23 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.946 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.19 -4.66 15.35 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.052 1.554 . . . . 0.0 110.49 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.13 -13.02 19.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.952 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.851 ' CD2' HD11 ' A' ' 62' ' ' LEU . 2.4 tt -146.43 11.2 1.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 110.263 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.617 ' CE2' ' CG1' ' B' ' 194' ' ' ILE . 2.2 t80 -166.2 112.6 0.74 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . 0.501 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.7 Cg_endo -74.43 -26.89 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.898 1.472 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.99 178.28 37.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.718 HD21 ' OG ' ' B' ' 183' ' ' SER . 8.3 tt -110.6 132.82 53.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -1.103 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.617 ' CG1' ' CE2' ' B' ' 190' ' ' PHE . 93.8 mt -100.46 118.39 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -120.85 128.95 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' B' ' 203' ' ' VAL . 7.6 mtp-105 -108.42 89.38 2.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.483 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 32.9 ttm -50.74 141.13 13.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.075 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.565 ' CG2' ' CE2' ' B' ' 182' ' ' PHE . 31.3 t -71.35 -59.27 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 20.5 tttp -127.13 117.18 21.84 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.952 . . . . 0.0 110.304 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.6 Cg_endo -74.08 156.46 99.72 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.92 -2.117 . . . . 0.0 110.277 -0.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 85.43 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.978 . . . . 0.0 110.106 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' B' ' 217' ' ' ALA . 25.3 mm -130.27 163.07 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' B' ' 196' ' ' ARG . 12.6 t -109.57 120.38 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.863 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.5 mp -114.76 124.49 51.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.161 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.799 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 1.8 mt -102.63 148.67 25.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.57 HG23 ' CD1' ' B' ' 212' ' ' ILE . 4.1 mp -139.56 127.16 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.327 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.509 ' HZ ' HD21 ' A' ' 52' ' ' LEU . 26.0 m-85 -105.13 155.61 18.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 72.6 t -51.33 -24.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 0.0 110.306 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -24.32 62.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 110.421 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 107.54 24.92 6.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.0 OUTLIER -91.15 126.18 36.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -1.114 . . . . 0.0 110.204 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.57 ' CD1' HG23 ' B' ' 206' ' ' ILE . 23.8 mm -114.37 116.17 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.507 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 29.0 t -107.61 143.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.063 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.594 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.1 mp -135.58 112.36 10.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 13.2 t -135.95 153.68 51.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.15 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.05 -5.59 34.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.621 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -81.99 127.47 33.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -1.194 . . . . 0.0 110.051 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -71.19 -38.61 72.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 110.432 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.568 ' O ' HD12 ' B' ' 160' ' ' ILE . 3.7 mt-30 -117.69 -173.01 2.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.274 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 35.5 ttp180 -88.48 -24.66 22.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.277 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.503 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 3.4 pt-20 -63.96 -22.47 66.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.21 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.621 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 33.2 mt-10 -76.39 -53.75 7.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 110.07 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.617 HG22 ' CG ' ' B' ' 65' ' ' PRO . 27.8 mm -56.59 -37.7 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 110.035 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.571 ' CE1' ' HG2' ' B' ' 220' ' ' ARG . 5.5 m-85 -66.11 -40.54 90.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 110.134 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -80.02 -22.48 42.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.872 . . . . 0.0 110.087 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.863 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -67.68 -47.49 69.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.747 ' HA ' HG22 ' B' ' 230' ' ' ILE . 19.6 t80 -76.92 -34.21 57.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' B' ' 224' ' ' TYR . 35.9 mm-40 -65.68 -18.48 65.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.213 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.443 ' HB3' ' SD ' ' B' ' 197' ' ' MET . . . -97.04 -25.91 15.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.065 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' B' ' 227' ' ' PHE . 2.9 tp -96.21 -11.3 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.05 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 2.4 t80 -53.89 -44.03 97.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.72 -43.74 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.468 1.246 . . . . 0.0 110.68 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.413 HG12 HD21 ' B' ' 175' ' ' LEU . 30.5 t -56.92 -36.51 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.455 HD21 HG12 ' B' ' 206' ' ' ILE . 20.2 mt -63.44 -62.13 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 43.1 m -53.79 -20.31 5.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.512 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 233' ' ' VAL . 2.0 tt0 -67.69 -40.25 84.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.452 -0.78 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -116.14 41.68 2.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 110.516 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -168.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.145 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -141.35 -41.38 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 30.2 mtp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.18 179.852 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.035 HD23 HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.522 ' HA ' HD11 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -100.55 128.07 46.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.764 -179.481 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.839 HD11 ' HB ' ' A' ' 72' ' ' ILE . 43.4 mt -123.92 22.69 8.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.54 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.642 ' OG1' HD23 ' A' ' 68' ' ' LEU . 6.4 m -43.7 -37.41 2.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.49 -32.02 5.89 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.674 HG12 HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -46.62 -41.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.392 -1.064 . . . . 0.0 108.644 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.869 HD22 ' HG2' ' A' ' 67' ' ' MET . 3.1 pp -84.29 -26.22 28.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.033 -1.042 . . . . 0.0 108.539 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.704 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.7 t80 -85.85 7.03 25.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 142.23 99.66 0.35 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.723 ' ND2' HD12 ' A' ' 35' ' ' LEU . 6.4 p-10 -20.84 115.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.912 0.863 . . . . 0.0 112.357 -178.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.676 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -136.42 158.81 38.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.568 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 31' ' ' GLU . 4.4 m-20 -88.12 123.57 32.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.605 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . 17.3 p -39.41 -26.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.588 -0.695 . . . . 0.0 110.145 -178.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.0 mt-10 -55.9 -14.32 2.38 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.65 26.56 6.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 28' ' ' ILE . 11.7 mmt-85 -116.55 123.88 48.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -1.149 . . . . 0.0 109.501 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.676 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.39 160.95 16.56 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 111.163 -178.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.723 HD12 ' ND2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 0.0 111.272 -178.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.237 0.541 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.65 -20.31 15.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.107 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 52' ' ' LEU . 3.5 mt -96.31 -43.78 7.53 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.702 . . . . 0.0 110.303 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.029 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.6 -52.96 34.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.577 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.13 -27.24 67.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.429 -0.794 . . . . 0.0 109.559 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.568 ' OD1' ' CD1' ' B' ' 190' ' ' PHE . 1.6 m-80 -77.8 -31.62 51.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.195 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.029 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -56.81 -47.41 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.386 -0.821 . . . . 0.0 109.195 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.54 -25.95 14.75 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB2' HD11 ' B' ' 189' ' ' LEU . 0.8 OUTLIER -124.03 25.63 7.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -1.114 . . . . 0.0 110.136 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 56' ' ' ILE . 2.6 mt -82.08 -21.2 36.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.891 . . . . 0.0 110.069 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.47 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.41 40.36 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 110.548 -179.817 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' HD13 ' A' ' 62' ' ' LEU . 3.4 ttpp -132.81 -4.61 3.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.957 . . . . 0.0 110.521 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -129.39 -2.96 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 111.331 -179.752 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.783 ' N ' HD22 ' A' ' 62' ' ' LEU . . . 168.8 -55.43 0.21 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 4.0 mm? -42.92 -24.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -1.205 . . . . 0.0 110.933 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t70 -44.05 -41.96 5.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 109.716 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.9 m -67.23 -51.19 56.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.435 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.869 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -71.12 -4.47 25.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 178.86 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.663 HD13 ' C ' ' A' ' 68' ' ' LEU . 1.8 tm? -72.32 -62.09 1.56 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.858 0.837 . . . . 0.0 109.032 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.7 0.69 12.18 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.24 0.543 . . . . 0.0 110.298 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 37.3 tt0 -84.36 8.12 17.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 111.196 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.951 HG12 HG11 ' B' ' 122' ' ' VAL . 6.0 t -140.69 2.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.121 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.035 HD13 HD23 ' A' ' 18' ' ' LEU . 3.1 tp -151.01 81.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.78 . . . . 0.0 109.232 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 8.6 t0 -83.98 49.78 1.7 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.095 -1.003 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.974 HD11 ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.343 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.569 HD13 ' CE2' ' B' ' 231' ' ' TYR . 1.3 mp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.011 0.434 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 90.3 t 58.61 125.13 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 110.583 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.7 Cg_endo -74.43 144.05 31.93 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.825 1.434 . . . . 0.0 110.589 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -107.19 129.76 54.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.532 HD22 ' CG2' ' B' ' 160' ' ' ILE . 73.4 mt -69.66 127.1 31.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' B' ' 68' ' ' GLN . 5.6 mm-40 -106.25 -20.28 13.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.441 ' HB2' ' HB ' ' B' ' 161' ' ' VAL . 7.3 m120 -161.42 137.02 7.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.074 -1.016 . . . . 0.0 110.567 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 13.1 mm -115.73 148.39 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.917 HG22 ' CB ' ' B' ' 124' ' ' THR . 27.6 t -137.89 129.18 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.505 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.58 155.55 46.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 65.0 p -111.34 139.26 46.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.182 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.476 ' HB ' ' CG ' ' B' ' 121' ' ' MET . 22.6 t -123.9 148.78 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.837 . . . . 0.0 110.13 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' B' ' 154' ' ' ASP . 4.7 m -119.06 127.52 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.977 HD22 ' HB1' ' B' ' 150' ' ' ALA . 70.2 mt -92.02 -42.94 9.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.004 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.72 68.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 52.9 m -132.84 151.14 52.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -1.198 . . . . 0.0 110.365 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.523 ' O ' HD23 ' B' ' 80' ' ' LEU . 39.2 mtp-105 -79.32 155.2 28.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 110.075 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.523 HD23 ' O ' ' B' ' 79' ' ' ARG . 18.7 mt -127.74 161.0 29.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 8.6 m-20 -94.63 82.11 3.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.81 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.727 ' CD1' ' HB2' ' B' ' 117' ' ' ALA . 92.6 mt -42.01 -27.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.241 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' B' ' 81' ' ' ASP . 18.9 mmmt -67.01 -44.99 78.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 10.9 p -85.41 -38.5 18.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.871 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 43.3 t -52.36 -44.61 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' B' ' 102' ' ' VAL . . . -77.81 -30.36 51.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' B' ' 87' ' ' LEU . 14.1 tp -80.53 -18.9 47.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' B' ' 84' ' ' THR . 1.2 m-70 -99.91 -32.87 10.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.338 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 150.48 45.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -87.15 -26.13 23.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' B' ' 104' ' ' MET . 90.6 m-20 -127.74 78.82 1.85 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.541 ' HB1' ' CG1' ' B' ' 102' ' ' VAL . . . -145.49 158.35 43.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 110.136 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.07 141.12 44.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.67 109.31 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 110.095 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.413 ' OD1' ' NH1' ' B' ' 98' ' ' ARG . 2.6 t-20 -129.35 128.31 23.19 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.83 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -16.16 31.79 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.842 1.443 . . . . 0.0 110.186 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.493 ' HE2' ' NH2' ' B' ' 98' ' ' ARG . 7.3 tttt -86.32 -16.92 35.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.86 . . . . 0.0 110.066 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.493 ' NH2' ' HE2' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -92.21 -67.0 0.88 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.486 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 1.18 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.08 161.67 8.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.288 -0.883 . . . . 0.0 111.225 -179.389 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.83 54.06 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.532 -0.73 . . . . 0.0 111.677 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.18 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -161.85 173.27 14.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.941 -1.099 . . . . 0.0 110.258 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.541 ' CG1' ' HB1' ' B' ' 92' ' ' ALA . 38.0 t -108.06 155.82 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.477 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.519 HD11 ' OG ' ' A' ' 30' ' ' SER . 16.1 mt -113.51 110.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' B' ' 91' ' ' ASN . 12.0 ttm -94.19 151.07 19.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.624 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -149.56 120.88 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.677 HG23 ' CE1' ' B' ' 139' ' ' TYR . 25.1 pt -107.57 156.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.116 -0.99 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -106.88 37.81 2.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.847 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER -175.63 82.19 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.592 -179.78 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.474 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.0 Cg_endo -80.64 161.49 83.41 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.801 -2.166 . . . . 0.0 110.472 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -64.24 104.74 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 109.995 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.435 HG23 ' C ' ' B' ' 110' ' ' LYS . 30.5 p -146.63 166.1 27.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.66 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' B' ' 113' ' ' ALA . 1.8 m -112.52 164.8 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -167.2 146.07 5.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.524 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.886 HD12 ' CE1' ' B' ' 116' ' ' PHE . 0.2 OUTLIER -124.28 119.4 29.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.726 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.566 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 78.6 mt -95.41 131.46 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.974 ' CD1' HD11 ' A' ' 74' ' ' LEU . 8.5 m-30 -90.13 155.19 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.727 ' HB2' ' CD1' ' B' ' 82' ' ' LEU . . . -69.99 -11.61 61.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 110.152 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . 0.413 ' HA ' ' HG2' ' B' ' 79' ' ' ARG . 3.9 m -85.7 -40.48 16.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.27 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.633 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 148.06 -34.79 1.2 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -67.8 150.19 48.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -1.218 . . . . 0.0 110.508 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.476 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -150.14 159.3 44.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.951 HG11 HG12 ' A' ' 71' ' ' VAL . 99.0 t -124.51 137.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 88.6 t -121.89 140.95 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.868 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.917 ' CB ' HG22 ' B' ' 71' ' ' VAL . 3.9 t -145.55 160.83 41.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.444 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.577 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 114.32 -35.26 4.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.42 147.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -1.191 . . . . 0.0 110.083 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.467 ' HB2' ' OD2' ' B' ' 131' ' ' ASP . 13.1 mmtt -96.11 0.74 51.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.63 -165.19 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.39 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.13 -40.38 74.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.04 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -44.64 92.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.482 ' CB ' ' HB1' ' B' ' 126' ' ' ALA . 8.8 m-20 -56.31 -53.51 56.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 0.0 109.964 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 1.5 p -57.81 -32.5 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.848 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . 0.438 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -67.69 -44.69 77.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 109.999 179.691 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -59.73 2.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.043 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.13 3.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.025 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' B' ' 152' ' ' PHE . 18.4 m -65.98 -58.69 4.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.138 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -46.2 -44.03 15.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.004 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -53.29 -47.12 69.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.677 ' CE1' HG23 ' B' ' 106' ' ' ILE . 31.7 m-85 -65.62 -55.05 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 0.0 109.912 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -17.66 8.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -47.02 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 42.0 mt -52.74 -38.06 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' B' ' 150' ' ' ALA . 34.0 mm -71.7 -55.63 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.098 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.26 -27.3 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.942 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -75.54 -21.71 57.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.94 . . . . 0.0 108.613 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 5.7 mt -86.17 -21.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.27 -18.86 6.86 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.569 ' HB2' HG22 ' B' ' 143' ' ' ILE . 11.0 m-85 -53.84 165.98 0.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.286 . . . . 0.0 110.882 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.56 23.8 13.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.552 -0.717 . . . . 0.0 109.823 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.977 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -54.94 148.3 13.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.83 . . . . 0.0 110.552 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -123.35 114.77 20.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 110.04 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' B' ' 136' ' ' SER . 36.2 t80 -69.89 90.9 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 1.4 p -145.6 171.89 14.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' B' ' 75' ' ' THR . 1.1 t0 63.21 29.79 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.438 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.9 t80 -77.36 136.73 38.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.88 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 134.17 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.404 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.68 121.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.862 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -119.68 -4.33 10.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.459 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 3.3 m120 -138.29 115.3 10.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.0 . . . . 0.0 110.616 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.532 ' CG2' HD22 ' B' ' 67' ' ' LEU . 68.9 mt -122.65 125.58 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' B' ' 69' ' ' ASN . 26.0 t -100.26 130.75 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.524 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.05 169.86 24.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 2.3 m -162.89 164.53 25.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -1.147 . . . . 0.0 110.119 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.486 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.6 p -170.34 166.93 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 0.0 110.607 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.67 137.45 50.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 109.74 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.74 HG21 HD11 ' B' ' 170' ' ' ILE . 20.9 m -89.71 12.07 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.423 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.1 OUTLIER 70.82 3.63 4.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.281 -0.887 . . . . 0.0 110.711 179.662 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.61 ' O ' HG23 ' B' ' 166' ' ' VAL . 8.1 p90 -162.58 150.98 12.13 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.386 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 45.1 Cg_endo -71.84 165.66 31.87 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.998 1.525 . . . . 0.0 110.512 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.74 HD11 HG21 ' B' ' 166' ' ' VAL . 3.7 mt -133.25 158.09 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.934 . . . . 0.0 110.79 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . 0.493 ' HD3' ' HG3' ' B' ' 173' ' ' GLU . 3.4 ttm180 -89.3 98.81 11.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.685 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' B' ' 193' ' ' LEU . 92.6 mt -53.66 -55.24 27.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.19 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . 0.493 ' HG3' ' HD3' ' B' ' 171' ' ' ARG . 15.4 pt-20 -54.02 -26.54 26.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.725 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . 0.413 ' HA3' ' HD2' ' B' ' 171' ' ' ARG . . . -73.55 -37.14 53.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' B' ' 175' ' ' LEU . 0.1 OUTLIER -71.54 -44.58 64.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -1.166 . . . . 0.0 110.056 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -59.38 -38.3 80.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -65.5 -32.69 74.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -58.66 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' B' ' 183' ' ' SER . 37.3 m80 -101.74 30.38 4.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.343 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -60.1 -14.71 33.42 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -30.38 64.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -1.19 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' B' ' 198' ' ' VAL . 60.4 m-85 -119.77 0.68 10.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' B' ' 194' ' ' ILE . 0.1 OUTLIER -120.59 174.07 6.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.074 179.873 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.29 152.98 35.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.265 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 0.76 ' HB2' HD12 ' B' ' 193' ' ' LEU . 75.0 t80 -148.75 100.94 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' B' ' 190' ' ' PHE . 23.5 mt-10 -101.31 103.5 27.0 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.936 . . . . 0.0 110.02 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.68 -6.32 18.89 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.938 1.493 . . . . 0.0 110.146 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -99.95 -2.92 33.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 58' ' ' SER . 0.8 OUTLIER -154.71 -41.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 0.0 110.626 -179.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.645 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -111.24 110.8 55.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 110.675 -179.524 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.46 -25.35 15.34 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.115 1.587 . . . . 0.0 110.07 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -95.64 -179.91 36.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.76 HD12 ' HB2' ' B' ' 185' ' ' TYR . 0.7 OUTLIER -113.22 140.62 47.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -1.163 . . . . 0.0 110.359 -179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.529 HG12 ' CD2' ' B' ' 205' ' ' LEU . 67.9 mt -104.87 104.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' B' ' 203' ' ' VAL . 17.9 t80 -96.78 137.21 36.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.546 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -115.66 83.6 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 30.4 ttm -51.87 139.84 21.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' B' ' 182' ' ' PHE . 25.6 t -82.4 -42.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.216 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 9.7 tttp -140.41 114.51 7.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.893 . . . . 0.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.9 Cg_endo -73.49 168.68 75.51 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.968 -2.097 . . . . 0.0 110.607 0.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.407 ' C ' HG12 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -72.69 87.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 0.0 110.005 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 19.1 mm -137.76 153.29 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 110.51 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 195' ' ' TYR . 43.0 t -105.73 126.85 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.573 HD21 ' HB1' ' B' ' 226' ' ' ALA . 5.0 mp -116.55 136.82 52.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 110.277 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.704 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 1.2 mt -119.32 132.69 55.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.329 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.654 HG13 HD12 ' B' ' 212' ' ' ILE . 3.5 mp -112.58 159.98 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.508 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 2.9 m-85 -135.75 147.74 48.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 37.9 t -45.87 -24.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -76.12 -22.65 55.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.438 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.689 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 107.24 4.31 35.4 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.592 ' O ' HD13 ' B' ' 212' ' ' ILE . 22.1 tttt -77.84 141.43 39.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.654 HD12 HG13 ' B' ' 206' ' ' ILE . 15.2 mm -124.53 142.14 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.102 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 11.1 t -124.24 151.9 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.199 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' B' ' 213' ' ' VAL . 3.1 mp -141.35 119.24 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 12.8 t -135.52 166.17 23.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 110.314 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.38 79.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -79.39 132.64 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -1.171 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' B' ' 218' ' ' LYS . 2.1 ttmt -79.24 -26.31 42.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.516 ' HB3' ' HG3' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -144.87 162.23 37.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.375 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -59.44 -26.56 65.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.806 . . . . 0.0 110.552 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -63.85 -27.55 69.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 -179.824 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.43 ' OE1' HD11 ' B' ' 202' ' ' ILE . 4.5 mt-10 -74.57 -42.27 59.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 109.879 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' B' ' 214' ' ' LEU . 32.0 mm -63.75 -40.35 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.37 -39.88 94.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.08 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -74.62 -31.45 62.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -63.92 -38.3 90.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.856 . . . . 0.0 110.156 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.689 ' HA ' HG22 ' B' ' 230' ' ' ILE . 27.5 t80 -79.55 -42.32 25.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 110.221 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' B' ' 228' ' ' GLU . 0.3 OUTLIER -61.83 -17.04 54.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.972 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -96.06 -32.96 12.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.3 tp -89.59 -16.34 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.995 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.594 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.4 t80 -53.86 -43.39 96.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.379 -0.825 . . . . 0.0 111.083 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 46.1 Cg_endo -74.58 -36.87 2.64 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.356 1.188 . . . . 0.0 110.613 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.42 HG12 HD21 ' B' ' 175' ' ' LEU . 40.9 t -63.11 -40.72 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.869 179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.547 HD13 HG11 ' B' ' 166' ' ' VAL . 26.3 mt -62.66 -48.81 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 110.233 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -42.54 84.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.988 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . 0.441 ' CA ' ' OE1' ' B' ' 236' ' ' GLU . 0.0 OUTLIER -61.73 -30.0 70.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 110.156 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -119.58 39.58 3.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' B' ' 239' ' ' LYS . 7.1 tmm_? -69.75 148.49 49.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.235 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.433 ' N ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -91.7 -56.19 3.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.343 -179.895 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 36.5 ttm . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.253 -179.998 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.011 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.227 0.537 . . . . 0.0 109.952 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.885 ' N ' HD12 ' A' ' 18' ' ' LEU . 5.6 p-10 -86.68 93.12 9.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 111.024 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.011 HD21 HD21 ' A' ' 18' ' ' LEU . 2.9 mt -99.21 2.62 45.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.317 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 59' ' ' LEU . 42.3 m -42.33 -39.29 2.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -89.41 -35.25 8.08 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.689 HG12 HG23 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -51.19 -45.44 31.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.459 -1.024 . . . . 0.0 109.076 -179.49 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.769 HD22 ' HG2' ' A' ' 67' ' ' MET . 3.8 pp -82.88 -19.62 37.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 109.827 178.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -100.22 11.62 38.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.246 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 146.58 89.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.986 ' ND2' HD11 ' A' ' 35' ' ' LEU . 4.3 p30 -16.06 124.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.075 0.941 . . . . 0.0 112.506 -179.264 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.689 HG23 HG12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -145.67 161.13 12.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.854 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 28' ' ' ILE . 68.9 m-20 -86.8 134.33 33.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 1.01 ' HB2' HD13 ' A' ' 18' ' ' LEU . 9.7 p -39.35 -27.36 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.598 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 10.3 tt0 -55.57 -15.41 2.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 178.275 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 31.26 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.72 129.32 49.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.957 -1.32 . . . . 0.0 110.571 179.83 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.35 150.58 20.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.299 -0.876 . . . . 0.0 110.698 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.986 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.522 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.172 0.51 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -22.8 14.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.192 -0.943 . . . . 0.0 108.833 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.644 HD21 ' CD1' ' B' ' 205' ' ' LEU . 4.0 mt -103.51 -40.06 6.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.591 -0.693 . . . . 0.0 110.435 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.924 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.75 -56.01 16.34 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.721 -179.16 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -64.88 -24.53 67.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.643 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 2.2 m-20 -80.04 -37.03 34.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.466 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.924 HD12 ' HA ' ' A' ' 53' ' ' ARG . 8.0 mt -53.71 -43.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.65 -22.46 46.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.6 p -127.21 17.83 7.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -1.117 . . . . 0.0 110.31 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.857 HD23 HD21 ' A' ' 62' ' ' LEU . 4.8 mt -79.02 -11.47 60.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.53 38.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.537 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 24.8 ttpt -137.16 12.99 3.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.996 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.857 HD21 HD23 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -136.96 -29.77 0.9 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 110.948 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.9 -44.35 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.112 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.8 mm? -44.83 -23.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -1.231 . . . . 0.0 110.793 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 64' ' ' LEU . 7.8 t0 -43.93 -41.65 5.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.022 . . . . 0.0 109.744 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.7 -45.82 74.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.428 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.769 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -72.22 -8.73 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.388 179.17 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.654 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.2 tm? -71.17 -60.89 1.99 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.948 0.88 . . . . 0.0 108.88 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -72.57 0.4 10.59 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.328 0.585 . . . . 0.0 110.14 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 44.8 tt0 -84.3 1.18 46.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -0.918 . . . . 0.0 111.171 -179.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.759 HG12 HG11 ' B' ' 122' ' ' VAL . 3.4 t -138.36 -2.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.128 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.98 HD11 HD12 ' A' ' 74' ' ' LEU . 4.4 tp -150.85 77.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.444 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.7 p-10 -78.57 55.35 1.62 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.962 -1.086 . . . . 0.0 108.851 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.042 HD11 ' HB2' ' B' ' 101' ' ' ALA . 8.7 mt . . . . . 0 C--N 1.306 -1.294 0 CA-C-O 121.672 0.748 . . . . 0.0 110.668 -179.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' B' ' 64' ' ' VAL . 1.5 mp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.317 0.58 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' B' ' 63' ' ' ILE . 4.3 t 61.04 130.65 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 0.0 110.318 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 45.6 Cg_endo -74.03 137.44 24.1 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.973 1.512 . . . . 0.0 110.388 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -99.06 128.51 45.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.537 HD22 HG22 ' B' ' 160' ' ' ILE . 69.9 mt -70.42 114.6 8.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 110.121 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -102.82 -9.62 19.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.291 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.498 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 0.6 OUTLIER -168.27 157.86 9.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 -179.857 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 126' ' ' ALA . 8.1 mt -156.9 159.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.965 . . . . 0.0 109.853 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.631 HG22 ' HB ' ' B' ' 124' ' ' THR . 50.7 t -139.47 143.02 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' B' ' 157' ' ' ILE . . . -132.82 151.55 51.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 14.8 p -108.58 120.77 43.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 65.4 t -116.76 151.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.165 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 27.5 m -122.8 152.24 40.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 1.006 HD22 ' HB1' ' B' ' 150' ' ' ALA . 14.0 mt -105.14 -44.52 4.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.95 -11.22 34.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 176.35 8.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -1.124 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.738 ' O ' HD23 ' B' ' 80' ' ' LEU . 9.6 ttt180 -93.73 160.95 14.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.999 HD11 ' CD1' ' B' ' 76' ' ' LEU . 13.5 mt -134.84 149.41 50.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.979 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 2.7 m-20 -95.45 100.44 12.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 21.2 mt -50.66 -39.4 50.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.042 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -42.28 84.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 4.2 m -87.64 -44.24 11.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.025 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -53.72 -37.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.551 ' HB2' ' CG2' ' B' ' 102' ' ' VAL . . . -83.67 -28.95 27.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 87' ' ' LEU . 1.9 tp -84.14 -23.63 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' B' ' 84' ' ' THR . 8.2 m80 -94.03 -32.49 13.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -64.02 139.41 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.044 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -73.47 -27.74 61.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.955 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 10.6 t-20 -134.69 79.48 1.8 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -149.38 154.72 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . 0.537 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 16.2 pt-20 -136.24 165.49 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -139.86 113.76 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.099 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -115.67 96.23 45.79 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.363 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -16.27 25.82 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.974 1.512 . . . . 0.0 110.412 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -3.94 44.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.406 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -126.54 -34.45 2.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.141 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.957 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.49 -171.59 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.402 -0.811 . . . . 0.0 110.842 -179.301 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.96 57.03 0.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 111.542 -178.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -147.84 155.82 42.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.959 -1.088 . . . . 0.0 110.775 179.22 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' B' ' 86' ' ' ALA . 73.0 t -97.79 126.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.919 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 20.0 mm -90.29 129.51 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.358 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 1.3 ttt -102.4 162.54 12.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.449 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 0.6 OUTLIER -154.36 124.3 6.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 110.601 -179.773 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.529 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 8.7 pt -129.06 155.62 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.631 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.457 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 0.4 OUTLIER -102.41 34.28 2.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.435 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.0 OUTLIER -177.06 87.45 0.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.8 Cg_endo -79.08 149.31 83.84 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.21 -0.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 3.9 tttt -62.05 97.69 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.153 -0.967 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' B' ' 124' ' ' THR . 23.8 p -149.67 170.95 17.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 110.749 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -110.79 156.55 20.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.557 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -136.82 143.64 43.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 110.938 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.53 ' HB3' ' CZ ' ' B' ' 116' ' ' PHE . 2.8 mm? -104.87 125.39 50.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.4 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.582 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 31.4 mm -110.13 121.56 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 0.0 110.868 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.53 ' CZ ' ' HB3' ' B' ' 114' ' ' LEU . 6.8 m-85 -106.24 128.43 53.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.301 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.25 -24.3 4.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.219 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.472 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 131.83 -26.47 3.81 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -71.61 149.96 45.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.481 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.9 OUTLIER -139.86 140.91 36.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -115.29 157.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.949 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 71' ' ' VAL . 33.6 t -142.46 153.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.672 HG21 HD13 ' A' ' 23' ' ' ILE . 1.8 t -149.71 163.12 38.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.562 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 112.0 -30.42 7.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -56.0 147.62 19.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -1.07 . . . . 0.0 110.253 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . 0.401 ' HG2' ' OD2' ' B' ' 131' ' ' ASP . 10.9 ptmt -119.41 -22.08 7.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m -121.88 -141.32 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.814 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.91 -41.92 5.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 131' ' ' ASP . 6.4 p30 -72.07 -21.87 61.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.204 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 73.9 m-20 -70.95 -35.16 72.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 110.434 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . 0.481 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 12.1 m -79.27 -32.59 43.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.278 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -74.82 -42.95 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 110.151 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' B' ' 130' ' ' ASP . 0.2 OUTLIER -64.12 -37.59 88.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.76 -60.79 2.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.518 ' OG ' HG21 ' B' ' 123' ' ' VAL . 2.8 m -51.08 -46.63 61.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -45.08 88.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.8 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.473 ' CD ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -58.93 -41.4 87.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.903 179.746 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.723 ' HA ' HD12 ' B' ' 142' ' ' ILE . 37.5 m-85 -66.79 -55.45 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.985 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . 0.521 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -48.57 -33.77 10.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 8.3 mmt180 -64.73 -41.32 96.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' B' ' 139' ' ' TYR . 28.1 mt -54.63 -49.75 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.624 HD13 HD13 ' B' ' 80' ' ' LEU . 9.0 mt -69.25 -54.23 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.579 HE21 ' HB3' ' B' ' 150' ' ' ALA . 0.9 OUTLIER -59.56 -32.89 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.94 . . . . 0.0 109.925 179.719 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 0.6 OUTLIER -72.92 -27.24 61.75 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.069 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.6 mt -76.28 -15.71 15.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 117.17 -27.34 7.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.481 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 9.6 m-85 -41.99 154.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.258 . . . . 0.0 110.765 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.52 24.63 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 1.006 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -72.42 165.59 24.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.11 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.533 ' O ' HD23 ' B' ' 76' ' ' LEU . 19.0 tttt -142.78 169.48 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.374 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . 0.503 ' O ' HG23 ' B' ' 153' ' ' THR . 60.6 t80 -101.1 91.47 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.161 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.503 HG23 ' O ' ' B' ' 152' ' ' PHE . 1.5 p -153.52 176.6 11.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.259 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . 0.506 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 20.5 t0 60.84 24.11 14.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.092 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 3.3 t80 -80.54 133.12 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -163.74 132.17 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 110.151 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' B' ' 72' ' ' ALA . 1.9 mp -79.96 109.4 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 109.917 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -103.47 -3.04 25.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 110.838 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.91 108.5 4.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.036 -1.04 . . . . 0.0 110.904 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.537 HG22 HD22 ' B' ' 67' ' ' LEU . 95.6 mt -113.21 120.03 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.177 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.589 HG22 ' OG1' ' B' ' 215' ' ' THR . 3.5 t -95.37 140.37 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.637 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.75 177.04 20.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 73.7 m -166.05 140.6 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -1.178 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.505 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 8.9 p -170.23 136.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.95 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 59.2 p30 -103.41 179.81 4.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.024 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.553 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.2 OUTLIER -124.44 -86.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.213 -0.929 . . . . 0.0 110.3 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.553 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 173.97 33.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.53 ' CD1' ' HG2' ' B' ' 238' ' ' ARG . 11.8 p90 -166.32 149.32 6.41 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.64 145.49 46.83 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.098 1.578 . . . . 0.0 110.484 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.43 HD13 ' CG2' ' B' ' 206' ' ' ILE . 6.0 mt -112.2 142.62 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 0.0 110.514 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -82.1 92.83 6.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -0.834 . . . . 0.0 109.793 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' B' ' 193' ' ' LEU . 11.5 mt -51.23 -47.48 62.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.72 -50.12 74.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.937 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -49.79 -34.09 21.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.4 OUTLIER -71.32 -59.44 2.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 109.92 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' B' ' 180' ' ' GLY . . . -58.63 -19.49 39.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.07 -51.09 23.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.33 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 -32.72 11.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.463 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' B' ' 183' ' ' SER . 54.5 m80 -108.75 19.98 19.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' B' ' 176' ' ' ALA . . . -45.3 -51.6 9.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 55.5 m -62.09 -18.58 61.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -1.135 . . . . 0.0 109.931 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . 0.446 ' N ' ' O ' ' B' ' 179' ' ' HIS . 1.4 m-85 -105.4 -10.5 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.058 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.478 ' N ' ' O ' ' B' ' 179' ' ' HIS . 13.9 p -154.07 154.96 34.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 0.5 OUTLIER -126.7 164.74 20.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 110.06 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 0.578 ' HB2' HD12 ' B' ' 193' ' ' LEU . 1.7 t80 -164.1 86.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -92.11 110.04 41.57 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 110.135 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -7.18 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.9 1.474 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.34 -6.43 56.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 189' ' ' LEU . 1.9 tt -146.97 -35.61 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.569 ' CD2' HD11 ' B' ' 194' ' ' ILE . 0.8 OUTLIER -118.47 130.38 24.81 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.992 . . . . 0.0 110.609 -179.888 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.45 -42.09 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.949 1.499 . . . . 0.0 110.376 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.69 -179.55 44.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' B' ' 185' ' ' TYR . 0.9 OUTLIER -96.46 147.49 23.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -1.156 . . . . 0.0 110.297 -179.92 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.691 HG21 HD13 ' A' ' 62' ' ' LEU . 63.4 mt -109.82 104.93 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -97.58 128.66 44.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.474 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' B' ' 203' ' ' VAL . 12.2 ttt-85 -110.92 80.74 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.456 ' N ' ' O ' ' B' ' 202' ' ' ILE . 37.1 tpp -45.81 134.59 7.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 75.3 t -88.17 -34.72 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.359 -0.838 . . . . 0.0 109.975 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.1 OUTLIER -143.58 108.34 5.17 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 110.049 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.2 Cg_endo -71.44 169.46 69.37 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.94 -2.109 . . . . 0.0 110.786 0.046 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.553 ' O ' HD13 ' B' ' 202' ' ' ILE . 5.6 mtmp? -75.22 81.56 2.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.34 -0.85 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.553 HD13 ' O ' ' B' ' 201' ' ' LYS . 10.4 mm -130.41 148.22 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.708 ' C ' HD12 ' B' ' 204' ' ' LEU . 10.5 t -108.42 137.46 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.019 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.83 ' N ' HD12 ' B' ' 204' ' ' LEU . 3.6 mp -131.51 151.82 51.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.925 . . . . 0.0 110.571 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.698 ' O ' HD13 ' B' ' 206' ' ' ILE . 25.1 mt -110.13 144.9 38.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.473 179.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.698 HD13 ' O ' ' B' ' 205' ' ' LEU . 11.8 mm -127.81 104.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.989 -1.07 . . . . 0.0 110.302 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' B' ' 209' ' ' SER . 66.8 m-85 -91.05 133.99 34.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 36.1 t -42.24 -26.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 110.416 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.439 ' N ' ' O ' ' B' ' 207' ' ' PHE . 0.0 OUTLIER -59.34 -38.63 80.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' B' ' 165' ' ' ASP . . . 121.35 15.86 4.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 124.98 41.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.031 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.577 HD12 HD12 ' B' ' 206' ' ' ILE . 21.1 mm -108.89 125.6 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.538 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.522 ' C ' HD12 ' B' ' 214' ' ' LEU . 17.1 t -105.77 159.4 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.395 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.1 mp -143.05 146.17 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.589 ' OG1' HG22 ' B' ' 161' ' ' VAL . 5.5 t -169.8 145.09 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 110.18 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.62 10.74 26.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -91.3 158.74 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -1.198 . . . . 0.0 110.227 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -103.39 -23.75 13.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.479 ' N ' ' HG2' ' B' ' 218' ' ' LYS . 0.0 OUTLIER -137.65 179.35 6.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . 0.454 ' HG3' ' CE1' ' B' ' 224' ' ' TYR . 1.6 ttt180 -75.88 -27.75 57.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.363 -0.836 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -61.05 -41.17 96.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.496 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -61.43 -52.16 65.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 0.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.468 HD11 ' O ' ' B' ' 160' ' ' ILE . 22.6 mm -58.05 -43.8 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' B' ' 220' ' ' ARG . 10.5 m-85 -70.98 -34.16 71.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.204 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 3.4 tp60 -80.48 -44.16 19.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 110.047 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.14 -38.42 68.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.627 ' O ' HG22 ' B' ' 230' ' ' ILE . 15.7 t80 -68.92 -52.72 26.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.995 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -54.29 -24.21 18.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.783 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.81 -30.82 45.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 110.039 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.627 HG22 ' O ' ' B' ' 227' ' ' PHE . 6.0 tp -93.38 -17.37 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.891 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.72 -47.88 60.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 111.015 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.77 -40.44 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.593 1.312 . . . . 0.0 110.612 -179.404 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.494 ' CG1' HD11 ' B' ' 175' ' ' LEU . 40.8 t -58.52 -42.32 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.907 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 77.5 mt -66.67 -40.22 88.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.34 -25.4 63.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.36 -27.15 59.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 59.9 m-85 -117.16 42.74 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.53 ' HG2' ' CD1' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -68.16 -172.01 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -35.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.142 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . 0.462 ' HG3' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.141 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.06 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.799 ' HA ' HD11 ' A' ' 68' ' ' LEU . 12.0 t0 -101.04 118.38 36.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.919 -1.113 . . . . 0.0 111.117 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.06 HD21 HD21 ' A' ' 18' ' ' LEU . 6.6 mt -113.78 12.79 18.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 110.641 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.687 ' OG1' HD23 ' A' ' 68' ' ' LEU . 3.1 m -42.43 -27.74 0.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 110.187 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.567 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -91.36 -30.2 11.2 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 20' ' ' LEU . 16.3 mm -50.65 -53.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.295 . . . . 0.0 108.771 -179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.1 pp -78.97 5.7 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.468 -0.77 . . . . 0.0 110.004 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CD1' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -107.99 -17.61 14.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.177 -0.952 . . . . 0.0 111.14 -179.516 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 151.79 48.74 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.252 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.988 ' OD1' HD21 ' A' ' 35' ' ' LEU . 0.9 OUTLIER 63.86 139.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.012 -1.287 . . . . 0.0 111.275 178.524 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.763 HG23 HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.35 157.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 68.1 m-20 -90.08 122.52 33.13 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 177.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.479 ' OG ' HG13 ' B' ' 103' ' ' ILE . 1.5 p -39.8 -26.67 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.727 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.1 tt0 -57.48 -13.53 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.447 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.92 26.3 5.58 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.98 117.43 26.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.076 -1.249 . . . . 0.0 109.814 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 35' ' ' LEU . 2.8 tt -88.36 156.9 18.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.778 -1.201 . . . . 0.0 110.244 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.988 HD21 ' OD1' ' A' ' 27' ' ' ASN . 4.2 pp . . . . . 0 N--CA 1.491 1.622 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.043 -179.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.113 0.482 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.01 -25.5 14.04 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.973 ' O ' HD12 ' A' ' 56' ' ' ILE . 2.7 mt -92.54 -42.28 9.78 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.552 -0.718 . . . . 0.0 110.139 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.66 -51.22 16.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 0.0 109.609 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -66.53 -13.83 61.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.825 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' A' ' 59' ' ' LEU . 9.7 m-80 -96.23 -40.19 9.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.825 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.973 HD12 ' O ' ' A' ' 52' ' ' LEU . 1.2 mp -51.42 -40.65 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.399 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.39 -14.54 49.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 p -134.53 18.11 3.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 110.39 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 6.7 mt -98.04 16.27 21.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.2 m -90.95 42.97 1.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 110.433 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HG3' ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -151.78 -30.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -0.971 . . . . 0.0 110.954 179.854 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -74.37 6.15 3.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.977 -1.077 . . . . 0.0 111.271 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.586 ' N ' HD13 ' A' ' 62' ' ' LEU . . . 144.03 -46.92 0.8 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.751 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.6 mm? -52.0 -18.15 1.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 110.678 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 66' ' ' SER . 2.7 p30 -43.0 -39.65 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 10.9 m -67.67 -55.92 11.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.387 -0.821 . . . . 0.0 109.976 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.461 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.52 -6.6 26.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.602 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.799 HD11 ' HA ' ' A' ' 19' ' ' ASP . 1.2 tm? -71.02 -62.89 1.23 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.179 0.99 . . . . 0.0 108.848 179.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.48 1.69 13.46 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.164 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 66' ' ' SER . 15.4 tt0 -91.24 11.36 23.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 111.696 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 20' ' ' LEU . 3.2 t -138.4 0.42 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.042 HD11 ' CD1' ' A' ' 74' ' ' LEU . 2.0 tp -152.0 74.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 110.233 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 56.9 t0 -79.74 56.65 2.32 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.923 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.042 ' CD1' HD11 ' A' ' 72' ' ' ILE . 5.8 mt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.719 0.771 . . . . 0.0 110.716 -179.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.0 mp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.152 0.501 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 14.5 t 60.54 126.93 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.301 -0.874 . . . . 0.0 110.057 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.475 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 44.2 Cg_endo -70.95 150.31 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.85 1.447 . . . . 0.0 110.484 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' B' ' 68' ' ' GLN . 18.1 m -122.04 128.02 50.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.486 HD21 HG21 ' B' ' 223' ' ' ILE . 21.7 mt -70.29 117.53 11.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 110.211 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.457 ' O ' ' OD1' ' B' ' 69' ' ' ASN . 19.8 mm-40 -112.35 -13.63 13.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.351 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.533 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 4.5 m120 -153.53 158.03 40.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.562 HG22 ' N ' ' B' ' 71' ' ' VAL . 8.4 mt -154.96 169.2 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.987 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' B' ' 124' ' ' THR . 27.0 t -139.23 130.48 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.94 143.96 50.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 94.7 m -93.62 128.93 40.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.89 . . . . 0.0 110.355 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.63 146.07 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.2 m -125.49 145.68 49.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 1.133 HD22 ' HB1' ' B' ' 150' ' ' ALA . 91.8 mt -97.08 -41.85 8.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.11 54.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 7.3 t -148.43 153.87 39.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -1.181 . . . . 0.0 110.335 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -77.52 149.21 34.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.097 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.938 HD11 ' CD1' ' B' ' 76' ' ' LEU . 68.9 mt -124.69 155.66 38.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -0.97 . . . . 0.0 110.505 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' B' ' 82' ' ' LEU . 4.9 m-20 -92.69 83.64 4.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 109.455 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.786 HD22 HG23 ' B' ' 102' ' ' VAL . 94.6 mt -40.1 -35.6 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.723 . . . . 0.0 110.536 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -50.12 73.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 110.008 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -77.47 -43.28 32.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.495 HG22 ' CE2' ' B' ' 148' ' ' PHE . 85.2 t -50.38 -43.96 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.142 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.96 -21.72 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 tp -86.2 -37.22 18.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -87.74 -24.95 23.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.478 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -70.63 136.34 49.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.145 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -24.08 58.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 9.6 t-20 -135.63 79.45 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.096 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.85 149.97 46.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -0.859 . . . . 0.0 109.955 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -125.78 119.36 27.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.341 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.525 ' CE1' ' HB3' ' B' ' 82' ' ' LEU . 8.1 t80 -114.37 118.96 35.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 109.929 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -129.05 110.22 18.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.277 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.47 -22.1 18.85 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.969 1.51 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -17.94 56.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -102.02 -45.34 5.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.752 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.54 -162.42 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.913 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.414 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -122.12 54.86 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 111.043 -179.357 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.997 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -143.14 172.16 13.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 110.095 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.786 HG23 HD22 ' B' ' 82' ' ' LEU . 42.1 t -114.56 123.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.36 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.81 ' CD1' HD13 ' B' ' 114' ' ' LEU . 15.2 mm -93.67 108.6 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.979 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.562 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 1.4 ttm -89.81 146.54 24.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.428 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 3.8 ttt85 -135.63 118.66 16.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.439 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.757 HG23 ' CE1' ' B' ' 139' ' ' TYR . 18.2 pt -114.71 165.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.934 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.7 ptm180 -110.59 22.9 14.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.389 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 2.4 tt0 -176.9 94.74 0.24 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.267 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.1 Cg_endo -76.73 143.93 77.33 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.477 -0.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.721 ' O ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -57.12 108.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.0 109.926 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.721 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -161.76 -179.14 6.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.753 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -126.54 158.74 35.4 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.7 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -132.82 124.98 29.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 111.103 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.81 HD13 ' CD1' ' B' ' 103' ' ' ILE . 3.9 mm? -92.24 89.83 7.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.711 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 41.1 mt -90.28 128.61 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.168 -178.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.787 ' CZ ' HD12 ' A' ' 72' ' ' ILE . 4.0 m-30 -110.19 144.75 38.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 109.593 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -54.36 -19.88 6.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 110.408 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -7.18 37.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 101.55 -25.93 26.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -56.23 173.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -1.206 . . . . 0.0 110.082 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.51 ' CG ' HG12 ' B' ' 115' ' ' ILE . 3.2 tmm? -169.05 119.89 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 71' ' ' VAL . 3.8 t -109.4 138.98 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.378 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.42 124.01 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 110.766 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.694 HG23 ' ND2' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -117.44 170.63 8.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 109.801 179.656 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 102.81 -35.67 4.83 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -50.04 157.09 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -1.187 . . . . 0.0 110.387 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -121.76 -25.39 5.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 164.82 27.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.88 -63.01 1.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.189 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -45.44 -37.48 5.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -70.4 -42.02 72.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.159 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -55.48 -40.64 71.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . 0.474 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -69.1 -49.05 60.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.328 -179.918 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.455 ' HB3' ' HG3' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -55.0 -51.66 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 110.168 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.3 -47.55 65.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.218 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -69.31 -47.24 65.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.07 -42.36 65.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.391 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.478 ' NZ ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -63.73 -36.73 84.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.757 ' CE1' HG23 ' B' ' 106' ' ' ILE . 13.4 m-85 -72.01 -56.95 4.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.61 -22.95 0.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.766 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . 0.451 ' HD3' ' HD3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -73.58 -50.53 20.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 110.073 179.803 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' B' ' 139' ' ' TYR . 46.4 mt -50.75 -38.83 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.69 HG22 ' HB2' ' B' ' 148' ' ' PHE . 38.8 mm -72.54 -58.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 110.039 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 56.7 mt-30 -61.39 -27.63 68.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 109.961 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.451 ' HD3' ' HD3' ' B' ' 141' ' ' ARG . 27.5 ttpt -75.39 -23.45 57.08 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.179 -0.95 . . . . 0.0 108.504 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.6 mt -83.79 -21.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.87 -16.23 7.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.69 ' HB2' HG22 ' B' ' 143' ' ' ILE . 14.9 m-85 -54.4 172.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.077 -1.249 . . . . 0.0 110.865 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.27 32.06 5.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.631 -0.668 . . . . 0.0 109.747 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 1.133 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -77.16 144.24 38.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 110.504 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.18 51.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -71.94 97.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.172 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 176.24 9.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.56 33.98 23.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.659 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . 0.474 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.0 t80 -76.16 127.91 33.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 109.927 179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -161.43 129.64 4.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.123 -0.985 . . . . 0.0 110.709 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 20.3 mt -87.65 131.0 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.73 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . 0.447 ' HA ' ' HG2' ' B' ' 218' ' ' LYS . 4.5 mt-30 -135.31 0.56 2.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.046 -1.034 . . . . 0.0 110.95 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.525 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.2 OUTLIER -142.53 96.85 3.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.01 -1.056 . . . . 0.0 110.932 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' B' ' 215' ' ' THR . 75.4 mt -98.71 153.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 15.8 t -134.15 131.12 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.031 . . . . 0.0 110.571 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.43 175.7 18.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.14 148.63 8.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -1.21 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.475 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.3 p -169.45 170.71 8.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . 0.417 ' O ' HD13 ' B' ' 63' ' ' ILE . 6.2 m-20 -116.29 155.77 27.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.294 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.56 ' O ' ' CD2' ' B' ' 168' ' ' PHE . 10.2 m -103.87 11.5 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.9 OUTLIER 71.89 3.46 4.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.368 -0.832 . . . . 0.0 110.789 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 8.3 p90 -162.02 156.04 18.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 110.495 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.494 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 45.3 Cg_endo -74.24 161.87 39.74 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.103 1.581 . . . . 0.0 110.357 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.485 HD11 HG21 ' B' ' 166' ' ' VAL . 3.0 mt -127.07 148.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.38 104.6 16.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.825 HD22 ' CB ' ' B' ' 193' ' ' LEU . 26.9 mt -61.7 -48.51 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.44 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.69 -51.45 69.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.599 -179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.8 -51.08 55.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' B' ' 237' ' ' PHE . 8.0 tp -68.4 -36.25 78.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -1.141 . . . . 0.0 110.676 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -61.11 -30.65 70.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 7.0 t80 -76.93 -44.59 30.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.6 t -68.73 -48.94 62.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.273 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -110.87 37.44 2.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -54.14 -34.32 52.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -15.92 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.191 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -111.32 -0.75 16.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.888 . . . . 0.0 110.283 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.563 ' HB2' HD21 ' B' ' 193' ' ' LEU . 1.1 p -140.86 168.92 18.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 110.429 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 69.1 m -139.95 130.64 25.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.032 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -132.75 120.31 21.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.128 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 190' ' ' PHE . 99.2 mt-10 -121.19 100.71 45.13 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.46 -0.71 9.15 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.932 1.49 . . . . 0.0 110.4 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.82 -18.62 17.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.151 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.646 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.6 tt -147.34 9.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.604 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.489 ' HB2' HD23 ' B' ' 189' ' ' LEU . 19.0 t80 -167.97 107.63 0.57 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.874 -1.141 . . . . 0.0 110.421 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.79 -15.77 23.82 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.916 1.482 . . . . 0.0 110.165 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.61 44.13 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.825 ' CB ' HD22 ' B' ' 172' ' ' LEU . 7.3 tt -124.53 134.29 53.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -1.169 . . . . 0.0 110.433 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.765 HD13 HD23 ' A' ' 62' ' ' LEU . 3.3 mt -104.74 113.85 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 109.886 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.633 ' CD2' HD11 ' B' ' 230' ' ' ILE . 4.5 t80 -93.32 127.06 38.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.442 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.442 ' NH2' ' HA3' ' A' ' 63' ' ' GLY . 65.0 mtt180 -99.12 103.15 15.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.108 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 47.4 tpp -75.97 131.1 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.096 -1.003 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' B' ' 199' ' ' LYS . 39.4 t -80.51 -32.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.587 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 10.2 mttt -147.39 108.26 3.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.47 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -73.9 172.32 62.09 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.96 -2.1 . . . . 0.0 110.328 -0.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.5 OUTLIER -78.2 81.47 4.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.004 179.835 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' B' ' 217' ' ' ALA . 35.3 mm -126.04 154.01 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.29 111.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 110.295 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.713 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.9 mp -99.71 133.13 44.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.927 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 0.5 OUTLIER -93.69 147.31 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 179.984 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.451 HG22 HD21 ' B' ' 172' ' ' LEU . 5.1 mt -137.86 120.14 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -110.72 150.11 29.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 93.2 t -52.16 -27.14 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.382 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -37.44 84.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 110.253 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 119.81 1.92 13.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.413 ' HA ' ' OD1' ' B' ' 165' ' ' ASP . 11.2 tttm -81.21 140.48 34.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 110.049 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.408 HD13 ' O ' ' B' ' 211' ' ' LYS . 22.0 mm -123.13 132.38 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.405 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 2.3 t -120.04 148.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.24 -0.912 . . . . 0.0 109.694 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.0 mp -135.17 127.76 30.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.077 -1.014 . . . . 0.0 110.654 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 3.4 t -150.42 174.46 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.58 -0.42 77.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.813 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -94.24 142.54 27.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 110.183 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' B' ' 158' ' ' GLN . 3.2 mttm -87.27 -25.34 24.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . 0.426 ' C ' HD12 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -127.41 168.45 14.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -73.93 -27.53 61.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.331 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -57.37 -42.53 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.446 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 31.3 mt-10 -59.45 -46.81 87.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 109.871 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.682 HG22 ' N ' ' B' ' 224' ' ' TYR . 0.9 OUTLIER -56.49 -56.96 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -0.821 . . . . 0.0 109.42 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . 0.682 ' N ' HG22 ' B' ' 223' ' ' ILE . 1.1 m-85 -53.09 -33.61 52.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 110.273 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -79.03 -40.69 30.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.005 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.713 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.77 -42.59 89.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.662 ' HA ' HG22 ' B' ' 230' ' ' ILE . 79.4 t80 -68.51 -55.98 9.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.05 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . 0.429 ' O ' ' HD3' ' B' ' 232' ' ' PRO . 0.4 OUTLIER -50.21 -29.87 10.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.886 . . . . 0.0 110.064 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.452 ' O ' ' HD2' ' B' ' 232' ' ' PRO . . . -81.49 -36.0 29.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 110.165 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.6 tp -88.14 -13.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 110.025 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.603 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 64.3 t80 -59.63 -43.21 95.12 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.852 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -75.9 -23.37 12.43 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.396 1.209 . . . . 0.0 110.24 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 37.7 t -72.59 -40.89 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.461 ' HB3' HG12 ' B' ' 170' ' ' ILE . 35.8 mt -67.0 -50.25 62.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -33.13 65.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 110.357 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.24 -40.89 90.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . 0.462 ' CD2' HD13 ' B' ' 175' ' ' LEU . 51.7 m-85 -113.72 38.81 2.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.17 -0.956 . . . . 0.0 110.194 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -179.99 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.494 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 4.3 tptt -116.87 -35.45 4.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.223 179.897 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.825 ' CD2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.543 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -82.56 63.18 6.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 0.0 111.917 -178.628 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.822 HD21 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -83.9 -3.16 57.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.964 -1.085 . . . . 0.0 109.604 178.627 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.632 ' OG1' HD23 ' A' ' 68' ' ' LEU . 3.4 m -52.95 -21.55 4.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.281 -0.887 . . . . 0.0 109.638 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -97.23 -37.9 4.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.629 HD11 HD21 ' B' ' 114' ' ' LEU . 0.6 OUTLIER -46.09 -46.33 5.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.22 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.914 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.9 OUTLIER -79.5 -19.48 49.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.144 -0.972 . . . . 0.0 108.944 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.5 OUTLIER -85.94 -17.44 35.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.395 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 158.34 93.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.066 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.688 ' ND2' HG23 ' B' ' 124' ' ' THR . 4.5 t-20 2.53 112.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.001 0.905 . . . . 0.0 113.043 178.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.703 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -138.41 159.66 31.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 31' ' ' GLU . 39.5 m-20 -86.76 125.99 34.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.565 ' CA ' HD11 ' A' ' 18' ' ' LEU . 3.0 p -37.99 -28.03 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.433 0.635 . . . . 0.0 109.895 -178.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 29' ' ' ASP . 8.7 tt0 -57.04 -13.43 2.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.449 178.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.56 34.5 3.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.08 129.65 53.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -1.131 . . . . 0.0 110.069 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.838 HD23 ' N ' ' A' ' 35' ' ' LEU . 5.6 tt -89.02 155.37 19.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 111.067 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.838 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 122.073 0.939 . . . . 0.0 111.304 -179.112 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.209 0.528 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -101.19 -26.34 13.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.079 -1.013 . . . . 0.0 110.141 -179.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.473 HD13 ' CE1' ' A' ' 25' ' ' PHE . 5.2 mt -105.31 -44.99 4.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 110.898 -179.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.91 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -51.76 -55.53 19.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.1 pp20? -65.82 -15.45 62.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.635 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 3.9 m-20 -87.61 -39.57 14.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.508 -0.745 . . . . 0.0 109.28 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.91 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.0 mt -52.26 -43.65 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.481 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.76 13.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -126.52 7.84 6.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -1.153 . . . . 0.0 110.669 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 56' ' ' ILE . 7.4 mt -72.02 -8.45 54.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 110.332 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -80.65 50.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.318 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -148.77 -39.62 0.16 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.812 HD22 HD12 ' B' ' 194' ' ' ILE . 0.1 OUTLIER -71.24 -70.12 0.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.341 -0.849 . . . . 0.0 110.519 -179.904 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.38 -35.07 0.08 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -51.22 -20.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -1.179 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.1 t0 -44.33 -40.62 5.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.95 . . . . 0.0 109.955 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.8 OUTLIER -65.36 -48.41 73.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.914 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.89 -4.26 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.732 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.725 HD13 ' C ' ' A' ' 68' ' ' LEU . 3.4 tm? -78.23 -54.91 5.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.73 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -83.64 1.34 42.81 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.46 0.648 . . . . 0.0 109.695 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 1.5 tt0 -88.31 -1.71 58.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 111.643 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 20' ' ' LEU . 2.2 t -131.74 -1.04 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 118.527 -1.269 . . . . 0.0 109.688 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.036 HD11 HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -151.23 67.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.504 -0.747 . . . . 0.0 110.042 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.6 58.65 0.43 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.993 -1.067 . . . . 0.0 108.622 179.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.036 HD12 HD11 ' A' ' 72' ' ' ILE . 27.9 mt . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 121.571 0.701 . . . . 0.0 110.907 -178.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.5 mt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.187 0.517 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 8.2 t 61.06 128.2 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.934 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 65' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 44.1 Cg_endo -70.14 161.55 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.8 1.421 . . . . 0.0 110.556 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 66' ' ' THR . . . . . 0.483 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.4 m -121.39 133.28 55.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.888 . . . . 0.0 110.161 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.746 HD22 ' CG2' ' B' ' 160' ' ' ILE . 80.9 mt -74.6 108.38 7.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 41.6 mm-40 -89.98 -15.04 32.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 69' ' ' ASN . . . . . 0.425 ' O ' HG13 ' B' ' 70' ' ' ILE . 2.1 m120 -167.84 164.51 14.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.528 HG12 HG23 ' B' ' 160' ' ' ILE . 7.4 mt -154.82 164.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.556 HG22 ' HB ' ' B' ' 124' ' ' THR . 71.5 t -141.49 132.97 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.265 -0.897 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.02 154.44 39.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.77 121.76 41.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' B' ' 121' ' ' MET . 66.2 t -121.63 134.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -122.79 131.25 53.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 110.16 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' B' ' 150' ' ' ALA . 15.0 mt -83.14 -51.27 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.88 27.4 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.0 134.73 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.266 . . . . 0.0 110.446 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.483 ' O ' HD23 ' B' ' 80' ' ' LEU . 71.6 ttt-85 -56.62 152.24 12.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.612 HD11 HD12 ' B' ' 76' ' ' LEU . 18.3 mt -133.65 158.63 42.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.416 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -102.05 94.01 5.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.029 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.714 HD22 HG23 ' B' ' 102' ' ' VAL . 16.0 mt -43.57 -37.53 2.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 110.341 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 83' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.5 OUTLIER -58.3 -38.88 77.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.183 -179.882 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 27.2 p -89.1 -43.08 11.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.202 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 63.2 t -56.37 -39.89 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -83.89 -26.37 29.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.399 -0.813 . . . . 0.0 109.934 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 25.9 tp -80.13 -43.83 20.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 88' ' ' HIS . . . . . 0.421 ' HB3' HG12 ' B' ' 146' ' ' ILE . 65.2 m80 -77.55 -28.81 51.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 89' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -69.8 139.88 53.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.067 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -23.46 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 110.334 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 91' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' B' ' 105' ' ' ARG . 3.2 t-20 -134.88 79.67 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 86' ' ' ALA . . . -141.8 152.58 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.12 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -130.75 131.54 44.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.79 103.59 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 0.5 OUTLIER -115.95 104.8 52.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 96' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' B' ' 95' ' ' ASN . 44.3 Cg_endo -70.67 -23.76 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.107 1.582 . . . . 0.0 110.26 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.33 60.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.545 ' HB3' ' CD1' ' B' ' 99' ' ' PHE . 4.2 tpm_? -112.66 -66.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 109.864 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 99' ' ' PHE . . . . . 0.696 ' CD1' HD13 ' A' ' 18' ' ' LEU . 30.5 p90 -141.55 -170.77 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 110.12 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.46 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -117.49 62.34 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -0.966 . . . . 0.0 110.652 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.883 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -152.02 170.4 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.083 -1.01 . . . . 0.0 110.649 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 102' ' ' VAL . . . . . 0.714 HG23 HD22 ' B' ' 82' ' ' LEU . 24.5 t -106.98 132.63 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.561 179.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.648 HD12 HD13 ' B' ' 114' ' ' LEU . 12.8 mm -99.85 97.47 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.135 -0.978 . . . . 0.0 110.507 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 104' ' ' MET . . . . . 0.46 ' HB2' ' HE3' ' B' ' 104' ' ' MET . 23.4 ttm -90.01 158.68 17.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.953 . . . . 0.0 109.824 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' OH ' ' B' ' 139' ' ' TYR . 0.1 OUTLIER -157.3 155.84 31.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.753 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 3.9 pt -136.09 162.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 107' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -102.0 25.11 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 110.083 179.973 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 3.6 tt0 -177.97 90.01 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.95 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 109' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 50.8 Cg_endo -83.11 155.5 73.97 Favored 'Cis proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.181 -2.008 . . . . 0.0 110.345 -0.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 5.3 ttmt -61.34 104.01 0.36 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.057 -1.027 . . . . 0.0 109.619 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 111' ' ' THR . . . . . 0.423 HG22 ' C ' ' B' ' 125' ' ' GLY . 29.3 p -144.89 179.49 7.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.754 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -138.64 128.97 25.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.556 -0.715 . . . . 0.0 109.228 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 113' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -106.0 123.69 48.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 111.063 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 114' ' ' LEU . . . . . 0.648 HD13 HD12 ' B' ' 103' ' ' ILE . 4.2 mm? -89.58 92.55 9.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 115' ' ' ILE . . . . . 0.613 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 10.5 mt -92.66 127.11 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.162 -0.961 . . . . 0.0 111.33 -178.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 116' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 2.8 m-85 -100.77 160.26 14.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 109.649 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -79.4 2.52 21.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.996 -1.065 . . . . 0.0 110.111 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.3 t -90.58 -21.71 21.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.97 -33.9 3.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -63.48 172.14 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 109.901 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 121' ' ' MET . . . . . 0.453 ' N ' ' O ' ' B' ' 74' ' ' VAL . 2.5 ttm -164.63 149.65 9.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.587 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.719 HG21 HG12 ' A' ' 71' ' ' VAL . 1.2 t -125.4 145.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.183 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.2 t -129.81 100.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.038 . . . . 0.0 111.029 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 124' ' ' THR . . . . . 0.688 HG23 ' ND2' ' A' ' 27' ' ' ASN . 1.2 t -99.62 165.28 11.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 108.908 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 125' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 27' ' ' ASN . . . 101.92 -3.51 52.35 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 126' ' ' ALA . . . . . 0.552 ' HB1' ' OG ' ' B' ' 132' ' ' SER . . . -73.22 133.79 44.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.262 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.42 -6.65 27.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 110.438 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 128' ' ' SER . . . . . 0.432 ' HB2' ' CG ' ' B' ' 131' ' ' ASP . 0.4 OUTLIER -160.25 -168.2 2.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 0.0 110.367 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.5 -56.03 4.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.187 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 130' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 7.9 m-20 -63.82 -22.45 66.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.878 . . . . 0.0 110.389 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' B' ' 128' ' ' SER . 5.0 m-20 -68.18 -48.8 64.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.99 . . . . 0.0 110.313 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 132' ' ' SER . . . . . 0.552 ' OG ' ' HB1' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -66.2 -36.59 83.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.217 -179.884 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -58.7 -42.16 87.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.56 -50.78 11.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.44 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -54.13 -50.49 66.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 136' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' B' ' 137' ' ' ARG . 20.6 p -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.771 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 137' ' ' ARG . . . . . 0.424 ' N ' ' OG ' ' B' ' 136' ' ' SER . 5.4 mtp180 -48.25 -43.23 32.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.363 -0.836 . . . . 0.0 109.95 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -57.25 -45.69 83.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.842 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 139' ' ' TYR . . . . . 0.838 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 11.8 m-85 -57.03 -53.23 60.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.77 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.55 -20.14 64.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.85 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -31.96 58.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' B' ' 139' ' ' TYR . 6.3 mt -70.29 -41.36 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 33.7 mt -68.31 -42.27 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -68.4 -33.98 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -71.47 -22.37 61.82 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' B' ' 88' ' ' HIS . 1.3 mt -81.21 -20.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 122.51 -32.15 4.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 148' ' ' PHE . . . . . 0.581 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 7.7 m-85 -40.85 150.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.132 . . . . 0.0 110.964 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.39 28.68 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.525 -0.734 . . . . 0.0 109.859 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -67.14 148.69 51.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.512 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.0 OUTLIER -136.73 117.86 14.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -56.02 100.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.179 -0.951 . . . . 0.0 110.087 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.2 OUTLIER -144.19 166.17 25.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.63 35.33 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 110.435 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -78.36 130.86 36.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -165.75 129.19 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 110.607 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 40.5 mt -79.51 129.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.598 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -125.56 -13.17 6.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.056 -1.028 . . . . 0.0 110.933 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 159' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' A' ' 24' ' ' LEU . 2.2 t30 -139.27 98.02 3.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.878 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 160' ' ' ILE . . . . . 0.746 ' CG2' HD22 ' B' ' 67' ' ' LEU . 53.1 mt -97.47 134.08 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.518 179.192 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 24' ' ' LEU . 5.9 t -101.71 133.96 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.665 -179.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 162' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -148.47 163.21 28.97 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 43.2 p -167.56 159.79 12.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 164' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 11.0 p -168.51 158.44 9.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.7 130.97 54.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.578 HG22 ' O ' ' B' ' 210' ' ' GLY . 35.1 m -105.25 12.21 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.181 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 48.79 41.59 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.969 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 168' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' B' ' 238' ' ' ARG . 0.1 OUTLIER -136.55 115.6 10.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 110.206 -179.953 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 169' ' ' PRO . . . . . 0.464 ' HB2' ' CB ' ' B' ' 239' ' ' LYS . 46.4 Cg_endo -72.28 140.21 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.904 1.476 . . . . 0.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.51 ' CD1' ' HA2' ' B' ' 210' ' ' GLY . 2.8 mp -130.17 151.43 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.616 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.5 88.32 7.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.803 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.579 ' CD1' HG23 ' B' ' 208' ' ' VAL . 68.9 mt -51.01 -23.69 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -55.37 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.202 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.63 -46.56 74.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.451 ' O ' HD12 ' B' ' 175' ' ' LEU . 10.3 tp -62.92 -36.95 85.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -1.155 . . . . 0.0 110.446 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 176' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' B' ' 185' ' ' TYR . . . -66.51 -19.87 65.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.277 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -93.84 -35.27 12.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 p -81.36 -26.71 35.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.046 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 179' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' B' ' 183' ' ' SER . 26.4 m-70 -122.83 12.82 9.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -0.853 . . . . 0.0 110.041 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.09 -36.59 5.3 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -26.1 65.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -1.144 . . . . 0.0 110.499 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -122.48 -18.89 6.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 110.344 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' B' ' 195' ' ' TYR . 57.8 m -115.83 165.61 12.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.432 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 2.5 p -141.46 143.2 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.403 -0.811 . . . . 0.0 109.987 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 185' ' ' TYR . . . . . 0.557 ' CD1' ' HB3' ' B' ' 172' ' ' LEU . 78.4 t80 -133.15 94.54 3.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 186' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' B' ' 190' ' ' PHE . 27.4 mt-10 -100.59 102.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.763 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 187' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' B' ' 185' ' ' TYR . 45.4 Cg_endo -71.5 -6.94 20.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.687 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.75 -13.99 18.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 189' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' B' ' 189' ' ' LEU . 2.4 tt -137.03 3.64 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 190' ' ' PHE . . . . . 0.478 ' HB2' HD23 ' B' ' 189' ' ' LEU . 1.4 t80 -169.73 113.4 0.49 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.211 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -19.66 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.923 1.486 . . . . 0.0 110.176 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 192' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' B' ' 172' ' ' LEU . . . -99.64 176.6 28.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 193' ' ' LEU . . . . . 0.457 ' CB ' HD22 ' B' ' 172' ' ' LEU . 5.7 tt -110.69 132.97 53.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 194' ' ' ILE . . . . . 0.812 HD12 HD22 ' A' ' 62' ' ' LEU . 6.8 mt -93.69 106.6 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.302 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 195' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' B' ' 183' ' ' SER . 3.9 t80 -101.33 107.48 18.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 196' ' ' ARG . . . . . 0.51 ' CG ' HG22 ' B' ' 203' ' ' VAL . 1.0 OUTLIER -92.12 99.72 12.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 110.103 -179.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 197' ' ' MET . . . . . 0.542 ' HE1' ' HB3' ' B' ' 229' ' ' ALA . 41.5 ttm -70.31 145.05 51.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.266 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.66 -39.14 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 199' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 1.0 OUTLIER -139.7 114.72 8.0 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.91 179.976 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 200' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -72.2 167.32 77.39 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.946 -2.106 . . . . 0.0 110.639 0.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -76.27 93.58 3.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 202' ' ' ILE . . . . . 0.833 HD11 ' CB ' ' B' ' 217' ' ' ALA . 4.5 mt -146.21 165.91 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.914 . . . . 0.0 110.342 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.51 HG22 ' CG ' ' B' ' 196' ' ' ARG . 26.0 t -111.09 119.32 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.43 -0.793 . . . . 0.0 109.661 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . 0.573 HD21 ' HB1' ' B' ' 226' ' ' ALA . 5.0 mp -106.37 117.95 35.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.662 HD12 ' HB ' ' B' ' 213' ' ' VAL . 3.4 mt -97.18 119.9 36.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 206' ' ' ILE . . . . . 0.597 HG23 HD21 ' B' ' 234' ' ' LEU . 17.9 mm -98.5 141.22 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.381 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.43 144.98 47.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.035 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.579 HG23 ' CD1' ' B' ' 172' ' ' LEU . 75.5 t -51.66 -24.72 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.291 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.9 t -78.16 -19.37 54.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.096 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.578 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 108.68 5.82 31.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . 0.788 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.5 OUTLIER -73.24 137.71 45.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 109.951 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 212' ' ' ILE . . . . . 0.788 HD13 ' O ' ' B' ' 211' ' ' LYS . 17.2 mm -125.37 131.55 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.557 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.662 ' HB ' HD12 ' B' ' 205' ' ' LEU . 21.8 t -114.3 150.28 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.821 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.523 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.2 mp -141.81 111.69 6.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 110.381 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 215' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 15.2 t -134.12 151.61 51.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.125 -0.984 . . . . 0.0 110.155 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.54 -5.4 48.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 217' ' ' ALA . . . . . 0.833 ' CB ' HD11 ' B' ' 202' ' ' ILE . . . -64.71 172.94 2.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -1.143 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -116.57 -16.44 10.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -167.42 163.14 14.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -51.85 -21.9 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.303 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -68.75 -35.93 77.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.54 -53.63 11.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 110.322 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.416 HG22 ' CG ' ' B' ' 65' ' ' PRO . 32.8 mm -50.53 -44.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.63 -34.71 77.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -36.31 59.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 226' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -57.88 -35.7 71.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.298 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 227' ' ' PHE . . . . . 0.643 ' HA ' HG22 ' B' ' 230' ' ' ILE . 20.7 t80 -80.85 -46.3 15.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -58.71 -27.61 65.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' B' ' 197' ' ' MET . . . -83.05 -36.78 24.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.643 HG22 ' HA ' ' B' ' 227' ' ' PHE . 0.8 OUTLIER -89.65 -11.94 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.916 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 231' ' ' TYR . . . . . 0.566 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -43.14 -50.53 14.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.799 . . . . 0.0 110.783 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 232' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.8 Cg_endo -73.27 -44.35 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.599 1.316 . . . . 0.0 110.624 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.65 -30.62 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 109.986 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 234' ' ' LEU . . . . . 0.597 HD21 HG23 ' B' ' 206' ' ' ILE . 9.8 mt -77.09 -47.67 19.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.187 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -21.15 63.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 236' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.2 OUTLIER -70.61 -54.3 12.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.83 . . . . 0.0 110.011 179.838 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.99 34.42 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -64.43 -178.23 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.516 -0.74 . . . . 0.0 110.571 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 239' ' ' LYS . . . . . 0.464 ' CB ' ' HB2' ' B' ' 169' ' ' PRO . 1.2 tttp -114.92 -33.74 5.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.139 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 15.7 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.262 -179.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.256 0.55 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.51 -163.44 22.5 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.2 t -118.54 163.33 16.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -1.159 . . . . 0.0 110.096 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.3 mt -106.0 115.76 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.161 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.73 85.17 1.6 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.511 ' CB ' ' HG3' ' A' ' 75' ' ' LYS . 2.2 m120 -80.41 155.09 27.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.32 -1.106 . . . . 0.0 110.228 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 122.59 162.88 11.68 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.952 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -108.05 170.01 8.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.251 -1.146 . . . . 0.0 109.756 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.55 ' HA ' HD11 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -88.61 93.08 9.44 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.123 -0.986 . . . . 0.0 111.233 -179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.952 HD21 HD21 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -99.79 23.14 10.04 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 1.025 HG22 HG23 ' A' ' 56' ' ' ILE . 3.4 m -52.22 -31.47 32.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.919 -1.113 . . . . 0.0 109.735 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.74 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -91.9 -26.4 19.56 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.824 HG13 HD22 ' A' ' 20' ' ' LEU . 1.8 mm -50.74 -48.8 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.935 -1.332 . . . . 0.0 108.944 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.7 OUTLIER -78.69 -10.68 59.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 0.0 110.193 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.482 ' HB2' ' HA2' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -87.99 -15.22 37.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 110.859 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 148.78 81.78 0.04 OUTLIER Glycine 0 N--CA 1.494 2.524 0 C-N-CA 118.898 -1.62 . . . . 0.0 111.116 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.635 ' HB2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 33.04 112.39 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.067 0.937 . . . . 0.0 112.719 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.0 OUTLIER -139.78 165.02 22.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.767 -1.208 . . . . 0.0 109.765 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.877 ' O ' HD12 ' A' ' 28' ' ' ILE . 69.8 m-20 -88.71 126.63 35.41 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' CD1' ' A' ' 18' ' ' LEU . 60.0 p -37.74 -28.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 110.113 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' ASP . 31.0 mt-10 -57.59 -12.7 2.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 0.0 110.447 178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 13.88 17.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -96.33 115.5 27.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -1.149 . . . . 0.0 109.515 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.109 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -89.05 138.72 31.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 0.0 109.431 -179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.109 ' N ' HD22 ' A' ' 34' ' ' LEU . 0.9 OUTLIER -131.72 -178.96 5.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.897 -1.127 . . . . 0.0 111.506 -179.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.544 ' N ' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -136.17 122.5 20.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.643 -0.66 . . . . 0.0 109.864 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 36' ' ' GLN . 1.3 t70 -41.68 -37.07 1.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.309 -0.869 . . . . 0.0 110.425 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -98.98 170.11 8.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 110.078 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -119.02 151.43 38.23 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 110.291 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -136.98 122.95 2.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -106.4 27.06 9.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -1.173 . . . . 0.0 110.354 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -109.14 170.56 14.61 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 43' ' ' ARG . 7.6 ttm180 -86.57 11.34 12.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -1.088 . . . . 0.0 110.306 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.32 106.85 0.2 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 46' ' ' THR . . . -159.84 -160.14 10.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 45' ' ' GLY . 3.9 t -43.48 131.55 4.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -1.147 . . . . 0.0 110.298 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.4 164.87 13.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.87 141.87 28.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -1.121 . . . . 0.0 110.246 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -62.97 -147.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.206 -0.933 . . . . 0.0 109.841 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -99.53 31.1 3.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.15 -0.969 . . . . 0.0 110.049 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 26.8 pt-20 -100.85 -21.12 15.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 109.828 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 52' ' ' LEU . 5.1 mt -102.1 -45.04 5.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 110.694 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.843 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.29 -54.36 21.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.381 -0.824 . . . . 0.0 110.056 -178.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -68.52 -19.86 64.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.48 -0.763 . . . . 0.0 110.113 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 44.6 m-20 -86.62 -37.88 17.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.025 HG23 HG22 ' A' ' 21' ' ' THR . 11.3 mt -52.56 -48.32 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 109.423 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.11 -22.02 4.48 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -124.53 8.97 8.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.685 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 56' ' ' ILE . 12.3 mt -75.17 -2.23 26.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.047 . . . . 0.0 110.272 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.72 42.42 0.97 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 110.248 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -143.89 13.05 1.67 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.222 -0.924 . . . . 0.0 109.747 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.779 ' CD1' HG21 ' B' ' 194' ' ' ILE . 3.7 pp -133.32 -31.9 1.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 110.655 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.527 ' N ' HD12 ' A' ' 62' ' ' LEU . . . -175.37 -40.11 0.05 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.637 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.7 mm? -49.84 -20.53 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -1.226 . . . . 0.0 110.531 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -46.89 -39.9 13.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.195 -0.941 . . . . 0.0 109.916 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.9 -51.0 60.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.81 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -72.37 -1.98 17.59 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.623 HD23 ' OG1' ' A' ' 21' ' ' THR . 1.5 tm? -76.46 -60.56 2.29 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.967 0.889 . . . . 0.0 108.944 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -78.87 0.53 26.87 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.251 0.548 . . . . 0.0 109.993 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 66' ' ' SER . 5.2 tt0 -88.16 8.55 26.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 0.0 111.364 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.013 HG12 HG11 ' B' ' 122' ' ' VAL . 2.1 t -138.19 1.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.941 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.019 HD11 ' CD1' ' A' ' 74' ' ' LEU . 4.1 tp -149.08 73.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 6.8 p-10 -75.96 55.77 0.93 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.173 -0.954 . . . . 0.0 108.843 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.019 ' CD1' HD11 ' A' ' 72' ' ' ILE . 6.0 mt -85.88 59.49 5.67 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.664 0.745 . . . . 0.0 110.583 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.511 ' HG3' ' CB ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -139.91 37.32 1.97 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.719 -0.613 . . . . 0.0 109.985 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -141.92 24.95 1.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.919 . . . . 0.0 110.423 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.175 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.208 0.528 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.74 63.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.469 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 35.6 mm -126.83 -55.79 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 0.0 110.015 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 5.3 t 62.11 129.28 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.329 -0.857 . . . . 0.0 110.58 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.485 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 49.8 Cg_endo -77.57 135.46 14.64 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 124.026 1.54 . . . . 0.0 110.253 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -97.59 137.77 36.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.251 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' B' ' 67' ' ' LEU . 20.2 mt -72.68 135.22 45.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 110.114 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -114.64 -29.96 6.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.18 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 1.8 m120 -170.0 171.78 6.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 110.119 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.834 HG22 ' HB3' ' B' ' 126' ' ' ALA . 0.5 OUTLIER -144.6 160.6 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 110.081 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.575 HG22 ' OG1' ' B' ' 124' ' ' THR . 20.5 t -134.96 132.37 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.851 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.29 156.21 48.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.33 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 13.5 m -108.7 144.25 36.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 110.16 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' B' ' 121' ' ' MET . 8.1 t -132.18 156.89 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.854 . . . . 0.0 109.961 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 35.1 m -130.15 130.56 44.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.476 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.981 HD22 ' HB1' ' B' ' 150' ' ' ALA . 53.3 mt -82.31 -19.65 38.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.023 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . 0.418 ' C ' ' SG ' ' B' ' 78' ' ' CYS . . . 79.75 4.53 89.44 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . 0.418 ' SG ' ' C ' ' B' ' 77' ' ' GLY . 23.1 m -143.66 146.72 33.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.193 -1.181 . . . . 0.0 110.381 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.682 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -78.95 153.02 30.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' B' ' 76' ' ' LEU . 14.4 mt -132.42 167.62 19.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.089 -1.007 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 2.8 t70 -99.88 94.77 6.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.628 HD22 HG23 ' B' ' 102' ' ' VAL . 26.2 mt -40.94 -46.15 2.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.36 -0.837 . . . . 0.0 110.827 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -54.51 -48.84 71.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.549 HG23 ' CE1' ' B' ' 88' ' ' HIS . 20.1 m -77.57 -38.54 48.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 110.349 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 55.3 t -54.73 -47.9 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 110.062 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.37 -29.56 63.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 110.023 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 28.5 tp -78.21 -30.16 48.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 109.987 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.549 ' CE1' HG23 ' B' ' 84' ' ' THR . 0.7 OUTLIER -91.5 -25.76 19.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.91 . . . . 0.0 109.945 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.01 131.82 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 110.071 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 -69.53 -29.74 67.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.187 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -133.5 79.25 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -143.31 152.79 42.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 110.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -130.3 136.97 49.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 110.149 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -125.89 101.54 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 110.386 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -107.21 110.33 63.25 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.861 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.82 -15.38 26.67 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.057 1.556 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.45 -15.29 53.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.651 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -102.65 -43.09 5.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.081 -1.012 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.762 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -165.19 0.43 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.156 -0.965 . . . . 0.0 111.314 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.29 54.0 0.81 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.143 -0.973 . . . . 0.0 111.128 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.935 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -149.42 166.14 29.98 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.628 HG23 HD22 ' B' ' 82' ' ' LEU . 66.8 t -99.43 166.28 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.93 . . . . 0.0 109.985 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.55 ' CD1' ' HB3' ' B' ' 114' ' ' LEU . 23.1 mm -129.84 107.45 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 0.0 110.38 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.54 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.0 OUTLIER -89.67 164.72 14.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.36 -0.837 . . . . 0.0 110.009 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -161.71 135.24 6.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.513 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 19.0 pt -133.58 159.48 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.795 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' B' ' 108' ' ' GLU . 1.4 ptt180 -102.62 17.65 23.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.523 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.5 OUTLIER -161.05 88.94 1.63 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.168 -0.957 . . . . 0.0 110.446 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.3 Cg_endo -75.88 162.37 92.4 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.791 -2.171 . . . . 0.0 110.35 -0.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -74.36 83.54 1.93 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.92 . . . . 0.0 110.055 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' B' ' 124' ' ' THR . 14.6 p -134.05 178.4 6.99 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.304 -0.872 . . . . 0.0 110.272 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.513 HG22 HG23 ' B' ' 124' ' ' THR . 5.2 t -131.82 159.24 39.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.238 -0.914 . . . . 0.0 109.6 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -152.8 155.44 37.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.966 -1.084 . . . . 0.0 110.868 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.55 ' HB3' ' CD1' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -131.66 115.1 15.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.739 . . . . 0.0 109.611 179.696 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' B' ' 121' ' ' MET . 10.8 mt -96.37 146.08 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.187 -0.946 . . . . 0.0 110.753 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 3.5 m-30 -104.51 157.81 16.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.374 -0.829 . . . . 0.0 109.705 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.91 -15.43 30.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.137 -0.977 . . . . 0.0 110.353 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 60.2 p -84.8 4.5 32.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.199 -0.938 . . . . 0.0 110.36 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.09 -28.59 7.17 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 3.6 ttmt -67.88 127.91 34.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -1.169 . . . . 0.0 110.116 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.425 ' HB3' HG12 ' B' ' 115' ' ' ILE . 0.2 OUTLIER -136.03 157.72 46.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.914 . . . . 0.0 110.416 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 1.013 HG11 HG12 ' A' ' 71' ' ' VAL . 11.4 t -123.06 129.86 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.366 -0.834 . . . . 0.0 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' B' ' 139' ' ' TYR . 60.2 t -113.85 139.55 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.944 . . . . 0.0 110.476 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.575 ' OG1' HG22 ' B' ' 71' ' ' VAL . 10.2 t -142.6 156.83 45.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 110.069 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.524 ' CA ' ' HB3' ' A' ' 27' ' ' ASN . . . 123.83 -13.89 8.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.834 ' HB3' HG22 ' B' ' 70' ' ' ILE . . . -76.87 158.71 30.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.117 . . . . 0.0 110.029 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.414 ' C ' ' OG ' ' B' ' 128' ' ' SER . 25.2 mtmt -109.47 -1.15 18.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 110.278 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -163.89 -170.12 2.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.239 -0.913 . . . . 0.0 110.195 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . 0.461 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.0 OUTLIER -68.44 -60.58 2.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 0.0 110.196 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -55.86 -31.95 63.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.031 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.409 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 9.9 m-20 -65.04 -42.1 94.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.72 -38.69 32.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.152 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . 0.423 ' CG ' ' CE2' ' B' ' 155' ' ' PHE . 10.8 mttm -53.1 -39.5 63.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 110.118 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.4 -47.04 29.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 110.158 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.97 -43.59 70.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.939 . . . . 0.0 110.326 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.01 -55.71 26.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 110.224 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 22.2 mtp85 -46.21 -44.8 16.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 110.082 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -57.79 -51.35 69.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.54 ' CE1' ' HB3' ' B' ' 104' ' ' MET . 22.7 m-85 -58.2 -57.63 12.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.943 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . 0.463 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -50.28 -31.68 14.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.11 62.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.312 -0.868 . . . . 0.0 109.855 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.423 HG21 ' SD ' ' B' ' 104' ' ' MET . 50.5 mt -45.03 -38.86 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.757 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.985 HG21 ' HB2' ' B' ' 150' ' ' ALA . 41.0 mm -69.37 -52.73 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.676 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.463 ' NE2' ' O ' ' B' ' 140' ' ' ALA . 16.1 mt-30 -64.97 -28.48 69.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.381 -0.824 . . . . 0.0 109.611 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -75.1 -21.2 59.06 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.8 mt -84.29 -21.24 8.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.74 -22.26 5.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.481 ' HB2' HG22 ' B' ' 143' ' ' ILE . 23.2 m-85 -64.41 179.74 0.56 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.312 . . . . 0.0 111.199 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -113.76 36.35 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.592 -0.692 . . . . 0.0 110.304 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.985 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -60.46 148.33 37.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.149 -0.97 . . . . 0.0 110.201 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -113.47 -157.97 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 110.227 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' B' ' 152' ' ' PHE . 1.0 OUTLIER -147.09 77.93 1.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 110.077 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -144.75 178.95 7.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 110.214 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' B' ' 153' ' ' THR . 15.1 t0 66.97 22.3 10.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 110.298 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' B' ' 73' ' ' THR . 8.4 t80 -77.38 132.74 38.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.841 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? -164.97 133.48 3.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.149 -0.969 . . . . 0.0 110.731 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.461 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 33.9 mt -81.2 108.37 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 109.721 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.09 -2.04 32.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.746 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 8.9 t-20 -152.24 120.36 6.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.936 -1.103 . . . . 0.0 110.983 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . . . . . . . . . 70.8 mt -114.38 137.76 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.39 -0.819 . . . . 0.0 109.428 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 39.1 t -106.99 135.28 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.053 -1.029 . . . . 0.0 110.798 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.78 177.08 20.77 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.1 OUTLIER -169.65 153.33 4.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.082 -1.246 . . . . 0.0 110.722 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.485 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 24.6 p -169.11 165.46 11.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.428 -0.795 . . . . 0.0 109.824 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 22.4 p-10 -115.94 134.05 55.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 110.328 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.846 HG21 HD11 ' B' ' 170' ' ' ILE . 33.6 m -80.06 4.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.257 -0.902 . . . . 0.0 110.089 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.59 -4.51 2.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.49 -0.756 . . . . 0.0 111.138 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.732 ' H ' HG23 ' B' ' 166' ' ' VAL . 22.4 p90 -145.91 153.11 49.47 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.9 -1.125 . . . . 0.0 110.532 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.51 159.72 50.52 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.072 1.564 . . . . 0.0 110.329 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.846 HD11 HG21 ' B' ' 166' ' ' VAL . 2.1 mp -128.38 152.93 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.186 -0.946 . . . . 0.0 110.514 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -82.11 101.45 10.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.81 . . . . 0.0 109.998 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.521 HD22 ' HB2' ' B' ' 193' ' ' LEU . 18.8 mt -55.0 -42.03 72.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 110.512 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -74.92 -21.61 59.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 110.29 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.14 -45.52 31.27 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 1.015 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -67.84 -36.67 80.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -1.175 . . . . 0.0 110.237 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.88 61.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -0.885 . . . . 0.0 110.303 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -91.12 -16.37 27.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.252 -0.905 . . . . 0.0 110.183 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . 0.534 ' OG ' ' CZ ' ' B' ' 237' ' ' PHE . 0.3 OUTLIER -99.59 -33.37 10.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 110.184 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -120.89 37.06 4.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.105 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -51.42 -21.2 6.03 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . 0.461 ' O ' ' CG ' ' B' ' 182' ' ' PHE . 16.2 p -87.53 23.47 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.196 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.506 ' CZ ' HG22 ' B' ' 198' ' ' VAL . 0.9 OUTLIER -169.82 -34.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.282 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 13.5 p -89.98 151.07 21.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -0.846 . . . . 0.0 110.276 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.9 m -128.69 148.73 50.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -158.1 112.6 2.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.375 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -115.55 104.02 53.48 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.94 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.35 -3.17 12.87 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.017 1.535 . . . . 0.0 110.467 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.8 -7.32 30.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' B' ' 190' ' ' PHE . 2.5 tt -148.66 -44.02 0.15 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.116 -0.99 . . . . 0.0 110.551 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.699 ' HB2' HD23 ' B' ' 189' ' ' LEU . 12.6 t80 -117.12 110.17 41.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.591 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . 0.513 ' O ' HD13 ' B' ' 172' ' ' LEU . 45.6 Cg_endo -74.79 -12.81 22.02 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.924 1.486 . . . . 0.0 110.21 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.514 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -92.9 179.52 39.77 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.863 HD23 ' N ' ' B' ' 194' ' ' ILE . 3.7 tt -115.18 148.34 39.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 110.102 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.863 ' N ' HD23 ' B' ' 193' ' ' LEU . 4.3 mt -123.3 103.37 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -0.874 . . . . 0.0 110.279 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.503 ' CD1' HD13 ' B' ' 230' ' ' ILE . 27.0 t80 -95.03 120.47 35.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.311 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 197' ' ' MET . 1.8 ttp180 -90.03 82.62 6.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.427 ' C ' ' O ' ' B' ' 196' ' ' ARG . 31.2 tpp -42.63 130.16 4.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 110.304 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.506 HG22 ' CZ ' ' B' ' 182' ' ' PHE . 14.9 t -70.51 -52.37 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.323 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 8.5 ttpp -143.68 117.11 5.92 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 109.955 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.1 Cg_endo -71.98 171.89 59.82 Favored 'Cis proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.025 -2.073 . . . . 0.0 110.601 -0.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -82.31 108.69 15.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.138 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.682 HD13 ' HB2' ' B' ' 217' ' ' ALA . 9.2 mt -150.8 155.95 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 110.476 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.496 HG13 HG23 ' B' ' 194' ' ' ILE . 70.0 t -105.39 131.21 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 109.671 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.506 HD22 HG21 ' B' ' 230' ' ' ILE . 5.3 mp -119.19 123.04 43.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.19 -0.944 . . . . 0.0 110.596 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.508 HD22 ' N ' ' B' ' 205' ' ' LEU . 4.4 mm? -94.12 124.04 37.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.517 HG12 HD12 ' B' ' 212' ' ' ILE . 2.5 mp -124.55 122.44 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.393 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.514 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 95.6 m-85 -110.36 149.84 29.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -0.857 . . . . 0.0 110.045 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 40.8 t -45.73 -24.55 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.905 . . . . 0.0 110.096 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -29.23 70.57 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.363 -0.836 . . . . 0.0 110.331 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 109.85 2.91 30.31 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.78 123.61 27.37 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -1.156 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.517 HD12 HG12 ' B' ' 206' ' ' ILE . 19.4 mm -116.56 125.43 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.64 ' C ' HD12 ' B' ' 214' ' ' LEU . 4.0 t -110.62 154.82 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.282 -0.886 . . . . 0.0 110.052 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.64 HD12 ' C ' ' B' ' 213' ' ' VAL . 5.2 mp -141.87 103.35 4.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.286 -0.884 . . . . 0.0 110.481 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.476 ' O ' HG23 ' B' ' 202' ' ' ILE . 13.3 t -126.66 152.57 46.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 0.0 109.984 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.473 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 106.64 -4.41 36.94 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' B' ' 202' ' ' ILE . . . -68.87 162.67 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -1.193 . . . . 0.0 110.013 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -114.68 -6.9 12.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.15 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' B' ' 222' ' ' GLU . 1.9 tt0 -159.66 147.44 17.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.196 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' B' ' 219' ' ' GLN . 20.7 ttm180 -43.85 -37.25 2.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -61.43 -34.07 74.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.858 . . . . 0.0 110.156 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.593 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 6.2 mt-10 -63.73 -53.31 53.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.895 . . . . 0.0 110.254 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.518 HG12 ' CB ' ' B' ' 217' ' ' ALA . 18.7 mm -57.71 -42.52 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.46 ' CE2' HG13 ' B' ' 64' ' ' VAL . 2.7 m-85 -66.56 -28.84 68.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 110.107 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 2.6 tt0 -82.4 -50.06 9.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 0.0 110.153 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' B' ' 225' ' ' GLN . . . -45.51 -43.59 11.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.728 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 26.2 t80 -69.69 -41.46 75.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -15.38 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 110.174 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -92.53 -42.0 9.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 110.027 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.506 HG21 HD22 ' B' ' 204' ' ' LEU . 1.5 tp -90.55 -14.74 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.339 -0.85 . . . . 0.0 109.988 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.5 t80 -49.28 -49.72 68.72 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.192 -0.942 . . . . 0.0 110.588 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.3 Cg_endo -70.39 -45.06 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.47 1.247 . . . . 0.0 110.272 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 1.015 HG12 HD21 ' B' ' 175' ' ' LEU . 22.4 t -49.96 -39.24 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 109.705 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.403 HD22 HG21 ' B' ' 170' ' ' ILE . 96.5 mt -73.33 -50.75 20.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.744 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 14.0 t -55.93 -33.16 64.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.17 -32.38 71.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.77 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.546 ' HD2' HD22 ' B' ' 175' ' ' LEU . 22.5 m-85 -117.36 37.72 3.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.357 -0.839 . . . . 0.0 110.092 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -61.31 171.95 1.25 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.868 . . . . 0.0 110.127 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -102.49 -47.14 4.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 110.111 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.197 0.522 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 147.93 67.04 0.01 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.0 p -58.24 174.29 0.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -1.124 . . . . 0.0 110.251 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 tp -111.76 -18.98 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' HA3' ' HD2' ' A' ' 75' ' ' LYS . . . 85.46 120.22 1.02 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -107.22 -41.5 5.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -1.134 . . . . 0.0 110.485 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' C ' ' CZ ' ' B' ' 99' ' ' PHE . . . 101.78 147.15 19.55 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.023 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.3 OUTLIER -65.24 171.54 3.72 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.058 -1.26 . . . . 0.0 109.825 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.896 ' N ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -66.91 82.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.174 -0.954 . . . . 0.0 110.762 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.92 HD21 HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -98.59 -0.16 43.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.08 -1.013 . . . . 0.0 110.706 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 59' ' ' LEU . 8.2 m -45.98 -29.34 1.41 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.014 -1.054 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.57 -32.26 5.78 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.875 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -55.81 -43.07 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.173 -1.192 . . . . 0.0 108.738 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.009 HD13 ' SD ' ' A' ' 67' ' ' MET . 3.4 pp -82.4 -28.71 31.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.545 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.2 OUTLIER -93.36 13.12 22.45 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.397 -0.814 . . . . 0.0 108.871 179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.587 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 142.85 94.46 0.2 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 1.008 ' ND2' HD11 ' A' ' 35' ' ' LEU . 7.0 p30 -20.27 132.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 122.031 0.919 . . . . 0.0 112.39 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.714 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -147.11 163.02 7.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 31' ' ' GLU . 80.3 m-20 -87.3 124.2 33.1 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.023 ' HB2' HD13 ' A' ' 18' ' ' LEU . 5.3 p -37.96 -28.07 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.793 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.4 mm-40 -55.1 -15.99 2.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 110.164 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.86 27.49 5.13 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.492 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -123.33 121.22 35.26 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.098 -1.236 . . . . 0.0 110.093 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.736 HD13 HD13 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -94.24 157.8 15.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.759 -1.213 . . . . 0.0 111.467 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.008 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp -136.38 -179.19 5.53 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.997 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.636 ' N ' HD12 ' A' ' 35' ' ' LEU . 11.5 mt-30 -152.65 13.91 0.55 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.259 -0.901 . . . . 0.0 110.399 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 36' ' ' GLN . 1.4 m-20 71.74 -53.17 0.69 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.256 -0.902 . . . . 0.0 110.382 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.5 t70 60.54 30.55 19.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.12 -0.987 . . . . 0.0 109.863 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.469 ' HB2' ' HD3' ' B' ' 110' ' ' LYS . 0.3 OUTLIER -145.69 70.05 1.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.802 . . . . 0.0 109.945 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 39' ' ' ASP . . . -41.83 -90.35 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -125.86 -32.46 2.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -1.114 . . . . 0.0 110.202 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.31 -52.42 0.07 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -167.96 56.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -1.173 . . . . 0.0 110.368 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.33 153.81 23.14 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.08 140.53 2.95 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.7 -80.03 0.59 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.317 -1.108 . . . . 0.0 110.076 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.93 153.7 9.28 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' O ' ' O ' ' A' ' 49' ' ' ASP . 5.4 m-85 -73.71 141.59 46.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -1.164 . . . . 0.0 110.168 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 48' ' ' PHE . 25.8 t0 -48.65 178.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 110.102 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.17 26.05 1.48 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.205 -0.934 . . . . 0.0 110.324 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -100.87 -17.73 16.71 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 52' ' ' LEU . 4.0 mt -99.26 -44.24 6.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.436 -0.79 . . . . 0.0 110.384 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.008 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.21 -54.25 42.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.291 -0.881 . . . . 0.0 110.085 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -67.41 -22.47 65.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.475 -0.765 . . . . 0.0 110.211 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.58 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 7.0 m-80 -87.4 -28.65 22.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.31 -0.869 . . . . 0.0 109.186 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' A' ' 53' ' ' ARG . 12.6 mt -56.93 -48.3 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.462 -0.773 . . . . 0.0 108.981 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.49 -22.09 5.11 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.413 ' HB3' HD11 ' B' ' 189' ' ' LEU . 0.5 OUTLIER -130.07 25.76 5.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -1.159 . . . . 0.0 110.847 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.789 HD21 ' CE2' ' B' ' 190' ' ' PHE . 6.2 mt -92.79 22.63 4.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.01 . . . . 0.0 109.88 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.38 52.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.447 -0.783 . . . . 0.0 110.362 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.687 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -169.82 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 0.0 110.22 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.697 ' CD1' HD23 ' A' ' 59' ' ' LEU . 3.4 mt -112.79 -50.03 2.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.177 -0.952 . . . . 0.0 109.805 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.85 -31.11 0.05 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.758 -1.21 . . . . 0.0 110.163 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -75.2 0.92 14.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.134 -1.215 . . . . 0.0 110.787 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' CB ' ' A' ' 68' ' ' LEU . 10.5 t70 -43.71 -41.34 4.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 0.0 109.777 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -46.23 78.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.414 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 1.009 ' SD ' HD13 ' A' ' 24' ' ' LEU . 15.9 ttm -65.99 -9.61 31.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.437 -0.789 . . . . 0.0 109.417 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 21' ' ' THR . 2.0 tm? -71.41 -61.73 1.67 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.987 0.899 . . . . 0.0 108.687 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.61 -1.74 26.0 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.19 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.528 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 11.9 tt0 -85.9 11.59 11.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.272 -0.893 . . . . 0.0 111.347 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.953 ' O ' HG21 ' B' ' 122' ' ' VAL . 2.2 t -144.88 3.95 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.963 -1.085 . . . . 0.0 110.565 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.002 ' CD1' HD23 ' A' ' 18' ' ' LEU . 4.1 tp -147.33 74.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.434 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.7 54.38 1.8 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.144 -0.972 . . . . 0.0 108.553 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.133 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 7.5 mt -103.96 66.94 0.85 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.564 0.697 . . . . 0.0 110.397 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.506 ' HD2' ' HA3' ' A' ' 15' ' ' GLY . 3.5 pttm -147.11 70.03 1.18 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.634 -0.666 . . . . 0.0 110.178 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 48.1 35.46 5.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.237 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.271 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.201 0.524 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' B' ' 64' ' ' VAL . . . 117.94 85.45 1.06 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.641 HG22 ' SG ' ' B' ' 164' ' ' CYS . 2.3 mp 64.57 -56.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.57 -0.959 . . . . 0.0 111.024 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' B' ' 62' ' ' GLY . 5.9 t 63.76 139.4 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.179 -0.951 . . . . 0.0 109.987 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.744 ' HG2' HG22 ' B' ' 223' ' ' ILE . 45.1 Cg_endo -72.32 135.67 25.06 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.115 1.587 . . . . 0.0 110.856 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 51.6 m -100.18 136.84 39.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.663 HD22 ' CG2' ' B' ' 160' ' ' ILE . 84.6 mt -70.4 133.79 47.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.155 -0.965 . . . . 0.0 110.128 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -130.82 -3.29 4.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 110.348 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.4 OUTLIER -162.51 126.41 3.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.332 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.971 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 14.1 mm -115.21 157.17 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.504 HG22 ' HB ' ' B' ' 124' ' ' THR . 7.7 t -141.82 121.53 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.366 -0.834 . . . . 0.0 109.692 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.5 162.88 26.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 110.549 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . 0.587 HG22 HG22 ' B' ' 122' ' ' VAL . 18.1 p -121.85 135.4 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -0.84 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.538 HG11 ' CD1' ' B' ' 152' ' ' PHE . 13.0 t -125.23 148.45 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.346 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 17.5 m -118.08 142.19 47.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.216 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.888 HD22 ' HB1' ' B' ' 150' ' ' ALA . 40.6 mt -101.29 -50.86 3.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 110.075 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 113.56 -12.5 23.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.46 172.46 9.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.215 -1.168 . . . . 0.0 110.237 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.623 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.5 OUTLIER -101.71 150.53 23.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.243 -0.91 . . . . 0.0 110.184 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.623 HD23 ' O ' ' B' ' 79' ' ' ARG . 17.4 mt -126.23 175.78 7.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.246 -0.908 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.59 96.85 5.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.337 -0.852 . . . . 0.0 110.049 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.612 HD22 HG23 ' B' ' 102' ' ' VAL . 17.7 mt -43.87 -41.13 4.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -0.875 . . . . 0.0 110.329 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.435 ' HE3' ' CD2' ' B' ' 94' ' ' TYR . 12.8 mmtp -55.55 -47.45 76.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 110.343 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 29.3 p -79.91 -41.24 26.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.244 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 54.4 t -54.8 -54.59 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 0.0 109.933 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.96 -27.71 69.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.927 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 34.9 tp -81.84 -25.1 35.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.431 -0.793 . . . . 0.0 109.896 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -98.34 -42.27 7.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 110.127 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -47.6 133.2 13.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 110.066 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . 0.506 ' HG3' ' N ' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -70.63 -25.28 62.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.202 -0.936 . . . . 0.0 110.24 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.506 ' N ' ' HG3' ' B' ' 90' ' ' ARG . 1.2 m-20 -138.7 79.18 1.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.345 -0.847 . . . . 0.0 109.794 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.814 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -159.13 171.9 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.531 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.529 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 0.2 OUTLIER -157.23 172.01 19.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.402 -0.811 . . . . 0.0 110.051 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.435 ' CD2' ' HE3' ' B' ' 83' ' ' LYS . 18.6 t80 -135.7 129.21 32.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.118 -0.989 . . . . 0.0 110.166 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' B' ' 95' ' ' ASN . 6.7 p30 -123.17 102.34 37.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.215 -0.928 . . . . 0.0 110.095 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.32 -26.06 17.83 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.015 1.534 . . . . 0.0 110.479 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -75.43 -20.94 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.256 -0.903 . . . . 0.0 110.166 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -100.07 -71.64 0.69 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.846 . . . . 0.0 110.06 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -149.3 163.5 37.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 110.402 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.411 ' O ' HD11 ' B' ' 82' ' ' LEU . . . -82.51 47.96 1.24 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.264 -0.898 . . . . 0.0 109.305 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.133 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -126.35 144.5 50.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.329 -0.857 . . . . 0.0 110.904 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.612 HG23 HD22 ' B' ' 82' ' ' LEU . 6.8 t -90.02 124.95 42.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.529 ' HB ' ' CG ' ' B' ' 93' ' ' GLU . 8.8 mm -88.27 110.35 20.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.857 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.814 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 3.1 ttm -106.49 161.08 14.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.446 -0.784 . . . . 0.0 110.387 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' B' ' 111' ' ' THR . 0.5 OUTLIER -162.29 126.6 3.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.893 . . . . 0.0 110.293 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.64 HG23 ' CE1' ' B' ' 139' ' ' TYR . 37.4 pt -107.85 176.37 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.981 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.475 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -120.04 42.05 3.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 110.569 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER 170.7 85.22 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 48.8 Cg_endo -78.3 160.23 91.81 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.723 -2.199 . . . . 0.0 110.467 -0.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.476 ' O ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -67.56 105.25 1.8 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.95 . . . . 0.0 109.777 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.666 HG22 ' HA3' ' B' ' 125' ' ' GLY . 11.2 p -152.85 176.67 11.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.615 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.85 HG22 HG23 ' B' ' 124' ' ' THR . 5.3 t -131.37 171.42 13.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 109.475 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -156.74 141.61 17.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.991 -1.068 . . . . 0.0 110.642 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.818 HD22 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -98.53 103.78 15.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.449 -0.782 . . . . 0.0 109.048 179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' B' ' 104' ' ' MET . 4.4 mt -89.76 135.74 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.119 -0.988 . . . . 0.0 110.61 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.905 ' CD1' HD11 ' A' ' 74' ' ' LEU . 3.0 m-30 -110.35 150.72 28.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.349 -0.845 . . . . 0.0 110.102 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.514 ' O ' ' CG ' ' B' ' 79' ' ' ARG . . . -70.05 -10.9 60.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 0.0 110.274 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -7.37 53.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 110.193 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.508 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 105.77 -18.61 40.23 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 8.6 mttm -88.32 160.07 17.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -1.183 . . . . 0.0 110.246 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 3.3 ptm -156.69 164.44 38.14 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.291 -0.881 . . . . 0.0 110.252 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.953 HG21 ' O ' ' A' ' 71' ' ' VAL . 35.7 t -128.57 161.94 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.945 . . . . 0.0 110.485 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.418 ' N ' HG12 ' B' ' 122' ' ' VAL . 53.3 t -138.76 151.23 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.891 . . . . 0.0 110.015 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.85 HG23 HG22 ' B' ' 112' ' ' THR . 1.2 t -157.23 164.26 37.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -0.931 . . . . 0.0 110.344 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.666 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 110.79 -39.2 2.98 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.971 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.48 158.58 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -1.106 . . . . 0.0 110.317 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -124.05 -6.02 7.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.039 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.6 175.44 9.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.146 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -63.59 -63.71 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.322 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.22 -16.71 5.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.244 -0.91 . . . . 0.0 110.264 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.678 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 0.3 OUTLIER -72.3 -49.66 32.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.902 . . . . 0.0 110.23 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -25.06 67.7 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 110.422 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -78.91 -26.09 43.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.521 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.473 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 7.4 mt -79.12 -49.82 12.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.474 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -65.79 -30.83 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 51.0 p -67.97 -60.57 2.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.198 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' B' ' 134' ' ' LEU . 1.4 ptm180 -54.68 -33.19 60.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.006 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.422 ' O ' HG13 ' B' ' 142' ' ' ILE . 0.1 OUTLIER -65.91 -40.78 91.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.368 -0.832 . . . . 0.0 110.074 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.64 ' CE1' HG23 ' B' ' 106' ' ' ILE . 11.7 m-85 -65.98 -49.25 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.656 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' B' ' 152' ' ' PHE . . . -55.62 -30.58 61.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.886 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -71.94 -31.68 66.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.422 HG13 ' O ' ' B' ' 138' ' ' LYS . 34.5 mt -61.79 -42.7 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.33 -0.856 . . . . 0.0 109.763 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.626 ' N ' HD12 ' B' ' 143' ' ' ILE . 1.8 mp -67.51 -44.5 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.238 -0.914 . . . . 0.0 109.548 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -72.94 -30.05 63.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.655 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -20.11 61.52 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.412 HD13 HG21 ' B' ' 146' ' ' ILE . 3.6 mt -86.14 -24.07 6.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.72 -26.27 3.65 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.93 -1.128 . . . . 0.0 110.535 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.497 ' CD1' HD22 ' B' ' 80' ' ' LEU . 12.3 m-85 -52.27 158.16 1.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.943 -1.328 . . . . 0.0 110.988 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.65 34.72 2.16 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.888 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -68.57 169.6 10.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.352 -0.842 . . . . 0.0 110.421 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.9 OUTLIER -148.91 112.74 5.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 110.264 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.573 ' O ' HG23 ' B' ' 153' ' ' THR . 83.5 t80 -58.97 108.34 0.65 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 110.247 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.573 HG23 ' O ' ' B' ' 152' ' ' PHE . 1.4 p -156.18 169.37 24.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 110.211 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' B' ' 153' ' ' THR . 4.2 t70 62.41 28.84 17.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 110.217 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -70.91 134.02 46.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.953 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.91 131.41 2.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.496 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.435 ' C ' ' HG2' ' B' ' 158' ' ' GLN . 14.7 mt -82.91 131.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.273 -0.892 . . . . 0.0 109.705 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.435 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 3.6 mt-30 -128.76 0.32 5.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.189 -0.944 . . . . 0.0 110.781 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.462 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 2.1 t-20 -147.79 110.11 4.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.921 -1.112 . . . . 0.0 110.709 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.663 ' CG2' HD22 ' B' ' 67' ' ' LEU . 66.4 mt -113.26 141.35 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.589 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.575 HG22 ' OG1' ' B' ' 215' ' ' THR . 72.8 t -115.93 130.05 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.13 -0.981 . . . . 0.0 110.645 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.97 168.3 19.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 1.0 OUTLIER -166.57 149.44 6.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.262 . . . . 0.0 110.545 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.641 ' SG ' HG22 ' B' ' 63' ' ' ILE . 0.8 OUTLIER -170.07 170.18 7.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.021 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 164.08 12.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 0.0 110.032 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.797 HG21 HD11 ' B' ' 170' ' ' ILE . 32.6 m -113.2 11.97 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.168 -0.958 . . . . 0.0 110.279 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 73.53 -2.25 2.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.585 ' O ' HG23 ' B' ' 166' ' ' VAL . 26.1 p90 -161.37 150.09 13.09 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 120.987 -1.071 . . . . 0.0 110.568 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.508 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 47.8 Cg_endo -73.88 170.24 20.53 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.133 1.596 . . . . 0.0 110.732 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.797 HD11 HG21 ' B' ' 166' ' ' VAL . 4.4 mp -140.36 151.28 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.237 -0.914 . . . . 0.0 110.378 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.76 80.27 7.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.243 -0.91 . . . . 0.0 109.946 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.792 HD21 HG22 ' B' ' 206' ' ' ILE . 18.9 mt -47.07 -37.97 10.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 110.42 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -64.17 -55.27 22.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.24 92.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 18.3 tp -70.12 -39.67 75.34 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -1.169 . . . . 0.0 110.373 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.64 -26.69 67.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.171 -0.955 . . . . 0.0 110.18 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -77.01 -30.05 55.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.144 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 1.3 p -87.42 -44.64 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 110.27 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -105.72 26.51 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.315 -0.866 . . . . 0.0 110.259 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.55 54.85 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.7 m -53.8 -39.03 65.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -1.188 . . . . 0.0 110.433 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' B' ' 198' ' ' VAL . 19.9 m-85 -108.26 -26.97 10.29 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 0.0 110.401 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.797 ' HB2' HD21 ' B' ' 193' ' ' LEU . 47.9 p -96.05 158.05 15.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.624 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 25.2 m -132.43 119.75 21.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.677 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -125.42 112.13 15.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.962 . . . . 0.0 110.565 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -118.94 102.55 49.11 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.364 -0.835 . . . . 0.0 109.666 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.61 -1.18 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.93 1.489 . . . . 0.0 110.601 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -98.95 -3.64 34.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.036 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.509 HD13 ' HE3' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -150.93 -37.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.892 . . . . 0.0 110.133 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.789 ' CE2' HD21 ' A' ' 59' ' ' LEU . 7.8 t80 -127.95 110.98 20.21 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.91 . . . . 0.0 110.129 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.86 -17.64 22.49 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.888 1.467 . . . . 0.0 110.569 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.87 -179.94 44.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.797 HD21 ' HB2' ' B' ' 183' ' ' SER . 7.6 tt -118.38 130.07 55.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -1.143 . . . . 0.0 110.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.482 HD13 ' CD1' ' A' ' 62' ' ' LEU . 5.7 mt -102.96 100.94 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 109.914 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -91.79 120.26 32.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 0.0 110.471 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' B' ' 203' ' ' VAL . 1.1 mtp180 -92.54 83.45 4.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.475 ' HB2' ' CD1' ' B' ' 204' ' ' LEU . 33.7 tpp -42.11 126.81 3.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.935 . . . . 0.0 110.189 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.507 HG22 ' CE1' ' B' ' 182' ' ' PHE . 61.9 t -63.17 -57.17 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 0.0 110.389 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 8.8 mtmt -137.4 118.13 10.65 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.6 Cg_endo -74.16 169.54 73.53 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.986 -2.089 . . . . 0.0 110.369 -0.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' B' ' 197' ' ' MET . 37.2 mttt -76.85 95.35 4.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -0.899 . . . . 0.0 110.044 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' B' ' 217' ' ' ALA . 31.8 mm -130.96 149.48 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 110.238 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.441 HG22 ' HG2' ' B' ' 196' ' ' ARG . 71.4 t -101.83 105.83 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 0.0 110.032 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.749 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.5 mp -95.82 118.5 32.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 110.45 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' B' ' 205' ' ' LEU . 0.5 OUTLIER -89.65 117.41 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.908 . . . . 0.0 109.935 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.792 HG22 HD21 ' B' ' 172' ' ' LEU . 3.2 mt -113.0 136.0 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 110.351 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.544 ' HA ' HD11 ' B' ' 172' ' ' LEU . 44.7 m-85 -119.62 145.2 46.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -0.923 . . . . 0.0 110.151 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.508 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 64.3 t -49.19 -24.36 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 110.064 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 1.2 t -62.67 -38.65 91.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 110.133 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.483 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 123.36 8.77 6.29 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -90.06 145.22 25.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.241 . . . . 0.0 110.232 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' B' ' 163' ' ' SER . 30.3 mm -130.05 121.69 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.335 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.516 HG11 ' HE1' ' A' ' 25' ' ' PHE . 57.4 t -113.86 155.74 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.051 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.487 HD12 ' N ' ' B' ' 214' ' ' LEU . 2.6 mp -140.12 121.94 15.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 110.629 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.575 ' OG1' HG22 ' B' ' 161' ' ' VAL . 6.2 t -137.02 146.48 45.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.897 . . . . 0.0 109.886 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 111.18 3.9 27.57 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -82.99 138.45 33.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.258 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -29.27 32.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.582 ' O ' HD12 ' B' ' 160' ' ' ILE . 3.2 tt0 -136.17 -152.04 0.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.368 -0.832 . . . . 0.0 110.029 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -100.11 -36.89 9.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 110.432 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 16.0 pt-20 -54.69 -27.38 39.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.119 -0.988 . . . . 0.0 110.518 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 0.8 OUTLIER -71.61 -47.43 54.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.242 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.744 HG22 ' HG2' ' B' ' 65' ' ' PRO . 40.8 mm -62.63 -37.61 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.321 -0.862 . . . . 0.0 110.329 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -69.29 -29.19 67.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.923 . . . . 0.0 110.275 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -37.63 41.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.321 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.749 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -61.32 -43.59 98.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.365 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.744 ' HA ' HG22 ' B' ' 230' ' ' ILE . 27.9 t80 -64.81 -46.54 81.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.394 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.42 -32.68 71.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.359 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -85.14 -25.94 27.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.426 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' B' ' 227' ' ' PHE . 8.7 tp -97.2 -17.94 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.236 -0.915 . . . . 0.0 110.24 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.595 ' N ' ' CD ' ' B' ' 232' ' ' PRO . 14.3 t80 -59.63 -41.34 85.76 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 110.943 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -77.93 -47.22 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.36 1.189 . . . . 0.0 110.384 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.49 -50.8 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.179 -0.951 . . . . 0.0 109.724 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.522 ' CD1' HG13 ' B' ' 230' ' ' ILE . 95.7 mt -59.14 -38.13 78.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.833 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 3.4 t -65.53 -39.39 91.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.392 -0.818 . . . . 0.0 109.816 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . 0.519 ' HG2' ' CE1' ' B' ' 237' ' ' PHE . 0.8 OUTLIER -60.14 -33.85 72.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.677 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.519 ' CE1' ' HG2' ' B' ' 236' ' ' GLU . 65.2 m-85 -115.39 37.41 3.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.827 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -62.52 168.64 3.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.325 -0.859 . . . . 0.0 110.257 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.429 ' HB2' ' C ' ' B' ' 169' ' ' PRO . 0.0 OUTLIER -111.84 -33.32 6.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 110.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.196 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.417 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.201 0.524 . . . . 0.0 110.178 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.89 165.94 23.28 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.21 37.33 28.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -1.143 . . . . 0.0 110.209 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 52.0 mt 47.58 90.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 110.244 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.17 172.67 12.64 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 11' ' ' GLU . 1.9 t30 -146.19 -68.73 0.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -1.095 . . . . 0.0 110.145 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.27 165.24 41.09 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.095 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -107.7 156.68 18.82 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.227 -1.161 . . . . 0.0 108.94 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 19' ' ' ASP . 1.9 p30 -86.19 109.12 18.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.088 -1.007 . . . . 0.0 110.303 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.095 HD21 HD21 ' A' ' 18' ' ' LEU . 3.4 mt -101.17 18.45 19.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.89 HG22 HG23 ' A' ' 56' ' ' ILE . 1.3 m -45.19 -29.86 1.05 Allowed 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.057 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -98.44 -27.8 8.4 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.495 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.934 HG13 HD22 ' A' ' 20' ' ' LEU . 1.1 mm -52.36 -45.87 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.912 -1.346 . . . . 0.0 109.359 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.704 HD22 ' HG2' ' A' ' 67' ' ' MET . 2.0 pp -85.86 -26.51 25.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.608 -1.308 . . . . 0.0 109.665 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CD1' HG21 ' B' ' 215' ' ' THR . 0.5 OUTLIER -83.88 7.41 18.22 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 142.61 106.04 0.57 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.58 ' N ' ' OD1' ' A' ' 27' ' ' ASN . 6.4 p-10 -24.49 135.73 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.784 0.802 . . . . 0.0 111.396 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.749 HG23 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -150.42 161.77 3.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.546 ' N ' HG12 ' A' ' 28' ' ' ILE . 5.3 m-20 -87.48 119.2 27.52 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.572 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 1.3 p -39.53 -26.69 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.898 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.1 tt0 -57.55 -13.37 3.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.117 -0.989 . . . . 0.0 110.43 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.23 27.71 4.67 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.416 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.5 mmt-85 -120.77 122.19 39.83 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.085 -1.244 . . . . 0.0 109.861 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.691 HD23 ' N ' ' A' ' 35' ' ' LEU . 3.1 tt -87.67 162.07 17.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.933 -1.105 . . . . 0.0 111.738 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.691 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -87.49 101.97 14.12 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.472 -0.767 . . . . 0.0 111.355 -178.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -101.29 12.21 37.88 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 49.12 65.98 1.23 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.703 -0.623 . . . . 0.0 110.332 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 24.8 t70 -54.01 125.88 20.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.232 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 59.6 m-20 -156.9 162.59 39.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.9 . . . . 0.0 110.327 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.56 -0.43 84.3 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -161.54 170.5 19.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -1.147 . . . . 0.0 110.12 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.68 103.63 1.0 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.71 35.8 4.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -1.105 . . . . 0.0 110.181 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.08 30.35 4.37 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.53 92.18 2.25 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.71 114.18 15.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.233 -1.157 . . . . 0.0 110.113 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.87 173.54 4.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.604 ' CD1' HD12 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -95.43 -170.98 2.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -1.17 . . . . 0.0 110.301 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -89.88 -177.67 5.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 0.0 110.285 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.8 14.03 11.2 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 110.072 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.503 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -100.28 -22.13 15.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.349 -0.844 . . . . 0.0 109.469 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.604 HD12 ' CD1' ' A' ' 48' ' ' PHE . 3.7 mt -95.39 -45.21 7.22 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.546 -0.721 . . . . 0.0 110.157 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.999 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -49.5 -52.47 29.21 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.152 -0.968 . . . . 0.0 109.6 -179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.79 -23.21 66.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.513 -0.742 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 12.5 m-20 -85.83 -33.99 21.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.999 HD12 ' HA ' ' A' ' 53' ' ' ARG . 15.6 mt -54.22 -42.14 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.466 -0.771 . . . . 0.0 109.372 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.35 -14.89 35.96 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.976 ' HB3' HD11 ' B' ' 189' ' ' LEU . 49.7 m -122.07 0.05 9.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.12 -1.223 . . . . 0.0 110.297 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.897 HD23 HD12 ' A' ' 62' ' ' LEU . 1.2 mt -81.38 8.32 9.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.267 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -91.18 43.5 1.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.697 ' C ' HD23 ' A' ' 62' ' ' LEU . 5.9 pttt -172.88 27.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.049 -1.032 . . . . 0.0 110.56 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.897 HD12 HD23 ' A' ' 59' ' ' LEU . 3.7 mt -105.15 -43.82 4.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.225 -0.922 . . . . 0.0 109.562 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.03 -28.3 0.09 OUTLIER Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.719 HD12 HD21 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -84.53 0.19 50.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.139 -1.212 . . . . 0.0 110.108 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.546 ' HA ' ' HG ' ' A' ' 68' ' ' LEU . 4.7 t70 -50.36 -39.69 47.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 109.732 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.76 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -58.7 -32.2 68.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.49 -0.756 . . . . 0.0 109.895 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.704 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -70.45 -26.79 63.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.885 . . . . 0.0 109.74 179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.719 HD21 HD12 ' A' ' 64' ' ' LEU . 7.4 mt -64.43 -61.7 2.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.725 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.76 HD21 ' HA ' ' A' ' 66' ' ' SER . 3.3 pp -58.04 -12.63 3.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.676 -0.64 . . . . 0.0 110.341 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -87.05 2.75 48.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.119 -0.988 . . . . 0.0 110.592 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.018 HG12 HG11 ' B' ' 122' ' ' VAL . 2.8 t -127.74 -0.54 3.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.393 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.054 HD11 HD12 ' A' ' 74' ' ' LEU . 2.8 tp -150.51 68.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.555 -0.716 . . . . 0.0 109.52 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -73.43 56.95 0.52 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.849 -1.157 . . . . 0.0 108.975 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.095 HD11 ' CB ' ' B' ' 101' ' ' ALA . 5.6 mt -84.18 57.82 4.43 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.693 0.759 . . . . 0.0 110.472 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.26 -173.27 2.25 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.693 -0.629 . . . . 0.0 109.923 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.98 106.73 1.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 110.2 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.235 179.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.177 0.513 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.455 ' O ' HG13 ' B' ' 63' ' ' ILE . . . 155.64 -52.87 0.43 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.495 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 4.2 mt -140.63 -39.0 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -1.124 . . . . 0.0 110.381 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.515 HG13 ' HD2' ' B' ' 65' ' ' PRO . 91.8 t 59.34 142.22 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.436 -0.79 . . . . 0.0 110.301 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.515 ' HD2' HG13 ' B' ' 64' ' ' VAL . 47.3 Cg_endo -72.97 123.96 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.844 1.444 . . . . 0.0 110.745 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.447 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 9.3 m -92.06 135.0 34.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.975 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.484 ' HG ' ' NH2' ' B' ' 220' ' ' ARG . 19.0 mt -69.95 125.41 26.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 110.323 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -101.4 -27.29 13.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.147 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' HB ' ' B' ' 161' ' ' VAL . 5.6 m120 -156.14 162.73 40.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.425 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.861 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 17.0 mm -136.48 150.64 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.794 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' B' ' 124' ' ' THR . 24.1 t -136.76 140.57 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.461 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.99 149.4 36.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.909 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.38 128.32 45.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.173 -0.954 . . . . 0.0 110.539 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' B' ' 121' ' ' MET . 59.0 t -119.67 151.2 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.294 -0.879 . . . . 0.0 109.955 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 23.5 m -129.49 142.91 50.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.187 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' B' ' 150' ' ' ALA . 49.4 mt -100.05 -46.2 5.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.117 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.53 1.18 55.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -138.5 158.65 43.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.198 -1.178 . . . . 0.0 110.212 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -80.13 142.96 34.31 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 1.028 HD11 ' CD1' ' B' ' 76' ' ' LEU . 25.7 mt -116.65 153.68 31.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -0.95 . . . . 0.0 110.423 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' B' ' 82' ' ' LEU . 8.2 t0 -96.93 86.9 4.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.365 -0.834 . . . . 0.0 109.633 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.468 ' HA ' HG21 ' B' ' 102' ' ' VAL . 8.6 mt -40.66 -43.62 1.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.845 . . . . 0.0 110.362 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -54.13 -45.45 71.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.94 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 14.7 m -81.02 -44.5 17.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.96 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 40.8 t -54.94 -43.08 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 110.159 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.86 -25.59 48.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 tp -86.69 -33.49 20.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.213 -0.929 . . . . 0.0 110.124 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.0 m80 -83.22 -44.83 14.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.359 -0.838 . . . . 0.0 110.247 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -53.31 141.84 22.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.348 -0.845 . . . . 0.0 110.089 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . 0.41 ' O ' ' OD1' ' B' ' 91' ' ' ASN . 21.7 mtt85 -81.05 -15.44 56.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.483 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' B' ' 104' ' ' MET . 16.0 m-20 -139.54 79.94 1.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 0.0 110.044 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' B' ' 93' ' ' GLU . . . -152.95 161.91 41.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.354 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' B' ' 92' ' ' ALA . 37.7 mt-10 -142.46 161.61 37.6 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 110.132 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -152.04 130.56 12.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.214 -0.928 . . . . 0.0 110.324 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -145.41 122.99 6.28 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 110.122 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.11 -16.71 28.56 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.908 1.478 . . . . 0.0 110.343 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 9.0 mtmm -77.78 -9.73 59.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 110.141 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -109.3 -59.94 1.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.261 -0.899 . . . . 0.0 110.137 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.666 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -163.07 -159.23 0.53 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.496 -0.753 . . . . 0.0 110.704 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.47 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -121.38 49.8 1.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.862 -1.149 . . . . 0.0 111.602 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.095 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -143.57 163.77 32.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' B' ' 82' ' ' LEU . 90.0 t -101.41 136.93 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.254 -0.904 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.524 HG21 ' HA ' ' A' ' 29' ' ' ASP . 3.1 mp -106.03 111.34 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 110.369 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.501 ' HB2' ' HE3' ' B' ' 104' ' ' MET . 14.6 ttm -94.53 170.52 9.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.323 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -157.56 113.15 2.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.841 HG23 ' CE1' ' B' ' 139' ' ' TYR . 48.3 pt -101.29 170.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.175 -0.953 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' B' ' 108' ' ' GLU . 5.3 mmt85 -124.93 46.32 2.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.312 -0.868 . . . . 0.0 110.291 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 175.27 79.21 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 0.0 110.338 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 52.5 Cg_endo -81.63 161.56 79.77 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.756 -2.185 . . . . 0.0 110.473 -0.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.15 106.38 1.29 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.746 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.556 HG22 ' HA3' ' B' ' 125' ' ' GLY . 1.7 p -147.27 177.5 9.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.19 -0.944 . . . . 0.0 110.645 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.7 m -124.57 159.14 31.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.41 -0.806 . . . . 0.0 109.442 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.568 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -147.48 138.35 23.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.138 -0.977 . . . . 0.0 110.41 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 121' ' ' MET . 8.0 mt -98.46 120.51 39.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 109.723 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.421 HG13 ' HG2' ' B' ' 121' ' ' MET . 3.6 mt -111.97 115.22 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.985 . . . . 0.0 110.375 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 3.6 m-30 -94.93 168.32 10.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.428 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -78.41 -13.52 59.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 110.124 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.4 t -81.05 -7.81 59.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.289 -0.882 . . . . 0.0 110.379 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.79 -26.27 20.03 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -56.2 149.74 15.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -1.135 . . . . 0.0 110.096 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 1.7 tmm? -148.66 128.82 13.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 110.214 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 1.018 HG11 HG12 ' A' ' 71' ' ' VAL . 73.4 t -114.91 128.1 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.128 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 97.2 t -112.86 151.56 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 0.0 110.349 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.559 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.8 t -155.09 164.42 38.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.35 -0.844 . . . . 0.0 109.983 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.569 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 110.83 -34.84 5.12 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.861 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.24 149.57 0.16 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.248 -1.148 . . . . 0.0 110.442 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.75 -3.19 30.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.181 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.492 ' N ' HG13 ' B' ' 70' ' ' ILE . 3.0 m -167.17 -163.23 0.51 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.243 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . 0.451 ' HA ' HD11 ' B' ' 157' ' ' ILE . 3.1 mt-10 -78.24 -44.65 24.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 110.316 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.11 -26.1 66.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 110.387 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.93 -58.29 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.283 -0.885 . . . . 0.0 110.286 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.652 ' OG ' HG21 ' B' ' 70' ' ' ILE . 2.2 m -47.57 -40.01 18.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 110.247 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 12.2 mttt -60.24 -51.06 71.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.175 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.472 ' O ' ' HG3' ' B' ' 137' ' ' ARG . 39.6 mt -62.88 -32.81 74.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 110.398 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -74.3 -41.1 61.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 110.271 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 3.6 p -65.7 -52.09 54.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 110.227 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.509 ' HB2' ' CZ ' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -55.15 -34.1 63.5 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 110.293 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.493 ' HD3' ' HD2' ' B' ' 137' ' ' ARG . 7.0 mptt -65.42 -36.67 84.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 110.032 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.877 ' HA ' HD12 ' B' ' 142' ' ' ILE . 31.4 m-85 -71.41 -52.3 19.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -0.875 . . . . 0.0 110.04 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.74 64.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.087 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -40.71 94.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.218 -0.926 . . . . 0.0 110.3 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.877 HD12 ' HA ' ' B' ' 139' ' ' TYR . 24.6 mt -59.37 -54.93 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.723 HG21 ' HB2' ' B' ' 150' ' ' ALA . 10.0 mt -55.73 -46.61 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.95 . . . . 0.0 110.026 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 35.0 mt-30 -66.26 -35.24 79.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.596 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' B' ' 145' ' ' LYS . 10.1 tttm -71.55 -21.05 61.94 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 3.6 mt -83.31 -18.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.88 -21.37 12.43 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.533 ' HB2' HG22 ' B' ' 143' ' ' ILE . 12.3 m-85 -57.55 172.6 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.028 -1.278 . . . . 0.0 111.016 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -105.54 54.41 0.7 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.501 -0.75 . . . . 0.0 110.328 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -90.74 130.57 36.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 110.423 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -121.85 119.28 31.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.186 -0.946 . . . . 0.0 110.173 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 17.0 t80 -60.79 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 110.134 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -140.6 171.35 14.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.216 -0.928 . . . . 0.0 110.227 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.474 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 56.5 m-20 58.37 19.32 6.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.367 -0.833 . . . . 0.0 110.559 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' B' ' 152' ' ' PHE . 15.1 t80 -68.69 136.79 53.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 109.822 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.92 136.5 1.93 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 0.0 110.449 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.451 HD11 ' HA ' ' B' ' 129' ' ' GLU . 70.7 mt -79.29 124.51 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.602 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -118.5 -8.81 10.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.114 -0.991 . . . . 0.0 110.992 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 30.4 t30 -148.98 134.42 18.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.783 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.414 ' CG2' HD22 ' B' ' 67' ' ' LEU . 60.0 mt -129.4 142.85 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.747 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 41.6 t -113.1 135.75 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.985 . . . . 0.0 110.55 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -136.94 173.11 22.32 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.3 t -164.82 151.18 10.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -1.184 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.478 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.0 p -170.21 146.57 2.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 110.275 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.406 ' O ' HD13 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -98.03 169.53 9.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.962 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.0 OUTLIER -113.31 -83.33 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.22 -0.925 . . . . 0.0 110.201 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -176.01 -31.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 110.208 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' B' ' 238' ' ' ARG . 14.8 p90 -131.8 159.45 71.92 Favored Pre-proline 0 C--N 1.303 -1.44 0 O-C-N 121.363 -0.836 . . . . 0.0 109.576 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -71.34 152.19 60.74 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 123.873 1.46 . . . . 0.0 110.146 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.26 148.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.561 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -86.88 106.45 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 109.934 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.51 HD22 ' CB ' ' B' ' 193' ' ' LEU . 21.9 mt -63.23 -59.91 4.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.214 -0.929 . . . . 0.0 110.342 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 23.5 pt-20 -50.19 -33.85 20.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.331 -0.855 . . . . 0.0 110.19 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -72.96 -41.57 48.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.457 ' O ' HD12 ' B' ' 175' ' ' LEU . 9.7 tp -80.23 -32.28 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -1.119 . . . . 0.0 110.23 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.808 ' HB2' ' CD1' ' B' ' 193' ' ' LEU . . . -73.95 -24.3 59.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 110.178 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -79.14 -42.61 25.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.0 110.045 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 t -78.74 -52.19 8.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 110.14 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -93.41 13.48 21.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.072 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -46.42 -32.97 5.63 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . 0.552 HG23 ' HD2' ' B' ' 182' ' ' PHE . 1.8 t -54.08 -24.15 16.4 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.125 -1.221 . . . . 0.0 110.378 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.829 ' CE1' HG22 ' B' ' 198' ' ' VAL . 26.4 m-85 -133.05 13.63 4.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.198 -0.939 . . . . 0.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.497 ' HB3' HD21 ' B' ' 193' ' ' LEU . 58.8 m -129.65 150.38 51.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 0.0 110.281 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.92 133.94 53.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 110.215 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 0.495 ' O ' ' CD2' ' B' ' 185' ' ' TYR . 26.4 t80 -150.45 102.61 3.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.224 -0.923 . . . . 0.0 110.101 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' B' ' 190' ' ' PHE . 1.3 mt-10 -113.31 115.26 47.56 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 110.091 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.82 -1.49 10.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.842 1.443 . . . . 0.0 110.403 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -100.27 6.82 44.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 0.0 110.308 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.976 HD11 ' HB3' ' A' ' 58' ' ' SER . 0.4 OUTLIER -166.36 -38.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.17 -0.956 . . . . 0.0 110.386 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.544 ' CZ ' HD11 ' B' ' 205' ' ' LEU . 1.8 t80 -118.65 114.05 36.08 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.4 -31.12 5.96 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.863 1.454 . . . . 0.0 110.568 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.96 -179.72 44.36 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.808 ' CD1' ' HB2' ' B' ' 176' ' ' ALA . 8.5 tt -113.42 133.78 55.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -1.125 . . . . 0.0 110.26 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.666 ' CD1' HD13 ' A' ' 62' ' ' LEU . 53.0 mt -100.68 109.11 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.232 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.737 ' CD2' HD13 ' B' ' 230' ' ' ILE . 15.4 t80 -99.69 114.15 27.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 0.0 110.24 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -90.63 98.47 11.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.128 -0.982 . . . . 0.0 110.104 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.416 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 0.5 OUTLIER -56.73 131.09 48.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.0 110.419 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.829 HG22 ' CE1' ' B' ' 182' ' ' PHE . 13.2 t -70.82 -48.75 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.061 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 6.9 tttm -144.29 117.03 5.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.941 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.7 Cg_endo -72.79 163.18 89.58 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.931 -2.112 . . . . 0.0 110.63 0.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.788 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -70.94 99.83 1.85 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.319 -0.863 . . . . 0.0 109.963 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.788 HD13 ' O ' ' B' ' 201' ' ' LYS . 37.6 mm -143.65 145.16 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 70.6 t -96.06 141.47 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.386 -0.821 . . . . 0.0 109.704 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 2.9 mp -126.57 133.99 50.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.042 -1.036 . . . . 0.0 110.716 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.544 HD11 ' CZ ' ' B' ' 190' ' ' PHE . 2.6 mm? -103.32 116.6 32.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.838 . . . . 0.0 109.794 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.714 HG13 HD12 ' B' ' 212' ' ' ILE . 3.5 mp -114.3 120.73 64.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.09 -1.006 . . . . 0.0 110.406 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.407 ' CD1' ' HA3' ' B' ' 192' ' ' GLY . 66.9 m-85 -110.88 143.76 40.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.267 -0.896 . . . . 0.0 110.208 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 17.2 t -44.11 -25.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -0.928 . . . . 0.0 110.182 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.403 ' N ' ' O ' ' B' ' 207' ' ' PHE . 25.2 m -59.94 -38.33 82.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.31 -0.869 . . . . 0.0 110.36 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.438 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 115.83 13.91 8.3 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.475 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -99.61 133.39 44.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -1.13 . . . . 0.0 110.023 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.714 HD12 HG13 ' B' ' 206' ' ' ILE . 29.0 mm -118.52 136.68 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.195 -0.941 . . . . 0.0 110.429 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 4.6 t -119.93 155.51 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.285 -0.885 . . . . 0.0 109.921 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.455 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.9 mp -134.34 123.2 23.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.141 -0.975 . . . . 0.0 110.376 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.568 HG21 ' CD1' ' A' ' 25' ' ' PHE . 8.3 t -141.27 147.57 38.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.07 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.42 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 103.92 5.82 43.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -89.08 134.6 33.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -1.124 . . . . 0.0 110.119 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -27.34 48.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.944 . . . . 0.0 110.363 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.22 163.0 33.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.267 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . 0.505 ' CG ' ' CE1' ' B' ' 224' ' ' TYR . 4.9 ttm180 -65.54 -20.58 66.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 110.119 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -54.67 -44.32 73.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 226' ' ' ALA . 30.1 mt-10 -72.71 -39.98 66.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.911 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.411 HD12 HG23 ' B' ' 223' ' ' ILE . 34.0 mm -57.91 -41.51 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 109.891 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' B' ' 220' ' ' ARG . 10.1 m-85 -79.04 -47.22 16.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 110.103 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -65.54 -42.72 91.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.093 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' B' ' 222' ' ' GLU . . . -57.47 -44.54 84.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 110.186 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.606 ' CZ ' ' CE2' ' B' ' 231' ' ' TYR . 32.6 t80 -67.6 -28.66 67.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.89 . . . . 0.0 110.145 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.27 -19.18 61.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 110.108 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.77 -31.86 15.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.737 HD13 ' CD2' ' B' ' 195' ' ' TYR . 9.2 tp -85.51 -22.61 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.265 -0.897 . . . . 0.0 109.942 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.606 ' CE2' ' CZ ' ' B' ' 227' ' ' PHE . 0.3 OUTLIER -40.89 -50.95 7.45 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.963 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.1 Cg_endo -69.22 -42.2 4.19 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.428 1.225 . . . . 0.0 110.633 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 24.4 t -53.66 -40.36 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.551 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 74.0 mt -61.25 -45.02 96.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.368 -0.832 . . . . 0.0 109.783 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 22.9 t -64.64 -46.71 81.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.09 -35.91 49.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -0.872 . . . . 0.0 110.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -108.58 38.56 2.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.258 -0.901 . . . . 0.0 110.25 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.494 ' HB3' ' CE1' ' B' ' 168' ' ' PHE . 1.0 OUTLIER -89.05 149.31 23.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.28 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -94.21 -60.16 1.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.5 mmm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.225 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.294 0.568 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 13' ' ' SER . . . -157.68 55.92 0.37 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' ILE . 6.5 t -44.27 167.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 110.173 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' SER . 5.3 mt 46.27 94.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.257 -0.902 . . . . 0.0 110.098 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' O ' ' CB ' ' A' ' 16' ' ' ASN . . . -101.32 15.8 57.32 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.5 OUTLIER 65.44 59.29 0.8 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -1.21 . . . . 0.0 110.119 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.54 145.73 4.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.119 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -98.62 159.75 14.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -1.164 . . . . 0.0 109.477 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.601 ' O ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -83.41 105.42 14.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 111.194 -179.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.119 HD21 HD21 ' A' ' 18' ' ' LEU . 6.8 mt -117.97 3.64 12.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.958 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.72 HG21 ' O ' ' A' ' 56' ' ' ILE . 6.2 m -38.44 -30.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.679 0.752 . . . . 0.0 109.549 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.577 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -100.55 -31.49 5.78 Favored Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.87 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.32 -43.36 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.074 -1.251 . . . . 0.0 108.762 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.812 HD13 ' HG2' ' A' ' 67' ' ' MET . 1.8 pp -80.78 6.34 13.27 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.117 -0.989 . . . . 0.0 108.977 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE1' HD13 ' A' ' 52' ' ' LEU . 4.3 t80 -110.65 -18.08 13.24 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.544 -0.723 . . . . 0.0 111.034 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 158.3 67.02 0.01 OUTLIER Glycine 0 N--CA 1.494 2.523 0 C-N-CA 118.448 -1.834 . . . . 0.0 111.59 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.579 ' HB3' ' CG ' ' A' ' 35' ' ' LEU . 4.0 m120 41.28 111.4 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.943 . . . . 0.0 113.271 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -156.02 151.44 9.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 31' ' ' GLU . 12.6 m-20 -89.06 137.09 32.63 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.596 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . 83.3 p -39.81 -26.09 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.241 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.4 OUTLIER -48.6 -21.84 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.6 29.5 5.0 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.33 131.5 54.23 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.122 -1.222 . . . . 0.0 110.085 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.765 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -101.86 139.16 37.88 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.183 -0.948 . . . . 0.0 111.104 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.934 HD12 ' N ' ' A' ' 36' ' ' GLN . 2.8 pp -124.57 -179.75 4.62 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.419 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.934 ' N ' HD12 ' A' ' 35' ' ' LEU . 7.5 mt-30 -135.02 144.95 47.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 110.143 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -50.71 -37.97 44.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.229 -0.92 . . . . 0.0 110.733 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.82 145.21 35.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.597 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -134.07 140.28 46.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 110.047 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.11 33.09 5.33 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.42 79.63 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -1.137 . . . . 0.0 110.314 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.82 -23.34 69.78 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.58 52.94 2.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -1.155 . . . . 0.0 110.21 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.25 -33.83 0.75 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.39 -141.24 15.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 28.5 p -91.13 -173.75 3.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -1.15 . . . . 0.0 110.185 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.89 135.88 5.22 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.659 ' CE1' HD12 ' A' ' 52' ' ' LEU . 21.6 p90 -88.6 16.58 6.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -1.157 . . . . 0.0 110.24 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 5.0 t70 -47.16 -53.09 13.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.9 . . . . 0.0 110.423 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.38 -4.96 24.89 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.414 -0.804 . . . . 0.0 110.463 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 18.3 tp10 -97.49 -25.46 15.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.014 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.659 HD12 ' CE1' ' A' ' 48' ' ' PHE . 5.9 mt -110.01 -44.94 3.69 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.626 -0.672 . . . . 0.0 110.055 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.79 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.02 -45.77 3.97 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.578 0.704 . . . . 0.0 109.984 -178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.27 -50.62 63.09 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.434 -0.791 . . . . 0.0 109.489 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.497 ' C ' HD12 ' A' ' 59' ' ' LEU . 64.0 m-20 -58.72 -38.77 79.07 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.337 -0.852 . . . . 0.0 109.174 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 53' ' ' ARG . 8.0 mt -50.91 -40.14 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.399 -0.813 . . . . 0.0 109.096 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.51 -12.97 48.71 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.851 -1.699 . . . . 0.0 108.851 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.68 ' HB2' HD11 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -125.09 -0.24 7.82 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -1.12 . . . . 0.0 110.344 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.886 HD23 HD21 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -80.52 51.86 1.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.209 -0.932 . . . . 0.0 110.575 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 24.3 t -134.06 50.24 2.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.887 . . . . 0.0 110.273 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 60' ' ' SER . 5.3 pttp 179.34 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.087 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.952 HD12 ' N ' ' A' ' 63' ' ' GLY . 1.1 pp -140.26 -29.54 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.054 -1.029 . . . . 0.0 111.146 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.952 ' N ' HD12 ' A' ' 62' ' ' LEU . . . 178.5 -48.99 0.09 OUTLIER Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.464 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.61 HD23 HD11 ' A' ' 62' ' ' LEU . 1.1 pp -82.95 -5.27 58.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.051 -1.264 . . . . 0.0 110.812 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 24.7 t70 -44.47 -35.35 2.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.041 -1.037 . . . . 0.0 109.66 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 m -63.8 -47.04 82.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 0.0 109.619 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.812 ' HG2' HD13 ' A' ' 24' ' ' LEU . 7.1 ttp -65.02 -10.92 33.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 0.0 109.692 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.758 HD21 ' H ' ' A' ' 20' ' ' LEU . 4.9 tt -73.35 -61.27 1.88 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.78 0.86 11.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.702 -0.624 . . . . 0.0 109.939 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 25.4 tt0 -91.78 15.28 13.19 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 0.0 110.796 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.574 ' HB ' HD12 ' A' ' 20' ' ' LEU . 1.6 t -130.43 0.35 2.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.917 0.865 . . . . 0.0 109.016 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.975 HD11 HD12 ' A' ' 74' ' ' LEU . 1.3 tp -151.0 76.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 5.4 t0 -75.09 57.09 0.81 Allowed 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.134 -0.979 . . . . 0.0 109.383 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.04 HD11 ' CB ' ' B' ' 101' ' ' ALA . 8.5 mt -89.83 30.28 1.07 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.469 -0.769 . . . . 0.0 110.572 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 77' ' ' ALA . 32.6 pttt -118.64 -157.39 0.68 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.505 -0.747 . . . . 0.0 110.419 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 75' ' ' LYS . 1.4 tp10 -50.92 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.818 . . . . 0.0 110.274 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.302 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.8 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.228 0.537 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.93 64.79 0.72 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.669 HG22 ' SG ' ' B' ' 164' ' ' CYS . 29.6 mt -99.5 -40.56 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -1.125 . . . . 0.0 110.044 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.506 HG23 ' C ' ' B' ' 63' ' ' ILE . 3.0 t 65.8 142.64 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.358 -0.839 . . . . 0.0 110.383 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.556 ' HG2' HG22 ' B' ' 223' ' ' ILE . 46.8 Cg_endo -75.96 137.88 20.17 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.098 1.578 . . . . 0.0 110.317 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.444 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 49.1 m -97.66 132.61 43.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.719 HD11 ' HG3' ' B' ' 220' ' ' ARG . 44.4 mt -69.72 120.61 15.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -0.961 . . . . 0.0 109.826 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 66' ' ' THR . 25.2 mm-40 -110.4 -14.04 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.617 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.443 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 1.7 t30 -162.56 144.52 10.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.12 -0.987 . . . . 0.0 110.812 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.84 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 6.0 mm -126.35 150.75 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.434 -0.791 . . . . 0.0 109.333 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.74 126.29 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.011 -1.056 . . . . 0.0 110.549 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.83 170.75 15.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 110.05 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -141.2 145.26 35.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 110.252 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' B' ' 136' ' ' SER . 3.8 t -127.97 155.74 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.289 -0.882 . . . . 0.0 110.108 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.446 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 25.9 m -106.0 129.64 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.835 HD22 ' HB1' ' B' ' 150' ' ' ALA . 72.8 mt -84.29 -69.91 0.61 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 116.89 28.39 2.48 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . 0.949 ' SG ' ' HB3' ' B' ' 149' ' ' ALA . 39.8 t -164.02 152.1 12.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -1.165 . . . . 0.0 110.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.457 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -73.23 139.81 46.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 110.162 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.707 HD11 ' CD1' ' B' ' 76' ' ' LEU . 28.9 mt -118.28 140.21 50.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 0.0 110.385 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.55 94.92 9.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.229 -0.919 . . . . 0.0 109.881 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.672 HD22 HG23 ' B' ' 102' ' ' VAL . 14.4 mt -44.05 -52.67 6.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.365 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -49.86 -43.46 49.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.144 -0.972 . . . . 0.0 110.028 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 28.0 m -76.27 -48.84 18.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 0.0 110.129 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.84 -47.81 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.076 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.56 65.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.932 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 tp -75.61 -42.22 52.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 0.0 110.189 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -88.26 -31.79 18.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 110.204 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' B' ' 92' ' ' ALA . . . -57.05 109.84 0.72 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.463 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -62.87 -22.35 66.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.173 -0.954 . . . . 0.0 110.052 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.491 ' ND2' ' HG3' ' B' ' 105' ' ' ARG . 2.4 t-20 -134.08 79.63 1.82 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 110.0 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.517 ' HB2' ' HB1' ' B' ' 89' ' ' ALA . . . -149.0 163.07 38.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.414 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -144.91 127.05 15.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.187 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -114.6 125.58 53.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 110.218 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.75 106.0 20.73 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 110.231 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.94 -21.78 20.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.033 1.544 . . . . 0.0 110.241 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -82.4 8.38 11.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.085 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.546 ' HB3' ' CD2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER -131.27 -70.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.314 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.594 ' HE2' ' HG ' ' A' ' 30' ' ' SER . 24.4 p90 -134.74 -173.62 3.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.026 -1.046 . . . . 0.0 110.436 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.06 64.16 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.04 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -159.29 177.0 11.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.298 -0.876 . . . . 0.0 110.566 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.672 HG23 HD22 ' B' ' 82' ' ' LEU . 92.2 t -119.13 124.93 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.38 -0.825 . . . . 0.0 109.671 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.543 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 5.5 mt -89.66 107.36 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.663 ' SD ' HD13 ' B' ' 142' ' ' ILE . 37.8 ttm -108.31 151.14 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.344 -0.847 . . . . 0.0 110.133 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.491 ' HG3' ' ND2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -139.23 145.36 39.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.554 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 15.0 pt -111.66 175.35 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.136 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.6 mtt180 -116.73 26.73 9.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.902 . . . . 0.0 110.408 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.5 tm-20 -175.88 87.13 0.29 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 0.0 110.752 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.0 Cg_endo -78.45 153.38 91.59 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.759 -2.184 . . . . 0.0 110.242 -0.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.6 OUTLIER -67.11 104.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 0.0 109.915 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.47 ' HA ' ' ND2' ' A' ' 27' ' ' ASN . 68.0 p -146.75 176.87 9.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.925 . . . . 0.0 110.566 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -115.76 144.18 44.34 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.604 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -135.21 129.58 33.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.959 -1.088 . . . . 0.0 110.885 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.647 ' HB2' HG12 ' B' ' 122' ' ' VAL . 3.5 mm? -89.59 120.49 30.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.452 -0.78 . . . . 0.0 109.044 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.56 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 1.6 mp -108.92 122.92 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.999 -1.063 . . . . 0.0 111.352 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' B' ' 120' ' ' LYS . 3.6 m-30 -96.49 149.04 22.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.305 -0.872 . . . . 0.0 109.71 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.51 -6.0 27.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.961 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.4 p -86.91 -16.77 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.115 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.427 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 119.31 -26.88 7.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 4.0 mttt -78.44 145.45 35.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -1.194 . . . . 0.0 110.157 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 7.3 ptt? -152.26 151.51 31.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 0.0 110.204 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.647 HG12 ' HB2' ' B' ' 114' ' ' LEU . 0.5 OUTLIER -110.47 162.38 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.902 . . . . 0.0 109.771 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.403 HG23 ' C ' ' B' ' 122' ' ' VAL . 12.7 t -145.2 119.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.681 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.52 ' O ' ' ND2' ' A' ' 27' ' ' ASN . 10.2 t -113.56 151.33 31.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.91 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.563 ' N ' ' OD1' ' A' ' 27' ' ' ASN . . . 118.45 -31.48 5.58 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.407 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.84 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -39.92 154.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -1.047 . . . . 0.0 110.305 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -104.4 -16.13 15.21 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.185 -0.947 . . . . 0.0 109.741 -179.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 7.2 t -169.22 175.24 5.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.92 . . . . 0.0 110.043 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.07 -40.63 73.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 110.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -69.3 -47.12 65.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.2 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' B' ' 127' ' ' LYS . 15.8 t0 -58.17 -55.01 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.188 -0.945 . . . . 0.0 110.018 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.403 ' HB2' ' HB1' ' B' ' 126' ' ' ALA . 8.7 t -49.46 -47.43 48.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' B' ' 133' ' ' LYS . 1.3 tppt? -49.83 -40.48 42.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.851 . . . . 0.0 109.912 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.41 -46.26 41.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.258 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.87 -39.38 53.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.985 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.785 ' HB3' HG21 ' B' ' 74' ' ' VAL . 0.6 OUTLIER -65.43 -53.35 44.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.4 -0.812 . . . . 0.0 110.067 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.09 -38.7 5.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.228 -0.92 . . . . 0.0 110.116 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -62.93 -56.39 17.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.262 -0.899 . . . . 0.0 110.051 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 51.6 m-85 -56.03 -47.54 77.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.855 . . . . 0.0 109.976 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.94 -24.72 54.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 110.012 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 19.0 ttt180 -77.32 -51.84 10.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.663 HD13 ' SD ' ' B' ' 104' ' ' MET . 7.1 mt -45.75 -36.79 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 0.0 109.955 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.754 HG21 ' HB2' ' B' ' 150' ' ' ALA . 34.8 mm -76.48 -52.79 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.883 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -63.82 -32.0 73.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 0.0 109.851 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.62 -26.15 60.64 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' B' ' 142' ' ' ILE . 11.3 mt -77.71 -24.58 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.86 -21.16 6.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.578 ' HB2' HG22 ' B' ' 143' ' ' ILE . 17.8 m-85 -57.82 178.6 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.03 -1.277 . . . . 0.0 110.944 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.949 ' HB3' ' SG ' ' B' ' 78' ' ' CYS . . . -113.89 45.15 1.51 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.528 -0.733 . . . . 0.0 110.073 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.835 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -81.59 109.84 16.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 110.475 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.505 ' O ' HD23 ' B' ' 76' ' ' LEU . 6.2 tttp -85.34 -170.28 3.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.136 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.427 ' HD1' HG11 ' B' ' 74' ' ' VAL . 9.7 t80 -136.75 103.53 5.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.87 . . . . 0.0 110.0 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -166.41 169.5 13.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.875 . . . . 0.0 110.308 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' B' ' 153' ' ' THR . 8.2 t0 69.58 10.99 7.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.39 -0.818 . . . . 0.0 110.63 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.636 ' HD1' HG22 ' B' ' 74' ' ' VAL . 39.8 t80 -48.25 151.64 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.27 142.85 3.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.539 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 42.7 mm -79.75 149.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.414 -0.804 . . . . 0.0 109.951 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -118.87 -60.18 1.79 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.353 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' B' ' 217' ' ' ALA . 24.3 m120 -143.07 169.28 17.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 110.643 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.77 HD12 ' O ' ' B' ' 219' ' ' GLN . 45.4 mt -140.87 138.01 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 0.0 109.775 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.946 HG22 ' OG1' ' B' ' 215' ' ' THR . 26.1 t -110.47 129.42 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.0 110.783 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -127.06 174.82 18.22 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -169.38 146.21 3.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -1.209 . . . . 0.0 110.128 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.669 ' SG ' HG22 ' B' ' 63' ' ' ILE . 0.5 OUTLIER -170.65 150.46 3.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 110.265 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.94 165.46 12.65 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.259 -0.901 . . . . 0.0 109.983 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.489 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -110.11 -83.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.256 -0.903 . . . . 0.0 110.29 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.489 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 179.65 -29.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 110.232 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 3.5 p90 -134.43 158.22 75.66 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.3 -0.875 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.464 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.3 Cg_endo -71.88 159.91 49.2 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.998 1.525 . . . . 0.0 110.588 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.0 151.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.172 -0.955 . . . . 0.0 110.459 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . 0.521 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 2.1 ptm180 -87.61 103.66 15.78 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.319 -0.863 . . . . 0.0 109.824 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.53 ' HB3' ' CE1' ' B' ' 185' ' ' TYR . 12.7 mt -53.54 -33.16 53.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.383 -0.823 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.28 -43.35 95.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.66 -29.32 73.79 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.553 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -79.32 -32.03 43.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -1.096 . . . . 0.0 110.068 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.929 ' HB2' HD11 ' B' ' 193' ' ' LEU . . . -87.0 -25.53 24.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -77.91 -39.6 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.218 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 29.9 t -84.73 -38.84 19.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.511 ' CE1' HG13 ' B' ' 233' ' ' VAL . 69.4 m80 -107.27 15.4 25.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 110.203 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -44.61 -35.89 4.33 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.55 4.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -1.142 . . . . 0.0 110.141 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -138.95 9.7 2.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.904 . . . . 0.0 110.264 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.615 ' OG ' HD21 ' B' ' 193' ' ' LEU . 1.8 t -122.19 122.31 38.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -99.12 127.84 45.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.942 . . . . 0.0 110.234 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 0.573 ' CD1' HD12 ' B' ' 193' ' ' LEU . 23.0 t80 -126.13 120.5 30.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.885 . . . . 0.0 110.258 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -137.68 102.33 8.64 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 110.054 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.32 0.1 8.46 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.13 1.594 . . . . 0.0 110.365 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -99.88 -4.78 29.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.062 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 58' ' ' SER . 0.5 OUTLIER -148.44 -38.55 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 110.472 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.572 ' HB2' HD23 ' B' ' 189' ' ' LEU . 6.7 t80 -124.39 113.78 27.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 110.382 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.04 -19.27 26.71 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.956 1.503 . . . . 0.0 110.079 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.492 ' HA3' ' CE2' ' B' ' 207' ' ' PHE . . . -97.72 179.92 33.14 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.929 HD11 ' HB2' ' B' ' 176' ' ' ALA . 0.9 OUTLIER -113.19 145.99 40.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -1.185 . . . . 0.0 110.533 -179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.505 ' CD1' HD22 ' A' ' 62' ' ' LEU . 5.8 mt -109.09 110.36 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.386 -0.821 . . . . 0.0 109.754 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -107.54 120.53 42.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.413 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.33 93.08 6.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.205 -0.934 . . . . 0.0 110.046 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 52.9 tpp -49.64 136.04 17.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.374 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.426 ' O ' ' HE2' ' B' ' 201' ' ' LYS . 73.0 t -73.12 -50.71 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 110.119 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 7.9 tttp -142.3 115.91 6.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.451 ' HG3' ' HA ' ' B' ' 222' ' ' GLU . 48.8 Cg_endo -73.73 165.21 85.44 Favored 'Cis proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.994 -2.086 . . . . 0.0 110.541 -0.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.445 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -74.75 98.86 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.992 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' B' ' 217' ' ' ALA . 31.7 mm -139.76 144.95 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.098 -1.001 . . . . 0.0 110.498 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.602 ' C ' HD12 ' B' ' 204' ' ' LEU . 90.4 t -93.45 118.61 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.738 ' N ' HD12 ' B' ' 204' ' ' LEU . 6.1 mp -115.58 123.77 49.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.568 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.502 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 5.7 mt -94.83 129.37 41.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.843 . . . . 0.0 109.914 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.547 HG12 HD21 ' B' ' 234' ' ' LEU . 3.7 mp -118.8 129.47 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.549 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.492 ' CE2' ' HA3' ' B' ' 192' ' ' GLY . 96.6 m-85 -114.26 149.72 35.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 110.062 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 65.1 t -55.19 -24.8 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.0 p -64.36 -26.48 68.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 110.328 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.427 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 108.06 19.9 8.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.88 138.97 33.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -1.162 . . . . 0.0 110.274 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 20.3 mm -123.72 132.99 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.161 -0.962 . . . . 0.0 110.384 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.586 ' C ' HD12 ' B' ' 214' ' ' LEU . 21.2 t -125.79 130.97 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 110.136 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.826 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.7 mp -118.42 126.28 51.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.403 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.946 ' OG1' HG22 ' B' ' 161' ' ' VAL . 1.1 t -147.3 136.03 22.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.968 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.468 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 120.45 7.55 8.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -86.87 134.36 33.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -1.213 . . . . 0.0 110.237 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -78.36 -21.19 49.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 110.113 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.77 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.0 OUTLIER -139.1 -170.38 2.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.062 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . 0.719 ' HG3' HD11 ' B' ' 67' ' ' LEU . 2.9 ttt180 -89.94 -36.54 14.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.133 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -52.79 -31.31 37.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.269 -0.895 . . . . 0.0 110.174 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' B' ' 200' ' ' PRO . 24.1 mt-10 -70.45 -56.99 5.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 110.109 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.556 HG22 ' HG2' ' B' ' 65' ' ' PRO . 31.0 mm -50.93 -38.73 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.215 -0.928 . . . . 0.0 109.821 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' B' ' 64' ' ' VAL . 1.1 m-30 -67.79 -50.97 54.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.0 110.156 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -27.47 67.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 110.044 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.43 -52.48 65.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.91 . . . . 0.0 109.96 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.672 ' HA ' HG22 ' B' ' 230' ' ' ILE . 41.9 t80 -61.93 -42.33 98.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.946 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -18.17 52.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.338 -0.851 . . . . 0.0 110.306 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -96.7 -28.57 14.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -0.908 . . . . 0.0 110.455 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' B' ' 227' ' ' PHE . 4.2 tp -98.29 -10.66 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.27 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.655 ' CD1' ' CZ ' ' B' ' 227' ' ' PHE . 14.9 t80 -59.18 -42.52 93.71 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 111.013 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 47.3 Cg_endo -76.23 -44.0 0.28 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.381 1.2 . . . . 0.0 110.353 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.553 HG12 HD21 ' B' ' 175' ' ' LEU . 7.7 t -55.27 -38.51 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.873 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.547 HD21 HG12 ' B' ' 206' ' ' ILE . 40.4 mt -67.27 -50.65 59.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.37 -0.831 . . . . 0.0 110.201 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 1.6 m -58.4 -29.48 66.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.85 -35.42 76.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.102 -0.999 . . . . 0.0 110.248 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.99 39.44 2.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 110.207 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.8 176.71 1.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 110.115 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.19 -59.53 1.7 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.9 ttt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.213 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.176 0.512 . . . . 0.0 110.246 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.43 85.56 0.15 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.561 ' O ' HD13 ' A' ' 14' ' ' ILE . 69.4 m -139.99 43.95 1.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -1.125 . . . . 0.0 110.156 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 13' ' ' SER . 21.1 mm -135.51 64.8 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 110.245 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.53 172.98 15.54 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -83.09 -104.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.159 . . . . 0.0 110.239 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.48 142.31 12.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.066 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -112.66 175.25 5.51 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.374 -1.074 . . . . 0.0 109.288 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.66 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.6 OUTLIER -93.7 97.4 10.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.063 -1.023 . . . . 0.0 111.004 -179.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.066 HD21 HD21 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -108.06 6.36 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 110.976 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.783 ' OG1' HD12 ' A' ' 68' ' ' LEU . 5.6 m -43.19 -26.77 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.133 -1.027 . . . . 0.0 109.483 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -98.55 -19.26 23.28 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.865 HG13 HD22 ' A' ' 20' ' ' LEU . 1.3 mm -57.07 -46.79 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.67 -1.488 . . . . 0.0 109.0 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.871 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.1 pp -83.53 -24.43 31.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.922 -1.111 . . . . 0.0 109.976 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -83.82 9.25 12.43 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.274 -0.891 . . . . 0.0 109.354 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.561 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 137.34 103.71 0.66 Allowed Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.843 ' ND2' HD11 ' A' ' 35' ' ' LEU . 20.0 p-10 -18.56 129.77 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.717 0.77 . . . . 0.0 111.827 -178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 29' ' ' ASP . 1.5 pp -138.93 170.49 16.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.726 -0.609 . . . . 0.0 109.533 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.806 ' C ' HD12 ' A' ' 28' ' ' ILE . 77.5 m-20 -88.17 120.34 29.43 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.732 ' O ' HD11 ' A' ' 18' ' ' LEU . 4.6 p -35.33 -31.27 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.594 0.711 . . . . 0.0 109.662 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.9 tt0 -47.14 -23.35 0.49 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.275 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.23 21.78 5.1 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.361 -1.399 . . . . 0.0 110.38 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.98 134.27 51.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.965 -1.315 . . . . 0.0 109.351 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.542 ' HA ' HG22 ' A' ' 28' ' ' ILE . 5.4 tt -87.82 162.06 17.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.895 -1.128 . . . . 0.0 111.157 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 36' ' ' GLN . 3.1 pp -139.05 -179.64 5.97 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.846 -179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.895 ' N ' HD12 ' A' ' 35' ' ' LEU . 22.2 mt-30 -125.89 145.4 50.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.467 -0.771 . . . . 0.0 109.842 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -98.73 -29.35 13.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.101 -0.999 . . . . 0.0 110.591 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 38' ' ' ASP . 58.2 p30 -156.37 -146.36 0.17 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 110.513 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -157.71 161.14 38.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' HA3' ' A' ' 44' ' ' GLY . . . -104.52 78.87 0.28 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -17.19 47.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -1.122 . . . . 0.0 110.281 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.78 -88.66 1.02 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -92.66 45.57 1.2 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -1.167 . . . . 0.0 109.988 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 40' ' ' GLY . . . -108.84 104.67 2.0 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -128.89 -102.45 1.06 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -85.05 137.24 33.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -1.164 . . . . 0.0 109.802 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.81 177.38 28.88 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.423 ' O ' ' C ' ' A' ' 49' ' ' ASP . 26.0 p90 -99.73 36.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.336 -1.097 . . . . 0.0 110.014 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' PHE . 2.0 m-20 -41.24 -80.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 110.714 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.82 26.62 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -0.915 . . . . 0.0 110.668 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.4 tp10 -100.24 -26.51 13.89 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.089 -1.007 . . . . 0.0 108.693 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.888 ' O ' HD12 ' A' ' 56' ' ' ILE . 2.8 mt -98.32 -39.01 9.03 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.402 0.62 . . . . 0.0 109.689 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -44.38 -46.71 9.56 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.391 -0.818 . . . . 0.0 109.472 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -66.29 -32.6 74.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.541 -0.724 . . . . 0.0 109.553 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.531 ' HB3' ' CD1' ' A' ' 59' ' ' LEU . 92.4 m-20 -76.76 -39.07 52.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.409 -0.807 . . . . 0.0 109.676 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.888 HD12 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -53.46 -34.38 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.384 -0.822 . . . . 0.0 109.341 179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.31 -27.12 72.08 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.975 ' O ' HD11 ' B' ' 189' ' ' LEU . 11.5 t -117.82 8.94 12.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.856 HD23 HD12 ' A' ' 62' ' ' LEU . 6.0 mt -96.16 13.8 26.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 110.203 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.44 41.9 1.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.23 -0.919 . . . . 0.0 110.306 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.586 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.57 19.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.856 HD12 HD23 ' A' ' 59' ' ' LEU . 6.0 mt -118.06 -58.64 1.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.361 -0.837 . . . . 0.0 109.232 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.4 -40.87 0.02 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.871 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.5 mm? -52.13 -26.0 10.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -1.19 . . . . 0.0 110.57 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -45.95 -36.77 5.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 17.4 m -70.04 -59.5 2.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 110.048 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.558 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -64.77 -11.96 42.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.245 -0.909 . . . . 0.0 110.03 179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.783 HD12 ' OG1' ' A' ' 21' ' ' THR . 6.1 tt -69.39 -62.17 1.49 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.391 -0.818 . . . . 0.0 109.292 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.8 pp -66.78 -6.3 15.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.627 -0.67 . . . . 0.0 110.029 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -84.58 16.37 3.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 110.619 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.919 HG12 HG11 ' B' ' 122' ' ' VAL . 2.9 t -141.37 4.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.932 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.779 ' HB ' HD11 ' A' ' 20' ' ' LEU . 1.4 tp -147.3 77.2 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.579 -0.701 . . . . 0.0 109.359 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.8 t70 -82.83 50.64 1.74 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 108.908 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.4 OUTLIER -75.89 43.47 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.74 -0.6 . . . . 0.0 111.657 -179.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -170.91 2.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.825 -1.172 . . . . 0.0 110.193 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' O ' ' OE2' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -64.16 129.49 40.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.895 . . . . 0.0 110.331 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' B' ' 118' ' ' SER . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.216 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.233 0.539 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.04 64.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -62.03 103.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 110.349 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 45.3 t -71.77 134.75 83.61 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.55 135.66 26.76 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.937 1.493 . . . . 0.0 110.318 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 98.6 m -96.44 130.58 43.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 110.361 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' B' ' 161' ' ' VAL . 33.2 mt -74.76 123.35 24.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.867 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -113.95 -3.66 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.281 -0.887 . . . . 0.0 110.705 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.532 ' CB ' ' HB ' ' B' ' 161' ' ' VAL . 0.2 OUTLIER -156.36 142.83 18.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.086 -1.009 . . . . 0.0 110.914 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.844 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 19.9 mm -132.13 150.2 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -0.829 . . . . 0.0 109.809 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.553 HG22 ' HB ' ' B' ' 124' ' ' THR . 22.0 t -141.44 134.65 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 110.178 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.64 165.27 27.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.252 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 68.1 p -110.15 145.65 36.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.313 -0.867 . . . . 0.0 110.179 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 38.5 t -134.72 131.21 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.288 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 41.4 m -111.84 128.59 56.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.263 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.855 HD22 ' HB1' ' B' ' 150' ' ' ALA . 49.0 mt -88.07 -17.33 31.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.247 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.01 -2.31 84.26 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' B' ' 149' ' ' ALA . 3.6 t -137.33 151.14 48.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.106 -1.232 . . . . 0.0 110.339 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.828 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.9 OUTLIER -78.46 164.15 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 110.043 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.828 HD23 ' O ' ' B' ' 79' ' ' ARG . 23.8 mt -140.48 153.38 46.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.209 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 82' ' ' LEU . 34.8 t0 -92.77 100.59 13.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.519 ' HB3' HG23 ' B' ' 102' ' ' VAL . 18.0 mt -44.23 -34.95 2.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.275 -0.891 . . . . 0.0 109.923 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.452 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 1.9 tmtm? -66.14 -36.12 82.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 20.8 m -89.25 -40.13 13.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.357 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -58.29 -50.48 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.974 . . . . 0.0 110.272 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.71 -40.78 63.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.139 -0.976 . . . . 0.0 110.197 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 27.6 tp -57.74 -28.48 63.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 110.223 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -98.94 -40.37 8.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.319 -0.863 . . . . 0.0 110.081 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -47.38 124.3 6.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 0.0 110.208 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 20.9 mtt180 -67.28 -21.35 65.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 0.0 110.217 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.42 79.82 1.79 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -158.13 165.18 35.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.879 . . . . 0.0 110.19 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -145.24 152.93 40.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.878 . . . . 0.0 110.154 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -139.52 122.53 16.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 110.265 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -146.73 134.72 10.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.87 . . . . 0.0 110.228 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.85 -41.04 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.948 1.499 . . . . 0.0 110.473 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -50.37 -23.2 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 110.293 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -98.32 -65.44 0.96 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -0.93 . . . . 0.0 110.062 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 1.012 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.79 167.15 7.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.469 -0.77 . . . . 0.0 111.295 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.92 56.07 3.54 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.23 -0.919 . . . . 0.0 110.684 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.012 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -148.88 159.62 44.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 0.0 109.977 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' B' ' 82' ' ' LEU . 30.8 t -101.02 132.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.848 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.476 HG12 ' OG ' ' A' ' 30' ' ' SER . 6.5 mt -95.74 112.46 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 2.8 ttm -102.29 157.76 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 110.014 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -161.66 131.58 4.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.137 -0.977 . . . . 0.0 110.439 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 26.7 pt -115.64 172.37 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.209 -0.932 . . . . 0.0 110.091 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' B' ' 110' ' ' LYS . 7.7 mtp180 -115.45 29.53 7.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 110.432 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -174.63 86.16 0.33 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.503 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 51.0 Cg_endo -78.23 148.77 85.4 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.777 -2.176 . . . . 0.0 110.319 -0.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.493 ' HG2' ' HA ' ' B' ' 107' ' ' ARG . 12.0 mtmm -58.25 86.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.148 -0.97 . . . . 0.0 109.879 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.47 HG22 ' C ' ' B' ' 125' ' ' GLY . 11.3 p -130.45 168.64 16.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 110.519 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.696 HG22 HG23 ' B' ' 124' ' ' THR . 4.0 t -130.38 164.22 25.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.61 166.26 30.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.01 -1.057 . . . . 0.0 110.903 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.575 HD13 HD11 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -113.17 107.88 16.52 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.549 ' CD1' ' HG3' ' B' ' 121' ' ' MET . 13.8 mm -91.75 125.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 111.186 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.56 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 4.6 m-30 -103.57 166.06 10.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.479 -0.763 . . . . 0.0 109.64 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.05 -14.85 58.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 110.263 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . 0.471 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 1.1 p -73.53 -30.27 62.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.219 -0.926 . . . . 0.0 110.305 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 127.75 -23.43 5.33 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -65.94 163.6 16.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.178 . . . . 0.0 110.049 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.549 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.8 OUTLIER -159.05 124.88 4.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.062 -1.024 . . . . 0.0 110.766 -179.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.919 HG11 HG12 ' A' ' 71' ' ' VAL . 2.9 t -101.8 136.22 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.239 -0.913 . . . . 0.0 109.655 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.483 HG12 ' N ' ' B' ' 124' ' ' THR . 76.9 t -115.71 165.42 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.156 -0.965 . . . . 0.0 110.662 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.696 HG23 HG22 ' B' ' 112' ' ' THR . 5.9 t -169.52 155.89 6.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.439 -0.788 . . . . 0.0 110.014 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.544 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 113.8 -4.06 24.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.844 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -84.21 168.99 15.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.192 -1.181 . . . . 0.0 110.502 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.465 ' C ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -121.89 -19.21 6.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 110.292 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' B' ' 129' ' ' GLU . 1.0 OUTLIER -139.86 -178.92 5.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 110.073 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . 0.446 ' N ' ' OG ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -68.74 -43.59 75.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.102 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -33.5 72.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.734 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 0.2 OUTLIER -70.24 -50.64 37.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 110.251 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' B' ' 136' ' ' SER . 5.2 t -61.21 -22.21 64.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.942 . . . . 0.0 110.082 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.5 -49.53 18.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -0.843 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -45.47 74.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.463 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -50.68 -49.01 58.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.832 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 132' ' ' SER . 0.6 OUTLIER -66.85 -49.5 65.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.933 . . . . 0.0 109.682 179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -54.05 -29.68 44.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.369 -0.832 . . . . 0.0 109.758 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.446 ' O ' ' HB3' ' B' ' 141' ' ' ARG . 27.4 mmtt -70.86 -55.84 7.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 0.0 109.702 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 47.0 m-85 -49.47 -48.49 47.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -57.01 -36.54 70.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.265 -0.897 . . . . 0.0 109.395 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 65.6 ttt180 -57.51 -38.36 74.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.425 -0.797 . . . . 0.0 109.949 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.407 ' O ' HG13 ' B' ' 146' ' ' ILE . 12.2 mt -66.76 -59.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.932 . . . . 0.0 110.075 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.53 HD13 HD13 ' B' ' 80' ' ' LEU . 89.3 mt -56.6 -42.98 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.848 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' B' ' 140' ' ' ALA . 20.5 mt-30 -67.55 -40.57 84.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.155 -0.965 . . . . 0.0 109.715 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -70.32 -21.29 62.94 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' B' ' 143' ' ' ILE . 6.5 mt -75.72 -29.46 20.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 125.07 -29.84 4.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' B' ' 147' ' ' GLY . 9.8 m-85 -43.89 156.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.014 -1.286 . . . . 0.0 110.637 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.513 ' HB3' ' SG ' ' B' ' 78' ' ' CYS . . . -91.62 48.58 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.442 -0.786 . . . . 0.0 110.129 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.855 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -84.42 171.49 12.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.264 -0.897 . . . . 0.0 110.403 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' B' ' 153' ' ' THR . 16.2 tttt -160.78 108.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 110.193 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.414 ' O ' ' CD2' ' B' ' 152' ' ' PHE . 47.7 t80 -49.7 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 110.265 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.9 OUTLIER -145.65 168.43 20.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.332 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.534 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t70 63.37 24.02 14.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.469 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' B' ' 73' ' ' THR . 43.5 t80 -67.72 132.98 48.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 110.023 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -166.24 134.69 2.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.413 HG21 HD13 ' B' ' 157' ' ' ILE . 18.0 mt -79.38 122.85 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 0.0 110.172 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.59 6.38 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.532 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 1.1 m120 -154.51 123.08 6.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 110.374 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' B' ' 215' ' ' THR . 30.8 mt -122.64 149.82 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.532 ' HB ' ' CB ' ' B' ' 69' ' ' ASN . 58.6 t -130.35 138.38 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.572 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.37 171.57 25.72 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.34 152.85 5.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.938 -1.33 . . . . 0.0 110.697 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.475 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 31.0 p -166.79 166.4 15.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 109.952 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -117.53 171.31 8.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.521 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -121.75 -83.8 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.236 -0.915 . . . . 0.0 110.341 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.521 ' H ' HG23 ' B' ' 166' ' ' VAL . 3.0 mmtt 178.1 -23.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.036 -1.04 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -125.48 153.67 72.5 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.979 -1.076 . . . . 0.0 109.703 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.34 147.29 46.87 Favored 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.943 1.496 . . . . 0.0 110.248 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.691 HG12 HD22 ' B' ' 234' ' ' LEU . 2.0 mp -108.23 156.89 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 110.599 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 14.2 mtt180 -91.29 101.97 14.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -0.866 . . . . 0.0 109.775 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 25.2 mt -63.9 -31.12 72.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 110.496 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -87.27 -34.29 18.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -64.97 -51.11 54.27 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 16.6 tp -65.71 -41.83 91.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -1.074 . . . . 0.0 109.907 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' B' ' 180' ' ' GLY . . . -58.46 -43.53 88.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.875 . . . . 0.0 109.777 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.8 t80 -59.76 -30.11 68.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.881 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.18 -59.56 2.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 0.0 110.079 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.42 ' O ' ' N ' ' B' ' 183' ' ' SER . 41.5 m170 -97.98 32.53 2.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.338 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' B' ' 176' ' ' ALA . . . -47.93 -62.74 3.97 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . 0.585 HG23 ' CD1' ' B' ' 182' ' ' PHE . 10.3 t -45.85 -24.27 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.169 -1.195 . . . . 0.0 110.272 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.585 ' CD1' HG23 ' B' ' 181' ' ' THR . 20.7 m-85 -102.43 -14.19 16.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.469 ' O ' ' O ' ' B' ' 180' ' ' GLY . 0.3 OUTLIER -140.86 149.04 41.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.21 -0.931 . . . . 0.0 110.089 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -121.01 137.58 54.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.127 -0.983 . . . . 0.0 110.588 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -134.71 109.43 8.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 0.0 109.79 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.03 121.63 33.58 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.458 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.19 -11.98 25.32 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.891 1.469 . . . . 0.0 110.279 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -88.73 -23.85 22.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.113 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.975 HD11 ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -89.84 -63.21 1.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.039 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.689 ' HZ ' HD11 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -169.68 161.07 7.18 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.43 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . 0.537 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.9 Cg_endo -69.82 0.37 5.8 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.136 1.598 . . . . 0.0 111.842 -178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.584 ' HA3' ' CE2' ' B' ' 190' ' ' PHE . . . -89.25 149.41 20.7 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.897 ' O ' HD13 ' B' ' 205' ' ' LEU . 10.3 tt -110.33 130.83 55.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -1.171 . . . . 0.0 110.184 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . . . . . . . . . 3.3 mt -95.63 111.21 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.225 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -100.89 113.7 26.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.297 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -91.1 88.58 7.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 110.145 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 46.1 tpp -57.55 125.2 21.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -0.867 . . . . 0.0 110.377 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.41 HG23 ' H ' ' B' ' 198' ' ' VAL . 34.7 t -57.52 -49.62 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.827 . . . . 0.0 110.168 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.57 124.73 5.7 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.997 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.405 ' O ' HG12 ' B' ' 202' ' ' ILE . 48.0 Cg_endo -74.8 148.68 92.39 Favored 'Cis proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.011 -2.079 . . . . 0.0 110.424 -0.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.414 ' O ' HD13 ' B' ' 202' ' ' ILE . 10.9 tptt -56.22 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.335 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.414 HD13 ' O ' ' B' ' 201' ' ' LYS . 36.6 mm -136.84 153.5 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 110.206 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -113.17 112.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.925 . . . . 0.0 110.297 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.859 HD21 ' HB1' ' B' ' 226' ' ' ALA . 1.7 mp -107.42 149.13 28.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 110.188 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.897 HD13 ' O ' ' B' ' 193' ' ' LEU . 0.2 OUTLIER -114.85 115.8 27.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 109.882 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.568 HD12 ' N ' ' B' ' 206' ' ' ILE . 4.6 mp -104.85 139.58 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 110.326 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -122.69 155.6 36.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.244 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 63.9 t -59.13 -31.17 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 0.0 110.348 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.3 t -57.04 -39.13 74.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.099 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.22 10.88 5.94 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.437 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -89.66 135.45 33.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.292 -1.122 . . . . 0.0 110.262 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.437 HD13 ' O ' ' B' ' 211' ' ' LYS . 25.5 mm -113.74 134.69 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.3 t -114.32 163.45 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 110.138 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.501 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 1.4 mp -145.92 129.8 17.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 0.0 109.915 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 15.1 t -158.83 149.05 19.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 110.333 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.505 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 101.95 5.17 50.75 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.94 33.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -1.191 . . . . 0.0 110.161 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -93.18 -6.12 48.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.123 -0.985 . . . . 0.0 110.275 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -154.68 -179.99 8.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.263 -0.898 . . . . 0.0 110.143 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 11.8 ttt180 -79.05 -25.34 43.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 110.22 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.79 -23.89 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.248 -0.907 . . . . 0.0 110.186 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.13 -50.37 12.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.984 . . . . 0.0 110.19 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.499 HG23 HD22 ' B' ' 214' ' ' LEU . 20.3 mm -58.8 -38.13 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -70.6 -38.53 74.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -0.874 . . . . 0.0 110.311 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.46 -30.3 59.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 110.551 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.859 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -64.72 -49.85 69.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -0.962 . . . . 0.0 110.417 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.513 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 16.1 t80 -69.07 -41.22 77.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.479 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -51.57 -38.19 53.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.308 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.82 -10.1 35.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.294 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.556 HG13 HD22 ' B' ' 204' ' ' LEU . 10.5 mm -96.22 -17.73 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 110.124 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.9 t80 -61.73 -42.1 81.41 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 110.829 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.5 Cg_endo -76.71 -49.26 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.346 1.182 . . . . 0.0 110.21 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 21.3 t -44.87 -40.48 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.764 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.691 HD22 HG12 ' B' ' 170' ' ' ILE . 74.0 mt -70.75 -63.36 1.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.779 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 48.9 m -46.9 -33.2 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.33 -34.19 77.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.403 -0.811 . . . . 0.0 110.014 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.445 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 57.3 m-85 -120.89 39.63 3.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.269 -0.894 . . . . 0.0 110.126 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.49 ' NH2' ' O ' ' B' ' 239' ' ' LYS . 0.0 OUTLIER -71.57 -173.72 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.927 . . . . 0.0 110.175 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.49 ' O ' ' NH2' ' B' ' 238' ' ' ARG . 2.4 ttpt -125.68 -39.55 2.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.21 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.47 ' OE2' HD11 ' A' ' 14' ' ' ILE . 29.6 tt0 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.264 0.554 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.67 -88.59 1.21 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.05 89.63 2.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.296 -1.12 . . . . 0.0 110.142 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.47 HD11 ' OE2' ' A' ' 11' ' ' GLU . 2.9 mp -52.52 97.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 110.312 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.06 69.98 0.32 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' N ' ' O ' ' A' ' 14' ' ' ILE . 20.1 p-10 -124.04 145.87 48.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.208 -1.172 . . . . 0.0 110.373 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.04 132.95 4.94 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.78 160.93 22.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.492 -1.005 . . . . 0.0 109.509 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.93 76.85 0.64 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.045 -1.034 . . . . 0.0 110.615 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.947 HD13 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -93.99 -0.32 55.59 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 111.253 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.719 ' N ' HD21 ' A' ' 68' ' ' LEU . 9.0 m -45.91 -24.25 0.38 Allowed 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.889 -1.132 . . . . 0.0 109.809 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.487 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -97.04 -31.93 6.7 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.947 HG21 HD13 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -47.94 -47.95 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.815 -1.403 . . . . 0.0 109.132 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.833 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.8 pp -83.51 -26.74 29.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.969 -1.082 . . . . 0.0 110.549 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.689 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.3 OUTLIER -80.96 6.92 11.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.165 -0.959 . . . . 0.0 109.096 178.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 28' ' ' ILE . . . 138.33 106.58 0.74 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.858 ' ND2' HD11 ' A' ' 35' ' ' LEU . 5.9 p30 -16.94 133.63 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.915 0.864 . . . . 0.0 112.186 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.806 HD12 ' C ' ' A' ' 29' ' ' ASP . 2.0 pp -146.44 167.29 7.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.648 -0.658 . . . . 0.0 109.487 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.806 ' C ' HD12 ' A' ' 28' ' ' ILE . 10.8 m-20 -87.88 121.14 29.93 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 175.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.542 ' OG ' ' CD1' ' B' ' 103' ' ' ILE . 9.3 p -36.93 -28.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.145 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.6 tt0 -58.51 -11.95 3.47 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.181 -0.949 . . . . 0.0 110.446 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.64 23.94 6.34 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.191 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.557 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 1.4 tpp180 -107.34 120.45 42.19 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.045 -1.268 . . . . 0.0 109.644 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.805 ' C ' HD13 ' A' ' 34' ' ' LEU . 2.5 tm? -88.59 134.07 33.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 110.405 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.033 HD12 ' N ' ' A' ' 36' ' ' GLN . 1.1 pp -129.53 176.83 7.67 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.053 -1.03 . . . . 0.0 109.993 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 1.033 ' N ' HD12 ' A' ' 35' ' ' LEU . 4.5 mt-30 -134.87 -76.73 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -0.967 . . . . 0.0 110.572 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 36' ' ' GLN . 9.3 p-10 178.4 -44.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 0.0 110.161 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.96 -173.75 3.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 0.0 110.344 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -100.83 71.48 1.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 110.125 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.33 143.09 16.17 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -175.79 153.89 1.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -1.086 . . . . 0.0 110.174 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.95 63.15 3.36 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -170.57 84.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.293 -1.122 . . . . 0.0 110.038 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.62 -123.71 27.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.55 79.98 0.34 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.34 2.54 56.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -1.185 . . . . 0.0 110.278 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.73 148.76 5.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD2' HD12 ' A' ' 52' ' ' LEU . 6.9 p90 -50.76 176.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -1.079 . . . . 0.0 110.029 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -97.39 -137.66 0.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 110.037 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.96 33.4 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.965 . . . . 0.0 110.224 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -100.46 -17.67 17.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.259 -0.901 . . . . 0.0 109.591 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.581 HD13 ' CE1' ' A' ' 25' ' ' PHE . 4.0 mt -95.32 -47.06 6.47 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.513 -0.742 . . . . 0.0 109.977 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.922 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.58 -50.89 52.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -63.75 -25.82 68.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.795 . . . . 0.0 110.06 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 3.5 m-80 -83.29 -33.88 25.87 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.31 -0.869 . . . . 0.0 109.452 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.922 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.3 mt -51.93 -46.03 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.378 -0.826 . . . . 0.0 109.292 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.28 -19.93 26.98 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -122.73 9.9 9.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -1.191 . . . . 0.0 110.605 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.654 HD23 HD21 ' A' ' 62' ' ' LEU . 3.0 mt -84.76 15.85 3.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.141 -0.974 . . . . 0.0 110.419 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.0 p -105.94 39.78 1.71 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.056 -1.027 . . . . 0.0 110.221 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 29.31 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.915 HD12 ' N ' ' A' ' 63' ' ' GLY . 2.1 pp -147.5 -35.44 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.103 -0.998 . . . . 0.0 111.152 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.915 ' N ' HD12 ' A' ' 62' ' ' LEU . . . -170.14 -51.29 0.04 OUTLIER Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.294 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.833 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.4 mm? -42.83 -24.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.106 -1.232 . . . . 0.0 110.572 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 1.8 t70 -42.79 -38.97 2.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.854 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.43 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 58.5 m -66.84 -56.88 8.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.406 -0.809 . . . . 0.0 109.809 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.641 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -65.22 -10.54 32.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.486 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.719 HD21 ' N ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -67.92 -63.93 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.745 0.783 . . . . 0.0 109.298 179.461 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -68.57 -5.12 18.02 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.808 -0.557 . . . . 0.0 110.226 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -83.17 5.68 21.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.26 -0.9 . . . . 0.0 111.201 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.835 HG12 HG11 ' B' ' 122' ' ' VAL . 2.3 t -140.22 4.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.173 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.882 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.2 tp -145.48 73.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.493 -0.754 . . . . 0.0 109.779 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.441 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t70 -81.8 51.77 1.79 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.897 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.3 OUTLIER -78.01 45.1 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.528 -0.732 . . . . 0.0 111.46 -178.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 76' ' ' GLU . 9.2 mtmt -100.23 153.45 19.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.056 -1.027 . . . . 0.0 110.069 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.52 ' CA ' ' OE1' ' A' ' 76' ' ' GLU . 0.0 OUTLIER 64.24 28.17 13.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.271 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' OXT' ' HB1' ' B' ' 100' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.193 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 91.7 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.21 0.529 . . . . 0.0 110.234 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 63' ' ' ILE . . . 167.51 41.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' B' ' 62' ' ' GLY . 2.1 mp -43.7 126.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -1.19 . . . . 0.0 110.089 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.536 HG13 ' HD2' ' B' ' 65' ' ' PRO . 70.2 t -89.82 142.2 28.9 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.158 -0.964 . . . . 0.0 110.505 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.536 ' HD2' HG13 ' B' ' 64' ' ' VAL . 47.2 Cg_endo -75.35 134.54 17.36 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.052 1.554 . . . . 0.0 110.417 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -90.71 127.17 36.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 110.135 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' B' ' 67' ' ' LEU . 17.6 mt -73.03 132.65 43.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.125 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -98.05 -41.08 8.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.287 -0.883 . . . . 0.0 110.101 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -170.03 179.07 3.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.561 HG12 HG23 ' B' ' 160' ' ' ILE . 9.5 mt -150.53 167.8 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 0.0 110.125 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.542 HG13 ' O ' ' B' ' 123' ' ' VAL . 52.8 t -137.4 140.64 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.131 -0.981 . . . . 0.0 110.426 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -136.51 154.55 50.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.426 -0.797 . . . . 0.0 110.068 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 1.8 t -115.24 133.85 55.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.196 -0.94 . . . . 0.0 110.373 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.451 HG21 ' OG ' ' B' ' 136' ' ' SER . 66.2 t -126.71 146.76 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.276 -0.89 . . . . 0.0 110.025 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 57.5 m -110.13 141.26 43.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.172 -0.955 . . . . 0.0 110.633 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.941 HD22 ' C ' ' B' ' 149' ' ' ALA . 7.4 mt -105.2 -72.93 0.69 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.485 -0.759 . . . . 0.0 109.898 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 120.33 -10.18 10.83 Favored Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.018 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . 0.484 ' HB3' ' HB3' ' B' ' 148' ' ' PHE . 68.5 m -109.31 119.92 40.95 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.034 -1.274 . . . . 0.0 109.354 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.507 ' HD3' ' O ' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -44.02 147.94 0.45 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.306 -0.871 . . . . 0.0 110.032 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.701 ' CD2' ' HB2' ' B' ' 149' ' ' ALA . 27.0 mt -116.73 144.59 44.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 111.173 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' B' ' 83' ' ' LYS . 0.2 OUTLIER -101.28 83.04 2.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.486 -0.758 . . . . 0.0 109.152 178.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' B' ' 81' ' ' ASP . 10.3 mt -37.09 -30.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.636 -0.665 . . . . 0.0 110.933 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' B' ' 81' ' ' ASP . 0.0 OUTLIER -70.28 -46.04 65.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 109.937 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 97.9 m -82.21 -31.41 30.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.382 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.5 -43.04 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.17 -0.956 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.77 51.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.234 -0.916 . . . . 0.0 109.974 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.9 tp -85.24 -43.23 13.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.261 -0.9 . . . . 0.0 110.452 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.767 ' HB2' HD11 ' B' ' 146' ' ' ILE . 0.3 OUTLIER -74.43 -44.84 50.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 110.591 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -54.88 128.48 33.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 110.438 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -66.55 -24.93 66.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.888 . . . . 0.0 110.08 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 9.0 p30 -135.22 79.5 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 110.077 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -160.07 137.04 9.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.276 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -117.39 171.18 8.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.173 -0.954 . . . . 0.0 110.248 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.692 ' HB2' HG22 ' B' ' 102' ' ' VAL . 13.3 t80 -164.2 102.2 0.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.177 -0.952 . . . . 0.0 110.301 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' B' ' 98' ' ' ARG . 0.7 OUTLIER -119.1 136.95 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 110.272 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.45 -21.01 17.64 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.996 1.524 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -76.65 -17.3 59.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.537 ' N ' ' HD2' ' B' ' 98' ' ' ARG . 3.2 mpt_? -96.45 -63.88 1.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.904 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 1.168 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.86 166.69 11.3 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.494 -0.754 . . . . 0.0 110.806 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.501 ' HB1' ' OXT' ' A' ' 77' ' ' ALA . . . -81.97 53.43 2.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.468 -0.77 . . . . 0.0 111.909 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.168 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -153.19 154.25 34.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.872 -1.143 . . . . 0.0 110.463 178.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.692 HG22 ' HB2' ' B' ' 94' ' ' TYR . 39.7 t -89.81 139.08 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.542 ' CD1' ' OG ' ' A' ' 30' ' ' SER . 8.4 mt -100.35 114.28 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.306 -0.871 . . . . 0.0 109.845 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.609 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 1.7 ttm -99.8 170.86 8.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 110.551 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 0.1 OUTLIER -169.99 132.42 1.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.409 -0.807 . . . . 0.0 110.046 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.558 HG23 ' CE1' ' B' ' 139' ' ' TYR . 22.8 pt -128.45 163.56 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.352 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -110.64 26.23 10.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 0.0 110.258 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER -172.76 86.28 0.41 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.267 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.731 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.3 Cg_endo -74.85 161.52 94.6 Favored 'Cis proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.675 -2.219 . . . . 0.0 110.564 -0.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -72.28 82.9 1.03 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 110.014 179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' B' ' 124' ' ' THR . 37.0 p -132.46 176.3 8.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 110.518 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.823 HG22 HG23 ' B' ' 124' ' ' THR . 5.8 t -135.68 174.07 11.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.0 109.6 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -170.25 176.45 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.967 -1.083 . . . . 0.0 111.091 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.832 HD13 HD13 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -143.17 122.89 13.35 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.423 ' CG2' ' CD1' ' B' ' 80' ' ' LEU . 20.4 mt -100.35 160.34 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.09 -1.006 . . . . 0.0 111.479 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.72 ' CZ ' HD12 ' B' ' 114' ' ' LEU . 34.8 m-85 -119.42 156.17 30.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.524 -0.735 . . . . 0.0 110.246 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.507 ' O ' ' HD3' ' B' ' 79' ' ' ARG . . . -64.8 -16.45 63.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.004 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 4.4 p -71.29 -36.73 71.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.245 -0.909 . . . . 0.0 110.623 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.629 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 129.41 4.24 4.96 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . 0.413 ' C ' ' HG3' ' B' ' 121' ' ' MET . 0.5 OUTLIER -100.4 138.89 36.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -1.175 . . . . 0.0 110.003 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.752 ' CG ' HD11 ' B' ' 76' ' ' LEU . 0.0 OUTLIER -128.03 129.45 46.72 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.037 -1.04 . . . . 0.0 110.163 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.835 HG11 HG12 ' A' ' 71' ' ' VAL . 18.3 t -97.44 132.36 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 0.0 109.713 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.542 ' O ' HG13 ' B' ' 71' ' ' VAL . 29.7 t -114.95 149.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.097 -1.002 . . . . 0.0 110.574 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.823 HG23 HG22 ' B' ' 112' ' ' THR . 6.2 t -149.54 156.48 42.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 0.0 110.109 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.543 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 110.04 -32.81 6.41 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -45.35 125.13 5.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -1.115 . . . . 0.0 110.089 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.2 OUTLIER -92.29 -17.92 24.09 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.23 -0.919 . . . . 0.0 109.802 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 42.0 t -142.44 151.87 42.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.387 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -45.16 -49.88 11.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 110.232 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -40.87 98.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.216 -0.927 . . . . 0.0 110.056 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.41 -38.67 77.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.204 -0.935 . . . . 0.0 110.015 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -44.43 72.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 110.161 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -25.56 65.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.13 -0.981 . . . . 0.0 110.23 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.498 ' HA ' ' HD3' ' B' ' 137' ' ' ARG . 0.6 OUTLIER -85.25 -36.26 21.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.338 -0.851 . . . . 0.0 110.287 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.731 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -70.49 -36.11 73.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.047 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.451 ' OG ' HG21 ' B' ' 74' ' ' VAL . 28.8 t -71.64 -59.8 2.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.527 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.0 ptm180 -46.19 -37.36 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.819 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.527 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 8.8 mttt -64.72 -45.98 84.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.524 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.558 ' CE1' HG23 ' B' ' 106' ' ' ILE . 9.5 m-85 -57.47 -56.95 15.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.417 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . 0.53 ' HA ' HG12 ' B' ' 143' ' ' ILE . . . -49.04 -40.77 32.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.474 ' HA ' ' OE1' ' B' ' 144' ' ' GLN . 2.4 ttt-85 -53.4 -47.29 69.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 110.085 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.439 ' C ' HD13 ' B' ' 143' ' ' ILE . 83.2 mt -61.81 -25.44 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.435 -0.791 . . . . 0.0 110.349 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 1.152 ' CG2' ' HB3' ' B' ' 149' ' ' ALA . 0.5 OUTLIER -83.83 -51.2 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 109.397 179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.878 ' HG2' ' HB1' ' B' ' 150' ' ' ALA . 19.9 mt-30 -46.96 -36.5 7.79 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.172 -0.955 . . . . 0.0 109.166 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -72.16 -31.65 66.14 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' B' ' 88' ' ' HIS . 0.1 OUTLIER -74.71 -45.02 45.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.41 -26.16 1.37 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.15 -1.5 . . . . 0.0 112.033 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.534 ' HB2' ' CD2' ' B' ' 80' ' ' LEU . 0.1 OUTLIER -142.31 -154.61 0.53 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.291 -1.711 . . . . 0.0 112.598 -178.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 1.152 ' HB3' ' CG2' ' B' ' 143' ' ' ILE . . . 41.22 29.77 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.54 1.162 . . . . 0.0 107.889 -178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.878 ' HB1' ' HG2' ' B' ' 144' ' ' GLN . . . -89.74 -19.06 25.21 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.814 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.83 ' O ' HD23 ' B' ' 76' ' ' LEU . 1.9 mptt -71.03 133.21 46.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.568 -1.333 . . . . 0.0 110.33 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -115.19 75.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.858 . . . . 0.0 110.269 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -137.79 -174.05 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -0.935 . . . . 0.0 110.229 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 1.9 t0 56.39 16.77 2.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 110.197 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -68.57 125.85 27.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.358 -0.839 . . . . 0.0 110.215 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -160.24 131.93 6.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 110.259 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.498 HD13 HG21 ' B' ' 70' ' ' ILE . 21.4 mt -79.43 132.01 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.908 . . . . 0.0 109.857 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.419 ' HG2' ' C ' ' B' ' 157' ' ' ILE . 38.3 mm-40 -130.7 1.16 4.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 110.652 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -148.33 108.53 4.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.977 -1.077 . . . . 0.0 111.236 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.682 HD12 ' N ' ' B' ' 219' ' ' GLN . 69.8 mt -117.67 137.26 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.36 -0.837 . . . . 0.0 109.209 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.547 HG22 ' OG1' ' B' ' 215' ' ' THR . 88.9 t -114.37 139.13 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 111.031 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -147.02 171.18 27.79 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 2.4 p -155.84 163.42 39.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.064 -1.257 . . . . 0.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.464 ' SG ' ' HB ' ' B' ' 212' ' ' ILE . 17.6 p -165.65 169.84 14.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.843 . . . . 0.0 110.223 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 165' ' ' ASP . 15.5 p-10 -120.55 144.01 48.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.901 . . . . 0.0 109.988 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 1.129 HG21 HD11 ' B' ' 170' ' ' ILE . 25.3 m -94.02 2.7 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.988 . . . . 0.0 110.284 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.511 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 28.2 tttp 71.86 10.16 6.21 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.0 110.917 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.602 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 9.3 p90 -166.23 154.58 9.79 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.004 -1.06 . . . . 0.0 110.416 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.65 158.02 51.35 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.996 1.524 . . . . 0.0 110.784 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 1.129 HD11 HG21 ' B' ' 166' ' ' VAL . 2.4 mp -131.07 147.86 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.954 . . . . 0.0 110.229 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -76.93 92.05 3.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 0.0 109.924 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.514 HD11 ' N ' ' B' ' 208' ' ' VAL . 13.6 mt -50.57 -37.25 38.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.215 -0.928 . . . . 0.0 110.219 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -73.39 -43.49 60.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.859 . . . . 0.0 110.245 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.39 80.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.727 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -71.36 -51.77 22.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -1.123 . . . . 0.0 110.12 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.498 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -57.84 -29.71 65.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.114 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -72.38 -36.54 68.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 110.13 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.59 -27.4 17.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.959 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -129.15 34.9 4.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 110.004 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.22 -18.29 64.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . 0.864 HG23 ' CD2' ' B' ' 182' ' ' PHE . 8.9 t -69.31 -21.43 63.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -1.137 . . . . 0.0 110.31 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.864 ' CD2' HG23 ' B' ' 181' ' ' THR . 41.3 m-85 -129.57 3.14 5.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.662 ' HB2' HD21 ' B' ' 193' ' ' LEU . 0.9 OUTLIER -139.47 135.42 33.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.16 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.2 154.98 29.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 110.071 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 0.479 ' HB2' HD12 ' B' ' 193' ' ' LEU . 82.8 t80 -147.08 105.72 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.157 -0.964 . . . . 0.0 110.342 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' B' ' 190' ' ' PHE . 7.4 mt-10 -108.75 105.27 56.71 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 110.082 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.0 Cg_endo -71.74 -2.07 10.85 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.981 1.516 . . . . 0.0 110.599 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -19.88 16.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 0.0 110.074 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.533 ' C ' HD23 ' B' ' 189' ' ' LEU . 4.7 tt -132.91 -29.73 1.44 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 0.0 110.551 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.627 ' CE2' HD21 ' A' ' 59' ' ' LEU . 1.9 t80 -131.8 111.29 14.7 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.121 -0.987 . . . . 0.0 110.346 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.32 -7.92 21.79 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.867 1.456 . . . . 0.0 110.231 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' B' ' 172' ' ' LEU . . . -107.97 179.98 21.89 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' B' ' 183' ' ' SER . 3.5 tt -113.74 125.95 54.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.133 -1.216 . . . . 0.0 110.398 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.678 HD13 HD13 ' A' ' 62' ' ' LEU . 44.2 mt -91.77 112.37 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.96 . . . . 0.0 109.953 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.492 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 2.2 t80 -108.49 124.61 50.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 110.381 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.458 ' HB2' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -105.82 79.86 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.347 -0.846 . . . . 0.0 110.057 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 32.1 ttm -49.11 134.72 17.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 110.311 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 40.5 t -73.01 -43.1 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.3 OUTLIER -143.2 116.43 6.05 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.21 -0.931 . . . . 0.0 110.113 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.1 Cg_endo -73.54 156.02 99.67 Favored 'Cis proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.99 -2.087 . . . . 0.0 110.529 -0.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.926 ' O ' HD13 ' B' ' 202' ' ' ILE . 2.9 tptt -67.37 94.87 0.41 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 110.03 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.926 HD13 ' O ' ' B' ' 201' ' ' LYS . 11.2 mm -141.09 158.64 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.154 -0.966 . . . . 0.0 110.215 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.415 HG22 ' HG3' ' B' ' 196' ' ' ARG . 62.2 t -105.54 116.22 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.943 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.2 mp -108.12 108.67 19.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.317 -0.864 . . . . 0.0 110.497 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.689 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -95.08 118.88 32.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.186 -0.946 . . . . 0.0 109.828 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.614 HG23 ' CD1' ' B' ' 212' ' ' ILE . 3.2 mp -116.76 120.9 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.162 -0.962 . . . . 0.0 110.486 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.463 ' N ' ' CD1' ' B' ' 207' ' ' PHE . 30.1 m-85 -93.33 172.22 8.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.03 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.514 ' N ' HD11 ' B' ' 172' ' ' LEU . 27.2 t -60.32 -39.83 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.147 -0.971 . . . . 0.0 110.327 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 50.6 m -53.16 -42.28 65.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.455 -0.778 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.655 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 125.81 4.34 6.75 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.31 136.45 44.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.152 -1.205 . . . . 0.0 110.089 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.614 ' CD1' HG23 ' B' ' 206' ' ' ILE . 14.6 mm -119.41 136.49 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 110.328 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 84.0 t -121.88 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -0.859 . . . . 0.0 109.939 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.452 HD12 ' N ' ' B' ' 214' ' ' LEU . 2.2 mp -127.03 117.16 21.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.431 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.547 ' OG1' HG22 ' B' ' 161' ' ' VAL . 13.6 t -135.57 160.53 38.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.105 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.57 -5.88 64.91 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.62 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -73.54 136.18 44.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.16 . . . . 0.0 110.15 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.425 ' N ' ' OE2' ' B' ' 222' ' ' GLU . 0.0 OUTLIER -84.57 -8.69 58.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.281 -0.887 . . . . 0.0 110.092 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.682 ' N ' HD12 ' B' ' 160' ' ' ILE . 1.0 OUTLIER -156.89 -174.02 4.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.867 . . . . 0.0 110.235 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -82.15 -32.63 29.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.202 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 1.0 OUTLIER -52.44 -29.61 25.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -0.953 . . . . 0.0 110.052 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.62 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 21.1 mt-10 -76.85 -48.0 19.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 110.033 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.2 mm -60.3 -39.03 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -69.88 -33.01 71.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -83.59 -46.77 12.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 110.265 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.442 ' O ' HG22 ' B' ' 230' ' ' ILE . . . -47.71 -40.65 20.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -74.37 -48.33 28.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.301 -0.874 . . . . 0.0 110.085 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.0 -17.38 62.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 110.007 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -86.4 -32.92 20.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.865 . . . . 0.0 109.922 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.442 HG22 ' O ' ' B' ' 226' ' ' ALA . 1.0 OUTLIER -99.12 -17.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.846 179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.616 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 51.9 t80 -47.71 -46.96 62.22 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 110.649 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.2 Cg_endo -71.43 -49.36 0.36 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.387 1.204 . . . . 0.0 110.18 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.727 HG12 HD21 ' B' ' 175' ' ' LEU . 9.3 t -47.71 -43.28 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.642 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.609 ' CD2' HG21 ' B' ' 170' ' ' ILE . 91.0 mt -63.12 -51.22 67.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 109.66 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 59.6 p -54.11 -27.76 35.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.65 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.82 -38.47 79.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.919 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.501 ' CD2' HD22 ' B' ' 175' ' ' LEU . 50.0 m-85 -110.15 37.77 2.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 110.089 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -63.21 163.21 10.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -0.89 . . . . 0.0 110.202 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.61 -28.83 6.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.877 . . . . 0.0 110.218 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.189 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.256 0.55 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.49 80.02 1.28 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.1 p -157.23 67.59 0.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.175 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 mt -83.3 148.74 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.235 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.72 -91.25 0.64 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -78.26 172.45 13.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.324 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 168.5 20.24 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.925 HD22 ' CD2' ' B' ' 99' ' ' PHE . 0.1 OUTLIER -128.82 158.63 38.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.447 -1.031 . . . . 0.0 109.196 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.847 ' O ' HD23 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -93.8 128.38 40.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.122 -0.987 . . . . 0.0 111.497 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.968 HD11 ' HB ' ' A' ' 72' ' ' ILE . 9.6 mt -124.64 24.98 7.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.448 -0.783 . . . . 0.0 110.47 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.59 ' OG1' HD23 ' A' ' 68' ' ' LEU . 8.4 m -49.01 -36.6 18.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.993 -1.067 . . . . 0.0 110.193 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.61 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -85.67 -24.66 41.54 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.986 -1.102 . . . . 0.0 110.497 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.831 HG21 HG11 ' A' ' 71' ' ' VAL . 9.5 mm -50.37 -54.22 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.883 -1.363 . . . . 0.0 109.011 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.961 HD13 ' SD ' ' A' ' 67' ' ' MET . 1.6 pp -79.33 8.89 5.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.444 -0.785 . . . . 0.0 110.023 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.742 ' HE2' HD21 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -111.75 -15.41 13.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.006 -1.059 . . . . 0.0 111.026 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 156.99 44.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.531 0 C-N-CA 118.571 -1.776 . . . . 0.0 111.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB2' ' CG ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER 61.72 132.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.929 -1.336 . . . . 0.0 110.185 178.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.757 HG21 ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -162.2 158.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-O 121.818 0.818 . . . . 0.0 109.524 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 31' ' ' GLU . 77.1 m-20 -88.49 118.36 28.08 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.623 ' HB2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -39.68 -26.82 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.992 -179.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 18.0 pt-20 -55.16 -16.33 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.043 -1.035 . . . . 0.0 109.991 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.98 14.29 10.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.536 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.69 115.88 28.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.074 -1.25 . . . . 0.0 109.939 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.61 HD12 ' HA3' ' A' ' 22' ' ' GLY . 1.2 tt -87.67 158.85 18.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.918 -1.114 . . . . 0.0 110.872 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.761 HD12 ' C ' ' A' ' 35' ' ' LEU . 4.0 pp -127.47 -179.57 4.98 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.65 -1.22 . . . . 0.0 110.711 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.757 ' N ' HD12 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -146.98 103.32 3.6 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.502 -0.749 . . . . 0.0 110.35 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 9.9 p-10 -46.45 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -0.825 . . . . 0.0 110.264 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 39' ' ' ASP . 7.2 t0 63.23 -158.75 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 110.129 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 38' ' ' ASP . 15.3 m-20 59.84 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 0.0 110.216 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.6 -113.24 0.65 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -123.82 109.73 14.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -1.14 . . . . 0.0 110.253 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 46.28 10.19 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.52 -29.0 3.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.175 -1.191 . . . . 0.0 110.273 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.81 0.1 10.91 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.04 150.67 46.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -136.79 146.11 45.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.137 . . . . 0.0 110.214 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 48' ' ' PHE . . . 135.68 171.26 12.31 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 48' ' ' PHE . 49.7 p90 -43.47 122.07 2.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -1.139 . . . . 0.0 110.013 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.58 -127.75 0.15 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 110.379 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . . . -99.79 23.23 9.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.957 -1.09 . . . . 0.0 110.348 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 1.6 tp10 -88.67 -52.04 5.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.325 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.742 HD21 ' HE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -93.5 -11.6 31.61 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.025 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -56.7 -54.05 50.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.107 -0.996 . . . . 0.0 108.784 178.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.63 -23.34 64.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 45.8 m-80 -80.06 -33.31 39.1 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.025 HD12 ' HA ' ' A' ' 53' ' ' ARG . 24.6 mt -50.01 -41.98 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 108.293 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.51 -14.61 28.74 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.99 -7.1 11.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 0.0 109.89 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.732 HD11 ' CE1' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -76.88 53.99 0.97 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.95 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.7 m -126.81 32.59 5.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.442 -0.786 . . . . 0.0 110.365 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.569 ' C ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -155.19 17.87 0.42 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.322 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 61' ' ' LYS . 6.9 mt -112.89 -63.09 1.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 109.561 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.5 -39.96 0.03 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.847 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.5 mm? -53.3 -19.4 3.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -1.117 . . . . 0.0 110.644 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 4.8 p-10 -46.07 -40.75 11.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 110.068 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -59.49 4.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.859 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.961 ' SD ' HD13 ' A' ' 24' ' ' LEU . 12.6 ttm -70.75 -3.49 19.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.766 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.69 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.5 tm? -69.43 -58.29 4.18 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pp -77.92 1.42 20.66 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.478 0.656 . . . . 0.0 109.613 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.493 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 3.9 tt0 -87.94 15.5 7.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.425 -0.797 . . . . 0.0 111.057 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.898 ' HB ' HD12 ' A' ' 20' ' ' LEU . 3.8 t -138.93 -0.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.729 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.072 HD11 HD12 ' A' ' 74' ' ' LEU . 2.9 tp -151.17 84.57 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.515 -0.741 . . . . 0.0 109.32 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 2.1 p-10 -87.4 49.19 1.76 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.964 -1.085 . . . . 0.0 108.486 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.072 HD12 HD11 ' A' ' 72' ' ' ILE . 9.9 mt -90.88 62.27 4.93 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.675 0.75 . . . . 0.0 110.872 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -168.32 110.86 0.58 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.618 -0.676 . . . . 0.0 110.211 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 1.2 mt-10 47.55 -112.7 0.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.149 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.853 -1.154 . . . . 0.0 110.318 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.177 0.513 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 53.87 39.72 62.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.485 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 6.3 mt -74.84 -40.54 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -1.124 . . . . 0.0 110.291 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 56.6 t 58.46 126.34 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.595 -0.691 . . . . 0.0 110.223 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.437 ' HA ' ' SG ' ' B' ' 164' ' ' CYS . 45.9 Cg_endo -73.49 151.53 47.68 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.858 1.451 . . . . 0.0 110.568 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.443 HG22 ' N ' ' B' ' 67' ' ' LEU . 98.1 m -101.47 164.79 11.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.286 -0.884 . . . . 0.0 110.097 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.443 ' N ' HG22 ' B' ' 66' ' ' THR . 19.4 mt -89.48 128.67 36.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -0.966 . . . . 0.0 110.28 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.33 -32.62 10.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 0.0 110.275 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.507 ' ND2' ' OD1' ' A' ' 27' ' ' ASN . 7.6 m-20 -170.05 171.62 6.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.285 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.939 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 16.5 mm -131.77 155.52 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.864 . . . . 0.0 110.149 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.53 ' HB ' ' CB ' ' B' ' 159' ' ' ASN . 37.6 t -138.29 113.7 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.864 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.51 ' HB2' ' CG1' ' B' ' 157' ' ' ILE . . . -128.42 156.46 43.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.937 . . . . 0.0 110.587 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 26.1 p -105.69 114.16 28.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 110.071 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.55 HG22 ' CD1' ' B' ' 155' ' ' PHE . 21.6 t -107.93 120.64 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 52.5 m -97.08 160.68 14.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.23 -0.919 . . . . 0.0 110.202 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' B' ' 150' ' ' ALA . 22.0 mt -107.32 -59.89 1.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 0.0 110.237 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 127.86 -0.1 6.65 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 21.6 p -142.37 170.18 16.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -1.152 . . . . 0.0 110.187 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.533 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -83.34 154.32 24.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.133 -0.98 . . . . 0.0 110.288 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 1.025 HD11 ' CD1' ' B' ' 76' ' ' LEU . 70.8 mt -128.32 144.49 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 110.093 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.463 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 5.7 m-20 -89.86 94.6 9.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.065 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.631 HD22 HG23 ' B' ' 102' ' ' VAL . 12.3 mt -46.63 -45.17 18.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 110.237 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -54.78 -45.06 74.21 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.138 -0.976 . . . . 0.0 110.106 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 7.0 m -82.5 -38.68 23.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.329 -0.857 . . . . 0.0 110.347 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.465 HG12 HG11 ' B' ' 102' ' ' VAL . 19.7 t -61.44 -48.06 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.526 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -73.43 -24.24 60.23 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 110.277 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 19.7 tp -85.98 -23.8 26.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 0.0 110.498 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.4 OUTLIER -96.75 -42.91 7.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.181 -0.95 . . . . 0.0 110.378 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.701 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -45.92 123.49 4.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.341 -0.85 . . . . 0.0 110.129 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.18 -24.05 64.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.25 -0.906 . . . . 0.0 110.293 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -137.14 79.59 1.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 110.129 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.737 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -164.96 161.24 19.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 0.0 109.856 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' B' ' 92' ' ' ALA . 58.6 mm-40 -152.78 138.38 17.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.062 -1.024 . . . . 0.0 110.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.535 ' HE1' HD13 ' B' ' 82' ' ' LEU . 19.8 t80 -93.17 148.24 22.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.725 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' B' ' 98' ' ' ARG . 0.1 OUTLIER -138.44 103.9 7.82 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 110.628 -179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -76.37 -17.71 16.44 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.045 1.55 . . . . 0.0 110.336 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.07 -4.23 58.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 0.0 110.269 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.515 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 0.3 OUTLIER -116.55 -65.39 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 110.273 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 1.07 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -153.67 -168.07 2.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.356 -0.84 . . . . 0.0 111.294 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -109.18 53.7 0.68 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 111.261 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.07 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -145.33 164.21 32.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 0.0 110.93 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.631 HG23 HD22 ' B' ' 82' ' ' LEU . 86.2 t -102.27 127.0 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.818 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -94.61 108.78 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.344 -0.848 . . . . 0.0 110.336 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.737 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 3.4 ttm -93.63 170.75 9.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 110.01 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.6 119.66 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.465 HG23 ' CE1' ' B' ' 139' ' ' TYR . 8.7 pt -122.58 149.34 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.0 110.32 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 2.3 ptt180 -99.12 33.13 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.1 tt0 -171.93 84.2 0.46 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.42 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 47.7 Cg_endo -76.51 162.1 92.49 Favored 'Cis proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.657 -2.226 . . . . 0.0 110.463 -0.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' B' ' 107' ' ' ARG . 0.0 OUTLIER -70.36 79.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.199 -0.938 . . . . 0.0 110.008 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.51 HG22 ' HA3' ' B' ' 125' ' ' GLY . 67.7 p -131.12 -179.7 5.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.364 -0.835 . . . . 0.0 109.992 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.51 HG22 HG23 ' B' ' 124' ' ' THR . 13.4 t -138.58 158.48 44.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.77 154.96 39.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.934 -1.104 . . . . 0.0 111.162 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.477 ' N ' HD23 ' B' ' 114' ' ' LEU . 0.1 OUTLIER -124.16 111.61 16.11 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.591 HD12 ' N ' ' B' ' 115' ' ' ILE . 5.2 mp -93.13 136.96 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 111.483 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 5.2 m-30 -96.84 169.33 9.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.533 -0.729 . . . . 0.0 109.77 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.06 -0.96 42.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.142 -0.974 . . . . 0.0 110.097 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.7 -7.31 44.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.218 -0.926 . . . . 0.0 110.157 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.08 -2.49 40.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . 0.541 ' HB3' ' CD2' ' B' ' 116' ' ' PHE . 0.1 OUTLIER -85.42 146.11 27.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.111 -1.229 . . . . 0.0 110.024 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 29.2 ttp -149.51 125.55 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 110.52 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.814 HG11 ' CG1' ' A' ' 71' ' ' VAL . 48.7 t -97.38 148.27 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 109.476 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.95 107.72 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.996 -1.065 . . . . 0.0 111.355 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.552 ' CG2' ' HA ' ' A' ' 27' ' ' ASN . 9.7 t -108.53 144.44 36.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.539 -0.726 . . . . 0.0 109.094 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.524 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 126.5 -27.2 5.03 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.939 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -52.92 149.01 6.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.03 -1.277 . . . . 0.0 109.719 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' B' ' 127' ' ' LYS . 0.0 OUTLIER -94.66 -19.97 19.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.027 -1.046 . . . . 0.0 109.862 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.436 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.6 OUTLIER -161.99 -159.37 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.167 -0.958 . . . . 0.0 110.18 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -75.34 -36.83 60.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.07 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -64.48 -38.94 92.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 110.086 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -69.61 -52.8 22.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.299 -0.876 . . . . 0.0 110.231 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 30.3 t -45.91 -36.4 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 0.0 110.203 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -73.83 -31.93 63.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.142 -0.974 . . . . 0.0 110.113 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.686 HD23 ' HD3' ' B' ' 137' ' ' ARG . 50.5 mt -80.95 -46.63 14.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.25 -0.906 . . . . 0.0 110.067 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.47 -29.57 61.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.143 -0.973 . . . . 0.0 109.88 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.438 ' O ' ' C ' ' B' ' 137' ' ' ARG . 23.4 t -76.3 -64.43 1.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.308 -0.87 . . . . 0.0 110.243 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.686 ' HD3' HD23 ' B' ' 134' ' ' LEU . 14.6 ptm180 -41.79 -31.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.37 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.537 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 4.9 mmtm -67.83 -50.99 53.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 109.471 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.465 ' CE1' HG23 ' B' ' 106' ' ' ILE . 18.1 m-85 -60.03 -52.13 66.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.342 -0.849 . . . . 0.0 109.673 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.33 62.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.639 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -52.26 -40.44 61.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.357 -0.839 . . . . 0.0 109.646 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' B' ' 139' ' ' TYR . 84.2 mt -63.34 -43.0 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.363 -0.835 . . . . 0.0 110.195 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.532 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 52.0 mt -75.5 -49.06 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.223 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -61.71 -37.43 84.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' B' ' 141' ' ' ARG . 32.5 tttp -71.82 -27.03 62.64 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.427 HG13 ' O ' ' B' ' 142' ' ' ILE . 6.2 mt -74.01 -10.64 13.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 109.67 -19.3 28.66 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.532 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 6.4 m-85 -55.18 157.98 3.22 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.123 -1.222 . . . . 0.0 111.057 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.41 49.72 0.99 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.62 -0.675 . . . . 0.0 109.742 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -96.26 144.78 26.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -0.892 . . . . 0.0 110.835 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.509 ' O ' HD23 ' B' ' 76' ' ' LEU . 9.2 ptpt -142.28 -157.6 0.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.45 -0.781 . . . . 0.0 109.551 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' B' ' 137' ' ' ARG . 33.8 m-85 -106.09 117.39 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.016 . . . . 0.0 110.265 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' B' ' 75' ' ' THR . 0.8 OUTLIER -151.27 163.28 39.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.336 -0.853 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' B' ' 75' ' ' THR . 13.8 t0 42.65 26.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 110.438 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' B' ' 74' ' ' VAL . 1.4 t80 -76.63 124.05 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 110.023 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . 0.443 ' N ' ' CD1' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -163.75 131.57 3.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 110.366 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.51 ' CG1' ' HB2' ' B' ' 72' ' ' ALA . 31.5 mt -78.78 107.87 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -110.45 12.01 23.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.265 -0.897 . . . . 0.0 110.657 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.53 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 6.2 m120 -153.46 115.44 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.548 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 215' ' ' THR . 31.2 mt -117.73 162.7 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 109.667 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.418 ' N ' HG22 ' B' ' 160' ' ' ILE . 21.5 t -137.34 128.64 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.048 -1.033 . . . . 0.0 110.624 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' B' ' 66' ' ' THR . . . -133.53 175.18 20.36 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 3.3 m -167.49 154.11 8.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.121 -1.223 . . . . 0.0 110.456 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -169.95 161.9 9.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.122 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.432 ' OD1' ' HA ' ' B' ' 211' ' ' LYS . 4.2 m-20 -106.65 157.54 17.62 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.134 -0.979 . . . . 0.0 110.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.541 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.0 OUTLIER -110.46 3.75 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.301 -0.874 . . . . 0.0 110.009 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 3.8 tmtm? 74.34 -4.06 2.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.504 -0.748 . . . . 0.0 111.166 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.502 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 38.5 p90 -149.57 144.91 18.31 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.009 -1.057 . . . . 0.0 110.278 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.468 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.7 Cg_endo -71.92 157.64 54.41 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.174 1.618 . . . . 0.0 110.714 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.18 154.35 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 0.0 110.284 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.34 90.4 8.31 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 109.994 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' B' ' 193' ' ' LEU . 24.3 mt -52.17 -34.25 44.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.518 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -62.86 -58.91 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 110.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -56.34 -42.24 88.66 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.527 HD12 ' CD2' ' B' ' 179' ' ' HIS . 14.5 tp -71.88 -38.37 70.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.185 -1.185 . . . . 0.0 110.185 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.662 ' HB2' HD12 ' B' ' 193' ' ' LEU . . . -71.13 -17.31 62.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 0.0 110.295 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -83.09 -40.86 19.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.123 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 15.3 t -81.61 -45.63 15.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.527 ' CD2' HD12 ' B' ' 175' ' ' LEU . 52.2 m-70 -95.4 14.93 20.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 110.083 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -47.33 -29.97 5.52 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 92.2 m -71.95 -25.44 61.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.249 -1.148 . . . . 0.0 110.3 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -106.1 -21.32 13.16 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.262 -0.899 . . . . 0.0 110.156 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.891 ' HB3' HD21 ' B' ' 193' ' ' LEU . 1.1 m -124.86 171.61 10.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.5 t -137.95 135.39 35.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 109.894 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 0.491 ' CD2' ' HD3' ' B' ' 187' ' ' PRO . 64.4 t80 -128.55 135.59 49.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.578 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' B' ' 190' ' ' PHE . 12.3 mm-40 -131.94 93.79 26.28 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.385 -0.822 . . . . 0.0 109.625 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.491 ' HD3' ' CD2' ' B' ' 185' ' ' TYR . 42.0 Cg_endo -68.99 -7.08 19.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.034 1.544 . . . . 0.0 110.365 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -100.41 -1.68 35.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.296 -0.878 . . . . 0.0 110.366 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -153.48 -48.33 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.134 -0.979 . . . . 0.0 110.565 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.816 ' HE2' HD11 ' B' ' 205' ' ' LEU . 3.0 t80 -108.76 117.56 53.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 110.514 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.53 -30.66 9.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.98 1.516 . . . . 0.0 110.178 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.75 -179.38 44.76 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.891 HD21 ' HB3' ' B' ' 183' ' ' SER . 3.6 tt -123.4 150.81 43.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -1.187 . . . . 0.0 110.223 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' B' ' 183' ' ' SER . 4.5 mt -107.52 100.79 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.48 ' OH ' ' ND1' ' B' ' 179' ' ' HIS . 0.6 OUTLIER -89.62 103.88 16.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.219 -0.926 . . . . 0.0 110.262 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' B' ' 202' ' ' ILE . 22.2 mtm180 -92.36 79.51 4.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.874 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.523 ' CE ' HG12 ' B' ' 230' ' ' ILE . 34.3 ttm -43.53 146.28 0.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 110.589 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 49.4 t -82.14 -34.61 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 110.079 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -155.8 116.05 2.24 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 110.017 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.3 Cg_endo -73.54 147.42 89.56 Favored 'Cis proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.89 -2.129 . . . . 0.0 110.377 0.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' B' ' 197' ' ' MET . 0.0 OUTLIER -59.27 101.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.156 -0.965 . . . . 0.0 109.992 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.783 HD12 ' HB2' ' B' ' 217' ' ' ALA . 37.9 mm -138.85 153.55 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.343 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 23.2 t -110.71 100.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.307 -0.871 . . . . 0.0 110.137 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.925 HD22 HG13 ' B' ' 230' ' ' ILE . 6.2 mp -94.67 127.25 40.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.391 -0.818 . . . . 0.0 110.46 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.816 HD11 ' HE2' ' B' ' 190' ' ' PHE . 0.1 OUTLIER -92.54 111.12 22.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.883 . . . . 0.0 109.747 179.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.45 HD12 HD21 ' B' ' 234' ' ' LEU . 10.9 mm -96.68 139.32 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.137 -0.977 . . . . 0.0 110.371 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' B' ' 205' ' ' LEU . 33.4 m-85 -128.81 136.41 50.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.141 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.468 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 54.8 t -49.19 -36.35 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.938 . . . . 0.0 110.215 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 61.6 m -53.3 -30.0 36.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.84 9.47 16.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.624 ' O ' HD13 ' B' ' 212' ' ' ILE . 8.8 mttt -92.26 133.97 35.32 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.13 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.624 HD13 ' O ' ' B' ' 211' ' ' LYS . 12.9 mm -117.54 135.69 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 110.371 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' B' ' 205' ' ' LEU . 69.3 t -123.06 113.68 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.812 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.533 ' H ' HD12 ' B' ' 214' ' ' LEU . 3.5 mp -103.74 117.37 34.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.462 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.9 t -147.8 165.64 29.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.152 -0.968 . . . . 0.0 110.183 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.447 ' HA3' ' HE1' ' A' ' 67' ' ' MET . . . 92.49 21.76 30.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.895 ' HB3' HD12 ' B' ' 223' ' ' ILE . . . -100.32 141.57 32.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -1.099 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -16.0 59.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.304 -0.872 . . . . 0.0 109.94 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -153.12 145.72 24.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 110.027 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . 0.427 ' HG3' HD11 ' B' ' 67' ' ' LEU . 0.6 OUTLIER -53.03 -25.73 13.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.244 -0.91 . . . . 0.0 110.329 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.24 -38.68 91.92 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.231 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.407 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 82.0 mt-10 -67.59 -52.09 42.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.292 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.895 HD12 ' HB3' ' B' ' 217' ' ' ALA . 0.0 OUTLIER -53.08 -56.64 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.235 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.685 ' N ' HG22 ' B' ' 223' ' ' ILE . 1.7 m-30 -47.56 -31.07 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.004 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' B' ' 228' ' ' GLU . 2.8 mt-30 -78.42 -41.97 31.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.32 -0.863 . . . . 0.0 110.219 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.801 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -45.88 -44.36 14.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.868 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -69.5 -45.18 69.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.812 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' B' ' 225' ' ' GLN . 0.5 OUTLIER -53.28 -28.77 29.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.973 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -98.31 -16.08 19.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.362 -0.836 . . . . 0.0 109.789 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.925 HG13 HD22 ' B' ' 204' ' ' LEU . 5.9 mm -97.58 -13.4 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.85 . . . . 0.0 109.821 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 41.7 t80 -52.46 -44.95 95.48 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.924 . . . . 0.0 110.694 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -74.28 -26.73 12.15 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.39 1.205 . . . . 0.0 110.315 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.41 HG13 HD13 ' B' ' 175' ' ' LEU . 25.0 t -66.23 -39.48 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 109.785 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.45 HD21 HD12 ' B' ' 206' ' ' ILE . 67.6 mt -68.5 -45.62 71.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.322 -0.861 . . . . 0.0 110.018 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 94.9 p -64.94 -44.58 88.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.87 . . . . 0.0 110.04 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.62 -37.33 49.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.927 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -110.62 36.59 3.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.968 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.488 ' C ' ' CD ' ' B' ' 238' ' ' ARG . 0.2 OUTLIER -74.55 163.46 27.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.336 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -121.37 -30.68 4.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.032 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.106 179.961 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.261 0.553 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.63 130.77 4.78 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.87 55.48 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 110.447 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.989 HD13 ' O ' ' A' ' 14' ' ' ILE . 0.0 OUTLIER -63.44 -27.35 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.101 -0.999 . . . . 0.0 110.156 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.9 138.35 5.54 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' GLY . 6.2 m120 -86.02 140.37 30.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -1.157 . . . . 0.0 110.343 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' ASN . . . 53.33 170.48 0.03 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.052 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.1 OUTLIER -60.29 159.57 9.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -1.144 . . . . 0.0 110.032 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 1.02 ' N ' HD12 ' A' ' 18' ' ' LEU . 37.0 t0 -68.28 67.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.753 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.985 HD21 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -84.28 -4.42 58.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.901 . . . . 0.0 110.397 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.594 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 31.1 m -43.48 -36.45 2.01 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 110.289 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.507 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -92.41 -36.45 6.21 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.755 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -49.93 -45.46 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.138 -1.213 . . . . 0.0 108.82 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.891 HD22 ' HB3' ' A' ' 67' ' ' MET . 3.8 pp -79.74 6.35 11.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.949 . . . . 0.0 109.607 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.786 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.3 t80 -114.94 -13.89 11.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.384 -0.823 . . . . 0.0 111.232 -178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 164.73 46.9 0.02 OUTLIER Glycine 0 N--CA 1.496 2.649 0 C-N-CA 118.861 -1.638 . . . . 0.0 110.746 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.552 ' HB2' ' CG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 44.96 112.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.307 1.051 . . . . 0.0 111.784 178.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.673 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -145.0 158.24 13.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.777 ' HA ' HG21 ' B' ' 103' ' ' ILE . 44.8 m-20 -88.05 131.99 34.45 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.052 ' HB2' HD13 ' A' ' 18' ' ' LEU . 13.7 p -38.66 -28.65 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.475 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.8 tt0 -54.02 -17.02 2.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.881 . . . . 0.0 110.233 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.53 28.22 5.5 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -123.97 125.87 45.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.003 -1.293 . . . . 0.0 110.359 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.673 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.31 153.16 17.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 110.706 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.747 HD12 ' C ' ' A' ' 35' ' ' LEU . 4.3 pp -128.34 -178.88 4.74 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.784 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.708 ' N ' HD12 ' A' ' 35' ' ' LEU . 23.8 mt-30 -131.42 122.8 26.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.639 -0.663 . . . . 0.0 110.101 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' B' ' 110' ' ' LYS . 10.8 t0 -63.02 -11.84 22.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.359 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -58.39 163.94 2.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 0.0 110.387 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -118.18 8.96 12.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 110.383 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.57 116.55 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.87 -174.5 2.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -1.144 . . . . 0.0 110.06 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.55 -64.15 2.32 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.5 mtm180 -59.84 117.47 5.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -1.12 . . . . 0.0 110.201 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.64 146.07 8.04 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.69 -157.3 32.61 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -124.2 120.13 31.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -1.168 . . . . 0.0 110.285 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -102.42 -163.69 26.36 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' A' ' 48' ' ' PHE . 25.1 p90 -78.47 149.33 33.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -1.166 . . . . 0.0 110.228 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -96.75 -114.87 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.73 34.94 2.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.875 -1.141 . . . . 0.0 110.295 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 13.8 pt-20 -95.53 -23.73 16.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.566 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.668 HD21 ' HZ ' ' B' ' 207' ' ' PHE . 4.4 mt -96.81 -43.7 7.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.016 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.904 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -45.23 -45.16 11.64 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.967 -179.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.98 -30.26 70.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.375 -0.828 . . . . 0.0 110.149 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.564 ' HB3' ' CE1' ' B' ' 190' ' ' PHE . 91.2 m-20 -80.69 -37.8 30.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.713 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.7 mt -49.28 -46.22 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.355 -0.841 . . . . 0.0 109.54 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.77 -17.12 26.69 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -119.46 7.75 11.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.257 -1.143 . . . . 0.0 110.315 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 56' ' ' ILE . 1.8 mt -86.76 31.49 0.69 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.956 . . . . 0.0 110.524 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 t -118.2 39.07 3.51 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.204 -0.935 . . . . 0.0 110.49 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' HD13 ' B' ' 189' ' ' LEU . 0.0 OUTLIER -162.42 31.43 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.522 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 63' ' ' GLY . 0.8 OUTLIER -145.22 -26.65 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.168 -0.958 . . . . 0.0 111.256 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.999 ' N ' HD12 ' A' ' 62' ' ' LEU . . . 177.47 -44.52 0.1 OUTLIER Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.157 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.86 HD12 HD11 ' A' ' 24' ' ' LEU . 3.9 mm? -53.4 -17.7 2.1 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -1.188 . . . . 0.0 110.67 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 80.6 m-20 -46.42 -39.82 11.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.085 -1.009 . . . . 0.0 110.116 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -62.26 -57.05 12.84 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.296 -0.877 . . . . 0.0 110.098 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.891 ' HB3' HD22 ' A' ' 24' ' ' LEU . 4.9 tpp -64.32 -11.01 27.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -0.92 . . . . 0.0 109.719 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 21' ' ' THR . 1.3 tm? -68.0 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.974 0.892 . . . . 0.0 109.024 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.82 -2.46 17.79 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.307 0.575 . . . . 0.0 110.222 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 13.3 tt0 -85.8 0.53 52.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.229 -0.919 . . . . 0.0 111.53 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.778 HG12 HG11 ' B' ' 122' ' ' VAL . 2.2 t -137.92 3.24 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 118.627 -1.229 . . . . 0.0 110.265 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 74' ' ' LEU . 6.0 tp -149.85 70.3 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -75.83 57.33 1.02 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.933 HD12 HD11 ' A' ' 72' ' ' ILE . 6.1 mt -107.09 67.2 0.69 Allowed 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.681 0.753 . . . . 0.0 110.382 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 76' ' ' GLU . 0.9 OUTLIER -129.83 60.64 1.59 Allowed 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.529 -0.732 . . . . 0.0 110.019 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' LYS . 1.1 tt0 66.27 31.38 8.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.284 -0.885 . . . . 0.0 110.183 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.25 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.306 0.574 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.13 69.45 0.05 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.79 136.99 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -1.15 . . . . 0.0 110.219 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.459 HG13 ' HD2' ' B' ' 65' ' ' PRO . 55.8 t -92.47 140.07 24.01 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.298 -0.876 . . . . 0.0 110.248 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.467 ' HG3' ' HB2' ' B' ' 227' ' ' PHE . 44.5 Cg_endo -71.29 138.45 33.1 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.011 1.532 . . . . 0.0 110.476 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.479 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 17.0 m -106.67 141.35 38.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.826 HD22 HG22 ' B' ' 160' ' ' ILE . 40.6 mt -78.66 122.24 25.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.521 ' O ' ' ND2' ' B' ' 69' ' ' ASN . 19.7 mm-40 -110.16 -15.71 13.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 110.383 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.544 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 10.4 m120 -160.94 121.7 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 110.299 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.716 HD11 HD13 ' B' ' 67' ' ' LEU . 10.1 mt -122.54 171.33 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.902 . . . . 0.0 110.219 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.579 ' N ' HG22 ' B' ' 70' ' ' ILE . 7.6 t -144.79 134.31 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 110.296 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -122.64 133.29 54.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 0.0 110.038 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 38.7 m -92.14 127.33 37.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.093 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.727 HG21 ' OG ' ' B' ' 136' ' ' SER . 40.6 t -131.12 133.04 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.883 . . . . 0.0 110.385 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 4.4 m -101.27 139.98 36.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.834 . . . . 0.0 110.056 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.831 HD22 ' HB1' ' B' ' 150' ' ' ALA . 29.2 mt -87.16 -67.25 0.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.084 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 143.32 -17.75 2.29 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 30.1 p -141.7 141.08 33.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 110.239 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.775 ' O ' HD23 ' B' ' 80' ' ' LEU . 1.5 ptt85 -57.9 163.56 2.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.203 -0.936 . . . . 0.0 110.002 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.775 HD23 ' O ' ' B' ' 79' ' ' ARG . 18.0 mt -139.86 155.98 46.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 110.326 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.466 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 3.7 m-20 -89.75 102.59 15.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' B' ' 102' ' ' VAL . 13.6 mt -48.39 -31.44 6.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.333 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -67.25 -38.59 85.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.197 -0.94 . . . . 0.0 110.255 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 31.7 p -81.9 -41.96 20.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.965 . . . . 0.0 110.239 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.543 HG12 HG11 ' B' ' 102' ' ' VAL . 24.2 t -58.66 -42.46 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.156 -0.965 . . . . 0.0 110.125 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.404 ' CB ' ' HB2' ' B' ' 94' ' ' TYR . . . -81.03 -18.39 46.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.452 ' O ' HD12 ' B' ' 87' ' ' LEU . 13.4 tp -87.08 -31.38 20.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 110.377 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -95.59 -29.3 14.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.915 . . . . 0.0 110.397 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -63.35 133.37 53.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.897 . . . . 0.0 110.072 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -25.45 59.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 110.383 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 2.4 m120 -132.25 79.42 1.86 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.231 -0.918 . . . . 0.0 109.825 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.75 158.41 44.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 110.063 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' B' ' 102' ' ' VAL . 1.7 mm-40 -129.78 147.34 51.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.404 ' HB2' ' CB ' ' B' ' 86' ' ' ALA . 28.8 t80 -147.6 111.14 4.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.875 . . . . 0.0 109.925 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -135.35 122.85 15.07 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 0.0 110.41 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.72 -17.3 26.11 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.916 1.482 . . . . 0.0 110.239 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.05 -21.6 62.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 110.208 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.452 ' HG3' ' NH1' ' B' ' 98' ' ' ARG . 0.0 OUTLIER -101.9 -56.95 2.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.606 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.731 ' CG ' ' HB2' ' A' ' 18' ' ' LEU 0.257 62.6 t80 -170.18 -179.14 3.02 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.866 -177.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.773 ' O ' HD13 ' A' ' 74' ' ' LEU . . . -99.41 70.72 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 109.969 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.869 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -155.43 149.67 25.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.558 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.543 HG11 HG12 ' B' ' 85' ' ' VAL . 44.7 t -102.03 117.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.777 HG21 ' HA ' ' A' ' 29' ' ' ASP . 1.3 mp -89.55 111.38 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.201 -0.937 . . . . 0.0 110.483 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.568 ' CB ' ' HB3' ' B' ' 113' ' ' ALA . 0.6 OUTLIER -89.93 153.01 20.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.774 179.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -149.53 118.05 6.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.047 -1.033 . . . . 0.0 110.728 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.584 HG23 ' CE1' ' B' ' 139' ' ' TYR . 34.6 pt -114.41 155.13 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.863 . . . . 0.0 109.706 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -104.03 35.59 2.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.134 -0.979 . . . . 0.0 110.39 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 5.9 tt0 -171.82 81.49 0.48 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.92 . . . . 0.0 110.461 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.483 ' O ' HG13 ' B' ' 106' ' ' ILE . 50.3 Cg_endo -79.63 165.35 80.08 Favored 'Cis proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.758 -2.184 . . . . 0.0 110.538 -0.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 8.4 tptt -70.24 94.17 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.518 HG22 ' HA3' ' B' ' 125' ' ' GLY . 18.4 p -139.59 177.66 7.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.713 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.58 ' HB ' HG23 ' B' ' 124' ' ' THR . 0.9 OUTLIER -119.7 173.43 7.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.451 -0.78 . . . . 0.0 109.383 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.568 ' HB3' ' CB ' ' B' ' 104' ' ' MET . . . -146.93 133.97 20.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 110.638 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.722 HD23 HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -107.22 97.18 6.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.892 179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.521 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 68.8 mt -97.34 150.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.101 -0.999 . . . . 0.0 111.274 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.3 m-85 -118.81 174.13 6.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.52 -0.737 . . . . 0.0 109.861 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -87.4 -3.29 59.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.01 . . . . 0.0 109.907 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.88 -22.34 24.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.158 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.531 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 126.57 -38.98 2.07 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.63 153.46 2.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.233 -1.157 . . . . 0.0 110.026 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.545 ' HE2' HD21 ' B' ' 76' ' ' LEU . 1.9 ttm -140.76 148.77 41.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.778 HG11 HG12 ' A' ' 71' ' ' VAL . 1.4 t -129.02 142.21 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.347 -0.845 . . . . 0.0 109.49 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.482 HG13 ' HE2' ' B' ' 139' ' ' TYR . 21.7 t -132.04 112.41 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 110.683 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.636 HG21 HD13 ' A' ' 23' ' ' ILE . 1.7 t -104.86 165.37 11.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.382 -0.824 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.518 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 107.87 -28.26 12.67 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -51.5 144.91 9.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -1.222 . . . . 0.0 110.241 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' B' ' 128' ' ' SER . 17.0 pttm -112.62 -23.54 10.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.101 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.442 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.6 OUTLIER -137.25 -153.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.79 -39.27 11.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.319 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.9 -42.45 90.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.232 -0.918 . . . . 0.0 110.277 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.62 -47.21 79.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.929 . . . . 0.0 110.204 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 35.7 t -52.27 -46.96 66.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.0 110.241 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -36.86 80.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.875 . . . . 0.0 110.212 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -70.82 -50.39 36.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.229 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.73 -50.27 66.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 110.108 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.727 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -62.35 -54.34 41.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 110.009 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' B' ' 138' ' ' LYS . 0.0 OUTLIER -46.5 -39.37 10.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.863 . . . . 0.0 109.961 179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.469 ' HD3' ' HD3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -61.29 -53.73 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.189 -0.945 . . . . 0.0 110.052 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.721 ' HA ' HD12 ' B' ' 142' ' ' ILE . 40.5 m-85 -54.21 -52.72 60.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 110.257 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.37 -31.93 16.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.204 -0.935 . . . . 0.0 110.114 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -35.98 81.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.721 HD12 ' HA ' ' B' ' 139' ' ' TYR . 13.8 mt -63.97 -48.62 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.526 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.84 HG21 ' HB2' ' B' ' 150' ' ' ALA . 20.4 mm -61.66 -49.32 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.408 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -68.95 -27.56 65.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.207 -0.933 . . . . 0.0 110.085 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -77.35 -20.6 54.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.237 -0.914 . . . . 0.0 108.75 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.8 mt -87.57 -19.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.697 -0.627 . . . . 0.0 109.34 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 124.45 -29.41 5.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.499 ' CB ' HG22 ' B' ' 143' ' ' ILE . 6.8 m-85 -47.88 159.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.032 -1.275 . . . . 0.0 110.934 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.12 42.07 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.651 -0.655 . . . . 0.0 109.936 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.84 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -71.33 154.87 41.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.601 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -144.42 120.52 10.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 0.0 109.768 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' B' ' 155' ' ' PHE . 63.3 t80 -60.89 111.46 1.67 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.452 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.466 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.1 OUTLIER -158.16 163.25 37.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.323 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 0.4 OUTLIER 63.43 13.95 7.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.649 ' HA ' HG22 ' B' ' 74' ' ' VAL . 19.8 t80 -61.41 126.41 27.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.972 -1.08 . . . . 0.0 109.838 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 155' ' ' PHE . 27.5 mtpt -160.77 133.35 6.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.272 -0.892 . . . . 0.0 110.548 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.479 HG23 ' CG2' ' B' ' 70' ' ' ILE . 2.9 mp -79.49 127.34 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 0.0 109.755 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -129.33 -25.69 2.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.209 -0.932 . . . . 0.0 110.88 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' B' ' 70' ' ' ILE . 0.1 OUTLIER -113.54 96.88 6.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.066 -1.021 . . . . 0.0 110.793 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.826 HG22 HD22 ' B' ' 67' ' ' LEU . 44.5 mt -107.85 111.36 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.552 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.874 HG22 ' OG1' ' B' ' 215' ' ' THR . 25.2 t -94.8 107.66 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.789 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -111.5 167.52 12.49 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.8 t -169.16 159.72 9.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.923 -1.339 . . . . 0.0 110.63 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -169.85 170.11 7.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.845 . . . . 0.0 109.928 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.89 161.05 14.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.969 . . . . 0.0 110.281 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.548 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.1 OUTLIER -111.54 -83.8 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.306 -0.871 . . . . 0.0 110.24 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.489 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER -173.89 -38.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.04 -1.038 . . . . 0.0 110.8 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.489 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 7.0 p90 -137.49 166.31 27.59 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 109.764 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.7 Cg_endo -71.18 149.42 57.89 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.782 1.412 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.6 mp -112.39 160.57 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.301 -0.874 . . . . 0.0 110.376 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.07 91.42 6.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.145 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' B' ' 193' ' ' LEU . 83.0 mt -48.34 -26.37 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 110.106 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.38 -58.57 4.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.214 -0.929 . . . . 0.0 110.292 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -51.22 -31.82 27.68 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.571 HD21 HG12 ' B' ' 233' ' ' VAL . 0.1 OUTLIER -72.97 -42.89 62.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -1.165 . . . . 0.0 110.229 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.444 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -68.09 -13.46 62.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.265 -0.897 . . . . 0.0 110.143 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 14.6 t80 -92.8 -37.52 12.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.89 . . . . 0.0 110.175 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . 0.491 ' HB2' ' CZ ' ' B' ' 237' ' ' PHE . 46.6 t -83.82 -50.27 8.26 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.202 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -105.4 19.4 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.887 . . . . 0.0 110.225 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' B' ' 176' ' ' ALA . . . -54.36 -25.74 34.72 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.07 -24.31 62.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -1.145 . . . . 0.0 110.263 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.706 ' CE1' HG22 ' B' ' 198' ' ' VAL . 0.9 OUTLIER -134.66 12.04 3.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.466 ' HB3' HD21 ' B' ' 193' ' ' LEU . 48.6 m -120.15 159.47 24.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 0.0 110.373 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 16.9 m -134.84 126.81 29.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.174 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -136.55 120.03 17.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 110.41 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -132.25 105.17 13.51 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 109.818 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.96 -2.86 12.17 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.084 1.571 . . . . 0.0 110.346 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -100.0 5.86 45.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.875 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.446 HD13 ' HE3' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -157.82 -41.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.383 -0.823 . . . . 0.0 110.266 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 55' ' ' ASN . 3.0 t80 -126.35 114.15 23.42 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -17.82 28.02 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.838 1.441 . . . . 0.0 110.49 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -94.31 179.79 37.84 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.9 ' HB2' HD22 ' B' ' 172' ' ' LEU . 9.5 tt -120.41 126.99 51.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.198 -1.178 . . . . 0.0 110.334 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.782 HD13 HD13 ' A' ' 62' ' ' LEU . 6.5 mt -90.95 107.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 110.165 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.4 t80 -96.44 116.7 29.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 110.36 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 87.55 4.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.469 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.0 ttm -59.53 144.07 48.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.191 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.706 HG22 ' CE1' ' B' ' 182' ' ' PHE . 65.2 t -88.26 -40.37 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 110.436 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.2 OUTLIER -140.93 107.49 6.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.98 . . . . 0.0 110.365 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.9 Cg_endo -75.96 166.31 83.26 Favored 'Cis proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.049 -2.063 . . . . 0.0 110.55 -0.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.0 OUTLIER -76.31 95.73 3.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.166 -0.959 . . . . 0.0 109.848 179.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.784 HD11 ' OE1' ' B' ' 222' ' ' GLU . 33.4 mm -134.91 160.54 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.205 -0.935 . . . . 0.0 110.501 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.45 107.04 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' B' ' 195' ' ' TYR . 1.5 mp -100.07 134.63 42.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 110.218 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.786 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 2.8 mt -110.83 116.26 30.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 110.169 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.489 HG12 HD21 ' B' ' 234' ' ' LEU . 3.6 mp -100.48 136.53 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.324 -0.86 . . . . 0.0 110.273 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.668 ' HZ ' HD21 ' A' ' 52' ' ' LEU . 49.0 m-85 -119.92 131.23 55.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 0.0 110.069 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 22.0 t -42.79 -27.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.414 ' N ' ' O ' ' B' ' 207' ' ' PHE . 98.3 p -64.51 -26.58 68.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.316 -0.865 . . . . 0.0 110.406 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.548 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 110.75 9.02 23.65 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.62 ' C ' HD12 ' B' ' 212' ' ' ILE . 0.1 OUTLIER -98.2 121.93 40.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.186 -1.185 . . . . 0.0 110.153 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.62 HD12 ' C ' ' B' ' 211' ' ' LYS . 1.2 mp -109.97 146.71 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.248 -0.907 . . . . 0.0 110.359 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.652 ' C ' HD12 ' B' ' 214' ' ' LEU . 27.6 t -127.81 146.65 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.805 . . . . 0.0 110.08 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.765 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.4 mp -133.2 109.51 9.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.202 -0.936 . . . . 0.0 110.277 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.874 ' OG1' HG22 ' B' ' 161' ' ' VAL . 14.7 t -130.23 152.04 50.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.164 -0.96 . . . . 0.0 110.149 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.413 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 109.03 -11.92 34.31 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.482 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -68.77 144.57 54.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.219 -1.165 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -90.04 -17.37 27.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.173 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.408 ' N ' ' CD1' ' B' ' 160' ' ' ILE . 1.7 mt-30 -147.95 168.94 20.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.304 -0.872 . . . . 0.0 110.234 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -14.54 62.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.138 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.468 ' CD ' ' N ' ' B' ' 221' ' ' GLU . 8.5 mp0 -68.73 -42.19 77.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.327 -0.858 . . . . 0.0 110.081 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.784 ' OE1' HD11 ' B' ' 202' ' ' ILE . 13.9 mt-10 -63.78 -51.15 66.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.449 HG22 ' HG2' ' B' ' 65' ' ' PRO . 45.8 mm -56.0 -37.2 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.186 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.419 ' CZ ' HG11 ' B' ' 64' ' ' VAL . 0.9 OUTLIER -65.05 -42.87 93.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' B' ' 226' ' ' ALA . 0.0 OUTLIER -75.9 -44.11 42.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 110.296 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.478 ' O ' HG22 ' B' ' 230' ' ' ILE . . . -45.3 -41.38 8.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.906 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.72 ' HA ' HG22 ' B' ' 230' ' ' ILE . 10.2 t80 -78.39 -50.26 12.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 0.0 109.88 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.75 -18.62 33.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.982 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -97.86 -32.61 11.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.227 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.72 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.8 tp -92.98 -17.79 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.605 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.3 t80 -50.88 -44.99 87.24 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.343 -0.848 . . . . 0.0 111.107 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.7 Cg_endo -71.93 -32.65 10.95 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.205 1.108 . . . . 0.0 110.496 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.571 HG12 HD21 ' B' ' 175' ' ' LEU . 25.2 t -64.37 -30.41 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 109.893 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.489 HD21 HG12 ' B' ' 206' ' ' ILE . 89.7 mt -70.91 -56.49 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.993 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.71 -25.3 17.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.871 . . . . 0.0 110.11 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -48.88 62.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 109.94 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' B' ' 178' ' ' SER . 92.4 m-85 -106.87 37.51 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.38 -0.825 . . . . 0.0 109.87 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -163.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 110.12 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' B' ' 169' ' ' PRO . 1.7 ttmm -126.7 -81.12 0.61 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.262 -0.899 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 1.8 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.314 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.274 0.559 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.11 -36.21 92.67 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 m -168.66 152.21 5.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.153 -1.204 . . . . 0.0 110.403 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.7 tt -172.33 159.93 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.24 -0.913 . . . . 0.0 110.175 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.26 83.89 0.05 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.83 -68.25 0.93 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -1.181 . . . . 0.0 109.977 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' C ' ' CZ ' ' B' ' 99' ' ' PHE . . . 78.81 139.14 1.57 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.883 HD23 ' CG1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -65.02 173.88 2.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.325 -1.103 . . . . 0.0 109.647 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.493 ' N ' HD12 ' A' ' 18' ' ' LEU . 29.1 t0 -61.26 75.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.126 -0.984 . . . . 0.0 110.25 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.743 HD11 ' HB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -91.14 -7.53 51.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 0.0 110.7 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.86 ' OG1' HD21 ' A' ' 68' ' ' LEU . 91.9 m -43.38 -30.7 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.43 -31.48 6.44 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.762 HD12 HD11 ' B' ' 114' ' ' LEU . 0.3 OUTLIER -52.79 -41.69 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.316 . . . . 0.0 109.333 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.496 ' CD2' HD12 ' A' ' 68' ' ' LEU . 1.4 pp -84.51 -18.94 34.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.742 -1.223 . . . . 0.0 108.652 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.688 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -99.6 14.57 29.55 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 141.18 93.27 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.934 ' HB2' HG23 ' B' ' 124' ' ' THR . 4.9 p30 -28.42 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.69 0.757 . . . . 0.0 112.066 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.77 HG22 HD12 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -94.79 169.1 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.629 ' HB3' HG21 ' B' ' 103' ' ' ILE . 94.9 m-20 -86.41 123.92 32.17 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.628 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -36.56 -29.5 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.923 -177.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.5 tt0 -50.26 -21.16 1.26 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 109.87 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.82 25.45 4.23 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.672 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -124.57 135.19 52.94 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.808 -1.407 . . . . 0.0 110.988 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.77 HD12 HG22 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -103.43 154.01 19.88 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.928 -1.108 . . . . 0.0 111.235 -179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.9 HD21 ' OD1' ' A' ' 27' ' ' ASN . 3.0 pp -126.66 -178.88 4.54 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.156 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 11.5 mt-30 -145.4 13.11 1.38 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.494 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.423 ' OD2' ' HB3' ' B' ' 110' ' ' LYS . 1.2 m-20 50.34 50.61 18.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 0.0 110.216 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 61.63 -178.2 0.12 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 0.0 110.147 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -118.73 -169.15 1.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.934 . . . . 0.0 110.232 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -120.13 133.77 10.08 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -116.2 -169.59 1.64 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.251 -1.146 . . . . 0.0 110.12 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.42 -88.5 1.3 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -21.76 66.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.324 -1.103 . . . . 0.0 110.245 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.98 171.28 40.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.21 -105.15 0.27 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.8 m 60.04 72.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.239 -1.154 . . . . 0.0 110.19 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.92 -161.62 0.27 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.571 ' O ' ' CD1' ' A' ' 48' ' ' PHE . 23.2 p90 -45.92 126.19 7.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -1.132 . . . . 0.0 110.203 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -100.26 -84.14 0.43 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 110.071 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.23 33.84 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 110.144 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.5 tt0 -100.65 -24.29 14.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.868 . . . . 0.0 109.551 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 55' ' ' ASN . 3.9 mt -99.61 -44.37 6.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.46 -0.775 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.856 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -42.73 -44.38 4.32 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.395 -0.816 . . . . 0.0 109.931 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -69.26 -27.25 65.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 109.78 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 52' ' ' LEU . 29.2 m-80 -81.45 -36.03 29.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.736 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 53' ' ' ARG . 6.8 mt -55.54 -44.05 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 0.0 109.541 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.42 -17.09 31.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -129.75 18.83 5.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -1.089 . . . . 0.0 110.192 179.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' A' ' 56' ' ' ILE . 3.0 mt -80.93 -5.1 57.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.135 -0.978 . . . . 0.0 110.215 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 97.9 p -90.08 37.88 0.91 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.37 -0.831 . . . . 0.0 109.691 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 58' ' ' SER . 13.7 mtpp -121.17 6.66 10.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.313 -0.867 . . . . 0.0 110.055 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 194' ' ' ILE . 0.1 OUTLIER -118.61 -85.02 0.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.311 -0.868 . . . . 0.0 110.473 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.48 28.9 0.2 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.307 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -100.69 -27.96 13.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.024 -1.28 . . . . 0.0 109.005 179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.694 ' HA ' HD22 ' A' ' 68' ' ' LEU . 50.2 t0 -45.21 -38.28 5.28 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.778 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.846 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.3 OUTLIER -53.9 -30.63 46.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.109 -0.994 . . . . 0.0 109.991 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.556 ' HB3' HD12 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -78.17 -25.63 47.29 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.291 -0.88 . . . . 0.0 109.803 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.86 HD21 ' OG1' ' A' ' 21' ' ' THR . 7.9 mp -61.93 -58.66 7.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.296 -0.877 . . . . 0.0 109.511 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.846 HD21 ' HA ' ' A' ' 66' ' ' SER . 2.1 pp -52.75 -19.1 2.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.555 -0.716 . . . . 0.0 110.023 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 67' ' ' MET . 35.3 tt0 -75.33 -2.98 30.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.306 -0.871 . . . . 0.0 110.356 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.959 ' O ' HG21 ' B' ' 122' ' ' VAL . 1.4 t -132.77 1.46 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.118 -0.989 . . . . 0.0 109.875 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.883 ' CG1' HD23 ' A' ' 18' ' ' LEU . 7.5 tp -146.82 67.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.638 -0.664 . . . . 0.0 109.918 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 46.4 t0 -76.8 57.84 1.35 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.145 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 6.0 mt -105.12 66.94 0.77 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.577 0.703 . . . . 0.0 110.85 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 58.47 0.82 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.531 -0.731 . . . . 0.0 110.184 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 1.2 pt-20 178.47 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.896 . . . . 0.0 110.141 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.878 -1.139 . . . . 0.0 110.162 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.332 0.587 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.02 67.28 0.34 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.605 HD13 ' O ' ' B' ' 165' ' ' ASP . 3.4 mt -81.07 -27.23 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.225 -1.162 . . . . 0.0 110.116 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' B' ' 63' ' ' ILE . 38.8 t 58.55 137.79 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 0.0 110.514 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.5 ' HD3' ' CD2' ' B' ' 227' ' ' PHE . 44.6 Cg_endo -73.27 124.74 9.7 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.859 1.452 . . . . 0.0 110.539 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.5 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 2.3 m -89.97 156.4 18.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 18.9 mt -92.96 137.97 31.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.133 -0.979 . . . . 0.0 110.213 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -126.91 -10.74 6.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.3 -0.875 . . . . 0.0 110.511 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.5 OUTLIER -168.02 131.0 1.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 110.474 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.744 HG12 HG23 ' B' ' 160' ' ' ILE . 4.1 mt -129.74 165.75 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.884 HG22 ' HB ' ' B' ' 124' ' ' THR . 42.5 t -139.89 144.76 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.143 -0.973 . . . . 0.0 110.568 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' B' ' 156' ' ' LYS . . . -139.97 162.31 35.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 0.0 110.055 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 42.1 p -110.76 141.64 43.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.067 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.92 146.6 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.875 . . . . 0.0 110.173 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.536 ' OG1' ' CB ' ' B' ' 154' ' ' ASP . 2.3 m -118.84 129.1 55.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.243 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.592 HD22 ' HB1' ' B' ' 150' ' ' ALA . 64.2 mt -89.67 -40.72 12.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 110.102 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.04 22.18 20.98 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.86 146.55 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -1.191 . . . . 0.0 110.381 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.631 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -77.16 148.58 35.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 110.092 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.8 HD22 ' HD2' ' B' ' 148' ' ' PHE . 13.7 mt -129.37 149.31 51.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 110.227 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.407 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 0.7 OUTLIER -90.07 94.74 9.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.733 179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.582 HD22 HG23 ' B' ' 102' ' ' VAL . 13.1 mt -40.24 -55.23 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.439 -0.788 . . . . 0.0 110.462 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -47.25 -39.72 14.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.997 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 99.3 m -76.35 -41.04 49.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.54 -56.76 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.349 -0.845 . . . . 0.0 110.448 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.81 55.9 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.324 -0.86 . . . . 0.0 110.734 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 0.9 OUTLIER -72.13 -51.26 22.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 0.0 110.543 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -72.77 -42.23 64.21 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 0.0 110.482 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -42.7 122.34 2.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 110.429 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -73.53 -26.07 60.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 110.094 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 1.8 m120 -130.05 78.99 1.88 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.365 -0.834 . . . . 0.0 109.744 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -170.28 170.23 7.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.429 -0.794 . . . . 0.0 110.085 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.623 ' O ' HD12 ' B' ' 103' ' ' ILE . 9.6 pt-20 -160.2 137.2 9.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 110.3 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -108.54 116.47 32.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 110.088 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.23 107.12 55.82 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.893 . . . . 0.0 110.314 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -23.13 18.95 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.895 1.471 . . . . 0.0 110.089 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -24.38 63.94 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 110.099 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.45 -69.32 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 110.031 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.655 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.36 166.23 26.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 110.185 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.4 44.85 1.23 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.145 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -122.83 146.83 47.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.62 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.582 HG23 HD22 ' B' ' 82' ' ' LEU . 30.9 t -89.97 122.15 41.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.325 -0.86 . . . . 0.0 109.05 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.629 HG21 ' HB3' ' A' ' 29' ' ' ASP . 4.1 mp -89.3 110.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.893 . . . . 0.0 110.264 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.58 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 7.2 ttm -103.93 163.95 12.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' B' ' 111' ' ' THR . 0.4 OUTLIER -163.6 127.38 2.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.0 110.587 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.643 HG23 ' CE1' ' B' ' 139' ' ' TYR . 7.2 pt -112.08 170.94 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.141 -0.975 . . . . 0.0 109.895 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.519 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 12.1 ptt180 -114.09 18.06 17.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.1 -1.0 . . . . 0.0 110.536 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 9.6 tt0 -177.67 94.02 0.23 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.081 -1.012 . . . . 0.0 110.478 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 51.6 Cg_endo -77.8 139.54 57.63 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.957 -2.101 . . . . 0.0 110.484 -0.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.74 ' O ' HG23 ' B' ' 111' ' ' THR . 18.9 mttp -56.65 118.98 5.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 110.061 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.74 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -163.59 178.33 8.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 0.0 110.419 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -131.91 172.4 12.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.82 . . . . 0.0 109.149 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.505 ' N ' ' CG2' ' B' ' 112' ' ' THR . . . -166.1 137.24 3.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.587 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.824 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -97.91 102.52 14.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' B' ' 104' ' ' MET . 2.3 mp -89.65 126.15 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.579 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.677 ' CD1' HD11 ' A' ' 74' ' ' LEU . 2.6 m-85 -101.32 157.44 16.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.296 -0.877 . . . . 0.0 109.913 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.485 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -73.56 -23.02 59.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 110.027 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 1.5 t -58.18 -18.91 29.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.0 110.184 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.11 -17.79 16.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -96.71 147.25 24.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -1.136 . . . . 0.0 110.142 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -138.5 169.24 18.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.959 HG21 ' O ' ' A' ' 71' ' ' VAL . 5.1 t -127.12 142.73 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.333 -0.854 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 71' ' ' VAL . 11.2 t -119.63 149.67 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.865 . . . . 0.0 109.794 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.934 HG23 ' HB2' ' A' ' 27' ' ' ASN . 3.0 t -162.36 160.21 26.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.84 . . . . 0.0 109.877 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.686 ' C ' HG22 ' B' ' 111' ' ' THR . . . 104.25 -1.56 43.62 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' B' ' 69' ' ' ASN . . . -75.53 -179.0 4.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.077 -1.249 . . . . 0.0 110.09 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -135.28 0.39 2.8 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.994 -1.066 . . . . 0.0 110.731 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -160.41 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.081 -1.012 . . . . 0.0 110.319 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -87.84 -34.12 18.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.339 -0.85 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -75.67 -34.94 60.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.056 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -53.49 53.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 110.093 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 3.1 m -55.0 -42.8 72.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.992 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.43 78.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.926 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -71.49 -56.69 5.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.88 . . . . 0.0 110.062 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.603 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -58.88 -31.44 68.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 21.0 t -65.77 -63.14 1.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.975 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 14.1 ptm180 -52.06 -31.15 28.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.499 ' N ' ' HG3' ' B' ' 137' ' ' ARG . 0.0 OUTLIER -62.99 -47.47 82.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.666 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.643 ' CE1' HG23 ' B' ' 106' ' ' ILE . 20.9 m-85 -63.73 -53.42 51.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 0.0 109.632 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.37 -22.94 13.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.461 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.33 -47.53 49.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.783 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.453 ' O ' HG13 ' B' ' 146' ' ' ILE . 1.8 mt -50.4 -43.3 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.167 -0.958 . . . . 0.0 109.606 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.643 ' N ' HD12 ' B' ' 143' ' ' ILE . 3.1 mp -73.08 -59.98 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.918 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 3.0 mm-40 -54.45 -34.82 62.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.617 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 6.4 tttm -73.22 -30.15 63.29 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.453 HG13 ' O ' ' B' ' 142' ' ' ILE . 3.4 mt -72.68 -16.16 17.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 113.1 -20.58 19.18 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.8 ' HD2' HD22 ' B' ' 80' ' ' LEU . 3.1 m-85 -49.8 171.13 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.961 -1.317 . . . . 0.0 110.548 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.7 43.55 1.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 110.097 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.592 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -85.68 151.97 23.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.579 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 6.6 mttp -120.98 -158.53 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.355 -0.84 . . . . 0.0 110.206 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.03 86.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.241 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -146.53 177.19 9.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.536 ' CB ' ' OG1' ' B' ' 75' ' ' THR . 2.8 t0 69.29 6.57 5.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.352 -0.842 . . . . 0.0 110.704 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -51.23 127.73 20.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.139 -0.976 . . . . 0.0 110.026 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -158.33 126.3 5.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.54 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 6.5 mt -82.67 117.16 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.752 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -117.98 2.5 12.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 110.602 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.466 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 0.4 OUTLIER -147.67 121.9 9.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.043 -1.036 . . . . 0.0 110.715 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.744 HG23 HG12 ' B' ' 70' ' ' ILE . 57.6 mt -130.93 126.14 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.716 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.9 HG22 ' OG1' ' B' ' 215' ' ' THR . 15.0 t -105.16 140.05 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 0.0 110.536 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -139.96 -179.81 18.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.9 OUTLIER -170.38 154.99 4.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.047 -1.266 . . . . 0.0 110.315 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.481 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 18.0 p -170.18 163.47 9.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.203 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.605 ' O ' HD13 ' B' ' 63' ' ' ILE . 4.3 t0 -106.24 133.73 50.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 0.0 109.974 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.775 HG21 HD11 ' B' ' 170' ' ' ILE . 12.8 m -83.48 7.43 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.211 -0.931 . . . . 0.0 110.595 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 45.7 tttt 70.68 12.43 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.274 -0.891 . . . . 0.0 110.809 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.58 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 16.0 p90 -169.35 145.6 2.77 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.048 -1.032 . . . . 0.0 110.425 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.482 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.66 154.77 54.65 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 124.092 1.575 . . . . 0.0 110.648 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.775 HD11 HG21 ' B' ' 166' ' ' VAL . 2.7 mp -125.11 151.18 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.317 -0.865 . . . . 0.0 110.152 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' B' ' 171' ' ' ARG . 5.8 ptm180 -88.51 98.51 11.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.115 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.509 HD22 ' CB ' ' B' ' 193' ' ' LEU . 30.3 mt -54.81 -42.06 71.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.011 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 16.1 pt-20 -55.65 -44.51 77.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.999 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -66.77 -37.89 92.67 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.821 HD21 HG12 ' B' ' 233' ' ' VAL . 0.2 OUTLIER -67.19 -38.6 85.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -1.111 . . . . 0.0 109.942 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -74.46 -11.64 60.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.933 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.91 -29.35 14.72 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.401 -0.812 . . . . 0.0 109.903 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 3.1 t -97.18 -30.89 12.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.379 -0.826 . . . . 0.0 109.949 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' B' ' 183' ' ' SER . 24.7 m170 -130.44 31.71 4.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 110.043 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -66.69 -10.88 56.07 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.9 m -64.71 -36.63 84.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -1.15 . . . . 0.0 110.251 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.0 -14.77 11.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.83 . . . . 0.0 110.303 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.592 ' HB2' ' CD2' ' B' ' 195' ' ' TYR . 0.9 OUTLIER -104.38 149.0 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.404 -179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 2.3 p -128.95 133.91 48.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 110.078 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -133.3 124.17 26.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.913 . . . . 0.0 110.286 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' B' ' 187' ' ' PRO . 2.3 mt-10 -122.81 104.78 35.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 110.074 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.3 Cg_endo -72.29 -2.52 11.79 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.97 1.511 . . . . 0.0 110.23 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -100.44 0.42 39.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.853 . . . . 0.0 110.398 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.476 HD23 ' N ' ' B' ' 190' ' ' PHE . 2.2 tt -161.13 -47.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' B' ' 194' ' ' ILE . 1.1 t80 -100.92 110.94 62.4 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.191 -0.943 . . . . 0.0 110.443 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.93 -25.64 16.29 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.994 1.523 . . . . 0.0 110.266 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.17 -179.68 34.07 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.719 HD23 ' C ' ' B' ' 193' ' ' LEU . 7.5 tt -115.91 127.25 54.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -1.226 . . . . 0.0 110.273 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.893 HD13 HD13 ' A' ' 62' ' ' LEU . 4.2 mt -90.07 111.45 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.897 . . . . 0.0 110.064 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.592 ' CD2' ' HB2' ' B' ' 183' ' ' SER . 10.2 t80 -108.92 113.32 26.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.347 -0.846 . . . . 0.0 110.144 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.1 91.63 5.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 110.409 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 28.0 ttm -60.3 131.34 50.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.266 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' B' ' 201' ' ' LYS . 38.5 t -70.71 -42.29 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 1.7 mttt -139.66 112.24 7.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 110.385 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.9 Cg_endo -73.23 169.94 71.42 Favored 'Cis proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.974 -2.094 . . . . 0.0 110.462 -0.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 8.6 mtmt -79.42 80.02 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 110.102 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' B' ' 217' ' ' ALA . 44.7 mm -121.97 150.82 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.0 110.527 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 79.6 t -101.81 104.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 0.0 109.904 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 5.3 mp -97.17 141.51 30.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 0.0 110.392 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.798 ' C ' HD13 ' B' ' 206' ' ' ILE . 2.5 mt -120.9 131.95 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.824 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.798 HD13 ' C ' ' B' ' 205' ' ' LEU . 5.0 mm -115.41 139.51 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 110.534 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -121.38 145.21 48.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.482 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 74.9 t -50.09 -33.5 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.119 -0.988 . . . . 0.0 110.415 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.2 t -63.72 -35.22 79.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 110.082 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.426 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 119.03 30.02 1.69 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.98 129.31 46.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -1.135 . . . . 0.0 110.312 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.546 HD12 HD12 ' B' ' 206' ' ' ILE . 19.2 mm -114.72 132.79 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.598 ' HB ' HD12 ' B' ' 205' ' ' LEU . 6.1 t -124.73 140.31 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.933 . . . . 0.0 110.213 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.566 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.1 mp -130.75 112.49 13.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.9 ' OG1' HG22 ' B' ' 161' ' ' VAL . 5.3 t -136.34 151.43 49.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.244 -0.91 . . . . 0.0 110.368 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.484 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 103.85 7.05 42.37 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -82.19 159.46 23.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -1.197 . . . . 0.0 110.165 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -99.57 -17.58 17.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 0.0 110.171 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.654 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.5 OUTLIER -147.44 -162.59 1.58 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -95.75 -21.08 18.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.23 -24.09 65.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.833 . . . . 0.0 110.224 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.43 ' HB3' HD11 ' B' ' 202' ' ' ILE . 21.0 mt-10 -79.92 -52.68 7.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.906 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 22.5 mm -52.94 -39.35 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 109.865 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.24 -43.84 60.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 110.008 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -36.61 82.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.278 -0.889 . . . . 0.0 110.287 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -65.28 -37.84 88.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.924 . . . . 0.0 110.208 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.5 ' CD2' ' HD3' ' B' ' 65' ' ' PRO . 53.1 t80 -70.0 -49.0 55.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.0 110.161 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -24.5 67.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.232 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.63 -31.33 46.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.945 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.465 ' C ' ' HD2' ' B' ' 232' ' ' PRO . 2.1 tp -96.96 -16.62 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 109.937 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.594 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.1 t80 -46.97 -46.34 53.15 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 110.827 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -72.67 -50.57 0.22 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.329 1.173 . . . . 0.0 110.427 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.821 HG12 HD21 ' B' ' 175' ' ' LEU . 25.5 t -44.26 -38.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 32.5 mt -72.62 -42.46 64.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.892 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.888 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -27.53 34.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.988 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.491 ' CA ' ' HD3' ' B' ' 171' ' ' ARG . 86.6 m-85 -121.44 38.77 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.78 167.07 21.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.913 . . . . 0.0 110.207 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -104.8 -36.92 7.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.318 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.263 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.308 0.575 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.62 31.28 3.12 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.23 100.41 5.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.144 -1.209 . . . . 0.0 110.243 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.474 HG13 ' N ' ' A' ' 15' ' ' GLY . 22.8 pt -108.93 -36.05 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.474 ' N ' HG13 ' A' ' 14' ' ' ILE . . . 78.06 99.62 0.2 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.94 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.257 -1.143 . . . . 0.0 110.145 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.512 ' C ' ' CE1' ' B' ' 99' ' ' PHE . . . -132.47 -145.54 5.49 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.967 HD12 ' N ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -69.43 161.0 30.34 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.354 -1.086 . . . . 0.0 109.705 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.967 ' N ' HD12 ' A' ' 18' ' ' LEU . 6.2 t70 -65.86 62.75 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.833 HD21 HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -84.4 -17.2 40.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.525 -0.734 . . . . 0.0 111.02 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.721 ' N ' HD21 ' A' ' 68' ' ' LEU . 8.8 m -44.65 -25.23 0.26 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.045 -1.034 . . . . 0.0 110.349 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -100.16 -34.57 4.78 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.808 HD12 HD11 ' B' ' 114' ' ' LEU . 0.3 OUTLIER -48.5 -40.35 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.216 -1.167 . . . . 0.0 109.688 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.4 pp -83.42 -18.24 39.39 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.943 -1.098 . . . . 0.0 108.724 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -98.68 6.32 47.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.631 -0.668 . . . . 0.0 109.381 179.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.56 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 151.26 89.96 0.08 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 1.001 ' ND2' HD11 ' A' ' 35' ' ' LEU . 12.5 p-10 -19.54 81.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.662 0.744 . . . . 0.0 112.896 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.639 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -89.44 164.54 2.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.571 ' N ' HG12 ' A' ' 28' ' ' ILE . 70.3 m-20 -86.49 132.77 33.84 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.546 ' OG ' HD11 ' B' ' 103' ' ' ILE . 1.0 OUTLIER -42.29 -22.69 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.178 -178.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' ASP . 2.1 tm-20 -62.77 -7.48 5.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.2 33.44 5.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HD3' ' N ' ' A' ' 34' ' ' LEU . 1.1 tpp180 -127.12 128.95 47.02 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.096 -1.238 . . . . 0.0 110.376 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.639 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -98.75 150.94 21.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.937 -1.102 . . . . 0.0 110.33 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.001 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.5 pp -135.57 -178.08 4.96 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.262 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.53 ' N ' HD12 ' A' ' 35' ' ' LEU . 5.5 mt-30 -125.1 -69.1 0.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.397 -0.815 . . . . 0.0 110.315 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.58 -63.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 110.204 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -174.09 58.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -108.84 97.27 6.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.917 . . . . 0.0 110.264 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.29 86.7 0.49 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 50.71 66.6 1.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.217 -1.167 . . . . 0.0 110.207 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 44' ' ' GLY . . . -139.27 106.23 0.5 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 44' ' ' GLY . 5.9 ttt-85 53.83 -88.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.191 -1.182 . . . . 0.0 110.072 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 42' ' ' GLY . . . -58.28 -163.53 0.07 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.94 -103.93 0.18 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.2 p -143.71 100.19 3.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -1.144 . . . . 0.0 110.31 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.73 -88.47 0.86 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.629 ' CD1' HD12 ' A' ' 52' ' ' LEU . 25.4 p90 -83.94 -0.95 53.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -1.152 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 48' ' ' PHE . 22.4 t70 -41.54 -62.64 0.84 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.331 -0.856 . . . . 0.0 110.67 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.75 -6.12 35.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.326 -0.859 . . . . 0.0 110.776 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.3 tt0 -100.37 -22.01 15.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.061 -1.025 . . . . 0.0 110.065 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.629 HD12 ' CD1' ' A' ' 48' ' ' PHE . 5.1 mt -101.19 -51.39 3.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 110.255 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.947 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -47.4 -51.26 20.44 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.394 -0.817 . . . . 0.0 109.889 -179.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -68.73 -15.29 63.47 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.729 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.592 ' HB3' ' CE2' ' B' ' 190' ' ' PHE . 1.9 m-80 -92.63 -35.0 13.77 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.459 -0.776 . . . . 0.0 109.321 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.947 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.5 mt -55.56 -42.44 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.416 -0.802 . . . . 0.0 109.309 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.4 -21.22 12.44 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.19 28.23 5.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -1.133 . . . . 0.0 110.383 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' A' ' 56' ' ' ILE . 5.0 mt -92.12 10.44 29.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.225 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.59 34.82 1.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.845 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.953 ' HG3' HD23 ' A' ' 62' ' ' LEU . 11.6 ptpt -135.55 26.03 3.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.436 -0.79 . . . . 0.0 109.969 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.953 HD23 ' HG3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -142.96 -56.86 0.42 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.553 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 64' ' ' LEU . . . -164.0 -35.74 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.4 mm? -42.07 -29.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -1.142 . . . . 0.0 110.331 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -51.6 -33.65 33.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.925 . . . . 0.0 109.739 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -68.9 -56.98 6.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.404 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.515 ' SD ' ' CA ' ' B' ' 216' ' ' GLY . 0.0 OUTLIER -67.3 -8.54 33.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.341 -0.849 . . . . 0.0 109.208 178.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.721 HD21 ' N ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -67.98 -63.84 0.98 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.805 0.812 . . . . 0.0 109.035 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD12 ' C ' ' A' ' 69' ' ' LEU . 3.4 pp -68.9 -5.95 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.215 0.531 . . . . 0.0 110.075 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 22.4 tt0 -80.92 3.37 23.04 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 111.2 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.981 HG12 HG11 ' B' ' 122' ' ' VAL . 2.1 t -143.27 4.96 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.816 -1.178 . . . . 0.0 110.656 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.867 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.9 tp -149.14 71.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.553 -0.717 . . . . 0.0 109.367 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.9 t0 -76.52 57.34 1.21 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.157 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 5.6 mt -107.51 67.39 0.69 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.66 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -153.44 29.28 0.49 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 109.872 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -174.33 74.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.463 -0.773 . . . . 0.0 110.221 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.236 -179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 95.4 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.91 76.8 1.28 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.2 mp -90.86 -22.87 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -1.118 . . . . 0.0 110.342 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 57.0 t 59.62 137.42 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.466 -0.771 . . . . 0.0 110.385 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.5 Cg_endo -75.53 149.61 34.82 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.928 1.489 . . . . 0.0 110.631 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.457 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.1 m -113.93 143.08 45.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.909 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.484 HD22 ' CG2' ' B' ' 160' ' ' ILE . 67.6 mt -80.44 117.61 21.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.0 110.264 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -108.3 -10.69 15.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.334 -0.854 . . . . 0.0 110.278 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.569 HD22 HG21 ' B' ' 161' ' ' VAL . 6.3 t30 -165.76 160.13 16.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.164 -0.96 . . . . 0.0 110.299 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.528 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 10.2 mt -157.45 166.67 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.936 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.503 ' N ' HG22 ' B' ' 70' ' ' ILE . 16.6 t -135.41 132.85 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.172 -0.955 . . . . 0.0 110.488 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -121.2 136.51 54.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 0.0 110.153 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 18.9 m -97.11 134.06 40.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 0.0 110.125 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' B' ' 155' ' ' PHE . 8.4 t -133.63 169.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -0.884 . . . . 0.0 110.11 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 56.2 m -144.11 133.66 23.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.387 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 1.103 HD12 HD11 ' B' ' 80' ' ' LEU . 82.9 mt -88.56 -14.39 37.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.0 110.272 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.67 -0.54 70.32 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 22.1 p -138.55 137.0 36.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -1.164 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 5.7 mtp85 -62.48 158.72 17.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 1.103 HD11 HD12 ' B' ' 76' ' ' LEU . 15.5 mt -130.36 150.45 51.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.245 -0.909 . . . . 0.0 110.271 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 1.0 OUTLIER -99.12 93.54 6.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.623 HD22 HG23 ' B' ' 102' ' ' VAL . 9.1 mt -39.16 -46.49 1.47 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.465 -0.772 . . . . 0.0 110.68 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -55.63 -43.56 76.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 110.272 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 84.8 m -83.58 -35.77 24.46 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.99 . . . . 0.0 110.22 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' B' ' 80' ' ' LEU . 30.4 t -65.96 -57.25 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.281 -0.887 . . . . 0.0 110.253 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.53 -36.59 80.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.876 . . . . 0.0 110.493 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 tp -61.03 -48.03 83.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 110.519 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.416 ' O ' ' C ' ' B' ' 89' ' ' ALA . 45.2 m-70 -78.61 -42.95 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.178 -0.951 . . . . 0.0 110.542 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -43.82 124.95 3.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 109.997 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.92 -18.01 62.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 3.3 m-20 -137.42 79.8 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.176 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.573 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -165.84 152.27 9.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 110.206 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -136.54 164.61 27.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 0.0 110.044 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -138.52 120.82 15.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 110.435 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.44 112.09 21.11 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.883 . . . . 0.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.99 -18.8 30.97 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.932 1.491 . . . . 0.0 110.268 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -71.95 -17.13 62.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -0.83 . . . . 0.0 110.019 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 11.1 mpt_? -105.54 -69.72 0.81 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -0.836 . . . . 0.0 109.947 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.644 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -152.09 -178.93 7.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.494 -0.754 . . . . 0.0 109.953 -179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -99.48 49.89 0.94 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.915 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.157 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -130.95 149.84 52.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.192 -0.943 . . . . 0.0 110.946 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.623 HG23 HD22 ' B' ' 82' ' ' LEU . 99.4 t -92.27 124.07 44.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.71 HD12 ' H ' ' B' ' 103' ' ' ILE . 5.0 mp -88.76 107.35 17.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.044 -1.035 . . . . 0.0 110.12 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.573 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 0.9 OUTLIER -93.27 161.39 14.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.482 -0.761 . . . . 0.0 109.844 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -163.85 123.31 2.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 0.0 110.832 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 4.6 pt -122.59 155.56 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.359 -0.838 . . . . 0.0 109.696 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 5.3 mtt180 -103.49 30.86 4.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.077 -1.015 . . . . 0.0 110.456 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 4.3 tm-20 -177.9 87.8 0.23 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 110.48 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.5 Cg_endo -76.49 159.58 96.24 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.351 -0.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.835 ' O ' HG23 ' B' ' 111' ' ' THR . 0.1 OUTLIER -73.12 115.37 12.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 0.0 110.037 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.835 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.8 OUTLIER -165.99 175.26 8.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.319 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.593 HG22 HG23 ' B' ' 124' ' ' THR . 0.5 OUTLIER -134.53 157.87 45.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.128 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -147.34 158.81 44.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 0.0 111.104 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.808 HD11 HD12 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -115.3 107.37 15.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.486 -0.758 . . . . 0.0 109.375 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' B' ' 102' ' ' VAL . 3.0 mp -89.93 131.47 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.785 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.735 ' CD1' HD11 ' A' ' 74' ' ' LEU . 4.5 m-30 -106.95 149.9 27.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 109.795 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' B' ' 80' ' ' LEU . . . -61.36 -20.06 62.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 110.342 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' B' ' 79' ' ' ARG . 12.2 t -62.86 -33.76 75.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 0.0 110.343 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.475 ' HA2' ' HG ' ' B' ' 80' ' ' LEU . . . 126.19 -13.77 7.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -76.16 171.57 14.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 110.192 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.411 ' SD ' HG13 ' B' ' 115' ' ' ILE . 6.7 ttp -155.99 135.0 12.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 110.158 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.981 HG11 HG12 ' A' ' 71' ' ' VAL . 12.6 t -115.51 119.02 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.258 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.694 HG13 ' HE2' ' B' ' 139' ' ' TYR . 18.7 t -105.24 144.49 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 109.988 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.707 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -146.78 165.96 28.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.571 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 101.55 -24.27 32.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.61 156.51 0.66 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.128 -1.219 . . . . 0.0 110.607 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -109.4 -14.5 14.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.864 . . . . 0.0 110.063 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 4.3 m -163.71 -178.49 5.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.907 . . . . 0.0 110.244 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . 0.405 ' HG2' HD11 ' B' ' 157' ' ' ILE . 93.3 mt-10 -58.18 -65.21 0.68 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 110.052 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.35 -30.44 2.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.079 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -71.33 -53.71 13.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.0 110.226 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 12.5 m -54.81 -37.85 66.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.5 -48.86 79.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.215 -0.928 . . . . 0.0 110.051 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 39.5 mt -61.57 -49.56 76.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.847 . . . . 0.0 110.054 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.475 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -58.05 -35.65 71.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 110.05 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 13.5 t -70.57 -65.83 0.68 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 110.022 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 53.7 mtp180 -46.79 -34.42 5.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.017 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -63.86 -49.61 72.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.026 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.694 ' HE2' HG13 ' B' ' 123' ' ' VAL . 18.4 m-85 -66.6 -54.91 18.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.235 -0.916 . . . . 0.0 109.959 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.98 -35.61 59.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 3.3 ttp180 -58.77 -41.71 87.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.99 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 139' ' ' TYR . 27.6 mt -59.0 -47.05 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 0.0 110.239 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.731 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.5 mp -60.46 -46.83 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.069 -1.02 . . . . 0.0 109.396 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.416 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 68.5 mt-30 -67.27 -31.89 72.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.452 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 3.1 mmtt -74.49 -28.71 61.12 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.3 mt -72.94 -22.86 19.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.2 -22.85 7.0 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.479 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.484 ' HB2' HG23 ' B' ' 143' ' ' ILE . 15.5 m-85 -51.63 175.88 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.907 -1.349 . . . . 0.0 110.756 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -109.16 36.03 3.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.478 -0.764 . . . . 0.0 110.542 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.909 ' CB ' HD22 ' B' ' 76' ' ' LEU . . . -62.47 131.09 48.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.569 ' O ' HG23 ' B' ' 153' ' ' THR . 2.0 ptpt -111.31 25.08 12.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.082 -1.011 . . . . 0.0 110.297 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.498 ' O ' HG23 ' B' ' 153' ' ' THR . 3.7 t80 31.55 95.35 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.124 0.488 . . . . 0.0 111.2 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.569 HG23 ' O ' ' B' ' 151' ' ' LYS . 1.9 p -153.23 174.41 14.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 153' ' ' THR . 1.6 t0 65.2 27.22 12.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.409 -0.807 . . . . 0.0 110.554 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.412 ' HA ' HG22 ' B' ' 74' ' ' VAL . 41.3 t80 -73.25 133.52 43.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.275 -0.89 . . . . 0.0 109.903 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -166.7 135.52 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 0.0 110.48 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.434 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 44.8 mt -78.9 133.66 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.432 -0.792 . . . . 0.0 109.638 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' B' ' 218' ' ' LYS . 23.2 mt-30 -125.53 -40.0 2.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.152 -0.968 . . . . 0.0 110.939 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.461 ' ND2' ' HA2' ' B' ' 216' ' ' GLY . 0.7 OUTLIER -114.06 109.27 18.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.066 -1.021 . . . . 0.0 110.959 -179.395 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.484 ' CG2' HD22 ' B' ' 67' ' ' LEU . 30.1 mt -105.94 123.6 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.7 HG22 ' OG1' ' B' ' 215' ' ' THR . 79.8 t -98.36 138.98 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 110.574 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -140.49 167.27 25.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 23.3 t -167.26 155.08 9.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.049 -1.265 . . . . 0.0 110.708 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 5.5 p -169.4 171.63 7.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.426 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 7.9 m-20 -128.57 140.39 51.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.0 110.419 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.472 ' HA ' HD13 ' B' ' 63' ' ' ILE . 22.6 m -119.34 8.66 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.337 -0.852 . . . . 0.0 109.936 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt 52.03 29.9 6.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 110.179 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.458 ' H ' HG23 ' B' ' 166' ' ' VAL . 1.2 t80 -121.0 115.86 31.58 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 110.263 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.26 120.16 6.8 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.904 1.476 . . . . 0.0 110.223 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.805 HD13 ' CG2' ' B' ' 206' ' ' ILE . 3.3 mt -101.49 145.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.568 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.64 84.86 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.981 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.719 HD22 ' HB2' ' B' ' 193' ' ' LEU . 15.1 mt -48.04 -23.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.171 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -80.98 -53.13 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.25 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.82 -38.61 96.26 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.499 HD23 HD13 ' B' ' 193' ' ' LEU . 11.7 tp -74.81 -38.58 62.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -1.104 . . . . 0.0 109.968 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' B' ' 172' ' ' LEU . . . -65.87 -38.66 89.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.222 -0.924 . . . . 0.0 110.291 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -72.38 -24.41 61.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.178 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -89.24 -48.9 7.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 110.28 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' B' ' 183' ' ' SER . 53.1 m170 -103.16 34.94 2.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.08 -33.63 51.52 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -19.09 44.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -1.095 . . . . 0.0 110.141 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' B' ' 198' ' ' VAL . 36.2 m-85 -136.37 6.02 3.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.447 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.664 ' OG ' HD21 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -133.64 135.57 44.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.933 . . . . 0.0 110.67 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.98 122.17 37.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 0.0 109.792 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -124.49 129.42 50.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 0.0 110.597 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' B' ' 190' ' ' PHE . 9.3 mt-10 -136.23 102.85 9.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.453 -0.779 . . . . 0.0 109.653 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.24 -2.45 11.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.932 1.49 . . . . 0.0 110.825 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -100.43 -6.02 26.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 0.0 110.324 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -143.91 -50.37 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 110.327 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.675 ' HB2' HD23 ' B' ' 189' ' ' LEU . 2.7 t80 -111.26 121.49 40.28 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.0 110.236 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . 0.474 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.4 Cg_endo -73.54 -35.55 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.923 1.486 . . . . 0.0 110.631 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.39 175.83 42.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.719 ' HB2' HD22 ' B' ' 172' ' ' LEU . 8.7 tt -106.83 138.19 43.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -1.163 . . . . 0.0 110.251 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.615 ' N ' HD23 ' B' ' 193' ' ' LEU . 2.6 mt -98.35 96.74 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.292 -0.88 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.523 ' HB2' ' CD1' ' B' ' 206' ' ' ILE . 7.6 t80 -93.89 120.37 34.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.856 ' HG2' HG22 ' B' ' 203' ' ' VAL . 17.0 mtp85 -108.2 97.82 7.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.328 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . . . . . . . . . 45.3 tpp -52.88 148.34 7.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 110.051 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.618 HG21 ' CE1' ' B' ' 182' ' ' PHE . 86.2 t -91.48 -40.91 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.905 . . . . 0.0 110.394 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.1 OUTLIER -140.7 107.79 6.48 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 110.491 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -73.92 165.45 84.97 Favored 'Cis proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.952 -2.103 . . . . 0.0 110.395 -0.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' B' ' 198' ' ' VAL . 16.9 mtmt -75.05 97.31 3.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.948 . . . . 0.0 110.01 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.795 HD11 ' HG2' ' B' ' 222' ' ' GLU . 23.9 mm -129.24 158.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.189 -0.944 . . . . 0.0 110.582 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.856 HG22 ' HG2' ' B' ' 196' ' ' ARG . 46.0 t -111.63 124.37 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.605 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 1.069 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.9 mp -123.9 135.85 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.171 -0.956 . . . . 0.0 110.623 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' B' ' 205' ' ' LEU . 3.8 mm? -101.33 125.23 47.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.83 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.805 ' CG2' HD13 ' B' ' 170' ' ' ILE . 2.8 mt -120.32 133.68 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.393 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' B' ' 207' ' ' PHE . 57.8 m-85 -119.46 154.22 34.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 110.197 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 52.7 t -60.44 -22.57 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.891 . . . . 0.0 110.074 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 8.5 t -64.52 -36.17 83.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.832 . . . . 0.0 110.533 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 121.29 11.04 6.35 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.851 ' O ' HD13 ' B' ' 212' ' ' ILE . 2.2 mptm? -92.51 141.65 28.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.105 . . . . 0.0 110.213 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.851 HD13 ' O ' ' B' ' 211' ' ' LYS . 24.6 mm -131.78 132.7 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.188 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 3.4 t -123.08 140.08 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.226 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 5.6 mp -121.47 145.03 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.293 -0.879 . . . . 0.0 110.226 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.7 ' OG1' HG22 ' B' ' 161' ' ' VAL . 6.6 t -165.3 157.3 15.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.19 -0.944 . . . . 0.0 110.187 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.515 ' CA ' ' SD ' ' A' ' 67' ' ' MET . . . 98.02 -15.78 61.1 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' B' ' 222' ' ' GLU . . . -65.83 141.7 58.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -1.122 . . . . 0.0 110.272 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' B' ' 158' ' ' GLN . 0.3 OUTLIER -92.56 -25.93 18.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -0.891 . . . . 0.0 110.109 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.86 151.37 47.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.149 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -47.05 -33.23 4.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 110.382 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -38.47 70.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.302 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.795 ' HG2' HD11 ' B' ' 202' ' ' ILE . 0.2 OUTLIER -60.66 -49.68 76.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.357 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.419 HG23 HD22 ' B' ' 214' ' ' LEU . 47.2 mm -56.03 -38.65 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.0 110.342 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -73.34 -40.38 64.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.307 -0.871 . . . . 0.0 110.326 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -40.86 94.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 1.069 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -60.3 -56.45 21.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 110.134 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.453 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 2.9 t80 -58.64 -44.49 90.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.131 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.9 -36.19 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -0.903 . . . . 0.0 110.14 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.48 -11.31 37.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 0.0 110.13 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.669 HG13 HD22 ' B' ' 204' ' ' LEU . 9.8 mm -97.77 -23.96 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 0.0 109.784 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -50.22 -48.45 79.93 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 110.758 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.72 -41.73 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.515 1.271 . . . . 0.0 110.376 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.443 ' CG1' HD13 ' B' ' 175' ' ' LEU . 57.1 t -50.53 -39.39 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.645 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.529 HD11 HG22 ' B' ' 230' ' ' ILE . 15.8 mt -68.65 -48.43 64.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.824 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 40.8 t -60.78 -31.99 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.845 . . . . 0.0 109.87 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -64.44 -37.94 89.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.371 -0.831 . . . . 0.0 110.099 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.494 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 76.6 m-85 -116.23 38.04 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -0.95 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.44 ' HB3' ' CE2' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -60.85 145.89 48.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.417 -0.802 . . . . 0.0 110.086 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 3.1 tttm -93.71 -39.2 10.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.918 . . . . 0.0 110.167 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 4.0 ttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.218 179.926 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.214 0.53 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.24 -22.98 2.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.19 24.8 1.03 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -1.116 . . . . 0.0 110.043 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 23.4 mt 48.36 61.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.313 -0.867 . . . . 0.0 110.08 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.18 156.81 28.06 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.507 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 13.6 p-10 -175.41 64.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.254 -1.144 . . . . 0.0 110.489 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.04 -176.83 54.55 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.981 ' CD2' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -132.33 166.09 22.73 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.058 -1.26 . . . . 0.0 110.247 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -63.43 81.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.981 HD22 ' CD2' ' A' ' 18' ' ' LEU . 4.1 tp -120.22 62.03 0.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.465 -0.894 . . . . 0.0 112.776 -176.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.708 HG23 ' HB3' ' A' ' 64' ' ' LEU . 1.2 m -92.05 -3.6 55.56 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.544 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -101.62 -31.51 5.46 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.563 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.931 ' CG1' HD11 ' A' ' 20' ' ' LEU . 2.2 mm -46.15 -44.12 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.416 -1.638 . . . . 0.0 109.171 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.826 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.6 OUTLIER -83.94 -23.44 31.13 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.057 178.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.594 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -85.26 10.64 11.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.499 -0.75 . . . . 0.0 109.16 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 135.55 104.83 0.78 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.596 ' ND2' HD12 ' A' ' 35' ' ' LEU . 7.5 p-10 -21.74 118.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.944 0.878 . . . . 0.0 111.438 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -140.37 161.67 24.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 121.546 0.688 . . . . 0.0 109.461 -178.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 28' ' ' ILE . 1.2 m-20 -87.58 119.32 27.77 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.571 ' OG ' ' CE2' ' B' ' 99' ' ' PHE . 26.7 p -39.15 -25.8 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.413 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.3 tt0 -66.3 -3.49 6.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.948 -1.095 . . . . 0.0 111.306 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.27 29.11 5.83 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.668 -1.253 . . . . 0.0 111.023 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.556 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -121.03 117.18 26.58 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.916 -1.343 . . . . 0.0 109.534 179.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.699 HD23 ' N ' ' A' ' 35' ' ' LEU . 0.8 OUTLIER -87.27 162.82 17.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.229 . . . . 0.0 111.906 -178.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.699 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -88.75 108.33 19.43 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.558 0.694 . . . . 0.0 111.67 -178.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 38' ' ' ASP . 3.6 pt20 -89.69 -5.37 57.12 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 49.02 -88.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.717 -0.614 . . . . 0.0 110.861 179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 36' ' ' GLN . 36.8 m-20 -79.51 -178.38 6.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 110.647 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -133.93 -35.67 0.95 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.398 -0.814 . . . . 0.0 110.102 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.11 -107.16 1.45 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 51.53 29.69 5.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -1.182 . . . . 0.0 109.943 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.02 -74.43 0.09 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -158.67 49.7 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -1.188 . . . . 0.0 110.379 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.41 51.09 60.76 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.87 -173.86 50.01 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.429 ' HA ' ' HB2' ' A' ' 36' ' ' GLN . 1.7 t -167.85 72.8 0.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.37 -1.076 . . . . 0.0 110.206 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 36' ' ' GLN . . . 66.04 -151.43 52.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 49' ' ' ASP . 1.9 m-85 -60.94 144.5 53.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.361 -1.082 . . . . 0.0 110.246 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 48' ' ' PHE . 1.6 m-20 -50.57 -176.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.978 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.71 25.52 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.16 -0.962 . . . . 0.0 109.935 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 17.6 pt-20 -97.47 -31.36 12.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.848 . . . . 0.0 110.29 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 55' ' ' ASN . 3.1 mt -90.99 -41.29 11.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 110.365 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.002 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -48.81 -52.96 21.26 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 -179.281 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -65.98 -26.53 67.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.368 -0.833 . . . . 0.0 109.524 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.537 ' HB3' HD23 ' A' ' 59' ' ' LEU . 1.9 m-80 -79.97 -42.9 23.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.459 -0.776 . . . . 0.0 110.05 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.002 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -48.43 -45.71 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.943 . . . . 0.0 109.619 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -76.81 0.74 64.8 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.494 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.3 OUTLIER -120.71 -44.47 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.165 -1.197 . . . . 0.0 110.884 -179.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.057 HD22 ' CE2' ' B' ' 190' ' ' PHE . 0.4 OUTLIER -85.59 34.84 0.59 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 110.698 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.69 34.38 0.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.894 -1.129 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.9 1.55 0.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 111.106 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 62' ' ' LEU . 5.7 mt -86.65 -67.62 0.8 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.661 -1.274 . . . . 0.0 109.93 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.63 -35.66 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.708 ' HB3' HG23 ' A' ' 21' ' ' THR . 3.9 mm? -54.24 -39.76 67.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.21 -1.17 . . . . 0.0 110.343 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 69' ' ' LEU . 16.4 t0 -43.91 -33.89 1.49 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.892 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 1.5 m -60.7 -62.88 1.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -0.877 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.826 ' HG2' HD13 ' A' ' 24' ' ' LEU . 1.1 ttp -72.01 -3.14 21.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.292 -0.88 . . . . 0.0 109.792 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.553 HD23 ' C ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -67.69 -54.98 15.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.332 -0.855 . . . . 0.0 108.933 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 65' ' ' ASP . 0.6 OUTLIER -69.92 0.28 6.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.72 -0.613 . . . . 0.0 109.953 179.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -91.83 -11.47 36.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.348 -0.845 . . . . 0.0 110.577 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.921 HG11 HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.58 -17.59 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.084 -1.01 . . . . 0.0 108.797 179.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.065 HD11 HD12 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -146.57 78.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.845 -0.534 . . . . 0.0 110.148 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 3.3 p-10 -79.46 53.24 1.51 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.885 -1.134 . . . . 0.0 109.049 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.126 HD11 ' CB ' ' B' ' 101' ' ' ALA . 8.0 mt -84.08 59.03 5.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 0.0 110.675 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 16' ' ' ASN . 1.8 tttm -121.38 81.31 1.78 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.667 -0.646 . . . . 0.0 110.085 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.624 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 1.9 mt-10 50.21 53.1 13.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.253 -0.904 . . . . 0.0 110.263 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.624 ' HB2' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.199 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.273 0.558 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.522 ' O ' HG23 ' B' ' 64' ' ' VAL . . . 137.28 60.42 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.579 ' C ' HG23 ' B' ' 64' ' ' VAL . 33.4 mt -65.35 -52.29 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.28 -1.129 . . . . 0.0 110.375 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.579 HG23 ' C ' ' B' ' 63' ' ' ILE . 2.7 t 67.2 125.19 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 46.5 Cg_endo -73.43 146.96 40.56 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.856 1.451 . . . . 0.0 110.617 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 3.3 m -105.4 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 110.07 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.448 HD22 HG23 ' B' ' 160' ' ' ILE . 27.3 mt -77.01 134.68 38.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 110.218 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -123.25 -18.39 6.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.405 ' OD1' ' HA2' ' B' ' 125' ' ' GLY . 5.4 t30 -169.88 154.24 5.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.399 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.478 ' CD1' HG12 ' B' ' 160' ' ' ILE . 5.0 mt -145.26 147.32 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 110.025 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.595 HG11 ' CG1' ' A' ' 71' ' ' VAL . 53.3 t -115.83 142.83 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.179 -0.95 . . . . 0.0 110.582 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.31 162.04 33.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 0.0 110.172 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' B' ' 155' ' ' PHE . 0.3 OUTLIER -116.48 135.0 54.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.254 -0.904 . . . . 0.0 110.319 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.567 HG12 ' N ' ' B' ' 75' ' ' THR . 91.5 t -132.04 171.21 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 109.871 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.567 ' N ' HG12 ' B' ' 74' ' ' VAL . 46.1 m -148.03 151.63 36.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 110.361 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.95 HD22 ' HB1' ' B' ' 150' ' ' ALA . 33.7 mt -104.77 -57.5 2.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.837 . . . . 0.0 110.195 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 111.95 21.54 6.3 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.68 142.76 12.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.151 -1.205 . . . . 0.0 110.282 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.46 146.86 53.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.045 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.741 HD11 ' CD1' ' B' ' 76' ' ' LEU . 15.5 mt -127.48 153.23 46.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 110.124 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.1 OUTLIER -90.37 88.12 7.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 110.017 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.659 HD22 HG23 ' B' ' 102' ' ' VAL . 10.7 mt -41.14 -44.04 2.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.421 -0.8 . . . . 0.0 110.277 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.4 OUTLIER -56.3 -42.28 77.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.319 -0.863 . . . . 0.0 110.092 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 7.4 m -83.96 -43.94 14.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.423 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 86.4 t -55.15 -48.2 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.244 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.625 ' HB2' HG13 ' B' ' 102' ' ' VAL . . . -72.96 -28.94 62.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 110.344 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 9.5 tp -77.21 -34.6 56.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.33 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -88.59 -25.71 22.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.163 -0.96 . . . . 0.0 110.364 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -65.52 143.09 57.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.914 . . . . 0.0 110.221 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -72.06 -27.59 62.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 110.061 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' B' ' 104' ' ' MET . 71.7 m-20 -134.78 79.44 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 110.007 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -152.32 130.83 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.613 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -124.34 142.78 51.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.355 -0.84 . . . . 0.0 109.671 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -118.24 137.94 52.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 0.0 110.811 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' B' ' 95' ' ' ASN . 8.5 p30 -133.66 109.97 12.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.939 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.9 -26.9 12.79 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.99 1.521 . . . . 0.0 110.381 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.28 -7.46 59.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 110.176 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' B' ' 95' ' ' ASN . 0.0 OUTLIER -102.45 -75.91 0.59 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.214 -0.929 . . . . 0.0 109.712 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.666 ' CE1' ' HB3' ' B' ' 101' ' ' ALA . 32.4 p90 -145.68 -178.86 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 110.075 179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.612 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -99.2 56.52 1.03 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.051 -1.03 . . . . 0.0 112.099 -178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.126 ' CB ' HD11 ' A' ' 74' ' ' LEU . . . -152.53 166.32 32.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.867 -1.146 . . . . 0.0 110.524 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.659 HG23 HD22 ' B' ' 82' ' ' LEU . 21.3 t -97.39 157.74 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.672 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.47 HD13 ' OG ' ' A' ' 30' ' ' SER . 2.0 mt -118.25 100.54 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.99 . . . . 0.0 110.429 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.501 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 2.2 ttm -92.39 145.2 24.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.345 -0.847 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.58 118.67 8.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.876 . . . . 0.0 110.257 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 30.8 pt -116.81 164.16 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -0.885 . . . . 0.0 110.063 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 1.1 ptm180 -120.04 42.44 2.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.236 -0.915 . . . . 0.0 110.465 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.2 OUTLIER 179.26 80.29 0.17 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 0.0 110.256 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.455 ' O ' HG13 ' B' ' 106' ' ' ILE . 49.4 Cg_endo -78.13 159.81 92.66 Favored 'Cis proline' 0 C--N 1.313 -1.323 0 C-N-CA 121.58 -2.258 . . . . 0.0 110.436 -0.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 2.1 tppt? -71.27 113.18 8.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 109.901 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.489 HG22 ' HA3' ' B' ' 125' ' ' GLY . 0.3 OUTLIER -154.47 164.8 38.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.152 -0.968 . . . . 0.0 110.687 -179.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.616 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.9 m -114.84 146.45 41.06 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.502 -0.748 . . . . 0.0 109.325 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.717 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -149.53 140.82 23.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.102 . . . . 0.0 111.305 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.653 ' N ' HD23 ' B' ' 114' ' ' LEU . 0.2 OUTLIER -119.37 126.65 51.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.555 -0.716 . . . . 0.0 109.223 179.178 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . . . . . . . . . 5.8 mt -108.36 136.65 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.203 -0.935 . . . . 0.0 111.111 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 4.5 m-85 -93.81 161.43 14.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.58 -1.19 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.972 -1.08 . . . . 0.0 110.296 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 35.9 t -91.19 -7.67 50.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.151 -0.968 . . . . 0.0 110.348 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 108.1 -30.72 8.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 26.5 mttt -74.12 151.78 40.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -1.138 . . . . 0.0 110.195 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -153.64 169.45 23.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.201 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.89 HG11 HG12 ' A' ' 71' ' ' VAL . 24.8 t -133.38 147.98 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.276 -0.89 . . . . 0.0 110.174 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.478 HG12 ' N ' ' B' ' 124' ' ' THR . 23.3 t -126.67 170.04 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.588 HG23 ' CB ' ' A' ' 27' ' ' ASN . 10.1 t -170.04 154.18 4.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.291 -0.881 . . . . 0.0 110.275 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.583 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 111.43 8.3 23.29 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.472 ' CB ' ' HB2' ' B' ' 132' ' ' SER . . . -82.41 141.21 32.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -1.154 . . . . 0.0 110.046 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.64 -0.04 41.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.873 . . . . 0.0 110.283 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.79 -159.9 0.65 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.209 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -83.68 -49.09 9.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.55 -28.98 65.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 0.0 110.076 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -43.82 96.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.283 -0.886 . . . . 0.0 110.034 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.472 ' HB2' ' CB ' ' B' ' 126' ' ' ALA . 44.9 t -68.33 -36.64 79.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.233 -0.917 . . . . 0.0 110.19 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.79 -38.22 81.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 110.205 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.45 ' O ' ' HD2' ' B' ' 138' ' ' LYS . 6.1 mt -69.94 -45.41 67.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 110.155 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.31 -52.12 67.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 110.117 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 72.3 m -60.55 -50.85 71.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.201 -0.937 . . . . 0.0 110.016 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.91 -39.66 69.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.887 . . . . 0.0 109.998 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -59.41 -40.4 86.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.717 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 26.8 m-85 -65.62 -52.08 54.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.805 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.71 -36.16 56.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.0 109.955 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -59.94 -43.33 95.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 110.191 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 32.1 mt -57.59 -35.26 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.853 HG21 ' HB2' ' B' ' 150' ' ' ALA . 39.8 mm -73.9 -57.65 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.65 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -61.14 -28.32 69.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.647 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.462 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 1.7 tttt -75.71 -19.27 59.22 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 8.1 mt -90.97 -23.81 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.72 -0.613 . . . . 0.0 109.371 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.4 -29.37 4.8 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.534 ' CB ' HG22 ' B' ' 143' ' ' ILE . 12.2 m-85 -46.4 163.05 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -1.214 . . . . 0.0 110.937 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -101.2 38.13 1.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.559 -0.713 . . . . 0.0 109.942 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.95 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -73.55 136.41 44.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 0.0 110.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.627 ' O ' HD23 ' B' ' 76' ' ' LEU . 5.1 tttt -112.44 157.65 20.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 110.338 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -99.69 89.95 4.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.474 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -148.92 172.8 14.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.121 -0.987 . . . . 0.0 110.387 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.525 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 4.2 t0 67.78 26.12 7.81 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.606 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 6.8 t80 -84.62 129.16 34.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.077 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -163.62 131.82 3.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.386 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.42 HG23 ' CG2' ' B' ' 70' ' ' ILE . 3.1 mt -79.88 123.74 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.666 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -119.69 -10.93 9.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 0.0 110.801 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 26.1 t30 -140.12 122.1 15.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.962 -1.086 . . . . 0.0 111.079 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' B' ' 215' ' ' THR . 3.9 mt -113.25 160.52 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.152 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.456 HG22 ' OG1' ' B' ' 215' ' ' THR . 54.7 t -138.67 126.35 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.714 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -130.95 176.2 19.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 1.1 p -158.33 154.54 27.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.077 -1.249 . . . . 0.0 110.523 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.447 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.9 p -170.2 174.21 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.818 . . . . 0.0 110.112 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.484 ' O ' HD13 ' B' ' 63' ' ' ILE . 14.9 t0 -121.59 136.11 54.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.087 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.686 HG21 HD11 ' B' ' 170' ' ' ILE . 26.8 m -85.47 2.54 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.28 -0.888 . . . . 0.0 110.347 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.12 23.72 4.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.254 -0.904 . . . . 0.0 110.925 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.594 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 8.4 p90 -177.93 148.19 0.65 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.406 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 45.4 Cg_endo -72.63 161.15 44.77 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.093 1.575 . . . . 0.0 110.485 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.686 HD11 HG21 ' B' ' 166' ' ' VAL . 4.0 mt -131.08 150.84 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.37 90.62 7.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.085 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.533 HD21 HG22 ' B' ' 206' ' ' ILE . 22.2 mt -48.2 -29.13 3.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.372 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -64.14 -60.22 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.292 -0.88 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.35 -34.15 25.5 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.573 ' HB3' HD13 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -63.99 -47.71 79.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -1.138 . . . . 0.0 110.17 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.54 -30.03 67.76 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.282 -0.886 . . . . 0.0 110.414 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -69.26 -27.35 65.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.279 -0.888 . . . . 0.0 110.583 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 11.3 p -99.14 -57.75 2.09 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.14 -0.975 . . . . 0.0 110.357 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' B' ' 183' ' ' SER . 26.6 m80 -100.54 38.26 1.55 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -0.937 . . . . 0.0 110.303 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -62.85 -30.18 76.37 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . 0.437 HG23 ' CG ' ' B' ' 182' ' ' PHE . 9.3 t -62.46 -33.47 74.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -1.123 . . . . 0.0 110.362 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.437 ' CG ' HG23 ' B' ' 181' ' ' THR . 21.4 m-85 -113.16 -12.2 13.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.493 ' N ' ' O ' ' B' ' 179' ' ' HIS . 37.7 m -104.77 171.29 7.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.855 . . . . 0.0 110.266 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.6 m -155.88 109.87 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.379 -0.825 . . . . 0.0 110.053 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 1.019 ' HB2' HD12 ' B' ' 193' ' ' LEU . 17.8 t80 -113.49 114.51 26.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 110.23 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 3.2 mm-40 -125.55 102.52 29.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.44 -0.15 8.85 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.083 1.57 . . . . 0.0 110.325 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -98.42 -20.03 17.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -0.886 . . . . 0.0 110.035 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.602 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.6 tt -142.11 8.13 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.3 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 1.057 ' CE2' HD22 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -169.94 108.54 0.46 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.264 -0.897 . . . . 0.0 110.419 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.95 -4.36 13.32 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.849 1.447 . . . . 0.0 110.516 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -117.47 162.96 12.76 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 1.019 HD12 ' HB2' ' B' ' 185' ' ' TYR . 2.4 tt -100.72 143.46 30.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -1.17 . . . . 0.0 110.129 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.55 HD11 ' CE2' ' B' ' 190' ' ' PHE . 31.7 mt -104.78 106.42 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.636 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' B' ' 179' ' ' HIS . 0.3 OUTLIER -97.95 111.88 24.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -0.98 . . . . 0.0 109.87 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.77 80.99 5.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 110.41 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 29.9 ttm -50.83 141.68 12.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 109.926 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 20.5 t -87.23 -43.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 110.56 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 4.5 mttp -141.32 110.6 6.39 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.146 -0.971 . . . . 0.0 110.31 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.475 ' O ' HG12 ' B' ' 202' ' ' ILE . 47.5 Cg_endo -73.21 149.95 94.94 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.956 -2.102 . . . . 0.0 110.443 -0.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.8 OUTLIER -64.22 95.82 0.14 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.898 . . . . 0.0 109.967 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.519 HD12 ' HB2' ' B' ' 217' ' ' ALA . 11.4 mm -134.1 151.62 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -0.887 . . . . 0.0 110.621 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 82.4 t -107.37 109.37 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.877 . . . . 0.0 109.667 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.483 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.9 mp -100.98 134.93 43.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.161 -0.962 . . . . 0.0 110.913 -179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' B' ' 205' ' ' LEU . 0.2 OUTLIER -108.72 117.79 35.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 0.0 109.473 179.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.533 HG22 HD21 ' B' ' 172' ' ' LEU . 4.4 mp -107.87 137.31 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.488 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -118.29 135.25 54.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.048 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' B' ' 172' ' ' LEU . 69.0 t -45.21 -24.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 110.344 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -35.06 78.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.594 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 124.95 -12.45 7.69 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.28 154.76 37.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -1.105 . . . . 0.0 110.307 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' B' ' 212' ' ' ILE . 12.2 mm -138.78 137.15 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 110.083 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.594 HG11 ' HE1' ' A' ' 25' ' ' PHE . 96.7 t -120.98 149.25 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.448 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 1.1 mt -133.35 102.14 5.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.266 -0.896 . . . . 0.0 109.965 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 14.2 t -131.53 153.65 49.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.0 110.388 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.25 15.05 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.519 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -100.03 131.23 46.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -1.199 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.422 ' N ' ' OE1' ' B' ' 222' ' ' GLU . 4.6 tttt -75.75 -13.98 60.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.072 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.434 ' C ' HD13 ' B' ' 160' ' ' ILE . 0.2 OUTLIER -152.91 173.46 15.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.274 -0.891 . . . . 0.0 110.091 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -32.23 70.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.117 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -55.98 -51.32 68.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.027 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.505 ' HB3' HD11 ' B' ' 202' ' ' ILE . 1.1 mt-10 -52.74 -42.28 64.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 109.943 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.444 HG12 ' CB ' ' B' ' 217' ' ' ALA . 18.4 mm -60.13 -45.83 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.994 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -68.63 -33.25 73.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.444 -0.785 . . . . 0.0 110.092 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 49.9 tp60 -71.79 -46.25 58.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 109.966 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.483 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -54.48 -51.49 64.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.879 . . . . 0.0 109.848 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.712 ' HA ' HG22 ' B' ' 230' ' ' ILE . 20.0 t80 -57.27 -37.34 72.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.451 -0.78 . . . . 0.0 109.93 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -69.48 -18.2 63.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -0.871 . . . . 0.0 110.037 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.97 -18.28 17.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.712 HG22 ' HA ' ' B' ' 227' ' ' PHE . 9.1 tp -100.03 -25.53 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 110.323 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 31.9 t80 -51.99 -44.18 91.22 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.901 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.02 -31.09 8.3 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.354 1.187 . . . . 0.0 110.555 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 30.7 t -70.06 -38.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 110.166 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 230' ' ' ILE . 37.0 mt -67.87 -42.99 80.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 0.0 110.168 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.8 -39.22 88.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -0.872 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.91 -31.37 72.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 110.092 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -117.32 42.65 2.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 110.213 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -96.65 -176.03 3.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 110.172 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.59 -38.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.157 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.288 0.566 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.0 -147.97 5.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.4 t -123.68 -15.21 7.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.163 . . . . 0.0 110.44 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.7 mt 51.2 94.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.134 -0.979 . . . . 0.0 110.258 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.33 -119.79 1.03 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -54.05 173.01 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -1.152 . . . . 0.0 110.087 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' C ' ' CE1' ' B' ' 99' ' ' PHE . . . -96.55 -133.22 7.58 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.047 HD13 ' HB2' ' A' ' 30' ' ' SER . 0.3 OUTLIER -65.64 176.33 1.55 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.107 -1.231 . . . . 0.0 109.731 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.993 ' N ' HD12 ' A' ' 18' ' ' LEU . 2.7 t70 -66.54 60.3 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.091 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.895 HD21 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -80.68 -17.23 51.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 110.691 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.551 ' N ' HD21 ' A' ' 68' ' ' LEU . 64.9 m -41.31 -28.96 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.325 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.94 -37.1 4.0 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.75 HD12 HD11 ' B' ' 114' ' ' LEU . 0.4 OUTLIER -48.59 -40.39 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.277 . . . . 0.0 108.853 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.601 HD13 ' CE ' ' A' ' 67' ' ' MET . 3.5 pp -82.97 -27.81 30.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.978 -1.076 . . . . 0.0 108.92 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.508 ' CE1' HD13 ' A' ' 52' ' ' LEU . 1.7 t80 -90.58 9.95 27.51 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.61 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 141.18 95.33 0.25 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.709 ' HB2' HG22 ' B' ' 112' ' ' THR . 6.8 p-10 -20.06 116.99 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.976 0.893 . . . . 0.0 112.315 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.689 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -126.33 163.79 27.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.774 ' HA ' HG21 ' B' ' 103' ' ' ILE . 75.7 m-20 -87.45 121.73 30.26 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.047 ' HB2' HD13 ' A' ' 18' ' ' LEU . 2.9 p -36.78 -28.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.471 0.653 . . . . 0.0 109.69 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.8 tt0 -51.64 -18.48 1.18 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 0.0 110.575 178.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.75 27.97 3.87 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.645 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -129.38 147.86 51.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.94 -1.33 . . . . 0.0 109.573 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.689 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -95.72 165.88 12.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -0.873 . . . . 0.0 111.872 -178.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.651 HD12 ' ND2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -88.31 113.69 24.17 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.928 0.871 . . . . 0.0 111.552 -178.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.02 17.72 2.28 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 54.93 86.99 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.798 -0.564 . . . . 0.0 109.987 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -70.35 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.351 -0.843 . . . . 0.0 110.323 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.13 -77.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.359 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.52 -144.88 24.7 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 20.3 tt0 -92.38 19.67 6.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.169 -1.195 . . . . 0.0 110.168 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.39 -59.86 0.51 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.24 158.78 15.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -1.109 . . . . 0.0 110.032 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.94 159.03 26.91 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.39 100.21 2.44 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.9 -36.11 0.84 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 0.0 110.098 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 48' ' ' PHE . . . -69.13 -146.86 0.2 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 47' ' ' GLY . 6.3 p90 -49.48 179.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -1.191 . . . . 0.0 110.267 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -91.9 -144.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.349 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -100.55 35.8 2.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.393 -0.817 . . . . 0.0 110.071 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 55' ' ' ASN . 0.4 OUTLIER -89.31 -26.66 21.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.242 -0.911 . . . . 0.0 109.074 179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.508 HD13 ' CE1' ' A' ' 25' ' ' PHE . 2.1 mt -88.81 -38.57 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.621 -0.674 . . . . 0.0 109.451 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.001 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -57.26 -57.49 12.39 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.362 -0.836 . . . . 0.0 109.913 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.12 -31.36 71.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 3.4 m-20 -73.21 -43.13 61.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.001 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.1 mt -46.26 -45.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.328 -0.857 . . . . 0.0 109.245 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.92 -26.48 18.77 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -136.51 44.19 2.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -1.104 . . . . 0.0 110.232 179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.156 HD21 ' CE1' ' B' ' 190' ' ' PHE . 6.7 mt -99.41 13.14 34.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.902 . . . . 0.0 110.118 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.22 47.21 1.11 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.79 . . . . 0.0 109.864 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.523 ' C ' HD23 ' A' ' 62' ' ' LEU . 17.7 mtpp -135.99 1.93 2.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.33 -0.856 . . . . 0.0 110.102 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.908 HD11 HD22 ' A' ' 59' ' ' LEU . 1.5 mt -88.69 -38.96 14.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.275 -0.891 . . . . 0.0 109.743 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.65 3.35 4.62 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 62' ' ' LEU . 1.5 pp -87.0 0.59 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.092 -1.24 . . . . 0.0 110.064 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.9 t70 -44.05 -32.91 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.914 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 m -56.75 -49.73 74.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.017 -1.052 . . . . 0.0 109.478 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.601 ' CE ' HD13 ' A' ' 24' ' ' LEU . 12.7 ttp -65.96 -12.62 56.24 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.789 . . . . 0.0 109.512 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.644 HD13 ' C ' ' A' ' 68' ' ' LEU . 1.3 tm? -70.09 -65.66 0.69 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.093 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.09 -6.33 22.34 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.332 0.587 . . . . 0.0 110.293 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -79.45 -4.77 52.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 110.646 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.914 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.1 OUTLIER -129.65 -6.0 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 110.371 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.929 ' CG1' HD23 ' A' ' 18' ' ' LEU . 5.8 tp -140.74 72.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.396 -0.815 . . . . 0.0 110.166 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.8 t70 -79.79 56.19 2.23 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.016 HD13 ' HB2' ' B' ' 101' ' ' ALA . 6.4 mt -110.48 69.01 0.68 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 121.634 0.731 . . . . 0.0 110.746 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -133.96 -164.81 1.55 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.563 -0.711 . . . . 0.0 110.064 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -69.0 114.05 6.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.302 -0.874 . . . . 0.0 110.165 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.218 179.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.25 0.548 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.15 75.64 1.3 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.453 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt -96.84 -51.58 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.223 -1.163 . . . . 0.0 110.237 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 4.8 t 62.1 132.09 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 109.961 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.523 ' HG2' HG22 ' B' ' 223' ' ' ILE . 49.3 Cg_endo -74.48 152.53 43.64 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.006 1.53 . . . . 0.0 110.778 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 24.3 m -118.92 129.86 55.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.359 -0.838 . . . . 0.0 109.865 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.787 HD22 HG22 ' B' ' 160' ' ' ILE . 29.2 mt -69.93 132.23 45.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 110.234 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.82 -16.36 7.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 0.0 110.421 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -152.49 111.6 3.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.122 -0.986 . . . . 0.0 110.577 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 20.0 mm -91.95 168.16 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.864 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' B' ' 159' ' ' ASN . 50.7 t -148.77 114.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.123 -0.986 . . . . 0.0 109.915 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.56 165.34 24.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.534 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . 0.725 HG22 HG22 ' B' ' 122' ' ' VAL . 69.5 p -120.71 141.44 50.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.685 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' B' ' 121' ' ' MET . 3.3 t -140.23 156.27 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.042 . . . . 0.0 110.722 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.665 HG22 ' H ' ' B' ' 77' ' ' GLY . 24.2 m -106.18 144.44 32.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.673 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.965 HD12 HD11 ' B' ' 80' ' ' LEU . 93.5 mt -94.73 -6.29 43.48 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.067 -1.021 . . . . 0.0 110.447 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . 0.665 ' H ' HG22 ' B' ' 75' ' ' THR . . . 103.59 -38.8 3.06 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . 0.724 ' H ' ' HB1' ' B' ' 149' ' ' ALA . 0.0 OUTLIER -142.47 -174.5 4.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.113 -1.228 . . . . 0.0 110.836 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.688 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -78.7 178.86 7.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 110.222 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.965 HD11 HD12 ' B' ' 76' ' ' LEU . 10.4 mt -140.89 165.01 28.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 110.422 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.634 ' O ' HG23 ' B' ' 85' ' ' VAL . 1.1 m-20 -110.27 83.27 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 0.0 109.283 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.448 ' C ' ' O ' ' B' ' 81' ' ' ASP . 8.4 mt -38.11 -49.1 1.3 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.39 -51.62 58.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.697 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.544 ' HA ' ' CD2' ' B' ' 87' ' ' LEU . 43.3 p -76.87 -41.9 42.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 0.0 110.077 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.851 HG22 ' CE2' ' B' ' 148' ' ' PHE . 43.9 t -60.49 -37.02 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.121 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.68 -36.27 78.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.544 ' CD2' ' HA ' ' B' ' 84' ' ' THR . 0.7 OUTLIER -90.74 -23.04 20.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.431 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.517 ' HB3' ' CD1' ' B' ' 146' ' ' ILE . 6.7 m-70 -82.97 -35.38 25.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 110.684 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.527 ' HB2' ' HE1' ' B' ' 104' ' ' MET . . . -72.06 145.15 48.43 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.278 -0.889 . . . . 0.0 110.387 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -73.94 -27.13 60.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 1.7 m120 -133.69 79.29 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.254 -0.904 . . . . 0.0 109.938 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 89' ' ' ALA . . . -138.07 159.64 41.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.83 ' O ' HD12 ' B' ' 103' ' ' ILE . 73.9 mt-10 -147.83 120.34 8.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.315 -0.865 . . . . 0.0 110.244 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.475 ' HB2' HG22 ' B' ' 102' ' ' VAL . 24.8 t80 -113.52 113.4 25.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.121 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -119.8 111.72 35.72 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 110.159 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.15 -19.77 29.29 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.937 1.493 . . . . 0.0 110.009 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -17.86 61.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -105.28 -76.46 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.444 -0.785 . . . . 0.0 110.027 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.658 ' CE1' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.25 173.15 11.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -0.891 . . . . 0.0 110.433 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.3 43.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.297 -0.877 . . . . 0.0 110.234 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.016 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -132.22 151.97 51.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 110.46 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.475 HG22 ' HB2' ' B' ' 94' ' ' TYR . 55.8 t -96.95 126.58 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.359 -0.838 . . . . 0.0 109.526 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.83 HD12 ' O ' ' B' ' 93' ' ' GLU . 3.3 mp -89.72 118.27 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 110.478 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.527 ' HE1' ' HB2' ' B' ' 89' ' ' ALA . 0.0 OUTLIER -95.56 165.32 12.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.439 -0.788 . . . . 0.0 110.015 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.455 ' O ' ' ND2' ' B' ' 91' ' ' ASN . 10.3 mtp180 -163.8 116.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 110.783 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' B' ' 138' ' ' LYS . 37.7 pt -120.71 150.19 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.466 -0.771 . . . . 0.0 109.554 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.5 OUTLIER -91.6 28.32 1.78 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.519 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 7.0 pt-20 -161.96 83.9 1.69 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.716 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' B' ' 111' ' ' THR . 51.1 Cg_endo -85.47 148.76 46.47 Favored 'Cis proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.172 -0.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -51.54 91.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.14 -0.975 . . . . 0.0 110.185 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 109' ' ' PRO . 13.2 p -146.62 -179.46 6.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 109.899 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.81 HG22 HG23 ' B' ' 124' ' ' THR . 1.2 t -131.57 179.22 6.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.014 -1.054 . . . . 0.0 110.208 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -166.85 137.82 3.25 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 0.0 110.312 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.882 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.3 OUTLIER -95.22 105.94 17.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.59 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.44 HD12 ' SD ' ' B' ' 104' ' ' MET . 33.8 mt -90.21 128.34 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.058 -1.026 . . . . 0.0 110.361 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.834 ' CD1' HD11 ' A' ' 74' ' ' LEU . 2.8 m-30 -99.84 162.31 13.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.789 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 79' ' ' ARG . . . -76.57 -11.09 59.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.699 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 m -83.05 -5.68 59.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.056 -1.027 . . . . 0.0 110.211 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' B' ' 78' ' ' CYS . . . 107.14 -39.16 2.99 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.93 135.21 55.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -1.114 . . . . 0.0 109.987 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -133.01 168.34 18.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 110.356 -179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.914 HG21 ' O ' ' A' ' 71' ' ' VAL . 10.3 t -130.37 143.64 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 109.971 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.16 144.38 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.904 . . . . 0.0 109.958 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.81 HG23 HG22 ' B' ' 112' ' ' THR . 1.2 t -153.08 165.58 35.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 0.0 110.121 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.568 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 108.72 -36.45 4.35 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -47.25 167.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.226 -1.161 . . . . 0.0 110.416 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -118.77 -12.09 9.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 110.504 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 3.1 m -154.43 173.65 15.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.062 -1.024 . . . . 0.0 110.406 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.2 mt-10 -57.96 -49.74 75.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.08 -35.3 73.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 0.0 110.284 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.69 -41.78 83.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 0.0 110.202 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -58.42 -54.61 45.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.164 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -50.17 -37.54 35.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 110.352 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' B' ' 138' ' ' LYS . 0.2 OUTLIER -70.09 -39.21 75.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 0.0 110.376 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -70.1 -35.37 74.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.14 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 50.7 m -72.28 -60.56 2.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.292 -0.88 . . . . 0.0 110.259 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.523 ' HG3' ' N ' ' B' ' 138' ' ' LYS . 5.7 ptm180 -47.51 -30.11 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.294 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.569 ' HB3' HD13 ' B' ' 106' ' ' ILE . 57.7 mmtt -66.89 -48.16 69.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.014 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' B' ' 135' ' ' ALA . 28.6 m-85 -64.79 -52.79 54.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 109.79 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . 0.853 ' HB1' ' NE2' ' B' ' 144' ' ' GLN . . . -50.01 -37.09 31.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.864 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -46.85 85.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.869 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 9.1 mt -64.2 -25.44 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 0.0 109.771 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.456 HG23 ' HB2' ' B' ' 148' ' ' PHE . 0.3 OUTLIER -84.43 -25.12 7.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.385 -0.822 . . . . 0.0 109.029 179.422 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.853 ' NE2' ' HB1' ' B' ' 140' ' ' ALA . 24.2 mt-30 -89.17 -22.3 22.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.452 -0.78 . . . . 0.0 109.763 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -82.18 -27.81 32.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.975 HG21 ' CE2' ' B' ' 148' ' ' PHE . 25.7 mt -83.48 -37.16 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.655 -0.653 . . . . 0.0 109.806 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 117.74 20.2 4.65 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.046 -1.222 . . . . 0.0 110.046 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.975 ' CE2' HG21 ' B' ' 146' ' ' ILE . 13.8 m-85 -86.19 -160.58 0.56 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.088 -1.242 . . . . 0.0 110.335 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' B' ' 76' ' ' LEU . . . -34.66 -71.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.304 0.573 . . . . 0.0 110.501 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' B' ' 149' ' ' ALA . . . 64.88 72.72 0.43 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.461 -0.774 . . . . 0.0 112.002 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' B' ' 76' ' ' LEU . 0.4 OUTLIER -162.92 101.56 1.0 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.167 -0.958 . . . . 0.0 110.057 178.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.639 ' O ' HG23 ' B' ' 153' ' ' THR . 2.7 t80 -72.18 103.22 3.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.0 110.353 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.639 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.7 OUTLIER -159.22 158.27 32.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.173 -0.954 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' B' ' 153' ' ' THR . 2.7 t70 70.45 18.5 6.6 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -0.885 . . . . 0.0 110.669 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.522 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 4.2 t80 -69.05 135.4 50.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.046 . . . . 0.0 109.749 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.0 131.82 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.171 -0.956 . . . . 0.0 110.704 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.402 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 51.5 mt -80.39 122.68 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.33 -0.856 . . . . 0.0 109.644 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -111.93 -3.6 14.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.119 -0.988 . . . . 0.0 110.972 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.479 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 11.2 m120 -155.8 140.42 16.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.855 -1.153 . . . . 0.0 110.87 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.787 HG22 HD22 ' B' ' 67' ' ' LEU . 48.4 mt -133.88 123.97 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.388 -0.82 . . . . 0.0 109.655 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 8.0 t -101.6 131.1 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 110.627 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.73 172.15 18.97 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.99 152.24 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.166 -1.197 . . . . 0.0 110.362 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.01 159.95 7.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' B' ' 166' ' ' VAL . 22.6 t0 -101.81 166.3 10.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.493 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.0 OUTLIER -114.32 -83.74 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.347 -0.846 . . . . 0.0 110.291 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -177.84 -30.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.095 -1.003 . . . . 0.0 110.636 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.475 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 2.2 p90 -137.6 166.7 24.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.1 Cg_endo -70.97 171.63 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.82 1.431 . . . . 0.0 110.527 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 1.6 mp -130.95 139.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.293 -0.88 . . . . 0.0 110.601 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . 0.428 ' CG ' ' H ' ' B' ' 174' ' ' GLY . 0.5 OUTLIER -75.13 88.07 2.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 179.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.607 HD22 ' CB ' ' B' ' 193' ' ' LEU . 71.9 mt -60.41 -34.27 73.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.625 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.71 -43.02 76.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 110.182 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . 0.428 ' H ' ' CG ' ' B' ' 171' ' ' ARG . . . -71.26 -31.03 66.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.459 ' O ' HD12 ' B' ' 175' ' ' LEU . 11.5 tp -75.45 -35.24 60.95 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -1.112 . . . . 0.0 110.293 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.89 -27.36 64.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.3 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -75.44 -40.82 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.328 -0.857 . . . . 0.0 110.397 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 2.1 t -78.3 -55.85 4.92 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.183 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -91.67 27.07 2.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.0 110.098 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.49 -26.71 45.92 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -12.48 52.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.145 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -115.38 -23.99 8.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.223 -0.923 . . . . 0.0 110.284 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.04 171.28 10.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 110.06 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.7 m -132.33 147.77 52.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 0.0 110.241 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' B' ' 172' ' ' LEU . 33.6 t80 -149.64 104.54 3.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 0.0 109.913 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' B' ' 190' ' ' PHE . 6.5 mt-10 -113.67 103.94 55.3 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.85 . . . . 0.0 110.098 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.81 -1.87 10.58 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.068 1.562 . . . . 0.0 110.113 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' B' ' 189' ' ' LEU . 1.7 pm0 -85.74 -18.21 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -148.7 -38.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.835 . . . . 0.0 110.11 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 1.156 ' CE1' HD21 ' A' ' 59' ' ' LEU . 4.5 t80 -113.82 108.61 51.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.959 . . . . 0.0 110.425 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.96 -20.52 19.42 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.031 1.543 . . . . 0.0 110.656 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.461 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -89.55 178.43 44.24 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.607 ' CB ' HD22 ' B' ' 172' ' ' LEU . 9.7 tt -118.73 125.75 50.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -1.116 . . . . 0.0 110.15 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.767 HD13 HD22 ' A' ' 62' ' ' LEU . 4.7 mt -101.66 111.0 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 110.228 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.431 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 6.5 t80 -96.39 124.38 40.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 110.261 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.523 ' CZ ' ' CB ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -104.91 101.19 10.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 110.24 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.54 ' HE1' HG12 ' B' ' 230' ' ' ILE . 16.8 ttm -69.58 128.51 36.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.922 . . . . 0.0 110.258 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.7 -51.38 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 110.102 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -138.06 119.05 10.36 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 110.103 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -74.69 150.28 95.25 Favored 'Cis proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.91 -2.121 . . . . 0.0 110.427 -0.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' B' ' 197' ' ' MET . 3.2 tttt -63.04 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 110.001 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.742 HD12 ' HB2' ' B' ' 217' ' ' ALA . 47.1 mm -128.96 150.96 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 0.0 110.293 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 98.5 t -108.62 128.71 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.918 . . . . 0.0 110.044 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.64 HD22 HG13 ' B' ' 230' ' ' ILE . 3.7 mp -120.36 135.05 55.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.149 -0.969 . . . . 0.0 110.548 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 1.9 mm? -102.97 126.66 50.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.276 -0.89 . . . . 0.0 109.795 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.556 HG12 HD21 ' B' ' 234' ' ' LEU . 3.7 mt -119.5 127.19 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.178 -0.951 . . . . 0.0 110.434 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.461 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 83.7 m-85 -118.23 143.67 46.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.387 -0.82 . . . . 0.0 110.241 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 25.4 t -48.06 -30.46 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.38 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.25 -45.74 68.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.933 . . . . 0.0 110.246 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.493 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 128.24 3.25 5.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.438 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.5 OUTLIER -92.57 135.98 33.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.159 -1.2 . . . . 0.0 110.301 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.438 HD13 ' O ' ' B' ' 211' ' ' LYS . 46.1 mm -121.09 125.3 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 110.348 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 24.7 t -107.07 154.78 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.163 -0.961 . . . . 0.0 110.046 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.1 mp -135.36 135.73 40.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 5.1 t -157.84 142.14 16.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.245 -0.909 . . . . 0.0 110.204 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.406 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 111.39 21.78 6.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.742 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -108.82 126.92 53.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.268 -1.136 . . . . 0.0 110.179 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -75.23 -25.69 58.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.157 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.415 ' HB3' ' HG2' ' B' ' 221' ' ' GLU . 1.2 tt0 -132.56 -178.57 4.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.12 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 28.4 ttp-105 -85.5 -37.42 19.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.953 . . . . 0.0 110.124 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' B' ' 219' ' ' GLN . 13.2 pt-20 -52.49 -26.71 13.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -76.35 -44.56 36.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -0.951 . . . . 0.0 109.828 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.523 HG22 ' HG2' ' B' ' 65' ' ' PRO . 28.2 mm -60.36 -38.23 76.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 109.64 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -64.99 -47.3 78.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.474 -0.766 . . . . 0.0 110.196 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -36.16 81.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 110.316 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.589 ' HB1' HD11 ' B' ' 204' ' ' LEU . . . -53.84 -52.86 59.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.524 ' HA ' ' HB ' ' B' ' 230' ' ' ILE . 25.5 t80 -71.57 -44.34 64.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 110.067 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.34 -32.36 2.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 110.197 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -99.51 -11.67 20.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.308 -0.87 . . . . 0.0 110.218 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.64 HG13 HD22 ' B' ' 204' ' ' LEU . 8.6 mm -100.03 -23.99 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.612 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 25.0 t80 -52.34 -48.22 90.23 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.37 -0.831 . . . . 0.0 110.939 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -70.31 -33.4 14.58 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.397 1.209 . . . . 0.0 110.391 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 9.5 t -57.84 -40.36 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.456 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.556 HD21 HG12 ' B' ' 206' ' ' ILE . 66.5 mt -68.11 -45.48 73.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 110.128 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -27.6 64.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.6 OUTLIER -66.49 -39.49 88.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -113.34 40.5 2.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.248 -0.908 . . . . 0.0 110.266 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 8.1 ptt85 -66.72 -170.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 110.11 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.466 ' HB2' ' HG2' ' B' ' 169' ' ' PRO . 1.3 mttp -123.33 -61.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 110.128 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.6 mtp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.171 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.175 0.512 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -132.7 -82.33 0.21 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.2 m -72.83 142.26 48.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -1.101 . . . . 0.0 110.057 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 14' ' ' ILE . 11.8 pt -108.63 144.7 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.204 -0.935 . . . . 0.0 110.518 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.421 ' O ' ' CB ' ' A' ' 16' ' ' ASN . . . 49.44 -173.08 0.07 OUTLIER Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 15' ' ' GLY . 0.1 OUTLIER 174.03 -152.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -1.141 . . . . 0.0 110.133 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -156.31 -172.28 23.53 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.968 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -63.01 156.38 24.84 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.988 -1.301 . . . . 0.0 109.101 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.671 ' N ' HD12 ' A' ' 18' ' ' LEU . 14.4 t70 -81.22 98.68 8.2 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.171 -0.956 . . . . 0.0 111.123 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.968 HD21 HD21 ' A' ' 18' ' ' LEU . 4.9 mt -97.71 4.93 49.87 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.253 -0.904 . . . . 0.0 109.697 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.601 HG21 ' CB ' ' A' ' 59' ' ' LEU . 18.7 m -39.81 -28.61 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.104 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.506 ' C ' ' CG2' ' A' ' 28' ' ' ILE . . . -100.19 -38.26 3.6 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.944 HG21 HD13 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -52.86 -46.87 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.375 -1.073 . . . . 0.0 109.022 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.767 HD13 ' HG2' ' A' ' 67' ' ' MET . 3.4 pp -80.51 -3.92 51.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.723 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' HB2' ' O ' ' A' ' 21' ' ' THR . 1.4 t80 -112.75 -4.76 13.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.421 -0.799 . . . . 0.0 110.895 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 162.19 69.08 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.517 -1.801 . . . . 0.0 111.337 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.589 ' ND2' ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER 20.37 111.88 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.15 0.976 . . . . 0.0 113.301 178.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.738 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -149.0 156.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.876 ' HA ' HG21 ' B' ' 103' ' ' ILE . 5.4 m-20 -88.85 138.3 31.54 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.749 ' HB3' HD11 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -41.77 -26.55 0.08 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.407 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HA ' ' HG2' ' B' ' 98' ' ' ARG . 0.0 OUTLIER -55.47 -14.99 2.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.33 -0.856 . . . . 0.0 110.74 178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.26 32.88 5.63 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -113.21 123.88 51.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.28 -1.13 . . . . 0.0 109.607 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 35' ' ' LEU . 0.7 OUTLIER -90.39 131.79 35.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.442 -0.786 . . . . 0.0 110.339 -179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.853 ' N ' HD13 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -130.18 179.93 5.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.985 -1.072 . . . . 0.0 109.693 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.767 ' N ' HD12 ' A' ' 35' ' ' LEU . 1.4 mt-30 -125.77 -102.15 0.37 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 110.179 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' B' ' 110' ' ' LYS . 8.9 p30 176.62 43.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.584 -1.323 . . . . 0.0 110.084 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' N ' ' HD3' ' B' ' 110' ' ' LYS . 0.2 OUTLIER -85.83 84.73 7.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 0.0 110.481 -179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 20.3 p-10 -82.71 -147.76 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.898 . . . . 0.0 109.994 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -56.19 -46.56 85.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -121.97 106.34 11.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -1.154 . . . . 0.0 110.358 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.46 -71.47 0.39 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.75 44.33 23.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -1.118 . . . . 0.0 110.265 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.79 -150.97 0.02 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.97 -121.71 0.65 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -48.3 151.93 0.96 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -1.112 . . . . 0.0 110.358 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.41 138.3 2.47 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 48' ' ' PHE . 13.3 p90 -58.07 161.37 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -1.123 . . . . 0.0 110.463 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -100.12 -137.5 0.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.391 -0.818 . . . . 0.0 110.215 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HA ' ' HB3' ' A' ' 53' ' ' ARG . . . -100.92 36.04 2.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.815 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.8 tt0 -79.3 -31.8 43.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -0.839 . . . . 0.0 109.777 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.84 HD22 ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -117.16 -9.17 11.06 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.483 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.84 ' N ' HD22 ' A' ' 52' ' ' LEU . 5.7 tpt180 -62.82 -54.25 41.84 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -57.64 -20.5 33.8 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.575 ' C ' HD12 ' A' ' 59' ' ' LEU . 85.7 m-20 -88.43 -25.45 22.64 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 53' ' ' ARG . 40.7 mt -51.2 -38.71 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.34 -13.29 42.9 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 55' ' ' ASN . 18.0 m -138.15 11.59 2.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.241 -1.152 . . . . 0.0 110.808 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 56' ' ' ILE . 0.5 OUTLIER -83.54 19.83 1.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 0.0 110.669 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.0 p -104.21 31.41 4.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.944 -1.098 . . . . 0.0 110.301 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.662 ' H ' HD13 ' A' ' 62' ' ' LEU . 5.7 pttt -130.64 11.24 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.472 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.853 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -124.86 -2.2 7.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.016 -1.053 . . . . 0.0 110.979 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.762 ' N ' HD22 ' A' ' 62' ' ' LEU . . . 150.71 -47.27 0.6 Allowed Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.313 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.581 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.1 mm? -41.83 -31.74 0.35 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -1.206 . . . . 0.0 110.718 -179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.517 ' CA ' ' HG ' ' A' ' 68' ' ' LEU . 36.0 t70 -41.02 -35.93 0.61 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.515 -0.741 . . . . 0.0 110.286 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.467 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 20.3 m -66.53 -43.64 84.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.832 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.767 ' HG2' HD13 ' A' ' 24' ' ' LEU . 5.2 tpp -70.32 -22.71 62.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.318 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.803 ' O ' HG22 ' A' ' 72' ' ' ILE . 4.7 mt -62.74 -61.25 2.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.973 -1.079 . . . . 0.0 108.904 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.496 ' C ' HD12 ' A' ' 69' ' ' LEU . 3.8 pp -62.48 -9.51 8.76 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.018 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.15 -17.23 37.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 111.274 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.68 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.1 OUTLIER -115.68 -20.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.688 -1.258 . . . . 0.0 109.319 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.913 HD11 HD12 ' A' ' 74' ' ' LEU . 3.9 tp -130.36 71.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.646 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.52 57.73 1.26 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.854 -1.154 . . . . 0.0 108.154 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.995 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 5.1 mt -102.23 65.65 0.97 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.534 0.683 . . . . 0.0 110.502 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -110.39 128.17 55.45 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.487 -0.758 . . . . 0.0 110.334 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 75' ' ' LYS . 16.1 mm-40 43.02 75.18 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.892 . . . . 0.0 110.242 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.182 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.325 0.583 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -159.37 58.36 0.33 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' B' ' 166' ' ' VAL . 5.2 mt -61.81 138.68 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -1.133 . . . . 0.0 110.38 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 55.5 t -99.37 132.19 23.72 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.857 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.34 148.91 49.9 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.922 1.485 . . . . 0.0 110.627 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 17.9 m -108.07 127.01 53.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -0.855 . . . . 0.0 110.245 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.92 131.06 43.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -123.26 -7.86 8.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.167 -0.958 . . . . 0.0 110.594 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.477 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.9 OUTLIER -163.47 110.16 1.14 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 110.466 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.931 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 19.4 mm -100.96 146.69 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.778 HG22 ' CB ' ' B' ' 124' ' ' THR . 47.4 t -136.75 131.16 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.969 -1.082 . . . . 0.0 110.487 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.95 156.78 44.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . 0.406 ' O ' ' O ' ' B' ' 154' ' ' ASP . 24.3 m -109.98 137.86 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.213 -0.929 . . . . 0.0 110.23 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.657 HG21 ' OG ' ' B' ' 136' ' ' SER . 90.2 t -134.12 171.01 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 110.135 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.764 HG23 ' HG3' ' B' ' 120' ' ' LYS . 50.9 m -146.14 144.4 29.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 0.0 110.314 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.901 HD22 ' HB1' ' B' ' 150' ' ' ALA . 71.3 mt -97.27 -71.59 0.68 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.84 -5.91 5.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . 0.465 ' SG ' HD21 ' B' ' 80' ' ' LEU . 31.0 p -129.29 130.5 46.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -1.159 . . . . 0.0 110.165 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.655 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.7 OUTLIER -53.5 151.84 5.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.272 -0.893 . . . . 0.0 110.261 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.691 HD11 HD12 ' B' ' 76' ' ' LEU . 25.5 mt -131.13 159.59 37.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -0.904 . . . . 0.0 110.23 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' B' ' 82' ' ' LEU . 31.9 t70 -105.58 92.03 4.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.296 -0.877 . . . . 0.0 109.846 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' B' ' 81' ' ' ASP . 16.3 mt -40.64 -34.39 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 0.1 OUTLIER -61.2 -49.04 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.052 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 41.3 m -80.24 -33.42 37.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 0.0 110.256 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.615 HG12 HG11 ' B' ' 102' ' ' VAL . 5.7 t -61.41 -50.1 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 110.192 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -76.45 -25.36 54.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 12.3 tp -68.39 -43.5 77.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 110.286 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -40.7 18.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -48.78 110.71 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.081 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -63.26 -11.35 20.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 0.0 110.391 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' B' ' 105' ' ' ARG . 0.8 OUTLIER -139.93 79.79 1.73 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.336 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.32 168.92 25.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.25 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.16 142.08 35.99 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.224 -0.923 . . . . 0.0 110.121 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -140.21 102.56 4.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.69 124.84 26.97 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 0.0 110.007 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.86 -20.98 21.79 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.828 1.436 . . . . 0.0 110.74 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -23.34 59.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.312 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 6.0 mpt_? -93.18 -60.1 1.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.95 . . . . 0.0 110.723 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.713 ' CG ' ' HB2' ' A' ' 18' ' ' LEU . 64.3 t80 -170.32 179.97 3.25 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.523 -177.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.813 ' O ' HD13 ' A' ' 74' ' ' LEU . . . -100.9 69.71 1.35 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.091 -1.005 . . . . 0.0 110.452 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.995 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -154.24 142.84 20.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.255 -0.903 . . . . 0.0 110.567 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.615 HG11 HG12 ' B' ' 85' ' ' VAL . 12.5 t -96.69 117.25 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.345 -0.847 . . . . 0.0 109.282 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.876 HG21 ' HA ' ' A' ' 29' ' ' ASP . 3.4 mt -89.58 105.82 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 110.498 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 4.0 ttm -91.72 148.94 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.313 -0.867 . . . . 0.0 110.043 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.447 ' HD3' ' OD1' ' A' ' 29' ' ' ASP . 30.4 mtm180 -142.78 144.16 32.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 19.4 pt -131.27 179.16 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.882 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.45 34.99 4.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.129 -0.982 . . . . 0.0 110.514 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER 179.25 81.05 0.17 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.0 Cg_endo -77.06 162.35 91.54 Favored 'Cis proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.507 -2.289 . . . . 0.0 110.364 -0.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.573 ' C ' HG23 ' B' ' 111' ' ' THR . 3.5 tttp -77.84 108.51 11.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.898 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.622 HG22 ' C ' ' B' ' 125' ' ' GLY . 61.8 p -156.26 -179.63 8.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.295 -0.878 . . . . 0.0 110.485 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.844 HG22 HG23 ' B' ' 124' ' ' THR . 4.9 t -125.58 172.7 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.545 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -150.79 136.21 17.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.906 -1.121 . . . . 0.0 111.416 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.72 HD23 HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -92.54 95.81 9.84 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.43 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 73.9 mt -89.69 139.26 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.99 -1.069 . . . . 0.0 111.116 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.643 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.0 m-85 -111.28 162.79 14.63 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 109.804 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.08 -15.59 57.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 8.2 m -76.85 -17.66 58.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.227 -0.921 . . . . 0.0 110.298 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 120.14 -26.22 7.16 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . 0.764 ' HG3' HG23 ' B' ' 75' ' ' THR . 3.4 mttt -77.75 163.02 26.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.306 -1.114 . . . . 0.0 110.189 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' B' ' 114' ' ' LEU . 5.2 ptt? -160.99 170.27 20.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.419 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.68 HG21 ' O ' ' A' ' 71' ' ' VAL . 1.0 OUTLIER -135.9 127.27 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.355 -0.84 . . . . 0.0 109.744 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 26.3 t -105.2 133.89 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.968 -1.083 . . . . 0.0 110.796 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.844 HG23 HG22 ' B' ' 112' ' ' THR . 2.4 t -140.64 159.03 43.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.616 -0.677 . . . . 0.0 109.23 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.622 ' C ' HG22 ' B' ' 111' ' ' THR . . . 112.58 -17.03 23.66 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -60.42 173.27 0.71 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -1.199 . . . . 0.0 110.191 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -120.47 -18.77 7.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.998 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.427 ' N ' HG13 ' B' ' 70' ' ' ILE . 14.5 t -146.7 -172.32 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.185 -0.947 . . . . 0.0 110.384 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -70.59 -59.23 2.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.214 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -52.53 -33.41 45.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.535 ' HB3' ' HB1' ' B' ' 126' ' ' ALA . 1.5 t0 -63.59 -46.4 85.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.277 -0.89 . . . . 0.0 110.246 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 4.0 t -63.27 -34.84 78.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.9 . . . . 0.0 110.321 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . 0.472 ' HA ' ' CE1' ' B' ' 155' ' ' PHE . 6.4 ttpt -66.37 -43.51 85.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 110.141 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 0.1 OUTLIER -70.36 -58.27 3.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.202 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.51 -26.95 0.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.121 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.657 ' OG ' HG21 ' B' ' 74' ' ' VAL . 47.7 t -77.52 -59.07 2.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.37 -0.831 . . . . 0.0 110.23 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' B' ' 134' ' ' LEU . 1.2 ptm180 -53.07 -26.01 14.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 110.003 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -70.65 -46.9 62.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.799 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.545 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 17.4 m-85 -60.76 -44.13 97.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -0.912 . . . . 0.0 109.797 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.95 -27.79 67.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.766 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.502 ' HG3' ' NH1' ' B' ' 141' ' ' ARG . 0.2 OUTLIER -68.69 -37.4 79.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.8 179.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 11.2 mt -61.5 -48.6 88.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.991 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.789 HG21 ' HB2' ' B' ' 150' ' ' ALA . 3.2 mp -63.66 -44.09 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.195 -0.941 . . . . 0.0 109.666 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.768 ' HG3' ' HB3' ' B' ' 150' ' ' ALA . 76.5 mt-30 -70.97 -33.81 70.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -71.73 -22.25 61.65 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 mt -81.7 -22.87 10.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 129.35 -34.65 2.75 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.468 ' CE1' ' HA ' ' B' ' 80' ' ' LEU . 11.8 m-85 -47.18 161.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.159 -1.201 . . . . 0.0 110.962 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.16 42.28 1.11 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 0.0 109.707 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.901 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -59.98 158.34 11.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 110.692 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' B' ' 76' ' ' LEU . 2.4 mttm -120.8 -156.11 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.539 -0.726 . . . . 0.0 109.688 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -153.0 71.02 0.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 0.0 110.211 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -142.85 -178.79 5.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.214 -0.929 . . . . 0.0 110.365 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' B' ' 153' ' ' THR . 0.6 OUTLIER 69.04 11.75 8.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 110.37 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.606 ' HA ' HG22 ' B' ' 74' ' ' VAL . 40.4 t80 -68.67 132.25 46.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.142 -0.974 . . . . 0.0 110.075 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -169.83 131.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 1.9 mp -79.97 118.93 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.836 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.443 ' OE1' ' HG3' ' B' ' 218' ' ' LYS . 17.4 mm-40 -122.49 3.36 9.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.071 -1.018 . . . . 0.0 110.849 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.47 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 8.2 t-20 -149.83 95.91 2.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.894 -1.129 . . . . 0.0 110.768 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' B' ' 217' ' ' ALA . 88.1 mt -100.71 141.91 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.377 -0.827 . . . . 0.0 109.668 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 1.022 HG22 ' OG1' ' B' ' 215' ' ' THR . 26.5 t -122.31 132.8 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.124 -0.985 . . . . 0.0 110.775 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -134.98 -179.92 17.0 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.04 143.23 3.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -1.213 . . . . 0.0 110.369 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 26.9 p -170.23 175.41 4.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -0.925 . . . . 0.0 110.117 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -119.35 173.82 6.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.029 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' B' ' 209' ' ' SER . 0.0 OUTLIER -112.84 -85.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.204 -0.935 . . . . 0.0 110.098 179.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 166.97 -22.85 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.142 -0.974 . . . . 0.0 110.672 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.443 ' CE2' HG12 ' B' ' 170' ' ' ILE . 28.7 p90 -121.33 152.44 57.57 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.093 -1.005 . . . . 0.0 109.705 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.535 ' HA ' ' OG ' ' B' ' 209' ' ' SER . 50.9 Cg_endo -79.78 158.44 24.64 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.908 1.478 . . . . 0.0 110.619 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.991 HD12 ' CB ' ' B' ' 209' ' ' SER . 5.7 mt -133.95 164.92 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 0.0 110.293 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . 0.486 ' N ' HG22 ' B' ' 170' ' ' ILE . 0.0 OUTLIER -100.17 93.2 5.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.358 -0.839 . . . . 0.0 109.934 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.935 HD22 ' HB2' ' B' ' 193' ' ' LEU . 55.5 mt -47.45 -49.99 24.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 0.0 110.063 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' B' ' 172' ' ' LEU . 1.5 mt-10 -44.61 -36.73 3.2 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.496 -0.752 . . . . 0.0 109.797 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.06 -38.57 63.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.66 HD11 ' HE2' ' B' ' 195' ' ' TYR . 0.1 OUTLIER -66.73 -38.06 85.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -1.125 . . . . 0.0 110.011 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.14 -13.74 59.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.923 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -89.18 -37.9 14.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -52.13 4.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.563 ' HB2' HD13 ' B' ' 175' ' ' LEU . 28.7 m80 -93.05 21.73 5.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 0.0 110.084 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' B' ' 179' ' ' HIS . . . -43.13 -65.29 1.48 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 9.3 t -48.71 -21.73 0.66 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.183 -1.186 . . . . 0.0 110.529 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.413 ' CZ ' ' CG2' ' B' ' 198' ' ' VAL . 1.1 m-30 -114.08 15.48 18.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' B' ' 179' ' ' HIS . 0.5 OUTLIER -151.52 153.45 34.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.77 141.23 51.64 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.875 . . . . 0.0 109.943 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -132.66 107.91 8.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.445 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' B' ' 190' ' ' PHE . 2.0 mm-40 -114.31 94.49 35.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.281 -0.887 . . . . 0.0 109.528 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.05 -8.94 24.67 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.948 1.499 . . . . 0.0 110.452 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.37 -3.91 27.92 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.432 HD13 ' CE ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -140.42 -35.22 0.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 110.456 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.651 ' CZ ' HD22 ' B' ' 205' ' ' LEU . 2.5 t80 -126.48 128.97 24.25 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.146 -0.971 . . . . 0.0 110.4 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . 0.412 ' HG3' ' CG ' ' A' ' 51' ' ' GLU . 47.9 Cg_endo -75.88 -38.6 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.927 1.488 . . . . 0.0 110.65 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.71 -179.98 44.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.935 ' HB2' HD22 ' B' ' 172' ' ' LEU . 4.9 tt -106.53 131.92 53.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -1.157 . . . . 0.0 110.269 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.655 ' N ' HD23 ' B' ' 193' ' ' LEU . 23.8 mt -90.31 105.94 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.66 ' HE2' HD11 ' B' ' 175' ' ' LEU . 2.1 t80 -90.35 116.26 28.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.259 -0.901 . . . . 0.0 110.446 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.29 79.87 1.77 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.0 110.048 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.496 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.0 OUTLIER -67.5 161.02 26.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.139 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.413 ' CG2' ' CZ ' ' B' ' 182' ' ' PHE . 53.0 t -111.8 -31.08 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 110.22 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -130.83 94.16 29.37 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.912 . . . . 0.0 110.218 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.5 Cg_endo -73.36 165.66 83.9 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.787 -2.172 . . . . 0.0 110.471 0.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' B' ' 197' ' ' MET . 35.2 tttm -88.72 93.11 9.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.934 . . . . 0.0 110.03 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.485 ' CD1' ' HB2' ' B' ' 217' ' ' ALA . 13.7 mt -144.39 148.5 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 0.0 110.112 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.521 ' C ' HD12 ' B' ' 204' ' ' LEU . 14.4 t -94.86 142.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.566 ' N ' HD12 ' B' ' 204' ' ' LEU . 5.2 mp -135.27 148.9 49.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 110.463 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.651 HD22 ' CZ ' ' B' ' 190' ' ' PHE . 69.7 mt -105.76 110.64 23.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.417 -0.802 . . . . 0.0 109.901 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' B' ' 208' ' ' VAL . 18.5 mm -94.79 96.15 5.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.211 -0.93 . . . . 0.0 110.477 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.633 ' C ' HG23 ' B' ' 208' ' ' VAL . 12.8 m-85 -70.31 58.93 0.18 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 109.702 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.633 HG23 ' C ' ' B' ' 207' ' ' PHE . 5.8 t 80.37 -37.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.937 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.991 ' CB ' HD12 ' B' ' 170' ' ' ILE . 2.9 p 156.74 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.937 0.875 . . . . 0.0 110.163 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . -68.76 -67.66 1.89 Allowed Glycine 0 C--N 1.287 -2.177 0 C-N-CA 120.059 -1.067 . . . . 0.0 110.698 -177.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 212' ' ' ILE . 4.8 mttp -100.74 139.92 35.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -1.15 . . . . 0.0 111.142 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.648 HD13 ' O ' ' B' ' 211' ' ' LYS . 27.1 mm -123.15 140.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.308 -0.87 . . . . 0.0 110.032 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.564 ' C ' HD12 ' B' ' 214' ' ' LEU . 12.0 t -123.63 152.91 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.185 -0.947 . . . . 0.0 110.492 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.643 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.4 mp -144.08 123.65 13.24 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.322 -0.862 . . . . 0.0 110.545 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 1.022 ' OG1' HG22 ' B' ' 161' ' ' VAL . 2.9 t -147.21 144.42 28.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.896 . . . . 0.0 110.088 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 116.88 1.16 19.49 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -75.59 152.41 37.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.289 -1.124 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.443 ' HG3' ' OE1' ' B' ' 158' ' ' GLN . 8.6 tttt -100.49 -2.53 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 110.074 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.3 164.93 19.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 110.086 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -60.28 -24.77 65.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.12 -0.988 . . . . 0.0 110.296 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.466 ' CA ' ' OE1' ' B' ' 221' ' ' GLU . 0.1 OUTLIER -69.1 -37.98 78.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.912 . . . . 0.0 109.964 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 2.9 mt-10 -63.66 -46.92 83.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.07 -1.019 . . . . 0.0 110.275 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.489 HG12 ' CB ' ' B' ' 217' ' ' ALA . 10.7 mm -58.46 -48.37 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.922 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -55.68 -26.8 46.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.078 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -48.72 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 110.331 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.26 -35.95 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.224 -0.923 . . . . 0.0 110.17 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -82.45 -47.43 12.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.345 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -25.97 68.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.159 -0.963 . . . . 0.0 110.509 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -83.37 -36.57 24.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.124 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.584 HD13 ' O ' ' B' ' 230' ' ' ILE . 0.3 OUTLIER -88.19 -29.37 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.343 -0.848 . . . . 0.0 109.906 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.606 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 6.7 t80 -44.21 -49.55 23.09 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.409 -0.807 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 41.1 Cg_endo -68.17 -45.11 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.35 1.184 . . . . 0.0 110.355 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.571 ' HB ' HD13 ' B' ' 230' ' ' ILE . 4.3 t -47.18 -37.78 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.063 -1.023 . . . . 0.0 108.981 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.814 HD22 HD13 ' B' ' 170' ' ' ILE . 57.3 mt -65.41 -53.0 49.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.84 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.91 -38.17 15.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.981 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -60.08 -45.43 92.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -97.63 34.38 1.86 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.931 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -52.01 146.71 8.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 110.276 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -29.94 9.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 110.37 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.327 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.293 0.568 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.29 -144.44 17.11 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.4 p -147.78 68.86 1.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -1.141 . . . . 0.0 110.199 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.86 -158.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.253 -0.904 . . . . 0.0 110.204 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 125.15 -41.15 1.74 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.76 99.39 3.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -1.098 . . . . 0.0 109.82 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.15 136.98 5.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.073 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -96.4 157.58 15.83 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.136 -1.214 . . . . 0.0 109.235 -179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.65 95.32 5.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.038 -1.039 . . . . 0.0 111.552 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.073 HD21 HD21 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -107.94 9.43 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.136 -0.978 . . . . 0.0 110.81 179.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.662 ' OG1' HD23 ' A' ' 68' ' ' LEU . 24.0 m -48.85 -23.79 1.21 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.857 -1.152 . . . . 0.0 109.452 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.2 -29.0 6.95 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.8 ' CG2' HG11 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -44.99 -44.49 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.294 . . . . 0.0 108.848 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.864 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.6 pp -84.41 -22.32 30.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.924 -1.11 . . . . 0.0 109.294 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.743 ' HZ ' HD11 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -86.12 2.82 45.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.49 -0.756 . . . . 0.0 109.35 178.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 149.98 101.03 0.23 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.744 ' ND2' HD11 ' A' ' 35' ' ' LEU . 13.6 p-10 -22.08 84.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.813 0.816 . . . . 0.0 111.878 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.907 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.2 pp -88.49 171.04 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.907 ' O ' HD12 ' A' ' 28' ' ' ILE . 66.0 m-20 -88.22 126.52 35.19 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.549 ' HB3' ' CD1' ' B' ' 103' ' ' ILE . 1.1 p -39.71 -25.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.758 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 29' ' ' ASP . 16.2 tt0 -59.77 -10.62 3.98 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.09 -1.006 . . . . 0.0 110.202 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.59 29.84 5.78 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -117.36 119.65 35.78 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.306 -1.114 . . . . 0.0 110.519 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.96 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -90.81 143.55 26.61 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.051 -1.03 . . . . 0.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.96 ' N ' HD22 ' A' ' 34' ' ' LEU . 4.5 pp -132.48 -178.77 5.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.786 -1.196 . . . . 0.0 110.959 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 35' ' ' LEU . 1.9 mt-30 -128.49 139.36 52.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 110.152 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 23.9 p-10 -78.28 67.21 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.877 . . . . 0.0 110.179 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -160.13 146.05 15.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.888 . . . . 0.0 110.169 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -150.19 92.26 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 110.24 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.62 102.41 1.01 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -65.13 94.44 0.15 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -1.159 . . . . 0.0 110.19 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.83 -80.38 1.39 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.96 162.87 39.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 110.314 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.21 -157.03 40.33 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.54 101.3 0.17 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.22 128.32 33.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 110.206 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.77 130.88 1.86 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.577 ' CG ' HD12 ' A' ' 52' ' ' LEU . 28.1 p90 -46.54 137.58 6.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -1.138 . . . . 0.0 110.3 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.73 -138.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 110.106 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -93.31 30.37 1.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -0.985 . . . . 0.0 110.163 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.39 -19.51 16.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.518 179.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.577 HD12 ' CG ' ' A' ' 48' ' ' PHE . 4.0 mt -100.28 -45.79 5.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.461 -0.775 . . . . 0.0 110.331 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.898 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -53.2 -57.56 10.05 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.274 -0.891 . . . . 0.0 109.738 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 3.0 pp20? -62.77 -19.99 64.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.451 -0.78 . . . . 0.0 109.416 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 7.7 m-20 -84.15 -35.79 23.36 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.5 -0.75 . . . . 0.0 109.211 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.898 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.5 mt -53.09 -41.51 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.394 -0.817 . . . . 0.0 109.141 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.54 -23.88 44.69 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p -118.52 12.8 13.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -1.182 . . . . 0.0 110.567 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.044 HD23 HD11 ' A' ' 62' ' ' LEU . 4.0 mt -87.81 26.46 1.32 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.098 -1.001 . . . . 0.0 110.369 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.26 52.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.044 -1.035 . . . . 0.0 110.333 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.527 ' HG3' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER -173.35 26.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 110.364 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.044 HD11 HD23 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -148.09 12.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.186 -0.947 . . . . 0.0 110.393 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.94 -58.49 0.51 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 4.1 mm? -50.34 -20.65 1.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.303 -1.116 . . . . 0.0 110.928 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 t70 -45.43 -43.03 11.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.065 -1.022 . . . . 0.0 109.822 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -66.78 -50.45 62.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.391 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.864 ' HG2' HD22 ' A' ' 24' ' ' LEU . 2.0 tpp -68.27 -7.67 32.75 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.407 -0.808 . . . . 0.0 109.296 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.662 HD23 ' OG1' ' A' ' 21' ' ' THR . 2.3 tm? -70.05 -59.63 2.79 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 122.061 0.934 . . . . 0.0 108.631 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 66' ' ' SER . 3.3 pp -75.74 0.56 17.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.037 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 4.1 tt0 -92.49 13.93 18.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.328 -0.858 . . . . 0.0 112.222 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.893 HG12 HG11 ' B' ' 122' ' ' VAL . 2.0 t -140.58 3.7 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.743 -1.223 . . . . 0.0 110.062 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.838 ' CG1' HD23 ' A' ' 18' ' ' LEU . 1.5 tp -148.99 76.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.428 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.6 t70 -77.73 55.43 1.36 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.12 -0.988 . . . . 0.0 108.455 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.577 HD12 ' HB2' ' B' ' 99' ' ' PHE . 0.5 OUTLIER -85.54 34.57 0.59 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.531 0.681 . . . . 0.0 110.629 -178.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.77 162.78 14.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 0.0 110.354 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 58.84 40.15 23.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.4 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.143 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.199 0.524 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.55 65.37 0.97 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.597 HD13 ' O ' ' B' ' 165' ' ' ASP . 89.8 mt -93.51 115.28 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -1.161 . . . . 0.0 110.196 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.474 ' CG1' ' OH ' ' B' ' 224' ' ' TYR . 6.6 t -70.96 140.14 85.83 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.259 -0.901 . . . . 0.0 110.321 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.9 Cg_endo -73.85 130.0 14.06 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.011 1.532 . . . . 0.0 110.548 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.406 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 2.3 m -91.17 135.57 33.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.239 -0.913 . . . . 0.0 110.328 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' B' ' 67' ' ' LEU . 49.9 mt -80.06 124.29 28.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.326 -0.859 . . . . 0.0 110.02 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -106.49 -18.76 13.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.487 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -168.9 163.94 11.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.178 -0.951 . . . . 0.0 110.447 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.591 HG12 HG23 ' B' ' 160' ' ' ILE . 5.6 mt -151.27 165.78 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.381 -0.824 . . . . 0.0 109.959 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.772 HG22 ' HB ' ' B' ' 124' ' ' THR . 3.4 t -148.17 142.09 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.095 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.48 152.28 48.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 0.0 109.986 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.29 132.2 45.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 0.0 110.342 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.658 HG21 ' OG ' ' B' ' 136' ' ' SER . 94.1 t -123.88 158.34 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.922 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.496 ' CB ' ' HB2' ' B' ' 154' ' ' ASP . 7.7 m -133.39 144.27 49.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 110.373 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 1.027 HD22 ' HB1' ' B' ' 150' ' ' ALA . 96.1 mt -101.4 -32.44 10.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.852 . . . . 0.0 110.032 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.93 18.36 59.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.73 144.91 20.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.139 -1.212 . . . . 0.0 110.313 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.571 ' O ' HD23 ' B' ' 80' ' ' LEU . 4.2 ttp85 -75.23 152.18 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 110.005 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.571 HD23 ' O ' ' B' ' 79' ' ' ARG . 39.7 mt -132.93 163.09 29.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 0.0 110.406 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.454 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 97.7 m-20 -98.21 113.7 25.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.281 -0.887 . . . . 0.0 109.752 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.25 -53.93 51.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.155 -0.966 . . . . 0.0 110.174 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 8.6 tppt? -51.42 -47.2 63.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.997 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 84.8 m -72.93 -45.71 56.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.08 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.638 HG12 HG11 ' B' ' 102' ' ' VAL . 25.2 t -58.04 -47.95 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.158 -0.963 . . . . 0.0 109.999 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.578 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -75.01 -10.24 59.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 110.276 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 7.7 tp -98.12 -24.78 15.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.264 -0.897 . . . . 0.0 110.167 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.451 ' O ' ' NH2' ' B' ' 90' ' ' ARG . 2.1 m-70 -98.67 -30.42 12.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.448 ' HB1' ' HE2' ' B' ' 104' ' ' MET . . . -62.28 146.36 51.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 110.139 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . 0.451 ' NH2' ' O ' ' B' ' 88' ' ' HIS . 5.2 mmt-85 -76.07 -33.57 59.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -0.99 . . . . 0.0 110.227 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -134.37 79.3 1.8 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.319 -0.863 . . . . 0.0 109.989 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.431 ' C ' ' HG2' ' B' ' 93' ' ' GLU . . . -127.13 156.71 41.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.406 -0.808 . . . . 0.0 110.174 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.437 ' HB2' ' HB ' ' B' ' 103' ' ' ILE . 1.5 mm-40 -134.1 126.05 29.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 110.031 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.594 ' HB2' HG22 ' B' ' 102' ' ' VAL . 9.6 t80 -134.93 111.89 10.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.195 -0.941 . . . . 0.0 110.441 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -128.59 126.19 23.34 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 109.997 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.58 -25.55 14.87 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 0.0 110.8 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -68.4 -17.04 64.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 0.0 110.299 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.6 -50.37 3.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.182 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 1.181 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.47 -173.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.436 -0.79 . . . . 0.0 111.582 -179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -110.24 56.46 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.36 -0.837 . . . . 0.0 110.947 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.181 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -145.07 152.82 40.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.965 -1.084 . . . . 0.0 110.523 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.638 HG11 HG12 ' B' ' 85' ' ' VAL . 23.8 t -98.46 135.74 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.57 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 25.4 mm -109.62 120.66 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.043 . . . . 0.0 110.887 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.572 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.9 OUTLIER -90.76 162.93 14.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.667 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.438 ' NH2' ' HG2' ' B' ' 105' ' ' ARG . 0.0 OUTLIER -155.96 126.76 6.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.076 -1.015 . . . . 0.0 110.44 -179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.577 HG23 ' CE1' ' B' ' 139' ' ' TYR . 43.9 pt -128.47 149.45 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.297 -0.877 . . . . 0.0 109.781 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -99.74 26.94 5.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 110.306 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 2.0 tt0 -162.62 83.0 1.59 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.205 -0.934 . . . . 0.0 110.483 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 51.3 Cg_endo -80.88 163.76 79.58 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 C-N-CA 121.977 -2.093 . . . . 0.0 110.635 -0.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -68.78 103.93 1.89 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.661 HG22 ' HA3' ' B' ' 125' ' ' GLY . 13.9 p -148.97 169.61 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 111.149 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.7 m -117.73 153.99 32.45 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.579 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -143.6 132.89 23.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.057 -1.027 . . . . 0.0 110.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.55 HD23 HD12 ' B' ' 103' ' ' ILE . 7.2 mt -96.35 137.05 36.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' B' ' 102' ' ' VAL . 46.5 mt -125.83 118.52 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.632 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 0.8 OUTLIER -99.89 141.24 32.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.904 . . . . 0.0 109.64 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.475 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -51.83 -20.52 2.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.207 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -21.44 64.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.7 -23.34 13.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . 0.481 ' HG3' HG23 ' B' ' 75' ' ' THR . 3.9 ttmt -72.66 177.22 4.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.224 -1.162 . . . . 0.0 110.383 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.526 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 6.0 ptm -168.83 140.96 2.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.181 -0.949 . . . . 0.0 110.257 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.893 HG11 HG12 ' A' ' 71' ' ' VAL . 4.2 t -115.1 132.98 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 0.0 109.92 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 5.1 t -109.31 167.88 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 110.091 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.772 ' HB ' HG22 ' B' ' 71' ' ' VAL . 4.7 t -169.16 160.25 9.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.954 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 113.2 -4.75 25.28 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -76.8 146.64 37.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -1.188 . . . . 0.0 110.309 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.69 -21.45 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 110.252 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' B' ' 129' ' ' GLU . 0.3 OUTLIER -127.23 32.34 5.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -0.934 . . . . 0.0 110.31 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . 0.524 ' HG3' ' CD1' ' B' ' 157' ' ' ILE . 1.1 tt0 66.6 -68.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 110.305 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' B' ' 128' ' ' SER . 7.3 t70 -44.07 -31.26 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -0.84 . . . . 0.0 110.363 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.487 ' HB3' ' HA ' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -63.02 -58.99 5.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.217 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.45 ' CB ' ' HB2' ' B' ' 126' ' ' ALA . 0.1 OUTLIER -52.48 -31.53 35.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 110.332 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.79 -46.41 75.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.958 . . . . 0.0 110.246 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.35 -45.9 71.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 110.257 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.484 ' HA ' HD11 ' B' ' 106' ' ' ILE . . . -53.01 -48.69 67.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.942 . . . . 0.0 110.083 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.658 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.1 OUTLIER -57.29 -53.63 55.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 110.034 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -51.83 -36.86 49.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.959 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -48.28 65.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.579 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 21.8 m-85 -61.78 -55.71 27.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.124 -0.985 . . . . 0.0 110.093 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -54.28 -21.65 9.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.877 . . . . 0.0 110.206 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -78.99 -29.34 43.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 110.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.435 ' O ' HG13 ' B' ' 146' ' ' ILE . 49.0 mt -68.62 -43.69 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 110.023 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.481 HG21 ' HB2' ' B' ' 150' ' ' ALA . 52.1 mt -70.66 -50.5 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.098 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 90.0 mt-30 -60.15 -37.2 79.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 109.693 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.53 -32.64 68.39 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.435 HG13 ' O ' ' B' ' 142' ' ' ILE . 5.2 mt -66.6 -17.93 23.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 114.6 -23.45 12.07 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.42 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 13.1 m-85 -52.34 169.01 0.09 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.007 -1.29 . . . . 0.0 110.745 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -103.53 50.42 0.81 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.491 -0.756 . . . . 0.0 110.308 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 1.027 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -80.32 144.6 32.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.419 ' O ' ' OG1' ' B' ' 153' ' ' THR . 0.1 OUTLIER -126.01 106.37 9.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.252 -0.905 . . . . 0.0 110.331 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -55.78 101.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.219 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.0 OUTLIER -162.08 -178.91 6.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.278 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.496 ' HB2' ' CB ' ' B' ' 75' ' ' THR . 3.4 m-20 57.8 26.47 13.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.318 -0.864 . . . . 0.0 110.445 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.529 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 5.7 t80 -78.99 133.14 36.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.073 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -161.91 130.52 4.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.609 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.524 ' CD1' ' HG3' ' B' ' 129' ' ' GLU . 30.0 mt -79.86 126.37 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.348 -0.845 . . . . 0.0 109.826 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' B' ' 218' ' ' LYS . 6.5 mt-30 -134.36 4.68 3.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.977 . . . . 0.0 110.455 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.511 ' HB2' ' HB ' ' B' ' 71' ' ' VAL . 16.1 m120 -147.5 90.8 1.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.816 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.591 HG23 HG12 ' B' ' 70' ' ' ILE . 96.7 mt -99.72 141.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -0.903 . . . . 0.0 109.863 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 11.4 t -109.36 135.44 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -0.952 . . . . 0.0 110.526 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.436 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.19 172.79 22.53 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 5.1 m -164.13 150.13 10.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.221 -1.164 . . . . 0.0 110.159 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.493 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 21.0 p -170.62 157.78 5.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 110.472 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.597 ' O ' HD13 ' B' ' 63' ' ' ILE . 2.7 p30 -113.6 175.22 5.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 109.796 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.575 HG22 ' O ' ' B' ' 210' ' ' GLY . 0.1 OUTLIER -119.44 -84.06 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.105 -0.997 . . . . 0.0 110.48 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.486 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.3 OUTLIER 178.39 -27.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.135 -0.978 . . . . 0.0 110.683 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.435 ' HB2' ' HD2' ' B' ' 169' ' ' PRO . 30.7 p90 -129.69 164.67 38.51 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.196 -0.94 . . . . 0.0 109.768 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 48.0 Cg_endo -76.86 156.55 34.86 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.023 1.539 . . . . 0.0 110.488 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.79 147.84 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 110.25 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -82.62 101.2 10.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 110.182 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.408 ' CD1' ' HA2' ' B' ' 192' ' ' GLY . 20.8 mt -58.65 -52.03 67.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' B' ' 177' ' ' PHE . 1.1 mt-10 -50.44 -45.71 56.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.93 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.12 70.59 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.488 ' HB3' HD13 ' B' ' 193' ' ' LEU . 0.2 OUTLIER -76.33 -51.95 10.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.46 -1.023 . . . . 0.0 109.83 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.454 ' O ' ' HA3' ' B' ' 180' ' ' GLY . . . -63.78 -11.69 28.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.76 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' B' ' 173' ' ' GLU . 3.4 t80 -88.89 -49.36 6.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 110.125 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . 0.466 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 36.4 t -88.38 -35.56 17.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.253 -0.905 . . . . 0.0 110.254 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -112.36 18.73 18.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' B' ' 176' ' ' ALA . . . -59.38 -18.77 44.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 5.6 t -64.95 -20.61 66.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -1.17 . . . . 0.0 110.21 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -131.85 5.53 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.897 . . . . 0.0 110.228 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.75 ' HB2' HD21 ' B' ' 193' ' ' LEU . 37.2 p -124.35 153.54 41.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 t -125.91 137.42 53.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -0.909 . . . . 0.0 110.23 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -129.69 101.09 5.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -124.77 111.85 27.37 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.917 . . . . 0.0 109.908 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 -2.03 10.96 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.881 1.464 . . . . 0.0 110.377 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.73 -22.51 50.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 110.305 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.517 ' CD2' ' HE2' ' A' ' 61' ' ' LYS . 2.6 pp -159.37 24.72 0.2 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.727 ' CZ ' HD22 ' B' ' 205' ' ' LEU . 0.6 OUTLIER -170.07 106.9 0.44 Allowed Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.066 -1.021 . . . . 0.0 110.475 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.66 -31.42 6.82 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.97 1.51 . . . . 0.0 109.986 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.408 ' HA2' ' CD1' ' B' ' 172' ' ' LEU . . . -89.78 171.33 37.58 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' B' ' 183' ' ' SER . 5.1 tt -101.01 140.06 35.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.237 -1.155 . . . . 0.0 110.463 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' B' ' 183' ' ' SER . 65.0 mt -96.04 123.22 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.333 -0.854 . . . . 0.0 110.109 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.51 ' O ' HD12 ' B' ' 204' ' ' LEU . 7.4 t80 -107.94 124.15 49.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.936 . . . . 0.0 110.367 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -99.66 90.95 4.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.959 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.539 ' HE1' ' HB ' ' B' ' 230' ' ' ILE . 29.7 tpp -47.11 134.51 10.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.228 -0.92 . . . . 0.0 110.349 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 56.5 t -65.62 -58.42 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.889 . . . . 0.0 110.403 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -138.72 118.55 9.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 -179.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -75.66 163.22 90.82 Favored 'Cis proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.962 -2.099 . . . . 0.0 110.377 -0.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' B' ' 197' ' ' MET . 6.3 mmtt -69.1 94.27 0.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 109.893 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.431 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 36.4 mm -126.43 146.29 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.95 . . . . 0.0 110.497 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 71.5 t -98.28 134.63 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.308 -0.87 . . . . 0.0 109.848 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.866 HD21 ' HB1' ' B' ' 226' ' ' ALA . 3.5 mp -136.34 136.83 40.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 110.542 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.743 HD11 ' HZ ' ' A' ' 25' ' ' PHE . 67.4 mt -99.12 145.2 27.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 110.08 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.507 HG12 HD21 ' B' ' 234' ' ' LEU . 6.6 mt -125.39 103.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 109.779 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -87.17 135.43 33.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.273 -0.892 . . . . 0.0 110.307 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 42.5 t -48.15 -24.45 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.966 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 59.2 p -66.38 -44.15 83.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 110.167 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.575 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 135.26 -3.43 4.02 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.99 137.16 34.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.116 -1.226 . . . . 0.0 110.492 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . . . . . . . . . 13.5 mm -121.66 152.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.209 -0.932 . . . . 0.0 110.28 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.496 ' C ' HD12 ' B' ' 214' ' ' LEU . 33.4 t -124.77 162.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -0.956 . . . . 0.0 110.056 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.496 HD12 ' C ' ' B' ' 213' ' ' VAL . 3.2 mp -148.29 135.41 20.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 0.0 110.404 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 4.8 t -166.6 141.17 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 110.082 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 112.9 14.59 9.99 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -90.23 160.35 16.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.168 -1.195 . . . . 0.0 110.361 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' B' ' 158' ' ' GLN . 3.7 mmmm -106.12 -5.34 19.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -168.59 159.46 10.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.353 -0.842 . . . . 0.0 110.109 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 43.1 ttt-85 -56.62 -17.79 9.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 110.337 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.28 -25.63 59.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.315 -0.865 . . . . 0.0 109.776 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.667 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 3.6 mt-10 -80.02 -44.76 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.358 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.34 -40.43 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.474 ' OH ' ' CG1' ' B' ' 64' ' ' VAL . 2.4 m-85 -66.77 -37.26 84.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -0.887 . . . . 0.0 110.189 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -72.54 -38.97 67.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 110.298 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.866 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.91 -33.98 71.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.266 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.631 ' HA ' HG22 ' B' ' 230' ' ' ILE . 33.0 t80 -77.84 -54.23 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.942 . . . . 0.0 110.276 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.4 -17.73 5.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.09 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.404 ' C ' ' HD2' ' B' ' 232' ' ' PRO . . . -93.39 -37.63 11.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.0 110.312 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.9 tp -84.47 -24.98 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.946 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.55 -49.24 56.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.874 . . . . 0.0 110.887 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.1 Cg_endo -71.4 -36.47 6.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.547 1.288 . . . . 0.0 110.339 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.67 -35.83 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.653 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.507 HD21 HG12 ' B' ' 206' ' ' ILE . 8.2 mt -71.27 -48.51 50.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.358 -0.839 . . . . 0.0 110.039 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.25 -22.66 53.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.177 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.2 -35.39 41.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 110.269 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.466 ' CZ ' ' CB ' ' B' ' 178' ' ' SER . 64.3 m-85 -113.75 40.77 2.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 110.343 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.497 ' NH2' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -63.67 172.58 2.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -117.88 -55.62 2.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.229 -0.919 . . . . 0.0 110.159 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 32.3 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.22 179.896 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 12' ' ' GLY . 52.0 tt0 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.302 0.572 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' N ' ' HG2' ' A' ' 11' ' ' GLU . . . -171.11 53.22 0.19 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.5 t -111.51 53.27 0.72 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.29 -1.124 . . . . 0.0 110.132 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 mm -130.11 -33.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.27 -0.894 . . . . 0.0 110.288 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' HA2' ' OD2' ' A' ' 65' ' ' ASP . . . 114.82 110.12 2.8 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 17' ' ' GLY . 57.3 m-20 -127.0 -158.69 0.88 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -1.166 . . . . 0.0 110.353 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 16' ' ' ASN . . . 62.07 125.72 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.808 HD11 ' CA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -60.0 -172.9 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.196 -1.179 . . . . 0.0 109.19 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.543 ' H ' HD12 ' A' ' 18' ' ' LEU . 2.0 t70 -57.62 83.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.856 -1.153 . . . . 0.0 110.049 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.812 HD13 ' CB ' ' A' ' 23' ' ' ILE . 1.4 mm? -107.21 -20.55 13.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 111.025 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.817 HG21 ' HB2' ' A' ' 59' ' ' LEU . 13.5 m -43.31 -26.83 0.2 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.782 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -95.59 -27.11 10.87 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.989 HG23 HG21 ' B' ' 124' ' ' THR . 4.6 mm -59.43 -50.99 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -1.104 . . . . 0.0 108.942 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.87 HD11 ' CD1' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -77.56 1.76 18.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -104.78 -21.49 13.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.384 -0.822 . . . . 0.0 110.74 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.536 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 159.86 48.32 0.01 OUTLIER Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.54 -1.314 . . . . 0.0 109.999 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.886 ' OD1' HD21 ' A' ' 35' ' ' LEU . 1.4 t-20 56.33 151.67 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.309 -1.112 . . . . 0.0 111.039 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.944 HD12 HG12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -171.06 156.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 31' ' ' GLU . 96.7 m-20 -86.18 116.1 24.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 176.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.808 ' CA ' HD11 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -35.34 -28.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.306 0.574 . . . . 0.0 110.318 -177.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' A' ' 29' ' ' ASP . 21.3 tt0 -51.77 -18.5 1.27 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.325 -0.86 . . . . 0.0 110.061 177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.74 26.59 3.03 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.082 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' HD3' ' N ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -121.44 132.13 54.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.089 -1.242 . . . . 0.0 110.438 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.965 HD13 HD13 ' A' ' 56' ' ' ILE . 1.6 tt -102.9 152.65 21.04 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.017 -1.052 . . . . 0.0 110.848 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.886 HD21 ' OD1' ' A' ' 27' ' ' ASN . 3.0 pp -127.88 -179.62 5.05 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.913 -1.115 . . . . 0.0 110.688 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.868 ' N ' HD12 ' A' ' 35' ' ' LEU . 7.2 mt-30 -132.24 110.78 10.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 110.231 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' GLN . 12.5 t0 -43.17 -34.88 1.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.312 -0.868 . . . . 0.0 110.275 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -94.82 70.2 3.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.384 -0.823 . . . . 0.0 110.33 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 20.4 p-10 -92.54 45.47 1.2 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.44 68.85 1.17 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' GLY . 3.2 mt-10 53.29 28.34 7.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.165 -1.197 . . . . 0.0 110.251 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 43' ' ' ARG . . . 44.88 -101.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER 43.45 92.04 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -1.131 . . . . 0.0 110.258 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 48.45 -118.76 4.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.27 -142.0 46.79 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.2 m -145.91 146.58 31.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.129 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.06 -166.6 39.83 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.66 127.26 34.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -1.133 . . . . 0.0 110.117 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.9 -171.81 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.143 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -93.54 22.62 5.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.923 . . . . 0.0 110.153 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -100.73 -19.01 16.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 52' ' ' LEU . 4.4 mt -94.59 -47.65 6.43 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.774 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.3 -48.87 18.1 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.434 -0.791 . . . . 0.0 109.593 -179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.35 -26.28 66.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.404 -0.81 . . . . 0.0 109.748 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 6.7 m-20 -79.85 -40.46 28.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.965 HD13 HD13 ' A' ' 34' ' ' LEU . 5.9 mt -50.97 -39.97 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.826 . . . . 0.0 109.141 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -22.75 48.91 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.2 p -129.67 18.85 5.69 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.12 -1.224 . . . . 0.0 110.805 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.02 HD21 ' CE2' ' B' ' 190' ' ' PHE . 4.3 mt -84.14 5.21 27.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.028 -1.045 . . . . 0.0 109.929 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 25.4 m -89.53 45.36 1.28 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.118 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 11.3 ttpt -147.52 12.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.0 110.147 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.985 HD13 HD13 ' B' ' 194' ' ' ILE . 0.8 OUTLIER -131.06 -27.17 2.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.622 -179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 174.31 -42.77 0.14 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.87 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.9 mm? -44.85 -36.99 3.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.157 -1.202 . . . . 0.0 110.54 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.561 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 15.3 t0 -42.39 -35.38 1.01 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 0.0 110.434 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 14.8 m -65.17 -46.8 79.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.335 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.613 ' HG2' HD13 ' A' ' 24' ' ' LEU . 6.4 tpp -66.76 -16.63 64.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 110.601 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 72' ' ' ILE . 6.5 mt -70.48 -61.42 1.78 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.953 -1.092 . . . . 0.0 109.305 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.1 pp -66.45 -2.66 4.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.58 -0.7 . . . . 0.0 110.808 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -91.51 -13.55 31.95 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.151 -0.968 . . . . 0.0 111.241 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.0 OUTLIER -119.05 -26.72 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.938 -1.101 . . . . 0.0 110.045 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.826 HD11 HD12 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -128.23 67.35 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' O ' ' A' ' 73' ' ' ASP . 16.5 t70 -70.09 59.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.092 HD22 ' HB3' ' B' ' 100' ' ' ALA . 3.0 mt -91.84 62.05 4.27 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.612 0.72 . . . . 0.0 110.97 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.26 132.11 56.76 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.12 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 57.98 18.72 5.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.223 -0.923 . . . . 0.0 110.17 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.228 179.974 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.2 0.524 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -146.87 18.17 1.6 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 87.5 mt -137.61 117.81 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.237 -1.155 . . . . 0.0 110.287 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' B' ' 65' ' ' PRO . 39.5 t -97.93 139.45 21.3 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.329 -0.857 . . . . 0.0 109.916 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.49 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 45.5 Cg_endo -71.58 130.12 16.68 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.94 1.495 . . . . 0.0 110.62 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.471 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 94.1 m -93.45 132.08 38.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.123 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 36.3 mt -70.17 128.61 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -0.97 . . . . 0.0 110.305 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.532 ' NE2' ' HB2' ' B' ' 163' ' ' SER . 2.0 mt-30 -106.86 -18.33 13.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 110.219 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.536 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -170.17 153.59 4.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 110.077 -179.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.909 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 37.7 mm -129.28 153.74 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.35 -0.844 . . . . 0.0 109.837 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.972 HG22 ' HB ' ' B' ' 124' ' ' THR . 22.4 t -141.76 129.9 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.0 110.341 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.535 ' HB2' HG13 ' B' ' 157' ' ' ILE . . . -137.9 157.19 46.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.274 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 41.6 p -104.04 146.19 29.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.251 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.462 HG21 ' OG ' ' B' ' 136' ' ' SER . 54.7 t -137.8 132.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 110.163 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.449 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 5.9 m -114.62 128.24 56.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 110.233 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.925 HD22 ' HB1' ' B' ' 150' ' ' ALA . 70.3 mt -83.25 -71.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.228 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.79 -11.11 3.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . 0.523 ' SG ' HD21 ' B' ' 80' ' ' LEU . 31.6 p -129.68 134.16 47.49 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.128 -1.219 . . . . 0.0 110.229 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.666 ' O ' HD23 ' B' ' 80' ' ' LEU . 5.8 ttt180 -58.16 155.26 11.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.666 HD23 ' O ' ' B' ' 79' ' ' ARG . 14.6 mt -137.38 153.19 50.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 40.7 t0 -93.9 101.11 13.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.808 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.766 HD22 HG23 ' B' ' 102' ' ' VAL . 17.8 mt -41.36 -49.33 3.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.358 -0.839 . . . . 0.0 110.185 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.0 OUTLIER -54.23 -34.57 61.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.002 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 85.9 m -80.24 -40.35 27.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 0.0 110.084 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.913 HG22 ' CE2' ' B' ' 148' ' ' PHE . 24.8 t -71.9 -37.94 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.065 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.99 -19.02 48.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.867 . . . . 0.0 110.192 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.464 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 13.1 tp -91.54 -30.63 16.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.17 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' B' ' 84' ' ' THR . 6.6 m80 -92.51 -17.77 24.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.339 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -74.7 133.4 42.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -70.32 -21.43 62.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.885 . . . . 0.0 110.351 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -139.44 79.28 1.71 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 110.083 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.784 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -160.2 154.29 23.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.319 -0.863 . . . . 0.0 110.473 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.48 ' HG2' ' HB ' ' B' ' 103' ' ' ILE . 8.2 pt-20 -141.27 171.59 13.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.447 ' CE1' HD13 ' B' ' 82' ' ' LEU . 21.5 t80 -140.46 124.89 17.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.148 -0.97 . . . . 0.0 110.568 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.467 ' ND2' ' HB2' ' A' ' 31' ' ' GLU . 7.5 m-20 -114.27 98.83 49.68 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.811 . . . . 0.0 109.825 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' B' ' 95' ' ' ASN . 47.5 Cg_endo -71.88 -24.01 21.56 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.076 1.566 . . . . 0.0 110.357 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -74.15 -20.78 60.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.384 -0.822 . . . . 0.0 110.298 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.24 -74.03 0.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.334 -0.854 . . . . 0.0 110.363 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.662 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -133.25 178.19 7.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 110.443 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 1.092 ' HB3' HD22 ' A' ' 74' ' ' LEU . . . -104.39 40.13 1.53 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.399 -0.813 . . . . 0.0 110.108 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.047 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -117.96 149.18 41.35 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.182 -0.949 . . . . 0.0 110.766 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.766 HG23 HD22 ' B' ' 82' ' ' LEU . 40.6 t -89.99 124.51 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.44 -0.788 . . . . 0.0 109.044 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 30' ' ' SER . 3.8 mm -89.28 111.77 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.037 -1.04 . . . . 0.0 110.224 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 2.1 ttm -107.72 155.77 19.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.423 -0.798 . . . . 0.0 109.701 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.42 ' CG ' ' C ' ' B' ' 104' ' ' MET . 56.5 mtm180 -146.33 148.01 31.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 110.567 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.696 HD11 ' OG1' ' B' ' 111' ' ' THR . 9.8 pt -131.44 157.36 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.465 -0.772 . . . . 0.0 109.656 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.07 -28.19 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 0.0 110.47 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 108' ' ' GLU . 0.5 OUTLIER -156.69 118.69 2.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.168 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.915 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.1 Cg_endo -73.63 122.36 7.71 Favored 'Cis proline' 0 C--N 1.315 -1.192 0 C-N-CA 121.881 -2.133 . . . . 0.0 110.36 -0.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.667 ' O ' HG23 ' B' ' 111' ' ' THR . 24.2 tttp -43.25 108.16 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.948 . . . . 0.0 109.94 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.696 ' OG1' HD11 ' B' ' 106' ' ' ILE . 18.8 p -158.67 -178.92 7.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 110.703 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' B' ' 104' ' ' MET . 1.2 m -135.23 154.79 51.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.461 -0.775 . . . . 0.0 109.096 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -136.48 123.92 22.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.962 -1.086 . . . . 0.0 110.836 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.788 HD12 ' HB ' ' B' ' 122' ' ' VAL . 0.1 OUTLIER -95.71 97.62 9.84 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.412 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 9.3 mt -89.51 140.54 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.09 -1.006 . . . . 0.0 110.912 -178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.579 ' N ' ' CD1' ' B' ' 116' ' ' PHE . 1.9 m-30 -106.51 150.89 25.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.498 -0.751 . . . . 0.0 109.878 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.571 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -65.25 -17.86 64.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 0.0 110.17 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 7.6 m -67.52 -18.93 65.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.879 . . . . 0.0 110.282 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 116.56 -13.49 15.39 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -87.95 164.61 15.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.167 -1.196 . . . . 0.0 110.224 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.44 ' HG3' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -163.18 161.74 25.14 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.229 -0.919 . . . . 0.0 110.251 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.788 ' HB ' HD12 ' B' ' 114' ' ' LEU . 24.8 t -129.98 154.39 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.41 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 14.3 t -133.11 104.11 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.989 HG21 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -112.04 172.62 6.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.36 -0.837 . . . . 0.0 110.167 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.592 ' C ' HG22 ' B' ' 111' ' ' THR . . . 97.31 -15.95 61.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.909 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -60.21 166.11 3.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -1.226 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -26.46 10.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.174 -0.954 . . . . 0.0 110.764 -179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.526 ' N ' HG13 ' B' ' 70' ' ' ILE . 40.0 m -153.68 166.44 32.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.0 110.429 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 128' ' ' SER . 3.8 mt-10 -43.64 -48.41 7.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 110.15 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -60.62 -50.63 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.46 -45.34 69.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 110.274 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.16 -36.66 78.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.93 . . . . 0.0 110.198 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -33.64 72.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.139 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.42 -42.91 64.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -0.898 . . . . 0.0 110.193 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.915 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -66.9 -39.81 87.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 110.194 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.462 ' OG ' HG21 ' B' ' 74' ' ' VAL . 1.0 OUTLIER -60.24 -57.4 12.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.964 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -44.75 -52.2 8.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.051 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -53.74 -47.75 70.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.3 -0.875 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.913 ' HA ' HD12 ' B' ' 142' ' ' ILE . 15.4 m-85 -61.68 -57.74 10.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.112 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' B' ' 152' ' ' PHE . . . -48.77 -26.91 2.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.453 ' HG2' ' HG3' ' B' ' 145' ' ' LYS . 9.0 ttm180 -73.84 -49.29 25.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.836 . . . . 0.0 110.092 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.913 HD12 ' HA ' ' B' ' 139' ' ' TYR . 42.2 mt -47.12 -39.2 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.938 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.758 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.8 mp -72.21 -53.04 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 110.017 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 3.5 mt-30 -66.92 -28.28 68.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -73.65 -24.85 60.05 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.146 -0.971 . . . . 0.0 108.436 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 7.1 mt -82.33 -24.12 9.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 130.35 -23.11 4.62 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.913 ' CE2' HG22 ' B' ' 85' ' ' VAL . 7.3 m-85 -49.32 165.64 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.293 . . . . 0.0 110.746 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.62 36.82 2.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.452 -0.78 . . . . 0.0 110.36 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.925 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -62.83 152.69 35.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.3 -0.875 . . . . 0.0 110.119 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.507 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 13.6 ptpt -136.99 24.07 3.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.124 -0.985 . . . . 0.0 110.462 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' B' ' 151' ' ' LYS . 2.7 t80 27.25 98.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.211 0.529 . . . . 0.0 111.795 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 0.1 OUTLIER -151.86 169.5 22.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 0.0 110.369 179.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.449 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 7.3 t0 65.45 30.12 10.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.489 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 7.1 t80 -71.85 122.87 21.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.172 -0.955 . . . . 0.0 109.924 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.36 131.19 8.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -0.951 . . . . 0.0 110.49 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.535 HG13 ' HB2' ' B' ' 72' ' ' ALA . 3.3 mp -79.53 123.91 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -110.91 -14.99 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 110.84 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.4 t30 -142.49 135.96 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.711 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.722 HG23 ' CD1' ' B' ' 70' ' ' ILE . 29.8 mt -131.26 129.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.543 -0.723 . . . . 0.0 109.74 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 24' ' ' LEU . 10.2 t -96.8 134.72 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.652 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -141.97 168.74 25.56 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.532 ' HB2' ' NE2' ' B' ' 68' ' ' GLN . 0.3 OUTLIER -161.76 153.05 18.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.285 . . . . 0.0 110.711 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.438 ' SG ' ' CE1' ' B' ' 227' ' ' PHE . 7.5 p -165.95 155.65 12.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.386 -0.821 . . . . 0.0 110.051 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -104.13 153.08 21.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.244 -0.91 . . . . 0.0 110.348 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.621 HG21 HD11 ' B' ' 170' ' ' ILE . 13.2 m -105.91 3.46 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.284 -0.885 . . . . 0.0 110.266 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.523 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.56 -2.8 2.52 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.361 -0.837 . . . . 0.0 111.262 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.588 ' CZ ' ' HB ' ' B' ' 166' ' ' VAL . 15.3 p90 -150.24 149.84 27.91 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.797 -1.189 . . . . 0.0 110.38 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.479 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 47.4 Cg_endo -73.64 160.62 43.67 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.135 1.597 . . . . 0.0 110.439 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.621 HD11 HG21 ' B' ' 166' ' ' VAL . 3.1 mt -131.34 150.83 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.872 . . . . 0.0 110.371 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.66 103.03 9.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.21 -0.931 . . . . 0.0 109.875 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.454 ' O ' HD12 ' B' ' 193' ' ' LEU . 15.5 mt -63.37 -34.68 78.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.662 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' B' ' 174' ' ' GLY . 9.4 pt-20 -78.3 -32.44 49.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.385 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . 0.533 ' N ' ' HG3' ' B' ' 173' ' ' GLU . . . -64.16 -48.02 79.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -60.63 -42.2 96.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -1.106 . . . . 0.0 110.296 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.76 64.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.451 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -83.23 -27.78 29.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 110.339 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 67.0 m -95.13 -44.72 7.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -123.72 49.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.09 -20.59 79.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 32.6 m -60.32 -23.58 64.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -1.146 . . . . 0.0 110.208 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' B' ' 196' ' ' ARG . 17.7 m-85 -123.5 -5.37 8.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.31 152.93 40.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 8.5 p -131.8 139.33 48.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.372 -0.83 . . . . 0.0 110.08 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -127.16 113.46 16.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.972 . . . . 0.0 110.135 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' B' ' 190' ' ' PHE . 8.6 mt-10 -117.72 92.15 40.55 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.127 -0.983 . . . . 0.0 109.921 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.64 -3.78 13.29 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.001 1.527 . . . . 0.0 110.167 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.57 -13.58 18.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.275 -0.89 . . . . 0.0 110.014 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.491 HD23 ' HB2' ' B' ' 190' ' ' PHE . 4.3 tt -138.54 -35.11 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.462 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 1.02 ' CE2' HD21 ' A' ' 59' ' ' LEU . 2.7 t80 -125.49 114.04 25.4 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.137 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.39 -10.32 25.36 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.897 1.472 . . . . 0.0 110.457 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -106.99 172.81 18.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.454 HD12 ' O ' ' B' ' 172' ' ' LEU . 6.1 tt -105.15 121.53 44.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 110.042 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.985 HD13 HD13 ' A' ' 62' ' ' LEU . 6.4 mt -90.3 106.27 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.214 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.428 ' O ' ' N ' ' B' ' 204' ' ' LEU . 5.7 t80 -101.58 122.32 43.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 0.0 110.016 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -111.67 80.06 1.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 110.405 -179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 0.5 OUTLIER -68.34 166.09 17.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.883 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' B' ' 201' ' ' LYS . 63.1 t -111.02 -31.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.97 . . . . 0.0 110.704 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 7.0 tttt -134.78 97.14 14.22 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.585 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -72.37 150.18 94.55 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.8 -2.167 . . . . 0.0 110.401 -0.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.54 ' O ' HD13 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -77.39 92.69 3.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.969 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' B' ' 217' ' ' ALA . 27.6 mm -140.33 153.53 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.472 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.07 103.8 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.211 -0.931 . . . . 0.0 109.844 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.442 HD12 ' H ' ' B' ' 204' ' ' LEU . 3.3 mp -95.01 142.45 27.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.881 HD12 ' HB ' ' B' ' 213' ' ' VAL . 4.4 mt -118.87 116.01 25.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 109.663 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.462 HG13 HG13 ' B' ' 212' ' ' ILE . 2.6 mt -108.71 119.87 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.257 -0.902 . . . . 0.0 110.79 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' B' ' 208' ' ' VAL . 10.0 m-85 -99.29 147.83 24.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 0.0 109.443 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 67.7 t -44.42 -25.72 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.055 -1.028 . . . . 0.0 110.021 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.406 ' N ' ' O ' ' B' ' 207' ' ' PHE . 3.8 p -66.11 -39.73 90.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 110.055 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.582 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 120.75 17.27 4.28 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.7 ' O ' HD12 ' B' ' 212' ' ' ILE . 0.1 OUTLIER -91.36 130.77 37.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.123 . . . . 0.0 110.135 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.855 HG22 HD11 ' B' ' 214' ' ' LEU . 1.2 mp -116.35 121.68 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 110.028 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.881 ' HB ' HD12 ' B' ' 205' ' ' LEU . 27.0 t -107.69 113.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 110.139 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.855 HD11 HG22 ' B' ' 212' ' ' ILE . 3.7 mp -101.23 103.5 14.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.177 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 5.0 t -130.31 142.95 50.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.971 . . . . 0.0 110.105 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 114.14 14.05 9.47 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.707 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -90.96 145.55 24.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.157 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -85.33 -13.76 48.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.348 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.509 ' CA ' ' CD1' ' B' ' 160' ' ' ILE . 1.3 tt0 -151.51 -173.44 4.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.066 -1.021 . . . . 0.0 110.539 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -79.77 -52.97 7.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 110.408 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.449 ' OE2' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -45.7 -25.72 0.53 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 110.538 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.543 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 56.3 mm-40 -69.83 -54.34 14.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.467 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 18.9 mm -58.6 -39.81 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 110.141 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.49 ' CE1' ' HG2' ' B' ' 65' ' ' PRO . 5.5 m-85 -67.35 -33.15 74.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.364 -0.835 . . . . 0.0 110.491 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.438 ' HB3' ' HG3' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -78.24 -37.09 46.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.956 . . . . 0.0 110.145 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -58.07 -40.3 80.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.313 -0.867 . . . . 0.0 110.22 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.515 ' HA ' HG22 ' B' ' 230' ' ' ILE . 2.3 t80 -67.85 -50.12 58.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -57.92 -15.19 7.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.253 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -95.88 -34.57 11.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.181 -0.95 . . . . 0.0 110.484 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.515 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.6 tp -95.48 -16.21 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.601 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 18.8 t80 -50.09 -45.3 81.77 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.0 110.768 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.3 Cg_endo -73.13 -51.03 0.17 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.327 1.172 . . . . 0.0 110.497 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' B' ' 232' ' ' PRO . 14.1 t -44.36 -37.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.074 -1.016 . . . . 0.0 109.761 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.4 -47.64 32.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.235 -0.916 . . . . 0.0 110.031 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 13.2 m -55.74 -33.21 64.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 0.0 109.902 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -74.03 -29.34 61.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.317 -0.864 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' B' ' 175' ' ' LEU . 52.5 m-85 -118.78 40.56 3.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.297 -0.877 . . . . 0.0 110.093 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -78.29 -170.74 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.266 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.4 -46.31 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . 0.422 ' OXT' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.279 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.248 0.547 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.6 77.37 1.76 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -104.29 74.71 1.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 110.483 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 18.0 mt -97.55 143.02 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 0.0 109.877 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.17 29.13 2.07 Favored Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.756 -1.211 . . . . 0.0 110.092 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.13 109.92 16.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.084 -1.245 . . . . 0.0 109.924 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.463 ' C ' ' CE1' ' B' ' 99' ' ' PHE . . . 63.65 165.26 0.73 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.117 HD21 HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -70.53 0.64 6.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.903 -1.351 . . . . 0.0 111.29 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 4.5 m-20 79.84 76.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.482 0.658 . . . . 0.0 110.749 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.117 HD21 HD21 ' A' ' 18' ' ' LEU . 1.1 mt -97.87 25.92 5.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.519 -0.738 . . . . 0.0 110.411 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.579 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 24.3 m -54.59 -19.55 6.19 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.961 -1.087 . . . . 0.0 109.533 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.664 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.37 -36.68 4.02 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.769 HG13 HD22 ' A' ' 20' ' ' LEU . 7.8 mm -43.93 -45.13 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.981 -1.305 . . . . 0.0 108.857 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.013 HD13 ' SD ' ' A' ' 67' ' ' MET . 1.2 pp -80.81 -21.92 40.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.64 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.73 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -101.14 13.84 33.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.545 -0.722 . . . . 0.0 109.757 179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 139.24 83.61 0.1 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.86 ' OD1' HD11 ' A' ' 35' ' ' LEU . 20.6 p-10 -15.18 94.43 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 121.698 0.761 . . . . 0.0 112.755 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.803 HD12 ' O ' ' A' ' 29' ' ' ASP . 1.2 pp -88.55 171.65 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.803 ' O ' HD12 ' A' ' 28' ' ' ILE . 71.2 m-20 -86.81 119.38 26.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.564 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -37.2 -27.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.024 -177.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 29' ' ' ASP . 22.2 tt0 -57.36 -13.29 3.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.142 -0.974 . . . . 0.0 110.252 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 110.21 27.32 4.55 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -116.25 116.77 28.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.085 -1.244 . . . . 0.0 110.778 -179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.988 HD22 ' N ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -88.94 143.58 26.77 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.822 -1.174 . . . . 0.0 109.83 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.988 ' N ' HD22 ' A' ' 34' ' ' LEU . 4.5 pp -130.91 -178.97 5.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.614 -1.304 . . . . 0.0 111.312 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' N ' HD12 ' A' ' 35' ' ' LEU . 3.1 mt-30 -130.56 133.01 45.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.578 -0.701 . . . . 0.0 109.726 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -64.69 75.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.206 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 36' ' ' GLN . 0.5 OUTLIER 58.22 -166.87 0.15 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.365 -0.835 . . . . 0.0 110.345 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.64 80.58 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 110.163 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.31 105.09 0.2 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -132.94 72.48 1.49 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -1.114 . . . . 0.0 110.161 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.66 -119.32 8.26 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -104.4 104.1 13.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 0.0 110.069 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.88 -125.49 1.8 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.16 114.59 2.08 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.8 -85.59 0.59 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -1.117 . . . . 0.0 110.282 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.42 157.33 33.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.541 ' HE1' HG21 ' B' ' 213' ' ' VAL . 27.5 m-85 -78.51 137.88 38.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -1.159 . . . . 0.0 110.262 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -77.22 -169.59 1.43 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 109.935 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -88.56 25.11 1.78 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.112 -0.992 . . . . 0.0 110.356 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' CD ' ' HG3' ' B' ' 191' ' ' PRO . 2.5 tp10 -101.03 -20.41 15.4 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.138 -0.977 . . . . 0.0 109.319 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.687 HD21 ' CD1' ' B' ' 205' ' ' LEU . 3.0 mt -95.5 -44.59 7.45 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.535 -0.728 . . . . 0.0 110.149 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.816 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -53.88 -59.05 5.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.243 -0.911 . . . . 0.0 109.595 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.2 pp20? -62.52 -13.38 30.0 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.497 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 2.8 m-20 -91.02 -39.15 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.424 -0.797 . . . . 0.0 109.278 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.816 HD12 ' HA ' ' A' ' 53' ' ' ARG . 4.5 mt -51.97 -39.38 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.357 -0.84 . . . . 0.0 109.531 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 -16.19 41.83 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.531 ' HB3' HD11 ' B' ' 189' ' ' LEU . 0.1 OUTLIER -133.15 9.87 4.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.243 -1.151 . . . . 0.0 110.781 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.563 HD21 ' CE2' ' B' ' 190' ' ' PHE . 1.2 mt -79.31 7.05 8.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.507 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.3 t -94.09 43.27 1.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.311 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' CD ' ' O ' ' A' ' 58' ' ' SER . 3.3 ptmm? -143.67 15.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.64 HD22 HD12 ' B' ' 194' ' ' ILE . 0.0 OUTLIER -131.42 -60.43 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 65' ' ' ASP . . . -146.84 -44.93 0.03 OUTLIER Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.709 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.4 mm? -42.06 -26.14 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -1.17 . . . . 0.0 110.394 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.472 ' O ' HD23 ' A' ' 69' ' ' LEU . 10.1 t70 -44.5 -37.7 3.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.079 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 m -71.11 -54.19 11.95 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 109.699 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 1.013 ' SD ' HD13 ' A' ' 24' ' ' LEU . 10.6 ttm -72.65 -3.7 26.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.553 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.653 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.9 tm? -75.81 -59.04 2.93 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.87 0.843 . . . . 0.0 108.975 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 65' ' ' ASP . 1.3 pp -78.48 1.01 23.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.246 0.546 . . . . 0.0 109.893 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -89.53 9.32 27.05 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.286 -0.884 . . . . 0.0 111.446 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.021 HG12 HG11 ' B' ' 122' ' ' VAL . 1.6 t -135.73 2.19 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.866 -1.146 . . . . 0.0 109.809 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.103 HD11 HD12 ' A' ' 74' ' ' LEU . 3.5 tp -149.86 75.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 7.4 t70 -77.84 57.47 1.71 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 108.26 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.114 ' CD1' ' HB2' ' B' ' 101' ' ' ALA . 8.0 mt -105.44 67.97 0.79 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.716 0.769 . . . . 0.0 110.727 -178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -169.05 131.57 1.26 Allowed 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.775 -0.578 . . . . 0.0 110.124 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 52.9 43.98 30.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.254 179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.318 0.58 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' B' ' 64' ' ' VAL . . . -146.14 -67.12 0.01 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' B' ' 62' ' ' GLY . 4.0 mt 60.61 -72.01 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.553 -0.969 . . . . 0.0 110.483 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 62' ' ' GLY . 14.0 t 61.07 128.91 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 0.0 110.054 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.4 ' CG ' HG22 ' B' ' 223' ' ' ILE . 44.5 Cg_endo -71.76 120.42 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.894 1.47 . . . . 0.0 110.193 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.48 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 90.5 m -89.68 135.11 33.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 110.124 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.59 HD22 ' CG2' ' B' ' 160' ' ' ILE . 32.4 mt -69.91 123.85 22.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.177 -0.952 . . . . 0.0 110.064 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.485 ' HA ' ' HD3' ' B' ' 127' ' ' LYS . 1.4 mm-40 -109.31 -7.1 15.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 110.192 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.479 ' ND2' ' HA2' ' A' ' 26' ' ' GLY . 4.1 t-20 -164.43 156.72 16.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.72 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 23.5 mm -137.47 147.2 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 14.6 t -137.02 138.44 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.899 . . . . 0.0 110.282 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -144.05 159.3 42.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 110.459 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.09 138.85 44.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.352 -0.842 . . . . 0.0 109.875 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 92.9 t -135.64 154.65 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.112 -0.992 . . . . 0.0 110.649 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.518 ' HG1' ' CG ' ' B' ' 154' ' ' ASP . 33.6 m -129.7 131.91 46.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 0.0 109.932 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.796 HD22 ' HB1' ' B' ' 150' ' ' ALA . 57.4 mt -89.43 -27.65 20.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.186 -0.946 . . . . 0.0 110.419 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 89.53 -0.38 80.38 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . 0.429 ' SG ' ' HA ' ' B' ' 150' ' ' ALA . 24.8 p -137.12 139.16 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -1.228 . . . . 0.0 110.241 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -69.26 152.27 45.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 0.0 110.06 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.682 HD11 ' CD1' ' B' ' 76' ' ' LEU . 16.6 mt -131.17 150.92 51.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.352 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' B' ' 82' ' ' LEU . 1.1 t0 -91.12 97.71 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.846 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' B' ' 100' ' ' ALA . 13.0 mt -41.16 -36.75 0.78 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 110.604 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.552 ' O ' HD23 ' B' ' 87' ' ' LEU . 0.0 OUTLIER -62.01 -40.7 96.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 0.0 110.475 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 26.7 p -85.83 -39.34 17.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.963 . . . . 0.0 110.425 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.596 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 56.7 t -62.55 -30.17 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.074 -1.016 . . . . 0.0 110.083 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.518 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -89.54 -23.93 21.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.326 -0.859 . . . . 0.0 110.12 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.552 HD23 ' O ' ' B' ' 83' ' ' LYS . 1.0 OUTLIER -76.98 -47.98 19.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 110.32 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -77.28 -39.16 49.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.375 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -50.23 113.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.837 . . . . 0.0 110.357 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -26.32 62.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 0.0 110.337 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.499 ' ND2' HG22 ' B' ' 106' ' ' ILE . 31.7 p30 -130.11 79.12 1.89 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 109.764 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.619 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -161.03 145.81 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 0.0 110.145 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.709 ' O ' HD12 ' B' ' 103' ' ' ILE . 12.5 mt-10 -134.85 136.65 42.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 110.285 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -114.58 110.75 20.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 109.988 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -106.51 112.69 63.65 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.299 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.98 -16.56 29.02 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.022 1.538 . . . . 0.0 110.405 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -87.61 -22.07 24.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.06 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 31' ' ' GLU . 5.3 mpt_? -91.8 -73.28 0.55 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.675 ' CG ' ' CB ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -153.6 164.14 38.76 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.43 -0.794 . . . . 0.0 110.253 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -81.7 47.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 109.889 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.114 ' HB2' ' CD1' ' A' ' 74' ' ' LEU . . . -129.61 146.49 51.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.19 -0.944 . . . . 0.0 111.087 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' B' ' 86' ' ' ALA . 20.1 t -93.28 122.23 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.447 -0.783 . . . . 0.0 108.997 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.709 HD12 ' O ' ' B' ' 93' ' ' GLU . 3.1 mp -89.18 115.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 110.52 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.555 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 0.4 OUTLIER -97.37 147.97 23.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.966 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.73 95.01 2.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -0.938 . . . . 0.0 110.441 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.499 HG22 ' ND2' ' B' ' 91' ' ' ASN . 16.5 pt -94.81 173.27 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.143 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -129.3 43.89 3.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 0.0 110.456 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.2 tt0 176.47 78.58 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.391 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.474 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.7 Cg_endo -79.66 157.03 89.34 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.681 -2.216 . . . . 0.0 110.455 -0.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 45.8 tttp -65.65 109.41 2.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.888 . . . . 0.0 109.945 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.462 HG22 ' C ' ' B' ' 125' ' ' GLY . 1.3 p -148.29 177.77 9.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 110.64 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.668 HG22 ' CG2' ' B' ' 124' ' ' THR . 0.4 OUTLIER -130.04 171.5 12.74 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.434 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -164.19 140.17 6.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.795 -1.191 . . . . 0.0 110.876 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.574 ' O ' ' CE1' ' B' ' 116' ' ' PHE . 0.4 OUTLIER -105.54 100.02 9.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.422 -0.799 . . . . 0.0 108.849 179.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.445 ' C ' ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt -89.21 137.31 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.091 -1.006 . . . . 0.0 110.569 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.726 ' CD1' HD11 ' A' ' 74' ' ' LEU . 1.9 m-30 -108.45 166.15 10.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.25 58.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 110.108 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 5.3 t -53.72 -20.02 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.06 -18.32 16.36 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.25 162.99 18.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -1.166 . . . . 0.0 110.15 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.422 ' HB2' HG12 ' B' ' 115' ' ' ILE . 4.0 ptt? -159.97 149.4 17.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.081 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 1.021 HG11 HG12 ' A' ' 71' ' ' VAL . 21.0 t -112.74 135.1 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.107 -0.996 . . . . 0.0 110.39 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.577 HG13 ' HE2' ' B' ' 139' ' ' TYR . 16.8 t -110.22 148.42 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 109.882 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.854 HG23 ' CB ' ' A' ' 27' ' ' ASN . 3.5 t -156.11 162.51 40.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 109.788 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.556 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 112.65 -37.1 3.79 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.72 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -46.1 160.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -1.142 . . . . 0.0 110.256 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' B' ' 68' ' ' GLN . 1.3 mmmt -115.92 -2.31 12.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 110.193 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.473 ' N ' HG13 ' B' ' 70' ' ' ILE . 0.5 OUTLIER -158.78 162.85 37.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.313 -0.867 . . . . 0.0 110.24 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.91 -31.79 67.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.898 . . . . 0.0 110.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.34 -50.95 33.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 110.045 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.11 -44.13 97.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.904 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.539 ' HB2' HG21 ' B' ' 70' ' ' ILE . 46.6 t -53.7 -47.45 70.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.964 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -54.85 -46.74 74.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.375 -0.828 . . . . 0.0 109.833 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 5.4 mt -68.39 -52.76 29.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 110.234 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.444 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -46.93 -41.78 16.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.304 -0.872 . . . . 0.0 110.033 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.405 ' O ' ' C ' ' B' ' 137' ' ' ARG . 1.6 p -71.65 -60.08 2.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.592 ' HD2' ' CE2' ' B' ' 152' ' ' PHE . 4.7 mtp180 -43.54 -46.22 6.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.293 -0.879 . . . . 0.0 110.005 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.42 -51.38 65.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.098 -1.001 . . . . 0.0 109.966 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.577 ' HE2' HG13 ' B' ' 123' ' ' VAL . 15.4 m-85 -50.33 -48.8 55.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 0.0 109.863 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.24 -24.86 67.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.821 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -71.0 -31.44 67.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.353 -0.842 . . . . 0.0 110.064 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.419 ' O ' HG13 ' B' ' 146' ' ' ILE . 23.1 mt -69.64 -47.02 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 110.238 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.647 HG21 ' HB2' ' B' ' 150' ' ' ALA . 1.7 mp -65.3 -49.52 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 1.5 mt-30 -64.39 -39.34 93.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.025 -1.047 . . . . 0.0 110.017 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -68.23 -21.68 64.82 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' B' ' 143' ' ' ILE . 9.2 mt -81.15 -24.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 133.52 -35.34 2.29 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.546 ' HB2' ' CG2' ' B' ' 143' ' ' ILE . 13.5 m-85 -51.03 165.86 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.138 -1.213 . . . . 0.0 110.89 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.99 48.52 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.674 -0.641 . . . . 0.0 109.975 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.796 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -71.55 134.88 46.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 110.7 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.27 -153.9 0.5 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.592 ' CE2' ' HD2' ' B' ' 137' ' ' ARG . 22.3 t80 -149.46 78.3 1.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.932 . . . . 0.0 110.267 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' B' ' 154' ' ' ASP . 1.1 p -141.66 179.55 6.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.518 ' CG ' ' HG1' ' B' ' 75' ' ' THR . 8.7 t0 66.31 13.93 9.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.952 . . . . 0.0 110.351 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -66.76 136.72 55.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 109.887 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -168.57 124.12 0.95 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.584 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 20.0 mt -79.7 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.243 -0.911 . . . . 0.0 109.483 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.475 ' HA ' ' HG3' ' B' ' 218' ' ' LYS . 1.6 mt-30 -122.98 -11.86 8.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.042 -1.036 . . . . 0.0 111.042 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.494 ' HB3' ' HB ' ' B' ' 71' ' ' VAL . 1.2 t30 -136.69 130.4 32.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.968 -1.082 . . . . 0.0 111.061 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.59 ' CG2' HD22 ' B' ' 67' ' ' LEU . 7.9 mt -129.56 122.53 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.38 -0.825 . . . . 0.0 109.45 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 24' ' ' LEU . 58.1 t -94.27 125.58 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 110.771 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -131.51 162.99 23.75 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 93.4 p -164.4 151.08 11.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.099 -1.236 . . . . 0.0 110.403 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.425 ' HB2' HG22 ' B' ' 63' ' ' ILE . 26.5 p -167.59 146.75 4.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.236 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 11.4 p-10 -91.26 163.36 14.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.1 OUTLIER -102.43 -71.91 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.18 -0.95 . . . . 0.0 109.856 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 165.43 -23.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.595 -0.691 . . . . 0.0 109.72 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' B' ' 168' ' ' PHE . 16.2 p90 -136.32 163.18 51.88 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.6 Cg_endo -72.04 142.09 37.73 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.8 1.421 . . . . 0.0 110.555 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.702 HD12 ' HA2' ' B' ' 210' ' ' GLY . 3.8 mt -101.83 149.82 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 110.32 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.58 98.5 10.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.29 -0.881 . . . . 0.0 110.014 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.775 HD11 HG23 ' B' ' 208' ' ' VAL . 91.4 mt -56.9 -30.01 63.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.344 -0.848 . . . . 0.0 110.391 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.67 -49.1 33.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.882 . . . . 0.0 110.419 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -60.79 -28.78 68.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' B' ' 175' ' ' LEU . 0.1 OUTLIER -71.19 -44.94 64.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 0.0 110.195 179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -79.63 -13.77 59.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.149 -0.969 . . . . 0.0 110.024 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.22 -34.71 37.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.778 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . 0.404 ' HB2' ' CZ ' ' B' ' 237' ' ' PHE . 0.3 OUTLIER -100.03 -35.08 9.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.443 -0.785 . . . . 0.0 109.888 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' B' ' 183' ' ' SER . 34.0 m170 -115.63 37.51 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.351 -0.843 . . . . 0.0 110.135 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.56 -9.96 82.4 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 7.0 t -76.11 -24.79 54.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -1.197 . . . . 0.0 110.061 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.435 ' CE2' HG22 ' B' ' 198' ' ' VAL . 0.2 OUTLIER -127.81 -2.44 5.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.122 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 1.017 ' OG ' HD21 ' B' ' 193' ' ' LEU . 0.9 OUTLIER -114.97 140.99 48.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 0.0 110.107 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 3.8 t -111.56 136.75 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -145.32 91.28 2.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.163 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -108.44 110.21 61.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.89 1.08 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.959 1.505 . . . . 0.0 110.462 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.9 -13.92 28.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.98 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.644 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.1 tt -155.71 16.64 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 110.278 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.563 ' CE2' HD21 ' A' ' 59' ' ' LEU . 1.7 t80 -170.18 106.16 0.44 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.762 -1.211 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . 0.466 ' HG3' ' CD ' ' A' ' 51' ' ' GLU . 45.5 Cg_endo -73.85 -23.41 16.5 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.987 1.519 . . . . 0.0 110.238 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.93 -179.88 42.96 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 1.017 HD21 ' OG ' ' B' ' 183' ' ' SER . 1.9 tt -115.11 146.69 41.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -1.195 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.787 HG12 HD21 ' B' ' 205' ' ' LEU . 77.0 mt -113.45 103.82 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.381 -0.825 . . . . 0.0 109.943 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 8.5 t80 -102.14 118.21 36.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.892 . . . . 0.0 110.351 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.876 ' HD3' HG22 ' B' ' 203' ' ' VAL . 3.3 tpp85 -92.41 92.72 8.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 56.4 tpp -50.8 125.65 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.335 -0.853 . . . . 0.0 110.354 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.435 HG22 ' CE2' ' B' ' 182' ' ' PHE . 30.8 t -64.23 -43.31 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.292 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 21.6 tttm -149.43 117.16 3.72 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.177 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.7 Cg_endo -72.89 166.96 79.81 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.916 -2.118 . . . . 0.0 110.304 -0.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.455 ' O ' ' CG1' ' B' ' 202' ' ' ILE . 4.9 mttm -75.35 108.38 8.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.755 ' CD1' ' HB2' ' B' ' 217' ' ' ALA . 13.3 mt -154.67 151.76 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.876 HG22 ' HD3' ' B' ' 196' ' ' ARG . 20.0 t -96.98 127.71 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 109.991 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' B' ' 213' ' ' VAL . 2.3 mp -112.53 125.7 54.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 110.313 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.787 HD21 HG12 ' B' ' 194' ' ' ILE . 13.1 mt -102.58 120.19 40.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.043 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.667 HG23 HD13 ' B' ' 170' ' ' ILE . 12.3 mt -114.84 115.17 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.277 -0.89 . . . . 0.0 110.192 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -95.07 154.84 16.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 110.245 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.775 HG23 HD11 ' B' ' 172' ' ' LEU . 52.9 t -49.98 -35.42 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -46.52 90.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 110.498 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.702 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 130.93 32.4 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.609 ' C ' HD12 ' B' ' 212' ' ' ILE . 0.0 OUTLIER -95.97 117.08 29.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -1.183 . . . . 0.0 109.828 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.746 HG22 HD11 ' B' ' 214' ' ' LEU . 1.2 mp -107.08 111.14 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 110.317 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.73 HG11 ' HE1' ' A' ' 25' ' ' PHE . 75.9 t -104.91 150.74 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.928 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.746 HD11 HG22 ' B' ' 212' ' ' ILE . 4.1 mp -142.33 107.96 5.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 110.406 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.549 ' O ' HG23 ' B' ' 202' ' ' ILE . 10.1 t -129.61 157.58 41.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.955 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.455 ' HA2' ' OD1' ' B' ' 159' ' ' ASN . . . 102.85 11.75 33.99 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.755 ' HB2' ' CD1' ' B' ' 202' ' ' ILE . . . -91.77 155.1 18.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.31 -1.112 . . . . 0.0 110.09 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' B' ' 218' ' ' LYS . 22.4 tttt -104.79 0.71 28.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.892 . . . . 0.0 110.375 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.2 137.78 5.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.028 . . . . 0.0 110.432 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' B' ' 220' ' ' ARG . 10.4 ttm180 -45.18 -26.62 0.5 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -34.03 77.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.0 109.989 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.604 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 1.4 mm-40 -67.82 -55.13 14.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' B' ' 217' ' ' ALA . 14.3 mm -51.08 -47.53 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.167 -0.958 . . . . 0.0 109.786 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.05 -27.58 67.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 0.0 109.778 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.16 -43.4 24.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.458 -0.776 . . . . 0.0 110.107 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' B' ' 204' ' ' LEU . . . -60.12 -40.16 88.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.15 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.533 ' HA ' HG22 ' B' ' 230' ' ' ILE . 46.8 t80 -70.28 -42.58 71.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 110.186 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.96 -20.09 66.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.263 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -93.84 -22.99 18.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 110.318 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' B' ' 227' ' ' PHE . 7.5 tp -100.36 -28.7 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.237 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 30.6 t80 -44.08 -49.52 22.24 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.926 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 42.4 Cg_endo -69.45 -40.49 5.73 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.36 1.189 . . . . 0.0 110.606 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.7 -39.53 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.213 -0.929 . . . . 0.0 109.881 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.42 HD21 HD13 ' B' ' 206' ' ' ILE . 95.1 mt -64.87 -55.16 21.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.251 -0.905 . . . . 0.0 110.115 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 24.6 m -50.69 -28.81 9.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.179 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.95 -32.92 65.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 110.446 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' B' ' 178' ' ' SER . 49.6 m-85 -113.66 41.4 2.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.393 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.24 -160.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.0 110.106 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -144.47 -54.73 0.34 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.187 -0.946 . . . . 0.0 110.236 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.36 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.259 0.552 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.89 43.57 97.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.8 -51.61 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.149 . . . . 0.0 110.2 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.9 tt -125.97 16.6 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 0.0 110.152 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.8 83.97 0.33 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -118.72 99.25 6.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -1.158 . . . . 0.0 109.965 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.57 115.94 1.7 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.009 HD23 ' CG1' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -80.64 2.29 26.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -1.206 . . . . 0.0 110.664 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.729 ' HA ' HD11 ' A' ' 68' ' ' LEU . 5.9 t0 75.5 90.33 0.08 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.291 0.567 . . . . 0.0 111.529 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.886 HD21 HD21 ' A' ' 18' ' ' LEU . 2.3 mt -107.27 35.45 3.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.44 -0.787 . . . . 0.0 110.034 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.708 ' OG1' HD23 ' A' ' 68' ' ' LEU . 20.2 m -56.6 -25.45 52.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.063 -1.023 . . . . 0.0 110.288 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.595 ' HA3' HD12 ' A' ' 34' ' ' LEU . . . -98.24 -27.49 8.69 Favored Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.798 -1.192 . . . . 0.0 110.239 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.781 HG13 HD13 ' A' ' 20' ' ' LEU . 14.8 mm -46.46 -46.65 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.801 -1.411 . . . . 0.0 108.849 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.874 HD22 ' HG2' ' A' ' 67' ' ' MET . 1.1 pp -82.66 -25.65 32.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 0.0 109.137 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.013 ' CZ ' HD13 ' B' ' 205' ' ' LEU . 0.1 OUTLIER -90.6 14.65 12.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 135.88 98.32 0.54 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.051 -2.02 . . . . 0.0 108.051 -178.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 1.033 ' HB2' HG23 ' B' ' 124' ' ' THR . 25.8 p-10 -33.9 93.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.519 -0.989 . . . . 0.0 111.737 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -90.63 175.57 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 31' ' ' GLU . 21.4 m-20 -87.86 126.19 34.89 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.49 ' HB3' HG12 ' B' ' 103' ' ' ILE . 0.0 OUTLIER -40.13 -25.03 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.318 -0.864 . . . . 0.0 110.133 -178.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.3 OUTLIER -64.12 -6.81 7.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.986 -1.071 . . . . 0.0 110.408 178.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 29' ' ' ASP . . . 102.35 29.43 6.01 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.685 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.511 ' C ' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -119.44 111.33 17.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.9 -1.353 . . . . 0.0 110.6 -179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.921 HD13 HD13 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -89.47 149.14 23.06 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.644 -1.285 . . . . 0.0 110.552 -179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.945 HD11 ' OD1' ' A' ' 27' ' ' ASN . 3.4 pp -127.47 -179.01 4.68 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.594 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.61 -41.88 1.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.431 -0.793 . . . . 0.0 109.958 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.33 -75.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.473 -0.767 . . . . 0.0 109.979 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 38' ' ' ASP . 6.9 p30 -132.48 164.15 27.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.826 . . . . 0.0 110.025 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -139.08 168.42 19.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.989 . . . . 0.0 110.307 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.69 -150.79 20.01 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 158.68 18.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 110.214 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.9 -100.06 0.27 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -122.41 -48.12 2.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 0.0 110.169 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.32 158.33 16.5 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.57 167.54 5.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -135.76 28.76 3.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 110.139 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.66 -162.2 10.91 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -51.8 153.31 2.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 110.247 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 20.4 p30 -86.07 -128.84 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.506 ' N ' ' OD1' ' A' ' 49' ' ' ASP . . . -99.89 36.54 1.8 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.955 -1.091 . . . . 0.0 110.146 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -97.13 -20.97 17.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.291 -0.881 . . . . 0.0 109.08 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.614 HD21 ' HZ ' ' B' ' 207' ' ' PHE . 3.5 mt -98.95 -42.66 7.03 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.608 -0.683 . . . . 0.0 110.094 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.758 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.71 -55.69 18.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.43 -0.794 . . . . 0.0 109.534 -179.522 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -61.79 -14.04 29.18 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.499 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 58' ' ' SER . 3.6 m-20 -92.75 -39.86 11.01 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.293 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.921 HD13 HD13 ' A' ' 34' ' ' LEU . 2.9 mt -47.7 -41.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.856 . . . . 0.0 108.922 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -53.93 -20.05 12.65 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.422 ' HB3' HD11 ' B' ' 189' ' ' LEU . 50.2 m -113.44 0.64 14.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -1.123 . . . . 0.0 110.371 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.898 HD12 ' HA ' ' A' ' 56' ' ' ILE . 29.8 mt -88.91 33.82 0.78 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.921 . . . . 0.0 110.172 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -115.88 23.15 12.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.391 -0.818 . . . . 0.0 110.501 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.87 50.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.242 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.859 HD12 ' H ' ' A' ' 63' ' ' GLY . 0.4 OUTLIER -152.19 -29.11 0.16 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.354 -0.841 . . . . 0.0 111.0 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.859 ' H ' HD12 ' A' ' 62' ' ' LEU . . . -175.8 -42.04 0.05 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.869 HD12 HD11 ' A' ' 24' ' ' LEU . 2.8 mm? -69.46 -3.53 14.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -1.132 . . . . 0.0 110.41 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -46.14 -41.8 13.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 110.129 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 p -65.99 -48.83 69.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.903 . . . . 0.0 109.907 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.874 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -70.87 -3.36 18.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.287 -0.883 . . . . 0.0 109.798 179.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.729 HD11 ' HA ' ' A' ' 19' ' ' ASP . 2.4 tm? -80.6 -60.49 2.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.284 -0.885 . . . . 0.0 109.343 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' C ' HD12 ' A' ' 69' ' ' LEU . 3.5 pp -78.74 0.3 27.36 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.444 0.64 . . . . 0.0 109.794 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 22.9 tt0 -93.01 10.47 31.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.384 -0.822 . . . . 0.0 111.07 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.804 ' HB ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -133.2 -4.26 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 120.954 -1.091 . . . . 0.0 110.072 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.009 ' CG1' HD23 ' A' ' 18' ' ' LEU . 2.6 tp -138.69 74.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.133 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 13.0 t0 -83.34 52.41 2.21 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.034 -1.041 . . . . 0.0 108.615 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.612 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -77.36 40.46 0.28 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.528 -0.733 . . . . 0.0 111.766 -178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -70.31 159.81 33.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.904 -1.123 . . . . 0.0 110.035 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 2.3 tt0 -51.35 -31.51 22.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 110.267 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' B' ' 118' ' ' SER . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.181 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.329 0.585 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.59 -44.92 0.33 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.474 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 5.1 mt -79.56 -23.47 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -1.13 . . . . 0.0 110.254 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 45.4 t 58.77 119.63 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 0.0 110.363 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.432 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 44.6 Cg_endo -72.02 137.88 30.0 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.781 1.411 . . . . 0.0 110.428 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.479 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 15.8 m -93.31 153.43 18.56 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 0.0 110.437 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 88.2 mt -86.52 133.06 33.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 110.068 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.432 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 2.9 mm-40 -116.06 -19.45 10.31 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.529 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 4.4 m120 -167.63 167.76 13.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.106 -0.996 . . . . 0.0 110.362 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.529 ' CG1' ' O ' ' B' ' 69' ' ' ASN . 9.2 mt -158.11 158.17 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.362 -0.836 . . . . 0.0 109.94 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' B' ' 123' ' ' VAL . 61.5 t -134.22 144.42 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.126 -0.984 . . . . 0.0 110.351 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.04 155.44 48.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.874 . . . . 0.0 110.17 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.87 141.56 42.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 110.241 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.725 HG21 ' OG ' ' B' ' 136' ' ' SER . 86.2 t -133.07 135.88 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 0.0 110.211 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 30.4 m -105.71 123.01 47.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.223 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.867 HD22 ' HB1' ' B' ' 150' ' ' ALA . 71.4 mt -78.45 -43.5 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -0.896 . . . . 0.0 110.08 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.83 9.71 42.27 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.781 -1.327 . . . . 0.0 109.781 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.53 150.24 21.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -1.189 . . . . 0.0 110.359 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.922 ' O ' HD23 ' B' ' 80' ' ' LEU . 9.6 mtp180 -70.65 164.94 23.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.163 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.922 HD23 ' O ' ' B' ' 79' ' ' ARG . 20.6 mt -140.39 160.22 40.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 110.331 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' B' ' 82' ' ' LEU . 0.3 OUTLIER -96.27 92.46 6.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 110.05 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 1.041 HD22 HG23 ' B' ' 102' ' ' VAL . 13.8 mt -42.35 -46.72 4.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 110.26 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' B' ' 87' ' ' LEU . 3.8 tptm -52.62 -46.57 67.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.444 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 18.6 p -86.89 -38.96 16.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 110.503 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.441 HG12 HG11 ' B' ' 102' ' ' VAL . 53.6 t -54.26 -37.51 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.094 -1.004 . . . . 0.0 109.798 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.65 -31.84 23.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.765 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' B' ' 83' ' ' LYS . 14.1 tp -76.8 -27.87 55.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.464 -0.772 . . . . 0.0 109.97 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -47.62 9.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.39 -0.819 . . . . 0.0 110.098 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -48.49 135.86 13.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.39 -0.819 . . . . 0.0 110.108 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -71.69 -24.59 61.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.238 -0.914 . . . . 0.0 110.257 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' B' ' 105' ' ' ARG . 10.1 p30 -136.14 79.83 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 110.111 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -151.6 153.56 34.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 0.0 110.389 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' OE1' ' B' ' 93' ' ' GLU . 52.7 mm-40 -134.49 141.54 46.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.36 -0.837 . . . . 0.0 110.108 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -134.41 117.79 16.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.392 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.5 125.3 26.89 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.55 -34.13 7.7 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.845 1.445 . . . . 0.0 110.098 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -15.49 62.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.021 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.513 ' N ' ' HD2' ' B' ' 98' ' ' ARG . 5.6 mpt_? -98.15 -59.76 1.69 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.375 -0.828 . . . . 0.0 110.202 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 1.201 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -168.57 175.0 6.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.629 -0.67 . . . . 0.0 111.375 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.41 55.89 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.46 -0.775 . . . . 0.0 111.298 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.201 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -147.87 160.23 43.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 1.041 HG23 HD22 ' B' ' 82' ' ' LEU . 84.6 t -92.61 162.27 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.543 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.49 HG12 ' HB3' ' A' ' 30' ' ' SER . 9.9 mt -131.57 125.32 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.384 -0.823 . . . . 0.0 109.711 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.85 162.85 12.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.129 -0.982 . . . . 0.0 110.591 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' B' ' 91' ' ' ASN . 0.0 OUTLIER -160.01 130.07 5.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 0.0 109.913 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 5.6 pt -139.72 167.96 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 110.44 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' B' ' 110' ' ' LYS . 0.0 OUTLIER -125.28 37.14 4.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.349 -0.844 . . . . 0.0 110.224 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.4 OUTLIER -177.88 80.05 0.23 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.33 -0.856 . . . . 0.0 110.461 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.8 Cg_endo -75.93 165.82 84.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.483 -2.299 . . . . 0.0 110.3 -0.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -78.58 109.47 12.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.228 -0.92 . . . . 0.0 110.334 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.563 HG22 ' O ' ' B' ' 124' ' ' THR . 0.2 OUTLIER -157.27 171.33 20.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 109.908 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.546 HG22 HG23 ' B' ' 124' ' ' THR . 6.5 t -137.12 155.35 49.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -150.8 167.22 28.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 110.808 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.745 HD13 HD13 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -140.86 113.56 8.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 0.0 109.507 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.723 HG23 ' O ' ' B' ' 120' ' ' LYS . 2.9 mp -98.22 149.85 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.432 -0.792 . . . . 0.0 111.02 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.623 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.1 m-85 -95.68 -177.65 4.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.491 -0.756 . . . . 0.0 109.511 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -84.96 -15.65 43.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.728 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 77' ' ' ALA . 66.7 p -73.09 -18.53 61.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.464 -0.773 . . . . 0.0 110.17 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 113.05 6.72 22.28 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . 0.723 ' O ' HG23 ' B' ' 115' ' ' ILE . 2.4 mttt -87.85 157.82 18.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -1.168 . . . . 0.0 110.015 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.551 ' CG ' HG13 ' B' ' 115' ' ' ILE . 7.2 tmm? -147.35 133.95 19.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.816 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.786 HG11 HG12 ' A' ' 71' ' ' VAL . 7.0 t -113.68 132.93 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.36 -0.837 . . . . 0.0 109.759 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.561 HG13 ' HE2' ' B' ' 139' ' ' TYR . 12.7 t -112.96 138.12 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 1.033 HG23 ' HB2' ' A' ' 27' ' ' ASN . 9.0 t -147.02 146.58 30.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.824 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.617 ' N ' ' HB3' ' A' ' 27' ' ' ASN . . . 119.42 -9.51 11.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -75.75 151.45 37.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -1.218 . . . . 0.0 110.167 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' B' ' 128' ' ' SER . 0.0 OUTLIER -117.88 -23.32 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.291 -0.881 . . . . 0.0 110.145 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' B' ' 127' ' ' LYS . 0.1 OUTLIER -123.02 -173.66 2.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -82.62 -48.68 10.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 110.294 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -65.77 -16.58 63.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.227 -0.921 . . . . 0.0 110.165 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.63 -46.54 14.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' B' ' 136' ' ' SER . 2.0 t -65.75 -30.36 71.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 110.13 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 tttt -71.18 -51.27 25.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.227 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 15.2 mt -61.3 -50.05 74.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.32 -0.862 . . . . 0.0 110.182 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.611 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -54.99 -46.06 75.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.725 ' OG ' HG21 ' B' ' 74' ' ' VAL . 0.3 OUTLIER -60.87 -58.61 7.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.161 -0.962 . . . . 0.0 110.05 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.55 -36.94 25.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 109.761 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -49.66 77.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.83 . . . . 0.0 109.938 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.561 ' HE2' HG13 ' B' ' 123' ' ' VAL . 25.2 m-85 -58.8 -50.07 75.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.853 . . . . 0.0 109.97 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.62 -39.65 71.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 110.064 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 1.3 mmt85 -60.38 -40.88 92.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.921 . . . . 0.0 110.039 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' B' ' 139' ' ' TYR . 38.6 mt -54.71 -48.14 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.514 HD13 HD13 ' B' ' 80' ' ' LEU . 57.5 mt -66.56 -49.77 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -61.24 -36.9 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.384 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.0 OUTLIER -71.84 -27.58 62.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 178.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.1 mt -72.8 -18.54 18.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.44 -27.07 7.44 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' B' ' 143' ' ' ILE . 12.1 m-85 -46.79 170.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.075 -1.25 . . . . 0.0 110.752 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.78 29.97 6.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.532 -0.73 . . . . 0.0 109.815 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.867 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -66.38 151.59 46.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 110.513 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.97 107.53 6.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.95 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -53.3 102.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.902 . . . . 0.0 110.308 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.8 p -148.39 172.21 14.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.201 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 t0 60.85 15.88 6.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 110.48 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -60.62 134.53 57.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 109.966 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -170.08 134.38 1.25 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 110.352 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 25.1 mt -78.96 126.81 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.365 -0.835 . . . . 0.0 109.665 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -115.67 -12.48 11.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.247 -0.908 . . . . 0.0 110.851 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.3 112.05 5.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.054 -1.029 . . . . 0.0 111.047 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' B' ' 215' ' ' THR . 11.0 mt -105.52 148.48 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 0.0 109.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' B' ' 69' ' ' ASN . 6.4 t -117.09 142.4 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.037 . . . . 0.0 111.079 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -159.9 164.81 34.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.0 OUTLIER -168.49 164.17 12.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.845 -1.385 . . . . 0.0 111.029 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.432 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.1 OUTLIER -170.01 175.81 4.94 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.405 -0.809 . . . . 0.0 109.846 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -108.03 149.02 28.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.743 HG21 HD11 ' B' ' 170' ' ' ILE . 16.1 m -97.22 4.34 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 110.224 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 71.69 12.92 6.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.259 -0.901 . . . . 0.0 110.722 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.569 ' CE1' HG13 ' B' ' 170' ' ' ILE . 10.3 p90 -171.43 139.82 1.19 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.164 -0.96 . . . . 0.0 110.133 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' B' ' 208' ' ' VAL . 44.0 Cg_endo -71.31 153.62 61.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.104 1.581 . . . . 0.0 111.007 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 1.022 HD13 HD22 ' B' ' 234' ' ' LEU . 3.2 mt -125.42 150.65 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 110.273 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -80.25 92.79 5.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 110.037 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.633 HD11 ' HA ' ' B' ' 207' ' ' PHE . 97.9 mt -52.73 -32.38 42.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.406 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.69 -59.82 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.946 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -50.61 -37.18 33.15 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.566 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.2 OUTLIER -64.89 -53.69 42.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -1.101 . . . . 0.0 109.98 179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.46 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -58.1 -20.98 44.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 0.0 110.075 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.66 -56.31 4.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.824 . . . . 0.0 109.878 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.7 t -69.9 -46.03 66.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.301 -0.874 . . . . 0.0 110.043 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -105.89 41.57 1.38 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.018 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.46 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -65.36 -16.89 63.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 68.0 p -85.82 -31.74 22.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.144 -1.209 . . . . 0.0 110.378 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -104.63 -10.36 17.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.352 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.792 ' HB2' HD21 ' B' ' 193' ' ' LEU . 1.2 p -140.88 123.41 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 110.419 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.57 165.89 11.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.866 . . . . 0.0 110.083 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -160.66 126.89 4.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.183 -0.948 . . . . 0.0 110.28 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' B' ' 187' ' ' PRO . 81.3 mt-10 -130.97 107.9 15.22 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.86 . . . . 0.0 110.273 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' B' ' 186' ' ' GLU . 45.9 Cg_endo -72.28 -7.77 21.54 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.996 1.524 . . . . 0.0 110.087 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -95.75 4.42 52.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 110.223 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.686 HD23 ' HB2' ' B' ' 190' ' ' PHE . 0.9 OUTLIER -159.78 -51.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 110.336 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.686 ' HB2' HD23 ' B' ' 189' ' ' LEU . 26.6 t80 -113.19 109.95 51.41 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 0.0 110.374 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.69 -20.8 22.59 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.975 1.513 . . . . 0.0 110.152 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' B' ' 190' ' ' PHE . . . -90.74 -179.94 43.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' B' ' 183' ' ' SER . 6.0 tt -123.79 131.8 53.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -1.18 . . . . 0.0 110.321 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.837 HD13 HD13 ' A' ' 62' ' ' LEU . 4.6 mt -96.32 111.26 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 110.163 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.448 ' HB3' ' HB2' ' B' ' 204' ' ' LEU . 20.5 t80 -95.31 111.57 23.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 110.259 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 -94.98 86.85 4.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.167 -0.958 . . . . 0.0 110.132 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.562 ' HE1' HG12 ' B' ' 230' ' ' ILE . 20.6 ttm -65.27 135.1 54.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.933 . . . . 0.0 110.169 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 74.2 t -86.11 -28.45 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.878 . . . . 0.0 110.307 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' B' ' 199' ' ' LYS . 0.0 OUTLIER -149.4 110.15 3.41 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 110.432 -179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.446 ' HB2' ' OE2' ' B' ' 222' ' ' GLU . 48.5 Cg_endo -73.72 171.28 67.23 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.035 -2.069 . . . . 0.0 110.485 -0.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.404 ' C ' HG12 ' B' ' 202' ' ' ILE . 11.8 tptt -74.46 92.57 2.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 109.87 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.827 HD12 ' HB2' ' B' ' 217' ' ' ALA . 24.6 mm -140.16 153.63 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 110.741 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' B' ' 195' ' ' TYR . 48.4 t -114.34 116.69 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.714 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.755 HD22 HG13 ' B' ' 230' ' ' ILE . 3.4 mp -110.71 131.21 55.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 1.013 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -110.59 122.65 48.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.19 -179.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.51 HG12 HD21 ' B' ' 234' ' ' LEU . 2.8 mp -113.68 145.0 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.108 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.633 ' HA ' HD11 ' B' ' 172' ' ' LEU . 84.2 m-85 -121.15 156.32 32.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 110.462 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' B' ' 169' ' ' PRO . 12.8 t -47.97 -27.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.421 -0.8 . . . . 0.0 110.137 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 4.7 m -71.54 -31.92 67.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.216 -0.927 . . . . 0.0 110.303 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 113.57 22.39 5.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.2 OUTLIER -87.77 133.65 33.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.215 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' B' ' 163' ' ' SER . 36.5 mm -117.49 132.93 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.359 -0.838 . . . . 0.0 110.105 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 25' ' ' PHE . 76.0 t -125.85 114.52 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 110.393 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.69 104.19 16.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 0.0 110.172 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 4.8 t -132.56 142.29 49.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.953 . . . . 0.0 110.235 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.428 ' HA2' ' SD ' ' A' ' 67' ' ' MET . . . 108.0 19.21 9.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.827 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -99.99 164.43 12.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -1.131 . . . . 0.0 110.288 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.15 -29.97 8.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 0.0 110.001 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.77 154.0 44.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.865 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -53.8 -18.69 3.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.208 -0.932 . . . . 0.0 110.229 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -59.44 -45.51 91.37 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.228 -0.92 . . . . 0.0 110.461 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.446 ' OE2' ' HB2' ' B' ' 200' ' ' PRO . 30.6 mt-10 -72.43 -46.4 55.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 13.6 mm -51.57 -44.71 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 110.025 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.462 ' CZ ' HG13 ' B' ' 64' ' ' VAL . 2.2 m-30 -71.38 -48.98 46.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.0 110.294 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.49 -33.91 73.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 110.446 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.585 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -61.44 -59.77 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 109.867 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' B' ' 231' ' ' TYR . 35.8 t80 -56.27 -26.83 53.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 109.836 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -32.26 73.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 0.0 109.871 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -94.75 -13.17 25.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.787 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.755 HG13 HD22 ' B' ' 204' ' ' LEU . 6.0 mm -96.77 -23.94 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.36 -0.837 . . . . 0.0 109.83 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.591 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 10.3 t80 -58.43 -42.3 93.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 0.0 110.966 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.2 Cg_endo -76.33 -31.17 4.76 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.416 1.219 . . . . 0.0 110.755 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.566 ' CG1' HD11 ' B' ' 175' ' ' LEU . 39.5 t -67.27 -35.89 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.135 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 1.022 HD22 HD13 ' B' ' 170' ' ' ILE . 18.3 mt -71.88 -39.72 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -0.938 . . . . 0.0 110.057 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.51 80.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 110.024 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.87 -39.92 91.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.343 -0.848 . . . . 0.0 110.006 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.458 ' HB2' ' CD2' ' B' ' 175' ' ' LEU . 84.4 m-85 -110.04 37.78 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.964 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 177.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -121.54 -51.42 2.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 110.094 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.225 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.18 0.514 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.71 -56.49 0.03 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.97 59.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.222 -1.163 . . . . 0.0 110.276 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 14' ' ' ILE . 1.0 OUTLIER -89.88 56.16 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 0.0 110.149 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . 162.86 -37.14 0.34 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 53.7 t-20 60.78 127.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.326 -1.102 . . . . 0.0 110.339 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.518 ' CA ' ' CZ ' ' B' ' 99' ' ' PHE . . . -72.57 -148.97 0.91 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.731 HD21 ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -77.49 161.61 27.8 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.186 -1.185 . . . . 0.0 109.701 -179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 2.6 m-20 -63.7 71.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.052 -1.03 . . . . 0.0 110.207 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.731 ' CD2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -86.65 8.98 20.09 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.35 -0.844 . . . . 0.0 111.322 -179.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.871 HG22 HG23 ' A' ' 56' ' ' ILE . 10.4 m -54.96 -18.87 5.59 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.689 -1.204 . . . . 0.0 109.467 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.645 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -100.43 -36.2 4.16 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.573 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 28' ' ' ILE . 1.1 mm -46.68 -47.42 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.802 -1.411 . . . . 0.0 108.985 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.072 HD11 ' CD1' ' A' ' 64' ' ' LEU . 2.0 pp -82.91 -28.06 30.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 0.0 110.404 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CE1' ' CD1' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -86.97 8.71 22.07 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.203 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.653 ' O ' HG23 ' A' ' 28' ' ' ILE . . . 141.57 98.54 0.33 Allowed Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.72 ' HB3' HG23 ' B' ' 124' ' ' THR . 0.2 OUTLIER -16.75 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.91 0.862 . . . . 0.0 111.436 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.897 HG22 HD22 ' A' ' 34' ' ' LEU . 2.3 pp -138.07 166.81 23.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 O-C-N 121.464 -0.773 . . . . 0.0 109.443 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.743 ' C ' HD12 ' A' ' 28' ' ' ILE . 80.6 m-20 -87.11 116.71 25.35 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 175.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.529 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -36.28 -28.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.484 0.659 . . . . 0.0 110.157 -177.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 29' ' ' ASP . 1.9 tt0 -57.04 -13.03 2.42 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.962 -1.086 . . . . 0.0 110.544 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.28 24.37 5.7 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.052 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.565 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -109.83 124.23 50.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -1.155 . . . . 0.0 109.235 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.03 HD13 ' N ' ' A' ' 35' ' ' LEU . 3.2 tm? -87.55 150.57 23.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.521 -0.737 . . . . 0.0 111.066 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.03 ' N ' HD13 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -86.72 106.46 17.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.053 -1.029 . . . . 0.0 111.23 -179.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -90.05 8.38 32.93 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.5 t70 50.92 -165.86 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.729 -0.607 . . . . 0.0 110.483 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.14 52.14 1.91 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.142 -0.974 . . . . 0.0 110.34 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.79 41.67 2.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -123.22 58.8 0.62 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -96.43 75.5 2.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -1.132 . . . . 0.0 110.206 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.44 22.97 4.6 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 47.18 -168.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -1.171 . . . . 0.0 110.202 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.45 5.67 8.44 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.17 70.12 0.28 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.0 p -59.8 159.97 8.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.236 -1.155 . . . . 0.0 110.125 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.53 -99.6 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.495 ' CD1' HD12 ' A' ' 52' ' ' LEU . 9.5 m-85 -85.79 101.66 12.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -1.121 . . . . 0.0 109.944 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 51' ' ' GLU . 19.7 p-10 -68.47 -158.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.74 23.25 2.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.839 . . . . 0.0 110.158 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 2.7 tt0 -93.42 -33.7 13.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.533 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 1.8 mt -90.97 -41.2 11.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.361 -0.837 . . . . 0.0 110.064 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.974 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.51 -50.26 17.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.54 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -68.29 -29.48 68.27 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.702 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.53 ' C ' HD23 ' A' ' 59' ' ' LEU . 8.4 m-80 -77.82 -40.58 40.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -0.851 . . . . 0.0 109.809 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.974 HD12 ' HA ' ' A' ' 53' ' ' ARG . 23.0 mt -49.97 -47.38 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.54 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.32 0.07 69.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.33 -46.57 3.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -1.143 . . . . 0.0 110.437 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.785 HD22 ' CE2' ' B' ' 190' ' ' PHE . 0.5 OUTLIER -85.98 44.54 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 0.0 110.421 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 t -84.86 22.36 1.39 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.194 -0.941 . . . . 0.0 109.739 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' C ' HD23 ' A' ' 62' ' ' LEU . 1.8 pttt -152.68 8.04 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 111.195 -179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 62' ' ' LEU . 3.0 mt -86.37 -34.68 20.15 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.621 -1.299 . . . . 0.0 109.852 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.48 -35.25 0.04 OUTLIER Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.072 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.8 mm? -56.92 -28.25 61.85 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.21 -1.171 . . . . 0.0 110.709 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 64' ' ' LEU . 11.5 t0 -43.67 -38.67 3.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.471 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 8.0 m -70.73 -51.01 30.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.374 -0.828 . . . . 0.0 110.088 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.827 ' HG2' HD13 ' A' ' 24' ' ' LEU . 3.5 tpp -65.38 -12.73 55.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.769 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -72.69 -64.03 1.04 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.344 -0.848 . . . . 0.0 109.719 179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 66' ' ' SER . 2.7 pp -60.85 -12.15 10.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.583 -0.698 . . . . 0.0 110.022 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -80.62 2.69 24.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.351 -0.843 . . . . 0.0 110.621 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.065 HG12 HG11 ' B' ' 122' ' ' VAL . 1.5 t -140.04 3.63 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.046 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.759 HG23 ' O ' ' A' ' 72' ' ' ILE . 2.6 tp -148.64 67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 110.396 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 11.1 t0 -77.1 53.54 0.98 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.975 -1.078 . . . . 0.0 109.359 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.959 HD11 ' CE1' ' B' ' 116' ' ' PHE . 1.5 mt -97.72 53.6 1.13 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -78.96 165.8 23.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.0 110.257 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -72.16 74.64 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.2 -0.938 . . . . 0.0 110.272 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.205 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.295 0.569 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.55 25.8 0.25 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' B' ' 64' ' ' VAL . 2.9 mp -121.77 -65.63 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -1.156 . . . . 0.0 110.29 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' B' ' 63' ' ' ILE . 91.5 t 58.03 119.62 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.482 -0.761 . . . . 0.0 110.25 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.604 ' HG2' HG22 ' B' ' 223' ' ' ILE . 43.4 Cg_endo -71.13 134.46 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.793 1.417 . . . . 0.0 110.407 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.6 m -96.82 137.5 35.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 110.379 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' B' ' 161' ' ' VAL . 33.2 mt -70.67 139.36 51.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -126.48 -5.64 6.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.104 -0.997 . . . . 0.0 110.655 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.478 ' ND2' ' C ' ' B' ' 69' ' ' ASN . 0.4 OUTLIER -168.41 124.53 1.0 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.0 -1.063 . . . . 0.0 110.755 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' B' ' 124' ' ' THR . 11.5 mm -108.89 147.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.484 -0.76 . . . . 0.0 109.311 179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 25.5 t -134.61 135.7 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.956 -1.09 . . . . 0.0 110.456 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -141.52 155.43 45.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 110.316 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 60.6 m -104.47 126.93 52.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 110.227 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 28.3 t -126.67 138.54 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.86 . . . . 0.0 109.926 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' B' ' 154' ' ' ASP . 9.5 m -109.65 145.86 35.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.469 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.553 ' CD1' HD11 ' B' ' 80' ' ' LEU . 59.3 mt -96.53 -30.13 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 109.751 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' B' ' 78' ' ' CYS . . . 80.52 32.48 34.0 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . 0.432 ' SG ' ' O ' ' B' ' 77' ' ' GLY . 1.2 m -166.29 164.88 17.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.224 -1.162 . . . . 0.0 110.273 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.811 ' O ' HD23 ' B' ' 80' ' ' LEU . 0.1 OUTLIER -91.82 152.71 20.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.0 110.113 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.811 HD23 ' O ' ' B' ' 79' ' ' ARG . 22.5 mt -138.95 163.88 31.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.422 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 2.8 t70 -108.74 97.92 7.5 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.526 -0.734 . . . . 0.0 109.518 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.46 HD22 HG23 ' B' ' 102' ' ' VAL . 14.3 mt -40.94 -35.78 0.57 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.361 -0.837 . . . . 0.0 110.295 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.45 -48.2 73.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.216 -0.927 . . . . 0.0 109.847 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' B' ' 88' ' ' HIS . 60.8 m -66.18 -37.78 86.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.326 -0.859 . . . . 0.0 109.995 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.622 HG12 HG11 ' B' ' 102' ' ' VAL . 22.7 t -72.88 -46.12 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.978 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.71 -13.01 61.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.032 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 tp -99.27 -29.64 12.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.33 -0.857 . . . . 0.0 110.231 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' B' ' 84' ' ' THR . 0.2 OUTLIER -99.81 -20.89 15.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.285 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -61.74 151.65 33.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 110.144 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -85.65 -37.8 19.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.219 -0.926 . . . . 0.0 110.195 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -131.38 78.76 1.85 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.593 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -146.92 160.51 42.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.865 . . . . 0.0 110.725 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.533 ' O ' HD12 ' B' ' 103' ' ' ILE . 3.0 mt-10 -137.35 157.62 46.21 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.343 -0.848 . . . . 0.0 109.939 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -147.44 101.48 3.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.222 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.539 ' O ' ' HG3' ' B' ' 98' ' ' ARG . 1.5 m-20 -109.86 121.16 42.8 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.237 -0.915 . . . . 0.0 110.433 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.63 -10.83 20.33 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 123.704 1.37 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -87.21 10.74 16.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.519 -0.738 . . . . 0.0 111.155 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' B' ' 95' ' ' ASN . 1.0 OUTLIER -139.68 -43.65 0.44 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.826 -1.172 . . . . 0.0 110.799 179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.698 ' CD2' ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -170.35 168.89 7.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.079 -1.013 . . . . 0.0 110.25 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.39 55.16 1.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 110.133 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.83 ' HB2' HD13 ' A' ' 74' ' ' LEU . . . -136.24 158.51 44.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 111.155 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.622 HG11 HG12 ' B' ' 85' ' ' VAL . 49.0 t -102.58 122.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.473 -0.767 . . . . 0.0 109.184 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.695 HD12 ' H ' ' B' ' 103' ' ' ILE . 3.6 mp -89.36 109.18 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.471 ' SD ' HD11 ' B' ' 115' ' ' ILE . 3.2 ttm -91.57 160.89 15.18 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 110.187 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.2 112.0 3.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.117 -0.989 . . . . 0.0 110.591 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.676 HD11 ' OG1' ' B' ' 111' ' ' THR . 44.5 pt -101.91 167.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -125.64 33.08 5.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.101 -0.999 . . . . 0.0 110.486 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 3.3 tt0 -178.89 83.35 0.22 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 49.5 Cg_endo -78.79 151.44 88.32 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.786 -2.173 . . . . 0.0 110.33 -0.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.455 ' C ' HG23 ' B' ' 111' ' ' THR . 7.1 mttt -61.53 110.15 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.192 -0.943 . . . . 0.0 109.8 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.676 ' OG1' HD11 ' B' ' 106' ' ' ILE . 74.0 p -148.57 175.17 11.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.907 . . . . 0.0 110.582 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 28' ' ' ILE . 1.0 OUTLIER -126.67 162.81 24.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.755 . . . . 0.0 109.416 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -156.35 133.4 10.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.392 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.805 HD12 ' CG1' ' B' ' 122' ' ' VAL . 0.2 OUTLIER -97.92 105.8 18.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.149 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.471 HD11 ' SD ' ' B' ' 104' ' ' MET . 9.7 mt -90.78 140.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.023 -1.048 . . . . 0.0 110.957 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.959 ' CE1' HD11 ' A' ' 74' ' ' LEU . 1.4 m-85 -111.31 159.42 17.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.479 -0.763 . . . . 0.0 109.585 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -77.94 -4.59 47.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 45.7 p -83.47 -15.2 50.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.45 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.406 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 114.02 -18.66 18.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -84.11 154.32 23.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 110.009 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . . . . . . . . . 50.9 ttp -149.42 149.2 30.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.166 -0.958 . . . . 0.0 110.333 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 1.065 HG11 HG12 ' A' ' 71' ' ' VAL . 7.3 t -116.21 141.18 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.898 . . . . 0.0 109.723 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 22.9 t -114.12 157.18 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 110.789 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 27' ' ' ASN . 14.6 t -167.73 147.76 5.07 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.652 -0.655 . . . . 0.0 109.433 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.546 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 123.09 -25.97 6.24 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -66.18 160.59 23.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -1.207 . . . . 0.0 110.336 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -120.15 4.38 10.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.233 -0.917 . . . . 0.0 110.143 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 131' ' ' ASP . 0.5 OUTLIER -158.1 162.55 38.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.361 -0.837 . . . . 0.0 110.034 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -56.12 -48.65 75.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.217 -0.927 . . . . 0.0 110.178 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.57 -29.27 70.47 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.375 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' B' ' 128' ' ' SER . 88.7 m-20 -65.81 -60.75 2.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.905 . . . . 0.0 110.42 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 60.3 p -61.68 -33.31 73.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.16 -44.64 75.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 110.23 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.78 -54.16 6.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 110.124 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.408 ' O ' ' CD2' ' B' ' 139' ' ' TYR . . . -45.96 -39.64 9.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.978 . . . . 0.0 109.829 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.8 m -63.1 -56.3 18.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -54.06 -32.94 56.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.841 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.5 ' N ' ' HD2' ' B' ' 138' ' ' LYS . 9.3 mptt -69.14 -42.09 76.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.952 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.834 ' HA ' HD12 ' B' ' 142' ' ' ILE . 22.3 m-85 -61.98 -47.66 83.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.15 75.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.347 -0.845 . . . . 0.0 109.933 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.65 -40.92 88.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.897 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.834 HD12 ' HA ' ' B' ' 139' ' ' TYR . 59.0 mt -54.02 -45.79 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.593 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' B' ' 150' ' ' ALA . 21.0 mm -65.37 -46.83 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.171 -0.956 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' B' ' 150' ' ' ALA . 29.4 mt-30 -66.63 -28.79 68.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.845 . . . . 0.0 109.525 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.79 -23.37 55.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 1.5 mt -81.47 -25.02 10.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 128.13 -32.66 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' B' ' 80' ' ' LEU . 12.5 m-85 -46.62 162.15 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.08 -1.247 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.93 44.48 1.03 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 0.0 110.169 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.608 ' HB2' HG21 ' B' ' 143' ' ' ILE . . . -81.44 154.56 26.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.72 -166.55 1.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.845 ' O ' HG23 ' B' ' 153' ' ' THR . 73.3 t80 -129.87 118.38 21.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -0.975 . . . . 0.0 110.141 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.845 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.6 OUTLIER -167.8 174.0 7.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.171 -0.956 . . . . 0.0 110.529 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.463 ' HB2' ' HB ' ' B' ' 75' ' ' THR . 4.0 m-20 52.15 42.48 30.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.614 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' B' ' 155' ' ' PHE . 8.4 t80 -90.13 132.71 35.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -0.928 . . . . 0.0 109.9 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.33 134.84 1.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 110.39 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 4.4 mt -78.9 124.24 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.82 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.72 -4.11 11.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.284 -0.885 . . . . 0.0 110.893 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.506 ' ND2' ' SD ' ' A' ' 67' ' ' MET . 28.6 t-20 -152.8 131.46 12.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.86 -1.15 . . . . 0.0 110.607 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.572 HG22 ' N ' ' B' ' 161' ' ' VAL . 7.0 mt -124.37 171.55 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.508 -0.745 . . . . 0.0 109.672 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.644 HG22 ' OG1' ' B' ' 215' ' ' THR . 72.8 t -144.11 128.89 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.014 -1.053 . . . . 0.0 110.884 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -134.02 165.18 24.37 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 4.8 t -165.45 149.85 8.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.028 -1.277 . . . . 0.0 110.37 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.0 OUTLIER -170.2 173.99 5.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 110.281 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -113.92 168.83 9.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.148 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.598 HG12 ' HE1' ' B' ' 231' ' ' TYR . 0.0 OUTLIER -112.74 -80.98 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.249 -0.907 . . . . 0.0 110.279 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.456 ' H ' HG23 ' B' ' 166' ' ' VAL . 4.7 tmtt? 177.96 -27.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.019 -1.051 . . . . 0.0 110.682 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.477 ' HB2' ' OXT' ' B' ' 240' ' ' MET . 13.7 p90 -131.29 158.09 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.131 -0.981 . . . . 0.0 109.705 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.8 Cg_endo -72.74 152.71 53.33 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.85 1.447 . . . . 0.0 110.072 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.472 HD13 HD22 ' B' ' 234' ' ' LEU . 4.0 mt -119.84 158.08 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.503 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . 0.467 ' NE ' ' HG3' ' B' ' 239' ' ' LYS . 6.5 mtt-85 -95.82 99.27 11.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 110.02 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' B' ' 191' ' ' PRO . 45.9 mt -50.08 -33.03 17.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' B' ' 174' ' ' GLY . 4.3 mt-10 -68.08 -56.38 9.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.165 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' B' ' 173' ' ' GLU . . . -44.35 -30.25 1.95 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.856 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.2 OUTLIER -80.86 -59.04 2.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 110.254 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' B' ' 185' ' ' TYR . . . -54.14 -24.39 17.72 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.339 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -78.47 -46.82 18.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.046 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 5.0 t -79.63 -58.43 3.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.253 -0.904 . . . . 0.0 110.037 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.571 ' HE1' HG22 ' B' ' 233' ' ' VAL . 16.5 m170 -92.63 36.43 1.01 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -0.905 . . . . 0.0 110.036 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -61.48 -13.54 37.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.97 -14.64 38.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -1.2 . . . . 0.0 110.306 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 -6.37 8.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.276 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.674 ' HB2' HD21 ' B' ' 193' ' ' LEU . 82.6 p -133.66 164.19 27.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.433 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . 0.471 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 14.7 m -135.13 147.43 49.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.133 -0.98 . . . . 0.0 110.07 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 0.476 ' HB2' ' HB2' ' B' ' 176' ' ' ALA . 16.1 t80 -133.77 115.98 15.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.881 . . . . 0.0 110.163 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 190' ' ' PHE . 9.3 mm-40 -115.87 92.75 35.59 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.202 -0.937 . . . . 0.0 109.737 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.89 -9.91 26.62 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 123.993 1.522 . . . . 0.0 110.356 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -9.57 21.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 110.053 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.632 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.7 tt -153.08 19.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 110.46 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.785 ' CE2' HD22 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -170.07 113.54 0.48 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.992 . . . . 0.0 110.317 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' B' ' 172' ' ' LEU . 44.7 Cg_endo -72.04 -37.28 4.96 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.048 1.552 . . . . 0.0 110.552 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -91.32 179.32 42.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.674 HD21 ' HB2' ' B' ' 183' ' ' SER . 3.1 tt -116.32 138.64 51.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -1.121 . . . . 0.0 110.225 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.469 HD11 ' CE2' ' B' ' 190' ' ' PHE . 25.1 mt -93.51 111.06 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -101.35 117.21 34.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.241 -0.912 . . . . 0.0 109.929 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.12 89.24 7.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.0 110.378 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.403 ' HB2' HD13 ' B' ' 204' ' ' LEU . 52.0 tpp -53.22 128.44 27.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 110.062 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 94.1 t -68.6 -47.28 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.29 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.5 OUTLIER -146.28 123.83 6.09 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.941 . . . . 0.0 110.246 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.8 Cg_endo -73.44 155.2 99.8 Favored 'Cis proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.891 -2.129 . . . . 0.0 110.321 -0.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.482 ' O ' HG13 ' B' ' 202' ' ' ILE . 16.2 tttt -56.64 112.03 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.223 -0.923 . . . . 0.0 110.274 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.482 HG13 ' O ' ' B' ' 201' ' ' LYS . 4.7 mt -158.58 154.72 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 0.0 110.471 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.6 114.99 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.39 -0.818 . . . . 0.0 109.479 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.538 ' N ' HD12 ' B' ' 204' ' ' LEU . 6.2 mp -101.53 135.09 43.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 110.95 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.506 HD13 ' HA ' ' B' ' 205' ' ' LEU . 0.9 OUTLIER -103.24 119.14 38.31 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.824 . . . . 0.0 109.535 179.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . . . . . . . . . 13.7 mm -105.16 147.16 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.094 -1.004 . . . . 0.0 110.566 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.521 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 21.0 m-85 -132.53 141.14 48.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 110.063 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.607 HG23 ' H ' ' B' ' 209' ' ' SER . 0.8 OUTLIER -46.48 -54.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 110.105 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.607 ' H ' HG23 ' B' ' 208' ' ' VAL . 68.2 m -39.2 -36.9 0.36 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.317 0.579 . . . . 0.0 110.187 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 118.01 24.23 3.36 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.528 ' O ' HD13 ' B' ' 212' ' ' ILE . 1.9 mttm -97.53 134.61 40.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -1.223 . . . . 0.0 110.099 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.528 HD13 ' O ' ' B' ' 211' ' ' LYS . 15.8 mm -119.82 138.45 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 0.0 110.402 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.462 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 59.6 t -128.41 132.32 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.87 . . . . 0.0 110.233 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.48 ' HB2' HD12 ' B' ' 223' ' ' ILE . 2.6 mp -118.77 119.14 33.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 110.16 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.644 ' OG1' HG22 ' B' ' 161' ' ' VAL . 12.6 t -139.0 157.67 45.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 110.241 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 92.71 14.38 55.34 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.659 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -83.92 144.42 29.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -1.09 . . . . 0.0 110.276 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -81.44 -7.28 59.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 110.03 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.567 ' C ' HD12 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -169.37 -176.69 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -73.98 -45.42 50.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.213 -0.929 . . . . 0.0 110.116 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.449 ' HG3' ' OE1' ' B' ' 222' ' ' GLU . 24.0 pt-20 -49.74 -32.76 14.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 110.165 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.659 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 8.7 mm-40 -61.17 -49.14 78.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.942 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.604 HG22 ' HG2' ' B' ' 65' ' ' PRO . 47.8 mm -59.43 -36.14 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 110.145 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -65.28 -35.54 81.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.47 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -82.08 -41.46 20.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.418 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.84 -34.4 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -0.908 . . . . 0.0 110.247 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.685 ' HA ' HG22 ' B' ' 230' ' ' ILE . 18.1 t80 -76.18 -49.45 17.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.366 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.81 -23.04 40.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.163 -0.96 . . . . 0.0 110.479 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.18 -24.78 19.83 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.114 -0.992 . . . . 0.0 110.255 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' B' ' 227' ' ' PHE . 6.6 tp -100.28 -17.98 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.181 -0.949 . . . . 0.0 110.341 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.632 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 7.6 t80 -55.1 -43.63 99.17 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 0.0 111.144 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.8 Cg_endo -72.87 -42.68 1.01 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.312 1.164 . . . . 0.0 110.343 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.856 ' CG1' HD11 ' B' ' 175' ' ' LEU . 40.6 t -53.97 -42.69 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.972 . . . . 0.0 109.682 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.472 HD22 HD13 ' B' ' 170' ' ' ILE . 81.9 mt -65.01 -58.16 6.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 109.966 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -52.9 -30.94 37.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.932 . . . . 0.0 110.035 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.71 -36.85 84.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.939 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.441 ' CD2' HD22 ' B' ' 175' ' ' LEU . 94.8 m-85 -113.04 41.47 2.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 109.991 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' B' ' 235' ' ' SER . 1.5 ptt180 -74.56 -176.14 2.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.38 -0.825 . . . . 0.0 110.551 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.499 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 6.2 ttmt -125.33 -29.46 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.834 . . . . 0.0 109.979 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . 0.477 ' OXT' ' HB2' ' B' ' 168' ' ' PHE . 10.8 mtp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.139 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.306 0.574 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.62 -109.76 0.46 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 14' ' ' ILE . 0.6 OUTLIER -166.89 -49.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -1.111 . . . . 0.0 110.03 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 13' ' ' SER . 30.8 mm 57.68 84.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 110.325 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 16' ' ' ASN . . . 128.97 31.76 0.62 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 27.9 m-20 -167.44 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -1.217 . . . . 0.0 110.216 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.677 ' HA3' HG23 ' A' ' 72' ' ' ILE . . . -145.52 158.8 27.77 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.97 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -67.8 -176.12 0.62 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.132 -1.216 . . . . 0.0 109.974 -179.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.442 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 4.8 t70 -76.1 96.27 3.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.049 -1.032 . . . . 0.0 111.1 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.043 HD13 HG21 ' A' ' 23' ' ' ILE . 2.0 mt -99.06 12.2 36.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.078 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.718 HG23 HG23 ' A' ' 56' ' ' ILE . 1.3 t -40.93 -33.63 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.417 -0.802 . . . . 0.0 109.635 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -98.51 -31.55 6.38 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.043 HG21 HD13 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -47.39 -44.38 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.685 -1.479 . . . . 0.0 109.084 -179.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.68 HD21 ' CD2' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -82.84 -22.56 34.06 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.022 -1.049 . . . . 0.0 109.0 178.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.594 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -92.77 11.09 28.14 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 28' ' ' ILE . . . 143.64 98.67 0.28 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.995 ' OD1' HD11 ' A' ' 35' ' ' LEU . 12.7 p-10 -30.73 90.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 122.05 0.928 . . . . 0.0 111.832 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.631 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -92.6 164.16 2.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 177.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 28' ' ' ILE . 26.0 m-20 -85.59 123.85 31.47 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.698 ' HA ' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -37.03 -29.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.363 0.601 . . . . 0.0 109.825 -178.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' ASP . 25.9 tt0 -54.85 -16.13 2.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.907 . . . . 0.0 110.147 178.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.09 27.97 4.61 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.049 -1.072 . . . . 0.0 110.589 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -123.27 126.41 46.87 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.998 -1.295 . . . . 0.0 110.557 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.86 HD13 HD13 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -98.95 155.34 17.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.688 -1.257 . . . . 0.0 110.645 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.995 HD11 ' OD1' ' A' ' 27' ' ' ASN . 3.3 pp -124.66 -179.29 4.44 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.117 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.453 ' OE1' ' HB2' ' A' ' 49' ' ' ASP . 5.8 mt-30 -118.06 135.48 54.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.679 -0.638 . . . . 0.0 109.778 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' OD2' ' HA2' ' B' ' 125' ' ' GLY . 47.0 m-20 -108.02 -16.25 14.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 110.581 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -97.79 172.05 7.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 110.316 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -69.11 173.93 5.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.955 . . . . 0.0 109.885 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.95 105.47 3.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.461 ' CG ' ' O ' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -144.8 23.86 1.54 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -1.132 . . . . 0.0 110.105 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.72 -121.57 0.18 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -128.9 65.45 1.44 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -1.203 . . . . 0.0 110.295 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.94 -129.08 20.86 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.19 -99.15 0.69 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.29 101.86 13.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.179 -1.189 . . . . 0.0 110.272 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.95 127.42 1.5 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 16.4 p90 -82.89 2.92 32.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.262 -1.14 . . . . 0.0 110.217 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 50' ' ' ALA . 13.0 p-10 -48.17 -42.37 29.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.239 -0.913 . . . . 0.0 110.194 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' N ' ' OD1' ' A' ' 49' ' ' ASP . . . -96.57 10.37 38.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.423 -0.798 . . . . 0.0 110.073 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 41.8 tt0 -100.59 -29.86 12.1 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.633 HD21 ' CD1' ' B' ' 205' ' ' LEU . 3.4 mt -98.58 -45.31 6.13 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 110.009 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -45.04 -49.05 11.7 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.348 -0.845 . . . . 0.0 109.763 -179.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -64.14 -20.7 66.17 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.719 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 76.5 m-20 -91.34 -38.12 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.351 -0.843 . . . . 0.0 109.653 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.86 HD13 HD13 ' A' ' 34' ' ' LEU . 3.2 mt -47.71 -43.49 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.95 -17.18 28.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.7 OUTLIER -138.39 35.54 2.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.168 -1.195 . . . . 0.0 110.468 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.065 ' CD2' HD11 ' A' ' 62' ' ' LEU . 12.2 mt -102.58 21.18 15.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.245 -0.909 . . . . 0.0 110.159 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.11 45.21 1.26 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.548 ' C ' HD23 ' A' ' 62' ' ' LEU . 21.7 ttpt -150.28 15.84 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 109.892 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.065 HD11 ' CD2' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -93.75 -31.83 14.25 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.28 -0.888 . . . . 0.0 109.768 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.53 1.77 7.64 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.949 HD12 HD21 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -95.28 0.19 53.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 110.2 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.539 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . 22.6 m-20 -46.2 -41.93 13.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.662 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.666 ' HA ' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -60.61 -35.36 75.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.454 -0.779 . . . . 0.0 109.894 179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.526 ' HE3' ' HB2' ' A' ' 64' ' ' LEU . 4.9 ttp -69.0 -18.98 64.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.663 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.949 HD21 HD12 ' A' ' 64' ' ' LEU . 7.4 mt -71.96 -60.18 2.36 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.526 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 66' ' ' SER . 2.7 pp -62.61 -9.02 7.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.687 -0.633 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -85.58 5.74 30.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.124 -0.985 . . . . 0.0 110.619 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.866 ' O ' HG21 ' B' ' 122' ' ' VAL . 0.7 OUTLIER -132.49 0.93 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.756 179.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.956 ' HB ' HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -150.94 66.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.611 -0.681 . . . . 0.0 110.08 -179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.3 p-10 -76.72 54.67 0.99 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.622 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.932 ' CD2' ' HB2' ' B' ' 101' ' ' ALA . 0.6 OUTLIER -89.75 54.77 2.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 110.751 -179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -96.59 121.24 38.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.078 -1.014 . . . . 0.0 110.16 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 1.7 mt-10 59.61 -157.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.928 . . . . 0.0 110.124 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.309 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.245 0.545 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -169.87 -41.0 0.03 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.552 HG22 ' N ' ' B' ' 64' ' ' VAL . 92.4 mt -90.15 169.79 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.26 -1.141 . . . . 0.0 110.147 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.552 ' N ' HG22 ' B' ' 63' ' ' ILE . 91.4 t -143.2 139.55 16.79 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.228 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.41 ' HD2' HG13 ' B' ' 64' ' ' VAL . 46.2 Cg_endo -73.12 122.57 8.16 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.0 110.177 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 67.7 m -91.07 132.38 36.07 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.507 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.848 HD11 ' HD2' ' B' ' 220' ' ' ARG . 34.2 mt -70.27 133.82 47.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.883 . . . . 0.0 109.89 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -121.18 -15.99 8.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 110.662 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.448 ' HB3' ' HB ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -161.38 119.53 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.115 -0.991 . . . . 0.0 110.595 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.951 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 13.8 mm -104.25 157.07 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.803 . . . . 0.0 109.87 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' B' ' 159' ' ' ASN . 30.8 t -135.9 136.85 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -148.8 166.29 28.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.34 -0.85 . . . . 0.0 110.208 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . 0.701 HG23 HG22 ' B' ' 122' ' ' VAL . 0.0 OUTLIER -119.01 151.93 37.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 110.107 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.51 151.3 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.292 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 88.2 m -118.34 142.35 47.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.33 -0.856 . . . . 0.0 110.022 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.789 HD13 ' HB1' ' B' ' 150' ' ' ALA . 49.4 mt -89.84 -61.1 1.76 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.77 4.75 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 1.3 m -162.3 151.28 15.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -1.172 . . . . 0.0 110.167 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.761 ' O ' HD23 ' B' ' 80' ' ' LEU . 18.1 ttp85 -71.46 155.55 40.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.242 -0.911 . . . . 0.0 110.24 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' B' ' 76' ' ' LEU . 44.6 mt -138.07 148.91 45.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 110.274 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' B' ' 84' ' ' THR . 29.9 t70 -89.81 95.59 10.31 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 110.013 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.453 HD22 HG23 ' B' ' 102' ' ' VAL . 14.5 mt -42.68 -48.61 5.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.351 -0.843 . . . . 0.0 110.181 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -46.13 61.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.864 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 9.0 m -76.46 -48.37 19.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.347 -0.846 . . . . 0.0 110.232 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.445 HG22 ' CE2' ' B' ' 148' ' ' PHE . 95.8 t -54.62 -50.42 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 0.0 110.236 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.08 -20.54 64.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.183 -0.948 . . . . 0.0 110.005 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 14.5 tp -88.27 -37.62 15.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.246 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.71 -26.78 29.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.892 . . . . 0.0 110.485 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -65.31 140.27 58.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 110.375 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -76.07 -27.05 57.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.402 -0.811 . . . . 0.0 109.983 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 105' ' ' ARG . 0.7 OUTLIER -132.54 79.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.946 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.818 ' HB2' ' HG3' ' B' ' 104' ' ' MET . . . -163.89 167.75 20.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.114 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.407 ' O ' HD12 ' B' ' 103' ' ' ILE . 17.3 pt-20 -161.27 141.04 10.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 110.135 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.405 ' HB2' HG22 ' B' ' 102' ' ' VAL . 30.3 t80 -114.06 105.4 13.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.274 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -102.67 105.35 43.98 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.911 . . . . 0.0 109.904 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.73 -16.58 33.48 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.986 1.519 . . . . 0.0 110.324 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -73.07 -27.54 61.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.811 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.71 -72.09 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.369 -0.832 . . . . 0.0 109.986 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.656 ' CZ ' ' N ' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -138.55 -177.28 4.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.31 44.58 1.0 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 110.116 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.932 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . . . -131.18 165.02 24.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.924 . . . . 0.0 110.563 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.453 HG23 HD22 ' B' ' 82' ' ' LEU . 57.9 t -102.97 123.64 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.354 -0.841 . . . . 0.0 109.586 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.5 mp -89.29 122.47 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.865 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.818 ' HG3' ' HB2' ' B' ' 92' ' ' ALA . 9.8 ttm -115.81 166.09 12.34 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.348 -0.845 . . . . 0.0 110.514 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' B' ' 111' ' ' THR . 3.9 ttt85 -164.71 118.98 1.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.974 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 12.9 pt -112.71 170.2 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 110.376 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.89 38.16 3.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.808 . . . . 0.0 109.799 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.2 tt0 -174.17 79.33 0.36 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 110.507 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 53.0 Cg_endo -83.65 162.47 70.67 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.795 -2.169 . . . . 0.0 110.444 -0.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.569 ' O ' HG23 ' B' ' 111' ' ' THR . 21.5 mttt -61.81 106.7 0.72 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.933 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.569 HG23 ' O ' ' B' ' 110' ' ' LYS . 20.7 p -156.45 173.33 17.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.163 -0.96 . . . . 0.0 110.656 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.607 HG22 HG23 ' B' ' 124' ' ' THR . 0.4 OUTLIER -121.97 -179.51 4.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.357 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.674 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -167.19 122.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 0.0 111.218 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.638 HD22 HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -89.87 103.29 15.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 178.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.442 ' HA ' ' HB3' ' B' ' 121' ' ' MET . 15.8 mt -91.05 141.58 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.114 -0.991 . . . . 0.0 111.468 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.898 ' CE1' HD11 ' A' ' 74' ' ' LEU . 1.8 m-85 -110.6 151.46 27.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.697 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.46 66.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.098 -1.001 . . . . 0.0 110.295 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.0 p -71.04 -3.94 22.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -0.925 . . . . 0.0 110.38 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.18 -28.36 16.27 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -73.2 163.99 27.33 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.385 -1.068 . . . . 0.0 110.099 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.442 ' HB3' ' HA ' ' B' ' 115' ' ' ILE . 0.0 OUTLIER -167.44 176.02 6.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 110.274 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.866 HG21 ' O ' ' A' ' 71' ' ' VAL . 9.3 t -132.15 160.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.876 . . . . 0.0 110.326 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.623 HG13 ' HE2' ' B' ' 139' ' ' TYR . 81.8 t -140.46 131.79 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.386 -0.821 . . . . 0.0 110.049 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.76 HG23 ' CB ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER -142.15 173.28 11.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.274 -0.891 . . . . 0.0 110.3 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.559 ' HA3' ' ND2' ' A' ' 27' ' ' ASN . . . 100.33 -18.82 54.87 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.951 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -54.81 162.77 1.13 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -1.158 . . . . 0.0 110.456 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.46 13.33 16.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.238 -0.914 . . . . 0.0 110.192 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.66 -164.86 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.452 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.76 -43.91 16.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.899 . . . . 0.0 110.264 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.17 -28.94 69.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.303 -0.873 . . . . 0.0 110.26 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.42 -53.41 12.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 110.187 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 88.8 p -49.97 -37.37 32.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.356 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt -66.71 -40.41 88.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.298 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' B' ' 138' ' ' LYS . 0.3 OUTLIER -70.85 -50.65 32.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.342 -179.799 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' B' ' 109' ' ' PRO . . . -53.21 -34.46 57.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 110.316 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 52.4 m -68.71 -56.52 7.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.231 -0.918 . . . . 0.0 110.24 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -48.08 -37.0 14.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.97 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.475 ' O ' HG12 ' B' ' 142' ' ' ILE . 9.8 mmtp -59.6 -51.62 69.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.761 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.674 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 26.2 m-85 -58.3 -54.72 43.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.393 -0.817 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . 0.425 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -52.54 -24.42 8.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 109.83 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.509 ' HG2' ' HE3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -79.23 -39.66 32.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.976 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.475 HG12 ' O ' ' B' ' 138' ' ' LYS . 25.1 mm -54.03 -47.34 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.881 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.754 HD13 HD13 ' B' ' 80' ' ' LEU . 51.0 mt -71.59 -41.09 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.914 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.452 ' CG ' ' O ' ' B' ' 150' ' ' ALA . 27.5 mt-30 -68.25 -38.92 82.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 109.852 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.509 ' HE3' ' HG2' ' B' ' 141' ' ' ARG . 0.5 OUTLIER -70.44 -20.74 62.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.9 mt -81.99 -16.23 11.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 111.75 -23.03 18.2 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.702 ' CB ' HG22 ' B' ' 143' ' ' ILE . 8.6 m-85 -50.13 176.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -1.203 . . . . 0.0 110.859 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.67 42.64 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.735 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.789 ' HB1' HD13 ' B' ' 76' ' ' LEU . . . -88.23 125.94 34.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 110.635 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.596 ' O ' HD23 ' B' ' 76' ' ' LEU . 0.0 OUTLIER -100.73 -152.83 0.43 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.359 -0.838 . . . . 0.0 109.887 179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.546 ' O ' HG23 ' B' ' 153' ' ' THR . 18.9 t80 -151.33 110.91 4.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.546 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.0 OUTLIER -165.26 -173.4 2.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 110.319 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.04 27.81 7.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.253 -0.904 . . . . 0.0 110.399 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' B' ' 73' ' ' THR . 10.6 t80 -74.06 136.63 43.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 0.0 109.92 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.06 133.98 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.978 . . . . 0.0 110.517 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 31.9 mt -79.84 135.29 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.984 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.401 ' HA ' ' HG2' ' B' ' 218' ' ' LYS . 31.9 mm-40 -121.77 -18.87 6.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 110.516 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.543 ' ND2' ' HB2' ' A' ' 24' ' ' LEU . 2.7 t-20 -142.69 130.53 21.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.138 -0.976 . . . . 0.0 110.622 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' B' ' 217' ' ' ALA . 32.5 mt -120.47 142.52 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.391 -0.818 . . . . 0.0 109.637 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.791 HG22 ' OG1' ' B' ' 215' ' ' THR . 94.7 t -116.5 125.72 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.145 -0.972 . . . . 0.0 110.512 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.38 171.01 18.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 0.2 OUTLIER -162.35 146.33 11.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -1.223 . . . . 0.0 110.427 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . . . . . . . . . 7.7 p -168.94 159.9 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.227 -0.921 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.44 ' OD1' ' HG2' ' B' ' 211' ' ' LYS . 5.6 t70 -103.55 154.78 19.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 1.061 HG21 HD11 ' B' ' 170' ' ' ILE . 22.5 m -97.48 11.88 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 0.0 110.298 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.0 OUTLIER 72.42 -2.06 2.74 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.408 -0.808 . . . . 0.0 111.214 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.573 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 11.6 p90 -155.22 157.3 31.74 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.869 -1.144 . . . . 0.0 110.641 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 45.0 Cg_endo -72.05 160.03 48.55 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.147 1.604 . . . . 0.0 110.487 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 1.061 HD11 HG21 ' B' ' 166' ' ' VAL . 1.5 mp -131.85 153.92 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 0.0 110.314 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -87.51 110.18 20.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.94 . . . . 0.0 109.931 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 15.6 mt -66.39 -64.03 0.95 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 110.331 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -25.95 64.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.769 . . . . 0.0 110.08 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -72.56 -48.21 24.14 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.501 ' HA ' ' OG ' ' B' ' 178' ' ' SER . 9.6 tp -74.77 -33.76 62.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.343 -1.093 . . . . 0.0 109.671 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -64.94 -30.73 71.74 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.879 . . . . 0.0 109.947 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -80.44 -28.31 37.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.992 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' B' ' 175' ' ' LEU . 1.2 p -83.58 -58.6 2.75 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.417 -0.802 . . . . 0.0 110.097 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -96.28 32.65 1.92 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.021 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 181' ' ' THR . . . -52.75 -26.49 25.35 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 180' ' ' GLY . 22.6 p -42.37 -55.27 3.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -1.174 . . . . 0.0 110.133 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.621 ' CZ ' ' CG2' ' B' ' 198' ' ' VAL . 3.2 m-85 -115.49 -3.24 12.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 110.118 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.611 ' OG ' HD21 ' B' ' 193' ' ' LEU . 9.4 t -92.11 140.78 29.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.99 130.46 41.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 0.414 ' HB2' ' HG ' ' B' ' 193' ' ' LEU . 5.6 t80 -146.52 101.42 3.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.171 -0.955 . . . . 0.0 110.272 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.16 116.99 46.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.152 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.73 -0.24 9.13 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.945 1.497 . . . . 0.0 110.525 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.87 -6.67 28.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.396 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.824 HD23 ' N ' ' B' ' 190' ' ' PHE . 3.8 tt -143.13 -57.31 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.157 -0.964 . . . . 0.0 110.425 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.824 ' N ' HD23 ' B' ' 189' ' ' LEU . 7.4 t80 -105.74 124.92 34.63 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . 0.497 ' HD2' ' CD1' ' B' ' 190' ' ' PHE . 46.3 Cg_endo -73.84 -35.77 4.15 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.905 1.477 . . . . 0.0 110.351 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.544 ' HA3' ' CD1' ' B' ' 207' ' ' PHE . . . -90.3 174.85 40.57 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.977 HD23 ' N ' ' B' ' 194' ' ' ILE . 9.1 tt -94.11 159.75 15.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -1.137 . . . . 0.0 110.272 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.977 ' N ' HD23 ' B' ' 193' ' ' LEU . 75.9 mt -130.82 107.58 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.4 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' B' ' 195' ' ' TYR . 12.5 t80 -98.56 119.65 37.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.932 . . . . 0.0 110.002 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.51 ' NH2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -91.96 117.73 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.29 -0.881 . . . . 0.0 110.457 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.428 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 30.1 ttm -93.45 144.26 25.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.937 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.621 ' CG2' ' CZ ' ' B' ' 182' ' ' PHE . 84.7 t -92.34 -50.07 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.965 . . . . 0.0 110.274 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.0 OUTLIER -129.44 106.41 17.43 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.323 -0.861 . . . . 0.0 110.314 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.1 Cg_endo -73.54 171.14 67.74 Favored 'Cis proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.359 -0.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' B' ' 197' ' ' MET . 4.2 tptt -85.14 98.58 10.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.789 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' B' ' 217' ' ' ALA . 29.2 mt -145.82 149.68 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 110.682 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' B' ' 196' ' ' ARG . 75.0 t -103.7 117.68 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.477 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.826 ' N ' HD12 ' B' ' 204' ' ' LEU . 4.8 mp -104.54 152.06 22.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.169 -0.957 . . . . 0.0 110.724 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.633 ' CD1' HD21 ' A' ' 52' ' ' LEU . 18.5 mt -117.13 143.51 45.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.371 -0.83 . . . . 0.0 110.013 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.601 HG12 HD21 ' B' ' 234' ' ' LEU . 6.5 mt -132.49 103.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.18 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.544 ' CD1' ' HA3' ' B' ' 192' ' ' GLY . 14.2 m-30 -94.48 145.74 24.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.254 -0.904 . . . . 0.0 110.111 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 37.6 t -45.46 -28.48 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.274 -0.892 . . . . 0.0 110.467 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -16.19 56.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 110.447 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.442 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 97.67 -4.36 61.54 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.44 ' HG2' ' OD1' ' B' ' 165' ' ' ASP . 8.7 mttm -73.22 131.96 42.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 110.166 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' B' ' 163' ' ' SER . 17.0 mm -119.73 143.98 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.594 HG11 ' HE1' ' A' ' 25' ' ' PHE . 12.0 t -124.76 157.38 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.526 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.8 mp -144.46 107.38 4.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.233 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.791 ' OG1' HG22 ' B' ' 161' ' ' VAL . 1.6 t -128.95 137.19 51.24 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.004 . . . . 0.0 110.144 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.461 ' C ' HG12 ' B' ' 202' ' ' ILE . . . 119.8 9.74 8.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.631 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -88.19 154.89 20.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -1.186 . . . . 0.0 110.308 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' B' ' 158' ' ' GLN . 0.8 OUTLIER -106.56 -12.26 15.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 109.986 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.512 ' CG ' ' HG2' ' B' ' 221' ' ' GLU . 9.4 tp60 -150.32 150.1 31.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 110.059 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . 0.848 ' HD2' HD11 ' B' ' 67' ' ' LEU . 0.0 OUTLIER -49.18 -38.72 26.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 110.368 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 16.0 pt-20 -54.45 -34.51 61.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.522 ' N ' ' HG3' ' B' ' 221' ' ' GLU . 16.8 mt-10 -65.16 -58.73 5.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.256 -0.902 . . . . 0.0 110.11 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.403 HG23 HD12 ' B' ' 223' ' ' ILE . 29.5 mm -50.67 -45.2 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.992 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -65.7 -33.14 75.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.932 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -77.67 -46.05 23.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.363 -0.836 . . . . 0.0 110.018 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.496 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -55.66 -27.61 50.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.89 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.572 ' HA ' HG22 ' B' ' 230' ' ' ILE . 16.9 t80 -78.78 -46.65 18.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.929 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -59.5 -22.61 61.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.26 -0.9 . . . . 0.0 110.087 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -88.25 -30.54 19.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.8 tp -99.82 -9.65 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.278 -0.889 . . . . 0.0 110.069 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 15.7 t80 -63.14 -46.73 86.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.368 -0.832 . . . . 0.0 110.852 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 45.7 Cg_endo -71.51 -25.95 20.62 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.229 1.12 . . . . 0.0 110.065 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.63 -36.69 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.901 . . . . 0.0 109.768 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.958 HD13 HG11 ' B' ' 166' ' ' VAL . 54.7 mt -71.4 -40.93 70.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 109.972 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -19.94 66.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.314 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -82.7 -41.8 18.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.194 -0.941 . . . . 0.0 110.4 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -109.04 38.54 2.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.385 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -75.22 176.01 7.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.277 -0.89 . . . . 0.0 110.078 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -128.93 -36.86 1.76 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.953 . . . . 0.0 110.154 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.216 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.316 0.579 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.09 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -175.14 89.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -1.127 . . . . 0.0 110.139 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 14' ' ' ILE . 2.9 mp -94.42 19.96 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.935 . . . . 0.0 110.222 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.92 66.31 2.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -121.8 89.65 3.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -1.094 . . . . 0.0 110.089 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.05 121.15 2.33 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.084 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -99.75 161.25 13.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -1.159 . . . . 0.0 109.166 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.845 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -88.38 78.26 7.98 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.089 -1.007 . . . . 0.0 111.565 -178.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.084 HD21 HD21 ' A' ' 18' ' ' LEU . 4.2 mt -86.3 30.11 0.72 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.154 -0.966 . . . . 0.0 110.465 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.836 HG22 HG23 ' A' ' 56' ' ' ILE . 1.8 m -77.76 -6.01 52.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.025 -1.047 . . . . 0.0 110.24 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.776 ' HA3' HG21 ' A' ' 28' ' ' ILE . . . -99.97 -41.73 2.79 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.002 -178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.679 HG22 HG21 ' B' ' 124' ' ' THR . 17.2 pt -51.93 -46.17 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.651 -1.5 . . . . 0.0 109.601 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.809 ' CD1' HD12 ' A' ' 64' ' ' LEU . 1.3 pp -75.27 0.33 16.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.132 -0.98 . . . . 0.0 109.272 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.749 ' HE1' HG11 ' B' ' 213' ' ' VAL . 0.1 OUTLIER -120.27 -13.99 8.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.327 -0.858 . . . . 0.0 110.721 -179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 27' ' ' ASN . . . 157.31 45.47 0.02 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.131 -1.509 . . . . 0.0 110.982 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB3' HG22 ' B' ' 112' ' ' THR . 0.0 OUTLIER 52.87 147.57 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.368 -1.078 . . . . 0.0 111.43 178.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -170.49 161.19 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.461 -0.775 . . . . 0.0 109.284 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 31' ' ' GLU . 81.1 m-20 -88.57 135.02 33.7 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.502 ' C ' ' O ' ' A' ' 29' ' ' ASP . 1.1 p -36.27 -31.48 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.449 -0.782 . . . . 0.0 109.904 -178.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -49.2 -21.94 0.9 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 110.007 179.121 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.87 21.1 7.99 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.975 -1.107 . . . . 0.0 110.85 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -114.48 130.84 56.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.805 -1.409 . . . . 0.0 109.586 179.204 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.875 HD22 ' C ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -102.77 151.02 22.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.084 -1.01 . . . . 0.0 111.703 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.664 HD11 ' OD1' ' A' ' 27' ' ' ASN . 4.0 pp -112.87 -178.86 3.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.618 -0.676 . . . . 0.0 110.367 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.651 ' N ' HD12 ' A' ' 35' ' ' LEU . 13.1 mt-30 -146.11 75.32 1.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.596 -0.69 . . . . 0.0 109.999 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 46.23 44.81 12.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 58.55 -177.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 110.091 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.39 141.35 57.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.926 . . . . 0.0 110.166 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.59 -136.13 2.65 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -172.04 145.93 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -1.11 . . . . 0.0 110.15 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.8 -104.69 0.81 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -152.96 -66.95 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 109.924 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.49 22.06 42.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.48 -168.69 36.07 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.28 67.66 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.14 . . . . 0.0 110.273 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 48' ' ' PHE . . . 98.72 -174.08 27.63 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 47' ' ' GLY . 5.1 m-30 -43.72 147.06 0.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -1.162 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -72.86 -172.1 0.97 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.862 . . . . 0.0 110.28 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.45 27.28 1.49 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 110.087 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -100.22 -25.53 14.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 109.6 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.521 HD21 ' CZ ' ' B' ' 190' ' ' PHE . 3.5 mt -96.43 -40.83 8.9 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.399 -0.813 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.958 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -47.98 -52.29 20.37 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.231 -179.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.38 -40.51 89.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.504 -0.748 . . . . 0.0 109.393 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' LEU . 3.9 m-80 -63.75 -45.36 90.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.479 -0.763 . . . . 0.0 109.664 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 53' ' ' ARG . 39.2 mt -46.75 -44.61 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.345 -0.847 . . . . 0.0 109.777 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.96 -22.65 60.5 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' HD11 ' B' ' 189' ' ' LEU . 0.7 OUTLIER -142.17 39.04 1.59 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.973 -1.31 . . . . 0.0 109.34 179.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.774 ' CD1' HD21 ' A' ' 62' ' ' LEU . 1.8 tp -104.05 -9.74 18.56 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.413 -0.805 . . . . 0.0 109.718 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.5 p -75.83 48.15 0.46 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.134 -0.979 . . . . 0.0 109.835 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -134.49 -19.4 1.89 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.475 -0.766 . . . . 0.0 110.325 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.89 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.25 22.73 4.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.673 -1.267 . . . . 0.0 111.19 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.91 -69.77 0.13 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.304 -1.426 . . . . 0.0 110.397 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.809 HD12 ' CD1' ' A' ' 24' ' ' LEU . 4.0 mm? -69.97 -2.09 11.56 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.239 . . . . 0.0 111.274 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -52.66 -49.62 64.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.075 -1.016 . . . . 0.0 109.837 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 54.3 p -67.56 -45.42 75.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.333 -0.854 . . . . 0.0 109.943 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.5 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -69.66 -4.41 19.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.777 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.881 HD11 ' O ' ' A' ' 18' ' ' LEU . 2.7 tm? -82.0 -60.49 2.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.891 . . . . 0.0 109.735 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.54 2.02 12.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.631 -0.668 . . . . 0.0 109.906 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 3.3 tt0 -97.32 16.94 18.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 111.109 -179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.738 ' HB ' HD12 ' A' ' 20' ' ' LEU . 4.2 t -136.62 -1.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.243 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.928 HD11 ' CD1' ' A' ' 74' ' ' LEU . 0.9 OUTLIER -151.73 76.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.419 -0.801 . . . . 0.0 109.81 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 1.9 p-10 -75.04 57.6 0.83 Allowed 'General case' 0 C--N 1.293 -1.866 0 O-C-N 120.739 -1.226 . . . . 0.0 108.563 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.928 ' CD1' HD11 ' A' ' 72' ' ' ILE . 8.7 mt -93.12 64.34 3.82 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.622 0.725 . . . . 0.0 110.815 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -135.07 -177.28 4.57 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.652 -0.655 . . . . 0.0 110.214 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -55.1 96.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 110.183 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.213 -179.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 34.1 t . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.29 0.567 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 101.86 76.74 1.2 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.462 ' C ' HG23 ' B' ' 64' ' ' VAL . 1.9 mp -76.52 -48.58 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -1.141 . . . . 0.0 110.115 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.628 ' CG1' ' CZ ' ' B' ' 224' ' ' TYR . 3.4 t 64.05 123.14 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.352 -0.842 . . . . 0.0 110.071 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' B' ' 164' ' ' CYS . 46.1 Cg_endo -72.72 145.93 42.19 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.938 1.494 . . . . 0.0 110.41 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 60.5 m -96.72 136.72 36.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.512 HD22 ' CG2' ' B' ' 160' ' ' ILE . 39.7 mt -70.0 121.36 17.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.897 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -95.34 -29.52 14.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 110.338 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.481 HD21 HG21 ' B' ' 161' ' ' VAL . 1.5 p-10 -170.37 -179.49 3.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 0.0 110.557 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.599 HG12 HG23 ' B' ' 160' ' ' ILE . 21.0 mt -153.93 164.45 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.971 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.708 HG21 ' HA ' ' A' ' 24' ' ' LEU . 25.8 t -130.6 133.65 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.121 -0.987 . . . . 0.0 110.143 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -130.24 169.74 15.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.289 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 28.1 p -122.48 144.19 49.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.876 . . . . 0.0 110.303 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' B' ' 136' ' ' SER . 47.8 t -136.08 142.4 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.365 -0.835 . . . . 0.0 109.919 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' B' ' 120' ' ' LYS . 1.3 m -123.99 132.75 53.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.164 -0.96 . . . . 0.0 110.729 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.997 HD22 ' HB1' ' B' ' 150' ' ' ALA . 11.7 mt -100.42 -26.09 13.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.417 -0.802 . . . . 0.0 109.963 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 51.78 39.36 47.06 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' B' ' 79' ' ' ARG . 89.0 m -134.67 -0.22 2.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 110.584 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.938 ' O ' HD23 ' B' ' 80' ' ' LEU . 4.9 mmm180 59.77 139.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.026 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.938 HD23 ' O ' ' B' ' 79' ' ' ARG . 24.1 mt -139.54 151.01 45.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.961 -1.087 . . . . 0.0 110.6 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' B' ' 81' ' ' ASP . 2.0 m-20 -89.83 89.25 7.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.311 -0.868 . . . . 0.0 109.612 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.84 HD22 HG23 ' B' ' 102' ' ' VAL . 32.3 mt -40.84 -43.07 1.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.403 -0.811 . . . . 0.0 110.689 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -54.59 -47.21 73.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.638 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.401 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 12.0 p -80.44 -40.87 25.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.713 -179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.405 HG12 HG11 ' B' ' 102' ' ' VAL . 55.9 t -52.56 -42.87 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.124 -0.985 . . . . 0.0 110.183 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.28 -23.53 40.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 110.067 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 tp -78.91 -27.26 43.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.368 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -100.43 -38.92 8.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.001 . . . . 0.0 110.831 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.479 ' HB1' ' SD ' ' B' ' 104' ' ' MET . . . -53.21 134.27 39.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.151 -0.968 . . . . 0.0 110.204 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -73.96 -22.9 59.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.04 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.444 ' O ' ' SD ' ' B' ' 104' ' ' MET . 1.4 m120 -134.79 79.52 1.8 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.307 -0.871 . . . . 0.0 109.829 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 1.006 ' HB2' ' SD ' ' B' ' 104' ' ' MET . . . -150.43 162.42 40.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.29 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -143.07 171.87 13.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.004 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -156.28 104.68 2.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 110.177 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.11 112.84 59.56 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.262 -0.899 . . . . 0.0 110.241 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.56 -17.48 23.44 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.911 1.479 . . . . 0.0 110.619 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -82.22 -17.7 45.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.175 -0.953 . . . . 0.0 110.158 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 -55.55 2.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.221 -0.924 . . . . 0.0 110.234 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 1.124 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -160.41 -164.65 1.29 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.317 -0.864 . . . . 0.0 111.397 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.38 54.39 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.935 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.124 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -143.9 167.45 22.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.001 . . . . 0.0 110.382 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.84 HG23 HD22 ' B' ' 82' ' ' LEU . 49.7 t -100.58 139.91 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.122 -0.986 . . . . 0.0 110.159 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.527 HD12 ' N ' ' B' ' 103' ' ' ILE . 4.8 mp -106.52 113.43 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.22 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 1.006 ' SD ' ' HB2' ' B' ' 92' ' ' ALA . 21.0 tpp -104.65 162.07 13.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 110.224 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.42 131.65 11.1 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.217 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.566 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 7.4 pt -125.8 169.68 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.287 -0.883 . . . . 0.0 110.23 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.512 ' O ' ' CG ' ' B' ' 108' ' ' GLU . 1.1 mtt180 -115.16 22.61 13.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.512 ' CG ' ' O ' ' B' ' 107' ' ' ARG . 3.1 mt-10 -166.1 93.14 0.81 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 110.455 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.697 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 47.5 Cg_endo -75.22 159.57 97.59 Favored 'Cis proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.818 -2.159 . . . . 0.0 110.423 -0.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.49 ' C ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -65.84 98.21 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 109.917 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.49 HG23 ' C ' ' B' ' 110' ' ' LYS . 38.3 p -153.17 -179.29 7.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.853 . . . . 0.0 110.113 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.704 HG22 ' HB3' ' A' ' 27' ' ' ASN . 15.1 t -134.38 162.47 32.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.102 -0.999 . . . . 0.0 110.062 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -161.51 156.76 23.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.913 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.742 HD12 ' HE1' ' B' ' 116' ' ' PHE . 0.3 OUTLIER -132.05 115.12 15.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.522 -0.736 . . . . 0.0 109.422 179.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' B' ' 102' ' ' VAL . 50.6 mt -90.77 137.75 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.209 -0.932 . . . . 0.0 110.867 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.742 ' HE1' HD12 ' B' ' 114' ' ' LEU . 2.6 m-30 -90.53 -171.04 2.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.347 -0.846 . . . . 0.0 109.515 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.485 ' O ' ' HD2' ' B' ' 79' ' ' ARG . . . -93.01 -10.25 36.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.243 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.52 -28.55 18.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.203 -0.936 . . . . 0.0 110.136 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.466 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 135.19 -38.65 1.78 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . 0.517 ' O ' ' CD2' ' B' ' 116' ' ' PHE . 5.0 tttt -61.24 139.83 58.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 110.139 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.442 ' HG3' ' HB ' ' B' ' 74' ' ' VAL . 3.7 ptt? -144.69 157.13 44.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.388 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 71' ' ' VAL . 31.3 t -104.37 154.01 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.438 HG23 ' C ' ' B' ' 122' ' ' VAL . 7.5 t -147.27 101.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.18 -0.95 . . . . 0.0 110.711 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.679 HG21 HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -104.92 179.88 4.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 0.0 109.001 178.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.592 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 98.46 -29.74 10.91 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.847 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.53 ' CB ' ' OG ' ' B' ' 132' ' ' SER . . . -48.19 131.62 16.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 109.991 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' B' ' 128' ' ' SER . 0.2 OUTLIER -101.09 13.67 34.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.382 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' B' ' 127' ' ' LYS . 0.3 OUTLIER 178.93 -169.67 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -74.21 -45.92 45.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -69.57 -27.03 64.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.68 -45.82 85.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 110.269 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 39.2 m -65.2 -48.52 73.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.263 -0.898 . . . . 0.0 110.52 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' B' ' 137' ' ' ARG . 10.8 ttpp -53.37 -41.28 65.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.241 -0.912 . . . . 0.0 110.47 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' B' ' 138' ' ' LYS . 0.7 OUTLIER -77.63 -43.76 30.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 110.444 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.697 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -64.38 -36.75 85.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.277 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.458 ' HB2' HG21 ' B' ' 74' ' ' VAL . 11.8 p -68.78 -59.93 2.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 110.121 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' B' ' 137' ' ' ARG . 8.5 ptm85 -51.82 -26.41 9.78 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.896 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' B' ' 134' ' ' LEU . 0.0 OUTLIER -67.1 -48.55 67.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.848 179.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.657 ' HA ' HD12 ' B' ' 142' ' ' ILE . 35.7 m-85 -62.56 -47.3 84.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.799 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' B' ' 144' ' ' GLN . . . -55.6 -28.36 54.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.245 -0.91 . . . . 0.0 109.69 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -70.95 -51.57 25.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 110.003 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' B' ' 139' ' ' TYR . 6.4 mt -45.69 -36.96 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 110.045 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.705 HG22 ' HB2' ' B' ' 148' ' ' PHE . 49.3 mm -73.64 -53.77 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.82 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 28.0 mt-30 -64.72 -29.95 70.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 109.989 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 0.1 OUTLIER -74.09 -22.61 59.44 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.088 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.419 HG13 ' O ' ' B' ' 142' ' ' ILE . 4.2 mt -81.04 -22.16 10.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 131.92 -17.94 4.85 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.705 ' HB2' HG22 ' B' ' 143' ' ' ILE . 24.2 m-85 -63.99 175.02 1.3 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.007 -1.29 . . . . 0.0 111.416 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -115.15 24.32 11.77 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.458 0.647 . . . . 0.0 109.679 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.997 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -46.24 150.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 110.598 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -124.44 101.53 7.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.369 -0.832 . . . . 0.0 110.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.434 ' O ' HG23 ' B' ' 153' ' ' THR . 23.6 t80 -57.95 96.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.304 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' B' ' 154' ' ' ASP . 0.9 OUTLIER -151.74 173.09 15.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.92 . . . . 0.0 110.395 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' B' ' 153' ' ' THR . 0.1 OUTLIER 65.39 21.46 11.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.341 -0.849 . . . . 0.0 110.436 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -65.67 135.13 54.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.989 . . . . 0.0 110.09 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -166.04 136.71 3.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 110.35 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 7.3 mt -79.04 154.23 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.897 . . . . 0.0 109.653 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -137.06 -23.8 1.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.005 -1.059 . . . . 0.0 111.63 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' B' ' 217' ' ' ALA . 13.7 t-20 -149.51 122.19 8.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.712 -1.243 . . . . 0.0 111.523 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.599 HG23 HG12 ' B' ' 70' ' ' ILE . 84.8 mt -106.92 144.89 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.446 -0.784 . . . . 0.0 108.903 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.481 HG21 HD21 ' B' ' 69' ' ' ASN . 48.6 t -118.06 142.5 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.827 -1.17 . . . . 0.0 111.435 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -139.72 162.03 26.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 54.5 p -161.2 143.93 12.48 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.966 -1.314 . . . . 0.0 110.676 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.441 ' HB2' ' HA ' ' B' ' 65' ' ' PRO . 0.5 OUTLIER -170.36 171.72 6.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.374 -0.829 . . . . 0.0 110.144 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.455 ' OD1' ' HG3' ' B' ' 211' ' ' LYS . 0.8 OUTLIER -114.83 131.53 56.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.042 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.709 HG23 ' H ' ' B' ' 167' ' ' LYS . 5.1 m -67.62 -61.85 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.121 -0.987 . . . . 0.0 110.957 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.709 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 169.59 -31.42 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.033 . . . . 0.0 110.441 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' B' ' 168' ' ' PHE . 17.0 p90 -134.34 165.78 34.17 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' B' ' 168' ' ' PHE . 44.2 Cg_endo -71.81 147.39 50.15 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 123.975 1.513 . . . . 0.0 110.26 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.641 HD12 ' HA2' ' B' ' 210' ' ' GLY . 4.1 mt -110.49 152.91 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.727 -179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -93.8 105.18 17.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 0.0 109.695 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.446 ' N ' HD23 ' B' ' 172' ' ' LEU . 8.5 mt -63.37 -43.95 96.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.269 -0.895 . . . . 0.0 110.615 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -57.4 -49.62 75.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.339 -0.85 . . . . 0.0 110.424 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -62.0 -38.07 95.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.582 HD23 ' HB2' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -74.37 -36.73 63.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -1.168 . . . . 0.0 110.451 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.64 67.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.271 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -92.39 -42.3 9.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.241 -0.912 . . . . 0.0 110.052 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . 0.414 ' CB ' ' CZ ' ' B' ' 237' ' ' PHE . 0.4 OUTLIER -63.36 -52.78 60.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 110.117 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -115.38 40.2 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.098 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -59.6 -19.8 49.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 16.0 m -58.03 -35.85 71.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -1.162 . . . . 0.0 110.257 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.858 ' CE1' HG22 ' B' ' 198' ' ' VAL . 44.1 m-85 -125.19 12.15 8.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.51 ' HB3' HD21 ' B' ' 193' ' ' LEU . 50.6 m -114.72 143.91 44.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 0.0 110.226 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.09 114.2 16.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 110.25 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -125.7 91.42 3.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 110.255 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.93 113.98 60.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.66 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.25 5.04 3.85 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.908 1.478 . . . . 0.0 110.937 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -97.87 -9.19 26.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.025 . . . . 0.0 110.248 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.579 ' C ' HD23 ' B' ' 189' ' ' LEU . 3.8 tt -152.51 -40.58 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.433 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.682 ' CE2' HD13 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -117.76 107.81 43.81 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.271 -0.893 . . . . 0.0 110.405 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.61 -23.69 19.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.029 1.542 . . . . 0.0 110.279 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.23 177.87 39.82 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.51 HD21 ' HB3' ' B' ' 183' ' ' SER . 7.4 tt -108.05 128.42 54.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.166 . . . . 0.0 110.402 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.543 ' HA ' HD23 ' B' ' 205' ' ' LEU . 22.2 mt -101.72 108.04 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.115 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.49 ' CD2' HD13 ' B' ' 230' ' ' ILE . 17.0 t80 -95.77 113.1 24.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.205 -0.934 . . . . 0.0 110.236 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.417 ' CB ' ' CZ ' ' B' ' 196' ' ' ARG . 0.0 OUTLIER -90.6 88.29 7.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.22 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.445 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 22.9 ttm -59.28 139.11 57.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 110.161 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.858 HG22 ' CE1' ' B' ' 182' ' ' PHE . 3.0 t -77.3 -46.09 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.253 -0.905 . . . . 0.0 109.949 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' B' ' 199' ' ' LYS . 34.2 pttt -142.21 118.56 7.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 0.0 109.863 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 47.4 Cg_endo -73.32 145.99 85.68 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.971 -2.096 . . . . 0.0 110.513 0.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.496 ' O ' HD13 ' B' ' 202' ' ' ILE . 1.4 tptm -57.34 92.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.264 -0.897 . . . . 0.0 110.115 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' B' ' 217' ' ' ALA . 42.5 mm -138.34 165.16 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.581 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.461 ' N ' HG22 ' B' ' 202' ' ' ILE . 45.1 t -121.91 125.24 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.939 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 1.101 HD21 ' HB1' ' B' ' 226' ' ' ALA . 1.6 mp -121.94 140.5 52.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.508 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' B' ' 194' ' ' ILE . 12.5 mt -103.96 156.0 18.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.333 -0.854 . . . . 0.0 109.952 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.704 HG12 HD21 ' B' ' 234' ' ' LEU . 2.8 mt -140.05 105.69 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 0.0 110.079 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -97.62 152.05 19.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.271 -0.893 . . . . 0.0 110.127 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 62.0 t -49.23 -34.11 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 97.5 p -55.66 -31.85 62.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.641 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 110.1 12.86 16.91 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.455 ' HG3' ' OD1' ' B' ' 165' ' ' ASP . 29.1 tttt -89.7 131.86 35.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.029 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' B' ' 206' ' ' ILE . 34.1 mm -118.12 122.14 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.273 -0.892 . . . . 0.0 110.4 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.749 HG11 ' HE1' ' A' ' 25' ' ' PHE . 16.1 t -92.39 154.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.894 . . . . 0.0 110.035 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.435 HD12 ' C ' ' B' ' 213' ' ' VAL . 4.2 mp -143.17 100.95 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -0.979 . . . . 0.0 110.716 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 0.9 OUTLIER -136.84 170.72 15.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.298 -0.876 . . . . 0.0 110.204 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . 0.515 ' HA2' ' ND2' ' B' ' 159' ' ' ASN . . . 92.28 13.33 57.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -98.48 157.15 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -1.131 . . . . 0.0 110.297 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -36.58 13.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.28 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.51 ' O ' HD12 ' B' ' 160' ' ' ILE . 0.1 OUTLIER -128.86 -158.8 0.91 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -0.815 . . . . 0.0 110.165 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -97.08 -22.52 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 110.182 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -60.48 -38.04 82.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 110.096 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.52 -48.82 65.93 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.153 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 23.9 mm -52.79 -41.64 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.894 . . . . 0.0 110.05 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.628 ' CZ ' ' CG1' ' B' ' 64' ' ' VAL . 3.8 m-85 -70.51 -28.15 64.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -45.53 21.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 1.101 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -56.21 -35.16 67.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.918 . . . . 0.0 110.354 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.532 ' HA ' HG22 ' B' ' 230' ' ' ILE . 21.5 t80 -72.47 -49.69 31.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.195 -0.941 . . . . 0.0 110.338 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -18.63 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.211 -0.931 . . . . 0.0 110.29 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -91.16 -28.41 17.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -0.938 . . . . 0.0 110.079 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' B' ' 227' ' ' PHE . 7.4 tp -99.59 -16.32 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 110.161 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.621 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 3.9 t80 -55.92 -43.25 99.12 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.846 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.9 Cg_endo -74.21 -31.24 7.82 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.449 1.237 . . . . 0.0 110.255 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' B' ' 175' ' ' LEU . 8.8 t -67.36 -43.84 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 0.0 109.707 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.704 HD21 HG12 ' B' ' 206' ' ' ILE . 71.2 mt -58.46 -44.24 89.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.967 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -28.02 67.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -0.913 . . . . 0.0 110.151 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -74.31 -24.41 59.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 110.113 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.582 ' HB2' HD23 ' B' ' 175' ' ' LEU . 86.8 m-85 -125.12 45.57 2.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.209 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.1 ptt-85 -63.26 -162.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.066 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 -42.45 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 110.145 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 8.7 tpt . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.216 179.871 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.18 0.514 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -129.97 -171.69 12.99 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.4 p -133.95 23.1 3.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.101 . . . . 0.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 14' ' ' ILE . 29.0 mm -108.87 49.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 110.272 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.95 -158.13 17.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -67.53 -71.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -1.174 . . . . 0.0 110.374 -179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA3' HD11 ' A' ' 74' ' ' LEU . . . -137.44 -52.49 0.06 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.08 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -114.58 160.95 18.69 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.362 -1.081 . . . . 0.0 109.281 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.716 ' N ' HD12 ' A' ' 18' ' ' LEU . 55.6 t0 -90.01 89.26 7.63 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.011 -1.056 . . . . 0.0 111.018 -178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.08 HD21 HD21 ' A' ' 18' ' ' LEU . 2.4 mt -87.93 -5.4 58.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.042 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.663 ' N ' HD23 ' A' ' 68' ' ' LEU . 96.0 m -39.38 -38.85 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.519 -0.738 . . . . 0.0 110.292 -179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -91.59 -32.34 8.74 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.734 HG12 HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -51.25 -44.28 30.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.198 -1.178 . . . . 0.0 109.46 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.94 ' HA ' HG21 ' B' ' 71' ' ' VAL . 1.6 pp -83.02 -25.98 31.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.892 -1.13 . . . . 0.0 109.417 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.799 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.9 t80 -87.22 0.4 55.42 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.723 0.773 . . . . 0.0 109.101 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 22' ' ' GLY . . . 150.1 98.68 0.19 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -179.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.84 ' HB2' HG22 ' B' ' 112' ' ' THR . 8.3 p-10 -21.99 119.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.095 0.95 . . . . 0.0 112.849 -178.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.734 HG23 HG12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -130.21 165.47 30.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.535 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 28' ' ' ILE . 77.2 m-20 -86.18 125.95 33.89 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.959 ' HB2' HD13 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -39.47 -24.82 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.631 -0.668 . . . . 0.0 110.121 -178.484 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.648 ' HG3' HD13 ' B' ' 103' ' ' ILE . 65.0 mt-10 -64.61 -4.91 4.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.07 -1.018 . . . . 0.0 111.142 178.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.55 38.07 4.06 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.525 ' O ' HG12 ' A' ' 28' ' ' ILE . 1.8 tpp180 -126.54 130.08 49.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.259 -1.142 . . . . 0.0 109.511 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.716 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -89.01 158.69 17.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.589 -1.32 . . . . 0.0 111.429 -179.046 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.52 ' CG ' ' O ' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -87.37 108.55 19.04 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.611 0.72 . . . . 0.0 111.504 -178.583 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 38' ' ' ASP . 14.0 mt-30 -91.0 -12.98 34.2 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 36' ' ' GLN . 2.8 m-20 65.65 -60.1 0.28 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.759 -0.588 . . . . 0.0 110.155 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 36' ' ' GLN . 33.8 p-10 -147.45 143.92 28.25 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.382 -0.824 . . . . 0.0 109.89 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -72.1 142.88 49.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -0.945 . . . . 0.0 110.406 -179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -103.98 121.88 7.19 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 -36.47 11.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -1.168 . . . . 0.0 110.501 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.27 60.41 0.42 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 54.08 98.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -1.124 . . . . 0.0 110.148 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.58 -114.05 0.25 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 155.27 -37.07 0.64 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.1 p -82.14 68.41 8.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.352 -1.087 . . . . 0.0 110.114 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.93 117.29 0.59 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -47.2 156.78 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -1.182 . . . . 0.0 110.239 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -90.73 -154.1 0.33 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.199 -0.938 . . . . 0.0 110.148 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 28.91 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.912 . . . . 0.0 110.241 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -95.45 -32.93 12.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 0.0 108.631 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.53 HD13 ' CE1' ' A' ' 25' ' ' PHE . 1.7 mt -88.87 -34.62 16.93 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.492 0.663 . . . . 0.0 109.334 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.018 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -46.08 -49.51 16.38 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.38 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.0 -29.53 68.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.593 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.501 ' OD1' ' HD2' ' B' ' 191' ' ' PRO . 20.8 m-80 -76.28 -41.06 50.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 0.0 109.613 179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' A' ' 53' ' ' ARG . 45.7 mt -49.96 -47.08 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -0.847 . . . . 0.0 109.735 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.58 0.52 60.57 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.51 -41.73 3.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.158 -1.201 . . . . 0.0 110.442 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.78 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -86.57 36.56 0.71 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.13 -0.981 . . . . 0.0 110.458 -179.757 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -80.21 17.12 1.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.112 179.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.556 ' HE2' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -152.99 11.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.922 -179.697 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.851 HD11 ' CD2' ' B' ' 189' ' ' LEU . 3.5 mt -90.32 -26.07 20.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.744 -1.223 . . . . 0.0 109.47 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.54 -38.71 0.04 OUTLIER Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.724 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.7 mm? -62.93 -12.14 23.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 110.537 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -48.03 -41.1 24.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.981 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -42.75 76.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.234 -0.916 . . . . 0.0 109.861 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.568 ' HB3' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -81.86 -1.92 49.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.298 -0.876 . . . . 0.0 109.995 179.739 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.763 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.8 tm? -82.29 -47.2 12.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -0.961 . . . . 0.0 109.413 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.5 pp -90.26 0.28 57.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 110.176 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' C ' HG23 ' A' ' 71' ' ' VAL . 3.1 tt0 -90.9 15.85 10.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.322 -0.861 . . . . 0.0 111.102 -179.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.643 ' HB ' HD12 ' A' ' 20' ' ' LEU . 45.0 t -145.67 5.91 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.328 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.951 ' CD1' HD23 ' A' ' 18' ' ' LEU . 4.0 tp -150.52 77.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.311 -0.868 . . . . 0.0 109.881 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 9.6 t70 -84.29 49.3 1.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.016 -1.053 . . . . 0.0 108.523 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.912 HD13 ' CG1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -74.91 47.29 0.33 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.319 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -148.17 41.13 0.98 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.989 -1.07 . . . . 0.0 110.129 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.96 24.63 2.56 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.397 -0.815 . . . . 0.0 109.956 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.115 -179.99 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.187 0.518 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.16 -53.85 0.07 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 mt -123.44 88.9 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -1.129 . . . . 0.0 110.407 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.531 ' CG1' ' HD2' ' B' ' 65' ' ' PRO . 15.5 t -57.9 145.51 71.36 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 110.006 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.617 ' CG ' HG22 ' B' ' 223' ' ' ILE . 44.1 Cg_endo -71.69 138.43 31.94 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.806 1.424 . . . . 0.0 110.377 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.472 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 72.8 m -105.17 135.19 46.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 110.322 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -75.03 122.04 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.202 -0.936 . . . . 0.0 109.91 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -113.38 -3.66 13.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.649 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.4 142.47 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.075 -1.016 . . . . 0.0 110.574 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.541 ' CD1' HG23 ' B' ' 160' ' ' ILE . 13.3 mm -126.99 161.16 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.355 -0.841 . . . . 0.0 109.927 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.94 HG21 ' HA ' ' A' ' 24' ' ' LEU . 47.8 t -141.74 121.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.126 -0.984 . . . . 0.0 110.233 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 157' ' ' ILE . . . -134.9 168.5 18.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 110.429 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . 0.774 HG23 HG22 ' B' ' 122' ' ' VAL . 0.2 OUTLIER -124.71 153.5 42.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.022 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 53.2 t -143.91 155.78 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 110.303 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 9.1 m -124.72 133.13 53.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.219 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.842 HD22 ' HB1' ' B' ' 150' ' ' ALA . 67.6 mt -87.56 -65.87 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.151 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 139.88 -20.83 2.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 40.6 m -135.18 143.78 46.63 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.247 . . . . 0.0 110.471 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.504 ' O ' HD23 ' B' ' 80' ' ' LEU . 7.3 ptm85 -59.54 163.37 4.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.913 . . . . 0.0 109.816 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.681 HD11 HD12 ' B' ' 76' ' ' LEU . 25.6 mt -131.43 153.6 49.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.533 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 82' ' ' LEU . 42.3 t0 -89.64 89.02 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.904 . . . . 0.0 109.523 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.495 HD11 ' O ' ' B' ' 100' ' ' ALA . 15.1 mt -38.52 -36.54 0.25 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 110.666 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -66.18 -42.51 88.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.903 . . . . 0.0 110.44 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' B' ' 81' ' ' ASP . 16.0 m -79.34 -25.73 42.23 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.159 -0.963 . . . . 0.0 110.543 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.478 HG12 HG11 ' B' ' 102' ' ' VAL . 22.9 t -75.26 -40.39 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.917 . . . . 0.0 110.334 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -80.13 -21.19 43.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 110.419 -179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.1 tp -88.9 -18.49 27.43 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.101 -0.999 . . . . 0.0 110.452 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -100.03 -41.13 7.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.164 -0.96 . . . . 0.0 110.362 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.48 140.42 58.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.855 . . . . 0.0 110.2 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -77.55 -14.43 59.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.096 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.427 ' HB3' ' HG2' ' B' ' 105' ' ' ARG . 8.6 m-20 -137.7 79.94 1.77 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.243 -0.91 . . . . 0.0 110.138 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 103' ' ' ILE . . . -162.02 154.0 19.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.17 -0.956 . . . . 0.0 110.286 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -143.34 155.63 44.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.052 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -119.3 135.74 54.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.0 110.166 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.83 101.57 3.43 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.198 -0.939 . . . . 0.0 110.178 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.87 -16.19 26.2 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.044 1.549 . . . . 0.0 110.406 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -72.66 -6.58 45.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.206 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -123.95 -65.72 1.04 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 0.0 110.377 -179.814 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.769 ' CZ ' ' HB2' ' B' ' 101' ' ' ALA . 0.1 OUTLIER -146.86 133.18 19.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.453 -0.779 . . . . 0.0 109.365 -179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.495 ' O ' HD11 ' B' ' 82' ' ' LEU . . . -60.62 57.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.989 -177.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.905 ' HB1' ' O ' ' B' ' 115' ' ' ILE . . . -152.48 169.02 23.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.872 -1.142 . . . . 0.0 111.159 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' B' ' 82' ' ' LEU . 17.2 t -102.23 130.39 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.609 -0.682 . . . . 0.0 109.303 178.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.648 HD13 ' HG3' ' A' ' 31' ' ' GLU . 2.4 mp -89.3 118.29 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.088 -1.007 . . . . 0.0 110.2 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 27.2 ttm -104.16 164.62 11.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 110.236 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.508 ' O ' ' CG ' ' B' ' 105' ' ' ARG . 9.0 ptm180 -156.03 122.41 5.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.888 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.818 HG23 ' CE1' ' B' ' 139' ' ' TYR . 10.4 pt -108.68 151.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 110.509 -179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 23.77 8.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.348 -0.845 . . . . 0.0 109.931 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.0 OUTLIER -175.9 94.92 0.26 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.88 . . . . 0.0 110.114 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 46.4 Cg_endo -72.8 162.22 91.72 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.546 0.146 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.412 ' C ' HG23 ' B' ' 111' ' ' THR . 6.6 tppt? -71.5 89.83 0.97 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.926 . . . . 0.0 109.918 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' B' ' 124' ' ' THR . 21.9 p -145.32 -179.83 6.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.201 -0.937 . . . . 0.0 110.293 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.84 HG22 ' HB2' ' A' ' 27' ' ' ASN . 6.1 t -133.69 176.06 8.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.196 -0.94 . . . . 0.0 109.862 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.598 ' HB1' ' O ' ' B' ' 122' ' ' VAL . . . -170.5 177.58 3.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.035 -1.04 . . . . 0.0 111.049 -179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.68 HD12 ' CE1' ' B' ' 116' ' ' PHE . 0.3 OUTLIER -145.7 123.44 11.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.631 -0.668 . . . . 0.0 109.532 179.432 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.905 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 18.0 mt -94.04 134.55 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.202 -0.936 . . . . 0.0 110.935 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.773 ' CZ ' HD12 ' A' ' 72' ' ' ILE . 8.3 m-85 -87.41 134.21 33.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.611 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' B' ' 82' ' ' LEU . . . -52.24 -19.69 2.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 55.0 m -79.41 -29.6 42.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 110.256 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 139.09 -31.28 2.38 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.42 163.3 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.225 -1.162 . . . . 0.0 110.135 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.417 ' SD ' ' CG2' ' B' ' 123' ' ' VAL . 8.1 tmm? -160.89 128.18 4.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -0.904 . . . . 0.0 110.287 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.774 HG22 HG23 ' B' ' 73' ' ' THR . 22.6 t -107.94 154.64 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 109.963 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.442 HG23 ' C ' ' B' ' 122' ' ' VAL . 25.7 t -146.37 131.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 0.0 110.469 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.617 HG23 ' CB ' ' A' ' 27' ' ' ASN . 1.2 t -139.04 167.01 23.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 110.337 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.578 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 117.36 -37.48 3.31 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -53.52 173.46 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -1.086 . . . . 0.0 110.196 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.507 ' HA ' HG12 ' B' ' 70' ' ' ILE . 8.5 mtmm -135.34 5.8 3.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 110.339 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.423 ' HB3' ' HB2' ' B' ' 131' ' ' ASP . 0.3 OUTLIER -147.23 163.18 37.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 110.188 179.863 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . 0.536 ' HG2' ' CD1' ' B' ' 157' ' ' ILE . 3.8 mt-10 -57.73 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 110.173 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' B' ' 133' ' ' LYS . 0.4 OUTLIER -47.92 -36.17 11.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.344 -0.847 . . . . 0.0 110.345 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' B' ' 128' ' ' SER . 9.3 t0 -53.89 -49.57 68.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.128 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 57.0 m -56.23 -42.04 76.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.839 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' B' ' 137' ' ' ARG . 3.7 mttt -53.86 -38.43 64.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 1.4 mt -66.25 -41.1 90.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 0.0 110.133 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.59 -54.59 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.38 -51.53 69.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' B' ' 133' ' ' LYS . 0.2 OUTLIER -53.41 -37.43 62.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.924 179.869 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' B' ' 134' ' ' LEU . 4.8 mmtt -68.15 -50.78 52.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.898 179.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.818 ' CE1' HG23 ' B' ' 106' ' ' ILE . 28.2 m-85 -52.75 -54.18 37.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.941 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.63 58.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.984 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -72.49 -46.25 55.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 110.023 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 57.0 mt -51.69 -41.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 109.877 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.672 HG22 ' HB2' ' B' ' 148' ' ' PHE . 23.5 mm -64.37 -49.95 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.531 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -65.75 -31.45 72.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.376 179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' B' ' 141' ' ' ARG . 2.7 tmtt? -74.23 -21.17 59.91 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 5.4 mt -84.58 -17.13 10.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 118.97 -21.88 9.33 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.672 ' HB2' HG22 ' B' ' 143' ' ' ILE . 15.3 m-85 -53.94 174.35 0.05 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 110.958 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.65 36.56 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.515 -0.74 . . . . 0.0 110.193 -179.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.842 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -71.06 144.47 50.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 110.389 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.451 ' O ' ' OG1' ' B' ' 153' ' ' THR . 4.2 tttp -128.74 104.52 7.68 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 110.011 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.459 ' O ' HG23 ' B' ' 153' ' ' THR . 54.9 t80 -53.41 102.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.16 -0.962 . . . . 0.0 110.319 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.459 HG23 ' O ' ' B' ' 152' ' ' PHE . 0.6 OUTLIER -154.09 172.09 18.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 110.164 179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.0 33.61 23.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 0.0 110.201 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -72.35 138.22 47.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -161.74 136.14 6.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 110.231 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.536 ' CD1' ' HG2' ' B' ' 129' ' ' GLU . 37.2 mt -80.23 140.77 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.853 . . . . 0.0 110.139 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -92.77 -61.76 1.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.425 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -145.75 168.77 19.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.568 HD12 ' O ' ' B' ' 219' ' ' GLN . 67.1 mt -119.54 144.4 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 12.4 t -112.0 121.46 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -132.64 172.28 21.32 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 28.3 t -166.1 161.16 16.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -1.173 . . . . 0.0 110.129 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.452 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 29.5 p -167.88 139.5 2.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -92.69 161.69 14.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.1 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.489 ' O ' ' CB ' ' B' ' 167' ' ' LYS . 0.0 OUTLIER -110.94 -81.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.182 -0.948 . . . . 0.0 110.198 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 6.1 mtpt 170.01 -24.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 0.0 110.407 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' B' ' 168' ' ' PHE . 10.5 p90 -129.56 155.99 79.37 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.201 -0.937 . . . . 0.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 44.6 Cg_endo -71.45 161.27 46.07 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.859 1.452 . . . . 0.0 110.307 -179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 1.7 mp -126.93 149.67 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.154 -0.967 . . . . 0.0 110.663 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.46 110.59 19.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.848 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' B' ' 193' ' ' LEU . 11.9 mt -65.61 -32.21 73.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 0.0 110.612 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -68.13 -28.96 67.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 110.175 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -70.87 -35.79 65.61 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' B' ' 175' ' ' LEU . 0.2 OUTLIER -71.41 -45.46 62.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 110.227 179.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.53 -13.63 62.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -90.31 -32.45 16.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . 0.508 ' OG ' ' ND1' ' B' ' 179' ' ' HIS . 37.6 p -98.27 -30.53 12.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.907 . . . . 0.0 110.218 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.508 ' ND1' ' OG ' ' B' ' 178' ' ' SER . 76.1 m80 -123.94 44.38 2.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.29 -0.881 . . . . 0.0 110.126 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -65.34 -27.68 72.72 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 2.2 t -54.16 -26.22 26.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -1.151 . . . . 0.0 110.221 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.565 ' CE2' ' CG2' ' B' ' 198' ' ' VAL . 31.4 m-85 -136.17 8.77 3.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.895 . . . . 0.0 110.196 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.718 ' OG ' HD21 ' B' ' 193' ' ' LEU . 22.9 t -110.96 120.72 43.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.969 . . . . 0.0 110.632 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 40.2 t -111.55 103.98 12.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 109.858 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -108.53 105.9 15.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.194 -0.941 . . . . 0.0 110.32 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' B' ' 190' ' ' PHE . 1.6 mm-40 -113.62 99.19 49.23 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.946 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.19 -4.66 15.35 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.052 1.554 . . . . 0.0 110.49 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -100.13 -13.02 19.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.952 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.851 ' CD2' HD11 ' A' ' 62' ' ' LEU . 2.4 tt -146.43 11.2 1.13 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 110.263 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.617 ' CE2' ' CG1' ' B' ' 194' ' ' ILE . 2.2 t80 -166.2 112.6 0.74 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.108 -0.995 . . . . 0.0 110.262 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . 0.501 ' HD2' ' OD1' ' A' ' 55' ' ' ASN . 47.7 Cg_endo -74.43 -26.89 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.898 1.472 . . . . 0.0 110.551 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -93.99 178.28 37.43 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.718 HD21 ' OG ' ' B' ' 183' ' ' SER . 8.3 tt -110.6 132.82 53.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.326 -1.103 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.617 ' CG1' ' CE2' ' B' ' 190' ' ' PHE . 93.8 mt -100.46 118.39 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 110.231 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -120.85 128.95 53.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.58 ' HG2' HG22 ' B' ' 203' ' ' VAL . 7.6 mtp-105 -108.42 89.38 2.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 110.152 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.483 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 32.9 ttm -50.74 141.13 13.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.075 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.565 ' CG2' ' CE2' ' B' ' 182' ' ' PHE . 31.3 t -71.35 -59.27 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.438 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 20.5 tttp -127.13 117.18 21.84 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.178 -0.952 . . . . 0.0 110.304 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.6 Cg_endo -74.08 156.46 99.72 Favored 'Cis proline' 0 C--N 1.315 -1.199 0 C-N-CA 121.92 -2.117 . . . . 0.0 110.277 -0.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 85.43 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.978 . . . . 0.0 110.106 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.425 HD12 ' HB2' ' B' ' 217' ' ' ALA . 25.3 mm -130.27 163.07 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.58 HG22 ' HG2' ' B' ' 196' ' ' ARG . 12.6 t -109.57 120.38 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.281 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.863 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.5 mp -114.76 124.49 51.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 110.161 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.799 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 1.8 mt -102.63 148.67 25.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.203 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.57 HG23 ' CD1' ' B' ' 212' ' ' ILE . 4.1 mp -139.56 127.16 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 110.327 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.509 ' HZ ' HD21 ' A' ' 52' ' ' LEU . 26.0 m-85 -105.13 155.61 18.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.245 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 72.6 t -51.33 -24.93 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 0.0 110.306 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -24.32 62.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.364 -0.835 . . . . 0.0 110.421 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 107.54 24.92 6.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' B' ' 206' ' ' ILE . 0.0 OUTLIER -91.15 126.18 36.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -1.114 . . . . 0.0 110.204 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.57 ' CD1' HG23 ' B' ' 206' ' ' ILE . 23.8 mm -114.37 116.17 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.189 -0.944 . . . . 0.0 110.507 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 29.0 t -107.61 143.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.908 . . . . 0.0 110.063 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.594 HD12 ' N ' ' B' ' 214' ' ' LEU . 3.1 mp -135.58 112.36 10.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 110.213 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 13.2 t -135.95 153.68 51.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.15 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 108.05 -5.59 34.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.621 ' HB1' ' HB2' ' B' ' 222' ' ' GLU . . . -81.99 127.47 33.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.17 -1.194 . . . . 0.0 110.051 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -71.19 -38.61 72.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 110.432 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.568 ' O ' HD12 ' B' ' 160' ' ' ILE . 3.7 mt-30 -117.69 -173.01 2.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.248 -0.908 . . . . 0.0 110.274 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . 0.571 ' HG2' ' CE1' ' B' ' 224' ' ' TYR . 35.5 ttp180 -88.48 -24.66 22.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.277 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.503 ' HG3' ' N ' ' B' ' 222' ' ' GLU . 3.4 pt-20 -63.96 -22.47 66.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.21 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.621 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 33.2 mt-10 -76.39 -53.75 7.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.957 . . . . 0.0 110.07 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.617 HG22 ' CG ' ' B' ' 65' ' ' PRO . 27.8 mm -56.59 -37.7 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 110.035 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.571 ' CE1' ' HG2' ' B' ' 220' ' ' ARG . 5.5 m-85 -66.11 -40.54 90.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 0.0 110.134 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -80.02 -22.48 42.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.872 . . . . 0.0 110.087 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.863 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -67.68 -47.49 69.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.042 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.747 ' HA ' HG22 ' B' ' 230' ' ' ILE . 19.6 t80 -76.92 -34.21 57.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.893 . . . . 0.0 110.037 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' B' ' 224' ' ' TYR . 35.9 mm-40 -65.68 -18.48 65.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.913 . . . . 0.0 110.213 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.443 ' HB3' ' SD ' ' B' ' 197' ' ' MET . . . -97.04 -25.91 15.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 110.065 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.747 HG22 ' HA ' ' B' ' 227' ' ' PHE . 2.9 tp -96.21 -11.3 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 0.0 110.05 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.607 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 2.4 t80 -53.89 -44.03 97.51 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.314 -0.866 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.4 Cg_endo -74.72 -43.74 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.468 1.246 . . . . 0.0 110.68 -179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.413 HG12 HD21 ' B' ' 175' ' ' LEU . 30.5 t -56.92 -36.51 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 0.0 109.956 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.455 HD21 HG12 ' B' ' 206' ' ' ILE . 20.2 mt -63.44 -62.13 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.818 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 43.1 m -53.79 -20.31 5.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.512 179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' B' ' 233' ' ' VAL . 2.0 tt0 -67.69 -40.25 84.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.452 -0.78 . . . . 0.0 110.044 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -116.14 41.68 2.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 110.516 -179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -168.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.918 . . . . 0.0 110.145 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.8 ttmm -141.35 -41.38 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 30.2 mtp . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.18 179.852 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.255 0.55 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.04 -133.38 10.6 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 p -138.04 -179.51 5.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -1.113 . . . . 0.0 110.273 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.0 tt -117.23 28.32 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 110.032 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.42 47.3 1.03 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.525 ' O ' ' CD ' ' A' ' 75' ' ' LYS . 2.2 t-20 -138.34 166.77 23.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -1.16 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 74' ' ' LEU . . . 95.33 159.11 32.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.035 HD23 HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -80.18 165.27 22.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -1.108 . . . . 0.0 109.534 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.522 ' HA ' HD11 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -100.55 128.07 46.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.105 -0.997 . . . . 0.0 110.764 -179.481 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.839 HD11 ' HB ' ' A' ' 72' ' ' ILE . 43.4 mt -123.92 22.69 8.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.415 -0.803 . . . . 0.0 110.54 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.642 ' OG1' HD23 ' A' ' 68' ' ' LEU . 6.4 m -43.7 -37.41 2.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.159 -0.963 . . . . 0.0 109.852 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -99.49 -32.02 5.89 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.674 HG12 HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -46.62 -41.53 5.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.392 -1.064 . . . . 0.0 108.644 -179.446 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.869 HD22 ' HG2' ' A' ' 67' ' ' MET . 3.1 pp -84.29 -26.22 28.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.033 -1.042 . . . . 0.0 108.539 177.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.704 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 1.7 t80 -85.85 7.03 25.55 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.602 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 142.23 99.66 0.35 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 -179.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.723 ' ND2' HD12 ' A' ' 35' ' ' LEU . 6.4 p-10 -20.84 115.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.912 0.863 . . . . 0.0 112.357 -178.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.676 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -136.42 158.81 38.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.568 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 31' ' ' GLU . 4.4 m-20 -88.12 123.57 32.92 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.605 ' CB ' ' CD1' ' A' ' 18' ' ' LEU . 17.3 p -39.41 -26.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.588 -0.695 . . . . 0.0 110.145 -178.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.0 mt-10 -55.9 -14.32 2.38 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 178.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.65 26.56 6.1 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.478 ' O ' HG12 ' A' ' 28' ' ' ILE . 11.7 mmt-85 -116.55 123.88 48.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -1.149 . . . . 0.0 109.501 179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.676 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.39 160.95 16.56 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.206 -0.934 . . . . 0.0 111.163 -178.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.723 HD12 ' ND2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -88.15 116.14 26.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.524 -0.735 . . . . 0.0 111.272 -178.78 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -88.94 6.42 39.52 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 38' ' ' ASP . 8.9 t70 50.16 20.25 0.6 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.759 -0.588 . . . . 0.0 110.485 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 37' ' ' ASP . 0.7 OUTLIER 42.78 39.26 1.62 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 110.313 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -105.89 176.06 5.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.324 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.86 98.54 1.74 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 143.26 36.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -1.148 . . . . 0.0 110.263 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.53 -112.97 5.44 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -94.77 -164.41 1.16 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -1.138 . . . . 0.0 110.269 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.49 -172.79 41.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.71 -45.25 0.26 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -79.44 101.49 8.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -1.113 . . . . 0.0 110.226 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.14 -74.5 0.29 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -63.24 148.79 47.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -1.138 . . . . 0.0 110.372 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.8 -175.14 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 110.315 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.63 21.02 7.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 110.294 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.65 -20.31 15.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.107 179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 52' ' ' LEU . 3.5 mt -96.31 -43.78 7.53 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.576 -0.702 . . . . 0.0 110.303 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.029 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -50.6 -52.96 34.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.244 -0.91 . . . . 0.0 109.577 -179.553 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.13 -27.24 67.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.429 -0.794 . . . . 0.0 109.559 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.568 ' OD1' ' CD1' ' B' ' 190' ' ' PHE . 1.6 m-80 -77.8 -31.62 51.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.427 -0.796 . . . . 0.0 109.195 179.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.029 HD12 ' HA ' ' A' ' 53' ' ' ARG . 16.3 mt -56.81 -47.41 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.386 -0.821 . . . . 0.0 109.195 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.54 -25.95 14.75 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB2' HD11 ' B' ' 189' ' ' LEU . 0.8 OUTLIER -124.03 25.63 7.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -1.114 . . . . 0.0 110.136 179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 56' ' ' ILE . 2.6 mt -82.08 -21.2 36.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.275 -0.891 . . . . 0.0 110.069 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.47 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 1.0 OUTLIER -83.41 40.36 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 110.548 -179.817 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' HD13 ' A' ' 62' ' ' LEU . 3.4 ttpp -132.81 -4.61 3.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.168 -0.957 . . . . 0.0 110.521 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -129.39 -2.96 4.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 111.331 -179.752 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.783 ' N ' HD22 ' A' ' 62' ' ' LEU . . . 168.8 -55.43 0.21 Allowed Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 4.0 mm? -42.92 -24.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -1.205 . . . . 0.0 110.933 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 8.2 t70 -44.05 -41.96 5.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 109.716 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.9 m -67.23 -51.19 56.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.435 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.869 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -71.12 -4.47 25.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.342 -0.849 . . . . 0.0 109.303 178.86 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.663 HD13 ' C ' ' A' ' 68' ' ' LEU . 1.8 tm? -72.32 -62.09 1.56 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.858 0.837 . . . . 0.0 109.032 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.7 0.69 12.18 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.24 0.543 . . . . 0.0 110.298 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.521 ' O ' ' CG ' ' A' ' 70' ' ' GLU . 37.3 tt0 -84.36 8.12 17.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -0.866 . . . . 0.0 111.196 -179.128 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.951 HG12 HG11 ' B' ' 122' ' ' VAL . 6.0 t -140.69 2.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.121 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.035 HD13 HD23 ' A' ' 18' ' ' LEU . 3.1 tp -151.01 81.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.451 -0.78 . . . . 0.0 109.232 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 8.6 t0 -83.98 49.78 1.7 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.095 -1.003 . . . . 0.0 109.408 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.974 HD11 ' CD1' ' B' ' 116' ' ' PHE . 11.2 mt -101.82 62.32 0.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.608 0.718 . . . . 0.0 110.343 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' A' ' 16' ' ' ASN . 11.5 mtmt -112.94 -173.01 2.16 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 110.321 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 5.8 mt-10 58.61 -79.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.435 -0.79 . . . . 0.0 110.458 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 75' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.32 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.201 0.524 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . -164.1 25.18 0.19 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.569 HD13 ' CE2' ' B' ' 231' ' ' TYR . 1.3 mp -130.13 -48.78 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -1.183 . . . . 0.0 110.197 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 90.3 t 58.61 125.13 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.488 -0.757 . . . . 0.0 110.583 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 47.7 Cg_endo -74.43 144.05 31.93 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.825 1.434 . . . . 0.0 110.589 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -107.19 129.76 54.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.082 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.532 HD22 ' CG2' ' B' ' 160' ' ' ILE . 73.4 mt -69.66 127.1 31.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.404 ' HA ' ' OE1' ' B' ' 68' ' ' GLN . 5.6 mm-40 -106.25 -20.28 13.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.262 -0.899 . . . . 0.0 110.527 -179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.441 ' HB2' ' HB ' ' B' ' 161' ' ' VAL . 7.3 m120 -161.42 137.02 7.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.074 -1.016 . . . . 0.0 110.567 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' B' ' 126' ' ' ALA . 13.1 mm -115.73 148.39 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.922 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.917 HG22 ' CB ' ' B' ' 124' ' ' THR . 27.6 t -137.89 129.18 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.17 -0.956 . . . . 0.0 110.505 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -130.58 155.55 46.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.83 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 65.0 p -111.34 139.26 46.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.182 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.476 ' HB ' ' CG ' ' B' ' 121' ' ' MET . 22.6 t -123.9 148.78 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.837 . . . . 0.0 110.13 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' B' ' 154' ' ' ASP . 4.7 m -119.06 127.52 53.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.974 . . . . 0.0 110.258 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.977 HD22 ' HB1' ' B' ' 150' ' ' ALA . 70.2 mt -92.02 -42.94 9.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 110.004 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.38 -2.72 68.29 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 52.9 m -132.84 151.14 52.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.163 -1.198 . . . . 0.0 110.365 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.523 ' O ' HD23 ' B' ' 80' ' ' LEU . 39.2 mtp-105 -79.32 155.2 28.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 110.075 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.523 HD23 ' O ' ' B' ' 79' ' ' ARG . 18.7 mt -127.74 161.0 29.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 0.0 110.27 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' B' ' 84' ' ' THR . 8.6 m-20 -94.63 82.11 3.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 109.81 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.727 ' CD1' ' HB2' ' B' ' 117' ' ' ALA . 92.6 mt -42.01 -27.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 110.241 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' B' ' 81' ' ' ASP . 18.9 mmmt -67.01 -44.99 78.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.246 -0.909 . . . . 0.0 109.697 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' B' ' 81' ' ' ASP . 10.9 p -85.41 -38.5 18.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.38 -0.825 . . . . 0.0 109.871 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 43.3 t -52.36 -44.61 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.826 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' B' ' 102' ' ' VAL . . . -77.81 -30.36 51.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.884 179.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' B' ' 87' ' ' LEU . 14.1 tp -80.53 -18.9 47.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.439 ' N ' ' O ' ' B' ' 84' ' ' THR . 1.2 m-70 -99.91 -32.87 10.77 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 110.338 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 150.48 45.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 0.0 110.555 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -87.15 -26.13 23.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' B' ' 104' ' ' MET . 90.6 m-20 -127.74 78.82 1.85 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -0.887 . . . . 0.0 109.652 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.541 ' HB1' ' CG1' ' B' ' 102' ' ' VAL . . . -145.49 158.35 43.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 110.136 -179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.07 141.12 44.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -131.67 109.31 10.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 110.095 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.413 ' OD1' ' NH1' ' B' ' 98' ' ' ARG . 2.6 t-20 -129.35 128.31 23.19 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.371 -0.83 . . . . 0.0 109.987 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.18 -16.16 31.79 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.842 1.443 . . . . 0.0 110.186 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.493 ' HE2' ' NH2' ' B' ' 98' ' ' ARG . 7.3 tttt -86.32 -16.92 35.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.86 . . . . 0.0 110.066 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.493 ' NH2' ' HE2' ' B' ' 97' ' ' LYS . 0.0 OUTLIER -92.21 -67.0 0.88 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.28 -0.888 . . . . 0.0 110.486 -179.991 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 1.18 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.08 161.67 8.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.288 -0.883 . . . . 0.0 111.225 -179.389 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.83 54.06 0.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.532 -0.73 . . . . 0.0 111.677 -178.698 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.18 ' HB3' ' CE2' ' B' ' 99' ' ' PHE . . . -161.85 173.27 14.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.941 -1.099 . . . . 0.0 110.258 179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.541 ' CG1' ' HB1' ' B' ' 92' ' ' ALA . 38.0 t -108.06 155.82 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.477 -179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.519 HD11 ' OG ' ' A' ' 30' ' ' SER . 16.1 mt -113.51 110.38 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.341 -0.849 . . . . 0.0 110.058 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' B' ' 91' ' ' ASN . 12.0 ttm -94.19 151.07 19.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 110.624 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -149.56 120.88 7.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.677 HG23 ' CE1' ' B' ' 139' ' ' TYR . 25.1 pt -107.57 156.35 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.116 -0.99 . . . . 0.0 110.325 -179.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -106.88 37.81 2.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.847 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 0.0 OUTLIER -175.63 82.19 0.3 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.592 -179.78 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.474 ' O ' HG13 ' B' ' 106' ' ' ILE . 51.0 Cg_endo -80.64 161.49 83.41 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.801 -2.166 . . . . 0.0 110.472 -0.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 0.1 OUTLIER -64.24 104.74 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 109.995 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.435 HG23 ' C ' ' B' ' 110' ' ' LYS . 30.5 p -146.63 166.1 27.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.127 -0.983 . . . . 0.0 110.66 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' B' ' 113' ' ' ALA . 1.8 m -112.52 164.8 12.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.644 179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' B' ' 122' ' ' VAL . . . -167.2 146.07 5.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.524 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.886 HD12 ' CE1' ' B' ' 116' ' ' PHE . 0.2 OUTLIER -124.28 119.4 29.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.726 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.566 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 78.6 mt -95.41 131.46 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.206 -0.934 . . . . 0.0 110.577 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.974 ' CD1' HD11 ' A' ' 74' ' ' LEU . 8.5 m-30 -90.13 155.19 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.42 -0.8 . . . . 0.0 109.906 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.727 ' HB2' ' CD1' ' B' ' 82' ' ' LEU . . . -69.99 -11.61 61.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 110.152 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . 0.413 ' HA ' ' HG2' ' B' ' 79' ' ' ARG . 3.9 m -85.7 -40.48 16.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.27 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.633 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 148.06 -34.79 1.2 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 30.0 tttm -67.8 150.19 48.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.13 -1.218 . . . . 0.0 110.508 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.476 ' CG ' ' HB ' ' B' ' 74' ' ' VAL . 0.0 OUTLIER -150.14 159.3 44.52 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.951 HG11 HG12 ' A' ' 71' ' ' VAL . 99.0 t -124.51 137.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' B' ' 71' ' ' VAL . 88.6 t -121.89 140.95 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 109.868 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.917 ' CB ' HG22 ' B' ' 71' ' ' VAL . 3.9 t -145.55 160.83 41.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.444 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.577 ' CA ' ' ND2' ' A' ' 27' ' ' ASN . . . 114.32 -35.26 4.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' B' ' 70' ' ' ILE . . . -42.42 147.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -1.191 . . . . 0.0 110.083 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.467 ' HB2' ' OD2' ' B' ' 131' ' ' ASP . 13.1 mmtt -96.11 0.74 51.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.234 -0.916 . . . . 0.0 110.431 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.63 -165.19 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 110.39 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.13 -40.38 74.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.04 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -44.64 92.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.482 ' CB ' ' HB1' ' B' ' 126' ' ' ALA . 8.8 m-20 -56.31 -53.51 56.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.203 -0.936 . . . . 0.0 109.964 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 1.5 p -57.81 -32.5 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.848 179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . 0.438 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -67.69 -44.69 77.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 109.999 179.691 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 -59.73 2.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.043 179.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -44.82 -36.13 3.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.025 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' B' ' 152' ' ' PHE . 18.4 m -65.98 -58.69 4.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 110.138 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -46.2 -44.03 15.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.004 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -53.29 -47.12 69.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.176 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.677 ' CE1' HG23 ' B' ' 106' ' ' ILE . 31.7 m-85 -65.62 -55.05 19.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.251 -0.905 . . . . 0.0 109.912 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 -17.66 8.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.297 -0.877 . . . . 0.0 109.737 179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -47.02 13.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 110.068 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 42.0 mt -52.74 -38.06 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' B' ' 150' ' ' ALA . 34.0 mm -71.7 -55.63 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 110.098 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.26 -27.3 68.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.942 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -75.54 -21.71 57.71 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.94 . . . . 0.0 108.613 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 5.7 mt -86.17 -21.34 7.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 125.27 -18.86 6.86 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.569 ' HB2' HG22 ' B' ' 143' ' ' ILE . 11.0 m-85 -53.84 165.98 0.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.013 -1.286 . . . . 0.0 110.882 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -106.56 23.8 13.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.552 -0.717 . . . . 0.0 109.823 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.977 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -54.94 148.3 13.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.83 . . . . 0.0 110.552 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -123.35 114.77 20.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.83 . . . . 0.0 110.04 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' B' ' 136' ' ' SER . 36.2 t80 -69.89 90.9 0.63 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.928 . . . . 0.0 110.395 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.4 ' O ' ' CB ' ' B' ' 154' ' ' ASP . 1.4 p -145.6 171.89 14.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 0.0 110.138 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.451 ' HB3' ' OG1' ' B' ' 75' ' ' THR . 1.1 t0 63.21 29.79 15.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.224 -0.922 . . . . 0.0 110.251 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.438 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.9 t80 -77.36 136.73 38.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.88 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.86 134.17 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.404 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 7.5 mt -79.68 121.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.862 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -119.68 -4.33 10.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.131 -0.981 . . . . 0.0 110.588 -179.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.459 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 3.3 m120 -138.29 115.3 10.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.0 . . . . 0.0 110.616 -179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.532 ' CG2' HD22 ' B' ' 67' ' ' LEU . 68.9 mt -122.65 125.58 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.388 -0.82 . . . . 0.0 109.83 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' B' ' 69' ' ' ASN . 26.0 t -100.26 130.75 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.524 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -139.05 169.86 24.29 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' B' ' 212' ' ' ILE . 2.3 m -162.89 164.53 25.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -1.147 . . . . 0.0 110.119 -179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.486 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.6 p -170.34 166.93 8.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 0.0 110.607 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.67 137.45 50.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 109.74 179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.74 HG21 HD11 ' B' ' 170' ' ' ILE . 20.9 m -89.71 12.07 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.423 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.1 OUTLIER 70.82 3.63 4.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.281 -0.887 . . . . 0.0 110.711 179.662 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.61 ' O ' HG23 ' B' ' 166' ' ' VAL . 8.1 p90 -162.58 150.98 12.13 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.122 -0.986 . . . . 0.0 110.386 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' B' ' 208' ' ' VAL . 45.1 Cg_endo -71.84 165.66 31.87 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.998 1.525 . . . . 0.0 110.512 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.74 HD11 HG21 ' B' ' 166' ' ' VAL . 3.7 mt -133.25 158.09 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.205 -0.934 . . . . 0.0 110.79 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . 0.493 ' HD3' ' HG3' ' B' ' 173' ' ' GLU . 3.4 ttm180 -89.3 98.81 11.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 109.685 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' B' ' 193' ' ' LEU . 92.6 mt -53.66 -55.24 27.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.182 -0.949 . . . . 0.0 110.19 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . 0.493 ' HG3' ' HD3' ' B' ' 171' ' ' ARG . 15.4 pt-20 -54.02 -26.54 26.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.539 -0.725 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . 0.413 ' HA3' ' HD2' ' B' ' 171' ' ' ARG . . . -73.55 -37.14 53.24 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' B' ' 175' ' ' LEU . 0.1 OUTLIER -71.54 -44.58 64.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -1.166 . . . . 0.0 110.056 179.754 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.491 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -59.38 -38.3 80.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -65.5 -32.69 74.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 0.0 110.084 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -58.66 2.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.248 -0.907 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' B' ' 183' ' ' SER . 37.3 m80 -101.74 30.38 4.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 110.343 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -60.1 -14.71 33.42 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.67 -30.38 64.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.177 -1.19 . . . . 0.0 110.578 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' B' ' 198' ' ' VAL . 60.4 m-85 -119.77 0.68 10.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' B' ' 194' ' ' ILE . 0.1 OUTLIER -120.59 174.07 6.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.074 179.873 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.29 152.98 35.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.265 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 0.76 ' HB2' HD12 ' B' ' 193' ' ' LEU . 75.0 t80 -148.75 100.94 3.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 0.0 110.194 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' B' ' 190' ' ' PHE . 23.5 mt-10 -101.31 103.5 27.0 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.203 -0.936 . . . . 0.0 110.02 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.68 -6.32 18.89 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.938 1.493 . . . . 0.0 110.146 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -99.95 -2.92 33.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 58' ' ' SER . 0.8 OUTLIER -154.71 -41.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.124 -0.985 . . . . 0.0 110.626 -179.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.645 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -111.24 110.8 55.98 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 110.675 -179.524 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.46 -25.35 15.34 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.115 1.587 . . . . 0.0 110.07 179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' B' ' 207' ' ' PHE . . . -95.64 -179.91 36.11 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.76 HD12 ' HB2' ' B' ' 185' ' ' TYR . 0.7 OUTLIER -113.22 140.62 47.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.223 -1.163 . . . . 0.0 110.359 -179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.529 HG12 ' CD2' ' B' ' 205' ' ' LEU . 67.9 mt -104.87 104.6 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' B' ' 203' ' ' VAL . 17.9 t80 -96.78 137.21 36.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 110.546 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -115.66 83.6 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 110.004 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' B' ' 226' ' ' ALA . 30.4 ttm -51.87 139.84 21.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.302 -0.874 . . . . 0.0 110.319 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' B' ' 182' ' ' PHE . 25.6 t -82.4 -42.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.216 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 9.7 tttp -140.41 114.51 7.46 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.27 -0.893 . . . . 0.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.9 Cg_endo -73.49 168.68 75.51 Favored 'Cis proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.968 -2.097 . . . . 0.0 110.607 0.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.407 ' C ' HG12 ' B' ' 202' ' ' ILE . 0.0 OUTLIER -72.69 87.96 1.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.296 -0.878 . . . . 0.0 110.005 179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.477 ' CD1' ' HA ' ' B' ' 217' ' ' ALA . 19.1 mm -137.76 153.29 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.155 -0.966 . . . . 0.0 110.51 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 195' ' ' TYR . 43.0 t -105.73 126.85 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.573 HD21 ' HB1' ' B' ' 226' ' ' ALA . 5.0 mp -116.55 136.82 52.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 110.277 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.704 HD13 ' HZ ' ' A' ' 25' ' ' PHE . 1.2 mt -119.32 132.69 55.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.345 -0.847 . . . . 0.0 110.329 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.654 HG13 HD12 ' B' ' 212' ' ' ILE . 3.5 mp -112.58 159.98 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.205 -0.934 . . . . 0.0 109.918 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.508 ' CE1' ' HA3' ' B' ' 192' ' ' GLY . 2.9 m-85 -135.75 147.74 48.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.203 -0.935 . . . . 0.0 110.363 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' B' ' 169' ' ' PRO . 37.9 t -45.87 -24.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 110.267 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -76.12 -22.65 55.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.91 . . . . 0.0 110.438 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.689 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 107.24 4.31 35.4 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.592 ' O ' HD13 ' B' ' 212' ' ' ILE . 22.1 tttt -77.84 141.43 39.16 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -1.152 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.654 HD12 HG13 ' B' ' 206' ' ' ILE . 15.2 mm -124.53 142.14 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.316 -0.865 . . . . 0.0 110.102 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' B' ' 204' ' ' LEU . 11.1 t -124.24 151.9 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.9 . . . . 0.0 110.199 -179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' B' ' 213' ' ' VAL . 3.1 mp -141.35 119.24 11.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.094 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . . . . . . . . . 12.8 t -135.52 166.17 23.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -0.968 . . . . 0.0 110.314 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.38 79.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' B' ' 202' ' ' ILE . . . -79.39 132.64 36.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.21 -1.171 . . . . 0.0 110.264 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' B' ' 218' ' ' LYS . 2.1 ttmt -79.24 -26.31 42.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.516 ' HB3' ' HG3' ' B' ' 221' ' ' GLU . 0.0 OUTLIER -144.87 162.23 37.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 110.375 -179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -59.44 -26.56 65.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.411 -0.806 . . . . 0.0 110.552 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.516 ' HG3' ' HB3' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -63.85 -27.55 69.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -0.949 . . . . 0.0 110.44 -179.824 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.43 ' OE1' HD11 ' B' ' 202' ' ' ILE . 4.5 mt-10 -74.57 -42.27 59.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.121 -0.987 . . . . 0.0 109.879 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' B' ' 214' ' ' LEU . 32.0 mm -63.75 -40.35 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 0.0 109.812 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.37 -39.88 94.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 110.08 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -74.62 -31.45 62.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -63.92 -38.3 90.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.856 . . . . 0.0 110.156 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.689 ' HA ' HG22 ' B' ' 230' ' ' ILE . 27.5 t80 -79.55 -42.32 25.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 110.221 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' B' ' 228' ' ' GLU . 0.3 OUTLIER -61.83 -17.04 54.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 109.972 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -96.06 -32.96 12.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.126 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.689 HG22 ' HA ' ' B' ' 227' ' ' PHE . 5.3 tp -89.59 -16.34 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.995 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.594 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 4.4 t80 -53.86 -43.39 96.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.379 -0.825 . . . . 0.0 111.083 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 46.1 Cg_endo -74.58 -36.87 2.64 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.356 1.188 . . . . 0.0 110.613 -179.662 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.42 HG12 HD21 ' B' ' 175' ' ' LEU . 40.9 t -63.11 -40.72 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.869 179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.547 HD13 HG11 ' B' ' 166' ' ' VAL . 26.3 mt -62.66 -48.81 77.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 110.233 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -42.54 84.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 109.988 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . 0.441 ' CA ' ' OE1' ' B' ' 236' ' ' GLU . 0.0 OUTLIER -61.73 -30.0 70.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 110.156 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -119.58 39.58 3.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 0.0 110.089 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' B' ' 239' ' ' LYS . 7.1 tmm_? -69.75 148.49 49.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 110.235 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.433 ' N ' ' HG2' ' B' ' 238' ' ' ARG . 0.0 OUTLIER -91.7 -56.19 3.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.343 -179.895 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 36.5 ttm . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.253 -179.998 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.222 0.534 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' SER . . . 63.3 -117.83 12.21 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 12' ' ' GLY . 5.5 t 56.86 112.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -1.101 . . . . 0.0 110.191 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.6 pt -105.88 48.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 110.153 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -93.13 -72.31 1.19 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -67.78 -162.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.17 -1.194 . . . . 0.0 110.11 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 64.63 147.6 0.04 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.011 HD21 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -111.18 166.88 10.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -1.196 . . . . 0.0 109.952 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.885 ' N ' HD12 ' A' ' 18' ' ' LEU . 5.6 p-10 -86.68 93.12 9.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -0.89 . . . . 0.0 111.024 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.011 HD21 HD21 ' A' ' 18' ' ' LEU . 2.9 mt -99.21 2.62 45.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 110.317 179.431 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 59' ' ' LEU . 42.3 m -42.33 -39.29 2.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 110.178 -179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -89.41 -35.25 8.08 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.689 HG12 HG23 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -51.19 -45.44 31.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.459 -1.024 . . . . 0.0 109.076 -179.49 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.769 HD22 ' HG2' ' A' ' 67' ' ' MET . 3.8 pp -82.88 -19.62 37.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.904 -1.123 . . . . 0.0 109.827 178.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.503 ' HB2' ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -100.22 11.62 38.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.246 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 28' ' ' ILE . . . 146.58 89.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.986 ' ND2' HD11 ' A' ' 35' ' ' LEU . 4.3 p30 -16.06 124.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 122.075 0.941 . . . . 0.0 112.506 -179.264 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.689 HG23 HG12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -145.67 161.13 12.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.854 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.551 ' N ' HG12 ' A' ' 28' ' ' ILE . 68.9 m-20 -86.8 134.33 33.57 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 1.01 ' HB2' HD13 ' A' ' 18' ' ' LEU . 9.7 p -39.35 -27.36 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.598 -179.227 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 29' ' ' ASP . 10.3 tt0 -55.57 -15.41 2.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.173 -0.954 . . . . 0.0 110.22 178.275 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.88 31.26 5.18 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -125.72 129.32 49.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.957 -1.32 . . . . 0.0 110.571 179.83 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' HA ' ' HB ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.35 150.58 20.36 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.299 -0.876 . . . . 0.0 110.698 179.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.986 HD11 ' ND2' ' A' ' 27' ' ' ASN . 4.4 pp -123.35 -178.79 4.1 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.522 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.605 ' N ' HD12 ' A' ' 35' ' ' LEU . 27.1 mt-30 -122.48 136.79 54.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.425 -0.797 . . . . 0.0 110.357 -179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.517 ' OD1' ' ND2' ' A' ' 27' ' ' ASN . 10.3 m-20 -64.79 -40.28 94.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 110.227 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.8 152.02 16.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 110.076 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 19.6 t0 -117.0 -23.18 8.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 110.263 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.63 -158.25 2.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.55 21.13 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.3 -1.118 . . . . 0.0 110.189 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.74 87.11 0.14 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.1 8.55 1.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -1.184 . . . . 0.0 110.357 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.93 8.08 14.14 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.97 48.81 7.43 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m -68.66 170.31 9.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 110.301 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' PHE . . . 106.99 124.61 5.27 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.71 ' CD2' HD12 ' A' ' 52' ' ' LEU . 4.9 m-85 -43.8 151.69 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -1.108 . . . . 0.0 110.28 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -79.92 -159.39 0.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 110.255 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -98.48 31.77 2.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.403 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.66 -22.8 14.81 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.192 -0.943 . . . . 0.0 108.833 179.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.71 HD12 ' CD2' ' A' ' 48' ' ' PHE . 4.0 mt -103.51 -40.06 6.49 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.591 -0.693 . . . . 0.0 110.435 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.924 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -51.75 -56.01 16.34 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.721 -179.16 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -64.88 -24.53 67.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.643 179.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' OD1' ' CD2' ' B' ' 190' ' ' PHE . 2.2 m-20 -80.04 -37.03 34.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.424 -0.797 . . . . 0.0 109.466 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.924 HD12 ' HA ' ' A' ' 53' ' ' ARG . 8.0 mt -53.71 -43.6 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.324 -0.86 . . . . 0.0 109.577 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.65 -22.46 46.54 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.6 p -127.21 17.83 7.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -1.117 . . . . 0.0 110.31 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.857 HD23 HD21 ' A' ' 62' ' ' LEU . 4.8 mt -79.02 -11.47 60.0 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.187 -0.946 . . . . 0.0 110.103 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.53 38.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.921 . . . . 0.0 110.537 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 24.8 ttpt -137.16 12.99 3.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.996 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.857 HD21 HD23 ' A' ' 59' ' ' LEU . 0.9 OUTLIER -136.96 -29.77 0.9 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.88 . . . . 0.0 110.948 -179.897 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.9 -44.35 0.07 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.112 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 3.8 mm? -44.83 -23.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -1.231 . . . . 0.0 110.793 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 64' ' ' LEU . 7.8 t0 -43.93 -41.65 5.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.022 . . . . 0.0 109.744 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.7 -45.82 74.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.791 . . . . 0.0 109.428 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.769 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -72.22 -8.73 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.388 179.17 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.654 HD13 ' C ' ' A' ' 68' ' ' LEU . 2.2 tm? -71.17 -60.89 1.99 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.948 0.88 . . . . 0.0 108.88 179.381 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 pp -72.57 0.4 10.59 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.328 0.585 . . . . 0.0 110.14 179.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 44.8 tt0 -84.3 1.18 46.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.231 -0.918 . . . . 0.0 111.171 -179.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.759 HG12 HG11 ' B' ' 122' ' ' VAL . 3.4 t -138.36 -2.23 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 C-N-CA 118.747 -1.181 . . . . 0.0 110.128 -179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.98 HD11 HD12 ' A' ' 74' ' ' LEU . 4.4 tp -150.85 77.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.444 ' O ' ' CG ' ' A' ' 73' ' ' ASP . 4.7 p-10 -78.57 55.35 1.62 Allowed 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.962 -1.086 . . . . 0.0 108.851 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.042 HD11 ' HB2' ' B' ' 101' ' ' ALA . 8.7 mt -99.78 65.44 1.33 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.672 0.748 . . . . 0.0 110.668 -179.109 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -156.25 155.06 31.69 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.696 -0.628 . . . . 0.0 110.006 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 52.84 44.13 30.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.151 -0.968 . . . . 0.0 110.064 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.343 -179.977 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.476 ' HA ' ' OH ' ' B' ' 231' ' ' TYR . 3.7 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.305 0.574 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . . . . . . . . . . . 141.29 37.96 0.09 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' B' ' 64' ' ' VAL . 1.5 mp -84.81 -25.23 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -1.188 . . . . 0.0 109.971 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' B' ' 63' ' ' ILE . 4.3 t 61.04 130.65 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 0.0 110.318 179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 45.6 Cg_endo -74.03 137.44 24.1 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.973 1.512 . . . . 0.0 110.388 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . . . . . . . . . 11.7 m -99.06 128.51 45.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.049 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.537 HD22 HG22 ' B' ' 160' ' ' ILE . 69.9 mt -70.42 114.6 8.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.336 -0.852 . . . . 0.0 110.121 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -102.82 -9.62 19.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.291 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.498 ' O ' ' CG1' ' B' ' 70' ' ' ILE . 0.6 OUTLIER -168.27 157.86 9.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 -179.857 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' B' ' 126' ' ' ALA . 8.1 mt -156.9 159.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.157 -0.965 . . . . 0.0 109.853 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.631 HG22 ' HB ' ' B' ' 124' ' ' THR . 50.7 t -139.47 143.02 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.226 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' B' ' 157' ' ' ILE . . . -132.82 151.55 51.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 110.361 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 14.8 p -108.58 120.77 43.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 0.0 110.118 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 65.4 t -116.76 151.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.908 . . . . 0.0 110.165 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' B' ' 154' ' ' ASP . 27.5 m -122.8 152.24 40.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.257 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 1.006 HD22 ' HB1' ' B' ' 150' ' ' ALA . 14.0 mt -105.14 -44.52 4.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.048 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 108.95 -11.22 34.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -129.46 176.35 8.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -1.124 . . . . 0.0 110.205 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.738 ' O ' HD23 ' B' ' 80' ' ' LEU . 9.6 ttt180 -93.73 160.95 14.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.999 HD11 ' CD1' ' B' ' 76' ' ' LEU . 13.5 mt -134.84 149.41 50.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.979 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.452 ' HB2' ' HB ' ' B' ' 84' ' ' THR . 2.7 m-20 -95.45 100.44 12.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.18 -0.95 . . . . 0.0 109.982 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 21.2 mt -50.66 -39.4 50.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.042 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -42.28 84.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' B' ' 81' ' ' ASP . 4.2 m -87.64 -44.24 11.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.261 -0.899 . . . . 0.0 110.025 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -53.72 -37.31 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.551 ' HB2' ' CG2' ' B' ' 102' ' ' VAL . . . -83.67 -28.95 27.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 87' ' ' LEU . 1.9 tp -84.14 -23.63 30.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 110.199 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' B' ' 84' ' ' THR . 8.2 m80 -94.03 -32.49 13.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.201 -0.937 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . . . -64.02 139.41 58.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 0.0 110.044 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -73.47 -27.74 61.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.955 . . . . 0.0 110.248 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 10.6 t-20 -134.69 79.48 1.8 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.196 -0.94 . . . . 0.0 109.971 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' B' ' 89' ' ' ALA . . . -149.38 154.72 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.257 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . 0.537 ' CG ' ' HB ' ' B' ' 103' ' ' ILE . 16.2 pt-20 -136.24 165.49 25.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.356 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -139.86 113.76 8.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.862 . . . . 0.0 110.099 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -115.67 96.23 45.79 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 110.363 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 -16.27 25.82 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.974 1.512 . . . . 0.0 110.412 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.06 -3.94 44.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 110.108 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.406 ' HD3' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -126.54 -34.45 2.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.141 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.957 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.3 OUTLIER -170.49 -171.59 1.1 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.402 -0.811 . . . . 0.0 110.842 -179.301 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.96 57.03 0.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.209 -0.932 . . . . 0.0 111.542 -178.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -147.84 155.82 42.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.959 -1.088 . . . . 0.0 110.775 179.22 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' B' ' 86' ' ' ALA . 73.0 t -97.79 126.83 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.422 -0.799 . . . . 0.0 109.919 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.743 HD11 ' CZ ' ' B' ' 99' ' ' PHE . 20.0 mm -90.29 129.51 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.358 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . . . . . . . . . 1.3 ttt -102.4 162.54 12.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.449 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 0.6 OUTLIER -154.36 124.3 6.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.072 -1.017 . . . . 0.0 110.601 -179.773 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.529 HG12 ' CZ ' ' B' ' 139' ' ' TYR . 8.7 pt -129.06 155.62 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.631 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.457 ' HA ' ' HG3' ' B' ' 110' ' ' LYS . 0.4 OUTLIER -102.41 34.28 2.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.435 -179.755 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 1.0 OUTLIER -177.06 87.45 0.25 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.162 -0.961 . . . . 0.0 110.745 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.8 Cg_endo -79.08 149.31 83.84 Favored 'Cis proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.945 -2.106 . . . . 0.0 110.21 -0.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 3.9 tttt -62.05 97.69 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.153 -0.967 . . . . 0.0 109.899 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' B' ' 124' ' ' THR . 23.8 p -149.67 170.95 17.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 110.749 -179.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -110.79 156.55 20.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.557 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -136.82 143.64 43.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 110.938 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.53 ' HB3' ' CZ ' ' B' ' 116' ' ' PHE . 2.8 mm? -104.87 125.39 50.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.377 -0.827 . . . . 0.0 109.4 179.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.582 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 31.4 mm -110.13 121.56 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 0.0 110.868 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.53 ' CZ ' ' HB3' ' B' ' 114' ' ' LEU . 6.8 m-85 -106.24 128.43 53.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.781 179.301 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.25 -24.3 4.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.219 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.472 ' O ' HD12 ' B' ' 76' ' ' LEU . . . 131.83 -26.47 3.81 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -71.61 149.96 45.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -1.143 . . . . 0.0 110.163 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.481 ' HG3' ' CD1' ' B' ' 115' ' ' ILE . 0.9 OUTLIER -139.86 140.91 36.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.949 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.759 HG11 HG12 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -115.29 157.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.949 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.534 ' O ' HG13 ' B' ' 71' ' ' VAL . 33.6 t -142.46 153.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 110.146 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.672 HG21 HD13 ' A' ' 23' ' ' ILE . 1.8 t -149.71 163.12 38.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.562 ' HA2' ' ND2' ' A' ' 27' ' ' ASN . . . 112.0 -30.42 7.73 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -56.0 147.62 19.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -1.07 . . . . 0.0 110.253 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . 0.401 ' HG2' ' OD2' ' B' ' 131' ' ' ASP . 10.9 ptmt -119.41 -22.08 7.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m -121.88 -141.32 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.814 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.91 -41.92 5.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.196 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' B' ' 131' ' ' ASP . 6.4 p30 -72.07 -21.87 61.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.204 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 73.9 m-20 -70.95 -35.16 72.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -0.872 . . . . 0.0 110.434 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.481 ' OG ' ' CB ' ' B' ' 126' ' ' ALA . 12.1 m -79.27 -32.59 43.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 110.278 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -74.82 -42.95 57.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.893 . . . . 0.0 110.151 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' B' ' 130' ' ' ASP . 0.2 OUTLIER -64.12 -37.59 88.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.26 -0.9 . . . . 0.0 110.207 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.76 -60.79 2.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.196 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.518 ' OG ' HG21 ' B' ' 123' ' ' VAL . 2.8 m -51.08 -46.63 61.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -45.08 88.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.8 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.473 ' CD ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -58.93 -41.4 87.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.903 179.746 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.723 ' HA ' HD12 ' B' ' 142' ' ' ILE . 37.5 m-85 -66.79 -55.45 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.985 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . 0.521 ' O ' ' NE2' ' B' ' 144' ' ' GLN . . . -48.57 -33.77 10.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' B' ' 145' ' ' LYS . 8.3 mmt180 -64.73 -41.32 96.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 109.924 179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.723 HD12 ' HA ' ' B' ' 139' ' ' TYR . 28.1 mt -54.63 -49.75 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.624 HD13 HD13 ' B' ' 80' ' ' LEU . 9.0 mt -69.25 -54.23 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 110.167 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.579 HE21 ' HB3' ' B' ' 150' ' ' ALA . 0.9 OUTLIER -59.56 -32.89 70.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.195 -0.94 . . . . 0.0 109.925 179.719 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' B' ' 141' ' ' ARG . 0.6 OUTLIER -72.92 -27.24 61.75 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.069 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 2.6 mt -76.28 -15.71 15.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 117.17 -27.34 7.79 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.481 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 9.6 m-85 -41.99 154.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.258 . . . . 0.0 110.765 -179.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -90.52 24.63 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.474 -0.766 . . . . 0.0 110.299 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 1.006 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -72.42 165.59 24.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.954 . . . . 0.0 110.11 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.533 ' O ' HD23 ' B' ' 76' ' ' LEU . 19.0 tttt -142.78 169.48 17.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.135 -0.978 . . . . 0.0 110.374 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . 0.503 ' O ' HG23 ' B' ' 153' ' ' THR . 60.6 t80 -101.1 91.47 4.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.335 -0.853 . . . . 0.0 110.161 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.503 HG23 ' O ' ' B' ' 152' ' ' PHE . 1.5 p -153.52 176.6 11.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.168 -0.957 . . . . 0.0 110.259 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.506 ' CB ' ' HB ' ' B' ' 75' ' ' THR . 20.5 t0 60.84 24.11 14.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.186 -0.946 . . . . 0.0 110.092 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.428 ' C ' ' CD1' ' B' ' 155' ' ' PHE . 3.3 t80 -80.54 133.12 35.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 110.113 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -163.74 132.17 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.32 -0.862 . . . . 0.0 110.151 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' B' ' 72' ' ' ALA . 1.9 mp -79.96 109.4 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 109.917 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -103.47 -3.04 25.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 110.838 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.91 108.5 4.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.036 -1.04 . . . . 0.0 110.904 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.537 HG22 HD22 ' B' ' 67' ' ' LEU . 95.6 mt -113.21 120.03 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.177 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.589 HG22 ' OG1' ' B' ' 215' ' ' THR . 3.5 t -95.37 140.37 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.162 -0.961 . . . . 0.0 110.637 -179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' B' ' 163' ' ' SER . . . -137.75 177.04 20.24 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' B' ' 162' ' ' GLY . 73.7 m -166.05 140.6 4.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.198 -1.178 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.505 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 8.9 p -170.23 136.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.179 -0.95 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 210' ' ' GLY . 59.2 p30 -103.41 179.81 4.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -0.929 . . . . 0.0 110.024 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.553 HG23 ' H ' ' B' ' 167' ' ' LYS . 0.2 OUTLIER -124.44 -86.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.213 -0.929 . . . . 0.0 110.3 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.553 ' H ' HG23 ' B' ' 166' ' ' VAL . 0.0 OUTLIER 173.97 33.15 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.153 -0.967 . . . . 0.0 110.458 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.53 ' CD1' ' HG2' ' B' ' 238' ' ' ARG . 11.8 p90 -166.32 149.32 6.41 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 110.067 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' B' ' 208' ' ' VAL . 44.7 Cg_endo -71.64 145.49 46.83 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.098 1.578 . . . . 0.0 110.484 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.43 HD13 ' CG2' ' B' ' 206' ' ' ILE . 6.0 mt -112.2 142.62 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.198 -0.939 . . . . 0.0 110.514 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' B' ' 237' ' ' PHE . 0.1 OUTLIER -82.1 92.83 6.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.365 -0.834 . . . . 0.0 109.793 179.665 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.408 HD22 ' HB2' ' B' ' 193' ' ' LEU . 11.5 mt -51.23 -47.48 62.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.0 110.09 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.72 -50.12 74.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.359 -0.838 . . . . 0.0 109.937 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -49.79 -34.09 21.18 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' B' ' 233' ' ' VAL . 0.4 OUTLIER -71.32 -59.44 2.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 109.92 179.868 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' B' ' 180' ' ' GLY . . . -58.63 -19.49 39.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -72.07 -51.09 23.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.366 -0.834 . . . . 0.0 110.33 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.11 -32.72 11.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.862 . . . . 0.0 110.463 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' B' ' 183' ' ' SER . 54.5 m80 -108.75 19.98 19.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.207 -0.933 . . . . 0.0 110.247 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' B' ' 176' ' ' ALA . . . -45.3 -51.6 9.11 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 55.5 m -62.09 -18.58 61.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -1.135 . . . . 0.0 109.931 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . 0.446 ' N ' ' O ' ' B' ' 179' ' ' HIS . 1.4 m-85 -105.4 -10.5 16.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.347 -0.846 . . . . 0.0 110.058 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.478 ' N ' ' O ' ' B' ' 179' ' ' HIS . 13.9 p -154.07 154.96 34.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.312 -0.867 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' B' ' 193' ' ' LEU . 0.5 OUTLIER -126.7 164.74 20.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 110.06 179.888 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 0.578 ' HB2' HD12 ' B' ' 193' ' ' LEU . 1.7 t80 -164.1 86.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 109.98 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -92.11 110.04 41.57 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.879 . . . . 0.0 110.135 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -7.18 20.41 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.9 1.474 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.34 -6.43 56.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 110.036 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 189' ' ' LEU . 1.9 tt -146.97 -35.61 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.569 ' CD2' HD11 ' B' ' 194' ' ' ILE . 0.8 OUTLIER -118.47 130.38 24.81 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.992 . . . . 0.0 110.609 -179.888 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -78.45 -42.09 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.949 1.499 . . . . 0.0 110.376 179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.69 -179.55 44.79 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' B' ' 185' ' ' TYR . 0.9 OUTLIER -96.46 147.49 23.78 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -1.156 . . . . 0.0 110.297 -179.92 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.691 HG21 HD13 ' A' ' 62' ' ' LEU . 63.4 mt -109.82 104.93 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.316 -0.865 . . . . 0.0 110.027 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -97.58 128.66 44.48 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 110.474 -179.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' B' ' 203' ' ' VAL . 12.2 ttt-85 -110.92 80.74 1.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.456 ' N ' ' O ' ' B' ' 202' ' ' ILE . 37.1 tpp -45.81 134.59 7.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 75.3 t -88.17 -34.72 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.359 -0.838 . . . . 0.0 109.975 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.495 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 0.1 OUTLIER -143.58 108.34 5.17 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 110.049 -179.918 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 45.2 Cg_endo -71.44 169.46 69.37 Favored 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.94 -2.109 . . . . 0.0 110.786 0.046 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.553 ' O ' HD13 ' B' ' 202' ' ' ILE . 5.6 mtmp? -75.22 81.56 2.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.34 -0.85 . . . . 0.0 110.094 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.553 HD13 ' O ' ' B' ' 201' ' ' LYS . 10.4 mm -130.41 148.22 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -0.888 . . . . 0.0 110.183 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.708 ' C ' HD12 ' B' ' 204' ' ' LEU . 10.5 t -108.42 137.46 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.019 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.83 ' N ' HD12 ' B' ' 204' ' ' LEU . 3.6 mp -131.51 151.82 51.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.925 . . . . 0.0 110.571 -179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.698 ' O ' HD13 ' B' ' 206' ' ' ILE . 25.1 mt -110.13 144.9 38.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.473 179.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.698 HD13 ' O ' ' B' ' 205' ' ' LEU . 11.8 mm -127.81 104.0 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.989 -1.07 . . . . 0.0 110.302 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.439 ' O ' ' N ' ' B' ' 209' ' ' SER . 66.8 m-85 -91.05 133.99 34.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' B' ' 169' ' ' PRO . 36.1 t -42.24 -26.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -0.967 . . . . 0.0 110.416 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.439 ' N ' ' O ' ' B' ' 207' ' ' PHE . 0.0 OUTLIER -59.34 -38.63 80.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' B' ' 165' ' ' ASP . . . 121.35 15.86 4.46 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 124.98 41.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -1.142 . . . . 0.0 110.031 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.577 HD12 HD12 ' B' ' 206' ' ' ILE . 21.1 mm -108.89 125.6 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.202 -0.936 . . . . 0.0 110.538 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.522 ' C ' HD12 ' B' ' 214' ' ' LEU . 17.1 t -105.77 159.4 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 110.395 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.1 mp -143.05 146.17 33.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.589 ' OG1' HG22 ' B' ' 161' ' ' VAL . 5.5 t -169.8 145.09 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.256 -0.903 . . . . 0.0 110.18 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 107.62 10.74 26.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' B' ' 160' ' ' ILE . . . -91.3 158.74 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -1.198 . . . . 0.0 110.227 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' B' ' 219' ' ' GLN . 0.0 OUTLIER -103.39 -23.75 13.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.26 -0.9 . . . . 0.0 110.165 179.986 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.479 ' N ' ' HG2' ' B' ' 218' ' ' LYS . 0.0 OUTLIER -137.65 179.35 6.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . 0.454 ' HG3' ' CE1' ' B' ' 224' ' ' TYR . 1.6 ttt180 -75.88 -27.75 57.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.363 -0.836 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' B' ' 225' ' ' GLN . 0.0 OUTLIER -61.05 -41.17 96.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 110.496 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -61.43 -52.16 65.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.145 -0.972 . . . . 0.0 110.201 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.468 HD11 ' O ' ' B' ' 160' ' ' ILE . 22.6 mm -58.05 -43.8 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' B' ' 220' ' ' ARG . 10.5 m-85 -70.98 -34.16 71.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -0.876 . . . . 0.0 110.204 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' B' ' 221' ' ' GLU . 3.4 tp60 -80.48 -44.16 19.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.125 -0.984 . . . . 0.0 110.047 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.14 -38.42 68.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 109.953 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.627 ' O ' HG22 ' B' ' 230' ' ' ILE . 15.7 t80 -68.92 -52.72 26.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.0 109.995 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -54.29 -24.21 18.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.143 -0.973 . . . . 0.0 109.783 179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.81 -30.82 45.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 0.0 110.039 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.627 HG22 ' O ' ' B' ' 227' ' ' PHE . 6.0 tp -93.38 -17.37 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.875 . . . . 0.0 109.891 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -47.72 -47.88 60.93 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.404 -0.81 . . . . 0.0 111.015 179.809 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 43.9 Cg_endo -72.77 -40.44 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.593 1.312 . . . . 0.0 110.612 -179.404 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.494 ' CG1' HD11 ' B' ' 175' ' ' LEU . 40.8 t -58.52 -42.32 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.127 -0.983 . . . . 0.0 109.907 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . . . . . . . . . 77.5 mt -66.67 -40.22 88.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.087 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.34 -25.4 63.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 110.178 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -75.36 -27.15 59.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.239 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' B' ' 171' ' ' ARG . 59.9 m-85 -117.16 42.74 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.186 -0.946 . . . . 0.0 110.25 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.53 ' HG2' ' CD1' ' B' ' 168' ' ' PHE . 0.0 OUTLIER -68.16 -172.01 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.229 179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.8 -35.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 110.142 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . 0.462 ' HG3' ' HD3' ' B' ' 238' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.141 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.177 0.513 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.77 62.78 0.02 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.721 ' OG ' HD12 ' A' ' 14' ' ' ILE . 96.7 p -172.13 -70.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -1.185 . . . . 0.0 110.243 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.721 HD12 ' OG ' ' A' ' 13' ' ' SER . 2.6 mp -90.52 164.86 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' N ' HG22 ' A' ' 14' ' ' ILE . . . -89.25 168.02 34.78 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -60.55 163.51 5.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 110.146 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.76 154.86 30.08 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.06 HD21 HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -113.2 172.18 7.11 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.33 -1.1 . . . . 0.0 108.747 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.799 ' HA ' HD11 ' A' ' 68' ' ' LEU . 12.0 t0 -101.04 118.38 36.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.919 -1.113 . . . . 0.0 111.117 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.06 HD21 HD21 ' A' ' 18' ' ' LEU . 6.6 mt -113.78 12.79 18.36 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 110.641 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.687 ' OG1' HD23 ' A' ' 68' ' ' LEU . 3.1 m -42.43 -27.74 0.17 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 0.0 110.187 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.567 ' C ' HG21 ' A' ' 28' ' ' ILE . . . -91.36 -30.2 11.2 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 20' ' ' LEU . 16.3 mm -50.65 -53.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.998 -1.295 . . . . 0.0 108.771 -179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.751 HD11 ' CD1' ' A' ' 64' ' ' LEU . 1.1 pp -78.97 5.7 11.04 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.468 -0.77 . . . . 0.0 110.004 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' ' CD1' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -107.99 -17.61 14.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.177 -0.952 . . . . 0.0 111.14 -179.516 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' B' ' 69' ' ' ASN . . . 151.79 48.74 0.02 OUTLIER Glycine 0 N--CA 1.493 2.45 0 C-N-CA 118.719 -1.705 . . . . 0.0 111.252 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.988 ' OD1' HD21 ' A' ' 35' ' ' LEU . 0.9 OUTLIER 63.86 139.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.012 -1.287 . . . . 0.0 111.275 178.524 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.763 HG23 HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -170.35 157.83 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.63 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 31' ' ' GLU . 68.1 m-20 -90.08 122.52 33.13 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 177.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.479 ' OG ' HG13 ' B' ' 103' ' ' ILE . 1.5 p -39.8 -26.67 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.727 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' ASP . 3.1 tt0 -57.48 -13.53 3.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.134 -0.979 . . . . 0.0 110.447 178.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.92 26.3 5.58 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.538 ' O ' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.98 117.43 26.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.076 -1.249 . . . . 0.0 109.814 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 35' ' ' LEU . 2.8 tt -88.36 156.9 18.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.778 -1.201 . . . . 0.0 110.244 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.988 HD21 ' OD1' ' A' ' 27' ' ' ASN . 4.2 pp -136.68 -178.77 5.33 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.655 -1.218 . . . . 0.0 111.043 -179.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.742 ' N ' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -163.94 23.47 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.611 -0.68 . . . . 0.0 110.23 -179.324 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 36' ' ' GLN . 20.5 t0 61.5 97.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.143 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.77 134.3 39.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 110.311 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.54 -158.47 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.77 -120.59 3.4 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.14 97.06 2.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.216 -1.167 . . . . 0.0 110.334 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.86 -63.01 0.07 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -74.88 -7.4 53.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -1.175 . . . . 0.0 110.139 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 111.52 12.19 15.57 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.08 144.32 4.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.3 m -152.72 139.81 19.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.136 -1.214 . . . . 0.0 110.288 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.08 -170.99 29.4 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 49' ' ' ASP . 28.0 m-85 -90.0 121.02 31.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.364 -1.08 . . . . 0.0 110.235 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 48' ' ' PHE . 23.3 p30 -56.79 -166.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.731 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -100.07 28.64 4.73 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.028 . . . . 0.0 110.321 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.01 -25.5 14.04 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.129 -0.982 . . . . 0.0 109.291 179.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.973 ' O ' HD12 ' A' ' 56' ' ' ILE . 2.7 mt -92.54 -42.28 9.78 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.552 -0.718 . . . . 0.0 110.139 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.66 -51.22 16.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 0.0 109.609 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -66.53 -13.83 61.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.825 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' A' ' 59' ' ' LEU . 9.7 m-80 -96.23 -40.19 9.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.825 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.973 HD12 ' O ' ' A' ' 52' ' ' LEU . 1.2 mp -51.42 -40.65 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.399 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.39 -14.54 49.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.6 p -134.53 18.11 3.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -1.184 . . . . 0.0 110.39 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 56' ' ' ILE . 6.7 mt -98.04 16.27 21.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.2 m -90.95 42.97 1.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 110.433 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.544 ' HG3' ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -151.78 -30.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.147 -0.971 . . . . 0.0 110.954 179.854 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -74.37 6.15 3.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.977 -1.077 . . . . 0.0 111.271 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.586 ' N ' HD13 ' A' ' 62' ' ' LEU . . . 144.03 -46.92 0.8 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.751 ' CD1' HD11 ' A' ' 24' ' ' LEU . 3.6 mm? -52.0 -18.15 1.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 110.678 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 66' ' ' SER . 2.7 p30 -43.0 -39.65 2.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 109.928 179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.48 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 10.9 m -67.67 -55.92 11.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.387 -0.821 . . . . 0.0 109.976 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.461 ' HG2' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -68.52 -6.6 26.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.602 179.418 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.799 HD11 ' HA ' ' A' ' 19' ' ' ASP . 1.2 tm? -71.02 -62.89 1.23 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.179 0.99 . . . . 0.0 108.848 179.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.48 1.69 13.46 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.164 179.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 66' ' ' SER . 15.4 tt0 -91.24 11.36 23.69 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 111.696 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 20' ' ' LEU . 3.2 t -138.4 0.42 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.974 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.042 HD11 ' CD1' ' A' ' 74' ' ' LEU . 2.0 tp -152.0 74.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.386 -0.821 . . . . 0.0 110.233 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 56.9 t0 -79.74 56.65 2.32 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 108.923 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.042 ' CD1' HD11 ' A' ' 72' ' ' ILE . 5.8 mt -82.11 59.56 4.48 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.719 0.771 . . . . 0.0 110.716 -179.193 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -126.45 37.63 4.28 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.758 -0.588 . . . . 0.0 110.134 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.88 88.0 1.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 110.197 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.167 -179.899 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.306 0.574 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.484 ' HA3' ' CE1' ' B' ' 231' ' ' TYR . . . -148.94 -68.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.0 mp -115.01 -6.51 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -1.188 . . . . 0.0 110.148 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 14.5 t 60.54 126.93 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.301 -0.874 . . . . 0.0 110.057 -179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.475 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 44.2 Cg_endo -70.95 150.31 60.73 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.85 1.447 . . . . 0.0 110.484 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' B' ' 68' ' ' GLN . 18.1 m -122.04 128.02 50.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 110.193 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.486 HD21 HG21 ' B' ' 223' ' ' ILE . 21.7 mt -70.29 117.53 11.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 110.211 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.457 ' O ' ' OD1' ' B' ' 69' ' ' ASN . 19.8 mm-40 -112.35 -13.63 13.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.865 . . . . 0.0 110.351 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.533 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 4.5 m120 -153.53 158.03 40.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.367 -179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.562 HG22 ' N ' ' B' ' 71' ' ' VAL . 8.4 mt -154.96 169.2 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.299 -0.876 . . . . 0.0 109.987 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' B' ' 124' ' ' THR . 27.0 t -139.23 130.48 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.145 -0.972 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.94 143.96 50.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 94.7 m -93.62 128.93 40.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.277 -0.89 . . . . 0.0 110.355 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.63 146.07 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 24.2 m -125.49 145.68 49.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 1.133 HD22 ' HB1' ' B' ' 150' ' ' ALA . 91.8 mt -97.08 -41.85 8.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 110.013 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.11 54.43 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 7.3 t -148.43 153.87 39.12 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -1.181 . . . . 0.0 110.335 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -77.52 149.21 34.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 0.0 110.097 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.938 HD11 ' CD1' ' B' ' 76' ' ' LEU . 68.9 mt -124.69 155.66 38.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.148 -0.97 . . . . 0.0 110.505 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.434 ' O ' ' C ' ' B' ' 82' ' ' LEU . 4.9 m-20 -92.69 83.64 4.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.378 -0.826 . . . . 0.0 109.455 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.786 HD22 HG23 ' B' ' 102' ' ' VAL . 94.6 mt -40.1 -35.6 0.4 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.544 -0.723 . . . . 0.0 110.536 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -50.12 73.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 110.008 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -77.47 -43.28 32.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.297 -0.877 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.495 HG22 ' CE2' ' B' ' 148' ' ' PHE . 85.2 t -50.38 -43.96 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.197 -0.939 . . . . 0.0 110.142 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.96 -21.72 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 110.071 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 tp -86.2 -37.22 18.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 0.0 110.294 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -87.74 -24.95 23.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.249 -0.907 . . . . 0.0 110.478 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -70.63 136.34 49.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.182 -0.949 . . . . 0.0 110.145 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -24.08 58.97 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.428 ' OD1' ' HB3' ' B' ' 105' ' ' ARG . 9.6 t-20 -135.63 79.45 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 110.096 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.85 149.97 46.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.326 -0.859 . . . . 0.0 109.955 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -125.78 119.36 27.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.341 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.525 ' CE1' ' HB3' ' B' ' 82' ' ' LEU . 8.1 t80 -114.37 118.96 35.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 109.929 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -129.05 110.22 18.26 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.206 -0.934 . . . . 0.0 110.277 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.47 -22.1 18.85 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.969 1.51 . . . . 0.0 110.164 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -17.94 56.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 110.252 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -102.02 -45.34 5.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.083 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.752 ' CE2' ' HB3' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -170.54 -162.42 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.841 . . . . 0.0 110.913 -179.836 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.414 ' O ' ' CD1' ' B' ' 82' ' ' LEU . . . -122.12 54.86 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.102 -0.999 . . . . 0.0 111.043 -179.357 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.997 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -143.14 172.16 13.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.085 -1.009 . . . . 0.0 110.095 179.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.786 HG23 HD22 ' B' ' 82' ' ' LEU . 42.1 t -114.56 123.93 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 110.36 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.81 ' CD1' HD13 ' B' ' 114' ' ' LEU . 15.2 mm -93.67 108.6 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.979 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.562 ' HB3' ' CE1' ' B' ' 139' ' ' TYR . 1.4 ttm -89.81 146.54 24.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 110.206 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.428 ' HB3' ' OD1' ' B' ' 91' ' ' ASN . 3.8 ttt85 -135.63 118.66 16.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.439 -179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.757 HG23 ' CE1' ' B' ' 139' ' ' TYR . 18.2 pt -114.71 165.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.934 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 2.7 ptm180 -110.59 22.9 14.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -0.933 . . . . 0.0 110.389 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 109' ' ' PRO . 2.4 tt0 -176.9 94.74 0.24 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 110.267 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' B' ' 108' ' ' GLU . 50.1 Cg_endo -76.73 143.93 77.33 Favored 'Cis proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.872 -2.137 . . . . 0.0 110.477 -0.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.721 ' O ' HG23 ' B' ' 111' ' ' THR . 0.0 OUTLIER -57.12 108.13 0.49 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.0 109.926 179.692 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.721 HG23 ' O ' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -161.76 -179.14 6.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.753 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -126.54 158.74 35.4 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.7 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -132.82 124.98 29.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 111.103 -179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.81 HD13 ' CD1' ' B' ' 103' ' ' ILE . 3.9 mm? -92.24 89.83 7.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.711 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 41.1 mt -90.28 128.61 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.076 -1.015 . . . . 0.0 111.168 -178.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.787 ' CZ ' HD12 ' A' ' 72' ' ' ILE . 4.0 m-30 -110.19 144.75 38.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 109.593 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' B' ' 79' ' ' ARG . . . -54.36 -19.88 6.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 110.408 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -7.18 37.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.36 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' B' ' 76' ' ' LEU . . . 101.55 -25.93 26.32 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -56.23 173.07 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -1.206 . . . . 0.0 110.082 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.51 ' CG ' HG12 ' B' ' 115' ' ' ILE . 3.2 tmm? -169.05 119.89 0.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.804 HG11 HG12 ' A' ' 71' ' ' VAL . 3.8 t -109.4 138.98 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.378 179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.42 124.01 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 110.766 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.694 HG23 ' ND2' ' A' ' 27' ' ' ASN . 0.5 OUTLIER -117.44 170.63 8.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.564 -0.71 . . . . 0.0 109.801 179.656 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' B' ' 111' ' ' THR . . . 102.81 -35.67 4.83 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' B' ' 70' ' ' ILE . . . -50.04 157.09 0.67 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -1.187 . . . . 0.0 110.387 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -121.76 -25.39 5.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.211 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.16 164.82 27.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -0.928 . . . . 0.0 110.26 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -51.88 -63.01 1.28 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 0.0 110.189 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -45.44 -37.48 5.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.094 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -70.4 -42.02 72.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 110.159 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . . . . . . . . . 6.0 m -55.48 -40.64 71.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 110.211 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . 0.474 ' CD ' ' CE2' ' B' ' 155' ' ' PHE . 0.0 OUTLIER -69.1 -49.05 60.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.297 -0.877 . . . . 0.0 110.328 -179.918 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.455 ' HB3' ' HG3' ' B' ' 109' ' ' PRO . 0.3 OUTLIER -55.0 -51.66 65.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 110.168 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.3 -47.55 65.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 110.218 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . . . . . . . . . 1.7 p -69.31 -47.24 65.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 110.17 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.07 -42.36 65.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 110.391 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.478 ' NZ ' ' O ' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -63.73 -36.73 84.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.365 -179.958 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.757 ' CE1' HG23 ' B' ' 106' ' ' ILE . 13.4 m-85 -72.01 -56.95 4.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 110.088 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.61 -22.95 0.85 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.766 179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . 0.451 ' HD3' ' HD3' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -73.58 -50.53 20.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 110.073 179.803 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' B' ' 139' ' ' TYR . 46.4 mt -50.75 -38.83 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.101 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.69 HG22 ' HB2' ' B' ' 148' ' ' PHE . 38.8 mm -72.54 -58.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 110.039 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.466 ' NE2' ' O ' ' B' ' 150' ' ' ALA . 56.7 mt-30 -61.39 -27.63 68.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 109.961 179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.451 ' HD3' ' HD3' ' B' ' 141' ' ' ARG . 27.5 ttpt -75.39 -23.45 57.08 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.179 -0.95 . . . . 0.0 108.504 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 6.6 mt -83.79 -21.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 123.87 -16.23 7.82 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.69 ' HB2' HG22 ' B' ' 143' ' ' ILE . 14.9 m-85 -54.4 172.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.077 -1.249 . . . . 0.0 110.865 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -110.27 32.06 5.44 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.631 -0.668 . . . . 0.0 109.747 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 1.133 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -77.16 144.24 38.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 110.504 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 138.18 51.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.102 179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -71.94 97.05 1.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.927 . . . . 0.0 110.172 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 176.24 9.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.219 -0.925 . . . . 0.0 110.283 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.56 33.98 23.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 110.659 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . 0.474 ' CE2' ' CD ' ' B' ' 133' ' ' LYS . 34.0 t80 -76.16 127.91 33.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 109.927 179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -161.43 129.64 4.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.123 -0.985 . . . . 0.0 110.709 -179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 20.3 mt -87.65 131.0 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.73 179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . 0.447 ' HA ' ' HG2' ' B' ' 218' ' ' LYS . 4.5 mt-30 -135.31 0.56 2.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.046 -1.034 . . . . 0.0 110.95 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.525 ' CB ' ' HB ' ' B' ' 71' ' ' VAL . 0.2 OUTLIER -142.53 96.85 3.01 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.01 -1.056 . . . . 0.0 110.932 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' B' ' 215' ' ' THR . 75.4 mt -98.71 153.56 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 179.161 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 214' ' ' LEU . 15.8 t -134.15 131.12 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.031 . . . . 0.0 110.571 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.43 175.7 18.49 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -165.14 148.63 8.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -1.21 . . . . 0.0 110.412 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.475 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 6.3 p -169.45 170.71 8.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 110.134 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . 0.417 ' O ' HD13 ' B' ' 63' ' ' ILE . 6.2 m-20 -116.29 155.77 27.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 110.294 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.56 ' O ' ' CD2' ' B' ' 168' ' ' PHE . 10.2 m -103.87 11.5 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.391 -179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' B' ' 166' ' ' VAL . 0.9 OUTLIER 71.89 3.46 4.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.368 -0.832 . . . . 0.0 110.789 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.56 ' CD2' ' O ' ' B' ' 166' ' ' VAL . 8.3 p90 -162.02 156.04 18.5 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 110.495 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.494 ' HG2' ' HB3' ' B' ' 239' ' ' LYS . 45.3 Cg_endo -74.24 161.87 39.74 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.103 1.581 . . . . 0.0 110.357 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.485 HD11 HG21 ' B' ' 166' ' ' VAL . 3.0 mt -127.07 148.78 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.148 -0.97 . . . . 0.0 110.405 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.38 104.6 16.03 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 109.922 179.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.825 HD22 ' CB ' ' B' ' 193' ' ' LEU . 26.9 mt -61.7 -48.51 80.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.44 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -58.69 -51.45 69.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.599 -179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.8 -51.08 55.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' B' ' 237' ' ' PHE . 8.0 tp -68.4 -36.25 78.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -1.141 . . . . 0.0 110.676 -179.644 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.476 ' O ' ' CA ' ' B' ' 180' ' ' GLY . . . -61.11 -30.65 70.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.251 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . 0.464 ' CD1' ' C ' ' B' ' 177' ' ' PHE . 7.0 t80 -76.93 -44.59 30.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.0 110.292 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.6 t -68.73 -48.94 62.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.273 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -110.87 37.44 2.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.358 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' B' ' 176' ' ' ALA . . . -54.14 -34.32 52.81 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -15.92 59.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.277 -1.131 . . . . 0.0 110.191 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -111.32 -0.75 16.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.888 . . . . 0.0 110.283 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.563 ' HB2' HD21 ' B' ' 193' ' ' LEU . 1.1 p -140.86 168.92 18.64 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -0.953 . . . . 0.0 110.429 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 69.1 m -139.95 130.64 25.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.379 -0.825 . . . . 0.0 110.032 179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -132.75 120.31 21.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.128 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 190' ' ' PHE . 99.2 mt-10 -121.19 100.71 45.13 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.175 -0.953 . . . . 0.0 110.149 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.46 -0.71 9.15 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.932 1.49 . . . . 0.0 110.4 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -98.82 -18.62 17.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 110.151 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.646 ' O ' HD23 ' B' ' 189' ' ' LEU . 2.6 tt -147.34 9.81 0.96 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.241 -0.912 . . . . 0.0 110.604 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.489 ' HB2' HD23 ' B' ' 189' ' ' LEU . 19.0 t80 -167.97 107.63 0.57 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.874 -1.141 . . . . 0.0 110.421 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.79 -15.77 23.82 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.916 1.482 . . . . 0.0 110.165 179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.61 44.13 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.825 ' CB ' HD22 ' B' ' 172' ' ' LEU . 7.3 tt -124.53 134.29 53.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -1.169 . . . . 0.0 110.433 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.765 HD13 HD23 ' A' ' 62' ' ' LEU . 3.3 mt -104.74 113.85 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 0.0 109.886 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.633 ' CD2' HD11 ' B' ' 230' ' ' ILE . 4.5 t80 -93.32 127.06 38.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 110.442 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.442 ' NH2' ' HA3' ' A' ' 63' ' ' GLY . 65.0 mtt180 -99.12 103.15 15.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.35 -0.844 . . . . 0.0 110.108 179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' B' ' 201' ' ' LYS . 47.4 tpp -75.97 131.1 39.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.096 -1.003 . . . . 0.0 110.112 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' B' ' 199' ' ' LYS . 39.4 t -80.51 -32.87 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 110.587 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 10.2 mttt -147.39 108.26 3.87 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.47 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 46.6 Cg_endo -73.9 172.32 62.09 Favored 'Cis proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.96 -2.1 . . . . 0.0 110.328 -0.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' B' ' 197' ' ' MET . 0.5 OUTLIER -78.2 81.47 4.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.004 179.835 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' B' ' 217' ' ' ALA . 35.3 mm -126.04 154.01 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.29 111.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.22 -0.925 . . . . 0.0 110.295 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.713 HD21 ' HB1' ' B' ' 226' ' ' ALA . 4.9 mp -99.71 133.13 44.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.216 -0.927 . . . . 0.0 110.28 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.486 ' HB2' ' HB ' ' B' ' 213' ' ' VAL . 0.5 OUTLIER -93.69 147.31 23.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.194 -0.941 . . . . 0.0 110.223 179.984 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.451 HG22 HD21 ' B' ' 172' ' ' LEU . 5.1 mt -137.86 120.14 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 0.0 109.944 179.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -110.72 150.11 29.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 110.362 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 93.2 t -52.16 -27.14 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 110.382 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -37.44 84.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 110.253 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' B' ' 170' ' ' ILE . . . 119.81 1.92 13.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.413 ' HA ' ' OD1' ' B' ' 165' ' ' ASP . 11.2 tttm -81.21 140.48 34.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 110.049 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.408 HD13 ' O ' ' B' ' 211' ' ' LYS . 22.0 mm -123.13 132.38 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 0.0 110.405 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' B' ' 205' ' ' LEU . 2.3 t -120.04 148.32 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.24 -0.912 . . . . 0.0 109.694 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' B' ' 161' ' ' VAL . 4.0 mp -135.17 127.76 30.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.077 -1.014 . . . . 0.0 110.654 -179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 3.4 t -150.42 174.46 12.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 90.58 -0.42 77.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.813 ' HB2' HD12 ' B' ' 202' ' ' ILE . . . -94.24 142.54 27.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 110.183 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' B' ' 158' ' ' GLN . 3.2 mttm -87.27 -25.34 24.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 110.252 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.426 ' C ' HD12 ' B' ' 160' ' ' ILE . 0.7 OUTLIER -127.41 168.45 14.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.197 -0.939 . . . . 0.0 110.08 -179.959 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -73.93 -27.53 61.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.331 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -57.37 -42.53 82.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.93 . . . . 0.0 110.199 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.446 ' HB2' ' HB1' ' B' ' 217' ' ' ALA . 31.3 mt-10 -59.45 -46.81 87.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 109.871 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.682 HG22 ' N ' ' B' ' 224' ' ' TYR . 0.9 OUTLIER -56.49 -56.96 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.387 -0.821 . . . . 0.0 109.42 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . 0.682 ' N ' HG22 ' B' ' 223' ' ' ILE . 1.1 m-85 -53.09 -33.61 52.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 110.273 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -79.03 -40.69 30.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.005 179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.713 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -58.77 -42.59 89.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.077 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.662 ' HA ' HG22 ' B' ' 230' ' ' ILE . 79.4 t80 -68.51 -55.98 9.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.191 -0.943 . . . . 0.0 110.05 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . 0.429 ' O ' ' HD3' ' B' ' 232' ' ' PRO . 0.4 OUTLIER -50.21 -29.87 10.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.886 . . . . 0.0 110.064 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.452 ' O ' ' HD2' ' B' ' 232' ' ' PRO . . . -81.49 -36.0 29.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 110.165 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.662 HG22 ' HA ' ' B' ' 227' ' ' PHE . 3.6 tp -88.14 -13.62 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.336 -0.852 . . . . 0.0 110.025 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.603 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 64.3 t80 -59.63 -43.21 95.12 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.852 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 48.1 Cg_endo -75.9 -23.37 12.43 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.396 1.209 . . . . 0.0 110.24 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 37.7 t -72.59 -40.89 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.461 ' HB3' HG12 ' B' ' 170' ' ' ILE . 35.8 mt -67.0 -50.25 62.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.319 -0.863 . . . . 0.0 110.189 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.53 -33.13 65.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.937 . . . . 0.0 110.357 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.24 -40.89 90.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.0 110.29 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . 0.462 ' CD2' HD13 ' B' ' 175' ' ' LEU . 51.7 m-85 -113.72 38.81 2.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.17 -0.956 . . . . 0.0 110.194 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.55 -179.99 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 110.088 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.494 ' HB3' ' HG2' ' B' ' 169' ' ' PRO . 4.3 tptt -116.87 -35.45 4.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.223 179.897 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.302 0.573 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.97 -108.77 0.41 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.95 98.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.215 -1.168 . . . . 0.0 110.272 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.49 148.93 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.0 110.108 179.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.35 172.29 45.27 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 59.4 m-20 -106.22 108.41 19.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -1.085 . . . . 0.0 110.118 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.39 159.97 10.05 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.825 ' CD2' HD13 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -116.35 174.75 5.89 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.088 -1.242 . . . . 0.0 109.031 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.543 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -82.56 63.18 6.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.939 -1.1 . . . . 0.0 111.917 -178.628 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.822 HD21 HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -83.9 -3.16 57.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.964 -1.085 . . . . 0.0 109.604 178.627 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.632 ' OG1' HD23 ' A' ' 68' ' ' LEU . 3.4 m -52.95 -21.55 4.5 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.281 -0.887 . . . . 0.0 109.638 -179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' GLY . . . -97.23 -37.9 4.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.629 HD11 HD21 ' B' ' 114' ' ' LEU . 0.6 OUTLIER -46.09 -46.33 5.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.197 -1.178 . . . . 0.0 109.414 -179.22 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.914 HD13 ' HG2' ' A' ' 67' ' ' MET . 0.9 OUTLIER -79.5 -19.48 49.57 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.144 -0.972 . . . . 0.0 108.944 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' HZ ' HD13 ' B' ' 205' ' ' LEU . 0.5 OUTLIER -85.94 -17.44 35.41 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.395 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.551 ' O ' ' C ' ' A' ' 27' ' ' ASN . . . 158.34 93.9 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.066 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.688 ' ND2' HG23 ' B' ' 124' ' ' THR . 4.5 t-20 2.53 112.75 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 CA-C-O 122.001 0.905 . . . . 0.0 113.043 178.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.703 ' HB ' ' HA ' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -138.41 159.66 31.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 31' ' ' GLU . 39.5 m-20 -86.76 125.99 34.29 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.565 ' CA ' HD11 ' A' ' 18' ' ' LEU . 3.0 p -37.99 -28.03 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.433 0.635 . . . . 0.0 109.895 -178.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 29' ' ' ASP . 8.7 tt0 -57.04 -13.43 2.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.449 178.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.56 34.5 3.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -121.08 129.65 53.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -1.131 . . . . 0.0 110.069 179.936 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.838 HD23 ' N ' ' A' ' 35' ' ' LEU . 5.6 tt -89.02 155.37 19.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 111.067 -179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.838 ' N ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -86.98 107.34 18.36 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 122.073 0.939 . . . . 0.0 111.304 -179.112 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 38' ' ' ASP . 10.6 pt20 -120.59 10.34 11.05 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' OD1' ' HD2' ' B' ' 110' ' ' LYS . 0.7 OUTLIER 53.81 -84.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.721 -0.612 . . . . 0.0 110.371 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 36' ' ' GLN . 0.3 OUTLIER -95.05 148.89 21.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.953 . . . . 0.0 110.405 -179.723 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.36 108.27 7.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.268 -0.895 . . . . 0.0 110.169 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.68 69.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -89.97 57.94 4.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -1.096 . . . . 0.0 110.291 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.75 -48.28 0.04 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 16.8 ttt180 -115.01 10.35 16.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 110.118 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.42 -51.62 5.17 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.4 -117.5 2.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.03 170.1 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.277 -1.131 . . . . 0.0 110.186 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.69 150.37 25.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.581 ' CG ' HD12 ' A' ' 52' ' ' LEU . 11.2 m-85 -76.69 145.57 38.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.209 -1.171 . . . . 0.0 110.245 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -83.0 -141.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 0.0 109.892 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 54' ' ' GLU . . . -89.57 25.83 1.89 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.132 -0.98 . . . . 0.0 110.097 179.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -101.19 -26.34 13.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.079 -1.013 . . . . 0.0 110.141 -179.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.581 HD12 ' CG ' ' A' ' 48' ' ' PHE . 5.2 mt -105.31 -44.99 4.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 110.898 -179.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.91 ' HA ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -51.76 -55.53 19.18 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 110.062 -178.855 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 50' ' ' ALA . 1.1 pp20? -65.82 -15.45 62.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.635 179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 3.9 m-20 -87.61 -39.57 14.95 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.508 -0.745 . . . . 0.0 109.28 179.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.91 HD12 ' HA ' ' A' ' 53' ' ' ARG . 7.0 mt -52.26 -43.65 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.418 -0.801 . . . . 0.0 109.481 179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -54.25 -19.76 13.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -126.52 7.84 6.99 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.239 -1.153 . . . . 0.0 110.669 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 56' ' ' ILE . 7.4 mt -72.02 -8.45 54.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 110.332 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -80.65 50.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 110.318 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -148.77 -39.62 0.16 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 110.276 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.812 HD22 HD12 ' B' ' 194' ' ' ILE . 0.1 OUTLIER -71.24 -70.12 0.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.341 -0.849 . . . . 0.0 110.519 -179.904 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.38 -35.07 0.08 OUTLIER Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 64' ' ' LEU . 3.9 mm? -51.22 -20.21 1.5 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -1.179 . . . . 0.0 110.269 -179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 68' ' ' LEU . 3.1 t0 -44.33 -40.62 5.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.179 -0.95 . . . . 0.0 109.955 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 0.8 OUTLIER -65.36 -48.41 73.07 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.381 -0.825 . . . . 0.0 109.946 179.852 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.914 ' HG2' HD13 ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.89 -4.26 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.217 -0.927 . . . . 0.0 109.96 179.732 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.725 HD13 ' C ' ' A' ' 68' ' ' LEU . 3.4 tm? -78.23 -54.91 5.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 108.73 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pp -83.64 1.34 42.81 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.46 0.648 . . . . 0.0 109.695 178.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 67' ' ' MET . 1.5 tt0 -88.31 -1.71 58.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 111.643 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.75 ' HB ' HD12 ' A' ' 20' ' ' LEU . 2.2 t -131.74 -1.04 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 118.527 -1.269 . . . . 0.0 109.688 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.036 HD11 HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -151.23 67.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.504 -0.747 . . . . 0.0 110.042 179.578 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.6 58.65 0.43 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.993 -1.067 . . . . 0.0 108.622 179.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.036 HD12 HD11 ' A' ' 72' ' ' ILE . 27.9 mt -91.59 61.46 4.28 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.571 0.701 . . . . 0.0 110.907 -178.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -100.43 58.59 0.96 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.488 -0.758 . . . . 0.0 110.146 179.763 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 75' ' ' LYS . 18.6 pt-20 37.05 51.66 1.02 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.724 -0.61 . . . . 0.0 110.797 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.361 -179.88 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 61' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' B' ' 62' ' ' GLY . 2.5 t . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.239 0.542 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 62' ' ' GLY . . . . . 0.401 ' N ' ' OG ' ' B' ' 61' ' ' SER . . . -112.77 -42.99 0.9 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' B' ' 64' ' ' VAL . 2.5 mt -115.14 -27.21 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.15 -1.206 . . . . 0.0 110.202 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' B' ' 63' ' ' ILE . 8.2 t 61.06 128.2 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.934 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' B' ' 164' ' ' CYS . 44.1 Cg_endo -70.14 161.55 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.8 1.421 . . . . 0.0 110.556 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 66' ' ' THR . . . . . 0.483 ' O ' ' HA2' ' B' ' 162' ' ' GLY . 6.4 m -121.39 133.28 55.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.28 -0.888 . . . . 0.0 110.161 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.746 HD22 ' CG2' ' B' ' 160' ' ' ILE . 80.9 mt -74.6 108.38 7.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 110.313 -179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.408 ' O ' ' CG ' ' B' ' 69' ' ' ASN . 41.6 mm-40 -89.98 -15.04 32.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 110.119 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.425 ' O ' HG13 ' B' ' 70' ' ' ILE . 2.1 m120 -167.84 164.51 14.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.09 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.528 HG12 HG23 ' B' ' 160' ' ' ILE . 7.4 mt -154.82 164.07 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.556 HG22 ' HB ' ' B' ' 124' ' ' THR . 71.5 t -141.49 132.97 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.265 -0.897 . . . . 0.0 110.263 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' B' ' 157' ' ' ILE . . . -124.02 154.44 39.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.17 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.77 121.76 41.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' B' ' 121' ' ' MET . 66.2 t -121.63 134.55 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.342 -0.849 . . . . 0.0 110.166 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 75' ' ' THR . . . . . . . . . . . . . 32.8 m -122.79 131.25 53.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 110.16 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' B' ' 150' ' ' ALA . 15.0 mt -83.14 -51.27 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 110.215 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.88 27.4 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 78' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.0 134.73 4.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.266 . . . . 0.0 110.446 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.483 ' O ' HD23 ' B' ' 80' ' ' LEU . 71.6 ttt-85 -56.62 152.24 12.34 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.612 HD11 HD12 ' B' ' 76' ' ' LEU . 18.3 mt -133.65 158.63 42.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.416 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -102.05 94.01 5.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.029 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.714 HD22 HG23 ' B' ' 102' ' ' VAL . 16.0 mt -43.57 -37.53 2.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.168 -0.958 . . . . 0.0 110.341 -179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 83' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' B' ' 87' ' ' LEU . 0.5 OUTLIER -58.3 -38.88 77.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -0.944 . . . . 0.0 110.183 -179.882 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 27.2 p -89.1 -43.08 11.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.202 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' B' ' 89' ' ' ALA . 63.2 t -56.37 -39.89 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' B' ' 102' ' ' VAL . . . -83.89 -26.37 29.45 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.399 -0.813 . . . . 0.0 109.934 179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.406 ' CB ' ' O ' ' B' ' 83' ' ' LYS . 25.9 tp -80.13 -43.83 20.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 110.155 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . 0.421 ' HB3' HG12 ' B' ' 146' ' ' ILE . 65.2 m80 -77.55 -28.81 51.99 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.281 -0.887 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 89' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' B' ' 85' ' ' VAL . . . -69.8 139.88 53.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.337 -0.852 . . . . 0.0 110.067 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.46 -23.46 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 110.334 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.415 ' OD1' ' NH1' ' B' ' 105' ' ' ARG . 3.2 t-20 -134.88 79.67 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.193 -0.942 . . . . 0.0 110.075 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' B' ' 86' ' ' ALA . . . -141.8 152.58 43.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.12 179.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 93' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -130.75 131.54 44.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -0.919 . . . . 0.0 110.272 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.79 103.59 7.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.135 -0.978 . . . . 0.0 110.064 179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' B' ' 96' ' ' PRO . 0.5 OUTLIER -115.95 104.8 52.15 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 110.153 -179.835 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 96' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' B' ' 95' ' ' ASN . 44.3 Cg_endo -70.67 -23.76 26.29 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.107 1.582 . . . . 0.0 110.26 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -11.33 60.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 109.733 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.545 ' HB3' ' CD1' ' B' ' 99' ' ' PHE . 4.2 tpm_? -112.66 -66.85 1.04 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.826 . . . . 0.0 109.864 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 99' ' ' PHE . . . . . 0.696 ' CD1' HD13 ' A' ' 18' ' ' LEU . 30.5 p90 -141.55 -170.77 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.385 -0.822 . . . . 0.0 110.12 179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.46 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -117.49 62.34 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -0.966 . . . . 0.0 110.652 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.883 ' HB2' HD11 ' A' ' 74' ' ' LEU . . . -152.02 170.4 20.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.083 -1.01 . . . . 0.0 110.649 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 102' ' ' VAL . . . . . 0.714 HG23 HD22 ' B' ' 82' ' ' LEU . 24.5 t -106.98 132.63 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.561 179.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.648 HD12 HD13 ' B' ' 114' ' ' LEU . 12.8 mm -99.85 97.47 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.135 -0.978 . . . . 0.0 110.507 -179.568 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 104' ' ' MET . . . . . 0.46 ' HB2' ' HE3' ' B' ' 104' ' ' MET . 23.4 ttm -90.01 158.68 17.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.174 -0.953 . . . . 0.0 109.824 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.471 ' HA ' ' OH ' ' B' ' 139' ' ' TYR . 0.1 OUTLIER -157.3 155.84 31.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 110.338 -179.753 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' B' ' 110' ' ' LYS . 3.9 pt -136.09 162.88 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 0.0 110.305 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 107' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -102.0 25.11 9.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.305 -0.872 . . . . 0.0 110.083 179.973 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' B' ' 107' ' ' ARG . 3.6 tt0 -177.97 90.01 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.179 -0.95 . . . . 0.0 110.457 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 109' ' ' PRO . . . . . 0.44 ' HG2' ' HB2' ' B' ' 135' ' ' ALA . 50.8 Cg_endo -83.11 155.5 73.97 Favored 'Cis proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.181 -2.008 . . . . 0.0 110.345 -0.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' B' ' 106' ' ' ILE . 5.3 ttmt -61.34 104.01 0.36 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.057 -1.027 . . . . 0.0 109.619 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 111' ' ' THR . . . . . 0.423 HG22 ' C ' ' B' ' 125' ' ' GLY . 29.3 p -144.89 179.49 7.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.149 -0.969 . . . . 0.0 110.754 -179.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 2.8 m -138.64 128.97 25.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.556 -0.715 . . . . 0.0 109.228 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 113' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' B' ' 139' ' ' TYR . . . -106.0 123.69 48.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.079 -1.013 . . . . 0.0 111.063 -178.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 114' ' ' LEU . . . . . 0.648 HD13 HD12 ' B' ' 103' ' ' ILE . 4.2 mm? -89.58 92.55 9.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 115' ' ' ILE . . . . . 0.613 ' O ' ' HB1' ' B' ' 101' ' ' ALA . 10.5 mt -92.66 127.11 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.162 -0.961 . . . . 0.0 111.33 -178.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 116' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' B' ' 116' ' ' PHE . 2.8 m-85 -100.77 160.26 14.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.3 -0.875 . . . . 0.0 109.649 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' B' ' 82' ' ' LEU . . . -79.4 2.52 21.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.996 -1.065 . . . . 0.0 110.111 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.3 t -90.58 -21.71 21.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.938 . . . . 0.0 110.209 179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.97 -33.9 3.57 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -63.48 172.14 2.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -1.143 . . . . 0.0 109.901 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 121' ' ' MET . . . . . 0.453 ' N ' ' O ' ' B' ' 74' ' ' VAL . 2.5 ttm -164.63 149.65 9.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.587 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.719 HG21 HG12 ' A' ' 71' ' ' VAL . 1.2 t -125.4 145.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.449 -0.782 . . . . 0.0 109.183 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 70.2 t -129.81 100.08 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.038 -1.038 . . . . 0.0 111.029 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 124' ' ' THR . . . . . 0.688 HG23 ' ND2' ' A' ' 27' ' ' ASN . 1.2 t -99.62 165.28 11.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.387 -0.821 . . . . 0.0 108.908 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 27' ' ' ASN . . . 101.92 -3.51 52.35 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.552 ' HB1' ' OG ' ' B' ' 132' ' ' SER . . . -73.22 133.79 44.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.054 -1.262 . . . . 0.0 110.096 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 127' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.42 -6.65 27.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 110.438 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 128' ' ' SER . . . . . 0.432 ' HB2' ' CG ' ' B' ' 131' ' ' ASP . 0.4 OUTLIER -160.25 -168.2 2.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.112 -0.992 . . . . 0.0 110.367 -179.924 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.5 -56.03 4.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -0.866 . . . . 0.0 110.187 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 130' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' B' ' 130' ' ' ASP . 7.9 m-20 -63.82 -22.45 66.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.294 -0.878 . . . . 0.0 110.389 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' B' ' 128' ' ' SER . 5.0 m-20 -68.18 -48.8 64.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.115 -0.99 . . . . 0.0 110.313 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 132' ' ' SER . . . . . 0.552 ' OG ' ' HB1' ' B' ' 126' ' ' ALA . 0.9 OUTLIER -66.2 -36.59 83.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.206 -0.934 . . . . 0.0 110.217 -179.884 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -58.7 -42.16 87.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 110.264 -179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.56 -50.78 11.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.202 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.44 ' HB2' ' HG2' ' B' ' 109' ' ' PRO . . . -54.13 -50.49 66.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.953 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 136' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' B' ' 137' ' ' ARG . 20.6 p -58.75 -53.47 57.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.289 -0.882 . . . . 0.0 109.771 179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 137' ' ' ARG . . . . . 0.424 ' N ' ' OG ' ' B' ' 136' ' ' SER . 5.4 mtp180 -48.25 -43.23 32.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.363 -0.836 . . . . 0.0 109.95 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -57.25 -45.69 83.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.842 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 139' ' ' TYR . . . . . 0.838 ' CE2' ' HB2' ' B' ' 113' ' ' ALA . 11.8 m-85 -57.03 -53.23 60.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.77 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.55 -20.14 64.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.291 -0.88 . . . . 0.0 109.85 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.25 -31.96 58.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.553 HD12 ' HA ' ' B' ' 139' ' ' TYR . 6.3 mt -70.29 -41.36 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 110.059 179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . 0.581 ' CG2' ' CB ' ' B' ' 148' ' ' PHE . 33.7 mt -68.31 -42.27 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.896 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -68.4 -33.98 75.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -71.47 -22.37 61.82 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.421 HG12 ' HB3' ' B' ' 88' ' ' HIS . 1.3 mt -81.21 -20.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' B' ' 148' ' ' PHE . . . 122.51 -32.15 4.59 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 148' ' ' PHE . . . . . 0.581 ' CB ' ' CG2' ' B' ' 143' ' ' ILE . 7.7 m-85 -40.85 150.04 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.132 . . . . 0.0 110.964 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.39 28.68 1.88 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.525 -0.734 . . . . 0.0 109.859 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' B' ' 76' ' ' LEU . . . -67.14 148.69 51.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.421 -0.799 . . . . 0.0 110.512 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 76' ' ' LEU . 0.0 OUTLIER -136.73 117.86 14.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -56.02 100.02 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.179 -0.951 . . . . 0.0 110.087 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' B' ' 151' ' ' LYS . 0.2 OUTLIER -144.19 166.17 25.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.964 . . . . 0.0 110.455 -179.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.63 35.33 14.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.364 -0.835 . . . . 0.0 110.435 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 155' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -78.36 130.86 36.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.199 -0.938 . . . . 0.0 110.036 179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 156' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -165.75 129.19 2.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.169 -0.957 . . . . 0.0 110.607 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' B' ' 72' ' ' ALA . 40.5 mt -79.51 129.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.598 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 158' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -125.56 -13.17 6.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.056 -1.028 . . . . 0.0 110.933 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 159' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' A' ' 24' ' ' LEU . 2.2 t30 -139.27 98.02 3.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.994 -1.066 . . . . 0.0 110.878 -179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 160' ' ' ILE . . . . . 0.746 ' CG2' HD22 ' B' ' 67' ' ' LEU . 53.1 mt -97.47 134.08 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.518 179.192 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 24' ' ' LEU . 5.9 t -101.71 133.96 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.074 -1.016 . . . . 0.0 110.665 -179.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 162' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' B' ' 66' ' ' THR . . . -148.47 163.21 28.97 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 43.2 p -167.56 159.79 12.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 164' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' B' ' 65' ' ' PRO . 11.0 p -168.51 158.44 9.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 0.0 110.243 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -107.7 130.97 54.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 0.0 110.098 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.578 HG22 ' O ' ' B' ' 210' ' ' GLY . 35.1 m -105.25 12.21 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.234 -0.917 . . . . 0.0 110.181 -179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 48.79 41.59 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 0.0 109.969 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 168' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' B' ' 238' ' ' ARG . 0.1 OUTLIER -136.55 115.6 10.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 0.0 110.206 -179.953 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 169' ' ' PRO . . . . . 0.464 ' HB2' ' CB ' ' B' ' 239' ' ' LYS . 46.4 Cg_endo -72.28 140.21 33.44 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.904 1.476 . . . . 0.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.51 ' CD1' ' HA2' ' B' ' 210' ' ' GLY . 2.8 mp -130.17 151.43 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.616 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 171' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.5 88.32 7.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.803 179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.579 ' CD1' HG23 ' B' ' 208' ' ' VAL . 68.9 mt -51.01 -23.69 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 173' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.13 -55.37 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.202 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.63 -46.56 74.07 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.451 ' O ' HD12 ' B' ' 175' ' ' LEU . 10.3 tp -62.92 -36.95 85.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.236 -1.155 . . . . 0.0 110.446 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 176' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' B' ' 185' ' ' TYR . . . -66.51 -19.87 65.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.277 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 177' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -93.84 -35.27 12.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.969 179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 8.4 p -81.36 -26.71 35.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.046 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 179' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' B' ' 183' ' ' SER . 26.4 m-70 -122.83 12.82 9.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -0.853 . . . . 0.0 110.041 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 180' ' ' GLY . . . . . . . . . . . . . . . -45.09 -36.59 5.3 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 181' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -26.1 65.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -1.144 . . . . 0.0 110.499 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 182' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -122.48 -18.89 6.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.1 -1.0 . . . . 0.0 110.344 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.572 ' OG ' ' CD2' ' B' ' 195' ' ' TYR . 57.8 m -115.83 165.61 12.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 110.432 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 2.5 p -141.46 143.2 33.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.403 -0.811 . . . . 0.0 109.987 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 185' ' ' TYR . . . . . 0.557 ' CD1' ' HB3' ' B' ' 172' ' ' LEU . 78.4 t80 -133.15 94.54 3.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 110.526 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 186' ' ' GLU . . . . . 0.431 ' O ' ' O ' ' B' ' 190' ' ' PHE . 27.4 mt-10 -100.59 102.98 21.09 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.763 179.623 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' B' ' 185' ' ' TYR . 45.4 Cg_endo -71.5 -6.94 20.22 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.955 1.503 . . . . 0.0 110.687 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 188' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.75 -13.99 18.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.313 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 189' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' B' ' 189' ' ' LEU . 2.4 tt -137.03 3.64 2.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 0.0 110.414 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.478 ' HB2' HD23 ' B' ' 189' ' ' LEU . 1.4 t80 -169.73 113.4 0.49 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.211 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 191' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.69 -19.66 27.51 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.923 1.486 . . . . 0.0 110.176 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' B' ' 172' ' ' LEU . . . -99.64 176.6 28.8 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 193' ' ' LEU . . . . . 0.457 ' CB ' HD22 ' B' ' 172' ' ' LEU . 5.7 tt -110.69 132.97 53.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.242 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 194' ' ' ILE . . . . . 0.812 HD12 HD22 ' A' ' 62' ' ' LEU . 6.8 mt -93.69 106.6 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.302 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 195' ' ' TYR . . . . . 0.572 ' CD2' ' OG ' ' B' ' 183' ' ' SER . 3.9 t80 -101.33 107.48 18.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.318 -0.864 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 196' ' ' ARG . . . . . 0.51 ' CG ' HG22 ' B' ' 203' ' ' VAL . 1.0 OUTLIER -92.12 99.72 12.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.164 -0.96 . . . . 0.0 110.103 -179.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 197' ' ' MET . . . . . 0.542 ' HE1' ' HB3' ' B' ' 229' ' ' ALA . 41.5 ttm -70.31 145.05 51.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.878 . . . . 0.0 110.266 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 198' ' ' VAL . . . . . . . . . . . . . 93.7 t -80.66 -39.14 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.313 -0.867 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 199' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' B' ' 200' ' ' PRO . 1.0 OUTLIER -139.7 114.72 8.0 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.91 179.976 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 200' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 199' ' ' LYS . 48.4 Cg_endo -72.2 167.32 77.39 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.946 -2.106 . . . . 0.0 110.639 0.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -76.27 93.58 3.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.371 -0.831 . . . . 0.0 110.016 179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 202' ' ' ILE . . . . . 0.833 HD11 ' CB ' ' B' ' 217' ' ' ALA . 4.5 mt -146.21 165.91 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.914 . . . . 0.0 110.342 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.51 HG22 ' CG ' ' B' ' 196' ' ' ARG . 26.0 t -111.09 119.32 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.43 -0.793 . . . . 0.0 109.661 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . 0.573 HD21 ' HB1' ' B' ' 226' ' ' ALA . 5.0 mp -106.37 117.95 35.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.375 -0.828 . . . . 0.0 110.269 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.662 HD12 ' HB ' ' B' ' 213' ' ' VAL . 3.4 mt -97.18 119.9 36.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 206' ' ' ILE . . . . . 0.597 HG23 HD21 ' B' ' 234' ' ' LEU . 17.9 mm -98.5 141.22 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 110.381 -179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -120.43 144.98 47.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.228 -0.92 . . . . 0.0 110.035 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.579 HG23 ' CD1' ' B' ' 172' ' ' LEU . 75.5 t -51.66 -24.72 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.961 . . . . 0.0 110.291 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.9 t -78.16 -19.37 54.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.096 -179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.578 ' O ' HG22 ' B' ' 166' ' ' VAL . . . 108.68 5.82 31.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . 0.788 ' O ' HD13 ' B' ' 212' ' ' ILE . 0.5 OUTLIER -73.24 137.71 45.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.291 -1.123 . . . . 0.0 109.951 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 212' ' ' ILE . . . . . 0.788 HD13 ' O ' ' B' ' 211' ' ' LYS . 17.2 mm -125.37 131.55 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 110.557 -179.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.662 ' HB ' HD12 ' B' ' 205' ' ' LEU . 21.8 t -114.3 150.28 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 0.0 109.821 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.523 HD12 ' N ' ' B' ' 214' ' ' LEU . 4.2 mp -141.81 111.69 6.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 110.381 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 215' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' B' ' 160' ' ' ILE . 15.2 t -134.12 151.61 51.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.125 -0.984 . . . . 0.0 110.155 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 216' ' ' GLY . . . . . . . . . . . . . . . 103.54 -5.4 48.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 217' ' ' ALA . . . . . 0.833 ' CB ' HD11 ' B' ' 202' ' ' ILE . . . -64.71 172.94 2.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -1.143 . . . . 0.0 110.326 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -116.57 -16.44 10.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.381 -0.824 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -167.42 163.14 14.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 0.0 109.991 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -51.85 -21.9 3.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.303 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -68.75 -35.93 77.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.387 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -72.54 -53.63 11.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 110.322 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.416 HG22 ' CG ' ' B' ' 65' ' ' PRO . 32.8 mm -50.53 -44.11 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 224' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -62.63 -34.71 77.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.18 -0.95 . . . . 0.0 110.161 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -36.31 59.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.889 . . . . 0.0 110.299 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 226' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' B' ' 204' ' ' LEU . . . -57.88 -35.7 71.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.298 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 227' ' ' PHE . . . . . 0.643 ' HA ' HG22 ' B' ' 230' ' ' ILE . 20.7 t80 -80.85 -46.3 15.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 110.326 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 228' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -58.71 -27.61 65.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 110.095 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' B' ' 197' ' ' MET . . . -83.05 -36.78 24.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.278 -0.889 . . . . 0.0 110.172 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.643 HG22 ' HA ' ' B' ' 227' ' ' PHE . 0.8 OUTLIER -89.65 -11.94 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 0.0 109.916 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 231' ' ' TYR . . . . . 0.566 ' N ' ' HD2' ' B' ' 232' ' ' PRO . 0.1 OUTLIER -43.14 -50.53 14.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.421 -0.799 . . . . 0.0 110.783 179.854 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 232' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' B' ' 231' ' ' TYR . 44.8 Cg_endo -73.27 -44.35 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.599 1.316 . . . . 0.0 110.624 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . . . . . . . . . 39.2 t -54.65 -30.62 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 109.986 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 234' ' ' LEU . . . . . 0.597 HD21 HG23 ' B' ' 206' ' ' ILE . 9.8 mt -77.09 -47.67 19.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.187 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 235' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.07 -21.15 63.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 109.895 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 236' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 232' ' ' PRO . 0.2 OUTLIER -70.61 -54.3 12.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.371 -0.83 . . . . 0.0 110.011 179.838 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 237' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -96.99 34.42 1.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.639 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' B' ' 170' ' ' ILE . 0.0 OUTLIER -64.43 -178.23 0.36 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.516 -0.74 . . . . 0.0 110.571 -179.978 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . 0.464 ' CB ' ' HB2' ' B' ' 169' ' ' PRO . 1.2 tttp -114.92 -33.74 5.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.38 -0.825 . . . . 0.0 110.139 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 240' ' ' MET . . . . . . . . . . . . . 15.7 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.262 -179.834 . . . . . . . . 0 0 . 1 stop_ save_